PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Royal, CD; Novembre, J; Fullerton, SM; Goldstein, DB; Long, JC; Bamshad, MJ; Clark, AG				Royal, Charmaine D.; Novembre, John; Fullerton, Stephanie M.; Goldstein, David B.; Long, Jeffrey C.; Bamshad, Michael J.; Clark, Andrew G.			Inferring Genetic Ancestry: Opportunities, Challenges, and Implications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFRICAN-AMERICANS; Y-CHROMOSOME; BIOGEOGRAPHICAL ANCESTRY; EUROPEAN POPULATIONS; BIOMEDICAL-RESEARCH; NATURAL-SELECTION; FORENSIC-SCIENCE; RISK LOCUS; RACE; ADMIXTURE	Increasing public interest in direct-to-consumer (DTC) genetic ancestry testing has been accompanied by growing concern about issues ranging from the personal and societal implications of the testing to the scientific validity of ancestry inference. The very concept of "ancestry" is subject to misunderstanding in both the general and scientific communities. What do we mean by ancestry? How exactly is ancestry measured? How far back can such ancestry be defined and by which genetic tools? How do we validate inferences about ancestry in genetic research? What are the data that demonstrate our ability to do this correctly? What can we say and what can we not say from our research findings and the test results that we generate? This white paper from the American Society of Human Genetics (ASHG) Ancestry and Ancestry Testing Task Force builds upon the 2008 ASHG Ancestry Testing Summary Statement in providing a more in-depth analysis of key scientific and non-scientific aspects of genetic ancestry inference in academia and industry. It culminates with recommendations for advancing the current debate and facilitating the development of scientifically based, ethically sound, and socially attentive guidelines concerning the use of these continually evolving technologies.	[Royal, Charmaine D.; Goldstein, David B.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Novembre, John] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Fullerton, Stephanie M.] Univ Washington, Sch Med, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Long, Jeffrey C.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Duke University; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; University of New Mexico; University of Washington; University of Washington Seattle; Cornell University	Royal, CD (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	charmaine.royal@duke.edu	Fullerton, Stephanie Malia/H-8696-2019; Goldstein, David/AAY-8125-2020; Novembre, John/G-1339-2011	Fullerton, Stephanie Malia/0000-0002-0938-6048; Clark, Andrew/0000-0001-7159-8511	NHGRI NIH HHS [R01 HG003229-05, R01 HG003229] Funding Source: Medline; NHLBI NIH HHS [R01 HL072810-02, R01 HL072810-08, R01 HL072810-01, R01 HL072810-09, R01 HL072904-08, R01 HL072810-07, R01 HL072810-03, R01 HL072810-05A1, R01 HL072810-06, R01 HL072904, R01 HL072810-04, R01 HL072810] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072904, R01HL072810] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Azoulay Katya Gibel, 2003, Dev World Bioeth, V3, P119, DOI 10.1046/j.1471-8731.2003.00067.x; Bamshad M, 2005, JAMA-J AM MED ASSOC, V294, P937, DOI 10.1001/jama.294.8.937; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Barnholtz-Sloan JS, 2008, CANCER EPIDEM BIOMAR, V17, P471, DOI 10.1158/1055-9965.EPI-07-0491; Basu A, 2009, OBESITY, V17, P1226, DOI 10.1038/oby.2009.24; Bathe OF, 2009, GENET MED, V11, P712, DOI 10.1097/GIM.0b013e3181b2e168; Baylis Francoise, 2003, Dev World Bioeth, V3, P142, DOI 10.1046/j.1471-8731.2003.00070.x; Bolnick DA, 2007, SCIENCE, V318, P399, DOI 10.1126/science.1150098; Braun L, 2006, INT J HEALTH SERV, V36, P557, DOI 10.2190/8JAF-D8ED-8WPD-J9WH; Brodwin P, 2002, ANTHROPOL QUART, V75, P323, DOI 10.1353/anq.2002.0027; Cann HM, 2002, SCIENCE, V296, P261; Caspari R, 2009, AM J PHYS ANTHROPOL, V139, P5, DOI 10.1002/ajpa.20975; Caulfield T, 2009, GENOME MED, V1, DOI 10.1186/gm8; Cavalli-Sforza LL, 2007, ANNU REV GENOM HUM G, V8, P1, DOI 10.1146/annurev.genom.8.080706.092403; Chakravarti A, 2009, NATURE, V457, P380, DOI 10.1038/457380a; Cho MK, 2004, NAT GENET, V36, pS8, DOI 10.1038/ng1594; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cooper RS, 1998, HYPERTENSION, V32, P813, DOI 10.1161/01.HYP.32.5.813; CUSTRED G, 2000, ACAD QUESTIONS, V13, P12; Dalton R, 2004, NATURE, V430, P500, DOI 10.1038/430500a; Duster T, 2009, GENEWATCH, V22, P16; Duster T, 2006, PATTERNS PREJUDICE, V40, P427, DOI 10.1080/00313220601020148; Elliott C, 2002, BRIT MED J, V325, P1469, DOI 10.1136/bmj.325.7378.1469; Ely B, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-34; Enoch Mary-Anne, 2006, J Psychopharmacol, V20, P19, DOI 10.1177/1359786806066041; Evans JP, 2009, GENET MED, V11, P568, DOI 10.1097/GIM.0b013e3181afbaed; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Fullwiley D, 2008, GENEWATCH, V21, P12; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gravlee CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006821; Gravlee CC, 2009, AM J PHYS ANTHROPOL, V139, P47, DOI 10.1002/ajpa.20983; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Harmon A., 2006, NY TIMES        0412; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Holloway KFC, 2007, LIT MED, V26, P269, DOI 10.1353/lm.2008.0004; Hudson K, 2007, OBSTET GYNECOL, V110, P1392, DOI 10.1097/01.AOG.0000292086.98514.8b; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; KAPLAN E, 2003, LA WEEKLY; Keita SOY, 2004, NAT GENET, V36, pS17, DOI 10.1038/ng1455; Koenig Barbara A., 2008, REVISITING RACE GENO, P215; Koerner Brendan, 2005, WIRED MAGAZINE ONLIN; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lee C, 2009, SOC SCI MED, V68, P1183, DOI 10.1016/j.socscimed.2008.12.036; Lee SSJ, 2009, SCIENCE, V325, P38, DOI 10.1126/science.1173038; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lopez IanHaney., 2006, WHITE LAW LEGAL CONS; Malhi RS, 2004, HUM BIOL, V76, P33, DOI 10.1353/hub.2004.0023; Malin B, 2010, J INVEST MED, V58, P11, DOI 10.2310/JIM.0b013e3181c9b2ea; McElreavey K, 2005, ANN HUM BIOL, V32, P154, DOI 10.1080/03014460500076223; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; McGuire AL, 2009, AM J BIOETHICS, V9, P3, DOI 10.1080/15265160902928209; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; MOORE L, 2009, FEDERAL PRIVACY REGU; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nelson A, 2008, SOC STUD SCI, V38, P759, DOI 10.1177/0306312708091929; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Nordgren A, 2009, NEW GENET SOC, V28, P157, DOI 10.1080/14636770902901595; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Palsson Gisli, 2003, Dev World Bioeth, V3, P159, DOI 10.1046/j.1471-8731.2003.00072.x; Palsson Gisli, 2002, Med Anthropol, V21, P337, DOI 10.1080/01459740214078; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Ramos E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-29; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Robbins C, 2007, GENOME RES, V17, P1717, DOI 10.1101/gr.6782707; Rotimi Charles N, 2003, Dev World Bioeth, V3, P151, DOI 10.1046/j.1471-8731.2003.00071.x; Sabatti C, 2008, J AM STAT ASSOC, V103, P89, DOI 10.1198/016214507000000338; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; SARATA AK, 2008, CRS REPORT C GENETIC; Seldin MF, 2007, CURR OPIN GENET DEV, V17, P177, DOI 10.1016/j.gde.2007.03.002; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; SWEET FW, 2005, LEGAL HIST COLOR LIN, P3; TALLBEAR K, 2003, WICAZO SA REV, V18, P88; TALLBEAR K, 2003, WICAZO SA REV, V18, P98; Tallbear K, 2007, J LAW MED ETHICS, V35, P412, DOI 10.1111/j.1748-720X.2007.00164.x; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Travis J, 2009, SCIENCE, V326, P30, DOI 10.1126/science.326_30; Tutton R, 2004, NEW GENET SOC, V23, P105, DOI 10.1080/1463677042000189606; US Department of Health and Human Services, SURG GEN FAM HLTH HI; Via M, 2009, CLIN GENET, V76, P225, DOI 10.1111/j.1399-0004.2009.01263.x; WADE N, 2003, NY TIMES        0603, pA28; Watanabe T., 2009, LOS ANGELES TIMES; Weiss KM, 2009, GENOME RES, V19, P703, DOI 10.1101/gr.076539.108; WINSTON C, 2005, BIOL ANTHR ETHICS; Wolinsky H, 2006, EMBO REP, V7, P1072, DOI 10.1038/sj.embor.7400843; Xu J, 2009, NATL VITAL STAT REP, V58, P1; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zoloth Laurie, 2003, Dev World Bioeth, V3, P128; 2009, NATURE, V461, P697	112	155	162	2	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					661	673		10.1016/j.ajhg.2010.03.011	http://dx.doi.org/10.1016/j.ajhg.2010.03.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20466090	Green Published, Bronze			2022-12-18	WOS:000278045300003
J	van Genderen, MM; Bijveld, MMC; Claassen, YB; Florijn, RJ; Pearring, JN; Meire, FM; McCall, MA; Riemslag, FCC; Gregg, RG; Bergen, AAB; Kamermans, M				van Genderen, Maria M.; Bijveld, Mieke M. C.; Claassen, Yvonne B.; Florijn, Ralph J.; Pearring, Jillian N.; Meire, Francoise M.; McCall, Maureen A.; Riemslag, Frans C. C.; Gregg, Ronald G.; Bergen, Arthur A. B.; Kamermans, Maarten			Mutations in TRPM1 Are a Common Cause of Complete Congenital Stationary Night Blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINAL BIPOLAR CELLS; MOUSE MODEL; G-PROTEIN; GENE; ELECTRORETINOGRAM; RESPONSES; MGLUR6; NYX; TRANSMISSION; EXPRESSION	Congenital stationary night blindness (CSNB) is a clinically and genetically heterogeneous group of retinal disorders characterized by nonprogressive impaired night vision and variable decreased visual acuity. We report here that six out of eight female probands with autosomal-recessive complete CSNB (cCSNB) had mutations in TRPM1, a retinal transient receptor potential (TRP) cation channel gene. These data suggest that TRMP1 mutations are a major cause of autosomal-recessive CSNB in individuals of European ancestry. We localized TRPM I in human retina to the ON bipolar cell dendrites in the outer plexifom layer. Our results suggest that in humans, TRPM1 is the channel gated by the mGluR6 (GRM6) signaling cascade, which results in the light-evoked response of ON bipolar cells. Finally, we showed that detailed electroretinography is an effective way to discriminate among patients with mutations in either TRPM1 or GRM6, another autosomal-recessive cCSNB disease gene. These results add to the growing importance of the diverse group of TRP channels in human disease and also provide new insights into retinal circuitry.	[Claassen, Yvonne B.; Florijn, Ralph J.; Bergen, Arthur A. B.; Kamermans, Maarten] Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [van Genderen, Maria M.; Bijveld, Mieke M. C.; Riemslag, Frans C. C.] Inst Visually Impaired, NL-3702 AD Zeist, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [McCall, Maureen A.; Gregg, Ronald G.] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA; [Pearring, Jillian N.; Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Meire, Francoise M.] Hop Univ Enfants Reine Fabiola, Dept Pediat Ophtalmol, B-1020 Brussels, Belgium; [Meire, Francoise M.] Ghent Univ Hosp, Dept Pediat Ophthalmol, B-9000 Ghent, Belgium	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Louisville; University of Louisville; Ghent University; Ghent University Hospital	Kamermans, M (corresponding author), Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands.	m.kamermans@nin.knaw.nl	Bergen, Arthur/J-3637-2013	Pearring, Jillian/0000-0002-5352-2852; Bergen, Arthur/0000-0002-6333-9576; Gregg, Ronald/0000-0001-5805-224X; McCall, Maureen/0000-0002-9781-315X	Netherlands Organization for Scientific Research; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB); ODAS; U.S. National Institutes of Health (NIH) [R01EY12354, R01EY014701]; NATIONAL EYE INSTITUTE [R01EY014701, R01EY012354] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB); ODAS; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants from the Netherlands Organization for Scientific Research (NWO) (to M.K.), Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB) (to A.B.), ODAS (to M.G., M.B., and F.R.), and the U.S. National Institutes of Health (NIH) (R01EY12354 to R.G.G. and R01EY014701 to M.A.M.). We would like to thank all of the probands and their families for their collaboration in this project.	Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; BOJANG P, 2009, ARVO ABSTR; Dhingra A, 2004, J NEUROSCI, V24, P5684, DOI 10.1523/JNEUROSCI.0492-04.2004; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; Maddox DM, 2008, J PHYSIOL-LONDON, V586, P4409, DOI 10.1113/jphysiol.2008.157289; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; MARMOR MF, 1989, DOC OPHTHALMOL, V73, P299, DOI 10.1007/BF00154485; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; McCall MA, 2008, J PHYSIOL-LONDON, V586, P4385, DOI 10.1113/jphysiol.2008.159327; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Scholl HPN, 2001, INVEST OPHTH VIS SCI, V42, P2728; SHARPE LT, 1989, VISION RES, V29, P1539, DOI 10.1016/0042-6989(89)90137-5; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; STOCKMAN A, 1995, VISUAL NEUROSCI, V12, P951, DOI 10.1017/S0952523800009500; Vardi N, 1997, VISUAL NEUROSCI, V14, P789, DOI 10.1017/S0952523800012736; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2005, MOL VIS, V11, P179	24	155	157	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					730	736		10.1016/j.ajhg.2009.10.012	http://dx.doi.org/10.1016/j.ajhg.2009.10.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19896109	Bronze, Green Published			2022-12-18	WOS:000271916500020
J	Bliek, J; Terhal, P; van den Bogaard, MJ; Maas, S; Hamel, B; Salieb-Beugelaar, G; Simon, M; Letteboer, T; van der Smagt, J; Kroes, H; Mannens, M				Bliek, J; Terhal, P; van den Bogaard, MJ; Maas, S; Hamel, B; Salieb-Beugelaar, G; Simon, M; Letteboer, T; van der Smagt, J; Kroes, H; Mannens, M			Hypomethylation of the h19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; MONOZYGOTIC TWINS DISCORDANT; IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; CHROMOSOME 11P15; MULIBREY NANISM; EPIGENETIC ALTERATIONS; DIAGNOSTIC-CRITERIA; IMPRINTING CENTER; REGION	The H19 differentially methylated region ( DMR) controls the allele-specific expression of both the imprinted H19 tumor-suppressor gene and the IGF2 growth factor. Hypermethylation of this DMR - and subsequently of the H19 promoter region - is a major cause of the clinical features of gigantism and/or asymmetry seen in Beckwith-Wiedemann syndrome or in isolated hemihypertrophy. Here, we report a series of patients with hypomethylation of the H19 locus. Their main clinical features of asymmetry and growth retardation are the opposite of those seen in patients with hypermethylation of this region. In addition, we show that complete hypomethylation of the H19 promoter is found in two of three patients with the full clinical spectrum of Silver-Russell syndrome. This syndrome is also characterized by growth retardation and asymmetry, among other clinical features. We conclude that patients with these clinical features should be analyzed for H19 hypomethylation.	Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1100 DE Amsterdam, Netherlands; Univ Utrecht, Dept Med Genet, Med Ctr, Utrecht, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Erasmus Med Ctr, Dept Clin Genet, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Mannens, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, POB 22700, NL-1100 DE Amsterdam, Netherlands.	m.a.mannens@amc.uva.nl		Salieb-Beugelaar, Georgette B./0000-0002-9219-5778; Bliek, Jet/0000-0003-4549-6655				AlFifi S, 1996, AM J MED GENET, V61, P96, DOI 10.1002/ajmg.1320610108; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; BAILEY W, 1995, AM J MED GENET, V58, P101, DOI 10.1002/ajmg.1320580202; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BELVERPRADAS J, 2001, ARCH GYNECOL OBSTET, V265, P155; Bliek J, 2001, HUM MOL GENET, V10, P467, DOI 10.1093/hmg/10.5.467; CHITAYAT D, 1988, AM J MED GENET, V31, P909, DOI 10.1002/ajmg.1320310425; CHRISTENSEN MF, 1978, ACTA PAEDIATR SCAND, V67, P101, DOI 10.1111/j.1651-2227.1978.tb16284.x; CURI JFJ, 1967, AM J DIS CHILD, V114, P658, DOI 10.1001/archpedi.1967.02090270114015; Dang YNT, 2004, J AAPOS, V8, P588, DOI 10.1016/j.jaapos.2004.09.005; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; Dorr S, 2001, GENOMICS, V71, P174, DOI 10.1006/geno.2000.6413; DUNCAN PA, 1990, AM J MED GENET, V35, P245, DOI 10.1002/ajmg.1320350220; Eggermann T, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028936; Eggermann T, 1998, J MED GENET, V35, P784, DOI 10.1136/jmg.35.9.784; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Fisher AM, 2002, HUM GENET, V111, P290, DOI 10.1007/s00439-002-0787-2; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Hannula K, 2001, AM J HUM GENET, V68, P247, DOI 10.1086/316937; Kallen B, 2005, BIRTH DEFECTS RES A, V73, P162, DOI 10.1002/bdra.20107; Karlberg N, 2004, J MED GENET, V41, P92, DOI 10.1136/jmg.2003.014118; Karlberg S, 2004, NEW ENGL J MED, V351, P2559, DOI 10.1056/NEJM200412093512423; Maher ER, 2005, HUM MOL GENET, V14, pR133, DOI 10.1093/hmg/ddi107; MCMINN J, 2005, PLACENTA; Monk D, 2002, HUM GENET, V111, P376, DOI 10.1007/s00439-002-0777-4; Ounap K, 2004, AM J MED GENET A, V131A, P301, DOI 10.1002/ajmg.a.30379; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Price SM, 1999, J MED GENET, V36, P837; RAMIREZDUENAS ML, 1992, CLIN GENET, V41, P51; Rogan PK, 1996, AM J MED GENET, V62, P10, DOI 10.1002/(SICI)1096-8628(19960301)62:1<10::AID-AJMG3>3.3.CO;2-5; RUSSELL A, 1954, P ROY SOC MED, V47, P1040; SAMN M, 1990, AM J MED GENET, V37, P543, DOI 10.1002/ajmg.1320370424; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; SILVER HK, 1953, PEDIATRICS, V12, P368; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Svensson J, 2005, ACTA PAEDIATR, V94, P1163, DOI 10.1080/08035250510030125; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Teebi A S, 1992, Clin Dysmorphol, V1, P151; van Haelst MM, 2002, J MED GENET, V39, P582, DOI 10.1136/jmg.39.8.582; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317	41	155	164	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					604	614		10.1086/502981	http://dx.doi.org/10.1086/502981			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532391	Green Published, Bronze			2022-12-18	WOS:000236755900007
J	Sriram, G; Martinez, JA; McCabe, ERB; Liao, JC; Dipple, KM				Sriram, G; Martinez, JA; McCabe, ERB; Liao, JC; Dipple, KM			Single-gene disorders: What role could moonlighting enzymes play?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GLYCEROL KINASE-DEFICIENCY; ELEMENT-BINDING-PROTEIN; RAT-LIVER MITOCHONDRIA; POTENTIAL ANTIDEMENTIA DRUG; NETWORK COMPONENT ANALYSIS; SIMPLE MENDELIAN DISORDERS; IRON REGULATORY PROTEIN-1; LACTATING MAMMARY-GLAND; URACIL DNA-GLYCOSYLASE; VACUOLAR H+-ATPASE	Single-gene disorders with "simple" Mendelian inheritance do not always imply that there will be an easy prediction of the phenotype from the genotype, which has been shown for a number of metabolic disorders. We propose that moonlighting enzymes (i.e., metabolic enzymes with additional functional activities) could contribute to the complexity of such disorders. The lack of knowledge about the additional functional activities of proteins could result in a lack of correlation between genotype and phenotype. In this review, we highlight some notable and recent examples of moonlighting enzymes and their possible contributions to human disease. Because knowledge and cataloging of the moonlighting activities of proteins are essential for the study of cellular function and human physiology, we also review recently reported and recommended methods for the discovery of moonlighting activities.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Div Med Genet, Dept Pediat, David Geffen Sch Med, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Chem Engn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA USA; Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Dipple, KM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda 5335B,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	kdipple@mednet.ucla.edu	Sriram, Ganesh/A-5154-2010	Liao, James/0000-0002-4580-7276; Sriram, Ganesh/0000-0002-6303-1328	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK060055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067929] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD022563, R01 HD22563] Funding Source: Medline; NIDDK NIH HHS [K08 DK060055, K08 DK60055] Funding Source: Medline; NIGMS NIH HHS [R01 GM067929] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amraei M, 2002, FEBS LETT, V525, P151, DOI 10.1016/S0014-5793(02)03072-7; Arai K, 2002, J BIOCHEM, V132, P529, DOI 10.1093/oxfordjournals.jbchem.a003253; ARNOLD H, 1970, EUR J BIOCHEM, V15, P360, DOI 10.1111/j.1432-1033.1970.tb01016.x; ASHIZAWA K, 1992, BIOCHEMISTRY-US, V31, P2774, DOI 10.1021/bi00125a018; ASHIZAWA K, 1991, BIOCHEMISTRY-US, V30, P7105, DOI 10.1021/bi00243a010; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; Bateman OA, 2003, BIOCHEMISTRY-US, V42, P4349, DOI 10.1021/bi027367w; BAXI MD, 1995, BIOCHEMISTRY-US, V34, P9700, DOI 10.1021/bi00030a007; Berry MD, 2000, J NEUROSCI RES, V60, P150, DOI 10.1002/(SICI)1097-4547(20000415)60:2<150::AID-JNR3>3.0.CO;2-4; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bielli P, 2002, CELL MOL LIFE SCI, V59, P1413, DOI 10.1007/s00018-002-8519-2; Blomquist HK, 1996, CLIN GENET, V50, P375; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Clipsham R, 2002, MOL GENET METAB, V77, P159, DOI 10.1016/S1096-7192(02)00119-1; Clipsham R, 2003, MOL GENET METAB, V80, P81, DOI 10.1016/j.ymgme.2003.08.023; Dipple KM, 2001, MOL GENET METAB, V74, P45, DOI 10.1006/mgme.2001.3227; Dipple KM, 2001, HUM GENET, V109, P55, DOI 10.1007/s004390100545; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Duclos-Vallee JC, 1998, J GEN VIROL, V79, P1665, DOI 10.1099/0022-1317-79-7-1665; DUDANI AK, 1993, THROMB RES, V69, P185, DOI 10.1016/0049-3848(93)90044-O; ELZINGA SDJ, 1993, NUCLEIC ACIDS RES, V21, P5328, DOI 10.1093/nar/21.23.5328; Engel M, 1998, J BIOL CHEM, V273, P20058, DOI 10.1074/jbc.273.32.20058; FAIK P, 1988, NATURE, V332, P455, DOI 10.1038/332455a0; FIEK C, 1982, BIOCHIM BIOPHYS ACTA, V688, P429, DOI 10.1016/0005-2736(82)90354-6; FILLEBEEN C, IN PRESS BIOCH J; Gomez A, 2003, BIOINFORMATICS, V19, P895, DOI 10.1093/bioinformatics/btg111; GURNEY ME, 1986, SCIENCE, V234, P566, DOI 10.1126/science.3764429; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Harrison R, 2004, DRUG METAB REV, V36, P363, DOI 10.1081/DMR-120037569; Huq AHMM, 1996, GENOMICS, V36, P530, DOI 10.1006/geno.1996.0500; Ishitani R, 1997, MOL PHARMACOL, V51, P542, DOI 10.1124/mol.51.4.542; Jeffery C.J., 2004, DRUG DISCOV, V3, P71, DOI [10.1016/S1741-8372(04)02405-3, DOI 10.1016/S1741-8372(04)02405-3]; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jeffery CJ, 2003, ANN MED, V35, P28, DOI 10.1080/07853890310004101; JEFFERY CJ, IN PRESS MASS SPECTR; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kao KC, 2004, P NATL ACAD SCI USA, V101, P641, DOI 10.1073/pnas.0305287101; Katsube N, 1999, J PHARMACOL EXP THER, V288, P6; Katsube N, 1996, NEUROSCI LETT, V214, P151, DOI 10.1016/0304-3940(96)12912-8; KAWAMOTO RM, 1986, BIOCHEMISTRY-US, V25, P656, DOI 10.1021/bi00351a022; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; Kugler W, 1998, HUM GENET, V103, P450, DOI 10.1007/s004390050849; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Lay AJ, 2002, J BIOL CHEM, V277, P9062, DOI 10.1074/jbc.M111531200; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; LINDEN M, 1982, FEBS LETT, V141, P189, DOI 10.1016/0014-5793(82)80044-6; Lipinski P, 2005, BIOCHEM BIOPH RES CO, V327, P349, DOI 10.1016/j.bbrc.2004.12.012; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; MARTINEZ JA, 2004, AM SOC HUM GEN ANN M; MCCABE ERB, 1983, BIOCHEM MED METAB B, V30, P215, DOI 10.1016/0006-2944(83)90088-1; McManaman JL, 2002, J PHYSIOL-LONDON, V545, P567, DOI 10.1113/jphysiol.2002.027185; McManaman JL, 2004, ADV EXP MED BIOL, V554, P263; McManaman JL, 1999, ARCH BIOCHEM BIOPHYS, V371, P308, DOI 10.1006/abbi.1999.1432; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Mitsuzawa H, 2005, FEBS LETT, V579, P48, DOI 10.1016/j.febslet.2004.11.045; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; NAKAJIMA K, 1994, J NEUROCHEM, V63, P2048; NUMATA O, 1991, BIOCHEM BIOPH RES CO, V174, P1028, DOI 10.1016/0006-291X(91)91522-E; Numata O, 1996, Int Rev Cytol, V164, P1; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; OKAMOTO K, 1984, BIOCHEM BIOPH RES CO, V121, P940, DOI 10.1016/0006-291X(84)90767-8; OKAMOTO K, 1989, ENDOCRINOLOGY, V124, P675, DOI 10.1210/endo-124-2-675; OKAMOTO K, 1993, BIOCHEM BIOPH RES CO, V193, P848, DOI 10.1006/bbrc.1993.1703; OSTLUND AK, 1983, BIOCHEM MED METAB B, V30, P231, DOI 10.1016/0006-2944(83)90089-3; Page S, 1998, BBA-GEN SUBJECTS, V1381, P191, DOI 10.1016/S0304-4165(98)00028-2; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Petrini JHJ, 2000, NAT GENET, V26, P257, DOI 10.1038/81529; Piatigorsky J, 1998, PROG RETIN EYE RES, V17, P145, DOI 10.1016/S1350-9462(97)00004-9; Piatigorsky J, 1998, ANN NY ACAD SCI, V842, P7, DOI 10.1111/j.1749-6632.1998.tb09626.x; Piatigorsky Joram, 2003, Journal of Structural and Functional Genomics, V3, P131; RAMASARMA T, 1994, CURR SCI INDIA, V67, P24; ROBBINS AR, 1995, J CELL BIOL, V130, P1093, DOI 10.1083/jcb.130.5.1093; ROUAULT TA, 1992, BIOMETALS, V5, P131, DOI 10.1007/BF01061319; Rusing D, 2004, CELL BIOCHEM FUNCT, V22, P333, DOI 10.1002/cbf.1111; RYAZANOV AG, 1985, FEBS LETT, V192, P131, DOI 10.1016/0014-5793(85)80058-2; SAEKI T, 1974, J BIOCHEM-TOKYO, V76, P631, DOI 10.1093/oxfordjournals.jbchem.a130607; Sargent CA, 2000, J MED GENET, V37, P434, DOI 10.1136/jmg.37.6.434; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shashidharan P, 1999, NEUROREPORT, V10, P1149, DOI 10.1097/00001756-199904060-00045; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sjarif DR, 2000, J INHERIT METAB DIS, V23, P529, DOI 10.1023/A:1005660826652; Starzynski RR, 2004, CELL MOL BIOL LETT, V9, P651; SUNAGA K, 1995, NEUROSCI LETT, V200, P133, DOI 10.1016/0304-3940(95)12098-O; Sundin GW, 1996, MOL MICROBIOL, V20, P965, DOI 10.1111/j.1365-2958.1996.tb02538.x; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Tsuchiya K, 2004, LIFE SCI, V74, P3245, DOI 10.1016/j.lfs.2003.11.029; Vartanian Amalia A, 2003, Ital J Biochem, V52, P9; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; WANG Q, IN PRESS FASEB J; Wang WY, 2005, J ENDOCRINOL, V184, P85, DOI 10.1677/joe.1.05909; Wang Y, 2003, J NEUROSCI, V23, P7958; Wang-Su ST, 2003, INVEST OPHTH VIS SCI, V44, P4829, DOI 10.1167/iovs.03-0556; Watanabe H, 1996, CANCER RES, V56, P2960; WISTOW GJ, 1988, J CELL BIOL, V107, P2729, DOI 10.1083/jcb.107.6.2729; Xu W, 1996, BLOOD, V87, P4502, DOI 10.1182/blood.V87.11.4502.bloodjournal87114502; Yanagawa T, 2005, J BIOL CHEM, V280, P10419, DOI 10.1074/jbc.M409457200; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	124	155	157	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					911	924		10.1086/430799	http://dx.doi.org/10.1086/430799			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15877277	Bronze, Green Published			2022-12-18	WOS:000229047900001
J	Marazita, ML; Murray, JC; Lidral, AC; Arcos-Burgos, M; Cooper, ME; Goldstein, T; Maher, BS; Daack-Hirsch, S; Schultz, R; Mansilla, MA; Field, LL; Liu, Y; Prescott, N; Malcolm, S; Winter, R; Ray, A; Moreno, L; Valencia, C; Neiswanger, K; Wyszynski, DF; Bailey-Wilson, JE; Albacha-Hejazi, H; Beaty, TH; McIntosh, I; Hetmanski, JB; Tuncbilek, G; Edwards, M; Harkin, L; Scott, R; Roddick, LG				Marazita, ML; Murray, JC; Lidral, AC; Arcos-Burgos, M; Cooper, ME; Goldstein, T; Maher, BS; Daack-Hirsch, S; Schultz, R; Mansilla, MA; Field, LL; Liu, Y; Prescott, N; Malcolm, S; Winter, R; Ray, A; Moreno, L; Valencia, C; Neiswanger, K; Wyszynski, DF; Bailey-Wilson, JE; Albacha-Hejazi, H; Beaty, TH; McIntosh, I; Hetmanski, JB; Tuncbilek, G; Edwards, M; Harkin, L; Scott, R; Roddick, LG			Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32-35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PALATE CL/P; PART I; LIP; LINKAGE; IDENTIFICATION; ASSOCIATION; PHENOTYPE; FAMILIES; POWER; HETEROGENEITY	Isolated or nonsyndromic cleft lip with or without cleft palate (CL/P) is a common birth defect with a complex etiology. A 10-cM genome scan of 388 extended multiplex families with CL/P from seven diverse populations (2,551 genotyped individuals) revealed CL/P genes in six chromosomal regions, including a novel region at 9q21 (heterogeneity LOD score [HLOD] = 6.6). In addition, meta-analyses with the addition of results from 186 more families ( six populations; 1,033 genotyped individuals) showed genomewide significance for 10 more regions, including another novel region at 2q32-35 (P = .0004). These are the first genomewide significant linkage results ever reported for CL/P, and they represent an unprecedented demonstration of the power of linkage analysis to detect multiple genes simultaneously for a complex disorder.	Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Div Oral Biol, Sch Dent Med, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15219 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Orthodont, Iowa City, IA USA; Univ Iowa, Dow Inst Dent Res, Iowa City, IA USA; Univ Antioquia, Medellin, Colombia; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; British Columbia Res Inst Childrens & Womens Hlth, Vancouver, BC, Canada; Zhabei Genet Inst, Shanghai, Peoples R China; Inst Child Hlth, Mol Genet Unit, London, England; Univ Toronto, Dept Anthropol Emeritus, Toronto, ON, Canada; Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; Boston Univ, Dept Med, Genet Program, Boston, MA 02215 USA; NHGRI, Stat Genet Sect, NIH, Baltimore, MD USA; Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Sch Med, Inst Med Genet, Baltimore, MD USA; Ibn Al Nafees Hosp, Damascus, Syria; Hacettepe Univ, Dept Plast Surg, Ankara, Turkey; Hunter Area Hlth Serv, Newcastle, NSW, Australia; Univ Newcastle, Sch Biomed Sci, Discipline Med Genet, Newcastle, NSW 2308, Australia; John Hunter Childrens Hosp, Hunter Med Res Inst, Newcastle, NSW, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; University of Iowa; Universidad de Antioquia; University of British Columbia; University of London; University College London; University of Toronto; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Medicine; Hacettepe University; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Adelaide; University of Adelaide; Womens & Childrens Hospital Australia	Marazita, ML (corresponding author), Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Div Oral Biol, Sch Dent Med, 100 Technol Dr,Suite 500 Cellom Bldg, Pittsburgh, PA 15219 USA.	marazita@sdmgenetics.pitt.edu	Edwards, Matthew/A-7560-2011; Edwards, Matthew/L-8698-2019; Prescott, Natalie J/F-6490-2011; Maher, Brion S/F-9185-2010; Arcos-Burgos, Mauricio/H-1326-2017; Scott, Rodney/B-2827-2013	Edwards, Matthew/0000-0001-8437-8120; Edwards, Matthew/0000-0001-8437-8120; Prescott, Natalie J/0000-0002-5901-7371; Daack-Hirsch, Sandra/0000-0003-1192-7154; Bailey-Wilson, Joan/0000-0002-9153-2920; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Scott, Rodney/0000-0001-7724-3404	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000084] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013078, R01DE008559, R01DE009886, P60DE013076, R01DE012472, K02DE015291, R01DE014667] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00084, M01 RR000084] Funding Source: Medline; NIDCR NIH HHS [P60 DE013076-010005, K02 DE015291-01, P60 DE013078, R01 DE014667-07, K02 DE015291-03, R01 DE014667-04, R01 DE008559, R01 DE009886, R01 DE014667-05, R01-DE-12472, P60 DE013076-01S10005, R01 DE014667, R01-DE-08559, R01-DE-14667, R01 DE014667-08, P60-DE-13076, P60 DE013076, R01-DE-09886, K02 DE015291-05, R01 DE014667-06, P60 DE013076-040005, R01 DE014667-02, P60-DE13076, P60 DE013076-050005, K02 DE015291, K02 DE015291-04, P60 DE013076-030005, R01 DE014667-03, K02 DE015291-02, P60 DE013076-03S10005, R01 DE014667-01, P60 DE013076-020005, R01 DE016148, P60-DE-13078] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ARDINGER HH, 1989, AM J HUM GENET, V45, P348; Berk N.W., 2002, CLEFT LIP PALATE ORI, P458; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Castanet M, 2002, HUM MOL GENET, V11, P2051, DOI 10.1093/hmg/11.17.2051; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dathan N, 2002, DEV DYNAM, V224, P450, DOI 10.1002/dvdy.10118; Edwards M, 2003, AM J HUM GENET, V73, P284; EIBERG H, 1987, CLIN GENET, V32, P129; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FARRALL M, 1992, AM J HUM GENET, V50, P270; FIELD LL, IN PRESS AM J MED GE; Fisher RA, 1925, STAT METHODS RES WOR, P99; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 2002, AM J HUM GENET, V70, P556, DOI 10.1086/338923; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; JURILOFF DM, 2002, CLEFT LIP PALATE ORI, P265; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 2002, MATH STAT METHODS GE, P167; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Marazita M., 2002, CLEFT LIP PALATE ORI, P222; Marazita ML, 2004, AM J MED GENET A, V126A, P111, DOI 10.1002/ajmg.a.20564; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; MARAZITA ML, 2002, UNDERSTANDING CRANIO, P147; Mitchell LE, 1997, GENET EPIDEMIOL, V14, P231; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; Moreno L, 2003, AM J HUM GENET, V73, P478; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Neiswanger K, 2003, AM J HUM GENET, V73, P493; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Province MA, 2001, AM J HUM GENET, V69, P660, DOI 10.1086/323316; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; RAY AK, IN PRESS CLIN GENET; Schliekelman P, 2002, AM J HUM GENET, V71, P1369, DOI 10.1086/344779; Schultz R, 2003, AM J HUM GENET, V73, P536; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Sobel E, 1996, AM J HUM GENET, V58, P1323; SOBEL E, 1996, GENETIC MAPPING DNA, P89; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TREW CJ, 1757, NOVA ACTA PHYS MED A, V1, P445; Vieland VJ, 2001, HUM HERED, V51, P199, DOI 10.1159/000053343; Weinberg SM, 2003, AM J HUM GENET, V73, P291; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x; Wyszynski DF, 2003, AM J MED GENET A, V123A, P140, DOI 10.1002/ajmg.a.20283; Yoshiura K, 1998, GENOMICS, V54, P231, DOI 10.1006/geno.1998.5577; Yuan B, 1997, AM J HUM GENET, V60, P459; Zeiger JS, 2003, EUR J HUM GENET, V11, P835, DOI 10.1038/sj.ejhg.5201052; ZUCCHERO TM, IN PRESS NEW ENGL J	57	155	166	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					161	173		10.1086/422475	http://dx.doi.org/10.1086/422475			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15185170	Green Published, Bronze			2022-12-18	WOS:000222702000002
J	Buratti, E; Brindisi, A; Pagani, F; Baralle, FE				Buratti, E; Brindisi, A; Pagani, F; Baralle, FE			Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of Exon 9: A functional link with disease penetrance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							REGULATOR; CONDUCTANCE; GENE		Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Baralle, FE (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	baralle@icgeb.org	Buratti, Emanuele/K-4691-2016	Buratti, Emanuele/0000-0002-1356-9074; Pagani, Franco/0000-0002-2678-3459	Telethon [GGP02453] Funding Source: Medline	Telethon(Fondazione Telethon)		Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; DELANEY SJ, 1993, NAT GENET, V4, P426, DOI 10.1038/ng0893-426; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Groman JD, 2004, AM J HUM GENET, V74, P176, DOI 10.1086/381001; STRONG TV, 1993, HUM MOL GENET, V2, P225, DOI 10.1093/hmg/2.3.225; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3	8	155	157	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1322	1325		10.1086/420978	http://dx.doi.org/10.1086/420978			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15195661	Green Published, Bronze			2022-12-18	WOS:000221651900029
J	Geller, F; Reichwald, K; Dempfle, A; Illig, T; Vollmert, C; Herpertz, S; Siffert, W; Platzer, M; Hess, C; Gudermann, T; Biebermann, H; Wichmann, HE; Schafer, H; Hinney, A; Hebebrand, J				Geller, F; Reichwald, K; Dempfle, A; Illig, T; Vollmert, C; Herpertz, S; Siffert, W; Platzer, M; Hess, C; Gudermann, T; Biebermann, H; Wichmann, HE; Schafer, H; Hinney, A; Hebebrand, J			Melanocortin-4 receptor gene variant I103 is negatively associated with obesity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; COMPLEX DISEASES; MISSENSE VARIANT; MORBID-OBESITY; MUTATIONS; IDENTIFICATION; SUSCEPTIBILITY; POLYMORPHISMS; METAANALYSIS; SEQUENCE	Several rare mutations in the melanocortin-4 receptor gene ( MC4R) predispose to obesity. For the most common missense variant V103I (rs2229616), however, the previously reported similar carrier frequencies in obese and nonobese individuals are in line with in vitro studies, which have not shown a functional implication of this variant. In the present study, we initially performed a transmission/disequilibrium test on 520 trios with obesity, and we observed a lower transmission rate of the I103 allele (P = .017), which was an unexpected finding. Therefore, we initiated two large case-control studies (N = 2,334 and N = 661) and combined the data with those from 12 published studies, for a total of 7,713 individuals. The resulting meta-analysis provides evidence for a negative association of the I103 allele with obesity ( odds ratio 0.69; 95% confidence interval 0.50 - 0.96; P = .03), mainly comprising samples of European origin. Additional screening of four other ethnic groups showed comparable I103 carrier frequencies well below 10%. Genomic sequencing of the MC4R gene revealed three polymorphisms in the noncoding region that displayed strong linkage disequilibrium with V103I. In our functional in vitro assays, the variant was indistinguishable from the wild-type allele, as was the result in previous studies. This report on an SNP/haplotype that is negatively associated with obesity expands the successful application of meta-analysis of modest effects in common diseases to a variant with a carrier frequency well below 10%. The respective protective effect against obesity implies that variation in the MC4R gene entails both loss and gain of function.	Univ Marburg, Dept Child & Adolescent Psychiat, Clin Res Grp, D-35039 Marburg, Germany; Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; Univ Marburg, Dept Pharmacol & Toxicol, Marburg, Germany; Inst Mol Biotechnol, Dept Genome Anal, Jena, Germany; GSF, Natl Res Ctr Environm & Hlth, Genome Anal Ctr, Neuherberg, Germany; Ruhr Univ Bochum, Dept Psychosomat Med & Psychotherapy, D-4630 Bochum, Germany; Univ Essen Gesamthsch, Dept Pharmacol, Essen, Germany; Humboldt Univ, Charite Childrens Hosp, Dept Pediat Endocrinol, Berlin, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruhr University Bochum; University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hebebrand, J (corresponding author), Univ Marburg, Dept Child & Adolescent Psychiat, Clin Res Grp, Schutzenstr 49, D-35039 Marburg, Germany.	Johannes.Hebebrand@med.uni-marburg.de	Dempfle, Astrid/D-1513-2012; Hinney, Anke/D-6953-2011; Wichmann, Heinz Erich/AAA-5695-2022; Dempfle, Astrid/ABB-8889-2020	Dempfle, Astrid/0000-0002-2618-3920; Hinney, Anke/0000-0001-5659-0706; Biebermann, Heike/0000-0002-2024-7778; Geller, Frank/0000-0002-9238-3269				Allison DB, 1998, INT J OBESITY, V22, P559, DOI 10.1038/sj.ijo.0800625; Alvaro JD, 1996, MOL PHARMACOL, V50, P583; Biebermann H, 1997, J CLIN ENDOCR METAB, V82, P3471, DOI 10.1210/jc.82.10.3471; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Branson R, 2003, NEW ENGL J MED, V348, P1096, DOI 10.1056/NEJMoa021971; Breslow NE, 1980, INT AGENCY RES CANC, V1; Dubern B, 2001, J PEDIATR-US, V139, P204, DOI 10.1067/mpd.2001.116284; Dumont LM, 2001, MOL CELL ENDOCRINOL, V184, P173, DOI 10.1016/S0303-7207(01)00558-5; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Filipiak B, 2001, CLIN EXP ALLERGY, V31, P1829, DOI 10.1046/j.1365-2222.2001.01246.x; Fujisawa T, 1998, J CLIN ENDOCR METAB, V83, P2441, DOI 10.1210/jc.83.7.2441; Gotoda T, 1997, DIABETOLOGIA, V40, P976, DOI 10.1007/s001250050777; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; Haegeman A, 2001, ANIM GENET, V32, P189, DOI 10.1046/j.1365-2052.2001.00750.x; Heo M, 2002, INT J OBESITY, V26, P640, DOI 10.1038/sj.ijo.0801990; Herpertz S, 2003, NEW ENGL J MED, V349, P606; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Jacobson P, 2002, J CLIN ENDOCR METAB, V87, P4442, DOI 10.1210/jc.2002-020568; Kim KS, 2000, MAMM GENOME, V11, P131, DOI 10.1007/s003350010025; LAMAR CR, 2002, 5 INT MEL M SUNR OR; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Marti A, 2003, INT J OBESITY, V27, P385, DOI 10.1038/sj.ijo.0802244; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ohshiro Y, 1999, ANN HUM GENET, V63, P483, DOI 10.1017/S0003480099007782; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Rosmond R, 2001, DIABETOLOGIA, V44, P1335, DOI 10.1007/s001250100649; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Siffert W, 1999, J AM SOC NEPHROL, V10, P1921; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Yang QH, 2003, AM J HUM GENET, V72, P636, DOI 10.1086/367923; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057	36	155	162	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					572	581		10.1086/382490	http://dx.doi.org/10.1086/382490			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14973783	Green Published, Bronze			2022-12-18	WOS:000220118500024
J	Waterham, HR; Koster, J; Mooyer, P; van Noort, G; Kelley, RI; Wilcox, WR; Wanders, RJA; Hennekam, RCM; Oosterwijk, JC				Waterham, HR; Koster, J; Mooyer, P; van Noort, G; Kelley, RI; Wilcox, WR; Wanders, RJA; Hennekam, RCM; Oosterwijk, JC			Autosomal recessive HEM/greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol Delta(14)-reductase deficiency due to mutations in the lamin B receptor gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEMLI-OPITZ-SYNDROME; SACCHAROMYCES-CEREVISIAE; CHOLESTEROL-BIOSYNTHESIS; GREENBERG DYSPLASIA; REDUCTASE GENE; INBORN-ERRORS; EXPRESSION; DISORDER; HYDROPS; PRODUCE	Hydrops-ectopic calcification-"moth-eaten" ( HEM) or Greenberg skeletal dysplasia is an autosomal recessive chondrodystrophy with a lethal course, characterized by fetal hydrops, short limbs, and abnormal chondro-osseous calcification. We found elevated levels of cholesta-8,14-dien-3beta-ol in cultured skin fibroblasts of an 18-wk-old fetus with HEM, compatible with a deficiency of the cholesterol biosynthetic enzyme 3beta-hydroxysterol Delta(14)-reductase. Sequence analysis of two candidate genes encoding putative human sterol Delta(14)-reductases (TM7SF2 and LBR) identified a homozygous 1599-1605TCTTCTA-->CTAGAAG substitution in exon 13 of the LBR gene encoding the lamin B receptor, which results in a truncated protein. Functional complementation of the HEM cells by transfection with control LBR cDNA confirmed that LBR encoded the defective sterol Delta(14)-reductase. Mutations in LBR recently have been reported also to cause Pelger-Huet anomaly, an autosomal dominant trait characterized by hypolobulated nuclei and abnormal chromatin structure in granulocytes. The fact that the healthy mother of the fetus showed hypolobulated nuclei in 60% of her granulocytes confirms that classic Pelger-Huet anomaly represents the heterozygous state of 3beta-hydroxysterol Delta(14)-reductase deficiency.	Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat,Lab Genet Metab Dis F0 224, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; Reg Pathol Lab, Enschede, Netherlands; Kennedy Krieger Inst, Baltimore, MD USA; Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; Univ Groningen, Univ Med Ctr Groningen, Dept Clin Genet, Groningen, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Kennedy Krieger Institute; Cedars Sinai Medical Center; University of Groningen	Waterham, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat,Lab Genet Metab Dis F0 224, POB 22700, NL-1100 DE Amsterdam, Netherlands.	h.r.waterham@amc.uva.nl	Oosterwijk, Jan C./G-5770-2011					AZNAR J, 1981, ACTA HAEMATOL-BASEL, V66, P59, DOI 10.1159/000207095; Beier L, 1983, KINDERARZTL PRAX, V51, P164; Braverman N, 1999, NAT GENET, V22, P291, DOI 10.1038/10357; Brunetti-Pierri N, 2002, AM J HUM GENET, V71, P952, DOI 10.1086/342668; CHITAYAT D, 1993, AM J MED GENET, V47, P272, DOI 10.1002/ajmg.1320470226; Crowley JH, 1996, J BACTERIOL, V178, P2991, DOI 10.1128/jb.178.10.2991-2993.1996; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; GREENBERG CR, 1988, AM J MED GENET, V29, P623, DOI 10.1002/ajmg.1320290321; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; Horn LC, 2000, PRENATAL DIAG, V20, P1008, DOI 10.1002/1097-0223(200012)20:12<1008::AID-PD954>3.0.CO;2-S; Houten SM, 2001, EUR J HUM GENET, V9, P253, DOI 10.1038/sj.ejhg.5200595; HUET GJ, 1932, KLIN WOCHENSCHR, V11, P1264; Kelley RI, 2001, ANNU REV GENOM HUM G, V2, P299, DOI 10.1146/annurev.genom.2.1.299; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Konig A, 2000, AM J MED GENET, V90, P339; LATIMER KS, 1988, VET PATHOL, V25, P325, DOI 10.1177/030098588802500416; Michiels F, 2000, METHOD ENZYMOL, V325, P295; NACHTSHEIM H, 1950, J HERED, V41, P131, DOI 10.1093/oxfordjournals.jhered.a106108; Pelger K, 1928, NED TIJDSCHR GENEES, V72, P1178; Porter FD, 2002, J CLIN INVEST, V110, P715, DOI 10.1172/JCI200216386; Roberti R, 2002, EUR J BIOCHEM, V269, P283, DOI 10.1046/j.0014-2956.2001.02646.x; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Waterham HR, 2002, CLIN GENET, V61, P393, DOI 10.1034/j.1399-0004.2002.610601.x; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Waterham HR, 1998, AM J HUM GENET, V63, P329, DOI 10.1086/301982; YE Q, 1994, J BIOL CHEM, V269, P11306	29	155	163	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1013	1017		10.1086/373938	http://dx.doi.org/10.1086/373938			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12618959	Green Published, Bronze			2022-12-18	WOS:000181972600021
J	Otto, E; Hoefele, J; Ruf, R; Mueller, AM; Hiller, KS; Wolf, MTF; Schuermann, MJ; Becker, A; Birkenhager, R; Sudbrak, R; Hennies, HC; Nurnberg, P; Hildebrandt, F				Otto, E; Hoefele, J; Ruf, R; Mueller, AM; Hiller, KS; Wolf, MTF; Schuermann, MJ; Becker, A; Birkenhager, R; Sudbrak, R; Hennies, HC; Nurnberg, P; Hildebrandt, F			A gene mutated in nephronophthisis and retinitis pigmentosa encodes a novel protein, nephroretinin, conserved in evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC KIDNEY-DISEASE; NEPHROCYSTIN; MAP; INTERACTS; P130(CAS); LOCUS	Nephronophthisis (NPHP) comprises a group of autosomal recessive cystic kidney diseases, which constitute the most frequent genetic cause for end-stage renal failure in children and young adults. The most prominent histologic feature of NPHP consists of development of renal fibrosis, which, in chronic renal failure of any origin, represents the pathogenic event correlated most strongly to loss of renal function. Four gene loci for NPHP have been mapped to chromosomes 2q13 (NPHP1), 9q22 (NPHP2), 3q22 (NPHP3), and 1p36 (NPHP4). At all four loci, linkage has also been demonstrated in families with the association of NPHP and retinitis pigmentosa, known as "Senior-Loken syndrome" (SLS). Identification of the gene for NPHP type 1 had revealed nephrocystin as a novel docking protein, providing new insights into mechanisms of cell-cell and cell-matrix signaling. We here report identification of the gene (NPHP4) causing NPHP type 4, by use of high-resolution haplotype analysis and by demonstration of nine likely loss-of-function mutations in six affected families. NPHP4 encodes a novel protein, nephroretinin, that is conserved in evolution-for example, in the nematode Caenorhabditis elegans. In addition, we demonstrate two loss-of-function mutations of NPHP4 in patients from two families with SLS. Thus, we have identified a novel gene with critical roles in renal tissue architecture and ophthalmic function.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Max Planck Inst Mol Genet, Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hildebrandt, F (corresponding author), Univ Michigan Hlth Syst, 8220C MSRB III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.		Hennies, Hans C/G-9424-2014; Hoefele, Julia/AAB-6448-2020	Hennies, Hans C/0000-0001-7210-2389; Hoefele, Julia/0000-0002-7917-7129; Otto, Edgar/0000-0002-2387-9973				ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; Fillastre J P, 1976, Clin Nephrol, V5, P14; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; Hildebrandt F, 2000, J AM SOC NEPHROL, V11, P1753, DOI 10.1681/ASN.V1191753; HILDEBRANDT F, 1993, AM J HUM GENET, V53, P1256; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; HILDEBRANDT F, 1999, PEDIAT NEPHROLOGY; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; Omran H, 2002, J AM SOC NEPHROL, V13, P75, DOI 10.1681/ASN.V13175; Omran H, 2000, AM J HUM GENET, V66, P118, DOI 10.1086/302705; Otto E, 2000, J AM SOC NEPHROL, V11, P270, DOI 10.1681/ASN.V112270; POLAK BCP, 1983, AM J OPHTHALMOL, V95, P487, DOI 10.1016/0002-9394(83)90269-6; Schuermann MJ, 2002, AM J HUM GENET, V70, P1240, DOI 10.1086/340317; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; SMITH CH, 1945, AM J DIS CHILD, V69, P369; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668; Zeisberg M, 2001, CURR OPIN NEPHROL HY, V10, P315, DOI 10.1097/00041552-200105000-00004	26	155	160	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1161	1167		10.1086/344395	http://dx.doi.org/10.1086/344395			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12205563	Bronze, Green Published			2022-12-18	WOS:000178884300013
J	Petrini, JHJ				Petrini, JHJ			The mammalian Mre11-Rad50-Mbs1 protein complex: Integration of functions in the cellular DNA-damage response	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NIJMEGEN BREAKAGE SYNDROME; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; ILLEGITIMATE RECOMBINATION; MEIOTIC RECOMBINATION; ATAXIA-TELANGIECTASIA; NUCLEAR FOCI; REPAIR; GENES; CELLS		Univ Wisconsin, Sch Med, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Petrini, JHJ (corresponding author), Univ Wisconsin, Sch Med, Genet Lab, 445 Henry Mall, Madison, WI 53706 USA.	jpetrini@facstaff.wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056888] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56888] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AJIMURA M, 1993, GENETICS, V133, P51; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cleaver J E, 1989, Birth Defects Orig Artic Ser, V25, P61; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; FABRE F, 1984, MOL GEN GENET, V195, P139, DOI 10.1007/BF00332736; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; GERMAN J, 1983, CHROMOSOME MUTATION, P11; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; HABER J E, 1992, Current Opinion in Cell Biology, V4, P401, DOI 10.1016/0955-0674(92)90005-W; IVANOV EL, 1992, GENETICS, V132, P651; JACKSON SP, 1995, CURR BIOL, V5, P1210, DOI 10.1016/S0960-9822(95)00238-7; KADYK LC, 1992, GENETICS, V132, P387; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Maizels N, 1999, AM J HUM GENET, V64, P1270, DOI 10.1086/302393; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; MASER RS, 1999, DNA DAMAGE REPAIR, V3; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; NOVE J, 1986, MUTAT RES, V163, P255, DOI 10.1016/0027-5107(86)90023-0; Petrini J H, 1997, Semin Immunol, V9, P181, DOI 10.1006/smim.1997.0067; ROWLEY JD, 1994, LEUKEMIA, V8, pS1; SCHIESTL RH, 1994, MOL CELL BIOL, V14, P4493, DOI 10.1128/MCB.14.7.4493; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stumm M, 1997, AM J HUM GENET, V60, P1246; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TIMME TL, 1988, AM J MED SCI, V295, P40, DOI 10.1097/00000441-198801000-00009; Tsukamoto Y, 1996, GENETICS, V142, P383; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yamazaki V, 1998, CANCER RES, V58, P2316	33	155	162	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1264	1269		10.1086/302391	http://dx.doi.org/10.1086/302391			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205255	Bronze, Green Published			2022-12-18	WOS:000080093000002
J	Browne, CE; Dennis, NR; Maher, E; Long, FL; Nicholson, JC; Sillibourne, J; Barber, JCK				Browne, CE; Dennis, NR; Maher, E; Long, FL; Nicholson, JC; Sillibourne, J; Barber, JCK			Inherited interstitial duplications of proximal 15q: Genotype-phenotype correlations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; DINUCLEOTIDE REPEAT POLYMORPHISM; ANGELMAN SYNDROME; CLINICAL HETEROGENEITY; CYTOGENETIC ANALYSIS; DNA METHYLATION; SYNDROME REGION; EXPRESSED GENE; CHROMOSOME-15; 15Q11-13	We present the cytogenetic, molecular cytogenetic, and molecular genetic results on 20 unrelated patients with an interstitial duplication of the proximal long arm of chromosome 15. Multiple probes showed that the Prader-Willi/Angelman critical region (PWACR) was included in the duplication in 4/20 patients, each ascertained with developmental delay. The duplication was also found in two affected but not in three unaffected sibs of one of these patients. All four probands had inherited their duplication from their mothers, three of whom were also affected. Two of the affected mothers also carried a maternally inherited duplication, whereas the duplication in the unaffected mother and in an unaffected grandmother was paternal in origin, raising the possibility of a parental-origin effect. The PWACR was not duplicated in the remaining 16 patients, of whom 4 were referred with developmental delay. In the 14 families for which parental samples were available, the duplication was inherited with equal frequency from a phenotypically normal parent, mother or father. Comparative genomic hybridization undertaken on two patients suggested that proximal 15q outside the PWACR was the origin of the duplicated material. The use of PWACR probes discriminates between a large group of duplications of no apparent clinical significance and a smaller group, in which a maternally derived PWACR duplication is consistently associated with developmental delay and speech difficulties but not with overt features of either Prader-Willi syndrome or Angelman syndrome.	Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; Univ Birmingham, Birmingham Womens Hosp, Dept Pediat & Child Hlth, Div Med Genet, Birmingham, W Midlands, England	Salisbury District Hospital; Birmingham Women's Hospital; University of Birmingham	Browne, CE (corresponding author), Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England.	wessex.genetics@dial.pipex.com	MAHER, EAMONN R/A-9507-2008	MAHER, EAMONN R/0000-0002-6226-6918	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bedell MA, 1996, NAT GENET, V12, P229, DOI 10.1038/ng0396-229; BUNDEY S, 1994, DEV MED CHILD NEUROL, V36, P736; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CHENG SD, 1994, AM J HUM GENET, V55, P753; CHOO KH, 1990, GENOMICS, V7, P143, DOI 10.1016/0888-7543(90)90534-2; Clayton-Smith J., 1992, HUM GENET, V88, P376; CLAYTONSMITH J, 1993, J MED GENET, V30, P529, DOI 10.1136/jmg.30.6.529; Cook EH, 1997, AM J HUM GENET, V60, P928; CROLLA JA, 1995, HUM GENET, V95, P161; DEFRANCE HF, 1984, CLIN GENET, V26, P379; DITTRICH B, 1992, HUM GENET, V90, P313; FUHRMANNRIEGER A, 1984, CLIN GENET, V25, P347; HIGGINS MJ, 1985, CHROMOSOMA, V93, P77, DOI 10.1007/BF01259449; HOLOWINSKY S, 1993, AM J HUM GENET, V53, P125; JALAL SM, 1994, AM J MED GENET, V52, P495, DOI 10.1002/ajmg.1320520421; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEANACOX J, 1994, AM J HUM GENET, V54, P748; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; LONG FL, IN PRESS J MED GENET; LUDOWESE CJ, 1991, CLIN GENET, V40, P194; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MATTEI JF, 1983, HUM GENET, V64, P356, DOI 10.1007/BF00292367; MCMULLAN D, 1996, J MED GENET S1, V33, pS48; Mignon C, 1996, EUR J HUM GENET, V4, P88; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MUTIRANGURA A, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67; Mutirangura A., 1992, Human Molecular Genetics, V1, P139, DOI 10.1093/hmg/1.2.139-a; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PETTIGREW AL, 1987, AM J MED GENET, V28, P791, DOI 10.1002/ajmg.1320280403; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; REIS A, 1994, AM J HUM GENET, V54, P741; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; ROBINSON WP, 1993, J MED GENET, V30, P756, DOI 10.1136/jmg.30.9.756; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; SCHINZEL AA, 1994, J MED GENET, V31, P798, DOI 10.1136/jmg.31.10.798; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; WEBB T, 1992, J MED GENET, V29, P921, DOI 10.1136/jmg.29.12.921; WEBB T, 1994, J MED GENET, V31, P585, DOI 10.1136/jmg.31.8.585; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308	43	155	158	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1342	1352		10.1086/301624	http://dx.doi.org/10.1086/301624			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399882	Green Published, Bronze			2022-12-18	WOS:000071555900018
J	KUWANO, A; LEDBETTER, SA; DOBYNS, WB; EMANUEL, BS; LEDBETTER, DH				KUWANO, A; LEDBETTER, SA; DOBYNS, WB; EMANUEL, BS; LEDBETTER, DH			DETECTION OF DELETIONS AND CRYPTIC TRANSLOCATIONS IN MILLER-DIEKER SYNDROME BY INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBMICROSCOPIC DELETIONS; COSMID CLONES; LEUKEMIA; LOCALIZATION; CHROMOSOMES; PROBES; LOCUS; GENE	Fluorescence in situ hybridization (FISH) using two cosmid probes (41A and P13) from the Miller-Dieker syndrome (MDS) critical region in 17p13.3 was performed in a blinded comparison of three MDS patients with submicroscopic deletions and in four normal relatives used as controls. The controls showed both chromosome 17 homologues labeled in 85%-95% of cells, while each patient showed only one homologue labeled in 75%-80% of cells. Two MDS patients with cryptic translocations were also studied. In one case, a patient and her mother had the same der(17) (p +), but the reciprocal product of the translocation could not be identified in the mother by G-banding (i.e., it was a "half-cryptic" translocation). FISH revealed a 3q;17p translocation. The other case involved a patient with apparently normal karyotype. Because a large molecular deletion was found, a translocation involving two G-negative telomeres (i.e., a "full-cryptic" translocation) was postulated. FISH studies on her father and normal brother showed an 8q;17p translocation. These studies demonstrate that in situ hybridization is an efficient method for deletion detection in Miller-Dieker syndrome. More important, parental studies by FISH on patients demonstrating molecular deletions and a normal karyotype may identify cryptic translocation events, which cannot be detected by other molecular genetic strategies. Similar in situ strategies for deletion detection can be developed for other microdeletion syndromes, such as Prader-Willi/Angelman syndrome or DiGeorge syndrome.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030; CHILDRENS HOSP,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; INDIANA UNIV,DEPT NEUROL,INDIANAPOLIS,IN 46204; INDIANA UNIV,DEPT MOLEC GENET,INDIANAPOLIS,IN 46204	Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis			Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; 	NICHD NIH HHS [P30 HD 24064, HD20619] Funding Source: Medline; BHP HRSA HHS [P30 DH26979] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); BHP HRSA HHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARNOLDUS EPJ, 1990, CYTOGENET CELL GENET, V54, P108, DOI 10.1159/000132972; BATANIAN JR, 1990, HUM GENET, V85, P555; CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; DAUWERSE JG, 1990, CYTOGENET CELL GENET, V53, P126, DOI 10.1159/000132911; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; DOBYNS WB, 1984, AM J MED GENET, V18, P509, DOI 10.1002/ajmg.1320180320; KIEVITS T, 1990, CYTOGENET CELL GENET, V53, P134, DOI 10.1159/000132913; LEDBETTER DH, 1989, P NATL ACAD SCI USA, V86, P5136, DOI 10.1073/pnas.86.13.5136; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; RIED T, 1990, HUM GENET, V85, P581, DOI 10.1007/BF00193578; ROWLEY JD, 1990, P NATL ACAD SCI USA, V87, P9358, DOI 10.1073/pnas.87.23.9358; SCHWARTZ CE, 1988, AM J HUM GENET, V43, P597; TKACHUK DC, 1990, SCIENCE, V250, P559, DOI 10.1126/science.2237408; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; ZHANG FR, 1990, CHROMOSOMA, V99, P436, DOI 10.1007/BF01726696	17	155	161	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					707	714						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897521				2022-12-18	WOS:A1991GG66500002
J	KURDIHAIDAR, B; MASON, PJ; BERREBI, A; ANKRABADU, G; ALALI, A; OPPENHEIM, A; LUZZATTO, L				KURDIHAIDAR, B; MASON, PJ; BERREBI, A; ANKRABADU, G; ALALI, A; OPPENHEIM, A; LUZZATTO, L			ORIGIN AND SPREAD OF THE GLUCOSE-6-PHOSPHATE-DEHYDROGENASE VARIANT (G6PD-MEDITERRANEAN) IN THE MIDDLE-EAST	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ROYAL POST GRAD MED SCH,DEPT HAEMATOL,LONDON W12 0NN,ENGLAND; KAPLAN HOSP,HAEMATOL UNIT,IL-76100 REHOVOT,ISRAEL; QATIF CENT HOSP,AL JESH,SAUDI ARABIA; KING FAISAL UNIV,KING FAHED TEACHING HOSP,DAMMAM,SAUDI ARABIA; HADASSAH UNIV HOSP,IL-91120 JERUSALEM,ISRAEL	Imperial College London; Hebrew University of Jerusalem; Kaplan Medical Center; Qatif Central Hospital; Imam Abdulrahman Bin Faisal University; King Faisal University; Hebrew University of Jerusalem			Mason, Philip J/B-1087-2008; Al-Ali, Amein/AAR-3020-2020		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKSOY M, 1980, HUM HERED, V30, P3, DOI 10.1159/000153079; AMINZAKI L, 1972, B WORLD HEALTH ORGAN, V47, P1; BANERJEE B, 1981, HUM HERED, V31, P65, DOI 10.1159/000153179; BEUTLER E, 1989, BLOOD, V74, P2550; Beutler E, 1983, METABOLIC BASIS INHE, P1629; BONNETAMIR B, 1978, AM J PHYS ANTHROPOL, V49, P457, DOI 10.1002/ajpa.1330490405; COLONNAROMANO S, 1985, HUM GENET, V69, P228, DOI 10.1007/BF00293030; DEVITA G, 1989, AM J HUM GENET, V44, P233; DURSO M, 1988, AM J HUM GENET, V42, P735; ELHAZMI MAF, 1986, HUM HERED, V36, P45, DOI 10.1159/000153599; FEY MF, 1990, HUM GENET, V84, P471; FOULKES NS, 1988, NUCLEIC ACIDS RES, V16, P5687, DOI 10.1093/nar/16.12.5687; FRISCHER H, 1973, J LAB CLIN MED, V81, P603; GELPI AP, 1977, HUM HERED, V27, P285, DOI 10.1159/000152880; GELPI AP, 1965, BLOOD-J HEMATOL, V25, P486, DOI 10.1182/blood.V25.4.486.486; Livingstone F. B., 1985, FREQUENCIES HEMOGLOB; LUZZATTO L, 1985, ADV HUM GENET, V14, P217; MCCURDY PR, 1974, J LAB CLIN MED, V84, P673; MCCURDY PR, 1970, J LAB CLIN MED, V76, P943; MCCURDY PR, 1972, REV EUR ETUD CL BIOL, V17, P66; Mourant AE, 1976, DISTRIBUTION HUMAN B; PANICH V, 1986, GLUCOSE 6 PHOSPHATE, P195; RAMOT B, 1964, J LAB CLIN MED, V64, P895; RATTAZZI MC, 1967, NATURE, V213, P79, DOI 10.1038/213079b0; SANSONE G, 1958, 2 FAVISMO; SHAKER Y, 1966, AM J HUM GENET, V18, P609; SHATSKAYA TL, 1980, HUM GENET, V54, P115, DOI 10.1007/BF00279060; SHEBA C, 1961, INT C SER, V32, P633; STAMATOYANNOPOULOS G, 1971, J CLIN INVEST, V50, P1253, DOI 10.1172/JCI106603; SYKES BC, 1983, LANCET, V2, P787; TALEB N, 1964, C R SEANCE ACAD SCI, V25, P5749; VIGLIETTO G, 1990, ANN HUM GENET, V54, P1, DOI 10.1111/j.1469-1809.1990.tb00355.x; Vives Corrons J L, 1982, Hum Genet, V60, P216; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; YOSHIDA A, 1988, AM J HUM GENET, V42, P872; 1967, WHO366 TECH REP	36	155	158	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					1013	1019						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978555				2022-12-18	WOS:A1990EK40000020
J	ORIOL, R; DANILOVS, J; HAWKINS, BR				ORIOL, R; DANILOVS, J; HAWKINS, BR			A NEW GENETIC MODEL PROPOSING THAT THE SE GENE IS A STRUCTURAL GENE CLOSELY LINKED TO THE H-GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES, DEPT BIOL & MED, LOS ANGELES, CA 90024 USA; QUEEN ELIZABETH II MED CTR, DEPT CLIN IMMUNOL, NEDLANDS, WA 6009, AUSTRALIA	University of California System; University of California Los Angeles; University of Western Australia	ORIOL, R (corresponding author), HOP BROUSSAIS, INST IMMUNOBIOL, F-75674 PARIS 14, FRANCE.							ABUSIN AYH, 1976, VOX SANG, V31, P48, DOI 10.1111/j.1423-0410.1976.tb02858.x; ALOYSIA M, 1961, TRANSFUSION, V1, P212; AUST CH, 1962, AM J CLIN PATHOL, V37, P579; BERANOVA G, 1969, VOX SANG, V16, P449, DOI 10.1111/j.1423-0410.1969.tb04771.x; BHATIA H M, 1955, J Indian Med Assoc, V25, P545; BHATIA HM, 1977, HUMAN BLOOD GROUPS, P296; BHENDE YM, 1952, LANCET, V262, P903; DAVEY RJ, 1978, TRANSFUSION, V18, P738, DOI 10.1046/j.1537-2995.1978.18679077959.x; DZIERZKOWA-BORODEJ W, 1972, Archivum Immunologiae et Therapiae Experimentalis, V20, P841; FAWCETT KJ, 1970, VOX SANG, V19, P457, DOI 10.1111/j.1423-0410.1970.tb01777.x; GALLASCH E, 1976, BLUT, V33, P319, DOI 10.1007/BF01002129; GANDINI E, 1968, VOX SANG, V15, P142, DOI 10.1111/j.1423-0410.1968.tb03419.x; GILES CM, 1963, VOX SANG, V8, P269, DOI 10.1111/j.1423-0410.1963.tb05236.x; GOLD ER, 1964, VOX SANG, V9, P153, DOI 10.1111/j.1423-0410.1964.tb03674.x; HAKIM SA, 1961, TRANSFUSION, V1, P218, DOI 10.1111/j.1537-2995.1961.tb00045.x; Hrubisko M, 1969, Vnitr Lek, V15, P696; HRUBISKO M, 1970, VOX SANG, V19, P113, DOI 10.1111/j.1423-0410.1970.tb01503.x; ISEKI S, 1970, Proceedings of the Japan Academy, V46, P803; JAKOBOWICZ R, 1961, MED J AUSTRALIA, V2, P868, DOI 10.5694/j.1326-5377.1961.tb90600.x; KITAHAMA M, 1967, VOX SANG, V12, P354, DOI 10.1111/j.1423-0410.1967.tb03365.x; KOGURE T, 1968, J JPN SOC BLOOD TRAN, V15, P161; LANSET SUZANNE, 1966, TRANSFUSION [PARIS], V9, P255, DOI 10.1016/S0372-1248(66)80081-4; LEMIEUX RU, 1978, CHEM SOC REV, V7, P423, DOI 10.1039/cs9780700423; LEVINE P, 1955, BLOOD, V10, P1100, DOI 10.1182/blood.V10.11.1100.1100; LEVINE P, 1961, VOX SANG, V6, P561, DOI 10.1111/j.1423-0410.1961.tb03204.x; LEWI S, 1967, Transfusion (Paris), V10, P335, DOI 10.1016/S0372-1248(67)80043-2; Liberge G, 1970, Rev Fr Transfus, V13, P357, DOI 10.1016/S0035-2977(70)80047-5; MORTON NE, 1955, AM J HUM GENET, V7, P277; MULET C, 1977, FEBS LETT, V84, P74, DOI 10.1016/0014-5793(77)81060-0; MULET C, 1978, FEBS LETT, V90, P233, DOI 10.1016/0014-5793(78)80375-5; ORIOL R, AM J HUM GENET; OTT J, 1974, AM J HUM GENET, V26, P588; PARKIN DM, 1956, BRIT J HAEMATOL, V2, P106, DOI 10.1111/j.1365-2141.1956.tb06692.x; PETTENKOFER H J, 1960, Z Immun exp ther, V120, P288; POSCHMANN A, 1974, VOX SANG, V27, P338, DOI 10.1111/j.1423-0410.1974.tb02426.x; PRETTY HM, 1969, VOX SANG, V16, P179, DOI 10.1111/j.1423-0410.1969.tb04732.x; RACE C, 1972, FEBS LETT, V27, P125, DOI 10.1016/0014-5793(72)80424-1; RACE C, 1972, VOX SANG, V23, P385, DOI 10.1111/j.1423-0410.1972.tb03826.x; Race RR., 1975, BLOOD GROUPS MAN; RODIER L, 1974, BIOMED EXPRESS, V21, P312; ROUGER P, 1980, IMMUNOL COMMUN, V9, P161, DOI 10.3109/08820138009065991; SATHE M, 1976, VOX SANG, V30, P312, DOI 10.1111/j.1423-0410.1976.tb02834.x; SCHENKELBRUNNER H, 1972, EUR J BIOCHEM, V30, P269, DOI 10.1111/j.1432-1033.1972.tb02095.x; SOLOMON JM, 1965, BLOOD-J HEMATOL, V25, P470, DOI 10.1182/blood.V25.4.470.470; SRINGARM S, 1972, VOX SANG, V23, P537, DOI 10.1111/j.1423-0410.1972.tb03847.x; SRINGARM S, 1977, VOX SANG, V33, P364, DOI 10.1111/j.1423-0410.1977.tb02258.x; VOAK D, 1968, VOX SANG, V15, P353, DOI 10.1111/j.1423-0410.1968.tb04076.x; VOAK D, 1968, VOX SANG, V14, P18; VOS GH, 1976, TRANSFUSION, V16, P421; WATKINS WM, 1978, PROC R SOC SER B-BIO, V202, P31, DOI 10.1098/rspb.1978.0056; WIENER AS, 1966, INT ARCH ALLER A IMM, V29, P82, DOI 10.1159/000229689; YAMAGUCHI H, 1972, P JPN ACAD, V48, P629, DOI 10.2183/pjab1945.48.629; YUNIS EJ, 1969, BLOOD-J HEMATOL, V33, P124, DOI 10.1182/blood.V33.1.124.124	53	155	159	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	3					421	431						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LT725	7246545				2022-12-18	WOS:A1981LT72500010
J	GERRARD, JW; RAO, DC; MORTON, NE				GERRARD, JW; RAO, DC; MORTON, NE			GENETIC STUDY OF IMMUNOGLOBULIN-E	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,POPULAT GENET LAB,HONOLULU,HI 96822	University of Hawaii System								Adkinson J, 1920, GENETICS, V5, P363; BAZARAL M, 1974, J ALLERGY CLIN IMMUN, V54, P288, DOI 10.1016/0091-6749(74)90015-3; BAZARAL M, 1971, J IMMUNOL, V107, P794; BUCHER CS, 1934, J ALLERGY, V5, P611; Cooke RA, 1916, J IMMUNOL, V1, P201; ELSTON RC, 1975, BIOMETRIKA, V62, P133, DOI 10.2307/2334495; GERRARD JW, 1974, J PEDIATR-US, V85, P660, DOI 10.1016/S0022-3476(74)80510-X; GRUNDBACHER FJ, 1975, J ALLERGY CLIN IMMUN, V56, P104, DOI 10.1016/0091-6749(75)90114-1; ISHIZAKA K, 1966, J IMMUNOL, V97, P840; JOHANSSO.SG, 1967, LANCET, V2, P951; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MARSH DG, 1974, P NATL ACAD SCI USA, V71, P3588, DOI 10.1073/pnas.71.9.3588; MORTON NE, 1974, AM J HUM GENET, V26, P489; RAO DC, ANN HUM GENET; Spain WC, 1924, J IMMUNOL, V9, P521; Wiener AS, 1936, ANN EUGENIC, V7, P141, DOI 10.1111/j.1469-1809.1936.tb02135.x	16	155	157	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	1					46	58						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL575	623102				2022-12-18	WOS:A1978EL57500006
J	Starita, LM; Ahituv, N; Dunham, MJ; Kitzman, JO; Roth, FP; Seelig, G; Shendure, J; Fowler, DM				Starita, Lea M.; Ahituv, Nadav; Dunham, Maitreya J.; Kitzman, Jacob O.; Roth, Frederick P.; Seelig, Georg; Shendure, Jay; Fowler, Douglas M.			Variant Interpretation: Functional Assays to the Rescue	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-INTERACTION NETWORK; GENETIC-VARIATION; HUMAN-DISEASE; UNCERTAIN SIGNIFICANCE; MAMMALIAN ENHANCERS; INCIDENTAL FINDINGS; SEQUENCE VARIATION; MISSENSE VARIANTS; MEDICAL GENETICS; AMERICAN-COLLEGE	Classical genetic approaches for interpreting variants, such as case-control or co-segregation studies, require finding many individuals with each variant. Because the overwhelming majority of variants are present in only a few living humans, this strategy has clear limits. Fully realizing the clinical potential of genetics requires that we accurately infer pathogenicity even for rare or private variation. Many computational approaches to predicting variant effects have been developed, but they can identify only a small fraction of pathogenic variants with the high confidence that is required in the clinic. Experimentally measuring a variant's functional consequences can provide clearer guidance, but individual assays performed only after the discovery of the variant are both time and resource intensive. Here, we discuss how multiplex assays of variant effect (MAVEs) can be used to measure the functional consequences of all possible variants in disease-relevant loci for a variety of molecular and cellular phenotypes. The resulting large-scale functional data can be combined with machine learning and clinical knowledge for the development of "lookup tables" of accurate pathogenicity predictions. A coordinated effort to produce, analyze, and disseminate large-scale functional data generated by multiplex assays could be essential to addressing the variant-interpretation crisis.	[Starita, Lea M.; Dunham, Maitreya J.; Shendure, Jay; Fowler, Douglas M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Ahituv, Nadav] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA; [Kitzman, Jacob O.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Kitzman, Jacob O.] Univ Michigan, Dept Bioinformat & Computat Med, Ann Arbor, MI 48109 USA; [Roth, Frederick P.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3E1, Canada; [Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Roth, Frederick P.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA; [Roth, Frederick P.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Seelig, Georg] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Seelig, Georg] Univ Washington, Dept Comp Sci Engn, Seattle, WA 98195 USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Fowler, Douglas M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Harvard University; Dana-Farber Cancer Institute; Canadian Institute for Advanced Research (CIFAR); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Starita, LM; Fowler, DM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Fowler, DM (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	lstarita@uw.edu; dfowler@uw.edu	Shendure, Jay/AAU-3684-2021	Kitzman, Jacob/0000-0002-6145-882X	NIH National Human Genome Research Institute (NHGRI) [1UM1HG009408]; National Cancer Institute Division of Cancer Prevention [1R01CA197139]; NHGRI Centers of Excellence in Genomic Sciences [P50HG004233]; NHGRI [U01HG001715]; One Brave Idea; Canada Excellence Research Chairs Program; NIH [5R01CA207029-02]; National Science Foundation [CCF-1317653]; NIH Director's Pioneer Award [DP1HG007811]; Howard Hughes Medical Institute; NIH National Institute of General Medical Sciences [R01GM109110]; NATIONAL CANCER INSTITUTE [R01CA207029, R01CA197139] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG001715, DP1HG007811, UM1HG009408, U01HG001715, P50HG004233, R01HG009136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109110] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute Division of Cancer Prevention(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI Centers of Excellence in Genomic Sciences; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); One Brave Idea; Canada Excellence Research Chairs Program(Canada Research Chairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alan Rubin for assistance with the figures. N.A. and J.S. is supported in part by grants from the NIH National Human Genome Research Institute (NHGRI; 1UM1HG009408) and National Cancer Institute Division of Cancer Prevention (1R01CA197139). F.P.R. is supported by NHGRI Centers of Excellence in Genomic Sciences grant P50HG004233, NHGRI grant U01HG001715, One Brave Idea, and the Canada Excellence Research Chairs Program. G.S. is supported by NIH award 5R01CA207029-02 and National Science Foundation award CCF-1317653. J.S. is supported by an NIH Director's Pioneer Award (DP1HG007811) and is an Investigator of the Howard Hughes Medical Institute. M.J.D. is supported in part by a Faculty Scholars grant from the Howard Hughes Medical Institute. M.J.D is also a senior fellow in the Genetic Networks program at the Canadian Institute for Advanced Research. D.M.F. is supported by NIH National Institute of General Medical Sciences grant R01GM109110.	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Barrera LA, 2016, SCIENCE, V351, P1450, DOI 10.1126/science.aad2257; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Cooper GM, 2015, GENOME RES, V25, P1423, DOI 10.1101/gr.190116.115; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Dailey L, 2015, GENOMICS, V106, P151, DOI 10.1016/j.ygeno.2015.06.004; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Diao YR, 2017, NAT METHODS, V14, P629, DOI [10.1038/NMETH.4264, 10.1038/nmeth.4264]; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Fanen P, 2014, INT J BIOCHEM CELL B, V52, P94, DOI 10.1016/j.biocel.2014.02.023; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fowler DM, 2014, NAT PROTOC, V9, P2267, DOI 10.1038/nprot.2014.153; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Gasperini M, 2016, NAT PROTOC, V11, P1782, DOI 10.1038/nprot.2016.135; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Grimm DG, 2015, HUM MUTAT, V36, P513, DOI 10.1002/humu.22768; Harrison S.M., 2017, GENET MED; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hendriks G, 2014, HUM MUTAT, V35, P1382, DOI 10.1002/humu.22678; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Hopf TA, 2017, NAT BIOTECHNOL, V35, P128, DOI 10.1038/nbt.3769; Inoue F, 2017, GENOME RES, V27, P38, DOI 10.1101/gr.212092.116; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Ipe J, 2017, CTS-CLIN TRANSL SCI, V10, P67, DOI 10.1111/cts.12440; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Julien P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11558; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Majithia AR, 2016, NAT GENET, V48, P1570, DOI 10.1038/ng.3700; Manning KS, 2017, NAT REV MOL CELL BIO, V18, P102, DOI 10.1038/nrm.2016.139; Manolio TA, 2017, CELL, V169, P6, DOI 10.1016/j.cell.2017.03.005; Matuszewski S, 2016, GENETICS, V204, P77, DOI 10.1534/genetics.116.190462; Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112; Muerdter F, 2015, GENOMICS, V106, P145, DOI 10.1016/j.ygeno.2015.06.001; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Pevzner S.J., 2014, CELL, V159, P1212; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Relling MV, 2015, NATURE, V526, P343, DOI 10.1038/nature15817; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosenberg AB, 2015, CELL, V163, P698, DOI 10.1016/j.cell.2015.09.054; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rubin AF, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1272-5; Rubinstein WS, 2013, NUCLEIC ACIDS RES, V41, pD925, DOI 10.1093/nar/gks1173; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Shalem O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005147; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sokolina K, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167430; Spain SL, 2015, HUM MOL GENET, V24, pR111, DOI 10.1093/hmg/ddv260; Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628; Starita Lea M, 2015, Cold Spring Harb Protoc, V2015, P711, DOI 10.1101/pdb.top077503; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Sun S, 2016, GENOME RES, V26, P670, DOI 10.1101/gr.192526.115; Tai DJC, 2016, NAT NEUROSCI, V19, P517, DOI 10.1038/nn.4235; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; VanderMeer JE, 2011, DEV DYNAM, V240, P920, DOI 10.1002/dvdy.22535; Vockley CM, 2015, GENOME RES, V25, P1206, DOI 10.1101/gr.190090.115; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Yao Z, 2017, MOL CELL, V65, P347, DOI 10.1016/j.molcel.2016.12.004; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhang F, 2015, HUM MOL GENET, V24, pR102, DOI 10.1093/hmg/ddv259; Zhao WX, 2014, NAT BIOTECHNOL, V32, P387, DOI 10.1038/nbt.2851; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	87	154	154	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					315	325		10.1016/j.ajhg.2017.07.014	http://dx.doi.org/10.1016/j.ajhg.2017.07.014			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28886340	Green Published, Bronze			2022-12-18	WOS:000409530900001
J	Zhao, N; Chen, J; Carroll, IM; Ringel-Kulka, T; Epstein, MP; Zhou, H; Zhou, JJ; Ringel, Y; Li, HZ; Wu, MC				Zhao, Ni; Chen, Jun; Carroll, Ian M.; Ringel-Kulka, Tamar; Epstein, Michael P.; Zhou, Hua; Zhou, Jin J.; Ringel, Yehuda; Li, Hongzhe; Wu, Michael C.			Testing in Microbiome-Profiling Studies with MiRKAT, the Microbiome Regression-Based Kernel Association Test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINEAR MIXED MODELS; QUANTITATIVE TRAITS; VARIANCE COMPONENT; GENETIC PATHWAY; GUT MICROBIOME; COMMUNITIES; UNIFRAC	High-throughput sequencing technology has enabled population-based studies of the role of the human microbiome in disease etiology and exposure response. Distance-based analysis is a popular strategy for evaluating the overall association between microbiome diversity and outcome, wherein the phylogenetic distance between individuals' microbiome profiles is computed and tested for association via permutation. Despite their practical popularity, distance-based approaches suffer from important challenges, especially in selecting the best distance and extending the methods to alternative outcomes, such as survival outcomes. We propose the microbiome regression-based kernel association test (MiRKAT), which directly regresses the outcome on the microbiome profiles via the semi-parametric kernel machine regression framework. MiRKAT allows for easy covariate adjustment and extension to alternative outcomes while non-parametrically modeling the microbiome through a kernel that incorporates phylogenetic distance. It uses a variance-component score statistic to test for the association with analytical p value calculation. The model also allows simultaneous examination of multiple distances, alleviating the problem of choosing the best distance. Our simulations demonstrated that MiRKAT provides correctly controlled type I error and adequate power in detecting overall association. "Optimal'' MiRKAT, which considers multiple candidate distances, is robust in that it suffers from little power loss in comparison to when the best distance is used and can achieve tremendous power gain in comparison to when a poor distance is chosen. Finally, we applied MiRKAT to real microbiome datasets to show that microbial communities are associated with smoking and with fecal protease levels after confounders are controlled for.	[Zhao, Ni; Wu, Michael C.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Chen, Jun] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Chen, Jun] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA; [Carroll, Ian M.; Ringel, Yehuda] Univ N Carolina, Div Gastroenterol & Hepatol, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27516 USA; [Ringel-Kulka, Tamar] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC 27599 USA; [Epstein, Michael P.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Zhou, Hua] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Zhou, Jin J.] Univ Arizona, Div Epidemiol & Biostat, Tucson, AZ 85724 USA; [Li, Hongzhe] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19014 USA	Fred Hutchinson Cancer Center; Mayo Clinic; Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Emory University; University of North Carolina; North Carolina State University; University of Arizona; University of Pennsylvania	Chen, J (corresponding author), Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA.	chen.jun2@mayo.edu; mcwu@fhcrc.org	Zhao, Ni/P-9086-2014; Wu, Michael/X-5084-2019	Zhao, Ni/0000-0002-7762-3949; Wu, Michael/0000-0002-3357-6570; Zhou, Hua/0000-0003-1320-7118	NIH [K01DK092330, R01HG007508, R01HG006139, R01GM097505]; Center for Gastrointestinal Biology and Disease [P30DK03498]; Hope Foundation; Gerstner Family Career Development Award in Individualized Medicine; Division Of Mathematical Sciences [1310319] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006139, R01HG007508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, K01DK092330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097505] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Gastrointestinal Biology and Disease; Hope Foundation; Gerstner Family Career Development Award in Individualized Medicine; Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by NIH grants K01DK092330, R01HG007508, R01HG006139, and R01GM097505; Center for Gastrointestinal Biology and Disease pilot feasibility grant P30DK03498; the Hope Foundation; and the Gerstner Family Career Development Award in Individualized Medicine.	Allen GI, 2013, J COMPUT GRAPH STAT, V22, P284, DOI 10.1080/10618600.2012.681213; Annahazi A, 2009, PAIN, V144, P209, DOI 10.1016/j.pain.2009.04.017; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Carroll IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078017; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Chen JL, 2013, IEEE DATA COMPR CONF, P191, DOI 10.1109/DCC.2013.27; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Chen W., 2015, SMALL SAMPLE KERNEL; Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x; DAVIES R. B., 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025; Epstein MP, 2012, AM J HUM GENET, V91, P215, DOI 10.1016/j.ajhg.2012.06.004; Fog A, 2008, COMMUN STAT-SIMUL C, V37, P241, DOI 10.1080/03610910701790236; Freedman D., 1983, J BUS ECON STAT, V1, P292, DOI DOI 10.2307/1391660; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Greven S, 2008, J COMPUT GRAPH STAT, V17, P870, DOI 10.1198/106186008X386599; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Liu H, 2009, COMPUT STAT DATA AN, V53, P853, DOI 10.1016/j.csda.2008.11.025; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Pan W, 2011, GENET EPIDEMIOL, V35, P211, DOI 10.1002/gepi.20567; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; WOESE CR, 1975, NATURE, V254, P83, DOI 10.1038/254083a0; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu MC, 2013, GENET EPIDEMIOL, V37, P267, DOI 10.1002/gepi.21715; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	39	154	155	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					797	807		10.1016/j.ajhg.2015.04.003	http://dx.doi.org/10.1016/j.ajhg.2015.04.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25957468	Bronze, Green Published			2022-12-18	WOS:000354189300010
J	Maier, R; Moser, G; Chen, GB; Ripke, S; Coryell, W; Potash, JB; Scheftner, WA; Shi, JX; Weissman, MM; Hultman, CM; Landen, M; Levinson, DF; Kendler, KS; Smoller, JW; Wray, NR; Lee, SH				Maier, Robert; Moser, Gerhard; Chen, Guo-Bo; Ripke, Stephan; Coryell, William; Potash, James B.; Scheftner, William A.; Shi, Jianxin; Weissman, Myrna M.; Hultman, Christina M.; Landen, Mikael; Levinson, Douglas F.; Kendler, Kenneth S.; Smoller, Jordan W.; Wray, Naomi R.; Lee, S. Hong		Psychiat Genomics Consortium	Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC RISK; SELECTION; POPULATION; ALGORITHMS; DISEASES; TRAIT; LOCI	Genetic risk prediction has several potential applications in medical research and clinical practice and could be used, for example, to stratify a heterogeneous population of patients by their predicted genetic risk. However, for polygenic traits, such as psychiatric disorders, the accuracy of risk prediction is low. Here we use a multivariate linear mixed model and apply multi-trait genomic best linear unbiased prediction for genetic risk prediction. This method exploits correlations between disorders and simultaneously evaluates individual risk for each disorder. We show that the multivariate approach significantly increases the prediction accuracy for schizophrenia, bipolar disorder, and major depressive disorder in the discovery as well as in independent validation datasets. By grouping SNPs based on genome annotation and fitting multiple random effects, we show that the prediction accuracy could be further improved. The gain in prediction accuracy of the multivariate approach is equivalent to an increase in sample size of 34% for schizophrenia, 68% for bipolar disorder, and 76% for major depressive disorders using single trait models. Because our approach can be readily applied to any number of GWAS datasets of correlated traits, it is a flexible and powerful tool to maximize prediction accuracy. With current sample size, risk predictors are not useful in a clinical setting but already are a valuable research tool, for example in experimental designs comparing cases with high and low polygenic risk.	[Maier, Robert; Moser, Gerhard; Chen, Guo-Bo; Wray, Naomi R.; Lee, S. Hong] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Coryell, William; Potash, James B.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Scheftner, William A.] Rush Univ, Dept Psychiat, Med Ctr, Chicago, IL 60612 USA; [Shi, Jianxin] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Weissman, Myrna M.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Weissman, Myrna M.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Hultman, Christina M.; Landen, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Landen, Mikael] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, S-41345 Gothenburg, Sweden; [Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23298 USA; [Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA 02114 USA	University of Queensland; Harvard University; Massachusetts General Hospital; University of Iowa; Rush University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University; New York State Psychiatry Institute; Karolinska Institutet; University of Gothenburg; Stanford University; Virginia Commonwealth University; Harvard University; Massachusetts General Hospital	Lee, SH (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	hong.lee@uq.edu.au	Muglia, Pierandrea/ABD-9235-2020; Oliveira, Guiomar/AAF-3911-2021; BELLIVIER, FRANK/H-5197-2012; Moser, Gerhard/H-7054-2012; Betancur, Catalina/K-3791-2017; Breen, Gerome/Y-2706-2019; Meier, Sandra/AAB-1242-2021; Kendler, Kenneth/AAF-2876-2019; Collier, David A/D-1649-2011; Scherer, Stephen W./B-3785-2013; Medland, Sarah E/C-7630-2013; Leboyer, Marion/AAW-3648-2021; Fombonne, Eric/M-4893-2018; Hartmann, Annette/AAS-6331-2021; Hickie, Ian B/K-8975-2015; Franke, Barbara/D-4836-2009; van Os, Jim/C-2113-2014; Thapar, Anita/AAH-5555-2020; Etain, Bruno/L-6647-2017; McMahon, Francis J/A-7290-2009; Landen, Mikael/AAD-7917-2020; Andreassen, Ole A./AAY-7531-2020; Miranda, Ana/G-8619-2015; Degenhardt, Franziska/H-4169-2017; Ruderfer, Douglas M/M-5795-2016; de Geus, Eco J.C./M-9318-2015; Ripke, Stephan/AAK-5486-2021; Battaglia, Agatino/AAG-1406-2020; Breen, Gerome D/A-5540-2010; Fanous, Ayman H/O-1263-2017; Lee, Sang Hong/A-2569-2011; McQuillin, Andrew/C-1623-2008; Bergen, Sarah/I-8313-2012; Grice, Dorothy E/X-3372-2019; McIntosh, Andrew M/B-9379-2008; O'Donovan, Michael C/P-7005-2018; Konte, Bettina/AAT-1142-2021; Greenwood, Tiffany/F-6356-2012; Mahon, Pamela Belmonte/O-9806-2018; Kuntsi, Jonna/G-9750-2011; Zhang, Peng/N-2920-2014; Mattheisen, Manuel/B-4949-2012; Jamain, Stéphane/L-1822-2019; Yu, Timothy W./AAF-5738-2019; Hansen, Thomas Folkmann/O-5965-2014; Jamain, Stéphane/P-3710-2017; Mattheisen, Manuel/S-3725-2019; Lesch, Klaus-Peter/J-4906-2013; Mattingsdal, Morten/Q-9367-2016; Lohoff, Falk W/M-7951-2016; Cormand, Bru/H-5338-2015; Wray, Naomi/C-8639-2015; Schumacher, Johannes/F-4970-2015; Myin-Germeys, Inez/L-5106-2014; Middeldorp, Christel M/L-7728-2017; Melle, Ingrid S/B-4858-2011; Nyholt, Dale/J-3174-2017; Paterson, Andrew/A-4088-2011; Mowry, Bryan/G-5046-2010; van Grootheest, Gerard/C-6942-2014; Ribases, Marta/B-5309-2019; Lawson, William/O-9758-2017; Roeyers, Herbert/A-5557-2018; Chen, Guo-Bo/C-2435-2009; Lewis, Cathryn/A-5225-2010; Morrow, Eric/J-2767-2013; Vicente, Astrid/F-8692-2014	Muglia, Pierandrea/0000-0002-3973-8606; Oliveira, Guiomar/0000-0002-7049-1277; Moser, Gerhard/0000-0003-3104-5730; Betancur, Catalina/0000-0002-3327-4804; Breen, Gerome/0000-0003-2053-1792; Collier, David A/0000-0003-4087-1559; Scherer, Stephen W./0000-0002-8326-1999; Medland, Sarah E/0000-0003-1382-380X; Leboyer, Marion/0000-0001-5473-3697; Fombonne, Eric/0000-0002-8605-3538; Hickie, Ian B/0000-0001-8832-9895; Franke, Barbara/0000-0003-4375-6572; Thapar, Anita/0000-0002-3689-737X; Etain, Bruno/0000-0002-5377-1488; McMahon, Francis J/0000-0002-9469-305X; Miranda, Ana/0000-0001-6998-5686; Ruderfer, Douglas M/0000-0002-2365-386X; de Geus, Eco J.C./0000-0001-6022-2666; Battaglia, Agatino/0000-0002-7128-7606; Breen, Gerome D/0000-0003-2053-1792; Lee, Sang Hong/0000-0001-9701-2718; McQuillin, Andrew/0000-0003-1567-2240; Bergen, Sarah/0000-0002-5888-0034; Grice, Dorothy E/0000-0002-8833-2549; McIntosh, Andrew M/0000-0002-0198-4588; O'Donovan, Michael C/0000-0001-7073-2379; Konte, Bettina/0000-0001-5287-308X; Greenwood, Tiffany/0000-0002-6080-6503; Mahon, Pamela Belmonte/0000-0002-3947-441X; Kuntsi, Jonna/0000-0002-0113-8162; Zhang, Peng/0000-0003-1182-1392; Mattheisen, Manuel/0000-0002-8442-493X; Yu, Timothy W./0000-0003-2988-7701; Hansen, Thomas Folkmann/0000-0001-6703-7762; Jamain, Stéphane/0000-0002-4321-4100; Mattheisen, Manuel/0000-0002-8442-493X; Lesch, Klaus-Peter/0000-0001-8348-153X; Mattingsdal, Morten/0000-0003-4440-0324; Cormand, Bru/0000-0001-5318-4382; Wray, Naomi/0000-0001-7421-3357; Schumacher, Johannes/0000-0001-9217-6457; Middeldorp, Christel M/0000-0002-6218-0428; Melle, Ingrid S/0000-0002-9783-548X; Young, Allan/0000-0003-2291-6952; State, Matthew/0000-0003-1624-8302; Nyholt, Dale/0000-0001-7159-3040; Walters, James/0000-0002-6980-4053; Freitag, Christine Margarete/0000-0001-9676-4782; Middleton, Lefkos/0000-0002-8615-3723; Paterson, Andrew/0000-0002-9169-118X; Buccola, Nancy/0000-0003-1378-4636; BELLIVIER, FRANK/0000-0002-3660-6640; Jones, Lisa/0000-0002-5122-8334; Nothen, Markus/0000-0002-8770-2464; Mowry, Bryan/0000-0002-4115-5645; Djurovic, Srdjan/0000-0002-8140-8061; Banaschewski, Tobias/0000-0003-4595-1144; van Grootheest, Gerard/0000-0003-4350-6661; Ribases, Marta/0000-0003-1039-1116; Anney, Richard/0000-0002-6083-407X; Schork, Nicholas/0000-0003-0920-5013; Langstrom, Niklas/0000-0002-2686-6799; Willemsen, Gonneke/0000-0003-3755-0236; Kent, Lindsey/0000-0002-5315-3399; MacIntyre, Donald J/0000-0001-6963-1335; Grozeva, Detelina/0000-0003-3239-8415; Curtis, David/0000-0002-4089-9183; MAESTRINI, ELENA/0000-0001-5924-3179; Wassink, Thomas/0000-0002-0952-8333; Tozzi, Federica/0000-0002-3536-2920; Dawson, Geraldine/0000-0003-1410-2764; Ramos-Quiroga, Josep Antoni/0000-0003-1622-0350; ripke, stephan/0000-0003-3622-835X; coryell, william/0000-0003-3989-7276; Zammit, Stanley/0000-0002-2647-9211; Barnes, Michael/0000-0001-9097-7381; Roeder, Kathryn/0000-0002-8869-6254; Boomsma, Dorret/0000-0002-7099-7972; Myin-Germeys, Inez/0000-0002-3731-4930; Lawson, William/0000-0002-9324-7090; Roeyers, Herbert/0000-0002-4895-583X; Bruggeman, Richard/0000-0002-3238-8471; Chen, Guo-Bo/0000-0001-5475-8237; Sanders, Stephan/0000-0001-9112-5148; Raychaudhuri, Soumya/0000-0002-1901-8265; Buxbaum, Joseph/0000-0001-8898-8313; Lewis, Cathryn/0000-0002-8249-8476; Freedman, Robert/0000-0002-2181-2898; Asherson, Philip/0000-0003-2667-2254; Lee, Sang hyuck/0000-0002-5610-033X; Bloss, Cinnamon/0000-0003-1315-8387; Gordon-Smith, Katherine/0000-0003-4083-1143; Weissman, Myrna/0000-0003-3490-3075; Morrow, Eric/0000-0003-3430-3520; Black, Donald/0000-0001-8038-1971; Casas Brugue, Miquel/0000-0003-3496-8522; Hamilton, Steven/0000-0001-8106-6260; Gallagher, Louise/0000-0001-9462-2836; Ennis, Sean/0000-0002-4330-1386; Bass, Nicholas James/0000-0002-4481-778X; Sonuga-Barke, Edmund/0000-0002-6996-3935; Vicente, Astrid/0000-0001-7134-8037; Backlund, Lena/0000-0001-9399-5024; Morken, Gunnar/0000-0003-1972-5901; Donohoe, Gary/0000-0003-3037-7426; Moran, Jennifer/0000-0002-5664-4716	Australian Research Council [FT0991360, DE130100614]; National Health and Medical Research Council [613608, 1011506, 1047956, 1080157]; National Institute of Mental Health (NIMH) [U01 MH085520]; Stanley Center for Psychiatric Research; Sylvan Herman Foundation; Karolinska Institutet, Karolinska University Hospital; Swedish Research Council; Stockholm County Council; Soderstrom Konigska Foundation; Netherlands Scientific Organization [NWO 645-000-003]; Netherlands Scientific Organization (NOW) [480-05-003]; NIMH R01 [MH061686, MH059542, MH075131, MH059552, MH059541, MH060912];  [NIMH R01 MH077139]; MRC [G0300189, G1000708, G0800509] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482, R01MH059541, R01MH090553, R01MH094293, R01MH077139, R01MH063480, R01MH075131, R01MH060912, R01MH059552, U01MH085520, R01MH061686, R01MH059542] Funding Source: NIH RePORTER; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [G0300189, MR/L010305/1, G0800509] Funding Source: researchfish	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanley Center for Psychiatric Research; Sylvan Herman Foundation; Karolinska Institutet, Karolinska University Hospital(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Soderstrom Konigska Foundation; Netherlands Scientific Organization; Netherlands Scientific Organization (NOW); NIMH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Australian Research Council (FT0991360 and DE130100614) and the National Health and Medical Research Council (613608, 1011506, 1047956, and 1080157). The Psychiatric Genomics Consortium is supported by National Institute of Mental Health (NIMH) grant U01 MH085520. We acknowledge the funding that supported the Swedish schizophrenia study (NIMH R01 MH077139), the Stanley Center for Psychiatric Research, the Sylvan Herman Foundation, the Karolinska Institutet, Karolinska University Hospital, the Swedish Research Council, the Stockholm County Council, the Soderstrom Konigska Foundation, and the Netherlands Scientific Organization (NWO 645-000-003). Statistical analyses were carried out on the Genetic Cluster Computer, which is financially supported by the Netherlands Scientific Organization (NOW; 480-05-003). The GenRED GWAS project was supported by NIMH R01 grants MH061686 (D.F.L.), MH059542 (W.C.), MH075131 (W.B. Lawson), MH059552 (J.B.P.), MH059541 (W.A.S.), and MH060912 (M.M.W.).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Chen CY, 2013, BIOINFORMATICS, V29, P1399, DOI 10.1093/bioinformatics/btt144; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Erbe M, 2012, J DAIRY SCI, V95, P4114, DOI 10.3168/jds.2011-5019; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Guo G, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-30; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; HENDERSON CR, 1976, J ANIM SCI, V43, P1188, DOI 10.2527/jas1976.4361188x; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; JOHNSON DL, 1995, J DAIRY SCI, V78, P449, DOI 10.3168/jds.S0022-0302(95)76654-1; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; KIRKPATRICK M, 1990, GENETICS, V124, P979; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071494; Li C, 2014, HUM GENET, V133, P639, DOI 10.1007/s00439-013-1401-5; Lynch M, 1998, GENETICS ANAL QUANTI; Meyer K, 1997, LIVEST PROD SCI, V47, P185, DOI 10.1016/S0301-6226(96)01414-5; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Roche O, 2002, J MED CHEM, V45, P137, DOI 10.1021/jm010934d; Searle SR, 1992, VARIANCE COMPONENTS; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Speed D, 2014, GENOME RES, V24, P1550, DOI 10.1101/gr.169375.113; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; Trusheim MR, 2007, NAT REV DRUG DISCOV, V6, P287, DOI 10.1038/nrd2251; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	45	154	158	1	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					283	294		10.1016/j.ajhg.2014.12.006	http://dx.doi.org/10.1016/j.ajhg.2014.12.006			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25640677	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000349276700010
J	Talmud, PJ; Drenos, F; Shah, S; Shah, T; Palmen, J; Verzilli, C; Gaunt, TR; Pallas, J; Lovering, R; Li, K; Casas, JP; Sofat, R; Kumari, M; Rodriguez, S; Johnson, T; Newhouse, SJ; Dominiczak, A; Samani, NJ; Caulfield, M; Sever, P; Stanton, A; Shields, DC; Padmanabhan, S; Melander, O; Hastie, C; Delles, C; Ebrahim, S; Marmot, MG; Smith, GD; Lawlor, DA; Munroe, PB; Day, IN; Kivimaki, M; Whittaker, J; Humphries, SE; Hingorani, AD				Talmud, Philippa J.; Drenos, Fotios; Shah, Sonia; Shah, Tina; Palmen, Jutta; Verzilli, Claudio; Gaunt, Tom R.; Pallas, Jacky; Lovering, Ruth; Li, Kawah; Casas, Juan Pablo; Sofat, Reecha; Kumari, Meena; Rodriguez, Santiago; Johnson, Toby; Newhouse, Stephen J.; Dominiczak, Anna; Samani, Nilesh J.; Caulfield, Mark; Sever, Peter; Stanton, Alice; Shields, Denis C.; Padmanabhan, Sandosh; Melander, Olle; Hastie, Claire; Delles, Christian; Ebrahim, Shah; Marmot, Michael G.; Smith, George Davey; Lawlor, Debbie A.; Munroe, Patricia B.; Day, Ian N.; Kivimaki, Mika; Whittaker, John; Humphries, Steve E.; Hingorani, Aroon D.		ASCOT Investigators; NORDIL Investigators; BRIGHT Consortium	Gene-centric Association Signals for Lipids and Apolipoproteins Identified via the HumanCVD BeadChip	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; GENOME-WIDE ASSOCIATION; WHITEHALL-II; MYOCARDIAL-INFARCTION; STATISTICAL-MODEL; RISK; LOCI; POPULATION; COHORT	Blood lipids are important cardiovascular disease (CVD) risk factors with both genetic and environmental determinants. The Whitehall II study (n = 5592) was genotyped with the gene-centric HumanCVD BeadChip (Illumina). We identified 195 SNPs in 16 genes/regions associated with 3 major lipid fractions and 2 apolipoprotein components at p < 10(-5), with the associations being broadly concordant with prior genome-wide analysis. SNPs associated with LDL cholesterol and apolipoprotein B were located in LDLR, PCSK9, APOB, CELSR2, HWGCR, CETP, the TOMM40-APOE-C1-C2-C4 cluster, and the APOA5-A4-C3-A1 cluster; SNPs associated with HDL cholesterol and apolipoprotein AI were in CETP, LPL, LIPC, APOA5-A4-C3-A1, and ABCA1; and SNPs associated with triglycerides in GCKR, BAZIB, MLXIPL, LPL, and APOA5-A4-C3-A1. For 48 SNPs in previously unreported loci that were significant at p < 10(-4) in Whitehall II, in silico analysis including the British Women's Heart and Health Study, BRIGHT, ASCOT, and NORDIL studies (total n > 12,500) revealed previously unreported associations of SH2B3 (p < 2.2 x 10(-6)), BMPR2 (p < 2.3 x 10(-7)), BCL3/PVRL2 (flanking APOE; p < 4.4 x 10(-8)), and SMARCA4 (flanking LDLR; p < 2.5 x 10(-7)) with LDL cholesterol. Common alleles in these genes explained 6.1%-14.7% of the variance in the five lipid-related traits, and individuals at opposite tails of the additive allele score exhibited substantial differences in trait levels (e.g., > 1 mmol/L in LDL cholesterol [similar to 1 SD of the trait distribution]). These data suggest that multiple common alleles of small effect can make important contributions to individual differences in blood lipids potentially relevant to the assessment of CVD risk. These genes provide further insights into lipid metabolism and the likely effects of modifying the encoded targets therapeutically.	[Verzilli, Claudio; Casas, Juan Pablo; Ebrahim, Shah; Whittaker, John] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Talmud, Philippa J.; Drenos, Fotios; Pallas, Jacky; Lovering, Ruth; Li, Kawah; Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Shah, Tina; Sofat, Reecha; Hingorani, Aroon D.] UCL, Dept Med, Ctr Clin Pharmacol, London WC1E 6JF, England; [Shah, Sonia; Humphries, Steve E.] UCL, Genet Inst, Dept Genet Environm & Evolut, London WC1E 6BT, England; [Palmen, Jutta] UCL, Wolfson Inst Biol Res, London WC1E 6BT, England; [Kumari, Meena; Marmot, Michael G.; Kivimaki, Mika; Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London WC1E 6BT, England; [Gaunt, Tom R.; Rodriguez, Santiago; Smith, George Davey; Lawlor, Debbie A.; Day, Ian N.] Univ Bristol, Dept Social Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Johnson, Toby; Newhouse, Stephen J.; Caulfield, Mark; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Barts & London Genome Ctr, London EC1M 6BQ, England; [Dominiczak, Anna; Padmanabhan, Sandosh; Hastie, Claire; Delles, Christian] Univ Glasgow, Div Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Western Infirm, Glasgow G12 8TA, Lanark, Scotland; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Sever, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1NY, England; [Stanton, Alice] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Shields, Denis C.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Melander, Olle] Malmo Univ Hosp, Clin Res Ctr, SE-20502 Malmo, Sweden	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Bristol; University of London; Queen Mary University London; University of Glasgow; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Imperial College London; Royal College of Surgeons - Ireland; University College Dublin; Lund University; Skane University Hospital	Whittaker, J (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England.	john.whittaker@Ishtm.ac.uk	Kivimaki, Mika/B-3607-2012; Padmanabhan, Sandosh/S-3963-2016; Shah, Sonia/N-7547-2013; Gaunt, Tom R/O-3918-2014; Newhouse, Stephen J/C-9330-2011; Dominiczak, Anna F/P-9390-2017; Whittaker, John C/B-8609-2012; Stanton, Alice V/F-4697-2012; Dominiczak, Anna F/D-2262-2009; Marmot, M G/Y-3920-2019; Davey Smith, George/A-7407-2013; Pallas, Jacqueline A/C-2994-2008	Kivimaki, Mika/0000-0002-4699-5627; Shah, Sonia/0000-0001-5860-4526; Gaunt, Tom R/0000-0003-0924-3247; Newhouse, Stephen J/0000-0002-1843-9842; Dominiczak, Anna F/0000-0003-4913-3608; Whittaker, John C/0000-0002-3529-2379; Marmot, M G/0000-0002-2431-6419; Davey Smith, George/0000-0002-1407-8314; Munroe, Patricia/0000-0002-4176-2947; Hingorani, Aroon/0000-0001-8365-0081; Stanton, Alice/0000-0002-4961-165X; s, hema/0000-0002-3440-9475; Melander, Olle/0000-0002-2581-484X; Humphries, Stephen E/0000-0002-8221-6547; Sofat, Reecha/0000-0002-0242-6115; Shah, Tina/0000-0001-7724-7210; Pallas, Jacqueline/0000-0002-2207-3185; Talmud, Philippa/0000-0002-5560-1933; Kumari, Meena/0000-0001-9716-1035; Caulfield, Mark/0000-0001-9295-3594; Shields, Denis/0000-0003-4015-2474; Johnson, Toby/0000-0002-5998-3270; Rodriguez, Santiago/0000-0001-6551-932X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lawlor, Debbie A/0000-0002-6793-2262; Padmanabhan, Sandosh/0000-0003-3869-5808; Lovering, Ruth/0000-0002-9791-0064	British Heart Foundation (BHF) [PG/07/133/24260, RG/08/008, SP/07/007/23671, FS/2005/125]; National Heart Lung and Blood Institute (NHLBI) [HL36310]; Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Institute on Aging, NIH, US [AG13196]; Agency for Health Care Policy Research [HS06516]; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; BHF; UK Department of Health; BHF [PG/07/131/24254, FS/05/065/19497, RG/07/005/23633, SP/08/005/25115]; Medical Research Council of Great Britain [G9521010D]; British Heart Foundation [PG/02/128]; EU Ingenious HyperCare Consortium; Integrated Genomics, Clinical Research, and Care in Hypertension [LSHM-C7-2006-037093]; Pfizer, New York, NY, USA; Servier Research Group, Paris, France; Leo Laboratories, Copenhagen, Denmark; MRC UK; US NIH [NHLBI 33014]; Du Pont Pharma, Wilmington, VA, USA; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R37AG013196] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674, SP/07/007/23671, RG/08/008/25291] Funding Source: researchfish; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G8802774, G0100222, G0600705, G19/35, G9521010] Funding Source: researchfish; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0600705, G9521010] Funding Source: UKRI	British Heart Foundation (BHF)(British Heart Foundation); National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive; Department of Health; National Institute on Aging, NIH, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; BHF(British Heart Foundation); UK Department of Health; BHF(British Heart Foundation); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); EU Ingenious HyperCare Consortium; Integrated Genomics, Clinical Research, and Care in Hypertension; Pfizer, New York, NY, USA(Pfizer); Servier Research Group, Paris, France; Leo Laboratories, Copenhagen, Denmark; MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Du Pont Pharma, Wilmington, VA, USA; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work on WH-II was supported by the British Heart Foundation (BHF) PG/07/133/24260, RG/08/008, SP/07/007/23671, and a Senior Fellowship to A.D.H. (FS/2005/125). S.E.H., A.D., and N.J.S. are BHF Chairholders. M. Kumari's time on this manuscript was partially supported by the National Heart Lung and Blood Institute (NHLBI: HL36310). The WH-II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Institute on Aging, NIH, US (AG13196); Agency for Health Care Policy Research (HS06516); and the John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. The British Women's Heart and Health Study (BWHHS) has been supported by funding from the BHF and the UK Department of Health. We thank all BWHHS participants and the BWHHS team for their contributions. HumanCVD BeadChip genotyping was funded by the BHF (PG/07/131/24254, PI T.R.G.). I.N.D. thanks the University of Bristol for set-up costs for Bristol Genetics Epidemiology Laboratory. Gemma Wiacek is thanked for sample handling. T.R.G. was a BHF Intermediate Fellow (FS/05/065/19497). The BRIGHT study is supported by the Medical Research Council of Great Britain (G9521010D) and the British Heart Foundation (PG/02/128). We would also like to thank Charles Mein, Richard Dobson, and the Barts Genome Centre staff. The BRIGHT study is extremely grateful to all the patients who participated in the study and the BRIGHT nursing team. A.D. is also supported by BHF grants (RG/07/005/23633 and SP/08/005/25115) and EU Ingenious HyperCare Consortium: Integrated Genomics, Clinical Research, and Care in Hypertension (LSHM-C7-2006-037093).; We thank all ASCOT trial participants, physicians, nurses, and practices in the participating countries for their important contribution to the study. In particular we thank Clare Muckian and David Toomey for their help in DNA extraction, storage, and handling. The ASCOT study and the collection of the ASCOT DNA repository were supported by Pfizer, New York, NY, USA. Funding for the ASCOT study was also provided by Servier Research Group, Paris, France, and Leo Laboratories, Copenhagen, Denmark. NPHSII was supported by MRC UK, US NIH (NHLBI 33014), and Du Pont Pharma, Wilmington, VA, USA. We thank Professor Thomas Hedner (Department of Clinical Pharmacology, Sahlgrenska Academy, Gotheburg, Sweden) and Professor Sverre Kjeldsen (Ullevaal University Hospital, University of Oslo, Oslo, Norway), who are investigators of the NORDIL study. Professor Kjeldsen is also an investigator of the ASCOT trial.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Boekholdt SM, 2005, CIRCULATION, V111, P278, DOI 10.1161/01.CIR.0000153341.46271.40; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Giltay EJ, 2009, J AFFECT DISORDERS, V115, P471, DOI 10.1016/j.jad.2008.10.004; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Hunter DJ, 2008, NEW ENGL J MED, V358, P2760, DOI 10.1056/NEJMp0804318; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lanktree MB, 2009, J LIPID RES, V50, P1487, DOI 10.1194/jlr.P900008-JLR200; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; LINSELNITSCHKE P, 2009, ATHEROSCLER IN PRESS, DOI DOI 10.1016/J.ATHEROSCIEROSIS.2009.06.034; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; MILLER GJ, 1995, THROMB HAEMOSTASIS, V73, P82; MOUNT JN, 1988, J CLIN PATHOL, V41, P471, DOI 10.1136/jcp.41.4.471; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sever PS, 2001, J HYPERTENS, V19, P1139, DOI 10.1097/00004872-200106000-00020; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; SOFAT R, 2009, CIRCULATION IN PRESS; Talmud PJ, 2004, ATHEROSCLEROSIS, V177, P105, DOI 10.1016/j.atherosclerosis.2004.06.008; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P2450, DOI 10.1161/ATVBAHA.107.150680; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	46	154	159	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					628	642		10.1016/j.ajhg.2009.10.014	http://dx.doi.org/10.1016/j.ajhg.2009.10.014			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19913121	Green Published, Bronze			2022-12-18	WOS:000271916500010
J	Xiong, DH; Liu, XG; Guo, YF; Tan, LJ; Wang, L; Sha, BY; Tang, ZH; Pan, F; Yang, TL; Chen, XD; Lei, SF; Yerges, LM; Zhu, XZ; Wheeler, VW; Patrick, AL; Bunker, CH; Guo, Y; Yan, H; Pei, YF; Zhang, YP; Levy, S; Papasian, CJ; Xiao, P; Lundberg, YW; Recker, RR; Liu, YZ; Liu, YJ; Zmuda, JM; Deng, HW				Xiong, Dong-Hai; Liu, Xiao-Gang; Guo, Yan-Fang; Tan, Li-Jun; Wang, Liang; Sha, Bao-Yong; Tang, Zi-Hui; Pan, Feng; Yang, Tie-Lin; Chen, Xiang-Ding; Lei, Shu-Feng; Yerges, Laura M.; Zhu, Xue-Zen; Wheeler, Victor W.; Patrick, Alan L.; Bunker, ClareAnn H.; Guo, Yan; Yan, Han; Pei, Yu-Fang; Zhang, Yin-Pin; Levy, Shawn; Papasian, Christopher J.; Xiao, Peng; Lundberg, Y. Wang; Recker, Robert R.; Liu, Yao-Zhong; Liu, Yong-Jun; Zmuda, Joseph M.; Deng, Hong-Wen			Genome-wide Association and Follow-Up Replication Studies Identified ADAMTS18 and TGFBR3 as Bone Mass Candidate Genes in Different Ethnic Groups	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MINERAL DENSITY; ELDERLY-MEN; OSTEOPOROSIS; RECEPTOR; POLYMORPHISM; ANCESTRY; AFRICAN; TESTS; WOMEN; HEART	To identify and validate genes associated with bone mineral density (BMD), which is a prominent osteoporosis risk factor, we tested 379,319 SNPs in 1000 unrelated white U.S. subjects for associations with BMD. For replication, we genotyped the most significant SNPs in S93 white U.S. families (1972 subjects), a Chinese hip fracture (HF) sample (350 cases, 350 controls), a Chinese BMD sample (2955 subjects), and a Tobago cohort of African ancestry (908 males). Publicly available Framingham genome-wide association study (GWAS) data (29S3 whites) were also used for in silico replication. The GWAS detected two BMD candidate genes, ADAMTS18 (ADAM metallopeptidase with thrombospondin type 1 motif, 18) and TGFBR3 (transforming growth factor, beta receptor III). Replication studies verified the significant findings by GWAS. We also detected significant associations with hip fracture for ADAMTS18 SNPs in the Chinese HF sample. Meta-analyses supported the significant associations of ADAMTS18 and TGFBR3 with BMD (p values; 2.56 x 1.0(-5) to 2.13 x 10(-8); total sample size: n = 5925 to 9828). Electrophoretic mobility shift assay suggested that the minor allele of one significant ADAMTS18 SNP might promote binding of the TEL2 factor, which may repress ADAMTS18 expression. The data from NCBI GEO expression profiles also showed that ADAMTS18 and TGFBR3 genes were differentially expressed in subjects with normal skeletal fracture versus subjects with nonunion skeletal fracture. Overall, the evidence supports that ADAMTS18 and TGFBR3 might underlie BMD determination in the major human ethnic groups.	[Xiong, Dong-Hai; Zhang, Yin-Pin; Papasian, Christopher J.; Liu, Yao-Zhong; Liu, Yong-Jun; Deng, Hong-Wen] Univ Missouri, Dept Orthoped Surg & Basic Med Sci, Kansas City, MO 64108 USA; [Liu, Xiao-Gang; Guo, Yan-Fang; Wang, Liang; Pan, Feng; Yang, Tie-Lin; Zhu, Xue-Zen; Guo, Yan; Yan, Han; Pei, Yu-Fang; Deng, Hong-Wen] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China; [Liu, Xiao-Gang; Guo, Yan-Fang; Wang, Liang; Pan, Feng; Yang, Tie-Lin; Zhu, Xue-Zen; Guo, Yan; Yan, Han; Pei, Yu-Fang; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Peoples R China; [Tan, Li-Jun; Sha, Bao-Yong; Tang, Zi-Hui; Chen, Xiang-Ding; Lei, Shu-Feng; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha 410081, Hunan, Peoples R China; [Xiao, Peng; Recker, Robert R.; Deng, Hong-Wen] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68131 USA; [Yerges, Laura M.; Bunker, ClareAnn H.; Zmuda, Joseph M.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Zmuda, Joseph M.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA; [Wheeler, Victor W.; Patrick, Alan L.] Tobago Hlth Studies Off, Scarborough, Tobago, Trinidad Tobago; [Levy, Shawn] Vanderbilt Univ, Nashville, TN 37232 USA; [Lundberg, Y. Wang] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA	University of Missouri System; University of Missouri Kansas City; Xi'an Jiaotong University; Xi'an Jiaotong University; Hunan Normal University; Creighton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Boys Town National Research Hospital	Deng, HW (corresponding author), Univ Missouri, Dept Orthoped Surg & Basic Med Sci, Kansas City, MO 64108 USA.	dengh@umkc.edu	Liu, Yaozhong/ABD-5544-2020; Guo, Yan/G-8742-2014; Yang, Tie-Lin/G-8365-2014; Liu, Yong/GWQ-6163-2022; XIONG, DONGHAI/A-3691-2010; Tan, Li-Jun/AAO-1130-2020; Tang, Zihui/P-2222-2016	Guo, Yan/0000-0002-7364-2392; Yang, Tie-Lin/0000-0001-7062-3025; Deng, Hong-Wen/0000-0002-0387-8818; Levy, Shawn/0000-0002-1369-5740	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, R01AR049747, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR049747, R01 AR050496, R01 AR050496-01, P50 AR055081] Funding Source: Medline; NIA NIH HHS [R01 AG026564, R21 AG027110] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Braun A, 2003, EUR J PEDIATR, V162, pS13, DOI 10.1007/s00431-003-1343-3; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; CUMMINGS SR, 1995, AM J MED, V98, pS24, DOI 10.1016/S0002-9343(05)80041-5; Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1; Gu XS, 2001, J BIOL CHEM, V276, P9421, DOI 10.1074/jbc.M010070200; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; HANNAN MT, 1992, J BONE MINER RES, V7, P547; Hill DD, 2008, OSTEOPOROSIS INT, V19, P227, DOI 10.1007/s00198-007-0450-9; Horner A, 1998, BONE, V23, P95, DOI 10.1016/S8756-3282(98)00080-5; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Liu YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003160; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Liu YZ, 2003, J ENDOCRINOL, V177, P147, DOI 10.1677/joe.0.1770147; Macdonald HM, 2006, J BONE MINER RES, V21, P151, DOI 10.1359/JBMR.050906; Miljkovic-Gacic I, 2005, HUM HERED, V60, P129, DOI 10.1159/000089553; Potter MD, 2000, BLOOD, V95, P3341, DOI 10.1182/blood.V95.11.3341.011k44_3341_3348; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ralston SH, 2006, PLOS MED, V3, P515, DOI 10.1371/journal.pmed.0030090; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	34	154	164	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					388	398		10.1016/j.ajhg.2009.01.025	http://dx.doi.org/10.1016/j.ajhg.2009.01.025			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19249006	Bronze, Green Published			2022-12-18	WOS:000264304200009
J	Roeder, K; Bacanu, SA; Wasserman, L; Devlin, B				Roeder, K; Bacanu, SA; Wasserman, L; Devlin, B			Using linkage genome scans to improve power of association in genome scans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FALSE DISCOVERY RATE; COMPLEX TRAITS; RATES	Scanning the genome for association between markers and complex diseases typically requires testing hundreds of thousands of genetic polymorphisms. Testing such a large number of hypotheses exacerbates the trade-off between power to detect meaningful associations and the chance of making false discoveries. Even before the full genome is scanned, investigators often favor certain regions on the basis of the results of prior investigations, such as previous linkage scans. The remaining regions of the genome are investigated simultaneously because genotyping is relatively inexpensive compared with the cost of recruiting participants for a genetic study and because prior evidence is rarely sufficient to rule out these regions as harboring genes with variation of conferring liability ( liability genes). However, the multiple testing inherent in broad genomic searches diminishes power to detect association, even for genes falling in regions of the genome favored a priori. Multiple testing problems of this nature are well suited for application of the false-discovery rate ( FDR) principle, which can improve power. To enhance power further, a new FDR approach is proposed that involves weighting the hypotheses on the basis of prior data. We present a method for using linkage data to weight the association P values. Our investigations reveal that if the linkage study is informative, the procedure improves power considerably. Remarkably, the loss in power is small, even when the linkage study is uninformative. For a class of genetic models, we calculate the sample size required to obtain useful prior information from a linkage study. This inquiry reveals that, among genetic models that are seemingly equal in genetic information, some are much more promising than others for this mode of analysis.	Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; GlaxoSmithKline, Dept Genet Res, Res Triangle Pk, NC USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; GlaxoSmithKline	Roeder, K (corresponding author), Carnegie Mellon Univ, Dept Stat, 232 Baker Hall, Pittsburgh, PA 15213 USA.	roeder@stat.cmu.edu		Roeder, Kathryn/0000-0002-8869-6254; Bacanu, Silviu-Alin/0000-0002-4364-1583	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057881] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH057881, MH057881, R37 MH057881] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bacanu SA, 2005, GENET EPIDEMIOL, V28, P24, DOI 10.1002/gepi.20030; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Devlin B, 2003, HEREDITY, V91, P537, DOI 10.1038/sj.hdy.6800370; Devlin B, 2003, GENET EPIDEMIOL, V25, P36, DOI 10.1002/gepi.10237; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Genovese C, 2003, BAYESIAN STATISTICS 7, P145; Genovese C, 2002, J ROY STAT SOC B, V64, P499, DOI 10.1111/1467-9868.00347; GENOVESE CR, IN PRESS BIOMETRIKA; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HOLM S, 1979, SCAND J STAT, V6, P65; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Pfeiffer RM, 2003, GENET EPIDEMIOL, V25, P136, DOI 10.1002/gepi.10245; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; Sabatti C, 2003, GENETICS, V164, P829; Satagopan JM, 2003, GENET EPIDEMIOL, V25, P149, DOI 10.1002/gepi.10260; SOBELL JL, 1993, AM J MED GENET, V48, P28, DOI 10.1002/ajmg.1320480108; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1198/TECH.2003.S33, 10.1007/978-0-387-21706-2]	27	154	162	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					243	252		10.1086/500026	http://dx.doi.org/10.1086/500026			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16400608	Green Published, Bronze			2022-12-18	WOS:000236744900006
J	Arcos-Burgos, M; Castellanos, FX; Pineda, D; Lopera, F; Palacio, JD; Palacio, LG; Rapoport, JL; Berg, K; Bailey-Wilson, JE; Muenke, M				Arcos-Burgos, M; Castellanos, FX; Pineda, D; Lopera, F; Palacio, JD; Palacio, LG; Rapoport, JL; Berg, K; Bailey-Wilson, JE; Muenke, M			Attention-deficit/hyperactivity disorder in a population isolate: Linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIT HYPERACTIVITY DISORDER; FAMILY-BASED ASSOCIATION; SEGREGATION ANALYSIS; BIPOLAR DISORDER; GENERAL-CLASS; GENETIC-ANALYSIS; GENOMEWIDE SCAN; COMPLEX TRAITS; POWER; CHILDREN	Attention-deficit/hyperactivity disorder (ADHD [MIM 143465]) is the most common behavioral disorder of childhood. Twin, adoption, segregation, association, and linkage studies have confirmed that genetics plays a major role in conferring susceptibility to ADHD. We applied model-based and model-free linkage analyses, as well as the pedigree disequilibrium test, to the results of a genomewide scan of extended and multigenerational families with ADHD from a genetic isolate. In these families, ADHD is highly comorbid with conduct and oppositional defiant disorders, as well as with alcohol and tobacco dependence. We found evidence of linkage to markers at chromosomes 4q13.2, 5q33.3, 8q11.23, 11q22, and 17p11 in individual families. Fine mapping applied to these regions resulted in significant linkage in the combined families at chromosomes 4q13.2 (two-point allele-sharing LOD score from LODPAL = 4.44 at D4S3248), 5q33.3 (two-point allele-sharing LOD score from LODPAL = 8.22 at D5S490), 11q22 (two-point allele-sharing LOD score from LODPAL = 5.77 at D11S1998; multipoint nonparametric linkage [NPL] - log [P value] = 5.49 at similar to128 cM), and 17p11 (multipoint NPL - log [P value] >12 at similar to12 cM; multipoint maximum location score 2.48 [alpha = 0.10] at similar to12 cM; two-point allele-sharing LOD score from LODPAL = 3.73 at D17S1159). Additionally, suggestive linkage was found at chromosome 8q11.23 (combined two-point NPL - log [P value] >3.0 at D8S2332). Several of these regions are novel (4q13.2, 5q33.3, and 8q11.23), whereas others replicate already-published loci (11q22 and 17p11). The concordance between results from different analytical methods of linkage and the replication of data between two independent studies suggest that these loci truly harbor ADHD susceptibility genes.	NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NIMH, NIH, Bethesda, MD 20892 USA; Univ Antioquia, Populat Genet Mutacarcinogenesis & Genet Epidemio, Medellin, Colombia; Univ Antioquia, Neurosci Grp, Medellin, Colombia; NYU, Ctr Child Study, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Universidad de Antioquia; Universidad de Antioquia; New York University	Muenke, M (corresponding author), NHGRI, Med Genet Branch, NIH, 35 Convent Dr,MSC 3717,Bldg 35,Room 1B-203, Bethesda, MD 20892 USA.	mmuenke@nhgri.nih.gov	LOPERA, FRANCISCO/AAR-5968-2021; Palacio, Luis/AAG-7435-2020; Pineda, David/AAE-4785-2020; Castellanos, Francisco Xavier/K-1892-2014; Arcos-Burgos, Mauricio/H-1326-2017	Castellanos, Francisco Xavier/0000-0001-9192-9437; Palacio, Juan David/0000-0002-1584-4391; Palacio, Luis G/0000-0002-5203-8268; Muenke, Maximilian/0000-0002-7719-6545; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Pineda, David A/0000-0002-1080-4796; Bailey-Wilson, Joan/0000-0002-9153-2920	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000175, Z01HG200327, Z01HG000175, ZIAHG200327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002240, ZIAMH002240] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Acosta MT, 2004, GENET MED, V6, P1, DOI 10.1097/01.GIM.0000110413.07490.0B; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Arcos-Burgos M, 2004, MOL PSYCHIATR, V9, P252, DOI 10.1038/sj.mp.4001396; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Arcos-Burgos M, 2002, CLIN GENET, V61, P335, DOI 10.1034/j.1399-0004.2002.610503.x; Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; Bhat A, 1999, HUM HERED, V49, P229, DOI 10.1159/000022879; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; Bravo ML, 1996, GENE GEOGR, V10, P11; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chang KKD, 2000, J AM ACAD CHILD PSY, V39, P453, DOI 10.1097/00004583-200004000-00014; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Elston RC, 2002, BIOSTATISTICAL GENET; Faraone SV, 1996, J AM ACAD CHILD PSY, V35, P1449, DOI 10.1097/00004583-199611000-00013; Faraone SV, 2000, GENET EPIDEMIOL, V18, P1; FARAONE SV, 1992, PSYCHIATR GENET, V2, P257, DOI 10.1097/00041444-199210000-00004; Faraone SV, 2001, J AFFECT DISORDERS, V64, P19, DOI 10.1016/S0165-0327(00)00213-5; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; Foley HA, 1996, B AM ACAD PSYCH LAW, V24, P333; Geller B, 2002, J CHILD ADOL PSYCHOP, V12, P3, DOI 10.1089/10445460252943524; Giedd JN, 2000, J CLIN PSYCHIAT, V61, P31; GILLIS JJ, 1992, J ABNORM CHILD PSYCH, V20, P303, DOI 10.1007/BF00916694; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; GREENBERG DA, 1994, AM J HUM GENET, V55, P834; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GREENFIELD B, 1988, CAN J PSYCHIAT, V33, P505, DOI 10.1177/070674378803300612; Harada Y, 2002, PSYCHIAT CLIN NEUROS, V56, P365, DOI 10.1046/j.1440-1819.2002.01024.x; Jimenez I., 1996, Biological Research, V29, P297; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Lopera F, 1999, REV NEUROLOGIA, V28, P660, DOI 10.33588/rn.2807.98517; Lopera F, 2001, REV NEUROLOGIA, V32, P222, DOI 10.33588/rn.3203.2000427; Maher BS, 1999, AM J MED GENET, V88, P71, DOI 10.1002/(SICI)1096-8628(19990205)88:1<71::AID-AJMG13>3.0.CO;2-D; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; MORRISON JR, 1973, ARCH GEN PSYCHIAT, V28, P888; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Ogdie MN, 2004, AM J HUM GENET, V75, P661, DOI 10.1086/424387; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Ott J, 1999, EUR CHILD ADOLES PSY, V8, P43; Pineda D, 1999, J ABNORM CHILD PSYCH, V27, P455, DOI 10.1023/A:1021932009936; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; RISCH N, 1990, AM J HUM GENET, V46, P229; Risch N, 1997, SCIENCE, V275, P1329; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RISCH N, 1991, AM J HUM GENET, V48, P1058; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tacchini G, 1994, Minerva Psichiatr, V35, P63; VANDENOORD EJCG, 1994, BEHAV GENET, V24, P193, DOI 10.1007/BF01067187	60	154	164	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					998	1014		10.1086/426154	http://dx.doi.org/10.1086/426154			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15497111	Green Published, Bronze			2022-12-18	WOS:000224866400006
J	Trimborn, M; Bell, SM; Felix, C; Rashid, Y; Jafri, H; Griffiths, PD; Neumann, LM; Krebs, A; Reis, A; Sperling, K; Neitzel, H; Jackson, AP				Trimborn, M; Bell, SM; Felix, C; Rashid, Y; Jafri, H; Griffiths, PD; Neumann, LM; Krebs, A; Reis, A; Sperling, K; Neitzel, H; Jackson, AP			Mutations in Microcephalin cause aberrant regulation of chromosome condensation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAPS; LOCUS; MITOSIS; SIZE	Microcephalin (MCPH1) is a gene mutated in primary microcephaly, an autosomal recessive neurodevelopmental disorder in which there is a marked reduction in brain size. PCC syndrome is a recently described disorder of microcephaly, short stature, and misregulated chromosome condensation. Here, we report the finding that MCPH1 primary microcephaly and PCC syndrome are allelic disorders, both having mutations in the MCPH1 gene. The two conditions share a common cellular phenotype of premature chromosome condensation in the early G2 phase of the cell cycle, which, therefore, appears to be a useful diagnostic marker for individuals with MCPH1 gene mutations. We demonstrate that an siRNA-mediated depletion of MCPH1 is sufficient to reproduce this phenotype and also show that MCPH1-deficient cells exhibit delayed decondensation postmitosis. These findings implicate microcephalin as a novel regulator of chromosome condensation and link the apparently disparate fields of neurogenesis and chromosome biology. Further characterization of MCPH1 is thus likely to lead to fundamental insights into both the regulation of chromosome condensation and neurodevelopment.	Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Humboldt Univ, Charite Univ Med Berlin, Inst Human Genet, Berlin, Germany; St Jamess Univ Hosp, Dept Clin Genet, Leeds, W Yorkshire, England; St Jamess Univ Hosp, Reg Cytogenet Unit, Leeds, W Yorkshire, England; Genetec Lab, Lahore, Pakistan; Univ Sheffield, Acad Unit Radiol, Sheffield, S Yorkshire, England; Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany	Saint James's University Hospital; University of Leeds; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; University of Sheffield; University of Erlangen Nuremberg	Jackson, AP (corresponding author), Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England.	medapj@leeds.ac.uk	Reis, André/D-2309-2009; Jackson, Andrew/D-3442-2009	Reis, André/0000-0002-6301-6363; Jackson, Andrew/0000-0002-8739-2646; Bell, Sandra/0000-0002-3022-9864				Barkovich AJ, 2001, NEUROLOGY, V57, P2168, DOI 10.1212/WNL.57.12.2168; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Dobyns WB, 2002, AM J MED GENET, V112, P315, DOI 10.1002/ajmg.10580; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; ROONEY DE, 2001, HUM CYTOGENETICS PRA; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Watrin E, 2003, BIOL CELL, V95, P507, DOI 10.1016/j.biolcel.2003.08.003	20	154	165	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					261	266		10.1086/422855	http://dx.doi.org/10.1086/422855			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15199523	Green Published, Bronze			2022-12-18	WOS:000222702000010
J	Durrant, C; Zondervan, KT; Cardon, LR; Hunt, S; Deloukas, P; Morris, AP				Durrant, C; Zondervan, KT; Cardon, LR; Hunt, S; Deloukas, P; Morris, AP			Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; DISEASE; ASSOCIATION; RECONSTRUCTION; GENE	We present a novel approach to disease-gene mapping via cladistic analysis of single-nucleotide polymorphism (SNP) haplotypes obtained from large-scale, population-based association studies, applicable to whole-genome screens, candidate-gene studies, or fine-scale mapping. Clades of haplotypes are tested for association with disease, exploiting the expected similarity of chromosomes with recent shared ancestry in the region flanking the disease gene. The method is developed in a logistic-regression framework and can easily incorporate covariates such as environmental risk factors or additional unlinked loci to allow for population structure. To evaluate the power of this approach to detect disease-marker association, we have developed a simulation algorithm to generate high-density SNP data with short-range linkage disequilibrium based on empirical patterns of haplotype diversity. The results of the simulation study highlight substantial gains in power over single-locus tests for a wide range of disease models, despite overcorrection for multiple testing.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Wellcome Trust Sanger Inst, Hinxton, England	University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute	Morris, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	amorris@well.ox.ac.uk	Zondervan, Krina T/M-1143-2013; Deloukas, Panos/B-2922-2013	Zondervan, Krina T/0000-0002-0275-9905; Deloukas, Panos/0000-0001-9251-070X; Hunt, Sarah/0000-0002-8350-1235				Bertranpetit J, 1996, CIBA F SYMP, V197, P97; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; EVERITT BS, 1993, CLUSTER ANAL, P55; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Molitor J, 2003, AM J HUM GENET, V73, P1368, DOI 10.1086/380415; Molitor J, 2003, GENET EPIDEMIOL, V25, P95, DOI 10.1002/gepi.10251; Morris AP, 2002, AM J HUM GENET, V70, P686, DOI 10.1086/339271; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rubinsztein DC, 1999, DEMENT GERIATR COGN, V10, P199, DOI 10.1159/000017120; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	20	154	157	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					35	43		10.1086/422174	http://dx.doi.org/10.1086/422174			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15148658	Green Published, Bronze			2022-12-18	WOS:000222031300005
J	Tiranti, V; D'Adamo, P; Briem, E; Ferrari, G; Mineri, R; Lamantea, E; Mandel, H; Balestri, P; Garcia-Silva, MT; Vollmer, B; Rinaldo, P; Hahn, SH; Leonard, J; Rahman, S; Dionisi-Vici, C; Garavaglia, B; Gasparini, P; Zeviani, M				Tiranti, V; D'Adamo, P; Briem, E; Ferrari, G; Mineri, R; Lamantea, E; Mandel, H; Balestri, P; Garcia-Silva, MT; Vollmer, B; Rinaldo, P; Hahn, SH; Leonard, J; Rahman, S; Dionisi-Vici, C; Garavaglia, B; Gasparini, P; Zeviani, M			Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-OXIDASE DEFICIENCY; HUMAN GLYOXALASE II; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; CLINICAL PHENOTYPE; LIVER-MITOCHONDRIA; ACIDURIA; IDENTIFICATION; OXIDATION; ENZYMES	Ethylmalonic encephalopathy (EE) is a devastating infantile metabolic disorder affecting the brain, gastrointestinal tract, and peripheral vessels. High levels of ethylmalonic acid are detected in the body fluids, and cytochrome c oxidase activity is decreased in skeletal muscle. By use of a combination of homozygosity mapping, integration of physical and functional genomic data sets, and mutational screening, we identified GenBank D83198 as the gene responsible for EE. We also demonstrated that the D83198 protein product is targeted to mitochondria and internalized into the matrix after energy-dependent cleavage of a short leader peptide. The gene had previously been known as "HSCO" (for (h) under bar epatoma (s) under bar ubtracted (c) under bar lone (o) under bar ne). However, given its role in EE, the name of the gene has been changed to "ETHE1." The severe consequences of its malfunctioning indicate an important role of the ETHE1 gene product in mitochondrial homeostasis and energy metabolism.	Natl Neurol Inst Carlo Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, I-20133 Milan, Italy; TIGEM, Linkage Unit & Serv, Naples, Italy; Technion Fac Med, Rambam Med Ctr, Dept Pediat, Metab Dis Unit, Haifa, Israel; Univ Siena, Dept Pediat, I-53100 Siena, Italy; Hosp 12 Octubre, Dept Pediat, E-28041 Madrid, Spain; Univ Tubingen, Childrens Hosp, Tubingen, Germany; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Biochem Genet Lab, Rochester, MN 55905 USA; Inst Child Hlth, Biochem Endocrinol & Metab Unit, London, England; Childrens Hosp Bambino Gesu, Metab Dis Unit, Rome, Italy	IRCCS Istituto Neurologico Besta; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Siena; Hospital Universitario 12 de Octubre; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Mayo Clinic; University of London; University College London; IRCCS Bambino Gesu	Zeviani, M (corresponding author), Natl Neurol Inst Carlo Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Via Temolo 4, I-20133 Milan, Italy.	zeviani@tin.it	Lamantea, Eleonora/J-8339-2016; Garavaglia, Barbara/J-5257-2018; Tiranti, Valeria/J-8233-2016; Rahman, Shamima/M-7904-2019; Zeviani, Massimo/AAU-2632-2021; Rahman, Shamima/C-5232-2008; Dionisi-Vici, Carlo/K-2045-2018; d'Adamo, Adamo Pio/G-4064-2011; Zeviani, Massimo/K-2891-2014; Tiranti, Valeria/AFN-5783-2022	Lamantea, Eleonora/0000-0001-5090-6028; Garavaglia, Barbara/0000-0003-4323-9145; Tiranti, Valeria/0000-0002-3584-7338; Zeviani, Massimo/0000-0002-9067-5508; Rahman, Shamima/0000-0003-2088-730X; Dionisi-Vici, Carlo/0000-0002-0007-3379; d'Adamo, Adamo Pio/0000-0001-9367-4909; Tiranti, Valeria/0000-0002-3584-7338; Vollmer, Brigitte/0000-0003-4088-5336; /0000-0003-2897-4918; Gasparini, Paolo/0000-0002-0859-0856	Telethon [TGM06S01, TGM03Z03, 1180] Funding Source: Medline	Telethon(Fondazione Telethon)		Aravind L, 1999, In Silico Biol, V1, P69; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445; Bito A, 1997, J BIOL CHEM, V272, P21509, DOI 10.1074/jbc.272.34.21509; Bito A, 1999, PROTEIN EXPRES PURIF, V17, P456, DOI 10.1006/prep.1999.1151; BURLINA AB, 1991, LANCET, V338, P1522, DOI 10.1016/0140-6736(91)92338-3; BURLINA AB, 1994, J PEDIATR-US, V124, P79, DOI 10.1016/S0022-3476(94)70257-8; CORNBERG A, 1955, METHOD ENZYMOL, V1, P441; Corydon MJ, 2001, PEDIATR RES, V49, P18; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; GARAVAGLIA B, 1994, J INHERIT METAB DIS, V17, P301, DOI 10.1007/BF00711813; GarciaSilva MT, 1997, PEDIATR NEUROL, V17, P165, DOI 10.1016/S0887-8994(97)00048-9; Grosso S, 2002, J NEUROL, V249, P1446, DOI 10.1007/s00415-002-0880-4; Higashitsuji H, 2002, CANCER CELL, V2, P335, DOI 10.1016/S1535-6108(02)00152-6; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAMER OA, 1976, BIOCHEM J, V160, P417, DOI 10.1042/bj1600417a; MANTAGOS S, 1979, J CLIN INVEST, V64, P1580, DOI 10.1172/JCI109619; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Nowaczyk MJM, 1998, METABOLISM, V47, P836, DOI 10.1016/S0026-0495(98)90122-6; OZAND PT, 1994, BRAIN DEV-JPN, V16, P12, DOI 10.1016/0387-7604(94)90092-2; Ridderstrom M, 2000, BBA-PROTEIN STRUCT M, V1481, P344, DOI 10.1016/S0167-4838(00)00178-3; Ridderstrom M, 1996, J BIOL CHEM, V271, P319, DOI 10.1074/jbc.271.1.319; Sobel E, 1996, AM J HUM GENET, V58, P1323; Srere P.A., 1969, METHODS ENZYM, V13, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; TALESA V, 1989, BIOCHIM BIOPHYS ACTA, V993, P7, DOI 10.1016/0304-4165(89)90135-9; TALESA V, 1990, BIOCHEM INT, V20, P53; TANAKA K, 1976, CLIN CHIM ACTA, V69, P105, DOI 10.1016/0009-8981(76)90478-2; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Yoon HR, 2001, J INHERIT METAB DIS, V24, P870, DOI 10.1023/A:1013948409790	31	154	161	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					239	252		10.1086/381653	http://dx.doi.org/10.1086/381653			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14732903	Green Published, Bronze			2022-12-18	WOS:000188860000005
J	Aartsma-Rus, A; Janson, AAM; Kaman, WE; Bremmer-Bout, M; van Ommen, GJB; den Dunnen, JT; van Deutekom, JCT				Aartsma-Rus, A; Janson, AAM; Kaman, WE; Bremmer-Bout, M; van Ommen, GJB; den Dunnen, JT; van Deutekom, JCT			Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MDX MUSCLE-CELLS; MESSENGER-RNA; NONSENSE MUTATION; SPLICE JUNCTIONS; DMD GENE; EXON; OLIGONUCLEOTIDE; EXPRESSION; DELETIONS; DIFFERENTIATION	Dystrophin deficiency, which leads to severe and progressive muscle degeneration in patients with Duchenne muscular dystrophy (DMD), is caused by frameshifting mutations in the dystrophin gene. A relatively new therapeutic strategy is based on antisense oligonucleotides (AONs) that induce the specific skipping of a single exon, such that the reading frame is restored. This allows the synthesis of a largely functional dystrophin, associated with a milder Becker muscular dystrophy phenotype. We have previously successfully targeted 20 different DMD exons that would, theoretically, be beneficial for 175% of all patients. To further enlarge this proportion, we here studied the feasibility of double and multiexon skipping. Using a combination of AONs, double skipping of exon 43 and 44 was induced, and dystrophin synthesis was restored in myotubes from one patient affected by a nonsense mutation in exon 43. For another patient, with an exon 46 - 50 deletion, the therapeutic double skipping of exon 45 and 51 was achieved. Remarkably, in control myotubes, the latter combination of AONs caused the skipping of the entire stretch of exons from 45 through 51. This in-frame multiexon skipping would be therapeutic for a series of patients carrying different DMD-causing mutations. In fact, we here demonstrate its feasibility in myotubes from a patient with an exon 48 - 50 deletion. The application of multiexon skipping may provide a more uniform methodology for a larger group of patients with DMD.	Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Deutekom, JCT (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.	deutekom@lumc.nl	dunnen, johan den/ABH-4228-2020; Kaman, Wendy/B-2976-2012	dunnen, johan den/0000-0002-6304-1710; 				Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Bertoni C, 2003, HUM MOL GENET, V12, P1087, DOI 10.1093/hmg/ddg133; Buratti E, 2003, TRENDS MOL MED, V9, P229, DOI 10.1016/S1471-4914(03)00072-8; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Corey DR, 2001, GENOME BIOL, V2; De Angelis FG, 2002, P NATL ACAD SCI USA, V99, P9456, DOI 10.1073/pnas.142302299; DENDUNNEN J, 1996, LEIDEN MUSCULAR DYST; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; Dennis JU, 1998, CANCER LETT, V128, P65, DOI 10.1016/S0304-3835(98)00052-4; DiBlasi C, 1996, ACTA NEUROPATHOL, V92, P369; Dove A, 2002, NAT BIOTECHNOL, V20, P121, DOI 10.1038/nbt0202-121; Dunckley MG, 1998, HUM MOL GENET, V7, P1083, DOI 10.1093/hmg/7.7.1083; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Friedman KJ, 1999, J BIOL CHEM, V274, P36193, DOI 10.1074/jbc.274.51.36193; Havenga MJE, 2002, J VIROL, V76, P4612, DOI 10.1128/JVI.76.9.4612-4620.2002; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Mann CJ, 2002, J GENE MED, V4, P644, DOI 10.1002/jgm.295; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Mercatante DR, 2001, CURR CANCER DRUG TAR, V1, P211, DOI 10.2174/1568009013334124; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Mirabella M, 1998, NEUROLOGY, V51, P592, DOI 10.1212/WNL.51.2.592; Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; ROEST PAM, 1993, NEUROMUSCULAR DISORD, V3, P391, DOI 10.1016/0960-8966(93)90083-V; Roest PAM, 1996, NEUROMUSCULAR DISORD, V6, P195, DOI 10.1016/0960-8966(96)00006-5; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; Sierakowska H, 1996, P NATL ACAD SCI USA, V93, P12840, DOI 10.1073/pnas.93.23.12840; Sironi M, 2002, FEBS LETT, V517, P163, DOI 10.1016/S0014-5793(02)02613-3; Stevenson JP, 1999, J CLIN ONCOL, V17, P2227, DOI 10.1200/JCO.1999.17.7.2227; Takeshima Y, 2001, BRAIN DEV-JPN, V23, P788, DOI 10.1016/S0387-7604(01)00326-6; THANH LT, 1995, AM J MED GENET, V58, P177, DOI 10.1002/ajmg.1320580217; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; Wilton SD, 1999, NEUROMUSCULAR DISORD, V9, P330, DOI 10.1016/S0960-8966(99)00010-3; WINNARD AV, 1993, HUM MOL GENET, V2, P737, DOI 10.1093/hmg/2.6.737; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	44	154	218	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					83	92		10.1086/381039	http://dx.doi.org/10.1086/381039			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14681829	Bronze, Green Published			2022-12-18	WOS:000187723500008
J	Andelfinger, G; Tapper, AR; Welch, RC; Vanoye, CG; George, AL; Benson, DW				Andelfinger, G; Tapper, AR; Welch, RC; Vanoye, CG; George, AL; Benson, DW			KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; RECTIFYING K+ CURRENT; POTASSIUM CHANNEL; KIR2.2 GENES; EXPRESSION; SUBUNITS	Evaluation of candidate loci culminated in the identification of a heterozygous missense mutation (R67W) in KCNJ2, the gene encoding the inward-rectifying potassium current, Kir2.1, in 41 members of a kindred in which ventricular arrhythmias (13 of 16 female members [81%]) and periodic paralysis (10 of 25 male members [40%]) segregated as autosomal dominant traits with sex-specific variable expressivity. Some mutation carriers exhibited dysmorphic features, including hypertelorism, small mandible, syndactyly, clinodactyly, cleft palate, and scoliosis, which, together with cardiodysrhythmic periodic paralysis, have been termed "Andersen syndrome." However, no individual exhibited all manifestations of Andersen syndrome, and this diagnosis was not considered in the proband until other family members were examined. Other features seen in this kindred included unilateral dysplastic kidney and cardiovascular malformation (i. e., bicuspid aortic valve, bicuspid aortic valve with coarctation of the aorta, or valvular pulmonary stenosis), which have not been previously associated. Nonspecific electrocardiographic abnormalities were identified in some individuals, but none had a prolonged QT interval. Biophysical characterization of R67W demonstrated loss of function and a dominant-negative effect on Kir2.1 current. These findings support the suggestion that, in addition to its recognized role in function of cardiac and skeletal muscle, KCNJ2 plays an important role in developmental signaling.	Univ Cincinnati, Childrens Hosp, Med Ctr,Dept Pediat,Div Cardiol, OSB 4, Cincinnati, OH 45229 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Med Genet, Nashville, TN 37212 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Vanderbilt University; Vanderbilt University	Benson, DW (corresponding author), Univ Cincinnati, Childrens Hosp, Med Ctr,Dept Pediat,Div Cardiol, OSB 4, 3333 Burnet Ave, Cincinnati, OH 45229 USA.				NHLBI NIH HHS [HL/HD04300, P01 HL046681, HL46681, HL61006] Funding Source: Medline; NIGMS NIH HHS [F32 GM020415, F32-GM20415] Funding Source: Medline; NINDS NIH HHS [R01 NS032387, NS32387, R37 NS032387] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046681, P50HL061006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032387, R37NS032387] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Benson DW, 1998, CIRCULATION, V97, P2043, DOI 10.1161/01.CIR.97.20.2043; Canun S, 1999, AM J MED GENET, V85, P147, DOI 10.1002/(SICI)1096-8628(19990716)85:2<147::AID-AJMG9>3.0.CO;2-0; Derst C, 2001, FEBS LETT, V491, P305, DOI 10.1016/S0014-5793(01)02202-5; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JEN J, 2001, METABOLIC MOL BASES, P5223; Karschin C, 1997, MOL CELL NEUROSCI, V10, P131, DOI 10.1006/mcne.1997.0655; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; Little S, 1995, CURRENT PROTOCOLS HU; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Pham TV, 2002, CARDIOVASC RES, V53, P740, DOI 10.1016/S0008-6363(01)00429-1; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Priori SG, 2001, CIRCULATION, V103, P196; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Wolbrette D, 2002, CLIN CARDIOL, V25, P49, DOI 10.1002/clc.4950250203; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	20	154	164	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					663	668		10.1086/342360	http://dx.doi.org/10.1086/342360			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12148092	Bronze, Green Published			2022-12-18	WOS:000177489600022
J	Ober, C; Abney, M; McPeek, MS				Ober, C; Abney, M; McPeek, MS			The genetic dissection of complex traits in a founder population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESTING BLOOD-PRESSURE; BODY-MASS INDEX; FAMILIAL AGGREGATION; QUANTITATIVE TRAITS; LIPOPROTEIN(A) CONCENTRATIONS; SEGREGATION ANALYSIS; VARIANCE-COMPONENTS; RISK-FACTORS; HEART; HERITABILITY	We estimated broad heritabilities (H-2) and narrow heritabilities (h(2)) and conducted genomewide screens, using a novel association-based mapping approach for 20 quantitative trait loci (QTLs) among the Hutterites, a founder population that practices a communal lifestyle. Heritability estimates ranged from .21 for diastolic blood pressure (DBP) to .99 for whole-blood serotonin levels. Using a multipoint method to detect association under a recessive model we found evidence of major QTLs for six traits: low-density lipoprotein (LDL), triglycerides, lipoprotein (a) (Lp[ a]), systolic blood pressure (SBP), serum cortisol, and whole-blood serotonin. Second major QTLs for Lp( a) and for cortisol were identified using a single-point method to detect association under a general two-allele model. The heritabilities for these six traits ranged from .37 for triglycerides to .99 for serotonin, and three traits (LDL, SBP, and serotonin) had significant dominance variances (i.e., H-2/h(2)). Surprisingly, there was little correlation between measures of heritability and the strength of association on a genomewide screen (P>.50), suggesting that heritability estimates per se do not identify phenotypes that are influenced by genes with major effects. The present study demonstrates the feasibility of genomewide association studies for QTL mapping. However, even in this young founder population that has extensive linkage disequilibrium, map densities much less than 5 cM may be required to detect all major QTLs.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu			NHGRI NIH HHS [HG01645, R01 HG001645, R29 HG001645] Funding Source: Medline; NHLBI NIH HHS [P50 HL056399, HL56399, R01 HL066533, R01 HL072414, U01 HL049596] Funding Source: Medline; NIDDK NIH HHS [DK55889, R01 DK055889] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066533, R01HL072414, U01HL049596, P50HL056399] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645, R29HG001645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; An P, 1999, AM J HYPERTENS, V12, P264, DOI 10.1016/S0895-7061(98)00261-1; ANDERSON GM, 1981, CLIN CHEM, V27, P775; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; BLUNDELL JE, 1984, NEUROPHARMACOLOGY, V23, P1537, DOI 10.1016/0028-3908(84)90098-4; BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; BRENN T, 1994, ANN HUM GENET, V58, P369, DOI 10.1111/j.1469-1809.1994.tb00733.x; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chatterjee Satipati, 1999, Applied Human Science, V18, P1, DOI 10.2114/jpa.18.1; Cheng LSC, 1998, HUM BIOL, V70, P59; Comuzzie AG, 1999, GENET EPIDEMIOL, V17, pS109; De Fanti BA, 2001, BRAIN RES, V902, P164, DOI 10.1016/S0006-8993(01)02371-X; Edwards KL, 1999, ARTERIOSCL THROM VAS, V19, P2456, DOI 10.1161/01.ATV.19.10.2456; Faith MS, 1999, PEDIATRICS, V104, P61, DOI 10.1542/peds.104.1.61; FLESS GM, 1989, J LIPID RES, V30, P651; Gu C, 1998, HUM BIOL, V70, P77; HICKS JM, 1979, CLIN CHEM, V25, P1005; HONG YL, 1995, ATHEROSCLEROSIS, V117, P295, DOI 10.1016/0021-9150(95)05584-J; HOPP RJ, 1984, J ALLERGY CLIN IMMUN, V73, P265, DOI 10.1016/S0091-6749(84)80018-4; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; KUSHNER RF, 1992, AM J CLIN NUTR, V56, P835, DOI 10.1093/ajcn/56.5.835; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEIBOWITZ SF, 1986, APPETITE, V7, P1, DOI 10.1016/S0195-6663(86)80049-6; Lester LA, 2001, J ALLERGY CLIN IMMUN, V108, P357, DOI 10.1067/mai.2001.117796; LEWONTIN RC, 1976, IQ CONTROVERSY, P179; Luo ZC, 1998, PEDIATR RES, V44, P563, DOI 10.1203/00006450-199810000-00016; Mathias RA, 2001, GENET EPIDEMIOL, V20, P340, DOI 10.1002/gepi.5; MEIKLE AW, 1988, METABOLISM, V37, P514, DOI 10.1016/0026-0495(88)90164-3; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; MORGAN CR, 1963, DIABETES, V12, P115, DOI 10.2337/diab.12.2.115; MORTON NE, 1974, AM J HUM GENET, V26, P318; Narkiewicz K, 1997, AM J HYPERTENS, V10, P467; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Ober C, 2000, CLIN CHEST MED, V21, P245, DOI 10.1016/S0272-5231(05)70264-1; Palmer LJ, 2000, EUR J HUM GENET, V8, P853, DOI 10.1038/sj.ejhg.5200551; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3263, DOI 10.1161/01.ATV.17.11.3263; Pierson L, 1998, J IMMUNOL METHODS, V211, P97, DOI 10.1016/S0022-1759(97)00204-4; Rainwater DL, 1997, ATHEROSCLEROSIS, V128, P223, DOI 10.1016/S0021-9150(96)05993-X; RICE JP, 2001, GENETIC DISSECTION C, P35; Rice T, 1997, OBES RES, V5, P417, DOI 10.1002/j.1550-8528.1997.tb00664.x; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rotimi CN, 1999, HYPERTENSION, V33, P874, DOI 10.1161/01.HYP.33.3.874; Saljukov V B, 1992, Arctic Med Res, V51, P143; Scholz M, 1999, EUR J HUM GENET, V7, P169, DOI 10.1038/sj.ejhg.5200290; SELBY JV, 1990, INT J OBESITY, V14, P593; SELLERS TA, 1994, INT J OBESITY, V18, P607; Shearman AM, 2000, HUM MOL GENET, V9, P1315, DOI 10.1093/hmg/9.9.1315; SHIMAMOTO K, 1980, J CLIN ENDOCR METAB, V51, P840, DOI 10.1210/jcem-51-4-840; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; TAYLOR T, 1983, J CLIN ENDOCR METAB, V57, P592, DOI 10.1210/jcem-57-3-592; WEITKAMP LR, 1988, HUM GENET, V79, P80, DOI 10.1007/BF00291716; Whitfield KE, 1999, EXP AGING RES, V25, P255, DOI 10.1080/036107399244020; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190	63	154	155	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1068	1079		10.1086/324025	http://dx.doi.org/10.1086/324025			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11590547	Green Published, Bronze			2022-12-18	WOS:000171413400015
J	Ioannou, YA; Zeidner, KM; Gordon, RE; Desnick, RJ				Ioannou, YA; Zeidner, KM; Gordon, RE; Desnick, RJ			Fabry disease: Preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOUSE KIDNEY GLYCOSPHINGOLIPIDS; CELLS; PLASMA; RECOGNITION; ENDOCYTOSIS; LYSOSOMES; TISSUE; URINE	Preclinical studies of enzyme-replacement therapy for Fabry disease (deficient alpha -galactosidase A [alpha -Gal A] activity) were performed in alpha -Gal A-deficient mice. The pharmacokinetics and biodistributions were determined for four recombinant human alpha -Gal A glycoforms, which differed in sialic acid and mannose-6-phosphate content. The plasma half-lives of the glycoforms were similar to2-5 min, with the more sialylated glycoforms circulating longer. After intravenous doses of 1 or 10 mg/kg body weight were administered, each glycoform was primarily recovered in the liver, with detectable activity in other tissues but not in the brain. Normal or greater activity levels were reconstituted in various tissues after repeated doses (10 mg/kg every other day for eight doses) of the highly sialylated AGA-1 glycoform; 4 d later, enzyme activity was retained in the liver and spleen at levels that were, respectively, 30% and 10% of that recovered 1 h postinjection. Importantly, the globotriaosylceramide (GL-3) substrate was depleted in various tissues and plasma in a dose-dependent manner. A single or repeated doses (every 48 h for eight doses) of AGA-1 at 0.3-10.0 mg/kg cleared hepatic GL-3, whereas higher doses were required for depletion of GL-3 in other tissues. After a single dose of 3 mg/kg, hepatic GL-3 was cleared for greater than or equal to4 wk, whereas cardiac and splenic GL-3 reaccumulated at 3 wk to similar to 30% and similar to 10% of pretreatment levels, respectively. Ultrastructural studies demonstrated reduced GL-3 storage posttreatment. These preclinical animal studies demonstrate the dose-dependent clearance of tissue and plasma GL-3 by administered alpha -Gal A, thereby providing the in vivo rationale-and the critical pharmacokinetic and pharmacodynamic data-for the design of enzyme-replacement trials in patients with Fabry disease.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, 5th Ave & 100th St, New York, NY 10029 USA.				NCRR NIH HHS [5 M01 RR00071, M01 RR000071] Funding Source: Medline; NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHS [R37 DK034045, 5 R37 DK34045] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHORD DT, 1978, CELL, V15, P269, DOI 10.1016/0092-8674(78)90102-2; [Anonymous], 2014, METABOLIC MOL BASES; ATTIE AD, 1982, HEPATOLOGY, V2, P269; BEUTLER E, 1983, BIOCHEM MED METAB B, V30, P363, DOI 10.1016/0006-2944(83)90029-7; Bijsterbosch MK, 1996, EUR J BIOCHEM, V237, P344, DOI 10.1111/j.1432-1033.1996.00344.x; BISHOP DF, 1986, P NATL ACAD SCI USA, V83, P4859, DOI 10.1073/pnas.83.13.4859; BISHOP DF, 1980, ENZYME THERAPY GENET, V2, P17; BISHOP DF, 1981, ENZYME THERAPY, V20, P381; BOHLEN P, 1973, ARCH BIOCHEM BIOPHYS, V155, P213, DOI 10.1016/S0003-9861(73)80023-2; BOYD B, 1989, NEPHRON, V51, P207, DOI 10.1159/000185286; BRADY RO, 1973, NEW ENGL J MED, V289, P9, DOI 10.1056/NEJM197307052890103; CHATTERJEE S, 1984, CAN J BIOCHEM CELL B, V62, P385, DOI 10.1139/o84-054; COLOMBI A, 1967, HELV MED ACTA, V34, P67; Desnick R J, 1980, Birth Defects Orig Artic Ser, V16, P393; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; DESNICK RJ, 1979, P NATL ACAD SCI USA, V76, P5326, DOI 10.1073/pnas.76.10.5326; Desnick RJ., 1995, METABOLIC MOL BASES, P2741; DINI L, 1992, BIOL CELL, V74, P217, DOI 10.1016/0248-4900(92)90028-Y; Eng C., 2000, Journal of Inherited Metabolic Disease, V23, P222; Eng CM, 2000, AM J HUM GENET, V67, P38; FIDDLER MB, 1977, BIOCHEM J, V168, P141, DOI 10.1042/bj1680141; GROSS SK, 1991, J LIPID RES, V32, P157; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; Ioannou YA, 1998, BIOCHEM J, V332, P789, DOI 10.1042/bj3320789; JANSEN RW, 1991, J BIOL CHEM, V266, P3343; KOLODNY EH, 1981, LYSOSOMES LYSOSOMAL, P395; KUPKE IR, 1978, J CHROMATOGR, V146, P261, DOI 10.1016/S0378-4347(00)81892-7; LEE SJ, 1988, J BIOL CHEM, V263, P3521; MAIZEL SE, 1981, TRANSPLANT P, V13, P57; MAPES CA, 1970, SCIENCE, V169, P987, DOI 10.1126/science.169.3949.987; Matsuura F, 1998, GLYCOBIOLOGY, V8, P329, DOI 10.1093/glycob/8.4.329; MCCLUER RH, 1981, J BIOL CHEM, V256, P3112; MCCLUER RH, 1983, ENDOCRINOLOGY, V113, P251, DOI 10.1210/endo-113-1-251; RATTAZZI MC, 1980, ENZYME THERAPY GENET, V2; Schiffmann R, 2000, AM J HUM GENET, V67, P38; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Wang A. M., 1996, American Journal of Human Genetics, V59, pA208; WEN DX, 1992, J BIOL CHEM, V267, P2512; Zeidner KM, 1999, ANAL BIOCHEM, V267, P104, DOI 10.1006/abio.1998.2966	39	154	173	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					14	25		10.1086/316953	http://dx.doi.org/10.1086/316953			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11115376	Green Published, Bronze			2022-12-18	WOS:000166399900002
J	Witsch-Baumgartner, M; Fitzky, BU; Ogorelkova, M; Kraft, HG; Moebius, FF; Glossmann, H; Seedorf, U; Gillessen-Kaesbach, G; Hoffmann, GF; Clayton, P; Kelley, RI; Utermann, G				Witsch-Baumgartner, M; Fitzky, BU; Ogorelkova, M; Kraft, HG; Moebius, FF; Glossmann, H; Seedorf, U; Gillessen-Kaesbach, G; Hoffmann, GF; Clayton, P; Kelley, RI; Utermann, G			Mutational spectrum in the Delta 7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFECTIVE CHOLESTEROL-BIOSYNTHESIS; STEROL-METABOLISM; 7-DEHYDROCHOLESTEROL REDUCTASE; CHONDRODYSPLASIA PUNCTATA; MOLECULAR-CLONING; DIAGNOSIS; EXPRESSION	Smith-Lemli-Opitz syndrome (SLOS), an autosomal recessive malformation syndrome, ranges in clinical severity from mild dysmorphism and moderate mental retardation to severe congenital malformation and intrauterine lethality. Mutations in the gene for Delta 7-sterol reductase (DHCR7), which catalyzes the final step in cholesterol biosynthesis in the endoplasmic reticulum (ER), cause SLOS. We have determined, in 84 patients with clinically and biochemically characterized SLOS (detection rate 96%), the mutational spectrum in the DHCR7 gene. Forty different SLOS mutations, some frequent, were identified. On the basis of mutation type and expression studies in the HEK293-derived cell line tsA-201, we grouped mutations into four classes: nonsense and splice-site mutations resulting in putative null alleles, missense mutations in the transmembrane domains (TM), mutations in the 4th cytoplasmic loop (4L), and mutations in the C-terminal ER domain (CT). All but one of the tested missense mutations reduced protein stability Concentrations of the cholesterol precursor 7-dehydrocholesterol and clinical severity scores correlated with mutation classes. The mildest clinical phenotypes were associated with TM and CT mutations, and the most severe types were associated with 0 and 4L mutations. Most homozygotes for null alleles had severe SLOS; one patient had a moderate phenotype. Homozygosity for 0 mutations in DHCR7 appears compatible with life, suggesting that cholesterol may be synthesized in the absence of this enzyme or that exogenous sources of cholesterol can be used.	Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria; Inst Biochem Pharmacol, Innsbruck, Austria; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Univ Munster, Inst Arterioskleroseforsch, D-4400 Munster, Germany; Univ Essen Gesamthsch, Inst Human Genet, Essen, Germany; Univ Marburg, Dept Neuropediat & Metab Dis, Marburg, Germany; Inst Child Hlth, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; University of Munster; University of Duisburg Essen; Philipps University Marburg; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University	Utermann, G (corresponding author), Inst Med Biol & Human Genet, Schoepfstr 41, A-6020 Innsbruck, Austria.	gerd.utermann@uibk.ac.at	Glossmann, Hartmut/AAL-9790-2020; Clayton, Peter T/C-1523-2008	glossmann, hartmut h./0000-0002-7392-3266; Clayton, Peter/0000-0001-7592-4302				Anderson AJ, 1998, AM J MED GENET, V78, P413, DOI 10.1002/(SICI)1096-8628(19980806)78:5<413::AID-AJMG4>3.0.CO;2-M; Angle B, 1998, AM J MED GENET, V80, P322, DOI 10.1002/(SICI)1096-8628(19981204)80:4<322::AID-AJMG4>3.0.CO;2-E; Bae SH, 1999, J BIOL CHEM, V274, P14624, DOI 10.1074/jbc.274.21.14624; Braverman N, 1999, NAT GENET, V22, P291, DOI 10.1038/10357; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Cunniff C, 1997, AM J MED GENET, V68, P263, DOI 10.1002/(SICI)1096-8628(19970131)68:3<263::AID-AJMG4>3.3.CO;2-5; CURRY C J R, 1987, American Journal of Medical Genetics, V26, P45, DOI 10.1002/ajmg.1320260110; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; Fitzky BU, 1999, CURR OPIN LIPIDOL, V10, P123, DOI 10.1097/00041433-199904000-00006; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; IRONS M, 1994, AM J MED GENET, V50, P347, DOI 10.1002/ajmg.1320500409; IRONS M, 1993, LANCET, V341, P1414, DOI 10.1016/0140-6736(93)90983-N; Kelley RI, 1997, AM J MED GENET, V68, P251, DOI 10.1002/(SICI)1096-8628(19970131)68:3<251::AID-AJMG1>3.0.CO;2-P; Kelley RI, 1999, AM J MED GENET, V83, P213, DOI 10.1002/(SICI)1096-8628(19990319)83:3<213::AID-AJMG15>3.0.CO;2-C; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; Kratz LE, 1999, AM J MED GENET, V82, P376, DOI 10.1002/(SICI)1096-8628(19990219)82:5<376::AID-AJMG4>3.0.CO;2-B; Maquat LE, 1996, AM J HUM GENET, V59, P279; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; Nelis E, 1999, HUM MUTAT, V13, P11, DOI 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A; Nwokoro NA, 1997, AM J MED GENET, V68, P315, DOI 10.1002/(SICI)1096-8628(19970131)68:3<315::AID-AJMG13>3.0.CO;2-W; OPITZ JM, 1994, AM J MED GENET, V50, P344, DOI 10.1002/ajmg.1320500408; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Waterham HR, 1998, AM J HUM GENET, V63, P329, DOI 10.1086/301982	28	154	161	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					402	412		10.1086/302760	http://dx.doi.org/10.1086/302760			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677299	Green Published, Bronze			2022-12-18	WOS:000088373100006
J	Paulson, HL				Paulson, HL			Protein fate in neurodegenerative proteinopathies: Polyglutamine diseases join the (mis)fold	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE; IN-VITRO; HUNTINGTIN; VIVO		Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA	University of Iowa	Paulson, HL (corresponding author), Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA.							BAILEY CK, 1998, AM J HUM GENET S, V63, pA8; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; CHAI Y, IN PRESS HUM MOL GEN; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Knight SAB, 1999, AM J HUM GENET, V64, P365, DOI 10.1086/302270; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PAULSON HL, 1998, AM J HUM GENET S, V63, pA8; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Price DL, 1998, SCIENCE, V282, P1079, DOI 10.1126/science.282.5391.1079; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158	37	154	180	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					339	345		10.1086/302269	http://dx.doi.org/10.1086/302269			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973270	Green Published, Bronze			2022-12-18	WOS:000078740600002
J	REED, TE; CHANDLER, JH				REED, TE; CHANDLER, JH			HUNTINGTONS CHOREA IN MICHIGAN .1. DEMOGRAPHY AND GENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Beeton M, 1899, P ROY SOC LONDON, VB67, P290; Bell, 1934, TREASURY HUMAN INH 1, VIV; Crowe FW, 1956, CLIN PATHOLOGICAL GE; Davenport CB, 1916, AM J INSANITY, V73, P195, DOI 10.1176/ajp.73.2.195; FIELLER EC, 1951, ANN EUGENIC, V16, P97, DOI 10.1111/j.1469-1809.1951.tb02461.x; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; Huntington G., 1872, MED SURG REP, V26, P320; KISHIMOTO K, 1957, 1ST P INT C NEUR SC; MORCH ET, 1941, OPERA DOMO BIOL HERE, V3; NEEL JV, 1957, NEW ENGL J MED, V256, P161, DOI 10.1056/NEJM195701242560405; ORBECK AL, 1954, SETESDALSRYKKA; PEARSON JS, 1955, P STAFF M MAYO CLIN, V30, P349; PEARSON JS, 1957, COMMUNICATION; PLEYDELL M J, 1954, Br Med J, V2, P1121; PLEYDELL MJ, 1955, BRIT MED J, V2, P889, DOI 10.1136/bmj.2.4944.889; PLEYDELL MJ, 1957, COMMUNICATION; REED SC, 1951, SCIENCE, V113, P294, DOI 10.1126/science.113.2933.294; REED TE, 1957, JAPAN J HUMAN GENE S, V2, P48; SJOGREN TORSTEN, 1935, ZEITSCHR MENSCHL VERERBUNGS U KONSTITUTIONSL, V19, P131; Vessie PR, 1932, J NERV MENT DIS, V76, P553, DOI 10.1097/00005053-193212000-00001; [No title captured]	21	154	155	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	2					201	225						25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA219	13533397				2022-12-18	WOS:A1958WA21900008
J	Wilson, GR; Sim, JCH; McLean, C; Giannandrea, M; Galea, CA; Riseley, JR; Stephenson, SEM; Fitzpatrick, E; Haas, SA; Pope, K; Hogan, KJ; Gregg, RG; Bromhead, CJ; Wargowski, DS; Lawrence, CH; James, PA; Churchyard, A; Gao, YJ; Phelan, DG; Gillies, G; Salce, N; Stanford, L; Marsh, APL; Mignogna, ML; Hayflick, SJ; Leventer, RJ; Delatycki, MB; Mellick, GD; Kalscheuer, VM; D'Adamo, P; Bahlo, M; Amor, DJ; Lockhart, PJ				Wilson, Gabrielle R.; Sim, Joe C. H.; McLean, Catriona; Giannandrea, Maila; Galea, Charles A.; Riseley, Jessica R.; Stephenson, Sarah E. M.; Fitzpatrick, Elizabeth; Haas, Stefan A.; Pope, Kate; Hogan, Kirk J.; Gregg, Ronald G.; Bromhead, Catherine J.; Wargowski, David S.; Lawrence, Christopher H.; James, Paul A.; Churchyard, Andrew; Gao, Yujing; Phelan, Dean G.; Gillies, Greta; Salce, Nicholas; Stanford, Lynn; Marsh, Ashley P. L.; Mignogna, Maria L.; Hayflick, Susan J.; Leventer, Richard J.; Delatycki, Martin B.; Mellick, George D.; Kalscheuer, Vera M.; D'Adamo, Patrizia; Bahlo, Melanie; Amor, David J.; Lockhart, Paul J.			Mutations in RAB39B Cause X-Linked Intellectual Disability and Early-Onset Parkinson Disease with alpha-Synuclein Pathology	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASAL GANGLIA DISORDER; MENTAL-RETARDATION; DISTAL XQ28; IRON; TRAFFICKING; DEMENTIA; GTPASES; BRAIN	Advances in understanding the etiology of Parkinson disease have been driven by the identification of causative mutations in families. Genetic analysis of an Australian family with three males displaying clinical features of early-onset parkinsonism and intellectual disability identified a -45 kb deletion resulting in the complete loss of RAB39B. We subsequently identified a missense mutation (c.503C>A [p.Thr168Lys]) in RAB39B in an unrelated Wisconsin kindred affected by a similar clinical phenotype. In silico and in vitro studies demonstrated that the mutation destabilized the protein, consistent with loss of function. In vitro small-hairpin-RNA-mediated knockdown of Rab39b resulted in a reduction in the density of a-synuclein immunoreactive puncta in dendritic processes of cultured neurons. In addition, in multiple cell models, we demonstrated that knockdown of Rab39b was associated with reduced steady-state levels of a-synuclein. Post mortem studies demonstrated that loss of RAB39B resulted in pathologically confirmed Parkinson disease. There was extensive dopaminergic neuron loss in the substantia nigra and widespread classic Lewy body pathology. Additional pathological features included cortical Lewy bodies, brain iron accumulation, tau immunoreactivity, and axonal spheroids. Overall, we have shown that loss-of-function mutations in RAB39B cause intellectual disability and pathologically confirmed early-onset Parkinson disease. The loss of RAB39B results in dysregulation of a-synuclein homeostasis and a spectrum of neuropathological features that implicate RAB39B in the pathogenesis of Parkinson disease and potentially other neurodegenerative disorders.	[Wilson, Gabrielle R.; Sim, Joe C. H.; Riseley, Jessica R.; Stephenson, Sarah E. M.; Fitzpatrick, Elizabeth; Pope, Kate; Gao, Yujing; Phelan, Dean G.; Gillies, Greta; Salce, Nicholas; Marsh, Ashley P. L.; Leventer, Richard J.; Delatycki, Martin B.; Amor, David J.; Lockhart, Paul J.] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Melbourne, Vic 3052, Australia; [Wilson, Gabrielle R.; Stephenson, Sarah E. M.; Phelan, Dean G.; Marsh, Ashley P. L.; Leventer, Richard J.; Delatycki, Martin B.; Amor, David J.; Lockhart, Paul J.] Univ Melbourne, Dept Pediat, Melbourne, Vic 3052, Australia; [McLean, Catriona] The Alfred, Anat Pathol, Melbourne, Vic 3181, Australia; [McLean, Catriona] Natl Neurosci Facil, Australian Brain Bank Network, Melbourne, Vic 3053, Australia; [Giannandrea, Maila; Mignogna, Maria L.; D'Adamo, Patrizia] Ist Sci San Raffaele, Div Neurosci, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Giannandrea, Maila; Mignogna, Maria L.; Hayflick, Susan J.] F Hoffmann La Roche, Pharmaceut Res & Early Dev Neurosci Ophthalmol &, CH-4070 Basel, Switzerland; [Galea, Charles A.] Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic 3052, Australia; [Haas, Stefan A.] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Hogan, Kirk J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Anesthesiol, Madison, WI 53792 USA; [Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Ctr Genet & Mol Med, Louisville, KY 40202 USA; [Bromhead, Catherine J.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3052, Australia; [Wargowski, David S.] Univ Wisconsin, Sch Med & Publ Hlth, Waisman Ctr, Dept Pediat, Madison, WI 53705 USA; [Lawrence, Christopher H.] Royal Hobart Hosp, Off State Forens Pathologist, Hobart, Tas 7000, Australia; [James, Paul A.] Royal Melbourne Hosp, Dept Med Genet, Melbourne, Vic 3050, Australia; [Churchyard, Andrew] Monash Childrens Hosp, Dept Neurol, Melbourne, Vic 3168, Australia; [Stanford, Lynn; Hayflick, Susan J.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Leventer, Richard J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Leventer, Richard J.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic 3052, Australia; [Delatycki, Martin B.] Austin Hlth, Clin Genet, Melbourne, Vic 3084, Australia; [Mellick, George D.] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia; [Kalscheuer, Vera M.] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia; [Bahlo, Melanie] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	Murdoch Children's Research Institute; University of Melbourne; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Roche Holding; Monash University; Max Planck Society; University of Wisconsin System; University of Wisconsin Madison; University of Louisville; Walter & Eliza Hall Institute; University of Wisconsin System; University of Wisconsin Madison; Royal Hobart Hospital; Royal Melbourne Hospital; Oregon Health & Science University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Florey Institute of Neuroscience & Mental Health; Griffith University; Max Planck Society; University of Melbourne; University of Melbourne	Lockhart, PJ (corresponding author), Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Melbourne, Vic 3052, Australia.	paul.lockhart@mcri.edu.au	Stephenson, Sarah E M/AGK-4623-2022; Gao, Yujing/N-7382-2019; Mellick, George D./A-7650-2010; Lockhart, Paul J/E-7753-2011; Amor, David J/A-6478-2018; D'Adamo, Patrizia/AAN-3919-2020; Marsh, Ashley Pamela Lesle/W-1981-2017; Stephenson, Sarah/O-5742-2015; Galea, Charles/O-8800-2014	Gao, Yujing/0000-0002-4542-7062; Mellick, George D./0000-0002-7211-4651; Lockhart, Paul J/0000-0003-2531-8413; Amor, David J/0000-0001-7191-8511; D'Adamo, Patrizia/0000-0002-0312-5541; Marsh, Ashley Pamela Lesle/0000-0001-6049-6931; Stephenson, Sarah/0000-0001-7860-9527; Galea, Charles/0000-0003-2730-1105; Haas, Stefan/0000-0003-3418-3688; James, Paul/0000-0002-4361-4657; Phelan, Dean/0000-0002-1076-2821; McLean, Catriona/0000-0002-0302-5727; Kalscheuer, Vera/0000-0001-6898-3259; Bahlo, Melanie/0000-0001-5132-0774; mignogna, maria lidia/0000-0001-9144-6363	Australian National Health and Medical Research Council (NHMRC) [490037]; NHMRC [APP1041860, APP1032364]; Parkinson's Disease Foundation [PDF-IRG-1220]; GENCODYS by European Union [241995]; Australian Research Council Future Fellowship [FT100100764]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Parkinson's Disease Foundation; GENCODYS by European Union; Australian Research Council Future Fellowship(Australian Research Council)	We thank the families for their participation in this study and the generous support of the Lefroy and Handbury families. This work was funded in part by Australian National Health and Medical Research Council (NHMRC) program grant 490037 to D.J.A. and M.B., NHMRC project grant APP1041860 to P.J.L., Parkinson's Disease Foundation grant PDF-IRG-1220 to P.J.L. and G.R.W., and the project GENCODYS (grant 241995 to V.M.K.), which was funded by the European Union Framework Programme 7. P.J.L. was supported by an NHMRC Career Development Fellowship (APP1032364), and M.B. was supported by an Australian Research Council Future Fellowship (FT100100764). This work was made possible through Victorian State Government Operational Infrastructure Support and the NHMRC Independent Medical Research Institutes Infrastructure Support Scheme.	Cheng H, 2002, CYTOGENET GENOME RES, V97, P72, DOI 10.1159/000064047; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Cook C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009423; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Culvenor JG, 1999, AM J PATHOL, V155, P1173, DOI 10.1016/S0002-9440(10)65220-0; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Eisbach SE, 2013, J MOL MED, V91, P693, DOI 10.1007/s00109-013-1038-9; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; Fodero-Tavoletti MT, 2007, J NEUROSCI, V27, P10365, DOI 10.1523/JNEUROSCI.0630-07.2007; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; GREGG RG, 1991, GENOMICS, V9, P701, DOI 10.1016/0888-7543(91)90363-J; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Huang Y, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-4; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Keller MF, 2012, HUM MOL GENET, V21, P4996, DOI 10.1093/hmg/dds335; Khan AR, 2013, STRUCTURE, V21, P1284, DOI 10.1016/j.str.2013.06.016; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LAXOVA R, 1985, AM J MED GENET, V21, P681, DOI 10.1002/ajmg.1320210409; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Meguro R, 2008, ARCH HISTOL CYTOL, V71, P205, DOI 10.1679/aohc.71.205; Mellick GD, 2009, PARKINSONISM RELAT D, V15, P105, DOI 10.1016/j.parkreldis.2007.11.016; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Mrak Robert E, 2007, Neuropsychiatr Dis Treat, V3, P619; Park HH, 2013, INT J MOL SCI, V14, P8912, DOI 10.3390/ijms14058912; Russo S, 2000, AM J MED GENET, V94, P376, DOI 10.1002/1096-8628(20001023)94:5<376::AID-AJMG6>3.0.CO;2-A; Schipper HM, 2012, BBA-MOL BASIS DIS, V1822, P350, DOI 10.1016/j.bbadis.2011.06.016; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Takano K, 2012, HUM MOL GENET, V21, P4497, DOI 10.1093/hmg/dds292; Vanmarsenille L, 2014, HUM MUTAT, V35, P377, DOI 10.1002/humu.22497; Wray Selina, 2010, Front Psychiatry, V1, P150, DOI 10.3389/fpsyt.2010.00150; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466	37	153	160	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					729	735		10.1016/j.ajhg.2014.10.015	http://dx.doi.org/10.1016/j.ajhg.2014.10.015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25434005	Bronze, Green Published			2022-12-18	WOS:000346623100009
J	Warby, SC; Montpetit, A; Hayden, AR; Carroll, JB; Butland, SL; Visscher, F; Collins, JA; Semaka, A; Hudson, TJ; Hayden, MR				Warby, Simon C.; Montpetit, Alexandre; Hayden, Anna R.; Carroll, Jeffrey B.; Butland, Stefanie L.; Visscher, Flenk; Collins, Jennifer A.; Semaka, Alicia; Hudson, Thomas J.; Hayden, Michael R.			CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing Haplogroup	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA HAPLOTYPE ANALYSIS; REPEAT INSTABILITY; MUTANT HUNTINGTIN; MOLECULAR ANALYSIS; SPINOCEREBELLAR ATAXIA; LINKAGE DISEQUILIBRIUM; EMBRYONIC LETHALITY; TRIPLET REPEATS; EVOLUTION; FAMILIES	Huntington disease (HD) is an autosomal-dominant disorder that results from >36 CAG repeats in the HD gene (HTT). Approximately 10% of patients inherit a chromosome that underwent CAG expansion from an unaffected parent with <36 CAG repeats. This study is a comprehensive analysis of genetic diversity in HTTand reveals that HD patients of European origin (n = 65) have a significant enrichment (95%) of a specific set of 22 tagging single nucleotide polymorphisms (SNPs) that constitute a single haplogroup. The disease association of many SNPs is much stronger than any previously reported polymorphism and was confirmed in a replication cohort (n = 203). Importantly, the same haplogroup is also significantly enriched (83%) in individuals with 27-35 CAG repeats (intermediate alleles, n = 66), who are unaffected by the disease, but have increased CAG tract sizes relative to the general Population (n = 116). These data Support a stepwise model for CAG expansion into the affected range (>36 CAG) and identifies specific haplogroup variants in the general population associated with this instability. The specific variants at risk for CAG expansion are not present in the general population in China, Japan, and Nigeria where the prevalence of I ID is much lower. The current data argue that cis-elements have a major predisposing influence on CAG Instability in HTT. The strong association between specific SNP alleles and CAG expansion also provides an opportunity of personalized therapeutics in HD where the clinical development of only a small number of allele-specific targets may be sufficient to treat up to 88% of the HD patient population.	[Warby, Simon C.; Hayden, Anna R.; Carroll, Jeffrey B.; Butland, Stefanie L.; Visscher, Flenk; Collins, Jennifer A.; Semaka, Alicia; Hayden, Michael R.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Montpetit, Alexandre; Hayden, Anna R.; Hudson, Thomas J.] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Montpetit, Alexandre; Hayden, Anna R.; Hudson, Thomas J.] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada	Child & Family Research Institute; University of British Columbia; McGill University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Hayden, MR (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Visscher, Henk/B-5442-2013; Collins, Jennifer/AAE-1895-2020; Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Carroll, Jeffrey Bryan/0000-0003-1711-8868; Butland, Stefanie/0000-0002-5427-8951; Visscher, Henk/0000-0001-8407-2893	Canadian Genetic Diseases Network (CGDN); Huntington Society of Canada (HSC); Michael Smith Foundation for Health Research (MSFHR); Canadian Institutes of Health Research (CIHR); Child and Family Research Institute (CFRI); HDSA/High Q Foundation	Canadian Genetic Diseases Network (CGDN); Huntington Society of Canada (HSC); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute (CFRI); HDSA/High Q Foundation	Funding for these Studies has been provided by the Canadian Genetic Diseases Network (CGDN), Huntington Society of Canada (HSC), Michael Smith Foundation for Health Research (MSFHR), Canadian Institutes of Health Research (CIHR), Child and Family Research Institute (CFRI), and the HDSA/High Q Foundation. J.B.C. Is funded by MSFHR and CIHR. M.R.H. is a Killam University Professor and holds a Canada Research Chair in Human Genetics and Molecular Medicine.	Adachi Y, 1999, Nihon Rinsho, V57, P900; ALMQVIST E, 1994, HUM GENET, V94, P124; ALMQVIST E, 1995, HUM MOL GENET, V4, P207, DOI 10.1093/hmg/4.2.207; Almqvist EW, 2001, CLIN GENET, V60, P198, DOI 10.1034/j.1399-0004.2001.600305.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ANDREW S, 1993, CLIN GENET, V43, P286; ANDREW SE, 1995, NEURODEGENERATION, V4, P239, DOI 10.1016/1055-8330(95)90013-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEIGHTON P, 1981, S AFR MED J, V59, P250; Bell PA, 2002, BIOTECHNIQUES, P70; Bonini NM, 2005, NEURON, V48, P715, DOI 10.1016/j.neuron.2005.11.008; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Chang C M, 1994, Clin Exp Neurol, V31, P43; Cleary JD, 2003, CYTOGENET GENOME RES, V100, P25, DOI 10.1159/000072837; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Costa MD, 2006, J HUM GENET, V51, P189, DOI 10.1007/s10038-005-0343-8; De Bakker Paul I W, 2006, Pac Symp Biocomput, P478, DOI 10.1142/9789812701626_0044; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; DODE C, 1993, CR ACAD SCI III-VIE, V316, P1374; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Ennis S, 2007, HUM MUTAT, V28, P1216, DOI 10.1002/humu.20600; Falush D, 2001, AM J HUM GENET, V68, P373, DOI 10.1086/318193; FOLSTEIN SE, 1987, AM J HUM GENET, V41, P168; Franich NR, 2008, MOL THER, V16, P947, DOI 10.1038/mt.2008.50; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao R, 2008, EUR J HUM GENET, V16, P215, DOI 10.1038/sj.ejhg.5201954; Garcia-Planells J, 2005, HUM MUTAT, V25, P453, DOI 10.1002/humu.20167; Gellera C, 1996, AM J HUM GENET, V59, P475; Giovannone B, 1997, HUM MUTAT, V10, P458, DOI 10.1002/(SICI)1098-1004(1997)10:6<458::AID-HUMU7>3.0.CO;2-9; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; Graham RK, 2006, NEUROBIOL DIS, V21, P444, DOI 10.1016/j.nbd.2005.08.007; Harper PS, 2000, J MED GENET, V37, P567, DOI 10.1136/jmg.37.8.567; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; HAYDEN MR, 1980, S AFR MED J, V58, P193; Hecimovic S, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9055; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; Kartsaki E, 2006, INT J MOL MED, V17, P335; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; La Spada AR, 1998, HUM MOL GENET, V7, P959, DOI 10.1093/hmg/7.6.959; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; LEUNG CM, 1992, J NEUROL NEUROSUR PS, V55, P681, DOI 10.1136/jnnp.55.8.681; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; Libby RT, 2003, HUM MOL GENET, V12, P41, DOI 10.1093/hmg/ddg006; Liquori CL, 2003, AM J HUM GENET, V73, P849, DOI 10.1086/378720; Machida Y, 2006, BIOCHEM BIOPH RES CO, V343, P190, DOI 10.1016/j.bbrc.2006.02.141; Magazi DS, 2008, SAMJ S AFR MED J, V98, P200; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; MASUDA N, 1995, J MED GENET, V32, P701, DOI 10.1136/jmg.32.9.701; McMurray CT, 2008, DNA REPAIR, V7, P1121, DOI 10.1016/j.dnarep.2008.03.013; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; MORRISON PJ, 1995, J MED GENET, V32, P524, DOI 10.1136/jmg.32.7.524; Mulvihill DJ, 2005, J BIOL CHEM, V280, P4498, DOI 10.1074/jbc.M413239200; Nakashima K, 1996, NEUROEPIDEMIOLOGY, V15, P126, DOI 10.1159/000109899; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; Nguyen GH, 2003, AM J MED GENET B, V120B, P1, DOI 10.1002/ajmg.b.20010; Norremolle A, 2004, AM J MED GENET A, V130A, P154, DOI 10.1002/ajmg.a.30128; PALO J, 1987, LANCET, V2, P805; Paradisi I, 2008, J HUM GENET, V53, P127, DOI 10.1007/s10038-007-0227-1; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pramanik S, 2000, EUR J HUM GENET, V8, P678, DOI 10.1038/sj.ejhg.5200515; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; RUBINSZTEIN DC, 1995, HUM MOL GENET, V4, P203, DOI 10.1093/hmg/4.2.203; Saleem Q, 2003, ACTA NEUROL SCAND, V108, P281, DOI 10.1034/j.1600-0404.2003.00133.x; Scholefield J, 2007, EUR J HUM GENET, V15, P590, DOI 10.1038/sj.ejhg.5201796; Semaka A, 2006, CLIN GENET, V70, P283, DOI 10.1111/j.1399-0004.2006.00668.x; Silber E, 1998, MOVEMENT DISORD, V13, P726, DOI 10.1002/mds.870130420; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang CK, 2004, EUR NEUROL, V52, P96, DOI 10.1159/000079938; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; WHITING EJ, 1995, EUR J HUM GENET, V3, P195; Williams LC, 2000, GENET TEST, V4, P55, DOI 10.1089/109065700316480; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yu S, 2000, CLIN GENET, V58, P469, DOI 10.1034/j.1399-0004.2000.580607.x; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x	90	153	177	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					351	366		10.1016/j.ajhg.2009.02.003	http://dx.doi.org/10.1016/j.ajhg.2009.02.003			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19249009	Green Published, Bronze			2022-12-18	WOS:000264304200006
J	Mochel, F; Knight, MA; Tong, WH; Hernandez, D; Ayyad, K; Taivassalo, T; Andersen, PM; Singleton, A; Rouault, TA; Fischbeck, KH; Haller, RG				Mochel, Fanny; Knight, Melanie A.; Tong, Wing-Hang; Hernandez, Dena; Ayyad, Karen; Taivassalo, Tanja; Andersen, Peter M.; Singleton, Andrew; Rouault, Tracey A.; Fischbeck, Kenneth H.; Hallers, Ronald G.			Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUCCINATE-DEHYDROGENASE; PAROXYSMAL MYOGLOBINURIA; ACONITASE DEFICIENCY; HEREDITARY MYOPATHY; FRIEDREICH ATAXIA; 4FE-4S CLUSTERS; FRATAXIN; HOMEOSTASIS; DISEASE; BIOGENESIS	A myopathy with severe exercise intolerance and myoglobinuria has been described in patients from northern Sweden, with associated deficiencies of succinate dehydrogenase and aconitase in skeletal muscle. We identified the gene for the iron-sulfur cluster scaffold protein ISCU as a candidate within a region of shared homozygosity among patients with this disease. We found a single mutation in ISCU that likely strengthens a weak splice acceptor site, with consequent exon retention. A marked reduction of ISCU mRNA and mitochondrial ISCU protein in patient muscle was associated with a decrease in the iron regulatory protein IRP1 and intracellular iron overload in skeletal muscle, consistent with a muscle-specific alteration of iron homeostasis in this disease. ISCU interacts with the Friedreich ataxia gene product frataxin in iron-sulfur cluster biosynthesis. Our results therefore extend the range of known human diseases that are caused by defects in iron-sulfur cluster biogenesis.	[Mochel, Fanny] NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA; [Knight, Melanie A.; Fischbeck, Kenneth H.] NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Tong, Wing-Hang; Rouault, Tracey A.] NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; [Hernandez, Dena; Singleton, Andrew] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Ayyad, Karen; Hallers, Ronald G.] VA N Texas Med Ctr, Dallas, TX 75216 USA; [Taivassalo, Tanja] McGill Univ, Dept Kinesiol, Montreal, PQ H2W 1S4, Canada; [Andersen, Peter M.] Umea Univ Hosp, Inst Clin Neurosci, S-90185 Umea, Sweden; [Hallers, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Hallers, Ronald G.] Presbyterian Med Ctr, Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX 75231 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; McGill University; Umea University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mochel, F (corresponding author), NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA.	mochelf@ninds.nih.gov	Singleton, Andrew B/C-3010-2009		Intramural NIH HHS Funding Source: Medline; NIAMS NIH HHS [R01 AR050597] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000958] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; ANDERSEN H, 1973, HISTOCHEMISTRY, V35, P173, DOI 10.1007/BF00306043; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; DRUGGE U, 1995, J MED GENET, V32, P344, DOI 10.1136/jmg.32.5.344; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361; LINDERHOLM H, 1969, ACTA MED SCAND, V185, P153; LINDERHOLM H, 1990, J INTERN MED, V228, P43, DOI 10.1111/j.1365-2796.1990.tb00191.x; Liu JY, 2005, PROTEINS, V59, P875, DOI 10.1002/prot.20421; Malkani R, 2006, NEUROBIOL DIS, V22, P401, DOI 10.1016/j.nbd.2005.12.001; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rump A, 2006, GENE, V371, P174, DOI 10.1016/j.gene.2005.11.036; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887	30	153	158	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					652	660		10.1016/j.ajhg.2007.12.012	http://dx.doi.org/10.1016/j.ajhg.2007.12.012			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18304497	Green Published, Bronze			2022-12-18	WOS:000254067800010
J	Otonkoski, T; Jiao, H; Kaminen-Ahola, N; Tapia-Paez, I; Ullah, MS; Parton, LE; Schuit, F; Quintens, R; Sipila, I; Mayatepek, E; Meissner, T; Halestrap, AP; Rutter, GA; Kere, J				Otonkoski, Timo; Jiao, Hong; Kaminen-Ahola, Nina; Tapia-Paez, Isabel; Ullah, Mohammed S.; Parton, Laura E.; Schuit, Frans; Quintens, Roel; Sipilae, Ilkka; Mayatepek, Ertan; Meissner, Thomas; Halestrap, Andrew P.; Rutter, Guy A.; Kere, Juha			Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LACTATE-DEHYDROGENASE; INSULIN-SECRETION; EXPRESSION; GLUCOSE; OVEREXPRESSION; RELEASE; FAMILY; GENE; MCT1; HYPERINSULINISM	Exercise-induced hyperinsulinism (EIHI) is a dominantly inherited hypoglycemic disorder characterized by inappropriate insulin secretion during anaerobic exercise or on pyruvate load. We aimed to identify the molecular basis of this novel disorder of beta-cell regulation. EIHI mapped to chromosome 1 (LOD score 3.6) in a genome scan performed for two families with 10 EIHI-affected patients. Mutational analysis of the promoter of the SLC16A1 gene, which encodes monocarboxylate transporter 1 (MCT1), located under the linkage peak, revealed changes in all 13 identified patients with EIHI. Patient fibroblasts displayed abnormally high SLC16A1 transcript levels, although monocarboxylate transport activities were not changed in these cells, reflecting additional posttranscriptional control of MCT1 levels in extrapancreatic tissues. By contrast, when examined in S cells, either of two SLC16A1 mutations identified in separate pedigrees resulted in increased protein binding to the corresponding promoter elements and marked (3- or 10-fold) transcriptional stimulation of SLC16A1 promoter-reporter constructs. These studies show that promoter-activating mutations in EIHI induce SLC16A1 expression in (3 cells, where this gene is not usually transcribed, permitting pyruvate uptake and pyruvate-stimulated insulin release despite ensuing hypoglycemia. These findings describe a novel disease mechanism based on the failure of cell-specific transcriptional silencing of a gene that is highly expressed in other tissues.	Univ Helsinki, Fac Med, FIN-00014 Helsinki, Finland; Univ Helsinki, Hosp Childerns & Adolescents, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Karolinska Inst, Dept Biochem & Nutr, Stockholm, Sweden; Univ Bristol, Sch Med Sci, Wellcome Labs Integrated Cell Signalling, Bristol BS8 1TD, Avon, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Katholieke Univ Leuven, Dept Mol Cell Biol, Louvain, Belgium; Univ Children Hosp, Dept Gen Pediat, Dusseldorf, Germany; Univ London Imperial Coll Sci Technol & Med, Dept Cell Biol, Div Med, London, England	University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; University of Bristol; University of Bristol; KU Leuven; Imperial College London	Otonkoski, T (corresponding author), Univ Helsinki, Fac Med, Room C507b,POB 63, FIN-00014 Helsinki, Finland.	timo.otonkoski@helsinki.fi	Otonkoski, Timo/F-1189-2011; Kere, Juha/A-9179-2008; Quintens, Roel/G-5339-2017; Tapia-Páez, Isabel/ABD-7197-2021; Halestrap, Andrew P/G-7275-2011; Tapia-Páez, Isabel/N-1210-2013; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Quintens, Roel/0000-0002-4359-3403; Kere, Juha/0000-0003-1974-0271; Tapia-Paez, Isabel/0000-0002-0535-4233; Kaminen-Ahola, Nina/0000-0003-1255-4716; Halestrap, Andrew/0000-0001-5374-2778; Rutter, Guy/0000-0001-6360-0343	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Cuff MA, 2002, BIOCHEM BIOPH RES CO, V292, P1048, DOI 10.1006/bbrc.2002.6763; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Liang Y, 1996, AM J PHYSIOL-ENDOC M, V270, pE846, DOI 10.1152/ajpendo.1996.270.5.E846; Meissner T, 2005, HORM METAB RES, V37, P690, DOI 10.1055/s-2005-870583; Meissner T, 2001, ARCH DIS CHILD, V84, P254, DOI 10.1136/adc.84.3.254; Otonkoski T, 2003, DIABETES, V52, P199, DOI 10.2337/diabetes.52.1.199; Parton LE, 2004, AM J PHYSIOL-ENDOC M, V287, pE390, DOI 10.1152/ajpendo.00016.2004; Price NT, 1998, BIOCHEM J, V329, P321; Rutter GA, 2004, DIABETOLOGIA, V47, P1861, DOI 10.1007/s00125-004-1541-1; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; SAMBROOK J, 2001, GEL RETARDATION ASSA; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Van Lommel L, 2006, DIABETES, V55, P3214, DOI 10.2337/db06-0774; Zhao C, 1998, FEBS LETT, V430, P213, DOI 10.1016/S0014-5793(98)00600-0; Zhao C, 2001, DIABETES, V50, P361, DOI 10.2337/diabetes.50.2.361	24	153	164	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					467	474		10.1086/520960	http://dx.doi.org/10.1086/520960			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701893	Green Published, Bronze			2022-12-18	WOS:000249128200004
J	Jenkins, D; Seelow, D; Jehee, FS; Perlyn, CA; Alonso, LG; Bueno, DF; Donnai, D; Josifiova, D; Mathijssen, IMJ; Morton, JEV; Orstavik, KH; Sweeney, E; Wall, SA; Marsh, JL; Nurnberg, P; Passos-Bueno, MR; Wilkie, AOM				Jenkins, Dagan; Seelow, Dominik; Jehee, Fernanda S.; Perlyn, Chad A.; Alonso, Luis G.; Bueno, Daniela F.; Donnai, Dian; Josifiova, Dragana; Mathijssen, Irene M. J.; Morton, Jenny E. V.; Orstavik, Karen Helene; Sweeney, Elizabeth; Wall, Steven A.; Marsh, Jeffrey L.; Nurnberg, Peter; Passos-Bueno, Maria Rita; Wilkie, Andrew O. M.			RAB23 mutations in carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPEN BRAIN; EXPRESSION PATTERNS; NEGATIVE REGULATOR; FAMILY; PATHWAYS; FGF	Carpenter syndrome is a pleiotropic disorder with autosomal recessive inheritance, the cardinal features of which include craniosynostosis, polysyndactyly, obesity, and cardiac defects. Using homozygosity mapping, we found linkage to chromosome 6p12.1-q12 and, in 15 independent families, identified five different mutations (four truncating and one missense) in RAB23, which encodes a member of the RAB guanosine triphosphatase (GTPase) family of vesicle transport proteins and acts as a negative regulator of hedgehog (HH) signaling. In 10 patients, the disease was caused by homozygosity for the same nonsense mutation, L145X, that resides on a common haplotype, indicative of a founder effect in patients of northern European descent. Surprisingly, nonsense mutations of Rab23 in open brain mice cause recessive embryonic lethality with neural-tube defects, suggesting a species difference in the requirement for RAB23 during early development. The discovery of RAB23 mutations in patients with Carpenter syndrome implicates HH signaling in cranial-suture biogenesis-an unexpected finding, given that craniosynostosis is not usually associated with mutations of other HH-pathway components-and provides a new molecular target for studies of obesity.	Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Oxford Radcliffe Hosp, Craniofacial Unit, Natl Hlth Serv Trust, Oxford, England; Univ Cologne, Cologne Ctr Genom, Cologne, Germany; Univ Cologne, Inst Genet, D-5000 Cologne, Germany; Univ Sao Paulo, Ctr Estudos Genoma Humano, Dept Biol, Sao Paulo, Brazil; Univ Fed Sao Paulo, Dept Morfol, Sao Paulo, Brazil; Univ Estadual Campinas, SOBRAPAR, Sao Paulo, Brazil; Washington Univ, Sch Med, Div Plast Surg, St Louis, MO 63110 USA; St Johns Mercy Med Ctr, Cleft Lip Palate & Craniofacial Deform Ctr, St Louis, MO 63141 USA; Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; Guys Hosp, London SE1 9RT, England; Erasmus MC, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands; Womens Hosp Med Ctr, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; Univ Oslo, Rikshosp, Dept Med Genet, Radiumhosp,Med Ctr, N-0027 Oslo, Norway; Univ Oslo, Rikshosp, Fac Div, N-0027 Oslo, Norway; Womens Hosp Med Ctr, Merseyside & Cheshire Clin Genet Serv, Liverpool, Merseyside, England	University of Oxford; University of Oxford; University of Cologne; University of Cologne; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual de Campinas; Washington University (WUSTL); Saint Johns Mercy Medical Center; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; Erasmus University Rotterdam; Erasmus MC; Birmingham Women's Hospital; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	awilkie@hammer.imm.ox.ac.uk	Bueno, Daniela/AAK-2926-2020; Alonso, Luis/I-2841-2013; Seelow, Dominik/HGB-3124-2022; Mathijssen, Irene M.J./B-1955-2013; Bueno, Daniela F/K-9977-2018; Wilkie, Andrew/AAC-3820-2020; Passos-Bueno, Maria Rita/I-6796-2016	Alonso, Luis/0000-0002-1704-6676; Seelow, Dominik/0000-0002-9746-4412; Bueno, Daniela F/0000-0001-5932-6134; Wilkie, Andrew/0000-0002-2972-5481; Passos-Bueno, Maria Rita/0000-0002-9248-3008	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Biesecker Leslie G., 2004, P257; Carpenter G, 1909, Proc R Soc Med, V2, P45; Carpenter G., 1901, REP SOC STUDY DIS CH, V1, P110; COHEN DM, 1987, AM J MED GENET, V28, P311, DOI 10.1002/ajmg.1320280208; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Davey MG, 2006, GENE DEV, V20, P1365, DOI 10.1101/gad.369106; Dietter J, 2007, BIOINFORMATICS, V23, P64, DOI 10.1093/bioinformatics/btl539; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Eggenschwiler JT, 2000, DEV BIOL, V227, P648, DOI 10.1006/dbio.2000.9918; Eggenschwiler JT, 2006, DEV BIOL, V290, P1, DOI 10.1016/j.ydbio.2005.09.022; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Evans TM, 2003, TRAFFIC, V4, P869, DOI 10.1046/j.1600-0854.2003.00141.x; GUNTHER T, 1994, DEVELOPMENT, V120, P3119; Guo AC, 2006, J NEUROSCI RES, V83, P1118, DOI 10.1002/jnr.20788; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kim HJ, 1998, DEVELOPMENT, V125, P1241; KING JA, 1994, DEV BIOL, V166, P112, DOI 10.1006/dbio.1994.1300; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Miletich I, 2005, ARCH ORAL BIOL, V50, P147, DOI 10.1016/j.archoralbio.2004.09.006; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Nieuwenhuis E, 2005, CLIN GENET, V67, P193, DOI 10.1111/j.1399-0004.2004.00360.x; O'Rourke MP, 2002, DEV BIOL, V248, P143, DOI 10.1006/dbio.2002.0730; OLKKONEN VM, 1994, GENE, V138, P207, DOI 10.1016/0378-1119(94)90809-5; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; PERLYN CA, 2007, IN PRESS PLAST RECON; Rice R, 2006, GENE EXPR PATTERNS, V6, P206, DOI 10.1016/j.modgep.2005.06.005; ROBINSON LK, 1985, AM J MED GENET, V20, P461, DOI 10.1002/ajmg.1320200307; Rosen ED, 2006, CELL METAB, V3, P1, DOI 10.1016/j.cmet.2005.12.002; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; TEMTAMY SA, 1966, J PEDIATR-US, V69, P111, DOI 10.1016/S0022-3476(66)80368-2; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847	38	153	166	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1162	1170		10.1086/518047	http://dx.doi.org/10.1086/518047			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503333	Green Published, Bronze			2022-12-18	WOS:000246553800014
J	van Wijk, E; Pennings, RJE; te Brinke, H; Claassen, A; Yntema, HG; Hoefsloot, LH; Cremers, FPM; Cremers, CWRJ; Kremer, H				van Wijk, E; Pennings, RJE; te Brinke, H; Claassen, A; Yntema, HG; Hoefsloot, LH; Cremers, FPM; Cremers, CWRJ; Kremer, H			Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; PREVALENCE; MUTATIONS; EXPRESSION; PROTEIN; LOCALIZATION; FAMILIES; DEAFNESS; LOCUS; MOUSE	The USH2A gene is mutated in patients with Usher syndrome type IIa, which is the most common subtype of Usher syndrome and is characterized by hearing loss and retinitis pigmentosa. Since mutation analysis by DNA sequencing of exons 1 - 21 revealed only similar to 63% of the expected USH2A mutations, we searched for so-far-uncharacterized exons of the gene. We identified 51 novel exons at the 3' end of the gene, and we obtained indications for alternative splicing. The putative protein encoded by the longest open reading frame harbors, in addition to the known functional domains, two laminin G and 28 fibronectin type III repeats, as well as a transmembrane region followed by an intracellular domain with a PDZ-binding domain at its C-terminal end. Semiquantitative expression profile analysis suggested a low level of expression for both the long and the short isoform(s) and partial overlap in spatial and temporal expression patterns. Mutation analysis in 12 unrelated patients with Usher syndrome, each with one mutation in exons 1 - 21, revealed three different truncating mutations in four patients and two missense mutations in one patient. The presence of pathogenic mutations in the novel exons indicates that at least one of the putative long isoforms of the USH2A protein plays a role in both hearing and vision.	Univ Med Ctr Nijmegen, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kremer, H (corresponding author), Univ Med Ctr Nijmegen, Dept Otorhinolaryngol, Internal Postal Code 811,POB 9101, NL-6500 HB Nijmegen, Netherlands.	h.kremer@antrg.umcn.nl	Cremers, C.W.R.J./L-4254-2015; Cremers, Frans/A-5625-2014; Pennings, Ronald JE/J-6651-2012; van Wijk, Erwin/J-8913-2014; Yntema, H.G./L-4771-2015; Kremer, Hannie/F-5126-2010	Cremers, Frans/0000-0002-4954-5592; Pennings, Ronald JE/0000-0001-5517-9683; van Wijk, Erwin/0000-0002-5702-3460; Kremer, Hannie/0000-0002-0841-8693				Adato A, 2000, HUM MUTAT, V15, P388, DOI 10.1002/(SICI)1098-1004(200004)15:4<388::AID-HUMU27>3.0.CO;2-N; Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bernal S, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e89; Bhattacharya G, 2004, J CELL SCI, V117, P233, DOI 10.1242/jcs.00850; Bhattacharya G, 2002, HEARING RES, V163, P1, DOI 10.1016/S0378-5955(01)00344-6; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dreyer B, 2000, EUR J HUM GENET, V8, P500, DOI 10.1038/sj.ejhg.5200491; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Hmani M, 1999, EUR J HUM GENET, V7, P363, DOI 10.1038/sj.ejhg.5200307; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Huang DL, 2002, GENOMICS, V80, P195, DOI 10.1006/geno.2002.6823; KEATS BJB, 1994, AM J HUM GENET, V54, P681; Liu XZ, 1999, AM J HUM GENET, V64, P1221, DOI 10.1086/302332; Luijendijk MWJ, 2003, GENOMICS, V82, P480, DOI 10.1016/S0888-7543(03)00150-2; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Ness SL, 2003, J MED GENET, V40, P767, DOI 10.1136/jmg.40.10.767; Otterstedde CR, 2001, LARYNGOSCOPE, V111, P84, DOI 10.1097/00005537-200101000-00014; PAKARINEN L, 1995, LARYNGOSCOPE, V105, P613, DOI 10.1288/00005537-199506000-00010; Pearsall N, 2002, HEARING RES, V174, P55, DOI 10.1016/S0378-5955(02)00635-4; PENNINGS RJE, IN PRESS HUM MUTAT; PIAZZA L, 1986, ARCH OPHTHALMOL-CHIC, V104, P1336; Pieke-Dahl S, 2000, J MED GENET, V37, P256, DOI 10.1136/jmg.37.4.256; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Rosenberg T, 1997, CLIN GENET, V51, P314; Rozen S, 2000, Methods Mol Biol, V132, P365; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shroyer NF, 2001, HUM MOL GENET, V10, P2671, DOI 10.1093/hmg/10.23.2671; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Spandau UHM, 2002, GRAEF ARCH CLIN EXP, V240, P495, DOI 10.1007/s00417-002-0485-8; Weston MD, 2000, AM J HUM GENET, V66, P1199, DOI 10.1086/302855	35	153	159	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					738	744		10.1086/383096	http://dx.doi.org/10.1086/383096			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15015129	Bronze, Green Published			2022-12-18	WOS:000220280800013
J	Palmer, LJ; Buxbaum, SG; Larkin, E; Patel, SR; Elston, RC; Tishler, PV; Redline, S				Palmer, LJ; Buxbaum, SG; Larkin, E; Patel, SR; Elston, RC; Tishler, PV; Redline, S			A whole-genome scan for obstructive sleep apnea and obesity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROOPIOMELANOCORTIN POMC GENE; QUANTITATIVE TRAIT LOCUS; APOLIPOPROTEIN-B GENE; SERUM LEPTIN LEVELS; LINKAGE ANALYSIS; AUTONOMIC NEUROPATHY; DIABETES-MELLITUS; AFRICAN-AMERICANS; VISCERAL OBESITY; QUEBEC FAMILY	Obstructive sleep apnea (OSA) is a common, chronic, complex disease associated with serious cardiovascular and neuropsychological sequelae and with substantial social and economic costs. Along with male gender, obesity is the most characteristic feature of OSA in adults. To identify susceptibility loci for OSA, we undertook a 9-cM genome scan in 66 white pedigrees (n = 349 subjects) ascertained on the basis of either an affected individual with laboratory-confirmed OSA or a proband who was a neighborhood control individual. Multipoint variance-component linkage analysis was performed for the OSA-associated quantitative phenotypes apnea-hypopnea index (AHI) and body mass index (BMI). Candidate regions on chromosomes 1p (LOD score 1.39), 2p (LOD score 1.64), 12p (LOD score 1.43), and 19p (LOD score 1.40) gave the most evidence for linkage to AHI. BMI was also linked to multiple regions, most significantly to markers on chromosomes 2p (LOD score 3.08), 7p (LOD score 2.53), and 12p (LOD score 3.41). Extended modeling indicated that the evidence for linkage to AHI was effectively removed after adjustment for BMI, with the exception of the candidate regions on chromosomes 2p (adjusted LOD score 1.33) and 19p (adjusted LOD score 1.45). After adjustment for AHI, the primary linkages to BMI remained suggestive but were roughly halved. Our results suggest that there are both shared and unshared genetic factors underlying susceptibility to OSA and obesity and that the interrelationship of OSA and obesity in white individuals may be partially explained by a common causal pathway involving one or more genes regulating both AHI and BMI levels.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University	Palmer, LJ (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.		Buxbaum, Sarah G./E-1970-2013; Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019	Buxbaum, Sarah G./0000-0002-4886-3564; Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Patel, Sanjay/0000-0002-9142-5172	NHLBI NIH HHS [U01 HL 66795, HL43680, HL07567, U01 HL066795, T32 HL007567] Funding Source: Medline; NIGMS NIH HHS [R01 GM028356, R37 GM028356, GM28356] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Al-Delaimy WK, 2002, AM J EPIDEMIOL, V155, P387, DOI 10.1093/aje/155.5.387; ALI NJ, 1993, ARCH DIS CHILD, V68, P360, DOI 10.1136/adc.68.3.360; Allison DB, 1996, INT J OBESITY, V20, P501; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; BAILEYWILSON JE, 1993, GENET EPIDEMIOL, V10, P665, DOI 10.1002/gepi.1370100656; Boston B A, 2001, J Pediatr Endocrinol Metab, V14 Suppl 6, P1409; Bray MS, 2000, OBES RES, V8, P219, DOI 10.1038/oby.2000.25; Bray MS, 1999, GENET EPIDEMIOL, V16, P397; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Buxbaum SG, 2002, GENET EPIDEMIOL, V22, P243, DOI 10.1002/gepi.0170; CATTERALL JR, 1984, DIABETES, V33, P1025, DOI 10.2337/diabetes.33.11.1025; Chagnon YC, 2000, METABOLISM, V49, P203, DOI 10.1016/S0026-0495(00)91299-X; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; del Giudice EM, 2001, INT J OBESITY, V25, P61, DOI 10.1038/sj.ijo.0801485; Delplanque J, 2000, DIABETOLOGIA, V43, P1554, DOI 10.1007/s001250051568; Elmasry A, 2001, J INTERN MED, V249, P153, DOI 10.1046/j.1365-2796.2001.00787.x; Elmasry A, 2000, J INTERN MED, V248, P13, DOI 10.1046/j.1365-2796.2000.00683.x; FERINISTRAMBI L, 1995, RESP MED, V89, P337, DOI 10.1016/0954-6111(95)90004-7; Ficker JH, 1998, EUR RESPIR J, V11, P14, DOI 10.1183/09031936.98.11010014; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Guilleminault C, 1998, ANN MED, V30, P350, DOI 10.3109/07853899809029934; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Heath A C, 1998, Twin Res, V1, P176, DOI 10.1375/twin.1.4.176; Heinonen P, 1999, J CLIN ENDOCR METAB, V84, P2429, DOI 10.1210/jc.84.7.2429; Hixson JE, 1999, J CLIN ENDOCR METAB, V84, P3187, DOI 10.1210/jc.84.9.3187; Janssens JP, 2000, AGING-CLIN EXP RES, V12, P417, DOI 10.1007/BF03339872; Kadotani H, 2001, JAMA-J AM MED ASSOC, V285, P2888, DOI 10.1001/jama.285.22.2888; KATSUMATA K, 1991, DIABETES RES CLIN PR, V13, P45, DOI 10.1016/0168-8227(91)90032-9; Khoury M, 1993, FUNDAMENTALS GENETIC; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; KUMP K, 1994, AM J RESP CRIT CARE, V150, P735, DOI 10.1164/ajrccm.150.3.8087345; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Linkowski P, 1999, J SLEEP RES, V8, P11; LUCARINI N, 1990, EXPERIENTIA, V46, P90, DOI 10.1007/BF01955426; Lucarini N, 1997, HUM BIOL, V69, P509; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; McCarthy MI, 2002, J MOL ENDOCRINOL, V28, P1, DOI 10.1677/jme.0.0280001; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Donnell CP, 1999, AM J RESP CRIT CARE, V159, P1477, DOI 10.1164/ajrccm.159.5.9809025; Oh JY, 2001, CLIN GENET, V60, P132, DOI 10.1034/j.1399-0004.2001.600207.x; Perusse L, 2001, DIABETES, V50, P614, DOI 10.2337/diabetes.50.3.614; POULIOT MC, 1994, ARTERIOSCLER THROMB, V14, P527, DOI 10.1161/01.ATV.14.4.527; RAJPUTWILLIAMS J, 1988, LANCET, V2, P1442; Rankinen T, 2002, OBES RES, V10, P196, DOI 10.1038/oby.2002.30; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 1997, AM J RESP CRIT CARE, V155, P186, DOI 10.1164/ajrccm.155.1.9001310; REDLINE S, 1991, CHEST, V100, P1281, DOI 10.1378/chest.100.5.1281; Redline S, 1998, AM J RESP CRIT CARE, V157, P858, DOI 10.1164/ajrccm.157.3.9709042; Redline S, 2000, SLEEP MED REV, V4, P583, DOI 10.1053/smrv.2000.0120; Redline S, 1993, NATL COMMISSION SLEE; Redline Susan, 1993, Ear Nose and Throat Journal, V72, P20; Rotimi CN, 1999, DIABETES, V48, P643, DOI 10.2337/diabetes.48.3.643; SAHA N, 1993, CLIN GENET, V44, P113; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sinton CM, 1999, J SLEEP RES, V8, P197, DOI 10.1046/j.1365-2869.1999.00158.x; SMITH PL, 1985, ANN INTERN MED, V103, P850, DOI 10.7326/0003-4819-103-6-850; STRADLING JR, 1995, THORAX, V50, P683, DOI 10.1136/thx.50.6.683; STROHL KP, 1994, SLEEP, V17, P614, DOI 10.1093/sleep/17.7.614; Strohl KP, 1996, AM J RESP CRIT CARE, V154, P279, DOI 10.1164/ajrccm.154.2.8756795; Strohl KP, 1996, SLEEP, V19, pS225, DOI 10.1093/sleep/19.suppl_10.S225; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Sun G, 1999, INT J OBESITY, V23, P929, DOI 10.1038/sj.ijo.0801021; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; WILSON AF, 1991, AM J HUM GENET, V48, P862; Yanagisawa Y, 2001, BIOCHEM BIOPH RES CO, V281, P772, DOI 10.1006/bbrc.2001.4417; Ye WZ, 2001, EUR J ENDOCRINOL, V145, P181, DOI 10.1530/eje.0.1450181; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	73	153	158	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					340	350		10.1086/346064	http://dx.doi.org/10.1086/346064			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12506338	Green Published, Bronze			2022-12-18	WOS:000180680000014
J	Giglio, S; Calvari, V; Gregato, G; Gimelli, G; Camanini, S; Giorda, R; Ragusa, A; Guerneri, S; Selicorni, A; Stumm, M; Tonnies, H; Ventura, M; Zollino, M; Neri, G; Barber, J; Wieczorek, D; Rocchi, M; Zuffardi, O				Giglio, S; Calvari, V; Gregato, G; Gimelli, G; Camanini, S; Giorda, R; Ragusa, A; Guerneri, S; Selicorni, A; Stumm, M; Tonnies, H; Ventura, M; Zollino, M; Neri, G; Barber, J; Wieczorek, D; Rocchi, M; Zuffardi, O			Heterozygous submicroscopic inversions involving olfactory receptor-gene clusters mediate the recurrent t(4;8)(p16;p23) translocation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILLIAMS-BEUREN-SYNDROME; SEGMENTAL DUPLICATIONS; HUMAN-GENOME; COMMON-CAUSE; MECHANISM; FAMILY	The t(4;8)(p16; p23) translocation, in either the balanced form or the unbalanced form, has been reported several times. Taking into consideration the fact that this translocation may be undetected in routine cytogenetics, we find that it may be the most frequent translocation after t(11q;22q), which is the most common reciprocal translocation in humans. Case subjects with der(4) have the Wolf-Hirschhorn syndrome, whereas case subjects with der( 8) show a milder spectrum of dysmorphic features. Two pairs of the many olfactory receptor (OR)-gene clusters are located close to each other, on both 4p16 and 8p23. Previously, we demonstrated that an inversion polymorphism of the OR region at 8p23 plays a crucial role in the generation of chromosomal imbalances through unusual meiotic exchanges. These findings prompted us to investigate whether OR-related inversion polymorphisms at 4p16 and 8p23 might also be involved in the origin of the t(4;8)(p16;p23) translocation. In seven case subjects (five of whom both represented de novo cases and were of maternal origin), including individuals with unbalanced and balanced translocations, we demonstrated that the breakpoints fell within the 4p and 8p OR-gene clusters. FISH experiments with appropriate bacterial-artificial-chromosome probes detected heterozygous submicroscopic inversions of both 4p and 8p regions in all the five mothers of the de novo case subjects. Heterozygous inversions on 4p16 and 8p23 were detected in 12.5% and 26% of control subjects, respectively, whereas 2.5% of them were scored as doubly heterozygous. These novel data emphasize the importance of segmental duplications and large-scale genomic polymorphisms in the evolution and pathology of the human genome.	Univ Pavia, I-27100 Pavia, Italy; Policlin San Matteo, Ist Ricovero & Cura & Carattere Sci, I-27100 Pavia, Italy; Ist Giannina Gaslini, Lab Citogenet, I-16148 Genoa, Italy; Ist Ricovero & Cura & Carattere Sci Eugenio Medea, Bosisio Parini, Lecco, Italy; Ist Ricovero & Cura & Carattere Sci Oasi Maria Sa, Troina, Enna, Italy; Univ Milan, Genet Lab, Ist Clin Perfezionamento, Milan, Italy; Univ Milan, Pediat Clin, Milan, Italy; Univ Magdeburg, Inst Human Genet, D-39106 Magdeburg, Germany; Humboldt Univ, Charite, Dept Human Genet, Berlin, Germany; Dipartimento Anat Patol & Genet, Sez Genet, Bari, Italy; Catholic Univ, Ist Genet Med, Rome, Italy; Salisbury Dist Hosp, Salisbury Hlth Care Trust, Wessex Reg Genet Lab, Salisbury, Wilts, England; Univ Klinikum Essen, Inst Human Genet, Essen, Germany	University of Pavia; IRCCS Fondazione San Matteo; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Eugenio Medea; University of Milan; University of Milan; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Salisbury District Hospital; University of Duisburg Essen	Zuffardi, O (corresponding author), Univ Pavia, Via Forlanini 14, I-27100 Pavia, Italy.	zuffardi@unipv.it	Giorda, Roberto/J-1052-2014; Zollino, Marcella/AAC-3891-2022; Ventura, Mario/E-6420-2011; Giglio, Sabrina Rita/ABB-1093-2020; Gregato, Giuliana/AAO-5668-2020	Giorda, Roberto/0000-0001-8175-9606; Zollino, Marcella/0000-0003-4871-9519; Ventura, Mario/0000-0001-7762-8777; Giglio, Sabrina Rita/0000-0002-3954-326X; zuffardi, orsetta/0000-0002-1466-4559	Telethon [GP0247Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BONDESON ML, 1995, HUM MOL GENET, V4, P615, DOI 10.1093/hmg/4.4.615; Crosier M, 2002, GENOME RES, V12, P67, DOI 10.1101/gr.213702; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Floridia G, 1996, AM J HUM GENET, V58, P785; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kara-Mostefa A, 1999, AM J HUM GENET, V64, P1475, DOI 10.1086/302362; Kurahashi H, 2000, HUM MOL GENET, V9, P2727, DOI 10.1093/hmg/9.18.2727; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Saunier S, 2000, AM J HUM GENET, V66, P778, DOI 10.1086/302819; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tonnies H, 2001, J MED GENET, V38, P617, DOI 10.1136/jmg.38.9.617; TRANEBJAERG L, 1984, ANN GENET-PARIS, V27, P224; Warburton PE, 2001, TRENDS GENET, V17, P243, DOI 10.1016/S0168-9525(01)02283-1; Wieczorek D, 2000, J MED GENET, V37, P798, DOI 10.1136/jmg.37.10.798	22	153	157	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					276	285		10.1086/341610	http://dx.doi.org/10.1086/341610			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12058347	Bronze, Green Published			2022-12-18	WOS:000176977700006
J	Boerkoel, CF; Takashima, H; Stankiewicz, P; Garcia, CA; Leber, SM; Rhee-Morris, L; Lupski, JR				Boerkoel, CF; Takashima, H; Stankiewicz, P; Garcia, CA; Leber, SM; Rhee-Morris, L; Lupski, JR			Periaxin mutations cause recessive Dejerine-Sottas neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYELINATING SCHWANN-CELLS; POINT MUTATION; GENE; PROTEIN; LOCALIZATION; EXPRESSION; DISEASE	The periaxin gene (PRX) encodes two PDZ-domain proteins, L- and S-periaxin, that are required for maintenance of peripheral nerve myelin. Prx(-/-) mice develop a severe demyelinating peripheral neuropathy, despite apparently normal initial formation of myelin sheaths. We hypothesized that mutations in PRX could cause human peripheral myelinopathies. In accordance with this, we identified three unrelated Dejerine-Sottas neuropathy patients with recessive PRX mutations-two with compound heterozygous nonsense and frameshift mutations, and one with a homozygous frameshift mutation. We mapped PRX to 19q13.13-13.2, a region recently associated with a severe autosomal recessive demyelinating neuropathy in a Lebanese family (Delague et al. 2000) and syntenic to the location of Prx on murine chromosome 7 (Gillespie et al. 1997).	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Tulane Univ, Dept Neurol, New Orleans, LA 70118 USA; Tulane Univ, Dept Pathol, New Orleans, LA 70118 USA; Univ Michigan, Med Ctr, Div Pediat Neurol, Ann Arbor, MI USA; Univ Calif Davis Hlth Syst, Dept Obstet & Gynecol, Prenatal Diag & Treatment Ctr, Sacramento, CA USA	Baylor College of Medicine; Baylor College of Medicine; Tulane University; Tulane University; University of Michigan System; University of Michigan; University of California System; University of California Davis	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 609E, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Stankiewicz, Paweł/AAP-7906-2021; Boerkoel, Cornelius Franciscus/AFW-4948-2022	Stankiewicz, Paweł/0000-0002-6456-7490; Boerkoel, Cornelius Franciscus/0000-0003-3097-241X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK02738] Funding Source: Medline; NINDS NIH HHS [R01 NS027042, R01 NS27042] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dejerine J J, 1893, COMPTES RENDUS SOC B, V45, P63; Delague V, 2000, AM J HUM GENET, V67, P236, DOI 10.1086/302980; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dytrych L, 1998, J BIOL CHEM, V273, P5794, DOI 10.1074/jbc.273.10.5794; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gillespie CS, 1997, GENOMICS, V41, P297, DOI 10.1006/geno.1997.4630; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; Lupski JR, 2000, ANN NEUROL, V47, P6, DOI 10.1002/1531-8249(200001)47:1<6::AID-ANA4>3.3.CO;2-L; Lupski JR, 2001, METABOLIC MOL BASES, P5759; Montell C, 2000, NAT GENET, V26, P6, DOI 10.1038/79186; Parman Y, 1999, ANN NEUROL, V45, P518, DOI 10.1002/1531-8249(199904)45:4<518::AID-ANA15>3.0.CO;2-U; Paul RH, 2000, MUSCLE NERVE, V23, P1402, DOI 10.1002/1097-4598(200009)23:9<1402::AID-MUS11>3.0.CO;2-B; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Timmerman V, 1999, NEUROLOGY, V52, P1827, DOI 10.1212/WNL.52.9.1827; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382	24	153	163	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					325	333		10.1086/318208	http://dx.doi.org/10.1086/318208			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11133365	Green Published, Bronze			2022-12-18	WOS:000166524800003
J	Lie, BA; Todd, JA; Pociot, F; Nerup, J; Akselsen, HE; Joner, G; Dahl-Jorgensen, K; Ronningen, KS; Thorsby, E; Undlien, DE				Lie, BA; Todd, JA; Pociot, F; Nerup, J; Akselsen, HE; Joner, G; Dahl-Jorgensen, K; Ronningen, KS; Thorsby, E; Undlien, DE			The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HLA-DQ ALLELES; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; FINNISH POPULATION; INSULIN GENE; MELLITUS; IDDM; ASSOCIATION; HAPLOTYPES; REGION	The human leukocyte antigen (HLA) complex, encompassing 3.5 Mb of DNA from the centromeric HLA-DPB2 locus to the telomeric HLA-F locus on chromosome 6p21, encodes a major part of the genetic predisposition to develop type 1 diabetes, designated "IDDM1." A primary role for allelic variation of the class II HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci has been established. However, studies of animals and humans have indicated that other, unmapped, major histocompatibility complex (MHC)-linked genes are participating in IDDM1. The strong linkage disequilibrium between genes in this complex makes mapping a difficult task. In the present paper, we report on the approach we have devised to circumvent the confounding effects of disequilibrium between class II alleles and alleles at other MHC loci. We have scanned 12 Mb of the MHC and flanking chromosome regions with microsatellite polymorphisms and analyzed the transmission of these marker alleles to diabetic probands from parents who were homozygous for the alleles of the HLA-DRB1, HLA-DQA1, and HLA-DQB1 genes. Our analysis, using three independent family sets, suggests the presence of an additional type I diabetes gene (or genes). This approach is useful for the analysis of other loci linked to common diseases, to verify if a candidate polymorphism can explain all of the association of a region or if the association is due to two or more loci in linkage disequilibrium with each other.	Natl Hosp Norway, Inst Transplantat Immunol, N-0027 Oslo, Norway; Aker Univ Hosp, Aker Diabet Res Ctr, Oslo, Norway; Natl Inst Publ Hlth, Dept Populat Hlth Sci, Oslo, Norway; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oslo; National Hospital Norway; University of Oslo; Steno Diabetes Center; University of Oxford; Wellcome Centre for Human Genetics	Lie, BA (corresponding author), Natl Hosp Norway, Inst Transplantat Immunol, N-0027 Oslo, Norway.		Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Pociot, Flemming/0000-0003-3274-5448	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; CAPLEN NJ, 1990, IMMUNOGENETICS, V32, P427; CUCCA F, 1995, HUM IMMUNOL, V43, P301, DOI 10.1016/0198-8859(95)00042-3; DAlfonso S, 1996, IMMUNOGENETICS, V44, P321, DOI 10.1007/BF02602566; DEGLIESPOSTI MA, 1992, HUM IMMUNOL, V34, P242, DOI 10.1016/0198-8859(92)90023-G; Delepine M, 1997, AM J HUM GENET, V60, P174; Erlich HA, 1996, DIABETES, V45, P610, DOI 10.2337/diabetes.45.5.610; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FENNESSY M, 1994, DIABETOLOGIA, V37, P937, DOI 10.1007/s001250050200; FUJISAWA T, 1995, DIABETOLOGIA, V38, P1493; IKEGAMI H, 1995, J CLIN INVEST, V96, P1936, DOI 10.1172/JCI118239; KLITZ W, 1995, AM J HUM GENET, V57, P1436; LANGHOLZ B, 1995, GENET EPIDEMIOL, V12, P441, DOI 10.1002/gepi.1370120502; Lie BA, 1997, HUM IMMUNOL, V55, P170, DOI 10.1016/S0198-8859(97)00095-5; Merriman T, 1997, HUM MOL GENET, V6, P1003, DOI 10.1093/hmg/6.7.1003; Moghaddam PH, 1998, DIABETES, V47, P263, DOI 10.2337/diab.47.2.263; NAKANISHI K, 1993, DIABETES, V42, P1086, DOI 10.2337/diabetes.42.7.1086; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; RISCH N, 1989, GENET EPIDEMIOL, V6, P143, DOI 10.1002/gepi.1370060127; ROBINSON WP, 1993, GENET EPIDEMIOL, V10, P273, DOI 10.1002/gepi.1370100502; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TAIT BD, 1995, HUM IMMUNOL, V42, P116, DOI 10.1016/0198-8859(94)00075-2; THOMSEN M, 1988, IMMUNOGENETICS, V28, P320, DOI 10.1007/BF00364230; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; Undlien DE, 1997, DIABETES, V46, P307, DOI 10.2337/diabetes.46.2.307; Undlien DE, 1997, DIABETES, V46, P143, DOI 10.2337/diabetes.46.1.143; UNDLIEN DE, 1995, AM J HUM GENET, V57, P1511; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143	33	153	154	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					793	800		10.1086/302283	http://dx.doi.org/10.1086/302283			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053014	Green Published, Bronze			2022-12-18	WOS:000079204700017
J	Ohadi, M; Lalloz, MRA; Sham, P; Zhao, JH; Dearlove, AM; Shiach, C; Kinsey, S; Rhodes, M; Layton, DM				Ohadi, M; Lalloz, MRA; Sham, P; Zhao, JH; Dearlove, AM; Shiach, C; Kinsey, S; Rhodes, M; Layton, DM			Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHEDIAK-HIGASHI-SYNDROME; CYCLOSPORINE-A; HUMAN GENOME; LINKAGE MAP; IDENTIFICATION; DISORDERS; DEFICIENT; DNA	Familial hemophagocytic lymphohistiocytosis (FHL), also known as familial erythrophagocytic lymphohistiocytosis and familial histiocytic reticulosis, is a rare autosomal recessive disorder of early childhood characterized by excessive immune activation. Linkage of the disease gene to an similar to 7.8-cM region between markers D9S1867 and D9S1790 at 9q21.3-22 was identified by homozygosity mapping in four inbred FHL families of Pakistani descent with a combined maximum multipoint LOD score of 6.05. This is the first genetic locus to Poe described in FHL. However, homozygosity by descent across this interval could not be demonstrated in an additional affected kindred of Arab origin, whose maximum multipoint LOD score was -0.12. The combined sample revealed significant evidence for linkage to 9q markers (LOD score with heterogeneity, 5.00). Identification of the gene(s) involved in the pathogenesis of FHL will contribute to an understanding of the control of T-lymphocyte and macrophage activation, which is central to homeostasis in the immune system.	Kings Coll London, Sch Med & Dent, Dept Haematol Med, London SE5 9PJ, England; Inst Psychiat, Dept Psychol Med, London, England; UK HGMP, Resource Ctr, Cambridge, England; St James Univ Hosp, Dept Pediat Haematol Oncol, Leeds LS9 7TF, W Yorkshire, England	University of London; King's College London; University of London; King's College London; Saint James's University Hospital	Layton, DM (corresponding author), Kings Coll London, Sch Med & Dent, Dept Haematol Med, Denmark Hill, London SE5 9PJ, England.	mlayton@hgmp.mrc.ac.uk	Ohadi, Mina/D-8549-2017	Ohadi, Mina/0000-0003-1967-0576				Abella EM, 1997, J PEDIATR-US, V130, P467, DOI 10.1016/S0022-3476(97)70212-9; ARICO M, 1988, ARCH DIS CHILD, V63, P292, DOI 10.1136/adc.63.3.292; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; BLANCHE S, 1991, BLOOD, V78, P51; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Demetrick DJ, 1996, CYTOGENET CELL GENET, V73, P250, DOI 10.1159/000134349; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIEHL SR, 1990, AM J HUM GENET, V47, pA177; Egeler RM, 1996, J PEDIAT HEMATOL ONC, V18, P340, DOI 10.1097/00043426-199611000-00002; EVDOKIOU A, 1993, GENOMICS, V18, P731, DOI 10.1016/S0888-7543(05)80388-X; FALINI B, 1990, BLOOD, V75, P434; FARQUHAR JW, 1952, ARCH DIS CHILD, V27, P519, DOI 10.1136/adc.27.136.519; Favara BE, 1997, MED PEDIATR ONCOL, V29, P157, DOI 10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hasle H, 1996, BRIT J HAEMATOL, V93, P808, DOI 10.1046/j.1365-2141.1996.d01-1718.x; HENTER JI, 1991, ACTA PAEDIATR SCAND, V80, P428, DOI 10.1111/j.1651-2227.1991.tb11878.x; HENTER JI, 1991, BLOOD, V78, P2918, DOI 10.1182/blood.V78.11.2918.2918; HENTER JI, 1991, SEMIN ONCOL, V18, P29; HIRST WJR, 1994, BRIT J HAEMATOL, V88, P731, DOI 10.1111/j.1365-2141.1994.tb05111.x; JANKA GE, 1983, EUR J PEDIATR, V140, P221, DOI 10.1007/BF00443367; KOMP DM, 1989, BLOOD, V73, P2128; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LADISCH S, 1982, BLOOD, V60, P814; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LANDMANPARKER J, 1993, BRIT J HAEMATOL, V85, P37, DOI 10.1111/j.1365-2141.1993.tb08642.x; LeDeist F, 1996, LANCET, V348, P719, DOI 10.1016/S0140-6736(96)02293-3; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Moynihan LM, 1998, AM J HUM GENET, V62, P1123, DOI 10.1086/301824; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; Osugi Y, 1997, BLOOD, V89, P4100, DOI 10.1182/blood.V89.11.4100; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; PEREZ N, 1984, J PEDIATR-US, V104, P569, DOI 10.1016/S0022-3476(84)80549-1; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Sal G.D., 1992, CELL, V70, P595; SAMBROOK J, 1989, MOL CLONING LAB MANU, V103; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; STARK B, 1987, CANCER, V60, P2629, DOI 10.1002/1097-0142(19871201)60:11<2629::AID-CNCR2820601110>3.0.CO;2-Q; STEPHAN JL, 1993, BLOOD, V82, P2319; Tabrizi M, 1998, LEUKEMIA, V12, P200, DOI 10.1038/sj.leu.2400949; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P243; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	45	153	163	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					165	171		10.1086/302187	http://dx.doi.org/10.1086/302187			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915955	Bronze, Green Published			2022-12-18	WOS:000078477400021
J	Smalley, SL				Smalley, SL			Genetic influences in childhood-onset psychiatric disorders: Autism and attention-deficit hyperactivity disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROPSYCHIATRIC DISORDERS; TOURETTE SYNDROME; FAMILY HISTORY; SEGREGATION ANALYSIS; INFANTILE-AUTISM; ASSOCIATION; RELATIVES; ETIOLOGY; TWIN; COMORBIDITY		UNIV CALIF LOS ANGELES,SCH MED,DEPT ADOLESCENT & CHILD PSYCHIAT,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA								Achenbach T., 2007, CBCL PROFILE SCORING; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P251; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Bolton PF, 1997, LANCET, V349, P392, DOI 10.1016/S0140-6736(97)80012-8; Campbell M, 1996, J AM ACAD CHILD PSY, V35, P134, DOI 10.1097/00004583-199602000-00005; Cantwell DP, 1996, J AM ACAD CHILD PSY, V35, P978, DOI 10.1097/00004583-199608000-00008; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; COMINGS DE, 1989, AM J HUM GENET, V44, P452; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; COMINGS DE, 1995, J DEV BEHAV PEDIATR, V16, P142; Comings DE, 1996, PSYCHIAT RES, V63, P25, DOI 10.1016/0165-1781(96)02829-6; COMINGS DE, 1987, AM J HUM GENET, V41, P839; CONNERS K, 1994, CONNERS ABBREVIATED; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Cook EH, 1997, AM J HUM GENET, V60, P928; Cook EH, 1997, MOL PSYCHIATR, V2, P247; COOK EH, 1995, AM J HUM GENET, V56, P993; DANIELS WW, 1995, NEUROPSYCHOBIOLOGY, V32, P120, DOI 10.1159/000119223; DELONG GR, 1988, DEV MED CHILD NEUROL, V36, P441; DEMYER MK, 1981, SCHIZOPHRENIA BULL, V7, P388, DOI 10.1093/schbul/7.3.388; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; FARAONE SV, 1993, AM J PSYCHIAT, V150, P891; FARAONE SV, 1994, BIOL PSYCHIAT, V35, P398, DOI 10.1016/0006-3223(94)90006-X; FARAONE SV, 1992, PSYCHIATR GENET, V2, P257, DOI 10.1097/00041444-199210000-00004; Flejter WL, 1996, AM J MED GENET, V61, P182, DOI 10.1002/(SICI)1096-8628(19960111)61:2<182::AID-AJMG17>3.3.CO;2-K; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Gillberg C, 1996, DEV MED CHILD NEUROL, V38, P191; GILLIS JJ, 1992, J ABNORM CHILD PSYCH, V20, P303, DOI 10.1007/BF00916694; GIONE H, 1996, AM J ACAD CHILD ADOL, V35, P588; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GORDON CT, 1993, ARCH GEN PSYCHIAT, V50, P441; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Hallmayer J, 1996, ARCH GEN PSYCHIAT, V53, P985; HECHTMAN L, 1994, J PSYCHIATR NEUROSCI, V19, P193; HERAULT J, 1994, J AUTISM DEV DISORD, V24, P233, DOI 10.1007/BF02172100; HERAULT J, 1993, PSYCHIAT RES, V46, P261, DOI 10.1016/0165-1781(93)90094-W; Hill JC, 1996, AM J PSYCHIAT, V153, P1143; Hunziker MHL, 1996, J EXP ANAL BEHAV, V65, P129, DOI 10.1901/jeab.1996.65-129; JORDE LB, 1991, AM J HUM GENET, V49, P932; Kanner L, 1943, NERV CHILD, V2, P217; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; McDougle CJ, 1996, ARCH GEN PSYCHIAT, V53, P1001; NELSON KB, 1991, PEDIATRICS, V87, P761; PAULS DL, 1993, J AM ACAD CHILD PSY, V32, P1044, DOI 10.1097/00004583-199309000-00025; PAULS DL, 1986, ARCH GEN PSYCHIAT, V43, P1177; PAULS DL, 1988, AM J HUM GENET, V43, P206; PICKLES A, 1995, AM J HUM GENET, V57, P717; PIVEN J, 1990, J AM ACAD CHILD PSY, V29, P177, DOI 10.1097/00004583-199003000-00004; PIVEN J, 1991, J AM ACAD CHILD PSY, V30, P471, DOI 10.1097/00004583-199105000-00019; ROSSI PG, 1995, BRAIN DEV-JPN, V17, P169, DOI 10.1016/0387-7604(95)00019-8; RUTTER M, 1994, J CHILD PSYCHOL PSYC, V35, P311, DOI 10.1111/j.1469-7610.1994.tb01164.x; Rutter M, 1988, ASSESSMENT DIAGNOSIS, P408; SEMRUDCLIKEMAN M, 1992, J AM ACAD CHILD PSY, V31, P439, DOI 10.1097/00004583-199205000-00009; Sherman SL, 1997, AM J HUM GENET, V60, P1265, DOI 10.1086/515473; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; SMALLEY SL, 1995, AM J MED GENET, V60, P19, DOI 10.1002/ajmg.1320600105; SMALLEY SL, IN PRESS TXB PEDIAT; SMALLEY SL, 1995, PSYCHIAT GENET S, V1, pS88; Spencer T, 1996, J AM ACAD CHILD PSY, V35, P409, DOI 10.1097/00004583-199604000-00008; STEIN MA, 1995, DEV BEHAV PEDIAT, V16, P406; STEVENSON J, 1992, BEHAV GENET, V22, P337, DOI 10.1007/BF01066665; Swanson JM., 1995, SNAP 4 SCALE; THAPAR A, 1995, BEHAV GENET, V25, P537, DOI 10.1007/BF02327577; Waldman I. D., 1996, American Journal of Human Genetics, V59, pA25; Warren RP, 1996, MOL CHEM NEUROPATHOL, V28, P77, DOI 10.1007/BF02815207; WARREN RP, 1990, IMMUNOL INVEST, V19, P245, DOI 10.3109/08820139009041839; WARREN RP, 1986, J AUTISM DEV DISORD, V16, P189, DOI 10.1007/BF01531729; Wolraich ML, 1996, J AM ACAD CHILD PSY, V35, P319, DOI 10.1097/00004583-199603000-00013; WOZNIAK J, 1995, J AM ACAD CHILD PSY, V34, P1577, DOI 10.1097/00004583-199512000-00007	74	153	168	1	18	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1276	1282		10.1086/515485	http://dx.doi.org/10.1086/515485			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	XE294	9199546	Bronze, Green Published			2022-12-18	WOS:A1997XE29400003
J	Risch, NJ; Zhang, HP				Risch, NJ; Zhang, HP			Mapping quantitative trait loci with extreme discordant sib pairs: Sampling considerations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; DISEASE	Elsewhere we have proposed the use of extreme discordant sib pairs (EDSPs) for mapping quantitative trait loci in humans. Here we present sample sizes necessary to achieve a given level of power with this study design, as well as the number of sibs that need to be screened to obtain the required sample. Further, we present simple formulas for adjusting sample sizes to account for variable significance levels and power, as well as the density and informativeness of linkage markers in a multipoint sib-pair analysis. We conclude that with EDSPs, the most powerful study design, the smallest genetic effect detectable with a realistic sample size is similar to 10% of the variance of the trait.	YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510	Yale University	Risch, NJ (corresponding author), STANFORD UNIV,SCH MED,DEPT GENET,M322,STANFORD,CA 94305, USA.				NHGRI NIH HHS [HG00348] Funding Source: Medline; NICHD NIH HHS [HD30712] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD030712] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000348] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; CAREY G, 1991, AM J HUM GENET, V49, P786; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; HAUSER ER, IN PRESS GENET EPIDE; HOLMANS P, 1993, AM J HUM GENET, V52, P362; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; RISCH N, 1987, AM J HUM GENET, V40, P1; RISCH N, 1992, AM J HUM GENET, V51, P673	10	153	155	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					836	843						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644748				2022-12-18	WOS:A1996UA38000022
J	SCHORK, NJ; BOEHNKE, M; TERWILLIGER, JD; OTT, J				SCHORK, NJ; BOEHNKE, M; TERWILLIGER, JD; OTT, J			2-TRAIT-LOCUS LINKAGE ANALYSIS - A POWERFUL STRATEGY FOR MAPPING COMPLEX GENETIC-TRAITS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALZHEIMERS-DISEASE; SINGLE-LOCUS; HETEROGENEITY; 2-LOCUS; MODELS; PEDIGREES; DISORDER; HUMANS	Recent advances in molecular biology have provided geneticists with ever-increasing numbers of highly polymorphic genetic markers that have made possible linkage mapping of loci responsible for many human diseases. However, nearly all diseases mapped to date follow clear Mendelian, single-locus segregation patterns. In contrast, many common familial diseases such as diabetes, psoriasis, several forms of cancer, and schizophrenia are familial and appear to have a genetic component but do not exhibit simple Mendelian transmission. More complex models are required to explain the genetics of these important diseases. In this paper, we explore two-trait-locus, two-marker-locus linkage analysis in which two trait loci are mapped simultaneously to separate genetic markers. We compare the utility of this approach to standard one-trait-locus, one-marker-locus linkage analysis with and without allowance for heterogeneity. We also compare the utility of the two-trait-locus, two-marker-locus analysis to two-trait-locus, one-marker-locus linkage analysis. For common diseases, pedigrees are often bilineal, with disease genes entering via two or more unrelated pedigree members. Since such pedigrees often are avoided in linkage studies, we also investigate the relative information content of unilineal and bilineal pedigrees. For the dominant-or-recessive and threshold models that we consider, we find that two-trait-locus, two-marker-locus linkage analysis can provide substantially more linkage information, as measured by expected maximum lod score, than standard one-trait-locus, one-marker-locus methods, even allowing for heterogeneity, while, for a dominant-or-dominant generating model, one-locus models that allow for heterogeneity extract essentially as much information as the two-trait-locus methods. For these three models, we also find that bilineal pedigrees provide sufficient linkage information to warrant their inclusion in such studies. We also discuss strategies for assessing the significance of the two linkages assumed in two-trait-locus, two-marker-locus models.	UNIV MICHIGAN,DEPT BIOSTAT,ANN ARBOR,MI 48109; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10027; UNIV MICHIGAN,DEPT EPIDEMIOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; Columbia University; University of Michigan System; University of Michigan	SCHORK, NJ (corresponding author), UNIV MICHIGAN,DEPT MED,DIV HYPERTENS,R6592 KRESGE 1,ANN ARBOR,MI 48109, USA.			Schork, Nicholas/0000-0003-0920-5013	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL048957] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000376, R01HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044292, R37MH044292] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00376] Funding Source: Medline; NHLBI NIH HHS [HL48957] Funding Source: Medline; NIMH NIH HHS [MH44292] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMOS CI, 1989, GENET EPIDEMIOL, V6, P349, DOI 10.1002/gepi.1370060205; COCKERHAM CC, 1983, AM J HUM GENET, V35, P263; DURNER M, 1992, AM J HUM GENET, V51, P859; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; HAINES JL, IN PRESS NEUROBIOL A; HEARN AC, 1985, REDUCE USERS MANUAL; HODGE SE, 1992, GENET EPIDEMIOL, V9, P191, DOI 10.1002/gepi.1370090306; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MERETTE C, 1992, AM J HUM GENET, V50, P515; MERIKANGAS KR, 1989, ARCH GEN PSYCHIAT, V46, P1137; MORTON NE, 1956, AM J HUM GENET, V8, P80; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1990, AM J HUM GENET, V46, P219; Ott J., 1991, ANAL HUMAN GENETIC L; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Press WH., 1980, NUMERICAL RECIPES FO; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHORK NJ, 1992, GENET EPIDEMIOL, V9, P207, DOI 10.1002/gepi.1370090307; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; TIENARI PT, UNPUB 2 LOCUS LINKAG; VIELAND V, 1992, CYTOGENET CELL GENET, V59, P145, DOI 10.1159/000133229; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; WILSON AF, 1988, AM J HUM GENET, V42, P160	32	153	154	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1127	1136						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213836				2022-12-18	WOS:A1993MC33300017
J	WOHRLE, D; KOTZOT, D; HIRST, MC; MANCA, A; KORN, B; SCHMIDT, A; BARBI, G; ROTT, HD; POUSTKA, A; DAVIES, KE; STEINBACH, P				WOHRLE, D; KOTZOT, D; HIRST, MC; MANCA, A; KORN, B; SCHMIDT, A; BARBI, G; ROTT, HD; POUSTKA, A; DAVIES, KE; STEINBACH, P			A MICRODELETION OF LESS THAN 250 KB, INCLUDING THE PROXIMAL PART OF THE FMR-I GENE AND THE FRAGILE-X SITE, IN A MALE WITH THE CLINICAL PHENOTYPE OF FRAGILE-X SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; EXPRESSION; DNA; REGION; XQ27.3; INACTIVATION; INSTABILITY; INHERITANCE; DEFINES	A gene designated "FMR-1" has been isolated at the fragile-X locus. One exon of this gene is carried on a 5.1-kb EcoRI fragment that exhibits length variation in fragile-X patients because of amplification of or insertion into a CGG-repeat sequence. This repeat probably represents the fragile site. The EcoRI fragment also includes an HTF island that is hypermethylated in fragile-X patients showing absence of FMR-1 mRNA. In this paper, we present further evidence that the FMR-1 gene is involved in the clinical manifestation of the fragile-X syndrome and also in the expression of the cellular phenotype. A deletion including the HTF island and exons of the FMR-1 gene was detected in a fragile X-negative mentally retarded male who presented the clinical phenotype of the fragile-X syndrome. The deletion involves less than 250 kb of genomic DNA, including DXS548 and at least five exons of the FMR-1 gene. These data support the hypothesis that loss of function of the FMR-1 gene leads to the clinical phenotype of the fragile-X syndrome. In the fragile-X syndrome, there are pathogenetic mechanisms other than amplification of the CGG repeat that do have the same phenotypic consequences.	UNIV ERLANGEN NURNBERG,INST ANAT,W-8520 ERLANGEN,GERMANY; JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC GENET GRP,OXFORD OX3 9DU,ENGLAND; UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMAN GENET,W-4300 ESSEN 1,GERMANY; GERMAN CANC RES CTR,INST VIRUSFORSCHUNG,W-6900 HEIDELBERG 1,GERMANY	University of Erlangen Nuremberg; University of Oxford; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	WOHRLE, D (corresponding author), UNIV ULM,KLIN GENET ABT,PK STR 11,W-7900 ULM,GERMANY.		Manca, Antonella/AAH-3481-2019; Manca, Antonella/C-4502-2015	Manca, Antonella/0000-0003-2497-1541; Manca, Antonella/0000-0003-2497-1541; Hirst, Mark/0000-0003-3851-9740				BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; DIETRICH A, 1991, NUCLEIC ACIDS RES, V19, P2567, DOI 10.1093/nar/19.10.2567; HIRST MC, 1991, NUCLEIC ACIDS RES, V19, P3283, DOI 10.1093/nar/19.12.3283; HIRST MC, 1991, GENOMICS, V10, P243, DOI 10.1016/0888-7543(91)90506-A; HIRST MC, 1991, J MED GENET, V28, P824, DOI 10.1136/jmg.28.12.824; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LAIRD CD, 1987, GENETICS, V117, P587; LUBS HA, 1969, AM J HUM GENET, V21, P231; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PEMBREY ME, 1985, AM J MED GENET, V21, P709, DOI 10.1002/ajmg.1320210413; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SUTHERLAND GR, 1977, SCIENCE, V197, P256; SUTHERS GK, 1991, AM J HUM GENET, V48, P460; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WARREN ST, 1990, P NATL ACAD SCI USA, V87, P3856, DOI 10.1073/pnas.87.10.3856; WEBB T, 1989, FRAGILE X SYNDROME, P40; WOHRLE D, 1990, HUM GENET, V85, P659; WOHRLE D, 1991, HUM GENET, V87, P421; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	23	153	157	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					299	306						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642231				2022-12-18	WOS:A1992JF77600009
J	PYERITZ, RE; FISHMAN, EK; BERNHARDT, BA; SIEGELMAN, SS				PYERITZ, RE; FISHMAN, EK; BERNHARDT, BA; SIEGELMAN, SS			DURAL ECTASIA IS A COMMON FEATURE OF THE MARFAN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT MED, DIV MED GENET, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, RUSSELL H MORGAN DEPT RADIOL & RADIOL SCI, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins University			Pyeritz, Reed/A-1364-2010		NCRR NIH HHS [RR 00722] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		CHU NS, 1983, EPILEPSIA, V24, P49, DOI 10.1111/j.1528-1157.1983.tb04865.x; CILLUFFO JM, 1981, MAYO CLIN PROC, V56, P93; CLERICUZIO C, 1986, AM J MED GENET, V25, P724; FELDMAN F, 1988, DIAGNOSIS BONE JOINT, P4033; FISHMAN EK, 1983, J COMPUT ASSIST TOMO, V7, P851, DOI 10.1097/00004728-198310000-00019; GOTT VL, 1986, NEW ENGL J MED, V314, P1070, DOI 10.1056/NEJM198604243141702; HALL JR, 1984, ANN THORAC SURG, V37, P500, DOI 10.1016/S0003-4975(10)61142-3; LEMERCIER Y, 1980, ANN MED INTERNE, V131, P289; McKusick V.A., 1972, HERITABLE DISORDERS, P61; MESCHAN I, 1985, ROENTGEN SIGNS DIAGN, V3, P135; MITCHELL GE, 1967, RADIOLOGY, V89, P67, DOI 10.1148/89.1.67; MURDOCH JL, 1972, NEW ENGL J MED, V286, P804, DOI 10.1056/NEJM197204132861502; NELSON JD, 1958, BRIT J RADIOL, V31, P561, DOI 10.1259/0007-1285-31-370-561; NEWMAN PK, 1979, J NEUROL NEUROSUR PS, V42, P176, DOI 10.1136/jnnp.42.2.176; PAGES M, 1985, EUR NEUROL, V24, P170, DOI 10.1159/000115842; PYERITZ RE, 1986, AM FAM PHYSICIAN, V34, P83; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; STRAND RD, 1971, RADIOLOGY, V99, P653, DOI 10.1148/99.3.653; STREETEN EA, 1987, CHEST, V91, P408, DOI 10.1378/chest.91.3.408; THIERRY A, 1969, NEURO-CHIR, V15, P389; WEIT B, 1973, J NEUROSURG, V38, P650; WILNER HI, 1963, JAMA-J AM MED ASSOC, V187, P490	22	153	156	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					726	732						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	3189335				2022-12-18	WOS:A1988Q933600019
J	Woo, D; Falcone, GJ; Devan, WJ; Brown, WM; Biffi, A; Howard, TD; Anderson, CD; Brouwers, HB; Valant, V; Battey, TWK; Radmanesh, F; Raffeld, MR; Baedorf-Kassis, S; Deka, R; Woo, JG; Martin, LJ; Haverbusch, M; Moomaw, CJ; Sun, GY; Broderick, JP; Flaherty, ML; Martini, SR; Kleindorfer, DO; Kissela, B; Comeau, ME; Jagiella, JM; Schmidt, H; Freudenberger, P; Pichler, A; Enzinger, C; Hansen, BM; Norrving, B; Jimenez-Conde, J; Giralt-Steinhauer, E; Elosua, R; Cuadrado-Godia, E; Soriano, C; Roquer, J; Kraft, P; Ayres, AM; Schwab, K; McCauley, JL; Pera, J; Urbanik, A; Rost, NS; Goldstein, JN; Viswanathan, A; Stogerer, EM; Tirschwell, DL; Selim, M; Brown, DL; Silliman, SL; Worrall, BB; Meschia, JF; Kidwell, CS; Montaner, J; Fernandez-Cadenas, I; Delgado, P; Malik, R; Dichgans, M; Greenberg, SM; Rothwell, PM; Lindgren, A; Slowik, A; Schmidt, R; Langefeld, CD; Rosand, J				Woo, Daniel; Falcone, Guido J.; Devan, William J.; Brown, W. Mark; Biffi, Alessandro; Howard, Timothy D.; Anderson, Christopher D.; Brouwers, H. Bart; Valant, Valerie; Battey, Thomas W. K.; Radmanesh, Farid; Raffeld, Miriam R.; Baedorf-Kassis, Sylvia; Deka, Ranjan; Woo, Jessica G.; Martin, Lisa J.; Haverbusch, Mary; Moomaw, Charles J.; Sun, Guangyun; Broderick, Joseph P.; Flaherty, Matthew L.; Martini, Sharyl R.; Kleindorfer, Dawn O.; Kissela, Brett; Comeau, Mary E.; Jagiella, Jeremiasz M.; Schmidt, Helena; Freudenberger, Paul; Pichler, Alexander; Enzinger, Christian; Hansen, Bjorn M.; Norrving, Bo; Jimenez-Conde, Jordi; Giralt-Steinhauer, Eva; Elosua, Roberto; Cuadrado-Godia, Elisa; Soriano, Carolina; Roquer, Jaume; Kraft, Peter; Ayres, Alison M.; Schwab, Kristin; McCauley, Jacob L.; Pera, Joanna; Urbanik, Andrzej; Rost, Natalia S.; Goldstein, Joshua N.; Viswanathan, Anand; Stoegerer, Eva-Maria; Tirschwell, David L.; Selim, Magdy; Brown, Devin L.; Silliman, Scott L.; Worrall, Bradford B.; Meschia, James F.; Kidwell, Chelsea S.; Montaner, Joan; Fernandez-Cadenas, Israel; Delgado, Pilar; Malik, Rainer; Dichgans, Martin; Greenberg, Steven M.; Rothwell, Peter M.; Lindgren, Arne; Slowik, Agnieszka; Schmidt, Reinhold; Langefeld, Carl D.; Rosand, Jonathan		Int Stroke Genetics Consortium	Meta-analysis of Genome-wide Association Studies Identifies 1q22 as a Susceptibility Locus for Intracerebral Hemorrhage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRAIN-BARRIER BREAKDOWN; POLYAMINE-SITE; RISK-FACTORS; STROKE; POPULATION; BURDEN; VOLUME; TRANSCRIPTION; MECHANISMS; DISEASE	Intracerebral hemorrhage (ICH) is the stroke subtype with the worst prognosis and has no established acute treatment. ICH is classified as lobar or nonlobar based on the location of ruptured blood vessels within the brain. These different locations also signal different underlying vascular pathologies. Heritability estimates indicate a substantial genetic contribution to risk of ICH in both locations. We report a genome-wide association study of this condition that meta-analyzed data from six studies that enrolled individuals of European ancestry. Case subjects were ascertained by neurologists blinded to genotype data and classified as lobar or nonlobar based on brain computed tomography. ICH-free control subjects were sampled from ambulatory clinics or random digit dialing. Replication of signals identified in the discovery cohort with p < 1 x 10(-6) was pursued in an independent multiethnic sample utilizing both direct and genome-wide genotyping. The discovery phase included a case cohort of 1,545 individuals (664 lobar and 881 nonlobar cases) and a control cohort of 1,481 individuals and identified two susceptibility loci: for lobar ICH, chromosomal region 12q21.1 (rs11179580, odds ratio [OR] = 1.56, p = 7.0 x 10(-8)); and for nonlobar ICH, chromosomal region 1q22 (rs2984613, OR = 1.44, p 1.6 x 10(-8)). The replication included a case cohort of 1,681 individuals (484 lobar and 1,194 nonlobar cases) and a control cohort of 2,261 individuals and corroborated the association for 1q22 (p = 6.5 x 10(-4); meta-analysis p = 2.2 x 10(-10)) but not for 12q21.1 (p = 0.55; metaanalysis p = 2.6 x 10(-5)). These results demonstrate biological heterogeneity across ICH subtypes and highlight the importance of ascertaining ICH cases accordingly.	[Woo, Daniel; Haverbusch, Mary; Moomaw, Charles J.; Broderick, Joseph P.; Flaherty, Matthew L.; Martini, Sharyl R.; Kleindorfer, Dawn O.; Kissela, Brett] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH 45267 USA; [Falcone, Guido J.; Devan, William J.; Biffi, Alessandro; Anderson, Christopher D.; Brouwers, H. Bart; Valant, Valerie; Battey, Thomas W. K.; Radmanesh, Farid; Raffeld, Miriam R.; Baedorf-Kassis, Sylvia; Rost, Natalia S.; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Woo, Daniel; Falcone, Guido J.; Devan, William J.; Biffi, Alessandro; Anderson, Christopher D.; Brouwers, H. Bart; Valant, Valerie; Battey, Thomas W. K.; Radmanesh, Farid; Raffeld, Miriam R.; Baedorf-Kassis, Sylvia; Rost, Natalia S.; Rosand, Jonathan] Massachusetts Gen Hosp, Div Neurocrit Care & Emergency Neurol, Dept Neurol, Boston, MA 02114 USA; [Woo, Daniel; Falcone, Guido J.; Devan, William J.; Biffi, Alessandro; Anderson, Christopher D.; Brouwers, H. Bart; Valant, Valerie; Battey, Thomas W. K.; Radmanesh, Farid; Raffeld, Miriam R.; Baedorf-Kassis, Sylvia; Ayres, Alison M.; Schwab, Kristin; Rost, Natalia S.; Viswanathan, Anand; Greenberg, Steven M.; Rosand, Jonathan] Massachusetts Gen Hosp, J Philip Kistler Stroke Res Ctr, Boston, MA 02114 USA; [Falcone, Guido J.; Devan, William J.; Biffi, Alessandro; Anderson, Christopher D.; Brouwers, H. Bart; Valant, Valerie; Battey, Thomas W. K.; Radmanesh, Farid; Raffeld, Miriam R.; Baedorf-Kassis, Sylvia; Rost, Natalia S.; Rosand, Jonathan] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Falcone, Guido J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Brown, W. Mark; Howard, Timothy D.; Comeau, Mary E.; Langefeld, Carl D.] Wake Forest Univ, Ctr Publ Hlth Genom, Winston Salem, NC 27157 USA; [Brown, W. Mark; Howard, Timothy D.; Comeau, Mary E.; Langefeld, Carl D.] Wake Forest Univ, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Deka, Ranjan; Sun, Guangyun] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Woo, Jessica G.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Jagiella, Jeremiasz M.; Pera, Joanna; Slowik, Agnieszka] Jagiellonian Univ, Dept Neurol, Coll Med, PL-31008 Krakow, Poland; [Schmidt, Helena; Freudenberger, Paul] Med Univ Graz, Inst Mol Biol & Med Biochem, A-8010 Graz, Austria; [Pichler, Alexander; Enzinger, Christian; Stoegerer, Eva-Maria; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, A-8036 Graz, Austria; [Enzinger, Christian] Med Univ Graz, Div Neuroradiol, Dept Radiol, A-8036 Graz, Austria; [Hansen, Bjorn M.; Norrving, Bo; Lindgren, Arne] Lund Univ, Dept Clin Sci Lund, S-22185 Lund, Sweden; [Hansen, Bjorn M.; Norrving, Bo; Lindgren, Arne] Skane Univ Hosp, Dept Neurol, S-22185 Lund, Sweden; [Jimenez-Conde, Jordi; Giralt-Steinhauer, Eva; Elosua, Roberto; Cuadrado-Godia, Elisa; Soriano, Carolina; Roquer, Jaume] Univ Autonoma Barcelona, Inst Hosp del Mar Invest Med, Dept Neurol, DCEXS UPF,Neurovasc Res Unit, Barcelona 08035, Spain; [Jimenez-Conde, Jordi; Giralt-Steinhauer, Eva; Elosua, Roberto; Cuadrado-Godia, Elisa; Soriano, Carolina; Roquer, Jaume] Inst Hosp del Mar Invest Med, Cardiovasc Epidemiol & Genet Res Grp, Barcelona 08003, Spain; [McCauley, Jacob L.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Urbanik, Andrzej] Jagiellonian Univ, Coll Med, Dept Radiol, PL-31008 Krakow, Poland; [Goldstein, Joshua N.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Tirschwell, David L.] Univ Washington, Stroke Ctr, Harborview Med Ctr, Seattle, WA 98104 USA; [Selim, Magdy] Beth Israel Deaconess Med Ctr, Stroke Div, Dept Neurol, Boston, MA 02215 USA; [Brown, Devin L.] Univ Michigan Hlth Syst, Dept Neurol, Stroke Program, Ann Arbor, MI 48109 USA; [Silliman, Scott L.] Univ Florida, Coll Med, Dept Neurol, Jacksonville, FL 32209 USA; [Worrall, Bradford B.] Univ Virginia Hlth Syst, Dept Neurol & Publ Hlth Sci, Charlottesville, VA 22908 USA; [Meschia, James F.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Kidwell, Chelsea S.] Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA; [Montaner, Joan; Fernandez-Cadenas, Israel; Delgado, Pilar] Univ Autonoma Barcelona, Hosp Vall dHebron, Inst Recerca, Neurovasc Res Lab, Barcelona 08035, Spain; [Montaner, Joan; Fernandez-Cadenas, Israel; Delgado, Pilar] Univ Autonoma Barcelona, Hosp Vall dHebron, Inst Recerca, Neurovasc Unit, Barcelona 08035, Spain; [Fernandez-Cadenas, Israel] Fundacio Docencia & Recerca Mutuaterrassa, Barcelona 08010, Spain; [Malik, Rainer; Dichgans, Martin] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, D-80539 Munich, Germany; [Malik, Rainer; Dichgans, Martin] Munich Cluster Syst Neurol Synergy, D-80539 Munich, Germany; [Rothwell, Peter M.] Univ Oxford, Nuffield Dept Clin Neurosci, Stroke Prevent Res Unit, Oxford OX3 9DU, England	University System of Ohio; University of Cincinnati; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Wake Forest University; Wake Forest University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Jagiellonian University; Collegium Medicum Jagiellonian University; Medical University of Graz; Medical University of Graz; Medical University of Graz; Lund University; Lund University; Skane University Hospital; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Miami; Jagiellonian University; Collegium Medicum Jagiellonian University; Harvard University; Massachusetts General Hospital; Harborview Medical Center; University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; University of Virginia; Mayo Clinic; University of Arizona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Munich; University of Munich; University of Oxford	Woo, D (corresponding author), Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH 45267 USA.	daniel.woo@uc.edu; jrosand@partners.org	JIMENEZ-CONDE, JORDI/C-1941-2012; Resource Center, NINDS Human Genetics/AGF-2474-2022; Woo, Jessica/M-4984-2015; Roquer, Jaume/G-8919-2017; Dichgans, Martin/HCH-3247-2022; Demchuk, Andrew M/E-1103-2012; Rothwell, Peter/ABE-5913-2020; Pera, Joanna/U-5552-2018; Radmanesh, Farid/AAN-3362-2021; Martin, Lisa/E-2425-2016; Meschia, James/GPP-1636-2022; Montaner, Joan/D-3063-2015; Sander-Effron, Samuel/AAX-2231-2020; Schmidt, Reinhold/E-1137-2014; Goldstein, Joshua N/H-8953-2016; Brown, William/GXN-2777-2022; Falcone, Guido/L-2287-2016; TARRAGA, CAROLINA SORIANO/AAG-8777-2019	Woo, Jessica/0000-0003-3644-8432; Roquer, Jaume/0000-0001-5992-2606; Dichgans, Martin/0000-0002-0654-387X; Demchuk, Andrew M/0000-0002-4930-7789; Rothwell, Peter/0000-0001-9739-9211; Pera, Joanna/0000-0001-6142-2969; Radmanesh, Farid/0000-0001-5431-0176; Martin, Lisa/0000-0001-8702-9946; Meschia, James/0000-0002-4475-8142; Montaner, Joan/0000-0003-4845-2279; Falcone, Guido/0000-0002-6407-0302; Delgado Martinez, Maria Pilar/0000-0002-1628-4488; Norrving, Bo/0000-0002-8024-5096; Tirschwell, David/0000-0002-8059-2901; Kissela, Brett/0000-0002-9773-4013; Fernandez-Cadenas, Israel/0000-0003-4821-2363; Malik, Rainer/0000-0001-9212-2520; Cuadrado-Godia, Elisa/0000-0002-9147-875X; Anderson, Christopher/0000-0002-0053-2002; McCauley, Jacob/0000-0002-1805-1733; Hansen, Bjorn/0000-0001-8661-9063; Soriano Tarraga, Carolina/0000-0002-5635-273X; Brown, Devin/0000-0002-9815-3421; Giralt Steinhauer, Eva/0000-0002-7463-0983; ELOSUA, ROBERTO/0000-0001-8235-0095	GERFHS, NIH [NS36695, NS30678]; GOCHA, NIH [R01NS059727]; Keane Stroke Genetics Research Fund; Edward and Maybeth Sonn Research Fund; University of Michigan General Clinical Research Center [M01 RR000042]; ERICH, NIH [NS069763]; HM-ICH, Instituto de Salud Carlos III [PI051737]; Fondos de Investigacion Sanitaria ISC III [PI10/02064]; Fondos FEDER/EDRF Red de Investigacion Cardiovascular [RD12/0042]; JUHSS, Polish Ministry of Education [N402 083934]; LSR, Lund University, Region Skane; Swedish Research Council [K2010-61X-20378-04-3]; Swedish Stroke Association; Freemasons Lodge of Instruction EOS in Lund; King Gustaf V foundation; Queen Victoria's foundation; NIH SPOTRIAS fellowship [P50NS061343]; American Brain Foundation; NIH [5K23NS059774, U01 NS074425, R01 NS062675, R01 HL098065, R01 NS070941, R18 HS017690]; NIHR; Wellcome Trust; Blue Cross Blue Shield of Michigan Foundation; Michigan Department of Community Health; University of Michigan; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS017690] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS036695, K23NS059774, R55NS030678, R01NS062675, U10NS077311, R01NS070941, T32NS047996, U01NS069763, R01NS030678, R01NS036695, U01NS074425, R01NS059727] Funding Source: NIH RePORTER	GERFHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GOCHA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keane Stroke Genetics Research Fund; Edward and Maybeth Sonn Research Fund; University of Michigan General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ERICH, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HM-ICH, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondos de Investigacion Sanitaria ISC III; Fondos FEDER/EDRF Red de Investigacion Cardiovascular; JUHSS, Polish Ministry of Education; LSR, Lund University, Region Skane; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Stroke Association; Freemasons Lodge of Instruction EOS in Lund; King Gustaf V foundation; Queen Victoria's foundation; NIH SPOTRIAS fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Blue Cross Blue Shield of Michigan Foundation; Michigan Department of Community Health; University of Michigan(University of Michigan System); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Biorepository and Center for Genome Technology (University of Miami) (specifically Sandra West, Ioanna Konidari, and Susan Slifer) and Miguel Hernan for providing expert advice. Computing support, in part, provided by the Wake Forest Center for Public Health Genomics. Funding entities had no direct involvement in study design; data collection, analysis, and interpretation; writing of the manuscript; or the decision to submit for publication. Funding provided as follows: GERFHS, NIH grants NS36695 and NS30678; GOCHA, NIH grant R01NS059727, the Keane Stroke Genetics Research Fund, the Edward and Maybeth Sonn Research Fund, and the University of Michigan General Clinical Research Center M01 RR000042; ERICH, NIH grant NS069763; HM-ICH, Instituto de Salud Carlos III with the grants "Registro BASICMAR" Funding for Research in Health (PI051737), "GWALA project" from Fondos de Investigacion Sanitaria ISC III (PI10/02064), and Fondos FEDER/EDRF Red de Investigacion Cardiovascular (RD12/0042); JUHSS, Polish Ministry of Education grant N402 083934; LSR, Lund University, Region Skane, the Swedish Research Council (K2010-61X-20378-04-3), the Swedish Stroke Association, the Freemasons Lodge of Instruction EOS in Lund, and the King Gustaf V and Queen Victoria's foundations; G.J.F. and H.B.B., NIH SPOTRIAS fellowship P50NS061343; C.D.D., fellowship from the American Brain Foundation; J.N.G., NIH grant 5K23NS059774; P.M.R., awards from the NIHR and the Wellcome Trust; M.S., NIH grant U01 NS074425; and D.L.B., NIH grants R01 NS062675, R01 HL098065, R01 NS070941, and R18 HS017690, the Blue Cross Blue Shield of Michigan Foundation, Michigan Department of Community Health, and the University of Michigan.	Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Biffi A, 2010, ANN NEUROL, V68, P934, DOI 10.1002/ana.22134; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; del Zoppo GJ, 2013, STROKE, V44, P263, DOI 10.1161/STROKEAHA.112.653618; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Devan WJ, 2013, STROKE, V44, P1578, DOI 10.1161/STROKEAHA.111.000089; Domingues-Montanari S, 2011, NEUROBIOL AGING, V32, pe13; Falcone GJ, 2013, JAMA NEUROL, V70, P988, DOI 10.1001/jamaneurol.2013.98; Falcone GJ, 2012, STROKE, V43, P2877, DOI 10.1161/STROKEAHA.112.659755; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Flaherty ML, 2007, NEUROLOGY, V68, P116, DOI 10.1212/01.wnl.0000250340.05202.8b; Fornage M, 2011, ANN NEUROL, V69, P928, DOI 10.1002/ana.22403; Georgiev D, 2008, EXP CELL RES, V314, P2603, DOI 10.1016/j.yexcr.2008.06.009; Gomis M, 2010, EUR J NEUROL, V17, P443, DOI 10.1111/j.1468-1331.2009.02838.x; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Holliday EG, 2012, NAT GENET, V44, P1147, DOI 10.1038/ng.2397; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; KOENIG H, 1989, J NEUROCHEM, V52, P101, DOI 10.1111/j.1471-4159.1989.tb10903.x; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martini SR, 2012, NEUROLOGY, V79, P2275, DOI 10.1212/WNL.0b013e318276896f; Mayo NE, 2007, NEUROLOGY, V68, P1122, DOI 10.1212/01.wnl.0000258664.12423.4c; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rost NS, 2010, NEUROLOGY, V75, P1670, DOI 10.1212/WNL.0b013e3181fc279a; Rost NS, 2010, STROKE, V41, P2807, DOI 10.1161/STROKEAHA.110.595355; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Taylor CL, 1997, J NEUROSURG, V86, P583, DOI 10.3171/jns.1997.86.4.0583; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Wang YL, 1999, J BIOL CHEM, V274, P22095, DOI 10.1074/jbc.274.31.22095; Wang YL, 2001, BIOCHEM J, V355, P45, DOI 10.1042/0264-6021:3550045; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22	34	152	156	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					511	521		10.1016/j.ajhg.2014.02.012	http://dx.doi.org/10.1016/j.ajhg.2014.02.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24656865	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000333765300003
J	Chen, K; Coonrod, EM; Kumanovics, A; Franks, ZF; Durtschi, JD; Margraf, RL; Wu, W; Heikal, NM; Augustine, NH; Ridge, PG; Hill, HR; Jorde, LB; Weyrich, AS; Zimmerman, GA; Gundlapalli, AV; Bohnsack, JF; Voelkerding, KV				Chen, Karin; Coonrod, Emily M.; Kumanovics, Attila; Franks, Zechariah F.; Durtschi, Jacob D.; Margraf, Rebecca L.; Wu, Wilfred; Heikal, Nahla M.; Augustine, Nancy H.; Ridge, Perry G.; Hill, Harry R.; Jorde, Lynn B.; Weyrich, Andrew S.; Zimmerman, Guy A.; Gundlapalli, Adi V.; Bohnsack, John F.; Voelkerding, Karl V.			Germline Mutations in NFKB2 Implicate the Noncanonical NF-kappa B Pathway in the Pathogenesis of Common Variable Immunodeficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; ANTIBODY-DEFICIENCY SYNDROME; SELECTIVE IGA DEFICIENCY; SPLENIC MICROARCHITECTURE; HETEROGENEOUS DISEASE; IMMUNE-DEFICIENCY; NF-KAPPA-B2 P100; GENE; AUTOIMMUNITY; GENOME	Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by antibody deficiency, poor humoral response to antigens, and recurrent infections. To investigate the molecular cause of CVID, we carried out exome sequence analysis of a family diagnosed with CVID and identified a heterozygous frameshift mutation, c.2564delA (p.Lys855Serfs*7), in NFKB2 affecting the C terminus of NF-kappa B2 (also known as p100/p52 or p100/p49). Subsequent screening of NFKB2 in 33 unrelated CVID-affected individuals uncovered a second heterozygous nonsense mutation, c.2557C>T (p.Arg853*), in one simplex case. Affected individuals in both families presented with an unusual combination of childhood-onset hypogammaglobulinemia with recurrent infections, autoimmune features, and adrenal insufficiency. NF-kappa B2 is the principal protein involved in the noncanonical NF-kappa B pathway, is evolutionarily conserved, and functions in peripheral lymphoid organ development, B cell development, and antibody production. In addition, Nfkb2 mouse models demonstrate a CVID-like phenotype with hypogammaglobulinemia and poor humoral response to antigens. Immunoblot analysis and immunofluorescence microscopy of transformed B cells from affected individuals show that the NFKB2 mutations affect phosphorylation and proteasomal processing of p100 and, ultimately, p52 nuclear translocation. These findings describe germline mutations in NFKB2 and establish the noncanonical NF-kappa B signaling pathway as a genetic etiology for this primary immunodeficiency syndrome.	[Chen, Karin; Bohnsack, John F.] Univ Utah, Dept Pediat, Div Allergy Immunol & Rheumatol, Salt Lake City, UT 84108 USA; [Coonrod, Emily M.; Kumanovics, Attila; Durtschi, Jacob D.; Margraf, Rebecca L.; Heikal, Nahla M.; Augustine, Nancy H.; Ridge, Perry G.; Hill, Harry R.; Voelkerding, Karl V.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA; [Kumanovics, Attila; Heikal, Nahla M.; Augustine, Nancy H.; Hill, Harry R.; Gundlapalli, Adi V.; Voelkerding, Karl V.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Franks, Zechariah F.; Weyrich, Andrew S.] Univ Utah, Program Mol Med, Salt Lake City, UT 84108 USA; [Wu, Wilfred; Jorde, Lynn B.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Hill, Harry R.; Weyrich, Andrew S.; Zimmerman, Guy A.; Gundlapalli, Adi V.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84108 USA; [Hill, Harry R.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84108 USA; [Gundlapalli, Adi V.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84132 USA; [Gundlapalli, Adi V.] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Chen, K (corresponding author), Univ Utah, Dept Pediat, Div Allergy Immunol & Rheumatol, Salt Lake City, UT 84108 USA.	karin.chen@hsc.utah.edu		Weyrich, Andrew/0000-0001-9622-4647	NIH from the University of Utah Department of Pediatrics [1R21AI094004-01, 5K12HD001410-10]; Primary Children's Medical Center Foundation Early Career Development Award; NIH [GM59290, U54HL112311-01, R37HL6044525]; Utah Genome Project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001410] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290, R01GM104390] Funding Source: NIH RePORTER	NIH from the University of Utah Department of Pediatrics; Primary Children's Medical Center Foundation Early Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Utah Genome Project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the families for their willingness to participate in this study; the Phenotyping Core in the Department of Pediatrics, Division of Medical Genetics at the University of Utah including study coordinators Megan Grandemange, Kyle Berg, Suzy Jones, and Ann Rutherford; the University of Utah School of Medicine Cell Imaging Facility; and Kalyan Mallempati, Mark Cody, C. Con Yost, and Eugene Ravkov for their assistance. We would also like to thank Diana Lim for assistance with figure generation. Confocal images were obtained at the University of Utah School of Medicine Cell Imaging Facility DNA extractions and B cell transformation was performed by the University of Utah Center for Clinical & Translational Science (CCTS) Translational Technologies & Resources (TTR) core. This research was funded in part by an NIH 1R21AI094004-01 grant to K.V.V., A.K., and H.R.H.; NIH 5K12HD001410-10 Child Health Research Career Development Award (PI: E.B. Clark) from the University of Utah Department of Pediatrics to K.C.; and the Primary Children's Medical Center Foundation Early Career Development Award to K.C. L.B.J. is supported by NIH grant GM59290 and the Utah Genome Project. A.S.W. and G.A.Z. are supported by NIH U54HL112311-01. G.A.Z. is also supported by NIH R37HL6044525. The views expressed in this article are those of the author (A.V.G.) and do not necessarily represent the views of the Department of Veterans Affairs.	Agarwal S, 2009, CURR ALLERGY ASTHM R, V9, P347, DOI 10.1007/s11882-009-0051-0; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 1997, CLIN EXP IMMUNOL S1, V109, P1; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bonfig W, 2011, EUR J PEDIATR, V170, P1017, DOI 10.1007/s00431-011-1393-x; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2007, NAT GENET, V39, P430, DOI 10.1038/ng0407-430; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Coonrod EM, 2013, ARCH PATHOL LAB MED, V137, P415, DOI 10.5858/arpa.2012-0107-RA; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; FRACCHIOLLA NS, 1993, ONCOGENE, V8, P2839; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Geha RS, 2007, J ALLERGY CLIN IMMUN, V120, P776, DOI 10.1016/j.jaci.2007.08.053; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang CY, 2006, CELL SIGNAL, V18, P1309, DOI 10.1016/j.cellsig.2005.10.011; Lopez-Herrera G, 2012, AM J HUM GENET, V90, P986, DOI 10.1016/j.ajhg.2012.04.015; Machinis K, 2001, AM J HUM GENET, V69, P961, DOI 10.1086/323764; Margraf Rebecca L, 2011, J Biomol Tech, V22, P74; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Oksenhendler E, 2008, CLIN INFECT DIS, V46, P1547, DOI 10.1086/587669; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Orange JS, 2011, J ALLERGY CLIN IMMUN, V127, P1360, DOI 10.1016/j.jaci.2011.02.039; Pan-Hammarstrom Q, 2007, NAT GENET, V39, P429, DOI 10.1038/ng0407-429; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; Piatosa B, 2010, CYTOM PART B-CLIN CY, V78B, P372, DOI 10.1002/cyto.b.20536; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Quentien MH, 2012, J CLIN ENDOCR METAB, V97, pE121, DOI 10.1210/jc.2011-0407; Salzer E, 2013, BLOOD, V121, P3112, DOI 10.1182/blood-2012-10-460741; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Salzer U, 2012, ANN NY ACAD SCI, V1250, P41, DOI 10.1111/j.1749-6632.2011.06377.x; Schimke LF, 2013, J CLIN IMMUNOL, V33, P1088, DOI 10.1007/s10875-013-9906-1; Shanmugam R, 2012, CLIN CANCER RES, V18, P360, DOI 10.1158/1078-0432.CCR-10-3022; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; TOVO PA, 1991, EUR J PEDIATR, V150, P400, DOI 10.1007/BF02093717; Tucker E, 2007, J IMMUNOL, V179, P7514, DOI 10.4049/jimmunol.179.11.7514; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Younes JS, 2002, ANN ALLERG ASTHMA IM, V89, P322, DOI 10.1016/S1081-1206(10)61963-1	60	152	158	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					812	824		10.1016/j.ajhg.2013.09.009	http://dx.doi.org/10.1016/j.ajhg.2013.09.009			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24140114	Green Published, Bronze			2022-12-18	WOS:000326996600003
J	Fuchs-Telem, D; Sarig, O; van Steensel, MAM; Isakov, O; Israeli, S; Nousbeck, J; Richard, K; Winnepenninckx, V; Vernooij, M; Shomron, N; Uitto, J; Fleckman, P; Richard, G; Sprecher, E				Fuchs-Telem, Dana; Sarig, Ofer; van Steensel, Maurice A. M.; Isakov, Ofer; Israeli, Shirli; Nousbeck, Janna; Richard, Katharina; Winnepenninckx, Veronique; Vernooij, Marigje; Shomron, Noam; Uitto, Jouni; Fleckman, Philip; Richard, Gabriele; Sprecher, Eli			Familial Pityriasis Rubra Pilaris Is Caused by Mutations in CARD14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; HUMAN-IMMUNODEFICIENCY-VIRUS; PSORIASIS; INFLAMMATION; ETANERCEPT; REGULATOR; INFECTION; DIAGNOSIS; ARTHRITIS; FEATURES	Pityriasis rubra pilaris (PRP) is a papulosquamous disorder phenotypically related to psoriasis. The disease has been occasionally shown to be inherited in an autosomal-dominant fashion. To identify the genetic cause of familial PRP, we ascertained four unrelated families affected by autosomal-dominant PRP. We initially mapped PRP to 17q25.3, a region overlapping with psoriasis susceptibility locus 2 (PSORS2 [MIM 602723]). Using a combination of linkage analysis followed by targeted whole-exome sequencing and candidate-gene screening, we identified three different heterozygous mutations in CARD14, which encodes caspase recruitment domain family, member 14. CARD14 was found to be specifically expressed in the skin. CARD14 is a known activator of nuclear factor kappa B signaling, which has been implicated in inflammatory disorders. Accordingly, CARD14 levels were increased, and p65 was found to be activated in the skin of PRP-affected individuals. The present data demonstrate that autosomal-dominant PRP is allelic to familial psoriasis, which was recently shown to also be caused by mutations in CARD14.	[Fuchs-Telem, Dana; Sarig, Ofer; Israeli, Shirli; Nousbeck, Janna; Sprecher, Eli] Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-64239 Tel Aviv, Israel; [Fuchs-Telem, Dana; Israeli, Shirli; Sprecher, Eli] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Ramat Aviv, Israel; [van Steensel, Maurice A. M.; Vernooij, Marigje] Maastricht Univ, Med Ctr, Dept Dermatol, NL-6200 Maastricht, Netherlands; [van Steensel, Maurice A. M.; Winnepenninckx, Veronique] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, NL-6200 Maastricht, Netherlands; [Isakov, Ofer; Shomron, Noam] Tel Aviv Univ, Dept Cell & Dev Biol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Richard, Katharina] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Richard, Katharina; Uitto, Jouni] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Winnepenninckx, Veronique] Maastricht Univ, Dept Pathol, Med Ctr, NL-6200 Maastricht, Netherlands; [Fleckman, Philip] Univ Washington, Div Dermatol, Seattle, WA 98195 USA; [Richard, Gabriele] GeneDx, Gaithersburg, MD 20877 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Maastricht University; Maastricht University; Tel Aviv University; Sackler Faculty of Medicine; University System of Maryland; University of Maryland Baltimore; Jefferson University; Maastricht University; University of Washington; University of Washington Seattle	Sprecher, E (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-64239 Tel Aviv, Israel.	elisp@tasmc.health.gov.il	van Steensel, Maurice A.M./V-3852-2019	van Steensel, Maurice/0000-0002-7507-2442; Richard, Katharina/0000-0003-0939-2103				Albert MR, 1999, INT J DERMATOL, V38, P1, DOI 10.1046/j.1365-4362.1999.00513.x; AUFFRET N, 1992, J AM ACAD DERMATOL, V27, P260, DOI 10.1016/S0190-9622(08)80734-7; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Betlloch I, 2001, PEDIATR DERMATOL, V18, P411, DOI 10.1046/j.1525-1470.2001.01967.x; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; BRAUNFALCO O, 1983, ARCH DERMATOL RES, V275, P287, DOI 10.1007/BF00417199; De Beurmann B., 1910, ANN DERMATOL, V1, P609; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; GRIFFITHS WAD, 1980, CLIN EXP DERMATOL, V5, P105, DOI 10.1111/j.1365-2230.1980.tb01676.x; GRIFFITHS WAD, 1992, J AM ACAD DERMATOL, V26, P140, DOI 10.1016/S0190-9622(08)80543-9; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kint A, 1972, Arch Belg Dermatol Syphiligr, V28, P371; Klein A, 2010, AM J CLIN DERMATOL, V11, P157, DOI 10.2165/11530070-000000000-00000; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lories RJU, 2008, CLIN EXP RHEUMATOL, V26, P96; Magro CM, 1997, J CUTAN PATHOL, V24, P416, DOI 10.1111/j.1600-0560.1997.tb00816.x; MENNI S, 1992, J AM ACAD DERMATOL, V27, P1009, DOI 10.1016/S0190-9622(08)80267-8; Miralles ES, 1995, BRIT J DERMATOL, V133, P990, DOI 10.1111/j.1365-2133.1995.tb06939.x; Misery L, 1996, BRIT J DERMATOL, V135, P1008, DOI 10.1046/j.1365-2133.1996.d01-1114.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Sehgal V N, 2000, J Dermatol, V27, P174; Sehgal Virendra N, 2002, Skinmed, V1, P161; Sehgal VN, 2006, INT J DERMATOL, V45, P438, DOI 10.1111/j.1365-4632.2006.02666.x; Seibl R, 2004, CURR OPIN RHEUMATOL, V16, P411, DOI 10.1097/01.bor.0000127108.08398.34; Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630; SOEPRONO FF, 1986, AM J DERMATOPATH, V8, P277, DOI 10.1097/00000372-198608000-00001; Thomson MA, 2007, BRIT J DERMATOL, V157, P202, DOI 10.1111/j.1365-2133.2007.07938.x; VANDERHOOFT SL, 1995, ARCH DERMATOL, V131, P448, DOI 10.1001/archderm.131.4.448; Vasher M, 2010, J DRUGS DERMATOL, V9, P844; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175	37	152	160	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					163	170		10.1016/j.ajhg.2012.05.010	http://dx.doi.org/10.1016/j.ajhg.2012.05.010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22703878	Green Published, Bronze			2022-12-18	WOS:000306445000014
J	Asharani, PV; Keupp, K; Semler, O; Wang, WS; Li, Y; Thiele, H; Yigit, G; Pohl, E; Becker, J; Frommolt, P; Sonntag, C; Altmuller, J; Zimmermann, K; Greenspan, DS; Akarsu, NA; Netzer, C; Schonau, E; Wirth, R; Hammerschmidt, M; Nurnberg, P; Wollnik, B; Carney, TJ				Asharani, P. V.; Keupp, Katharina; Semler, Oliver; Wang, Wenshen; Li, Yun; Thiele, Holger; Yigit, Goekhan; Pohl, Esther; Becker, Jutta; Frommolt, Peter; Sonntag, Carmen; Altmueller, Janine; Zimmermann, Katharina; Greenspan, Daniel S.; Akarsu, Nurten A.; Netzer, Christian; Schoenau, Eckhard; Wirth, Radu; Hammerschmidt, Matthias; Nuernberg, Peter; Wollnik, Bernd; Carney, Thomas J.			Attenuated BMP1 Function Compromises Osteogenesis, Leading to Bone Fragility in Humans and Zebrafish	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROCOLLAGEN C-PROTEINASE; MORPHOGENETIC PROTEIN-1; AXIAL SKELETON; RETINOIC ACID; IMPERFECTA; MUTATIONS; METALLOPROTEINASES; CLEAVAGE; IDENTIFICATION; EXPRESSION	Bone morphogenetic protein 1 (BMP1) is an astacin metalloprotease with important cellular functions and diverse substrates, including extracellular-matrix proteins and antagonists of some TGF beta superfamily members. Combining whole-exome sequencing and filtering for homozygous stretches of identified variants, we found a homozygous causative BMP1 mutation, c.34G>C, in a consanguineous family affected by increased bone mineral density and multiple recurrent fractures. The mutation is located within the BMP1 signal peptide and leads to impaired secretion and an alteration in posttranslational modification. We also characterize a zebrafish bone mutant harboring lesions in bmp1a, demonstrating conservation of BMP1 function in osteogenesis across species. Genetic, biochemical, and histological analyses of this mutant and a comparison to a second, similar locus reveal that Bmp1a is critically required for mature-collagen generation, downstream of osteoblast maturation, in bone. We thus define the molecular and cellular bases of BMP1-dependent osteogenesis and show the importance of this protein for bone formation and stability.	[Keupp, Katharina; Li, Yun; Yigit, Goekhan; Pohl, Esther; Hammerschmidt, Matthias; Nuernberg, Peter; Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Asharani, P. V.; Wang, Wenshen; Carney, Thomas J.] Proteos, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Keupp, Katharina; Li, Yun; Yigit, Goekhan; Pohl, Esther; Becker, Jutta; Zimmermann, Katharina; Netzer, Christian; Wirth, Radu; Wollnik, Bernd] Univ Cologne, Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Semler, Oliver; Schoenau, Eckhard] Univ Cologne, Childrens Hosp, D-50937 Cologne, Germany; [Thiele, Holger; Frommolt, Peter; Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Sonntag, Carmen] Univ Cologne, Inst Dev Biol, D-50674 Cologne, Germany; [Greenspan, Daniel S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Akarsu, Nurten A.] Hacettepe Univ, Fac Med, Dept Med Genet, TR-06100 Ankara, Turkey	University of Cologne; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Wisconsin System; University of Wisconsin Madison; Hacettepe University	Wollnik, B (corresponding author), Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany.	bwollnik@uni-koeln.de; tcarney@imcb.a-star.edu.sg	Carney, Tom J/H-4389-2011; Akarsu, Nurten/E-9758-2013; Wollnik, Bernd/GRY-6062-2022; Frommolt, Peter/L-9656-2016; Thiele, Holger/ABE-6792-2020; RANI, ASHA/AAF-8641-2019	Carney, Tom J/0000-0003-2371-1924; Akarsu, Nurten/0000-0001-5432-0032; Wollnik, Bernd/0000-0003-2589-0364; Frommolt, Peter/0000-0002-1966-8014; Thiele, Holger/0000-0002-0169-998X; RANI, ASHA/0000-0001-8215-5214; Altmuller, Janine/0000-0003-4372-1521; Greenspan, Daniel/0000-0001-8096-7446; Sonntag, Carmen/0000-0003-2560-1710; Semler, Oliver/0000-0003-0029-7556	German Federal Ministry of Education and Research [01GM0880]; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047746] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Lung GO Sequencing Project; Women's Health Initiative; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to all family members that participated in this study, Esther Milz for excellent technical assistance, Karin Boss for critically reading the manuscript, and Kaicheng Liang from the Singapore Bioimaging Consortium for microCT imaging. This work was supported by the German Federal Ministry of Education and Research by grant 01GM0880 (SKELNET) to B.W. The authors would like to thank the National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project and the following ongoing studies that produced and provided exome-variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010).	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Basel D, 2009, GENET MED, V11, P375, DOI 10.1097/GIM.0b013e3181a1ff7b; Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Borges LF, 2007, MICRON, V38, P580, DOI 10.1016/j.micron.2006.10.005; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Brown AM, 2009, DEV DYNAM, V238, P2922, DOI 10.1002/dvdy.22114; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Fisher S, 1999, NAT GENET, V23, P442, DOI 10.1038/70557; Garrigue-Antar L, 2002, J BIOL CHEM, V277, P43327, DOI 10.1074/jbc.M207342200; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Geisler Robert, 2002, P175; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lindahl K, 2011, HUM MUTAT, V32, P598, DOI 10.1002/humu.21475; Mann V, 2003, BONE, V32, P711, DOI 10.1016/S8756-3282(03)00087-5; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Pollitt R, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9430; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; SILLENCE DO, 1978, LANCET, V1, P1041; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Suzuki N, 1996, DEVELOPMENT, V122, P3587; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558	43	152	157	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					661	674		10.1016/j.ajhg.2012.02.026	http://dx.doi.org/10.1016/j.ajhg.2012.02.026			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22482805	Green Published, Bronze			2022-12-18	WOS:000302833400008
J	Fluck, CE; Meyer-Boni, M; Pandey, AV; Kempna, P; Miller, WL; Schoenle, EJ; Biason-Lauber, A				Flueck, Christa E.; Meyer-Boeni, Monika; Pandey, Amit V.; Kempna, Petra; Miller, Walter L.; Schoenle, Eugen J.; Biason-Lauber, Anna			Why Boys Will Be Boys: Two Pathways of Fetal Testicular Androgen Biosynthesis Are Needed for Male Sexual Differentiation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYPE-3 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE; KETO REDUCTASE SUPERFAMILY; ANTLEY-BIXLER-SYNDROME; CYTOCHROME-P450 OXIDOREDUCTASE DEFICIENCY; STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE; ISOLATED 17,20-LYASE DEFICIENCY; CONGENITAL ADRENAL-HYPERPLASIA; MUTANT P450 OXIDOREDUCTASE; DIHYDRODIOL DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE	Human sexual determination is initiated by a cascade of genes that lead to the development of the fetal gonad. Whereas development of the female external genitalia does not require fetal ovarian hormones, male genital development requires the action of testicular testosterone and its more potent derivative dihydrotestosterone (DHT). The "classic" biosynthetic pathway from cholesterol to testosterone in the testis and the subsequent conversion of testosterone to DHT in genital skin is well established. Recently, an alternative pathway leading to DHT has been described in marsupials, but its potential importance to human development is unclear. AKR1C2 is an enzyme that participates in the alternative but not the classic pathway. Using a candidate gene approach, we identified AKR1C2 mutations with sex-limited recessive inheritance in four 46,XY individuals with disordered sexual development (DSD). Analysis of the inheritance of microsatellite markers excluded other candidate loci. Affected individuals had moderate to severe undervirilization at birth; when recreated by site-directed mutagenesis and expressed in bacteria, the mutant AKR1C2 had diminished but not absent catalytic activities. The 46,XY DSD individuals also carry a mutation causing aberrant splicing in AKR1C4, which encodes an enzyme with similar activity. This suggests a mode of inheritance where the severity of the developmental defect depends on the number of mutations in the two genes. An unrelated 46,XY DSD patient carried AKR1C2 mutations on both alleles, confirming the essential role of AKR1C2 and corroborating the hypothesis that both the classic and alternative pathways of testicular androgen biosynthesis are needed for normal human male sexual differentiation.	[Flueck, Christa E.; Pandey, Amit V.; Kempna, Petra] Univ Bern, Univ Childrens Hosp Bern, Dept Pediat Endocrinol Diabetol & Metab, CH-3010 Bern, Switzerland; [Meyer-Boeni, Monika; Schoenle, Eugen J.; Biason-Lauber, Anna] Univ Childrens Hosp Zurich, Dept Pediat Endocrinol & Diabetol, CH-8032 Zurich, Switzerland; [Miller, Walter L.] Univ Calif San Francisco, Dept Pediat, Div Endocrinol, San Francisco, CA 94143 USA	University of Bern; University Hospital of Bern; University Children's Hospital Zurich; University of California System; University of California San Francisco	Fluck, CE (corresponding author), Univ Bern, Univ Childrens Hosp Bern, Dept Pediat Endocrinol Diabetol & Metab, CH-3010 Bern, Switzerland.	christa.flueck@dkf.unibe.ch; anna.lauber@kispi.uzh.ch	Miller, Walter L/J-3696-2012; Pandey, Amit V/AAO-6442-2020; Pandey, Amit V/A-7223-2008	Pandey, Amit V/0000-0001-8331-5902; Pandey, Amit V/0000-0001-8331-5902; Flueck, Christa/0000-0002-4568-5504	Swiss National Science Foundation [31003A-130710, 320000-116636]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the grants from the Swiss National Science Foundation (31003A-130710 to C.E.F. and 320000-116636 to A.B.L.). We thank Rock Breton for providing the human WT AKR1C2 expression vector, Synthia H Mellon for the generous gift of radiochemicals and George Thalmann for providing normal testes and adrenal tissues. We thank Gaby Hofer for excellent technical assistance.	Arlt W, 2004, LANCET, V363, P2128, DOI 10.1016/S0140-6736(04)16503-3; Auchus RJ, 2004, TRENDS ENDOCRIN MET, V15, P432, DOI 10.1016/j.tem.2004.09.004; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Barbaccia ML, 1997, BRIT J PHARMACOL, V120, P1582, DOI 10.1038/sj.bjp.0701046; Bennett MJ, 1996, BIOCHEMISTRY-US, V35, P10702, DOI 10.1021/bi9604688; Bennett MJ, 1997, STRUCTURE, V5, P799, DOI 10.1016/S0969-2126(97)00234-7; Biason-Lauber A, 2009, AM J HUM GENET, V84, P658, DOI 10.1016/j.ajhg.2009.03.016; Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; Couture JF, 2005, PROTEIN SCI, V14, P1485, DOI 10.1110/ps.051353205; Damborsky Jiri, 2007, Biotechnology Journal, V2, P62, DOI 10.1002/biot.200600208; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Draper N, 2003, NAT GENET, V34, P434, DOI 10.1038/ng1214; Dufort I, 1996, BIOCHEM BIOPH RES CO, V228, P474, DOI 10.1006/bbrc.1996.1684; Dufort I, 2001, J CLIN ENDOCR METAB, V86, P841, DOI 10.1210/jc.86.2.841; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; FRIEDRICH W, 1988, NIACIN NICOTINIC ACI; Fukami M, 2005, J CLIN ENDOCR METAB, V90, P414, DOI 10.1210/jc.2004-0810; Fukami M, 2009, J CLIN ENDOCR METAB, V94, P1723, DOI 10.1210/jc.2008-2816; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Ghayee Hans K., 2008, V13, P55, DOI 10.1159/000134780; GLOCK GE, 1955, BIOCHEM J, V61, P388, DOI 10.1042/bj0610388; GRINO PB, 1990, ENDOCRINOLOGY, V126, P1165, DOI 10.1210/endo-126-2-1165; HAMMOND GL, 1977, J CLIN ENDOCR METAB, V45, P16, DOI 10.1210/jcem-45-1-16; Hershkovitz E, 2008, J CLIN ENDOCR METAB, V93, P3584, DOI 10.1210/jc.2008-0051; Homma K, 2006, J CLIN ENDOCR METAB, V91, P2643, DOI 10.1210/jc.2005-2460; HOOG SS, 1994, P NATL ACAD SCI USA, V91, P2517, DOI 10.1073/pnas.91.7.2517; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; IMPERATOMCGINLEY J, 1991, CLIN ENDOCRINOL, V34, P293, DOI 10.1111/j.1365-2265.1991.tb03769.x; ITO T, 1971, J CLIN INVEST, V50, P1621, DOI 10.1172/JCI106650; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r; KHANNA M, 1995, GENOMICS, V25, P588, DOI 10.1016/0888-7543(95)80066-U; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; Kralovicova J, 2007, NUCLEIC ACIDS RES, V35, P6399, DOI 10.1093/nar/gkm680; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lin HK, 1997, MOL ENDOCRINOL, V11, P1971, DOI 10.1210/me.11.13.1971; Mahendroo M, 2004, MOL CELL ENDOCRINOL, V222, P113, DOI 10.1016/j.mce.2004.04.009; Mendonca BB, 2009, CLIN ENDOCRINOL, V70, P173, DOI 10.1111/j.1365-2265.2008.03392.x; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Nahoum V, 2001, J BIOL CHEM, V276, P42091, DOI 10.1074/jbc.M105610200; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; Pandey AV, 2007, MOL ENDOCRINOL, V21, P2579, DOI 10.1210/me.2007-0245; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2004, MOL CELL ENDOCRINOL, V215, P63, DOI 10.1016/j.mce.2003.11.006; Penning TM, 1996, STEROIDS, V61, P508, DOI 10.1016/S0039-128X(96)00093-1; PICADOLEONARD J, 1987, DNA-J MOLEC CELL BIO, V6, P439, DOI 10.1089/dna.1987.6.439; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; QIN KN, 1993, J STEROID BIOCHEM, V46, P673, DOI 10.1016/0960-0760(93)90308-J; QUIGLEY CA, 1992, J CLIN ENDOCR METAB, V74, P927, DOI 10.1210/jc.74.4.927; Rizner TL, 2003, ENDOCRINOLOGY, V144, P2922, DOI 10.1210/en.2002-0032; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Shackleton C, 2004, AM J MED GENET A, V129A, P105, DOI 10.1002/ajmg.a.30171; Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Vollmer M, 1998, AM J HUM GENET, V63, P1724, DOI 10.1086/302162; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wilson JD, 1999, BIOL REPROD, V61, P471, DOI 10.1095/biolreprod61.2.471; Wilson JD, 1999, ENDOCR REV, V20, P726, DOI 10.1210/er.20.5.726; Wilson JD, 2003, ENDOCRINOLOGY, V144, P575, DOI 10.1210/en.2002-220721; WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577; WINTERS CJ, 1990, BIOCHEMISTRY-US, V29, P1080, DOI 10.1021/bi00456a034; ZACHMANN M, 1972, Clinical Endocrinology, V1, P369, DOI 10.1111/j.1365-2265.1972.tb00407.x; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619	71	152	155	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					201	218		10.1016/j.ajhg.2011.06.009	http://dx.doi.org/10.1016/j.ajhg.2011.06.009			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21802064	Bronze, Green Published			2022-12-18	WOS:000294148800001
J	Zeharia, A; Shaag, A; Pappo, O; Mager-Heckel, AM; Saada, A; Beinat, M; Karicheva, O; Mandel, H; Ofek, N; Segel, R; Marom, D; Rotig, A; Tarassovs, I; Elpeleg, O				Zeharia, Avraham; Shaag, Avraham; Pappo, Orit; Mager-Heckel, Anne-Marie; Saada, Ann; Beinat, Marine; Karicheva, Olga; Mandel, Hanna; Ofek, Noa; Segel, Reeval; Marom, Daphna; Roetig, Agnes; Tarassovs, Ivan; Elpeleg, Orly			Acute Infantile Liver Failure Due to Mutations in the TRMU Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA DEPLETION; CULTURED HUMAN-CELLS; TRANSFER-RNA; 1ST YEAR; BINDING; PROTEIN; LIFE	Acute liver failure in infancy accompanied by lactic acidemia was previously shown to result from mtDNA depletion. We report on 13 unrelated infants who presented with acute liver failure and lactic acidemia with normal mtDNA content. Four died during the acute episodes, and the survivors never had a recurrence. The longest follow-up period was 14 years. Using homozygosity mapping, we identified mutations in the TRMU gene, which encodes a mitochondria-specific tRNA-modifying enzyme, tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase. Accordingly, the 2-thiouridylation levels of the mitochondrial tRNAs were markedly reduced. Given that sulfur is a TRMU substrate and its availability is limited during the neonatal period, we propose that there is a window of time whereby patients with TRMU mutations are at increased risk of developing liver failure.	[Zeharia, Avraham; Shaag, Avraham; Saada, Ann; Elpeleg, Orly] Hebrew Univ Jerusalem, Med Ctr, Dept Human Genet & Metab Dis, Jerusalem, Israel; [Pappo, Orit] Hebrew Univ Jerusalem, Med Ctr, Dept Pathol, Jerusalem, Israel; [Ofek, Noa] Hebrew Univ Jerusalem, Med Ctr, Dept Neonatol, Jerusalem, Israel; [Zeharia, Avraham; Marom, Daphna] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Zeharia, Avraham; Marom, Daphna] Tel Aviv Univ, Day Hospitalizat Unit, Tel Aviv, Israel; [Zeharia, Avraham; Marom, Daphna] Tel Aviv Univ, Dept Pediat A, Schneider Childrens Med Ctr, Tel Aviv, Israel; [Mager-Heckel, Anne-Marie; Karicheva, Olga; Tarassovs, Ivan] Univ Strasbourg, CNRS, UMR 7156, Strasbourg, France; [Beinat, Marine; Roetig, Agnes] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; [Beinat, Marine; Roetig, Agnes] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Mandel, Hanna] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Segel, Reeval] Shaare Zedek Med Ctr, Inst Med Genet, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Elpeleg, O (corresponding author), Hebrew Univ Jerusalem, Med Ctr, Dept Human Genet & Metab Dis, Jerusalem, Israel.	elpeleg@cc.huji.ac.il	Segel, Reeval/AAT-1498-2020; Rötig, Agnès/G-9592-2017; Saada, Ann/J-6864-2017	Rötig, Agnès/0000-0003-0589-0703; Saada, Ann/0000-0003-2951-0656; Tarassov, Ivan/0000-0001-8763-6703	Hebrew University; Hadassah Medical Organization; Israel Science Foundation [1354-2005]; Israeli Ministry of Health and Association Francaise contre les Myopathies; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche Scientifique	Hebrew University; Hadassah Medical Organization; Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Health and Association Francaise contre les Myopathies; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche Scientifique(French National Research Agency (ANR))	We are grateful to the patients and their families, to Mrs. Noa Cohen and Mrs. Corinne Belaiche for their dedicated assistance, to Prof. Shoshy Alluvia for fruitful discussions, to Prof. Michael Wilschanski for sharing of patient 1116 data, and to Dr. Israela Lerer and Prof. Elon Pras for provision of anonymous control samples. This work was supported in part by funding from the joint Research Fund of the Hebrew University and Hadassah Medical Organization to N.O.; the Israel Science Foundation (1354-2005) to A.S and O.E; the Israeli Ministry of Health and Association Francaise contre les Myopathies to A.S, I.T., and O.K.; and the Fondation pour la Recherche Medicale and Agence Nationale de la Recherche Scientifique to I.T. and A.M.M.H.	Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Enriquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Yarian C, 2000, BIOCHEMISTRY-US, V39, P13390, DOI 10.1021/bi001302g; ZLOTKIN SH, 1988, PEDIATR RES, V24, P326, DOI 10.1203/00006450-198809000-00010; ZLOTKIN SH, 1982, PEDIATR RES, V16, P65	16	152	159	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					401	407		10.1016/j.ajhg.2009.08.004	http://dx.doi.org/10.1016/j.ajhg.2009.08.004			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19732863	Green Published, Bronze			2022-12-18	WOS:000270104500009
J	Tuson, M; Marfany, G; Gonzalez-Duarte, R				Tuson, M; Marfany, G; Gonzalez-Duarte, R			Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEVELOPING INNER-EAR; NERVE GROWTH-FACTOR; CELL-DEATH; DEGENERATION; DISEASE	Retinitis pigmentosa ( RP), the main cause of adult blindness, is a genetically heterogeneous disorder characterized by progressive loss of photoreceptors through apoptosis. Up to now, 39 genes and loci have been implicated in nonsyndromic RP, yet the genetic bases of >50% of the cases, particularly of the recessive forms, remain unknown. Previous linkage analysis in a Spanish consanguineous family allowed us to define a novel autosomal recessive RP (arRP) locus, RP26, within an 11-cM interval (17.4 Mb) on 2q31.2-q32.3. In the present study, we further refine the RP26 locus down to 2.5 Mb, by microsatellite and single-nucleotide polymorphism ( SNP) homozygosity mapping. After unsuccessful mutational analysis of the nine genes initially reported in this region, a detailed gene search based on expressed-sequence-tag data was undertaken. We finally identified a novel gene encoding a ceramide kinase (CERKL), which encompassed 13 exons. All of the patients from the RP26 family bear a homozygous mutation in exon 5, which generates a premature termination codon. The same mutation was also characterized in another, unrelated, Spanish pedigree with arRP. Human CERKL is expressed in the retina, among other adult and fetal tissues. A more detailed analysis by in situ hybridization on adult murine retina sections shows expression of Cerkl in the ganglion cell layer. Ceramide kinases convert the sphingolipid metabolite ceramide into ceramide-1-phosphate, both key mediators of cellular apoptosis and survival. Ceramide metabolism plays an essential role in the viability of neuronal cells, the membranes of which are particularly rich in sphingolipids. Therefore, CERKL deficiency could shift the relative levels of the signaling sphingolipid metabolites and increase sensitivity of photoreceptor and other retinal cells to apoptotic stimuli. This is the first genetic report suggesting a direct link between retinal neurodegeneration in RP and sphingolipid- mediated apoptosis.	Univ Barcelona, Fac Biol, Dept Genet, E-08028 Barcelona, Spain	University of Barcelona	Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Av Diagonal 645, E-08028 Barcelona, Spain.		Marfany, Gemma/I-5668-2015	Marfany, Gemma/0000-0001-7941-983X; Tuson, Miquel/0000-0003-2239-0532				Acharya U, 2003, SCIENCE, V299, P1740, DOI 10.1126/science.1080549; Bayes M, 1996, CLIN GENET, V50, P380; Bayes M, 1998, J MED GENET, V35, P141, DOI 10.1136/jmg.35.2.141; Buccoliero R, 2003, PHARMACOL RES, V47, P409, DOI 10.1016/S1043-6618(03)00049-5; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Frago LM, 2003, J CELL SCI, V116, P475, DOI 10.1242/jcs.00223; Frago LM, 1998, J CELL SCI, V111, P549; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hims MM, 2003, DEV OPHTHALMOL, V37, P109; Luberto C, 2002, NEUROCHEM RES, V27, P609, DOI 10.1023/A:1020267831851; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Paloma E, 2000, INVEST OPHTH VIS SCI, V41, P656; Paloma E, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.10.e66; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Puranam KL, 1999, MOL GENET METAB, V66, P294, DOI 10.1006/mgme.1999.2834; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Sullivan LS, 1996, MOL MED TODAY, V2, P380, DOI 10.1016/S1357-4310(96)10037-X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang Q, 2001, Ophthalmic Genet, V22, P133, DOI 10.1076/opge.22.3.133.2224	22	152	158	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					128	138		10.1086/381055	http://dx.doi.org/10.1086/381055			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14681825	Green Published, Bronze			2022-12-18	WOS:000187723500012
J	Hanks, S; Adams, S; Douglas, J; Arbour, L; Atherton, DJ; Balci, S; Bode, H; Campbell, ME; Feingold, M; Keser, G; Kleijer, W; Mancini, G; McGrath, JA; Muntoni, F; Nanda, A; Teare, MD; Warman, M; Pope, FM; Superti-Furga, A; Futreal, PA; Rahman, N				Hanks, S; Adams, S; Douglas, J; Arbour, L; Atherton, DJ; Balci, S; Bode, H; Campbell, ME; Feingold, M; Keser, G; Kleijer, W; Mancini, G; McGrath, JA; Muntoni, F; Nanda, A; Teare, MD; Warman, M; Pope, FM; Superti-Furga, A; Futreal, PA; Rahman, N			Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ULTRASTRUCTURAL FINDINGS; SKIN FIBROBLASTS; ANTHRAX TOXIN; COLLAGEN; RECEPTOR	Juvenile hyaline fibromatosis (JHF) and infantile systemic hyalinosis (ISH) are autosomal recessive conditions characterized by multiple subcutaneous skin nodules, gingival hypertrophy, joint contractures, and hyaline deposition. We previously mapped the gene for JHF to chromosome 4q21. We now report the identification of 15 different mutations in the gene encoding capillary morphogenesis protein 2 (CMG2) in 17 families with JHF or ISH. CMG2 is a transmembrane protein that is induced during capillary morphogenesis and that binds laminin and collagen IV via a von Willebrand factor type A (vWA) domain. Of interest, CMG2 also functions as a cellular receptor for anthrax toxin. Preliminary genotype-phenotype analyses suggest that abrogation of binding by the vWA domain results in severe disease typical of ISH, whereas in-frame mutations affecting a novel, highly conserved cytoplasmic domain result in a milder phenotype. These data (1) demonstrate that JHF and ISH are allelic conditions and (2) implicate perturbation of basement-membrane matrix assembly as the cause of the characteristic perivascular hyaline deposition seen in these conditions.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Great Ormond St Hosp Children, London WC1N 3JH, England; Univ London Kings Coll, Div Life Sci, Connect Tissue Matrix Genet Grp, London W8 7AH, England; Guys Kings Coll & St Thomas Hosp Med Sch, Div Skin Sci, St Johns Inst Dermatol, Dept Cell & Genet Skin Dis Grp, London, England; Univ London Imperial Coll Sci Technol & Med, Dubowitz Neuromuscular Ctr, Dept Paediat, London, England; Univ Hacettepe, Clin Genet Unit, TR-06100 Ankara, Turkey; Univ Kinderklin, Sozialpadiatr Zentrum, Ulm, Germany; Natl Birth Defects Ctr, Waltham, MA USA; Ege Univ, Dept Rheumatol, Izmir, Turkey; Erasmus Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; Al Sabah Hosp, Asad Al Hamad Dermatol Ctr, Kuwait, Kuwait; Univ Sheffield, Math Modelling & Genet Epidemiol Grp, Sheffield, S Yorkshire, England; Case Western Reserve Univ, Dept Genet, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; CHU Vaudois, Div Mol Pediat, Lausanne, Switzerland; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England	University of London; Institute of Cancer Research - UK; University of British Columbia; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Imperial College London; University of London; University College London; Hacettepe University; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ege University; Erasmus University Rotterdam; Erasmus MC; Al Sabah Hospital; University of Sheffield; Case Western Reserve University; Howard Hughes Medical Institute; Case Western Reserve University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Wellcome Trust Sanger Institute	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Brookes Lawley Bldg,15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.		superti-furga, andrea/E-9162-2015; Nanda, Arti/H-8565-2019; Keser, Gokhan/I-4282-2019; Rahman, Nazneen/B-8890-2012; McGrath, John/N-3529-2019; Rahman, Nazneen/D-2802-2013; McGrath, John/D-6824-2012	superti-furga, andrea/0000-0002-3543-7531; Rahman, Nazneen/0000-0003-4376-0440; McGrath, John/0000-0002-3708-9964; Nanda, Arti/0000-0002-1223-3181; Teare, Marion Dawn/0000-0003-3994-0051; Arbour, Laura/0000-0002-9589-0880				Allen PW, 2001, ADV ANAT PATHOL, V8, P173, DOI 10.1097/00125480-200105000-00006; Balci S, 2002, EUR J HUM GENET, V10, P121; Bell SE, 2001, J CELL SCI, V114, P2755; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Breier F, 1997, ARCH DIS CHILD, V77, P436, DOI 10.1136/adc.77.5.436; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GLOVER MT, 1991, PEDIATRICS, V87, P228; GLOVER MT, 1992, PEDIATR DERMATOL, V9, P255, DOI 10.1111/j.1525-1470.1992.tb00342.x; ISHIKAWA H, 1979, ARCH DERMATOL RES, V265, P195, DOI 10.1007/BF00407885; IWATA S, 1980, ARCH DERMATOL RES, V267, P115, DOI 10.1007/BF00569097; KESER G, 1994, CLIN RHEUMATOL, P329; KITANO Y, 1972, ARCH DERMATOL, V106, P877, DOI 10.1001/archderm.106.6.877; LANDING B H, 1986, Pediatric Pathology, V6, P55; LUBEC B, 1995, ARCH DIS CHILD, V73, P246, DOI 10.1136/adc.73.3.246; Mancini GMS, 1999, DERMATOLOGY, V198, P18, DOI 10.1159/000018058; MAYERDASILVA A, 1988, ARCH PATHOL LAB MED, V112, P928; NEZELOF C, 1978, ARCH FR PEDIATR, V35, P1063; Rahman N, 2002, AM J HUM GENET, V71, P975, DOI 10.1086/342776; REMBERGER K, 1985, CANCER-AM CANCER SOC, V56, P614, DOI 10.1002/1097-0142(19850801)56:3<614::AID-CNCR2820560331>3.0.CO;2-T; Richter D, 1999, MONATSSCHR KINDERH, V147, P473, DOI 10.1007/s001120050448; SAHN EE, 1994, PEDIATR DERMATOL, V11, P52, DOI 10.1111/j.1525-1470.1994.tb00076.x; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; St Croix B, 2000, SCIENCE, V289, P1197; Stucki U, 2001, AM J MED GENET, V100, P122, DOI 10.1002/1096-8628(20010422)100:2<122::AID-AJMG1236>3.0.CO;2-0	24	152	162	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					791	800		10.1086/378418	http://dx.doi.org/10.1086/378418			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	14508707	Green Published, Bronze			2022-12-18	WOS:000185676100007
J	Joensuu, T; Hamalainen, R; Yuan, B; Johnson, C; Tegelberg, S; Gasparini, P; Zelante, L; Pirvola, U; Pakarinen, L; Lehesjoki, AE; de la Chapelle, A; Sankila, EM				Joensuu, T; Hamalainen, R; Yuan, B; Johnson, C; Tegelberg, S; Gasparini, P; Zelante, L; Pirvola, U; Pakarinen, L; Lehesjoki, AE; de la Chapelle, A; Sankila, EM			Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-III; MYOSIN VIIA GENE; POSITIONAL CLONING; CHROMOSOME 3Q; HAIR-CELLS; DEAFNESS; PROTEIN; REGION; MAP; 1C	Usher syndrome type 3 (USH3) is an autosomal recessive disorder characterized by progressive hearing loss, severe retinal degeneration, and variably present vestibular dysfunction, assigned to 3q21-q25. Here, we report on the positional cloning of the USH3 gene. By haplotype and linkage-disequilibrium analyses in Finnish carriers of a putative founder mutation, the critical region was narrowed to 250 kb, of which we sequenced, assembled, and annotated 207 kb. Two novel genes-NOPAR and UCRP-and one previously identified gene-H963-were excluded as USH3, on the basis of mutational analysis. USH3, the candidate gene that we identified, encodes a 120-amino-acid protein. Fifty-two Finnish patients were homozygous for a termination mutation, Y100X; patients in two Finnish families were compound heterozygous for Y100X and for a missense mutation, M44K, whereas patients in an Italian family were homozygous for a 3-bp deletion leading to an amino acid deletion and substitution. USH3 has two predicted transmembrane domains, and it shows no homology to known genes. As revealed by northern blotting and reverse-transcriptase PCR, it is expressed in many tissues, including the retina.	Univ Helsinki, Biomedicum, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Hosp Eye, FIN-00014 Helsinki, Finland; Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; Inst Biotechnol, Helsinki, Finland; IRCCS CSS Hosp, Med Genet Serv, San Giovanni Rotondo, Italy; Telethon Inst Genet & Med, Naples, Italy; Tampere Univ Hosp, Dept Phoniatr, Tampere, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University System of Ohio; Ohio State University; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Tampere University; Tampere University Hospital	Sankila, EM (corresponding author), Univ Helsinki, Biomedicum, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland.	eeva-marja.sankila@helsinki.fi	Joensuu, Tarja/F-3059-2011; Gasparini, Paolo/B-6173-2014; Martikainen, Riikka/AAR-8397-2020	Martikainen, Riikka/0000-0002-5102-0672; Gasparini, Paolo/0000-0002-0859-0856	NCI NIH HHS [CA16058, P30 CA016058] Funding Source: Medline; Telethon [TGM06S01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adato A, 1999, AM J HUM GENET, V65, P261, DOI 10.1086/302438; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Espinos C, 1998, J MED GENET, V35, P391, DOI 10.1136/jmg.35.5.391; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Gasparini P, 1998, J MED GENET, V35, P666, DOI 10.1136/jmg.35.8.666; Harris NL, 1997, GENOME RES, V7, P754, DOI 10.1101/gr.7.7.754; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Joensuu T, 1996, GENOMICS, V38, P255, DOI 10.1006/geno.1996.0626; Joensuu T, 2000, GENOMICS, V63, P409, DOI 10.1006/geno.1999.6096; KIMBERLING WJ, 1995, AM J HUM GENET, V56, P216; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Liu X, 2001, EXP EYE RES, V72, P351, DOI 10.1006/exer.2000.0963; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Nomura N, 1994, DNA Res, V1, P47, DOI 10.1093/dnares/1.1.47; Pakarinen L, 1996, INT OPHTHALMOL, V19, P307; Philibert RA, 1999, HUM GENET, V105, P174, DOI 10.1007/s004390051084; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Sankila, 1995, SCAND J LOG PHON, V20, P141, DOI 10.3109/14015439509098741; SANKILA EM, 1995, HUM MOL GENET, V4, P93, DOI 10.1093/hmg/4.1.93; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Self T, 1998, DEVELOPMENT, V125, P557; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WILKINSON DG, 1990, POSTIMPLANTATION MAM, P151; Zhuo D, 2001, GENOME RES, V11, P904, DOI 10.1101/gr.GR-1645R	41	152	159	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					673	684		10.1086/323610	http://dx.doi.org/10.1086/323610			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11524702	Green Published, Bronze			2022-12-18	WOS:000171008200001
J	Niida, Y; Stemmer-Rachamimov, AO; Logrip, M; Tapon, D; Perez, R; Kwiatkowski, DJ; Sims, K; MacCollin, M; Louis, DN; Ramesh, V				Niida, Y; Stemmer-Rachamimov, AO; Logrip, M; Tapon, D; Perez, R; Kwiatkowski, DJ; Sims, K; MacCollin, M; Louis, DN; Ramesh, V			Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-CHROMOSOME INACTIVATION; ALLELIC LOSS; EKER RAT; GERMLINE MUTATIONS; UNRELATED PATIENTS; GROWTH SUPPRESSOR; TUMOR SUPPRESSION; PRODUCT TUBERIN; HUMAN BRAIN; KIDNEY	Tuberous sclerosis complex (TSC), an autosomal dominant disease caused by mutations in either TSC1 or TSC2, is characterized by the development of hamartomas in a variety of organs. Concordant with the tumor-suppressor model, loss of heterozygosity (LOH) is known to occur in these hamartomas at loci of both TSC1 and TSC2. LOH has been documented in renal angiomyolipomas (AMLs), but loss of the wild-type allele in cortical tubers appears to be very uncommon. Analysis of second, somatic events in tumors for which the status of both TSC1 and TSC2 is known is essential for exploration of the pathogenesis of TSC-lesion development. We analyzed 24 hamartomas from 10 patients for second-hit mutations, by several methods, including LOH, scanning of all exons of both TSC1 and TSC2, promoter methylation of TSC2, and clonality analysis. Our results document loss of the wild-type allele in six of seven AMLs, without evidence of the inactivation of the second allele in many of the other lesions, including tumors that appear to be clonally derived. Laser-capture microdissection further demonstrated loss of the second allele in all three cellular components of an AML. This study thus provides evidence that, in both TSC1 and TSC2, somatic mutations resulting in the loss of wild-type alleles may not be necessary in some tumor types-and that other mechanisms may contribute to tumorigenesis in this setting.	Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; Massachusetts Gen Hosp, Mol Neurooncol Lab, Charlestown, MA USA; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA USA; Kanazawa Univ, Fac Med, Sch Med, Dept Pediat, Kanazawa, Ishikawa 920, Japan; Brigham & Womens Hosp, Div Hematol, Genet Lab, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Kanazawa University; Harvard University; Brigham & Women's Hospital	Ramesh, V (corresponding author), Bldg 149,13th St, Charlestown, MA 02129 USA.	ramesh@helix.mgh.harvard.edu		Tapon, Dagmar/0000-0003-3837-4764; Logrip, Marian L/0000-0001-6602-1283	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031535, R01NS031535, P01NS024279] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31535, NS24279, R01 NS031535, R37 NS031535, P01 NS024279] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Arai Y, 1999, ACTA NEUROPATHOL, V98, P233, DOI 10.1007/s004010051074; Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; Au KS, 1999, AM J HUM GENET, V65, P1790, DOI 10.1086/302648; Beauchamp RL, 1998, HUM MUTAT, V12, P408, DOI 10.1002/(SICI)1098-1004(1998)12:6<408::AID-HUMU7>3.3.CO;2-G; CARBONARA C, 1994, HUM MOL GENET, V3, P1829, DOI 10.1093/hmg/3.10.1829; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; Choy YS, 1999, ANN HUM GENET, V63, P383, DOI 10.1046/j.1469-1809.1999.6350383.x; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; GREEN AJ, 1994, HUM MOL GENET, V3, P1833, DOI 10.1093/hmg/3.10.1833; Green AJ, 1996, HUM GENET, V97, P240, DOI 10.1007/BF02265273; Henske EP, 1996, AM J HUM GENET, V59, P400; Henske EP, 1997, AM J PATHOL, V151, P1639; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; Johnson MW, 1999, BRAIN PATHOL, V9, P45; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Kerfoot C, 1996, BRAIN PATHOL, V6, P367, DOI 10.1111/j.1750-3639.1996.tb00866.x; Kobayashi T, 1997, MAMM GENOME, V8, P554, DOI 10.1007/s003359900502; Koptides M, 2000, HUM MOL GENET, V9, P447, DOI 10.1093/hmg/9.3.447; KUBO Y, 1994, CANCER RES, V54, P2633; KUBO Y, 1995, CANCER RES, V55, P989; LOUIS DN, 1992, AM J PATHOL, V141, P777; Macleod K, 2000, CURR OPIN GENET DEV, V10, P81, DOI 10.1016/S0959-437X(99)00041-6; Maheshwar MM, 1996, HUM MOL GENET, V5, P131, DOI 10.1093/hmg/5.1.131; Marsh DJ, 1998, GENE CHROMOSOME CANC, V21, P61, DOI 10.1002/(SICI)1098-2264(199801)21:1<61::AID-GCC8>3.0.CO;2-6; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Mizuguchi M, 2000, ACTA NEUROPATHOL, V99, P503, DOI 10.1007/s004010051152; Murthy V, 2000, AM J PHYSIOL-RENAL, V278, pF737; Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647; NELLIST M, 1993, CELL, V75, P1305; Niida Y, 1999, HUM MUTAT, V14, P412, DOI 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K; Olsson PG, 1996, MAMM GENOME, V7, P212, DOI 10.1007/s003359900057; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Plank TL, 1999, MODERN PATHOL, V12, P539; Plank TL, 1998, CANCER RES, V58, P4766; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Prowse AH, 1997, AM J HUM GENET, V60, P765; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Watnick T, 2000, NAT GENET, V25, P143, DOI 10.1038/75981; XU L, 1995, GENOMICS, V27, P475, DOI 10.1006/geno.1995.1079; YEUNG RS, 1995, MOL CARCINOGEN, V14, P28, DOI 10.1002/mc.2940140107; ZHU JG, 1995, CANCER RES, V55, P3865	50	152	157	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					493	503		10.1086/321972	http://dx.doi.org/10.1086/321972			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11468687	Green Published, Bronze			2022-12-18	WOS:000170271400003
J	Hirschhorn, JN; Lindgren, CM; Daly, MJ; Kirby, A; Schaffner, SF; Burtt, NP; Altshuler, D; Parker, A; Rioux, JD; Platko, J; Gaudet, D; Hudson, TJ; Groop, LC; Lander, ES				Hirschhorn, JN; Lindgren, CM; Daly, MJ; Kirby, A; Schaffner, SF; Burtt, NP; Altshuler, D; Parker, A; Rioux, JD; Platko, J; Gaudet, D; Hudson, TJ; Groop, LC; Lander, ES			Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR GENE; QUANTITATIVE TRAITS; VARIANCE-COMPONENTS; HIP FRACTURE; BODY HEIGHT; POLYMORPHISM; CHILDREN; WOMEN; RISK; PEDIGREES	Genomewide linkage analysis has been extremely successful at identification of the genetic variation underlying single-gene disorders. However, linkage analysis has been less successful for common human diseases and other complex traits in which multiple genetic and environmental factors interact to influence disease risk. We hypothesized that a highly heritable complex trait, in which the contribution of environmental factors was relatively limited, might be more amenable to linkage analysis. We therefore chose to study stature (adult height), for which heritability is 75%-90% (Phillips and Matheny 1990; Carmichael and McGue 1995; Preece 1996; Silventoinen et al. 2000). We reanalyzed genomewide scans from four populations for which genotype and height data were available, using a variance-components method implemented in GENEHUNTER 2.0 (Pratt et al. 2000). The populations consisted of 408 individuals in 58 families from the Botnia region of Finland, 753 individuals in 183 families from other parts of Finland, 746 individuals in 179 families from Southern Sweden, and 420 individuals in 63 families from the Saguenay-Lac-St.-Jean region of Quebec. Four regions showed evidence of linkage to stature: 6q24-25, multipoint LOD score 3.85 at marker D6S1007 in Botnia (genomewide P<.06), 7q31.3-36 (LOD 3.40 at marker D7S2195 in Sweden, P<.02), 12p11.2-q14 (LOD 3.35 at markers D12S10990-D12S398 in Finland,P<.05) and 13q32-33 (LOD 3.56 at markers D13S779-D13S797 in Finland, P<.05). In a companion article (Perola et al. 2001 [in this issue]), strong supporting evidence is obtained for linkage to the region on chromosome 7. These studies suggest that highly heritable complex traits such as stature may be genetically tractable and provide insight into the genetic architecture of complex traits.	MIT, Whitehead Ctr Genome Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Millennium Pharmaceut Inc, Dept Genet, Cambridge, England; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Genet, Boston, MA 02114 USA; Univ Lund, Dept Endocrinol, Malmo, Sweden; Ctr Hosp Univ Montreal, Chicoutimi Hosp, Prevent Genet & Community Genet Ctr, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Montreal Genome Ctr, Montreal, PQ, Canada	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Lund University; Universite de Montreal; McGill University	Hirschhorn, JN (corresponding author), MIT, Whitehead Ctr Genome Res, 1 Kendall Sq, Cambridge, MA 02139 USA.		Rioux, John D/A-9599-2015; Altshuler, David M/A-4476-2009; Schaffner, Stephen F/D-1189-2011; Daly, Mark J/B-2453-2017	Rioux, John D/0000-0001-7560-8326; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Lindgren, Cecilia/0000-0002-4903-9374; Schaffner, Stephen/0000-0001-6699-3568	Wellcome Trust [090532] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; CARMICHAEL CM, 1995, J GERONTOL A-BIOL, V50, pB237, DOI 10.1093/gerona/50A.4.B237; Forsen T, 2000, J INTERN MED, V248, P326, DOI 10.1046/j.1365-2796.2000.00747.x; Garnero P, 1998, J BONE MINER RES, V13, P813, DOI 10.1359/jbmr.1998.13.5.813; Giovannucci E, 1997, CANCER EPIDEM BIOMAR, V6, P557; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Hebert PR, 1997, CANCER CAUSE CONTROL, V8, P591, DOI 10.1023/A:1018442329319; HEMENWAY D, 1994, AM J PUBLIC HEALTH, V84, P1843, DOI 10.2105/AJPH.84.11.1843; HEMENWAY D, 1995, INT J EPIDEMIOL, V24, P783, DOI 10.1093/ije/24.4.783; JEPSON A, 1994, ANN TROP PAEDIATR, V14, P309, DOI 10.1080/02724936.1994.11747734; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1989, GENETICS, V121, P185; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Lindgren CM, 2001, ENDOCRINOLOGIST, V11, P178, DOI 10.1097/00019616-200105000-00004; Lorentzon M, 1999, J CLIN ENDOCR METAB, V84, P4597, DOI 10.1210/jc.84.12.4597; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Minamitani K, 1998, PEDIATR RES, V44, P628, DOI 10.1203/00006450-199811000-00002; Miyake H, 1999, J HUM GENET, V44, P26, DOI 10.1007/s100380050101; Parker A, 2001, DIABETES, V50, P675, DOI 10.2337/diabetes.50.3.675; PAZ I, 1993, AM J DIS CHILD, V147, P337, DOI 10.1001/archpedi.1993.02160270099030; Pearson K., 1903, BIOMETRIKA, V2, P357; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; Phillips DIW, 1998, DIABETES CARE, V21, pB150; PHILLIPS K, 1990, ACTA GENET MED GEMEL, V39, P143, DOI 10.1017/S0001566000005389; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; Raivio T, 1996, J CLIN ENDOCR METAB, V81, P3278, DOI 10.1210/jc.81.9.3278; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROCHE AF, 1972, PEDIATRICS, V50, P874; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; THOMPSON DB, 1995, AM J MED GENET, V59, P495, DOI 10.1002/ajmg.1320590417; Tuvemo T, 1999, PEDIATR RES, V46, P491, DOI 10.1203/00006450-199911000-00001; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x	37	152	155	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					106	116		10.1086/321287	http://dx.doi.org/10.1086/321287			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11410839	Green Published, Bronze			2022-12-18	WOS:000170108100011
J	Geschwind, DH; Loginov, M; Stern, JM				Geschwind, DH; Loginov, M; Stern, JM			Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT INHERITANCE; TYROSINE-HYDROXYLASE GENE; CYCLOHYDROLASE-I GENE; COMPUTED-TOMOGRAPHY; CEREBRAL CALCIFICATIONS; FAMILIAL CALCIFICATION; BRAIN CALCIFICATION; TORSION DYSTONIA; LINKAGE ANALYSIS; POINT MUTATION	Idiopathic basal ganglia calcification (IBGC) is a neurodegenerative syndrome that is associated with a variety of movement disorders and neurobehavioral and cognitive manifestations. Despite numerous clinical, pathological, and biochemical investigations, its etiology remains unknown. We have identified a multigenerational family with dominantly inherited IBGC and, in 24 members of this family, performed a whole-genome scan using polymorphic microsatellite markers to identify the first chromosomal locus for this disorder (IBGC1). A maximum two-point LOD score of 3.37 was obtained at marker D14S1014, and a maximum multipoint LOD score of 4.95 was obtained between D14S75 and D14S306. The minimal haplotype shared by affected patients extended over a 17.1-cM region bounded by D14S70 and D14S66, which is potentially further narrowed to a 13.3-cM region by a recombination observed in a patient with probable affected status. The age at onset appeared to be decreasing by an average of >20 years with each transmission, which is consistent with genetic anticipation.	Univ Calif Los Angeles, Dept Neurol, Neurogenet Program, Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Dept Neurol, Neurogenet Program, Sch Med, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	dhg@ucla.edu		Stern, John/0000-0002-3549-1642				Benton A, 1978, PSYCHOL ASSESSMENT R; BOLLER F, 1977, J NEUROL NEUROSUR PS, V40, P280, DOI 10.1136/jnnp.40.3.280; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUCKETT S, 1977, ACTA NEUROPATHOL, V38, P7, DOI 10.1007/BF00691269; ELLIE E, 1989, NEUROLOGY, V39, P381, DOI 10.1212/WNL.39.3.381; EtcharryBouyx F, 1995, REV NEUROL, V151, P731; FENELON G, 1993, J NEUROL NEUROSUR PS, V56, P622, DOI 10.1136/jnnp.56.6.622; FLINT J, 1992, PSYCHOL MED, V22, P581, DOI 10.1017/S0033291700038046; FRANCIS A, 1984, J NERV MENT DIS, V172, P166, DOI 10.1097/00005053-198403000-00006; Gasser T, 1997, J NEUROL, V244, P341, DOI 10.1007/s004150050100; Geschwind DH, 1997, AM J HUM GENET, V60, P842; HARRINGTON MG, 1981, J NEUROL NEUROSUR PS, V44, P1168, DOI 10.1136/jnnp.44.12.1168; Ichinose H, 1997, BRAIN RES BULL, V43, P35, DOI 10.1016/S0361-9230(96)00353-X; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KNAPPSKOG PM, 1995, HUM MOL GENET, V4, P1209, DOI 10.1093/hmg/4.7.1209; Kobari M, 1997, NEUROLOGY, V48, P645, DOI 10.1212/WNL.48.3.645; KOLLER WC, 1979, NEUROLOGY, V29, P328, DOI 10.1212/WNL.29.3.328; KONIG P, 1989, BIOL PSYCHIAT, V25, P459, DOI 10.1016/0006-3223(89)90199-6; KONIG P, 1985, EUR ARCH PSY CLIN N, V234, P325, DOI 10.1007/BF00381044; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LAPLANE D, 1989, BRAIN, V112, P699, DOI 10.1093/brain/112.3.699; LARSEN TA, 1985, NEUROLOGY, V35, P533, DOI 10.1212/WNL.35.4.533; LEGIDO A, 1988, PEDIATR NEUROSCI, V14, P64, DOI 10.1159/000120365; Leube B, 1996, HUM MOL GENET, V5, P1673, DOI 10.1093/hmg/5.10.1673; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th ed.; LopezVillegas D, 1996, ARCH NEUROL-CHICAGO, V53, P251, DOI 10.1001/archneur.1996.00550030061023; LOWENTHAL A, 1986, HDB CLIN NEUROLOGY, V49, P417; LUDECKE B, 1995, HUM GENET, V95, P123; MANYAM BV, 1992, ANN NEUROL, V31, P379, DOI 10.1002/ana.410310406; MOSKOWITZ MA, 1971, NEW ENGL J MED, V285, P72, DOI 10.1056/NEJM197107082850202; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OKADA J, 1981, ACTA NEUROL SCAND, V64, P273; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROSENBERG DR, 1991, J NERV MENT DIS, V179, P48, DOI 10.1097/00005053-199101000-00010; ROSENBERG RN, 1995, NEUROLOGY, V45, P1; Rosenberg RN, 1996, NEW ENGL J MED, V335, P1222, DOI 10.1056/NEJM199610173351609; SMEYERSVERBEKE J, 1975, NEUROLOGY, V25, P48, DOI 10.1212/WNL.25.1.48; Strub R, 1985, MENTAL STATUS EXAMIN; TRAUTNER RJ, 1988, AM J PSYCHIAT, V145, P350; Wilhelmsen Kirk C., 1996, Neurology, V46, pA188; [No title captured]	47	152	171	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					764	772		10.1086/302558	http://dx.doi.org/10.1086/302558			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441584	Green Published, Bronze			2022-12-18	WOS:000082426400022
J	Tang, MX; Maestre, G; Tsai, WY; Liu, XH; Feng, L; Chung, WY; Chun, M; Schofield, P; Stern, Y; Tycko, B; Mayeux, R				Tang, MX; Maestre, G; Tsai, WY; Liu, XH; Feng, L; Chung, WY; Chun, M; Schofield, P; Stern, Y; Tycko, B; Mayeux, R			Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; PARADIGM-BASED DIAGNOSIS; HETEROGENEOUS POPULATION; TYPE-4 ALLELE; ASSOCIATION; EPSILON-4; DEMENTIA; BINDING; BLACKS	Apolipoprotein-E epsilon 4 (APOE-epsilon 4) has been consistently associated with Alzheimer disease (AD) and may be responsible for an earlier age at onset. We have previously reported a diminished association between APOE-epsilon 4 and AD in African Americans. Using a new method, which allows inclusion of censored information, we compared relative risks by APOE genotypes in an expanded collection of cases and controls from three ethnic groups in a New York community. The relative risk for AD associated with APOE-epsilon 4 homozygosity was increased in all ethnic groups (African American relative risk [RR] = 3.0; 95% confidence interval [CI] = 1.5-5.9; Caucasian RR = 7.3, 95% CI = 2.5-21.6; and Hispanic RR = 2.5, 95% CI = 1.1-5.7), compared with those with APOE-epsilon 3/epsilon 3 genotypes. The risk was also increased for APOE-epsilon 4 heterozygous Caucasians (RR = 2.9, 35% CI = 1.7-5.1) and Hispanics (RR = 1.6, 95% CI = 1.1-2.3), but not for African Americans (RR = 0.6, 95% CI = 0.4-0.9). The age distribution of the proportion of Caucasians and Hispanics without AD was consistently lower for APOE-epsilon 4 homozygous and APOE-epsilon 4 heterozygous individuals than for those with other APOE genotypes. In African Americans this relationship was observed only in APOE-epsilon 4 homozygotes. These results confirm that APOE genotypes influence the RR of AD in Caucasians and Hispanics. Differences in risk among APOE-epsilon 4 heterozygote African Americans suggest that other genetic or environmental factors may modify the effect of APOE-epsilon 4 in some populations.	COLUMBIA UNIV COLL PHYS & SURG,GERTRUDE H SERGIEVSKY CTR,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,TAUB CTR ALZHEIMERS DIS RES CITY NEW YORK,SCH PUBL HLTH,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,TAUB CTR ALZHEIMERS DIS RES CITY NEW YORK,SCH PUBL HLTH,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University			Schofield, Peter/J-7133-2013; Maestre, Gladys/L-5092-2015	Maestre, Gladys/0000-0001-5690-8833; Stern, Yaakov/0000-0001-7542-3241; Schofield, Peter/0000-0001-8298-8590	NATIONAL INSTITUTE ON AGING [P50AG008702, P01AG007232, R35AG010963] Funding Source: NIH RePORTER; NIA NIH HHS [AG07232, AG10963, AG08702] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BORGAONKAR DS, 1993, LANCET, V342, P625, DOI 10.1016/0140-6736(93)91458-X; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; CHUN MR, 1995, NEUROLOGY, V45, pA373; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CUPPLES LA, 1989, GENET EPIDEMIOL, V6, P361, DOI 10.1002/gepi.1370060206; CUPPLES LA, 1991, AM J HUM GENET, V49, P76; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EICHNER JE, 1993, AM J CARDIOL, V71, P160, DOI 10.1016/0002-9149(93)90732-R; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FLEISS JL, 1981, STATISTICAL METHODS, P160; GARJA B, 1994, HUM HERED, V44, P209; GURLAND B, 1995, AM J GERIAT PSYCHIAT, V3, P6, DOI 10.1097/00019442-199524310-00002; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; HENDRIE HC, 1995, ANN NEUROL, V37, P118, DOI 10.1002/ana.410370123; HERBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354; HIXSON J, 1991, J LIPID RES, V31, P545; Isaacson E., 1966, ANAL NUMERICAL METHO; KAMBOH MI, 1989, DIS MARKERS, V7, P49; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6; KUUSISTO J, 1994, BRIT MED J, V309, P636, DOI 10.1136/bmj.309.6955.636; LANNFELT L, 1994, NEUROSCI LETT, V169, P175, DOI 10.1016/0304-3940(94)90384-0; LAWLESS JF, 1982, STATISTICAL MODELS M; LIDDELL M, 1994, J MED GENET, V31, P197, DOI 10.1136/jmg.31.3.197; LOUHIJA J, 1994, ARTERIOSCLER THROMB, V14, P1084, DOI 10.1161/01.ATV.14.7.1084; LUC G, 1994, ARTERIOSCLER THROMB, V14, P1412, DOI 10.1161/01.ATV.14.9.1412; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; NOGUCHI S, 1993, LANCET, V342, P737, DOI 10.1016/0140-6736(93)91728-5; OSUNTOKUN BO, 1995, ANN NEUROL, V38, P463, DOI 10.1002/ana.410380319; PAYAMI H, 1993, LANCET, V342, P738; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; PITTMAN J, 1992, ARCH NEUROL-CHICAGO, V49, P461, DOI 10.1001/archneur.1992.00530290043010; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; REILLY SL, 1992, AM J HUM GENET, V51, P1311; ROSES AD, 1995, ANN NEUROL, V38, P6, DOI 10.1002/ana.410380105; ROSES AD, 1994, LANCET, V343, P1564, DOI 10.1016/S0140-6736(94)92960-2; SANDHOLZER C, 1995, HUM GENET, V95, P46; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHOFIELD PW, IN PRESS NEUROLOGY; SEPEHRNIA B, 1989, AM J HUM GENET, V45, P586; SORBI S, 1994, NEUROSCI LETT, V177, P100, DOI 10.1016/0304-3940(94)90054-X; SRINIVASAN SR, 1993, METABOLISM, V42, P381, DOI 10.1016/0026-0495(93)90091-2; STENGARD JH, 1995, CIRCULATION, V91, P265, DOI 10.1161/01.CIR.91.2.265; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TANG MX, IN PRESS STAT MED; TURNBULL BW, 1974, J AM STAT ASSOC, V69, P169, DOI 10.2307/2285518; VANDUIJN CM, 1995, ANN NEUROL, V37, P605, DOI 10.1002/ana.410370510; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; ZEKRAOUI L, 1995, MAY IBS F M PAR; 1991, CENSUS POPULATION HO; 1987, DIAGNOSTIC STATISTIC, P205	58	152	154	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					574	584						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644717				2022-12-18	WOS:A1996TV56400016
J	GENCIC, S; ABUELO, D; AMBLER, M; HUDSON, LD				GENCIC, S; ABUELO, D; AMBLER, M; HUDSON, LD			PELIZAEUS-MERZBACHER DISEASE - AN X-LINKED NEUROLOGIC DISORDER OF MYELIN METABOLISM WITH A NOVEL MUTATION IN THE GENE ENCODING PROTEOLIPID PROTEIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NINCDS,VIRAL & MOLEC PATHOGENESIS LAB,BLDG 36,ROOM 5D04,BETHESDA,MD 20892; BROWN UNIV,DEPT PEDIAT,PROVIDENCE,RI 02912; BROWN UNIV,DEPT PATHOL,PROVIDENCE,RI 02912	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Brown University; Brown University								[Anonymous], MYELIN; BILLINGSGAGLIARDI S, 1980, BRAIN RES, V200, P135, DOI 10.1016/0006-8993(80)91100-2; BILLINGSGAGLIARDI S, 1980, BRAIN RES, V194, P325, DOI 10.1016/0006-8993(80)91215-9; Camp CD, 1941, ARCH NEURO PSYCHIATR, V45, P261, DOI 10.1001/archneurpsyc.1941.02280140071006; CASSIDY SB, 1987, PEDIATR NEUROL, V3, P300, DOI 10.1016/0887-8994(87)90072-5; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; DUNCAN ID, 1983, NEUROPATH APPL NEURO, V9, P355, DOI 10.1111/j.1365-2990.1983.tb00121.x; DUNCAN ID, IN PRESS GLIA; ELDRIDGE R, 1984, NEW ENGL J MED, V311, P948, DOI 10.1056/NEJM198410113111504; GENCIC S, IN PRESS J NEUROSCI; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; HUDSON LD, 1987, P NATL ACAD SCI USA, V84, P1454, DOI 10.1073/pnas.84.5.1454; HUDSON LD, IN PRESS J CELL BIOL; HUDSON LD, IN PRESS P NATL ACAD; IKENAKA K, 1988, J MOL BIOL, V199, P587, DOI 10.1016/0022-2836(88)90303-8; KOEPPEN AH, 1988, J NEUROL SCI, V84, P315, DOI 10.1016/0022-510X(88)90135-9; KOEPPEN AH, 1987, ANN NEUROL, V21, P159, DOI 10.1002/ana.410210208; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; MACKLIN WB, 1987, FEBS LETT, V223, P417, DOI 10.1016/0014-5793(87)80331-9; Maniatis T., 1982, MOL CLONING; MATTEI MG, 1986, HUM GENET, V72, P352, DOI 10.1007/BF00290964; MATTHIEU JM, 1973, BRAIN RES, V55, P403, DOI 10.1016/0006-8993(73)90305-3; MCKUSICK VA, 1988, MENDELIAN INHERITANC, P573; Merzbacher L., 1910, Z F R GESAMTE NEUROL, V3, P1, DOI [10.1007/BF02893591, DOI 10.1007/BF02893591]; MOLINEAUX SM, 1986, P NATL ACAD SCI USA, V83, P7542, DOI 10.1073/pnas.83.19.7542; MORELLO D, 1986, EMBO J, V5, P3489, DOI 10.1002/j.1460-2075.1986.tb04674.x; NADON N, 1988, J NEUROSCI, V14, pA829; NAVE KA, 1987, J NEUROCHEM, V49, P1873, DOI 10.1111/j.1471-4159.1987.tb02449.x; NAVE KA, 1986, P NATL ACAD SCI USA, V83, P9264, DOI 10.1073/pnas.83.23.9264; Pelizaeus F., 1885, ARCH PSYCHIAT NERVEN, V16, P698; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; ROIZEN L, 1982, HISTOL HISTOPATHOL, V1, P1375; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SEITELBERGER F, 1957, Wien Z Nervenheilkd Grenzgeb, V14, P74; SEITELBERGER F, 1960, MODERN SCIENTIFIC AS, P146; Seitelberger F., 1970, HDB CLINICAL NEUROLO, V10, P150; SKOFF RP, 1982, BRAIN RES, V248, P19, DOI 10.1016/0006-8993(82)91143-X; SPIELMEYER W, 1923, Z GES NEUROL PSYCH, V32, P202; SUTCLIFFE JG, 1987, TRENDS GENET, V3, P73, DOI 10.1016/0168-9525(87)90179-X; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; WATANABE I, 1973, J NEUROPATH EXP NEUR, V32, P313, DOI 10.1097/00005072-197304000-00010; WILLARD HF, 1985, SCIENCE, V230, P940, DOI 10.1126/science.3840606; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; ZEMAN W, 1964, J NEUROPATH EXP NEUR, V23, P334, DOI 10.1097/00005072-196404000-00008	46	152	158	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					435	442						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2773936				2022-12-18	WOS:A1989AN87900012
J	CHAKRABORTY, R; SMOUSE, PE; NEEL, JV				CHAKRABORTY, R; SMOUSE, PE; NEEL, JV			POPULATION AMALGAMATION AND GENETIC-VARIATION - OBSERVATIONS ON ARTIFICIALLY AGGLOMERATED TRIBAL POPULATIONS OF CENTRAL AND SOUTH-AMERICA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48104	University of Michigan System; University of Michigan	CHAKRABORTY, R (corresponding author), UNIV TEXAS,GRAD SCH BIOMED SCI,CTR DEMOG & POPULAT GENET,POB 20334,HOUSTON,TX 77225, USA.				NIGMS NIH HHS [GM-R01-22394, GM-R01-32589] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032589] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1984, AM NAT; BARRANTES R, 1982, AM J PHYS ANTHROPOL, V58, P201, DOI 10.1002/ajpa.1330580213; CHAGNON NA, 1970, AM J PHYS ANTHROPOL, V32, P339, DOI 10.1002/ajpa.1330320304; CHAKRABORTY R, 1980, GENETICS, V94, P1039; CHAKRABORTY R, 1978, AM J HUM GENET, V30, P550; CHAKRABORTY R, 1982, THEOR POPUL BIOL, V21, P205, DOI 10.1016/0040-5809(82)90014-4; CHAKRABORTY R, 1981, AM J HUM GENET, V33, P481; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Ewens W.J., 1979, MATH POPULATION GENE; EWENS WJ, 1974, THEOR POPUL BIOL, V6, P143, DOI 10.1016/0040-5809(74)90020-3; EWENS WJ, 1974, THEOR POPUL BIOL, V6, P35, DOI 10.1016/0040-5809(74)90030-6; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; GERSHOWITZ H, 1978, AM J PHYS ANTHROPOL, V49, P289, DOI 10.1002/ajpa.1330490302; HARRIS H, 1974, ANN HUM GENET, V37, P237, DOI 10.1111/j.1469-1809.1974.tb01832.x; KIMURA M, 1964, GENETICS, V49, P725; LONG JC, 1983, AM J PHYS ANTHROPOL, V61, P411, DOI 10.1002/ajpa.1330610403; MESTRINER MA, 1980, AM J PHYS ANTHROPOL, V52, P95, DOI 10.1002/ajpa.1330520112; MOHRENWEISER H, 1979, AM J PHYS ANTHROPOL, V50, P237, DOI 10.1002/ajpa.1330500212; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; NEEL IV, 1978, AM J HUM GENET, V41, P429; NEEL JV, 1986, AM J HUM GENET, V38, P649; NEEL JV, 1978, P NATL ACAD SCI USA, V75, P1904, DOI 10.1073/pnas.75.4.1904; NEEL JV, 1986, P NATL ACAD SCI USA, V83, P389, DOI 10.1073/pnas.83.2.389; NEEL JV, 1980, ANN HUM GENET, V44, P37, DOI 10.1111/j.1469-1809.1980.tb00944.x; NEEL JV, 1978, P NATL ACAD SCI USA, V75, P5585, DOI 10.1073/pnas.75.11.5585; NEEL JV, 1978, AM J HUM GENET, V30, P465; NEEL JV, 1977, HUM GENET, V36, P81, DOI 10.1007/BF00390440; NEEL JV, 1973, P NATL ACAD SCI USA, V70, P3311, DOI 10.1073/pnas.70.12.3311; NEEL JV, 1977, HUM GENET, V37, P207, DOI 10.1007/BF00393584; NEEL JV, 1988, UNPUB AM J HUM GENET; NEEL JV, 1980, POPULATION STRUCTURE, P173; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; NEI M, 1974, GENETICS, V76, P379; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M., 1975, MOL POPULATION GENET; OHTA T, 1976, THEOR POPUL BIOL, V10, P254, DOI 10.1016/0040-5809(76)90019-8; SALZANO FM, 1986, AM J PHYS ANTHROPOL, V69, P3, DOI 10.1002/ajpa.1330690103; SALZANO FM, 1972, AM J PHYS ANTHROPOL, V36, P417, DOI 10.1002/ajpa.1330360313; SALZANO FM, 1977, AM J PHYS ANTHROPOL, V47, P337, DOI 10.1002/ajpa.1330470214; SALZANO FM, 1978, HUM BIOL, V50, P121; SALZANO FM, 1984, ANN HUM BIOL, V11, P337, DOI 10.1080/03014468400007241; SINGH RS, 1987, GENETICS, V115, P313; SLATKIN M, 1985, THEOR POPUL BIOL, V28, P314, DOI 10.1016/0040-5809(85)90032-2; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.1111/j.1558-5646.1985.tb04079.x; SMOUSE PE, 1982, AM NAT, V119, P445, DOI 10.1086/283925; Sneath PHA., 1973, NUMERICAL TAXONOMY; SPIELMAN RS, 1974, SCIENCE, V184, P637, DOI 10.1126/science.184.4137.637; STROBECK C, 1987, GENETICS, V117, P149; THOMPSON EA, 1978, P NATL ACAD SCI USA, V75, P1442, DOI 10.1073/pnas.75.3.1442; WARD RH, 1975, AM J HUM GENET, V27, P1; WATTERSON GA, 1978, GENETICS, V88, P171; [No title captured]	56	152	154	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					709	725						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	Q9336	3189334				2022-12-18	WOS:A1988Q933600018
J	Acuna-Hidalgo, R; Bo, T; Kwint, MP; van de Vorst, M; Pinelli, M; Veltman, JA; Hoischen, A; Vissers, LELM; Gilissen, C				Acuna-Hidalgo, Rocio; Bo, Tan; Kwint, Michael P.; van de Vorst, Maartje; Pinelli, Michele; Veltman, Joris A.; Hoischen, Alexander; Vissers, Lisenka E. L. M.; Gilissen, Christian			Post-zygotic Point Mutations Are an Underrecognized Source of De Novo Genomic Variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECURRENCE RISK; WHOLE-GENOME; MOSAICISM; AGE; INDIVIDUALS; NUCLEOTIDE; DISORDERS; DISEASE; SIBS; DNA	De novo mutations are recognized both as an important source of genetic variation and as a prominent cause of sporadic disease in humans. Mutations identified as de novo are generally assumed to have occurred during gametogenesis and, consequently, to be present as germline events in an individual. Because Sanger sequencing does not provide the sensitivity to reliably distinguish somatic from germline mutations, the proportion of de novo mutations that occur somatically rather than in the germline remains largely unknown. To determine the contribution of post-zygotic events to de novo mutations, we analyzed a set of 107 de novo mutations in SO parent-offspring trios. Using four different sequencing techniques, we found that 7 (6.5%) of these presumed gemiline di novo mutations were in fact present as mosaic mutations in the blood of the offspring and were therefore likely to have occurred post-zygotically. Furthermore, genome-wide analysis of "de novo" variants in the proband led to the identification of 4/4,081 variants that were also detectable in the blood of one of the parents, implying parental mosaicism as the origin of these variants. Thus, our results show that an important fraction of de novo mutations presumed to be germline in fact occurred either post-zygotically in the offspring or were inherited as a consequence of low-level mosaicism in one of the parents.	[Acuna-Hidalgo, Rocio; Kwint, Michael P.; van de Vorst, Maartje; Veltman, Joris A.; Hoischen, Alexander; Vissers, Lisenka E. L. M.; Gilissen, Christian] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Acuna-Hidalgo, Rocio; Kwint, Michael P.; van de Vorst, Maartje; Veltman, Joris A.; Hoischen, Alexander; Vissers, Lisenka E. L. M.; Gilissen, Christian] Radboud Univ Nijmegen, Med Ctr, Donders Inst Neurosci, NL-6525 GA Nijmegen, Netherlands; [Bo, Tan] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Pinelli, Michele] Telethon Inst Genet & Med, I-80078 Naples, Italy; [Veltman, Joris A.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 ER Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Central South University; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Maastricht University	Hoischen, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands.	alexander.hoischen@radboudumc.nl	Gilissen, Christian/E-5246-2012; Acuna-Hidalgo, Rocio/D-9607-2016; Hoischen, Alexander/AGF-7293-2022; Vissers, Lisenka ELM/A-2598-2015; Pinelli, Michele/A-1584-2010; Kwint, Michael/AAC-9062-2019; Hoischen, Alexander/D-1282-2013; Veltman, Joris A/F-5128-2010	Gilissen, Christian/0000-0003-1693-9699; Acuna-Hidalgo, Rocio/0000-0001-9413-0348; Hoischen, Alexander/0000-0002-8072-4476; Vissers, Lisenka ELM/0000-0001-6470-5497; Pinelli, Michele/0000-0002-5927-1185; Hoischen, Alexander/0000-0002-8072-4476; Veltman, Joris A/0000-0002-3218-8250	Netherlands Organization for Scientific Research [916-14-043, 916-12-095, SH-271-13]; European Research Council (ERC) [DENOVO 281964]; Radboud University Medical Center grant; Fondazione Telethon Funding Source: Custom	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)); Radboud University Medical Center grant; Fondazione Telethon(Fondazione Telethon)	We thank Drs. Bregje van Bon, Marjolein Willemsen, Bert de Vries, Tjitske Kleefstra, and Han Brunner from the Department of Human Genetics of the Radboud University Medical Center for the inclusion of affected individuals. We also thank Richard Leach, Robert Klein, and Rick Tear le from Complete Genomics for whole-genome sequencing. This work was in part financially supported by grants from the Netherlands Organization for Scientific Research (916-14-043 to C.G., 916-12-095 to A.H., and SH-271-13 to C.G. and J.A.V.) and the European Research Council (ERC Starting Grant DENOVO 281964 to J.A.V.). R.A.-H. was supported by a Radboud University Medical Center grant.	Campbell IM, 2014, AM J HUM GENET, V95, P345, DOI 10.1016/j.ajhg.2014.08.010; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Dal GM, 2014, J MED GENET, V51, P455, DOI 10.1136/jmedgenet-2013-102197; Elalaoui SC, 2010, AM J MED GENET A, V152A, P2850, DOI 10.1002/ajmg.a.33685; Faivre L, 2006, AM J MED GENET A, V140A, P636, DOI 10.1002/ajmg.a.31114; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Huang AY, 2014, CELL RES, V24, P1311, DOI 10.1038/cr.2014.131; Huisman SA, 2013, J MED GENET, V50, P339, DOI 10.1136/jmedgenet-2012-101477; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Nachman MW, 2000, GENETICS, V156, P297; Natacci F, 2008, AM J MED GENET A, V146A, P784, DOI 10.1002/ajmg.a.32228; Nemirovsky SI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116358; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Petersen BS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-564; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohlin A, 2009, HUM MUTAT, V30, P1012, DOI 10.1002/humu.20980; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Veal CD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-455; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733	32	151	154	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					67	74		10.1016/j.ajhg.2015.05.008	http://dx.doi.org/10.1016/j.ajhg.2015.05.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26054435	Green Published, Bronze			2022-12-18	WOS:000358189500006
J	Bredrup, C; Saunier, S; Oud, MM; Fiskerstrand, T; Hoischen, A; Brackman, D; Leh, SM; Midtbo, M; Filhol, E; Bole-Feysot, C; Nitschke, P; Gilissen, C; Haugen, OH; Sanders, JSF; Stolte-Dijkstra, I; Mans, DA; Steenbergen, EJ; Hamel, BCJ; Matignon, M; Pfundt, R; Jeanpierre, C; Boman, H; Rodahl, E; Veltman, JA; Knappskog, PM; Knoers, NVAM; Roepman, R; Arts, HH				Bredrup, Cecilie; Saunier, Sophie; Oud, Machteld M.; Fiskerstrand, Torunn; Hoischen, Alexander; Brackman, Damien; Leh, Sabine M.; Midtbo, Marit; Filhol, Emilie; Bole-Feysot, Christine; Nitschke, Patrick; Gilissen, Christian; Haugen, Olav H.; Sanders, Jan-Stephan F.; Stolte-Dijkstra, Irene; Mans, Dorus A.; Steenbergen, Eric J.; Hamel, Ben C. J.; Matignon, Marie; Pfundt, Rolph; Jeanpierre, Cecile; Boman, Helge; Rodahl, Eyvind; Veltman, Joris A.; Knappskog, Per M.; Knoers, Nine V. A. M.; Roepman, Ronald; Arts, Heleen H.			Ciliopathies with Skeletal Anomalies and Renal Insufficiency due to Mutations in the IFT-A Gene WDR19	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPHYXIATING THORACIC DYSTROPHY; RIB-POLYDACTYLY SYNDROME; INTRAFLAGELLAR TRANSPORT; CRANIOECTODERMAL DYSPLASIA; PRIMARY CILIA; PROTEIN	A subset of ciliopathies, including Sensenbrenner, Jeune, and short-rib polydactyly syndromes are characterized by skeletal anomalies accompanied by multiorgan defects such as chronic renal failure and retinitis pigmentosa. Through exome sequencing we identified compound heterozygous mutations in WDR19 in a Norwegian family with Sensenbrenner syndrome. In a Dutch family with the clinically overlapping Jeune syndrome, a homozygous missense mutation in the same gene was found. Both families displayed a nephronophthisis-like nephropathy. Independently, we also identified compound heterozygous WDR19 mutations by exome sequencing in a Moroccan family with isolated nephronophthisis. WDR19 encodes IFT144, a member of the intraflagellar transport (IFT) complex A that drives retrograde ciliary transport. We show that IFT144 is absent from the cilia of fibroblasts from one of the Sensenbrenner patients and that ciliary abundance and morphology is perturbed, demonstrating the ciliary pathogenesis. Our results suggest that isolated nephronophthisis, Jeune, and Sensenbrenner syndromes are clinically overlapping disorders that can result from a similar molecular cause.	[Oud, Machteld M.; Hoischen, Alexander; Gilissen, Christian; Mans, Dorus A.; Hamel, Ben C. J.; Pfundt, Rolph; Veltman, Joris A.; Roepman, Ronald; Arts, Heleen H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Bredrup, Cecilie; Haugen, Olav H.; Rodahl, Eyvind] Haukeland Hosp, Dept Ophthalmol, N-5021 Bergen, Norway; [Bredrup, Cecilie; Fiskerstrand, Torunn; Hoischen, Alexander; Boman, Helge; Knappskog, Per M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Saunier, Sophie; Filhol, Emilie; Jeanpierre, Cecile] Hop Necker Enfants Malad, INSERM, U983, F-75015 Paris, France; [Saunier, Sophie; Filhol, Emilie; Jeanpierre, Cecile] Univ Paris 05, F-75006 Paris, France; [Oud, Machteld M.; Hoischen, Alexander; Gilissen, Christian; Mans, Dorus A.; Veltman, Joris A.; Roepman, Ronald; Arts, Heleen H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Oud, Machteld M.; Roepman, Ronald; Arts, Heleen H.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Fiskerstrand, Torunn; Haugen, Olav H.; Boman, Helge; Rodahl, Eyvind; Knappskog, Per M.] Univ Bergen, Dept Clin Med, N-5021 Bergen, Norway; [Brackman, Damien] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Leh, Sabine M.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Midtbo, Marit] Univ Bergen, Dept Clin Dent Orthodont & Facial Orthoped, N-5020 Bergen, Norway; [Nitschke, Patrick] Univ Paris 05, Hop Necker Enfants Malad, F-75015 Paris, France; [Sanders, Jan-Stephan F.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9700 RB Groningen, Netherlands; [Stolte-Dijkstra, Irene] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Steenbergen, Eric J.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 GA Nijmegen, Netherlands; [Matignon, Marie] Henri Mondor Hosp, APHP, Dept Nephrol & Transplantat, IFRNT, F-94010 Creteil, France; [Matignon, Marie] Univ Paris 12, F-94010 Creteil, France; [Knoers, Nine V. A. M.; Arts, Heleen H.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands	Radboud University Nijmegen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; Radboud University Nijmegen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Groningen; University of Groningen; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Utrecht University; Utrecht University Medical Center	Arts, HH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands.	h.arts@antrg.umcn.nl	Veltman, Joris A/F-5128-2010; arts, heleen/ACL-6040-2022; Oud, Machteld/P-6939-2015; Roepman, Ronald/B-1339-2014; Steenbergen, H.J./L-4669-2015; Pfundt, Rolph/L-4576-2015; Hoischen, Alexander/AGF-7293-2022; Gilissen, Christian/E-5246-2012; Oud, Machteld/S-9062-2019; Sanders, Jan-Stephan/ABC-6782-2021; Hoischen, Alexander/D-1282-2013; Jeanpierre, cecile/H-3770-2017; Bredrup, Cecilie/GPK-4303-2022; Matignon, Marie B/Q-8091-2018; Leh, Sabine/E-6053-2011; Saunier, Sophie/G-6044-2015	Veltman, Joris A/0000-0002-3218-8250; Oud, Machteld/0000-0003-4864-9346; Roepman, Ronald/0000-0002-5178-8163; Hoischen, Alexander/0000-0002-8072-4476; Gilissen, Christian/0000-0003-1693-9699; Hoischen, Alexander/0000-0002-8072-4476; Jeanpierre, cecile/0000-0002-3463-5907; Leh, Sabine/0000-0002-0764-2941; Saunier, Sophie/0000-0002-1069-0047; Sanders, Jan-Stephan/0000-0002-0904-3969; Arts, Heleen/0000-0002-9860-3744	Dutch Kidney Foundation [KJPB09.009, IP11.58]; European Community [241955]; Fondation pour la Recherche Medicale (FRM) [DEQ20071210558]; Agence National de la Recherche [RPV11012KK]; Netherlands Organization for Scientific Research (NWO) [Vidi-91786396]; Western Norway Regional Health Authority [911466, 911688]	Dutch Kidney Foundation; European Community(European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence National de la Recherche(French National Research Agency (ANR)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Western Norway Regional Health Authority	We thank the families with Sensenbrenner and Jeune syndromes and nephronophthisis for their participation in this study. We thank H.G. Brunner, K. Rosendahl, E.M.H.F. Bongers, M.C. Gubler, N. Aitsahlia, and C.M.A. van Ravenswaaij for useful discussions and communications and B. Kjersem, T. Peters, C. Arrondel, N. Prince, C. Masson, M. Zarhrate, and S. Pruvost for technical assistance. We also thank P.L. Beales, J. de Vries, J.L. Yntema, and A.F.M. Hoogeboom and other clinicians for supplying additional patients with Sensenbrenner and Jeune syndromes. This study was supported by grants from the Dutch Kidney Foundation (KJPB09.009 and IP11.58 to H.H.A.), the European Community's Seventh Framework Programme FP7/2009 under grant agreement number 241955, SYSCILIA (to R.R.), grants from the Fondation pour la Recherche Medicale (FRM DEQ20071210558 to S.S.), the Agence National de la Recherche (grant RPV11012KK to S.S.), a grant from the Netherlands Organization for Scientific Research (NWO Vidi-91786396; to R.R.), and grants from the Western Norway Regional Health Authority (911466 and 911688 to C.B.). None of the authors have any conflicts of interests.	*1000 GEN, 1000 GEN PROJ; Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Amar MJA, 1997, AM J MED GENET, V70, P349, DOI 10.1002/(SICI)1096-8628(19970627)70:4<349::AID-AJMG3>3.0.CO;2-O; [Anonymous], IGV BROWSER; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; Borgstrom MK, 1996, J ORAL PATHOL MED, V25, P86, DOI 10.1111/j.1600-0714.1996.tb00198.x; Cavalcanti DP, 2011, J MED GENET, V48, P88, DOI 10.1136/jmg.2009.069468; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 2009, CELL, V137, P784, DOI 10.1016/j.cell.2009.04.053; Hanemann JA, 2010, J ORAL MAXIL SURG, V68, P456, DOI 10.1016/j.joms.2009.07.026; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; de Vries J, 2010, EUR J PEDIATR, V169, P77, DOI 10.1007/s00431-009-0991-3; Fry AE, 2009, AM J MED GENET A, V149A, P2212, DOI 10.1002/ajmg.a.33027; Gascue C, 2011, PEDIATR NEPHROL, V26, P1181, DOI 10.1007/s00467-010-1697-5; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Ho NC, 2000, AM J MED GENET, V90, P310, DOI 10.1002/(SICI)1096-8628(20000214)90:4<310::AID-AJMG9>3.0.CO;2-N; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Hurd TW, 2011, NEPHRON EXP NEPHROL, V118, pE9, DOI 10.1159/000320888; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; JEUNE M, 1955, Arch Fr Pediatr, V12, P886; Ko HW, 2009, METHOD CELL BIOL, V93, P347, DOI 10.1016/S0091-679X(08)93017-X; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Machuca E, 2009, KIDNEY INT, V75, P727, DOI 10.1038/ki.2008.650; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Ohazama A, 2009, DEVELOPMENT, V136, P897, DOI 10.1242/dev.027979; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Sensenbrenner J A, 1975, Birth Defects Orig Artic Ser, V11, P372; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Thivichon-Prince B, 2009, J DENT RES, V88, P910, DOI 10.1177/0022034509345822; Tonna SJ, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-13; ucsc, UCSC GEN BROWS; Venugopalan SR, 2011, J BIOL CHEM, V286, P21372, DOI 10.1074/jbc.M111.252031; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; YOUNG ID, 1989, J MED GENET, V26, P393, DOI 10.1136/jmg.26.6.393; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	47	151	153	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					634	643		10.1016/j.ajhg.2011.10.001	http://dx.doi.org/10.1016/j.ajhg.2011.10.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	22019273	Green Published, Bronze			2022-12-18	WOS:000297090100005
J	Browning, SR; Browning, BL				Browning, Sharon R.; Browning, Brian L.			High-Resolution Detection of Identity by Descent in Unrelated Individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; EXTENDED PEDIGREES; WIDE ASSOCIATION; HOMOZYGOSITY; SEGMENTS; MODEL	Detection of recent identity by descent (IBD) in population samples is important for population-based linkage mapping and for highly accurate genotype imputation and haplotype-phase inference. We present a method for detection of recent IBD in population samples. Our method accounts for linkage disequilibrium between SNPs to enable full use of high-density SNP data. We find that our method can detect segments of a length of 2 cM with moderate power and negligible false discovery rate in II lumina 550K data in Northwestern Europeans. We compare our method with GERMLINE and PUNK, and we show that our method has a level of resolution that is significantly better than these existing methods, thus extending the usefulness of recent IBD in analysis of high-density SNP data. We survey four genomic regions in a sample of UK individuals of European descent and find that on average, at a given location, our method detects IBD in 2.7 per 10,000 pairs of individuals in II lumina 550K data. We also present methodology and results for detection of homozygosity by descent (HBD) and survey the whole genome in a sample of 1373 UK individuals of European descent. We detect HBD in 4.7 individuals per 10,000 on average at a given location. Our methodology is implemented in the freely available BEAGLE software package.	[Browning, Sharon R.; Browning, Brian L.] Univ Auckland, Dept Stat, Auckland 1, New Zealand	University of Auckland	Browning, SR (corresponding author), Univ Auckland, Dept Stat, Auckland 1, New Zealand.	s.browning@auckland.ac.nz	Browning, Sharon/B-1530-2008; Browning, Brian L/A-1178-2010	Browning, Sharon/0000-0001-7251-9715; Browning, Brian L/0000-0001-6454-6633	Wellcome Trust [076113]; New Zealand Marsden Fund [07-U0A-175]; National Institutes of Health (NIH) [R01GM075091, R01HG004960]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005701, R01HG004960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075091] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study makes use of data generated by the Wellcome Trust Case Control Consortium and the Wellcome Trust Sanger Institute. The Illumina 550K genotype data for individuals in the 1958 British Birth Cohort was generated by the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the Wellcome Trust Case Control Consortium data is available from www.wtccc.org.uk. Funding for the Wellcome Trust Case Control Consortium project was provided by the Wellcome Trust under award 076113.; This work was supported by New Zealand Marsden Fund award 07-U0A-175 and by National Institutes of Health (NIH) awards R01GM075091 and R01HG004960. The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, the New Zealand Marsden Fund, or the Wellcome Trust.	Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Albrechtsen A, 2009, GENET EPIDEMIOL, V33, P266, DOI 10.1002/gepi.20378; Baum L.E., 1972, P 3 S INE, P1; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Browning SR, 2008, GENETICS, V178, P2123, DOI 10.1534/genetics.107.084624; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Leibon G, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1340; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Miyazawa H, 2007, AM J HUM GENET, V80, P1090, DOI 10.1086/518176; Nelson S, 2006, ANN M AM SOC HUM GEN; NELSON S, 2005, ANN M AM SOC HUM GEN; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; TEMEERMAN GJ, 1995, CLIN EXP ALLERGY, V25, P97; Thomas A, 2008, ANN HUM GENET, V72, P279, DOI 10.1111/j.1469-1809.2007.00406.x; Thompson EA, 2008, 539 U WASH DEP STAT; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S	28	151	156	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					526	539		10.1016/j.ajhg.2010.02.021	http://dx.doi.org/10.1016/j.ajhg.2010.02.021			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20303063	Green Published, Bronze			2022-12-18	WOS:000276716800003
J	Loges, NT; Olbrich, H; Becker-Heck, A; Haffner, K; Heer, A; Reinhard, C; Schmidts, M; Kispert, A; Zariwal, MA; Leigh, MW; Knowles, MR; Zentgraf, H; Seithe, H; Nurnberg, G; Nurnberg, P; Reinhardt, R; Omran, H				Loges, Niki Tomas; Olbrich, Heike; Becker-Heck, Anita; Haeffner, Karsten; Heer, Angelina; Reinhard, Christina; Schmidts, Miriam; Kispert, Andreas; Zariwal, Maimoona A.; Leigh, Margaret W.; Knowles, Michael R.; Zentgraf, Hanswalter; Seithe, Horst; Nuernberg, Gudrun; Nuernberg, Peter; Reinhardt, Richard; Omran, Heymut			Deletions and Point Mutations of LRRC50 Cause Primary Ciliary Dyskinesia Due to Dynein Arm Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KUPFFERS VESICLE; PROSTATE-CANCER; ASYMMETRY; DISEASE; PROTEIN; FLOW; RANDOMIZATION; MECHANISM; BRAIN; FLUID	Genetic defects affecting motility of cilia and flagella cause chronic destructive airway disease, randomization of left-right body asymmetry, and, frequently, male infertility in primary ciliary dyskinesia (PCD). The most frequent defects involve outer and inner dynein arms (ODAs and IDAs) that are large multiprotein complexes responsible for cilia-beat generation and regulation, respectively. Here, we demonstrate that large genomic deletions, as well as point mutations involving LRRC50, are responsible for a distinct PCD variant that is characterized by a combined defect involving assembly of the ODAs and IDAs. Functional analyses showed that LRRC50 deficiency disrupts assembly of distally and proximally DNAHS- and DNA12-containing ODA complexes, as well as DNALI1-containing IDA complexes, resulting in immotile cilia. On the basis of these findings, we assume that LRRC50 plays a role in assembly of distinct dynein-arm complexes.	[Loges, Niki Tomas; Olbrich, Heike; Becker-Heck, Anita; Haeffner, Karsten; Heer, Angelina; Reinhard, Christina; Schmidts, Miriam; Omran, Heymut] Univ Hosp, Dept Paediat & Adolescent Med, D-79106 Freiburg, Germany; [Loges, Niki Tomas; Becker-Heck, Anita] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; [Zariwal, Maimoona A.] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [Leigh, Margaret W.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Knowles, Michael R.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Zentgraf, Hanswalter] German Canc Res Ctr, Dept Tumor Virol, D-69120 Heidelberg, Germany; [Seithe, Horst] Klinikum Nurnberg Sud, Zentrum Neugeborene Kinder & Jugendl, D-90471 Nurnberg, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Cologne Ctr Genom, D-50674 Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Inst Genet, D-50674 Cologne, Germany; [Nuernberg, Peter] Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Loges, Niki Tomas; Olbrich, Heike; Omran, Heymut] Univ Klinikum Munster, KIin & Poliklin Kinder & Jugendmed Allgemeine Pad, D-48149 Munster, Germany	University of Freiburg; University of Freiburg; Hannover Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; University of Munster	Omran, H (corresponding author), Univ Hosp, Dept Paediat & Adolescent Med, D-79106 Freiburg, Germany.	heymut.omran@uniklinik-freiburg.de	Schmidts, Miriam/A-3777-2012	Schmidts, Miriam/0000-0002-1714-6749; Reinhardt, Richard/0000-0001-9376-2132; Omran, Heymut/0000-0003-0282-6765	Deutsche Forschungsgemeinschaft (DFG) [Om 6/4, GRK1104, SF13592]; U.S. National Heart, Lung and Blood Institute and the National Institutes of Health (NIH) [GCRC 00046, R01 HL071798]; U.S. National Center for Research Resources and the NIH [5 U54 RR019480]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019480] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071798] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); U.S. National Heart, Lung and Blood Institute and the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. National Center for Research Resources and the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to the patients and their families for their participation in this study. We thank the German patient Support group Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V. and the U.S. PCD Foundation. We thank Carmen Kopp, Karin Sutter, Marianne Petry, Christian Muck, Claudia Tessmer, Theresia de Ledezina, and Susanne Franz for excellent technical assistance. We also thank Peadar Noone, Marcus Kennedy, Johnny Carson, Milan Hazucha, Susan Minnix, Kim Burns, Lucy Morgan, Robbert De Iongand, Sharon Dell, and Tom Ferkol for evaluation of PCD patients. This work was Supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (Om 6/4, GRK1104, BIOSS, and SF13592; to H.O.), grants from the U.S. National Heart, Lung and Blood Institute and the National Institutes of Health (NIH) (GCRC 00046 and R01 HL071798), and a grant from the 5 U54 RR019480 from the U.S. National Center for Research Resources and the NIH (to M.R.K.).	Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Elo JP, 1999, BRIT J CANCER, V79, P156, DOI 10.1038/sj.bjc.6690025; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Freshour J, 2007, J BIOL CHEM, V282, P5404, DOI 10.1074/jbc.M607509200; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lange EM, 2009, PROSTATE, V69, P385, DOI 10.1002/pros.20891; Larsen M, 2000, MAMM GENOME, V11, P767, DOI 10.1007/s003350010135; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917	19	151	157	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					883	889		10.1016/j.ajhg.2009.10.018	http://dx.doi.org/10.1016/j.ajhg.2009.10.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	19944400	Green Published, Bronze			2022-12-18	WOS:000272797100011
J	Gilfillan, GD; Selmer, KK; Roxrud, I; Smith, R; Kyllerman, M; Eiklid, K; Kroken, M; Mattingsdal, M; Egeland, T; Stenmark, H; Sjoholm, H; Server, A; Samuelsson, L; Christianson, A; Tarpey, P; Whibley, A; Stratton, MR; Futreal, PA; Teague, J; Edkins, S; Gecz, J; Turner, G; Raymond, FL; Schwartz, C; Stevenson, RE; Undlien, DE; Stromme, P				Gilfillan, Gregor D.; Selmer, Kaja K.; Roxrud, Ingrid; Smith, Raffaella; Kyllerman, Marten; Eiklid, Kristin; Kroken, Mette; Mattingsdal, Morten; Egeland, Thore; Stenmark, Harald; Sjoholm, Hans; Server, Andres; Samuelsson, Lena; Christianson, Arnold; Tarpey, Patrick; Whibley, Annabel; Stratton, Michael R.; Futreal, P. Andrew; Teague, Jon; Edkins, Sarah; Gecz, Jozef; Turner, Gillian; Raymond, F. Lucy; Schwartz, Charles; Stevenson, Roger E.; Undlien, Dag E.; Stromme, Petter			SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NA+/H+ EXCHANGER ISOFORMS; RECYCLING ENDOSOMES; DIAGNOSTIC-CRITERIA; GENES; NHE1; IDENTIFICATION; PLASTICITY; LOCALIZES; CONSENSUS; MEMBRANE	Linkage analysis and DNA sequencing in a family exhibiting an X-linked mental retardation (XLMR) syndrome, characterized by microcephaly, epilepsy, ataxia, and absent speech and resembling Angelman syndrome, identified a deletion in the SLC9A6 gene encoding the Na+/H+ exchanger NHE6. Subsequently, other mutations were found in a male with mental retardation (MR) who had been investigated for Angelman syndrome and in two XLMR families with epilepsy and ataxia, including the family designated as having Christianson syndrome. Therefore, mutations in SLC9A6 cause X-linked mental retardation. Additionally, males with findings suggestive of unexplained Angelman syndrome should be considered as potential candidates for SLC9A6 mutations.	[Gilfillan, Gregor D.; Selmer, Kaja K.; Undlien, Dag E.; Stromme, Petter] Ullevaal Univ Hosp, Fac Div, Fac Med, NO-0316 Oslo, Norway; [Gilfillan, Gregor D.; Selmer, Kaja K.; Eiklid, Kristin; Kroken, Mette; Mattingsdal, Morten; Egeland, Thore; Undlien, Dag E.] Ullevaal Univ Hosp, Dept Med Genet, NO-0407 Oslo, Norway; [Roxrud, Ingrid; Stenmark, Harald] Ullevaal Univ Hosp, Rikshosp, Radium Hosp Med Ctr, Inst Canc Res,Dept Biochem, NO-0310 Oslo, Norway; [Smith, Raffaella; Tarpey, Patrick; Stratton, Michael R.; Futreal, P. Andrew; Teague, Jon; Edkins, Sarah] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; [Kyllerman, Marten] Gothenburg Univ, Queen Silvia Childrens Hosp, S-41685 Gothenburg, Sweden; [Sjoholm, Hans] Ullevaal Univ Hosp, Dept Neurol, Sect Neurophysiol, NO-0407 Oslo, Norway; [Server, Andres] Ullevaal Univ Hosp, Dept Neuroradiol, NO-0407 Oslo, Norway; [Samuelsson, Lena] Gothenburg Univ, Sahlgrens Univ Hosp, Dept Clin Genet, S-41685 Gothenburg, Sweden; [Christianson, Arnold] Univ Witwatersrand, ZA-2000 Johannesburg, South Africa; [Christianson, Arnold] Natl Hlth Lab Serv, Div Human Genet, ZA-2000 Johannesburg, South Africa; [Whibley, Annabel; Raymond, F. Lucy] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Gecz, Jozef] Womens & Childrens Hosp, Dept Med Genet, Neurogenet Lab, Adelaide, SA 5006, Australia; [Turner, Gillian] Hunter Genet & Univ Newcastle, Newcastle, NSW 2300, Australia; [Schwartz, Charles; Stevenson, Roger E.] Greenwood Genet Ctr, JC Self Res Inst Genet, Greenwood, SC 29646 USA; [Stromme, Petter] Ullevaal Univ Hosp, Dept Pediat, NO-0407 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Cambridge; Wellcome Trust Sanger Institute; Queen Silvia Children's Hospital; University of Gothenburg; University of Oslo; University of Oslo; Sahlgrenska University Hospital; University of Gothenburg; University of Witwatersrand; National Health Laboratory Service; University of Cambridge; Womens & Childrens Hospital Australia; University of Newcastle; Greenwood Genetic Center; University of Oslo	Stromme, P (corresponding author), Ullevaal Univ Hosp, Fac Div, Fac Med, NO-0316 Oslo, Norway.	petter.stromme@medisin.uio.no	Stenmark, Harald/B-8868-2008; Patterson, Marc/AAI-5056-2020; Patterson, Marc C./H-5331-2019; Gecz, Jozef/X-3469-2019; Whibley, Annabel/P-2509-2017; Gilfillan, Gregor/A-5630-2009; Whibley, Annabel/G-2836-2011; Gilfillan, Gregor Duncan/N-9541-2019; Mattingsdal, Morten/Q-9367-2016	Gecz, Jozef/0000-0002-7884-6861; Whibley, Annabel/0000-0003-1878-7705; Mattingsdal, Morten/0000-0003-4440-0324; Gilfillan, Gregor/0000-0001-8116-0134; Selmer, Kaja Kristine/0000-0003-4871-112X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031564] Funding Source: NIH RePORTER; NICHD NIH HHS [HD2606] Funding Source: Medline; NINDS NIH HHS [NS31564, R01 NS031564] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BELL SM, 2009, AM J PHYSIOL, V276, pC788; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Chiurazzi P, 2001, EUR J HUM GENET, V9, P71, DOI 10.1038/sj.ejhg.5200603; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; Christianson AL, 1999, J MED GENET, V36, P759, DOI 10.1136/jmg.36.10.759; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Clayton-Smith J, 2001, DEV MED CHILD NEUROL, V43, P476, DOI 10.1017/S0012162201000871; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Hou JW, 1998, J INTELL DISABIL RES, V42, P137, DOI 10.1046/j.1365-2788.1998.00104.x; Jedele Kerry Baldwin, 2007, Semin Pediatr Neurol, V14, P108, DOI 10.1016/j.spen.2007.07.002; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Laan LAEM, 1996, AM J MED GENET, V66, P356, DOI 10.1002/(SICI)1096-8628(19961218)66:3<356::AID-AJMG21>3.3.CO;2-U; Laan LAEM, 2005, BRAIN DEV-JPN, V27, P80, DOI 10.1016/j.braindev.2003.09.013; Laan LAEM, 1997, EPILEPSIA, V38, P195, DOI 10.1111/j.1528-1157.1997.tb01097.x; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Miyazaki E, 2001, J BIOL CHEM, V276, P49221, DOI 10.1074/jbc.M106267200; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Numata M, 1998, J BIOL CHEM, V273, P6951, DOI 10.1074/jbc.273.12.6951; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; PETERSEN MB, 1995, AM J MED GENET, V60, P261, DOI 10.1002/ajmg.1320600317; Simonsen A, 1998, EUR J CELL BIOL, V75, P223, DOI 10.1016/S0171-9335(98)80116-7; Stromme P, 2000, DEV MED CHILD NEUROL, V42, P76, DOI 10.1017/S0012162200000165; Thomson AK, 2006, DISABIL REHABIL, V28, P299, DOI 10.1080/09638280500190631; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Williams CA, 2001, AM J MED GENET, V101, P59, DOI 10.1002/ajmg.1316; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224	37	151	157	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					1003	1010		10.1016/j.ajhg.2008.01.013	http://dx.doi.org/10.1016/j.ajhg.2008.01.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18342287	Green Published, Bronze			2022-12-18	WOS:000255103900018
J	Zhang, W; Duan, S; Kistner, EO; Bleibel, WK; Huang, RS; Clark, TA; Chen, TX; Schweitzer, AC; Biume, JE; Cox, NJ; Dolan, ME				Zhang, Wei; Duan, Shiwei; Kistner, Emily O.; Bleibel, Wasim K.; Huang, R. Stephanie; Clark, Tyson A.; Chen, Tina X.; Schweitzer, Anthony C.; Biume, John E.; Cox, Nancy J.; Dolan, M. Eileen			Evaluation of genetic variation contributing to differences in gene expression between populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ETHNIC-DIFFERENCES; ONTO-TOOLS; DESIGN; CLUSTER	Gene expression is a complex quantitative trait partially regulated by genetic variation in DNA sequence. Population differences in gene expression could contribute to some of the observed differences in susceptibility to common diseases and response to drug treatments. We characterized gene expression in the full set of HapMap lymphoblastoid cell lines derived from individuals of European and African ancestry for 9156 transcript clusters (gene-level) evaluated with the Affymetrix GeneChip Human Exon 1.0 ST Array. Gene expression was found to differ significantly between these samples for 383 transcript clusters. Biological processes including ribosome biogenesis and antimicrobial humoral response were found to be enriched in these differential genes, suggesting their possible roles in contributing to the population differences at a higher level than that of mRNA expression and in response to environmental information. Genome-wide association studies for local or distant genetic variants that correlate with the differentially expressed genes enabled identification of significant associations with one or more single-nucleotide polymorphisms (SNPs), consistent with the hypothesis that genetic factors and not simply population identity or other characteristics (age of cell lines, length of culture, etc.) contribute to differences in gene expression in these samples. Our results provide a comprehensive view of the genes differentially expressed between populations and the enriched biological processes involved in these genes. We also provide an evaluation of the contributions of genetic variation and nongenetic factors to the population differences in gene expression.	[Zhang, Wei; Duan, Shiwei; Bleibel, Wasim K.; Huang, R. Stephanie; Cox, Nancy J.; Dolan, M. Eileen] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kistner, Emily O.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Clark, Tyson A.; Chen, Tina X.; Schweitzer, Anthony C.; Biume, John E.] Affymetrix Lab, Express Res, Santa Clara, CA 95051 USA	University of Chicago; University of Chicago; University of Chicago; Affymetrix	Dolan, ME (corresponding author), Univ Chicago, Dept Med, Chicago, IL 60637 USA.	edolan@medicinie.bsd.uchicago.edu	Duan, Shiwei/AAA-4782-2022; Duan, Shiwei/J-9633-2012; Pillay, Nischalan/F-9536-2012	Duan, Shiwei/0000-0001-7682-2877; Blume, John/0000-0003-3026-953X; Clark, Tyson/0000-0002-7779-3227; Huang, R. Stephanie/0000-0002-9862-0368	NIGMS NIH HHS [GM61393, U01 GM061374, R24 GM061374, U01 GM061393, GM61374] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; *AFF INC, 2007, HUM GEN 1 0 ST ARR P; Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowen RL, 2006, PHARMACOGENOMICS, V7, P935, DOI 10.2217/14622416.7.6.935; Calvo E, 2006, J CLIN ONCOL, V24, P2158, DOI 10.1200/JCO.2006.06.5961; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, COLD SPRING HARB SYM, V68, P403, DOI 10.1101/sqb.2003.68.403; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FALKNER B, 1990, HYPERTENSION, V15, P681, DOI 10.1161/01.HYP.15.6.681; Forton JT, 2006, BIOESSAYS, V28, P968, DOI 10.1002/bies.20466; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ghai R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-348; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Huang RS, 2007, MOL CANCER THER, V6, P31, DOI 10.1158/1535-7163.MCT-06-0591; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jordan WJ, 2005, GENES IMMUN, V6, P632, DOI 10.1038/sj.gene.6364239; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Khatri P, 2004, NUCLEIC ACIDS RES, V32, pW449, DOI 10.1093/nar/gkh409; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; NOBLE RC, 1980, BRIT J VENER DIS, V56, P26; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Westfall P.H., 1993, RESAMPLING BASED MUL; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0	44	151	160	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					631	640		10.1016/j.ajhg.2007.12.015	http://dx.doi.org/10.1016/j.ajhg.2007.12.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18313023	Green Published, Bronze			2022-12-18	WOS:000254067800008
J	Lemmers, RJLF; Wohlgemuth, M; van der Gaag, KJ; van der Vliet, PJ; van Teijlingen, CMM; de Knijff, P; Padberg, GW; Frants, RR; van der Maarel, SM				Lemmers, Richard J. L. F.; Wohlgemuth, Marielle; van der Gaag, Kristiaan J.; van der Vliet, Patrick J.; van Teijlingen, Corrie M. M.; de Knijff, Peter; Padberg, George W.; Frants, Rune R.; van der Maarel, Silvere M.			Specific sequence variations within the 4q35 region are associated with Facioscapulohumeral muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA REARRANGEMENTS; FSHD; D4Z4; LOCUS; GENE; EXPRESSION; MUSCLE	Autosomal dominant facioscapulohumeral muscular dystrophy ( FSHD) is mainly characterized by progressive wasting and weakness of the facial, shoulder, and upper-arm muscles. FSHD is caused by contraction of the macrosatellite repeat D4Z4 on chromosome 4q35. The D4Z4 repeat is very polymorphic in length, and D4Z4 rearrangements occur almost exclusively via intrachromosomal gene conversions. Several disease mechanisms have been proposed, but none of these models can comprehensively explain FSHD, because repeat contraction alone is not sufficient to cause disease. Almost-identical D4Z4-repeat arrays have been identified on chromosome 10q26 and on two equally common chromosome 4 variants, 4qA and 4qB. Yet only repeat contractions of D4Z4 on chromosome 4qA cause FSHD; contractions on the other chromosomes are nonpathogenic. We hypothesized that allele-specific sequence differences among 4qA, 4qB, and 10q alleles underlie the 4qA specificity of FSHD. Sequence variations between these alleles have been described before, but the extent and significance of these variations proximal to, within, and distal to D4Z4 have not been studied in detail. We examined additional sequence variations in the FSHD locus, including a relatively stable simple sequence-length polymorphism proximal to D4Z4, a single-nucleotide polymorphism ( SNP) within D4Z4, and the A/B variation distal to D4Z4. On the basis of these polymorphisms, we demonstrate that the subtelomeric domain of chromosome 4q can be subdivided into nine distinct haplotypes, of which three carry the distal 4qA variation. Interestingly, we show that repeat contractions in two of the nine haplotypes, one of which is a 4qA haplotype, are not associated with FSHD. We also show that each of these haplotypes has its unique sequence signature, and we propose that specific SNPs in the disease haplotype are essential for the development of FSHD.	Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; Univ Med Ctr Nijmegen, Dept Neurol, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human & Clin Genet, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	maarel@lumc.nl	Padberg, G.W.A.M./H-8079-2014; de Knijff, Peter/Y-2519-2018; van der Maarel, Silvere/X-3631-2018	de Knijff, Peter/0000-0002-0899-771X; van der Maarel, Silvere/0000-0001-8103-711X; van der Gaag, Kristiaan/0000-0001-7976-1977				Alexiadis V, 2007, BBA-GENE STRUCT EXPR, V1769, P29, DOI 10.1016/j.bbaexp.2006.11.006; BAKKER E, 1995, MUSCLE NERVE, pS39; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2004, AM J HUM GENET, V75, P44, DOI 10.1086/422175; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lernmers RJLF, 2001, ANN NEUROL, V50, P816, DOI 10.1002/ana.10057; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; Padberg GW, 1982, FACIOSCAPULOHUMERAL; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wohlgemuth M, 2003, NEUROLOGY, V61, P909, DOI 10.1212/WNL.61.7.909	23	151	158	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					884	894		10.1086/521986	http://dx.doi.org/10.1086/521986			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924332	Bronze, Green Published			2022-12-18	WOS:000250480900002
J	Zweier, C; Sticht, H; Aydin-Yaylagul, I; Campbell, CE; Rauch, A				Zweier, Christiane; Sticht, Heinrich; Aydin-Yaylaguel, Inci; Campbell, Christine E.; Rauch, Anita			Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACIAL SYNDROME/DIGEORGE-SYNDROME; DIGEORGE-SYNDROME; TRANSCRIPTION FACTOR; PROTEIN STRUCTURES; CHROMOSOME 22Q11; GENE; DEFECTS; MICRODUPLICATION; DISORDERS; SPECTRUM	Deletion 22q11.2 syndrome is the most frequent known microdeletion syndrome and is associated with a highly variable phenotype, including DiGeorge and Shprintzen (velocardiofacial) syndromes. Although haploinsufficiency of the T-box transcription factor gene TBX1 is thought to cause the phenotype, to date, only four different point mutations in TBX1 have been reported in association with six of the major features of 22q11.2 deletion syndrome. Although, for the two truncating mutations, loss of function was previously shown, the pathomechanism of the missense mutations remains unknown. We report a novel heterozygous missense mutation, H194Q, in a familial case of Shprintzen syndrome and show that this and the two previously reported missense mutations result in gain of function, possibly through stabilization of the protein dimer DNA complex. We therefore conclude that TBX1 gain-of-function mutations can result in the same phenotypic spectrum as haploinsufficiency caused by loss-of-function mutations or deletions.	Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Dept Bioinformat, Inst Biochem, D-91054 Erlangen, Germany; SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	University of Erlangen Nuremberg; University of Erlangen Nuremberg; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Rauch, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Schwabachanlage 10, D-91054 Erlangen, Germany.	anita.rauch@humgenet.uni-erlangen.de	Zweier, Christiane/F-2202-2015; Rauch, Anita/C-5568-2014	Zweier, Christiane/0000-0001-8002-2020; Rauch, Anita/0000-0003-2930-3163; Sticht, Heinrich/0000-0001-5644-045X	NIDDK NIH HHS [R01 DK048796, DK48796] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048796] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baldini A, 2005, CURR OPIN GENET DEV, V15, P279, DOI 10.1016/j.gde.2005.03.001; Chieffo C, 1997, GENOMICS, V43, P267, DOI 10.1006/geno.1997.4829; Coll M, 2002, STRUCTURE, V10, P343, DOI 10.1016/S0969-2126(02)00722-0; Conti E, 2003, EUR J HUM GENET, V11, P349, DOI 10.1038/sj.ejhg.5200956; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Funke B, 2001, HUM MOL GENET, V10, P2549, DOI 10.1093/hmg/10.22.2549; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; GOTHELF D, 2006, INT J NEUROPSYCHOPH, V31, P1; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Plageman TF, 2005, DEV DYNAM, V232, P11, DOI 10.1002/dvdy.20201; Portnoi MF, 2005, AM J MED GENET A, V137A, P47, DOI 10.1002/ajmg.a.30847; Rauch A, 2005, J MED GENET, V42, P871, DOI 10.1136/jmg.2004.030619; Rauch A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010975; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Shashi V, 2006, CLIN GENET, V69, P234, DOI 10.1111/j.1399-0004.2006.00569.x; SHPRINTZEN RJ, 1981, PEDIATRICS, V67, P167; Sinha S, 2000, GENE, V258, P15, DOI 10.1016/S0378-1119(00)00417-0; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Stoller JZ, 2005, HUM MOL GENET, V14, P885, DOI 10.1093/hmg/ddi081; Thiel CT, 2003, EUR J HUM GENET, V11, P170, DOI 10.1038/sj.ejhg.5200920; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilson D. I., 1994, American Journal of Human Genetics, V55, pA169; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yobb TM, 2005, AM J HUM GENET, V76, P865, DOI 10.1086/429841	36	151	159	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					510	517		10.1086/511993	http://dx.doi.org/10.1086/511993			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273972	Green Published, Bronze			2022-12-18	WOS:000244403300012
J	Feng, Y; Niu, TH; Xing, HX; Xu, X; Chen, CZ; Peng, SJ; Wang, LH; Laird, N; Xu, XP				Feng, Y; Niu, TH; Xing, HX; Xu, X; Chen, CZ; Peng, SJ; Wang, LH; Laird, N; Xu, XP			A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FAMILY-BASED TESTS; SMOKING INITIATION; CHRNA4; DEPENDENCE; DISORDER; MUTATION; MECHANISMS; REVISION; BEHAVIOR	Nicotine is the major addictive substance in cigarettes, and genes involved in sensing nicotine are logical candidates for vulnerability to nicotine addiction. We studied six single-nucleotide polymorphisms (SNPs) in the CHRNA4 gene and four SNPs in the CHRNB2 gene with respect to nicotine dependence in a collection of 901 subjects (815 siblings and 86 parents) from 222 nuclear families with multiple nicotine-addicted siblings. The subjects were assessed for addiction by both the Fagerstrom Test for Nicotine Dependence (FTND) and the Revised Tolerance Questionnaire (RTQ). Because only 5.8% of female offspring were smokers, only male subjects were included in the final analyses ( 621 men from 206 families). Univariate (single-marker) family-based association tests (FBATs) demonstrated that variant alleles at two SNPs, rs1044396 and rs1044397, in exon 5 of the CHRNA4 gene were significantly associated with a protective effect against nicotine addiction as either a dichotomized trait or a quantitative phenotype (i.e., age-adjusted FTND and RTQ scores), which was consistent with the results of the global haplotype FBAT. Furthermore, the haplotype-specific FBAT showed a common (22.5%) CHRNA4 haplotype, GCTATA, which was significantly associated with both a protective effect against nicotine addiction as a dichotomized trait (Z = -3.04, P < .005) and significant decreases of age-adjusted FTND (Z = -3.31, P < .005) or RTQ scores (Z = -2.73, P = .006). Our findings provide strong evidence suggesting a common CHRNA4 haplotype might be protective against vulnerability to nicotine addiction in men.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Peking Univ, Hlth Sci Ctr, Ctr Ecogenet & Reprod Hlth, Beijing 100871, Peoples R China; Anhui Med Univ, Anhui Inst Biomed, Hefei, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Peking University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Niu, TH (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	tniu@hsph.harvard.edu	Xu, Xin/A-1687-2016	Xu, Xin/0000-0002-6324-5211	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012905] Funding Source: NIH RePORTER; NIDA NIH HHS [1R01 DA12905] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Batra V, 2003, CHEST, V123, P1730, DOI 10.1378/chest.123.5.1730; Bergen AW, 1999, JNCI-J NATL CANCER I, V91, P1365, DOI 10.1093/jnci/91.16.1365; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; BRIONI JD, 1993, EUR J PHARMACOL, V238, P1, DOI 10.1016/0014-2999(93)90498-7; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Chioza B, 2000, AM J MED GENET, V96, P814, DOI 10.1002/1096-8628(20001204)96:6<814::AID-AJMG24>3.0.CO;2-M; Chou IC, 2003, EPILEPSIA, V44, P1089, DOI 10.1046/j.1528-1157.2003.t01-1-44702.x; Dani JA, 2001, PHARMACOL BIOCHEM BE, V70, P439, DOI 10.1016/S0091-3057(01)00652-9; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; FAGERSTROM K O, 1990, Ear Nose and Throat Journal, V69, P763; FAGERSTROM KO, 1978, ADDICT BEHAV, V3, P235, DOI 10.1016/0306-4603(78)90024-2; Faraday M M, 1999, Nicotine Tob Res, V1, P143, DOI 10.1080/14622299050011251; Fenster CP, 1999, ANN NY ACAD SCI, V868, P620, DOI 10.1111/j.1749-6632.1999.tb11335.x; GILBERT DG, 1989, PSYCHOPHYSIOLOGY, V26, P311, DOI 10.1111/j.1469-8986.1989.tb01924.x; Hao K, 2002, BIOTECHNIQUES, V33, P822, DOI 10.2144/02334st06; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hirose S, 1999, NEUROLOGY, V53, P1749, DOI 10.1212/WNL.53.8.1749; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kawamata J, 2002, J ALZHEIMERS DIS, V4, P71, DOI 10.3233/JAD-2002-4201; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; Kent L, 2001, PSYCHIATR GENET, V11, P37, DOI 10.1097/00041444-200103000-00007; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Leckman JF, 2001, AM J MED GENET, V105, P28, DOI 10.1002/1096-8628(20010108)105:1<28::AID-AJMG1050>3.3.CO;2-#; LEWONTIN RC, 1964, GENETICS, V49, P49; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Lueders Kira K, 2002, Nicotine Tob Res, V4, P115, DOI 10.1080/14622200110098419; Lueders KK, 1999, MAMM GENOME, V10, P900, DOI 10.1007/s003359901111; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Mathieu-Kia AM, 2002, PSYCHOPHARMACOLOGY, V162, P102, DOI 10.1007/s00213-002-1096-0; Nair A K, 2000, J Okla State Med Assoc, V93, P245; Niu T, 2001, HUM HERED, V52, P102, DOI 10.1159/000053361; Niu TH, 2000, INT J EPIDEMIOL, V29, P248, DOI 10.1093/ije/29.2.248; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Perkins K A, 1999, Nicotine Tob Res, V1, P301, DOI 10.1080/14622299050011431; Perry WL, 2002, BIOTECHNIQUES, V33, P1318; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; POMERLEAU OF, 1986, PSYCHOPHARMACOL BULL, V22, P865; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rempel N, 1998, HUM GENET, V103, P645, DOI 10.1007/s004390050885; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; Rowe DC, 2001, MOL PSYCHIATR, V6, P429, DOI 10.1038/sj.mp.4000874; Rozycka A, 2003, EPILEPSIA, V44, P1113, DOI 10.1046/j.1528-1157.2003.07603.x; Silverman MA, 2000, AM J MED GENET, V96, P646, DOI 10.1002/1096-8628(20001009)96:5<646::AID-AJMG10>3.3.CO;2-N; Steinlein O, 1996, GENOMICS, V32, P289, DOI 10.1006/geno.1996.0119; STEINLEIN O, 1994, GENOMICS, V22, P493, DOI 10.1006/geno.1994.1420; Steinlein OK, 2000, EPILEPSIA, V41, P529, DOI 10.1111/j.1528-1157.2000.tb00205.x; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; Straub RE, 1999, MOL PSYCHIATR, V4, P129, DOI 10.1038/sj.mp.4000518; Swan G E, 1999, Nicotine Tob Res, V1 Suppl 1, pS49; TATE JC, 1993, ADDICT BEHAV, V18, P135, DOI 10.1016/0306-4603(93)90043-9; Todd RD, 2003, MOL PSYCHIATR, V8, P103, DOI 10.1038/sj.mp.4001257; Watanabe H, 1998, EUR J NEUROSCI, V10, P2244, DOI 10.1046/j.1460-9568.1998.00235.x; Whiteaker P, 1998, MOL PHARMACOL, V53, P950; World Health Organization, 1997, TOB HLTH GLOB STAT R; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	61	151	157	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					112	121		10.1086/422194	http://dx.doi.org/10.1086/422194			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	829FG	15154117	Green Published			2022-12-18	WOS:000222031300014
J	Zimprich, A; Muller-Myhsok, B; Farrer, M; Leitner, P; Sharma, M; Hulihan, M; Lockhart, P; Strongosky, A; Kachergus, J; Calne, DB; Stoessl, J; Uitti, RJ; Pfeiffer, RF; Trenkwalder, C; Homann, N; Ott, E; Wenzel, K; Asmus, F; Hardy, J; Wszolek, Z; Gasser, T				Zimprich, A; Muller-Myhsok, B; Farrer, M; Leitner, P; Sharma, M; Hulihan, M; Lockhart, P; Strongosky, A; Kachergus, J; Calne, DB; Stoessl, J; Uitti, RJ; Pfeiffer, RF; Trenkwalder, C; Homann, N; Ott, E; Wenzel, K; Asmus, F; Hardy, J; Wszolek, Z; Gasser, T			The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE JUVENILE PARKINSONISM; ALPHA-SYNUCLEIN; LEWY BODIES; TAU-SYNUCLEIN; GENE; MUTATIONS; FAMILY; PROTEIN; BRAIN; ONSET	Recently, a new locus (PARK8) for autosomal dominant parkinsonism has been identified in one large Japanese family. Linkage has been shown to a 16-cM centromeric region of chromosome 12, between markers D12S1631 and D12S339. We tested 21 white families with Parkinson disease and an inheritance pattern compatible with autosomal dominant transmission for linkage in this region. Criteria for inclusion were at least three affected individuals in more than one generation. A total of 29 markers were used to saturate the candidate region. One hundred sixty-seven family members were tested ( 84 affected and 83 unaffected). Under the assumption of heterogeneity and through use of an affecteds- only model, a maximum multipoint LOD score of 2.01 was achieved in the total sample, with an estimated proportion of families with linkage of 0.32. This LOD score is significant for linkage in a replication study and corresponds to a P value of .0047. Two families ( family A [ German Canadian] and family D [ from western Nebraska]) reached significant linkage on their own, with a combined maximum multipoint LOD score of 3.33, calculated with an affecteds- only model (family A: LOD score 1.67; P =.0028 family D: LOD score 1.67, P = .0028). When a penetrance-dependent model was calculated, the combined multipoint LOD score achieved was 3.92 (family A: LOD score 1.68, P = .0027; family D: LOD score 2.24, P =.0007). On the basis of the multipoint analysis for the combined families A and D, the 1-LOD support interval suggests that the most likely disease location is between a CA repeat polymorphism on genomic clone AC025253 (44.5 Mb) and marker D12S1701 (47.7 Mb). Our data provide evidence that the PARK8 locus is responsible for the disease in a subset of families of white ancestry with autosomal dominant parkinsonism, suggesting that it could be a more common locus.	Univ Tubingen, Dept Neurodegenerat Disorders, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; Max Planck Inst Psychiat, D-80804 Munich, Germany; Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL 32224 USA; Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; Univ Hosp, Pacific Parkinsons Res Ctr, Vancouver, BC, Canada; Univ British Columbia, Dept Neurol, Vancouver, BC V5Z 1M9, Canada; Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA; Univ Goettingen, Dept Clin Neurophysiol, Gottingen, Germany; Karl Franzens Univ Graz, Univ Hosp Graz, Dept Neurol, Graz, Austria; NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Mayo Clinic; Mayo Clinic; University of British Columbia; University of British Columbia; University of Tennessee System; University of Tennessee Health Science Center; University of Gottingen; University of Graz; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Gasser, T (corresponding author), Univ Tubingen, Dept Neurodegenerat Disorders, Hertie Inst Clin Brain Res, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	Thomas.Gasser@med.uni-tuebingen.de	Hardy, John/C-2451-2009; Zimprich, Alexander/A-5232-2017; Müller-Myhsok, Bertram/A-3289-2013; Stoessl, A Jon/J-9661-2015; Sharma, Manu/AAX-2594-2020; Wszolek, Zbigniew K./AAB-1431-2019; Trenkwalder, Claudia/ABD-6559-2021; Gasser, Thomas/GNH-5293-2022; Trenkwalder, Claudia/AHD-1232-2022; Lockhart, Paul J/E-7753-2011	Hardy, John/0000-0002-3122-0423; Zimprich, Alexander/0000-0002-1668-5177; Stoessl, A Jon/0000-0002-9778-7246; Gasser, Thomas/0000-0002-1069-1146; Trenkwalder, Claudia/0000-0001-6407-1199; Lockhart, Paul J/0000-0003-2531-8413; Farrer, Matthew/0000-0003-1159-5321	NINDS NIH HHS [NS 40256, P50 NS040256, P01 NS040256] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040256, P50NS040256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000952] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bugiani O, 2000, MICROSC RES TECHNIQ, V50, P10, DOI 10.1002/1097-0029(20000701)50:1<10::AID-JEMT3>3.3.CO;2-Y; CALNE DB, 1992, ANN NEUROL S, V32, P125; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Denson M A, 1995, Parkinsonism Relat Disord, V1, P35, DOI 10.1016/1353-8020(95)00010-4; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; DeStefano AL, 2001, NEUROLOGY, V57, P1124, DOI 10.1212/WNL.57.6.1124; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gasser T, 1997, SCIENCE, V277, P388; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Ghetti B., 2003, NEURODEGENERATION MO; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; Ishikawa A, 1998, J NEUROL, V245, pP4, DOI 10.1007/PL00007745; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANTOS PL, 1994, NEUROSCI LETT, V172, P77, DOI 10.1016/0304-3940(94)90666-1; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Maraganore DM, 1999, NEUROLOGY, V53, P1858, DOI 10.1212/WNL.53.8.1858; Morales B, 2002, MOVEMENT DISORD, V17, P1374, DOI 10.1002/mds.10264; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Neumann M, 2000, ACTA NEUROPATHOL, V100, P568, DOI 10.1007/s004010000224; Pankratz N, 2002, AM J HUM GENET, V71, P124, DOI 10.1086/341282; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Scott WK, 2000, AM J HUM GENET, V66, P922, DOI 10.1086/302828; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Simard M, 2001, INT J GERIATR PSYCH, V16, P311; Skipper L, 2002, NEUROTOXICOLOGY, V23, P503, DOI 10.1016/S0161-813X(02)00038-4; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; van de Warrenburg BPC, 2001, NEUROLOGY, V56, P555, DOI 10.1212/WNL.56.4.555; Wszolek Z K, 1997, Parkinsonism Relat Disord, V3, P125, DOI 10.1016/S1353-8020(97)00013-8; WSZOLEK ZK, 1995, NEUROLOGY, V45, P502, DOI 10.1212/WNL.45.3.502; Wszolek ZK, 1999, PARKINSONISM RELAT D, V5, P145, DOI 10.1016/S1353-8020(99)00030-9; WSZOLEK ZK, 2003, NEUROLOGY S1, V60, P282	42	151	158	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					11	19		10.1086/380647	http://dx.doi.org/10.1086/380647			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14691730	Green Published, Bronze			2022-12-18	WOS:000187723500002
J	Kato, J; Fujikawa, K; Kanda, M; Fukuda, N; Sasaki, K; Takayama, T; Kobune, M; Takada, K; Takimoto, R; Hamada, H; Ikeda, T; Niitsu, Y				Kato, J; Fujikawa, K; Kanda, M; Fukuda, N; Sasaki, K; Takayama, T; Kobune, M; Takada, K; Takimoto, R; Hamada, H; Ikeda, T; Niitsu, Y			A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERFERRITINEMIA-CATARACT SYNDROME; MESSENGER-RNA TRANSLATION; HEREDITARY HEMOCHROMATOSIS; UNTRANSLATED REGION; REGULATORY PROTEINS; BINDING-PROTEIN; GENE; SEQUENCE; METABOLISM; HEAVY	Ferritin, which is composed of H and L subunits, plays an important role in iron storage and in the control of intracellular iron distribution. Synthesis of both ferritin subunits is controlled by a common cytosolic protein, iron regulatory protein (IRP), which binds to the iron-responsive element (IRE) in the 5'-UTR of the H- and L-ferritin mRNAs. In the present study, we have identified a single point mutation (A49U) in the IRE motif of H- ferritin mRNA, in four of seven members of a Japanese family affected by dominantly inherited iron overload. Gel-shift mobility assay and Scatchard-plot analysis revealed that a mutated IRE probe had a higher binding affinity to IRP than did the wild-type probe. When mutated H subunit was overexpressed in COS-1 cells, suppression of H- subunit synthesis and of the increment of radiolabeled iron uptake were observed. These data suggest that the A49U mutation in the IRE of H-subunit is responsible for tissue iron deposition and is a novel cause of hereditary iron overload, most likely related to impairment of the ferroxidase activity generated by H subunit.	Sapporo Med Univ, Sch Med, Dept Internal Med 4, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; Sapporo Med Univ, Sch Med, Dept Mol Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; Sapporo Med Univ Hosp, Dept Clin Pathol, Sapporo, Hokkaido, Japan; Hokkaido Univ, Grad Sch Pharmaceut Sci, Div Pharmacobiodynam, Lab Drug Metab, Sapporo, Hokkaido 060, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Hokkaido University	Niitsu, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Internal Med 4, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.							AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; BEAUMONT C, 1995, NAT GENET, V11, P444, DOI 10.1038/ng1295-444; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Cazzola M, 1997, BLOOD, V90, P814, DOI 10.1182/blood.V90.2.814.814_814_821; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; HENTZE MW, 1986, P NATL ACAD SCI USA, V83, P7726; JAFFREY SR, 1993, NUCLEIC ACIDS RES, V21, P4627, DOI 10.1093/nar/21.19.4627; KAWANAKA K, 1998, NIPPON SHOKAKIBYO GA, V95, P910; KAWANISHI J, 1995, MOL CELL BIOL, V15, P1175; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Levi S, 1998, BLOOD, V91, P4180, DOI 10.1182/blood.V91.11.4180.411k38_4180_4187; MCGILL JR, 1987, HUM GENET, V76, P66; Monaghan KG, 1998, AM J HEMATOL, V58, P213, DOI 10.1002/(SICI)1096-8652(199807)58:3<213::AID-AJH9>3.0.CO;2-U; RUGGERI G, 1992, BRIT J HAEMATOL, V81, P118, DOI 10.1111/j.1365-2141.1992.tb08183.x; SANTAMBROGIO P, 1992, J BIOL CHEM, V267, P14077; Sohda T, 1999, BIOCHEM GENET, V37, P63, DOI 10.1023/A:1018718101579; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Theil EC, 2000, BIOCHEM PHARMACOL, V59, P87, DOI 10.1016/S0006-2952(99)00300-7; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; YOSHIDA K, 1995, NAT GENET, V9, P267, DOI 10.1038/ng0395-267; ZHENG H, 1994, HUM GENET, V94, P159	27	151	158	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					191	197		10.1086/321261	http://dx.doi.org/10.1086/321261			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11389486	Green Published, Bronze			2022-12-18	WOS:000170108100018
J	Dessein, AJ; Hillaire, D; Elwali, NEMA; Marquet, S; Mohamed-Ali, Q; Mirghani, A; Henri, S; Abdelhameed, AA; Saeed, OK; Magzoub, MMA; Abel, L				Dessein, AJ; Hillaire, D; Elwali, NEMA; Marquet, S; Mohamed-Ali, Q; Mirghani, A; Henri, S; Abdelhameed, AA; Saeed, OK; Magzoub, MMA; Abel, L			Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; REGRESSIVE LOGISTIC-MODELS; HEPATOSPLENIC SCHISTOSOMIASIS; COLLAGEN-SYNTHESIS; MURINE SCHISTOSOMIASIS; PERIPORTAL FIBROSIS; CHROMOSOME 5Q31-Q33; SYSTEMIC-SCLEROSIS; SUDANESE PATIENTS; TNF-ALPHA	Lethal disease due to hepatic periportal fibrosis occurs in 2%-10% of subjects infected by Schistosoma mansoni in endemic regions such as Sudan. It is unknown why few infected individuals present with severe disease, and inherited factors may play a role in fibrosis development. Schistosoma mansoni infection levels have been shown to be controlled by a locus that maps to chromosome 5q31-q33. To investigate the genetic control of severe hepatic fibrosis (assessed by ultrasound examination) causing portal hypertension, a segregation analysis was performed in 65 Sudanese pedigrees from the same village. Results provide evidence for a codominant major gene, with .16 as the estimated allele A frequency predisposing to advanced periportal fibrosis. For AA males, AA females, and Aa males a 50% penetrance is reached after, respectively, 9, 14, and 19 years of residency in the area, whereas for other subjects the penetrance remains <.02 after 20 years of exposure. Linkage analysis performed in four candidate regions shows that this major locus maps to chromosome 6q22-q23 and that it is closely linked (multipoint LOD score 3.12) to the IFN-gamma RI gene encoding the receptor of the strongly antifibrogenic cytokine interferon-gamma. These results show that infection levels and advanced hepatic fibrosis in human schistosomiasis are controlled by distinct loci; they suggest that polymorphisms within the IFN-gamma R1 gene could determine severe hepatic disease due to S. mansoni infection and that the IFN-gamma R1 gene is a strong candidate for the control of abnormal fibrosis observed in other diseases.	Univ Mediterranee, INSERM U399, Fac Med, Lab Parasitol Mycol, Marseille, France; Univ Khartoum, Khartoum, Sudan; Univ Gezira, Fac Med, Wad Medani, Sudan; Univ Gezira, Inst Nucl Med & Mol Biol, Wad Medani, Sudan; Grp Hosp Pitie Salpetriere, INSERM U436, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Khartoum; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Dessein, AJ (corresponding author), Univ Mediterranee, INSERM U399, Fac Med, Lab Parasitol Mycol, Marseille, France.		MARQUET, Sandrine/B-2843-2008; Abel, Laurent/H-8888-2017; Alain, Dessein/A-3142-2009; MARQUET, Sandrine/I-6566-2016; Henri, Sandrine/O-3045-2016	Abel, Laurent/0000-0001-7016-6493; MARQUET, Sandrine/0000-0001-7011-6496; HENRI, Sandrine/0000-0002-8980-9193				ABAZA H, 1985, TISSUE ANTIGENS, V26, P307, DOI 10.1111/j.1399-0039.1985.tb02228.x; ABDELLATIF Z, 1981, J CLIN ULTRASOUND, V9, P409, DOI 10.1002/jcu.1870090802; ABDELSALAM E, 1986, TISSUE ANTIGENS, V27, P142, DOI 10.1111/j.1399-0039.1986.tb01513.x; ABDELWAHAB MF, 1990, T ROY SOC TROP MED H, V84, P69, DOI 10.1016/0035-9203(90)90388-U; ABDELWAHAB MF, 1989, AM J TROP MED HYG, V40, P72, DOI 10.4269/ajtmh.1989.40.72; ABEL L, 1993, AM J HUM GENET, V53, P894; ABEL L, 1991, AM J HUM GENET, V48, P959; Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; ARAP STK, 1976, AM J TROP MED HYG, V25, P273; Barnes KC, 1996, GENOMICS, V37, P41, DOI 10.1006/geno.1996.0518; BOGLIOLO L, 1954, Hospital (Rio J), V45, P283; BONNEY GE, 1988, AM J HUM GENET, V43, P29; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CABELLO PH, 1991, MEM I OSWALDO CRUZ, V86, P37, DOI 10.1590/S0074-02761991000100007; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; CERRI GG, 1984, RADIOLOGY, V153, P777, DOI 10.1148/radiology.153.3.6387793; CHEEVER AW, 1994, J IMMUNOL, V153, P753; CHEEVER AW, 1968, AM J TROP MED HYG, V17, P38, DOI 10.4269/ajtmh.1968.17.38; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; COOK J A, 1974, American Journal of Tropical Medicine and Hygiene, V23, P625; CZAJA MJ, 1989, J CELL BIOL, V108, P2477, DOI 10.1083/jcb.108.6.2477; CZAJA MJ, 1989, HEPATOLOGY, V10, P795, DOI 10.1002/hep.1840100508; DEMENAIS FM, 1991, AM J HUM GENET, V49, P773; DEMENAIS FM, 1994, 3 ANN M INT GEN EP S; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOEHRINGSCHWERDTFEGER E, 1990, AM J TROP MED HYG, V42, P581, DOI 10.4269/ajtmh.1990.42.581; DOEHRINGSCHWERDTFEGER E, 1992, TROP MED PARASITOL, V43, P245; DOMINGUES ALC, 1993, T ROY SOC TROP MED H, V87, P555, DOI 10.1016/0035-9203(93)90087-7; DUNCAN MR, 1985, J EXP MED, V162, P516, DOI 10.1084/jem.162.2.516; GRANSTEIN RD, 1990, ARCH DERMATOL, V126, P1295, DOI 10.1001/archderm.126.10.1295; HEIN R, 1992, BRIT J DERMATOL, V126, P496, DOI 10.1111/j.1365-2133.1992.tb15122.x; HOMEIDA M, 1988, AM J TROP MED HYG, V39, P196, DOI 10.4269/ajtmh.1988.39.196; HOMEIDA M, 1988, AM J TROP MED HYG, V38, P86, DOI 10.4269/ajtmh.1988.38.86; JENKINS JM, 1992, ACTA TROP, V51, P45, DOI 10.1016/0001-706X(92)90020-X; JIMENEZ SA, 1984, J CLIN INVEST, V74, P1112, DOI 10.1172/JCI111480; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; KAWAGUCHI Y, 1992, J RHEUMATOL, V19, P1195; KLOETZEL K, 1962, AM J TROP MED HYG, V25, P472; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Leptak CL, 1997, J IMMUNOL, V158, P301; MALLAT A, 1995, HEPATOLOGY, V21, P1003, DOI 10.1016/0270-9139(95)90247-3; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; MOHAMEDALI Q, 1999, IN PRESS J INFECT DI; MullerMyhsok B, 1997, AM J HUM GENET, V61, P452, DOI 10.1016/S0002-9297(07)64073-7; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Nickel R, 1997, GENOMICS, V46, P159, DOI 10.1006/geno.1997.5013; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OMER AHS, 1976, J TROP MED HYG, V79, P151; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; RICHTER J, 1992, RADIOLOGY, V184, P711, DOI 10.1148/radiology.184.3.1509054; RICHTER J, 1992, ACTA TROP, V51, P281, DOI 10.1016/0001-706X(92)90046-Z; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; SALAM EA, 1979, J IMMUNOL, V123, P1829; Secor WE, 1996, J INFECT DIS, V174, P1131, DOI 10.1093/infdis/174.5.1131; Symmers WSC, 1904, J PATHOL BACTERIOL, V9, P237, DOI 10.1002/path.1700090211; TAMAI K, 1995, J INVEST DERMATOL, V104, P384, DOI 10.1111/1523-1747.ep12665857; Wynn TA, 1998, J IMMUNOL, V160, P4473; WYNN TA, 1995, NATURE, V376, P594, DOI 10.1038/376594a0	61	151	167	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					709	721		10.1086/302526	http://dx.doi.org/10.1086/302526			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441577	Green Published, Bronze			2022-12-18	WOS:000082426400015
J	Hastbacka, J; SupertiFurga, A; Wilcox, WR; Rimoin, DL; Cohn, DH; Lander, ES				Hastbacka, J; SupertiFurga, A; Wilcox, WR; Rimoin, DL; Cohn, DH; Lander, ES			Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): Evidence for a phenotypic series involving three chondrodysplasias	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTEINE; CELLS	Atelosteogenesis type II (AO II) is a neonatally Lethal chondrodysplasia whose clinical and histological characteristics resemble those of another chondrodysplasia, the much less severe diastrophic dysplasia (DTD). The similarity suggests a shared pathogenesis involving lesions in the same biochemical pathway and perhaps the same gene. DTD is caused by mutations in the recently identified diastrophic dysplasia sulfate-transporter gene (DTDST). Here, we report that AOII patients also have DTDST mutations, which lead to defective uptake of inorganic sulfate and insufficient sulfation of macromolecules by patient mesenchymal cells in vitro. Together with our recent observation that a third even more severe chondrodysplasia, achondrogenesis type IB, is also caused by mutations in DTDST, these results demonstrate a phenotypic series of three chondrodysplasias of increasing severity caused by lesions in a single sulfate-transporter gene. The severity of the phenotype appears to be correlated with the predicted effect of the mutations on the residual activity of the DTDST protein.	WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA; UNIV ZURICH,DEPT PEDIAT,DIV METAB & MOLEC DIS,ZURICH,SWITZERLAND; UNIV CALIF LOS ANGELES,SCH MED,CEDARS SINAI RES INST,AHMANSON DEPT PEDIAT,LOS ANGELES,CA; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Zurich; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA			superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531	NHGRI NIH HHS [HG00098] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOROCHOWITZ Z, 1988, J PEDIATR-US, V112, P23, DOI 10.1016/S0022-3476(88)80113-6; COLE DEC, 1981, J CHROMATOGR, V225, P359, DOI 10.1016/S0378-4347(00)80284-4; DIETRICH W, 1992, GENETICS, V131, P423; ELGAVISH A, 1985, J CELL PHYSIOL, V125, P243, DOI 10.1002/jcp.1041250211; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; ESKO JD, 1986, J BIOL CHEM, V261, P5725; GRAY ML, 1988, J ORTHOPAED RES, V6, P777, DOI 10.1002/jor.1100060602; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HORTON WA, 1978, J PEDIATR-US, V93, P609, DOI 10.1016/S0022-3476(78)80896-8; HUMPHRIES DE, 1988, BIOCHEM J, V252, P305, DOI 10.1042/bj2520305; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; MORTIER GR, 1995, HUM MOL GENET, V4, P285, DOI 10.1093/hmg/4.2.285; NORES JA, 1992, PRENATAL DIAG, V12, P741, DOI 10.1002/pd.1970120907; PILLION DJ, 1984, CLIN CHIM ACTA, V142, P241, DOI 10.1016/0009-8981(84)90382-6; QURESHI F, 1995, AM J MED GENET, V56, P300, DOI 10.1002/ajmg.1320560317; Qureshi F., 1994, American Journal of Human Genetics, V55, pA90; Schrander-Stumpel C, 1994, Clin Dysmorphol, V3, P318; SILLENCE DO, 1987, PEDIATR RADIOL, V17, P112, DOI 10.1007/BF02388086; SPRANGER J, 1990, ADV HUM GENET, V19, P1; STERN HJ, 1990, AM J MED GENET, V36, P183, DOI 10.1002/ajmg.1320360212; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; SUPERTIFURGA A, 1994, AM J HUM GENET, V55, P1137; WALKER BA, 1972, MEDICINE, V51, P41, DOI 10.1097/00005792-197201000-00003; WALLIS GA, 1995, CURR BIOL, V5, P225, DOI 10.1016/S0960-9822(95)00044-3	24	151	152	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					255	262						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571951				2022-12-18	WOS:A1996TR79100001
J	HASSTEDT, SJ; WU, LL; ASH, KO; KUIDA, H; WILLIAMS, RR				HASSTEDT, SJ; WU, LL; ASH, KO; KUIDA, H; WILLIAMS, RR			HYPERTENSION AND SODIUM-LITHIUM COUNTERTRANSPORT IN UTAH PEDIGREES - EVIDENCE FOR MAJOR-LOCUS INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,DEPT PATHOL,SALT LAKE CITY,UT 84132; UNIV UTAH,DEPT MED,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	HASSTEDT, SJ (corresponding author), UNIV UTAH,MED CTR,DEPT HUMAN GENET,50 N MED DR,SALT LAKE CITY,UT 84132, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024855] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 24855-08] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEUCKELMANN D, 1984, EUR J CLIN INVEST, V14, P392, DOI 10.1111/j.1365-2362.1984.tb01200.x; BLAUSTEIN MP, 1984, HYPERTENSION, V6, P445, DOI 10.1161/01.HYP.6.4.445; BOERWINKLE E, 1986, GENET EPIDEMIOL, V3, P365, DOI 10.1002/gepi.1370030509; BOERWINKLE E, 1984, RED CELL, P479; BOYLE CR, 1979, BIOMETRICS, V35, P55, DOI 10.2307/2529936; CANESSA M, 1980, NEW ENGL J MED, V302, P772, DOI 10.1056/NEJM198004033021403; CANNINGS C, 1980, CURRENT DEV ANTHR GE, V1, P251; CORROCHER R, 1985, LIFE SCI, V36, P649, DOI 10.1016/0024-3205(85)90169-9; DADONE MM, 1984, AM J MED GENET, V17, P565, DOI 10.1002/ajmg.1320170304; DORUS E, 1983, ARCH GEN PSYCHIAT, V40, P545; EGELAND JA, 1984, AM J PSYCHIAT, V141, P1049; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; HASSTEDT S J, 1985, Genetic Epidemiology, V2, P339, DOI 10.1002/gepi.1370020403; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1986, AM J MED GENET, V24, P57, DOI 10.1002/ajmg.1320240108; HASSTEDT SJ, 1987, GENET EPIDEMIOL, V4, P67, DOI 10.1002/gepi.1370040202; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; HILTON PJ, 1986, NEW ENGL J MED, V314, P222, DOI 10.1056/NEJM198601233140407; HUNT SC, 1986, HYPERTENSION, V8, P30, DOI 10.1161/01.HYP.8.1.30; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; KAGAMIMORI S, 1984, CLIN EXP HYPERTENS A, V6, P951, DOI 10.3109/10641968409044049; KAGAMIMORI S, 1985, AM J EPIDEMIOL, V122, P386, DOI 10.1093/oxfordjournals.aje.a114119; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LEPPERT MF, 1986, AM J HUM GENET, V39, P300; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MIILUNPALO S, 1985, INT J OBESITY, V9, P313; MOLL PP, 1986, AM J HUM GENET, V38, P361; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1974, AM J HUM GENET, V26, P489; OSTROW DG, 1978, AM J PSYCHIAT, V135, P1070; SEMPOS C, 1984, CLIN EXP HYPERTENS A, V6, P1379, DOI 10.3109/10641968409039604; SHAUGHNESSY R, 1985, BIOL PSYCHIAT, V20, P451, DOI 10.1016/0006-3223(85)90047-2; SMITH JB, 1982, CLIN CHIM ACTA, V122, P327, DOI 10.1016/0009-8981(82)90135-8; SMITH JB, 1984, HYPERTENSION, V6, P159, DOI 10.1161/01.HYP.6.2_Pt_1.159; TURNER ST, 1985, HYPERTENSION, V7, P955, DOI 10.1161/01.HYP.7.6.955; WAHLEFELD A., 1974, METHOD ENZYMAT AN, P1831; WILLIAMS RR, 1986, JAMA-J AM MED ASSOC, V255, P219, DOI 10.1001/jama.255.2.219; WILLIAMS RR, 1983, AM J EPIDEMIOL, V118, P338, DOI 10.1093/oxfordjournals.aje.a113640; WILLIAMS RR, 1984, GENETIC EPIDEMIOLOGY, P419; WILLIAMS RR, 1984, TOPICS PATHOPHYSIOLO, P112; WOODS JW, 1982, NEW ENGL J MED, V306, P593, DOI 10.1056/NEJM198203113061007; WOODS JW, 1984, NEW ENGL J MED, V310, P1191; WORLEY RJ, 1982, NEW ENGL J MED, V307, P412, DOI 10.1056/NEJM198208123070706; [No title captured]	45	151	152	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					14	22						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	3163887				2022-12-18	WOS:A1988N986300003
J	LIDSKY, AS; LEDLEY, FD; DILELLA, AG; KWOK, SCM; DAIGER, SP; ROBSON, KJH; WOO, SLC				LIDSKY, AS; LEDLEY, FD; DILELLA, AG; KWOK, SCM; DAIGER, SP; ROBSON, KJH; WOO, SLC			EXTENSIVE RESTRICTION SITE POLYMORPHISM AT THE HUMAN PHENYLALANINE-HYDROXYLASE LOCUS AND APPLICATION IN PRENATAL-DIAGNOSIS OF PHENYLKETONURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,HOUSTON,TX 77030; UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,OXFORD OX3 9DU,ENGLAND	University of Texas System; University of Texas Health Science Center Houston; University of Oxford	LIDSKY, AS (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT CELL BIOL,HOUSTON,TX 77030, USA.			Kwok, Simon/0000-0001-6003-5350	NIADDK NIH HHS [AM-30471] Funding Source: Medline; NICHD NIH HHS [HD-06495, HD-17711] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017711, R01HD017711, F32HD006495] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARMSTRONG MD, 1955, J CLIN INVEST, V34, P565, DOI 10.1172/JCI103105; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BICKEL H, 1954, Acta Paediatr, V43, P64, DOI 10.1111/j.1651-2227.1954.tb04000.x; BICKEL H, 1981, EUR J PEDIATR, V137, P133; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Folling A, 1934, H-S Z PHYSIOL CHEM, V227, P169, DOI 10.1515/bchm2.1934.227.1-4.169; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUTHRIE R, 1963, PEDIATRICS, V32, P338; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JERVIS GA, 1953, P SOC EXP BIOL MED, V82, P514; KAZAZIAN HH, 1984, NATURE, V310, P152, DOI 10.1038/310152a0; KOCH R, 1982, J INHERIT DIS S1, V5, P36; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LIDSKY AS, 1985, LANCET, V1, P549; LIDSKY AS, 1984, AM J HUM GENET, V36, P527; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MURRAY JC, 1983, P NATL ACAD SCI-BIOL, V80, P5951, DOI 10.1073/pnas.80.19.5951; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; ROBSON KJH, 1982, P NATL ACAD SCI-BIOL, V79, P4701, DOI 10.1073/pnas.79.15.4701; SCHUETT VE, 1980, AM J PUBLIC HEALTH, V70, P498, DOI 10.2105/AJPH.70.5.498; SMITH I, 1978, BMJ-BRIT MED J, V2, P723, DOI 10.1136/bmj.2.6139.723; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THALHAMMER O, 1975, HUMANGENETIK, V30, P273, DOI 10.1007/BF00275139; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	25	151	151	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					619	634						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556654				2022-12-18	WOS:A1985APR1800001
J	SANDBERG, AA; KOEPF, GF; CROSSWHITE, LH; HAUSCHKA, TS				SANDBERG, AA; KOEPF, GF; CROSSWHITE, LH; HAUSCHKA, TS			THE CHROMOSOME CONSTITUTION OF HUMAN MARROW IN VARIOUS DEVELOPMENTAL AND BLOOD DISORDERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAIKIE AG, 1960, LANCET, V1, P280; BAIKIE AG, 1960, LANCET, V1, P168; BAIKIE AG, 1959, LANCET, V2, P425; BARR ML, 1959, SCIENCE, V130, P1302, DOI 10.1126/science.130.3385.1302; BARR ML, 1959, SCIENCE, V130, P679, DOI 10.1126/science.130.3377.679; BAYREUTHER K, 1960, NATURE, V186, P6, DOI 10.1038/186006a0; BOOK J A, 1959, Acta Paediatr, V48, P453; CHU EHY, 1960, AM J HUM GENET, V12, P97; CHU EHY, 1959, AM J HUM GENET, V11, P63; FORD CE, 1959, NATURE, V183, P1030, DOI 10.1038/1831030a0; FORD CE, 1959, LANCET, V1, P711; FORD CE, 1958, NATURE, V181, P1565, DOI 10.1038/1811565a0; FORD CE, 1959, LANCET, V2, P732; FORD CE, 1959, LANCET, V1, P709; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; FRACCARO M, 1959, LANCET, V1, P886; FRACCARO M, 1960, ACTA ENDOCR; HARNDEN DG, 1959, LANCET, V2, P126; HUNGERFORD DA, 1959, AM J HUM GENET, V11, P215; JACOBS P, 1959, LANCET, V2, P732; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; JACOBS PA, 1959, LANCET, V2, P423; JACOBS PA, 1959, LANCET, V2, P591; JACOBS PA, 1959, LANCET, V1, P710; KATO R, 1959, REC GENET SOC AMER, V28, P79; KINOSITA R, 1954, EXP CELL RES, V6, P557, DOI 10.1016/0014-4827(54)90213-X; KODANI M, 1957, P NATL ACAD SCI USA, V43, P285, DOI 10.1073/pnas.43.3.285; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P602; LIMADEFARIA A, 1959, SCIENCE, V130, P503, DOI 10.1126/science.130.3374.503; MAKINO S., 1959, PROC JAPANESE ACAD, V35, P99; NACHTSHEIM, 1959, NATURWISSENSCHAFTEN, V46, P637; NILSSON IM, 1959, LANCET, V2, P264; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; NOWELL PC, 1958, P AM ASSOC CANC RES, V2, P331; OHNO S, 1959, EXP CELL RES, V18, P415, DOI 10.1016/0014-4827(59)90031-X; OHNO S, 1960, CANCER RES, V20, P541; STERN C, 1959, AM J HUM GENET, V11, P301; STERN C, 1959, NATURE, V183, P1452, DOI 10.1038/1831452a0; STEWART JSS, 1959, LANCET, V1, P833; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]; TJIO JH, 1959, P NATL ACAD SCI USA, V45, P1008, DOI 10.1073/pnas.45.7.1008; TURPIN R, 1959, CR HEBD ACAD SCI, V248, P3636; YERGANIAN GEORGE, 1959, CYTOLOGIA [TOKYO], V24, P66; 1959, LANCET, V2, P448	45	151	151	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	3					231	249						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF079	13746117				2022-12-18	WOS:A1960WF07900001
J	Fliegauf, M; Bryant, VL; Frede, N; Slade, C; Woon, ST; Lehnert, K; Winzer, S; Bulashevska, A; Scerri, T; Leung, E; Jordan, A; Keller, B; de Vries, E; Cao, HZ; Yang, F; Schaffer, AA; Warnatz, K; Browett, P; Douglass, J; Ameratunga, RV; van der Meer, JWM; Grimbacher, B				Fliegauf, Manfred; Bryant, Vanessa L.; Frede, Natalie; Slade, Charlotte; Woon, See-Tarn; Lehnert, Klaus; Winzer, Sandra; Bulashevska, Alla; Scerri, Thomas; Leung, Euphemia; Jordan, Anthony; Keller, Baerbel; de Vries, Esther; Cao, Hongzhi; Yang, Fang; Schaeffer, Alejandro A.; Warnatz, Klaus; Browett, Peter; Douglass, Jo; Ameratunga, Rohan V.; van der Meer, Jos W. M.; Grimbacher, Bodo			Haploinsufficiency of the NF-kappa B1 Subunit p50 in Common Variable Immunodeficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; ANHIDROTIC ECTODERMAL DYSPLASIA; SELECTIVE IGA DEFICIENCY; NFKB1 PROMOTER POLYMORPHISM; REGULATORY T-CELLS; AUTOSOMAL-DOMINANT; SIGNALING PATHWAY; IMMUNE DYSREGULATION; GERMLINE MUTATIONS; NONSENSE MUTATION	Common variable immunodeficiency (CVID), characterized by recurrent infections, is the most prevalent symptomatic antibody deficiency. In -90% of CVID-affected individuals, no genetic cause of the disease has been identified. In a Dutch-Australian CVID-affected family, we identified a NFKB1 heterozygous splice-donor-site mutation (c.730+4A>G), causing in-frame skipping of exon 8. NFKB1 encodes the transcription-factor precursor p105, which is processed to p50 (canonical NF-kappa B pathway). The altered protein bearing an internal deletion (p.Asp191_Lys244delinsGlu; p105 Delta Ex8) is degraded, but is not processed to p50AEx8. Altered NF-kappa B1 proteins were also undetectable in a German CVID-affected family with a heterozygous in-frame exon 9 skipping mutation (c.835+2T>G) and in a CVID-affected family from New Zealand with a heterozygous frameshift mutation (c.465dupA) in exon 7. Given that residual p105 and p50-translated from the non-mutated alleles-were normal, and altered p50 proteins were absent, we conclude that the CVID phenotype in these families is caused by NF-kappa B1 p50 haploinsufficiency.	[Fliegauf, Manfred; Frede, Natalie; Winzer, Sandra; Bulashevska, Alla; Keller, Baerbel; Warnatz, Klaus; Grimbacher, Bodo] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, D-79108 Freiburg, Germany; [Fliegauf, Manfred; Frede, Natalie; Winzer, Sandra; Bulashevska, Alla; Keller, Baerbel; Warnatz, Klaus; Grimbacher, Bodo] Univ Freiburg, D-79108 Freiburg, Germany; [Bryant, Vanessa L.; Slade, Charlotte; Scerri, Thomas; Douglass, Jo] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia; [Bryant, Vanessa L.; Slade, Charlotte; Scerri, Thomas] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Slade, Charlotte; Douglass, Jo] Royal Melbourne Hosp, Dept Allergy & Clin Immunol, Parkville, Vic 3050, Australia; [Woon, See-Tarn; Ameratunga, Rohan V.] Auckland City Hosp, Dept Virol & Immunol, Auckland 1023, New Zealand; [Lehnert, Klaus] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Leung, Euphemia; Browett, Peter] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1142, New Zealand; [Leung, Euphemia; Browett, Peter] Univ Auckland, Mol Med & Pathol Dept, Auckland 1142, New Zealand; [Jordan, Anthony] Auckland City Hosp, Dept Clin Immunol, Auckland 1023, New Zealand; [de Vries, Esther] Jeroen Bosch Hosp, Dept Pediat, NL-5200 ME Shertogenbosch, Netherlands; [Cao, Hongzhi; Yang, Fang] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Schaeffer, Alejandro A.] NIH, NCBI, US Dept HHS, Bethesda, MD 20892 USA; [Douglass, Jo] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 HP Nijmegen, Netherlands; [Grimbacher, Bodo] UCL, Inst Immun & Transplantat, London WC1E 6BT, England	University of Freiburg; University of Freiburg; Walter & Eliza Hall Institute; University of Melbourne; Royal Melbourne Hospital; Auckland City Hospital; University of Auckland; University of Auckland; University of Auckland; Auckland City Hospital; Jeroen Bosch Ziekenhuis; Beijing Genomics Institute (BGI); National Institutes of Health (NIH) - USA; University of Melbourne; Radboud University Nijmegen; University of London; University College London	Grimbacher, B (corresponding author), Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, D-79108 Freiburg, Germany.	bodo.grimbacher@uniklinik-freiburg.de	van der Meer, Jos W.M./C-8521-2013; Warnatz, Klaus/AAD-3464-2022; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019; Bryant, Vanessa/S-5333-2019; Bulashevska, Alla/C-4910-2019; Slade, Charlotte/ABC-5612-2020	van der Meer, Jos W.M./0000-0001-5120-3690; Bryant, Vanessa/0000-0002-4697-7410; de Vries, Esther/0000-0003-4311-3550; Ameratunga, Rohan/0000-0002-3011-8654; Douglass, Jo/0000-0002-1200-8048; Slade, Charlotte/0000-0001-9020-1487	German Federal Ministry of Education and Research [01EO1303]; E:med SysINFLAME Collaborative Project 1 [01ZX1306]; Australian National Health and Medical Research Council [1054925]; Auckland Medical Research Foundation; Auckland District Health Board Charitable Trust; New Zealand eScience Infrastructure; Intramural Research Program of the NIH, National Library of Medicine; National Health and Medical Research Council [1075666]; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); E:med SysINFLAME Collaborative Project 1; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Auckland Medical Research Foundation; Auckland District Health Board Charitable Trust; New Zealand eScience Infrastructure; Intramural Research Program of the NIH, National Library of Medicine; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are deeply grateful to all the affected individuals and their families who participated in this study. We thank Mary Buchta, Franziska Nussbaumer, Pay la Mrovecova, Katrin Hubscher, Tobias Kratina, and Isabella Kong for their excellent technical assistance. We thank Marcel van Deuren for sharing clinical data on the Dutch family. This study was supported by the German Federal Ministry of Education and Research (01EO1303), E:med SysINFLAME Collaborative Project 1 (01ZX1306), the Australian National Health and Medical Research Council (1054925) and the Auckland Medical Research Foundation, the Auckland District Health Board Charitable Trust, and the New Zealand eScience Infrastructure. This work was supported in part by the Intramural Research Program of the NIH, National Library of Medicine. C.S. was supported by National Health and Medical Research Council postgraduate scholarship 1075666.	Aghamohammadi A, 2008, INT ARCH ALLERGY IMM, V147, P87, DOI 10.1159/000135694; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Ameratunga R, 2013, CLIN EXP IMMUNOL, V174, P203, DOI 10.1111/cei.12178; Ameratunga R, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00415; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bendall HH, 1999, MOL IMMUNOL, V36, P187, DOI 10.1016/S0161-5890(99)00031-0; Bernal GM, 2014, AGING-US, V6, P931, DOI 10.18632/aging.100702; Boland BS, 2015, J IMMUNOL, V194, P2551, DOI 10.4049/jimmunol.1401463; Borm MEA, 2005, INT J IMMUNOGENET, V32, P401, DOI 10.1111/j.1744-313X.2005.00546.x; Brue T, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0139-9; Burns SO, 2014, J ALLERGY CLIN IMMUN, V134, P215, DOI 10.1016/j.jaci.2013.12.1093; Capitani N, 2012, INT J IMMUNOPATH PH, V25, P811, DOI 10.1177/039463201202500332; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Chinen J, 2011, J ALLERGY CLIN IMMUN, V127, P1579, DOI 10.1016/j.jaci.2011.02.046; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Cunningham-Rundles C, 2012, HEMATOL-AM SOC HEMAT, P301, DOI 10.1182/asheducation-2012.1.301; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Driessen G, 2011, EUR J PEDIATR, V170, P693, DOI 10.1007/s00431-011-1474-x; Espanol T, 1996, CLIN IMMUNOL IMMUNOP, V80, P333, DOI 10.1006/clin.1996.0132; Fevang B, 2007, CLIN EXP IMMUNOL, V147, P521, DOI 10.1111/j.1365-2249.2006.03314.x; Finck A, 2006, EUR J HUM GENET, V14, P867, DOI 10.1038/sj.ejhg.5201634; Gasparini C, 2014, CELL MOL LIFE SCI, V71, P2083, DOI 10.1007/s00018-013-1545-4; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gugasyan R, 2000, IMMUNOL REV, V176, P134; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; Horn J, 2009, CLIN EXP IMMUNOL, V156, P446, DOI 10.1111/j.1365-2249.2009.03913.x; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Johnson ML, 1997, CLIN EXP IMMUNOL, V108, P477, DOI 10.1046/j.1365-2249.1997.3801278.x; Kaileh M, 2012, IMMUNOL REV, V246, P254, DOI 10.1111/j.1600-065X.2012.01106.x; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lee CE, 2014, BLOOD, V124, P2964, DOI 10.1182/blood-2014-06-578542; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindsley AW, 2014, J CLIN IMMUNOL, V34, P910, DOI 10.1007/s10875-014-0095-3; Liu YW, 2014, J CLIN IMMUNOL, V34, P686, DOI 10.1007/s10875-014-0064-x; Lougaris V, 2015, J ALLERGY CLIN IMMUN, V135, P1641, DOI 10.1016/j.jaci.2014.11.038; McDonald DR, 2007, J ALLERGY CLIN IMMUN, V120, P900, DOI 10.1016/j.jaci.2007.08.035; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Mousallem T, 2014, BLOOD, V124, P2046, DOI 10.1182/blood-2014-04-571265; Nijenhuis T, 2001, NETH J MED, V59, P134, DOI 10.1016/S0300-2977(01)00151-6; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orange JS, 2005, IMMUNOL REV, V203, P21, DOI 10.1111/j.0105-2896.2005.00221.x; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rieux-Laucat F, 2014, SCIENCE, V345, P1560, DOI 10.1126/science.1260791; Romberg N., 2015, J ALLERGY CLIN IMMUN; Salzer U, 2005, CURR OPIN ALLERGY CL, V5, P496, DOI 10.1097/01.all.0000191887.89773.cc; Salzer U, 2012, ANN NY ACAD SCI, V1250, P41, DOI 10.1111/j.1749-6632.2011.06377.x; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; von Bulow GU, 2000, MAMM GENOME, V11, P628, DOI 10.1007/s003350010125; VORECHOVSKY I, 1995, CLIN IMMUNOL IMMUNOP, V77, P185, DOI 10.1006/clin.1995.1142; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Yong PFK, 2011, ADV IMMUNOL, V111, P47, DOI 10.1016/B978-0-12-385991-4.00002-7; Yoshioka T, 2013, J CLIN IMMUNOL, V33, P1165, DOI 10.1007/s10875-013-9924-z	68	150	155	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					389	403		10.1016/j.ajhg.2015.07.008	http://dx.doi.org/10.1016/j.ajhg.2015.07.008			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26279205	Green Published, Bronze			2022-12-18	WOS:000361084700003
J	Vaags, AK; Lionel, AC; Sato, D; Goodenberger, M; Stein, QP; Curran, S; Ogilvie, C; Ahn, JW; Drmic, I; Senman, L; Chrysler, C; Thompson, A; Russell, C; Prasad, A; Walker, S; Pinto, D; Marshall, CR; Stavropoulos, DJ; Zwaigenbaum, L; Fernandez, BA; Fombonne, E; Bolton, PF; Collier, DA; Hodge, JC; Roberts, W; Szatmari, P; Scherer, SW				Vaags, Andrea K.; Lionel, Anath C.; Sato, Daisuke; Goodenberger, McKinsey; Stein, Quinn P.; Curran, Sarah; Ogilvie, Caroline; Ahn, Joo Wook; Drmic, Irene; Senman, Lili; Chrysler, Christina; Thompson, Ann; Russell, Carolyn; Prasad, Aparna; Walker, Susan; Pinto, Dalila; Marshall, Christian R.; Stavropoulos, Dimitri J.; Zwaigenbaum, Lonnie; Fernandez, Bridget A.; Fombonne, Eric; Bolton, Patrick F.; Collier, David A.; Hodge, Jennelle C.; Roberts, Wendy; Szatmari, Peter; Scherer, Stephen W.			Rare Deletions at the Neurexin 3 Locus in Autism Spectrum Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; GENOME-WIDE ASSOCIATION; MENTAL-RETARDATION; STRUCTURAL VARIANTS; INCREASE RISK; DE-NOVO; SCHIZOPHRENIA; GENES; MUTATIONS; COMMON	The three members of the human neurexin gene family, neurexin 1 (NRXN1), neurexin 2 (NRXN2), and neurexin 3 (NRXN3), encode neuronal adhesion proteins that have important roles in synapse development and function. In autism spectrum disorder (ASD), as well as in other neurodevelopmental conditions, rare exonic copy-number variants and/or point mutations have been identified in the NRXN1 and NRXN2 loci. We present clinical characterization of four index cases who have been diagnosed with ASD and who possess rare inherited or de novo microdeletions at 14q24.3-31.1, a region that overlaps exons of the alpha and/or beta isoforms of NRXN3. NRXN3 deletions were found in one father with subclinical autism and in a carrier mother and father without formal ASD diagnoses, indicating issues of penetrance and expressivity at this locus. Notwithstanding these clinical complexities, this report on ASD-affected individuals who harbor NRXN3 exonic deletions advances the understanding of the genetic etiology of autism, further enabling molecular diagnoses.	[Vaags, Andrea K.; Lionel, Anath C.; Sato, Daisuke; Prasad, Aparna; Walker, Susan; Pinto, Dalila; Marshall, Christian R.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Lionel, Anath C.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Goodenberger, McKinsey; Hodge, Jennelle C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Stein, Quinn P.] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD 57105 USA; [Curran, Sarah; Bolton, Patrick F.] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; [Curran, Sarah; Bolton, Patrick F.; Collier, David A.] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England; [Ogilvie, Caroline; Ahn, Joo Wook] Guys Hosp, Cytogenet Lab, London SE1 9RT, England; [Ogilvie, Caroline; Ahn, Joo Wook] Kings Coll London, London SE1 9RT, England; [Drmic, Irene; Senman, Lili; Roberts, Wendy] Hosp Sick Children, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Chrysler, Christina; Thompson, Ann; Russell, Carolyn; Szatmari, Peter] McMaster Univ, Offord Ctr Child Studies, Dept Psychiat & Behav Neurosci, Hamilton, ON L8S 4K1, Canada; [Stavropoulos, Dimitri J.] Hosp Sick Children, Dept Pediat Lab Med, Cytogenet Lab, Toronto, ON M5G 1L7, Canada; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T5G 0B7, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Med, St John, NF A1B 3V6, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet, St John, NF A1B 3V6, Canada; [Fombonne, Eric] Montreal Childrens Hosp, Dept Psychiat, Montreal, PQ H3Z 1P2, Canada; [Fombonne, Eric] McGill Univ, Montreal, PQ H3Z 1P2, Canada; [Roberts, Wendy] Univ Toronto, Bloorview Res Inst, Toronto, ON M4G 1R8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Mayo Clinic; University of South Dakota; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; Memorial University Newfoundland; Memorial University Newfoundland; McGill University; McGill University; University of Toronto	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada.	stephen.scherer@sickkids.ca	Prasad, Aparna/N-4253-2015; Hodge, Jennelle/AAW-5082-2020; Fombonne, Eric/M-4893-2018; Pinto, Dalila/C-4218-2016; Ogilve, Caroline/AAW-3793-2021; Ahn, Joo Wook/AAM-9454-2020; Scherer, Stephen W./B-3785-2013; Stein, Quinn/AAJ-4738-2021; curran, sarah/D-1027-2009; Collier, David A/D-1649-2011	Prasad, Aparna/0000-0002-6786-2313; Fombonne, Eric/0000-0002-8605-3538; Pinto, Dalila/0000-0002-8769-0846; Ahn, Joo Wook/0000-0002-5628-2321; Scherer, Stephen W./0000-0002-8326-1999; Stein, Quinn/0000-0002-7670-9281; Collier, David A/0000-0003-4087-1559; Goodenberger, McKinsey/0000-0001-9560-6344	The Centre for Applied Genomics, Genome Canada; Ontario Genomics Institute; Canadian Institutes for Health Research; Canadian Institute for Advanced Research; McLaughlin Centre; Canada Foundation for Innovation; Ontario Ministry of Research and Innovation; Autism Speaks; NeuroDevNet; Hospital for Sick Children Foundation; Ontario Ministry of Education and Training; Medical Research Council [G9817803B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish	The Centre for Applied Genomics, Genome Canada; Ontario Genomics Institute; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); McLaughlin Centre; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Autism Speaks; NeuroDevNet; Hospital for Sick Children Foundation; Ontario Ministry of Education and Training; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the WTCCC and the SAGE (Study of Addiction: Genetics and Environment) consortium and A. Fiebig, A. Franke, and S. Schreiber at PopGen (University of Kiel, Kiel, Germany) and A. Stewart, R. McPherson, and R. Roberts of the University of Ottawa Heart Institute (University of Ottawa, Ottawa, Canada), for providing control data. This work was supported by The Centre for Applied Genomics, Genome Canada and the Ontario Genomics Institute, the Canadian Institutes for Health Research, the Canadian Institute for Advanced Research, the McLaughlin Centre, the Canada Foundation for Innovation, the Ontario Ministry of Research and Innovation, Autism Speaks, NeuroDevNet, and the Hospital for Sick Children Foundation. A.C.L. holds an Ontario graduate scholarship from the Ontario Ministry of Education and Training and a NeuroDevNet doctoral fellowship. S.W.S. holds the GlaxoSmithKline-CIHR chair in Genome Sciences at the University of Toronto and the Hospital for Sick Children.	Ahn JW, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-9; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bradley WEC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009401; Bremer A, 2011, AM J MED GENET B, V156B, P115, DOI 10.1002/ajmg.b.31142; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scherer SW, 2011, HUM GENET, V130, P123, DOI 10.1007/s00439-011-1037-2; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Stewart AFR, 2009, J AM COLL CARDIOL, V53, P1471, DOI 10.1016/j.jacc.2008.12.051; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sundaram SK, 2010, NEUROLOGY, V74, P1583, DOI 10.1212/WNL.0b013e3181e0f147; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tsuchiya KD, 2009, GENET MED, V11, P866, DOI 10.1097/GIM.0b013e3181c0c3b0; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	56	150	152	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					133	141		10.1016/j.ajhg.2011.11.025	http://dx.doi.org/10.1016/j.ajhg.2011.11.025			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22209245	Green Published, Bronze			2022-12-18	WOS:000299409100014
J	Atzmon, G; Hao, L; Pe'er, I; Velez, C; Pearlman, A; Palamara, PF; Morrow, B; Friedman, E; Oddoux, C; Burns, E; Ostrer, H				Atzmon, Gil; Hao, Li; Pe'er, Itsik; Velez, Christopher; Pearlman, Alexander; Palamara, Pier Francesco; Morrow, Bernice; Friedman, Eitan; Oddoux, Carole; Burns, Edward; Ostrer, Harry			Abraham's Children in the Genome Era: Major Jewish Diaspora Populations Comprise Distinct Genetic Clusters with Shared Middle Eastern Ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JEWS; SUBSTRUCTURE; PATTERNS; PROGRAM; DISEASE; SAMPLE; POOL	For more than a century, Jews and non-Jews alike have tried to define the relatedness of contemporary Jewish people. Previous genetic studies of blood group and serum markers suggested that Jewish groups had Middle Eastern origin with greater genetic similarity between paired Jewish populations. However, these and successor studies of monoallelic Y chromosomal and mitochondrial genetic markers did not resolve the issues of within and between-group Jewish genetic identity. Here, genome-wide analysis of seven Jewish groups (Iranian, Iraqi, Syrian, Italian, Turkish, Greek, and Ashkenazi) and comparison with non-Jewish groups demonstrated distinctive Jewish population clusters, each with shared Middle Eastern ancestry, proximity to contemporary Middle Eastern populations, and variable degrees of European and North African admixture. Two major groups were identified by principal component, phylogenetic, and identity by descent (IBD) analysis: Middle Eastern Jews and European/Syrian Jews. The IBD segment sharing and the proximity of European Jews to each other and to southern European populations suggested similar origins for European Jewry and refuted large-scale genetic contributions of Central and Eastern European and Slavic populations to the formation of Ashkenazi Jewry. Rapid decay of IBD in Ashkenazi Jewish genomes was consistent with a severe bottleneck followed by large expansion, such as occurred with the so-called demographic miracle of population expansion from 50,000 people at the beginning of the 15(th) century to 5,000,000 people at the beginning of the 19(th) century. Thus, this study demonstrates that European/Syrian and Middle Eastern Jews represent a series of geographical isolates or clusters woven together by shared IBD genetic threads.	[Hao, Li; Velez, Christopher; Pearlman, Alexander; Oddoux, Carole; Ostrer, Harry] NYU, Dept Pediat, Sch Med, Human Genet Program, New York, NY 10016 USA; [Atzmon, Gil; Burns, Edward] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Atzmon, Gil; Morrow, Bernice] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Pe'er, Itsik; Palamara, Pier Francesco] Columbia Univ, Dept Comp Sci, New York, NY 10025 USA; [Friedman, Eitan] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel; [Friedman, Eitan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	New York University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Ostrer, H (corresponding author), NYU, Dept Pediat, Sch Med, Human Genet Program, New York, NY 10016 USA.	harry.ostrer@nyumc.org		Palamara, Pier Francesco/0000-0002-7999-1972; Pearlman, Alexander/0000-0002-0465-5886; Morrow, Bernice/0000-0002-8076-4726	Lewis and Rachel Rudin Foundation; Iranian-American Jewish Federation of New York; U.S.-Israel Binational Science Foundation; US National Institutes of Health [5 U54 CA121852]; Ruth and Sidney Lapidus; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER	Lewis and Rachel Rudin Foundation; Iranian-American Jewish Federation of New York; U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth and Sidney Lapidus; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in part, by the Lewis and Rachel Rudin Foundation, the Iranian-American Jewish Federation of New York, the U.S.-Israel Binational Science Foundation, the US National Institutes of Health (5 U54 CA121852), and Ruth and Sidney Lapidus. The authors thank Alon Keinan, Alkes Price, Yongzhao Shao, Carlos Bustamante, and David Goldstein for useful technical discussions; Lanchi U, Malka Sasson, Bridget Riley, Christopher Campbell, Jidong Shan, David Reynolds, Michael Bamshad, Nora Iny, Robert Ohebshalom, Lana Bahhash, Rabbi Salomon Cohen-Scali, Inc) Angel, and Avram Fortis for technical contributions; and Lawrence Schiffman, Robert Chazen, Aron Rodrigue, and Harvey Goldberg for informative historical discussions.	Baron SaloW., 1937, SOCIAL RELIG HIST JE, Vvol. 1; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Ben-Sasson HH, 1976, HIST JEWISH PEOPLE; BIRAN A, 1993, ISRAEL EXPLOR J, V43, P81; CARMELLI D, 1979, HUM BIOL, V51, P41; Cohen Shaye J. D., 1999, BEGINNINGS JEWISHNES; CURTIS M, 1975, PALESTINIANS PEOPLE; Fishberg Maurice, 1911, JEWS STUDY RACE ENV; Goudet J., 2001, CLADISTICS; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; JACOBS JOSEPH, 1891, JEWISH STAT SOCIAL V; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; KARLIN S, 1979, AM J HUM GENET, V31, P341; Koestler A., 1976, 13 TRIBE; Kopelman NM, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-80; Levy Habib, 1999, COMPREHENSIVE HIST J, P448; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liang LM, 2007, BIOINFORMATICS, V23, P1565, DOI 10.1093/bioinformatics/btm138; LIVSHITS G, 1991, AM J HUM GENET, V49, P131; Nebel A, 2005, EUR J HUM GENET, V13, P388, DOI 10.1038/sj.ejhg.5201319; Nebel A, 2001, AM J HUM GENET, V69, P1095, DOI 10.1086/324070; Need AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r7; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Oddoux C, 1999, J CLIN ENDOCR METAB, V84, P4405, DOI 10.1210/jc.84.12.4405; Olshen AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-14; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rejwan Nissim, 1985, JEWS IRAQ 3000 YEARS; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2001, P NATL ACAD SCI USA, V98, P858, DOI 10.1073/pnas.98.3.858; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; WEINRYB B, 1973, HIST JEWS POLAND; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wexler P, 2002, 2 TIERED RELEXIFICAT; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015	42	150	155	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					850	859		10.1016/j.ajhg.2010.04.015	http://dx.doi.org/10.1016/j.ajhg.2010.04.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20560205	Green Published, Bronze			2022-12-18	WOS:000278948900003
J	Morales, J; Al-Sharif, L; Khalil, DS; Shinwari, JMA; Bavi, P; Al-Mahrouqi, RA; Al-Raihi, A; Alkuraya, FS; Meyer, BF; Al Tassan, N				Morales, Jose; Al-Sharif, Latifa; Khalil, Dania S.; Shinwari, Jameela M. A.; Bavi, Prashant; Al-Mahrouqi, Rahima A.; Al-Raihi, Ali; Alkuraya, Fowzan S.; Meyer, Brian F.; Al Tassan, Nada			Homozygous Mutations in ADAMTS10 and ADAMTS17 Cause Lenticular Myopia, Ectopia Lentis, Glaucoma, Spherophakia, and Short Stature	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WEILL-MARCHESANI-SYNDROME; MARFAN-SYNDROME; GENE; METALLOPROTEINASES; EXPRESSION; PROTEASES; DOMAINS; DISEASE; FAMILY; FBN1	Weill-Marchesani syndrome (WMS) is a well-characterized disorder in which patients develop eye and skeletal abnormalities. Autosomal-recessive and autosomal-dominant forms of WMS are caused by mutations in ADAMTS10 and FBN1 genes, respectively Here we report on 13 patients from seven unrelated families from the Arabian peninsula. These patients have a constellation of features that fall within the WMS spectrum and follow an autosomal-recessive mode of inheritance. Individuals who came from two families and met the diagnostic criteria for WMS were each found to have a different homozygous missense mutation in ADAMTS10. Linkage analysis and direct sequencing of candidate genes in another two families and a sporadic case with phenotypes best described as WMS-like led to the identification of three homozygous mutations in the closely related ADAMTS17 gene. Our clinical and genetic findings suggest that ADAMTS17 plays a role in crystalline lens zonules and connective tissue formation and that mutations in ADAMTS17 are sufficient to produce some of the main features typically described in WMS.	[Al-Sharif, Latifa; Khalil, Dania S.; Shinwari, Jameela M. A.; Alkuraya, Fowzan S.; Meyer, Brian F.; Al Tassan, Nada] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Morales, Jose; Al-Mahrouqi, Rahima A.; Al-Raihi, Ali] King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia; [Bavi, Prashant] King Faisal Specialist Hosp & Res Ctr, Biol Repository Sect, Riyadh 11211, Saudi Arabia; [Al-Mahrouqi, Rahima A.] Al Nahda Hosp, Dept Ophthalmol, Muscat 134, Oman; [Alkuraya, Fowzan S.] Childrens Hosp, Dept Med, Div Genet & Metab, Boston, MA 02115 USA; [Alkuraya, Fowzan S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Alkuraya, Fowzan S.] King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Dept Anat & Cell Biol, Coll Med, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Khaled Eye Specialist Hospital; King Faisal Specialist Hospital & Research Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; King Saud University; King Khalid University Hospital; King Saud University; Alfaisal University	Al Tassan, N (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	naltassan@kfshrc.edu.sa	Bavi, Prashant/B-2123-2009; Alkuraya, Fowzan S./A-1542-2009; Tassan, Nada Al/K-5605-2019	Bavi, Prashant/0000-0002-7711-2911; Alkuraya, Fowzan S./0000-0003-4158-341X; Tassan, Nada Al/0000-0001-9076-0334; Meyer, Brian/0000-0002-0388-9568	King Faisal Specialist Hospital and Research Centre [2070008]; KKESH [0664-P]	King Faisal Specialist Hospital and Research Centre; KKESH	The authors would like to thank Valorie Balde, Zakia Shinwari, Ayodele. A. Alaiya, and Tarfa Al Sheddi for all their technical assistance; Faisal Al Hamidi for his help in patient recruitment; members of the photography department of the King Khaled Eye Specialist Hospital (KKESH) for their detailed documentation of the clinical signs; Mohamad Rajab, Shamsa Al Enazi, and Dorota Moniez for their help with DNA Sequencing; Batoul Baz and Salma Wakil of the genotyping core facility for their hell) in processing the 10K affymetrix chip; and Futwan Al Mohanna for his help and efforts. This work was approved and funded by King Faisal Specialist Hospital and Research Centre (RAC# 2070008). and KKESH (RP# 0664-P).	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Bavi P, 2008, HUM PATHOL, V39, P885, DOI 10.1016/j.humpath.2007.10.014; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Chu BS, 2006, CLIN EXP OPTOM, V89, P95, DOI 10.1111/j.1444-0938.2006.00014.x; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; El Mouzan MI, 2008, ANN SAUDI MED, V28, P334; Evereklioglu C, 1999, EYE, V13, P773, DOI 10.1038/eye.1999.226; Faivre L, 2003, AM J MED GENET A, V123A, P204, DOI 10.1002/ajmg.a.20289; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Giordano N, 1997, CALCIFIED TISSUE INT, V60, P358, DOI 10.1007/s002239900243; Herrera J, 1986, Rev Chil Pediatr, V57, P571; Huxley-Jones J, 2005, INT J BIOCHEM CELL B, V37, P1838, DOI 10.1016/j.biocel.2005.03.009; Kojuri J, 2007, AM J MED GENET A, V143A, P2062, DOI 10.1002/ajmg.a.31861; Kutz WE, 2008, HUM MUTAT, V29, P1425, DOI 10.1002/humu.20797; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; RENNERT OM, 1969, AM J DIS CHILD, V117, P703, DOI 10.1001/archpedi.1969.02100030705016; VERLOES A, 1992, AM J MED GENET, V44, P48, DOI 10.1002/ajmg.1320440112; Wride Michael A., 2006, Birth Defects Research, V78, P90, DOI 10.1002/bdrc.20063; Wright K W, 1985, J Pediatr Ophthalmol Strabismus, V22, P129; YOUNG ID, 1986, CLIN GENET, V30, P475	26	150	154	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					558	568		10.1016/j.ajhg.2009.09.011	http://dx.doi.org/10.1016/j.ajhg.2009.09.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19836009	Green Published, Bronze			2022-12-18	WOS:000271916500004
J	Bohring, A; Stamm, T; Spaich, C; Haase, C; Spree, K; Hehr, U; Hoffmann, M; Ledig, S; Sel, S; Wieacker, P; Ropke, A				Bohring, Axel; Stamm, Thomas; Spaich, Christiane; Haase, Claudia; Spree, Kerstin; Hehr, Ute; Hoffmann, Mandy; Ledig, Susanne; Sel, Saadettin; Wieacker, Peter; Roepke, Albrecht			WNT10A Mutations Are a Frequent Cause of a Broad Spectrum of Ectodermal Dysplasias with Sex-Biased Manifestation Pattern in Heterozygotes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXILLARY LATERAL INCISORS; SCHULZ-PASSARGE-SYNDROME; GENE; EXPRESSION; DELINEATION; HYPODONTIA; PHENOTYPE; PATHWAY; DISEASE; VARIANT	Odonto-onycho-dermal dysplasia (OODD), a rare autosomal-recessive inherited form of ectodermal dysplasia including severe oligodontia, nail dystrophy, palmoplantar hyperkeratosis, and hyperhidrosis, was recently shown to be caused by a homozygous nonsense WNT10A mutation in three consanguineous Lebanese families. Here, we report on 12 patients, from I I unrelated families, with ectodermal dysplasia caused by five previously undescribed WNT10A mutations. In this study, we show that (1) VMT10A mutations cause not only OODD but also other forms of ectodermal dysplasia, reaching from apparently monosymptomatic severe oligodontia to Schopf-Schulz-Passarge syndrome, which is so far considered a unique entity by the findings of numerous cysts along eyelid margins and the increased risk of benign and malignant skin tumors; (2) WNT10A mutations are a frequent cause of ectodermal dysplasia and were found in about 9% of an unselected patient cohort; (3) about half of the heterozygotes (53.8%) show a phenotype manifestation, including mainly tooth and nail anomalies, which was not reported before in OODD; and (4) heterozygotes show a sex-biased manifestation pattern, with a significantly higher proportion of tooth anomalies in males than in females, which may implicate gender-specific differences of WNT10A expression.	[Bohring, Axel; Spree, Kerstin; Hoffmann, Mandy; Ledig, Susanne; Wieacker, Peter; Roepke, Albrecht] Univ Munster, Inst Humangenet, D-48149 Munster, Germany; [Stamm, Thomas] Univ Munster, Poliklin Kieferorthopadie, D-48149 Munster, Germany; [Spaich, Christiane] Olga Hosp, Inst Klin Genet, D-70176 Stuttgart, Germany; [Haase, Claudia] Univ Kinderklin Jena, Stoffwechselzentrum Thuringen, Klin Genet, D-07740 Jena, Germany; [Hehr, Ute] Univ Regensburg, Zentrum & Inst Humangenet, D-93053 Regensburg, Germany; [Sel, Saadettin] Univ Halle Wittenberg, Klin & Poliklin Augenheilkunde, D-06120 Halle, Germany	University of Munster; University of Munster; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart; University of Regensburg; Martin Luther University Halle Wittenberg	Bohring, A (corresponding author), Univ Munster, Inst Humangenet, D-48149 Munster, Germany.	abohring@aol.com		Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305				Acharya AB, 2007, FORENSIC SCI INT, V173, P47, DOI 10.1016/j.forsciint.2007.01.024; Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; ARNOLD WP, 1995, AM J MED GENET, V59, P242, DOI 10.1002/ajmg.1320590224; Blanche H, 1997, HUM GENET, V101, P56, DOI 10.1007/s004390050586; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; BURKET JM, 1984, J AM ACAD DERMATOL, V10, P922, DOI 10.1016/S0190-9622(84)80448-X; BURZYNSKI NJ, 1983, BIRTH DEFECTS-ORIG, V19, P95; Castori M, 2008, ACTA DERM-VENEREOL, V88, P607, DOI 10.2340/00015555-0547; Craigen WJ, 1997, AM J MED GENET, V71, P186, DOI 10.1002/(SICI)1096-8628(19970808)71:2<186::AID-AJMG12>3.0.CO;2-A; CRAMER M, 1947, AM J ORTHOD ORAL SUR, V33, P760, DOI 10.1016/S0096-6347(47)90074-4; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; FADHIL M, 1983, AM J MED GENET, V14, P335, DOI 10.1002/ajmg.1320140213; Fischer HP, 2000, J HEPATOL, V33, P883, DOI 10.1016/S0168-8278(00)80119-1; FONT RL, 1986, ARCH OPHTHALMOL-CHIC, V104, P1811; FRIED K, 1977, J MED GENET, V14, P137, DOI 10.1136/jmg.14.2.137; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GORLIN RJ, 1980, AM J MED GENET, V5, P207, DOI 10.1002/ajmg.1320050215; Guatelli-Steinberg D, 2008, AM J PHYS ANTHROPOL, V137, P324, DOI 10.1002/ajpa.20878; Hersh CP, 2004, THORAX, V59, P843, DOI 10.1136/thx.2004.022541; Hoo JJ, 2000, AM J MED GENET, V90, P326, DOI 10.1002/(SICI)1096-8628(20000214)90:4<326::AID-AJMG12>3.0.CO;2-O; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; KUSTER W, 1992, HAUTARZT, V43, P763; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Megarbane A, 1998, AM J MED GENET, V75, P196, DOI 10.1002/(SICI)1096-8628(19980113)75:2<196::AID-AJMG15>3.3.CO;2-X; Megarbane H, 2004, AM J MED GENET A, V129A, P193, DOI 10.1002/ajmg.a.30188; Miletich I, 2003, HUM MOL GENET, V12, pR69, DOI 10.1093/hmg/ddg085; MONK BE, 1992, BRIT J DERMATOL, V127, P33, DOI 10.1111/j.1365-2133.1992.tb14822.x; Narita T, 2005, DEV DYNAM, V233, P282, DOI 10.1002/dvdy.20321; NORDIN H, 1988, ACTA DERM-VENEREOL, V68, P523; Perret C., 1989, BRIT J DERMATOL, V120, P131; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; SCHOPF E, 1971, Birth Defects Original Article Series, V7, P219; Tiret A, 1999, Curr Opin Ophthalmol, V10, P168, DOI 10.1097/00055735-199906000-00003; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; van der Hout AH, 2008, EUR J HUM GENET, V16, P673, DOI 10.1038/sj.ejhg.5202012; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; Wang JW, 1996, ONCOGENE, V13, P1537; WITKOP CJ, 1987, AM J MED GENET, V26, P431, DOI 10.1002/ajmg.1320260222; WOOLF CM, 1971, AM J HUM GENET, V23, P289; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yi H, 2007, INVEST OPHTH VIS SCI, V48, P5733, DOI 10.1167/iovs.07-0097; ZIRBEL GM, 1995, BRIT J DERMATOL, V133, P797	44	150	153	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					97	105		10.1016/j.ajhg.2009.06.001	http://dx.doi.org/10.1016/j.ajhg.2009.06.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19559398	Green Published, Bronze			2022-12-18	WOS:000267997600011
J	Dagoneau, N; Goulet, M; Genevieve, D; Sznajer, Y; Martinovic, J; Smithson, S; Huber, C; Baujat, G; Flori, E; Tecco, L; Cavalcanti, D; Delezoide, AL; Serre, V; Le Merrer, M; Munnich, A; Cormier-Daire, V				Dagoneau, Nathalie; Goulet, Marie; Genevieve, David; Sznajer, Yves; Martinovic, Jelena; Smithson, Sarah; Huber, Celine; Baujat, Genevieve; Flori, Elisabeth; Tecco, Laura; Cavalcanti, Denise; Delezoide, Anne-Lise; Serre, Valerie; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie			DYNC2H1 Mutations Cause Asphyxiating Thoracic Dystrophy and Short Rib-Polydactyly Syndrome, Type III	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTRAFLAGELLAR TRANSPORT PROTEIN	Jeune asphyxiating thoracic dystrophy (ATD) is an autosomal-recessive chondrodysplasia characterized by short ribs and a narrow thorax, short long bones, inconstant polydactyly, and trident acetabular roof. ATD is closely related to the short rib polydactyly syndrome (SRP) type III, which is a more severe condition characterized by early prenatal expression and lethality and variable malformations. We first excluded IFT80 in a series of 26 fetuses and children belonging to 14 families diagnosed with either ATD or SRP type III. Studying a consanguineous family from Morocco, we mapped an ATD gene to chromosome 11q14.3-q23.1 in a 20.4 Mb region and identified homozygous mutations in the cytoplasmic dynein 2 heavy chain 1 (DYNC2HI) gene in the affected children. Compound heterozygosity for DYNC2H1 mutations was also identified in four additional families. Among the five families, 3/5 were diagnosed with ATD and 2/5 included pregnancies terminated for SRP type III. DYNC2H1 is a component of a cytoplasmic dynein complex and is directly involved in the generation and maintenance of cilia. From this study, we conclude that ATD and SRP type Ill are variants of a single disorder belonging to the ciliopathy group.	[Dagoneau, Nathalie; Goulet, Marie; Genevieve, David; Martinovic, Jelena; Huber, Celine; Baujat, Genevieve; Cavalcanti, Denise; Serre, Valerie; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Unite INSERM,U781,Dept Genet, F-75015 Paris, France; [Sznajer, Yves] Hop Univ Enfants Reine Fabiola, B-1020 Brussels, Belgium; [Sznajer, Yves] ULB, Ctr Human Genet, B-1020 Brussels, Belgium; [Smithson, Sarah] St Michaels Hosp, Dept Clin Genet, Bristol BS2 8EG, Avon, England; [Flori, Elisabeth] Hop Hautepierre, Cytogenet Serv, F-67091 Strasbourg, France; [Tecco, Laura] CHU Brugmann, Brugmann Univ Hosp, Dept Gynaecol & Obstet, B-1020 Brussels, Belgium; [Delezoide, Anne-Lise] Univ Paris Diderot, Dept Dev Biol, AP HP, Hop Robert Debre, F-75935 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, AP HP, Unite INSERM,U781,Dept Genet, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	Cavalcanti, Denise/D-3579-2012; cormier-daire, valerie/H-6520-2017	cormier-daire, valerie/0000-0002-2839-9856; huber, celine/0000-0002-8601-9655				Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Gouttenoire J, 2007, J BIOL CHEM, V282, P30960, DOI 10.1074/jbc.M705730200; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Ho NC, 2000, AM J MED GENET, V90, P310, DOI 10.1002/(SICI)1096-8628(20000214)90:4<310::AID-AJMG9>3.0.CO;2-N; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Morgan NV, 2003, J MED GENET, V40, P431, DOI 10.1136/jmg.40.6.431; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Yang S S, 1987, Am J Med Genet Suppl, V3, P191	15	150	161	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					706	711		10.1016/j.ajhg.2009.04.016	http://dx.doi.org/10.1016/j.ajhg.2009.04.016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19442771	Bronze, Green Published			2022-12-18	WOS:000266338800017
J	Linglart, A; Gensure, RC; Olney, RC; Juppner, HJ; Bastepe, M				Linglart, A; Gensure, RC; Olney, RC; Juppner, HJ; Bastepe, M			A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							XL-ALPHA-S; SUBUNIT G(S)ALPHA; GENE; TRANSCRIPTS; METHYLATION; ANTISENSE; REGION; IDENTIFICATION; EXPRESSION; CLUSTER	A unique heterozygous 3-kb microdeletion within STX16, a closely linked gene centromeric of GNAS, was previously identified in multiple unrelated kindreds as a cause of autosomal dominant pseudohypoparathyroidism type Ib (AD-PHP-Ib). We now report a novel heterozygous 4.4-kb microdeletion in a large kindred with AD-PHP-Ib. Affected individuals from this kindred share an epigenetic defect that is indistinguishable from that observed in patients with AD-PHP-Ib who carry the 3-kb microdeletion in the STX16 region (i.e., an isolated loss of methylation at GNAS exon A/B). The novel 4.4-kb microdeletion overlaps with the previously identified deletion by 1,286 bp and, similar to the latter deletion, removes several exons of STX16 (encoding syntaxin-16). Because these microdeletions lead to AD-PHP-Ib only after maternal transmission, we analyzed expression of this gene in lymphoblastoid cells of affected individuals with the 3-kb or the 4.4-kb microdeletion, an individual with a NESP55 deletion, and a healthy control. We found that STX16 mRNA was expressed in all cases from both parental alleles. Thus, STX16 is apparently not imprinted, and a loss-of-function mutation in one allele is therefore unlikely to be responsible for this disorder. Instead, the region of overlap between the two microdeletions likely harbors a cis-acting imprinting control element that is necessary for establishing and/or maintaining methylation at GNAS exon A/B, thus allowing normal Gas expression in the proximal renal tubules. In the presence of either of the two microdeletions, parathyroid hormone resistance appears to develop over time, as documented in an affected individual who was diagnosed at birth with the 4.4-kb deletion of STX16 and who had normal serum parathyroid hormone levels until the age of 21 mo.	Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Massgen Hosp Children, Pediat Nephrol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; Nemours Childrens Clin, Jacksonville, FL USA; Mayo Clin & Mayo Grad Sch Med, Jacksonville, FL USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tulane University; Mayo Clinic	Bastepe, M (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Dept Med, 50 Blossom St,WEL 5, Boston, MA 02114 USA.	bastepe@helix.mgh.harvard.edu	Linglart, Agnès/A-8047-2016; Bastepe, Murat/GQQ-3389-2022	Linglart, Agnès/0000-0003-3455-002X; Bastepe, Murat/0000-0002-2643-3504	NIDDK NIH HHS [K01 DK062973, KO1 DK-062973-01] Funding Source: Medline; PHS HHS [R01 46718-10] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK062973] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Bastepe M, 2001, HUM MOL GENET, V10, P1231, DOI 10.1093/hmg/10.12.1231; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; CAMPBELL R, 1994, J MED GENET, V31, P607, DOI 10.1136/jmg.31.8.607; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Ischia R, 1997, J BIOL CHEM, V272, P11657; ISHIKAWA Y, 1990, J BIOL CHEM, V265, P8458; Juppner H, 1998, P NATL ACAD SCI USA, V95, P11798, DOI 10.1073/pnas.95.20.11798; KEHLENBACH RH, 1994, NATURE, V372, P804; LEVINE MA, 2002, PRINCIPLES BONE BIOL, V2, P1137; Li T, 2000, GENOMICS, V69, P295, DOI 10.1006/geno.2000.6337; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Liu J, 2005, HUM MOL GENET, V14, P95, DOI 10.1093/hmg/ddi009; Liu J, 2003, J CLIN ENDOCR METAB, V88, P4336, DOI 10.1210/jc.2003-030393; Mahmud FH, 2005, PEDIATRICS, V115, pE242, DOI 10.1542/peds.2004-1878; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P4736, DOI 10.1210/jc.2002-020183; Marguet C, 1997, HORM RES, V48, P120, DOI 10.1159/000185501; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Spahn L, 2003, NAT GENET, V35, P11, DOI 10.1038/ng0903-11; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; SWAROOP A, 1991, NUCLEIC ACIDS RES, V19, P4725, DOI 10.1093/nar/19.17.4725; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zheng H, 2001, J CLIN ENDOCR METAB, V86, P4627, DOI 10.1210/jc.86.10.4627	35	150	158	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					804	814		10.1086/429932	http://dx.doi.org/10.1086/429932			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15800843	Green Published, Bronze			2022-12-18	WOS:000228198300008
J	Meijers-Heijboer, H; Wijnen, J; Vasen, H; Wasielewski, M; Wagner, A; Hollestelle, A; Elstrodt, F; van den Bos, R; de Snoo, A; Fat, GTA; Brekelmans, C; Jagmohan, S; Franken, P; Verkuijlen, P; van den Ouweland, A; Chapman, P; Tops, C; Moslein, G; Burn, J; Lynch, H; Klijn, J; Fodde, R; Schutte, M				Meijers-Heijboer, H; Wijnen, J; Vasen, H; Wasielewski, M; Wagner, A; Hollestelle, A; Elstrodt, F; van den Bos, R; de Snoo, A; Fat, GTA; Brekelmans, C; Jagmohan, S; Franken, P; Verkuijlen, P; van den Ouweland, A; Chapman, P; Tops, C; Moslein, G; Burn, J; Lynch, H; Klijn, J; Fodde, R; Schutte, M			The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							S-PHASE CHECKPOINT; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; GENOMIC DELETIONS; SUPPRESSION; PATHWAYS; REPAIR; BRCA1; GENE	Because of genetic heterogeneity, the identification of breast cancer-susceptibility genes has proven to be exceedingly difficult. Here, we define a new subset of families with breast cancer characterized by the presence of colorectal cancer cases. The 1100delC variant of the cell cycle checkpoint kinase CHEK2 gene was present in 18% of 55 families with hereditary breast and colorectal cancer (HBCC) as compared with 4% of 380 families with non-HBCC (P < .001), thus providing genetic evidence for the HBCC phenotype. The CHEK2 1100delC mutation was, however, not the major predisposing factor for the HBCC phenotype but appeared to act in synergy with another, as-yet-unknown susceptibility gene(s). The unequivocal definition of the HBCC phenotype opens new avenues to search for this putative HBCC-susceptibility gene.	Erasmus MC, Dept Med Oncol, Josephine Nefkens Inst BE424, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Gastroenterol, Leiden, Netherlands; Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Dusseldorf, Dept Surg, D-4000 Dusseldorf, Germany; Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Newcastle University - UK; Heinrich Heine University Dusseldorf; Creighton University	Schutte, M (corresponding author), Erasmus MC, Dept Med Oncol, Josephine Nefkens Inst BE424, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Fodde, Riccardo/AAW-9394-2021	Fodde, Riccardo/0000-0001-9839-4324; Burn, John/0000-0002-9823-2322; Hollestelle, Antoinette/0000-0003-1166-1966; Vasen, Hans/0000-0003-2682-2603				Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; LYNCH HT, 1972, J AMER MED ASSOC, V222, P1631, DOI 10.1001/jama.222.13.1631; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MEIJERSHEIJBOER.H, IN PRESS J CLIN ONCO; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sodha N, 2002, HUM MUTAT, V19, P173, DOI 10.1002/humu.10031; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; vanderLuijt RB, 1997, HUM MUTAT, V9, P7, DOI 10.1002/(SICI)1098-1004(1997)9:1<7::AID-HUMU2>3.0.CO;2-8; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	17	150	153	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1308	1314		10.1086/375121	http://dx.doi.org/10.1086/375121			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12690581	Green Published, Bronze			2022-12-18	WOS:000182474400024
J	Froenicke, L; Anderson, LK; Wienberg, J; Ashley, T				Froenicke, L; Anderson, LK; Wienberg, J; Ashley, T			Male mouse recombination maps for each autosome identified by chromosome painting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEIOTIC RECOMBINATION; SYNAPTONEMAL COMPLEXES; CROSSING-OVER; SACCHAROMYCES-CEREVISIAE; LYCOPERSICON-ESCULENTUM; CROSSOVER INTERFERENCE; CHIASMA DISTRIBUTION; PACHYTENE BIVALENTS; HUMAN SPERMATOCYTES; SOLANACEOUS PLANTS	Linkage maps constructed from genetic analysis of gene order and crossover frequency provide few clues to the basis of genomewide distribution of meiotic recombination, such as chromosome structure, that influences meiotic recombination. To bridge this gap, we have generated the first cytological recombination map that identifies individual autosomes in the male mouse. We prepared meiotic chromosome (synaptonemal complex [SC]) spreads from 110 mouse spermatocytes, identified each autosome by multicolor fluorescence in situ hybridization of chromosome-specific DNA libraries, and mapped 1 2,000 sites of recombination along individual autosomes, using immunolocalization of MLH1, a mismatch repair protein that marks crossover sites. We show that SC length is strongly correlated with crossover frequency and distribution. Although the length of most SCs corresponds to that predicted from their mitotic chromosome length rank, several SCs are longer or shorter than expected, with corresponding increases and decreases in MLH1 frequency. Although all bivalents share certain general recombination features, such as few crossovers near the centromeres and a high rate of distal recombination, individual bivalents have unique patterns of crossover distribution along their length. In addition to SC length, other, as-yet-unidentified, factors influence crossover distribution leading to hot regions on individual chromosomes, with recombination frequencies as much as six times higher than average, as well as cold spots with no recombination. By reprobing the SC spreads with genetically mapped BACs, we demonstrate a robust strategy for integrating genetic linkage and physical contig maps with mitotic and meiotic chromosome structure.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Tech Univ, Inst Human Genet, Munich, Germany; GSF Forschungszentrum, Munich, Germany; Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; Natl Canc Inst, Comparat Mol Cytogenet Sect, Genet Branch, Frederick, MD USA	Yale University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Colorado State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashley, T (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055300] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM55300] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson LK, 1999, GENETICS, V151, P1569; Badge RM, 2000, HUM MOL GENET, V9, P1239, DOI 10.1093/hmg/9.8.1239; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Blake JA, 2002, NUCLEIC ACIDS RES, V30, P113, DOI 10.1093/nar/30.1.113; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 2002, GENETICS, V160, P1123; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Carpenter ATC, 1988, GENETIC RECOMBINATIO, P529, DOI [10.1038/ng1287, DOI 10.1038/NG1287]; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; EVANS E, 1996, GENETIC VARIANTS STR, V2, P1446; EVANS EP, 1989, GENETIC VARIANTS STR, P576; Hassold T, 2000, HUM MOL GENET, V9, P2409, DOI 10.1093/hmg/9.16.2409; Heng HHQ, 2001, GENOME, V44, P293, DOI 10.1139/gen-44-2-293; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; HULTEN MA, 1995, CHROMOSOMA, V104, P223, DOI 10.1007/BF00352187; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; JOHN B, 1985, GENETICA, V66, P183, DOI 10.1007/BF00128039; JONES GH, 1984, CONTROLLING EVENTS M, P293; Kaback DB, 1999, GENETICS, V152, P1475; King J, 2002, GENETICS, V161, P307; Koehler KE, 2002, GENETICS, V162, P297; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Korenberg JR, 1999, GENOME RES, V9, P514; LAFUSE WP, 1986, IMMUNOGENETICS, V24, P352, DOI 10.1007/BF00377952; LAWRIE NM, 1995, CHROMOSOMA, V140, P308; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LUCIANI JM, 1975, CHROMOSOMA, V52, P275, DOI 10.1007/BF00332116; LUCIANI JM, 1988, CHROMOSOMA, V97, P19, DOI 10.1007/BF00331791; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Lynn A, 2000, GENOME RES, V10, P1319, DOI 10.1101/gr.138100; MATHER K, 1937, CYTOLOGIA, V8, P514; MOSES MJ, 1977, CHROMOSOMA, V60, P345, DOI 10.1007/BF00292859; Muller S, 2002, CHROMOSOME RES, V10, P223, DOI 10.1023/A:1015296122470; Nachman MW, 1996, GENETICS, V142, P537; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Osoegawa K, 2000, GENOME RES, V10, P116; PATHAK S, 1976, CYTOGENET CELL GENET, V17, P1, DOI 10.1159/000130681; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Pigozzi MI, 1999, GENOME, V42, P308, DOI 10.1139/gen-42-2-308; Pigozzi MI, 2001, CYTOGENET CELL GENET, V95, P129, DOI 10.1159/000059334; RABBITTS P, 1995, NAT GENET, V9, P369, DOI 10.1038/ng0495-369; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Schneider JA, 2002, HUM MOL GENET, V11, P207, DOI 10.1093/hmg/11.3.207; SHENKAR R, 1991, MOL CELL BIOL, V11, P1813, DOI 10.1128/MCB.11.4.1813; SHERMAN JD, 1995, GENETICS, V141, P683; SOLARI AJ, 1980, CHROMOSOMA, V81, P315, DOI 10.1007/BF00368145; STACK SM, 1989, GENOME, V32, P486, DOI 10.1139/g89-473; STACK SM, 1986, AM J BOT, V73, P264, DOI 10.2307/2444181; STACK SM, 1984, J CELL SCI, V71, P159; Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734; Wienberg J, 2000, COMPARATIVE GENOMICS, P207; Wintle RF, 1997, GENOMICS, V40, P409, DOI 10.1006/geno.1996.4572; WU TC, 1995, GENETICS, V140, P55; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; ZICKLER D, 1992, GENETICS, V132, P135	59	150	156	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1353	1368		10.1086/344714	http://dx.doi.org/10.1086/344714			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12432495	Green Published, Bronze			2022-12-18	WOS:000179586800010
J	Ludecke, HJ; Schaper, J; Meinecke, P; Momeni, P; Gross, S; von Holtum, D; Hirche, H; Abramowicz, MJ; Albrecht, B; Apacik, C; Christen, HJ; Claussen, U; Devriendt, K; Fastnacht, E; Forderer, A; Friedrich, U; Goodship, THJ; Greiwe, M; Hamm, H; Hennekam, RCM; Hinkel, GK; Hoeltzenbein, M; Kayserili, H; Majewski, F; Mathieu, M; McLeod, R; Midro, AT; Moog, U; Nagai, T; Niikawa, N; Orstavik, KH; Plochl, E; Seitz, C; Schmidtke, J; Tranebjaerg, L; Tsukahara, M; Wittwer, B; Zabel, B; Gillessen-Kaesbach, G; Horsthemke, B				Ludecke, HJ; Schaper, J; Meinecke, P; Momeni, P; Gross, S; von Holtum, D; Hirche, H; Abramowicz, MJ; Albrecht, B; Apacik, C; Christen, HJ; Claussen, U; Devriendt, K; Fastnacht, E; Forderer, A; Friedrich, U; Goodship, THJ; Greiwe, M; Hamm, H; Hennekam, RCM; Hinkel, GK; Hoeltzenbein, M; Kayserili, H; Majewski, F; Mathieu, M; McLeod, R; Midro, AT; Moog, U; Nagai, T; Niikawa, N; Orstavik, KH; Plochl, E; Seitz, C; Schmidtke, J; Tranebjaerg, L; Tsukahara, M; Wittwer, B; Zabel, B; Gillessen-Kaesbach, G; Horsthemke, B			Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METACARPOPHALANGEAL PATTERN PROFILES; LANGER-GIEDION SYNDROME; CONE-SHAPED EPIPHYSES; SUGIO-KAJII SYNDROME; MENTAL-RETARDATION; DELETION; PATIENT; TRANSLOCATION	Tricho-rhino-phalangeal syndrome (TRPS) is characterized by craniofacial and skeletal abnormalities. Three subtypes have been described: TRPS I, caused by mutations in the TRPS1 gene on chromosome 8; TRPS II, a microdeletion syndrome affecting the TRPS1 and EXT1 genes; and TRPS III, a form with severe brachydaayly, due to short metacarpals, and severe short stature, but without exostoses. To investigate whether TRPS III is caused by TRPS1 mutations and to establish a genotype-phenotype correlation in TRPS, we performed extensive mutation analysis and evaluated the height and degree of brachydactyly in patients with TRPS I or TRPS III. We found 35 different mutations in 44 of 51 unrelated patients. The detection rate (86%) indicates that TRPS1 is the major locus for TRPS I and TRPS III. We did not find any mutation in the parents of sporadic patients or in apparently healthy relatives of familial patients, indicating complete penetrance of TRPS1 mutations. Evaluation of skeletal abnormalities of patients with TRPS1 mutations revealed a wide clinical spectrum. The phenotype was variable in unrelated, age- and sex-matched patients with identical mutations, as well as in families. Four of the five missense mutations alter the GATA DNA-binding zinc finger, and six of the seven unrelated patients with these mutations may be classified as having TRPS III. Our data indicate that TRPS III is at the severe end of the TRPS spectrum and that it is most often caused by a specific class of mutations in the TRPS1 gene.	Univ Essen Gesamthsch Klinikum, Inst Human Genet, D-45122 Essen, Germany; Univ Essen Gesamthsch Klinikum, Zent Inst Rontgendiagnost Kinderradiol, D-45122 Essen, Germany; Univ Essen Gesamthsch Klinikum, Inst Med Informat Biometrie & Epidemiol, D-45122 Essen, Germany; Altonaer Kinderkrankenhaus, Hamburg, Germany; Free Univ Brussels, Hop Erasme, Gen Med Serv, B-1070 Brussels, Belgium; Kinderzentrum Munchen, Munich, Germany; Kinderkrankenhaus Bult, Hannover, Germany; Med Hsch Hannover, Inst Humangenet, Hannover, Germany; Inst Humangenet & Anthropol, Jena, Germany; Univ Ziekenhuis St Rafael, Ctr Human Genet, B-3000 Louvain, Belgium; Kreiskrankenhaus Ludenscheid, Zentrum Kinder & Jugendmed, Ludenscheid, Germany; Praxis Kinderheilkunde, Fulda, Germany; Univ Aarhus, Inst Human Genet, Aarhus, Denmark; Univ Newcastle Upon Tyne, Dept Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Klinikum Lubeck, Inst Humangenet, Lubeck, Germany; Univ Wurzburg, Klin & Poliklin Haut & Geschlechtskrankheiten, Wurzburg, Germany; Univ Amsterdam, Dept Clin Genet & Pediat, Amsterdam, Netherlands; Tech Univ Dresden, Inst Med Genet, D-8027 Dresden, Germany; Univ Greifswald, Inst Humangenet, Greifswald, Germany; Univ Istanbul, Div Med Genet, Inst Child Hlth, Istanbul, Turkey; Univ Dusseldorf, Inst Humangenet & Anthropol, D-4000 Dusseldorf, Germany; CHU Amiens, Clin Genet Unit, Amiens, France; Alberta Childrens Prov Gen Hosp, Dept Med Genet, Calgary, AB T2T 5C7, Canada; Med Univ Bialystok, Dept Clin Genet, Bialystok, Poland; Stichting Klin Genet, Maastricht, Netherlands; Dokkyo Univ, Koshigaya Hosp, Sch Med, Dept Pediat, Koshigaya, Japan; Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan; Ulleval Sykehus, Avdeling Med Genet, Oslo, Norway; St Johanns Spital, Klin Genet, Salzburg, Austria; Univ Tromso Hosp, Regionsykehuset Tromso, Dept Med Genet, N-9012 Tromso, Norway; Yamaguchi Univ, Sch Allied Hlth Sci, Yamaguchi 753, Japan; Univ Munster, Inst Humangenet, D-4400 Munster, Germany; Univ Mainz Klinikum, Kinderklin & Poliklin, Mainz, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Hannover Medical School; Aarhus University; Newcastle University - UK; University of Lubeck; University of Wurzburg; University of Amsterdam; Technische Universitat Dresden; Ernst Moritz Arndt Universitat Greifswald; Istanbul University; Heinrich Heine University Dusseldorf; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Alberta Childrens Hospital; University of Calgary; Medical University of Bialystok; Maastricht University; Dokkyo Medical University; Nagasaki University; University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; Yamaguchi University; University of Munster; Johannes Gutenberg University of Mainz	Ludecke, HJ (corresponding author), Univ Essen Gesamthsch Klinikum, Inst Human Genet, D-45122 Essen, Germany.		Midro, Alina/T-8523-2018; Hoeltzenbein, Maria/AAP-4145-2020; Abramowicz, Marc/AAX-6419-2020; Kayserili, Hülya/AAA-5593-2021	Midro, Alina/0000-0002-9889-1969; Hoeltzenbein, Maria/0000-0002-2451-4247; Kayserili, Hülya/0000-0003-0376-499X; Abramowicz, Marc/0000-0003-0623-8768				Brandt CA, 1997, HUM GENET, V100, P334, DOI 10.1007/s004390050512; FELMAN AH, 1977, AM J ROENTGENOL, V129, P631, DOI 10.2214/ajr.129.4.631; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GARN SM, 1972, RADIOLOGY, V105, P375, DOI 10.1148/105.2.375; Giedion A, 1998, PEDIATR RADIOL, V28, P751, DOI 10.1007/s002470050460; GIEDION A, 1973, HELV PAEDIATR ACTA, V28, P249; GIEDION A, 1968, ERGEBNISSE MED RADIO, P59; Greulich W, 1959, RADIOGRAPHIC ATLAS S; HAMERS A, 1990, EUR J PEDIATR, V149, P618, DOI 10.1007/BF02034746; HOSENFELD D, 1991, CLIN GENET, V39, P396; Itin PH, 1996, DERMATOLOGY, V193, P349, DOI 10.1159/000246290; KAJII T, 1994, AM J MED GENET, V49, P349, DOI 10.1002/ajmg.1320490323; LANGER LO, 1984, AM J MED GENET, V19, P81, DOI 10.1002/ajmg.1320190110; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; Ludecke HJ, 1999, HUM GENET, V105, P619, DOI 10.1007/s004390051154; MARCHAU FE, 1993, AM J MED GENET, V45, P450, DOI 10.1002/ajmg.1320450411; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; NAGAI T, 1994, AM J MED GENET, V49, P278, DOI 10.1002/ajmg.1320490307; Nardmann J, 1997, HUM GENET, V99, P638, DOI 10.1007/s004390050420; Naselli A, 1998, PEDIATR RADIOL, V28, P851, DOI 10.1007/s002470050481; NEYZI O, 1973, ENV CHILD HLTH, V19, P5; NIIKAWA N, 1986, AM J MED GENET, V24, P759, DOI 10.1002/ajmg.1320240420; POZNANSK.AK, 1972, RADIOLOGY, V104, P1; POZNANSKI A K, 1974, Birth Defects Original Article Series, V10, P209; Poznanski AK, 1997, PEDIATR RADIOL, V27, P358, DOI 10.1007/s002470050152; Sasaki T, 1997, J MED GENET, V34, P335, DOI 10.1136/jmg.34.4.335; SUGIO Y, 1984, AM J MED GENET, V19, P741, DOI 10.1002/ajmg.1320190414; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; van Wieringen JC., 1971, GROWTH DIAGRAMS 1965; Vilain C, 1999, AM J MED GENET, V85, P495, DOI 10.1002/(SICI)1096-8628(19990827)85:5<495::AID-AJMG12>3.3.CO;2-B; YAMAMOTO Y, 1989, AM J MED GENET, V32, P524, DOI 10.1002/ajmg.1320320420	31	150	162	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					81	91		10.1086/316926	http://dx.doi.org/10.1086/316926			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11112658	Bronze, Green Published			2022-12-18	WOS:000166399900007
J	Tremblay, M; Vezina, H				Tremblay, M; Vezina, H			New estimates of intergenerational time intervals for the calculation of age and origins of mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION; QUEBEC; DISEQUILIBRIUM; VARIABILITY; DEMOGRAPHY; LINKAGE; HISTORY	Intergenerational time intervals are frequently used in human population-genetics studies concerned with the ages and origins of mutations. In most cases, mean intervals of 20 or 25 years are used, regardless of the demographic characteristics of the population under study. Although these characteristics may vary from prehistoric to historical times, we suggest that this value is probably too low and that the ages of some mutations may have been underestimated. Analyses were performed by using the BALSAC Population Register (Quebec, Canada), from which several intergenerational comparisons can be made. Family reconstitutions were used to measure interval lengths and variations in descending lineages. Various parameters were considered, such as spouse age at marriage, parental age, and reproduction levels. Mother-child and father-child intervals were compared. Intergenerational male and female intervals were also analyzed in 100 extended ascending genealogies. Results showed that a mean value of 30 years is a better estimate of intergenerational intervals than 20 or 25 years. As marked differences between male and female interval length were observed, specific values are proposed for mtDNA, autosomal, X-chromosomal, and Y-chromosomal loci. The applicability of these results for age estimates of mutations is discussed.	Univ Quebec, Interuniv Inst Populat Res, Chicoutimi, PQ G7H 2B1, Canada	University of Quebec; University of Quebec Chicoutimi	Tremblay, M (corresponding author), Univ Quebec, Interuniv Inst Populat Res, 555 Blvd Univ, Chicoutimi, PQ G7H 2B1, Canada.							Alesan A, 1999, AM J PHYS ANTHROPOL, V110, P285, DOI 10.1002/(SICI)1096-8644(199911)110:3<285::AID-AJPA3>3.3.CO;2-U; BECKER S, 1993, BIOMEDICAL DEMOGRAPH, P21; BOQUETAPPEL JP, 1997, AM J PHYS ANTHROPOL, V102, P569; BOQUETAPPEL JP, 1996, AM J PHYS ANTHROPOL, V99, P571; BOUCHARD G, 1986, HIST METHOD, V19, P9, DOI 10.1080/01615440.1986.10594162; BOUCHARD G, 1992, HIST METHOD, V25, P67, DOI 10.1080/01615440.1992.9956344; BOUCHARD G, 1989, CAN STUD POPUL, V16, P61; BOUCHARD G, 1998, PROJECT BALSAC RAPPO; BOUCHARD G, 1995, INFORMATION KNOWLEDG, P201; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHARBONNEAU H, 1993, 1 FRENCH CANADIAN PI; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; FORSTER P, 1996, THESIS HAMBURG U HAM; Heyer E, 1997, HUM BIOL, V69, P209; HEYER E, 1995, AM J HUM GENET, V56, P970; JOMPHE M, 1997, 3C97 IREP PROGR RECH; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; KONIGSBERG LW, 1992, AM J PHYS ANTHROPOL, V89, P235, DOI 10.1002/ajpa.1330890208; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Moisio AL, 1996, AM J HUM GENET, V59, P1243; Pouyez C., 1983, SAGUENAYENS INTRO HI; Rallu Jean-Louis, 1991, EUROPEAN POPULATION, Vi; Riley A, 1996, POPULATION, V51, P883, DOI 10.2307/1534358; ROSENBERG M, 1991, ANN HUM BIOL, V18, P207, DOI 10.1080/03014469100001532; Roy R, 1988, Cah Que Demogr, V17, P113; Saunders SR., 1992, CANADIAN SOC FORENSI, V25, P97, DOI [10.1080/00085030.1992.10757005, DOI 10.1080/00085030.1992.10757005]; Shryock H. S., 1976, METHODS MAT DEMOGRAP; Slatkin M, 1997, AM J HUM GENET, V60, P447; Thompson EA, 1996, MOL PHYLOGENET EVOL, V5, P220, DOI 10.1006/mpev.1996.0015; Thompson EA, 1997, AM J HUM GENET, V60, P197; TRYGGVADOTTIR L, 1994, ANN HUM BIOL, V21, P179, DOI 10.1080/03014469400003202; Varilo T, 1996, AM J HUM GENET, V58, P506	32	150	151	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					651	658		10.1086/302770	http://dx.doi.org/10.1086/302770			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677323	Green Published, Bronze			2022-12-18	WOS:000088373100030
J	Santorelli, FM; Mak, SC; ElSchahawi, M; Casali, C; Shanske, S; Baram, TZ; Madrid, RE; DiMauro, S				Santorelli, FM; Mak, SC; ElSchahawi, M; Casali, C; Shanske, S; Baram, TZ; Madrid, RE; DiMauro, S			Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363A)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLINICAL-FEATURES; DNA; MELAS; MTDNA	A novel G8363A mutation in the mtDNA tRNA(Lys) gene was associated, in two unrelated families, with a syndrome consisting of encephalomyopathy, sensorineural hearing loss, and hypertrophic cardiomyopathy. Muscle biopsies from the probands showed mitochondrial proliferation and partial defects of complexes I, III, and IV of the electron-transport chain. The G8363A mutation was very abundant (> 95%) in muscle samples from the probands and was less copious in blood from 18 maternal relatives (mean 81.3% +/- 8.5%). Single-muscle-fiber analysis showed significantly higher levels of mutant genomes in cytochrome c oxidase-negative fibers than in cytochrome c oxidase-positive fibers. The mutation was not found in > 200 individuals, including normal controls and patients with other mitochondrial encephalomyopathies, thus fulfilling accepted criteria for pathogenicity.	COLUMBIA UNIV COLL PHYS & SURG,DEPT NEUROL,H HOUSTON MERRIT CTR MUSCULAR RES & RELATED DISOR,NEW YORK,NY 10032; UNIV ROMA LA SAPIENZA,IST CLIN MALATTIE NERVOSE & MENTALI,I-00185 ROME,ITALY; CHILDRENS HOSP LOS ANGELES,DEPT PEDIAT,LOS ANGELES,CA 90027; NEW YORK STATE INST BASIC RES DEV DISABIL,STATEN ISL,NY 10314	Columbia University; Sapienza University Rome; Children's Hospital Los Angeles; Institute for Basic Research in Developmental Disabilities			Baram, Tallie Z/J-6447-2014; Santorelli, Filippo M/ABE-5124-2020	Santorelli, Filippo M/0000-0002-1359-9062	NICHD NIH HHS [HD32062] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CASALI, 1995, BIOCHEM BIOPH RES CO, V213, P588; CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; DUTKA S, 1993, NUCLEIC ACIDS RES, V21, P4025, DOI 10.1093/nar/21.17.4025; HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102; JAHN M, 1991, NATURE, V352, P258, DOI 10.1038/352258a0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913; MORAES CT, 1992, AM J HUM GENET, V50, P934; Ozawa M., 1995, American Journal of Human Genetics, V57, pA223; SAKS ME, 1994, SCIENCE, V263, P191, DOI 10.1126/science.7506844; SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972; SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; SILVESTRI G, 1994, HUM MUTAT, V3, P37, DOI 10.1002/humu.1380030107; SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200; SUOMALAINEN A, 1992, J NEUROL SCI, V111, P222, DOI 10.1016/0022-510X(92)90074-U; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	23	150	156	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					933	939						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651277				2022-12-18	WOS:A1996UH19200005
J	LARSSON, NG; TULINIUS, MH; HOLME, E; OLDFORS, A; ANDERSEN, O; WAHLSTROM, J; AASLY, J				LARSSON, NG; TULINIUS, MH; HOLME, E; OLDFORS, A; ANDERSEN, O; WAHLSTROM, J; AASLY, J			SEGREGATION AND MANIFESTATIONS OF THE MTDNA TRANS RNALYS A-]G(8344) MUTATION OF MYOCLONUS EPILEPSY AND RAGGED-RED FIBERS (MERRF) SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL ENCEPHALOMYOPATHY MERRF; KEARNS-SAYRE SYNDROME; DNA MUTATION; DISEASE; DEFICIENCY; CHILDHOOD; MYOPATHY; PATIENT; GENOMES; MUSCLE	We have studied the segregation and manifestations of the tRNA(Lys) A-->G(8344) mutation of mtDNA. Three unrelated patients with myoclonus epilepsy and ragged-red fibers (MERRF) syndrome were investigated, along with 30 of their maternal relatives. Mutated mtDNA was not always found in the offspring of women carrying the tRNA(Lys) mutation. Four women had 10%-33% of mutated mtDNA in lymphocytes, and no mutated mtDNA was found in 7 of their 14 investigated children. The presence of mutated mtDNA was excluded at a level of 3:1,000. Five women had a proportion of 43%-73% mutated mtDNA in lymphocytes, and mutated mtDNA was found in all their 12 investigated children. This suggests that the risk for transmission of mutated mtDNA to the offspring increases if high levels are present in the mother and that, above a threshold level of 35%-40%, it is very likely that transmission will occur to all children. The three patients with MERRF syndrome had, in muscle, both 94%-96% mutated mtDNA and biochemical and histochemical evidence of a respiratory-chain dysfunction. Four relatives had a proportion of 61%-92% mutated mtDNA in muscle, and biochemical measurements showed a normal respiratory-chain function in muscle in all cases. These findings suggest that >92% of mtDNA with the tRNA(Lys) mutation in muscle is required to cause a respiratory-chain dysfunction that can be detected by biochemical methods. There was a positive correlation between the levels of mtDNA with the tRNA(Lys) mutation in lymphocytes and the levels in muscle, in all nine investigated cases. The levels of mutated mtDNA were higher in muscle than in lymphocytes in all cases. In two of the patients with MERRF syndrome, muscle specimens were obtained at different times. In both cases, biochemical measurements revealed a deteriorating respiratory-chain function, and in one case a progressive increase in the amount of cytochrome c oxidase-deficient muscle fibers was found.	GOTHENBURG UNIV,DEPT CLIN CHEM,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT PEDIAT,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT PATHOL,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT NEUROL,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT CLIN GENET,S-41124 GOTHENBURG,SWEDEN; UNIV TRONDHEIM,DEPT NEUROL,TRONDHEIM,NORWAY	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg	LARSSON, NG (corresponding author), SAHLGRENS UNIV HOSP,DEPT CLIN CHEM,S-41345 GOTHENBURG,SWEDEN.		Larsson, Nils-Göran/GVS-5578-2022	Larsson, Nils-Göran/0000-0001-5100-996X; Oldfors, Anders/0000-0002-5758-7397				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; Ausubel F.M., 1989, SHORT PROTOCOLS MOL; BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H; BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HOLME E, UNPUB MULTIPLE SYMME; HOLT IJ, 1990, AM J HUM GENET, V46, P428; LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104; MIQUEL J, 1986, FREE RADICALS AGING, P51; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; NOER AS, 1991, AM J HUM GENET, V49, P715; OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; SCHOLTE HR, 1981, MITOCHONDRIA MUSCULA, P133; SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W; TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6; TULINIUS MH, 1991, J PEDIATR-US, V119, P251, DOI 10.1016/S0022-3476(05)80735-8; VILKKI J, 1990, AM J HUM GENET, V47, P95; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; YONEDA M, 1990, BIOCHEM INT, V21, P789; ZEVIANI M, 1991, AM J HUM GENET, V48, P203	30	150	152	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1201	1212						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463006				2022-12-18	WOS:A1992KC99500003
J	PTACEK, LJ; TRIMMER, JS; AGNEW, WS; ROBERTS, JW; PETAJAN, JH; LEPPERT, M				PTACEK, LJ; TRIMMER, JS; AGNEW, WS; ROBERTS, JW; PETAJAN, JH; LEPPERT, M			PARAMYOTONIA-CONGENITA AND HYPERKALEMIC PERIODIC PARALYSIS MAP TO THE SAME SODIUM-CHANNEL GENE LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADYNAMIA EPISODICA HEREDITARIA; MEMBRANE DEFECTS; MUSCLE; MYOTONIA	Paramyotonia congenita (PC), an autosomal dominant muscle disease, shares some clinical and electrophysiological similarities with another myotonic muscle disorder, hyperkalemic periodic paralysis (HYPP). However, clinical and electrophysiologic differences allow differentiation of the two disorders. The HYPP locus was recently shown to be linked to a skeletal muscle sodium-channel gene probe. We now report that PC maps to the same locus (LOD score 4.4, theta = 0 at assumed penetrance of .95). These linkage results, coupled with physiological data demonstrating abnormal sodium-channel function in patients with PC, implicate a sodium-channel gene as an important candidate for the site of mutation responsible for PC. Furthermore, this is strong evidence for the hypothesis that PC and HYPP are allelic disorders.	UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; SUNY STONY BROOK,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794; YALE UNIV,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06520	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University	PTACEK, LJ (corresponding author), UNIV UTAH,SCH MED,DEPT NEUROL 3R210,50 N MED DR,SALT LAKE CITY,UT 84132, USA.				NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NHGRI NIH HHS [8R01 HG00367] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARCHI RL, 1988, NEUROL CLIN, V6, P473, DOI 10.1016/S0733-8619(18)30855-7; DESILVA SM, 1990, MUSCLE NERVE, V13, P21, DOI 10.1002/mus.880130106; EULENBURG A, 1986, Z BL NEUROLOGIE, V5, P265; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEHMANNHORN F, 1981, MUSCLE NERVE, V4, P396, DOI 10.1002/mus.880040508; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEHMANNHORN F, 1983, MUSCLE NERVE, V6, P113, DOI 10.1002/mus.880060206; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P633, DOI 10.1002/mus.880100709; MOXLEY RT, 1989, NEUROLOGY, V39, P952, DOI 10.1212/WNL.39.7.952; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; RICH EC, 1894, MED NEWS, V65, P210; RIGGS JE, 1988, NEUROL CLIN, V6, P485, DOI 10.1016/S0733-8619(18)30856-9; RUDEL R, 1989, MUSCLE NERVE, V12, P281; STREIB EW, 1987, MUSCLE NERVE, V10, P603, DOI 10.1002/mus.880100704; SUBRAMONY SH, 1986, MUSCLE NERVE, V9, P700, DOI 10.1002/mus.880090804; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X	17	150	150	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					851	854						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1654742				2022-12-18	WOS:A1991GG66500016
J	JEFFREYS, AJ; TURNER, M; DEBENHAM, P				JEFFREYS, AJ; TURNER, M; DEBENHAM, P			THE EFFICIENCY OF MULTILOCUS DNA FINGERPRINT PROBES FOR INDIVIDUALIZATION AND ESTABLISHMENT OF FAMILY RELATIONSHIPS, DETERMINED FROM EXTENSIVE CASEWORK	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HUMAN MINISATELLITES; HYPERVARIABLE LOCI; ENZYMATIC AMPLIFICATION; OLIGONUCLEOTIDE PROBES; REPEAT; PATERNITY; MUTATION; MARKERS; TANDEM	The properties of human DNA fingerprints detected by multilocus minisatellite probes 33.6 and 33.15 have been investigated in 36 large sibships and in 1,702 Caucasian paternity cases involving the analysis of over 180,000 DNA fingerprint bands. The degree of overlap of minisatellite loci detected by these two probes is shown to be negligible (approximately 1%), and the resulting DNA fingerprints are therefore derived from independent sets of hypervariable loci. The level of allelism and linkage between different hypervariable DNA fragments scored with these probes is also low, implying substantial statistical independence of DNA fragments. Variation between the DNA fingerprints of different individuals indicates that the probability of chance identity is very low (<< 10(-7) per probe). Empirical observations and theoretical considerations both indicate that genetic heterogeneity between subpopulations is unlikely to affect substantially the statistical evaluation of DNA fingerprints, at least among Caucasians. In paternity analysis, the proportion of nonmaternal DNA fragments in a child which cannot be attributed to the alleged father is shown to be an efficient statistic for distinguishing fathers from nonfathers, even in the presence of minisatellite mutation. Band-sharing estimates between a claimed parent and a child can also distinguish paternity from nonpaternity, though with less efficiency than comparison of a trio of mother, child, and alleged father.	CELLMARK DIAGNOST,ABINGDON,OXON,ENGLAND		JEFFREYS, AJ (corresponding author), UNIV LEICESTER,DEPT GENET,UNIV RD,LEICESTER LE1 7RH,ENGLAND.							ALI S, 1986, HUM GENET, V74, P239; ARMOUR JAL, 1989, GENOMICS, V4, P328, DOI 10.1016/0888-7543(89)90338-8; ARMOUR JAL, 1989, NUCLEIC ACIDS RES, V17, P4925, DOI 10.1093/nar/17.13.4925; ARMOUR JAL, 1990, GENOMICS, V8, P501, DOI 10.1016/0888-7543(90)90037-U; BALAZS I, 1989, AM J HUM GENET, V44, P182; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BROOKFIELD JFY, 1989, IMA J MATH APPL MED, V6, P111; COHEN JE, 1990, AM J HUM GENET, V46, P358; EVETT IW, 1989, J FORENSIC SCI SOC, V29, P191, DOI 10.1016/S0015-7368(89)73247-3; EVETT IW, 1989, J FORENSIC SCI SOC, V29, P249, DOI 10.1016/S0015-7368(89)73259-X; FLINT J, 1989, HUM GENET, V83, P257, DOI 10.1007/BF00285167; FOWLER SJ, 1988, HUM GENET, V79, P142, DOI 10.1007/BF00280553; GEORGES M, 1988, CYTOGENET CELL GENET, V47, P127, DOI 10.1159/000132529; GILL P, 1987, FORENSIC SCI INT, V35, P145, DOI 10.1016/0379-0738(87)90050-8; GILL P, 1987, ELECTROPHORESIS, V8, P38, DOI 10.1002/elps.1150080109; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HELMINEN P, 1988, LANCET, V1, P574; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; HILL WG, 1986, NATURE, V322, P290, DOI 10.1038/322290a0; HORN GT, 1989, NUCLEIC ACIDS RES, V17, P2140, DOI 10.1093/nar/17.5.2140; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; JEFFREYS AJ, 1985, NATURE, V317, P818, DOI 10.1038/317818a0; JEFFREYS AJ, 1986, AM J HUM GENET, V39, P11; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1987, ANIM GENET, V18, P1, DOI 10.1111/j.1365-2052.1987.tb00739.x; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JEFFREYS AJ, 1987, NUCLEIC ACIDS RES, V15, P2823, DOI 10.1093/nar/15.7.2823; JEFFREYS AJ, 1990, GENOMICS, V70, P449; KELLY R, 1989, GENOMICS, V5, P844, DOI 10.1016/0888-7543(89)90126-2; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LITT M, 1989, AM J HUM GENET, V44, P397; LYNCH M, 1988, MOL BIOL EVOL, V5, P584; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SMITH JC, 1990, J FORENSIC SCI SOC, V30, P3, DOI 10.1016/S0015-7368(90)73297-5; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; VASSART G, 1987, SCIENCE, V235, P683, DOI 10.1126/science.2880398; WEBER JL, 1989, AM J HUM GENET, V44, P388; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; 1988, DNA PROFILING IMMIGR	46	150	155	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					824	840						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	FK897	2018036				2022-12-18	WOS:A1991FK89700002
J	Zeharia, A; Shaag, A; Houtkooper, RH; Hindi, T; de Lonlay, P; Erez, G; Hubert, L; Saada, A; de Keyzer, Y; Eshel, G; Vaz, FM; Pines, O; Elpeleg, O				Zeharia, Avraharn; Shaag, Avraham; Houtkooper, Riekelt H.; Hindi, Tareq; de Lonlay, Pascale; Erez, Gilli; Hubert, Laurence; Saada, Ann; de Keyzer, Yves; Eshel, Gideon; Vaz, Frederic M.; Pines, Ophry; Elpeleg, Orly			Mutations in LPIN1 Cause Recurrent Acute Myoglobinuria in Childhood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYSTROPHY FLD MUTATION; SACCHAROMYCES-CEREVISIAE; LIPIN HOMOLOG; METABOLISM; GENE; LIPODYSTROPHY; MOUSE	Recurrent episodes of life-threatening myoglobinuria in childhood are caused by inborn errors of glycogenolysis, mitochondrial fatty acid beta-oxidation, and oxidative phosphorylation. Nonetheless, approximately half of the patients do not suffer from a defect in any of these pathways. Using homozygosity mapping, we identified six deleterious mutations in the LPIN1 gene in patients who presented at 2-7 years of age with recurrent, massive rhabdomyolysis. The LPIN1 gene encodes the muscle-specific phosphatidic acid phosphatase, a key enzyme in triglyceride and membrane phospholipid biosynthesis. Of six individuals who developed statin-induced myopathy, one was a carrier for Glu769Gly, a pathogenic mutation in the LPIN1 gene. Analysis of phospholipid content disclosed accumulation of phosphatidic acid and lysophospholipids in Muscle tissue of the more severe genotype. Mutations in the LPIN1 gene cause recurrent rhabdomyolysis in childhood, and a carrier state may predispose for statin-induced myopathy.	[Zeharia, Avraharn; Shaag, Avraham; Saada, Ann; Elpeleg, Orly] Hebrew Univ Jerusalem, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; [Zeharia, Avraharn] Tel Aviv Univ, Schneider Childrens Med Ctr, Day Hospitalizat Unit, IL-49202 Petah Tiqwa, Israel; [Zeharia, Avraharn] Tel Aviv Univ, Sackler Sch Med, IL-49202 Petah Tiqwa, Israel; [Houtkooper, Riekelt H.; Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Zeharia, Avraharn; Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Hindi, Tareq] Augusta Victoria Hosp, Dept Pediat, Jerusalem, Israel; [de Lonlay, Pascale; Hubert, Laurence; de Keyzer, Yves] Univ Paris 05, INSERM U781, AP HP,Serv Malad Metab, Hop Necker Enfants Malad,Dept Pediat, F-75015 Paris, France; [Erez, Gilli] Hadassah Hebrew Univ, Med Ctr, Ctr Res Prevent & Treatment Atherosclerosis, IL-91120 Jerusalem, Israel; [Erez, Gilli] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, IL-91120 Jerusalem, Israel; [Eshel, Gideon] Assaf Harofeh Med Ctr, Pediat Intens Care Unit, IL-70300 Zerifin, Israel; [Eshel, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-70300 Zerifin, Israel; [Pines, Ophry] Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem	Elpeleg, O (corresponding author), Hebrew Univ Jerusalem, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel.	elpeleg@cc.huji.ac.il	Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019; Saada, Ann/J-6864-2017; pines, ophry/C-4086-2011	Houtkooper, Riekelt H/0000-0001-9961-0842; Saada, Ann/0000-0003-2951-0656; pines, ophry/0000-0001-7126-2575; Vaz, Frederic/0000-0002-9048-1041	Prinses Beatrix Fonds [WAR05-0126]; Barth syndrome foundation; Fondation pour la Recherche Medicale	Prinses Beatrix Fonds; Barth syndrome foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We gratefully acknowledge the collaboration of the patients' families and the dedicated assistance of Yehudit Karp. We thank Arnold Munnich and Ron Wanders for creating the international collaborations, George M. Carman for kindly providing S. cerevisiae strains and plasmids, Jan Smeitink and Richard Rodenburg for kindly providing the disease control muscle samples, and Saul Yedgar for fruitful discussions. This work was supported by grants of the Prinses Beatrix Fonds (grant number WAR05-0126) and Barth syndrome foundation to F.M.V. and by Fondation pour la Recherche Medicale to P.d.L.	Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; DUBOWITZ V, 1995, MUSCLE DISORDERS CHI, P177; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; LANDS WEM, 1958, J BIOL CHEM, V231, P883; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; NAKAGAWA Y, 1989, PROG LIPID RES, V28, P205, DOI 10.1016/0163-7827(89)90013-1; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Shek A, 2001, ANN PHARMACOTHER, V35, P908, DOI 10.1345/aph.10315; STEIN I, 1994, MOL CELL BIOL, V14, P4770, DOI 10.1128/MCB.14.7.4770; Tein I, 1990, Adv Pediatr, V37, P77; TONIN P, 1990, ANN NEUROL, V27, P181, DOI 10.1002/ana.410270214; Ucar M, 2000, DRUG SAFETY, V22, P441, DOI 10.2165/00002018-200022060-00003; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; Vladutiu GD, 2006, MUSCLE NERVE, V34, P153, DOI 10.1002/mus.20567	20	149	157	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					489	494		10.1016/j.ajhg.2008.09.002	http://dx.doi.org/10.1016/j.ajhg.2008.09.002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18817903	Bronze, Green Published			2022-12-18	WOS:000260239200006
J	Ni, Y; Zbuk, KM; Sadler, T; Patocs, A; Lobo, G; Edelman, E; Platzer, P; Orloff, MS; Waite, KA; Eng, C				Ni, Ying; Zbuk, Kevin M.; Sadler, Tammy; Patocs, Attila; Lobo, Glenn; Edelman, Emily; Platzer, Petra; Orloff, Mohammed S.; Waite, Kristin A.; Eng, Charis			Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR PTEN; HEREDITARY PARAGANGLIOMA; OXIDATIVE STRESS; SDHD GENE; DISEASE; EXPRESSION; CANCER; CYCLE; STABILIZATION; PHOSPHATASE	Individuals with PTEN mutations have Cowden syndrome (CS), associated with breast, thyroid, and endometrial neoplasias. Many more patients with features of CS, not meeting diagnostic criteria (termed CS-like), are evaluated by clinicians for CS-related cancer risk. Germline mutations in succinate dehydrogenase subunits SDHB-D cause pheochromocytoma-paraganglioma syndrome. One to five percent of SDHB/SDHD mutation carriers have renal cell or papillary thyroid carcinomas, which are also CS-related features. SDHB-D may be candidate susceptibility genes for some PTEN mutation-negative individuals with CS-like cancers. To address this hypothesis, germline SDHB-D mutation analysis in 375 PTEN mutation-negative CS/CS-like individuals was performed, followed by functional analysis of identified SDH mutations/variants. Of 3 75 PTEN mutation-negative CS/CS-like individuals, 74 (20%) had increased manganese superoxide dismutase (MnSOD) expression, a manifestation of mitochondrial dysfunction. Among these, 10 (13.5%) had germline mutations/variants in SDHB (n = 3) or SDHD (7), not found in 700 controls (p < 0.001). Compared to PTEN mutation-positive CS/CS-like individuals, those with SDH mutations/variants were enriched for carcinomas of the female breast (6/9 SDH versus 30/107 PTEN, p < 0.001), thyroid (5/10 versus 15/106, p < 0.001), and kidney (2/10 versus 4/230, p = 0.026). In the absence of PTEN alteration, CS/ CS-like-related SDH mutations/variants show increased phosphorylation of AKT and/or MAPK, downstream manifestations of PTEN dysfunction. Germline SDH mutations/variants occur in a subset of PTEN mutation-negative CS/CS-like individuals and are associated with increased frequencies of breast, thyroid, and renal cancers beyond those conferred by germline PTEN mutations. SDH testing should be considered for germline PTEN mutation-negative CS/CS-like individuals, especially in the setting of breast, thyroid, and/or renal cancers.	[Ni, Ying; Zbuk, Kevin M.; Sadler, Tammy; Patocs, Attila; Lobo, Glenn; Edelman, Emily; Platzer, Petra; Orloff, Mohammed S.; Waite, Kristin A.; Eng, Charis] Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA; [Ni, Ying; Zbuk, Kevin M.; Sadler, Tammy; Patocs, Attila; Lobo, Glenn; Edelman, Emily; Platzer, Petra; Orloff, Mohammed S.; Waite, Kristin A.; Eng, Charis] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Ni, Ying; Eng, Charis] Cleveland Clin Fdn, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA; [Edelman, Emily; Orloff, Mohammed S.; Waite, Kristin A.; Eng, Charis] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin Fdn, Genom Med Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	engc@ccf.org	Waite, Kristin/AAB-1031-2021; Lobo, Glenn P./AAI-9736-2020	Patocs, Attila/0000-0001-7506-674X; Eng, Charis/0000-0002-3693-5145	Breast Cancer Research Foundation; William Randolph Hearst Foundation; National Cancer Institute, Bethesda, MD [1P01CA124570-01A1]; Doris Duke Distinguished Clinical Scientist Award; NATIONAL CANCER INSTITUTE [P01CA124570] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; William Randolph Hearst Foundation; National Cancer Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors have no conflicts of interest to declare. We thank Jen Stein, MS, CGC, then at the Genomic Medicine Institute, Cleveland Clinic, for acting as genetic counselor-coordinator of the PTEN study at an early stage of the study, and Frank Mularo, MS, and Jin-Liang Chen, MS, both of the Eng Laboratory, Genomic Medicine Institute, Cleveland Clinic, for technical assistance. This study was funded, in part, by the Breast Cancer Research Foundation, the William Randolph Hearst Foundation, and the National Cancer Institute, Bethesda, MD (1P01CA124570-01A1) (all to C.E.). K.M.Z. was a Cleveland Clinic Crile Fellow; A.P. was an International Scholar of The Endocrine Society; and Y.N. is a Howard Hughes Medical Institute Predoctoral Fellow in Molecular Medicine at the Cleveland Clinic Lerner College of Medicine. C.E. is a recipient of the Doris Duke Distinguished Clinical Scientist Award and is the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic.	Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benn DE, 2006, J CLIN ENDOCR METAB, V91, P827, DOI 10.1210/jc.2005-1862; Cascon A, 2003, GENE CHROMOSOME CANC, V37, P220, DOI 10.1002/gcc.10212; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Ishii T, 2005, CANCER RES, V65, P203; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kytola S, 2002, GENE CHROMOSOME CANC, V34, P325, DOI 10.1002/gcc.10081; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; McWhinney SR, 2004, J CLIN ENDOCR METAB, V89, P5694, DOI 10.1210/jc.2004-0769; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Perren A, 2002, ONCOGENE, V21, P7605, DOI 10.1038/sj.onc.1205812; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Vanharanta S, 2004, AM J HUM GENET, V74, P153, DOI 10.1086/381054; Weng LP, 2002, HUM MOL GENET, V11, P1687, DOI 10.1093/hmg/11.15.1687; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zundel W, 2000, GENE DEV, V14, P391	29	149	157	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					261	268		10.1016/j.ajhg.2008.07.011	http://dx.doi.org/10.1016/j.ajhg.2008.07.011			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18678321	Bronze, Green Published			2022-12-18	WOS:000258418200011
J	Di Paola, R; Frittitta, L; Miscio, G; Bozzali, M; Baratta, R; Centra, M; Spampinato, D; Santagati, MG; Ercolino, T; Cisternino, C; Soccio, T; Mastroianno, S; Tassi, V; Almgren, P; Pizzuti, A; Vigneri, R; Trischitta, V				Di Paola, R; Frittitta, L; Miscio, G; Bozzali, M; Baratta, R; Centra, M; Spampinato, D; Santagati, MG; Ercolino, T; Cisternino, C; Soccio, T; Mastroianno, S; Tassi, V; Almgren, P; Pizzuti, A; Vigneri, R; Trischitta, V			A variation in 3 ' UTR of hPTP1B increases specific gene expression and associates with insulin resistance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYROSINE-PHOSPHATASE 1B; HUMAN OBESITY; PC-1 GENE; PROTEIN; SENSITIVITY; RECEPTOR; MECHANISMS; DISEASE; GLUCOSE; LINKAGE	Protein tyrosine phosphatase 1B (PTP1B) inhibits insulin signaling and, when overexpressed, plays a role in insulin resistance (Ahmad et al. 1997). We identified, in the 3' untranslated region of the PTP1B gene, a 1484insG variation that, in two different populations, is associated with several features of insulin resistance: among male individuals, higher values of the insulin resistance HOMA(IR) index (P = .006), serum triglycerides (P = .0002), and total/HDL cholesterol ratio (P = .025) and, among female individuals, higher blood pressure (P = .01). Similar data were also obtained in a family-based association study by use of sib pairs discordant for genotype (Gu et al. 2000). Subjects carrying the 1484insG variant showed also PTP1B mRNA overexpression in skeletal muscle (6,166 +/- 1,879 copies/40 ng RNA vs. 2,983 +/- 1,620;). Finally, PTP1B mRNA stability was significantly higher (P < .01) in human embryo kidney 293 cells transfected with 1484insG PTP1B, as compared with those transfected with wild-type PTP1B. Our data indicate that the 1484insG allele causes PTP1B overexpression and plays a role in insulin resistance. Therefore, individuals carrying the 1484insG variant might particularly benefit from PTP1B inhibitors, a promising new tool for treatment of insulin resistance (Kennedy and Ramachandran 2000).	Sci Inst CSS, Unit Endocrinol, I-71013 G San Giovanni Rotondo, FG, Italy; Catania Univ, Garibaldi Hosp, Inst Internal Med Endocrine & Metab Dis, Catania, Italy; Univ Roma La Sapienza, Sci Inst CSS Mendel, Rome, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy; Lund Univ, Dept Endocrinol, Wallenberg Lab, Malmo, Sweden	University of Catania; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; Sapienza University Rome; Lund University	Trischitta, V (corresponding author), Sci Inst CSS, Unit Endocrinol, Viale Cappuccini 1, I-71013 G San Giovanni Rotondo, FG, Italy.		Di Paola, Rosa/G-7813-2011; frittitta, Lucia/J-2334-2012; Trischitta, Vincenzo/K-1487-2016; SANTAGATI, Maria/AAD-6281-2021; frittitta, lucia/AAA-4733-2019; Vigneri, Riccardo/M-3968-2017	Di Paola, Rosa/0000-0001-5837-9111; Trischitta, Vincenzo/0000-0003-1174-127X; frittitta, lucia/0000-0002-7941-5828; Mastroianno, Sandra/0000-0001-6898-4657; Baratta, Roberto/0000-0003-0524-4525; Tassi, Vittorio/0000-0003-3536-4480; PIZZUTI, Antonio/0000-0003-3245-1925; Vigneri, Riccardo/0000-0002-4401-3140	Telethon [E.1239] Funding Source: Medline	Telethon(Fondazione Telethon)		Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552; AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Altshuler D, 1998, NEW ENGL J MED, V338, P1626, DOI 10.1056/NEJM199805283382214; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Day DA, 1998, J ENDOCRINOL, V157, P361, DOI 10.1677/joe.0.1570361; DeCosmo S, 1997, DIABETOLOGIA, V40, P1191, DOI 10.1007/s001250050806; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FORSELL PKA, 1999, NAT GENET, V22, P1; Forsell PKAL, 2000, GENE, V260, P145, DOI 10.1016/S0378-1119(00)00464-9; Frittitta L, 2000, DIABETES-METAB RES, V16, P26, DOI 10.1002/(SICI)1520-7560(200001/02)16:1<26::AID-DMRR78>3.0.CO;2-N; Frittitta L, 2001, DIABETES, V50, P1952, DOI 10.2337/diabetes.50.8.1952; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Gu HF, 2000, DIABETES, V49, P1601, DOI 10.2337/diabetes.49.9.1601; Kennedy BP, 2000, BIOCHEM PHARMACOL, V60, P877, DOI 10.1016/S0006-2952(00)00305-1; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Klupa T, 2000, DIABETES, V49, P2212, DOI 10.2337/diabetes.49.12.2212; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Maegawa H, 1999, DIABETES, V48, P1469, DOI 10.2337/diabetes.48.7.1469; PIAZZA A, 1988, ANN HUM GENET, V52, P203, DOI 10.1111/j.1469-1809.1988.tb01098.x; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Trischitta V, 1997, DIABETES METAB REV, V13, P147, DOI 10.1002/(SICI)1099-0895(199709)13:3<147::AID-DMR180>3.0.CO;2-F; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Xia J, 1998, DIABETES, V47, P1519, DOI 10.2337/diabetes.47.9.1519	29	149	157	0	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					806	812		10.1086/339270	http://dx.doi.org/10.1086/339270			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11833006	Green Published, Bronze			2022-12-18	WOS:000173880000026
J	Scott, RJ; McPhillips, M; Meldrum, CJ; Fitzgerald, PE; Adams, K; Spigelman, AD; du Sart, D; Tucker, K; Kirk, J				Scott, RJ; McPhillips, M; Meldrum, CJ; Fitzgerald, PE; Adams, K; Spigelman, AD; du Sart, D; Tucker, K; Kirk, J		Hunter Family Canc Serv	Hereditary nonpolyposis colorectal cancer in 95 families: Differences and similarities between mutation-positive and mutation-negative kindreds	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISMATCH REPAIR GENES; COLON-CANCER; MICROSATELLITE INSTABILITY; HMLH1 GENES; GERMLINE MUTATIONS; HMSH2; HNPCC; HOMOLOG; DNA; BREAST	Hereditary nonpolyposis colorectal cancer (HNPCC) describes the condition of a disparate group of families that have in common a predisposition to colorectal cancer in the absence of a premalignant phenotype. The genetic basis of this disease has been linked to mutations in genes associated with DNA mismatch repair. A large proportion of families harbor changes in one of two genes, hMSH2 and hMLH1. Approximately 35% of families in which the diagnosis is based on the Amsterdam criteria do not appear to harbor mutations in DNA-mismatch-repair genes. In this report we present data from a large series of families with HNPCC and indicate that there are subtle differences between families that harbor germline changes in hMSH2 and families that harbor hMLH1 mutations. Furthermore, there are differences between the mutation-positive group (hMSH2 and hMLH1. combined) of families and the mutation-negative group of families. The major findings identified in this study focus primarily on the extracolonic disease profile observed between the mutation-positive families and the mutation-negative families. Breast cancer was not significantly overrepresented in the hMSH2 mutation-positive group but was overrepresented in the hMLH1 mutation-positive group and in the mutation-negative group. Prostate cancer was not overrepresented in the mutation-positive groups but was overrepresented in the mutation-negative group. In age at diagnosis of colorectal cancer, there was no difference between the hMSH2 mutation-positive group and the hMLH1 mutation-positive group, but there was a significant difference between these two groups and the mutation-negative group.	John Hunter Hosp, Hunter Area Pathol Serv, New Lambton, NSW 2305, Australia; Univ Newcastle, Disciplines Med Gen, Newcastle, NSW 2308, Australia; Univ Newcastle, Fac Med & Hlth Sci, Disciplines Sur Sci, Newcastle, NSW 2308, Australia; Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; Hunter Genet, Hunter Family Canc Serv, Waratah, NSW, Australia; Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic, Australia; Prince Wales Hosp, Family Canc Clin, Randwick, NSW 2031, Australia; Westmead Hosp, Canc Family Clin, Westmead, NSW 2145, Australia	John Hunter Hospital; University of Newcastle; University of Newcastle; University of Newcastle; Murdoch Children's Research Institute; University of Sydney	Scott, RJ (corresponding author), John Hunter Hosp, Hunter Area Pathol Serv, Lookout Rd, New Lambton, NSW 2305, Australia.		Scott, Rodney J/B-2827-2013	Scott, Rodney J/0000-0001-7724-3404; Meldrum, Cliff/0000-0002-5685-1918				Anderson LK, 1999, GENETICS, V151, P1569; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BUERSTEDDE JM, 1995, J MED GENET, V32, P909, DOI 10.1136/jmg.32.11.909; Cunningham JM, 1998, CANCER RES, V58, P3455; Farrington SM, 1998, AM J HUM GENET, V63, P749, DOI 10.1086/301996; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; HEINIMANN K, 1999, CANCER, P8; Hutter P, 1998, INT J CANCER, V78, P680, DOI 10.1002/(SICI)1097-0215(19981209)78:6<680::AID-IJC3>3.0.CO;2-U; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; ITOH H, 1990, BRIT J SURG, V77, P1367, DOI 10.1002/bjs.1800771216; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KohonenCorish M, 1996, AM J HUM GENET, V59, P818; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Maliaka YK, 1996, HUM GENET, V97, P251, DOI 10.1007/BF02265276; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NELSON CL, 1993, GENET EPIDEMIOL, V10, P235, DOI 10.1002/gepi.1370100404; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Papadopoulos N, 1997, HUM MUTAT, V10, P89, DOI 10.1002/(SICI)1098-1004(1997)10:2<89::AID-HUMU1>3.3.CO;2-K; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Risinger JI, 1996, CANCER, V77, P1836, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; Shashidharan M, 1999, DIS COLON RECTUM, V42, P722, DOI 10.1007/BF02236925; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Vasen HFA, 1999, CYTOGENET CELL GENET, V86, P136, DOI 10.1159/000015366; Wahlberg S, 1999, GENET TEST, V3, P259, DOI 10.1089/109065799316563; Wang Y, 2000, GENE DEV, V14, P927; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; Wehner M, 1997, HUM MUTAT, V10, P241; WIJNEN J, 1995, AM J HUM GENET, V56, P1060; Wijnen J, 1996, AM J HUM GENET, V58, P300; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804	35	149	160	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					118	127		10.1086/316942	http://dx.doi.org/10.1086/316942			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11112663	Green Published, Bronze			2022-12-18	WOS:000166399900010
J	Munroe, PB; Mitchison, HM; ORawe, AM; Anderson, JW; Boustany, RM; Lerner, TJ; Taschner, PEM; deVos, N; Breuning, MH; Gardiner, RM; Mole, SE				Munroe, PB; Mitchison, HM; ORawe, AM; Anderson, JW; Boustany, RM; Lerner, TJ; Taschner, PEM; deVos, N; Breuning, MH; Gardiner, RM; Mole, SE			Spectrum of mutations in the Batten disease gene, CLN3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; LOCUS CLN3; LINKAGE DISEQUILIBRIUM; ALLELIC ASSOCIATION; JUVENILE; CHROMOSOME-16; HAPLOTYPES	Batten disease (juvenile-onset neuronal ceroid lipofuscinosis [JNCL]) is an autosomal recessive condition characterized by accumulation of lipopigments (lipofuscin and ceroid) in neurons and other cell types. The Batten disease,gene, CLN3, was recently isolated, and four disease-causing mutations were identified, including a 1.02-kb deletion that is present in the majority of patients (The International Batten Disease Consortium 1995). One hundred eighty-eight unrelated patients with JNCL were screened in this study to determine how many disease chromosomes carried the 1.02-kb deletion and how many carried other mutations in CLN3. One hundred thirty-nine patients (74%) were found to have the 1.02-kb deletion on both chromosomes, whereas 49 patients (41 heterozygous for the 1,02-kb deletion) had mutations other than the 1.02-kb deletion. SSCP analysis and direct sequencing were used to screen for new mutations in these individuals. Nineteen novel mutations were found: six missense mutations, five nonsense mutations, three small deletions, three small insertions, one intronic mutation, and one splice-site mutation. This report brings the total number of disease-associated mutations in CLN3 to 23. All patients homozygous for mutations predicted to give rise to truncated proteins were found to have classical JNCL, However, a propertion of the patients (n = 4) who were compound heterozygotes for a missense mutation and the 1.02-kb deletion were found to display an atypical phenotype that was dominated by visual failure rather than by severe neurodegeneration. All missense mutations were found to affect residues conserved between the human protein and homologues in diverse species.	HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,MOL NEUROGENET UNIT,BOSTON,MA 02115; DUKE UNIV,MED CTR,DIV PEDIAT NEUROL,DURHAM,NC 27706; LEIDEN UNIV,DEPT HUMAN GENET,NL-2300 RA LEIDEN,NETHERLANDS	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Duke University; Leiden University; Leiden University - Excl LUMC	Munroe, PB (corresponding author), UNIV LONDON UNIV COLL,SCH MED,DEPT PEDIAT,RAYNE INST,5 UNIV ST,LONDON WC1E 6JJ,ENGLAND.		Breuning, Martijn H/E-3429-2010; Mole, Sara/C-2024-2008; Taschner, Peter/J-8853-2014; Mitchison, Hannah M./C-1891-2008	Mole, Sara/0000-0003-4385-4957; Taschner, Peter/0000-0001-9621-465X; Munroe, Patricia/0000-0002-4176-2947; Mitchison, Hannah/0000-0002-3163-6293	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030152, R29NS032009, R01NS028722] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28722, NS32009, NS30152] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		AMARAL O, 1994, J MED GENET, V31, P401, DOI 10.1136/jmg.31.5.401; CALLEN DF, 1991, AM J HUM GENET, V49, P1372; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; EIBERG H, 1989, CLIN GENET, V36, P217; GARDINER M, 1990, GENOMICS, V8, P387, DOI 10.1016/0888-7543(90)90297-8; *INT BATT DIS CONS, 1995, CELL, V82, P949; Janes RW, 1996, FEBS LETT, V399, P75, DOI 10.1016/S0014-5793(96)01290-2; Lee RL, 1996, GENOMICS, V35, P617, DOI 10.1006/geno.1996.0410; LERNER TJ, 1994, AM J HUM GENET, V54, P88; MITCHISON HM, 1993, GENOMICS, V16, P455, DOI 10.1006/geno.1993.1210; Mitchison HM, 1997, GENOMICS, V40, P346, DOI 10.1006/geno.1996.4576; MITCHISON HM, 1994, GENOMICS, V22, P465, DOI 10.1006/geno.1994.1412; MITCHISON HM, 1995, AM J HUM GENET, V56, P654; Munroe PB, 1996, LANCET, V347, P1014, DOI 10.1016/S0140-6736(96)90148-8; Sambrook J, 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; TYFIELD LA, 1995, J MED GENET, V32, P867, DOI 10.1136/jmg.32.11.867; Wisniewski K E, 1988, Am J Med Genet Suppl, V5, P27; YAN WL, 1993, AM J HUM GENET, V52, P89; ZEMAN W, 1974, J NEUROPATH EXP NEUR, V33, P1, DOI 10.1097/00005072-197401000-00001	21	149	159	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					310	316		10.1086/514846	http://dx.doi.org/10.1086/514846			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311735	Bronze, Green Published			2022-12-18	WOS:A1997XX70100008
J	MEULENBELT, I; DROOG, S; TROMMELEN, GJM; BOOMSMA, DI; SLAGBOOM, PE				MEULENBELT, I; DROOG, S; TROMMELEN, GJM; BOOMSMA, DI; SLAGBOOM, PE			HIGH-YIELD NONINVASIVE HUMAN GENOMIC DNA ISOLATION METHOD FOR GENETIC-STUDIES IN GEOGRAPHICALLY DISPERSED FAMILIES AND POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TETRANUCLEOTIDE REPEAT POLYMORPHISM; AMPLIFICATION		TNO PG,GAUBIUS LAB,DEPT VASC & CONNECT TISSUE RES,2301 CE LEIDEN,NETHERLANDS; FREE UNIV AMSTERDAM,DEPT PHYSIOL,AMSTERDAM,NETHERLANDS; GENE PHARMING EUROPE BV,LEIDEN,NETHERLANDS	Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam			Boomsma, Dorret I/AAX-4470-2020; Meulenbelt, Ingrid/F-4756-2011; Slagboom, P. Eline/R-4790-2016	Meulenbelt, Ingrid/0000-0001-7786-7081; Slagboom, P. Eline/0000-0002-2875-4723				ALLAMAND V, 1994, HUM MOL GENET, V3, P382, DOI 10.1093/hmg/3.2.382; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; KIMPTON CP, 1993, PCR METH APPL, V3, P13; POLYMEROPOULOS MH, 1992, NUCLEIC ACIDS RES, V20, P1432, DOI 10.1093/nar/20.6.1432; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; SAMBROOK J, 1990, MOL CLONING LABORATO, V2; SHARMA V, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67-a	8	149	154	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1252	1254						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485180				2022-12-18	WOS:A1995TA44900038
J	CHRISTIAN, SI; ROBINSON, WP; HUANG, B; MUTIRANGURA, A; LINE, MR; NAKAO, M; SURTI, U; CHAKRAVARTI, A; LEDBETTER, DH				CHRISTIAN, SI; ROBINSON, WP; HUANG, B; MUTIRANGURA, A; LINE, MR; NAKAO, M; SURTI, U; CHAKRAVARTI, A; LEDBETTER, DH			MOLECULAR CHARACTERIZATION OF 2 PROXIMAL DELETION BREAKPOINT REGIONS IN BOTH PRADER-WILLI-SYNDROME AND ANGELMAN-SYNDROME PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN OVARIAN TERATOMAS; HUMAN X-CHROMOSOME; DISTAL SHORT ARM; SUBMICROSCOPIC DELETION; DINUCLEOTIDE REPEATS; UNIPARENTAL DISOMY; RECOMBINATION; GENE; 15Q11-13; DUPLICATION	Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are distinct mental retardation syndromes caused by paternal and maternal deficiencies, respectively, in chromosome 15q11-q13. Approximately 70% of these patients have a large deletion of similar to 4 Mb extending from D15S9 (ML34) through D15S12 (IR10). To further characterize the deletion breakpoints proximal to D15S9, three new polymorphic microsatellite markers were developed that showed observed heterozygosities of 60%-87%. D15S541 and D15S542 were isolated from YAC A124A3 containing the D15S18 (IR39) locus. D15S543 was isolated from a cosmid cloned from the proximal right end of YAC 254B5 containing the D15S9 (ML34) locus. Gene-centromere mapping of these markers, using a panel of ovarian teratomas of known meiotic origin, extended the genetic map of chromosome 15 by 2-3 cM toward the centromere. Analysis of the more proximal S541/S542 markers on 53 Prader-Willi and 33 Angelman deletion patients indicated two classes of patients: 44% (35/80) of the informative patients were deleted for these markers (class I), while 56% (45/80) were not deleted (class II), with no difference between PWS and AS. In contrast, D15S543 was deleted in all informative patients (13/48) or showed the presence of a single allele (in 35/48 patients), suggesting that this marker is deleted in the majority of PWS and AS cases. These results confirm the presence of two common proximal deletion breakpoint regions in both Prader-Willi and Angelman syndromes and are consistent with the same deletion mechanism being responsible for paternal and maternal deletions. One breakpoint region lies between D15S541/S542 and D15S543, with an additional breakpoint region being proximal to D15S541/S542.	NIH,NATL CTR HUMAN GENOME RES,DIAGNOST DEV BRANCH,BETHESDA,MD 20892; UNIV ZURICH,INST MED GENET,ZURICH,SWITZERLAND; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC,CANADA; CHULALONGKORN UNIV,FAC MED,DEPT ANAT,BANGKOK 10330,THAILAND; UNIV WISCONSIN,STEVENS POINT,WI 54481; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT HUMAN & MOLEC GENET,HOUSTON,TX 77030; CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106; UNIV PITTSBURGH,DEPT PATHOL & GENET,PITTSBURGH,PA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Zurich; University of British Columbia; Chulalongkorn University; University of Wisconsin System; University of Wisconsin Stevens Point; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020; Mutirangura, Apiwat/C-8197-2009	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; 				BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; Ballabio Andrea, 1992, Human Molecular Genetics, V1, P221, DOI 10.1093/hmg/1.4.221; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BEUTEN J, 1993, HUM GENET, V90, P489, DOI 10.1007/BF00217446; BUITING K, 1992, P NATL ACAD SCI USA, V89, P5457, DOI 10.1073/pnas.89.12.5457; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; BUXTON JL, 1994, HUM MOL GENET, V3, P1409, DOI 10.1093/hmg/3.8.1409; CHAKRAVARTI A, 1989, MOL CYTOGENETIC STUD, P45; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CLAYTONSMITH J, 1992, J MED GENET, V29, P412, DOI 10.1136/jmg.29.6.412; CLAYTONSMITH J, 1993, J MED GENET, V30, P529, DOI 10.1136/jmg.30.6.529; CROLLA JA, 1995, HUM GENET, V95, P161; DEKA R, 1990, AM J HUM GENET, V47, P644; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; FEENER CA, 1991, AM J HUM GENET, V48, P621; GREGER V, 1993, HUM MOL GENET, V2, P921, DOI 10.1093/hmg/2.7.921; Holm V. A., 1981, PRADERWILLI SYNDROME, P27; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEDBETTER DH, 1995, METABOLIC MOL BASES, P811; LEDBETTER SA, 1990, GENOMICS, V8, P614, DOI 10.1016/0888-7543(90)90247-R; LITT M, 1993, BIOTECHNIQUES, V15, P280; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; NAGAOKA H, 1994, GENOMICS, V22, P189, DOI 10.1006/geno.1994.1360; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; PETTIGREW AL, 1987, AM J MED GENET, V38, P791; REIS A, 1994, AM J HUM GENET, V54, P741; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROBINSON WP, 1993, HUM GENET, V91, P181; SAADALLAH N, 1983, J MED GENET, V20, P290, DOI 10.1136/jmg.20.4.290; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SAITOH S, 1994, AM J MED GENET, V52, P158, DOI 10.1002/ajmg.1320520207; Sambrook J., 1989, MOL CLONING LAB MANU; SCHINZEL AA, 1994, J MED GENET, V31, P798, DOI 10.1136/jmg.31.10.798; Spurr N. K., 1994, European Journal of Human Genetics, V2, P193; SURTI U, 1990, AM J HUM GENET, V47, P635; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; TOMLINSON IM, 1994, HUM MOL GENET, V3, P853; WEBB T, 1994, J MED GENET, V31, P585, DOI 10.1136/jmg.31.8.585; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q; ZACKOWSKI JL, 1993, AM J MED GENET, V46, P7, DOI 10.1002/ajmg.1320460104	46	149	150	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					40	48						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611294				2022-12-18	WOS:A1995RE62900005
J	JANSEN, G; WILLEMS, P; COERWINKEL, M; NILLESEN, W; SMEETS, H; VITS, L; HOWELER, C; BRUNNER, H; WIERINGA, B				JANSEN, G; WILLEMS, P; COERWINKEL, M; NILLESEN, W; SMEETS, H; VITS, L; HOWELER, C; BRUNNER, H; WIERINGA, B			GONOSOMAL MOSAICISM IN MYOTONIC-DYSTROPHY PATIENTS - INVOLVEMENT OF MITOTIC EVENTS IN (CTG)(N) REPEAT VARIATION AND SELECTION AGAINST EXTREME EXPANSION IN SPERM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X SYNDROME; HYPERVARIABLE LOCI; UNSTABLE DNA; CTG REPEAT; GENE; REGION; RECOMBINATION; MUTATION; LINE; ANTICIPATION	Myotonic dystrophy (DM) is caused by abnormal expansion of a polymorphic (CTG)(n) repeat, located in the DM protein kinase gene. We determined the (CTG)(n) repeat lengths in a broad range of tissue DNAs from patients with mild, classical, or congenital manifestation of DM. Differences in the repeat length were seen in somatic tissues from single DM individuals and twins. Repeats appeared to expand to a similar extent in tissues originating from the same embryonal origin. In most male patients carrying intermediate- or small-sized expansions in blood, the repeat lengths covered a markedly wider range in sperm. In contrast, male patients with large allele expansions in blood (>700 CTGs) had similar or smaller repeats in sperm, when detectable. Sperm alleles with >1,000 CTGs were not seen. We conclude that DM patients can be considered gonosomal mosaics, i.e., combined somatic and germ-line tissue mosaics. Most remarkably, we observed multiple cases where the length distributions of intermediate- or small-sized alleles in fathers' sperm were significantly different from that in their offspring's blood. Our combined findings indicate that intergenerational length changes in the unstable CTG repeat are most likely to occur during early embryonic mitotic divisions in both somatic and germ-line tissue formation. Both the initial CTG length, the overall number of cell divisions involved in tissue formation, and perhaps a specific selection process in spermatogenesis may influence the dynamics of this process. A model explaining mitotic instability and sex-dependent segregation phenomena in DM manifestation is discussed.	UNIV NIJMEGEN, FAC MED SCI, DEPT CELL BIOL & HISTOL, 6500 HB NIJMEGEN, NETHERLANDS; UNIV NIJMEGEN, FAC MED SCI, DEPT HUMAN GENET, NIJMEGEN, NETHERLANDS; UNIV ANTWERP, DEPT MED GENET, ANTWERP, BELGIUM; UNIV MAASTRICHT, ACAD HOSP MAASTRICHT, DEPT NEUROL, MAASTRICHT, NETHERLANDS	Radboud University Nijmegen; Radboud University Nijmegen; University of Antwerp; Maastricht University; Maastricht University Medical Centre (MUMC)			Wieringa, Berend/A-5346-2011; Brunner, Han/C-9928-2013; Jansen, Gert/HCI-8852-2022	Wieringa, Berend/0000-0001-9192-8020; Jansen, Gert/0000-0002-7524-171X				ABELIOVICH D, 1993, AM J HUM GENET, V52, P1175; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BARAN N, 1991, P NATL ACAD SCI USA, V88, P507, DOI 10.1073/pnas.88.2.507; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1992, J MED GENET, V29, P780, DOI 10.1136/jmg.29.11.780; BRUNNER HG, 1993, NEW ENGL J MED, V328, P476, DOI 10.1056/NEJM199302183280705; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; EDWARDS JH, 1989, ANN HUM GENET, V53, P33, DOI 10.1111/j.1469-1809.1989.tb01120.x; EPPLEN JT, 1991, ADV MOL GENET, V4, P301; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GIBBS M, 1993, GENOMICS, V17, P121, DOI 10.1006/geno.1993.1292; GIBBS M, 1991, Genetical Research, V58, P78; GRIGGS RC, 1989, NEUROLOGY, V39, P420, DOI 10.1212/WNL.39.3.420; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper P.S., 1989, MYOTONIC DYSTROPHY; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; HUNTER AGW, 1993, AM J MED GENET, V45, P401, DOI 10.1002/ajmg.1320450330; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; JANSEN G, 1992, GENOMICS, V13, P509, DOI 10.1016/0888-7543(92)90118-C; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1987, NUCLEIC ACIDS RES, V15, P2823, DOI 10.1093/nar/15.7.2823; JESSBERGER R, 1991, MOL CELL BIOL, V11, P445, DOI 10.1128/MCB.11.1.445; KELLY R, 1989, GENOMICS, V5, P844, DOI 10.1016/0888-7543(89)90126-2; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LAVEDAN C, 1993, LANCET, V341, P237, DOI 10.1016/0140-6736(93)90097-Z; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACPHERSON JN, 1992, J MED GENET, V29, P802, DOI 10.1136/jmg.29.11.802; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MANIATIS T, 1988, MOL CLONING; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLEY JC, 1993, LANCET, V341, P236, DOI 10.1016/0140-6736(93)90096-Y; MURTI JR, 1992, MOL CELL BIOL, V12, P2545, DOI 10.1128/MCB.12.6.2545; NELSON FK, 1989, MOL CELL BIOL, V9, P1284, DOI 10.1128/MCB.9.3.1284; NURNBERG P, 1989, HUM GENET, V84, P75, DOI 10.1007/BF00210676; OHOY KL, 1993, SCIENCE, V259, P809, DOI 10.1126/science.8094260; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PHILLIPS DIW, 1993, LANCET, V341, P1008, DOI 10.1016/0140-6736(93)91086-2; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	58	149	149	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					575	585						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128954				2022-12-18	WOS:A1994NC83600001
J	REISS, AL; FREUND, L; ABRAMS, MT; BOEHM, C; KAZAZIAN, H				REISS, AL; FREUND, L; ABRAMS, MT; BOEHM, C; KAZAZIAN, H			NEUROBEHAVIORAL EFFECTS OF THE FRAGILE-X PREMUTATION IN ADULT WOMEN - A CONTROLLED-STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COGNITIVE PROFILES; MENTAL-RETARDATION; FRA(X) SYNDROME; FEMALES; EXPRESSION; MALES; INHERITANCE; CHROMOSOME; DISABILITY; INTERVIEW	Although previous studies have suggested that the fragile X premutation (fra [X] pM) does not cause deleterious effects, methodological constraints have prevented more definitive conclusions from being reached. In this report, we describe the neuropsychiatric and cognitive-neuropsychological status of 34 adult women with the fra (X) pM, as compared with a well-matched control group of 41 mothers of fra (X)-negative children with developmental disability. The results indicate that there are no meaningful differences between adult women with the fra (X) pM and control subjects with respect to cognitive abilities or profile, neuropsychological function, psychiatric diagnoses or symptoms, and self-rated personality profile. No measure for either group showed evidence of functioning outside the normal range except for a high lifetime prevalence of major depression in both groups. Additional exploratory analyses within the fra (X) group showed no significant effect of either the size of the fra (X) insert or X chromosome inactivation pattern in leukocytes, on any measure of neurobehavioral function. These findings provide additional information to professionals providing genetic counseling to, and assessment of, fra (X) families.	JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205	Johns Hopkins University	REISS, AL (corresponding author), JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BEHAV GENET & NEUROIMAGING RES CTR,BALTIMORE,MD 21205, USA.		Freund, Lisa/ABD-8855-2020	Freund, Lisa/0000-0003-2095-4023	NICHD NIH HHS [HD24061, HD25806] Funding Source: Medline; NIMH NIH HHS [MH00726] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD025806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K11MH000726] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAMS M, 1992, 3RD INT FRAG X C SNO; BORGHGRAEF M, 1990, CLIN GENET, V37, P341; BRAINARD SS, 1991, AM J MED GENET, V38, P505, DOI 10.1002/ajmg.1320380273; COHEN IL, 1988, AM J MENT RETARD, V92, P436; Costa P.T., 1985, NEO PERSONALITY INVE; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FREUND LS, 1993, PEDIATRICS, V91, P321; FREUND LS, 1991, AM J MED GENET, V38, P542, DOI 10.1002/ajmg.1320380409; FREUND LS, 1992, ARCH GEN PSYCHIAT, V49, P54; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GLOVER TW, 1981, AM J HUM GENET, V33, P234; GRIGSBY JP, 1990, AM J MED GENET, V35, P28, DOI 10.1002/ajmg.1320350107; Hagerman R, 1991, FRAGILE X SYNDROME D, P3; Hagerman R. J., 1991, FRAGILE X SYNDROME D, P173; HINTON VJ, 1992, AM J MED GENET, V43, P87, DOI 10.1002/ajmg.1320430113; Hiskey M.S., 1966, MANUAL HISKEY NEBRAS; KEMPER MB, 1988, AM J MED GENET, V30, P191, DOI 10.1002/ajmg.1320300118; KEMPER MB, 1986, AM J MED GENET, V23, P139, DOI 10.1002/ajmg.1320230109; LAIRD CD, 1987, GENETICS, V117, P587; LIPMAN RS, 1979, J AFFECT DISORDERS, V1, P9, DOI 10.1016/0165-0327(79)90021-1; MAZZOCCO MMM, 1992, J AM ACAD CHILD PSY, V31, P1141, DOI 10.1097/00004583-199211000-00025; MIEZEJESKI CM, 1986, NEUROPSYCHOLOGIA, V24, P405, DOI 10.1016/0028-3932(86)90026-6; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Overall J.E., 1974, PSYCHOL MEASUREMENTS, P67; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PFOHL B, 1987, J CLIN PSYCHIAT, V48, P468; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; PROUTY LA, 1988, AM J MED GENET, V30, P123, DOI 10.1002/ajmg.1320300111; RASBAND W, 1992, NIH IMAGE VERSION 14; REISS AL, 1992, AM J MED GENET, V43, P35, DOI 10.1002/ajmg.1320430106; REISS AL, 1989, AM J HUM GENET, V45, P697; REISS AL, 1988, ARCH GEN PSYCHIAT, V45, P25; Reitan RM, 1985, HALSTEAD REITAN NEUR; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Sherman S., 1991, FRAGILE X SYNDROME D, P69; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SNOW K, 1992, AM J MED GENET, V43, P244, DOI 10.1002/ajmg.1320430139; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; SUDHALTER V, 1990, AM J MENT RETARD, V94, P431; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; THEOBALD TM, 1987, AM J MED GENET, V28, P1, DOI 10.1002/ajmg.1320280102; TUCKERMAN E, 1985, J MED GENET, V22, P85, DOI 10.1136/jmg.22.2.85; UCHIDA IA, 1982, AM J HUM GENET, V34, P286; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; WING JK, 1985, HDB DEPRESSION TREAT, P765; 1987, DIAGNOSTIC STATISTIC	47	149	150	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					884	894						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488838				2022-12-18	WOS:A1993LB88900005
J	HANIOKA, N; KIMURA, S; MEYER, UA; GONZALEZ, FJ				HANIOKA, N; KIMURA, S; MEYER, UA; GONZALEZ, FJ			THE HUMAN CYP2D LOCUS ASSOCIATED WITH A COMMON GENETIC-DEFECT IN DRUG OXIDATION - A G1934-]A BASE CHANGE IN INTRON-3 OF A MUTANT CYP2D6 ALLELE RESULTS IN AN ABERRANT-3' SPLICE RECOGNITION SITE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NCI,MOLEC CARCINOGENESIS LAB,BLDG 37,RM 3E24,BETHESDA,MD 20892; UNIV BASEL,BIOCTR,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Basel								BLACK SD, 1986, CYTOCHROME P450 STRU, P161; DEININGER PL, 1983, ANAL BIOCHEM, V129, P216, DOI 10.1016/0003-2697(83)90072-6; GONZALEZ F J, 1988, Genomics, V2, P174, DOI 10.1016/0888-7543(88)90100-0; GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W; IDLE JR, 1979, DRUG METAB REV, V9, P301, DOI 10.3109/03602537908993896; KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209; KIMURA S, 1989, AM J HUM GENET, V45, P889; LOENEN WAM, 1980, GENE, V10, P249, DOI 10.1016/0378-1119(80)90054-2; MATSUNAGA E, 1990, J MOL EVOL, V30, P155, DOI 10.1007/BF02099942; MEYER UA, 1989, ADV DRUG RES, V19, P197; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NEBERT DW, 1990, PRINCIPLES DRUG ACTI, P252; SANGER F, 1977, ANAL BIOCHEM, V129, P216; SCHMID B, 1985, CLIN PHARMACOL THER, V38, P618, DOI 10.1038/clpt.1985.235; SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240	17	149	156	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					994	1001						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978565				2022-12-18	WOS:A1990EK40000017
J	Ahola-Olli, AV; Wurtz, P; Havulinna, AS; Aalto, K; Pitkanen, N; Lehtimaki, T; Kahonen, M; Lyytikainen, LP; Raitoharju, E; Seppala, I; Sarin, AP; Ripatti, S; Palotie, A; Perola, M; Viikari, JS; Jalkanen, S; Maksimow, M; Salomaa, V; Salmi, M; Kettunen, J; Raitakari, OT				Ahola-Olli, Ari V.; Wurtz, Peter; Havulinna, Aki S.; Aalto, Kristiina; Pitkanen, Niina; Lehtimaki, Terho; Kahonen, Mika; Lyytikainen, Leo-Pekka; Raitoharju, Emma; Seppala, Ilkka; Sarin, Antti-Pekka; Ripatti, Samuli; Palotie, Aarne; Perola, Markus; Viikari, Jorma S.; Jalkanen, Sirpa; Maksimow, Mikael; Salomaa, Veikko; Salmi, Marko; Kettunen, Johannes; Raitakari, Olli T.			Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; DUFFY ANTIGEN RECEPTOR; CROHNS-DISEASE; ULCERATIVE-COLITIS; METAANALYSIS; VARIANTS; INTERLEUKIN-16; IMPUTATION; RISK; INFLAMMATION	Circulating cytokines and growth factors are regulators of inflammation and have been implicated in autoimmune and metabolic diseases. In this genome-wide association study (GWAS) of up to 8,293 Finns we identified 27 genome-widely significant loci (p < 1.2 x 10(-9)) for one or more cytokines. Fifteen of the associated variants had expression quantitative trait loci in whole blood. We provide genetic instruments to clarify the causal roles of cytokine signaling and upstream inflammation in immune-related and other chronic diseases. We further link inflammatory markers with variants previously associated with autoimmune diseases such as Crohn disease, multiple sclerosis, and ulcerative colitis and hereby elucidate the molecular mechanisms underpinning these diseases and suggest potential drug targets.	[Ahola-Olli, Ari V.; Pitkanen, Niina; Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20520 Turku, Finland; [Wurtz, Peter; Kettunen, Johannes] Univ Oulu, Ctr Life Course Hlth Res, Computat Med, Oulu 90014, Finland; [Havulinna, Aki S.; Sarin, Antti-Pekka; Ripatti, Samuli; Perola, Markus; Salomaa, Veikko; Kettunen, Johannes] Natl Inst Hlth & Welf, Helsinki 00271, Finland; [Aalto, Kristiina; Jalkanen, Sirpa; Maksimow, Mikael; Salmi, Marko] Univ Turku, Dept Med Microbiol & Immunol, Medic Res Lab, FIN-20520 Turku, Finland; [Lehtimaki, Terho; Lyytikainen, Leo-Pekka; Raitoharju, Emma; Seppala, Ilkka] Univ Tampere, Sch Med, Pirkanmaa Hosp Dist, Dept Clin Chem,Fimlab Labs, Tampere 33014, Finland; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33521, Finland; [Sarin, Antti-Pekka; Ripatti, Samuli; Palotie, Aarne; Perola, Markus] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland; [Ripatti, Samuli] Univ Helsinki, Dept Publ Hlth, Helsinki 00271, Finland; [Palotie, Aarne] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Palotie, Aarne] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Palotie, Aarne] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Palotie, Aarne] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Palotie, Aarne] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Viikari, Jorma S.] Univ Turku, Dept Med, FIN-20520 Turku, Finland; [Viikari, Jorma S.] Turku Univ Hosp, Div Med, FIN-20520 Turku, Finland; [Kettunen, Johannes] Univ Eastern Finland, Sch Pharm, NMR Metabol Lab, Kuopio 70211, Finland; [Kettunen, Johannes; Raitakari, Olli T.] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland	University of Turku; University of Oulu; Finland National Institute for Health & Welfare; University of Turku; Pirkanmaa Hospital District; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; University of Helsinki; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Turku; University of Turku; University of Eastern Finland; University of Oulu; University of Turku	Ahola-Olli, AV (corresponding author), Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20520 Turku, Finland.	avahol@utu.fi	Havulinna, Aki/AAM-4769-2021; Lehtimäki, Terho/AAD-1094-2022; Raitakari, Olli/AAQ-7389-2021	Lehtimäki, Terho/0000-0002-2555-4427; Wurtz, Peter/0000-0002-5832-0221; Raitoharju, Emma/0000-0002-7023-8706; Ahola-Olli, Ari/0000-0002-4451-3487; Palotie, Aarno/0000-0002-2527-5874; Kahonen, Mika/0000-0002-4510-7341	Academy of Finland [286284, 134309, 126925, 121584, 124282, 129378, 117787, 41071, 139635]; Social Insurance Institution of Finland; Kuopio, Tampere, and Turku University Hospital Medical Funds [X51001]; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Finnish Diabetes Research Foundation; Novo Nordisk Foundation; Finnish Foundation for Cardiovascular Research; Novo Nordisk Fonden [NNF15OC0015998] Funding Source: researchfish	Academy of Finland(Academy of Finland); Social Insurance Institution of Finland; Kuopio, Tampere, and Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Finnish Diabetes Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Finnish Foundation for Cardiovascular Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	The Young Finns Study has been financially supported by the Academy of Finland: grants 286284 (T.L.), 134309, 126925, 121584, 124282, 129378, 117787, and 41071; the Social Insurance Institution of Finland; Kuopio, Tampere, and Turku University Hospital Medical Funds (grant X51001 for T.L.); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Tampere Tuberculosis Foundation (T.L.); Emil Aaltonen Foundation; and Yrjo Jahnsson Foundation. P.W. was supported by Finnish Diabetes Research Foundation, Novo Nordisk Foundation, and Yrjo Jahnsson Foundation. V.S. was supported by the Academy of Finland, grant number 139635, and the Finnish Foundation for Cardiovascular Research. We gratefully acknowledge Vine Aalto and Irina Lisinen for expert technical assistance in the data management.	Ahluwalia JP, 2012, MED CLIN N AM, V96, P525, DOI 10.1016/j.mcna.2012.04.009; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Alachkar N, 2010, TRANSPL P, V42, P3399, DOI 10.1016/j.transproceed.2010.06.013; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; BAIER M, 1995, NATURE, V378, P563, DOI 10.1038/378563a0; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Blomhoff A, 2006, GENES IMMUN, V7, P130, DOI 10.1038/sj.gene.6364272; Bowler RP, 2013, OMICS, V17, P619, DOI 10.1089/omi.2013.0038; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Debette S, 2011, CIRC RES, V109, P554, DOI 10.1161/CIRCRESAHA.111.243790; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freitag DF, 2015, LANCET DIABETES ENDO, V3, P243, DOI 10.1016/S2213-8587(15)00034-0; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Garner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101428; Gold R, 2013, LANCET, V381, P2167, DOI 10.1016/S0140-6736(12)62190-4; He MA, 2010, ARTERIOSCL THROM VAS, V30, P885, DOI 10.1161/ATVBAHA.109.199422; Heine A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128897; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Johnson EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118149; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070269; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Matteini AM, 2014, CYTOKINE, V65, P10, DOI 10.1016/j.cyto.2013.10.002; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Miller AV, 2012, MED CLIN N AM, V96, P475, DOI 10.1016/j.mcna.2012.04.003; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Nischwitz S, 2014, ACTA NEUROL SCAND, V130, P46, DOI 10.1111/ane.12215; Palagummi S, 2014, INT J LEGAL MED, V128, P403, DOI 10.1007/s00414-013-0941-5; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Ritchie SC, 2015, CELL SYST, V1, P293, DOI 10.1016/j.cels.2015.09.007; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Turpeinen H, 2015, HUM GENET, V134, P627, DOI 10.1007/s00439-015-1546-5; Voruganti VS, 2012, CYTOKINE, V60, P634, DOI 10.1016/j.cyto.2012.08.029; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	49	148	148	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					40	50		10.1016/j.ajhg.2016.11.007	http://dx.doi.org/10.1016/j.ajhg.2016.11.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	27989323	Bronze, Green Published			2022-12-18	WOS:000391910500004
J	Kashiyama, K; Nakazawa, Y; Pilz, DT; Guo, CW; Shimada, M; Sasaki, K; Fawcett, H; Wing, JF; Lewin, SO; Carr, L; Li, TS; Yoshiura, K; Utani, A; Hirano, A; Yamashita, S; Greenblatt, D; Nardo, T; Stefanini, M; McGibbon, D; Sarkany, R; Fassihi, H; Takahashi, Y; Nagayama, Y; Mitsutake, N; Lehmann, AR; Ogi, T				Kashiyama, Kazuya; Nakazawa, Yuka; Pilz, Daniela T.; Guo, Chaowan; Shimada, Mayuko; Sasaki, Kensaku; Fawcett, Heather; Wing, Jonathan F.; Lewin, Susan O.; Carr, Lucinda; Li, Tao-Sheng; Yoshiura, Koh-ichiro; Utani, Atsushi; Hirano, Akiyoshi; Yamashita, Shunichi; Greenblatt, Danielle; Nardo, Tiziana; Stefanini, Miria; McGibbon, David; Sarkany, Robert; Fassihi, Hiva; Takahashi, Yoshito; Nagayama, Yuji; Mitsutake, Norisato; Lehmann, Alan R.; Ogi, Tomoo			Malfunction of Nuclease ERCC1-XPF Results in Diverse Clinical Manifestations and Causes Cockayne Syndrome, Xeroderma Pigmentosum, and Fanconi Anemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE EXCISION-REPAIR; UV-SENSITIVE SYNDROME; FACIO-SKELETAL SYNDROME; GROUP-F; DNA; MUTATIONS; DEFECTS; DEFICIENCY; SLX4; ABNORMALITIES	Cockayne syndrome (CS) is a genetic disorder characterized by developmental abnormalities and photodermatosis resulting from the lack of transcription-coupled nucleotide excision repair, which is responsible for the removal of photodamage from actively transcribed genes. To date, all identified causative mutations for CS have been in the two known CS-associated genes, ERCC8 (GSA) and ERCC6 (CSB). For the rare combined xeroderma pigmentosum (XP) and CS phenotype, all identified mutations are in three of the XP-associated genes, ERCC3 (XPB), ERCC2 (XPD), and ERCC5 (XPG). In a previous report, we identified several CS cases who did not have mutations in any of these genes. In this paper, we describe three CS individuals deficient in ERCC1 or ERCC4 (XPF). Remarkably, one of these individuals with XP complementation group F (XP-F) had clinical features of three different DNA-repair disorders-CS, XP, and Fanconi anemia (FA). Our results, together with those from Bogliolo et al., who describe XPF alterations resulting in FA alone, indicate a multifunctional role for XPF.	[Kashiyama, Kazuya; Hirano, Akiyoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Plast & Reconstruct Surg, Nagasaki 8528501, Japan; [Kashiyama, Kazuya; Nakazawa, Yuka; Guo, Chaowan; Shimada, Mayuko; Sasaki, Kensaku; Mitsutake, Norisato; Ogi, Tomoo] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis, Nagasaki 8528523, Japan; [Kashiyama, Kazuya; Yamashita, Shunichi; Mitsutake, Norisato] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 8528523, Japan; [Nakazawa, Yuka; Guo, Chaowan; Shimada, Mayuko; Sasaki, Kensaku; Nagayama, Yuji; Ogi, Tomoo] Nagasaki Univ, Atom Bomb Dis Inst, Dept Mol Med, Nagasaki 8528523, Japan; [Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff CF14 4XW, S Glam, Wales; [Fawcett, Heather; Wing, Jonathan F.; Lehmann, Alan R.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Lewin, Susan O.] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA; [Carr, Lucinda] Great Ormond St Hosp Sick Children, London WC1N 3HJ, England; [Li, Tao-Sheng] Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, Nagasaki 8528523, Japan; [Yoshiura, Koh-ichiro] Nagasaki Univ, Atom Bomb Dis Inst, Dept Human Genet, Nagasaki 8528523, Japan; [Utani, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki 8528523, Japan; [Yamashita, Shunichi] Fukushima Med Univ, Fukushima 9601295, Japan; [Greenblatt, Danielle; McGibbon, David; Sarkany, Robert; Fassihi, Hiva] St Thomas Hosp, UK Natl Xeroderma Pigmentosum Serv, Dept Photodermatol, St Johns Inst Dermatol, London SE1 7EH, England; [Nardo, Tiziana; Stefanini, Miria] CNR, Inst Genet Mol, I-27100 Pavia, Italy; [Takahashi, Yoshito] Kanebo Cosmet Inc, Innovat Beauty Sci Lab, Odawara 2500002, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Cardiff University; University of Sussex; Utah System of Higher Education; University of Utah; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Nagasaki University; Nagasaki University; Nagasaki University; Fukushima Medical University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Consiglio Nazionale delle Ricerche (CNR); Kanebo Cosmetics Inc.	Ogi, T (corresponding author), Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	a.r.lehmann@sussex.ac.uk; togi@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022; Mitsutake, Norisato/U-9626-2018; Greenblatt, Danielle Talia/L-6167-2019; Guo, Chaowan/AAF-3876-2022; Guo, Chaowan/AFI-6708-2022	Mitsutake, Norisato/0000-0002-2744-8046; Yamashita, Shunichi/0000-0001-6399-6261; Ogi, Tomoo/0000-0002-5492-9072; Li, Tao-Sheng/0000-0002-7653-8873; Nakazawa, Yuka/0000-0002-3835-3093	Japan Society for the Promotion of Science [24681008, 24659533]; Inamori Foundation; Mochida Memorial Founds for Medical and Pharmaceutical Research; Daiichi-Sankyo Foundation of Life Science; Sumitomo Foundation; Takeda Science Foundation; Japan Science and Technology Agency; Associazione Italiana per la Ricerca sul Cancro (AIRC); National Commissioning Group of the UK National Health Service (NHS); UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; King's College London; King's College Hospital NHS Foundation Trust; Grants-in-Aid for Scientific Research [25293084, 25550033] Funding Source: KAKEN; Medical Research Council [G0801130B] Funding Source: researchfish	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Inamori Foundation; Mochida Memorial Founds for Medical and Pharmaceutical Research; Daiichi-Sankyo Foundation of Life Science; Sumitomo Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); National Commissioning Group of the UK National Health Service (NHS); UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; King's College London; King's College Hospital NHS Foundation Trust; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by KAKENHI Grants-in-Aid for Young Scientists A (24681008), Exploratory Research (24659533) from the Japan Society for the Promotion of Science, a science research grant from Inamori Foundation, a medical research grant from Mochida Memorial Founds for Medical and Pharmaceutical Research, a medical research grant from the Daiichi-Sankyo Foundation of Life Science, a grant for basic science research from The Sumitomo Foundation, and a medical research grant from Takeda Science Foundation to T.O.; Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency to Y.N.; and a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC) to M.S. We are grateful to the National Commissioning Group of the UK National Health Service (NHS) for funding the xeroderma pigmentosum service. In addition, the authors acknowledge financial support from the UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. Some early experiments were carried out by Di J. Sun. We are grateful to the families of the affected individuals for their helpful cooperation with these studies.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Ahmad A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000871; Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; Friedberg E.C., 2006, DNA REPAIR MUTAGENES; FUJIWARA Y, 1982, BIOCHIM BIOPHYS ACTA, V699, P217, DOI 10.1016/0167-4781(82)90110-5; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Gregg SQ, 2011, DNA REPAIR, V10, P781, DOI 10.1016/j.dnarep.2011.04.026; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HOY CA, 1985, CANCER RES, V45, P1737; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kleijer WJ, 2008, DNA REPAIR, V7, P744, DOI 10.1016/j.dnarep.2008.01.014; Laugel V, 2008, J MED GENET, V45, P564, DOI 10.1136/jmg.2007.057141; Laugel V, 2010, HUM MUTAT, V31, P113, DOI 10.1002/humu.21154; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; VANVUUREN AJ, 1993, EMBO J, V12, P3693, DOI 10.1002/j.1460-2075.1993.tb06044.x; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wood RD, 2010, ENVIRON MOL MUTAGEN, V51, P520, DOI 10.1002/em.20569; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	36	148	153	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					807	819		10.1016/j.ajhg.2013.04.007	http://dx.doi.org/10.1016/j.ajhg.2013.04.007			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23623389	Green Published, Bronze			2022-12-18	WOS:000318582800016
J	Pyott, SM; Tran, TT; Leistritz, DE; Pepin, MG; Mendelsohn, NJ; Temme, RT; Fernandez, BA; Elsayed, SM; Elsobky, E; Verma, I; Nair, S; Turner, EH; Smith, JD; Jarvik, GP; Byers, PH				Pyott, Shawna M.; Tran, Thao T.; Leistritz, Dru E.; Pepin, Melanie G.; Mendelsohn, Nancy J.; Temme, Renee T.; Fernandez, Bridget A.; Elsayed, Solaf M.; Elsobky, Ezzat; Verma, Ishwar; Nair, Sreelata; Turner, Emily H.; Smith, Joshua D.; Jarvik, Gail P.; Byers, Peter H.			WNT1 Mutations in Families Affected by Moderately Severe and Progressive Recessive Osteogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYCLOPHILIN-B; DIFFERENTIATION; IDENTIFICATION; PROTOONCOGENE; DEFICIENCY; PROTEIN; LETHAL; CRTAP	Osteogenesis imperfecta (OI) is a heritable disorder that ranges in severity from death in the perinatal period to an increased lifetime risk of fracture. Mutations in COL1A1 and COL1A2, which encode the chains of type I procollagen, result in dominant forms of OI, and mutations in several other genes result in recessive forms of OI. Here, we describe four recessive-OI-affected families in which we identified causative mutations in wingless-type MMTV integration site family 1 (WNT1). In family 1, we identified a homozygous missense mutation by exome sequencing. In family 2, we identified a homozygous nonsense mutation predicted to produce truncated WNT1. In family 3, we found a nonsense mutation and a single-nucleotide duplication on different alleles, and in family 4, we found a homozygous 14 bp deletion. The mutations in families 3 and 4 are predicted to result in nonsense-mediated mRNA decay and the absence of WNT1. WNT1 is a secreted signaling protein that binds the frizzled receptor (FZD) and the coreceptor low-density lipoprotein-receptor-related protein 5 (LRP5). Biallelic loss-of-function mutations in LRP5 result in recessive osteoporosis-pseudoglioma syndrome with low bone mass, whereas heterozygous gain-of-function mutations result in van Buchem disease with elevated bone density. Biallelic loss-of-function mutations in WNT1 result in a recessive clinical picture that includes bone fragility with a moderately severe and progressive presentation that is not easily distinguished from dominant OI type III.	[Pyott, Shawna M.; Tran, Thao T.; Leistritz, Dru E.; Pepin, Melanie G.; Byers, Peter H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Mendelsohn, Nancy J.; Temme, Renee T.] Childrens Hosp & Clin Minnesota, Div Med Genet, Minneapolis, MN 55404 USA; [Mendelsohn, Nancy J.] Univ Minnesota, Dept Pediat, Div Genet, Minneapolis, MN 55454 USA; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet, St John, NF A1B 3V6, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Med, St John, NF A1B 3V6, Canada; [Elsayed, Solaf M.; Elsobky, Ezzat] Ain Shams Univ, Dept Pediat, Genet Unit, Cairo 11566, Egypt; [Verma, Ishwar] Sir Ganga Ram Hosp, Dept Med Genet, New Delhi 110060, India; [Turner, Emily H.; Smith, Joshua D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Jarvik, Gail P.; Byers, Peter H.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Children's Hospitals & Clinics of Minnesota; University of Minnesota System; University of Minnesota Twin Cities; Memorial University Newfoundland; Memorial University Newfoundland; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pyott, SM (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	shawnap@uw.edu	Jarvik, Gail P/N-6476-2014; Elsayed, Solaf/AAJ-7898-2020	Jarvik, Gail P/0000-0002-6710-8708; Elsayed, Solaf/0000-0003-3054-9929; Byers, Peter H./0000-0001-7786-7030; Turner, Emily/0000-0001-9040-9229	Osteogenesis Imperfecta Foundation; Northwest Institute for Genetic Medicine; Washington State Life Sciences Discovery Fund [265508]; University of Washington; Department of Pathology, University of Washington	Osteogenesis Imperfecta Foundation; Northwest Institute for Genetic Medicine; Washington State Life Sciences Discovery Fund; University of Washington(University of Washington); Department of Pathology, University of Washington(University of Washington)	This work was supported in part by funds from the Osteogenesis Imperfecta Foundation (Michael Geisman Fellowship to S.M.P.), the Northwest Institute for Genetic Medicine and the Washington State Life Sciences Discovery Fund (grant 265508), the Freudmann Fund for Translational Research at the University of Washington, and research funds from the Department of Pathology, University of Washington. We are grateful to Brendan Lee and his collaborators for discussing their work with us prior to publication and for allowing us to cite the work to share credit for the recognition that WNT1 mutations play a role in recessive forms of osteogenesis imperfecta.	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bernier FP, 2012, AM J HUM GENET, V90, P925, DOI 10.1016/j.ajhg.2012.04.004; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Fujita K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-71; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Heo JS, 2010, MOL CELLS, V30, P449, DOI 10.1007/s10059-010-0139-3; Homan EP, 2011, J BONE MINER RES, V26, P2798, DOI 10.1002/jbmr.487; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Shaheen R, 2011, AM J MED GENET A, V155A, P1448, DOI 10.1002/ajmg.a.34025; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864	34	148	157	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					590	597		10.1016/j.ajhg.2013.02.009	http://dx.doi.org/10.1016/j.ajhg.2013.02.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23499310	Green Published, Bronze			2022-12-18	WOS:000317449700011
J	Walne, AJ; Vulliamy, T; Kirwan, M; Plagnol, V; Dokal, I				Walne, Amanda J.; Vulliamy, Tom; Kirwan, Michael; Plagnol, Vincent; Dokal, Inderjeet			Constitutional Mutations in RTEL1 Cause Severe Dyskeratosis Congenita	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOYERAAL-HREIDARSSON-SYNDROME; TELOMERE MAINTENANCE; LENGTH; HELICASE; GENETICS; PROTEIN; ANEMIA	Dyskeratosis congenita (DC) and its phenotypically severe variant, Hoyeraal-Hreidarsson syndrome (HHS), are multisystem bone-marrow-failure syndromes in which the principal pathology is defective telomere maintenance The genetic basis of many cases of DC and HHS remains unknown. Using whole-exome sequencing, we identified biallelic mutations in RTEL1, encoding a helicase essential for telomere maintenance and regulation of homologous recombination, in an individual with familial HHS. Additional screening of RTEL1 identified biallelic mutations in 6/23 index cases with HHS but none in 102 DC or DC-like cases. All 11 mutations in ten HHS individuals from seven families segregated in an autosomal-recessive manner, and telomere lengths were significantly shorter in cases than in controls (p = 0.0003). This group had significantly higher levels of telomeric circles, produced as a consequence of incorrect processing of telomere ends, than did controls (p = 0.0148). These biallelic RTEL1 mutations are responsible for a major subgroup (similar to 29%) of HHS. Our studies show that cells harboring these mutations have significant defects in telomere maintenance, but not in homologous recombination, and that incorrect resolution of T-loops is a mechanism for telomere shortening and disease causation in humans. They also demonstrate the severe multisystem consequences of its dysfunction.	[Walne, Amanda J.; Vulliamy, Tom; Kirwan, Michael; Dokal, Inderjeet] Queen Mary Univ London, Ctr Paediat, Barts & London Sch Med & Dent, Barts & London Childrens Hosp, London E1 2AT, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England	University of London; Queen Mary University London; University of London; University College London	Walne, AJ (corresponding author), Queen Mary Univ London, Ctr Paediat, Barts & London Sch Med & Dent, Barts & London Childrens Hosp, London E1 2AT, England.	a.walne@qmul.ac.uk		Plagnol, Vincent/0000-0002-5597-9215; Dokal, Inderjeet/0000-0003-4462-4782	Wellcome Trust; Medical Research Council; MRC [MR/K000292/1] Funding Source: UKRI; Medical Research Council [MR/K000292/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are very grateful to all the families who participated in this study, as well as their doctors, particularly Y. Dror, A. Durandy, T. Green, T. Gungor, J. Liu, I. Neri, and E. Plouvier, for referring samples to us. We thank the staff of the Genome Centre at Barts and The London School of Medicine and Dentistry and the Genomics Facility at King's College London for help with DNA sequencing. We thank our colleagues D. van Heel, D. Kelsell, and V. Rakyan for help and advice. We thank K. Riha for providing protocols. This work was supported by the Wellcome Trust and the Medical Research Council.	Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Keller RB, 2012, PEDIATR BLOOD CANCER, V59, P311, DOI 10.1002/pbc.24193; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Lamm N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005666; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Marrone A, 2007, BLOOD, V110, P4198, DOI 10.1182/blood-2006-12-062851; Mason PJ, 2011, CANCER GENET-NY, V204, P635, DOI 10.1016/j.cancergen.2011.11.002; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Nelson ND, 2012, MUTAT RES-FUND MOL M, V730, P43, DOI 10.1016/j.mrfmmm.2011.06.008; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Pickett HA, 2011, HUM MOL GENET, V20, P4684, DOI 10.1093/hmg/ddr402; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Touzot F, 2012, J ALLERGY CLIN IMMUN, V129, P473, DOI 10.1016/j.jaci.2011.09.043; Uringa EJ, 2012, MOL BIOL CELL, V23, P2782, DOI 10.1091/mbc.E12-03-0179; Uringa EJ, 2011, NUCLEIC ACIDS RES, V39, P1647, DOI 10.1093/nar/gkq1045; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Walne AJ, 2010, HUM MOL GENET, V19, P4453, DOI 10.1093/hmg/ddq371; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025	23	148	152	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					448	453		10.1016/j.ajhg.2013.02.001	http://dx.doi.org/10.1016/j.ajhg.2013.02.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23453664	hybrid, Green Published			2022-12-18	WOS:000316161700019
J	Talkowski, ME; Mullegama, SV; Rosenfeld, JA; van Bon, WM; Shen, YP; Repnikova, EA; Gastier-Foster, J; Thrush, DL; Kathiresan, S; Ruderfer, DM; Chiang, C; Hanscom, C; Ernst, C; Lindgren, AM; Morton, CC; An, Y; Astbury, C; Brueton, LA; Lichtenbelt, KD; Ades, LC; Fichera, M; Romano, C; Innis, JW; Williams, CA; Bartholomew, D; Van Allen, MI; Parikh, A; Zhang, LL; Wu, BL; Pyatt, RE; Schwartz, S; Shaffer, LG; de Vries, BBA; Gusella, JF; Elsea, SH				Talkowski, Michael E.; Mullegama, Sureni V.; Rosenfeld, Jill A.; van Bon, W. M.; Shen, Yiping; Repnikova, Elena A.; Gastier-Foster, Julie; Thrush, Devon Lamb; Kathiresan, Sekar; Ruderfer, Douglas M.; Chiang, Colby; Hanscom, Carrie; Ernst, Carl; Lindgren, Amelia M.; Morton, Cynthia C.; An, Yu; Astbury, Caroline; Brueton, Louise A.; Lichtenbelt, Klaske D.; Ades, Lesley C.; Fichera, Marco; Romano, Corrado; Innis, Jeffrey W.; Williams, Charles A.; Bartholomew, Dennis; Van Allen, Margot I.; Parikh, Aditi; Zhang, Lilei; Wu, Bai-Lin; Pyatt, Robert E.; Schwartz, Stuart; Shaffer, Lisa G.; de Vries, Bert B. A.; Gusella, James F.; Elsea, Sarah H.			Assessment of 2q23.1 Microdeletion Syndrome Implicates MBD5 as a Single Causal Locus of Intellectual Disability, Epilepsy, and Autism Spectrum Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SMITH-MAGENIS-SYNDROME; CHROMOSOME REARRANGEMENTS; PHENOTYPE; DELETIONS; PATIENT; SCHIZOPHRENIA; HYBRIDIZATION; FRAMEWORK; GENOTYPE	Persons with neurodevelopmental disorders or autism spectrum disorder (ASD) often harbor chromosomal microdeletions, yet the individual genetic contributors within these regions have not been systematically evaluated. We established a consortium of clinical diagnostic and research laboratories to accumulate a large cohort with genetic alterations of chromosomal region 2q23.1 and acquired 65 subjects with microdeletion or translocation. We sequenced translocation breakpoints; aligned microdeletions to determine the critical region; assessed effects on mRNA expression; and examined medical records, photos, and clinical evaluations. We identified a single gene, methyl-CpG-binding domain 5 (MBD5), as the only locus that defined the critical region. Partial or complete deletion of MBD5 was associated with haploinsufficiency of mRNA expression, intellectual disability, epilepsy, and autistic features. Fourteen alterations, including partial deletions of noncoding regions not typically captured or considered pathogenic by current diagnostic screening, disrupted MBD5 alone. Expression profiles and clinical characteristics were largely indistinguishable between MBD5-specific alteration and deletion of the entire 2q23.1 interval. No copy-number alterations of MBD5 were observed in 7878 controls, suggesting MBD5 alterations are highly penetrant. We surveyed MOOS coding variations among 747 ASD subjects compared to 2043 non-ASD subjects analyzed by whole-exome sequencing and detected an association with a highly conserved methyl-CpG-binding domain missense variant, p.79Gly>Glu (c.236G>A) (p = 0.012). These results suggest that genetic alterations of MBD5 cause features of 2q23.1 microdeletion syndrome and that this epigenetic regulator significantly contributes to ASD risk, warranting further consideration in research and clinical diagnostic screening and highlighting the importance of chromatin remodeling in the etiology of these complex disorders.	[Elsea, Sarah H.] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Talkowski, Michael E.; Kathiresan, Sekar; Ruderfer, Douglas M.; Chiang, Colby; Hanscom, Carrie; Ernst, Carl; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Talkowski, Michael E.; Gusella, James F.] Harvard Univ, Harvard Med Sch, Dept Genet, Cambridge, MA 02115 USA; [Talkowski, Michael E.; Gusella, James F.] Harvard Univ, Harvard Med Sch, Dept Neurol, Cambridge, MA 02115 USA; [Talkowski, Michael E.; Kathiresan, Sekar; Morton, Cynthia C.; Gusella, James F.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02143 USA; [Rosenfeld, Jill A.; Shaffer, Lisa G.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [van Bon, W. M.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Shen, Yiping] Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China; [Shen, Yiping; Wu, Bai-Lin] Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA; [Shen, Yiping; Wu, Bai-Lin] Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Kathiresan, Sekar; Wu, Bai-Lin] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Repnikova, Elena A.; Gastier-Foster, Julie; Thrush, Devon Lamb; Astbury, Caroline; Pyatt, Robert E.] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH 43205 USA; [Gastier-Foster, Julie; Astbury, Caroline; Pyatt, Robert E.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Gastier-Foster, Julie; Thrush, Devon Lamb] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ruderfer, Douglas M.] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Ruderfer, Douglas M.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ruderfer, Douglas M.] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02143 USA; [Lindgren, Amelia M.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Lindgren, Amelia M.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wu, Bai-Lin] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Wu, Bai-Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Brueton, Louise A.] Birmingham Womens Hosp, Clin Genet Unit, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Lichtenbelt, Klaske D.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Ades, Lesley C.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Fichera, Marco] Ist Ricovero & Cura, Lab Genet Diag, I-94018 Troina, Italy; [Romano, Corrado] Assoc Oasi Maria Santissima, IRCCS, I-94108 Troina, Italy; [Innis, Jeffrey W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Innis, Jeffrey W.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Williams, Charles A.] Univ Florida, Coll Med, Dept Pediat, Div Genet & Metab, Gainesville, FL 32611 USA; [Bartholomew, Dennis] Nationwide Childrens Hosp, Div Mol & Human Genet, Columbus, OH 43205 USA; [Van Allen, Margot I.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Parikh, Aditi; Zhang, Lilei] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Parikh, Aditi; Zhang, Lilei] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Schwartz, Stuart] LabCorp, Res Triangle Pk, NC 27709 USA; [Elsea, Sarah H.] Virginia Commonwealth Univ, Sch Med, Dept Pediat, Richmond, VA 23298 USA	Virginia Commonwealth University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Radboud University Nijmegen; Shanghai Jiao Tong University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Fudan University; Fudan University; Birmingham Women's Hospital; Utrecht University; Utrecht University Medical Center; University of Sydney; IRCCS Oasi Maria SS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of British Columbia; Case Western Reserve University; Case Western Reserve University; Virginia Commonwealth University	Elsea, SH (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA 23298 USA.	selsea@vcu.edu	Astbury, Caroline/E-2665-2011; Fichera, Marco/K-9220-2016; Gastier-Foster, Julie/E-3105-2011; Romano, Corrado/B-9695-2008; van Bon, Bregje/D-3720-2013; Ruderfer, Douglas M/M-5795-2016; van Bon, Bregje/Q-2445-2015	Fichera, Marco/0000-0002-8225-6880; Romano, Corrado/0000-0003-1049-0683; Ruderfer, Douglas M/0000-0002-2365-386X; van Bon, Bregje/0000-0003-2234-0105; Chiang, Colby/0000-0002-4113-6065; Talkowski, Michael/0000-0003-2889-0992; Elsea, Sarah/0000-0002-1400-8519	Developmental Genome Anatomy Project [GM061354, HD065286]; National "973" project on Population and Health of China [2010CB529601]; Science and Technology Council of Shanghai [09JC1402400, 09ZR1404500]; Simons Foundation Autism Research Initiative; National Institutes of Health [F32MH087123]; "5 per mille" program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH087123] Funding Source: NIH RePORTER	Developmental Genome Anatomy Project; National "973" project on Population and Health of China; Science and Technology Council of Shanghai; Simons Foundation Autism Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "5 per mille" program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are thankful to all of the subjects and families involved in this study. We are grateful for the assistance of Jennifer Defant, Santhosh Girirajan, Stephen Williams, Zalak Shah, and Tracey Oh in the collection of clinical data and in the preparation of this manuscript. We thank Pamela Sklar and the International Schizophrenia Consortium for contributing control data and Nancy J. Van Vranken for patient referral. We are also grateful to Manuel Rivas for assistance with the Syzygy analysis. We thank the Fondation Jerome Lejeune (SHE.) for funding portions of this study, Developmental Genome Anatomy Project(GM061354), HD065286, National "973" project on Population and Health of China (2010CB529601), Science and Technology Council of Shanghai (09JC1402400 and 09ZR1404500), and the Simons Foundation Autism Research Initiative. M.E.T. was supported by a National Institutes of Health National Research Service Award (F32MH087123). The authors would also like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). Fichera and Romano were supported by a grant from the "5 per mille" program.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aliferis K, 2010, OPHTHALMIC GENET, V31, P205, DOI 10.3109/13816810.2010.512355; Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Bremer A, 2011, AM J MED GENET B, V156B, P115, DOI 10.1002/ajmg.b.31142; Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Chung BHY, 2011, AM J MED GENET A, V155A, P424, DOI 10.1002/ajmg.a.33821; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; De Gregori M, 2007, J MED GENET, V44, P750, DOI 10.1136/jmg.2007.052787; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Durand CM, 2011, MOL PSYCHIAT; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Girirajan S, 2009, CLIN GENET, V75, P364, DOI 10.1111/j.1399-0004.2008.01135.x; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Jaillard S, 2009, J MED GENET, V46, P847, DOI 10.1136/jmg.2008.058156; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Koolen DA, 2004, CLIN GENET, V65, P429, DOI 10.1111/j.0009-9163.2004.00245.x; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Le Couteur A, 2008, J AUTISM DEV DISORD, V38, P362, DOI 10.1007/s10803-007-0403-3; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Li H, 2005, BRAIN DEV-JPN, V27, P321, DOI 10.1016/j.braindev.2004.08.003; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Luyster R, 2009, J AUTISM DEV DISORD, V39, P1305, DOI 10.1007/s10803-009-0746-z; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Nowakowska BA, 2010, AM J MED GENET B, V153B, P1042, DOI 10.1002/ajmg.b.31071; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rosenfeld JA, 2010, GENET MED, V12, P694, DOI 10.1097/GIM.0b013e3181f0c5f3; Rosenfeld JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006568; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Soysal Y, 2011, AM J MED GENET A, V155A, P1745, DOI 10.1002/ajmg.a.34101; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; van Bon BWM, 2010, EUR J HUM GENET, V18, P163, DOI 10.1038/ejhg.2009.152; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Williams SR, 2010, EUR J HUM GENET, V18, P436, DOI 10.1038/ejhg.2009.199	48	148	154	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					551	563		10.1016/j.ajhg.2011.09.011	http://dx.doi.org/10.1016/j.ajhg.2011.09.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	834HV	21981781	Green Published, Bronze			2022-12-18	WOS:000295951300009
J	Le Goff, C; Mahaut, C; Wang, LW; Allali, S; Abhyankar, A; Jensen, S; Zylberberg, L; Collod-Beroud, G; Bonnet, D; Alanay, Y; Brady, AF; Cordier, MP; Devriendt, K; Genevieve, D; Kiper, POS; Kitoh, H; Krakow, D; Lynch, SA; Le Merrer, M; Megarbane, A; Mortier, G; Odent, S; Polak, M; Rohrbach, M; Sillence, D; Stolte-Dijkstra, I; Superti-Furga, A; Rimoin, DL; Topouchian, V; Unger, S; Zabel, B; Bole-Feysot, C; Nitschke, P; Handford, P; Casanova, JL; Boileau, C; Apte, SS; Munnich, A; Cormier-Dairel, V				Le Goff, Carine; Mahaut, Clementine; Wang, Lauren W.; Allali, Slimane; Abhyankar, Avinash; Jensen, Sacha; Zylberberg, Louise; Collod-Beroud, Gwenaelle; Bonnet, Damien; Alanay, Yasemin; Brady, Angela. F.; Cordier, Marie-Pierre; Devriendt, Koen; Genevieve, David; Kiper, Pelin Ozlem Simsek; Kitoh, Hiroshi; Krakow, Deborah; Lynch, Sally Ann; Le Merrer, Martine; Megarbane, Andre; Mortier, Geert; Odent, Sylvie; Polak, Michel; Rohrbach, Marianne; Sillence, David; Stolte-Dijkstra, Irene; Superti-Furga, Andrea; Rimoin, David L.; Topouchian, Vicken; Unger, Sheila; Zabel, Bernhard; Bole-Feysot, Christine; Nitschke, Patrick; Handford, Penny; Casanova, Jean-Laurent; Boileau, Catherine; Apte, Suneel S.; Munnich, Arnold; Cormier-Dairel, Valerie			Mutations in the TGF beta Binding-Protein-Like Domain 5 of FBN1 Are Responsible for Acromicric and Geleophysic Dysplasias	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIBRILLIN-1; GENE	Geleophysic (GD) and acromicric dysplasia (AD) belong to the acromelic dysplasia group and are both characterized by severe short stature, short extremities, and stiff joints. Although All has an unknown molecular basis, we have previously identified ADAMTSL2 mutations in a subset of GD patients. After exome sequencing in GD and AD cases, we selected fibrillin 1 (FBN1) as a candidate gene, even though mutations in this gene have been described in Marfan syndrome, which is characterized by tall stature and arachnodactyly. We identified 16 heterozygous FBN1 mutations that are all located in exons 41 and 42 and encode TGF beta-binding protein-like domain 5 (TB5) of FBN1 in 29 GD and AD cases. Microfibrillar network disorganization and enhanced TGF beta signaling were consistent features in GD and AD fibroblasts. Importantly, a direct interaction between ADAMTS12 and FBN1 was demonstrated, suggesting a disruption of this interaction as the underlying mechanism of GD and AD phenotypes. Although enhanced TGF beta signaling caused by FBN1 mutations can trigger either Marfan syndrome or GD and AD, our findings support the fact that TB5 mutations in FBN1 are responsible for short stature phenotypes.	[Wang, Lauren W.; Apte, Suneel S.] Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Le Goff, Carine; Mahaut, Clementine; Allali, Slimane; Le Merrer, Martine; Munnich, Arnold; Cormier-Dairel, Valerie] Univ Paris 05, INSERM, Dept Genet, Hop Necker Enfants Malad,U781, F-75015 Paris, France; [Abhyankar, Avinash; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Jensen, Sacha; Handford, Penny] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Zylberberg, Louise] Univ Paris 06, CNRS, UMR71 93, F-75005 Paris, France; [Collod-Beroud, Gwenaelle] INSERM, U827, F-34000 Montpellier, France; [Collod-Beroud, Gwenaelle] Univ Montpellier I, UFR Med, F-34000 Montpellier, France; [Bonnet, Damien] Univ Paris 05, Hop Necker Enfants Malad, Ctr Reference Malformat Cardiaques Congenitales C, F-75015 Paris, France; [Alanay, Yasemin; Kiper, Pelin Ozlem Simsek] Hacettepe Univ, Fac Med, Dept Pediat, Pediat Genet Unit, TR-06100 Ankara, Turkey; [Brady, Angela. F.] Northwick Pk Hosp & Clin Res Ctr, Harrow HA1 3UJ, Middx, England; [Cordier, Marie-Pierre] Grp Hosp Est, HFME, Serv Genet, F-69677 Bron, France; [Devriendt, Koen] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Genevieve, David] Univ Montpellier I, INSERM, U844, Dept Med Genet, F-34000 Montpellier, France; [Kitoh, Hiroshi] Nagoya Univ, Sch Med, Dept Orthopaed Surg, Aichi 4668550, Japan; [Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90068 USA; [Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90068 USA; [Lynch, Sally Ann] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; [Megarbane, Andre] Univ St Joseph, Unite Genet Med, Beirut 11042020, Lebanon; [Mortier, Geert] Antwerp Univ & Hosp, Dept Med Genet, B-2650 Edegem, Belgium; [Odent, Sylvie] Univ Rennes 1, Hop Sud, Serv Genet Clin, UMR6061, F-35200 Rennes, France; [Polak, Michel] Univ Paris 05, Hop Necker Enfants Malad, AP HP, F-75015 Paris, France; [Rohrbach, Marianne] Univ Childrens Hosp, Connect Tissue Unit, Div Metab, CH-8032 Zurich, Switzerland; [Sillence, David] Childrens Hosp, Acad Dept Med Genet, Westmead, NSW 2145, Australia; [Stolte-Dijkstra, Irene] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 GZ Groningen, Netherlands; [Superti-Furga, Andrea; Unger, Sheila] Univ Lausanne, Dept Pediat, CH-1015 Lausanne, Switzerland; [Superti-Furga, Andrea; Unger, Sheila] Univ Lausanne, Dept Human Genet, CH-1015 Lausanne, Switzerland; [Rimoin, David L.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Topouchian, Vicken] Hop Necker Enfants Malad, Dept Pediat Orthoped Surg, F-75015 Paris, France; [Zabel, Bernhard] Univ Freiburg, Freiburg Univ Hosp, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Bole-Feysot, Christine] Hop Necker Enfants Malad, Fdn Imagine, F-75015 Paris, France; [Casanova, Jean-Laurent] Univ Paris 05, Necker branch, Lab Human Genet Infect Dis, F-75015 Paris, France; [Casanova, Jean-Laurent] Necker Med Sch, INSERM, U980, F-75015 Paris, France; [Boileau, Catherine] Univ Paris Diderot, INSERM, U698, F-92100 Boulogne, France; [Boileau, Catherine] Hop Ambroise Pare, AP HP, Lab Biochim & Genet Mol, F-92100 Boulogne, France	Cleveland Clinic Foundation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; University of Oxford; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hacettepe University; Imperial College London; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Nagoya University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Saint Joseph University Beirut; University of Antwerp; CHU Rennes; Universite de Rennes 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University Children's Hospital Zurich; University of Sydney; University of Groningen; University of Lausanne; University of Lausanne; Cedars Sinai Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Cormier-Dairel, V (corresponding author), Univ Paris 05, INSERM, Dept Genet, Hop Necker Enfants Malad,U781, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	Kitoh, Hiroshi/AAC-2093-2021; unger, sheila/E-9177-2015; boileau, catherine/M-4482-2017; Mortier, Geert/D-2542-2012; Casanova, Jean-Laurent/I-3418-2017; Krakow, Deborah/B-5778-2009; Jensen, Sacha A./AAB-4034-2019; Allali, Slimane/AGW-0037-2022; KITOH, Hiroshi/I-7256-2014; Le Goff, Carine/N-9940-2017; LE GOFF, Carine/AAG-2390-2020; COLLOD-BEROUD, Gwenaëlle/A-8342-2008; superti-furga, andrea/E-9162-2015; Alanay, Yasemin/A-1516-2016; Simsek-Kiper, Pelin Ozlem/AAI-3010-2021; Megarbane, Andre/ABD-5574-2021; cormier-daire, valerie/H-6520-2017	boileau, catherine/0000-0002-0371-7539; Mortier, Geert/0000-0001-9871-4578; Krakow, Deborah/0000-0001-9906-4968; Jensen, Sacha A./0000-0002-0560-9531; LE GOFF, Carine/0000-0002-7788-708X; COLLOD-BEROUD, Gwenaëlle/0000-0003-4098-6161; superti-furga, andrea/0000-0002-3543-7531; Alanay, Yasemin/0000-0003-0683-9731; Lynch, Sally Ann/0000-0003-3540-1333; Apte, Suneel/0000-0001-8441-1226; cormier-daire, valerie/0000-0002-2839-9856; Allali, Slimane/0000-0001-7068-4530	Medical Research Foundation (FRM); French National Research Agency (ANR) [R09183KS]; National Institutes of Health-National Institute of Arthritis and Musculoskeletal Skin Diseases [AR53890]; German Federal Ministry of Education and Research (BMBF); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053890] Funding Source: NIH RePORTER	Medical Research Foundation (FRM)(Fondation pour la Recherche Medicale); French National Research Agency (ANR)(French National Research Agency (ANR)); National Institutes of Health-National Institute of Arthritis and Musculoskeletal Skin Diseases; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank all the patients and their families for their contribution to this work. The work presented here was supported by the Medical Research Foundation (FRM to S.A.), a French National Research Agency (ANR) award (R09183KS to V.C.-D.), and a National Institutes of Health-National Institute of Arthritis and Musculoskeletal Skin Diseases grant (AR53890 to S.S.A). B.Z. is supported by the German Federal Ministry of Education and Research (BMBF, SKELNET project).	Allali S, 2011, J MED GENET, V48, P417, DOI 10.1136/jmg.2010.087544; [Anonymous], MARFAN MUTATION DATA; [Anonymous], MUTATION NOMENCLATUR; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; Faivre L, 2001, J MED GENET, V38, P745, DOI 10.1136/jmg.38.11.745; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Frederic MY, 2009, HUM MUTAT, V30, P952, DOI 10.1002/humu.20970; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Kettle S, 2000, INT J BIOCHEM CELL B, V32, P201, DOI 10.1016/S1357-2725(99)00120-X; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; MAROTEAUX P, 1986, AM J MED GENET, V24, P447, DOI 10.1002/ajmg.1320240307; SPRANGER JW, 1971, LANCET, V2, P97; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659	17	148	153	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					7	14		10.1016/j.ajhg.2011.05.012	http://dx.doi.org/10.1016/j.ajhg.2011.05.012			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21683322	Bronze, Green Published			2022-12-18	WOS:000293041700001
J	Thiadens, AAHJ; den Hollander, AI; Roosing, S; Nabuurs, SB; Zekveld-Vroon, RC; Collin, RWJ; De Baere, E; Koenekoop, RK; van Schooneveld, MJ; Strom, TM; van Lith-Verhoeven, JJC; Lotery, AJ; van Moll-Ramirez, N; Leroy, BP; van den Born, LI; Hoyng, CB; Cremers, FPM; Klaver, CCW				Thiadens, Alberta A. H. J.; den Hollander, Anneke I.; Roosing, Susanne; Nabuurs, Sander B.; Zekveld-Vroon, Renate C.; Collin, Rob W. J.; De Baere, Elfride; Koenekoop, Robert K.; van Schooneveld, Mary J.; Strom, Tim M.; van Lith-Verhoeven, Janneke J. C.; Lotery, Andrew J.; van Moll-Ramirez, Norka; Leroy, Bart P.; van den Born, L. Ingeborgh; Hoyng, Carel B.; Cremers, Frans P. M.; Klaver, Caroline C. W.			Homozygosity Mapping Reveals PDE6C Mutations in Patients with Early-Onset Cone Photoreceptor Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL RECESSIVE CONE; PROGRESSIVE CONE; GENE; DYSTROPHY; DEGENERATION	Cone photoreceptor disorders form a clinical spectrum of diseases that include progressive cone dystrophy (CD) and complete and incomplete achromatopsia (ACHM). The underlying disease mechanisms of autosomal recessive (ar)CD are largely unknown. Our aim was to identify causative genes for these disorders by genome-wide homozygosity mapping. We investigated 75 ACHM, 97 arCD, and 20 early-onset arCD probands and excluded the involvement of known genes for ACHM and arCD. Subsequently, we performed high-resolution SNP analysis and identified large homozygous regions spanning the PDE6C gene in one sibling pair with early-onset arCD and one sibling pair with incomplete ACHM. The PDE6C gene encodes the cone a subunit of cyclic guanosine monophosphate (cGMP) phosphodiesterase, which converts cGMP to 5'-GMP, and thereby plays an essential role in cone phototransduction. Sequence analysis of the coding region of PDE6C revealed homozygous missense mutations (p.R29W, p.Y323N) in both sibling pairs. Sequence analysis of 104 probands with arCD and 10 probands with ACHM revealed compound heterozygous PDE6C mutations in three complete ACHM patients from two families. One patient had a frameshift mutation and a splice defect; the other two had a splice defect and a missense variant (p.M455V). Cross-sectional retinal imaging via optical coherence tomography revealed a more pronounced absence of cone photoreceptors in patients with ACHM compared to patients with early-onset arCD. Our findings identify PDE6C as a gene for cone photoreceptor disorders and show that arCD and ACHM constitute genetically and clinically overlapping phenotypes.	[Thiadens, Alberta A. H. J.; Roosing, Susanne; Collin, Rob W. J.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Thiadens, Alberta A. H. J.; Zekveld-Vroon, Renate C.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, NL-3000 CA Rotterdam, Netherlands; [den Hollander, Anneke I.; Collin, Rob W. J.; van Lith-Verhoeven, Janneke J. C.; Hoyng, Carel B.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; [den Hollander, Anneke I.; Nabuurs, Sander B.; Collin, Rob W. J.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6500 HC Nijmegen, Netherlands; [Nabuurs, Sander B.] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, NL-6500 HC Nijmegen, Netherlands; [De Baere, Elfride; Leroy, Bart P.] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Koenekoop, Robert K.] McGill Univ, Ctr Hlth, McGill Ocular Genet Lab, Montreal, PQ H3H 1P3, Canada; [van Schooneveld, Mary J.] Netherlands Inst Neurosci, Dept Ophthalmogenet, NL-1105 BA Amsterdam, Netherlands; [Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Lotery, Andrew J.] Univ Southampton, Div Clin Neurosci, Southampton SO16 6YD, Hants, England; [van Moll-Ramirez, Norka] Sensis Grave, NL-5361 HK Grave, Netherlands; [Leroy, Bart P.] Ghent Univ Hosp, Dept Ophthalmol, B-9000 Ghent, Belgium; [van den Born, L. Ingeborgh] Rotterdam Eye Hosp, NL-3000 LM Rotterdam, Netherlands; [Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Ghent University; Ghent University Hospital; McGill University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Southampton; Ghent University; Ghent University Hospital; Rotterdam Eye Hospital; Erasmus University Rotterdam; Erasmus MC	Cremers, FPM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	f.cremers@antrg.umcn.nl	Roosing, Susanne/F-1616-2018; De Baere, Elfride/E-7405-2017; Klaver, Caroline C.W./A-2013-2016; Roosing, Susanne/ABF-9604-2021; Roosing, Susanne/AAK-3454-2020; Cremers, Frans/A-5625-2014; Koenekoop, Robert/AAT-6676-2021; Collin, Rob/N-3575-2014; Hollander, Anneke den/N-4911-2014; Hoyng, C.B./H-8050-2014	Roosing, Susanne/0000-0001-9038-0067; De Baere, Elfride/0000-0002-5609-6895; Roosing, Susanne/0000-0001-9038-0067; Roosing, Susanne/0000-0001-9038-0067; Cremers, Frans/0000-0002-4954-5592; Klaver, Caroline/0000-0002-2355-5258; Lotery, Andrew/0000-0001-5541-4305	Prof. Dr. Henkes Stichting, Nijmeegse Oogonderzoek Stichting; Stichting Wetenschappelijk Onderzoek Oogziekenhuis (SWOO); Rotterdam Eye Hospital, Macula Degeneratie Fonds (MD Fonds),; Algemene Nederiandse Vereniging ter Voorkoming van Blindheid; Dr. F.P. Fischer Stichting, Gelderse Blinden Stichting; Landelijke Stichting voor Blinden en Slechtzienclen (LSBS),; Stichting Blindenhulp; Stichting Blinden-penning; Stichting Nederlands Oogheetkundig Onderzoek (SNOO),; Stichting Ondersteuning Oogheel kunde's-Gravenhage (OOG); Stichting ter Verbetering van het Lot der Blinden Nederland; Research Foundation Flanders (FWO) [G.0043.06N]; Foundation Fighting Blindness-Canada; Fonds de la recherche en sante du Quebec (FRSQ); Canadian Institutes of Health Research (CIHR).; National Institute for Health Research [NF-SI-0507-10094] Funding Source: researchfish	Prof. Dr. Henkes Stichting, Nijmeegse Oogonderzoek Stichting; Stichting Wetenschappelijk Onderzoek Oogziekenhuis (SWOO); Rotterdam Eye Hospital, Macula Degeneratie Fonds (MD Fonds),; Algemene Nederiandse Vereniging ter Voorkoming van Blindheid; Dr. F.P. Fischer Stichting, Gelderse Blinden Stichting; Landelijke Stichting voor Blinden en Slechtzienclen (LSBS),; Stichting Blindenhulp; Stichting Blinden-penning; Stichting Nederlands Oogheetkundig Onderzoek (SNOO),; Stichting Ondersteuning Oogheel kunde's-Gravenhage (OOG); Stichting ter Verbetering van het Lot der Blinden Nederland; Research Foundation Flanders (FWO)(FWO); Foundation Fighting Blindness-Canada; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research (CIHR).(Canadian Institutes of Health Research (CIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank R. Bernaerts-Biskop for extensive assistance with data collection and V. Somervuo for performance of OCTs. We thank S. van der Velde-Visser and C. Beumer for expert technical assistance. This study was financially supported by Prof. Dr. Henkes Stichting, Nijmeegse Oogonderzoek Stichting, Stichting Wetenschappelijk Onderzoek Oogziekenhuis (SWOO), the Rotterdam Eye Hospital, Macula Degeneratie Fonds (MD Fonds), Algemene Nederiandse Vereniging ter Voorkoming van Blindheid (AN-VVB), Dr. F.P. Fischer Stichting, Gelderse Blinden Stichting, Landelijke Stichting voor Blinden en Slechtzienclen (LSBS), Stichting Blindenhulp, Stichting Blinden-penning, Stichting Nederlands Oogheetkundig Onderzoek (SNOO), Stichting Ondersteuning Oogheel kunde's-Gravenhage (OOG), Stichting ter Verbetering van het Lot der Blinden Nederland, Research Foundation Flanders (FWO) grant number G.0043.06N, Foundation Fighting Blindness-Canada, Fonds de la recherche en sante du Quebec (FRSQ), and the Canadian Institutes of Health Research (CIHR).	Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Jiang L, 2005, MOL VIS, V11, P143; Kitiratschky VBD, 2008, EUR J HUM GENET, V16, P812, DOI 10.1038/ejhg.2008.23; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; Michaelides M, 2004, INVEST OPHTH VIS SCI, V45, P1975, DOI 10.1167/iovs.03-0898; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P291, DOI 10.1136/bjo.2003.027102; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Nishiwaki Y, 2008, MECH DEVELOP, V125, P932, DOI 10.1016/j.mod.2008.09.001; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; THIADENS AAH, 2009, OPHTHALMOLO IN PRESS; Thiagalingam S, 2007, OPHTHALMIC GENET, V28, P135, DOI 10.1080/13816810701503681; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Wissinger B, 2008, INVEST OPHTH VIS SCI, V49, P751, DOI 10.1167/iovs.07-0471; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620	22	148	152	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					240	247		10.1016/j.ajhg.2009.06.016	http://dx.doi.org/10.1016/j.ajhg.2009.06.016			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19615668	Bronze, Green Published			2022-12-18	WOS:000269332900012
J	Golzio, C; Martinovic-Bouriel, J; Thomas, S; Mougou-Zrelli, S; Grattagliano-Bessiere, B; Bonniere, M; Delahaye, S; Munnich, A; Encha-Razavi, F; Lyonnet, S; Vekemans, M; Attie-Bitach, T; Etchevers, HC				Golzio, Christelle; Martinovic-Bouriel, Jelena; Thomas, Sophie; Mougou-Zrelli, Soumaya; Grattagliano-Bessieres, Bettina; Bonniere, Maryse; Delahaye, Sophie; Munnich, Arnold; Encha-Razavi, Ferechte; Lyonnet, Stanislas; Vekemans, Michel; Attie-Bitach, Tania; Etchevers, Heather C.			Matthew-Wood syndrome is caused by truncating mutations in the retinol-binding protein receptor gene STRA6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; EMBRYONAL CARCINOMA-CELLS; PAX6 GENE; ACID SYNTHESIS; CRANIOFRONTONASAL SYNDROME; PULMONARY HYPOPLASIA; EXPRESSION PATTERN; MENTAL-RETARDATION; NERVOUS-SYSTEM; HOMEOBOX GENE	Retinoic acid ( RA) is a potent teratogen in all vertebrates when tight homeostatic controls on its endogenous dose, location, or timing are perturbed during early embryogenesis. STRA6 encodes an integral cell-membrane protein that favors RA uptake from soluble retinol-binding protein; its transcription is directly regulated by RA levels. Molecular analysis of STRA6 was undertaken in two human fetuses from consanguineous families we previously described with Matthew-Wood syndrome in a context of severe microphthalmia, pulmonary agenesis, bilateral diaphragmatic eventration, duodenal stenosis, pancreatic malformations, and intrauterine growth retardation. The fetuses had either a homozygous insertion/deletion in exon 2 or a homozygous insertion in exon 7 predicting a premature stop codon in STRA6 transcripts. Five other fetuses presenting at least one of the two major signs of clinical anophthalmia or pulmonary hypoplasia with at least one of the two associated signs of diaphragmatic closure defect or cardiopathy had no STRA6 mutations. These findings suggest a molecular basis for the prenatal manifestations of Matthew-Wood syndrome and suggest that phenotypic overlap with other associations may be due to genetic heterogeneity of elements common to the RA- and fibroblast growth factor-signaling cascades.	Univ Paris 05, INSERM U781, Paris, France; Hop Necker Enfants Malad, APHP, Dept Genet, Paris, France; Hop Necker Enfants Malad, Dept Obstet, Paris, France; Inst Puericulture, Dept Fetal Pathol, Paris, France; Hop Purpan, INSERM U563, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Etchevers, HC (corresponding author), Hop Necker Enfants Malad, INSERM U781, 149 Rue Sevres, F-75743 Paris 15, France.	etchevers@necker.fr	thomas, sophie/GVS-1279-2022; ATTIE-BITACH, Tania/K-1453-2017; Etchevers, Heather C./B-5813-2012; THOMAS, Sophie/F-4492-2017; Lyonnet, Stanislas/H-5483-2017	ATTIE-BITACH, Tania/0000-0002-1155-3626; Etchevers, Heather C./0000-0003-0201-3799; THOMAS, Sophie/0000-0002-8569-3277; Lyonnet, Stanislas/0000-0001-5426-9417; Golzio, Christelle/0000-0002-4420-3921	NINDS NIH HHS [R01 NS039818, R01 NS039818-09] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039818] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; Azuma N, 2003, AM J HUM GENET, V72, P1565, DOI 10.1086/375555; Bar-Yosef U, 2004, HUM GENET, V115, P302, DOI 10.1007/s00439-004-1154-2; Berggren K, 1999, DEV BIOL, V210, P288, DOI 10.1006/dbio.1999.9286; Berkenstadt M, 1999, AM J MED GENET, V86, P6, DOI 10.1002/(SICI)1096-8628(19990903)86:1<6::AID-AJMG2>3.0.CO;2-2; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BOUILLET P, 1995, DEV DYNAM, V204, P372, DOI 10.1002/aja.1002040404; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Byrd NA, 2005, DEV BIOL, V284, P233, DOI 10.1016/j.ydbio.2005.05.023; Clugston RD, 2006, AM J PATHOL, V169, P1541, DOI 10.2353/ajpath.2006.060445; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Desai TJ, 2004, DEV BIOL, V273, P402, DOI 10.1016/j.ydbio.2004.04.039; ENGELLENNER W, 1989, Pediatric Pathology, V9, P725; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Halilagic A, 2007, DEV BIOL, V303, P362, DOI 10.1016/j.ydbio.2006.11.021; Hidalgo-Sanchez M, 2005, BRAIN RES REV, V49, P134, DOI 10.1016/j.brainresrev.2005.01.010; HOLDER AM, IN PRESS AM J HUM GE; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Li L, 2006, AM J MED GENET A, V140A, P1564, DOI 10.1002/ajmg.a.31298; Macayran JF, 2002, AM J MED GENET, V108, P229, DOI 10.1002/ajmg.10262; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Martinovic-Bouriel J, 2007, AM J MED GENET A, V143A, P219, DOI 10.1002/ajmg.a.31599; McGaughran J, 2002, AM J MED GENET, V110, P391, DOI 10.1002/ajmg.10176; Means AL, 2000, CELL GROWTH DIFFER, V11, P71; Min Q, 1998, TEACH LEARN MED, V10, P12, DOI 10.1207/S15328015TLM1001_3; Niederreither K, 2003, DEVELOPMENT, V130, P2525, DOI 10.1242/dev.00463; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Rozen S, 2000, Methods Mol Biol, V132, P365; Saugier-Veber P, 2006, EUR J HUM GENET, V14, P1009, DOI 10.1038/sj.ejhg.5201661; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Seller MJ, 1996, AM J MED GENET, V62, P227, DOI 10.1002/(SICI)1096-8628(19960329)62:3<227::AID-AJMG5>3.3.CO;2-R; Spear G S, 1987, Am J Med Genet Suppl, V3, P379; Steiner RD, 2002, AM J MED GENET, V108, P45, DOI 10.1002/ajmg.10167; Vasudevan PC, 2006, EUR J HUM GENET, V14, P884, DOI 10.1038/sj.ejhg.5201633; Vermot J, 2006, DIFFERENTIATION, V74, P661, DOI 10.1111/j.1432-0436.2006.00094.x; Vincent MC, 2003, EUR J HUM GENET, V11, P163, DOI 10.1038/sj.ejhg.5200940; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025	43	148	150	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1179	1187		10.1086/518177	http://dx.doi.org/10.1086/518177			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503335	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000246553800016
J	Holder, AM; Klaassens, M; Tibboel, D; de Klein, A; Lee, B; Scott, DA				Holder, A. M.; Klaassens, M.; Tibboel, D.; de Klein, A.; Lee, B.; Scott, D. A.			Genetic factors in congenital diaphragmatic hernia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							WOLF-HIRSCHHORN-SYNDROME; COMPARATIVE GENOMIC HYBRIDIZATION; PALLISTER-KILLIAN-SYNDROME; FRYNS-SYNDROME PHENOTYPE; PRENATAL-DIAGNOSIS; PARTIAL TRISOMY; INTERSTITIAL DELETION; TERMINAL DELETION; LONG ARM; UNBALANCED TRANSLOCATION	Congenital diaphragmatic hernia (CDH) is a relatively common birth defect associated with high mortality and morbidity. Although the exact etiology of most cases of CDH remains unknown, there is a growing body of evidence that genetic factors play an important role in the development of CDH. In this review, we examine key findings that are likely to form the basis for future research in this field. Specific topics include a short overview of normal and abnormal diaphragm development, a discussion of syndromic forms of CDH, a detailed review of chromosomal regions recurrently altered in CDH, a description of the retinoid hypothesis of CDH, and evidence of the roles of specific genes in the development of CDH.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Howard Hughes Med Inst, Houston, TX 77030 USA; Erasmus MC, Dept Pediat Surg, Rotterdam, Netherlands; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	Baylor College of Medicine; Howard Hughes Medical Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Lee, B (corresponding author), 635E,1 Baylor Plaza, Houston, TX 77030 USA.	blee@bcm.tmc.edu		Holder, Ashley/0000-0002-6506-5871	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD041648, K08HD050583] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; ACKERMAN KG, 2006, AM J RESP CELL MOL B; Ahmed AA, 2004, CLIN DYSMORPHOL, V13, P111, DOI 10.1097/00019605-200404000-00012; Ahn HY, 2005, J KOREAN MED SCI, V20, P895, DOI 10.3346/jkms.2005.20.5.895; ALFI O, 1973, ANN GENET-PARIS, V16, P17; ALFI OS, 1976, ANN GENET-PARIS, V19, P11; Allan DW, 1997, J APPL PHYSIOL, V83, P338, DOI 10.1152/jappl.1997.83.2.338; ANDERSEN DH, 1949, AM J PATHOL, V25, P163; Andersen DH., 1941, AM J DIS CHILD, V62, P888; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; AURIAS A, 1975, ANN GENET-PARIS, V18, P185; Aviram-Goldring A, 2000, AM J MED GENET, V90, P120, DOI 10.1002/(SICI)1096-8628(20000117)90:2<120::AID-AJMG6>3.0.CO;2-R; Azancot A, 2000, ARCH MAL COEUR VAISS, V93, P587; Babiuk RP, 2003, J COMP NEUROL, V455, P477, DOI 10.1002/cne.10503; Babiuk RP, 2002, AM J PHYSIOL-LUNG C, V283, pL1310, DOI 10.1152/ajplung.00257.2002; BALDERMANN C, 2000, AM J HUM GENET S, V2, P67; Baruch AC, 2001, AM J MED GENET, V100, P187, DOI 10.1002/ajmg.1256; Batanian JR, 2001, CLIN GENET, V59, P52, DOI 10.1034/j.1399-0004.2001.590109.x; BENDER K, 1969, HUMANGENETIK, V8, P94, DOI 10.1007/BF00295832; BENJAMIN DR, 1988, J PEDIATR SURG, V23, P899, DOI 10.1016/S0022-3468(88)80380-4; BERGOFFEN J, 1993, J PEDIATR-US, V122, P603, DOI 10.1016/S0022-3476(05)83546-2; Betremieux P, 2004, PRENATAL DIAG, V24, P487, DOI 10.1002/pd.909; Betremieux P, 2002, PRENATAL DIAG, V22, P988, DOI 10.1002/pd.454; Bettelheim D, 1998, CLIN GENET, V53, P319; Biggio JR, 2004, AM J MED GENET A, V126A, P183, DOI 10.1002/ajmg.a.20464; BOLLMANN R, 1995, FETAL DIAGN THER, V10, P52, DOI 10.1159/000264193; BONNEAU D, 1991, HUM GENET, V87, P317; Borys D, 2004, PEDIATR DEVEL PATHOL, V7, P35, DOI 10.1007/s10024-003-2133-7; Boyar FZ, 2001, CLIN GENET, V60, P421, DOI 10.1034/j.1399-0004.2001.600604.x; Brackley KJ, 1999, PRENATAL DIAG, V19, P570; Brennan P, 2001, J MED GENET, V38, P556, DOI 10.1136/jmg.38.8.556; CAPELLINI A, 1996, EUR J HUM GENET, V4, P29; Casaccia G, 2006, BIRTH DEFECTS RES A, V76, P210, DOI 10.1002/bdra.20235; Casas KA, 2004, AM J MED GENET A, V130A, P331, DOI 10.1002/ajmg.a.30156; Celle L, 2000, AM J MED GENET, V94, P125, DOI 10.1002/1096-8628(20000911)94:2<125::AID-AJMG5>3.0.CO;2-F; Chen CP, 1998, PRENATAL DIAG, V18, P1289, DOI 10.1002/(SICI)1097-0223(199812)18:12<1289::AID-PD432>3.0.CO;2-Y; Chen CP, 2004, PRENATAL DIAG, V24, P455, DOI 10.1002/pd.900; Chen CP, 2004, PRENATAL DIAG, V24, P63, DOI 10.1002/pd.796; Cho HY, 2006, PEDIATR NEPHROL, V21, P1909, DOI 10.1007/s00467-006-0273-5; CLARK RD, 1989, AM J MED GENET, V34, P422, DOI 10.1002/ajmg.1320340319; Clugston RD, 2006, AM J PATHOL, V169, P1541, DOI 10.2353/ajpath.2006.060445; CORNING K, 1999, P GREENWOOD GENET CT, V19, P24; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; CUNNIFF C, 1990, J PEDIATR-US, V116, P258, DOI 10.1016/S0022-3476(05)82884-7; CZEIZEL A, 1985, AM J MED GENET, V21, P105, DOI 10.1002/ajmg.1320210115; DAVID TJ, 1976, J MED GENET, V13, P253, DOI 10.1136/jmg.13.4.253; Dawani NMH, 2004, ANN SAUDI MED, V24, P129, DOI 10.5144/0256-4947.2004.129; de Beaufort C, 2000, GENET COUNSEL, V11, P181; DEAN JCS, 1991, CLIN GENET, V40, P349; Decker-Phillips M., 1995, American Journal of Human Genetics, V57, pA309; DEJONG G, 1989, J MED GENET, V26, P469, DOI 10.1136/jmg.26.7.469; DELAFUENTE AA, 1988, ANN GENET-PARIS, V31, P254; DELCAMPO M, 1997, P GREENWOOD GENET CT, V16, P217; DELORIMIER AA, 1967, SURGERY, V62, P12; Denamur E, 2000, KIDNEY INT, V57, P1868, DOI 10.1046/j.1523-1755.2000.00036.x; DEVRIENDT K, 1995, AM J MED GENET, V57, P97, DOI 10.1002/ajmg.1320570120; Devriendt K, 1998, PRENATAL DIAG, V18, P65, DOI 10.1002/(SICI)1097-0223(199801)18:1<65::AID-PD207>3.0.CO;2-4; Dillon E, 2000, BRIT J RADIOL, V73, P360, DOI 10.1259/bjr.73.868.10844860; DONNENFELD AE, 1993, AM J OBSTET GYNECOL, V169, P1017, DOI 10.1016/0002-9378(93)90046-L; Dott MM, 2003, BIRTH DEFECTS RES A, V67, P261, DOI 10.1002/bdra.10039; E XP, 2002, J BIOL CHEM, V277, P36617, DOI 10.1074/jbc.M205519200; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; ELGHEZAL H, 2006, EUR SOC HUM GEN C AM; Enns GM, 1998, AM J MED GENET, V79, P215, DOI 10.1002/(SICI)1096-8628(19980923)79:3<215::AID-AJMG13>3.0.CO;2-K; Faivre L, 1998, PRENATAL DIAG, V18, P1055, DOI 10.1002/(SICI)1097-0223(1998100)18:10<1055::AID-PD405>3.0.CO;2-I; FAUZA DO, 1994, J PEDIATR SURG, V29, P1113, DOI 10.1016/0022-3468(94)90290-9; Ferrero GB, 2006, AM J MED GENET A, V140A, P892, DOI 10.1002/ajmg.a.31188; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; Fraer L., 1992, American Journal of Human Genetics, V51, pA408; Frints SGM, 1996, GENET COUNSEL, V7, P135; FROHLICH GS, 1982, J MED GENET, V19, P316, DOI 10.1136/jmg.19.4.316-a; FUENMAYOR HM, 1980, AM J MED GENET, V7, P361; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Geneix A, 2001, GENET COUNSEL, V12, P169; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Golombek S, 1994, Iowa Med, V84, P31; Greer JJ, 2003, PEDIATR RES, V53, P726, DOI 10.1203/01.PDR.0000062660.12769.E6; GREVENGOOD C, 1993, AM J HUM GENET, V53, P1796; GUSTAVSON KH, 1984, CLIN GENET, V26, P247; HABEDANK M, 1983, J MED GENET, V20, P377, DOI 10.1136/jmg.20.5.377; HARNSBERGER J, 1982, BIRTH DEF C BIRM JUN; HARRISON MR, 1978, J PEDIATR SURG, V13, P227, DOI 10.1016/S0022-3468(78)80391-1; HAYASHI S, 1997, JPN J HUM GENET, V42, P127; HEATHCOTE JG, 1991, CAN J OPHTHALMOL, V26, P35; Hengstschlager M, 2004, FETAL DIAGN THER, V19, P510, DOI 10.1159/000080164; Henriques-Coelho T, 2005, J PEDIATR SURG, V40, DOI 10.1016/j.jpedsurg.2005.06.032; HERRMANN M, 1999, MED GENET, V11, P166; HICKMAN G, 2001, EUR J HUM GENET, V9, P230; Hilfiker ML, 1998, PEDIATR SURG INT, V13, P550, DOI 10.1007/s003830050400; Howe DT, 1996, PRENATAL DIAG, V16, P1003, DOI 10.1002/(SICI)1097-0223(199611)16:11<1003::AID-PD995>3.0.CO;2-D; Huggins GS, 2001, J BIOL CHEM, V276, P28029, DOI 10.1074/jbc.M103577200; IRITANI I, 1984, ANAT EMBRYOL, V169, P133, DOI 10.1007/BF00303142; ISELIUS L, 1983, HUM GENET, V64, P343, DOI 10.1007/BF00292366; Jay PY, 2007, DEV BIOL, V301, P602, DOI 10.1016/j.ydbio.2006.09.050; Johnson J. A., 1992, American Journal of Human Genetics, V51, pA290; Johnson P, 2000, PRENATAL DIAG, V20, P417, DOI 10.1002/(SICI)1097-0223(200005)20:5<417::AID-PD816>3.0.CO;2-M; Kadir RA, 1997, PRENATAL DIAG, V17, P761, DOI 10.1002/(SICI)1097-0223(199708)17:8<761::AID-PD121>3.0.CO;2-A; Kantarci S, 2006, AM J MED GENET A, V140A, P17, DOI 10.1002/ajmg.a.31025; KANTARCI S, 2006, ANN M AM SOC HUM GEN, P9; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Keijzer R, 2000, AM J PATHOL, V156, P1299, DOI 10.1016/S0002-9440(10)65000-6; KIM EH, 1992, AM J MED GENET, V44, P437, DOI 10.1002/ajmg.1320440410; KJAER I, 1991, J MED GENET, V28, P846, DOI 10.1136/jmg.28.12.846; Klaassens M, 2006, AM J MED GENET A, V140A, P1580, DOI 10.1002/ajmg.a.31321; Klaassens M, 2005, AM J HUM GENET, V76, P877, DOI 10.1086/429842; KLEPDEPATER JM, 1979, J MED GENET, V16, P151, DOI 10.1136/jmg.16.2.151; KOBORI JA, 1993, AM J HUM GENET, V53, P1578; Kocks A, 2002, J Med Genet, V39, pE23, DOI 10.1136/jmg.39.5.e23; KORNER H, 1991, Z KLIN MED, V46, P427; KOUSSEFF BG, 2000, P GREENWOOD GENET CT, V19, P130; KRASSIKOFF N, 1990, AM J MED GENET, V36, P363, DOI 10.1002/ajmg.1320360327; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KRISTESASHVILI JI, 1984, REGISTER CHROMOSOMAL, P100; KRISTOFFERSSON U, 1987, CLIN GENET, V32, P169; Ladonne JM, 1996, AM J MED GENET, V61, P68, DOI 10.1002/(SICI)1096-8628(19960102)61:1<68::AID-AJMG13>3.0.CO;2-U; Laziuk G I, 1979, Arkh Patol, V41, P40; LAZYUK GI, 1986, ARK PATOL, V48, P20; Le Caignec C, 2005, J MED GENET, V42, P121, DOI 10.1136/jmg.2004.025478; LIBERFARB RM, 1980, ANN GENET-PARIS, V23, P26; Liu JM, 2003, MECH DEVELOP, V120, P1059, DOI 10.1016/S0925-4773(03)00161-8; Lopez I, 2006, PRENATAL DIAG, V26, P577, DOI 10.1002/pd.1468; Lurie IW, 2003, GENET COUNSEL, V14, P75; LURIE IW, 1978, HUM GENET, V41, P235; MAERZKE S, 1993, MED GENET, V5, P121; Major D, 1998, PEDIATR SURG INT, V13, P547, DOI 10.1007/s003830050399; MASADA CT, 1989, AM J MED GENET, V34, P528, DOI 10.1002/ajmg.1320340415; MASUNO M, 1991, AM J MED GENET, V41, P32, DOI 10.1002/ajmg.1320410110; MEHRAEINY, 2000, MED GENET, V12, P96; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mey J, 2003, AM J PATHOL, V162, P673, DOI 10.1016/S0002-9440(10)63861-8; Migliazza L, 1999, J PEDIATR SURG, V34, P1352, DOI 10.1016/S0022-3468(99)90010-6; Moog U, 2000, AM J MED GENET, V94, P306, DOI 10.1002/1096-8628(20001002)94:4<306::AID-AJMG8>3.0.CO;2-V; MoweryRushton PA, 1997, PRENATAL DIAG, V17, P255, DOI 10.1002/(SICI)1097-0223(199703)17:3<255::AID-PD49>3.0.CO;2-T; NOEL B, 1976, ANN GENET-PARIS, V19, P137; NORIO R, 1984, AM J MED GENET, V17, P471, DOI 10.1002/ajmg.1320170210; Okubo A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.018895; Okuyama H, 2006, PEDIATR PULM, V41, P882, DOI 10.1002/ppul.20466; PARK JP, 1993, AM J MED GENET, V45, P46, DOI 10.1002/ajmg.1320450113; Park Yangsoon, 1993, Journal of Korean Medical Science, V8, P471; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; PECILE V, 1990, CLIN GENET, V37, P271; PELTOMAKI P, 1987, CLIN GENET, V31, P399; Pettigrew A. L., 1992, American Journal of Human Genetics, V51, pA86; Pfeiffer RA, 1998, ANN GENET-PARIS, V41, P17; PHELAN MC, 1987, P GREENWOOD GENET CT, V6, P22; PHILIP N, 1991, EUR J PEDIATR, V150, P726, DOI 10.1007/BF01958765; PHILLIPSON J, 1990, Pediatric Pathology, V10, P1001; PLAJA A, 1994, PRENATAL DIAG, V14, P410, DOI 10.1002/pd.1970140512; Pober BR, 2005, AM J MED GENET A, V138A, P81, DOI 10.1002/ajmg.a.30904; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; PUNNETT HH, 1994, AM J MED GENET, V50, P391, DOI 10.1002/ajmg.1320500424; Qiu Y, 1996, J STEROID BIOCHEM, V56, P81, DOI 10.1016/0960-0760(95)00225-1; Ramsing M, 2000, AM J MED GENET, V95, P415, DOI 10.1002/1096-8628(20001218)95:5<415::AID-AJMG2>3.0.CO;2-J; REARDON W, 2004, AM SOC HUM GEN ANN M; Reddy KS, 1999, PRENATAL DIAG, V19, P868, DOI 10.1002/(SICI)1097-0223(199909)19:9<868::AID-PD641>3.0.CO;2-A; Reddy KS, 1999, AM J MED GENET, V84, P460, DOI 10.1002/(SICI)1096-8628(19990611)84:5<460::AID-AJMG10>3.0.CO;2-L; Reiss RE, 1999, AM J HUM GENET, V65, pA340; Ringer K., 1995, American Journal of Human Genetics, V57, pA124; Robert E, 1997, EUR J EPIDEMIOL, V13, P665, DOI 10.1023/A:1007395727819; RODRIGUEZ JI, 1994, AM J MED GENET, V53, P176, DOI 10.1002/ajmg.1320530211; Rogers J. C., 1995, American Journal of Human Genetics, V57, pA125; ROSENBERG C, 1992, AM J HUM GENET, V50, P700; Rottier R, 2005, SEMIN PERINATOL, V29, P86, DOI 10.1053/j.semperi.2005.04.004; SARDA P, 1992, ANN GENET-PARIS, V35, P117; SCARBROUGH PR, 1986, J MED GENET, V23, P185, DOI 10.1136/jmg.23.2.185; Schlembach D, 2001, PRENATAL DIAG, V21, P289, DOI 10.1002/pd.50; Schneider T, 2001, VIERTELJAHR ZEITGES, V49, P275; Scott DA, 2005, AM J MED GENET A, V134A, P430, DOI 10.1002/ajmg.a.30654; Scott DA, 2007, HUM MOL GENET, V16, P424, DOI 10.1093/hmg/ddl475; Sepulveda W, 2003, ULTRASOUND OBST GYN, V22, P479, DOI 10.1002/uog.233; Sergi C., 1998, Pathologica (Genoa), V90, P285; SHENSCHWARZ S, 1989, AM J MED GENET, V32, P81, DOI 10.1002/ajmg.1320320117; Shimokawa O, 2005, AM J MED GENET A, V136A, P49, DOI 10.1002/ajmg.a.30778; SKANDALAKIS JE, 1994, EMBRYOLOGY SURG, P414; Skari H, 2000, J PEDIATR SURG, V35, P1187, DOI 10.1053/jpsu.2000.8725; Slavotinek A, 2005, J MED GENET, V42, P730, DOI 10.1136/jmg.2004.028787; Slavotinek AM, 2004, AM J MED GENET A, V124A, P427, DOI 10.1002/ajmg.a.20381; Slavotinek AM, 2006, EUR J HUM GENET, V14, P999, DOI 10.1038/sj.ejhg.5201652; SMITH NM, 1992, J MED GENET, V29, P503; Smith S A, 1994, Clin Dysmorphol, V3, P287; STEINHORN RH, 1994, ARCH PEDIAT ADOL MED, V148, P626, DOI 10.1001/archpedi.1994.02170060080016; Suzumori N, 2003, PRENATAL DIAG, V23, P866, DOI 10.1002/pd.704; TACHDJIAN G, 1992, CLIN GENET, V42, P281; Takakuwa Koichi, 1997, American Journal of Perinatology, V14, P641, DOI 10.1055/s-2008-1040769; Tapper JK, 2002, FETAL DIAGN THER, V17, P347, DOI 10.1159/000065383; TEMPLE IK, 1994, J MED GENET, V31, P735, DOI 10.1136/jmg.31.9.735; Thebaud B, 1999, AM J PHYSIOL-LUNG C, V277, pL423, DOI 10.1152/ajplung.1999.277.2.L423; THORPE-BEESTON J G, 1989, Fetal Therapy, V4, P21; Tibboel D, 1996, CLIN PERINATOL, V23, P689, DOI 10.1016/S0095-5108(18)30202-1; TOHMA T, 1998, AM J HUM GENET S, V64, pA862; Tonks A, 2004, PRENATAL DIAG, V24, P596, DOI 10.1002/pd.908; TORFS CP, 1992, TERATOLOGY, V46, P555, DOI 10.1002/tera.1420460605; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Tumer Z, 2004, AM J MED GENET A, V130A, P340, DOI 10.1002/ajmg.a.30035; Van Buggenhout G, 2004, J MED GENET, V41, P691, DOI 10.1136/jmg.2003.016865; van Dooren MF, 2004, AM J MED GENET A, V127A, P194, DOI 10.1002/ajmg.a.20613; VANDOOREN MF, 2004, THESIS ERASMUS U ROT; VANVOSS VH, 1982, KINDERARZT, V13, P693; Veldman A, 2002, AM J MED GENET, V111, P86, DOI 10.1002/ajmg.10438; WAKUI K, 1996, JPN J HUM GENET, V41, P69; Warburton PE, 2000, AM J HUM GENET, V66, P1794, DOI 10.1086/302924; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; WILSON WG, 1983, AM J DIS CHILD, V137, P444, DOI 10.1001/archpedi.1983.02140310026006; Witters I, 2001, AM J MED GENET, V103, P278; WOLSTENHOLME J, 1994, J MED GENET, V31, P647, DOI 10.1136/jmg.31.8.647; You LR, 2005, P NATL ACAD SCI USA, V102, P16351, DOI 10.1073/pnas.0507832102; YOUNG RS, 1982, AM J MED GENET, V12, P103, DOI 10.1002/ajmg.1320120114; YOUSSOUFIAN H, 1988, HUM GENET, V78, P267, DOI 10.1007/BF00291674; YU CW, 1997, P GREENWOOD GENET CT, V16, P283; Yuan WL, 2003, P NATL ACAD SCI USA, V100, P5217, DOI 10.1073/pnas.0730709100; YUNIS E, 1977, ANN GENET-PARIS, V20, P243; YUNIS E, 1976, ANN GENET-PARIS, V19, P57; ZABEL B, 1977, ANN GENET-PARIS, V20, P285; Zeng SM, 2003, AM J MED GENET A, V120A, P464, DOI 10.1002/ajmg.a.20189	214	148	151	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					825	845		10.1086/513442	http://dx.doi.org/10.1086/513442			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436238	Green Published, Bronze			2022-12-18	WOS:000245973200002
J	Carelli, V; Achilli, A; Valentino, ML; Rengo, C; Semino, O; Pala, M; Olivieri, A; Mattiazzi, M; Pallotti, F; Carrara, F; Zeviani, M; Leuzzi, V; Carducci, C; Valle, G; Simionati, B; Mendieta, L; Salomao, S; Belfort, R; Sadun, AA; Torroni, A				Carelli, V; Achilli, A; Valentino, ML; Rengo, C; Semino, O; Pala, M; Olivieri, A; Mattiazzi, M; Pallotti, F; Carrara, F; Zeviani, M; Leuzzi, V; Carducci, C; Valle, G; Simionati, B; Mendieta, L; Salomao, S; Belfort, R; Sadun, AA; Torroni, A			Haplogroup effects and recombination of mitochondrial DNA: Novel clues from the analysis of Leber hereditary optic neuropathy pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARKINSONS-DISEASE; MTDNA MUTATIONS; COMPLEX-III; RISK; POLYMORPHISMS; POPULATION; LONGEVITY; SEQUENCE; GENE; SUSCEPTIBILITY	The mitochondrial DNA ( mtDNA) of 87 index cases with Leber hereditary optic neuropathy ( LHON) sequentially diagnosed in Italy, including an extremely large Brazilian family of Italian maternal ancestry, was evaluated in detail. Only seven pairs and three triplets of identical haplotypes were observed, attesting that the large majority of the LHON mutations were due to independent mutational events. Assignment of the mutational events into haplogroups confirmed that J1 and J2 play a role in LHON expression but narrowed the association to the subclades J1c and J2b, thus suggesting that two specific combinations of amino acid changes in the cytochrome b are the cause of the mtDNA background effect and that this may occur at the level of the supercomplex formed by respiratory-chain complexes I and III. The families with identical haplotypes were genealogically reinvestigated, which led to the reconnection into extended pedigrees of three pairs of families, including the Brazilian family with its Italian counterpart. The sequencing of entire mtDNA samples from the reconnected families confirmed the genealogical reconstruction but showed that the Brazilian family was heteroplasmic at two control-region positions. The survey of the two sites in 12 of the Brazilian subjects revealed triplasmy in most cases, but there was no evidence of the tetraplasmy that would be expected in the case of mtDNA recombination.	Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA USA; Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy; Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY USA; Natl Neurol Inst Carlo Besta, Div Mol Neurogenet, Milan, Italy; Univ Roma La Sapienza, Dipartimento Sci Neurol & Psichiat Eta Evolut, Rome, Italy; Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Padua, Italy; Univ Fed Sao Paulo, Dept Oftalmol, Sao Paulo, Brazil	University of Pavia; Doheny Eye Institute; University of Southern California; University of Bologna; Columbia University; IRCCS Istituto Neurologico Besta; Sapienza University Rome; University of Padua; Universidade Federal de Sao Paulo (UNIFESP)	Torroni, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	OLIVIERI, ANNA/I-9235-2012; Salomao, Solange R/G-9500-2012; Zeviani, Massimo/AAU-2632-2021; Achilli, Alessandro/I-9236-2012; Salomao, Solange/AAB-3234-2021; Belfort, Rubens/E-2252-2012; Zeviani, Massimo/K-2891-2014; Torroni, Antonio/E-1557-2011	OLIVIERI, ANNA/0000-0002-3941-8098; Salomao, Solange R/0000-0002-3436-5599; Zeviani, Massimo/0000-0002-9067-5508; Achilli, Alessandro/0000-0001-6871-3451; Salomao, Solange/0000-0002-3436-5599; Belfort, Rubens/0000-0002-8422-3898; Torroni, Antonio/0000-0002-4163-4478; SEMINO, Ornella/0000-0002-9675-9403; simionati, barbara/0000-0002-0522-0737; VALENTINO, MARIA LUCIA/0000-0001-5323-0115; Pallotti, Francesco/0000-0001-9946-8516; Leuzzi, Vincenzo/0000-0002-2314-6139; Pala, Maria/0000-0001-9202-8331; CARELLI, VALERIO/0000-0003-4923-6404; VALLE, GIORGIO/0000-0003-4377-5685	Telethon [GGP030039] Funding Source: Medline	Telethon(Fondazione Telethon)		Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9; Brown MD, 1997, AM J HUM GENET, V60, P381; Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Houshmand M, 2004, ANN NY ACAD SCI, V1011, P345, DOI 10.1196/annals.1293.035; Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012; Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537; KIVISILD T, 2005, GENETICS; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Laberge AM, 2005, AM J HUM GENET, V77, P313, DOI 10.1086/432491; Lamminen T, 1997, EUR J HUM GENET, V5, P271, DOI 10.1159/000484777; Lodi R, 2000, BRAIN, V123, P1896, DOI 10.1093/brain/123.9.1896; Lodi R, 2002, J NEUROL NEUROSUR PS, V72, P805, DOI 10.1136/jnnp.72.6.805; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macmillan C, 2000, AM J HUM GENET, V66, P332, DOI 10.1086/302716; Majamaa K, 1998, LANCET, V352, P455, DOI 10.1016/S0140-6736(05)79190-X; Man PYW, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011247; Munakata K, 2004, GENOMICS, V84, P1041, DOI 10.1016/j.ygeno.2004.08.015; NEWMAN NJ, 2005, WALSH HOYTS CLIN NEU, P466; Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Reynier P, 1999, EUR J HUM GENET, V7, P404, DOI 10.1038/sj.ejhg.5200293; Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8; Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0; Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010; Salomao SR, 2004, DOC OPHTHALMOL, V108, P147, DOI 10.1023/B:DOOP.0000036829.37053.31; Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; Torroni A, 1997, AM J HUM GENET, V60, P1107; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323; Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606	51	148	153	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					564	574		10.1086/501236	http://dx.doi.org/10.1086/501236			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532388	Green Published, Bronze			2022-12-18	WOS:000236755900004
J	Hudson, G; Keers, S; Man, PYW; Griffiths, P; Huoponen, K; Savontaus, ML; Nikoskelainen, E; Zeviani, M; Carrara, F; Horvath, R; Karcagi, V; Spruijt, L; de Coo, IFM; Smeets, HJM; Chinnery, PF				Hudson, G; Keers, S; Man, PYW; Griffiths, P; Huoponen, K; Savontaus, ML; Nikoskelainen, E; Zeviani, M; Carrara, F; Horvath, R; Karcagi, V; Spruijt, L; de Coo, IFM; Smeets, HJM; Chinnery, PF			Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; MTDNA MUTATIONS; PEDIGREES; GENE; INACTIVATION; LINKAGE; NEURORETINOPATHY; GENOTYPE; DISEASE; ATROPHY	Mitochondrial DNA (mtDNA) mutations are a major cause of human disease. A large number of different molecular defects ultimately compromise oxidative phosphorylation, but it is not clear why the same biochemical defect can cause diverse clinical phenotypes. There is emerging evidence that nuclear genes modulate the phenotype of primary mtDNA disorders. Here, we define an X-chromosomal haplotype that interacts with specific MTND mutations to cause visual failure in the most common mtDNA disease, Leber hereditary optic neuropathy. This effect is independent of the mtDNA genetic background and explains the variable penetrance and sex bias that characterizes this disorder.	Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Ophthalmol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Turku, Dept Med Genet, Turku, Finland; Univ Turku, Cent Hosp, Dept Ophthalmol, FIN-20520 Turku, Finland; Natl Neurol Inst, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Milan, Italy; Acad Hosp Schwabing, Metab Dis Ctr Munich Schwabing, Inst Clin Chem Mol Diagnost & Mitochondrial Genet, Munich, Germany; Natl Ctr Publ Hlth, Budapest, Hungary; Univ Maastricht, Dept Cell Biol & Genet, Maastricht, Netherlands; Erasmus Univ, Med Ctr, Dept Child Neurol, Rotterdam, Netherlands	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Turku; University of Turku; IRCCS Istituto Neurologico Besta; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@ncl.ac.uk	Horvath, Rita/AAY-7042-2020; Hudson, Gavin/E-7117-2017; Zeviani, Massimo/AAU-2632-2021; Zeviani, Massimo/K-2891-2014	Zeviani, Massimo/0000-0002-9067-5508; de Coo, Irenaeus/0000-0003-0533-7422; Hudson, Gavin/0000-0001-7210-2733; Horvath, Rita/0000-0002-9841-170X; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; CARVALHO MRS, 1992, HUM HERED, V42, P316, DOI 10.1159/000154089; Chalmers RM, 1996, AM J HUM GENET, V59, P103; CHEN JD, 1989, HUM GENET, V82, P203, DOI 10.1007/BF00291154; Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209; Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Horvath S, 2000, AM J HUM GENET, V66, P1161, DOI 10.1086/302823; Howell N, 1997, J BIOENERG BIOMEMBR, V29, P165, DOI 10.1023/A:1022690030664; HOWELL N, 1991, AM J HUM GENET, V49, P939; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; JUVONEN V, 1993, AM J HUM GENET, V53, P289; Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6; MACKEY D, 1993, LANCET, V341, P1020, DOI 10.1016/0140-6736(93)91105-U; Mackey DA, 1996, AM J HUM GENET, V59, P481; Man PYW, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011247; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; NAKAMURA M, 1993, HUM GENET, V91, P339; Naumova AK, 1998, AM J HUM GENET, V62, P1493, DOI 10.1086/301860; Newman NJ, 2002, J NEURO-OPHTHALMOL, V22, P257, DOI 10.1097/00041327-200212000-00001; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; Pegoraro E, 2003, AM J MED GENET A, V119A, P37, DOI 10.1002/ajmg.a.10211; Pegoraro E, 1996, AM J MED GENET, V61, P356; Renieri A, 2003, J MOL MED, V81, P346, DOI 10.1007/s00109-003-0444-9; VILKKI J, 1991, American Journal of Human Genetics, V48, P486; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	27	148	154	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1086	1091		10.1086/498176	http://dx.doi.org/10.1086/498176			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380918	Green Published, Bronze			2022-12-18	WOS:000233241200016
J	Krafchak, CM; Pawar, H; Moroi, SE; Sugar, A; Lichter, PR; Mackey, DA; Mian, S; Nairus, T; Elner, V; Schteingart, MT; Downs, CA; Kijek, TG; Johnson, JM; Trager, EH; Rozsa, FW; Mandal, MNA; Epstein, MP; Vollrath, D; Ayyagari, R; Boehnke, M; Richards, JE				Krafchak, CM; Pawar, H; Moroi, SE; Sugar, A; Lichter, PR; Mackey, DA; Mian, S; Nairus, T; Elner, V; Schteingart, MT; Downs, CA; Kijek, TG; Johnson, JM; Trager, EH; Rozsa, FW; Mandal, MNA; Epstein, MP; Vollrath, D; Ayyagari, R; Boehnke, M; Richards, JE			Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE ALPORT SYNDROME; MESSENGER-RNA; COLLAGEN GENE; ZINC-FINGER; TRANSCRIPTION FACTOR; GERMLINE MOSAICISM; BASEMENT-MEMBRANE; E-CADHERIN; SEQUENCE; IDENTIFICATION	Posterior polymorphous corneal dystrophy (PPCD, also known as PPMD) is a rare disease involving metaplasia and overgrowth of corneal endothelial cells. In patients with PPCD, these cells manifest in an epithelial morphology and gene expression pattern, produce an aberrant basement membrane, and, sometimes, spread over the iris and nearby structures in a way that increases the risk for glaucoma. We previously mapped PPCD to a region (PPCD3) on chromosome 10 containing the gene that encodes the two-handed zinc-finger homeodomain transcription factor TCF8. Here, we report a heterozygous frameshift mutation in TCF8 that segregates with PPCD in the family used to map PPCD3 and four different heterozygous nonsense and frameshift mutations in TCF8 in four other PPCD probands. Family reports of inguinal hernia, hydrocele, and possible bone anomalies in affected individuals suggest that individuals with TCF8 mutations should be examined for nonocular anomalies. We detect transcripts of all three identified PPCD genes (VSX1, COL8A2, and TCF8) in the cornea. We show presence of a complex (core plus secondary) binding site for TCF8 in the promoter of Alport syndrome gene COL4A3, which encodes collagen type IV alpha 3, and we present immunohistochemical evidence of ectopic expression of COL4A3 in corneal endothelium of the proband of the original PPCD3 family. Identification of TCF8 as the PPCD3 gene provides a valuable tool for the study of critical gene regulation events in PPCD pathology and suggests a possible role for TCF8 mutations in altered structure and function of cells lining body cavities other than the anterior chamber of the eye. Thus, this study has identified TCF8 as the gene responsible for approximately half of the cases of PPCD, has implicated TCF8 mutations in developmental abnormalities outside the eye, and has presented the TCF8 regulatory target, COL4A3, as a key, shared molecular component of two different diseases, PPCD and Alport syndrome.	Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Melbourne, Dept Ophthalmol, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; Univ Tasmania, Sch Med, Hobart, Tas, Australia; Andersen Eye Ctr, Saginaw, MI USA; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Tasmania; Emory University; Stanford University	Richards, JE (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, 1000 Wall St, Ann Arbor, MI 48105 USA.	richj@umich.edu	Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709; Mian, Shahzad/0000-0002-5813-1527; Lichter, Paul/0000-0001-8394-4813; Moroi, Sayoko E/0000-0002-0418-0657; Elner, Victor/0000-0001-7708-1898; Rozsa, Frank/0000-0002-1378-7020; MIAN, SYED SHARIQ/0000-0001-7563-5121	NEI NIH HHS [R01 EY011405, EY07003, R01 EY011671, R56 EY011671, EY11405, EY09441, P30 EY007003, R01 EY009441, EY11671, F31 EY007003] Funding Source: Medline; NHGRI NIH HHS [T32 HG000040, T32 HG00040] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009441, F31EY007003, R01EY011405, R56EY011671, P30EY007003, R01EY011671] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; Bachoo S, 1999, EUR J HUM GENET, V7, P933, DOI 10.1038/sj.ejhg.5200387; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Beck JA, 2004, HUM MOL GENET, V13, P1219, DOI 10.1093/hmg/ddh134; Bendavid Robert, 2004, Hernia, V8, P171; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; BORUCHOFF SA, 1971, AM J OPHTHALMOL, V72, P879, DOI 10.1016/0002-9394(71)91683-7; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Bullock Sarah, 1996, Biochemical Society Transactions, V24, p273S; CARR AJ, 1994, J MED GENET, V31, P306, DOI 10.1136/jmg.31.4.306; CIBIS GW, 1977, ARCH OPHTHALMOL-CHIC, V95, P1529; Colville DJ, 1997, OPHTHALMIC GENET, V18, P161, DOI 10.3109/13816819709041431; Costantino ME, 2002, BIOCHEM BIOPH RES CO, V296, P368, DOI 10.1016/S0006-291X(02)00880-X; Cutler JA, 2004, AM J MED GENET A, V129A, P13, DOI 10.1002/ajmg.a.30162; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ferreiro Veronica, 2004, Mol Diagn, V8, P115, DOI 10.2165/00066982-200408020-00006; FRIEDMAN DW, 1993, ANN SURG, V218, P754, DOI 10.1097/00000658-199312000-00009; FRISCH SM, 1994, J CELL BIOL, V127, P1085, DOI 10.1083/jcb.127.4.1085; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hand CK, 1999, GENOMICS, V61, P1, DOI 10.1006/geno.1999.5920; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Higashi Y, 1997, J EXP MED, V185, P1467, DOI 10.1084/jem.185.8.1467; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; Kapur P, 1998, PEDIATR CLIN N AM, V45, P773, DOI 10.1016/S0031-3955(05)70044-4; KURPAKUS MA, 1992, DEV BIOL, V150, P243, DOI 10.1016/0012-1606(92)90239-D; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; Mandal MNA, 2004, GENOMICS, V83, P626, DOI 10.1016/j.ygeno.2003.09.020; MARTHA A, 1994, AM J HUM GENET, V54, P801; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; Miller CA, 1997, CORNEA, P453; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Moroi SE, 2003, AM J OPHTHALMOL, V135, P461, DOI 10.1016/S0002-9394(02)02032-9; Mukherjee M, 2003, EXP MOL MED, V35, P113, DOI 10.1038/emm.2003.16; NAVARRO P, 1993, J CELL SCI, V105, P923; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; PEARCE WG, 1969, BRIT J OPHTHALMOL, V53, P577, DOI 10.1136/bjo.53.9.577; Reardon W, 2001, J MED GENET, V38, P820, DOI 10.1136/jmg.38.12.820; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RODRIGUES MM, 1980, INVEST OPHTH VIS SCI, V19, P832; SAWADA H, 1984, EUR J CELL BIOL, V35, P226; SAWADA H, 1987, EXP CELL RES, V171, P94, DOI 10.1016/0014-4827(87)90254-0; Sgambati MT, 2000, AM J HUM GENET, V66, P84, DOI 10.1086/302726; Shimizu S, 2004, AM J MED GENET A, V130A, P372, DOI 10.1002/ajmg.a.30267; Skoumal M, 2004, MED KLIN, V99, P585, DOI 10.1007/s00063-004-1086-6; Spencer WH, 1996, OPHTHALMIC PATHOLOGY, V1; Takagi T, 1998, DEVELOPMENT, V125, P21; Tam P, 1990, NEONATAL SURGERY, P367; Terraz C, 2001, J BIOL CHEM, V276, P37011, DOI 10.1074/jbc.M104185200; TOMA NMG, 1995, HUM MOL GENET, V4, P2395, DOI 10.1093/hmg/4.12.2395; Vollrath D, 1998, HUM MOL GENET, V7, P1091, DOI 10.1093/hmg/7.7.1091; Waring GO, 1974, SURV OPHTHALMOL, V18, P325; Weisenthal R, 1997, CORNEA CORNEAL EXTER, V2, P1063; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704	58	148	153	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					694	708		10.1086/497348	http://dx.doi.org/10.1086/497348			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252232	Bronze, Green Published			2022-12-18	WOS:000232569600002
J	Jonkman, MF; Pasmooij, AMG; Pasmans, SGMA; van den Berg, MP; ter Horst, HJ; Timmer, A; Pas, HH				Jonkman, MF; Pasmooij, AMG; Pasmans, SGMA; van den Berg, MP; ter Horst, HJ; Timmer, A; Pas, HH			Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	12th Scientific Meeting on the Keratinocyte - Inter- and Extracellular Events	NOV   05, 2004	Paris, FRANCE	Fdn Rene Touraine Res Dermatol			INTERMEDIATE-FILAMENTS; PALMOPLANTAR KERATODERMA; DESMOSOMAL PLAQUE; WOOLLY HAIR; DILATED CARDIOMYOPATHY; RECESSIVE MUTATION; SKIN; HAPLOINSUFFICIENCY; PLAKOPHILIN-1; PLAKOGLOBIN	The cytoplasmic plaque protein desmoplakin (DP), which is located in desmosomes, plays a major role in epithelial and muscle cell adhesion by linking the transmembrane cadherins to the cytoplasmic intermediate filament network. Mutations of DP may cause striate palmoplantar keratoderma, arrhythmogenic right ventricular dysplasia, skin fragility/woolly hair syndrome, Naxos-like disease, and Carvajal syndrome. DP must be indispensable, because DP-/- mice are early abortive. Here, we report a patient with severe fragility of skin and mucous membranes caused by genetic truncation of the DP tail. The new phenotype is lethal in the neonatal period because of immense transcutaneous fluid loss. The phenotype also comprised universal alopecia, neonatal teeth, and nail loss. Histology showed suprabasal clefting and acantholysis throughout the spinous layer, mimicking pemphigus. Electron microscopy revealed disconnection of keratin intermediate filaments from desmosomes. Immunofluorescence staining of DP showed a distinct punctate intercellular pattern in the patient's skin. Protein analysis revealed expression of truncated DP polypeptides. Mutational analysis of the patient demonstrated compound heterozygosity for two DP mutations, 6079C -> T (R1934X) and 6370deITT, respectively. Aberrant mRNA transcripts that predict premature termination of translation with loss of the three intermediate filament-binding subdomains in the DP tail were detected by RT-PCR. The new dramatic phenotype, which we named "lethal acantholytic epidermolysis bullosa," underscores the paramount role of DP in epidermal integrity.	Univ Groningen, Med Ctr, Dept Dermatol, NL-9700 RB Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Cardiol, NL-9700 RB Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Pediat, NL-9700 RB Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Pathol, NL-9700 RB Groningen, Netherlands; Univ Utrecht, Med Ctr, Dept Dermatol, Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Utrecht University	Jonkman, MF (corresponding author), Univ Groningen, Med Ctr, Dept Dermatol, POB 30-001, NL-9700 RB Groningen, Netherlands.	m.f.jonkman@med.umcg.nl	Pasmooij, Anna/H-2419-2011; Pasmans, Suzanne/AAI-6016-2021; Pas, Hendri/G-9749-2011	Pasmans, Suzanne/0000-0003-1018-4475; Pasmooij, Anna Maria Gerdina/0000-0003-0641-3829; Pas, Hendri/0000-0001-8823-2591; van den Berg, Maarten/0000-0002-1493-2998				Alcalai R, 2003, J AM COLL CARDIOL, V42, P319, DOI 10.1016/S0735-1097(03)00628-4; Carvajal-Huerta L, 1998, J AM ACAD DERMATOL, V39, P418, DOI 10.1016/S0190-9622(98)70317-2; Cheong JEL, 2005, CLIN EXP DERMATOL, V30, P261, DOI 10.1111/j.1365-2230.2005.01736.x; Choi HJ, 2002, NAT STRUCT BIOL, V9, P612, DOI 10.1038/nsb818; Fontao L, 2003, MOL BIOL CELL, V14, P1978, DOI 10.1091/mbc.e02-08-0548; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; GREEN KJ, 1988, P NATL ACAD SCI USA, V85, P2613, DOI 10.1073/pnas.85.8.2613; GREEN KJ, 1990, J BIOL CHEM, V265, P2603; HOFFMAN MD, 1995, ARCH DERMATOL, V131, P586, DOI 10.1001/archderm.131.5.586; Jonkman MF, 2004, EXP DERMATOL, V13, P654, DOI 10.1111/j.0906-6705.2004.0250c.x; Keith D, 1999, HUM MOL GENET, V8, P143, DOI 10.1093/hmg/8.1.143; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McMillan JR, 2003, J INVEST DERMATOL, V121, P96, DOI 10.1046/j.1523-1747.2003.12324.x; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; Mimouni D, 2004, J AM ACAD DERMATOL, V51, P62, DOI 10.1016/j.jaad.2003.11.051; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; North AJ, 1999, J CELL SCI, V112, P4325; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Whittock NV, 1999, J INVEST DERMATOL, V113, P940, DOI 10.1046/j.1523-1747.1999.00783.x; Whittock NV, 2002, J INVEST DERMATOL, V118, P232, DOI 10.1046/j.0022-202x.2001.01664.x; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	27	148	155	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					653	660		10.1086/496901	http://dx.doi.org/10.1086/496901			8	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175511	Bronze, Green Published			2022-12-18	WOS:000232106900013
J	Strauch, K; Fimmers, R; Kurz, T; Deichmann, KA; Wienker, TF; Baur, MP				Strauch, K; Fimmers, R; Kurz, T; Deichmann, KA; Wienker, TF; Baur, MP			Parametric and nonparametric multipoint linkage analysis with imprinting and two-locus-trait models: Application to mite sensitization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORE ANALYSIS; SINGLE-LOCUS; COMPLEX TRAITS; REDUCED PENETRANCE; OLIGOGENIC TRAITS; 2-LOCUS MODELS; INFERRING MODE; HUMAN-DISEASES; INHERITANCE; HETEROGENEITY	We present two extensions to linkage analysis for genetically complex traits. The first extension allows investigators to perform parametric (LOD-score) analysis of traits caused by imprinted genes-that is, of traits showing a parent-of-origin effect. By specification of two heterozygote penetrance parameters, paternal and maternal origin of the mutation can be treated differently in terms of probability of expression of the trait. Therefore, a single-disease-locus-imprinting model includes four penetrances instead of only three. In the second extension, parametric and nonparametric linkage analysis with two trait loci is formulated for a multimarker setting, optionally taking imprinting into account. We have implemented both methods into the program GENEHUNTER. The new tools, GENEHUNTER-IMPRINTING and GENEHUNTER-TWOLOCUS, were applied to human family data for sensitization to mite allergens. The data set comprises pedigrees from England, Germany, Italy, and Portugal. With single-disease-locus-imprinting MOD-score analysis, we find several regions that show at least suggestive evidence for linkage. Most prominently, a maximum LOD score of 4.76 is obtained near D8S511, for the English population, when a model that implies complete maternal imprinting is used. Parametric two-trait-iocus analysis yields a maximum LOD score of 6.09 for the German population, occurring exactly at D45430 and D18S452. The heterogeneity model specified for analysis alludes to complete maternal imprinting at both disease loci. Altogether, our results suggest that the two novel formulations of linkage analysis provide valuable tools for genetic mapping of multifactorial traits.	Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany; Univ Freiburg, Childrens Hosp, Freiburg, Germany	University of Bonn; University of Freiburg	Strauch, K (corresponding author), Univ Bonn, Inst Med Biometry Informat & Epidemiol, Sigmund Freud Str 25, D-53105 Bonn, Germany.							Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Ainscough J. F. X., 1996, Epigenetic mechanisms of gene regulation., P173; Barnes KC, 1998, IMMUNOL TODAY, V19, P325, DOI 10.1016/S0167-5699(97)01241-3; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; CLERGETDARPOUX F, 1990, GENET EPIDEMIOL, V7, P245, DOI 10.1002/gepi.1370070403; CLERGETDARPOUX F, 1992, ANN HUM GENET, V56, P145, DOI 10.1111/j.1469-1809.1992.tb01140.x; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cordell HJ, 2000, AM J HUM GENET, V66, P1273, DOI 10.1086/302847; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUPUIS J, 1995, GENETICS, V140, P843; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; DURNER M, 1992, AM J HUM GENET, V51, P859; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Farrall M, 1997, GENET EPIDEMIOL, V14, P103, DOI 10.1002/(SICI)1098-2272(1997)14:2<103::AID-GEPI1>3.0.CO;2-8; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; GREENBERG DA, 1994, AM J HUM GENET, V55, P834; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; HALL JG, 1990, AM J HUM GENET, V46, P857; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1997, AM J HUM GENET, V60, P217; Howard TD, 1999, CLIN EXP ALLERGY, V29, P86; KNAPP M, 1994, AM J HUM GENET, V55, P1030; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MACLEAN CJ, 1993, AM J HUM GENET, V52, P354; MACLEAN CJ, 1992, AM J HUM GENET, V50, P1259; MACLEAN CJ, 1993, AM J HUM GENET, V53, P353; Moffatt MF, 1998, CLIN EXP ALLERGY, V28, P56; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; Olson JM, 1997, HUM HERED, V47, P110, DOI 10.1159/000154398; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Paterson AD, 1999, HUM HERED, V49, P197, DOI 10.1159/000022875; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1984, AM J HUM GENET, V36, P363; RISCH N, 1990, AM J HUM GENET, V46, P222; SCHORK NJ, 1994, AM J HUM GENET, V55, P856; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SHAM PC, 1994, AM J HUM GENET, V55, P855; SMALLEY SL, 1993, AM J HUM GENET, V52, P210; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Strauch K, 1999, GENET EPIDEMIOL, V17, pS331; VIELAND V, 1992, CYTOGENET CELL GENET, V59, P145, DOI 10.1159/000133229; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; Zinn-Justin A, 1998, GENET EPIDEMIOL, V15, P491	60	148	149	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1945	1957		10.1086/302911	http://dx.doi.org/10.1086/302911			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10796874	Green Published, Bronze			2022-12-18	WOS:000088373800022
J	Thomas, MG; Parfitt, T; Weiss, DA; Skorecki, K; Wilson, JF; le Roux, M; Bradman, N; Goldstein, DB				Thomas, MG; Parfitt, T; Weiss, DA; Skorecki, K; Wilson, JF; le Roux, M; Bradman, N; Goldstein, DB			Y chromosomes traveling south: The Cohen modal haplotype and the origins of the Lemba - the "black Jews of Southern Africa"	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROSATELLITE; FREQUENCIES; PRIESTS	The Lemba are a traditionally endogamous group speaking a variety of Bantu languages who live in a number of locations in southern Africa. They claim descent from Jews who came to Africa from "Sena." "Sena" is variously identified by them as Sanaa in Yemen, Judea, Egypt, or Ethiopia. A previous study using Y-chromosome markers suggested both a Bantu and a Semitic contribution to the Lemba gene pool, a suggestion that is not inconsistent with Lemba oral tradition. To provide a more detailed picture of the Lemba paternal genetic heritage, we analyzed 399 Y chromosomes for six microsatellites and six biallelic markers in six populations (Lemba, Bantu, Yemeni-Hadramaut, Yemeni-Sena, Sephardic Jews, and Ashkenazic Jews). The high resolution afforded by the markers shows that Lemba Y chromosomes are clearly divided into Semitic and Bantu clades. interestingly, one of the Lemba clans carries, at a very high frequency, a particular Y-chromosome type termed the "Cohen modal haplotype," which is known to be characteristic of the paternally inherited Jewish priesthood and is thought, more generally, to be a potential signature haplotype of Judaic origin. The Bantu Y-chromosome samples are predominantly (>80%) YAP(+) and include a modal haplotype at high frequency Assuming a rapid expansion of the eastern Bantu, we used variation in microsatellite alleles in YAP(+) sY81-G Bantu Y chromosomes to calculate a rough date, 3,000-5,000 years before the present, for the start of their expansion.	UCL, Dept Biol, Galton Lab, London NW1 2HE, England; UCL, Ctr Genet Anthropol, Dept Biol, London NW1 2HE, England; UCL, Ctr Genet Anthropol, Dept Anthropol, London NW1 2HE, England; Univ London, Sch Oriental & African Studies, London, England; Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; Rambam Med Ctr, Haifa, Israel; Univ S Africa, Dept Old Testament, ZA-0001 Pretoria, South Africa; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University of London School Oriental & African Studies (SOAS); University of California System; University of California Davis; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; University of South Africa; University of Oxford	Goldstein, DB (corresponding author), UCL, Dept Biol, Galton Lab, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	d.goldstein@ucl.ac.uk	Goldstein, David/AAY-8125-2020; Wilson, James F/A-5704-2009; Thomas, Mark G/A-2219-2012; Le Roux, Magdel/T-9811-2018	Wilson, James F/0000-0001-5751-9178; Thomas, Mark G/0000-0002-2452-981X; Le Roux, Magdel/0000-0002-0770-7303				[Anonymous], 1972, ENCY JUDAICA; BRADMAN N, IN PRESS POPULATION; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; LIESENBANG G, 1977, HIST AFR, V4, P162; MANDIVENGA EC, 1983, ISLAM ZIMBABWE; Mathew G., 1963, HIST E AFRICA, V1, P94; Mathivha M.E.R, 1992, BASENA VAMWENYA BALE; Nei M., 1987, MOL EVOLUTIONARY GEN; Parfitt T, 1997, JOURNEY VANISHED CIT; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Ruwitah A., 1997, ZIMBABWEA, V5, P53; Skorecki K, 1997, NATURE, V385, P32, DOI 10.1038/385032a0; SLATKIN M, 1995, GENETICS, V139, P457; Soodyall H, 1996, AM J HUM GENET, V58, P595; SOODYALL H, 1993, THESIS U WITWATERSRA; Spurdle AB, 1996, AM J HUM GENET, V59, P1126; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Wierdl M, 1997, GENETICS, V146, P769	26	148	151	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					674	686		10.1086/302749	http://dx.doi.org/10.1086/302749			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677325	Green Published, Bronze			2022-12-18	WOS:000088373100032
J	Wilkin, DJ; Szabo, JK; Cameron, R; Henderson, S; Bellus, GA; Mack, ML; Kaitila, I; Loughlin, J; Munnich, A; Sykes, B; Bonaventure, J; Francomano, CA				Wilkin, DJ; Szabo, JK; Cameron, R; Henderson, S; Bellus, GA; Mack, ML; Kaitila, I; Loughlin, J; Munnich, A; Sykes, B; Bonaventure, J; Francomano, CA			Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OSTEOGENESIS IMPERFECTA; THANATOPHORIC DYSPLASIA; APERT-SYNDROME; NORMAL PARENTS; FGFR3; AGE; MOSAICISM; DWARFISM; DOMAIN	More than 97% of achondroplasia cases are caused by one of two mutations (G1138A and G1138C) in the fibroblast growth factor receptor 3 (FGFR3) gene, which results in a specific amino acid substitution, G380R. Sporadic cases of achondroplasia have been associated with advanced paternal age, suggesting that these mutations occur preferentially during spermatogenesis. We have determined the parental origin of the achondroplasia mutation in 40 sporadic cases. Three distinct 1-bp polymorphisms were identified in the FGFR3 gene, within close proximity to the achondroplasia mutation site. Ninety-nine families, each with a sporadic case of achondroplasia in a child, were analyzed in this study. In this population, the achondroplasia mutation occurred on the paternal chromosome in all 40 cases in which parental origin was unambiguous. This observation is consistent with the clinical observation of advanced paternal age resulting in new cases of achondroplasia and suggests that factors influencing DNA replication or repair during spermatogenesis, but not during oogenesis, may predispose to the occurrence of the G1138 FGFR3 mutations.	NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; Inst Necker, INSERM, U393, Paris, France; Univ Oxford, John Radcliffe Hosp, Dept Cellular Sci, Inst Mol Med, Oxford OX3 9DU, England; Johns Hopkins Univ, Sch Med, Ctr Med Genet, Baltimore, MD 21205 USA; George Washington Univ, Inst Biomed Sci, Washington, DC USA; Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Johns Hopkins University; George Washington University; University of Helsinki; Helsinki University Central Hospital	Wilkin, DJ (corresponding author), NHGRI, Med Genet Branch, NIH, 10 Ctr Dr,MSC 1267,Bldg 10,Room 3D45, Bethesda, MD 20892 USA.	dwilkin@nhgri.nih.gov		Loughlin, John/0000-0003-2018-3361; Bellus, Gary/0000-0001-7492-3324				BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; BLANK CE, 1960, ANN HUM GENET, V24, P151; BOWEN P, 1974, Birth Defects Original Article Series, V10, P31; COLE WG, 1995, J MED GENET, V32, P284, DOI 10.1136/jmg.32.4.284; ERICKSON JD, 1974, ANN HUM GENET, V38, P89, DOI 10.1111/j.1469-1809.1974.tb01996.x; Ferguson HL, 1997, AM J MED GENET, V70, P287; Francomano C. A., 1996, American Journal of Human Genetics, V59, pA25; FRYNS JP, 1983, CLIN GENET, V24, P156; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; ORIOLI IM, 1995, AM J MED GENET, V59, P209, DOI 10.1002/ajmg.1320590218; PENROSE LS, 1955, LANCET, V2, P312; PENROSE LS, 1957, AM J HUM GENET, V9, P167; PHILIP N, 1988, J MED GENET, V25, P857, DOI 10.1136/jmg.25.12.857; REISER CA, 1984, AM J MED GENET, V19, P245, DOI 10.1002/ajmg.1320190206; RISCH N, 1987, AM J HUM GENET, V41, P218; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SOMMER SS, 1995, TRENDS GENET, V11, P141, DOI 10.1016/S0168-9525(00)89028-9; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; THEIN SL, 1991, BRIT J HAEMATOL, V79, P113, DOI 10.1111/j.1365-2141.1991.tb08016.x; THOMPSON JN, 1986, NEW ENGL J MED, V314, P521	26	148	152	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					711	716		10.1086/302000	http://dx.doi.org/10.1086/302000			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718331	hybrid, Green Published			2022-12-18	WOS:000075919000008
J	Boissy, RE; Zhao, HQ; Oetting, WS; Austin, LM; Wildenberg, SC; Boissy, YL; Zhao, Y; Sturm, RA; Hearing, VJ; King, RA; Nordlund, JJ				Boissy, RE; Zhao, HQ; Oetting, WS; Austin, LM; Wildenberg, SC; Boissy, YL; Zhao, Y; Sturm, RA; Hearing, VJ; King, RA; Nordlund, JJ			Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: A new subtype of albinism classified as ''OCA3''	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE BASE INSERTION; MESSENGER-RNA LEVELS; DOPACHROME TAUTOMERASE; B-LOCUS; MOUSE; GENE; CDNA; IDENTIFICATION; PIGMENTATION; MAPS	Most types of human oculocutaneous albinism (OCA) result from mutations in the gene for tyrosinase (OCA1) or the P protein (OCA2), although other types of OCA have been described but have not been mapped to specific loci, Melanocytes were cultured from an African-American with OCA, who exhibited the phenotype of Brown OCA, and his normal fraternal twin. Melanocytes cultured from the patient with OCA and the normal twin appeared brown versus black, respectively. Melanocytes from both the patient with OCA and the normal twin demonstrated equal amounts of NP-40-soluble melanin; however, melanocytes from the patient with OCA contained only 7% of the amount of insoluble melanin found from the normal twin. Tyrosinase-related protein-1 (TRP-1) was not detected in the OCA melanocytes by use of various anti-TRP-l probes. Furthermore, transcripts for TRP-1 were absent in cultured OCA melanocytes. The affected twin was homozygous for a single-bp deletion in exon 6, removing an A in codon 368 and leading to a premature stop at codon 384. Tyrosine hydroxylase activity of the OCA melanocytes was comparable to controls when assayed in cell lysates but was only 30% of controls when assayed in intact cells. We conclude that this mutation of the human TRP-1 gene affects its interaction with tyrosinase, resulting in dysregulation of tyrosinase activity, promotes the synthesis of brown versus black melanin, and is responsible for a third genetic type of OCA in humans, which we classify as ''OCA3.''	UNIV MINNESOTA, SCH MED, DEPT MED & PEDIAT, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, SCH MED, INST HUMAN GENET, MINNEAPOLIS, MN 55455 USA; UNIV QUEENSLAND, CTR MOL BIOL & CELLULAR BIOL, BRISBANE, QLD, AUSTRALIA; NCI, CELL BIOL LAB, NIH, BETHESDA, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Boissy, RE (corresponding author), UNIV CINCINNATI, COLL MED, DEPT DERMATOL, POB 670592, CINCINNATI, OH 45267 USA.		Sturm, Richard A/C-9943-2009	Sturm, Richard A/0000-0003-1301-0294	NIGMS NIH HHS [GM 22167] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022167] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RGW, 1984, P NATL ACAD SCI-BIOL, V81, P4838, DOI 10.1073/pnas.81.15.4838; AUSTIN LM, 1995, AM J PATHOL, V146, P1529; BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; BENNETT DC, 1990, DEVELOPMENT, V110, P471; BOISSY RE, 1991, J INVEST DERMATOL, V97, P395, DOI 10.1111/1523-1747.ep12480976; BOUCHARD B, 1989, J EXP MED, V169, P2029, DOI 10.1084/jem.169.6.2029; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; CHINTAMANENI CD, 1991, P NATL ACAD SCI USA, V88, P5272, DOI 10.1073/pnas.88.12.5272; CHINTAMANENI CD, 1991, BIOCHEM BIOPH RES CO, V178, P227, DOI 10.1016/0006-291X(91)91803-K; COCHRAN AJ, 1982, INT J CANCER, V30, P295, DOI 10.1002/ijc.2910300307; COHEN T, 1990, NUCLEIC ACIDS RES, V18, P2807, DOI 10.1093/nar/18.9.2807; COLEMAN DL, 1962, ARCH BIOCHEM BIOPHYS, V96, P562, DOI 10.1016/0003-9861(62)90337-5; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DURHAMPIERRE D, 1994, NAT GENET, V7, P176, DOI 10.1038/ng0694-176; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; GERRARD JM, 1991, BLOOD, V77, P101; GIEBEL LB, 1991, J CLIN INVEST, V87, P1119, DOI 10.1172/JCI115075; GIEBEL LB, 1991, AM J HUM GENET, V48, P1159; HALABAN R, 1990, P NATL ACAD SCI USA, V87, P4809, DOI 10.1073/pnas.87.12.4809; HALABAN R, 1983, J CELL BIOL, V97, P480, DOI 10.1083/jcb.97.2.480; HEARING VJ, 1992, PIGM CELL RES, V5, P264, DOI 10.1111/j.1600-0749.1992.tb00547.x; HEARING VJ, 1993, AM J HUM GENET, V52, P1; JACKSON IJ, 1990, GENETICS, V126, P451; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; JACKSON IJ, 1992, EMBO J, V11, P527, DOI 10.1002/j.1460-2075.1992.tb05083.x; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; JIMENEZ M, 1989, J BIOL CHEM, V264, P3397; JIMENEZ M, 1991, J BIOL CHEM, V266, P1147; JIMENEZCERVANTES C, 1993, EUR J BIOCHEM, V217, P549, DOI 10.1111/j.1432-1033.1993.tb18276.x; JIMENEZCERVANTES C, 1994, J BIOL CHEM, V269, P17993; KING RA, 1991, MOL BIOL MED, V8, P19; KING RA, 1980, CLIN GENET, V17, P259; KING RA, 1986, CLIN GENET, V29, P496; KING RA, 1985, OPHTHALMOLOGY, V92, P1496; KING RA, 1976, NATURE, V263, P69, DOI 10.1038/263069a0; KING RA, 1994, METABOLIC MOL BASES, V2, P4353; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; MURTY VVVS, 1992, GENOMICS, V13, P227, DOI 10.1016/0888-7543(92)90228-K; OETTING WS, 1994, ELECTROPHORESIS, V15, P159, DOI 10.1002/elps.1150150127; ORLOW SJ, 1992, PIGM CELL RES, V5, P113, DOI 10.1111/j.1600-0749.1992.tb00007.x; ORLOW SJ, 1994, J INVEST DERMATOL, V103, P196, DOI 10.1111/1523-1747.ep12392743; ORLOW SJ, 1993, J INVEST DERMATOL, V100, P55, DOI 10.1111/1523-1747.ep12354138; OSHIMA A, 1988, J BIOL CHEM, V263, P2553; PELTZ S W, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P99; PROTA G, 1995, PIGM CELL RES, V8, P153, DOI 10.1111/j.1600-0749.1995.tb00657.x; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; RAMSAY M, 1992, AM J HUM GENET, V51, P879; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; SHIBAHARA S, 1986, NUCLEIC ACIDS RES, V14, P2413, DOI 10.1093/nar/14.6.2413; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; SURDEJ P, 1994, ANNU REV GENET, V28, P263; THOMSON TM, 1985, J INVEST DERMATOL, V85, P169, DOI 10.1111/1523-1747.ep12276608; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; TOMITA Y, 1985, J INVEST DERMATOL, V84, P294; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; URQUHART A, 1991, NUCLEIC ACIDS RES, V19, P5803, DOI 10.1093/nar/19.20.5803; WINDER A, 1994, CELL MOL BIOL RES, V40, P613; WINDER AJ, 1993, J CELL SCI, V106, P153; WITKOP CJ, 1970, ADV HUM GENET, P61; ZHAO HQ, 1994, LAB INVEST, V71, P25; Zhao HQ, 1996, J INVEST DERMATOL, V106, P744, DOI 10.1111/1523-1747.ep12345799; ZHAO HQ, 1994, AM J MED SCI, V308, P322, DOI 10.1097/00000441-199412000-00003; ZHAO HQ, 1994, PIGM CELL RES, V7, P131, DOI 10.1111/j.1600-0749.1994.tb00040.x	68	148	158	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1145	1156						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651291				2022-12-18	WOS:A1996UM27100007
J	PENNY, LA; DELLAQUILA, M; JONES, MC; BERGOFFEN, JA; CUNNIFF, C; FRYNS, JP; GRACE, E; GRAHAM, JM; KOUSSEFF, B; MATTINA, T; SYME, J; VOULLAIRE, L; ZELANTE, L; ZENGERHAIN, J; JONES, OW; EVANS, GA				PENNY, LA; DELLAQUILA, M; JONES, MC; BERGOFFEN, JA; CUNNIFF, C; FRYNS, JP; GRACE, E; GRAHAM, JM; KOUSSEFF, B; MATTINA, T; SYME, J; VOULLAIRE, L; ZELANTE, L; ZENGERHAIN, J; JONES, OW; EVANS, GA			CLINICAL AND MOLECULAR CHARACTERIZATION OF PATIENTS WITH DISTAL 11Q DELETIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; JACOBSEN SYNDROME; FRAGILE SITES; GENE; FAMILY; MUTATION	Jacobsen syndrome is caused by segmental aneusomy for the distal end of the long arm of chromosome 11, Typical features include mild to moderate psychomotor retardation, trigonocephaly, facial dysmorphism, cardiac defects, and thrombocytopenia, though none of these features are invariably present. To define the critical regions responsible for these abnormalities, we studied 17 individuals with de novo terminal deletions of 11q. The patients were characterized in a loss-of-heterozygosity analysis using polymorphic dinucleotide repeats. The breakpoints in the complete two-generation families were localized with an average resolution of 3.9 cM. Eight patients with the largest deletions extending from 11q23.3 to 11qter have breakpoints, between D11S924 and D11S1341. This cytogenetic region accounts for the majority of 11q(-) patients and may be related to the FRA11B fragile site in 11q23.3. One patient with a small terminal deletion distal to D11S1351 had facial dysmorphism, cardiac defects, and thrombocytopenia, suggesting that the genes responsible for these features may lie distal to D11S1351. Twelve of 15 patients with deletion breakpoints as far distal as D11S1345 had trigonocephaly, while patients with deletions distal to D11S912 did not, suggesting that, if hemizygosity for a single gene is responsible for this dysmorphic feature, the gene may lie distal to D11S1345 and proximal to D11S912.	SALK INST BIOL STUDIES,MOLEC GENET LAB,LA JOLLA,CA 92037; CHILDRENS HOSP,DIV DYSMORPHOL & GENET,SAN DIEGO,CA; KAISER PERMANENTE MED GRP,DEPT GENET,SAN JOSE,CA; ARIZONA HLTH SCI CTR,DEPT PEDIAT,TUCSON,AZ 85724; UZ GASTHUISBERG,CTR HUMAN GENET,LOUVAIN,BELGIUM; ROYAL HOSP SICK CHILDREN,DEPT PATHOL & CYTOGENET,EDINBURGH EH9 1LF,MIDLOTHIAN,SCOTLAND; EASTERN GEN HOSP,MED GENET SERV,EDINBURGH,MIDLOTHIAN,SCOTLAND; CEDARS SINAI MED CTR,DIV CLIN GENET & DYSMORPHOL,LOS ANGELES,CA 90048; UNIV S FLORIDA,DIV GENET,TAMPA,FL; UNIV CATANIA,PEDIAT CLIN 1,CATANIA,ITALY; ROYAL CHILDRENS HOSP,MURDOCH INST,MELBOURNE,VIC,AUSTRALIA; CSS HOSP,SAN GIOVANNI ROTO,ITALY; OAKWOOD HOSP,DEPT CYTOGENET,DEARBORN,MI	Salk Institute; Children's Hospital Los Angeles; Kaiser Permanente; Permanente Medical Groups; University of Arizona Health Sciences; KU Leuven; University Hospital Leuven; Cedars Sinai Medical Center; State University System of Florida; University of South Florida; University of Catania; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Beaumont Health	PENNY, LA (corresponding author), UNIV CALIF SAN DIEGO,DIV MED GENET,9500 GILMAN DR,LA JOLLA,CA 92093, USA.		Graham, John M./J-1429-2019; Mattina, Teresa/AGB-4604-2022	Mattina, Teresa/0000-0001-6143-6682				ADAMS BS, 1992, GENOMICS, V14, P270, DOI 10.1016/S0888-7543(05)80216-2; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; COUSINEAU AJ, 1983, AM J MED GENET, V14, P29, DOI 10.1002/ajmg.1320140106; FRYNS JP, 1986, CLIN GENET, V30, P225; GLOVER T, 1987, AM J HUM GENET, V41, P822; GLOVER TW, 1988, AM J HUM GENET, V43, P265; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HELMUTH RA, 1989, AM J MED GENET, V32, P178, DOI 10.1002/ajmg.1320320207; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; JACOBSEN P, 1973, HUM HERED, V23, P568, DOI 10.1159/000152624; JONES C, 1994, HUM MOL GENET, V3, P2123, DOI 10.1093/hmg/3.12.2123; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; MIRO R, 1987, HUM GENET, V75, P345, DOI 10.1007/BF00284105; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; NIIKAWA N, 1981, ANN GENET-PARIS, V24, P172; OBREGON MG, 1992, ANN GENET-PARIS, V35, P208; OHARE AE, 1984, CLIN GENET, V25, P373; SELLERI L, 1994, GENOMICS, V22, P137, DOI 10.1006/geno.1994.1354; VANHEMEL JO, 1992, HUM GENET, V88, P661, DOI 10.1007/BF02265294; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VORTKAMP A, 1992, MAMM GENOME, V3, P461, DOI 10.1007/BF00356157; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; VOULLAIRE LE, 1987, HUM GENET, V76, P202, DOI 10.1007/BF00284923; WAKOZANO A, 1992, JPN J HUM GENET, V37, P229	28	148	154	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					676	683						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887422				2022-12-18	WOS:A1995QK91800017
J	SHERMAN, SL; TAKAESU, N; FREEMAN, SB; GRANTHAM, M; PHILLIPS, C; BLACKSTON, RD; JACOBS, PA; COCKWELL, AE; FREEMAN, V; UCHIDA, I; MIKKELSEN, M; KURNIT, DM; BURACZYNSKA, M; KEATS, BJB; HASSOLD, TJ				SHERMAN, SL; TAKAESU, N; FREEMAN, SB; GRANTHAM, M; PHILLIPS, C; BLACKSTON, RD; JACOBS, PA; COCKWELL, AE; FREEMAN, V; UCHIDA, I; MIKKELSEN, M; KURNIT, DM; BURACZYNSKA, M; KEATS, BJB; HASSOLD, TJ			TRISOMY-21 - ASSOCIATION BETWEEN REDUCED RECOMBINATION AND NONDISJUNCTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN CHROMOSOME-21; LINKAGE ANALYSIS; PARENTAL AGE; ORIGIN; MAP; POLYMORPHISMS; FRAGMENTS; GENE	To assess the association between recombination and nondisjunction of chromosome 21, we analyzed cytogenetic and DNA markers in 104 trisomy 21 individuals and their parents. Our DNA marker studies of parental origin were informative in 100 cases, with the overwhelming majority (94) being maternal in origin. This value is significantly higher than the 75%-80% maternal nondisjunction rate typically observed in cytogenetic studies of trisomy 21 and illustrates the increased accuracy of the molecular approach. Using the maternally derived cases and probing at 19 polymorphic sites on chromosome 21, we created a genetic map that spans most of the long arm of chromosome 21. The map was significantly shorter than the normal female linkage map, indicating that absence of pairing and/or recombination contributes to nondisjunction in a substantial proportion of cases of trisomy 21.	WESSEX REG GENET LAB, SALISBURY, ENGLAND; MCMASTER UNIV, DEPT PEDIAT, HAMILTON L8S 4L8, ONTARIO, CANADA; JOHN F KENNEDY INST, DEPT MED GENET, GLOSTRUP, DENMARK; UNIV MICHIGAN, HOWARD HUGHES MED INST, ANN ARBOR, MI 48109 USA; LOUISIANA STATE UNIV, MED CTR, DEPT BIOMETRY & GENET, NEW ORLEANS, LA 70112 USA	McMaster University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Louisiana State University System	SHERMAN, SL (corresponding author), EMORY UNIV, SCH MED, DEPT PEDIAT, DIV MED GENET, 2040 RIDGEWOOD DR, ATLANTA, GA 30322 USA.				NICHD NIH HHS [N01-HD 92707] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; AYME S, 1982, AM J HUM GENET, V34, P558; AYME S, 1986, 7TH EEC INT C HUM 1; BRICARELLI FD, 1989, HUM GENET, V82, P20, DOI 10.1007/BF00288265; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; CHAKRAVARTI A, 1987, Genomics, V1, P35, DOI 10.1016/0888-7543(87)90102-9; CHAKRAVARTI A, 1989, MOL CYTOGENETIC STUD, P45; de Grouchy J, 1970, Ann Genet, V13, P52; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLANNERY D B, 1986, American Journal of Human Genetics, V39, pA113; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; HAMERS AJH, 1990, CLIN GENET, V37, P463; HASSOLD T, 1985, AM J HUM GENET, V37, P965; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; HOOK EB, 1981, TRISOMY, V21, P3; JABS EW, 1991, GENOMICS, V9, P141, DOI 10.1016/0888-7543(91)90231-3; JACKSONCOOK CK, 1985, AM J HUM GENET, V37, P1049; JUBERG RC, 1983, AM J MED GENET, V16, P111, DOI 10.1002/ajmg.1320160117; JUBERG RC, 1970, NEW ENGL J MED, V282, P292, DOI 10.1056/NEJM197002052820602; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; Mather K, 1938, BIOL REV CAMB PHILOS, V13, P252, DOI 10.1111/j.1469-185X.1938.tb00516.x; MORTON NE, 1990, ANN HUM GENET, V54, P39, DOI 10.1111/j.1469-1809.1990.tb00359.x; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; MORTON NE, 1984, GENET RES, V44, P99, DOI 10.1017/S0016672300026276; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; ROULSTON D, 1989, MOL CYTOGENETIC STUD, P81; SHAHAR S, 1986, HUM GENET, V74, P215; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPEED RM, 1989, FERTILITY CHROMOSOME, P2; TAKAESU N, 1990, AM J MED GENET, P175; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6; WAYE JS, 1989, P NATL ACAD SCI USA, V86, P6250, DOI 10.1073/pnas.86.16.6250	36	148	152	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					608	620						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1831960				2022-12-18	WOS:A1991GE36700014
J	COHN, DH; STARMAN, BJ; BLUMBERG, B; BYERS, PH				COHN, DH; STARMAN, BJ; BLUMBERG, B; BYERS, PH			RECURRENCE OF LETHAL OSTEOGENESIS IMPERFECTA DUE TO PARENTAL MOSAICISM FOR A DOMINANT MUTATION IN A HUMAN TYPE-I COLLAGEN GENE (COLIAI)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT PATHOL,SM-30,SEATTLE,WA 98195; UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,CTR MED GENET BIRTH DEFECTR,DIV MED GENET,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195; PERMANENTE MED GRP INC,SAN FRANCISCO,CA	University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Permanente Medical Groups				Byers, Peter H./0000-0001-7786-7030	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557, F32AR007713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015253] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR07713, AR21557] Funding Source: Medline; NIGMS NIH HHS [GM15253] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLANSON JE, 1986, CLIN GENET, V29, P429; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; BARSH GS, 1984, J BIOL CHEM, V259, P4906; BARSH GS, 1985, P NATL ACAD SCI USA, V82, P2870, DOI 10.1073/pnas.82.9.2870; BATEMAN JF, 1987, J BIOL CHEM, V262, P7021; BENSON S A, 1984, Biotechniques, V2, P66; BENYA PD, 1981, COLLAGEN REL RES, V1, P17; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; BRADLEY TB, 1980, JOHNS HOPKINS MED J, V146, P236; BYERS PH, 1988, AM J HUM GENET, V42, P237; BYERS PH, 1988, J BIOL CHEM, V263, P7855; BYERS PH, 1985, METABOLIC GENETIC DI, P56; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; CHU ML, 1985, J BIOL CHEM, V260, P691; COHN DH, 1986, P NATL ACAD SCI USA, V83, P6045, DOI 10.1073/pnas.83.16.6045; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DAVID TJ, 1972, J MED GENET, V9, P316, DOI 10.1136/jmg.9.3.316; DEWET WJ, 1983, J BIOL CHEM, V258, P7721; DODINVAL P, 1987, AM J MED GENET, V28, P949, DOI 10.1002/ajmg.1320280421; Enquist L, 1979, Methods Enzymol, V68, P281; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; FRIEDMAN AM, 1982, GENE, V18, P289, DOI 10.1016/0378-1119(82)90167-6; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; MINTZ B, 1974, ANNU REV GENET, V8, P411, DOI 10.1146/annurev.ge.08.120174.002211; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; ROPERS HH, 1979, HUM GENET, V48, P113, DOI 10.1007/BF00273282; Russell L.B., 1964, ROLE CHROMOSOMES DEV, P153; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Searle A. G., 1978, Genetic mosaics and chimeras in mammals., P209; SILLENCE DO, 1984, AM J MED GENET, V17, P407, DOI 10.1002/ajmg.1320170204; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STACEY A, 1988, NATURE, V332, P131, DOI 10.1038/332131a0; THOMPSON EM, 1987, J MED GENET, V24, P386; VOGEL BE, 1987, J BIOL CHEM, V262, P14737; WILLING MC, 1988, J BIOL CHEM, V263, P8398	41	148	149	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					591	601						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309707				2022-12-18	WOS:A1990CT66800024
J	CHANG, HJ; CLARK, RD; BACHMAN, H				CHANG, HJ; CLARK, RD; BACHMAN, H			THE PHENOTYPE OF 45,X/46,XY MOSAICISM - AN ANALYSIS OF 92 PRENATALLY DIAGNOSED CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90509	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center								AARSKOG D, 1971, Birth Defects Original Article Series, V7, P122; AYUSO MC, 1984, CLIN GENET, V25, P336; BENN P, 1984, PRENATAL DIAG, V4, P1, DOI 10.1002/pd.1970040102; BOCZKOWSKI K, 1967, ACTA PATHOL MIC SC, V71, P46; BORGHI A, 1965, HELV PAEDIATR ACTA, V20, P185; BUI TH, 1984, PRENATAL DIAG, V4, P145, DOI 10.1002/pd.1970040710; EDWARDS J. H., 1966, J MED GEMET, V3, P117, DOI 10.1136/jmg.3.2.117; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FERRIER PE, 1970, AM J DIS CHILD, V120, P566, DOI 10.1001/archpedi.1970.02100110114019; GANTT PA, 1980, FERTIL STERIL, V34, P216; HAMERTON JL, 1975, CLIN GENET, V8, P223; HECHT F, 1982, PRENATAL DIAG, V2, P233, DOI 10.1002/pd.1970020314; HIRSCHHORN K, 1960, LANCET, V2, P319; HIRSCHHORN K, 1960, NEW ENGL J MED, V263, P1044, DOI 10.1056/NEJM196011242632102; HSU LYF, 1976, CLIN GENET, V10, P232; HSU LYF, 1984, PRENATAL DIAG, V4, P97, DOI 10.1002/pd.1970040708; HSU LYF, 1989, PRENATAL DIAG, V9, P31, DOI 10.1002/pd.1970090106; JACKSON W. P. U., 1966, J MED GENET, V3, P23, DOI 10.1136/jmg.3.1.23; KARP L, 1975, J MED GENET, V12, P70, DOI 10.1136/jmg.12.1.70; KIRKILIONIS AJ, 1987, PRENATAL DIAG, V7, P521, DOI 10.1002/pd.1970070708; KNUDTZON J, 1987, EUR J PEDIATR, V146, P266, DOI 10.1007/BF00716471; KOFMAN S, 1981, HUM GENET, V58, P373, DOI 10.1007/BF00282818; LIEBER E, 1986, CLIN GENET, V30, P366; LIPPE BM, 1982, CLIN PEDIAT ADOLESCE, P272; MANUEL M, 1976, AM J OBSTET GYNECOL, V124, P293, DOI 10.1016/0002-9378(76)90160-5; MULLER J, 1985, J PEDIATR-US, V106, P431, DOI 10.1016/S0022-3476(85)80670-3; MULLER U, 1983, AM J MED GENET, V15, P315, DOI 10.1002/ajmg.1320150215; REINDOLLAR RH, 1987, FERTIL STERIL, V47, P626; ROSENBERG C, 1987, AM J MED GENET, V27, P553, DOI 10.1002/ajmg.1320270308; RUSSELL A, 1966, J CLIN ENDOCR METAB, V26, P1282, DOI 10.1210/jcem-26-12-1282; SCHMIDT R, 1976, J MED GENET, V13, P64, DOI 10.1136/jmg.13.1.64; SCULLY RE, 1970, CANCER, V25, P1340, DOI 10.1002/1097-0142(197006)25:6<1340::AID-CNCR2820250612>3.0.CO;2-N; Simpson J L, 1976, Birth Defects Orig Artic Ser, V12, P15; SIMPSON JL, 1976, DISORDERS SEXUAL DIF, P184; SUTHERLAND GR, 1975, CLIN GENET, V7, P400; TETER J, 1967, CANCER-AM CANCER SOC, V20, P1301, DOI 10.1002/1097-0142(196708)20:8<1301::AID-CNCR2820200814>3.0.CO;2-4; WATSON MS, 1984, AM J MED GENET, V19, P805, DOI 10.1002/ajmg.1320190422; WHEELER M, 1986, American Journal of Human Genetics, V39, pA268; WILLEMSE CH, 1962, LANCET, V1, P488; WORTON RG, 1984, PRENATAL DIAG, V4, P131, DOI 10.1002/pd.1970040709; ZABEL B, 1981, CLIN GENET, V20, P401; ZAH W, 1975, ACTA ENDOCR-COP    S, V79, P1	42	148	154	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					156	167						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294747				2022-12-18	WOS:A1990CJ04300020
J	Khan, MA; Rafiq, MA; Noor, A; Hussain, S; Flores, JV; Rupp, V; Vincent, AK; Malli, R; Ali, G; Khan, FS; Ishak, GE; Doherty, D; Weksberg, R; Ayub, M; Windpassinger, C; Ibrahim, S; Frye, M; Ansar, M; Vincent, JB				Khan, Muzammil Ahmad; Rafiq, Muhammad Arshad; Noor, Abdul; Hussain, Shobbir; Flores, Joana V.; Rupp, Verena; Vincent, Akshita K.; Malli, Roland; Ali, Ghazanfar; Khan, Falak Sher; Ishak, Gisele E.; Doherty, Dan; Weksberg, Rosanna; Ayub, Muhammad; Windpassinger, Christian; Ibrahim, Shahnaz; Frye, Michaela; Ansar, Muhammad; Vincent, John B.			Mutation in NSUN2, which Encodes an RNA Methyltransferase, Causes Autosomal-Recessive Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; DISORDERS; EPILEPSY; ARRAYS; FTSJ1	Causes of autosomal-recessive intellectual disability (ID) have, until very recently, been under researched because of the high degree of genetic heterogeneity. However, now that genome-wide approaches can be applied to single multiplex consanguineous families, the identification of genes harboring disease-causing mutations by autozygosity mapping is expanding rapidly. Here, we have mapped a disease locus in a consanguineous Pakistani family affected by Ill and distal myopathy. We genotyped family members on genome-wide SNP microarrays and used the data to determine a single 2.5 Mb homozygosity-by-descent (HBD) locus in region 5p15.32-p15.31; we identified the missense change c.2035G>A (p.Gly679Arg) at a conserved residue within NSUN2. This gene encodes a methyltransferase that catalyzes formation of 5-methylcytosine at C34 of tRNA-leu(CAA) and plays a role in spindle assembly during mitosis as well as chromosome segregation. In mouse brains, we show that NSUN2 localizes to the nucleolus of Purkinje cells in the cerebellum. The effects of the mutation were confirmed by the transfection of wild-type and mutant constructs into cells and subsequent immunohistochemistry. We show that mutation to arginine at this residue causes NSUN2 to fail to localize within the nucleolus. The ID combined with a unique profile of comorbid features presented here makes this an important genetic discovery, and the involvement of NSUN2 highlights the role of RNA methyltransferase in human neurocognitive development.	[Khan, Muzammil Ahmad; Rafiq, Muhammad Arshad; Noor, Abdul; Vincent, Akshita K.; Windpassinger, Christian; Vincent, John B.] Ctr Addict & Mental Hlth, Neurogenet Sect, Mol Neuropsychiat & Dev Lab, Toronto, ON M5T 1R8, Canada; [Khan, Muzammil Ahmad; Ali, Ghazanfar; Khan, Falak Sher; Ansar, Muhammad] Quaid I Azam Univ, Dept Biochem, Islamabad 45320, Pakistan; [Hussain, Shobbir; Flores, Joana V.; Frye, Michaela] Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Rupp, Verena; Windpassinger, Christian] Med Univ Graz, Inst Human Genet, A-1080 Graz, Austria; [Malli, Roland] Med Univ Graz, Inst Mol Biol & Biochem, A-1080 Graz, Austria; [Ali, Ghazanfar] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh 11451, Saudi Arabia; [Ishak, Gisele E.] Univ Washington, Seattle Childrens Hosp, Dept Radiol, Seattle, WA 98105 USA; [Doherty, Dan] Univ Washington, Div Genet & Dev Med, Seattle, WA 98105 USA; [Doherty, Dan] Childrens Hosp, Seattle, WA 98105 USA; [Weksberg, Rosanna] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Ayub, Muhammad] Tees Esk & Wear Valleys Natl Hlth Serv Fdn Trust, Darlington DL2 2TS, Durham, England; [Ayub, Muhammad] Univ Durham, Sch Hlth & Med, Stockton On Tees TS17 6BH, N Yorkshire, England; [Ibrahim, Shahnaz] Aga Khan Univ, Dept Paediat, Karachi 75800, Pakistan; [Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Quaid I Azam University; University of Cambridge; Medical University of Graz; Medical University of Graz; King Saud University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Durham University; Aga Khan University; University of Toronto	Vincent, JB (corresponding author), Ctr Addict & Mental Hlth, Neurogenet Sect, Mol Neuropsychiat & Dev Lab, Toronto, ON M5T 1R8, Canada.	john_vincent@camh.net	Khan, Muzammil Ahmad/AAJ-5704-2020; Ali, Ghazanfar/L-9277-2019; Ansar, Muhammad/H-5967-2011; Noor, Abdul/J-2345-2016; Ansar, Muhammad/F-4808-2015; Ali, Ghazanfar/J-9971-2012	Khan, Muzammil Ahmad/0000-0001-8591-0377; Ali, Ghazanfar/0000-0002-6172-9503; Ansar, Muhammad/0000-0001-5891-7063; Malli, Roland/0000-0001-6327-8729; Rupp, Verena/0000-0003-0234-3325; Frye, Michaela/0000-0002-5636-6840	Higher Education Commission (HEC) of Pakistan; HEC [NRPU-1118]; Canadian Institutes of Health Research [MOP-102758]; MRC [G0800784, G0801904] Funding Source: UKRI; Medical Research Council [G0800784B, G0801904, G0800784] Funding Source: researchfish	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); HEC; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank all the members of this family for their willing participation and cooperation in this study. We also wish to acknowledge Claire Simon, who assisted with the cell staining. M.A.K. was supported by the Indigenous Scholarship and International Research Support Program from the Higher Education Commission (HEC) of Pakistan. J.B.V. is a National Alliance for Research on Schizophrenia and Depression Independent Investigator. This research was supported by grants from the HEC (NRPU-1118) and the Canadian Institutes of Health Research (MOP-102758).	Abbasi-Moheb L, 2012, AM J HUM GENET, V90, P847, DOI 10.1016/j.ajhg.2012.03.021; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Boycott KM, 2009, J CHILD NEUROL, V24, P1310, DOI 10.1177/0883073809332696; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Christianson AL, 1999, J MED GENET, V36, P759, DOI 10.1136/jmg.36.10.759; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kelly AM, 1997, ARCH DIS CHILD, V77, P401, DOI 10.1136/adc.77.5.401; Kuss AW, 2011, HUM GENET, V129, P141, DOI 10.1007/s00439-010-0907-3; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Ramser J, 2004, J MED GENET, V41, P679, DOI 10.1136/jmg.2004.019000; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; SCHURIG V, 1981, AM J MED GENET, V9, P43, DOI 10.1002/ajmg.1320090109; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Ventura P, 2006, J CHILD NEUROL, V21, P776, DOI 10.1177/08830738060210091301; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	26	147	155	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					856	863		10.1016/j.ajhg.2012.03.023	http://dx.doi.org/10.1016/j.ajhg.2012.03.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22541562	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000303907500009
J	Abou Jamra, R; Philippe, O; Raas-Rothschild, A; Eck, SH; Graf, E; Buchert, R; Borck, G; Ekici, A; Brockschmidt, FF; Nothen, MM; Munnich, A; Strom, TM; Reis, A; Colleaux, L				Abou Jamra, Rami; Philippe, Orianne; Raas-Rothschild, Annick; Eck, Sebastian H.; Graf, Elisabeth; Buchert, Rebecca; Borck, Guntram; Ekici, Arif; Brockschmidt, Felix F.; Noethen, Markus M.; Munnich, Arnold; Strom, Tim M.; Reis, Andre; Colleaux, Laurence			Adaptor Protein Complex 4 Deficiency Causes Severe Autosomal-Recessive Intellectual Disability, Progressive Spastic Paraplegia, Shy Character, and Short Stature	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; LINKAGE ANALYSES; MUTATIONS; GENE; AP-4; IDENTIFICATION; DEFECT; EASYLINKAGE; SUBUNIT; TRAPPC9	Intellectual disability inherited in an autosomal-recessive fashion represents an important fraction of severe cognitive-dysfunction disorders. Yet, the extreme heterogeneity of these conditions markedly hampers gene identification. Here, we report on eight affected individuals who were from three consanguineous families and presented with severe intellectual disability, absent speech, shy character, stereotypic laughter, muscular hypotonia that progressed to spastic paraplegia, microcephaly, foot deformity, decreased muscle mass of the lower limbs, inability to walk, and growth retardation. Using a combination of autozygosity mapping and either Sanger sequencing of candidate genes or next-generation exome sequencing, we identified one mutation in each of three genes encoding adaptor protein complex 4 (AP4) subunits: a nonsense mutation in AP4S1 (NM_007077.3: c.124C > T, p.Arg42*), a frameshift mutation in AP4B1 (NM_006594.2: c.487_488insTAT, p.Glu163_Ser739delinsVal), and a splice mutation in AP4E1 (NM_007347.3: c.542+1_542+4delGTAA, r.421_542del, p.Glu181Glyfs*20). Adaptor protein complexes (AP1-4) are ubiquitously expressed, evolutionarily conserved heterotetrameric complexes that mediate different types of vesicle formation and the selection of cargo molecules for inclusion into these vesicles. Interestingly, two mutations affecting AP4M1 and AP4E1 have recently been found to cause cerebral palsy associated with severe intellectual disability. Combined with previous observations, these results support the hypothesis that AP4-complex-mediated trafficking plays a crucial role in brain development and functioning and demonstrate the existence of a clinically recognizable syndrome due to deficiency of the AP4 complex.	[Abou Jamra, Rami; Buchert, Rebecca; Ekici, Arif; Reis, Andre] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Philippe, Orianne; Borck, Guntram; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, Fdn IMAGINE,INSERM U781, F-75015 Paris, France; [Philippe, Orianne; Borck, Guntram; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, Dept Pediat Radiol, F-75015 Paris, France; [Raas-Rothschild, Annick] Hadassah Hebrew Univ, Med Ctr, Dept Human Genet & Metab Dis, IL-91120 Jerusalem, Israel; [Eck, Sebastian H.; Graf, Elisabeth; Strom, Tim M.] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; [Brockschmidt, Felix F.; Noethen, Markus M.] Univ Bonn, Dept Genom Life & Brain Ctr, D-53127 Bonn, Germany; [Brockschmidt, Felix F.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, Klinikum Rechts Isar, D-80634 Munich, Germany	University of Erlangen Nuremberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hebrew University of Jerusalem; Hadassah University Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Bonn; Technical University of Munich	Abou Jamra, R (corresponding author), Univ Erlangen Nurnberg, D-91054 Erlangen, Germany.	rami.aboujamra@uk-erlangen.de; laurence.colleaux@inserm.fr	COLLEAUX, Laurence/H-6455-2017; Jamra, Rami Abou/I-2350-2012; Buchert, Rebecca/R-6386-2019; COLLEAUX, LAURENCE/AAA-8144-2022; Borck, Guntram/F-1868-2015; Abou Jamra, Rami/AAC-8192-2019; Ekici, Arif B/C-3971-2013; Reis, André/D-2309-2009; , WaNgtJ/AAR-7045-2020; Jamra, Rami Abou/I-4805-2015	Jamra, Rami Abou/0000-0002-1542-1399; Buchert, Rebecca/0000-0001-7576-3326; COLLEAUX, LAURENCE/0000-0002-0987-7648; Abou Jamra, Rami/0000-0002-1542-1399; Ekici, Arif B/0000-0001-6099-7066; Reis, André/0000-0002-6301-6363; Jamra, Rami Abou/0000-0002-1542-1399; Nothen, Markus/0000-0002-8770-2464	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche [ANR-08-MNP-010]; Ministere de la Recherche et de l'Enseignement Superieur; German Intellectual disability Network (MRNET) through German Ministry of Research and Education [01GS08160, 01GR0804-4]; European Commission [01GR0804-4, 261123]; Deutsche Forschungsgemeinschaft (DFG) [AB393/1-2]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de la Recherche et de l'Enseignement Superieur; German Intellectual disability Network (MRNET) through German Ministry of Research and Education; European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We are grateful to the families for their participation in the study. We also thank Angelika Diem, Petra Rothe, Bianca Schmick, and Anna Benet-Pages for the excellent technical support. This study was supported by the Centre National de la Recherche Scientifique (CNRS), the Agence Nationale de la Recherche (ANR-08-MNP-010), the Ministere de la Recherche et de l'Enseignement Superieur, the German Intellectual disability Network (MRNET) through a grant from the German Ministry of Research and Education to A. Reis and T. Strom (01GS08160 and 01GR0804-4), the European Commission 7th Framework Program, Project N. 261123, GEUVADIS, and by the Deutsche Forschungsgemeinschaft (DFG) (AB393/1-2).	ABOUJAMRA R, 2011, EUR J HUM G IN PRESS; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; Dell'Angelica EC, 1999, J BIOL CHEM, V274, P7278, DOI 10.1074/jbc.274.11.7278; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Mir A, 2009, AM J HUM GENET, V85, P909, DOI 10.1016/j.ajhg.2009.11.009; Mochida GH, 2009, AM J HUM GENET, V85, P897, DOI 10.1016/j.ajhg.2009.10.027; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Philippe O, 2009, AM J HUM GENET, V85, P903, DOI 10.1016/j.ajhg.2009.11.007; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Verkerk AJMH, 2009, AM J HUM GENET, V85, P40, DOI 10.1016/j.ajhg.2009.06.004; Wang XL, 1997, FEBS LETT, V402, P57, DOI 10.1016/S0014-5793(96)01500-1	32	147	153	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					788	795		10.1016/j.ajhg.2011.04.019	http://dx.doi.org/10.1016/j.ajhg.2011.04.019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21620353	Green Published, Bronze			2022-12-18	WOS:000291768500010
J	Alkuraya, FS; Cai, XY; Emery, C; Mochida, GH; Al-Dosari, MS; Felie, JM; Hill, RS; Barry, BJ; Partlow, JN; Gascon, GG; Kentab, A; Jan, M; Shaheen, R; Feng, YY; Walsh, CA				Alkuraya, Fowzan S.; Cai, Xuyu; Emery, Carina; Mochida, Ganeshwaran H.; Al-Dosari, Mohammed S.; Felie, Jillian M.; Hill, R. Sean; Barry, Brenda J.; Partlow, Jennifer N.; Gascon, Generoso G.; Kentab, Amal; Jan, Mohammad; Shaheen, Ranad; Feng, Yuanyi; Walsh, Christopher A.			Human Mutations in NDE1 Cause Extreme Microcephaly with Lissencephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBRAL CORTICAL SIZE; COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; NEURONAL MIGRATION; MITOTIC SPINDLE; MILLER-DIEKER; LIS1; PROTEIN; PHOSPHORYLATION; RECRUITMENT	Genes disrupted in human microcephaly (meaning "small brain") define key regulators of neural progenitor proliferation and cell-fate specification. In comparison, genes mutated in human lissencephaly (lissos means smooth and cephalos means brain) highlight critical regulators of neuronal migration. Here, we report two families with extreme microcephaly and grossly simplified cortical gyral structure, a condition referred to as microlissencephaly, and show that they carry homozygous frameshift mutations in NDE1, which encodes a multidomain protein that localizes to the centrosome and mitotic spindle poles. Both human mutations in NDE1 truncate the C-terminal NDE1 domains, which are essential for interactions with cytoplasmic dynein and thus for regulation of cytoskeletal dynamics in mitosis and for cell-cycle-dependent phosphorylation of NDE1 by Cdk1. We show that the patient NDE1 proteins are unstable, cannot bind cytoplasmic dynein, and do not localize properly to the centrosome. Additionally, we show that CDK1 phosphorylation at T246, which is within the C-terminal region disrupted by the mutations, is required for cell-cycle progression from the G2 to the M phase. The role of NDE1 in cell-cycle progression probably contributes to the profound neuronal proliferation defects evident in Nde1-null mice and patients with NDE1 mutations, demonstrating the essential role of NDE1 in human cerebral cortical neurogenesis.	[Emery, Carina; Feng, Yuanyi] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Emery, Carina; Feng, Yuanyi] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Alkuraya, Fowzan S.; Al-Dosari, Mohammed S.; Shaheen, Ranad] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Cai, Xuyu; Mochida, Ganeshwaran H.; Felie, Jillian M.; Hill, R. Sean; Barry, Brenda J.; Partlow, Jennifer N.; Walsh, Christopher A.] Childrens Hosp Boston, Howard Hughes Med Inst, Div Genet, Boston, MA 02215 USA; [Cai, Xuyu; Mochida, Ganeshwaran H.; Felie, Jillian M.; Hill, R. Sean; Barry, Brenda J.; Partlow, Jennifer N.; Walsh, Christopher A.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Boston, MA 02215 USA; [Cai, Xuyu; Walsh, Christopher A.] Harvard Univ, Sch Med, Program Biomed & Biol Sci, Boston, MA 02215 USA; [Mochida, Ganeshwaran H.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02215 USA; [Mochida, Ganeshwaran H.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Mochida, Ganeshwaran H.] Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA; [Gascon, Generoso G.; Jan, Mohammad] King Faisal Specialist Hosp & Res Ctr, Dept Neurol, Jeddah 11211, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.; Kentab, Amal] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11472, Saudi Arabia; [Alkuraya, Fowzan S.; Kentab, Amal] King Saud Univ, Coll Med, Riyadh 11472, Saudi Arabia; [Jan, Mohammad] King Saud Univ, Coll Pharm, Dept Pharmacognosy, Riyadh 11451, Saudi Arabia	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; King Faisal Specialist Hospital & Research Center; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; King Faisal Specialist Hospital & Research Center; Alfaisal University; King Saud University; King Khalid University Hospital; King Saud University; King Saud University	Feng, YY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	yuanyi-feng@northwestern.edu; christopher.walsh@childrens.harvard.edu	Alkuraya, Fowzan S./A-1542-2009; aldosari, mohammed/GZK-2460-2022	Alkuraya, Fowzan S./0000-0003-4158-341X; Kentab, Amal/0000-0002-3627-4973; SHAHEEN, RANAD/0000-0002-2590-1759; Mochida, Ganeshwaran/0000-0001-7912-4097; Jan, Mohammed/0000-0002-5188-8922; Walsh, Christopher/0000-0002-0156-2238	Dubai-Harvard Foundation for Medical Research; King Abdulaziz City for Science and Technology [10-MED941-20/Saudi Arabia]; National Institute of General Medical Sciences [T32 GM007726-35]; National Alliance for Research on Schizophrenia and Depression; NICHD [R01HD56380]; Schweppe Foundation; NINDS, Fogarty International Center [RO1 NS 32457, R21 NS061772]; Manton Center for Orphan Disease Research; National Library of Medicine Family Foundation; Simons Foundation; National Institutes of Health (NIH) [HHSN268200782096C, NIH N01-HG-65403]; Intellectual and Developmental Disabilities Research Centers [P30 HD18655]; National Human Genome Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, R01HD056380] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, R01NS032457] Funding Source: NIH RePORTER	Dubai-Harvard Foundation for Medical Research; King Abdulaziz City for Science and Technology; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Alliance for Research on Schizophrenia and Depression(NARSAD); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Schweppe Foundation; NINDS, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Fogarty International Center (FIC)); Manton Center for Orphan Disease Research; National Library of Medicine Family Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Simons Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual and Developmental Disabilities Research Centers; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the families, clinicians, and researchers who contributed to this study, including reviews of the MRI findings by Bernard Chang and Annapurna Poduri. We thank members of the Microcephaly Collaborative (Table S2) for contributing patient samples not directly used in this study. F.S.A., G.H.M, and C.A.W. are supported by a Collaborative Research Grant from the Dubai-Harvard Foundation for Medical Research. F.S.A. is also supported by the King Abdulaziz City for Science and Technology (Grant 10-MED941-20/Saudi Arabia). X.C. is supported by the National Institute of General Medical Sciences (T32 GM007726-35). G.H.M. was supported by National Alliance for Research on Schizophrenia and Depression as a Lieber Young Investigator. Y.F. is supported by the NICHD (R01HD56380), and the Schweppe Foundation. C.A.W is supported by the NINDS (RO1 NS 32457) the Fogarty International Center (R21 NS061772), the Manton Center for Orphan Disease Research, the National Library of Medicine Family Foundation, and the Simons Foundation. Genotyping at the Center for Inherited Disease Research is funded through a federal contract from the National Institutes of Health (NIH) to The Johns Hopkins University (HHSN268200782096C and NIH N01-HG-65403). Genotyping at Children's Hospital Boston is supported by the Intellectual and Developmental Disabilities Research Centers (P30 HD18655). SNP genotyping of family 2 was performed through the NIH Neuroscience Microarray Consortium. Genotyping at the Broad Institute is supported by the National Human Genome Research Institute. C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Bakircioglu M, 2011, AM J HUM GENET, V88, P523, DOI 10.1016/j.ajhg.2011.03.019; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; DOBYNS WB, 1984, AM J MED GENET, V18, P509, DOI 10.1002/ajmg.1320180320; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hirohashi Y, 2006, ONCOGENE, V25, P6048, DOI 10.1038/sj.onc.1209637; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Norman M G, 1976, Can J Neurol Sci, V3, P39; Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Van der Reijden BA, 2010, LEUKEMIA, V24, P857, DOI 10.1038/leu.2009.290; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Wynshaw-Boris A, 2010, SEMIN CELL DEV BIOL, V21, P823, DOI 10.1016/j.semcdb.2010.07.008; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683	38	147	152	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					536	547		10.1016/j.ajhg.2011.04.003	http://dx.doi.org/10.1016/j.ajhg.2011.04.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21529751	Green Published, Bronze			2022-12-18	WOS:000290832100002
J	Gueneau, L; Bertrand, AT; Jais, JP; Salih, MA; Stojkovic, T; Wehnert, M; Hoeltzenbein, M; Spuler, S; Saitoh, S; Verschueren, A; Tranchant, C; Beuvin, M; Lacene, E; Romero, NB; Heath, S; Zelenika, D; Voit, T; Eymard, B; Yaou, RB; Bonne, G				Gueneau, Lucie; Bertrand, Anne T.; Jais, Jean-Philippe; Salih, Mustafa A.; Stojkovic, Tanya; Wehnert, Manfred; Hoeltzenbein, Maria; Spuler, Simone; Saitoh, Shinji; Verschueren, Annie; Tranchant, Christine; Beuvin, Maud; Lacene, Emmanuelle; Romero, Norma B.; Heath, Simon; Zelenika, Diana; Voit, Thomas; Eymard, Bruno; Yaou, Rabah Ben; Bonne, Gisele			Mutations of the FHL1 Gene Cause Emery-Dreifuss Muscular Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REDUCING BODY MYOPATHY; CAUSE AUTOSOMAL-DOMINANT; LAMIN A/C GENE; LIM DOMAIN; NUCLEAR-ENVELOPE; BINDING PROTEIN; DIFFERENTIATION; CARDIOMYOPATHY; IDENTIFICATION; SPECTRUM	Emery-Dreifuss muscular dystrophy (EDMD) is a rare disorder characterized by early joint contractures, muscular dystrophy, and cardiac involvement with conduction defects and arrhythmias. So far, only 35% of EDMD cases are genetically elucidated and associated with EMD or LMNA gene mutations, suggesting the existence of additional major genes. By whole-genome scan, we identified linkage to the Xq26.3 locus containing the FHL1 gene in three informative families belonging to our EMD- and LMNA-negative cohort. Analysis of the FHL1 gene identified seven mutations, in the distal exons of FHL1 in these families, three additional families, and one isolated case, which differently affect the three FHL1 protein isoforms: two missense mutations affecting highly conserved cysteines, one abolishing the termination codon, and four out-of-frame insertions or deletions. The predominant phenotype was characterized by myopathy with scapulo-peroneal and/or axial distribution, as well as joint contractures, and associated with a peculiar cardiac disease characterized by conduction defects, arrhythmias, and hypertrophic cardiomyopathy in all index cases of the seven families. Heterozygous female carriers were either asymptomatic or had cardiac disease and/or mild myopathy. Interestingly, four of the FHL1-mutated male relatives had isolated cardiac disease, and an overt hypertrophic cardiomyopathy was present in two. Expression and functional studies demonstrated that the FHL1 proteins were severely reduced in all tested patients and that this was associated with a severe delay in myotube formation in the two patients for whom myoblasts were available. In conclusion, FHL1 should be considered as a gene associated with the X-linked EDMD phenotype, as well as with hypertrophic cardiomyopathy.	[Gueneau, Lucie; Bertrand, Anne T.; Stojkovic, Tanya; Beuvin, Maud; Romero, Norma B.; Voit, Thomas; Yaou, Rabah Ben; Bonne, Gisele] Univ Paris 06, INSERM, U974, F-75013 Paris, France; [Gueneau, Lucie; Bertrand, Anne T.; Stojkovic, Tanya; Beuvin, Maud; Romero, Norma B.; Voit, Thomas; Yaou, Rabah Ben; Bonne, Gisele] Univ Paris 06, CNRS, UMR S974, UMR 7215,Inst Myol,IFR14, F-75013 Paris, France; [Jais, Jean-Philippe] Univ Paris 05, Fac Med Biostat & Informat Med, GH Necker Enfants Malad, EA 4067, F-75015 Paris, France; [Salih, Mustafa A.] King Saud Univ, Coll Med, Div Pediat Neurol, Riyadh 11461, Saudi Arabia; [Stojkovic, Tanya; Lacene, Emmanuelle; Romero, Norma B.; Voit, Thomas; Eymard, Bruno] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Malad Rares Neuromusculaires, F-75013 Paris, France; [Spuler, Simone] Charite, Expt & Clin Res Ctr, Muscle Res Unit, D-13125 Berlin, Germany; [Wehnert, Manfred; Hoeltzenbein, Maria] Inst Human Genet, D-17487 Greifswald, Germany; [Saitoh, Shinji] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan; [Verschueren, Annie] Hop Enfants La Timone, AP HM, Serv Neurol & Malad Neurol, F-13000 Marseille, France; [Tranchant, Christine] Hop Univ, Serv Neurol, F-67000 Strasbourg, France; [Lacene, Emmanuelle; Romero, Norma B.; Voit, Thomas; Yaou, Rabah Ben] Grp Hosp Pitie Salpetriere, Assoc Inst Myol, Unite Morphol Neuromusculaire, F-75013 Paris, France; [Heath, Simon; Zelenika, Diana] Ctr Natl Genotypage, F-91000 Evry, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, AP HP, UF Cardiogenet & Myogenet, Serv Biochim Metab, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hokkaido University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Bonne, G (corresponding author), Univ Paris 06, INSERM, U974, F-75013 Paris, France.	g.bonne@institut-myologie.org	Heath, Simon C/J-4138-2012; Bonne, Gisèle/G-3121-2013; STOJKOVIC, Tanya/AAA-3967-2021; Salih, Mustafa/C-1222-2014; Hoeltzenbein, Maria/B-1134-2016; Hoeltzenbein, Maria/AAP-4145-2020; Bertrand, Anne/AAR-6751-2020; BEN YAOU, Rabah/S-1443-2017	Heath, Simon C/0000-0002-9550-0897; Bonne, Gisèle/0000-0002-2516-3258; Salih, Mustafa/0000-0002-4379-2111; Hoeltzenbein, Maria/0000-0002-2451-4247; Hoeltzenbein, Maria/0000-0002-2451-4247; BEN YAOU, Rabah/0000-0002-0492-3414; tranchant, christine/0000-0002-2895-1292; Bertrand, Anne/0000-0001-7153-848X; Saitoh, Shinji/0000-0001-6911-3351; Spuler, Simone/0000-0002-0155-1117	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris 06; Centre National de la Recherche Scientifique (CNRS); Association Francaise contre les Myopathies [11057, 11034]; European Union Sixth Framework Programme [Eurolaminopathies 018690]; German Network of Muscular Dystrophies [01GM0302]; German Ministry of Education and Research (BMBF); College of Medicine, King Saud University, Riyadh, Saudi Arabia [07-581]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris 06; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Union Sixth Framework Programme(European Commission); German Network of Muscular Dystrophies; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); College of Medicine, King Saud University, Riyadh, Saudi Arabia(King Saud University)	We thank Abdullah S. Al-Jarallah, Khalid H. Al Malki, Denis Duboc, Odile Dubourg, Essam A. Elgamal, Salah A. Elmalik, Yu-ichi Goto, Mohammad M. Kabiraj, Saleh A. Othman, jean Pouget, Maja Sukalo, Christine S. Wehnert, and Karim Whabi for their precious help in the clinical evaluation of EDMD families. We are also indebted to E Leturcq and P. Richard, as well as the "Banque de Cellules Cassini," for their support. We thank Myosix SA for allowing us access to the cell culture methodology and to the custom-made MYO1 medium. This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite Paris 06, the Centre National de la Recherche Scientifique (CNRS), the Association Francaise contre les Myopathies (no. 11057, no. 11034, and financial support for L.G.), the European Union Sixth Framework Programme (Eurolaminopathies no. 018690), the German Network of Muscular Dystrophies (MD-NET, 01GM0302), and the German Ministry of Education and Research (BMBF). M.A.S. was supported by CMRC (project no. 07-581), College of Medicine, King Saud University, Riyadh, Saudi Arabia.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Amack JD, 2001, HUM MOL GENET, V10, P1879, DOI 10.1093/hmg/10.18.1879; Becane HM, 2000, PACE, V23, P1661, DOI 10.1046/j.1460-9592.2000.01661.x; BETHMANN CI, 2004, 9 INT WORLD MUSCL SO, P593; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BONNE G, DISORDERS V IN PRESS; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Chen CL, 2007, BBA-MOL BASIS DIS, V1772, P317, DOI 10.1016/j.bbadis.2006.10.017; Colomer J, 2002, NEUROMUSCULAR DISORD, V12, P19, DOI 10.1016/S0960-8966(01)00239-5; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; de Luna N, 2006, J BIOL CHEM, V281, P17092, DOI 10.1074/jbc.M601885200; di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869; Ellis JA, 2006, CELL MOL LIFE SCI, V63, P2702, DOI 10.1007/s00018-006-6247-8; Emery AEH, 2000, NEUROMUSCULAR DISORD, V10, P228, DOI 10.1016/S0960-8966(00)00105-X; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Lee SMY, 1999, GENE, V237, P253, DOI 10.1016/S0378-1119(99)00251-6; Lee SMY, 1998, GENE, V216, P163, DOI 10.1016/S0378-1119(98)00302-3; Manilal S, 1997, NEUROMUSCULAR DISORD, V7, P63, DOI 10.1016/S0960-8966(96)00405-1; Matsumoto Y, 2005, J MUSCLE RES CELL M, V26, P367, DOI 10.1007/s10974-005-9018-5; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; MUCHIR A, 2007, HUM MOL GEN IN PRESS; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Ng EKO, 2001, J CELL BIOCHEM, V82, P1, DOI 10.1002/jcb.1110; Olive M, 2005, BRAIN, V128, P2315, DOI 10.1093/brain/awh576; Quinzi CM, 2008, AM J HUM GENET, V82, P208, DOI 10.1016/j.ajhg.2007.09.013; ROWLAND LP, 1979, ANN NEUROL, V5, P111, DOI 10.1002/ana.410050203; Sakata K, 2005, CIRCULATION, V111, P3352, DOI 10.1161/CIRCULATIONAHA.104.527184; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Schessl J, 2009, BRAIN, V132, P452, DOI 10.1093/brain/awn325; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; Shalaby S, 2009, NEUROLOGY, V72, P375, DOI 10.1212/01.wnl.0000341311.84347.a0; Shalaby S, 2008, NEUROMUSCULAR DISORD, V18, P959, DOI 10.1016/j.nmd.2008.09.012; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Talim B, 2003, NEUROMUSCULAR DISORD, V13, P660; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; van Berlo JH, 2004, EUR HEART J, V25, P812, DOI 10.1016/j.ehj.2004.03.007; VOIT T, 1988, NEUROPEDIATRICS, V19, P62, DOI 10.1055/s-2008-1052404; Vytopil M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.12.e132; Windpassinger C, 2008, AM J HUM GENET, V82, P88, DOI 10.1016/j.ajhg.2007.09.004; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Yang Z, 2008, CARDIOVASC RES, V78, P449, DOI 10.1093/cvr/cvn038; Yates JRW, 1997, NEUROMUSCULAR DISORD, V7, P67, DOI 10.1016/S0960-8966(96)00403-8; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238	51	147	159	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					338	353		10.1016/j.ajhg.2009.07.015	http://dx.doi.org/10.1016/j.ajhg.2009.07.015			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19716112	Bronze, Green Published			2022-12-18	WOS:000270104500004
J	Lefeber, DJ; Schonberger, J; Morava, E; Guillard, M; Huyben, KM; Verriip, K; Grafakou, O; Evangelioi, A; Preijers, FW; Manta, P; Yildiz, J; Grunewald, S; Spilioti, M; van den Elzen, C; Klein, D; Hess, D; Ashida, H; Hofsteenge, J; Maeda, Y; van den Heuvel, L; Lammens, M; Lehle, L; Wevers, RA				Lefeber, Dirk J.; Schoenberger, Johannes; Morava, Eva; Guillard, Mailys; Huyben, Karin M.; Verriip, Kiek; Grafakou, Olga; Evangelioi, Athanasios; Preijers, Frank W.; Manta, Panagiota; Yildiz, Jef; Gruenewald, Stephanie; Spilioti, Martha; van den Elzen, Christa; Klein, Dominique; Hess, Daniel; Ashida, Hisashi; Hofsteenge, Jan; Maeda, Yusuke; van den Heuvel, Lambert; Lammens, Martin; Lehle, Ludwig; Wevers, Ron A.			Deficiency of Dol-P-Man Synthase Subunit DPM3 Bridges the Congenital Disorders of Glycosylation with the Dystroglycanopathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOLICHOL-PHOSPHATE-MANNOSE; N-LINKED GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; DEFECTIVE GLYCOSYLATION; GLYCOPROTEIN SYNDROME; MUSCULAR-DYSTROPHIES; MAMMALIAN-CELLS; BIOSYNTHESIS; PROTEIN; GENE	Alpha-dystroglycanopathies such as Walker Warburg syndrome represent an important subgroup of the muscular dystrophies that have been related to defective O-mannosylation of alpha-dystroglycan. In many patients, the underlying genetic etiology remains unsolved. Isolated muscular dystrophy has not been described in the congenital disorders of glycosylation (CDG) caused by N-linked protein glycosylation defects. Here, we present a genetic N-glycosylation disorder with muscular dystrophy in the group of CDG type I. Extensive biochemical investigations revealed a strongly reduced dolichol-phosphate-mannose (Dol-P-Man) synthase activity. Sequencing of the three DPM subunits and complementation of DPM3-deficient CHO2.38 cells showed a pathogenic p.L85S missense mutation in the strongly conserved coiled-coil domain of DPM3 that tethers catalytic DPM1 to the ER membrane. Cotransfection experiments in CHO cells showed a reduced binding capacity of DPM3(L85S) for DPM1. Investigation of the four Dol-P-Man-dependent glycosylation pathways in the ER revealed strongly reduced O-mannosylation of alpha-dystroglycan in a muscle biopsy, thereby explaining the clinical phenotype of muscular dystrophy. This mild Dol-P-Man biosynthesis defect due to DPM3 mutations is a cause for alpha-dystroglycanopathy, thereby bridging the congenital disorders of glycosylation with the dystroglycanopathies.	[Lefeber, Dirk J.; Guillard, Mailys; Huyben, Karin M.; Yildiz, Jef; van den Heuvel, Lambert; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Lab Pediat & Neurol, NL-6500 HB Nijmegen, Netherlands; [Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Verriip, Kiek; Lammens, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [Preijers, Frank W.] Radboud Univ Nijmegen, Med Ctr, Cent Hematol Lab, NL-6500 HB Nijmegen, Netherlands; [van den Elzen, Christa] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Schoenberger, Johannes; Lehle, Ludwig] Univ Regensburg, D-93053 Regensburg, Germany; [Grafakou, Olga] Rethymnon Gen Hosp, Dept Pediat, Rethimnon 74100, Greece; [Evangelioi, Athanasios] Aristotle Univ Thessaloniki, Pediat Clin 4, Papageorgiou Hosp, GR-56403 Thessaloniki, Greece; [Gruenewald, Stephanie] Great Ormond St Hosp Sick Children, London WC1N 1EH, England; [Manta, Panagiota] Univ Athens, Dept Neurol, Athens 11528, Greece; [Spilioti, Martha] Univ Crete, Dept Neurol, Iraklion 71003, Greece; [Klein, Dominique; Hess, Daniel; Hofsteenge, Jan] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Ashida, Hisashi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Maeda, Yusuke] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Regensburg; Aristotle University of Thessaloniki; Papageorgiou Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; National & Kapodistrian University of Athens; University of Crete; Friedrich Miescher Institute for Biomedical Research; Kyoto University; Osaka University	Lefeber, DJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Lab Pediat & Neurol, NL-6500 HB Nijmegen, Netherlands.	d.lefeber@cukz.umcn.nl	van den Heuvel, L.P.W.J./H-8044-2014; Preijers, Frank/L-4586-2015; Wevers, Ron A./H-8116-2014; Lammens, Martin/H-1503-2011; lefeber, dirk/G-5063-2012; Lefeber, Dirk DJ/A-2146-2014; van den Heuvel, Lambertus/AAM-1772-2021; verrijp, kiek/F-4783-2018; Lammens, Martin/AAI-9343-2021; Ashida, Hisashi/HCI-0293-2022; Morava, E./L-4529-2015	van den Heuvel, L.P.W.J./0000-0003-3917-6727; Wevers, Ron A./0000-0003-2278-9746; Lammens, Martin/0000-0002-3881-6692; van den Heuvel, Lambertus/0000-0003-3917-6727; Ashida, Hisashi/0000-0001-5844-4075; Evangeliou, Athanasios/0000-0002-3878-8097				Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200; Babovic-Vuksanovic D, 2007, MOL DIAGN THER, V11, P303, DOI 10.1007/BF03256251; Bickel T, 2005, J BIOL CHEM, V280, P34500, DOI 10.1074/jbc.M506358200; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Callewaert N, 2003, GLYCOBIOLOGY, V13, P367, DOI 10.1093/glycob/cwg040; DEJONG G, 1994, ADV EXP MED BIOL, V356, P51; Doucey MA, 1998, MOL BIOL CELL, V9, P291, DOI 10.1091/mbc.9.2.291; Garcia-Silva MT, 2004, J INHERIT METAB DIS, V27, P591, DOI 10.1023/B:BOLI.0000042984.42433.d8; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Haeuptle MA, 2008, AM J HUM GENET, V82, P600, DOI 10.1016/j.ajhg.2007.12.021; Hess D, 2008, J BIOL CHEM, V283, P7354, DOI 10.1074/jbc.M710251200; Imbach T, 2000, J CLIN INVEST, V105, P233, DOI 10.1172/JCI8691; Ishikura F, 2008, HYPERTENS RES, V31, P243, DOI 10.1291/hypres.31.243; Jaeken J, 2008, J INHERIT METAB DIS, V31, P669, DOI 10.1007/s10545-008-0983-x; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; KEAN EL, 1985, J BIOL CHEM, V260, P2561; Kim S, 2000, J CLIN INVEST, V105, P191, DOI 10.1172/JCI7302; KNAUER R, 1994, J INHERIT METAB DIS, V17, P541, DOI 10.1007/BF00711588; Korner C, 1999, EMBO J, V18, P6816, DOI 10.1093/emboj/18.23.6816; Kranz C, 2001, J CLIN INVEST, V108, P1613, DOI 10.1172/JCI200113635; Kranz C, 2007, AM J HUM GENET, V80, P433, DOI 10.1086/512130; LEHLE L, 1980, EUR J BIOCHEM, V109, P589, DOI 10.1111/j.1432-1033.1980.tb04832.x; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Maeda Y, 1998, EMBO J, V17, P4920, DOI 10.1093/emboj/17.17.4920; Maeda Y, 2008, BBA-GEN SUBJECTS, V1780, P861, DOI 10.1016/j.bbagen.2008.03.005; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Marquardt T, 2002, EUR J PEDIATR, V161, P524, DOI 10.1007/s00431-002-1029-2; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; Mercuri E, 2009, NEUROLOGY, V72, P1802, DOI 10.1212/01.wnl.0000346518.68110.60; Murakami T, 2006, ANN NEUROL, V60, P597, DOI 10.1002/ana.20973; Peters V, 2002, NEUROPEDIATRICS, V33, P27, DOI 10.1055/s-2002-23597; Poppe M, 2004, ANN NEUROL, V56, P738, DOI 10.1002/ana.20283; Schenk B, 2001, J CLIN INVEST, V108, P1687, DOI 10.1172/JCI200113419; Schwarz M, 2004, AM J HUM GENET, V74, P472, DOI 10.1086/382492; SUGIYAMA E, 1991, J BIOL CHEM, V266, P12119; Tajima Y, 2005, AM J PATHOL, V166, P1121, DOI 10.1016/S0002-9440(10)62332-2; Tomita S, 1998, J BIOL CHEM, V273, P9249, DOI 10.1074/jbc.273.15.9249; Van Geet C, 2001, J INHERIT METAB DIS, V24, P477, DOI 10.1023/A:1010581613821; van Reeuwijk J, 2005, CLIN GENET, V67, P281, DOI 10.1111/j.1399-0004.2004.00368.x; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; Wopereis S, 2006, BBA-MOL BASIS DIS, V1762, P598, DOI 10.1016/j.bbadis.2006.03.009; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	45	147	153	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					76	86		10.1016/j.ajhg.2009.06.006	http://dx.doi.org/10.1016/j.ajhg.2009.06.006			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19576565	Bronze, Green Published			2022-12-18	WOS:000267997600009
J	Bassuk, AG; Wallace, RH; Buhr, A; Buller, AR; Afawi, Z; Shimojo, M; Miyata, S; Chen, S; Gonzalez-Alegre, P; Griesbach, HL; Wu, S; Nashelsky, M; Vladar, EK; Antic, D; Ferguson, PJ; Cirak, S; Voit, T; Scott, MP; Axelrod, JD; Gurnett, C; Daoud, AS; Kivity, S; Neufeld, MY; Mazarib, A; Straussberg, R; Walid, S; Korczyn, AD; Slusarski, DC; Berkovic, SF; El-Shanti, HI				Bassuk, Alexander G.; Wallace, Robyn H.; Buhr, Aimee; Buller, Andrew R.; Afawi, Zaid; Shimojo, Masahito; Miyata, Shingo; Chen, Shan; Gonzalez-Alegre, Pedro; Griesbach, Hilary L.; Wu, Shu; Nashelsky, Marcus; Vladar, Eszter K.; Antic, Dragana; Ferguson, Polly J.; Cirak, Sebahattin; Voit, Thomas; Scott, Matthew P.; Axelrod, Jeffrey D.; Gurnett, Christina; Daoud, Azhar S.; Kivity, Sara; Neufeld, Miriam Y.; Mazarib, Aziz; Straussberg, Rachel; Walid, Simri; Korczyn, Amos D.; Slusarski, Diane C.; Berkovic, Samuel F.; El-Shanti, Hatem I.			A Homozygous Mutation in Human PRICKLE1 Causes an Autosomal-Recessive Progressive Myoclonus Epilepsy-Ataxia Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIM DOMAIN PROTEIN; NERVOUS-SYSTEM; CELL MOVEMENTS; MOUSE PRICKLE1; VALPROIC ACID; BETA-CATENIN; EXPRESSION; GENE; GASTRULATION; DROSOPHILA	Progressive myoclonus epilepsy (PME) is a syndrome characterized by myoclonic seizures (lightning-like jerks), generalized convulsive seizures, and varying degrees of neurological decline, especially ataxia and dementia. Previously, we characterized three pedigrees of individuals with PME and ataxia, where either clinical features or linkage mapping excluded known PME loci. This report identifies a mutation in PRICKLE1 (also known as RILP for REST/NRSF interacting LIM domain protein) in all three of these pedigrees. The identified PRICKLE1 mutation blocks the PRICKLE1 and REST interaction in vitro and disrupts the normal function of PRICKLE1 in an in vivo zebrafish overexpression system. PRICKLE1 is expressed in brain regions implicated in epilepsy and ataxia in mice and humans, and, to our knowledge, is the first molecule in the noncanonical WNT signaling pathway to be directly implicated in human epilepsy.	[El-Shanti, Hatem I.] Univ Melbourne Austin Hlth, Epilepsy Res Ctr, Heidelberg West, Vic 3161, Australia; [Berkovic, Samuel F.] Univ Melbourne Austin Hlth, Dept Med, Heidelberg West, Vic 3161, Australia; [Bassuk, Alexander G.; Buller, Andrew R.; Chen, Shan; Wu, Shu; Ferguson, Polly J.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Bassuk, Alexander G.; Buhr, Aimee] Univ Iowa, Grad Program Genet, Iowa City, IA 52242 USA; [Bassuk, Alexander G.] Univ Iowa, Grad Program Neurosci, Iowa City, IA 52242 USA; [Gonzalez-Alegre, Pedro] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Griesbach, Hilary L.; Slusarski, Diane C.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Nashelsky, Marcus] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Wallace, Robyn H.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Afawi, Zaid; Neufeld, Miriam Y.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-64239 Tel Aviv, Israel; [Afawi, Zaid; Neufeld, Miriam Y.] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel; [Shimojo, Masahito] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Miyata, Shingo] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka 5650871, Japan; [Vladar, Eszter K.; Antic, Dragana; Axelrod, Jeffrey D.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Vladar, Eszter K.; Antic, Dragana; Scott, Matthew P.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Cirak, Sebahattin] Univ Kinder Klin Essen, Abt Allgemeine Padiat Schwerpunkt Neuropadiat, D-45122 Essen, Germany; [Voit, Thomas] Grp Hosp Pitie Salpetriere, Inst Myol, F-75013 Paris, France; [Gurnett, Christina] Washington Univ, Sch Med, Div Pediat Neurol, Dept Neurol, St Louis, MO 63110 USA; [Daoud, Azhar S.] Jordan Univ Sci & Technol, Dept Pediat, Irbid 22110, Jordan; [Straussberg, Rachel] Schneider Childrens Med Ctr Israel, Epilepsy Unit, IL-49202 Petah Tiqwa, Israel; [Mazarib, Aziz] Schneider Childrens Med Ctr Israel, Dept Child Neurol, IL-49202 Petah Tiqwa, Israel; [Mazarib, Aziz] Kupat Holim Clalit, IL-16000 Nazareth, Israel; [Walid, Simri] Western Galilee Hosp, Dept Neurol, IL-22100 Nahariyya, Israel; [Korczyn, Amos D.] Tel Aviv Univ, Sieratzki Chair Neurol, IL-69978 Ramat Aviv, Israel; [El-Shanti, Hatem I.] Shafallah Med Genet Ctr, Doha, Qatar	University of Melbourne; University of Melbourne; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Queensland; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Kentucky; Osaka University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Duisburg Essen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Washington University (WUSTL); Jordan University of Science & Technology; Western Galilee Hospital; Tel Aviv University; Al Shafallah Center	Berkovic, SF (corresponding author), Univ Melbourne Austin Hlth, Epilepsy Res Ctr, Heidelberg West, Vic 3161, Australia.	s.berkovic@unimelb.edu.au	Afawi, Zaid/AAE-7848-2022; EL-SHANTI, HATEM/Q-4932-2016; Shimojo, Masahito/T-8086-2019; Cirak, Sebahattin/AAX-9593-2020; El-Shanti, Hatem/O-5990-2014; jiang, yu/HGU-0029-2022; Cirak, Sebahattin/AAZ-6829-2020; Korczyn, Amos D/C-3461-2017	EL-SHANTI, HATEM/0000-0001-6230-8316; Shimojo, Masahito/0000-0003-1859-4444; El-Shanti, Hatem/0000-0001-6230-8316; Korczyn, Amos D/0000-0003-0125-2579; Slusarski, Diane/0000-0003-3793-8636; Nashelsky, Marcus/0000-0002-9685-6959; Gurnett, Christina/0000-0001-9129-315X; Berkovic, Samuel/0000-0003-4580-841X; Bassuk, Alexander/0000-0002-4067-2157; Vladar, Eszter/0000-0002-4160-8894; Buller, Andrew/0000-0002-9635-4844; Wallace, Robyn/0000-0001-6141-3317	NIH/NINDS [K08NS48174]; NIH/NCRR [P20RR020171, MH067123]; Epilepsy Foundation;  [CA112369]; NATIONAL CANCER INSTITUTE [T32CA009151, R01CA112369] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH067123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048174] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Epilepsy Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the families for their participation. We thank Chantal Allamargot and Kathy Walters for their assistance with immunostaining and confocal microscopy at the University of Iowa, and Kaye Suyama for her work with the antibodies at Stanford. A.G.B. is supported by NIH/NINDS grant K08NS48174. M.P.S. is an investigator of the Howard Hughes Medical Institute. D.C.S. and H.L.G. were Supported by NIH CA112369. M.S. was Supported by NIH/NCRR P20RR020171 and NIH MH067123. A.B. was supported by a grant from the Epilepsy Foundation. We thank Jeffrey Murray for access to the CEPH-HGD panel and for commentary on the manuscript. The authors have no disclosures and no conflicts of interest. A.G.B. wrote the manuscript, performed all immunohistochemical studies in HeLa cells and half of the tissue immunostaining, and oversaw all aspects of the resequencing, control genotyping, and coimmunoprecipitations. H.E. and A.D. clinically evaluated part of pedigree B. S.B. clinically evaluated all the pedigrees and integrated the clinical data, together with Z.A., S.K., A.K., M.N., S.W., A.Z., and R.S. H.E. and S.B. designed the mapping strategies. R.W., A.B., and S.C. performed the fine mapping, resequencing, and genotyping studies. A.B. compiled Table SI. S.C. compiled Table S2. A.R.B. performed the coimmunoprecipitations. RE and J.M.. assisted in the design and analysis of he genotyping assays. M.N. ascertained and prepared the specimens for human tissue staining. S.W. prepared the Prickle1 antibody at the University of Iowa. P.G. assisted in the development of the cell-culture experiments. D.C.S. oversaw all zebrafish injections and analyses performed by H.L.G. M.S. provided the myc-REST construct and guidance in cell transfections. S.M. provided a Mouse prickle1-GFP expression vector that was used in pilot studies in preparation for the use of a human Prickle1-EGFP construct. J.A., M.P.S., D.A., and E.K.V. produced the Prickle1 antibodies and performed the immunostaining at Stanford University.	Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Berkovic SF, 2005, BRAIN, V128, P652, DOI 10.1093/brain/awh377; Cann HM, 2002, SCIENCE, V296, P261; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Chen G, 1999, J NEUROCHEM, V72, P1327, DOI 10.1046/j.1471-4159.2000.0721327.x; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Crompton LA, 2007, DEV DYNAM, V236, P3137, DOI 10.1002/dvdy.21338; El-Shanti H, 2006, BRAIN DEV-JPN, V28, P353, DOI 10.1016/j.braindev.2005.11.003; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; Galit S, 2007, PHARMACOL REP, V59, P402; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Katoh M, 2003, INT J MOL MED, V11, P249; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Okuda H, 2007, FEBS LETT, V581, P4754, DOI 10.1016/j.febslet.2007.08.075; Olguin P, 2006, J NEUROSCI, V26, P2820, DOI 10.1523/JNEUROSCI.5037-05.2006; Palm K, 1998, J NEUROSCI, V18, P1280; Shimojo M, 2006, J NEUROCHEM, V96, P1130, DOI 10.1111/j.1471-4159.2005.03608.x; Shimojo M, 2003, MOL CELL BIOL, V23, P9025, DOI 10.1128/MCB.23.24.9025-9031.2003; Shimshoni JA, 2007, MOL PHARMACOL, V71, P884, DOI 10.1124/mol.106.030601; Straussberg R, 2005, NEUROLOGY, V64, P142, DOI 10.1212/01.WNL.0000148600.60470.E6; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Tokuoka SM, 2008, MOL BIOL CELL, V19, P2241, DOI 10.1091/mbc.E07-09-0982; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wiltse J, 2005, CRIT REV TOXICOL, V35, P727, DOI 10.1080/10408440591007403; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	31	147	155	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					572	581		10.1016/j.ajhg.2008.10.003	http://dx.doi.org/10.1016/j.ajhg.2008.10.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18976727	Green Published, Bronze			2022-12-18	WOS:000261006900003
J	Mandel, H; Shemer, R; Borochowitz, ZU; Okopnik, M; Knopf, C; Indelman, M; Drugan, A; Tiosano, D; Gershoni-Baruch, R; Choder, M; Sprecher, E				Mandel, Hannah; Shemer, Revital; Borochowitz, Zvi U.; Okopnik, Marina; Knopf, Carlos; Indelman, Margarita; Drugan, Arie; Tiosano, Dov; Gershoni-Baruch, Ruth; Choder, Mordechai; Sprecher, Eli			SERKAL syndrome: An autosomal-recessive disorder caused by a loss-of-function mutation in WNT4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; SEX DETERMINATION; DEFICIENCY; DIFFERENTIATION; EXPRESSION; REVERSAL; FEMALES; PATHWAY; GONAD; CELLS	The WNT-signaling pathway plays a major role during mammalian embryogenesis. We report a novel autosomal-recessive syndrome that consists of female to male sex reversal and renal, adrenal, and lung dysgenesis and is associated with additional developmental defects. Using a candidate-gene approach, we identified a disease-causing homozygous missense mutation in the human WNT4 gene. The mutation was found to result in markedly reduced WNT4 mRNA levels in vivo and in vitro and to downregulate WNT4-dependant inhibition of beta-catenin degradation. Taken together with previous observations in animal models, the present data attribute a pivotal role to WNT4 signaling during organogenesis in humans.	[Shemer, Revital; Indelman, Margarita; Sprecher, Eli] Rambam Hlth Care Campus, Dept Dermatol, IL-31096 Haifa, Israel; [Shemer, Revital; Indelman, Margarita; Sprecher, Eli] Rambam Hlth Care Campus, Lab Mol Dermatol, IL-31096 Haifa, Israel; [Okopnik, Marina] Rambam Hlth Care Campus, Dept Pathol, IL-31096 Haifa, Israel; [Gershoni-Baruch, Ruth] Rambam Hlth Care Campus, Inst Genet, IL-31096 Haifa, Israel; [Drugan, Arie] Rambam Hlth Care Campus, Dept Obstet & Gynecol, IL-31096 Haifa, Israel; [Tiosano, Dov] Rambam Hlth Care Campus, Dept Pediat Endocrinol, IL-31096 Haifa, Israel; [Mandel, Hannah; Knopf, Carlos] Meyer Childrens Hosp, Metab Dis Unit, IL-31096 Haifa, Israel; [Mandel, Hannah; Shemer, Revital; Borochowitz, Zvi U.; Drugan, Arie; Gershoni-Baruch, Ruth; Choder, Mordechai; Sprecher, Eli] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Fac Med, IL-31096 Haifa, Israel; [Shemer, Revital; Sprecher, Eli] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Ctr Translat Genet, IL-31096 Haifa, Israel; [Borochowitz, Zvi U.] Bnai Zion Med Ctr, Simon Winter Inst Human Genet, IL-31091 Haifa, Israel	Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center	Sprecher, E (corresponding author), Rambam Hlth Care Campus, Dept Dermatol, IL-31096 Haifa, Israel.	e_sprecher@rambam.health.gov.il						Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Else T, 2005, TRENDS ENDOCRIN MET, V16, P458, DOI 10.1016/j.tem.2005.10.004; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; HAWKINS JR, 1993, HUM MUTAT, V2, P347, DOI 10.1002/humu.1380020504; Heikkila M, 2005, ENDOCRINOLOGY, V146, P4016, DOI 10.1210/en.2005-0463; Heikkila M, 2002, ENDOCRINOLOGY, V143, P4358, DOI 10.1210/en.2002-220275; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; IGLESIAS DM, 2007, CANONICAL WNT SIGNAL, V293, pF494; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; SANNACHERCHI S, 2007, IN PRESS PEDIAT NEPH; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Weintrob N, 2006, PEDIATRICS, V117, pE322, DOI 10.1542/peds.2005-1973; Wudy SA, 2004, HORM METAB RES, V36, P415, DOI 10.1055/s-2004-814565; Yao HHC, 2005, MOL CELL ENDOCRINOL, V230, P87, DOI 10.1016/j.mce.2004.11.003	28	147	193	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					39	47		10.1016/j.ajhg.2007.08.005	http://dx.doi.org/10.1016/j.ajhg.2007.08.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179883	Green Published, Bronze			2022-12-18	WOS:000253223800005
J	Saxena, R; de Bakker, PIW; Singer, K; Mootha, V; Burtt, N; Hirschhorn, JN; Gaudet, D; Isomaa, B; Daly, MJ; Groop, L; Ardlie, KG; Altshuler, D				Saxena, Richa; de Bakker, Paul I. W.; Singer, Karyn; Mootha, Vamsi; Burtt, Noel; Hirschhorn, Joel N.; Gaudet, Daniel; Isomaa, Bo; Daly, Mark J.; Groop, Leif; Ardlie, Kristin G.; Altshuler, David			Comprehensive association testing of common mitochondrial DNA variation in metabolic disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSULIN-RESISTANCE; PARKINSONS-DISEASE; FRIEDREICHS-ATAXIA; SKELETAL-MUSCLE; POLYMORPHISMS; LONGEVITY; POPULATION; VARIANT; HUMANS; RISK	Many lines of evidence implicate mitochondria in phenotypic variation: ( a) rare mutations in mitochondrial proteins cause metabolic, neurological, and muscular disorders; ( b) alterations in oxidative phosphorylation are characteristic of type 2 diabetes, Parkinson disease, Huntington disease, and other diseases; and ( c) common missense variants in the mitochondrial genome ( mtDNA) have been implicated as having been subject to natural selection for adaptation to cold climates and contributing to "energy deficiency" diseases today. To test the hypothesis that common mtDNA variation influences human physiology and disease, we identified all 144 variants with frequency > 1% in Europeans from > 900 publicly available European mtDNA sequences and selected 64 tagging single-nucleotide polymorphisms that efficiently capture all common variation ( except the hypervariable D-loop). Next, we evaluated the complete set of common mtDNA variants for association with type 2 diabetes in a sample of 3,304 diabetics and 3,304 matched nondiabetic individuals. Association of mtDNA variants with other metabolic traits ( body mass index, measures of insulin secretion and action, blood pressure, and cholesterol) was also tested in subsets of this sample. We did not find a significant association of common mtDNA variants with these metabolic phenotypes. Moreover, we failed to identify any physiological effect of alleles that were previously proposed to have been adaptive for energy metabolism in human evolution. More generally, this comprehensive association-testing framework can readily be applied to other diseases for which mitochondrial dysfunction has been implicated.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; MIT, Cambridge, MA USA; Univ Montreal, Chicoutimi Hosp, Community Genom Ctr, Montreal, PQ, Canada; Folkhalsan Res Ctr, Folkhalsan Genet Inst, Helsinki, Finland; Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland; Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Universite de Montreal; Folkhalsan Research Center; Lund University; Skane University Hospital	Altshuler, D (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Sinches Res Bldg,175 Cambridge St,CPZN-6818, Boston, MA 02114 USA.	altshuler@molbio.mgh.harvard.edu	Altshuler, David M/A-4476-2009; Saxena, Richa/AAG-7279-2020; de Bakker, Paul IW/B-8730-2009; Daly, Mark J/B-2453-2017	Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Daly, Mark J/0000-0002-0949-8752; Saxena, Richa/0000-0003-2233-1065				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9; Barrett TG, 2001, BEST PRACT RES CL EN, V15, P325, DOI 10.1053/beem.2001.0149; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; De Benedictis G, 2000, ANN NY ACAD SCI, V908, P208; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Florez JC, 2004, DIABETES, V53, P3313, DOI 10.2337/diabetes.53.12.3313; Giacchetti M, 2004, J MED GENET, V41, P293, DOI 10.1136/jmg.2003.015289; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; Momiyama Y, 2003, BIOCHEM BIOPH RES CO, V312, P858, DOI 10.1016/j.bbrc.2003.10.195; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Poulton J, 2002, DIABETIC MED, V19, P969, DOI 10.1046/j.0742-3071.2002.00836.x; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P159, DOI 10.1016/S0005-2728(98)00164-9; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Tanaka Masashi, 2002, Journal of Neurology, V249, P11; Tang K, 2004, J PROTEOME RES, V3, P218, DOI 10.1021/pr034080s; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Torroni A, 1996, GENETICS, V144, P1835; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Winckler W, 2005, DIABETES, V54, P886, DOI 10.2337/diabetes.54.3.886; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259	59	147	155	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					54	61		10.1086/504926	http://dx.doi.org/10.1086/504926			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773565	Green Published, Bronze			2022-12-18	WOS:000238341200006
J	Chai, JH; Locke, DP; Greally, JM; Knoll, JHM; Ohta, T; Dunai, J; Yavor, A; Eichler, EE; Nicholls, RD				Chai, JH; Locke, DP; Greally, JM; Knoll, JHM; Ohta, T; Dunai, J; Yavor, A; Eichler, EE; Nicholls, RD			Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY SPASTIC PARAPLEGIA; SMALL NUCLEOLAR RNA; MULTISPANNING MEMBRANE-PROTEIN; HUMAN-CHROMOSOME 15Q11-Q13; INV DUP(15) CHROMOSOMES; WILLI-SYNDROME; ANGELMAN-SYNDROME; MOLECULAR CHARACTERIZATION; IMPRINTED GENE; ASYNCHRONOUS REPLICATION	Prader-Willi and Angelman syndromes (PWS and AS) typically result from an similar to4-Mb deletion of human chromosome 15q11-q13, with clustered breakpoints (BP) at either of two proximal sites (BP1 and BP2) and one distal site (BP3). HERC2 and other duplicons map to these BP regions, with the 2-Mb PWS/AS imprinted domain just distal of BP2. Previously, the presence of genes and their imprinted status have not been examined between BP1 and BP2. Here, we identify two known (CYFIP1 and GCP5) and two novel (NIPA1 and NIPA2) genes in this region in human and their orthologs in mouse chromosome 7C. These genes are expressed from a broad range of tissues and are nonimprinted, as they are expressed in cells derived from normal individuals, patients with PWS or AS, and the corresponding mouse models. However, replication-timing studies in the mouse reveal that they are located in a genomic domain showing asynchronous replication, a feature typically ascribed to monoallelically expressed loci. The novel genes NIPA1 and NIPA2 each encode putative polypeptides with nine transmembrane domains, suggesting function as receptors or as transporters. Phylogenetic analyses show that NIPA1 and NIPA2 are highly conserved in vertebrate species, with ancestral members in invertebrates and plants. Intriguingly, evolutionary studies show conservation of the four-gene cassette between BP1 and BP2 in human, including NIPA1/2, CYFIP1, and GCP5, and proximity to the Herc2 gene in both mouse and Fugu. These observations support a model in which duplications of the HERC2 gene at BP3 in primates first flanked the four-gene cassette, with subsequent transposition of these four unique genes by a HERC2 duplicon-mediated process to form the BP1-BP2 region. Duplicons therefore appear to mediate genomic fluidity in both disease and evolutionary processes.	Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, CRB 528, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Albert Einstein Coll Med, Dept Med, Div Hematol, Bronx, NY 10467 USA; Univ Missouri, Sch Med, Childrens Mercy Hosp & Clin, Div Med Res,Lab Human Mol Genet, Kansas City, MO 64108 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Case Western Reserve University; Yeshiva University; Albert Einstein College of Medicine; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City	Nicholls, RD (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, CRB 528, 415 Curie Blvd, Philadelphia, PA 19104 USA.	robertn@mail.med.upenn.edu	Greally, John/AAF-9540-2019	Greally, John/0000-0001-6069-7960; Knoll, Joan/0000-0001-6691-1710; Locke, Devin/0000-0002-2527-0475	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031491, R01HD036079] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK056786, K08DK002467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010631] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG02385, R01 HG002385] Funding Source: Medline; NICHD NIH HHS [HD36079, HD31491, R01 HD031491, T32 HD007518, HD07518] Funding Source: Medline; NIDDK NIH HHS [DK02467, DK56786] Funding Source: Medline; NIEHS NIH HHS [R01 ES010631, ES10631] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Buiting K, 1999, CYTOGENET CELL GENET, V87, P125, DOI 10.1159/000015378; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Butler MG, 2002, J MED GENET, V39, P202, DOI 10.1136/jmg.39.3.202; BUTLER MG, IN PRESS PEDIATRICS; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chai JH, 2001, MAMM GENOME, V12, P813, DOI 10.1007/s00335-001-2083-1; CHENG SD, 1994, AM J HUM GENET, V55, P753; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chluba-de Tapia J, 1997, GENE, V197, P195, DOI 10.1016/S0378-1119(97)00263-1; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; CLAYTONSMITH J, 1993, AM J MED GENET, V47, P683, DOI 10.1002/ajmg.1320470519; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; CULIAT CT, 1995, NAT GENET, V11, P344, DOI 10.1038/ng1195-344; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; Dhar M, 2000, PHYSIOL GENOMICS, V4, P93, DOI 10.1152/physiolgenomics.2000.4.1.93; Fantes JA, 2002, J MED GENET, V39, P170, DOI 10.1136/jmg.39.3.170; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; FINK JK, 1995, AM J HUM GENET, V56, P188; Fink JK, 1996, NEUROLOGY, V46, P835, DOI 10.1212/WNL.46.3.835; Gabriel JM, 1998, P NATL ACAD SCI USA, V95, P14857, DOI 10.1073/pnas.95.25.14857; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Greally JM, 1998, HUM MOL GENET, V7, P91, DOI 10.1093/hmg/7.1.91; Hagiwara N, 2003, DEV BIOL, V254, P93, DOI 10.1016/S0012-1606(02)00030-1; Henegariu O, 2001, CYTOMETRY, V43, P101, DOI 10.1002/1097-0320(20010201)43:2<101::AID-CYTO1024>3.0.CO;2-8; Herzing LBK, 2001, AM J HUM GENET, V68, P1501, DOI 10.1086/320616; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Huang B, 1997, HUM GENET, V99, P11; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; KNOLL JHM, 1994, CURRENT PROTOCOLS HU, V1; Kobayashi T, 1998, J MEMBRANE SCI, V140, P1, DOI 10.1016/S0376-7388(97)00251-2; Koster F, 1998, NEUROSCI LETT, V252, P69, DOI 10.1016/S0304-3940(98)00531-X; LEANACOX J, 1994, AM J HUM GENET, V54, P748; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Locke DP, 2001, AM J HUM GENET, V69, P179; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; NICHOLLS RD, 1993, P NATL ACAD SCI USA, V90, P2050, DOI 10.1073/pnas.90.5.2050; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nicholls RD, 1999, NAT GENET, V23, P132, DOI 10.1038/13758; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Pujana MA, 2001, GENOME RES, V11, P98, DOI 10.1101/gr.155601; Qiu ZY, 2001, J BIOL CHEM, V276, P194, DOI 10.1074/jbc.M005571200; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; RINCHIK EM, 1993, MUTAT RES, V286, P199, DOI 10.1016/0027-5107(93)90184-H; Ritchie RJ, 1998, HUM MOL GENET, V7, P1253, DOI 10.1093/hmg/7.8.1253; Roberts SE, 2002, HUM GENET, V110, P227, DOI 10.1007/s00439-002-0678-6; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schimmoller F, 1998, GENE, V216, P311, DOI 10.1016/S0378-1119(98)00349-7; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Spritz RA, 1997, AM J MED GENET, V71, P57, DOI 10.1002/(SICI)1096-8628(19970711)71:1<57::AID-AJMG11>3.0.CO;2-U; Sugasawa T, 2001, GENE, V273, P227, DOI 10.1016/S0378-1119(01)00587-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Walkowicz M, 1999, MAMM GENOME, V10, P870, DOI 10.1007/s003359901106; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Wu M, 2000, GENOMICS, V67, P228, DOI 10.1006/geno.2000.6236; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	84	147	163	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					898	925		10.1086/378816	http://dx.doi.org/10.1086/378816			28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	14508708	Green Published, Bronze			2022-12-18	WOS:000185676100016
J	Fullerton, J; Cubin, M; Tiwari, H; Wang, C; Bomhra, A; Davidson, S; Miller, S; Fairburn, C; Goodwin, G; Neale, MC; Fiddy, S; Mott, R; Allison, DB; Flint, J				Fullerton, J; Cubin, M; Tiwari, H; Wang, C; Bomhra, A; Davidson, S; Miller, S; Fairburn, C; Goodwin, G; Neale, MC; Fiddy, S; Mott, R; Allison, DB; Flint, J			Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEROTONIN TRANSPORTER GENE; ANXIETY-RELATED TRAITS; HASEMAN-ELSTON METHOD; SIB PAIRS; MAJOR DEPRESSION; PANIC DISORDER; PROMOTER POLYMORPHISM; REGULATORY REGION; MAPPING PROCEDURE; GENOME SCAN	Several theoretical studies have suggested that large samples of randomly ascertained siblings can be used to ascertain phenotypically extreme individuals and thereby increase power to detect genetic linkage in complex traits. Here, we report a genetic linkage scan using extremely discordant and concordant sibling pairs, selected from 34,580 sibling pairs in the southwest of England who completed a personality questionnaire. We performed a genomewide scan for quantitative-trait loci (QTLs) that influence variation in the personality trait of neuroticism, or emotional stability, and we established genomewide empirical significance thresholds by simulation. The maximum pointwise P values, expressed as the negative logarithm (base 10), were found on 1q (3.95), 4q (3.84), 7p (3.90), 12q (4.74), and 13q (3.81). These five loci met or exceeded the 5% genomewide significance threshold of 3.8 (negative logarithm of the P value). QTLs on chromosomes 1, 12, and 13 are likely to be female specific. One locus, on chromosome 1, is syntenic with that reported from QTL mapping of rodent emotionality, an animal model of neuroticism, suggesting that some animal and human QTLs influencing emotional stability may be homologous.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX2 7BN, England; Univ Oxford, Dept Psychiat, Oxford, England; Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; Virginia Inst Psychiat & Behav Genet, Richmond, VA USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Alabama System; University of Alabama Birmingham; Virginia Commonwealth University	Flint, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX2 7BN, England.		Goodwin, Guy/ABE-6084-2020; Neale, Michael/AAD-5056-2020; Fullerton, Janice/F-8485-2013; Neale, Michael C/B-1418-2008	Fullerton, Janice/0000-0003-4014-4490; Allison, David/0000-0003-3566-9399; Mott, Richard/0000-0002-1022-9330; Flint, Jonathan/0000-0002-9427-4429	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001458] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR006009, P41RR006009] Funding Source: Medline; NIDDK NIH HHS [R01 DK056366, R01DK056366] Funding Source: Medline; NIEHS NIH HHS [R01 ES009912, R01ES09912] Funding Source: Medline; NIMH NIH HHS [MH-01458] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Allison DB, 2000, AM J HUM GENET, V67, P249, DOI 10.1086/302966; Amos CI, 1997, GENET EPIDEMIOL, V14, P743, DOI 10.1002/(SICI)1098-2272(1997)14:6<743::AID-GEPI30>3.0.CO;2-O; BEAVIS WD, 1998, MOL ANAL COMPLEX TRA, P123; Boomsma D I, 2000, Twin Res, V3, P323, DOI 10.1375/twin.3.4.323; CARDON LR, 1994, AM J HUM GENET, V55, P825; CAREY G, 1991, AM J HUM GENET, V49, P786; Cloninger CR, 1998, AM J MED GENET, V81, P313, DOI 10.1002/(SICI)1096-8628(19980710)81:4<313::AID-AJMG7>3.0.CO;2-U; CLONINGER CR, 1994, CURR OPIN NEUROBIOL, V4, P266, DOI 10.1016/0959-4388(94)90083-3; Crowe RR, 2001, AM J MED GENET, V105, P105, DOI 10.1002/1096-8628(20010108)105:1<105::AID-AJMG1072>3.0.CO;2-P; DEARY IJ, 1993, PSYCHOLOGIST, V6, P299; Devlin B, 2002, HUM MOL GENET, V11, P689, DOI 10.1093/hmg/11.6.689; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Duggan C, 1995, J AFFECT DISORDERS, V35, P139, DOI 10.1016/0165-0327(95)00062-3; DUGGAN CF, 1990, BRIT J PSYCHIAT, V157, P19, DOI 10.1192/bjp.157.1.19; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Eaves L, 1999, Twin Res, V2, P62, DOI 10.1375/136905299320565933; Eaves L, 1989, GENES CULTURE PERSON; Eaves L J, 1998, Twin Res, V1, P131, DOI 10.1375/twin.1.3.131; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Eysenck H. J., 1975, MANUAL EYSENCK PERSO; Fanous A, 2002, PSYCHOL MED, V32, P719, DOI 10.1017/S003329170200541X; Fernandez JR, 2002, HUM HERED, V53, P59, DOI 10.1159/000057984; Fernandez-Teruel A, 2002, GENOME RES, V12, P618, DOI [10.1101/gr.203402, 10.1101/gr.203402. Article published online before print in March ]; FLODERUSMYRHED B, 1980, BEHAV GENET, V10, P153, DOI 10.1007/BF01066265; Forrest WF, 2001, HUM HERED, V52, P47, DOI 10.1159/000053353; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; Gelernter J, 2001, AM J MED GENET, V105, P548, DOI 10.1002/ajmg.1496; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Greenberg BD, 2000, AM J MED GENET, V96, P202, DOI 10.1002/(SICI)1096-8628(20000403)96:2<202::AID-AJMG16>3.0.CO;2-J; Heo M, 2002, BEHAV GENET, V32, P23, DOI 10.1023/A:1014403827957; HIRSCHFELD RMA, 1989, ARCH GEN PSYCHIAT, V46, P345; Hu S, 2000, MOL PSYCHIATR, V5, P181, DOI 10.1038/sj.mp.4000690; JARDINE R, 1984, Genetic Epidemiology, V1, P89, DOI 10.1002/gepi.1370010202; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Kirk K M, 2000, Twin Res, V3, P299, DOI 10.1375/136905200320565274; Knowles JA, 1998, AM J MED GENET, V81, P139, DOI 10.1002/(SICI)1096-8628(19980328)81:2<139::AID-AJMG4>3.0.CO;2-R; Kotler M, 1999, MOL PSYCHIATR, V4, P313, DOI 10.1038/sj.mp.4000499; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kumakiri C, 1999, NEUROSCI LETT, V263, P205, DOI 10.1016/S0304-3940(99)00098-1; Lake RIE, 2000, BEHAV GENET, V30, P223, DOI 10.1023/A:1001918408984; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Loehlin J., 1976, HEREDITY ENV PERSONA, DOI DOI 10.7560/730038; Loehlin J.C., 1992, GENES ENV PERSONALIT; Martin N, 2000, Twin Res, V3, P310, DOI 10.1375/twin.3.4.310; Martin NG., 1986, HANS EYSENCK CONSENS, P13; Mazzanti CM, 1998, ARCH GEN PSYCHIAT, V55, P936, DOI 10.1001/archpsyc.55.10.936; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; MUNAFO MR, IN PRESS MOL PSYCHIA; Murakami F, 1999, J HUM GENET, V44, P15, DOI 10.1007/s100380050098; Nurnberger JI, 2001, AM J PSYCHIAT, V158, P718, DOI 10.1176/appi.ajp.158.5.718; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Ricketts MH, 1998, PSYCHIATR GENET, V8, P41, DOI 10.1097/00041444-199800820-00001; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch NJ, 1996, AM J HUM GENET, V58, P836; ROSE RJ, 1988, J PERS SOC PSYCHOL, V54, P161, DOI 10.1037/0022-3514.54.1.161; ROY A, 1990, NEUROPSYCHOBIOLOGY, V23, P119, DOI 10.1159/000119436; Sham P C, 2000, Twin Res, V3, P316, DOI 10.1375/twin.3.4.316; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; Smoller JW, 2001, AM J MED GENET, V105, P195, DOI 10.1002/ajmg.1209; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; VIKEN RJ, 1994, J PERS SOC PSYCHOL, V66, P722, DOI 10.1037/0022-3514.66.4.722; Visscher PM, 2001, ANN HUM GENET, V65, P583, DOI [10.1046/j.1469-1809.2001.6560583.x, 10.1017/S0003480001008909]; Wang J, 1998, ANN HUM GENET, V62, P349, DOI 10.1046/j.1469-1809.1998.6240349.x; Wright FA, 1997, AM J HUM GENET, V60, P740; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081; ZEISS AM, 1988, BEHAV RES THER, V26, P151, DOI 10.1016/0005-7967(88)90114-3; Zubenko GS, 2002, AM J MED GENET, V114, P980, DOI 10.1002/ajmg.b.10933; ZUCKERMAN M, 1988, J PERS SOC PSYCHOL, V54, P96, DOI 10.1037/0022-3514.54.1.96	76	147	154	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					879	890		10.1086/374178	http://dx.doi.org/10.1086/374178			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	662WT	12612864	Green Published, Bronze			2022-12-18	WOS:000181972600009
J	Groussin, L; Kirschner, LS; Vincent-Dejean, C; Perlemoine, K; Jullian, E; Delemer, B; Zacharieva, S; Pignatelli, D; Carney, JA; Luton, JP; Bertagna, X; Stratakis, CA; Bertherat, J				Groussin, L; Kirschner, LS; Vincent-Dejean, C; Perlemoine, K; Jullian, E; Delemer, B; Zacharieva, S; Pignatelli, D; Carney, JA; Luton, JP; Bertagna, X; Stratakis, CA; Bertherat, J			Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: Augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPOTTY SKIN PIGMENTATION; PSAMMOMATOUS MELANOTIC SCHWANNOMA; FAMILIAL CARDIAC MYXOMAS; ENDOCRINE OVERACTIVITY; DUCTAL ADENOMA; ALPHA SUBUNIT; CAMP; CREB; TRANSCRIPTION; ABNORMALITIES	We studied 11 new kindreds with primary pigmented nodular adrenocortical disease (PPNAD) or Carney complex (CNC) and found that 82% of the kindreds had PRKAR1A gene defects (including seven novel inactivating mutations), most of which led to nonsense mRNA and, thus, were not expressed in patients' cells. However, a previously undescribed base substitution in intron 6 (exon 6 IVS +1G-->T) led to exon 6 skipping and an expressed shorter PRKAR1A protein. The mutant protein was present in patients' leukocytes and tumors, and in vitro studies indicated that the mutant PRKAR1A activated cAMP-dependent protein kinase A (PKA) signaling at the nuclear level. This is the first demonstration of an inactivating PRKAR1A mutation being expressed at the protein level and leading to stimulation of the PKA pathway in CNC patients. Along with the lack of allelic loss at the PRKAR1A locus in most of the tumors from this kindred, these data suggest that alteration of PRKAR1A function (not only its complete loss) is sufficient for augmenting PKA activity leading to tumorigenesis in tissues affected by CNC.	Hop Cochin, Serv Malad Endocriniennes & Metab, Dept Endocrinol, F-75014 Paris, France; Univ Paris 05, Inst Cochin,Dept Endocrinol, CNRS,UMR 8104, INSERM,U576, Paris, France; NICHHD, Unit Genet & Endocrinol, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA; CHU Reims, Dept Endocrinol, Reims, France; Clin Ctr endocrinol & Gerontol, Dept Endocrinol, Sofia, Bulgaria; Fac Med Porto, Inst Histol & Embryol, Oporto, Portugal; Mayo Clin, Rochester, MN USA; COMETE Network, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); CHU de Reims; Universite de Reims Champagne-Ardenne; Medical University Sofia; Universidade do Porto; Mayo Clinic	Bertherat, J (corresponding author), Hop Cochin, Serv Malad Endocriniennes & Metab, Dept Endocrinol, 27 Rue Fg St Jacques, F-75014 Paris, France.	jerome.bertherat@cch.ap-hop-paris.fr	Zacharieva, Sabina/GQO-9261-2022; Stratakis, Constantine A./AAP-4745-2020; Pignatelli, Duarte/AAG-8056-2021; Pignatelli, Duarte L/A-8892-2014	Zacharieva, Sabina/0000-0001-6087-7136; Pignatelli, Duarte/0000-0002-5555-7004; BERTHERAT, Jerome/0000-0003-2551-3008; Groussin, Lionel/0000-0003-1476-475X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000642, ZIAHD000642] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERTHERAT J, 1995, MOL ENDOCRINOL, V9, P777, DOI 10.1210/me.9.7.777; Carney JA, 1998, SEMIN DIAGN PATHOL, V15, P216; CARNEY JA, 1986, MAYO CLIN PROC, V61, P165, DOI 10.1016/S0025-6196(12)61843-6; Carney JA, 2001, AM J SURG PATHOL, V25, P164, DOI 10.1097/00000478-200102000-00004; CARNEY JA, 1985, MEDICINE, V64, P270, DOI 10.1097/00005792-198507000-00007; CARNEY JA, 1990, AM J SURG PATHOL, V14, P206, DOI 10.1097/00000478-199003000-00002; CARNEY JA, 1991, AM J SURG PATHOL, V15, P722, DOI 10.1097/00000478-199108000-00002; Carney JA, 1996, AM J SURG PATHOL, V20, P1154, DOI 10.1097/00000478-199609000-00014; Casey M, 1998, CIRCULATION, V98, P2560, DOI 10.1161/01.CIR.98.23.2560; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; Dahle MK, 2001, EUR J BIOCHEM, V268, P5920, DOI 10.1046/j.0014-2956.2001.02542.x; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Groussin L, 2002, J CLIN ENDOCR METAB, V87, P4324, DOI 10.1210/jc.2002-020592; Groussin L, 2000, J CLIN ENDOCR METAB, V85, P345, DOI 10.1210/jc.85.1.345; Huang LJS, 1998, J BIOL CHEM, V273, P26739, DOI 10.1074/jbc.273.41.26739; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; MCKNIGHT GS, 1988, RECENT PROG HORM RES, V44, P307; OGREID D, 1990, ADV SEC MESS PHOSPH, V24, P196; Pack SD, 2000, J CLIN ENDOCR METAB, V85, P3860, DOI 10.1210/jc.85.10.3860; Premkumar A, 1997, J CLIN ULTRASOUND, V25, P211, DOI 10.1002/(SICI)1097-0096(199705)25:4<211::AID-JCU10>3.0.CO;2-N; Raff SB, 2000, J PEDIATR ENDOCR MET, V13, P373; SANDRINI F, 2002, SOC PED RES SPR ANN; Stratakis CA, 2001, J CLIN ENDOCR METAB, V86, P4041, DOI 10.1210/jc.86.9.4041; Stratakis CA, 1997, J CLIN ENDOCR METAB, V82, P2037, DOI 10.1210/jc.82.7.2037; Stratakis CA, 1996, J CLIN INVEST, V97, P699, DOI 10.1172/JCI118467; Stratakis CA, 2000, J CLIN ENDOCR METAB, V85, P4359, DOI 10.1210/jc.85.11.4359; Stratakis CA, 1999, ANN INTERN MED, V131, P585, DOI 10.7326/0003-4819-131-8-199910190-00006	32	147	152	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1433	1442		10.1086/344579	http://dx.doi.org/10.1086/344579			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12424709	Green Published, Bronze			2022-12-18	WOS:000179586800017
J	Toledano-Alhadef, H; Basel-Vanagaite, L; Magal, N; Davidov, B; Ehrlich, S; Drasinover, V; Taub, E; Halpern, GJ; Ginott, N; Shohat, M				Toledano-Alhadef, H; Basel-Vanagaite, L; Magal, N; Davidov, B; Ehrlich, S; Drasinover, V; Taub, E; Halpern, GJ; Ginott, N; Shohat, M			Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COST-BENEFIT-ANALYSIS; CGG REPEAT; FMR1 GENE; POPULATION; DNA; TRANSMISSION; INSTABILITY; PROGRAM; DIAGNOSIS; FEMALES	Fragile-X syndrome is caused by an unstable CGG trinucleotide repeat in the FMR1 gene at Xq27. Intermediate alleles (51-200 repeats) can undergo expansion to the full mutation on transmission from mother to offspring. To evaluate the effectiveness of a fragile-X carrier-screening program, we tested 14,334 Israeli women of child-bearing age for fragile-X carrier status between 1992 and 2000. These women were either preconceptional or pregnant and had no family history of mental retardation. All those found to be carriers of premutation or full-mutation alleles were offered genetic counseling and also prenatal diagnosis, if applicable. We identified 207 carriers of an allele with >50 repeats, representing a prevalence of 1:69. There were 127 carriers with >54 repeats, representing a prevalence of 1:113. Three asymptomatic women carried the fully mutated allele. Among the premutation and full-mutation carriers, 177 prenatal diagnoses were performed. Expansion occurred in 30 fetuses, 5 of which had an expansion to the full mutation. On the basis of these results, the expected number of avoided patients born to women identified as carriers, the cost of the test in this study (U.S. $100), and the cost of lifetime care for a mentally retarded person (>$350,000), screening was calculated to be cost-effective. Because of the high prevalence of fragile-X premutation or full-mutation alleles, even in the general population, and because of the cost-effectiveness of the program, we recommend that screening to identify female carriers should be carried out on a wide scale.	Rabin Med Ctr, Dept Med Genet, IL-49100 Petah Tiqwa, Israel; Meir Hosp, Sapir Med Ctr, Dept Pediat, Kfar Saba, Israel; Rabin Med Ctr, Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Shohat, M (corresponding author), Rabin Med Ctr, Dept Med Genet, Beilinson Campus, IL-49100 Petah Tiqwa, Israel.			Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157				BONTHRON D, 1993, LANCET, V341, P769, DOI 10.1016/0140-6736(93)90552-R; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; BUNDEY S, 1993, LANCET, V341, P770; *CENTR BUR STAT, 1999, ISR STAT YB, V50; DAR H, 1995, ISRAEL J MED SCI, V31, P323; deVries BBA, 1996, AM J HUM GENET, V58, P1025; Drasinover V, 2000, AM J MED GENET, V93, P155, DOI 10.1002/1096-8628(20000717)93:2<155::AID-AJMG13>3.0.CO;2-G; FalikZaccai TC, 1997, AM J HUM GENET, V60, P103; Finucane B, 1996, CLIN OBSTET GYNECOL, V39, P772, DOI 10.1097/00003081-199612000-00006; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Ginsberg G, 1998, J MED SCREEN, V5, P120, DOI 10.1136/jms.5.3.120; GINSBERG G, 1994, HEALTH ECON, V3, P5, DOI 10.1002/hec.4730030104; Herman A, 1997, Harefuah, V132, P94; HOWARDPEEBLES PN, 1993, LANCET, V341, P770; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Murray A, 1996, HUM MOL GENET, V5, P727, DOI 10.1093/hmg/5.6.727; Murray J, 1997, J Med Screen, V4, P60; Nolin SL, 1996, AM J HUM GENET, V59, P1252; NOLIN SL, 1991, AM J MED GENET, V38, P251, DOI 10.1002/ajmg.1320380218; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PALOMAKI GE, 1993, LANCET, V341, P373, DOI 10.1016/0140-6736(93)90176-H; PARK V, 1994, AM J MED GENET, V53, P380, DOI 10.1002/ajmg.1320530416; Pesso R, 2000, PRENATAL DIAG, V20, P611, DOI 10.1002/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M; Pesso R, 1997, HUM GENET, V101, P186, DOI 10.1007/s004390050611; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; ROUSSEAU F, 1994, HUM MUTAT, V4, P51, DOI 10.1002/humu.1380040107; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Ryynanen M, 1999, EUR J HUM GENET, V7, P212, DOI 10.1038/sj.ejhg.5200285; SCHWARTZ CE, 1988, AM J MED GENET, V30, P641, DOI 10.1002/ajmg.1320300165; SHERMAN SL, 1994, AM J MED GENET, V51, P503, DOI 10.1002/ajmg.1320510442; Spence WC, 1996, AM J MED GENET, V64, P181, DOI 10.1002/(SICI)1096-8628(19960712)64:1<181::AID-AJMG31>3.3.CO;2-Q; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Tzeng CC, 1999, DIAGN MOL PATHOL, V8, P152, DOI 10.1097/00019606-199909000-00008; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; Wildhagen M F, 1998, Community Genet, V1, P36, DOI 10.1159/000016133; Wildhagen MF, 1999, J MED SCREEN, V6, P70, DOI 10.1136/jms.6.2.70; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	40	147	152	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					351	360		10.1086/321974	http://dx.doi.org/10.1086/321974			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443541	Green Published, Bronze			2022-12-18	WOS:000170108200010
J	Helgason, A; Siguroardottir, S; Nicholson, J; Sykes, B; Hill, EW; Bradley, DG; Bosnes, V; Gulcher, JR; Ward, R; Stefansson, K				Helgason, A; Siguroardottir, S; Nicholson, J; Sykes, B; Hill, EW; Bradley, DG; Bosnes, V; Gulcher, JR; Ward, R; Stefansson, K			Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; POPULATION-STRUCTURE; ORIGIN; ADMIXTURE; POLYMORPHISMS; MUTATION; MTDNA	We present findings based on a study of Y-chromosome diallelic and microsatellite variation in 181 Icelanders, 233 Scandinavians, and 283 Cads from Ireland and Scotland. All but one of the Icelandic Y chromosomes belong to haplogroup 1 (41.4%), haplogroup 2 (34.2%), or haplogroup 3 (23.8%). We present phylogenetic networks of Icelandic Y-chromosome variation, using haplotypes constructed from seven diallelic markers and eight microsatellite markers, and we propose two new clades. We also report, for the first time, the phylogenetic context of the microsatellite marker DYS385 in Europe. A comparison of haplotypes based on six diallelic loci and five microsatellite loci indicates that some Icelandic haplogroup-1 chromosomes are likely to have a Gaelic origin, whereas for most Icelandic haplogroup-2 and -3 chromosomes, a Scandinavian origin is probable. The data suggest that 20%-25% of Icelandic founding males had Gaelic ancestry, with the remainder having Norse ancestry. The closer relationship with the Scandinavian Y-chromosome pool is supported by the results of analyses of genetic distances and lineage sharing. These findings contrast with results based on mtDNA data, which indicate closer matrilineal links with populations of the British Isles. This supports the model, put forward by some historians, that the majority of females in the Icelandic founding population had Gaelic ancestry, whereas the majority of males had Scandinavian ancestry.	Univ Oxford, Inst Biol Anthropol, Oxford OX2 6QS, England; Univ Oxford, Inst Mol Med, Oxford OX2 6QS, England; deCODE Genet Inc, Reykjavik, Iceland; Trinity Coll, Dept Genet, Dublin, Ireland; Ulleval Sykehus, Blodbanken, Oslo, Norway	University of Oxford; University of Oxford; Trinity College Dublin; University of Oslo	Helgason, A (corresponding author), Univ Oxford, Inst Biol Anthropol, 58 Banbury Rd, Oxford OX2 6QS, England.		Stefansson, Kari/AAE-7187-2019; Bradley, Daniel G/A-3240-2012; Helgason, Agnar/K-1522-2015	Hill, Emmeline/0000-0002-1805-2250; Bradley, Daniel G/0000-0001-7335-7092; Helgason, Agnar/0000-0002-8545-3767	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bernstein F., 1931, COMITATO ITALIANO ST, P227; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; BJARNASO.O, 1973, ANN HUM GENET, V36, P425, DOI 10.1111/j.1469-1809.1973.tb00606.x; Calafell F, 2000, HUM GENET, V106, P133, DOI 10.1007/s004399900204; Casalotti R, 1999, P ROY SOC B-BIOL SCI, V266, P1959, DOI 10.1098/rspb.1999.0873; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CLOVER CJ, 1988, SCAND STUD, V60, P147; Davies Norman, 1999, ISLES HIST; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Forster P, 1996, AM J HUM GENET, V59, P935; Guldberg P, 1997, EUR J HUM GENET, V5, P376, DOI 10.1159/000484795; HAMMER MF, 1995, AM J HUM GENET, V56, P951; HELGASON A, IN PRESS MOL GENETIC; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; HNELGASON A, 2000, AM J HUM GENET, V66, P999; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; Jones Gwyn, 1984, HIST VIKINGS; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Karras R. M., 1988, SLAVERY SOC MEDIEVAL; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Lucotte G, 1999, HUM BIOL, V71, P431; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; Previdere C, 1999, EUR J HUM GENET, V7, P733, DOI 10.1038/sj.ejhg.5200359; PuYlsson H., 1972, BOOK SETTLEMENTS LAN; ROBERTS DF, 1965, HUM BIOL, V37, P38; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Sawyer Peter H., 1997, OXFORD ILLUSTRATED H, P1; SAYERS W, 1994, SCAND STUD, V66, P129; Sigurethsson G., 1988, GAELIC INFLUENCE ICE; Steffensen J., 1975, MENNING MEINSEMDIR R; THOMPSON EA, 1973, ANN HUM GENET, V37, P69, DOI 10.1111/j.1469-1809.1973.tb01815.x; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Tyler-Smith C, 1999, GENOMIC DIVERSITY, P65; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; WIJSMAN EM, 1984, HUM GENET, V67, P441, DOI 10.1007/BF00291407; WILLIAMS JT, 1993, HUM BIOL, V65, P167; Zerjal T, 1999, GENOMIC DIVERSITY, P91; Zerjal T, 1997, AM J HUM GENET, V60, P1174	45	147	150	0	16	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					697	717		10.1086/303046	http://dx.doi.org/10.1086/303046			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10931763	Green Published, Bronze			2022-12-18	WOS:000089002300016
J	Templeton, AR; Clark, AG; Weiss, KM; Nickerson, DA; Boerwinkle, E; Sing, CF				Templeton, AR; Clark, AG; Weiss, KM; Nickerson, DA; Boerwinkle, E; Sing, CF			Recombinational and mutational hotspots within the human lipoprotein lipase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENOTYPIC ASSOCIATIONS; CLADISTIC-ANALYSIS; DROSOPHILA-MELANOGASTER; PHYLOGENETIC INFERENCE; CLADOGRAM ESTIMATION; SEQUENCES SUBJECT; BRISTLE NUMBER; DNA; HAPLOTYPES; POPULATIONS	Here an analysis is presented of the roles of recombination and mutation in shaping previously determined haplotype variation in 9.7 kb of genomic DNA sequence from the human lipoprotein lipase gene (LPL), scored in 71 individuals from three populations: 24 African Americans, 24 Finns, and 23 non-Hispanic whites. Recombination and gene-conversion events inferred from data on ss haplotypes that were defined by 69 variable sites were tested. The analysis revealed 29 statistically significant recombination events and one gene-conversion event. The recombination events were concentrated in a 1.9-kb region, near the middle of the segment, that contains a microsatellite and a pair of tandem and complementary mononucleotide runs; both the microsatellite and the runs show length variation. An analysis of site variation revealed that 9.6% of the nucleotides at CpG sites were variable, as were 3% of the nucleotides found in mononucleotide runs of greater than or equal to 5 nucleotides, 3% of the nucleotides found less than or equal to 3 bp from certain putative polymerase alpha-arrest sites, and 0.5% of the remaining nucleotides. This nonhomogeneous distribution of variation suggests that multiple mutational hits at certain sites are common, an observation that challenges the fundamental assumption of the infinite-sites-mutation model. The nonrandom patterns of recombination and mutation suggest that randomly chosen single-nucleotide polymorphisms may not be optimal for disequilibrium mapping of this gene. Overall, these results indicate that both recombinational and mutational hotspots have played significant roles in shaping the haplotype variation at the LPL locus.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA	Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Templeton, AR (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.		Templeton, Alan R./F-5963-2011	Clark, Andrew/0000-0001-7159-8511; Sing, Charles/0000-0001-5872-7956; Templeton, Alan/0000-0002-0167-845X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058238, R01HL039107, R01HL058239] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL039107, HL39107, HL58239, HL58238] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CARTER C, 1984, ARTERIOSCLEROSIS, V4, P510, DOI 10.1161/01.ATV.4.5.510; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Crandall KA, 1999, EVOLUTION OF HIV, P153; CRANDALL KA, 1994, SYST BIOL, V43, P222; Crandall Keith A., 1996, P81; EDGINGTON ES, 1986, RANDOMIZATION TESTS; Fisher RM, 1997, ATHEROSCLEROSIS, V135, P145, DOI 10.1016/S0021-9150(97)00199-8; FUNKE H, 1995, NAT GENET, V10, P6, DOI 10.1038/ng0595-6; HEIN J, 1990, MATH BIOSCI, V98, P185, DOI 10.1016/0025-5564(90)90123-G; HEIN J, 1993, J MOL EVOL, V36, P396, DOI 10.1007/BF00182187; Hey J, 1997, GENETICS, V145, P833; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Jakobsen IB, 1997, MOL BIOL EVOL, V14, P474, DOI 10.1093/oxfordjournals.molbev.a025784; JONES PA, 1992, BIOESSAYS, V14, P33, DOI 10.1002/bies.950140107; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; KRAWCZAK M, 1995, HUM GENET, V96, P142, DOI 10.1007/BF00207369; KRAWCZAK M, 1991, HUM GENET, V86, P425; Long AD, 1998, GENETICS, V149, P999; Lyman RF, 1998, GENETICS, V149, P983; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; Mood AM., 1963, INTRO THEORY STAT, V2nd ed.; Nakagawa H, 1998, HUM GENET, V103, P168, DOI 10.1007/s004390050801; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; REISS J, 1991, HUM GENET, V87, P457; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Rozas J, 1997, COMPUT APPL BIOSCI, V13, P307; Schmutte C, 1998, BIOL CHEM, V379, P377; Sing C. F., 1995, INT CONGR SER, P638; SING CF, 1979, PROGR CLIN BIOL RES, V32; SWOFFORD DL, 1997, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 1987, MOL BIOL EVOL, V4, P315; TEMPLETON AR, 1993, GENETICS, V134, P659; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; TEMPLETON AR, 1996, VARIATION HUMAN GENO, P259; Todorova A, 1997, HUM MUTAT, V9, P537; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Tvrdik T, 1998, HUM GENET, V103, P311, DOI 10.1007/s004390050822; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wolfram, 2014, MATH 10; Yang AS, 1996, J MOL BIOL, V258, P240, DOI 10.1006/jmbi.1996.0246	47	147	149	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					69	83		10.1086/302699	http://dx.doi.org/10.1086/302699			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631137	Green Published, Bronze			2022-12-18	WOS:000085033600008
J	Serova, OM; Mazoyer, S; Puget, N; Dubois, V; Tonin, P; Shugart, YY; Goldgar, D; Narod, SA; Lynch, HT; Lenoir, GM				Serova, OM; Mazoyer, S; Puget, N; Dubois, V; Tonin, P; Shugart, YY; Goldgar, D; Narod, SA; Lynch, HT; Lenoir, GM			Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; GERMLINE MUTATIONS; LINKAGE ANALYSIS	To estimate the proportion of breast cancer families due to BRCA1 or BRCA2, we performed mutation screening of the entire coding regions of both genes supplemented with linkage analysis of 31 families, 8 containing male breast cancers and 23 site-specific female breast cancer. A combination of protein-truncation test and SSCP or heteroduplex analyses was used for mutation screening complemented, where possible, by the analysis of expression level of BRCA1 and BRCA2 alleles. Six of the eight families with male breast cancer revealed frameshift mutations, two in BRCA1 and four in BRCA2. Although most families with female site-specific breast cancers were thought to be due to mutations in either BRCA1: or BRCA2, we identified only eight mutations in our series of 23 site-specific female breast cancer families (34%), four in BRCA1 and four in BRCA2. According to the posterior probabilities calculated for mutation-negative families, based on linkage data and mutation screening results, we would expect 8-10 site-specific female breast cancer families of our series to be due to neither BRCA1 nor BRCA2. Thus, our results suggest the existence of at least one more major breast cancer-susceptibility gene.	INT AGCY RES CANC,F-69372 LYON 08,FRANCE; UMR 5641 CNRS,GENET LAB,LYON,FRANCE; MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL,PQ,CANADA; WOMENS COLL HOSP,TORONTO,ON M5S 1B2,CANADA; CREIGHTON UNIV,SCH MED,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE	World Health Organization; International Agency for Research on Cancer (IARC); Centre National de la Recherche Scientifique (CNRS); McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Creighton University			PUGET, Nadine/AAB-9689-2020; Narod, Steven A/AAA-6112-2022; Mazoyer, Sylvie/N-7559-2017	PUGET, Nadine/0000-0003-4046-737X; DUBOIS, VALERIE/0000-0002-1169-7697; Mazoyer, Sylvie/0000-0002-2135-0160	NATIONAL CANCER INSTITUTE [R01CA065673] Funding Source: NIH RePORTER; NCI NIH HHS [CA65673] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CLAUS EB, 1991, AM J HUM GENET, V48, P232; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; EASTON DF, 1993, AM J HUM GENET, V52, P678; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gudmundsson J, 1996, AM J HUM GENET, V58, P749; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; Johannsson O, 1996, AM J HUM GENET, V58, P441; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Montagna M, 1996, CANCER RES, V56, P5466; NAROD SA, 1995, AM J HUM GENET, V56, P254; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Rebbeck TR, 1996, AM J HUM GENET, V59, P547; Serova O, 1996, AM J HUM GENET, V58, P42; SOBOL H, 1994, LANCET, V344, P1151, DOI 10.1016/S0140-6736(94)90655-6; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	24	147	149	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					486	495						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042907				2022-12-18	WOS:A1997WK40300004
J	Hong, YL; Pedersen, NL; Brismar, K; deFaire, U				Hong, YL; Pedersen, NL; Brismar, K; deFaire, U			Genetic and environmental architecture of the features of the insulin-resistance syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOVASCULAR RISK-FACTORS; GLUCOSE-INTOLERANCE; HEART-DISEASE; ELDERLY TWINS; SYNDROME-X; HYPERINSULINEMIA; OBESITY; HYPERTENSION; CHOLESTEROL; INDIVIDUALS	The contribution of genetic and environmental effects to the clustering of metabolic factors contained in insulin-resistance syndrome (IRS) is still unclear. To explore the genetic architecture of IRS, we examined a population of elderly twins from the Swedish Adoption/Twin Study of Aging. A sample of 289 pairs of twins (mean age 65.5 years; range 52-86 years), of whom 140 pairs had been reared apart, was studied. The features contained in the IRS consisted of body-mass index (BMI), insulin resistance, triglycerides, HDL cholesterol, and systolic blood pressure. Intraclass correlations, cross-twin correlations, and model-fitting analyses were used to evaluate the relative importance of genetic and environmental influences for variation in and covariation among the components of the syndrome. All of the five principal metabolic components contained in IRS are more or less influenced by a single latent genetic factor, whereas only three of the components (triglycerides, insulin resistance, and HDL cholesterol) are influenced by a latent individual-specific environmental factor. The genetic factor reflected influences of importance to BMI and insulin resistance and to a lesser degree to triglycerides, HDL cholesterol, and systolic blood pressure, whereas the individual-specific environmental factor reflected influences in common to triglycerides and HDL cholesterol and to a lesser degree to insulin resistance. Systolic blood pressure was related to IRS, albeit weakly, only through genetic effects. In conclusion, IRS appears to be influenced by different sets of genetic and environmental mechanisms. The set of genetic influences in common to all the components may initiate the abnormalities underlying IRS.	KAROLINSKA INST, INST ENVIRONM MED, DIV GENET EPIDEMIOL, S-17177 STOCKHOLM, SWEDEN; KAROLINSKA HOSP, DEPT MED, DIV CARDIOVASC MED, S-10401 STOCKHOLM, SWEDEN; KAROLINSKA HOSP, DEPT ENDOCRINOL & DIABETOL, S-10401 STOCKHOLM, SWEDEN; PENN STATE UNIV, COLL HLTH & HUMAN DEV, CTR DEV & HLTH GENET, UNIVERSITY PK, PA 16802 USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hong, YL (corresponding author), KAROLINSKA INST, INST ENVIRONM MED, DIV CARDIOVASC, BOX 210, S-17177 STOCKHOLM, SWEDEN.			Brismar, Kerstin/0000-0002-5241-514X	NATIONAL INSTITUTE ON AGING [R01AG010175, R01AG004563] Funding Source: NIH RePORTER; NIA NIH HHS [AG-04563, AG-10175] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLISON DB, 1993, AM J DIS CHILD, V147, P1298, DOI 10.1001/archpedi.1993.02160360040014; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; BOGARDUS C, 1985, AM J PHYSIOL, V248, pE286, DOI 10.1152/ajpendo.1985.248.3.E286; CARMELLI D, 1994, AM J HUM GENET, V55, P566; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Falconer D. S., 1989, Introduction to quantitative genetics.; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; FERRANNINI E, 1993, HORM RES, V39, P107, DOI 10.1159/000182795; FONTBONNE A, 1991, DIABETOLOGIA, V34, P356, DOI 10.1007/BF00405009; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; HAFFNER SM, 1992, HYPERTENSION, V20, P38, DOI 10.1161/01.HYP.20.1.38; HAFFNER SM, 1988, NEW ENGL J MED, V319, P1297, DOI 10.1056/NEJM198811173192001; HAFFNER SM, 1986, NEW ENGL J MED, V315, P220, DOI 10.1056/NEJM198607243150403; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; HELLER DA, 1994, AM J HUM GENET, V55, P1255; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Hjermann Ingvar, 1992, Journal of Cardiovascular Pharmacology, V20, pS5, DOI 10.1097/00005344-199220008-00002; Hong YL, 1996, J CLIN ENDOCR METAB, V81, P1791, DOI 10.1210/jc.81.5.1791; HONG YL, 1994, HYPERTENSION, V24, P663, DOI 10.1161/01.HYP.24.6.663; Joreskog K. G., 1989, LISREL 7 GUIDE PROGR; KISSEBAH AH, 1991, INT J OBESITY, V15, P109; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; LAWS A, 1991, Annals of Behavioral Medicine, V13, P125; MAHANEY MC, 1995, CIRCULATION, V92, P3240, DOI 10.1161/01.CIR.92.11.3240; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MAYER EJ, 1993, DIABETES CARE, V16, P1459, DOI 10.2337/diacare.16.11.1459; Mayer EJ, 1996, AM J EPIDEMIOL, V143, P323; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; MOLLER DE, 1991, NEW ENGL J MED, V325, P938; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; OSTLUND RE, 1990, NEW ENGL J MED, V322, P229, DOI 10.1056/NEJM199001253220404; PEDERSEN NL, 1984, ACTA GENET MED GEMEL, V33, P243, DOI 10.1017/S0001566000007285; PEDERSEN NL, 1991, ACTA GENET MED GEMEL, V40, P7, DOI 10.1017/S0001566000006681; PYORALA K, 1985, ACTA MED SCAND S, V701, P8; RANDLE PJ, 1963, LANCET, V1, P785; Reaven GM, 1996, NEW ENGL J MED, V334, P374, DOI 10.1056/NEJM199602083340607; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SEIGLER L, 1981, CLIN CHEM, V27, P838; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; SWISLOCKI ALM, 1989, AM J HYPERTENS, V2, P419, DOI 10.1093/ajh/2.6.419; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; YARNELL JWG, 1994, BRIT HEART J, V71, P293	45	147	153	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					143	152						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981957				2022-12-18	WOS:A1997WA81800020
J	CHENEVIXTRENCH, G; JONES, K; GREEN, AC; DUFFY, DL; MARTIN, NG				CHENEVIXTRENCH, G; JONES, K; GREEN, AC; DUFFY, DL; MARTIN, NG			CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE - ASSOCIATIONS WITH TRANSFORMING GROWTH FACTOR-ALPHA AND RETINOIC ACID RECEPTOR LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTAINING GENE EN2; SEGREGATION ANALYSIS; HOX2G LOCUS; CELL-DEATH; 2 RFLPS; DNA; LINKAGE; DANISH; REGION; BCL-2	The first association study of cleft lip with or without cleft palate (CL/P), with candidate genes, found an association with the transforming growth-factor alpha (TGFA) locus. This finding has since been replicated, in whole or in part, in three independent studies. Here we extend our original analysis of the TGFA TaqI RFLP to two other TGFA RFLPs and seven other RFLPs at five candidate genes in 117 nonsyndromic cases of CL/P and 113 controls. The other candidate genes were the retinoic acid receptor (RARA), the bcl-2 oncogene, and the homeobox genes 2F, 2G, and EN2. Significant associations with the TGFA TaqI and BamHI RFLPs were confirmed, although associations of clefting with previously reported haplotypes did not reach significance. Of particular interest, in view of the known teratogenic role of retinoic acid, was a significant association with the RARA PstI RFLP (P = .016; not corrected for multiple testing). The effect on risk of the A2 allele appears to be additive, and although the A2A2 homozygote only has an odds ratio of about 2 and recurrence risk to first-degree relatives (lambda1) of 1.06, because it is so common it may account for as much as a third of the attributable risk of clefting. There is no evidence of interaction between the TGFA and RARA polymorphisms on risk, and jointly they appear to account for almost half the attributable risk of clefting.	QUEENSLAND INST MED RES, EPIDEMIOL UNIT, BRISBANE, QLD, AUSTRALIA; UNIV QUEENSLAND, DEPT PATHOL, ST LUCIA, QLD 4067, AUSTRALIA	QIMR Berghofer Medical Research Institute; University of Queensland	CHENEVIXTRENCH, G (corresponding author), QUEENSLAND INST MED RES, JOINT ONCOL PROGRAMME, QUEENSLAND CANC FUND RES UNIT, 300 HERSTON RD, BRISBANE, QLD 4029, AUSTRALIA.		Green, Adele C/B-5324-2011; Chenevix-Trench, Georgia/AAV-2014-2020; Duffy, David L/B-7392-2013	Chenevix-Trench, Georgia/0000-0002-1878-2587; Duffy, David L/0000-0001-7227-632X; Martin, Nicholas/0000-0003-4069-8020				ABBOTT BD, 1990, TERATOLOGY, V42, P597, DOI 10.1002/tera.1420420604; ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; ARVEILER B, 1988, NUCLEIC ACIDS RES, V16, P6252, DOI 10.1093/nar/16.13.6252; CAMERA G, 1992, LANCET, V339, P687, DOI 10.1016/0140-6736(92)90854-V; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHUNG CS, 1986, AM J HUM GENET, V39, P603; FARRALL M, 1992, AM J HUM GENET, V50, P270; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; HAYWARD N, 1988, INT J CANCER, V42, P558, DOI 10.1002/ijc.2910420415; HAYWARD NK, 1987, NUCLEIC ACIDS RES, V15, P5503, DOI 10.1093/nar/15.13.5503; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1991, AM J HUM GENET, V49, P682; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOLDER SE, 1992, J MED GENET, V29, P390, DOI 10.1136/jmg.29.6.390; KAROLYI J, 1990, GENETICS, V126, P201; KHOURY MJ, 1991, AM J MED GENET, V40, P177, DOI 10.1002/ajmg.1320400211; KIRK DB, 1973, PSYCHOMETRIKA, V38, P259, DOI 10.1007/BF02291118; LOGAN C, 1989, NUCLEIC ACIDS RES, V17, P2879, DOI 10.1093/nar/17.7.2879; LOGAN C, 1989, NUCLEIC ACIDS RES, V17, P2878, DOI 10.1093/nar/17.7.2878; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; MURRAY JC, 1986, NUCLEIC ACIDS RES, V14, P7136, DOI 10.1093/nar/14.17.7136; OGURA T, 1991, NUCLEIC ACIDS RES, V19, P1716; RAJA RH, 1991, MOL ENDOCRINOL, V5, P514, DOI 10.1210/mend-5-4-514; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; ROLLNICK BR, 1986, AM J MED GENET, V24, P465, DOI 10.1002/ajmg.1320240309; ROSA FW, 1986, TERATOLOGY, V33, P355, DOI 10.1002/tera.1420330315; Rothman K, 1986, MODERN EPIDEMIOLOGY; SATRE MA, 1988, TERATOLOGY, V37, P489; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SMITH C, 1970, ANN HUM GENET, V34, P85, DOI 10.1111/j.1469-1809.1970.tb00223.x; STOLL C, 1992, AM J HUM GENET, V50, P870; SULIK KK, 1988, DEVELOPMENT, V103, P213; THOMAS DG, 1992, COMPUT BIOMED RES, V25, P75, DOI 10.1016/0010-4809(92)90036-A; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TSUJIMOTO Y, 1987, P NATL ACAD SCI USA, V84, P1329, DOI 10.1073/pnas.84.5.1329; VINTINER GM, 1992, J MED GENET, V29, P393, DOI 10.1136/jmg.29.6.393	43	147	155	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1377	1385						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1361101				2022-12-18	WOS:A1992KC99500021
J	BAIRD, M; BALAZS, I; GIUSTI, A; MIYAZAKI, L; NICHOLAS, L; WEXLER, K; KANTER, E; GLASSBERG, J; ALLEN, F; RUBINSTEIN, P; SUSSMAN, L				BAIRD, M; BALAZS, I; GIUSTI, A; MIYAZAKI, L; NICHOLAS, L; WEXLER, K; KANTER, E; GLASSBERG, J; ALLEN, F; RUBINSTEIN, P; SUSSMAN, L			ALLELE FREQUENCY-DISTRIBUTION OF 2 HIGHLY POLYMORPHIC DNA-SEQUENCES IN 3 ETHNIC-GROUPS AND ITS APPLICATION TO THE DETERMINATION OF PATERNITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK BLOOD CTR,NEW YORK,NY 10021	New York Blood Center	BAIRD, M (corresponding author), LIFECODES CORP,4 WESTCHESTER PLAZA,ELMSFORD,NY 10523, USA.							ALLEN FH, INCLUSION PROBABILIT; [Anonymous], 1980, HISTOCOMPATIBILITY T; BALAZS I, 1982, P NATL ACAD SCI-BIOL, V79, P7395, DOI 10.1073/pnas.79.23.7395; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; DEMARTINVILLE B, 1983, SCIENCE, V219, P498, DOI 10.1126/science.6297001; DYKES DD, 1982, PROBABILITY INCLUSIO; DYKES DD, 1982, PROBABILITY EXCLUSIO; ELDER JK, 1983, ANAL BIOCHEM, V128, P227, DOI 10.1016/0003-2697(83)90369-X; Essen-Moller E., 1938, MITT ANTHR GES, V68, P9; FISHER RA, 1960, HEREDITY, V5, P95; GERALD PS, 1984, CYTOGENET CELL GENET, V37, P103, DOI 10.1159/000132006; GIUSTI A, 1986, J FORENSIC SCI, V31, P409; KANTER E, 1986, J FORENSIC SCI, V31, P403; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LEE CL, 1983, INCLUSION PROBABILIT; MARTEL JL, 1974, VOX SANG, V27, P13, DOI 10.1111/j.1423-0410.1974.tb02384.x; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180; WYMAN A, 1984, American Journal of Human Genetics, V36, p159S; WYMAN AR, 1985, P NATL ACAD SCI USA, V82, P2880, DOI 10.1073/pnas.82.9.2880; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	21	147	149	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1986	39	4					489	501						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7063	2876630				2022-12-18	WOS:A1986E706300007
J	Ligthart, S; Vaez, A; Vosa, U; Stathopoulou, MG; de Vries, PS; Prins, BP; Van der Most, PJ; Tanaka, T; Naderi, E; Rose, LM; Wu, Y; Karlsson, R; Barbalic, M; Lin, HH; Pool, R; Zhu, G; Mace, A; Sidore, C; Trompet, S; Mangino, M; Sabater-Lleal, M; Kemp, JP; Abbasi, A; Kacprowski, T; Verweij, N; Smith, AV; Huang, T; Marzi, C; Feitosa, MF; Lohman, KK; Kleber, ME; Milaneschi, Y; Mueller, C; Huq, M; Vlachopoulou, E; Lyytikainen, LP; Oldmeadow, C; Deelen, J; Perola, M; Zhao, JH; Feenstra, B; Amini, M; Lahti, J; Schraut, KE; Fornage, M; Suktitipat, B; Chen, WM; Li, XH; Nutile, T; Malerba, G; Luan, JA; Bak, T; Schork, N; Del Greco, MF; Thiering, E; Mahajan, A; Marioni, RE; Mihailov, E; Eriksson, J; Ozel, AB; Zhang, WH; Nethander, M; Cheng, YC; Aslibekyan, S; Ang, W; Gandin, I; Yengo, L; Portas, L; Kooperberg, C; Hofer, E; Rajan, KB; Schurmann, C; den Hollander, W; Ahluwalia, TS; Zhao, J; Draisma, HHM; Ford, I; Timpson, N; Teumer, A; Huang, HY; Wahl, S; Liu, YM; Huang, J; Uh, HW; Geller, F; Joshi, PK; Yanek, LR; Trabetti, E; Lehne, B; Vozzi, D; Verbanck, M; Biino, G; Saba, Y; Meulenbelt, I; O'Connell, JR; Laakso, M; Giulianini, F; Magnusson, PKE; Ballantyne, CM; Hottenga, JJ; Montgomery, G; Rivadineira, F; Rueedi, R; Steri, M; Herzig, KH; Stott, DJ; Menni, C; Franberg, M; St Pourcain, B; Felix, SB; Pers, TH; Bakker, SJL; Kraft, P; Peters, A; Vaidya, D; Delgado, G; Smit, JH; Grossmann, V; Sinisalo, J; Seppala, I; Williams, SR; Holliday, EG; Moed, M; Langenberg, C; Raikkonen, K; Ding, JZ; Campbell, H; Sale, MM; Chen, YDI; James, AL; Ruggiero, D; Soranzo, N; Hartman, CA; Smith, EN; Berenson, GS; Fuchsberger, C; Hernandez, D; Tiesler, CMT; Giedraitis, V; Liewald, D; Fischer, K; Mellstrom, D; Larsson, A; Wang, YM; Scott, WR; Lorentzon, M; Beilby, J; Ryan, KA; Pennell, CE; Vuckovic, D; Balkau, B; Concas, MP; Schmidt, R; de Leon, CFM; Bottinger, EP; Kloppenburg, M; Paternoster, L; Boehnke, M; Musk, AW; Willemsen, G; Evans, DM; Madden, PAF; Kahonen, M; Kutalik, Z; Zoledziewska, M; Karhunen, V; Kritchevsky, SB; Sattar, N; Lachance, G; Clarke, R; Harris, TB; Raitakari, OT; Attia, JR; Van Heemst, D; Kajantie, E; Sorice, R; Gambaro, G; Scott, RA; Hicks, AA; Ferrucci, L; Standl, M; Lindgren, CM; Starr, JM; Karlsson, M; Lind, L; Li, JZ; Chambers, JC; Mori, TA; de Geus, EJCN; Heath, AC; Martin, NG; Auvinen, J; Buckley, BM; de Craen, AJM; Waldenberger, M; Strauch, K; Meitinger, T; Scott, RJ; McEvoy, M; Beekman, M; Bombieri, C; Ridker, PM; Mohlke, KL; Pedersen, NL; Morrison, AC; Boomsma, DI; Whitfield, JB; Strachan, DP; Hofman, A; Vollenweider, P; Cucca, F; Jarvelin, MR; Jukema, JW; Spector, TD; Hamsten, A; Zeller, T; Uitterlinden, AG; Nauck, M; Gudnason, V; Qi, L; Grallert, H; Borecki, IB; Rotter, JI; Marz, W; Wild, PS; Lokki, ML; Boyle, M; Salomaa, V; Melbye, M; Eriksson, JG; Wilson, JF; Penninx, BWJH; Becker, DM; Worrall, BB; Gibson, G; Krauss, RM; Ciullo, M; Zaza, G; Wareham, NJ; Oldehinkel, AJ; Palmer, LJ; Murray, SS; Pramstaller, PP; Bandinelli, S; Heinrich, J; Ingelsson, E; Deary, IJ; Magi, R; Vandenput, L; van der Harst, P; Desch, KC; Kooner, JS; Ohlsson, C; Hayward, C; Lehtimaki, T; Shuldiner, AR; Arnett, DK; Beilin, LJ; Robino, A; Froguel, P; Pirastu, M; Jess, T; Koenig, W; Loos, RJF; Evans, DA; Schmidt, H; Smith, GD; Slagboom, PE; Eiriksdottir, G; Morris, AP; Psaty, BM; Tracy, RP; Nolte, IM; Boerwinkle, E; Visvikis-Siest, S; Reiner, AP; Gross, M; Bis, JC; Franke, L; Franco, OH; Benjamin, EJ; Chasman, DI; Dupuis, J; Snieder, H; Dehghan, A; Alizadeh, BZ				Ligthart, Symen; Vaez, Ahmad; Vosa, Urmo; Stathopoulou, Maria G.; de Vries, Paul S.; Prins, Bram P.; Van der Most, Peter J.; Tanaka, Toshiko; Naderi, Elnaz; Rose, Lynda M.; Wu, Ying; Karlsson, Robert; Barbalic, Maja; Lin, Honghuang; Pool, Rene; Zhu, Gu; Mace, Aurelien; Sidore, Carlo; Trompet, Stella; Mangino, Massimo; Sabater-Lleal, Maria; Kemp, John P.; Abbasi, Ali; Kacprowski, Tim; Verweij, Niek; Smith, Albert V.; Huang, Tao; Marzi, Carola; Feitosa, Mary F.; Lohman, Kurt K.; Kleber, Marcus E.; Milaneschi, Yuri; Mueller, Christian; Huq, Mahmudul; Vlachopoulou, Efthymia; Lyytikainen, Leo-Pekka; Oldmeadow, Christopher; Deelen, Joris; Perola, Markus; Zhao, Jing Hua; Feenstra, Bjarke; Amini, Marzyeh; Lahti, Jari; Schraut, Katharina E.; Fornage, Myriam; Suktitipat, Bhoom; Chen, Wei-Min; Li, Xiaohui; Nutile, Teresa; Malerba, Giovanni; Luan, Jian'an; Bak, Tom; Schork, Nicholas; Del Greco, Fabiola M.; Thiering, Elisabeth; Mahajan, Anubha; Marioni, Riccardo E.; Mihailov, Evelin; Eriksson, Joel; Ozel, Ayse Bilge; Zhang, Weihua; Nethander, Maria; Cheng, Yu-Ching; Aslibekyan, Stella; Ang, Wei; Gandin, Ilaria; Yengo, Loic; Portas, Laura; Kooperberg, Charles; Hofer, Edith; Rajan, Kumar B.; Schurmann, Claudia; den Hollander, Wouter; Ahluwalia, Tarunveer S.; Zhao, Jing; Draisma, Harmen H. M.; Ford, Ian; Timpson, Nicholas; Teumer, Alexander; Huang, Hongyan; Wahl, Simone; Liu, YongMei; Huang, Jie; Uh, Hae-Won; Geller, Frank; Joshi, Peter K.; Yanek, Lisa R.; Trabetti, Elisabetta; Lehne, Benjamin; Vozzi, Diego; Verbanck, Marie; Biino, Ginevra; Saba, Yasaman; Meulenbelt, Ingrid; O'Connell, Jeff R.; Laakso, Markku; Giulianini, Franco; Magnusson, Patrik K. E.; Ballantyne, Christie M.; Hottenga, Jouke Jan; Montgomery, GrantW.; Rivadineira, Fernando; Rueedi, Rico; Steri, Maristella; Herzig, Karl-Heinz; Stott, David J.; Menni, Cristina; Franberg, Mattias; St Pourcain, Beate; Felix, Stephan B.; Pers, Tune H.; Bakker, Stephan J. L.; Kraft, Peter; Peters, Annette; Vaidya, Dhananjay; Delgado, Graciela; Smit, Johannes H.; Grossmann, Vera; Sinisalo, Juha; Seppala, Ilkka; Williams, Stephen R.; Holliday, Elizabeth G.; Moed, Matthijs; Langenberg, Claudia; Raikkonen, Katri; Ding, Jingzhong; Campbell, Harry; Sale, Michele M.; Chen, Yii-Der I.; James, Alan L.; Ruggiero, Daniela; Soranzo, Nicole; Hartman, Catharina A.; Smith, Erin N.; Berenson, Gerald S.; Fuchsberger, Christian; Hernandez, Dena; Tiesler, Carla M. T.; Giedraitis, Vilmantas; Liewald, David; Fischer, Krista; Mellstrom, Dan; Larsson, Anders; Wang, Yunmei; Scott, William R.; Lorentzon, Matthias; Beilby, John; Ryan, Kathleen A.; Pennell, Craig E.; Vuckovic, Dragana; Balkau, Beverly; Concas, Maria Pina; Schmidt, Reinhold; de Leon, Carlos F. Mendes; Bottinger, Erwin P.; Kloppenburg, Margreet; Paternoster, Lavinia; Boehnke, Michael; Musk, A. W.; Willemsen, Gonneke; Evans, David M.; Madden, Pamela A. F.; Kahonen, Mika; Kutalik, Zoltan; Zoledziewska, Magdalena; Karhunen, Ville; Kritchevsky, Stephen B.; Sattar, Naveed; Lachance, Genevieve; Clarke, Robert; Harris, Tamara B.; Raitakari, Olli T.; Attia, John R.; Van Heemst, Diana; Kajantie, Eero; Sorice, Rossella; Gambaro, Giovanni; Scott, Robert A.; Hicks, Andrew A.; Ferrucci, Luigi; Standl, Marie; Lindgren, Cecilia M.; Starr, John M.; Karlsson, Magnus; Lind, Lars; Li, Jun Z.; Chambers, John C.; Mori, Trevor A.; de Geus, Eco J. C. N.; Heath, Andrew C.; Martin, Nicholas G.; Auvinen, Juha; Buckley, Brendan M.; de Craen, Anton J. M.; Waldenberger, Melanie; Strauch, Konstantin; Meitinger, Thomas; Scott, Rodney J.; McEvoy, Mark; Beekman, Marian; Bombieri, Cristina; Ridker, Paul M.; Mohlke, Karen L.; Pedersen, Nancy L.; Morrison, Alanna C.; Boomsma, Dorret I.; Whitfield, John B.; Strachan, David P.; Hofman, Albert; Vollenweider, Peter; Cucca, Francesco; Jarvelin, Marjo-Riitta; Jukema, J. Wouter; Spector, Tim D.; Hamsten, Anders; Zeller, Tanja; Uitterlinden, Andre G.; Nauck, Matthias; Gudnason, Vilmundur; Qi, Lu; Grallert, Harald; Borecki, Ingrid B.; Rotter, Jerome I.; Maerz, Winfried; Wild, Philipp S.; Lokki, Marja-Liisa; Boyle, Michael; Salomaa, Veikko; Melbye, Mads; Eriksson, Johan G.; Wilson, James F.; Penninx, Brenda W. J. H.; Becker, Diane M.; Worrall, Bradford B.; Gibson, Greg; Krauss, Ronald M.; Ciullo, Marina; Zaza, Gianluigi; Wareham, Nicholas J.; Oldehinkel, Albertine J.; Palmer, Lyle J.; Murray, Sarah S.; Pramstaller, Peter P.; Bandinelli, Stefania; Heinrich, Joachim; Ingelsson, Erik; Deary, Ian J.; Magi, Reedik; Vandenput, Liesbeth; van der Harst, Pim; Desch, Karl C.; Kooner, Jaspal S.; Ohlsson, Claes; Hayward, Caroline; Lehtimaki, Terho; Shuldiner, Alan R.; Arnett, Donna K.; Beilin, Lawrence J.; Robino, Antonietta; Froguel, Philippe; Pirastu, Mario; Jess, Tine; Koenig, Wolfgang; Loos, Ruth J. F.; Evans, Denis A.; Schmidt, Helena; Smith, George Davey; Slagboom, P. Eline; Eiriksdottir, Gudny; Morris, Andrew P.; Psaty, Bruce M.; Tracy, Russell P.; Nolte, Ilja M.; Boerwinkle, Eric; Visvikis-Siest, Sophie; Reiner, Alex P.; Gross, Myron; Bis, Joshua C.; Franke, Lude; Franco, Oscar H.; Benjamin, Emelia J.; Chasman, Daniel I.; Dupuis, Josee; Snieder, Harold; Dehghan, Abbas; Alizadeh, Behrooz Z.		LifeLines Cohort Study; CHARGE Inflammation Working Grp	Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-REACTIVE PROTEIN; LD SCORE REGRESSION; MENDELIAN RANDOMIZATION; WIDE ASSOCIATION; SCHIZOPHRENIA; INSTRUMENTS; HEART; IMMUNITY; RISK	C-reactive protein (CRP) is a sensitive biomarker of chronic low-grade inflammation and is associated with multiple complex diseases. The genetic determinants of chronic inflammation remain largely unknown, and the causal role of CRP in several clinical outcomes is debated. We performed two genome-wide association studies (GWASs), on HapMap and 1000 Genomes imputed data, of circulating amounts of CRP by using data from 88 studies comprising 204,402 European individuals. Additionally, we performed in silico functional analyses and Mendelian randomization analyses with several clinical outcomes. The GWAS meta-analyses of CRP revealed 58 distinct genetic loci (p < 5 x 10(-8)). After adjustment for body mass index in the regression analysis, the associations at all except three loci remained. The lead variants at the distinct loci explained up to 7.0% of the variance in circulating amounts of CRP. We identified 66 gene sets that were organized in two substantially correlated clusters, one mainly composed of immune pathways and the other characterized by metabolic pathways in the liver. Mendelian randomization analyses revealed a causal protective effect of CRP on schizophrenia and a risk-increasing effect on bipolar disorder. Our findings provide further insights into the biology of inflammation and could lead to interventions for treating inflammation and its clinical consequences.	[Ligthart, Symen; de Vries, Paul S.; Hofman, Albert; Franco, Oscar H.; Dehghan, Abbas] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Vaez, Ahmad; Van der Most, Peter J.; Naderi, Elnaz; Abbasi, Ali; Huq, Mahmudul; Amini, Marzyeh; Nolte, Ilja M.; Snieder, Harold; Alizadeh, Behrooz Z.; LifeLines Cohort Study] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Vaez, Ahmad] Isfahan Univ Med Sci, Dept Bioinformat, Esfahan 8174673461, Iran; [Vosa, Urmo; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Vosa, Urmo; Mihailov, Evelin; Fischer, Krista; Magi, Reedik] Univ Tartu, Inst Genom, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Stathopoulou, Maria G.; Visvikis-Siest, Sophie] Univ Lorraine, INSERM, IGE PCV, F-54000 Nancy, France; [de Vries, Paul S.; Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Ctr Human Genet, Houston, TX 77030 USA; [Prins, Bram P.] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton CB10 1SA, England; [Tanaka, Toshiko; Ferrucci, Luigi] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA; [Naderi, Elnaz] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, NL-9713 GZ Groningen, Netherlands; [Rose, Lynda M.; Giulianini, Franco; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Karlsson, Robert; Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Barbalic, Maja] Univ Split, Sch Med, Split 21000, Croatia; [Lin, Honghuang; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Pool, Rene; Draisma, Harmen H. M.; Hottenga, Jouke Jan; Willemsen, Gonneke; de Geus, Eco J. C. N.; Boomsma, Dorret I.] Vrije Univ, Netherlands Twin Register, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Pool, Rene; Draisma, Harmen H. M.; de Geus, Eco J. C. N.] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, NL-1081 BT Amsterdam, Netherlands; [Zhu, Gu; Montgomery, GrantW.; Martin, Nicholas G.; Whitfield, John B.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Mace, Aurelien; Rueedi, Rico] Univ Lausanne, Dept Computat Biol, CH-1010 Lausanne, Switzerland; [Mace, Aurelien; Rueedi, Rico; Kutalik, Zoltan] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Mace, Aurelien; Kutalik, Zoltan] Univ Hosp Lausanne, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland; [Sidore, Carlo; Steri, Maristella; Zoledziewska, Magdalena; Cucca, Francesco] CNR, Ist Ric Genet & Biomed, I-08045 Sardinia, Italy; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands; [Trompet, Stella; Van Heemst, Diana; de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, NL-2333 ZA Leiden, Netherlands; [Mangino, Massimo; Menni, Cristina; Lachance, Genevieve; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Mangino, Massimo] Guys & St Thomas Fdn Trust, NIHR Biomed Res Ctr, London SE1 9RT, England; [Sabater-Lleal, Maria] Inst Invest Biomed St Pau, Unit Genom Complex Dis, Barcelona 08025, Spain; [Sabater-Lleal, Maria; Franberg, Mattias; Hamsten, Anders] Karolinska Inst, Ctr Mol Med, Cardiovasc Med Unit, Dept Med, S-17176 Stockholm, Sweden; [Kemp, John P.; Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia; [Kemp, John P.; Timpson, Nicholas; St Pourcain, Beate; Paternoster, Lavinia; Evans, David M.; Smith, George Davey] Univ Bristol, Bristol Med Sch, MRC, Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Abbasi, Ali; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 GZ Groningen, Netherlands; [Abbasi, Ali] Univ Cambridge, Sch Med, Inst Metab Sci, MRC,Epidemiol Unit,Addenbrookes Hosp, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Kacprowski, Tim] Univ Med, Interfac Inst Genet & Funct Genom, Dept Funct Genom, D-17475 Greifswald, Germany; [Kacprowski, Tim] Ernst Moritz Arndt Univ Greifswald, D-17475 Greifswald, Germany; [Kacprowski, Tim; Felix, Stephan B.; Nauck, Matthias] German Ctr Cardiovasc Res, Partner Site Greifswald, D-17475 Greifswald, Germany; [Verweij, Niek; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 AV Groningen, Netherlands; [Smith, Albert V.; Gudnason, Vilmundur; Eiriksdottir, Gudny] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Huang, Tao] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China; [Huang, Tao; Qi, Lu] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Marzi, Carola; Wahl, Simone; Waldenberger, Melanie; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Marzi, Carola; Wahl, Simone; Grallert, Harald] German Ctr Diabet Res, Partner Site Munich, D-85764 Munich, Germany; [Feitosa, Mary F.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63108 USA; [Lohman, Kurt K.; Liu, YongMei] Wake Forest Univ Hlth Sci, Publ Hlth Sci, Dept Epidemiol & Prevent, Winston Salem, NC 27157 USA; [Kleber, Marcus E.; Delgado, Graciela; Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, D-68167 Mannheim, Germany; [Milaneschi, Yuri; Smit, Johannes H.; Penninx, Brenda W. J. H.] Univ Amsterdam, Med Ctr, GGZ InGeest Res & Innovat, Dept Psychiat,Amsterdam Neurosci, NL-1081 HJ Amsterdam, Netherlands; [Milaneschi, Yuri; Smit, Johannes H.; Penninx, Brenda W. J. H.] Univ Amsterdam, Med Ctr, GGZ InGeest Res & Innovat, Amsterdam Publ Hlth Res Inst, NL-1081 HJ Amsterdam, Netherlands; [Mueller, Christian; Zeller, Tanja] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, D-20246 Hamburg, Germany; [Mueller, Christian] Univ Med Ctr Schleswig Holstein, Inst Med Biometry & Stat, Campus Luebeck, D-23562 Lubeck, Germany; [Mueller, Christian; Zeller, Tanja; Wild, Philipp S.] German Ctr Cardiovasc Res, Partner Site RhineMain, D-55131 Mainz, Germany; [Vlachopoulou, Efthymia; Lokki, Marja-Liisa] Univ Helsinki, Transplantat Lab, Medicum, FIN-00014 Helsinki, Finland; [Lyytikainen, Leo-Pekka; Seppala, Ilkka; Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere 33014, Finland; [Lyytikainen, Leo-Pekka; Seppala, Ilkka; Lehtimaki, Terho] Univ Tampere, Fac Med & Life Sci, Finnish Cardiovasc Res Ctr Tampere, Dept Clin Chem, Tampere 33520, Finland; [Oldmeadow, Christopher; Holliday, Elizabeth G.; Attia, John R.; Scott, Rodney J.; McEvoy, Mark] Hunter Med Res Inst, New Lambon Hts, NSW 2305, Australia; [Oldmeadow, Christopher; Holliday, Elizabeth G.; Attia, John R.; McEvoy, Mark] Univ Newcastle, Fac Hlth & Med, Ctr Clin Epidemiol & Biostat, Callaghan, NSW 2308, Australia; [Deelen, Joris; Moed, Matthijs; Beekman, Marian; Slagboom, P. Eline] Leiden Univ, Med Ctr, Mol Epidemiol, NL-2333 ZC Leiden, Netherlands; [Deelen, Joris] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Perola, Markus; Salomaa, Veikko; Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki 00271, Finland; [Zhao, Jing Hua; Luan, Jian'an; Langenberg, Claudia; Scott, Robert A.; Wareham, Nicholas J.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC,Epidemiol Unit, Cambridge CB2 0QQ, England; [Feenstra, Bjarke; Geller, Frank; Pers, Tune H.; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Lahti, Jari] Univ Helsinki, Helsinki Coll Adv Studies, FIN-00014 Helsinki, Finland; [Lahti, Jari; Raikkonen, Katri] Univ Helsinki, Fac Med, Dept Psychol & Logoped, FIN-00014 Helsinki, Finland; [Lahti, Jari; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki 00250, Finland; [Schraut, Katharina E.; Joshi, Peter K.; Campbell, Harry; Wilson, James F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Teviot Pl, Edinburgh EH16 4UX, Midlothian, Scotland; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Suktitipat, Bhoom] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Chen, Wei-Min; Sale, Michele M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Li, Xiaohui; Chen, Yii-Der I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Pediat, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Nutile, Teresa; Ruggiero, Daniela; Sorice, Rossella; Ciullo, Marina] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80131 Naples, Italy; [Malerba, Giovanni; Trabetti, Elisabetta; Bombieri, Cristina] Univ Verona, Dept Neurosci Biomed & Movement Sci, I-37134 Verona, Italy; [Bak, Tom; Hartman, Catharina A.; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, NL-9700 RB Groningen, Netherlands; [Schork, Nicholas] J Craig Venter Inst, Human Biol, La Jolla, CA 92037 USA; [Schork, Nicholas] Translat Genom Res Inst, Quantitat Med, Phoenix, AZ 85004 USA; [Del Greco, Fabiola M.; Fuchsberger, Christian; Hicks, Andrew A.; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Eurac Res, Inst Biomed, I-39100 Bolzano, Italy; [Thiering, Elisabeth; Tiesler, Carla M. T.; Standl, Marie; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany; [Thiering, Elisabeth; Tiesler, Carla M. T.] Ludwig Maximilian Univ Munich, Dr von Hauner Childrens Hosp, D-80337 Munich, Germany; [Mahajan, Anubha; Lindgren, Cecilia M.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Marioni, Riccardo E.; Liewald, David; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Marioni, Riccardo E.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Eriksson, Joel; Mellstrom, Dan; Lorentzon, Matthias; Vandenput, Liesbeth; Ohlsson, Claes] Univ Gothenburg, Dept Internal Med & Clin Nutr, S-41345 Gothenburg, Sweden; [Ozel, Ayse Bilge; Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Zhang, Weihua; Lehne, Benjamin; Scott, William R.; Chambers, John C.] UCL, Dept Epidemiol & Biostat, London W2 1PG, England; [Zhang, Weihua; Chambers, John C.; Kooner, Jaspal S.] Ealing Gen Hosp, Dept Cardiol, Southall UB1 3HW, Middx, England; [Nethander, Maria] Univ Gothenburg, Sahlgrenska Acad, Bioinformat Core Facil, S-41390 Gothenburg, Sweden; [Cheng, Yu-Ching; O'Connell, Jeff R.; Ryan, Kathleen A.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Aslibekyan, Stella] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Ang, Wei; Pennell, Craig E.; Mori, Trevor A.; Beilin, Lawrence J.] Univ Western Australia, Sch Med, Perth, WA 6009, Australia; [Gandin, Ilaria] AREA Sci Pk, I-34149 Trieste, Italy; [Yengo, Loic; Verbanck, Marie; Froguel, Philippe] Univ Lille, Inst Pasteur Lille, European Genom Inst Diabet, CNRS,UMR 8199,FR 3508, F-59000 Lille, France; [Yengo, Loic] Univ Queensland, Inst Mol Biosci, Program Complex Trait Genom, Brisbane, Qld 4072, Australia; [Portas, Laura; Pirastu, Mario] CNR, Inst Genet & Biomed Res, Support OU, I-7100 Sassari, Italy; [Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Mail Stop M3-A410,1100 Fairview Ave N, Seattle, WA 98104 USA; [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, A-8036 Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, A-8036 Graz, Austria; [Rajan, Kumar B.; Evans, Denis A.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Schurmann, Claudia; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Schurmann, Claudia; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [den Hollander, Wouter; Meulenbelt, Ingrid] Leiden Univ, Med Ctr, Sect Mol Epidemiol, Dept Med Stat & Bioinformat, NL-2333 ZC Leiden, Netherlands; [Ahluwalia, Tarunveer S.] Steno Diabet Ctr Copenhagen, DK-2820 Gentofte, Denmark; [Ahluwalia, Tarunveer S.; Pers, Tune H.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Sect Metab Genet,Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Zhao, Jing; Gibson, Greg] Georgia Inst Technol, Sch Biol, Ctr Integrat Genom, Atlanta, GA 30332 USA; [Draisma, Harmen H. M.] Neurosci Campus Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; [Teumer, Alexander] Univ Med Greifswald, Inst Community Med, Dept SHIP KEF, D-17475 Greifswald, Germany; [Huang, Hongyan; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Huang, Jie] Boston VA Res Inst Inc, Boston, MA 02130 USA; [Uh, Hae-Won] Leiden Univ, Med Ctr, Med Stat & Bioinformat, NL-2333 ZC Leiden, Netherlands; [Yanek, Lisa R.; Vaidya, Dhananjay; Becker, Diane M.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Ctr, Baltimore, MD 21287 USA; [Vozzi, Diego; Concas, Maria Pina; Robino, Antonietta] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34140 Trieste, Italy; [Biino, Ginevra] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Saba, Yasaman] Gottfried Schatz Res Ctr, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio 70210, Finland; [Laakso, Markku] Kuopio Univ Hosp, Kuopio 70210, Finland; [Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Rivadineira, Fernando; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 CN Rotterdam, Netherlands; [Herzig, Karl-Heinz] Univ Oulu, Med Res Ctr Oulu, Dept Physiol, Inst Biomed, Oulu 90014, Finland; [Herzig, Karl-Heinz] Oulu Univ Hosp, Oulu 90014, Finland; [Herzig, Karl-Heinz; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, SF-90220 Oulu, Finland; [Herzig, Karl-Heinz] Poznan Univ Med Sci, Dept Gastroenterol & Metab, PL-60512 Poznan, Poland; [Stott, David J.] Univ Glasgow, Fac Med, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Franberg, Mattias] Stockholm Univ, Dept Numer Anal & Comp Sci, S-10044 Stockholm, Sweden; [St Pourcain, Beate] Radboud Univ Nijmegen, Donders Inst, NL-6525 XD Nijmegen, Netherlands; [Felix, Stephan B.] Univ Med Greifswald, Dept Internal Med B, D-17475 Greifswald, Germany; [Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherber, Germany; [Grossmann, Vera; Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, D-55131 Mainz, Germany; [Sinisalo, Juha] Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki 00029, Finland; [Sinisalo, Juha] Univ Helsinki, Helsinki 00029, Finland; [Williams, Stephen R.] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA; [Ding, Jingzhong] Wake Forest Univ Hlth Sci, Dept Internal Med Geriatr, Winston Salem, NC 27157 USA; [James, Alan L.; Musk, A. W.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Inst, Nedlands, WA 6009, Australia; [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, Nedlands, WA 6009, Australia; [Ruggiero, Daniela; Ciullo, Marina] IRCCS Neuromed, I-86077 Pozzilli, IS, Italy; [Soranzo, Nicole] Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England; [Smith, Erin N.] Univ Calif San Diego, Dept Pediat, Sch Med, La Jolla, CA 92037 USA; [Smith, Erin N.] Univ Calif San Diego, Rady Childrens Hosp, Sch Med, La Jolla, CA 92037 USA; [Berenson, Gerald S.] Tulane Univ, Ctr Cardiovasc Hlth, New Orleans, LA 70112 USA; [Hernandez, Dena] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Hernandez, Dena; Giedraitis, Vilmantas] Uppsala Univ, Dept Publ Hlth & Caring Sci, Mol Geriatr, S-75237 Uppsala, Sweden; [Larsson, Anders; Lind, Lars] Uppsala Univ, Dept Med Sci, S-75141 Uppsala, Sweden; [Wang, Yunmei] Case Western Reserve Univ, Case Cardiovasc Res Inst, Dept Med, Harrington Heart & Vasc Inst,Univ Hosp, Cleveland, OH 44106 USA; [Lorentzon, Matthias] Sahlgrens Univ Hosp, Geriatr Med, S-43180 Molndal, Sweden; [Beilby, John] PathWest Lab Med WA, Nedlands, WA 6009, Australia; [Beilby, John] Univ Western Australia, Sch Biomed Sci, Perth, WA 6009, Australia; [Vuckovic, Dragana] Univ Trieste, Med Sci Surg & Hlth Dept, I-34137 Trieste, Italy; [Balkau, Beverly] Univ Paris Saclay, Univ Versailles St Quentin En Yvelines, Team EpReC Renal & Cardiovasc Epidemiol 5, INSERM,U1018,Ctr Rech Epidemiol & Sante Populat, F-94807 Villejuif, France; [de Leon, Carlos F. Mendes] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bottinger, Erwin P.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Kloppenburg, Margreet] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Kloppenburg, Margreet] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2333 ZC Leiden, Netherlands; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Musk, A. W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Madden, Pamela A. F.; Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, 4560 Clayton Ave,Suite 1000, St Louis, MO 63110 USA; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere 33520, Finland; [Kahonen, Mika] Univ Tampere, Fac Med & Life Sci, Finnish Cardiovasc Res Ctr Tampere, Dept Clin Physiol, Tampere 33520, Finland; [Karhunen, Ville; Auvinen, Juha; Jarvelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Hlth Res, Fac Med, Oulu 90014, Finland; [Kritchevsky, Stephen B.] Wake Forest Univ Hlth Sci, Sticht Ctr Aging & Rehabil, Gerontol & Geriatr Med, Winston Salem, NC 27157 USA; [Sattar, Naveed] BHF Glasgow Cardiovasc Res Ctr, Fac Med, Glasgow G12 8TA, Lanark, Scotland; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England; [Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20520 Turku, Finland; [Attia, John R.; Boyle, Michael] John Hunter Hosp, New Lambton Hts, NSW 2305, Australia; [Kajantie, Eero] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki 00014, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, FIN-00290 Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, FIN-00290 Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, MRC Oulu, Dept Obstet & Gynaecol, Oulu 90014, Finland; [Kajantie, Eero] Univ Oulu, Oulu 90014, Finland; [Gambaro, Giovanni] Univ Cattolica Sacro Cuore, Columbus Gemelli Univ Hosp, Div Nephrol & Dialysis, I-168 Rome, Italy; [Lindgren, Cecilia M.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford OX3 7FZ, England; [Lindgren, Cecilia M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Starr, John M.] Univ Edinburgh, Alzheimers Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Karlsson, Magnus] Lund Univ, Dept Clin Sci & Orthopaed Surg, S-20502 Malmo, Sweden; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London W12 0HS, England; [Chambers, John C.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London W2 1PG, England; [Auvinen, Juha; Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Hlth Care, Oulu 90220, Finland; [Buckley, Brendan M.] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork T12 K8AF, Ireland; [Waldenberger, Melanie; Koenig, Wolfgang] German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-80636 Munich, Germany; [Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Strauch, Konstantin] Ludwig Maximilian Univ Munich, Fac Med, Inst Med Informat Biometry & Epidemiol, Genet Epidemiol, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-85764 Munich, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Scott, Rodney J.] Hunter Med Res Inst, Informat Based Med Stream, New Lambton Hts, NSW 2305, Australia; [Ridker, Paul M.; Chasman, Daniel I.] Harvard Med Sch, Boston, MA 02115 USA; [Strachan, David P.] St Georges Univ London, Populat Hlth Res Inst, London SW17 0RE, England; [Vollenweider, Peter] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Jarvelin, Marjo-Riitta; Dehghan, Abbas] Imperial Coll London, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, London W2 1PG, England; [Jarvelin, Marjo-Riitta] Brunel Univ London, Coll Hlth & Life Sci, Dept Life Sci, Kingston Lane, Uxbridge UB8 3PH, Middx, England; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, NL-3501 DG Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, NL-3511 EP Utrecht, Netherlands; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Qi, Lu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [Borecki, Ingrid B.] Regeneron Pharmaceut Inc, Regeneron Genet Ctr, Analyt Genet Grp, Tarrytown, NY 10591 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Dept Pediat, Torrance, CA 90502 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Dept Med, Torrance, CA 90502 USA; [Maerz, Winfried] Synlab Holding Deutschland GmbH, Synlab Acad, D-68161 Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Cardiol, Prevent Cardiol & Prevent Med, D-55131 Mainz, Germany; [Melbye, Mads] Univ Copenhagen, Dept Clin Med, DK-2300 Copenhagen, Denmark; [Melbye, Mads] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FIN-00014 Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki 00014, Finland; [Wilson, James F.; Hayward, Caroline] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Worrall, Bradford B.] Univ Virginia Charlottesville, Dept Neurol, Charlottesville, VA 22908 USA; [Worrall, Bradford B.] Univ Virginia Charlottesville, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Zaza, Gianluigi] Verona Univ Hosp, Dept Med, Renal Unit, I-37126 Verona, Italy; [Palmer, Lyle J.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA 5000, Australia; [Murray, Sarah S.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92121 USA; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, I-50122 Florence, Italy; [Heinrich, Joachim] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst & Clin Occupat Social & Environm Med, Comprehens Pneumol Ctr Munich,DZL,German Ctr Lung, D-81377 Munich, Germany; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, S-75141 Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Stanford, CA 94305 USA; [Ingelsson, Erik] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Desch, Karl C.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Kooner, Jaspal S.] Imperial Coll London, Natl Heart & Lung Inst, London W12 0NN, England; [Arnett, Donna K.] Univ Kentucky, Coll Publ Hlth, Lexington, KY 40508 USA; [Froguel, Philippe] Imperial Coll London, Sch Publ Hlth, Dept Genom Common Dis, London SW7 2AZ, England; [Jess, Tine] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, DK-2200 Frederiksberg, Denmark; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-80801 Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Muchen, D-80636 Munich, Germany; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Schmidt, Helena] Med Univ Graz, Dept Neurol, A-8010 Graz, Austria; [Schmidt, Helena] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3GL, Merseyside, England; [Psaty, Bruce M.; Bis, Joshua C.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.; Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA; [Tracy, Russell P.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gross, Myron] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Franco, Oscar H.] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Benjamin, Emelia J.; Dupuis, Josee] Natl Heart Lung & Blood Inst, Framingham Heart Study, Framingham, MA 01702 USA; [Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA	Erasmus University Rotterdam; Erasmus MC; University of Groningen; Isfahan University Medical Science; University of Groningen; University of Tartu; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Groningen; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; University of Split; Boston University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; QIMR Berghofer Medical Research Institute; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Karolinska Institutet; University of Queensland; University of Bristol; University of Groningen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Ernst Moritz Arndt Universitat Greifswald; German Centre for Cardiovascular Research; University of Groningen; Icelandic Heart Association; University of Iceland; Peking University; Harvard University; Harvard T.H. Chan School of Public Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Washington University (WUSTL); Wake Forest University; Wake Forest University School of Medicine; Ruprecht Karls University Heidelberg; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research; University of Helsinki; Tampere University; Hunter Medical Research Institute; University of Newcastle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society; Finland National Institute for Health & Welfare; University of Cambridge; Statens Serum Institut; University of Helsinki; University of Helsinki; Folkhalsan Research Center; University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Mahidol University; University of Virginia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Verona; University of Groningen; J. Craig Venter Institute; Translational Genomics Research Institute; European Academy of Bozen-Bolzano; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh; University of Edinburgh; University of Gothenburg; University of Michigan System; University of Michigan; University of London; University College London; University of Gothenburg; University System of Maryland; University of Maryland Baltimore; University of Alabama System; University of Alabama Birmingham; University of Western Australia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Queensland; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Fred Hutchinson Cancer Center; Medical University of Graz; Medical University of Graz; Rush University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Steno Diabetes Center; Novo Nordisk Foundation; University of Copenhagen; University System of Georgia; Georgia Institute of Technology; Vrije Universiteit Amsterdam; University of Glasgow; Greifswald Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johns Hopkins University; IRCCS Burlo Garofolo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Erasmus University Rotterdam; Erasmus MC; University of Oulu; University of Oulu; University of Oulu; Poznan University of Medical Sciences; University of Glasgow; Stockholm University; Radboud University Nijmegen; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johannes Gutenberg University of Mainz; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Virginia; Wake Forest University; Wake Forest University School of Medicine; University of Western Australia; University of Western Australia; IRCCS Neuromed; Wellcome Trust Sanger Institute; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Uppsala University; Uppsala University; Case Western Reserve University; University Hospitals of Cleveland; Sahlgrenska University Hospital; University of Western Australia; University of Trieste; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Western Australia; Washington University (WUSTL); Tampere University; Tampere University Hospital; Tampere University; University of Oulu; Wake Forest University; Wake Forest University School of Medicine; University of Glasgow; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Turku; University of Turku; John Hunter Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; Catholic University of the Sacred Heart; University of Oxford; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Edinburgh; Lund University; Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; University of Oulu; University College Cork; German Centre for Cardiovascular Research; Munich Heart Alliance; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Hunter Medical Research Institute; University of Newcastle; Harvard University; Harvard Medical School; St Georges University London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London; Brunel University; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Greifswald Medical School; Tulane University; Regeneron; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; SYNLAB Group; Medical University of Graz; Johannes Gutenberg University of Mainz; University of Copenhagen; Stanford University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Edinburgh; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Adelaide; University of California System; University of California San Diego; Krankenhaus Bozen; University of Lubeck; Azienda Sanitaria di Firenze; University of Munich; Uppsala University; Stanford University; Stanford University; University of Edinburgh; University of Michigan System; University of Michigan; Imperial College London; University of Kentucky; Imperial College London; University of Copenhagen; Bispebjerg Hospital; Ulm University; German Heart Centre Munich; Technical University of Munich; Icahn School of Medicine at Mount Sinai; Medical University of Graz; Medical University of Graz; University of Liverpool; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; University of Vermont; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Bern; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University	Dehghan, A (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands.; Alizadeh, BZ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands.; Dehghan, A (corresponding author), Imperial Coll London, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, London W2 1PG, England.	a.dehghan@imperial.ac.uk; b.z.alizadeh@umcg.nl	Visvikis-Siest, Sophie/H-2324-2014; Pool, René/AFO-8147-2022; Mägi, Reedik/AAJ-9679-2021; Heinrich, Joachim/N-1720-2013; Kacprowski, Tim/K-8650-2013; Benjamin, Emelia/E-7103-2011; Gudnason, Vilmundur/AAE-7126-2019; Loos, Ruth/GON-5877-2022; Ahluwalia, Tarunveer Singh/C-5549-2009; Kemp, John P./R-3091-2018; Smith, Albert Vernon/AHC-3838-2022; Teumer, Alexander/S-7438-2019; Deelen, Joris/H-3201-2019; Abdollahi, Mohammadreza/G-4701-2013; Jamshidi, Yalda/AAL-1377-2020; Lahti, Jari/P-2283-2019; Davey Smith, George/A-7407-2013; Verweij, Niek/ABC-6249-2021; Vandenput, Liesbeth/AAI-4100-2021; Wilson, James F/A-5704-2009; Grallert, Harald/B-3424-2013; Evans, David M/H-6325-2013; Naderi, Elnaz/ABE-1795-2021; Williams, Steve C/D-6979-2011; Timpson, Nicholas John/O-7548-2015; zhang, weihua/GXV-1334-2022; Malerba, Giovanni/T-3278-2019; Palmer, Lyle John/N-1948-2019; Lahti, Jari/P-7987-2018; Feitosa, Mary F/K-8044-2012; Zaza, Gianluigi/K-3827-2018; FROGUEL, Philippe/O-6799-2017; Lin, Honghuang/A-3269-2019; Langenberg, Claudia/ABG-9067-2021; Kraft, Peter/GQH-8448-2022; Attia, John R/F-5376-2013; Fuchsberger, Christian/ABD-7127-2021; Sidore, Carlo/AAV-7967-2020; ruggiero, daniela/K-5638-2016; Boomsma, Dorret I/AAX-4470-2020; Peters, Annette/A-6117-2011; Colaus, PsyColaus/K-6607-2013; Mori, Trevor/H-5485-2014; Stathopoulou, Maria/H-7324-2016; Vaez, Ahmad/B-4336-2018; Lleal, Maria Sabater/I-5832-2013; Suktitipat, Bhoom/H-4239-2019; Ohlsson, Claes/AGP-3544-2022; Loos, Ruth J F/Q-2862-2016; Ford, Ian/ABE-6145-2020; Lehtimäki, Terho/AAD-1094-2022; Ligthart, Symen/AAF-7185-2020; Campbell, Harry/E-2959-2010; Schmidt, Reinhold/E-1137-2014; Jukema, J. Wouter/ABD-6503-2021; Kacprowski, Tim/N-9692-2019; Võsa, Urmo/AAJ-5928-2020; Steri, Maristella/AAX-8760-2020; Magnusson, Patrik KE/C-4458-2017; Raitakari, Olli/AAQ-7389-2021; Ciullo, Marina/AAE-3041-2020; Ballantyne, Christie/A-6599-2008; Palmer, Lyle John/K-3196-2014; Dehghan, Abbas/ABE-7377-2020; Waldenberger, Melanie/B-5355-2014; Gandin, Ilaria/B-2634-2017; Rotter, Jerome/AAY-6598-2021; bandinelli, stefania/AAL-4570-2020; Hicks, Andrew Anthony/E-9518-2017; Franco, Óscar H/ABE-2305-2020; Pennell, Craig/ABD-6902-2020; Mangino, Massimo/F-5134-2011; Vandenput, Liesbeth/AAP-3655-2020; Schurmann, Claudia/L-1204-2016; Bracewell, Daniel/B-1988-2008; de Geus, Eco/M-9318-2015; Yengo, Loic/D-2692-2017; Scott, Rodney/B-2827-2013; concas, maria pina/K-2266-2018; Penninx, Brenda WJH/S-7627-2017; Robino, Antonietta/K-9398-2016	Visvikis-Siest, Sophie/0000-0001-8104-8425; Pool, René/0000-0001-5579-0933; Heinrich, Joachim/0000-0002-9620-1629; Kacprowski, Tim/0000-0002-5393-2413; Benjamin, Emelia/0000-0003-4076-2336; Gudnason, Vilmundur/0000-0001-5696-0084; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Kemp, John P./0000-0002-9105-2249; Smith, Albert Vernon/0000-0003-1942-5845; Teumer, Alexander/0000-0002-8309-094X; Deelen, Joris/0000-0003-4483-3701; Abdollahi, Mohammadreza/0000-0003-0455-4206; Jamshidi, Yalda/0000-0003-0151-6482; Lahti, Jari/0000-0002-4310-5297; Davey Smith, George/0000-0002-1407-8314; Verweij, Niek/0000-0002-4303-7685; Vandenput, Liesbeth/0000-0002-1712-6131; Wilson, James F/0000-0001-5751-9178; Evans, David M/0000-0003-0663-4621; Williams, Steve C/0000-0003-4299-1941; Timpson, Nicholas John/0000-0002-7141-9189; Palmer, Lyle John/0000-0002-1628-3055; Lahti, Jari/0000-0002-4310-5297; Feitosa, Mary F/0000-0002-0933-2410; FROGUEL, Philippe/0000-0003-2972-0784; Lin, Honghuang/0000-0003-3043-3942; Langenberg, Claudia/0000-0002-5017-7344; Attia, John R/0000-0001-9800-1308; Fuchsberger, Christian/0000-0002-5918-8947; Sidore, Carlo/0000-0001-7504-7477; ruggiero, daniela/0000-0003-3898-7827; Peters, Annette/0000-0001-6645-0985; Mori, Trevor/0000-0002-5264-9229; Stathopoulou, Maria/0000-0003-4376-2083; Vaez, Ahmad/0000-0001-9048-3795; Lleal, Maria Sabater/0000-0002-0128-379X; Suktitipat, Bhoom/0000-0001-8034-7757; Ohlsson, Claes/0000-0002-9633-2805; Loos, Ruth J F/0000-0002-8532-5087; Lehtimäki, Terho/0000-0002-2555-4427; Campbell, Harry/0000-0002-6169-6262; Jukema, J. Wouter/0000-0002-3246-8359; Kacprowski, Tim/0000-0002-5393-2413; Võsa, Urmo/0000-0003-3476-1652; Steri, Maristella/0000-0001-5869-3872; Magnusson, Patrik KE/0000-0002-7315-7899; Ciullo, Marina/0000-0002-9621-9984; Palmer, Lyle John/0000-0002-1628-3055; Waldenberger, Melanie/0000-0003-0583-5093; Gandin, Ilaria/0000-0003-3196-2491; Hicks, Andrew Anthony/0000-0001-6320-0411; Franco, Óscar H/0000-0002-4606-4929; Pennell, Craig/0000-0002-0937-6165; Mangino, Massimo/0000-0002-2167-7470; Vandenput, Liesbeth/0000-0002-1712-6131; Schurmann, Claudia/0000-0003-4158-9192; Karhunen, Ville/0000-0001-6064-1588; Ballantyne, Christie/0000-0002-6432-1730; Gambaro, Giovanni/0000-0001-5733-2370; Oldmeadow, Christopher/0000-0001-6104-1322; Bracewell, Daniel/0000-0003-3866-3304; Vuckovic, Dragana/0000-0001-9343-6142; ABBASI, ALI/0000-0002-6452-4765; Van Duijn, Cornelia/0000-0002-2374-9204; St Pourcain, Beate/0000-0002-4680-3517; Standl, Marie/0000-0002-5345-2049; Bandinelli, Stefania/0000-0002-6491-0850; Scott, William/0000-0001-5467-114X; Saba, Yasaman/0000-0002-3549-2493; Willemsen, Gonneke/0000-0003-3755-0236; Thiering, Elisabeth/0000-0002-5429-9584; Zaza, Gianluigi/0000-0002-6004-6196; Wild, Philipp/0000-0003-4413-9752; NUTILE, TERESA/0000-0001-7062-8352; Kahonen, Mika/0000-0002-4510-7341; Pers, Tune/0000-0003-0207-4831; de Geus, Eco/0000-0001-6022-2666; Uh, Hae-Won/0000-0003-4195-7872; Morris, Andrew/0000-0002-6805-6014; Joshi, Peter/0000-0002-6361-5059; Yengo, Loic/0000-0002-4272-9305; Feenstra, Bjarke/0000-0003-1478-649X; Ozel, Ayse Bilge/0000-0002-1112-4258; melbye, mads/0000-0001-8264-6785; Beilby, John/0000-0002-4915-2254; Sinisalo, Juha/0000-0002-0169-5137; Schork, Nicholas/0000-0003-0920-5013; Raikkonen, Katri/0000-0003-3124-3470; Kraft, Peter/0000-0002-4472-8103; McEvoy, Mark/0000-0002-5505-5557; Soranzo, Nicole/0000-0003-1095-3852; Pramstaller, Peter P/0000-0002-9831-8302; Scott, Rodney/0000-0001-7724-3404; Marioni, Riccardo/0000-0003-4430-4260; Zoledziewska, Magdalena/0000-0002-3033-6133; Nethander, Maria/0000-0003-3688-906X; concas, maria pina/0000-0003-3598-2537; Draisma, Harmen/0000-0001-6279-0368; CUCCA, Francesco/0000-0002-7414-1995; Pedersen, Nancy/0000-0001-8057-3543; Lindgren, Cecilia/0000-0002-4903-9374; Portas, Laura/0000-0003-1789-1893; den Hollander, Wouter/0000-0002-0061-9511; Penninx, Brenda WJH/0000-0001-7779-9672; Lorentzon, Mattias/0000-0003-0749-1431; Prins, Bram/0000-0001-5774-034X; Naderi, Elnaz/0000-0003-1671-7471; Verbanck, Marie/0000-0002-1669-572X; Koenig, Wolfgang/0000-0002-2064-9603; Zeller, Tanja/0000-0003-3379-2641; Robino, Antonietta/0000-0003-2152-2353	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, R01HL141399, U01HL130114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072193, U01DK062370, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG049638, P30AG010129] Funding Source: NIH RePORTER; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [MC_UU_12015/1, MC_UU_12013/4, MR/J012165/1, MR/K002414/1, MC_UU_00011/1, MC_UP_1605/7] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: Medline; Medical Research Council [MC_UU_12015/1, MR/J012165/1, MC_UU_00007/10, MC_PC_15018, MC_UU_00011/1, MR/K026992/1, MR/K002414/1, MC_UP_1605/7, MC_UU_12013/4, G9815508] Funding Source: Medline; NHLBI NIH HHS [U01 HL130114, R01 HL120393, R01 HL141399, R01 HL105756, U01 HL120393] Funding Source: Medline; NIA NIH HHS [P30 AG049638, P30 AG010129] Funding Source: Medline; NIDDK NIH HHS [P30 DK020572, U01 DK062370, R01 DK072193] Funding Source: Medline; NIH HHS [S10 OD020069] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alizadeh BZ, 2007, ANN RHEUM DIS, V66, P1436, DOI 10.1136/ard.2006.063099; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Blomstrom A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.142; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; de Vries PS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167742; Dehghan A, 2007, DIABETES, V56, P872, DOI 10.2337/db06-0922; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Fernandes BS, 2016, MOL PSYCHIATR, V21, P554, DOI 10.1038/mp.2015.87; Fernandes BS, 2016, LANCET PSYCHIAT, V3, P1147, DOI 10.1016/S2215-0366(16)30370-4; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Gardner RM, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.5; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Hartwig FP, 2017, JAMA PSYCHIAT, V74, P1226, DOI 10.1001/jamapsychiatry.2017.3191; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Khandaker GM, 2015, LANCET PSYCHIAT, V2, P258, DOI 10.1016/S2215-0366(14)00122-9; Kolde R., 2013, PHEATMAP PRETTY HEAT; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; MOSHAGE HJ, 1988, BIOCHEM BIOPH RES CO, V155, P112, DOI 10.1016/S0006-291X(88)81056-8; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pepys M.B., 1995, OXFORD TXB MED, VVolume 2, P1527; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Prins BP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001976; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; ROBINSON LD, 1991, INT STAT REV, V59, P227, DOI 10.2307/1403444; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wium-Andersen MK, 2014, SCHIZOPHRENIA BULL, V40, P1117, DOI 10.1093/schbul/sbt120; Wood AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064343; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613	54	146	147	9	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					691	706		10.1016/j.ajhg.2018.09.009	http://dx.doi.org/10.1016/j.ajhg.2018.09.009			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30388399	Green Submitted, Bronze, Green Accepted, Green Published			2022-12-18	WOS:000448942100006
J	Halbritter, J; Bizet, AA; Schmidts, M; Porath, JD; Braun, DA; Gee, HY; McInerney-Leo, AM; Krug, P; Filhol, E; Davis, EE; Airik, R; Czarnecki, PG; Lehman, AM; Trnka, P; Nitschke, P; Bole-Feysot, C; Schueler, M; Knebelmann, B; Burtey, S; Szabo, AJ; Tory, K; Leo, PJ; Gardiner, B; McKenzie, FA; Zankl, A; Brown, MA; Hartley, JL; Maher, ER; Li, CM; Leroux, MR; Scambler, PJ; Zhan, SH; Jones, SJ; Kayserili, H; Tuysuz, B; Moorani, KN; Constantinescu, A; Krantz, ID; Kaplan, BS; Shah, JV; Hurd, TW; Doherty, D; Katsanis, N; Duncan, EL; Otto, EA; Beales, PL; Mitchison, HM; Saunier, S; Hildebrandt, F				Halbritter, Jan; Bizet, Albane A.; Schmidts, Miriam; Porath, Jonathan D.; Braun, Daniela A.; Gee, Heon Yung; McInerney-Leo, Aideen M.; Krug, Pauline; Filhol, Emilie; Davis, Erica E.; Airik, Rannar; Czarnecki, Peter G.; Lehman, Anna M.; Trnka, Peter; Nitschke, Patrick; Bole-Feysot, Christine; Schueler, Markus; Knebelmann, Bertrand; Burtey, Stephane; Szabo, Attila J.; Tory, Kalman; Leo, Paul J.; Gardiner, Brooke; McKenzie, Fiona A.; Zankl, Andreas; Brown, Matthew A.; Hartley, Jane L.; Maher, Eamonn R.; Li, Chunmei; Leroux, Michel R.; Scambler, Peter J.; Zhan, Shing H.; Jones, Steven J.; Kayserili, Hulya; Tuysuz, Beyhan; Moorani, Khemchand N.; Constantinescu, Alexandru; Krantz, Ian D.; Kaplan, Bernard S.; Shah, Jagesh V.; Hurd, Toby W.; Doherty, Dan; Katsanis, Nicholas; Duncan, Emma L.; Otto, Edgar A.; Beales, Philip L.; Mitchison, Hannah M.; Saunier, Sophie; Hildebrandt, Friedhelm		UK10K Consortium	Defects in the IFT-B Component IFT172 Cause Jeune and Mainzer-Saldino Syndromes in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPHYXIATING THORACIC DYSTROPHY; INTRAFLAGELLAR TRANSPORT PROTEIN; RIB-POLYDACTYLY SYNDROME; VAN-CREVELD-SYNDROME; DYNC2H1 MUTATIONS; CILIOPATHY; DISEASE; GENE; CILIA; KIDNEY	Intraflagellar transport (IFT) depends on two evolutionarily conserved modules, subcomplexes A (IFT-A) and B (IFT-B), to drive ciliary assembly and maintenance. All six IFT-A components and their motor protein, DYNC2H1, have been linked to human skeletal ciliopathies, including asphyxiating thoracic dystrophy (ATD; also known as Jeune syndrome), Sensenbrenner syndrome, and Mainzer-Saldino syndrome (MZSDS). Conversely, the 14 subunits in the IFT-B module, with the exception of IFT80, have unknown roles in human disease. To identify additional IFT-B components defective in ciliopathies, we independently performed different mutation analyses: candidate-based sequencing of all IFT-B-encoding genes in 1,467 individuals with a nephronophthisis-related ciliopathy or whole-exome resequencing in 63 individuals with ATD. We thereby detected biallelic mutations in the IFT-B-encoding gene IFT172 in 12 families. All affected individuals displayed abnormalities of the thorax and/or long bones, as well as renal, hepatic, or retinal involvement, consistent with the diagnosis of ATD or MZSDS. Additionally, cerebellar aplasia or hypoplasia characteristic of Joubert syndrome was present in 2 out of 12 families. Fibroblasts from affected individuals showed disturbed ciliary composition, suggesting alteration of ciliary transport and signaling. Knockdown of ift172 in zebrafish recapitulated the human phenotype and demonstrated a genetic interaction between ift172 and ift80. In summary, we have identified defects in IFT172 as a cause of complex ATD and MZSDS. Our findings link the group of skeletal ciliopathies to an additional IFT-B component, IFT172, similar to what has been shown for IFT-A.	[Halbritter, Jan; Porath, Jonathan D.; Braun, Daniela A.; Gee, Heon Yung; Airik, Rannar; Schueler, Markus; Hildebrandt, Friedhelm] Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA; [Halbritter, Jan; Porath, Jonathan D.; Braun, Daniela A.; Gee, Heon Yung; Airik, Rannar; Schueler, Markus; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bizet, Albane A.; Krug, Pauline; Filhol, Emilie; Tory, Kalman; Saunier, Sophie] Hop Necker Enfants Malad, INSERM, U983, F-75015 Paris, France; [Bizet, Albane A.; Krug, Pauline; Filhol, Emilie; Saunier, Sophie] Paris Descartes Univ, Imagine Inst, Sorbonne Paris Cite, F-75015 Paris, France; [Schmidts, Miriam; Scambler, Peter J.; Beales, Philip L.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Schmidts, Miriam; Scambler, Peter J.; Beales, Philip L.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Birth Defects Res Ctr, London WC1N 1EH, England; [McInerney-Leo, Aideen M.; Leo, Paul J.; Gardiner, Brooke; Zankl, Andreas; Brown, Matthew A.; Duncan, Emma L.] Univ Queensland, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld 4102, Australia; [Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Czarnecki, Peter G.; Shah, Jagesh V.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Czarnecki, Peter G.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Czarnecki, Peter G.; Shah, Jagesh V.] Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lehman, Anna M.; Jones, Steven J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Trnka, Peter] Univ Queensland, Sch Paediat & Child Hlth, Herston, Qld 4029, Australia; [Nitschke, Patrick] Paris Descartes Univ, Sorbonne Paris Cite, Bioinformat Platform, F-75270 Paris, France; [Bole-Feysot, Christine] Imagine Inst, Genom Platform, F-75015 Paris, France; [Knebelmann, Bertrand] Hop Necker Enfants Malad, AP HP, Dept Nephrol, F-75015 Paris, France; [Burtey, Stephane] Hop Conception, Ctr Nephrol & Transplantat Renale, F-13005 Marseille, France; [Szabo, Attila J.; Tory, Kalman] Semmelweis Univ, Dept Pediat 1, H-1083 Budapest, Hungary; [McKenzie, Fiona A.] Genet Serv Western Australia, Subiaco, WA 6008, Australia; [McKenzie, Fiona A.; Duncan, Emma L.] Univ Western Australia, Sch Paediat & Child Hlth, Crawley, WA 6009, Australia; [Zankl, Andreas] Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia; [Zankl, Andreas] Univ Sydney, Sydney, NSW 2006, Australia; [Zankl, Andreas] Childrens Hosp Westmead, Acad Dept Med Genet, Sydney, NSW 2145, Australia; [Hartley, Jane L.] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England; [Maher, Eamonn R.] Univ Birmingham, Ctr Rare Dis & Personalised Med, Birmingham B15 2TT, W Midlands, England; [Maher, Eamonn R.] Univ Cambridge, Dept Med Genet, Cambridge CB2 0QQ, England; [Li, Chunmei; Leroux, Michel R.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Zhan, Shing H.; Jones, Steven J.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Istanbul, Turkey; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Med Sch, Dept Pediat, Div Pediat Genet, TR-34098 Istanbul, Turkey; [Moorani, Khemchand N.] Natl Inst Child Hlth, Dept Paediat Nephrol, Karachi 75510, Pakistan; [Constantinescu, Alexandru] Joe DiMaggio Childrens Hosp, Div Pediat Nephrol, Hollywood, FL 33021 USA; [Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Kaplan, Bernard S.] Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA; [Shah, Jagesh V.] Brigham & Womens Hosp, Boston, MA 02215 USA; [Hurd, Toby W.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Doherty, Dan] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Duncan, Emma L.] Royal Brisbane & Womens Hosp, Dept Endocrinol, Herston, Qld 4029, Australia; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of London; University College London; University of Queensland; Duke University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; University of British Columbia; University of Queensland; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Semmelweis University; University of Western Australia; University of Queensland; University of Sydney; University of Sydney; University of Birmingham; University of Birmingham; University of Cambridge; Simon Fraser University; British Columbia Cancer Agency; Istanbul University; Istanbul University; Istanbul University - Cerrahpasa; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Royal Brisbane & Women's Hospital; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA.	sophie.saunier@inserm.fr; friedhelm.hildebrandt@childrens.harvard.edu	Schueler, Markus/AAF-6057-2021; Schmidts, Miriam/A-3777-2012; Beales, Philip L/C-7367-2009; Saunier, Sophie/G-6044-2015; Leo, Paul/R-4464-2019; Leo, Paul J/B-3470-2011; Tüysüz, Beyhan/AAN-4858-2020; Mckenzie, Fiona/AAB-1456-2021; McInerney-Leo, Aideen M/D-8302-2016; Scambler, Peter/AAZ-6026-2020; Duncan, Emma L/L-1224-2013; Trnka, Peter/I-7700-2016; Braun, Daniela A/R-2259-2017; Brown, Matthew A/E-5749-2010; Jones, Steven J/C-3621-2009; Kayserili, Hülya/AAA-5593-2021; Airik, Rannar/AAS-7810-2021; Gardiner, Brooke B/C-7773-2011; Burtey, Stéphane/S-2433-2019; Lehman, Anna/R-6706-2017; Gee, Heon Yung/K-7781-2019; McInerney-Leo, Aideen M/E-1788-2018; Bizet, Albane/L-2622-2017	Schmidts, Miriam/0000-0002-1714-6749; Saunier, Sophie/0000-0002-1069-0047; Leo, Paul J/0000-0001-8325-4134; McInerney-Leo, Aideen M/0000-0002-0059-5732; Scambler, Peter/0000-0002-1487-4628; Duncan, Emma L/0000-0002-8143-4403; Trnka, Peter/0000-0002-5584-2622; Braun, Daniela A/0000-0003-3146-1566; Brown, Matthew A/0000-0003-0538-8211; Jones, Steven J/0000-0003-3394-2208; Kayserili, Hülya/0000-0003-0376-499X; Airik, Rannar/0000-0002-7055-6325; Gardiner, Brooke B/0000-0003-3740-3244; Burtey, Stéphane/0000-0003-1813-7884; Lehman, Anna/0000-0003-0636-123X; Gee, Heon Yung/0000-0002-8741-6177; Kelly, Kirsten/0000-0003-4234-543X; Katsanis, Nicholas/0000-0002-2480-0171; Bizet, Albane/0000-0003-4187-9659; Mitchison, Hannah/0000-0002-3163-6293; Zhan, Shing/0000-0002-6351-8873; Otto, Edgar/0000-0002-2387-9973; Tuysuz, Beyhan/0000-0002-9620-5021; Davis, Erica/0000-0002-2412-8397	Howard Hughes Medical Institute; National Institutes of Health; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Institute National de la Sante et de la Recherche Medicale; Imagine Institute; Wellcome Trust; Dutch Kidney Foundation; European Community; Royal Children's Hospital Brisbane Foundation; Newlife Foundation for Disabled Children UK; Action Medical Research UK; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1299] Funding Source: researchfish; Action Medical Research [1794] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, R01DK075972, R01DK072301, RC4DK090917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064077] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institute National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Imagine Institute; Wellcome Trust(Wellcome Trust); Dutch Kidney Foundation; European Community(European Commission); Royal Children's Hospital Brisbane Foundation; Newlife Foundation for Disabled Children UK; Action Medical Research UK; National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity; Action Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to all individuals with nephronophthisis-related ciliopathies, asphyxiating thoracic dystrophy, and Mainzer-Saldino syndrome and their family members for their participation. We further thank the investigators of the UK10K Consortium (www.uk10k.org) and the FORGE Canada Consortium, as well as the following funding agencies that supported this work: the Howard Hughes Medical Institute, the National Institutes of Health, the Agence Nationale de la Recherche, the Fondation pour la Recherche Medicale, the Institute National de la Sante et de la Recherche Medicale, the Imagine Institute, the Wellcome Trust, the Dutch Kidney Foundation, the European Community, the Royal Children's Hospital Brisbane Foundation, the Newlife Foundation for Disabled Children UK, and the Action Medical Research UK. Detailed Supplemental Acknowledgments can be found in the Supplemental Data.	Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Casteels I, 2000, Eur J Paediatr Neurol, V4, P243, DOI 10.1053/ejpn.2000.0313; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Czarnecki PG, 2012, TRENDS CELL BIOL, V22, P201, DOI 10.1016/j.tcb.2012.02.001; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Friedland-Little JM, 2011, HUM MOL GENET, V20, P3725, DOI 10.1093/hmg/ddr241; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Huber C, 2012, AM J MED GENET C, V160C, P165, DOI 10.1002/ajmg.c.31336; Lehman AM, 2010, AM J MED GENET A, V152A, P1411, DOI 10.1002/ajmg.a.33416; Lunt SC, 2009, DEV DYNAM, V238, P1744, DOI 10.1002/dvdy.21999; McInerney-Leo AM, 2013, AM J HUM GENET, V93, P515, DOI 10.1016/j.ajhg.2013.06.022; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; Perrault I, 2012, AM J HUM GENET, V90, P864, DOI 10.1016/j.ajhg.2012.03.006; Ruiz-Perez VL, 2003, AM J HUM GENET, V72, P728, DOI 10.1086/368063; Ruiz-Perez VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schmidts M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/humu.22294; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Tsao CC, 2008, MOL BIOL CELL, V19, P1450, DOI 10.1091/mbc.E07-05-0403; Tuysuz B, 2009, AM J MED GENET A, V149A, P1727, DOI 10.1002/ajmg.a.32962; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012	39	146	150	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					915	925		10.1016/j.ajhg.2013.09.012	http://dx.doi.org/10.1016/j.ajhg.2013.09.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24140113	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000326996600012
J	McLaughlin, HM; Sakaguchi, R; Liu, CP; Igarashi, T; Pehlivan, D; Chu, K; Iyer, R; Cruz, P; Cherukuri, PF; Hansen, NF; Mullikin, JC; Biesecker, LG; Wilson, TE; Ionasescu, V; Nicholson, G; Searby, C; Talbot, K; Vance, JM; Zuchner, S; Szigeti, K; Lupski, JR; Hou, YM; Green, ED; Antonellis, A				McLaughlin, Heather M.; Sakaguchi, Reiko; Liu, Cuiping; Igarashi, Takao; Pehlivan, Davut; Chu, Kristine; Iyer, Ram; Cruz, Pedro; Cherukuri, Praveen F.; Hansen, Nancy F.; Mullikin, James C.; Biesecker, Leslie G.; Wilson, Thomas E.; Ionasescu, Victor; Nicholson, Garth; Searby, Charles; Talbot, Kevin; Vance, Jeffrey M.; Zuchner, Stephan; Szigeti, Kinga; Lupski, James R.; Hou, Ya-Ming; Green, Eric D.; Antonellis, Anthony		NISC Comparative Sequencing	Compound Heterozygosity for Loss-of-Function Lysyl-tRNA Synthetase Mutations in a Patient with Peripheral Neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; HEREDITARY NEUROPATHY; MISSENSE MUTATIONS; MUSCULAR-ATROPHY; GENE; FORM; LIABILITY; ENZYMES; SERVER; 2D	Charcot-Mane-Tooth (CMT) disease comprises a genetically and clinically heterogeneous group of peripheral nerve disorders characterized by unpaired distal motor and sensory function Mutations in three genes encoding ammoacyl-tRNA synthetases (ARSs) have been implicated in CMT disease primarily associated with an axonal pathology ARSs are ubiquitously expressed, essential enzymes responsible for charging tRNA molecules with their cognate amino acids To further explore the role of ARSs in CMT disease, we performed a large-scale mutation screen of the 37 human ARS genes in a cohort of 355 patients with a phenotype consistent with CMT Here we describe three variants (p.Leu133His, p Tyr173SerfsX7, and p Ile302Met) in the lysyl-tRNA synthetase (KARS) gene in two patients from this cohort Functional analyses revealed that two of these mutations (pLeu133His and p Tyr173SerfsX7) severely affect enzyme activity. Interestingly, both functional variants were found in a single patient with CMT disease and additional neurological and non-neurological sequelae Based on these data, KARS becomes the fourth ARS gene associated with CMT disease, indicating that this family of enzymes is specifically critical for axon function.	[McLaughlin, Heather M.; Antonellis, Anthony] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA; [Sakaguchi, Reiko; Liu, Cuiping; Igarashi, Takao; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Pharmacol, Philadelphia, PA 19107 USA; [Pehlivan, Davut; Szigeti, Kinga; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Chu, Kristine; Cruz, Pedro; Cherukuri, Praveen F.; Hansen, Nancy F.; Mullikin, James C.; Green, Eric D.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Iyer, Ram; Wilson, Thomas E.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; [Mullikin, James C.; Green, Eric D.; NISC Comparative Sequencing] NHGRI, NIH Intramural Sequencing Ctr NISC, NIH, Bethesda, MD 20892 USA; [Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Ionasescu, Victor; Searby, Charles] Univ Iowa, Div Med Genet, Dept Pediat, Iowa City, IA 52242 USA; [Nicholson, Garth] Concord Hosp, Northcott Neurosci Lab, ANZAC Res Inst, Concord, NSW 2139, Australia; [Nicholson, Garth] Concord Hosp, Mol Med Lab, Concord, NSW 2139, Australia; [Nicholson, Garth] Univ Sydney, Fac Med, Camperdown, NSW 2006, Australia; [Talbot, Kevin] Univ Oxford, Dept Clin Neurol, Oxford OX1 3QX, England; [Vance, Jeffrey M.; Zuchner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Szigeti, Kinga] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Antonellis, Anthony] Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Jefferson University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Iowa; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; University of Sydney; University of Oxford; University of Miami; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Michigan System; University of Michigan	Antonellis, A (corresponding author), Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA.		Research Institute, ANZAC/CAE-9030-2022; Biesecker, Leslie/AAG-2526-2021; Talbot, Kevin/F-7361-2011; Sander-Effron, Samuel/AAX-2231-2020; Pehlivan, Davut/I-3235-2019; Cherukuri, Praveen/AFU-2005-2022; Resource Center, NINDS Human Genetics/AGF-2474-2022	Cherukuri, Praveen/0000-0002-9509-1245; Nicholson, Garth/0000-0001-9694-066X; Hou, Ya-Ming/0000-0001-6546-2597; Pehlivan, Davut/0000-0001-5788-0270; Talbot, Kevin/0000-0001-5490-1697; Vance, Jeffery/0000-0003-3815-8199; Searby, Charles/0000-0002-8108-8782	National Institute of Neurological Diseases and Stroke [R00NS060983]; National Human Genome Research Institute (NIH); National Human Genome Research Institute; NIH [T32 GM007544-32]; Muscular Dystrophy Association [157681]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIAHG200359, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS060983] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to the patients and their families for their participation in this study We thank Ellen Pederson, Bob Lyons, and the University of Michigan DNA Sequencing Core for sequencing and genotyping assistance, Jeffrey Innis and the Michigan Medical Genetics Laboratory for anonymized DNA samples, Giovanni Manfredi and Kiyotaka Shiba for KARS cDNA constructs, and Jiqiang Ling and Dieter Soil for sharing unpublished data We are also very grateful to the two anonymous reviewers for their helpful comments and suggestions, which dramatically improved the study. This work was supported in part by grant R00NS060983 from the National Institute of Neurological Diseases and Stroke (AA) and by the Intramural Research Program of the National Human Genome Research Institute (NIH). The ClinSeq cohort and sequencing were also supported by Intramural Funding from the National Human Genome Research Institute H M M was supported by the Rackham Merit Fellowship and the NIH Genetics Training Grant T32 GM007544-32 Y.-M H. and R.S were supported by a grant from the Muscular Dystrophy Association (157681 to Y-M H).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Chung KW, 2005, NEUROGENETICS, V6, P159, DOI 10.1007/s10048-005-0217-4; DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; Hodapp JA, 2006, ARCH NEUROL-CHICAGO, V63, P112, DOI 10.1001/archneur.63.1.112; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kovaleski BJ, 2006, J BIOL CHEM, V281, P19449, DOI 10.1074/jbc.M601189200; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Li J, 2002, NEUROLOGY, V58, P1769, DOI 10.1212/WNL.58.12.1769; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Meggouh F, 2005, ANN NEUROL, V57, P589, DOI 10.1002/ana.20434; Murakami T, 1996, MEDICINE, V75, P233, DOI 10.1097/00005792-199609000-00001; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Nelis E, 1997, HUM MUTAT, V9, P47, DOI 10.1002/(SICI)1098-1004(1997)9:1<47::AID-HUMU8>3.0.CO;2-M; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nicholson G, 2006, NEUROMOL MED, V8, P123, DOI 10.1385/NMM:8:1:123; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reilly Mary M, 2007, Pract Neurol, V7, P93; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; SKRE H, 1974, CLIN GENET, V6, P98; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200	33	146	147	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					560	566		10.1016/j.ajhg.2010.09.008	http://dx.doi.org/10.1016/j.ajhg.2010.09.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20920668	Green Published, Bronze			2022-12-18	WOS:000283037600013
J	Ben-Shachar, S; Ou, Z; Shaw, CA; Belmont, JW; Patel, MS; Hummel, M; Amato, S; Tartaglia, N; Berg, J; Sutton, VR; Lalani, SR; Chinault, AC; Cheung, SW; Lupski, JR; Patel, A				Ben-Shachar, Shay; Ou, Zhishuo; Shaw, Chad A.; Belmont, John W.; Patel, Millan S.; Hummel, Marybeth; Amato, Stephen; Tartaglia, Nicole; Berg, Jonathan; Sutton, V. Reid; Lalani, Seema R.; Chinault, A. Craig; Cheung, Sau W.; Lupski, James R.; Patel, Ankita			22q11.2 distal deletion: A recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL-SYNDROME; SYNDROME CRITICAL REGION; LOW COPY REPEATS; CLINICAL-FEATURES; CHROMOSOME 22Q11; NO OVERLAP; MICRODELETION; ANOMALIES; PATIENT; REARRANGEMENTS	Microdeletions within chromosome 22q11.2 cause a variable phenotype, including DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS). About 97% of patients with DGS/VCFS have either a common recurrent similar to 3 Mb deletion or a smaller, less common, similar to 1.5 Mb nested deletion. Both deletions apparently occur as a result of homologous recombination between nonallelic flanking low-copy repeat (LCR) sequences located in 22q11.2. Interestingly, although eight different LCRs are located in proximal 22q, only a few cases of atypical deletions utilizing alternative LCRs have been described. Using array-based comparative genomic hybridization (CGH) analysis, we have detected six unrelated cases of deletions that are within 22q11.2 and are located distal to the similar to 3 Mb common deletion region. Further analyses revealed that the rearrangements had clustered breakpoints and either a similar to 1.4 Mb or similar to 2.1 Mb recurrent deletion flanked proximally by LCR22-4 and distally by either LCR22-5 or LCR22-6, respectively. Parental fluorescence in situ hybridization (FISH) analyses revealed that none of the available parents (11 out of 12 were available) had the deletion, indicating de novo, events. All patients presented with characteristic facial dysmorphic features. A history of prematurity, prenatal and postnatal growth delay, developmental delay, and mild skeletal abnormalities was prevalent among the patients. Two patients were found to have a cardiovascular malformation, one had truncus arteriosus, and another had a bicuspid aortic valve. A single patient had a cleft palate. We conclude that distal deletions of chromosome 22q11.2 between LCR22-4 and LCR22-6, although they share some characteristic features with DGS/VCFS, represent a novel genomic disorder distinct genomically and clinically from the well-known DGS/VCF deletion syndromes.	[Ben-Shachar, Shay; Ou, Zhishuo; Shaw, Chad A.; Belmont, John W.; Berg, Jonathan; Sutton, V. Reid; Lalani, Seema R.; Chinault, A. Craig; Cheung, Sau W.; Lupski, James R.; Patel, Ankita] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Patel, Millan S.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Hummel, Marybeth] W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA; [Amato, Stephen] Eastern Maine Med Ctr, Dept Med Genet, Bangor, ME 04401 USA; [Tartaglia, Nicole] Univ Calif Davis, Med Ctr, Dept Pediat, MIND Inst, Sacramento, CA 95817 USA	Baylor College of Medicine; University of British Columbia; West Virginia University; Eastern Maine Medical Center; University of California System; University of California Davis	Patel, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	ankitap@bcm.tmc.edu	Lalani, Seema/AAI-5090-2020; Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021; Patel, Ankita/D-3247-2013	Belmont, John W/0000-0001-7409-3578; /0000-0001-7061-6837; Shaw, Chad/0000-0001-7267-5398; Tartaglia, Nicole/0000-0002-8529-6722				Amati F, 1999, EUR J HUM GENET, V7, P903, DOI 10.1038/sj.ejhg.5200399; Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Emanuel B S, 2001, Adv Pediatr, V48, P39; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Garcia-Minaur S, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.10.e62; Goc B, 2006, J APPL GENET, V47, P165, DOI 10.1007/BF03194617; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Hamilton BE, 2007, PEDIATRICS, V119, P345, DOI 10.1542/peds.2006-3226; Iserin L, 1998, EUR J PEDIATR, V157, P881, DOI 10.1007/s004310050959; JONES KL, 2006, SMITHS RECOGNIZABLE, V6; Kerstjens-Frederikse WS, 1999, J MED GENET, V36, P721; Kurahashi H, 1997, AM J MED GENET, V72, P180, DOI 10.1002/(SICI)1096-8628(19971017)72:2<180::AID-AJMG10>3.0.CO;2-J; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; McDonald-McGinn DM, 1999, GENET COUNSEL, V10, P11; McQuade L, 1999, AM J MED GENET, V86, P27, DOI 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7; Mikhail FM, 2007, AM J MED GENET A, V143A, P2178, DOI 10.1002/ajmg.a.31882; Ming JE, 1997, AM J MED GENET, V72, P210, DOI 10.1002/(SICI)1096-8628(19971017)72:2<210::AID-AJMG16>3.0.CO;2-Q; ODonnell H, 1997, AM J HUM GENET, V60, P1544; OU Z, IN PRESS GENET MED; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Rauch A, 1999, AM J HUM GENET, V64, P659, DOI 10.1086/302235; Rauch A, 2005, J MED GENET, V42, P871, DOI 10.1136/jmg.2004.030619; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Saitta SC, 1999, AM J HUM GENET, V65, P562, DOI 10.1086/302514; Scambler PJ, 2000, HUM MOL GENET, V9, P2421, DOI 10.1093/hmg/9.16.2421; Shaikh TH, 2007, GENOME RES, V17, P482, DOI 10.1101/gr.5986507; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Smyk M, 2007, HUM GENET, V122, P63, DOI 10.1007/s00439-007-0373-8; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; WILSON MS, 1992, J APPL ELECTROCHEM, V22, P1, DOI 10.1007/BF01093004	39	146	148	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					214	221		10.1016/j.ajhg.2007.09.014	http://dx.doi.org/10.1016/j.ajhg.2007.09.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179902	Green Published, Bronze			2022-12-18	WOS:000253223800024
J	Ellard, S; Flanagan, SE; Girard, CA; Patch, AM; Harries, LW; Parrish, A; Edghill, EL; Mackay, DJG; Proks, P; Shimomura, K; Haberland, H; Carson, DJ; Shield, JPH; Hattersley, AT; Ashcroft, FM				Ellard, Sian; Flanagan, Sarah E.; Girard, Christophe A.; Patch, Ann-Marie; Harries, Lorna W.; Parrish, Andrew; Edghill, Emma L.; Mackay, Deborah J. G.; Proks, Peter; Shimomura, Kenju; Haberland, Holger; Carson, Dennis J.; Shield, Julian P. H.; Hattersley, Andrew T.; Ashcroft, Frances M.			Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; AFFINITY SULFONYLUREA RECEPTOR; ACTIVATING MUTATIONS; KIR6.2; GENE; THERAPY; INFANCY; INSULIN; KCNJ11; MELLITUS	Heterozygous activating mutations in the KCNj11 gene encoding the pore-forming Kir6.2 subunit of the pancreatic beta cell KAT, channel are the most common cause of permanent neonatal diabetes (PNDM). Patients with PNDM due to a heterozygous activating mutation in the ABCC8 gene encoding the SUR1 regulatory subunit of the K-ATP, channel have recently been reported. We studied a cohort of 59 patients with permanent diabetes who received a diagnosis before 6 mo of a-e and who did not have a KCNJ11 mutation. ABCC8 gene mutations were identified in 16 of 59 patients and included 8 patients with heterozygous de novo mutations. A recessive mode of inheritance was observed in eight patients with homozygous, mosaic, or compound heterozygous mutations. Functional studies of selected mutations showed a reduced response to ATP consistent with an activating mutation that results in reduced insulin secretion. A novel mutational mechanism was observed in which a heterozygous activating mutation resulted in PNDM only when a second, loss-of-function mutation was also present.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; Univ Oxford, Physiol Lab, Oxford OX1 2JD, England; Salisbury Dist Hosp, Wessex Reg Genet Labs, Salisbury, Wilts, England; Sana Klinikum Lichtenberg, Dept Paediat, Berlin, Germany; Queens Univ Belfast, Dept Child Hlth, Belfast BT7 1NN, Antrim, North Ireland; Univ Bristol, Bristol BS8 1TH, Avon, England; Bristol Royal Hosp Children, Bristol, Avon, England	University of Exeter; University of Oxford; Salisbury District Hospital; Queens University Belfast; University of Bristol; Bristol Royal Hospital For Children	Hattersley, AT (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Barrack Rd, Exeter EX2 5DW, Devon, England.	A.T.Hattersley@exeter.ac.uk	Harries, Lorna/D-2241-2014; Girard, Christophe/O-8455-2016; Patch, Ann-Marie/C-4201-2018; Patch, Ann-Marie/F-8060-2011; Shield, Julian PH/D-6297-2014; Mackay, Deborah JG/B-2879-2015	Girard, Christophe/0000-0002-4560-4479; Patch, Ann-Marie/0000-0001-6121-4019; Shield, Julian PH/0000-0003-2601-7575; Mackay, Deborah JG/0000-0003-3088-4401; Flanagan, Sarah/0000-0002-8670-6340; Proks, Peter/0000-0001-6097-3646; Ellard, Sian/0000-0002-7620-5526; Harries, Lorna/0000-0001-7791-8061; Hattersley, Andrew/0000-0001-5620-473X	Wellcome Trust [lshm-ct-2006-518153] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Codner Ethel, 2007, Diabetes Care, V30, pe28, DOI 10.2337/dc06-2134; Flanagan SE, 2006, DIABETOLOGIA, V49, P1190, DOI 10.1007/s00125-006-0246-z; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; GRIBBLE RM, 1997, EMBO J, V16, P1145; Hansen T, 1998, DIABETES, V47, P598, DOI 10.2337/diabetes.47.4.598; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Huopio H, 2000, J CLIN INVEST, V106, P897, DOI 10.1172/JCI9804; Masia R, 2007, DIABETES, V56, P1357, DOI 10.2337/db06-1746; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Proks P, 2006, DIABETES, V55, P1731, DOI 10.2337/db05-1420; Stanik J, 2007, J CLIN ENDOCR METAB, V92, P1276, DOI 10.1210/jc.2006-2490; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Thornton PS, 2003, DIABETES, V52, P2403, DOI 10.2337/diabetes.52.9.2403	20	146	159	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					375	382		10.1086/519174	http://dx.doi.org/10.1086/519174			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668386	Green Published, Bronze			2022-12-18	WOS:000248540400016
J	Thomas, DC; Haile, RW; Duggan, D				Thomas, DC; Haile, RW; Duggan, D			Recent developments in genomewide association scans: A workshop summary and review	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							FALSE DISCOVERY RATES; POPULATION STRATIFICATION; LINKAGE-DISEQUILIBRIUM; GENOTYPING ERRORS; WIDE ASSOCIATION; COMPLEX DISEASES; 2-STAGE DESIGNS; RARE VARIANTS; GENE; SUSCEPTIBILITY	With the imminent availability of ultra-high-volume genotyping platforms (on the order of 100,000-1,000,000 genotypes per sample) at a manageable cost, there is growing interest in the possibility of conducting genomewide association studies for a variety of diseases but, so far, little consensus on methods to design and analyze them. In April 2005, an international group of 1100 investigators convened at the University of Southern California over the course of 2 days to compare notes on planned or ongoing studies and to debate alternative technologies, study designs, and statistical methods. This report summarizes these discussions in the context of the relevant literature. A broad consensus emerged that the time was now ripe for launching such studies, and several common themes were identified-most notably the considerable efficiency gains of multistage sampling design, specifically those made by testing only a portion of the subjects with a high-density genomewide technology, followed by testing additional subjects and/or additional SNPs at regions identified by this initial scan.	Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; Translat Genom Res Inst TGen, Phoenix, AZ USA	University of Southern California; Translational Genomics Research Institute	Thomas, DC (corresponding author), Univ So Calif, Dept Prevent Med, 1540 Alcazar St, Los Angeles, CA 90089 USA.	dthomas@usc.edu			NATIONAL CANCER INSTITUTE [U01CA074799] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA074799] Funding Source: Medline; NHGRI NIH HHS [P50 HG002790, 1P50 HG002790] Funding Source: Medline; NIEHS NIH HHS [P30 ES007048, 5P30 ES07048] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Barratt BJ, 2002, ANN HUM GENET, V66, P393, DOI [10.1046/j.1469-1809.2002.00125.x, 10.1017/S0003480002001252]; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cargill M, 2000, Pharmacogenomics, V1, P27, DOI 10.1517/14622416.1.1.27; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Fearnhead NS, 2004, P NATL ACAD SCI USA, V101, P15992, DOI 10.1073/pnas.0407187101; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Gordon D., 2004, STAT APPL GENET MOL, V3, P1; Hao K, 2004, HUM HERED, V58, P154, DOI 10.1159/000083542; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; LANGHOLZ B, 1999, MONOGR NATL CANC I, V26, P39; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lin Z, 2004, AM J HUM GENET, V75, P850, DOI 10.1086/425587; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; MACK TM, 1995, NEW ENGL J MED, V332, P413, DOI 10.1056/NEJM199502163320701; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Newton MA, 1998, STAT MED, V17, P1425, DOI 10.1002/(SICI)1097-0258(19980715)17:13<1425::AID-SIM861>3.0.CO;2-V; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; PALMER LJ, IN PRESS LANCET; Pfeiffer RM, 2002, GENET EPIDEMIOL, V22, P94, DOI 10.1002/gepi.1046; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rice KM, 2003, ANN HUM GENET, V67, P165, DOI 10.1046/j.1469-1809.2003.00020.x; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sabatti C, 2003, GENETICS, V164, P829; Satagopan JM, 2003, GENET EPIDEMIOL, V25, P149, DOI 10.1002/gepi.10260; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Sidow A, 2002, CELL, V111, P13, DOI 10.1016/S0092-8674(02)01003-6; SOBELL JL, 1993, AM J MED GENET, V48, P28, DOI 10.1002/ajmg.1320480108; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Thomas D, 2004, GENET EPIDEMIOL, V27, P401, DOI 10.1002/gepi.20047; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; van den Oord EJCG, 2003, HUM HERED, V56, P188, DOI 10.1159/000076393; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang WYS, 2003, GENET EPIDEMIOL, V24, P36, DOI 10.1002/gepi.10216; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wijsman EM, 2003, MOL PSYCHIATR, V8, P695, DOI 10.1038/sj.mp.4001356; Witte JS, 1999, AM J EPIDEMIOL, V149, P693; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhu Y, 2004, CANCER RES, V64, P2251, DOI 10.1158/0008-5472.CAN-03-2800	82	146	155	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					337	345		10.1086/432962	http://dx.doi.org/10.1086/432962			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080110	Green Published, Bronze			2022-12-18	WOS:000231314100001
J	Becker, T; Knapp, M				Becker, T; Knapp, M			A powerful strategy to account for multiple testing in the context of haplotype analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TIGHTLY LINKED MARKERS; MONTE-CARLO PROCEDURES; EMPIRICAL P-VALUES; LINKAGE DISEQUILIBRIUM; GENETIC-VARIATION; 6P22.3 GENE; ASSOCIATION; INFORMATION; EFFICIENCY; DISEASE	Haplotypes - that is, linear arrangements of alleles on the same chromosome that were inherited as a unit - are expected to carry important information in the context of association fine mapping of complex diseases. In consideration of a set of tightly linked markers, there is an enormous number of different marker combinations that can be analyzed. Therefore, a severe multiple-testing problem is introduced. One method to deal with this problem is Bonferroni correction by the number of combinations that are considered. Bonferroni correction is appropriate for independent tests but will result in a loss of power in the presence of linkage disequilibrium in the region. A second method is to perform simulations. It is unfortunate that most methods of haplotype analysis already require simulations to obtain an uncorrected P value for a specific marker combination. Thus, it seems that nested simulations are necessary to obtain P values that are corrected for multiple testing, which, apparently, limits the applicability of this approach because of computer running-time restrictions. Here, an algorithm is described that avoids such nested simulations. We check the validity of our approach under two disease models for haplotype analysis of family data. The true type I error rate of our algorithm corresponds to the nominal significance level. Furthermore, we observe a strong gain in power with our method to obtain the global P value, compared with the Bonferroni procedure to calculate the global P value. The method described here has been implemented in the latest update of our program FAMHAP.	Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany	University of Bonn	Becker, T (corresponding author), Univ Bonn, Inst Med Biometry Informat & Epidemiol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	becker@imsdd.meb.uni-bonn.de		Becker, Tim/0000-0002-6573-1109				Becker T, 2004, GENET EPIDEMIOL, V27, P21, DOI 10.1002/gepi.10323; Becker T, 2002, HUM HERED, V54, P45, DOI 10.1159/000066692; Broman KW, 2003, AM J HUM GENET, V72, P496, DOI 10.1086/346175; Ewens WJ, 2003, AM J HUM GENET, V72, P496, DOI 10.1086/346174; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811; Jannot AS, 2003, GENET EPIDEMIOL, V25, P158, DOI 10.1002/gepi.10256; Kaplan N, 2001, GENET EPIDEMIOL, V20, P432, DOI 10.1002/gepi.1012; Knapp M, 2003, HUM HERED, V56, P2, DOI 10.1159/000073727; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; North BV, 2003, AM J HUM GENET, V72, P498, DOI 10.1086/346173; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Schaid DJ, 2002, GENET EPIDEMIOL, V23, P426, DOI 10.1002/gepi.10184; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Westfall P.H., 1993, RESAMPLING BASED MUL; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073	22	146	146	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					561	570		10.1086/424390	http://dx.doi.org/10.1086/424390			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15290652	Green Published, Bronze			2022-12-18	WOS:000223634100003
J	Graham, RR; Ortmann, WA; Langefeld, CD; Jawaheer, D; Selby, SA; Rodine, PR; Baechler, EC; Rohlf, KE; Shark, KB; Espe, KJ; Green, LE; Nair, RP; Stuart, PE; Elder, JT; King, RA; Moser, KL; Gaffney, PM; Bugawan, TL; Erlich, HA; Rich, SS; Gregersen, PK; Behrens, TW				Graham, RR; Ortmann, WA; Langefeld, CD; Jawaheer, D; Selby, SA; Rodine, PR; Baechler, EC; Rohlf, KE; Shark, KB; Espe, KJ; Green, LE; Nair, RP; Stuart, PE; Elder, JT; King, RA; Moser, KL; Gaffney, PM; Bugawan, TL; Erlich, HA; Rich, SS; Gregersen, PK; Behrens, TW			Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SIB-PAIR FAMILIES; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; HLA-C; REGION; ASSOCIATION; DISEASE; GENE	Human leukocyte antigen (HLA) class I and class II alleles are implicated as genetic risk factors for many autoimmune diseases. However, the role of the HLA loci in human systemic lupus erythematosus (SLE) remains unclear. Using a dense map of polymorphic microsatellites across the HLA region in a large collection of families with SLE, we identified three distinct haplotypes that encompassed the class II region and exhibited transmission distortion. DRB1 and DQB1 typing of founders showed that the three haplotypes contained DRB1*1501/DQB1*0602, DRB1*0801/DQB1*0402, and DRB1*0301/DQB1*0201 alleles, respectively. By visualizing ancestral recombinants, we narrowed the disease-associated haplotypes containing DRB1*1501 and DRB1*0801 to an 500-kb region. We conclude that HLA class II haplotypes containing DRB1 and DQB1 alleles are strong risk factors for human SLE.	Univ Minnesota, Sch Med, Dept Med, Div Rheumat & Autoimmune Dis, Minneapolis, MN 55455 USA; Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27109 USA; N Shore Univ Hosp, Div Biol & Human Genet, Manhasset, NY USA; Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; Roche Mol Syst, Dept Human Genet, Alameda, CA USA	University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Northwell Health; North Shore University Hospital; University of Michigan System; University of Michigan; Roche Holding	Behrens, TW (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Rheumat & Autoimmune Dis, 6-126 BSBE Bldg,312 Church St SE, Minneapolis, MN 55455 USA.		Jawaheer, Damini/AFR-8556-2022; Gillespie, Emily/N-1265-2013	Gillespie, Emily/0000-0001-5261-3931; Jawaheer, Damini/0000-0003-4954-874X; Rich, Stephen/0000-0003-3872-7793; Gaffney, Patrick/0000-0002-1580-869X	NATIONAL CANCER INSTITUTE [F32CA072232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043274, N01AR072232, P50AR045231] Funding Source: NIH RePORTER; NCI NIH HHS [N01AR72232] Funding Source: Medline; NIAMS NIH HHS [N01-AR72232, R01-AR44222, R01 AR043274, P01-AR45231, R01-AR43274] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Dawkins R, 1999, IMMUNOL REV, V167, P275, DOI 10.1111/j.1600-065X.1999.tb01399.x; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Gaffney PM, 2002, RHEUM DIS CLIN N AM, V28, P111, DOI 10.1016/S0889-857X(03)00072-3; Graham RR, 2001, ARTHRITIS RES, V3, P299, DOI 10.1186/ar319; Harley JB, 1998, CURR OPIN IMMUNOL, V10, P690, DOI 10.1016/S0952-7915(98)80090-3; HOCHBERG MC, 1997, DUBOIS LUPUS ERYTHEM, P49; Jawaheer D, 2002, AM J HUM GENET, V71, P585, DOI 10.1086/342407; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Koeleman BPC, 2000, ANN HUM GENET, V64, P215, DOI 10.1017/S0003480000008101; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; Ota M, 1999, AM J HUM GENET, V64, P1406, DOI 10.1086/302364; Rhodes D A, 1999, Rev Immunogenet, V1, P21; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rood MJ, 2000, ARTHRITIS RHEUM, V43, P129, DOI 10.1002/1529-0131(200001)43:1<129::AID-ANR16>3.0.CO;2-S; SNELL GD, 1948, J GENET, V49, P87, DOI 10.1007/BF02986826; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Tan Filemon K., 1998, Current Opinion in Rheumatology, V10, P399, DOI 10.1097/00002281-199809000-00002; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Vyse TJ, 1998, ANNU REV IMMUNOL, V16, P261, DOI 10.1146/annurev.immunol.16.1.261; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Zavattari P, 2001, HUM MOL GENET, V10, P881, DOI 10.1093/hmg/10.8.881	35	146	152	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					543	553		10.1086/342290	http://dx.doi.org/10.1086/342290			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12145745	Bronze, Green Published			2022-12-18	WOS:000177489600008
J	Baron, M				Baron, M			Genetics of schizophrenia and the new millennium: Progress and pitfalls	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GENOME-WIDE SEARCH; MAJOR SUSCEPTIBILITY LOCUS; FAMILIAL SCHIZOPHRENIA; VULNERABILITY LOCUS; POTENTIAL LINKAGE; COMPLEX TRAITS; FOLLOW-UP; PSYCHIATRIC-DISORDERS; SUGGESTIVE EVIDENCE; PERIODIC CATATONIA		Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Med Genet, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Baron, M (corresponding author), Columbia Univ, Dept Psychiat, 1051 Riverside Dr,Unit 6, New York, NY 10032 USA.	mb17@columbia.edu						[Anonymous], 1998, Psychiatr Genet, V8, P59; ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; ASHERSON P, 1994, BRIT J PSYCHIAT, V164, P619, DOI 10.1192/bjp.164.5.619; Austin CP, 1999, MOL PSYCHIATR, V4, P261, DOI 10.1038/sj.mp.4000548; BARON M, 1986, BIOL PSYCHIAT, V21, P1189, DOI 10.1016/0006-3223(86)90225-8; BARON M, 1982, ACTA PSYCHIAT SCAND, V65, P253, DOI 10.1111/j.1600-0447.1982.tb00845.x; Baron M, 2000, PSYCHIATR GENET, V10, P55, DOI 10.1097/00041444-200010010-00010; BARON M, 1988, BRIT J PSYCHIAT, V152, P741, DOI 10.1192/bjp.152.6.741; BARON M, 1990, NATURE, V346, P618, DOI 10.1038/346618a0; Baron M, 1997, MOL PSYCHIATR, V2, P278, DOI 10.1038/sj.mp.4000276; BARON M, 1986, BIOL PSYCHIAT, V21, P1051, DOI 10.1016/0006-3223(86)90286-6; Baron M, 2001, MOL PSYCHIATR, V6, P143, DOI 10.1038/sj.mp.4000845; BARON M, 1990, BRIT J PSYCHIAT, V157, P645, DOI 10.1192/bjp.157.5.645; BASSETT AS, 1992, BRIT J PSYCHIAT, V161, P323, DOI 10.1192/bjp.161.3.323; BASSETT AS, 1988, LANCET, V1, P799; Bennett RL, 1997, AM J HUM GENET, V61, P1450, DOI 10.1086/301634; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Brzustowicz LM, 1997, AM J HUM GENET, V61, P1388, DOI 10.1086/301623; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; CLONINGER CR, 1994, AM J MED GENET, V54, P83, DOI 10.1002/ajmg.1320540202; COON H, 1994, AM J MED GENET, V54, P72, DOI 10.1002/ajmg.1320540112; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; CROWE RR, 1993, AM J MED GENET, V48, P74, DOI 10.1002/ajmg.1320480203; Dann J, 1997, PSYCHIAT RES, V70, P131, DOI 10.1016/S0165-1781(97)03138-7; DELISI LE, 1994, SCHIZOPHRENIA BULL, V20, P495, DOI 10.1093/schbul/20.3.495; DeLisi LE, 1999, AM J MED GENET, V88, P215, DOI 10.1002/(SICI)1096-8628(19990618)88:3<215::AID-AJMG1>3.3.CO;2-I; DELISI LE, 1994, AM J MED GENET, V54, P113, DOI 10.1002/ajmg.1320540206; DeLisi LE, 2000, AM J MED GENET, V96, P434, DOI 10.1002/1096-8628(20000612)96:3<434::AID-AJMG40>3.0.CO;2-C; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Dror V, 1999, MOL PSYCHIATR, V4, P254, DOI 10.1038/sj.mp.4000508; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Foroud T, 2000, AM J MED GENET, V96, P18, DOI 10.1002/(SICI)1096-8628(20000207)96:1<18::AID-AJMG6>3.3.CO;2-7; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; FREEMAN WH, 1991, SCHIZOPHRENIA GENESI; GAROFALO G, 1993, ANN GENET-PARIS, V36, P132; GENES BM, 1995, ACTA PSYCHIAT SCAND, V92, P81, DOI 10.1111/j.1600-0447.1995.tb09547.x; GERSHON ES, 1988, ARCH GEN PSYCHIAT, V45, P328; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Goldgar DE, 1997, AM J HUM GENET, V60, P1222; GORDON CT, 1994, J AUTISM DEV DISORD, V24, P537, DOI 10.1007/BF02172134; Greenberg DA, 1998, AM J HUM GENET, V62, P202, DOI 10.1086/301690; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hoh JJ, 2000, HUM HERED, V50, P85, DOI 10.1159/000022894; HOLZMAN PS, 1988, ARCH GEN PSYCHIAT, V45, P641; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; JUDD LL, 1992, AM J PSYCHIAT, V149, P488; Kainulainen K, 1999, HYPERTENSION, V33, P844, DOI 10.1161/01.HYP.33.3.844; Kalsi G, 1999, ANN HUM GENET, V63, P235, DOI 10.1046/j.1469-1809.1999.6330235.x; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; Kendler KS, 2000, AM J PSYCHIAT, V157, P402, DOI 10.1176/appi.ajp.157.3.402; KENDLER KS, 1994, AM J PSYCHIAT, V151, P849; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; KIDD KK, 1993, AM J MED GENET, V48, P71, DOI 10.1002/ajmg.1320480202; Kruglyak L, 1997, AM J HUM GENET, V61, P254; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LASSETER VK, 1995, AM J MED GENET, V60, P172, DOI 10.1002/ajmg.1320600217; LEBOYER M, 1992, PSYCHIAT RES, V41, P107, DOI 10.1016/0165-1781(92)90103-A; Leonard S, 1998, AM J MED GENET, V81, P308, DOI 10.1002/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; LEVY DL, 1993, SCHIZOPHRENIA BULL, V19, P461, DOI 10.1093/schbul/19.3.461; Lin HK, 1997, ACTA PHYS-CHIM SIN, V13, P417, DOI 10.3866/PKU.WHXB19970507; Lucek P, 1998, HUM HERED, V48, P275, DOI 10.1159/000022816; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; MALASPINA D, 1992, SCHIZOPHR RES, V7, P191, DOI 10.1016/0920-9964(92)90050-F; MARTIN JB, 1987, SCIENCE, V238, P765, DOI 10.1126/science.2890208; Martinez M, 1999, AM J MED GENET, V88, P337, DOI 10.1002/(SICI)1096-8628(19990820)88:4<337::AID-AJMG9>3.3.CO;2-1; MAZIADE M, 1993, ARCH GEN PSYCHIAT, V50, P73; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; MORRIS AG, 1995, HUM MOL GENET, V4, P1957, DOI 10.1093/hmg/4.10.1957; Myles-Worsley M, 1999, AM J MED GENET, V88, P544, DOI 10.1002/(SICI)1096-8628(19991015)88:5<544::AID-AJMG20>3.0.CO;2-V; NANKO S, 1993, BIOL PSYCHIAT, V33, P655, DOI 10.1016/0006-3223(93)90107-O; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; ONG SH, 1995, PSYCHIATR GENET, V5, P67, DOI 10.1097/00041444-199522000-00004; Ott J, 2000, AM J HUM GENET, V67, P289, DOI 10.1086/303031; Owen MJ, 1996, MOL PSYCHIATR, V1, P21; Owen MJ, 1997, MOL PSYCHIATR, V2, P270, DOI 10.1038/sj.mp.4000292; OWEN MJ, 1992, PSYCHOL MED, V22, P289, DOI 10.1017/S0033291700030221; PALMOUR RM, 1994, J PSYCHIATR NEUROSCI, V19, P270; PAULS DL, 1993, NAT GENET, V3, P4, DOI 10.1038/ng0193-4; POLYMEROPOULOS MH, 1994, AM J MED GENET, V54, P93, DOI 10.1002/ajmg.1320540203; Pulver AE, 2000, MOL PSYCHIATR, V5, P650, DOI 10.1038/sj.mp.4000814; PULVER AE, 1994, AM J MED GENET, V54, P44, DOI 10.1002/ajmg.1320540109; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; Rao DC, 2000, HUM HERED, V50, P34, DOI 10.1159/000022889; Rice JP, 1997, AM J MED GENET, V74, P112, DOI 10.1002/(SICI)1096-8628(19970221)74:1<112::AID-AJMG22>3.0.CO;2-T; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sasaki T, 1996, HUM GENET, V97, P244, DOI 10.1007/BF02265274; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; Schwab SG, 1998, AM J HUM GENET, V63, P1139, DOI 10.1086/302046; Schwab SG, 1998, AM J MED GENET, V81, P302, DOI 10.1002/(SICI)1096-8628(19980710)81:4<302::AID-AJMG5>3.3.CO;2-4; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; Shields J., 1982, SCHIZOPHRENIA EPIGEN; Silverman JM, 1996, AM J MED GENET, V67, P162, DOI 10.1002/(SICI)1096-8628(19960409)67:2<162::AID-AJMG6>3.0.CO;2-U; SPENCE MA, 1993, HUM HERED, V43, P166; Spurlock G, 1998, AM J MED GENET, V81, P24, DOI 10.1002/(SICI)1096-8628(19980207)81:1<24::AID-AJMG5>3.0.CO;2-N; Stober G, 2000, AM J HUM GENET, V67, P1201, DOI 10.1086/321183; STOBER G, 1995, EUR ARCH PSY CLIN N, V245, P135, DOI 10.1007/BF02193085; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 1998, AM J MED GENET, V81, P296, DOI 10.1002/(SICI)1096-8628(19980710)81:4<296::AID-AJMG4>3.0.CO;2-S; SUEAREZ BK, 1994, GENETIC APPROACHES M, P23; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; TERWILLIGER JD, 1998, ENCY BIOSTATISTICS, V3, P2279; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Wei J, 2000, NAT GENET, V25, P376, DOI 10.1038/78044; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Williams J, 1996, LANCET, V347, P1294, DOI 10.1016/S0140-6736(96)90939-3; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073	125	146	154	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					299	312		10.1086/318212	http://dx.doi.org/10.1086/318212			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	394LD	11170887	Bronze, Green Published			2022-12-18	WOS:000166524800001
J	Umehara, F; Tate, G; Itoh, K; Yamaguchi, N; Douchi, T; Mitsuya, T; Osame, M				Umehara, F; Tate, G; Itoh, K; Yamaguchi, N; Douchi, T; Mitsuya, T; Osame, M			A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by minifascicular neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SONIC HEDGEHOG; GENE	We describe a patient with 46,XY partial gonadal dysgenesis (PGD) who presented with polyneuropathy. Sural nerve pathology revealed peculiar findings characterized by extensive minifascicular formation within the endoneurium and with a decreased density of myelinated fibers. We found, in the patient, a homozygous missense mutation (ATG-->ACG) at the initiating codon in exon 1 of the desert hedgehog (DHH) gene, which predicts a failure of translation of the gene. The same heterozygous mutation was found in the patient's father. This is the first report of a human DHH gene mutation, and the findings demonstrate that mutation of the DHH gene may cause 46,XY PGD associated with minifascicular neuropathy.	Kagoshima Univ, Sch Med, Dept Internal Med 3, Kagoshima 890, Japan; Kagoshima Univ, Sch Med, Dept Obstet & Gynecol, Kagoshima 890, Japan; Showa Univ, Fujigaoka Hosp, Dept Surg Pathol, Kanagawa, Japan	Kagoshima University; Kagoshima University; Showa University	Umehara, F (corresponding author), Kagoshima Univ, Sch Med, Dept Internal Med 3, Sakuragaoka 8-35-1, Kagoshima 890, Japan.							Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; MENDEZ JP, 1993, AM J MED GENET, V46, P263, DOI 10.1002/ajmg.1320460304; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Tate G, 2000, CYTOGENET CELL GENET, V88, P93, DOI 10.1159/000015495; TATE G, 2000, J BIOCH MOL BIOL BIO, V4, P27; Umehara F, 1999, ACTA NEUROPATHOL, V98, P309, DOI 10.1007/s004010051085	12	146	151	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1302	1305		10.1016/S0002-9297(07)62958-9	http://dx.doi.org/10.1016/S0002-9297(07)62958-9			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11017805	Green Published, Bronze			2022-12-18	WOS:000165091600025
J	White, SL; Collins, VR; Wolfe, R; Cleary, MA; Shanske, S; DiMauro, S; Dahl, HHM; Thorburn, DR				White, SL; Collins, VR; Wolfe, R; Cleary, MA; Shanske, S; DiMauro, S; Dahl, HHM; Thorburn, DR			Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAGGED-RED FIBERS; DE-NOVO MUTATION; LEIGH-SYNDROME; POINT MUTATION; MENTAL-RETARDATION; T8993G MUTATION; MTDNA MUTATION; T->G MUTATION; ATPASE-6 GENE; NARP SYNDROME	Mitochondrial genetics is complicated by heteroplasmy, or mutant load, which may be from 1%-99%, and thus may produce a gene dosage-type effect. Limited data are available for genotype/phenotype correlations in disorders caused by mtDNA mutations; therefore, prenatal diagnosis for mtDNA mutations has been hindered by an inability to predict accurately the clinical severity expected from a mutant load measured in fetal tissue. After reviewing 44 published and 12 unpublished pedigrees, we considered the possibility of prenatal diagnosis for two common mtDNA mutations at nucleotide 8993. We related the severity of symptoms to the mutant load and predicted the clinical outcome of a given mutant load. We also used the available data to generate empirical recurrence risks for genetic counseling, which may be used in conjunction with prenatal diagnosis.	Royal Childrens Hosp, Murdoch Inst, Melbourne, Vic 3052, Australia; Royal Childrens Hosp, Clin Epidemiol & Biostat Unit, Melbourne, Vic 3052, Australia; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Columbia University	Thorburn, DR (corresponding author), Royal Childrens Hosp, Murdoch Inst, Flemington Rd, Melbourne, Vic 3052, Australia.	thorburd@cryptic.rch.unimelb.edu.au	Thorburn, David R/G-6266-2013	Wolfe, Rory/0000-0002-2126-1045; thorburn, david/0000-0002-7725-9470				Bartley J., 1996, American Journal of Human Genetics, V59, pA316; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; BOULET L, 1992, AM J HUM GENET, V51, P1187; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; CIAFALONI E, 1993, J PEDIATR-US, V122, P419, DOI 10.1016/S0022-3476(05)83431-6; deCoo IFM, 1996, AM J HUM GENET, V58, P636; Degoul F, 1997, J INHERIT METAB DIS, V20, P49, DOI 10.1023/A:1005357506614; Degoul F, 1995, J INHERIT METAB DIS, V18, P682, DOI 10.1007/BF02436757; DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319; Ferlin T, 1997, J PEDIATR-US, V131, P447, DOI 10.1016/S0022-3476(97)80074-1; FRYER A, 1994, ARCH DIS CHILD, V71, P419, DOI 10.1136/adc.71.5.419; HARDING AE, 1992, AM J HUM GENET, V50, P629; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A; HOWELL N, 1983, SOMAT CELL GENET, V9, P1, DOI 10.1007/BF01544045; KLEMENT P, 1994, J INHERIT METAB DIS, V17, P249, DOI 10.1007/BF00711630; LODI R, 1994, J NEUROL NEUROSUR PS, V57, P1492, DOI 10.1136/jnnp.57.12.1492; Mak SC, 1996, PEDIATR NEUROL, V15, P72, DOI 10.1016/0887-8994(96)00126-9; MAKELABENGS P, 1995, PEDIATR RES, V37, P634; ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031; PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124; PUDDU P, 1993, BRIT J OPHTHALMOL, V77, P84, DOI 10.1136/bjo.77.2.84; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Rasbash J., 1995, MLN COMMAND REFERENC; SAKUTA R, 1992, ANN NEUROL, V32, P597, DOI 10.1002/ana.410320428; Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270; Santorelli FM, 1996, AM J HUM GENET, V58, P933; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; SANTORELLI FM, 1994, NEUROLOGY, V44, P972, DOI 10.1212/WNL.44.5.972; Seller A, 1997, J INHERIT METAB DIS, V20, P102, DOI 10.1023/A:1005378011157; SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168; SHOFFNER JM, 1995, METABOLIC MOL BASIS, V1, P1535; TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TULINIUS MH, 1995, HUM GENET, V96, P290; Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16; VANERVEN PMM, 1987, J NEUROL, V234, P215; VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347; WHITE SL, 1999, IN PRESS J INHERIT M; YONEDA M, 1995, MUSCLE NERVE, pS95; YOSHINAGA H, 1993, J CHILD NEUROL, V8, P129, DOI 10.1177/088307389300800204	44	146	149	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					474	482		10.1086/302488	http://dx.doi.org/10.1086/302488			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417290	Bronze, Green Published			2022-12-18	WOS:000081836900023
J	Krings, M; Salem, AH; Bauer, K; Geisert, H; Malek, AK; Chaix, L; Simon, C; Welsby, D; Di Rienzo, A; Utermann, G; Sajantila, A; Paabo, S; Stoneking, M				Krings, M; Salem, AH; Bauer, K; Geisert, H; Malek, AK; Chaix, L; Simon, C; Welsby, D; Di Rienzo, A; Utermann, G; Sajantila, A; Paabo, S; Stoneking, M			mtDNA analysis of Nile River Valley populations: A genetic corridor or a barrier to migration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMORPHISMS; ENDONUCLEASE CLEAVAGE PATTERNS; MODERN HUMAN ORIGINS; HUMAN-EVOLUTION; ASIAN POPULATIONS; SINGLE HAIRS; SEQUENCES; ANCIENT; AFRICA; DIVERSITY	To assess the extent to which the Nile River Valley has been a corridor for human migrations between Egypt and sub-Saharan Africa, we analyzed mtDNA variation in 224 individuals from various locations along the river. Sequences of the first hypervariable segment (HV1) of the mtDNA control region and a polymorphic HpaI site at position 3592 allowed us to designate each mtDNA as being of "northern" or "southern" affiliation. Proportions of northern and southern mtDNA differed significantly between Egypt, Nubia, and the southern Sudan. At slowly evolving sites within HV1, northern-mtDNA diversity was highest in Egypt and lowest in the southern Sudan, and southern-mtDNA diversity was highest in the southern Sudan and lowest in Egypt, indicating that migrations had occurred bidirectionally along the Nile River Valley. Egypt and Nubia have low and similar amounts of divergence for both mtDNA types, which is consistent with historical evidence for long-term interactions between Egypt and Nubia. Spatial autocorrelation analysis demonstrates a smooth gradient of decreasing genetic similarity of mtDNA types as geographic distance between sampling localities increases, strongly suggesting gene now along the Nile, with no evident barriers. We conclude that these migrations probably occurred within the past few hundred to few thousand years and that the migration from north to south was either earlier or lesser in the extent of gene flow than the migration from south to north.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Univ Munich, Dept Zool, Munich, Germany; Suez Canal Univ, Fac Med, Dept Anat, Ismaelia, Egypt; Univ Assiut, Coll Med, Dept Anat, Assiut, Egypt; Museum Hist Nat, Dept Archezool, Geneva, Switzerland; British Museum, Dept Egyptian Antiquities, London WC1B 3DG, England; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Innsbruck, Inst Med Biol & Genet, A-6020 Innsbruck, Austria; Univ Helsinki, Dept Forens Med, SF-00300 Helsinki, Finland; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	Max Planck Society; University of Munich; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Assiut University; Natural History Museum London; University of Chicago; University of Innsbruck; University of Helsinki; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Stoneking, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Inselstr 22, D-04103 Leipzig, Germany.	stoneking@eva.mpg.de	Sajantila, Antti/AAY-9084-2021; Salem, Abdel Halim A/A-3026-2013	Salem, Abdel Halim A/0000-0002-0733-4631; Di Rienzo, Anna/0000-0002-8982-9098; Sajantila, Antti/0000-0003-4117-5248				Alexander J., 1988, AFR ARCHAEOL REV, V6, P73; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BERTORELLE G, 1995, GENETICS, V140, P811; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; Burckhardt F, 1999, NUCLEIC ACIDS RES, V27, P138, DOI 10.1093/nar/27.1.138; CABOT EL, 1989, COMPUT APPL BIOSCI, V5, P233; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza LL, 1998, TRENDS GENET, V14, P60, DOI 10.1016/S0168-9525(97)01327-9; CHEN YS, 1995, AM J HUM GENET, V57, P133; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; EXCOFFIER L, 1992, GENETICS, V131, P479; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Fox CL, 1997, ANN HUM BIOL, V24, P217, DOI 10.1080/03014469700004952; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; GRIMES BF, 1996, ETHNOLOGUE LANGUAGES; Handt O, 1998, NUCLEIC ACIDS RES, V26, P126, DOI 10.1093/nar/26.1.126; Handt O, 1996, AM J HUM GENET, V59, P368; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; LAHR MM, 1994, J HUM EVOL, V26, P23, DOI 10.1006/jhev.1994.1003; LIEBERMAN DE, 1995, CURR ANTHROPOL, V36, P159, DOI 10.1086/204348; MELTON T, 1995, AM J HUM GENET, V57, P403; Merriwether DA, 1996, AM J HUM GENET, V59, P204; Nei M., 1987, MOL EVOLUTIONARY GEN; NORIO R, 1973, ANN CLIN RES, V5, P109; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; RITTE U, 1993, HUM BIOL, V65, P359; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Sambrook J, 1989, MOL CLONING LAB MANU; SCHNEIDER S, 1997, ARLEQUIN EXPLORATORY; SCOZZARI R, 1994, HUM BIOL, V66, P1; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SEMINO O, 1991, ANN HUM GENET, V55, P123, DOI 10.1111/j.1469-1809.1991.tb00405.x; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; Shaw I, 1995, BRIT MUSEUM DICT ANC; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; STONEKING M, 1996, MITOCHONDRIAL DNA VA, P263; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; SYKES B, 1995, AM J HUM GENET, V57, P1463; TIKOCHINSKI Y, 1991, AM J HUM GENET, V48, P129; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALLACE DC, 1992, HUM BIOL, V64, P403; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1996, AM J HUM GENET, V59, P437	57	146	148	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1166	1176		10.1086/302314	http://dx.doi.org/10.1086/302314			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090902	Green Published, Bronze			2022-12-18	WOS:000079632900028
J	Tishkoff, SA; Goldman, A; Calafell, F; Speed, WC; Deinard, AS; Bonne-Tamir, B; Kidd, JR; Pakstis, AJ; Jenkins, T; Kidd, KK				Tishkoff, SA; Goldman, A; Calafell, F; Speed, WC; Deinard, AS; Bonne-Tamir, B; Kidd, JR; Pakstis, AJ; Jenkins, T; Kidd, KK			A global haplotype analysis of the myotonic dystrophy locus: Implications for the evolution of modern humans and for the origin of myotonic dystrophy mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-KINASE GENE; UNSTABLE DNA REGION; CTG REPEAT; HUMAN-POPULATIONS; LINKAGE DISEQUILIBRIUM; TRINUCLEOTIDE REPEATS; DELETION POLYMORPHISM; ALU INSERTION; EXPANSION; ALLELE	Haplotypes consisting of the (CTG)(n) repeat, as well as several flanking markers at the myotonic dystrophy (DM) locus, were analyzed in normal individuals from 25 human populations (5 African, 2 Middle Eastern, 3 European, 6 East Asian, 3 Pacific/Australo-Melanesian, sind 6 Amerindian) and in five nonhuman primate species. Non-African populations have a subset of the haplotype diversity present in Africa, as well as a shared pattern of allelic association. (CTG)(18-35) alleles (large normal) were observed only in northeastern African and non-African populations and exhibit strong linkage disequilibrium with three markers flanking the (CTG)(n) repeat. The pattern of haplotype diversity and linkage disequilibrium observed supports a recent African-origin model of modern human evolution and suggests that the original mutation event that gave rise to DM-causing alleles arose in a population ancestral to non-Africans prior to migration of modern humans out of Africa.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Univ Witwatersrand, Sch Pathol, S African Inst Med Res, Dept Human Genet, Johannesburg, South Africa; Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel	Yale University; University of Witwatersrand; Tel Aviv University; Sackler Faculty of Medicine	Kidd, KK (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.		Calafell, Francesc/C-8595-2014	Calafell, Francesc/0000-0002-1083-9438	NIAAA NIH HHS [AA09379] Funding Source: Medline; NIMH NIH HHS [MH39239, MH50390] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039239, R01MH050390, R01MH039239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ADOVASIO JM, 1978, AM ANTIQUITY, V43, P632, DOI 10.2307/279496; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BARCELO JM, 1993, HUM MOL GENET, V2, P705, DOI 10.1093/hmg/2.6.705; BARR CL, 1993, BIOL PSYCHIAT, V34, P204, DOI 10.1016/0006-3223(93)90073-M; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Dada T O, 1973, East Afr Med J, V50, P213; DAVIES J, 1992, J MED GENET, V29, P766, DOI 10.1136/jmg.29.11.766; Deka R, 1996, GENOME RES, V6, P142, DOI 10.1101/gr.6.2.142; Dillehay T.D., 1989, PALEOENVIRONMENT SIT, V1; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GOLDMAN A, 1994, J MED GENET, V31, P37, DOI 10.1136/jmg.31.1.37; GOLDMAN A, 1995, AM J HUM GENET, V56, P1373; Goldman A, 1996, AM J HUM GENET, V59, P445; Goldman A, 1996, ANN HUM GENET, V60, P57, DOI 10.1111/j.1469-1809.1996.tb01172.x; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper P.S., 1989, MYOTONIC DYSTROPHY; Harris S, 1996, HUM MOL GENET, V5, P1417, DOI 10.1093/hmg/5.Supplement_1.1417; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hill A., 1994, INTEGRATIVE PATHS PA, P123; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JANSEN G, 1995, HUM MOL GENET, V4, P843, DOI 10.1093/hmg/4.5.843; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Kidd KK, 1996, ALCOHOL CLIN EXP RES, V20, P697, DOI 10.1111/j.1530-0277.1996.tb01674.x; KIDD KK, IN PRESS HUM GENET; KORCZYN AD, 1994, BIOMED PHARMACOTHER, V48, P391, DOI 10.1016/0753-3322(94)90057-4; KRAHE R, 1995, AM J HUM GENET, V56, P1067; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; LEWONTIN RC, 1964, GENETICS, V49, P49; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; LOTZ BP, 1985, S AFR MED J, V67, P812; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, GENOMICS, V15, P446, DOI 10.1006/geno.1993.1087; MorCohen R, 1997, ISRAEL J MED SCI, V33, P190; MorCohen R, 1997, AM J MED GENET, V71, P156, DOI 10.1002/(SICI)1096-8628(19970808)71:2<156::AID-AJMG7>3.0.CO;2-W; MULLEY JC, 1993, LANCET, V341, P236, DOI 10.1016/0140-6736(93)90096-Y; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; Primmer CR, 1996, NAT GENET, V13, P391, DOI 10.1038/ng0896-391; RUBINSZTEIN DC, 1994, HUM MOL GENET, V3, P2031; SHRIVER MD, 1993, GENETICS, V134, P983; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tishkoff SA, 1996, HUM GENET, V97, P759; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VALDES AM, 1993, GENETICS, V133, P737; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weir B., 1996, GENETIC DATA ANAL; WILSON AC, 1969, P NATL ACAD SCI USA, V63, P1088, DOI 10.1073/pnas.63.4.1088; YAMAGATA H, 1992, LANCET, V339, P692, DOI 10.1016/0140-6736(92)90862-W; Yamagata H, 1996, HUM GENET, V97, P145, DOI 10.1007/BF02265255; ZERYLNICK C, 1995, AM J HUM GENET, V56, P123; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531	63	146	147	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1389	1402		10.1086/301861	http://dx.doi.org/10.1086/301861			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585589	Green Published, hybrid			2022-12-18	WOS:000074174700015
J	Kittles, RA; Perola, M; Peltonen, L; Bergen, AW; Aragon, RA; Virkkunen, M; Linnoila, M; Goldman, D; Long, JC				Kittles, RA; Perola, M; Peltonen, L; Bergen, AW; Aragon, RA; Virkkunen, M; Linnoila, M; Goldman, D; Long, JC			Dual origins of Finns revealed by Y chromosome haplotype variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHOID SATELLITE DNA; HUMAN-POPULATIONS; MICROSATELLITE LOCI; ALLELE FREQUENCIES; REPEAT LOCI; FINLAND; POLYMORPHISMS; DISTANCES; LAPPS	The Finnish population has often been viewed as an isolate founded 2,000 years ago via a route across the Gulf of Finland. The founding event has been characterized as involving a limited number of homogeneous founders, isolation, and subsequent rapid population growth. Despite the purported isolation of the population, levels of gene diversity for the Finns at autosomal and mitochondrial DNA loci are indistinguishable from those of other Europeans. Thus, mixed or dual origins for the Finns have been proposed. Here we present genetic evidence for the dual origins of Finns by evaluating the pattern of Y chromosome variation in 280 unrelated males from nine Finnish provinces. Phylogenetic analysis of 77 haplotype configurations revealed two major starshaped clusters of Y haplotypes, indicative of a population expansion from two common Y haplotypes. Dramatic and quite significant differences in Y haplotype variation were observed between eastern and western regions of Finland, revealing contributions from different paternal types. The geographic distribution and time of expansion for the two common Y haplotypes correlate well with archeological evidence for two culturally and geographically distinct groups of settlers. Also, a northeastern to southwestern gradient of Y haplotype frequencies provides convincing evidence for recent male migration from rural areas into urban Finland.	NIAAA, Sect Populat Genet & Linkage, NIH, Bethesda, MD USA; NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA; NIAAA, Clin Studies Lab, NIH, Bethesda, MD USA; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Finland National Institute for Health & Welfare; University of Helsinki	Kittles, RA (corresponding author), Howard Univ, Ctr Canc, 2041 Georgia Ave,Room 507 NW, Washington, DC 20060 USA.		Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020	Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Bergen, Andrew/0000-0002-1237-7644				Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; ERIKSSON AW, 1973, ISRAEL J MED SCI, V9, P1156; EXCOFFIER L, 1992, GENETICS, V131, P479; FODOR I, 1991, GENETICS HUNGARIAN P; HAJDU P, 1975, FINNOUGRIAN LANGUAGE; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; KITTLES RA, 1996, AM J PHYS ANTHR S, V22, P139; Lahermo P, 1996, AM J HUM GENET, V58, P1309; LUHO V, 1976, ANCIENT CULTURES URA, P115; MEINANDER CF, 1973, 7 U HELS ARCH I; Michalakis Y, 1996, GENETICS, V142, P1061; Nei M., 1987, MOL EVOLUTIONARY GEN; NEVANLINNA HR, 1973, HEREDITAS, V74, P127; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NORIO R, 1973, ANN CLIN RES, V5, P109; Norio R., 1981, BIOCULTURAL ASPECTS, P359; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; Ruhlen M., 1987, GUIDE WORLDS LANGUAG, V1; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; SAJANTILA A, 1995, NAT GENET, V11, P359, DOI 10.1038/ng1295-359; SANTOS FR, 1995, GENE, V165, P191, DOI 10.1016/0378-1119(95)00501-V; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; SLATKIN M, 1995, GENETICS, V139, P457; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; TYLERSMITH C, 1987, J MOL BIOL, V195, P457, DOI 10.1016/0022-2836(87)90175-6; VALDES AM, 1993, GENETICS, V133, P737; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; VILKUNA K, 1976, ANCIENT CULTURES URA, P183; VIRKKUNEN M, 1994, ARCH GEN PSYCHIAT, V51, P28; Zerjal T, 1997, AM J HUM GENET, V60, P1174; [No title captured]	37	146	146	0	7	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1171	1179		10.1086/301831	http://dx.doi.org/10.1086/301831			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545401	Green Published, Bronze			2022-12-18	WOS:000073487000022
J	Eccles, DM; vanderLuijt, R; Breukel, C; Bullman, H; Bunyan, D; Fisher, A; Barber, J; duBoulay, C; Primrose, J; Burn, J; Fodde, R				Eccles, DM; vanderLuijt, R; Breukel, C; Bullman, H; Bunyan, D; Fisher, A; Barber, J; duBoulay, C; Primrose, J; Burn, J; Fodde, R			Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; CA REPEAT POLYMORPHISM; TRANSLATION-TERMINATING MUTATIONS; PROTEIN TRUNCATION TEST; GERM-LINE MUTATIONS; COLI APC; RAPID DETECTION; TUMOR; PRODUCT; ASSOCIATION	Desmoid tumors are slowly growing fibrous tumors highly resistant to therapy and often fatal. Here, we report hereditary desmoid disease (HDD), a novel autosomal dominant trait with 100% penetrance affecting a three-generation kindred. Desmoid tumors are usually a complication of familial adenomatous polyposis, a predisposition to the early development of premalignant adenomatous polyps in the colorectum due to chain-terminating mutations of the APC gene. In general, one or more members in similar to 10% of the FAP families manifest desmoid tumors. Affected individuals from the HDD kindred are characterized by multifocal fibromatosis of the paraspinal muscles, breast, occiput, arms, lower ribs, abdominal wall, and mesentery. Osteomas, epidermal cysts, and other congenital features were also observed. We show that HDD segregates with an unusual germline chain-terminating mutation at the 3' end of the APC gene (codon 1924) with somatic loss of the wild-type allele leading to tumor development.	LEIDEN UNIV,MGC DEPT HUMAN GENET,NL-2300 RA LEIDEN,NETHERLANDS; UNIV SOUTHAMPTON,WESSEX CLIN GENET SERV,SOUTHAMPTON,HANTS,ENGLAND; UNIV SOUTHAMPTON,DEPT SURG,SOUTHAMPTON,HANTS,ENGLAND; UNIV SOUTHAMPTON,HOSP TRUST,DEPT PATHOL,SOUTHAMPTON,HANTS,ENGLAND; SALISBURY DIST HOSP,WESSEX REG GENET LAB,SALISBURY,WILTS,ENGLAND; UNIV NEWCASTLE,DEPT HUMAN GENET,NEWCASTLE TYNE,TYNE & WEAR,ENGLAND	Leiden University; Leiden University - Excl LUMC; University of Southampton; University of Southampton; University of Southampton; Salisbury District Hospital; Newcastle University - UK			Eccles, Diana/K-6327-2019; Fodde, Riccardo/AAW-9394-2021	Eccles, Diana/0000-0002-9935-3169; Fodde, Riccardo/0000-0001-9839-4324				BAEG GH, 1995, EMBO J, V14, P5618, DOI 10.1002/j.1460-2075.1995.tb00249.x; BREUKEL C, 1991, NUCLEIC ACIDS RES, V19, P5804, DOI 10.1093/nar/19.20.5804; BULOW S, 1987, DAN MED BULL, V34, P1; BUNYAN DJ, 1995, J MED GENET, V32, P728, DOI 10.1136/jmg.32.9.728; Bussey H, 1975, FAMILIAL POLYPOSIS C; CASPARI R, 1995, HUM MOL GENET, V4, P337, DOI 10.1093/hmg/4.3.337; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Fisher AM, 1996, PRENATAL DIAG, V16, P615, DOI 10.1002/(SICI)1097-0223(199607)16:7<615::AID-PD920>3.0.CO;2-9; Friedl W, 1996, HUM GENET, V97, P579; GIARDIELLO FM, 1994, GASTROENTEROLOGY, V106, P1542, DOI 10.1016/0016-5085(94)90408-1; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; JONES IT, 1986, ANN SURG, V204, P94, DOI 10.1097/00000658-198607000-00014; JOSLYN G, 1993, P NATL ACAD SCI USA, V90, P11109, DOI 10.1073/pnas.90.23.11109; KLEMMER S, 1987, AM J MED GENET, V28, P385, DOI 10.1002/ajmg.1320280217; MAHER ER, 1992, CANCER, V69, P2049, DOI 10.1002/1097-0142(19920415)69:8<2049::AID-CNCR2820690807>3.0.CO;2-6; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; MIYAKI M, 1993, CANCER RES, V53, P5079; MOEN CJA, 1992, ONCOGENE, V7, P563; MUNEMITSU S, 1994, CANCER RES, V54, P3676; NAGASE H, 1992, CANCER RES, V52, P4055; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; OLSCHWANG S, 1993, CELL, V75, P959, DOI 10.1016/0092-8674(93)90539-3; POLAKIS P, 1995, CURR OPIN GENET DEV, V5, P66, DOI 10.1016/S0959-437X(95)90055-1; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; RODRIGUEZBIGAS MA, 1994, CANCER, V74, P1270, DOI 10.1002/1097-0142(19940815)74:4<1270::AID-CNCR2820740415>3.0.CO;2-7; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SCOTT RJ, 1995, GUT, V36, P731, DOI 10.1136/gut.36.5.731; SCOTT RJ, IN PRESS HUM MOL GEN; SENGUPTA S, 1993, LANCET, V342, P552, DOI 10.1016/0140-6736(93)91677-E; SMITH KJ, 1994, CANCER RES, V54, P3672; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; TALBOT IC, 1994, FAMILIAL ADENOMATOUS, P15; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; VanDerLuijt RB, 1996, LABORATORY PROTOCOLS FOR MUTATION DETECTION, P140; VANDERLUIJT RB, IN PRESS HUM GENET; VANLEEUWEN C, 1991, NUCLEIC ACIDS RES, V19, P5805, DOI 10.1093/nar/19.20.5805; WIJNEN J, 1995, AM J HUM GENET, V56, P1060; WIJNEN J, 1991, NUCLEIC ACIDS RES, V19, P6965, DOI 10.1093/nar/19.24.6965-a	44	146	151	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1193	1201						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940264				2022-12-18	WOS:A1996VV31500005
J	HILL, WG; WEIR, BS				HILL, WG; WEIR, BS			MAXIMUM-LIKELIHOOD-ESTIMATION OF GENE LOCATION BY LINKAGE DISEQUILIBRIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATIONS; CANDIDATE; SELECTION; DISEASE	Linkage disequilibrium, D, between a polymorphic disease and mapped markers can, in principle, be used to help find the map position of the disease gene. Likelihoods are therefore derived for the value of D conditional on the observed number of haplotypes in the sample and on the population parameter Nc, where N is the effective population size and c the recombination fraction between the disease and marker loci. The likelihood is computed explicitly for the case of two loci with heterozygote superiority and, more generally, by computer simulations assuming a steady state of constant population size and selective pressures or neutrality. It is found that the likelihood is, in general, not very dependent on the degree of selection at the loci and is very flat. This suggests that precise information on map position will not be obtained from estimates of linkage disequilibrium.	N CAROLINA STATE UNIV,PROGRAM STAT GENET,RALEIGH,NC 27695; UNIV EDINBURGH,INST CELL ANIM & POPULAT BIOL,EDINBURGH,SCOTLAND	University of North Carolina; North Carolina State University; University of Edinburgh					NIGMS NIH HHS [GM45344] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVERY PJ, 1979, GENET RES, V33, P29, DOI 10.1017/S0016672300018140; BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HUDSON RR, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P23; HUDSON RR, 1985, GENETICS, V109, P611; KAPLAN N, 1992, AM J HUM GENET, V51, P333; Kimura M., 1982, MOL EVOLUTION PROTEI, P151; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; PRITCHARD C, 1991, AM J HUM GENET, V49, P1; SVED JA, 1973, THEOR POPUL BIOL, V4, P129, DOI 10.1016/0040-5809(73)90008-7	15	146	150	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					705	714						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128969				2022-12-18	WOS:A1994NC83600016
J	ROBBINS, WA; SEGRAVES, R; PINKEL, D; WYROBEK, AJ				ROBBINS, WA; SEGRAVES, R; PINKEL, D; WYROBEK, AJ			DETECTION OF ANEUPLOID HUMAN SPERM BY FLUORESCENCE INSITU HYBRIDIZATION - EVIDENCE FOR A DONOR DIFFERENCE IN FREQUENCY OF SPERM DISOMIC FOR CHROMOSOMES-I AND CHROMOSOMES-Y	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-SPERMATOZOA; CYTOGENETIC ANALYSIS; DNA; TRANSLOCATION; NUCLEI; NONDISJUNCTION; ABNORMALITIES; PROBES	Fluorescence in situ hybridization with repetitive-sequence DNA probes was used to detect human sperm disomic for chromosomes 1 and Y in three healthy men. Data on these same men had been obtained previously, using the human-sperm/hamster-egg cytogenetic technique, providing a cytogenetic reference for validating sperm hybridization measurements. Air-dried smears were prepared from semen samples and treated with DTT and lithium diiodosalicylate to expand sperm chromatin. Hybridization with fluorescently tagged DNA probes for chromosomes 1 (pUC177) or Y (pY3.4) yielded average frequencies of sperm with two fluorescent domains of 14.2+/-2.4/10,000 and 5.6+/-1.6/10,000 sperm, respectively. These frequencies did not differ statistically from frequencies of hyperploidy observed for these chromosomes with the hamster technique. In addition, frequencies of disomic sperm from one donor were elevated approximately 2.5-fold above those of other donors, for both chromosomes 1 (P = .045) and Y (P = .01), consistent with a trend found with the hamster technique. We conclude that fluorescence in situ hybridization to sperm chromosomes provides a valid and promising measure of the frequency of disomic human sperm.	LAWRENCE LIVERMORE NATL LAB, BIOL & BIOTECHNOL RES PROGRAM, L-452, 7000 E AVE, LIVERMORE, CA 94550 USA; UNIV CALIF BERKELEY, SCH PUBL HLTH, BERKELEY, CA 94720 USA; UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco				Wyrobek, Andrew/0000-0002-5921-5298				BARLOW P, 1970, NATURE, V226, P961, DOI 10.1038/226961a0; BOBROW M, 1972, NATURE-NEW BIOL, V238, P122, DOI 10.1038/newbio238122a0; Bond D, 1983, OXFORD MONOGRAPHS ME, P198; BOND DJ, 1987, MUTAT RES, V181, P257, DOI 10.1016/0027-5107(87)90103-5; BRANDRIFF B, 1986, AM J HUM GENET, V38, P197; BRANDRIFF B, 1984, AM J HUM GENET S, V36, pA87; BRANDRIFF B, 1986, GENETIC TOXICOLOGY B, P469; Brandriff B.F., 1990, BIOL MAMMALIAN GERM, P183; BRANDRIFF BF, 1988, ENVIRON MOL MUTAGEN, V12, P167, DOI 10.1002/em.2860120203; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; COONEN E, 1991, MOL REPROD DEV, V28, P18, DOI 10.1002/mrd.1080280104; EASTMOND DA, 1990, MUTAT RES, V234, P303, DOI 10.1016/0165-1161(90)90041-L; Epstein C.J, 1986, CONSEQUENCES CHROMOS; GENESCA A, 1990, CANCER GENET CYTOGEN, V46, P251, DOI 10.1016/0165-4608(90)90110-V; GUTTENBACH M, 1990, AM J HUM GENET, V46, P553; GUTTENBACH M, 1991, HUM GENET, V87, P261; Hecht F, 1987, ANEUPLOIDY A, P9; Hook E B, 1985, Basic Life Sci, V36, P7; JENDERNY J, 1987, HUM GENET, V76, P385, DOI 10.1007/BF00272450; JOHNSON LA, 1989, BIOL REPROD, V41, P199, DOI 10.1095/biolreprod41.2.199; JOSEPH AM, 1984, HUM GENET, V66, P234, DOI 10.1007/BF00286608; KAPP RW, 1979, MUTAT RES, V64, P47, DOI 10.1016/0165-1161(79)90136-5; MARTIN RH, 1987, AM J HUM GENET, V41, P484; MARTIN RH, 1986, MUTAT RES, V174, P219, DOI 10.1016/0165-7992(86)90155-7; MARTIN RH, 1990, CYTOGENET CELL GENET, V53, P103, DOI 10.1159/000132905; MARTIN RH, 1990, HUM GENET, V86, P33; MEISTRICH ML, 1979, CHROMOSOMA, V74, P141, DOI 10.1007/BF00292269; Nielsen J, 1990, Birth Defects Orig Artic Ser, V26, P209; PEARSON P, 1972, J MED GENET, V9, P264, DOI 10.1136/jmg.9.3.264; PIETERS MHEC, 1990, CYTOGENET CELL GENET, V53, P15, DOI 10.1159/000132886; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PINKEL D, 1982, CYTOMETRY, V3, P1, DOI 10.1002/cyto.990030103; PINKEL D, 1983, RADIAT RES, V95, P550, DOI 10.2307/3576100; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; SMITH KD, 1987, DEVELOPMENT, V101, P77; Snedecor G.W., 1980, STAT METHODS, V7; SUMNER AT, 1976, J REPROD FERTIL, V48, P9; WATT JL, 1987, J MED GENET, V24, P60, DOI 10.1136/jmg.24.1.60; WYROBEK AJ, 1990, MOL REPROD DEV, V27, P200, DOI 10.1002/mrd.1080270304; WYROBEK AJ, 1983, MUTAT RES, V115, P73, DOI 10.1016/0165-1110(83)90015-5; WYROBEK AJ, 1992, ENVIRON MOL MUT  S20, V19, P72; WYROBEK AJ, 1984, AM J HUM GENET S, V36, pA118	42	146	162	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					799	807						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460647				2022-12-18	WOS:A1993KY05900021
J	GRODEN, J; GELBERT, L; THLIVERIS, A; NELSON, L; ROBERTSON, M; JOSLYN, G; SAMOWITZ, W; SPIRIO, L; CARLSON, M; BURT, R; LEPPERT, M; WHITE, R				GRODEN, J; GELBERT, L; THLIVERIS, A; NELSON, L; ROBERTSON, M; JOSLYN, G; SAMOWITZ, W; SPIRIO, L; CARLSON, M; BURT, R; LEPPERT, M; WHITE, R			MUTATIONAL ANALYSIS OF PATIENTS WITH ADENOMATOUS POLYPOSIS - IDENTICAL INACTIVATING MUTATIONS IN UNRELATED INDIVIDUALS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POINT MUTATIONS; COLON CANCER; GENE; IDENTIFICATION; CHROMOSOME-5Q21; DELETION; POLYMORPHISMS; LOCUS; FAP; DNA	Samples of constitutional DNA from 60 unrelated patients with adenomatous polyposis coli (APC) were examined for mutations in the APC gene. Five inactivating mutations were observed among 12 individuals with APC; all were different from the six inactivating mutations previously reported in this panel of patients. The newly discovered mutations included single-nucleotide substitutions leading to stop codons and small deletions leading to frameshifts. Two of the mutations were observed in multiple APC families and in sporadic cases of APC; allele-specific PCR primers were designed for detecting mutations at these common sites. No missense mutations that segregated with the disease were found.	UNIV UTAH,DEPT MED,DIV GASTROENTEROL,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT PATHOL,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	GRODEN, J (corresponding author), UNIV UTAH,HOWARD HUGHES MED INST,ECCLES INST HUMAN GENET,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112, USA.							BEGGS AH, 1991, AM J HUM GENET, V49, P54; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BOURNE HR, 1991, NATURE, V353, P696, DOI 10.1038/353696b0; BOURNE HR, 1991, NATURE, V351, P188, DOI 10.1038/351188a0; BURT RW, 1991, TXB GASTROENTEROLOGY, V2, P1674; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; FODDE R, 1992, GENOMICS, V13, P1162, DOI 10.1016/0888-7543(92)90032-N; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HERRERA L, 1986, AM J MED GENET, V25, P473, DOI 10.1002/ajmg.1320250309; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; JOSLYN G, UNPUB DIMER FORMATIO; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; OLSCHWANG S, 1993, AM J HUM GENET, V52, P273; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RIVERA H, 1990, J MED GENET, V27, P267, DOI 10.1136/jmg.27.4.267; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348; SPIRIO L, UNPUB ALLELES APC GE; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; VARESCO L, 1993, AM J HUM GENET, V52, P280	28	146	147	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					263	272						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8381579				2022-12-18	WOS:A1993KN27500003
J	ANTONARAKIS, SE; PETERSEN, MB; MCINNIS, MG; ADELSBERGER, PA; SCHINZEL, AA; BINKERT, F; PANGALOS, C; RAOUL, O; SLAUGENHAUPT, SA; HAFEZ, M; COHEN, MM; ROULSON, D; SCHWARTZ, S; MIKKELSEN, M; TRANEBJAERG, L; GREENBERG, F; HOAR, DI; RUDD, NL; WARREN, AC; METAXOTOU, C; BARTSOCAS, C; CHAKRAVARTI, A				ANTONARAKIS, SE; PETERSEN, MB; MCINNIS, MG; ADELSBERGER, PA; SCHINZEL, AA; BINKERT, F; PANGALOS, C; RAOUL, O; SLAUGENHAUPT, SA; HAFEZ, M; COHEN, MM; ROULSON, D; SCHWARTZ, S; MIKKELSEN, M; TRANEBJAERG, L; GREENBERG, F; HOAR, DI; RUDD, NL; WARREN, AC; METAXOTOU, C; BARTSOCAS, C; CHAKRAVARTI, A			THE MEIOTIC STAGE OF NONDISJUNCTION IN TRISOMY-21 - DETERMINATION BY USING DNA POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN CHROMOSOME-21; HUMAN GENOME; RECOMBINATION; SEQUENCES; ORIGIN; PROBES; LOCUS; GENE	We have studied DNA polymorphisms at loci in the pericentromeric region on the long arm of chromosome 21 in 200 families with trisomy 21, in order to determine the meiotic origin of nondisjunction. Maintenance of heterozygosity for parental markers in the individual with trisomy 21 was interpreted as resulting from a meiosis I error, while reduction to homozygosity was attributed to a meiosis II error. Nondisjunction was paternal in 9 cases and was maternal in 188 cases, as reported earlier. Among the 188 maternal cases, nondisjunction occurred in meiosis I in 128 cases and in meiosis II in 38 cases; in 22 cases the DNA markers used were uninformative. Therefore meiosis I was responsible for 77.1% and meiosis II for 22.9% of maternal nondisjunction. Among the 9 paternal nondisjunction cases the error occurred in meiosis I in 2 cases (22.2%) and in meiosis II in 7 (77.8%) cases. Since there was no significant difference in the distribution of maternal ages between maternal I error versus maternal II error, it is unlikely that an error at a particular meiotic stage contributes significantly to the increasing incidence of Down syndrome with advancing maternal age. Although the DNA polymorphisms used were at loci which map close to the centromere, it is likely that rare errors in meiotic-origin assignments may have occurred because of a small number of crossovers between the markers and the centromere. Analysis of these polymorphisms may provide a more accurate understanding of the meiotic stage of nondisjunction in trisomy 21 than that previously provided by chromosomal heteromorphisms.	JOHN F KENNEDY INST,GLOSTRUP,DENMARK; ALBERTA CHILDRENS PROV GEN HOSP,DEPT PEDIAT,CALGARY,ALBERTA,CANADA; P & A KYRIAKOU CHILDRENS HOSP,DEPT PEDIAT,ATHENS,GREECE; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PSYCHIAT,BALTIMORE,MD 21205; UNIV MARYLAND,DEPT OBSTET & GYNECOL,DIV HUMAN GENET,BALTIMORE,MD 21201; UNIV MARYLAND,DEPT PEDIAT,DIV HUMAN GENET,BALTIMORE,MD 21201; UNIV ZURICH,INST MED GENET,CH-8006 ZURICH,SWITZERLAND; HOP NECKER ENFANTS MALAD,INST PROGENESE,F-75730 PARIS 15,FRANCE; UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15260; MANSOURA UNIV,MANSOURA,EGYPT; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; ALBERTA CHILDRENS PROV GEN HOSP,DEPT MED BIOCHEM,CALGARY,ALBERTA,CANADA; UNIV ATHENS,SCH MED,DEPT PEDIAT 1,CYTOGENET LAB,ATHENS,GREECE	Alberta Childrens Hospital; University of Calgary; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Zurich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Egyptian Knowledge Bank (EKB); Mansoura University; Baylor College of Medicine; Baylor College of Medicine; Alberta Childrens Hospital; University of Calgary; Athens Medical School; National & Kapodistrian University of Athens	ANTONARAKIS, SE (corresponding author), JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT,CMSC 1003,BALTIMORE,MD 21205, USA.		Antonarakis, Stylianos E/N-8866-2014; Petersen, Michael Bjørn B/D-1483-2017; McInnis, Melvin G/F-6963-2012	Antonarakis, Stylianos E/0000-0001-8907-5823; Petersen, Michael Bjørn B/0000-0003-0316-8207; McInnis, Melvin G/0000-0002-0375-6247	NHGRI NIH HHS [HG00344] Funding Source: Medline; NICHD NIH HHS [HD19591, HD24605] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605, R01HD019591] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000344] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1985, P NATL ACAD SCI USA, V82, P3360, DOI 10.1073/pnas.82.10.3360; AYME S, 1982, AM J HUM GENET, V34, P558; BURMELSTER M, 1990, NUCLEIC ACIDS RES, V18, P4969, DOI 10.1093/nar/18.16.4969; DAGNABRICARELLI F, 1989, HUM GENET, V82, P20; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DAVIES KE, 1984, HUM GENET, V66, P54, DOI 10.1007/BF00275186; DEKA R, 1990, AM J HUM GENET, V47, P644; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Epstein C. J., 1989, METABOLIC BASIS INHE, P291; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GUO Z, 1990, NUCLEIC ACIDS RES, V18, P7470, DOI 10.1093/nar/18.24.7470-a; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; JABS EW, 1991, GENOMICS, V9, P141, DOI 10.1016/0888-7543(91)90231-3; JORGENSEN AL, 1987, P NATL ACAD SCI USA, V84, P1075, DOI 10.1073/pnas.84.4.1075; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1988, AM J HUM GENET, V42, P498; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; OWEN MJ, 1990, AM J HUM GENET, V46, P316; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; ROEDER GS, 1988, TRENDS GENET, V4, P263; RUDD NL, 1988, HUM GENET, V78, P175, DOI 10.1007/BF00278191; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1169, DOI 10.1093/nar/19.5.1169; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEWART GD, 1988, AM J HUM GENET, V42, P227; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; STINISSEN P, 1990, NUCLEIC ACIDS RES, V18, P3672, DOI 10.1093/nar/18.12.3672; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; [No title captured]	32	146	156	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					544	550						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1347192				2022-12-18	WOS:A1992HH97400013
J	COMINGS, DE; COMINGS, BG				COMINGS, DE; COMINGS, BG			TOURETTE SYNDROME - CLINICAL AND PSYCHOLOGICAL-ASPECTS OF 250 CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											COMINGS, DE (corresponding author), CITY HOPE NATL MED CTR,DEPT MED GENET,1500 E DUARTE RD,DUARTE,CA 91010, USA.							ANTELMAN SM, 1977, SCIENCE, V195, P646, DOI 10.1126/science.841304; BARKLEY RA, 1981, HYPERACTIVE CHILDREN, P458; BARON M, 1981, AM J HUM GENET, V33, P767; CAINE ED, 1982, G DELATOURETTE ETTE, P437; COHEN DJ, 1979, LANCET, V2, P551; COMINGS DE, 1982, AM J PSYCHIAT, V139, P913; COMINGS DE, 1984, J AM ACAD CHILD PSY, V23, P138, DOI 10.1097/00004583-198403000-00004; COMINGS DE, 1984, AM J HUM GENET, V36, P586; COMINGS DE, 1985, BR J PSYCHIATRY; DEVOR EJ, 1984, AM J HUM GENET, V36, P704; ELDRIDGE R, 1977, NEUROLOGY, V27, P115, DOI 10.1212/WNL.27.2.115; FRIEDHOFF AJ, 1982, GILLES TOURETTE SYND, P454; GOLDEN GS, 1977, AM J DIS CHILD, V131, P531, DOI 10.1001/archpedi.1977.02120180045008; GOLDEN GS, 1982, GILLES TOURETTE SYND, P287; JAGGER J, 1982, SCHIZOPHRENIA BULL, V8, P267, DOI 10.1093/schbul/8.2.267; MIKKELSEN EJ, 1981, AM J PSYCHIAT, V138, P1572; NEE LE, 1980, ANN NEUROL, V7, P41, DOI 10.1002/ana.410070109; PAULS DL, 1981, ARCH GEN PSYCHIAT, V38, P1091; RANDRUP A, 1967, PSYCHOPHARMACOLOGIA, V11, P300, DOI 10.1007/BF00404607; RAPOPORT JL, 1982, GILLES TOURETTES SYN, P423; Shapiro A K, 1976, Adv Neurol, V14, P277; SHAPIRO A K, 1978, P437; SHAPIRO AK, 1984, J AM ACAD CHILD PSY, V23, P161, DOI 10.1097/00004583-198403000-00007; STEWART MA, 1980, J CHILD PSYCHOL PSYC, V21, P283, DOI 10.1111/j.1469-7610.1980.tb00033.x; STEWART MA, 1980, J NERV MENT DIS, V168, P604, DOI 10.1097/00005053-198010000-00003; VANWOERT MH, 1976, BASAL GANGLIA, P459; WASSMAN ER, 1978, NEUROLOGY, V28, P304, DOI 10.1212/WNL.28.3.304; WILSON RS, 1982, GILLES TOURETTE SYND, P329; 1980, DIAGNOSTIC STATISTIC, P494	29	146	149	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					435	450						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	AKE07	3859204				2022-12-18	WOS:A1985AKE0700001
J	Mayes, MD; Bossini-Castillo, L; Gorlova, O; Martin, JE; Zhou, XD; Chen, WV; Assassi, S; Ying, J; Tan, FK; Arnett, FC; Reveille, JD; Guerra, S; Terue, M; Carmona, FD; Gregersen, PK; Lee, AT; Lopez-Isac, E; Ochoa, E; Carreira, P; Simeon, CP; Castellvi, I; Gonzalez-Gay, MA; Zhernakova, A; Padyukov, L; Aarcon-Riquelme, M; Wijmenga, C; Brown, M; Beretta, L; Riemekasten, G; Witte, T; Hunzelmann, N; Kreuter, A; Distler, JHW; Voskuy, AE; Schuerwegh, AJ; Hesselstrand, R; Nordin, A; Airo, P; Lunardi, C; Shiels, P; van Laar, JM; Herrick, A; Worthington, J; Denton, C; Wigley, FM; Hummers, LK; Varga, J; Hinchcliff, ME; Baron, M; Hudson, M; Pope, JE; Furst, DE; Khanna, D; Phillips, K; Schiopu, E; Segal, BM; Molitor, JA; Silver, RM; Steen, VD; Simms, RW; Lafyatis, RA; Fessler, BIJ; Frech, TM; AlKassab, F; Docherty, P; Kaminska, E; Khalidi, N; Jones, HN; Markland, J; Robinson, D; Broen, J; Radstake, TRDJ; Fonseca, C; Koeleman, BP; Martin, J				Mayes, Maureen D.; Bossini-Castillo, Lara; Gorlova, Olga; Martin, Jose Ezequiel; Zhou, Xiaodong; Chen, Wei V.; Assassi, Shervin; Ying, Jun; Tan, Filemon K.; Arnett, Frank C.; Reveille, John D.; Guerra, Sandra; Terue, Maria; Carmona, Francisco David; Gregersen, Peter K.; Lee, Annette T.; Lopez-Isac, Elena; Ochoa, Eguzkine; Carreira, Patricia; Simeon, Carmen Pilar; Castellvi, Ivan; Angel Gonzalez-Gay, Miguel; Zhernakova, Alexandra; Padyukov, Leonid; Aarcon-Riquelme, Marta; Wijmenga, Cisca; Brown, Matthew; Beretta, Lorenzo; Riemekasten, Gabriela; Witte, Torsten; Hunzelmann, Nicolas; Kreuter, Alexander; Distler, Jorg H. W.; Voskuy, Alexandre E.; Schuerwegh, Annemie J.; Hesselstrand, Roger; Nordin, Annika; Airo, Paolo; Lunardi, Claudio; Shiels, Paul; van Laar, Jacob M.; Herrick, Ariane; Worthington, Jane; Denton, Christopher; Wigley, Fredrick M.; Hummers, Laura K.; Varga, John; Hinchcliff, Monique E.; Baron, Murray; Hudson, Marie; Pope, Janet E.; Furst, Daniel E.; Khanna, Dinesh; Phillips, Kristin; Schiopu, Elena; Segal, Barbara M.; Molitor, Jerry A.; Silver, Richard M.; Steen, Virginia D.; Simms, Robert W.; Lafyatis, Robert A.; Fessler, Barn I. J.; Frech, Tracy M.; AlKassab, Firas; Docherty, Peter; Kaminska, Elzbieta; Khalidi, Nader; Jones, Henry Niall; Markland, Janet; Robinson, David; Broen, Jasper; Radstake, Timothy R. D. J.; Fonseca, Carmen; Koeleman, Bobby P.; Martin, Javier		Spanish Scleroderma Grp	Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; GENETIC RISK-FACTOR; FUNCTIONAL POLYMORPHISM; WIDE ASSOCIATION; DNASE-GAMMA; DISEASE; STAT4; IRF5; VARIANTS; PRDM1	In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human leukocyte antigen (HLA) region were imputed and tested. These analyses resulted in a model composed of six polymorphic amino acid positions and seven SNPs that explained the observed significant associations in the region. In addition, a replication step comprising 4,017 SSc cases and 5,935 controls was carried out for several selected non-HLA variants, reaching a total of 5,850 cases and 9,401 controls of European ancestry. Following this strategy, we identified and validated three SSc risk loci, including DNASE1L3 at 3p14, the SCHIP1-IL12A locus at 3q25, and ATG5 at 6q21, as well as a suggested association of the TREH-DDX6 locus at 11q23. The associations of several previously reported SSc risk loci were validated and further refined, and the observed peak of association in PXK was related to DNASE1L3. Our study has increased the number of known genetic associations with SSc, provided further insight into the pleiotropic effects of shared autoimmune risk factors, and highlighted the power of dense mapping for detecting previously overlooked susceptibility loci.	[Mayes, Maureen D.; Zhou, Xiaodong; Assassi, Shervin; Tan, Filemon K.; Arnett, Frank C.; Reveille, John D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Bossini-Castillo, Lara; Martin, Jose Ezequiel; Terue, Maria; Carmona, Francisco David; Lopez-Isac, Elena; Ochoa, Eguzkine; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18016, Spain; [Gorlova, Olga; Chen, Wei V.; Ying, Jun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Guerra, Sandra; Denton, Christopher; Fonseca, Carmen] UCL, Sch Med, Ctr Rheumatol, London WC1E 6BT, England; [Gregersen, Peter K.; Lee, Annette T.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Carreira, Patricia] Hosp Univ 12 Octubre, Dept Rheumatol, Madrid 28041, Spain; [Simeon, Carmen Pilar] Hosp Valle De Hebron, Dept Internal Med, Barcelona 08035, Spain; [Castellvi, Ivan] Hosp Santa Creu & Sant Pau, Dept Rheumatol, Barcelona 08025, Spain; [Angel Gonzalez-Gay, Miguel] Hosp Univ Marques de Valdecilla, Inst Formac Invest Marques de Valdecilla, Dept Rheumatol, Santander 39008, Spain; [Zhernakova, Alexandra; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 Groningen, Netherlands; [Zhernakova, Alexandra; Padyukov, Leonid; Wijmenga, Cisca; Nordin, Annika] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden; [Aarcon-Riquelme, Marta] Univ Granada, Ctr Pfizer, Area Variabilidad ADN Humano, Junta Andalucia Genom & Invest Oncol, Granada 18016, Spain; [Aarcon-Riquelme, Marta] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Brown, Matthew] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4072, Australia; [Beretta, Lorenzo] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Referral Ctr Syst Autoimmune Dis, I-20122 Milan, Italy; [Riemekasten, Gabriela] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Witte, Torsten] Hannover Med Sch, Dept Clin Immunol, D-30625 Hannover, Germany; [Hunzelmann, Nicolas] Univ Cologne, Dept Dermatol, D-50924 Cologne, Germany; [Kreuter, Alexander] HELIOS St Elisabeth Hosp, Dept Dermatol Venereol & Allergol, D-46045 Oberhausen, Germany; [Distler, Jorg H. W.] Univ Erlangen Nurnberg, Inst Clin Immunol, Dept Internal Med, D-91054 Erlangen, Germany; [Voskuy, Alexandre E.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, NL-1081 HV Amsterdam, Netherlands; [Schuerwegh, Annemie J.] Leiden Univ, Med Ctr, Dept Rheumatol & Pathol, NL-2300 RC Leiden, Netherlands; [Schuerwegh, Annemie J.] Leiden Univ, Med Ctr, Cent Med Immunol Lab, NL-2300 RC Leiden, Netherlands; [Hesselstrand, Roger] Lund Univ, Dept Rheumatol, S-22185 Lund, Sweden; [Airo, Paolo] Spedali Civil Brescia, Serv Reumatol & Immunol Clin, I-25123 Brescia, Italy; [Lunardi, Claudio] Univ Verona, Dept Med, I-37134 Verona, Italy; [Shiels, Paul] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow G61 1BD, Lanark, Scotland; [van Laar, Jacob M.] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Herrick, Ariane; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Wigley, Fredrick M.; Hummers, Laura K.] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD 21224 USA; [Varga, John; Hinchcliff, Monique E.] Northwestern Univ, Div Rheumatol, Chicago, IL 60611 USA; [Baron, Murray; Hudson, Marie] McGill Univ, Jewish Gen Hosp, Dept Rheumatol, Montreal, PQ H3T 1E2, Canada; [Pope, Janet E.] Univ Western Ontario, Div Rheumatol, London, ON N6A 4V2, Canada; [Furst, Daniel E.] Univ Calif Los Angeles, Div Rheumatol, Los Angeles, CA 90095 USA; [Khanna, Dinesh; Phillips, Kristin; Schiopu, Elena] Univ Michigan, Div Rheumatol, Ann Arbor, MI 48109 USA; [Segal, Barbara M.] Univ Minnesota, Div Rheumatol, Minneapolis, MN 55455 USA; [Molitor, Jerry A.] Univ Minnesota, Div Rheumat & Autoimmune Dis, Minneapolis, MN 55455 USA; [Silver, Richard M.] Med Univ S Carolina, Div Rheumatol, Charleston, SC 29425 USA; [Steen, Virginia D.] Georgetown Univ, Med Ctr, Div Rheumatol, Washington, DC 20007 USA; [Simms, Robert W.; Lafyatis, Robert A.] Boston Univ, Div Rheumatol, Boston, MA 02118 USA; [Fessler, Barn I. J.] Univ Alabama Birmingham, Div Rheumatol, Birmingham, AL 35294 USA; [Frech, Tracy M.] Univ Utah, Div Rheumatol, Salt Lake City, UT 84132 USA; [AlKassab, Firas] Carolinas Healthcare Syst, Dept Rheumatol, Charlotte, NC 28211 USA; [Docherty, Peter] Moncton Hosp, Dept Rheumatol, Moncton, NB E1C 6Z8, Canada; [Kaminska, Elzbieta] Alberta Hlth Serv, Dept Med, Rheumatol Sect, Calgary, AB T2N 2T9, Canada; [Khalidi, Nader] McMaster Univ, Dept Med, Div Rheumatol, Hamilton, ON L8N 1Y2, Canada; [Jones, Henry Niall] Univ Edmonton, Dept Rheumatol, Edmonton, AB T5M 0H4, Canada; [Markland, Janet] Univ Saskatchewan, Dept Rheumatol, Saskatoon, SK S7K 0H6, Canada; [Robinson, David] Univ Manitoba, Dept Rheumatol, Arthrit Ctr, Winnipeg, MB R3A 1M4, Canada; [Broen, Jasper; Radstake, Timothy R. D. J.] Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6500 HC Nijmegen, Netherlands; [Broen, Jasper; Radstake, Timothy R. D. J.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, NL-3584 CX Utrecht, Netherlands; [Koeleman, Bobby P.] Univ Med Ctr Utrecht, Dept Med Genet, Complex Genet Sect, NL-3584 CX Utrecht, Netherlands	University of Texas System; University of Texas Health Science Center Houston; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Texas System; UTMD Anderson Cancer Center; University of London; University College London; UCL Medical School; Northwell Health; Hospital Universitario 12 de Octubre; Hospital Universitari Vall d'Hebron; Hospital of Santa Creu i Sant Pau; Hospital Universitario Marques de Valdecilla (HUMV); University of Groningen; Karolinska Institutet; Karolinska University Hospital; Pfizer; University of Granada; Oklahoma Medical Research Foundation; University of Queensland; IRCCS Ca Granda Ospedale Maggiore Policlinico; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; University of Cologne; University of Erlangen Nuremberg; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Lund University; Hospital Spedali Civili Brescia; University of Verona; University of Glasgow; Newcastle University - UK; University of Manchester; Johns Hopkins University; Northwestern University; McGill University; Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Medical University of South Carolina; Georgetown University; Boston University; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Carolinas HealthCare System; Alberta Health Services (AHS); University of Calgary; McMaster University; University of Saskatchewan; University of Manitoba; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Mayes, MD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA.	maureen.d.mayes@uth.tmc.edu; larabossc@gmail.com	Teruel, Maria/V-3205-2017; Andreu, José Luis/E-5115-2012; Catalán, Emma EBC Beltrán/H-5606-2016; Martín, María/HDL-9512-2022; González-Gay, Miguel A./B-2306-2008; Zhernakova, Alexandra/ABA-9372-2020; Carballeir, Monica Rodriguez/AAQ-8337-2021; Carmona, F. David/F-9953-2016; Wijmenga, Cisca/D-2173-2009; Carreira, Patricia E/D-4429-2018; Baron, Murray/AAF-9486-2019; Pope, Janet/G-3342-2011; Brown, Matthew A/E-5749-2010; Varga, John/AAK-6472-2021; Alarcón-Riquelme, Marta E./ABF-8163-2020; Espinosa, Gerard/J-2603-2016; Wijmenga, Cisca/AAE-7719-2019; Beretta, Lorenzo/AAB-8605-2019; Martín, Javier/AAV-5209-2021; Worthington, Jane/M-9770-2014; Narvaez, Javier/AAD-7456-2020; López-Isac, Elena/AAA-9644-2020; Blanco, Francisco J./C-3192-2014; Comet, Luis Sáez/I-7301-2017; Bossini-Castillo, Lara/G-1234-2016; Witte, Torsten/B-5783-2016; Riemekasten, Gabriela/B-5019-2017; Centeno, Norberto Ortego/C-4793-2019; Martin, Javier/B-8141-2008; Ochoa, Eguzkine/AAO-5639-2020; Padyukov, Leonid/A-4890-2009; Fernandez-Nebro, Antonio/K-7628-2012; Martin, Jose Ezequiel/F-4869-2012	Teruel, Maria/0000-0002-5315-2660; Andreu, José Luis/0000-0002-6002-1239; Catalán, Emma EBC Beltrán/0000-0001-8070-6916; González-Gay, Miguel A./0000-0002-7924-7406; Carballeir, Monica Rodriguez/0000-0002-8802-0238; Carmona, F. David/0000-0002-1427-7639; Carreira, Patricia E/0000-0001-8279-3806; Pope, Janet/0000-0003-1479-5302; Brown, Matthew A/0000-0003-0538-8211; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Espinosa, Gerard/0000-0003-1336-0163; Wijmenga, Cisca/0000-0002-5635-1614; Beretta, Lorenzo/0000-0002-6529-6258; Worthington, Jane/0000-0003-0544-042X; Narvaez, Javier/0000-0002-1614-8064; López-Isac, Elena/0000-0001-8806-5148; Blanco, Francisco J./0000-0001-9821-7635; Bossini-Castillo, Lara/0000-0002-5471-5824; Centeno, Norberto Ortego/0000-0003-2325-0937; Martin, Javier/0000-0002-2202-0622; Padyukov, Leonid/0000-0003-2950-5670; Castellvi, Ivan/0000-0002-5410-5807; Alegre Sancho, Juan Jose/0000-0003-1641-0875; Andreu Sanchez, Jose Luis/0000-0001-9126-8819; Zhernakova, Alexandra/0000-0002-4574-0841; Kreuter, Alexander/0000-0003-2275-499X; Hinchcliff, Monique/0000-0002-8652-9890; Herrick, Ariane/0000-0003-4941-7926; Fernandez-Nebro, Antonio/0000-0002-2962-9844; Shiels, Paul/0000-0002-7577-9843; Garcia-Hernandez, Francisco Jose/0000-0002-2600-0485; Ochoa, Eguzkine/0000-0002-1506-9065; Voskuyl, Alexandre/0000-0002-9699-1827; Martin, Jose Ezequiel/0000-0002-0051-8868; ORTIZ-SANTAMARIA, VERA/0000-0001-6016-606X; Nordin, Annika/0000-0003-1976-4679	National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Centers of Research Translation (CORT) grant [P50AR054144]; NIH [KL2RR024149-04]; NIH NIAMS [N01-AR02251]; NIH National Center for Research Resources grant [3UL1RR024148]; GEN-FER from the Spanish Society of Rheumatology; Spanish Ministry of Science [SAF2009-11110, SAF2012-34435]; Junta de Andalucia [CTS-4977]; Redes Tematicas de Investigacion Cooperativa en Salud (Red de Investigacion en Inflamacion y Enfermedades Reumaticas) [RD08/0075, RD12/0009/0004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024149, UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI090909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054144, P50AR060780, R01AR055258, R01AR051089, K23AR059763, N01AR002251, K23AR060241] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Centers of Research Translation (CORT) grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Center for Research Resources grant; GEN-FER from the Spanish Society of Rheumatology; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Redes Tematicas de Investigacion Cooperativa en Salud (Red de Investigacion en Inflamacion y Enfermedades Reumaticas); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Centers of Research Translation (CORT) grant P50AR054144, NIH grant KL2RR024149-04, NIH NIAMS grant N01-AR02251, and NIH National Center for Research Resources grant 3UL1RR024148. This study was supported by GEN-FER from the Spanish Society of Rheumatology, SAF2009-11110 and SAF2012-34435 from the Spanish Ministry of Science, CTS-4977 from Junta de Andalucia, and RD08/0075 and RD12/0009/0004 from the Redes Tematicas de Investigacion Cooperativa en Salud (Red de Investigacion en Inflamacion y Enfermedades Reumaticas). We are indebted to the Immunochip Consortium for provision of the control data. We are grateful to Julio Charles, Marilyn Perry, Suzanne S. Taillefer (National Study Coordinator for the Canadian Scleroderma Research Group), Sofia Vargas, Sonia Garcia, and Gema Robledo. We also thank the Scleroderma Foundation, the Spanish Scleroderma Patient Group, the Canadian Scleroderma Patient Group, the Federation of European Scleroderma Associations, National DNA Bank Carlos III (University of Salamanca), the European League against Rheumatism Scleroderma Trials and Research group, the German Network of Systemic Sclerosis, and the affected individuals, friends, spouses, and others who generously provided the samples for these studies.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Assassi S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-9; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; Baron WF, 1998, GENE, V215, P291, DOI 10.1016/S0378-1119(98)00281-9; Bellemare-Pelletier A, 2005, J LEUKOCYTE BIOL, V78, P95, DOI 10.1189/jlb.0105020; Bolster M., 2011, RHEUMATOLOGY, P1373; Bossini-Castillo L, 2013, ANN RHEUM DIS, V72, P602, DOI 10.1136/annrheumdis-2012-201888; Bossini-Castillo L, 2012, HUM MOL GENET, V21, P926, DOI 10.1093/hmg/ddr522; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Carmona FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054419; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; de Vries S, 2013, J BIOL CHEM, V288, P5815, DOI 10.1074/jbc.M112.420711; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P2472, DOI 10.1002/art.24688; Dieude P, 2010, J RHEUMATOL, V37, P987, DOI 10.3899/jrheum.091163; Ellinghaus D, 2013, GASTROENTEROLOGY, V145, P339, DOI 10.1053/j.gastro.2013.04.040; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Errami Y, 2013, J BIOL CHEM, V288, P3460, DOI 10.1074/jbc.M112.423061; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Martin JE, 2012, HUM GENET, V131, P1023, DOI 10.1007/s00439-011-1137-z; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Gourh P, 2009, ARTHRITIS RHEUM-US, V60, P3794, DOI 10.1002/art.24958; Gu YS, 2008, SEMIN ARTHRITIS RHEU, V38, P132, DOI 10.1016/j.semarthrit.2007.10.010; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ito I, 2009, ARTHRITIS RHEUM-US, V60, P1845, DOI 10.1002/art.24600; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Juran BD, 2012, HUM MOL GENET, V21, P5209, DOI 10.1093/hmg/dds359; Karp DR, 2010, HUM MOL GENET, V19, P707, DOI 10.1093/hmg/ddp521; LEROY EC, 1988, J RHEUMATOL, V15, P202; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Martin JE, 2013, HUM MOL GENET, V22, P4021, DOI 10.1093/hmg/ddt248; Martin JE, 2012, HUM MOL GENET, V21, P2825, DOI 10.1093/hmg/dds099; Mayes MD, 2012, CURR OPIN RHEUMATOL, V24, P677, DOI 10.1097/BOR.0b013e328358575b; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Okamoto M, 2005, BIOCHEM BIOPH RES CO, V327, P76, DOI 10.1016/j.bbrc.2004.11.142; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polychronakos C, 2011, NAT GENET, V43, P1173, DOI 10.1038/ng.1015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Reveille JD, 2001, SEMIN ARTHRITIS RHEU, V30, P332, DOI 10.1053/sarh.2001.20268; Rueda B, 2009, HUM MOL GENET, V18, P2071, DOI 10.1093/hmg/ddp119; Saruhan-Direskeneli G, 2013, AM J HUM GENET, V93, P298, DOI 10.1016/j.ajhg.2013.05.026; Sato S, 2000, J RHEUMATOL, V27, P2838; Sharif R, 2012, ANN RHEUM DIS, V71, P1197, DOI 10.1136/annrheumdis-2011-200901; Shiokawa D, 2001, BIOCHEMISTRY-US, V40, P143, DOI 10.1021/bi001041a; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; Tollefsen S, 2012, J BIOL CHEM, V287, P13611, DOI 10.1074/jbc.M111.320374; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Tsuchiya N, 2009, ANN RHEUM DIS, V68, P1375, DOI 10.1136/ard.2009.111310; Ueki M, 2009, CLIN CHIM ACTA, V407, P20, DOI 10.1016/j.cca.2009.06.022; Voight BF, 2012, CURR OPIN IMMUNOL, V24, P552, DOI 10.1016/j.coi.2012.07.013; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	74	145	147	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					47	61		10.1016/j.ajhg.2013.12.002	http://dx.doi.org/10.1016/j.ajhg.2013.12.002			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24387989	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000329888400005
J	Yang, WL; Tang, HY; Zhang, Y; Tang, XF; Zhang, J; Sun, LD; Yang, J; Cui, Y; Zhang, L; Hirankarn, N; Cheng, H; Pan, HF; Gao, JP; Lee, TL; Sheng, YJ; Lau, CS; Li, Y; Chan, TM; Yin, XY; Ying, DG; Lu, QJ; Leung, AMH; Zuo, XB; Chen, X; Tong, KL; Zhou, FS; Diao, QC; Tse, NKC; Xie, HF; Mok, CC; Hao, F; Wong, SN; Shi, BJ; Lee, KW; Hui, Y; Ho, MHK; Liang, B; Lee, PPW; Cui, HZ; Guo, Q; Chung, BHY; Pu, XM; Liu, QJ; Zhang, XG; Zhang, CG; Chong, CY; Fang, H; Wong, RWS; Sun, YH; Mok, MY; Li, XP; Avihingsanon, Y; Zhai, ZF; Rianthavorn, P; Deekajorndej, T; Suphapeetiporn, K; Gao, F; Shotelersuk, V; Kang, XJ; Ying, SKY; Zhang, LJ; Wong, WHS; Zhu, DX; Fung, SKS; Zeng, FQ; Lai, WM; Wong, CM; Ng, IOL; Garcia-Barcelo, MM; Cherny, SS; Shen, N; Tam, PKH; Sham, PC; Ye, DQ; Yang, S; Zhang, XJ; Lau, YL				Yang, Wanling; Tang, Huayang; Zhang, Yan; Tang, Xianfa; Zhang, Jing; Sun, Liangdan; Yang, Jing; Cui, Yong; Zhang, Lu; Hirankarn, Nattiya; Cheng, Hui; Pan, Hai-Feng; Gao, Jinping; Lee, Tsz Leung; Sheng, Yujun; Lau, Chak Sing; Li, Yang; Chan, Tak Mao; Yin, Xianyong; Ying, Dingge; Lu, Qianjin; Leung, Alexander Moon Ho; Zuo, Xianbo; Chen, Xiang; Tong, Kwok Lung; Zhou, Fusheng; Diao, Qingchun; Tse, Niko Kei Chiu; Xie, Hongfu; Mok, Chi Chiu; Hao, Fei; Wong, Sik Nin; Shi, Bingjun; Lee, Ka Wing; Hui, Yan; Ho, Marco Hok Kung; Liang, Bo; Lee, Pamela Pui Wah; Cui, Hongzhou; Guo, Qing; Chung, Brian Hon-Yin; Pu, Xiongming; Liu, Qiji; Zhang, Xiaoguang; Zhang, Change; Chong, Chun Yin; Fang, Hong; Wong, Raymond Woon Sing; Sun, Yonghu; Mok, Mo Yin; Li, Xiang-Pei; Avihingsanon, Yingyos; Zhai, Zhifang; Rianthavorn, Pompimol; Deekajorndej, Thavatchai; Suphapeetiporn, Kanya; Gao, Fei; Shotelersuk, Vorasuk; Kang, Xiaojing; Ying, Shirley King Yee; Zhang, Lijuan; Wong, Wilfred Hing Sang; Zhu, Dingxian; Fung, Samuel Ka Shun; Zeng, Fanqin; Lai, Wai Ming; Wong, Chun-Ming; Ng, Irene Oi Lin; Garcia-Barcelo, Maria-Merce; Cherny, Stacey S.; Shen, Nan; Tam, Paul Kwong-Hang; Sham, Pak Chung; Ye, Dong-Qing; Yang, Sen; Zhang, Xuejun; Lau, Yu Lung			Meta-analysis Followed by Replication Identifies Loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as Associated with Systemic Lupus Erythematosus in Asians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HONG-KONG CHINESE; GENOME-WIDE ASSOCIATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; KINASE INHIBITOR P27(KIP1); EPIGENETIC MECHANISMS; RHEUMATOID-ARTHRITIS; HAN POPULATION; SUSCEPTIBILITY; ITGAM; EXPRESSION	Systemic lupus erythematosus (SLE) is a prototype autoimmune disease with a strong genetic involvement and ethnic differences. Susceptibility genes identified so far only explain a small portion of the genetic heritability of SLE, suggesting that many more loci are yet to be uncovered for this disease. In this study, we performed a meta-analysis of genome-wide association studies on SLE in Chinese Han populations and followed up the findings by replication in four additional Asian cohorts with a total of 5,365 cases and 10,054 corresponding controls. We identified genetic variants in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with the disease. These findings point to potential roles of cell-cycle regulation, autophagy, and DNA demethylation in SLE pathogenesis. For the region involving TET3 and that involving CDKN1B, multiple independent SNPs were identified, highlighting a phenomenon that might partially explain the missing heritability of complex diseases.	[Yang, Wanling; Zhang, Yan; Zhang, Jing; Yang, Jing; Zhang, Lu; Lee, Tsz Leung; Ying, Dingge; Ho, Marco Hok Kung; Lee, Pamela Pui Wah; Chung, Brian Hon-Yin; Chong, Chun Yin; Wong, Wilfred Hing Sang; Lau, Yu Lung] Univ Hong Kong, Li Ka Shing Fac Med, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Tang, Huayang; Tang, Xianfa; Sun, Liangdan; Cui, Yong; Cheng, Hui; Gao, Jinping; Sheng, Yujun; Li, Yang; Yin, Xianyong; Zuo, Xianbo; Zhou, Fusheng; Liang, Bo; Cui, Hongzhou; Zhang, Xiaoguang; Zhang, Change; Sun, Yonghu; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Minist Educ China, Key Lab Dermatol, State Key Lab Incubat Base Dermatol, Hefei 230032, Anhui, Peoples R China; [Hirankarn, Nattiya] Chulalongkorn Univ, Fac Med, Dept Microbiol, Lupus Res Unit, Bangkok 10330, Thailand; [Pan, Hai-Feng; Ye, Dong-Qing] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei 230032, Anhui, Peoples R China; [Mok, Chi Chiu] Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lau, Chak Sing; Chan, Tak Mao; Wong, Raymond Woon Sing; Mok, Mo Yin] Univ Hong Kong, Li Ka Shing Fac Med, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lu, Qianjin; Gao, Fei] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Epigenet Res Ctr, Changsha 410011, Hunan, Peoples R China; [Lee, Ka Wing] Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Sik Nin] Tuen Mun Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Leung, Alexander Moon Ho] Queen Elizabeth Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Xiang; Xie, Hongfu] Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha 410008, Hunan, Peoples R China; [Tong, Kwok Lung; Ying, Shirley King Yee; Fung, Samuel Ka Shun] Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Diao, Qingchun; Shi, Bingjun] First Peoples Hosp Chongqing City, Dept Dermatol, Chongqing 400015, Peoples R China; [Tse, Niko Kei Chiu; Lai, Wai Ming] Princess Margaret Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Hao, Fei; Zhai, Zhifang] Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing 400015, Peoples R China; [Hui, Yan; Zhang, Lijuan] Xinjiang Med Univ, Affiliated Hosp 1, Dept Dermatol, Urumqi 830053, Xinjiang Uygur, Peoples R China; [Guo, Qing; Zeng, Fanqin] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Dermatol, Guangzhou 510120, Peoples R China; [Pu, Xiongming; Kang, Xiaojing] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Dermatol, Urumqi 830001, Peoples R China; [Liu, Qiji] Shandong Univ, Dept Med Genet, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Peoples R China; [Fang, Hong; Zhu, Dingxian] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Xiang-Pei] Anhui Prov Hosp, Dept Rheumatol, Hefei 230001, Peoples R China; [Avihingsanon, Yingyos] Chulalongkorn Univ, Dept Med, Fac Med, Bangkok 10330, Thailand; [Rianthavorn, Pompimol; Deekajorndej, Thavatchai; Suphapeetiporn, Kanya; Shotelersuk, Vorasuk] Chulalongkorn Univ, Dept Pediat, Fac Med, Bangkok 10330, Thailand; [Suphapeetiporn, Kanya; Shotelersuk, Vorasuk] King Chulalongkorn Mem Hosp, Excellence Ctr Med Genet, Thai Red Cross Soc, Bangkok 10330, Thailand; [Wong, Chun-Ming; Ng, Irene Oi Lin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Garcia-Barcelo, Maria-Merce; Tam, Paul Kwong-Hang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Cherny, Stacey S.; Sham, Pak Chung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Shen, Nan] Shanghai Jiao Tong Univ, Inst Hlth Sci, Joint Mol Rheumatol Lab, Shanghai 200001, Peoples R China; [Shen, Nan] Shanghai Jiao Tong Univ, Shanghai Renji Hosp, Shanghai 200001, Peoples R China	University of Hong Kong; Anhui Medical University; Ministry of Education, China; Chulalongkorn University; Anhui Medical University; Tuen Mun Hospital; University of Hong Kong; Central South University; Pamela Youde Nethersole Eastern Hospital; Tuen Mun Hospital; Central South University; Army Medical University; Xinjiang Medical University; Sun Yat Sen University; Shandong University; Zhejiang University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; University of Hong Kong; University of Hong Kong; University of Hong Kong; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lau, YL (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Queen Mary Hosp, Dept Paediat & Adolescent Med, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	ayzxj@vip.sina.com; lauylung@hkucc.hku.hk	SHENG, Yu/GXZ-8269-2022; Shen, Nan/AGK-6807-2022; WONG, Chun-Ming/A-6739-2009; FUNG, Samuel Ka Shun/H-4603-2019; Wong, Wilfred/Q-8751-2019; Chen, Gang/G-2722-2010; Cherny, Stacey S/B-3315-2008; Cui, Yong/AAF-9300-2020; /C-4369-2009; /C-4405-2009; Lau, Yu Lung/C-4322-2009; Lee, Pamela Pui-Wah/C-4331-2009	WONG, Chun-Ming/0000-0002-2497-7858; FUNG, Samuel Ka Shun/0000-0003-2955-638X; Cherny, Stacey S/0000-0002-0269-3352; Shen, Nan/0000-0002-5875-4417; /0000-0003-4898-2114; Ho, Marco/0000-0003-1802-2120; Sun, Yonghu/0000-0003-4553-2871; Zhang, Lu/0000-0002-2794-7371; Shotelersuk, Vorasuk/0000-0002-1856-0589; Pan, Hai-Feng/0000-0001-6814-1553; Hirankarn, Nattiya/0000-0003-2224-6856; Lau, Wallace Chak Sing/0000-0001-6698-8355; Chan, Tak Mao/0000-0002-3495-4051; Zhang, Chengfei/0000-0002-6016-9436; Ng, Irene Oi-lin/0000-0001-7532-2029; Pan, Hai-Feng/0000-0001-8218-5747; Wong, Hing Sang Wilfred/0000-0001-8396-2368; /0000-0001-6231-3035; Lau, Yu Lung/0000-0002-4780-0289; Lee, Pamela Pui-Wah/0000-0002-5934-7338	Shun Tak District Min Yuen Tong of Hong Kong; Research Grant Council of the Hong Kong Government [HKU781709M, HKU 784611M, HKU 770411M]; Ministry of Education of China [IRT-1046]; National Natural Science Foundation of China (NSFC) [81171505, 30972727, 81071940, 31000528, 81102192, 30830089]; State Key Basic Research Program 973 of China [2011CB512103, 2012CB722404]; National Research University Project of The Commission on Higher Education of Thailand; Ratchadaphiseksomphot Endowment Fund [HR1163A]; National Research Council of Thailand; Thailand Research Fund; Hong Kong GRF [HKU 7623/08M, HKU 7747/07M]; Edward the Sal Kim Hotung Pediatric Education and Research Fund	Shun Tak District Min Yuen Tong of Hong Kong; Research Grant Council of the Hong Kong Government; Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Key Basic Research Program 973 of China; National Research University Project of The Commission on Higher Education of Thailand; Ratchadaphiseksomphot Endowment Fund; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Thailand Research Fund(Thailand Research Fund (TRF)); Hong Kong GRF(Hong Kong Research Grants Council); Edward the Sal Kim Hotung Pediatric Education and Research Fund	This study was supported by a generous donation from Shun Tak District Min Yuen Tong of Hong Kong. We thank Winnie Lau and her team for the collection of samples and clinical records for Hong Kong cases. This study also received support from the Research Grant Council of the Hong Kong Government (General Research Fund [GRF] grants HKU781709M, HKU 784611M, and HKU 770411M to W.Y. and Y.L.L.), the Ministry of Education of China (IRT-1046 to X.Z.), National Natural Science Foundation of China (NSFC) grants (81171505 and 30972727 to S.Y., 81071940 to Y.C., 31000528 to X.Z., 81102192 to H.F.P., and 30830089 to D.Q.Y.), the Preproject of State Key Basic Research Program 973 of China (grant 2011CB512103 to S.Y. and grant 2012CB722404 to L.D.S.), the National Research University Project of The Commission on Higher Education of Thailand (N.H. and Y.A.), the Ratchadaphiseksomphot Endowment Fund (HR1163A to N.H. and Y.A.), the National Research Council of Thailand (N.H. and Y.A.), and the Thailand Research Fund (K.S. and V.S.). We thank P.K. and A.C. for their contributions to Thai pediatric patient care and sample collections, as well as Sukkapan P. for retrieving the microarray expression data. Genotyping of samples serving as controls in this study was supported by Hong Kong GRF grants HKU 7623/08M and HKU 7747/07M. Y.Z. and J.Z. are supported by Edward the Sal Kim Hotung Pediatric Education and Research Fund.	ARNETT FC, 1976, MEDICINE, V55, P313, DOI 10.1097/00005792-197607000-00003; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Chang YK, 2009, GENES IMMUN, V10, P414, DOI 10.1038/gene.2009.16; Collier FM, 2004, BIOCHEM BIOPH RES CO, V324, P1360, DOI 10.1016/j.bbrc.2004.09.205; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iwata S, 2011, J RHEUMATOL, V38, P633, DOI 10.3899/jrheum.100729; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Langemeijer SMC, 2009, CELL CYCLE, V8, P4044, DOI 10.4161/cc.8.24.10239; Lessard CJ, 2011, AM J HUM GENET, V88, P83, DOI 10.1016/j.ajhg.2010.11.014; Li G, 2010, MOL CANCER RES, V8, P885, DOI 10.1158/1541-7786.MCR-09-0467; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Li R, 2012, LUPUS, V21, P75, DOI 10.1177/0961203311422724; Liu Z, 2005, NUCLEIC ACIDS RES, V33, P3763, DOI 10.1093/nar/gki680; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Ma X, 2011, BIOCHEM J, V439, P27, DOI 10.1042/BJ20101475; Maas K, 2002, J IMMUNOL, V169, P5, DOI 10.4049/jimmunol.169.1.5; Mok CC, 2003, LUPUS, V12, P717, DOI 10.1191/0961203303lu451xx; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Ni JD, 2009, RHEUMATOL INT, V29, P1323, DOI 10.1007/s00296-009-0855-1; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Ophascharoensuk V, 1998, NAT MED, V4, P575, DOI 10.1038/nm0598-575; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Patel DR, 2010, CURR OPIN RHEUMATOL, V22, P478, DOI 10.1097/BOR.0b013e32833ae915; Pierdominici M, 2012, FASEB J, V26, P1400, DOI 10.1096/fj.11-194175; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Tang HF, 2009, CELL CYCLE, V8, P2789, DOI 10.4161/cc.8.17.9446; Tokunaga M, 2005, RHEUMATOLOGY, V44, P176, DOI 10.1093/rheumatology/keh443; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yang J, 2011, HUM MOL GENET, V20, P601, DOI 10.1093/hmg/ddq474; Yang W, 2009, GENES IMMUN, V10, P219, DOI 10.1038/gene.2009.1; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yang WL, 2009, HUM MOL GENET, V18, P2063, DOI 10.1093/hmg/ddp118; Zhang Y, 2011, GENES IMMUN, V12, P231, DOI 10.1038/gene.2010.66; Zhao H, 2012, GENES IMMUN, V13, P536, DOI 10.1038/gene.2012.33; Zhong H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3514	55	145	157	0	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					41	51		10.1016/j.ajhg.2012.11.018	http://dx.doi.org/10.1016/j.ajhg.2012.11.018			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23273568	Bronze, Green Published			2022-12-18	WOS:000313759000004
J	Ameur, A; Enroth, S; Johansson, A; Zaboli, G; Igl, W; Johansson, ACV; Rivas, MA; Daly, MJ; Schmitz, G; Hicks, AA; Meitinger, T; Feuk, L; van Duijn, C; Oostra, B; Pramstaller, PP; Rudan, I; Wright, AF; Wilson, JF; Campbell, H; Gyllensten, U				Ameur, Adam; Enroth, Stefan; Johansson, Asa; Zaboli, Ghazal; Igl, Wilmar; Johansson, Anna C. V.; Rivas, Manuel A.; Daly, Mark J.; Schmitz, Gerd; Hicks, Andrew A.; Meitinger, Thomas; Feuk, Lars; van Duijn, Cornelia; Oostra, Ben; Pramstaller, Peter P.; Rudan, Igor; Wright, Alan F.; Wilson, James F.; Campbell, Harry; Gyllensten, Ulf			Genetic Adaptation of Fatty-Acid Metabolism: A Human-Specific Haplotype Increasing the Biosynthesis of Long-Chain Omega-3 and Omega-6 Fatty Acids	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOCOSAHEXAENOIC ACID; POSITIVE SELECTION; ARACHIDONIC-ACID; HUMAN GENOME; VARIANTS; ASSOCIATION; CLUSTER; SEQUENCE; COMMON; LOCI	Omega-3 and omega-6 long-chain polyunsaturated fatty acids (LC-PUFAs) are essential for the development and function of the human brain. They can be obtained directly from food, e.g., fish, or synthesized from precursor molecules found in vegetable oils. To determine the importance of genetic variability to fatty-acid biosynthesis, we studied FADS1 and FADS2, which encode rate-limiting enzymes for fatty-acid conversion. We performed genome-wide genotyping (n = 5,652 individuals) and targeted resequencing (n = 960 individuals) of the FADS region in five European population cohorts. We also analyzed available genomic data from human populations, archaic hominins, and more distant primates. Our results show that present-day humans have two common FADS haplotypes-defined by 28 closely linked SNPs across 38.9 kb-that differ dramatically in their ability to generate LC-PUFAs. No independent effects on FADS activity were seen for rare SNPs detected by targeted resequencing. The more efficient, evolutionarily derived haplotype appeared after the lineage split leading to modern humans and Neanderthals and shows evidence of positive selection. This human-specific haplotype increases the efficiency of synthesizing essential long-chain fatty acids from precursors and thereby might have provided an advantage in environments with limited access to dietary LC-PUFAs. In the modern world, this haplotype has been associated with lifestyle-related diseases, such as coronary artery disease.	[Ameur, Adam; Enroth, Stefan; Johansson, Asa; Zaboli, Ghazal; Igl, Wilmar; Johansson, Anna C. V.; Feuk, Lars; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, SciLifeLab Uppsala, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Rivas, Manuel A.; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Rivas, Manuel A.; Daly, Mark J.] Broad Inst MIT & Harvard, Boston, MA 02114 USA; [Schmitz, Gerd] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93042 Regensburg, Germany; [van Duijn, Cornelia] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Oostra, Ben] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano, Ctr Biomed, I-39100 Bolzano, Italy; [Hicks, Andrew A.; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, D-23562 Lubeck, Germany; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Rudan, Igor] Univ Split, Fac Med, Croatian Ctr Global Hlth, Split 21000, Croatia; [Rudan, Igor; Wilson, James F.; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Wright, Alan F.] Univ Edinburgh, Med Res Council Inst Genet & Mol Med, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	SciLifeLab; Uppsala University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Regensburg; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; European Academy of Bozen-Bolzano; University of Lubeck; Krankenhaus Bozen; University of Lubeck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Split; University of Edinburgh; University of Edinburgh	Gyllensten, U (corresponding author), Uppsala Univ, Rudbeck Lab, SciLifeLab Uppsala, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden.	ulf.gyllensten@igp.uu.se	Meitinger, Thomas/O-1318-2015; Wilson, James F/A-5704-2009; Johansson, Åsa/AAG-6799-2021; Ameur, Adam/E-6207-2011; Daly, Mark J/B-2453-2017; Enroth, Stefan/C-7396-2009; Rudan, Igor/I-1467-2012; Pramstaller, Peter P/C-2357-2008; Campbell, Harry/E-2959-2010; Hicks, Andrew Anthony/E-9518-2017; Johansson, Åsa/G-5270-2011; Rivas, Manuel/ABE-8173-2020	Wilson, James F/0000-0001-5751-9178; Johansson, Åsa/0000-0002-2915-4498; Ameur, Adam/0000-0001-6085-6749; Daly, Mark J/0000-0002-0949-8752; Enroth, Stefan/0000-0002-5056-9137; Rudan, Igor/0000-0001-6993-6884; Campbell, Harry/0000-0002-6169-6262; Hicks, Andrew Anthony/0000-0001-6320-0411; Johansson, Åsa/0000-0002-2915-4498; Rivas, Manuel/0000-0003-1457-9925; Meitinger, Thomas/0000-0002-8838-8403; Pramstaller, Peter P/0000-0002-9831-8302; Van Duijn, Cornelia/0000-0002-2374-9204	Knut and Alice Wallenberg foundation (CMS); Swedish Research Council (SNISS); Science for Life Laboratory Uppsala; Swedish Research Council; MRC [MC_PC_U127561128, MC_U127561128] Funding Source: UKRI; Medical Research Council [MC_PC_U127561128, MC_U127561128] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish	Knut and Alice Wallenberg foundation (CMS); Swedish Research Council (SNISS)(Swedish Research Council); Science for Life Laboratory Uppsala; Swedish Research Council(Swedish Research CouncilEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The SOLiD DNA sequencing and Taqman genotyping were performed by the Uppsala Genome Center, funded by the Knut and Alice Wallenberg foundation (CMS), The Swedish Research Council (SNISS), and Science for Life Laboratory Uppsala. The study was supported by grants from the Swedish Research Council.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cordain L, 2001, WORLD REV NUTR DIET, V90, P144; Crawford MA, 1999, LIPIDS, V34, pS39, DOI 10.1007/BF02562227; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koletzko B, 2008, NESTLE NUTR WORKS SE, V62, P35, DOI 10.1159/000146246; Lattka E, 2011, AM J CLIN NUTR, V93, P382, DOI 10.3945/ajcn.110.004515; Leonard W. R., 2010, FAT DETECTION TASTE; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Martinelli N, 2009, J NUTRIGENET NUTRIGE, V2, P129, DOI 10.1159/000238177; Mascalzoni D, 2010, EUR J HUM GENET, V18, P296, DOI 10.1038/ejhg.2009.155; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; Matsuzaka T, 2002, J LIPID RES, V43, P107; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Ratnayake WMN, 2009, ANN NUTR METAB, V55, P8, DOI 10.1159/000228994; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rudan I, 1999, COLLEGIUM ANTROPOL, V23, P531; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; TITUSTRACHTENBERG EA, 1994, AM J HUM GENET, V55, P160; Vitart V, 2006, EUR J HUM GENET, V14, P478, DOI 10.1038/sj.ejhg.5201589; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zaboli G, 2012, EUR J HUM GENET, V20, P77, DOI 10.1038/ejhg.2011.138; Zietemann V, 2010, BRIT J NUTR, V104, P1748, DOI 10.1017/S0007114510002916	66	145	147	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					809	820		10.1016/j.ajhg.2012.03.014	http://dx.doi.org/10.1016/j.ajhg.2012.03.014			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22503634	Green Published, Bronze			2022-12-18	WOS:000303907500005
J	Suzuki, S; Marazita, ML; Cooper, ME; Miwa, N; Hing, A; Jugessur, A; Natsume, N; Shimozato, K; Ohbayashi, N; Suzuki, Y; Niimi, T; Minami, K; Yamamoto, M; Altannamar, TJ; Erkhembaatar, T; Furukawa, H; Daack-Hirsch, S; L'Heureux, J; Brandon, CA; Weinberg, SM; Neiswanger, K; Deleyiannis, FWB; Salamanca, JE; Vieira, AR; Lidral, AC; Martin, JF; Murray, JC				Suzuki, Satoshi; Marazita, Mary L.; Cooper, Margaret E.; Miwa, Nobutomo; Hing, Anne; Jugessur, Astanand; Natsume, Nagato; Shimozato, Kazuo; Ohbayashi, Naofumi; Suzuki, Yasushi; Niimi, Teruyuki; Minami, Katsuhiro; Yamamoto, Masahiko; Altannamar, Tserendorj J.; Erkhembaatar, Tudevdorj; Furukawa, Hiroo; Daack-Hirsch, Sandra; L'Heureux, Jamie; Brandon, Carla A.; Weinberg, Seth M.; Neiswanger, Katherine; Deleyiannis, Frederic W. B.; de Salamanca, Javier E.; Vieira, Alexandre R.; Lidral, Andrew C.; Martin, James F.; Murray, Jeffrey C.			Mutations in BMP4 Are Associated with Subepithelial, Microform, and Overt Cleft Lip	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE VARIANTS; PALATE; PHENOTYPE; SPECTRUM; DEFECTS; MSX1	Cleft lip with or without cleft palate (CL/P) is a complex trait with evidence that the clinical spectrum includes both microform and subepithelial lip defects. We identified missense and nonsense mutations in the BMP4 gene in 1 of 30 cases of microform clefts, 2 of 87 cases with subepithelial defects in the orbicularis oils muscle (OOM), 5 of 968 cases of overt CL/P, and 0 of 529 controls. These results provide confirmation that microforms and subepithelial OOM defects are part of the spectrum of CL/P and should be considered during clinical evaluation of families with clefts. Furthermore, we suggest a role for BMP4 in wound healing.	[Suzuki, Satoshi; L'Heureux, Jamie; Lidral, Andrew C.; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Suzuki, Satoshi; Natsume, Nagato; Suzuki, Yasushi; Niimi, Teruyuki; Minami, Katsuhiro; Furukawa, Hiroo] Aichi Gakuin Univ, Sch Dent, Div Res & Treatment Oral & Maxillofacial Congenit, Chikusa Ku, Nagoya, Aichi 4648651, Japan; [Shimozato, Kazuo; Ohbayashi, Naofumi] Aichi Gakuin Univ, Sch Dent, Dept Maxillofacial Surg, Chikusa Ku, Nagoya, Aichi 4648651, Japan; [Suzuki, Satoshi; Yamamoto, Masahiko] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Iwatsuki, Nisshin 4700195, Japan; [Marazita, Mary L.; Cooper, Margaret E.; Brandon, Carla A.; Weinberg, Seth M.; Neiswanger, Katherine; Vieira, Alexandre R.] Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15219 USA; [Marazita, Mary L.; Cooper, Margaret E.; Brandon, Carla A.; Weinberg, Seth M.; Neiswanger, Katherine; Vieira, Alexandre R.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15219 USA; [Marazita, Mary L.; Cooper, Margaret E.; Brandon, Carla A.; Weinberg, Seth M.; Neiswanger, Katherine; Vieira, Alexandre R.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15219 USA; [Marazita, Mary L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15219 USA; [Miwa, Nobutomo] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 8528523, Japan; [Miwa, Nobutomo] Japan Sci & Technol Agcy, Tokyo, Japan; [Hing, Anne] Univ Washington, Ctr Human Dev & Disabil, Seattle, WA USA; [Jugessur, Astanand] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Altannamar, Tserendorj J.; Erkhembaatar, Tudevdorj] Maternal & Childrens Hlth Res Ctr Hosp, Ulaanbaatar 210624, Mongolia; [Daack-Hirsch, Sandra; Murray, Jeffrey C.] Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA; [Weinberg, Seth M.] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Deleyiannis, Frederic W. B.] Univ Pittsburgh, Sch Med, Dept Surg, Div Plast Surg, Pittsburgh, PA 15219 USA; [de Salamanca, Javier E.] Univ Autonoma Madrid, Nano Jesus Univ Hosp, Dept Plast Surg, E-28049 Madrid, Spain; [Vieira, Alexandre R.] Univ Pittsburgh, Dept Plast Surg, Pittsburgh, PA 15219 USA; [Martin, James F.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat Dent, Iowa City, IA 52242 USA; [Murray, Jeffrey C.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; [Murray, Jeffrey C.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa; Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nagasaki University; Japan Science & Technology Agency (JST); University of Washington; University of Washington Seattle; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Iowa; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Autonomous University of Madrid; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Iowa; University of Iowa; University of Iowa	Murray, JC (corresponding author), Univ Iowa, Dept Pediat, S Grand Ave,2182 ML, Iowa City, IA 52242 USA.	jeff-murray@uiowa.edu		Daack-Hirsch, Sandra/0000-0003-1192-7154; Weinberg, Seth/0000-0001-9467-4556	NCRR NIH HHS [UL1 RR024153, UL1-RR024153] Funding Source: Medline; NIDCR NIH HHS [R01 DE014667-05, R01 DE014667-06, R37-DE08559, K02 DE015291-01, R01 DE014667-07, K02 DE015291-03, R37 DE008559, R01 DE014667-04, R01 DE014667, R01 DE/HD012324, R01 DE014667-08, K02 DE015291-02, P50 DE016215, R01 DE016148, K02 DE015291, R21-DE016930, R01 DE014667-02, R21 DE016930, R01 DE014667-03, K02 DE015291-05, P50-DE016215, K02 DE015291-04, R01-DE016148, R01 DE014667-01] Funding Source: Medline; NIEHS NIH HHS [P30ES05605, P30 ES005605] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148, R37DE008559, R01DE012324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE016930, K02DE015291, R01DE014667, P50DE016215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Carstens MH, 2000, J CRANIOFAC SURG, V11, P270, DOI 10.1097/00001665-200011030-00013; CASTILLA EE, 1995, AM J MED GENET, V58, P106, DOI 10.1002/ajmg.1320580203; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; COSMAN B, 1966, PLAST RECONSTR SURG, V37, P334, DOI 10.1097/00006534-196604000-00008; Eppley BL, 2005, PLAST RECONSTR SURG, V115, p101E, DOI 10.1097/01.PRS.0000164494.45986.91; Gorlin RJ., 2001, SYNDROMES HEAD NECK, V4th, P850; HECKLER FR, 1979, CLEFT PALATE J, V16, P240; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; LEHMAN JA, 1976, PLAST RECONSTR SURG, V58, P306, DOI 10.1097/00006534-197609000-00008; Lin JY, 2008, DNA CELL BIOL, V27, P601, DOI 10.1089/dna.2008.0777; Liu W, 2005, DEV BIOL, V283, P282, DOI 10.1016/j.ydbio.2005.04.019; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Mansilla MA, 2006, CLEFT PALATE-CRAN J, V43, P21, DOI 10.1597/04-169R.1; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; MARTIN RA, 1993, AM J MED GENET, V47, P744, DOI 10.1002/ajmg.1320470529; Martin RA, 2000, AM J MED GENET, V90, P155, DOI 10.1002/(SICI)1096-8628(20000117)90:2<155::AID-AJMG13>3.0.CO;2-V; Murray JC, 1997, CLEFT PALATE-CRAN J, V34, P7, DOI 10.1597/1545-1569(1997)034<0007:CAESOC>2.3.CO;2; Neiswanger K, 2007, AM J MED GENET A, V143A, P1143, DOI 10.1002/ajmg.a.31760; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Rogers CR, 2008, CLEFT PALATE-CRAN J, V45, P518, DOI 10.1597/07-115.1; Scapoli L, 2006, ANN HUM GENET, V70, P410, DOI 10.1111/j.1469-1809.2005.00237.x; Thomason HA, 2008, DEV BIOL, V321, P273, DOI 10.1016/j.ydbio.2008.06.030; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Watanabe A, 2006, CLEFT PALATE-CRAN J, V43, P310, DOI 10.1597/04-145.1; Weinberg SM, 2006, CLEFT PALATE-CRAN J, V43, P7, DOI 10.1597/04-122R1.1; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	33	145	151	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					406	411		10.1016/j.ajhg.2009.02.002	http://dx.doi.org/10.1016/j.ajhg.2009.02.002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19249007	Green Published, Bronze			2022-12-18	WOS:000264304200011
J	Thornton, T; McPeek, MS				Thornton, Tirnothy; McPeek, Mary Sara			Case-control association testing with related individuals: A more powerful quasi-likelihood score test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; STATISTICAL-METHOD; ALCOHOL-ABUSE; MARKER; GENES	We consider the problem of genomewide association testing of a binary trait when some sampled individuals are related, with known relationships. This commonly arises when families sampled for a linkage study are included in an association studv. Furthermore, power to detect association with complex traits can be increased when affected individuals with affected relatives are sampled, because they are more likely to carry disease alleles than are randomly sampled affected individuals. With related individuals, correlations among relatives must be taken into account, to ensure validity of the test, and consideration of these correlations can also improve power. We provide new insight into the use of pecligree-based weights to improve power, and we propose a novel test, the M,,,,, test, which, as we demonstrate, represents an overall, and in many cases, substantial, improvement in power over previous tests, while retaining a computational simplicity that makes it useful in genomewide association studies in arbitrary pedigrees. Other features of the M-QLS, are as follows: (1) it is applicable to completely general combinations of family and case-control designs, (2) it can incorporate both unaffected controls and controls of unknown phenotype into the same analysis, and (3) it can incorporate phenotype data about relatives with missing genotype data. The methods are applied to data from the Genetic Analysis Workshop 14 Collaborative Study of the Genetics of Alcoholism, where the M-QLs detects genomewide significant association (after Bonferroni correction) with an alcoholism-related phenotype for four different single-nucleotide polymorphisms: tsc1177811 (p = 5.9 X 10(-7)), tsc1750530 (P = 4.0 x 10-7), tsc0046696 (P = 4.7 x 10-7), and tsc0057290 (P = 5.2 x 10(-1)) on chromosomes 1, 16, 18, and 18, respectively. Three of these four significant associations were not detected in previous studies analyzing these data.	Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	McPeek, MS (corresponding author), Univ Chicago, Dept Stat, 5734 S Univ Ave, Chicago, IL 60637 USA.	mcpeek@galton.uchicago.edu			NHGRI NIH HHS [R29 HG001645, HG001645, R01 HG001645] Funding Source: Medline; NHLBI NIH HHS [U01 HL084715, HL084715] Funding Source: Medline; NIAAA NIH HHS [U10 AA008401, U10AA008401] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084715] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645, R29HG001645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Browning SR, 2005, GENET EPIDEMIOL, V28, P110, DOI 10.1002/gepi.20051; Chen L, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S130; Chiu YF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S89; EDENBERG HJ, 2005, BMC GENET S, V6, P2; GRANT BF, 1994, ALCOHOL HEALTH RES W, V18, P243; Hwu HG, 2000, AM J MED GENET, V96, P797, DOI 10.1002/1096-8628(20001204)96:6<797::AID-AJMG20>3.0.CO;2-K; McPeek MS, 2004, BIOMETRICS, V60, P359; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Schott J. R, 1996, MATRIX ANAL STAT; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stankovich J, 2005, HUM GENET, V117, P188, DOI 10.1007/s00439-005-1279-y; Sun L, 2002, AM J HUM GENET, V70, P399, DOI 10.1086/338660; Zhu XF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S128	18	145	147	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					321	337		10.1086/519497	http://dx.doi.org/10.1086/519497			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668381	Bronze, Green Published			2022-12-18	WOS:000248540400011
J	Chen, SH; Ondo, WG; Rao, SQ; Li, L; Chen, QY; Wang, Q				Chen, SH; Ondo, WG; Rao, SQ; Li, L; Chen, QY; Wang, Q			Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRAIN IRON; SYMPTOMS; FEATURES; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; DISORDER; SEVERITY; CRITERIA; CLONING	Restless legs syndrome (RLS) is a common neurological disorder that affects 5%-12% of all whites. To genetically dissect this complex disease, we characterized 15 large and extended multiplex pedigrees, consisting of 453 subjects ( 134 affected with RLS). A familial aggregation analysis was performed, and SAGE FCOR was used to quantify the total genetic contribution in these families. A weighted average correlation of 0.17 between first-degree relatives was obtained, and heritability was estimated to be 0.60 for all types of relative pairs, indicating that RLS is a highly heritable trait in this ascertained cohort. A genomewide linkage scan, which involved 1400 10-cM-spaced markers and spanned the entire human genome, was then performed for 144 individuals in the cohort. Model-free linkage analysis identified one novel significant RLS-susceptibility locus on chromosome 9p24-22 with a multipoint nonparametric linkage (NPL) score of 3.22. Suggestive evidence of linkage was found on chromosome 3q26.31 (NPL score 2.03), chromosome 4q31.21 (NPL score 2.28), chromosome 5p13.3 (NPL score 2.68), and chromosome 6p22.3 (NPL score 2.06). Model-based linkage analysis, with the assumption of an autosomal-dominant mode of inheritance, validated the 9p24-22 linkage to RLS in two families (two-point LOD score of 3.77; multipoint LOD score of 3.91). Further fine mapping confirmed the linkage result and defined this novel RLS disease locus to a critical interval. This study establishes RLS as a highly heritable trait, identifies a novel genetic locus for RLS, and will facilitate further cloning and identification of the genes for RLS.	Cleveland Clin Fdn, Lerner Res Inst, Ctr Mol Genet, Dept Mol Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Baylor College of Medicine	Wang, Q (corresponding author), Cleveland Clin Fdn, Lerner Res Inst ND40, Ctr Mol Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wangq2@ccf.org		Rao, Shaoqi/0000-0001-7809-3700	NHLBI NIH HHS [R01 HL066251, R01 HL66251, R01 HL065630, R01 HL65630] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065630, R01HL066251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen RP, 2002, SLEEP MED, V3, pS3, DOI 10.1016/S1389-9457(02)00140-5; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2001, J CLIN NEUROPHYSIOL, V18, P128, DOI 10.1097/00004691-200103000-00004; Allen RP, 2003, SLEEP MED, V4, P133, DOI 10.1016/S1389-9457(02)00193-4; Allen RP, 2001, NEUROLOGY, V56, P263, DOI 10.1212/WNL.56.2.263; Bonati MT, 2003, BRAIN, V126, P1485, DOI 10.1093/brain/awg137; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Connor JR, 2003, NEUROLOGY, V61, P304, DOI 10.1212/01.WNL.0000078887.16593.12; Desautels A, 2001, AM J HUM GENET, V69, P1266, DOI 10.1086/324649; Earley CJ, 2000, NEUROLOGY, V54, P1698, DOI 10.1212/WNL.54.8.1698; Hening WA, 2003, SLEEP MED, V4, P95, DOI 10.1016/S1389-9457(03)00009-1; Kageyama T, 2000, PSYCHIAT CLIN NEUROS, V54, P296, DOI 10.1046/j.1440-1819.2000.00685.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANGE K, 1991, AM J HUM GENET, V49, P1320; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lazzarini A, 1999, MOVEMENT DISORD, V14, P111, DOI 10.1002/1531-8257(199901)14:1<111::AID-MDS1018>3.3.CO;2-0; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Mukhopadhyay N, 1999, AM J HUM GENET, V65, pA436; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; Ondo W, 1996, NEUROLOGY, V47, P1435, DOI 10.1212/WNL.47.6.1435; Ondo WG, 2000, NEUROLOGY, V55, P1404, DOI 10.1212/WNL.55.9.1404; Phillips B, 2000, ARCH INTERN MED, V160, P2137, DOI 10.1001/archinte.160.14.2137; Picchietti DL, 1998, J CHILD NEUROL, V13, P588, DOI 10.1177/088307389801301202; RISCH N, 1990, AM J HUM GENET, V46, P222; Rothdach AJ, 2000, NEUROLOGY, V54, P1064, DOI 10.1212/WNL.54.5.1064; *SAGE, 2003, STAT AN GEN EP; Tan EK, 2000, AM J MED SCI, V319, P397, DOI 10.1097/00000441-200006000-00010; Ulfberg J, 2001, EUR NEUROL, V46, P17, DOI 10.1159/000050750; Ulfberg J, 2001, MOVEMENT DISORD, V16, P1159, DOI 10.1002/mds.1209; Ullmer C, 1998, FEBS LETT, V424, P63, DOI 10.1016/S0014-5793(98)00141-0; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Winkelmann J, 2002, ANN NEUROL, V52, P297, DOI 10.1002/ana.10282	37	145	150	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					876	885		10.1086/420772	http://dx.doi.org/10.1086/420772			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15077200	Bronze, Green Published			2022-12-18	WOS:000220926100009
J	Ranum, LPW; Day, JW				Ranum, LPW; Day, JW			Myotonic dystrophy: RNA pathogenesis comes into focus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							TRINUCLEOTIDE REPEAT EXPANSION; 3 UNTRANSLATED REGION; CTG REPEAT; BINDING-PROTEIN; MESSENGER-RNA; TRIPLET REPEAT; DEVELOPMENTAL EXPRESSION; REDUCES EXPRESSION; SKELETAL-MUSCLE; NUCLEAR FOCI	Myotonic dystrophy (DM)-the most common form of muscular dystrophy in adults, affecting 1/8,000 individuals-is a dominantly inherited disorder with a peculiar and rare pattern of multisystemic clinical features affecting skeletal muscle, the heart, the eye, and the endocrine system. Two genetic loci have been associated with the DM phenotype: DM1, on chromosome 19, and DM2, on chromosome 3. In 1992, the mutation responsible for DM1 was identified as a CTG expansion located in the 3' untranslated region of the dystrophia myotonica-protein kinase gene ( DMPK). How this untranslated CTG expansion causes myotonic dystrophy type 1( DM1) has been controversial. The recent discovery that myotonic dystrophy type 2 ( DM2) is caused by an untranslated CCTG expansion, along with other discoveries on DM1 pathogenesis, indicate that the clinical features common to both diseases are caused by a gain-of-function RNA mechanism in which the CUG and CCUG repeats alter cellular function, including alternative splicing of various genes. We discuss the pathogenic mechanisms that have been proposed for the myotonic dystrophies, the clinical and molecular features of DM1 and DM2, and the characterization of murine and cell-culture models that have been generated to better understand these diseases.	Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ranum, LPW (corresponding author), MMC 206,420 Delaware St SE, Minneapolis, MN 55455 USA.	ranum001@umn.edu		Day, John/0000-0002-0086-9529				Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Aziz M, 2003, AM J MED GENET B, V121B, P119, DOI 10.1002/ajmg.b.20030; Bachinski LL, 2003, AM J HUM GENET, V73, P835, DOI 10.1086/378566; Batten FE, 1909, BRAIN, V32, P187, DOI 10.1093/brain/32.2.187; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Brunberg JA, 2002, AM J NEURORADIOL, V23, P1757; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Bungener C, 1998, J NEUROL NEUROSUR PS, V65, P353, DOI 10.1136/jnnp.65.3.353; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Chakraborty R, 1996, AM J HUM GENET, V59, P109; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Colleran JA, 1997, AM J CARDIOL, V80, P1494, DOI 10.1016/S0002-9149(97)00742-X; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Day JW, 1999, NEUROMUSCULAR DISORD, V9, P19, DOI 10.1016/S0960-8966(98)00094-7; Delaporte C, 1998, ARCH NEUROL-CHICAGO, V55, P635, DOI 10.1001/archneur.55.5.635; Ebralidze A, 2004, SCIENCE, V303, P383, DOI 10.1126/science.1088679; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gonzalez I, 2000, NEUROLOGY, V54, P1218; Groenen P, 1998, BIOESSAYS, V20, P901, DOI 10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0; Gunter C, 1998, HUM MOL GENET, V7, P1935, DOI 10.1093/hmg/7.12.1935; Hamshere MG, 1999, J MED GENET, V36, P59; Hamshere MG, 1997, P NATL ACAD SCI USA, V94, P7394, DOI 10.1073/pnas.94.14.7394; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARPER PS, 2001, MYOTONIC DYSTROPHY, V37; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Hund E, 1997, NEUROLOGY, V48, P33, DOI 10.1212/WNL.48.1.33; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; JANSEN G, 1995, HUM MOL GENET, V4, P843, DOI 10.1093/hmg/4.5.843; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Junghans RP, 2001, NEUROGENETICS, V3, P59, DOI 10.1007/s100480000103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; Larkin K, 2001, BRAIN RES BULL, V56, P389, DOI 10.1016/S0361-9230(01)00656-6; Lazarus A, 1999, CIRCULATION, V99, P1041, DOI 10.1161/01.CIR.99.8.1041; Liquori CL, 2003, AM J HUM GENET, V73, P849, DOI 10.1086/378720; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lu XH, 1999, HUM MOL GENET, V8, P53, DOI 10.1093/hmg/8.1.53; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Martorell L, 1998, HUM MOL GENET, V7, P307, DOI 10.1093/hmg/7.2.307; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Merino JL, 1998, CIRCULATION, V98, P541, DOI 10.1161/01.CIR.98.6.541; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Monckton DG, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P181; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; Moxley RT, 1996, NEUROMUSCULAR DISORD, V6, P87, DOI 10.1016/0960-8966(95)00036-4; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; NGUYEN HH, 1988, J AM COLL CARDIOL, V11, P662, DOI 10.1016/0735-1097(88)91547-1; NOVELLI G, 1993, BIOCHEM MOL BIOL INT, V29, P291; Ogata A, 1998, NEURORADIOLOGY, V40, P411, DOI 10.1007/s002340050613; Ono S, 1998, NEUROLOGY, V50, P535, DOI 10.1212/WNL.50.2.535; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Pellizzoni L, 1998, J MOL BIOL, V281, P593, DOI 10.1006/jmbi.1998.1961; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Ricker K, 1999, J NEUROL, V246, P334, DOI 10.1007/s004150050359; Ricker K, 1999, NEUROLOGY, V52, P170, DOI 10.1212/WNL.52.1.170; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; ROWLAND LP, 1994, ANN NEUROL, V36, P803, DOI 10.1002/ana.410360526; Rubinsztein JS, 1997, J MED GENET, V34, P229, DOI 10.1136/jmg.34.3.229; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schneider C, 2000, NEUROLOGY, V55, P383, DOI 10.1212/WNL.55.3.383; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; SHAW DJ, 1993, GENOMICS, V18, P673, DOI 10.1016/S0888-7543(05)80372-6; Shimizu K, 2003, GENE, V307, P51, DOI 10.1016/S0378-1119(03)00406-2; Steinert H., 1909, DTSCH Z NERVENHEILKU, V37, P58, DOI [10.1007/BF01671719, DOI 10.1007/BF01671719]; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tapscott SJ, 2000, SCIENCE, V289, P1701, DOI 10.1126/science.289.5485.1701; Thornton C, 1999, SEMIN NEUROL, V19, P25, DOI 10.1055/s-2008-1040823; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; THORNTON CA, 1994, ANN NEUROL, V35, P269, DOI 10.1002/ana.410350305; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115; Udd B, 1997, NEUROMUSCULAR DISORD, V7, P217, DOI 10.1016/S0960-8966(97)00041-2; Vihola A, 2003, NEUROLOGY, V60, P1854, DOI 10.1212/01.WNL.0000065898.61358.09; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; Wilson BA, 1999, CORTEX, V35, P113, DOI 10.1016/S0010-9452(08)70789-5	98	145	152	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					793	804		10.1086/383590	http://dx.doi.org/10.1086/383590			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15065017	Bronze, Green Published			2022-12-18	WOS:000220926100002
J	Page, GP; George, V; Go, RC; Page, PZ; Allison, DB				Page, GP; George, V; Go, RC; Page, PZ; Allison, DB			"Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							FALSE DISCOVERY RATE; POPULATION STRATIFICATION; STATISTICAL SIGNIFICANCE; SEQUENCE DIVERSITY; LINKAGE; ADMIXTURE; IDENTIFICATION; METAANALYSIS; ASSOCIATIONS; MODELS	Although mathematical relationships can be proven by deductive logic, biological relationships can only be inferred from empirical observations. This is a distinct disadvantage for those of us who strive to identify the genes involved in complex diseases and quantitative traits. If causation cannot be proven, however, what does constitute sufficient evidence for causation? The philosopher Karl Popper said, "Our belief in a hypothesis can have no stronger basis than our repeated unsuccessful critical attempts to refute it." We believe that to establish causation, as scientists, we must make a serious attempt to refute our own hypotheses and to eliminate all known sources of bias before association becomes causation. In addition, we suggest that investigators must provide sufficient data and evidence of their unsuccessful efforts to find any confounding biases. In this editorial, we discuss what "causation" means in the context of complex diseases and quantitative traits, and we suggest guidelines for steps that may be taken to address possible confounders of association before polymorphisms may be called "causative."	Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Div Rheumatol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; Univ Alabama Birmingham, Clin Nutr Res Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Page, GP (corresponding author), RPHB 327, 1530 3rd Ave S, Birmingham, AL 35294 USA.	gpage@ms.soph.uab.edu		Page, Grier/0000-0003-2582-3786; Allison, David/0000-0003-3566-9399	NCRR NIH HHS [P20RR016430, P20 RR016430] Funding Source: Medline; NIAMS NIH HHS [P01AR049084, P01 AR049084] Funding Source: Medline; NIDDK NIH HHS [R56 DK056366, R01 DK056366, DK056366, P30DK056336, P30 DK056336] Funding Source: Medline; NIEHS NIH HHS [R01 ES009912, R01ES09912] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, R56DK056366, R01DK056366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahmad-Annuar A, 2003, CURR OPIN NEUROL, V16, P451, DOI 10.1097/01.wco.0000084221.82329.29; Ball CA, 2002, BIOINFORMATICS, V18, P1409, DOI 10.1093/bioinformatics/18.11.1409; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; COLLINGWOOD R, 1940, CAUSATION PRACTICAL; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Deng HW, 2001, GENETICS, V157, P885; Deng HW, 2001, GENETICS, V159, P1319; DOYLE AC, 1998, COMPLETE S HOLMES 4; Egan S, 2003, AUST NZ J PSYCHIAT, V37, P484, DOI 10.1046/j.1440-1614.2003.01226.x; Ellsworth DL, 1999, ANN EPIDEMIOL, V9, P75, DOI 10.1016/S1047-2797(98)00064-7; Etzel CJ, 2002, AM J HUM GENET, V71, P56, DOI 10.1086/341126; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Falconer DS, 1996, INTRO QUANTITATIVE G; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Gianfrancesco F, 2003, AM J HUM GENET, V72, P1479, DOI 10.1086/375628; Glantz S.A., 2016, PRIMER APPL REGRESSI; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Goldstein DR, 1999, GENET EPIDEMIOL, V17, pS581; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D, 2003, Pac Symp Biocomput, P490; Gratacos M, 2001, CELL, V106, P367, DOI 10.1016/S0092-8674(01)00447-0; Guerra R, 1999, GENET EPIDEMIOL, V17, pS605; Hall JG, 2003, NAT GENET, V33, P440, DOI 10.1038/ng0403-440; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hirschhorn JN, 2002, J CLIN ENDOCR METAB, V87, P4438, DOI 10.1210/jc.2002-021329; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; HUEBNER RJ, 1957, ANN NY ACAD SCI, V67, P430, DOI 10.1111/j.1749-6632.1957.tb46066.x; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2003, TRENDS MOL MED, V9, P135, DOI 10.1016/S1471-4914(03)00030-3; Kaprio J, 2002, TWIN RES, V5, P366, DOI 10.1375/twin.5.5.366; KOCH R, 1891, 10 INT MED C BERL 18; KOCH R, 1882, AETIOLOGIE TUBERCULO; KRAMER MS, 1992, J CLIN EPIDEMIOL, V45, P639, DOI 10.1016/0895-4356(92)90136-B; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; LYKKEN DT, 1968, PSYCHOL BULL, V70, P151, DOI 10.1037/h0026141; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; MacMahon B, 1970, EPIDEMIOLOGY PRINCIP; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; MORTON NE, 1955, AM J HUM GENET, V7, P277; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Olsen J, 1993, EUR J PUBLIC HEALTH, V3, P204; Ott J., 1991, ANAL HUMAN GENETIC L; Parascandola M, 2001, J EPIDEMIOL COMMUN H, V55, P905, DOI 10.1136/jech.55.12.905; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PHILLIPS CV, 2001, MESSED LESSONS AB HI, P765; Phillips PC, 1999, TRENDS GENET, V15, P6, DOI 10.1016/S0168-9525(98)01622-9; Popper KR, 1961, LOGIC SCI DISCOVERY; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; RICE J, 2001, GENETIC DISSECTION C, P31; RIORDAN JR, 1989, SCIENCE, V245, P1066; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rivers TM, 1937, J BACTERIOL, V33, P1; Rosenbaum Paul R, 1995, OBSERVATIONAL STUDIE; RUBIN DB, 1991, BIOMETRICS, V47, P1213, DOI 10.2307/2532381; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Terwilliger JD, 2000, HUM BIOL, V72, P63; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Thorisson GA, 2003, NUCLEIC ACIDS RES, V31, P124, DOI 10.1093/nar/gkg052; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Uhl GR, 2002, TRENDS GENET, V18, P420, DOI 10.1016/S0168-9525(02)02719-1; Vieland VJ, 1998, AM J HUM GENET, V63, P947, DOI 10.1086/302076; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	75	145	152	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					711	719		10.1086/378900	http://dx.doi.org/10.1086/378900			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	727TL	13680525	Green Published, Bronze			2022-12-18	WOS:000185676100001
J	Majewski, J; Schultz, DW; Weleber, RG; Schain, MB; Edwards, AO; Matise, TC; Acott, TS; Ott, J; Klein, ML				Majewski, J; Schultz, DW; Weleber, RG; Schain, MB; Edwards, AO; Matise, TC; Acott, TS; Ott, J; Klein, ML			Age-related macular degeneration - a genome scan in extended families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; MACULOPATHY; SUSCEPTIBILITY; PROGRAM; LOCI	We performed a genomewide scan and genetic linkage analysis, to identify loci associated with age-related macular degeneration (AMD). We collected 70 families, ranging from small nuclear families to extended multigenerational pedigrees and consisting of a total of 344 affected and 217 unaffected members available for genotyping. We performed linkage analyses using parametric and allele-sharing models. We performed the analyses on the complete pedigrees but also subdivided the families into nuclear pedigrees. Finally, to dissect potential genetic factors responsible for differences in disease manifestation, we stratified the sample by two major AMD phenotypes (neovascular AMD and geographic atrophy) and by age of affected family members at the time of our evaluation. We have previously demonstrated linkage between AMD and 1q25-31 in a single large family. In the combined sample, we have detected the following loci with scores exceeding a cutoff under at least one LOD = 2 of the models considered: 1q31 (HLOD = 2.07 at D1S518), 3p13 (HLOD = 2.19 at D3S1304/D3S4545), 4q32 (HLOD = 2.66 at D4S2368, for the subset of families with predominantly dry AMD), 9q33 (LODzir = 2.01 at D9S930/D9S934), and 10q26 (HLOD = 3.06 at D10S1230). Using correlation analysis, we have found a statistically significant correlation between LOD scores at 3p13 and 10q26, providing evidence for epistatic interactions between the loci and, hence, a complex basis of AMD. Our study has identified new loci that should be considered in future mapping and mutational analyses of AMD and has strengthened the evidence in support of loci suggested by other studies.	Oregon Hlth Sci Univ, Dept Ophthalmol, Macular Degenerat Ctr, Casey Eye Inst, Portland, OR 97201 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX USA	Oregon Health & Science University; Rockefeller University; Oregon Health & Science University; Oregon Health & Science University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Klein, ML (corresponding author), Oregon Hlth Sci Univ, Dept Ophthalmol, Macular Degenerat Ctr, Casey Eye Inst, 3375 SW Terwilliger Blvd, Portland, OR 97201 USA.				NATIONAL EYE INSTITUTE [R01EY008247, R01EY003279, P30EY010572, R01EY012203] Funding Source: NIH RePORTER; NEI NIH HHS [EY 03279, EY 12203, R01 EY003279, EY 08247, R01 EY012203, EY 10572, P30 EY010572, R01 EY008247] Funding Source: Medline; NHGRI NIH HHS [R01 HG000008, HG00008] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Badner JA, 1998, AM J HUM GENET, V63, P880, DOI 10.1086/302007; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Evans J, 1996, BRIT J OPHTHALMOL, V80, P9, DOI 10.1136/bjo.80.1.9; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HAINES JL, 2002, ASS RES VIS OPHTH M; IYENGAR SK, 2002, ASS RES VIS OPHTH M; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Majewski J, 2001, AM J HUM GENET, V69, P853, DOI 10.1086/323419; McPeek MS, 1999, GENET EPIDEMIOL, V16, P225, DOI 10.1002/(SICI)1098-2272(1999)16:3<225::AID-GEPI1>3.0.CO;2-#; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ott J, 1999, ANAL HUMAN GENETIC L; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4; Whittemore AS, 2001, AM J HUM GENET, V68, P457, DOI 10.1086/318186; WILLIAMSON JA, 1995, GENET EPIDEMIOL, V12, P163, DOI 10.1002/gepi.1370120205	24	145	152	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					540	550		10.1086/377701	http://dx.doi.org/10.1086/377701			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12900797	Green Published, Bronze			2022-12-18	WOS:000185134000007
J	Grice, DE; Halmi, KA; Fichter, MM; Strober, M; Woodside, DB; Treasure, JT; Kaplan, AS; Magistretti, PJ; Goldman, D; Bulik, CM; Kaye, WH; Berrettini, WH				Grice, DE; Halmi, KA; Fichter, MM; Strober, M; Woodside, DB; Treasure, JT; Kaplan, AS; Magistretti, PJ; Goldman, D; Bulik, CM; Kaye, WH; Berrettini, WH			Evidence for a susceptibility gene for anorexia nervosa on chromosome 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTROLLED FAMILY; BULIMIA-NERVOSA; DISORDERS; LINKAGE; POWER	Eating disorders, such as anorexia nervosa (AN), have a significant genetic component. In the current study, a genomewide linkage analysis of 192 families with at least one affected relative pair with AN and related eating disorders, including bulimia nervosa, was performed, resulting in only modest evidence for linkage, with the highest nonparametric linkage (NPL) score, 1.80, at marker D4S2367 on chromosome 4. Since the reduction of sample heterogeneity would increase power to detect linkage, we performed linkage analysis in a subset (n = 37) of families in which at least two affected relatives had diagnoses of restricting AN, a clinically defined subtype of AN characterized by severe limitation of food intake without the presence of binge-eating or purging behavior. When we limited the linkage analysis to this clinically more homogeneous subgroup, the highest multipoint NPL score observed was 3.03, at marker D1S3721 on chromosome 1p. The genotyping of additional markers in this region led to a peak multipoint NPL score of 3.45, thereby providing suggestive evidence for the presence of an AN-susceptibility locus on chromosome 1p.	Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Cornell Univ, Dept Psychiat, White Plains, NY USA; Univ Munich, Hosp Behav Med, Klin Roseneck, Prien Am Chiemsee, Germany; Univ Calif Los Angeles, Inst Neuropsychiat, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; Univ Toronto, Toronto Hosp, Dept Psychiat, Toronto, ON, Canada; Univ Lausanne, Inst Physiol, Lausanne, Switzerland; Univ London Kings Coll, Inst Psychiat, London WC2R 2LS, England; NIAAA, Neurogenet Lab, Bethesda, MD USA; Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	University of Pennsylvania; Cornell University; University of Munich; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Lausanne; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Berrettini, WH (corresponding author), Univ Penn, Dept Psychiat, Room 111,Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.		Grice, Dorothy E/X-3372-2019; Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020	Grice, Dorothy E/0000-0002-8833-2549; Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Treasure, Janet/0000-0003-0871-4596; Magistretti, Pierre Julius/0000-0002-6678-320X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000016] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Bulik CM, 1997, J NERV MENT DIS, V185, P704, DOI 10.1097/00005053-199711000-00009; CASPER RC, 1980, ARCH GEN PSYCHIAT, V37, P1030, DOI 10.1001/archpsyc.1980.01780220068007; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Fichter MM, 1998, INT J EAT DISORDER, V24, P227, DOI 10.1002/(SICI)1098-108X(199811)24:3<227::AID-EAT1>3.3.CO;2-O; Garfinkel P. E., 1982, ANOREXIA NERVOSA MUL; Gershon ES, 1983, CHILDHOOD PSYCHOPATH, P279; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Herzog DB, 1996, J AM ACAD CHILD PSY, V35, P928, DOI 10.1097/00004583-199607000-00020; HOLLAND AJ, 1984, BRIT J PSYCHIAT, V145, P414, DOI 10.1192/bjp.145.4.414; HOLLAND AJ, 1988, J PSYCHOSOM RES, V32, P561, DOI 10.1016/0022-3999(88)90004-9; HSU LKG, 1979, LANCET, V1, P61; HUDSON JI, 1987, PSYCHOL MED, V17, P883, DOI 10.1017/S0033291700000684; KAYE WH, 1984, AM J PSYCHIAT, V141, P1598; Kaye WH, 2000, BIOL PSYCHIAT, V47, P794, DOI 10.1016/S0006-3223(99)00240-1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Lilenfeld LR, 1998, ARCH GEN PSYCHIAT, V55, P603, DOI 10.1001/archpsyc.55.7.603; MORTON NE, 1956, AM J HUM GENET, V8, P80; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; STROBER M, 1985, J PSYCHIATR RES, V19, P239, DOI 10.1016/0022-3956(85)90024-X; STROBER M, 1982, J NERV MENT DIS, V170, P345, DOI 10.1097/00005053-198206000-00004; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; Wade TD, 2000, AM J PSYCHIAT, V157, P469, DOI 10.1176/appi.ajp.157.3.469	25	145	149	0	18	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					787	792		10.1086/339250	http://dx.doi.org/10.1086/339250			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11799475	Bronze, Green Published			2022-12-18	WOS:000173880000023
J	Ewen, KR; Bahlo, M; Treloar, SA; Levinson, DF; Mowry, B; Barlow, JW; Foote, SJ				Ewen, KR; Bahlo, M; Treloar, SA; Levinson, DF; Mowry, B; Barlow, JW; Foote, SJ			Identification and analysis of error types in high-throughput genotyping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; LOCUS; MARKERS	Although it is clear that errors in genotyping data can lead to severe errors in linkage analysis, there is as yet no consensus strategy for identification of genotyping errors. Strategies include comparison of duplicate samples, independent calling of alleles, and Mendelian-inheritance-error checking. This study aimed to develop a better understanding of error types associated with microsatellite genotyping, as a first step toward development of a rational error-detection strategy. Two microsatellite marker sets (a commercial genomewide set and a custom-designed fine-resolution mapping set) were used to generate 118,420 and 22,500 initial genotypes and 10,088 and 8,328 duplicates, respectively. Mendelian-inheritance errors were identified by PedManager software, and concordance was determined for the duplicate samples. Concordance checking identifies only human errors, whereas Mendelian-inheritance-error checking is capable of detection of additional errors, such as mutations and null alleles. Neither strategy is able to detect all errors. Inheritance checking of the commercial marker data identified that the results contained 0.13% human errors and 0.12% other errors (0.25% total error), whereas concordance checking found 0.16% human errors. Similarly, Mendelian-inheritance-error checking of the custom-set data identified 1.37% errors, compared with 2.38% human errors identified by concordance checking. A greater variety of error types were detected by Mendelian-inheritance-error checking than by duplication of samples or by independent reanalysis of gels. These data suggest that Mendelian-inheritance-error checking is a worthwhile strategy for both types of genotyping data, whereas fine-mapping studies benefit more from concordance checking than do studies using commercial marker data. Maximization of error identification increases the likelihood of linkage when complex diseases are analyzed.	PO Royal Melbourne Hosp, Australian Genome Res Facil, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; PO Royal Melbourne Hosp, Genet & Bioinformat Grp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; Royal Brisbane Hosp, Queensland Inst Med Res, Epidemiol & Populat Hlth Unit, Brisbane, Qld 4029, Australia; Wolston Pk Hosp, Queensland Ctr Schizophrenia Res, Brisbane, Qld, Australia; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Pennsylvania	Ewen, KR (corresponding author), PO Royal Melbourne Hosp, Australian Genome Res Facil, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.		Foote, Simon J/F-2802-2013; Mowry, Bryan/G-5046-2010	Foote, Simon/0000-0002-9142-2107; Mowry, Bryan/0000-0002-4115-5645; Bahlo, Melanie/0000-0001-5132-0774	NIMH NIH HHS [MH45097] Funding Source: Medline; PHS HHS [KO2-01207] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bahlo M, 1999, AM J HUM GENET, V65, pA241; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Dixon Michael J., 1992, Human Molecular Genetics, V1, P249, DOI 10.1093/hmg/1.4.249; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; GEORGES M, 1993, P NATL ACAD SCI USA, V90, P1058, DOI 10.1073/pnas.90.3.1058; Ghosh S, 1997, GENOME RES, V7, P165, DOI 10.1101/gr.7.2.165; Goldstein DR, 1997, HUM HERED, V47, P86, DOI 10.1159/000154396; HENDERSON ST, 1992, MOL CELL BIOL, V12, P2749, DOI 10.1128/MCB.12.6.2749; Herber B, 1998, J FORENSIC SCI, V43, P648; HUGES CR, 1993, MOL ECOL, V2, P131; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; Roberts LJ, 1999, EUR J IMMUNOL, V29, P3047, DOI 10.1002/(SICI)1521-4141(199909)29:09&lt;3047::AID-IMMU3047&gt;3.0.CO;2-L; Sacchetti L, 1999, CLIN CHEM, V45, P178; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; TAYLOR AC, 1994, MOL ECOL, V3, P277, DOI 10.1111/j.1365-294X.1994.tb00068.x	19	145	150	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					727	736		10.1086/303048	http://dx.doi.org/10.1086/303048			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10924406	Green Published, Bronze			2022-12-18	WOS:000089002300018
J	Strautnieks, SS; Kagalwalla, AF; Tanner, MS; Knisely, AS; Bull, L; Freimer, N; Kocoshis, SA; Gardiner, RM; Thompson, RJ				Strautnieks, SS; Kagalwalla, AF; Tanner, MS; Knisely, AS; Bull, L; Freimer, N; Kocoshis, SA; Gardiner, RM; Thompson, RJ			Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSPORT; CHILDREN; DISEASE; SYSTEM; GENE; MAP	Progressive familial intrahepatic cholestasis (PFIC; OMIM 211600) is the second most common familial cholestatic syndrome presenting in infancy. A locus has previously been mapped to chromosome 18q21-22 in the original Byler pedigree, This chromosomal region also harbors the locus for benign recurrent intrahepatic cholestasis (BRIC) a related phenotype. Linkage analysis in six consanguineous PFIC pedigrees from the Middle East has previously excluded linkage to chromosome 18q21-22, indicating the existence of locus heterogeneity within the PFIC phenotype, By use of homozygosity mapping and a genome scan in these pedigrees, a locus designated ''PFIC2'' has been mapped to chromosome 2q24. A maximum LOD score of 8.5 was obtained in the interval between marker loci D2S306 and D25124, with all families linked.	UNIV LONDON UNIV COLL,SCH MED,RAYNE INST,DEPT PEDIAT,LONDON WC1E 6JJ,ENGLAND; KING FAHAD HOSP,RIYADH,SAUDI ARABIA; SHEFFIELD CHILDRENS HOSP,SHEFFIELD,S YORKSHIRE,ENGLAND; DENVER AURORA PATHOL ASSOCIATES,DENVER,CO; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; CHILDRENS HOSP PITTSBURGH,PITTSBURGH,PA 15213	University of London; King's College London; University College London; UCL Medical School; King Saud Bin Abdulaziz University for Health Sciences; King Fahad Hospital - National Guard; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Thompson, Richard J/B-7954-2009	Thompson, Richard J/0000-0001-5652-0150	NIDDK NIH HHS [R01 DK50697] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050697] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADLER M, 1980, AM J PATHOL, V98, P603; ANNEREN G, 1996, EUR J HUM GENET S1, V4, P99; Bull LN, 1997, HEPATOLOGY, V26, P155; CARLTON VEH, 1995, HUM MOL GENET, V4, P1049, DOI 10.1093/hmg/4.6.1049; CLAYTON RJ, 1965, J PEDIATR-US, V67, P1025, DOI 10.1016/S0022-3476(65)82107-2; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FRIMMER M, 1988, BIOCHIM BIOPHYS ACTA, V947, P75, DOI 10.1016/0304-4157(88)90020-2; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; INOUE M, 1984, J CLIN INVEST, V73, P659, DOI 10.1172/JCI111257; KAGALWALLA AF, 1995, ANN TROP PAEDIATR, V15, P321, DOI 10.1080/02724936.1995.11747792; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; RIELY CA, 1994, LIVER DIS CHILDREN, P451; Strautnieks SS, 1996, J MED GENET, V33, P833, DOI 10.1136/jmg.33.10.833; WEBER AM, 1981, GASTROENTEROLOGY, V81, P653; WHITINGTON PF, 1994, J PEDIATR GASTR NUTR, V18, P134, DOI 10.1097/00005176-199402000-00003; Wong MH, 1996, GENOMICS, V33, P538, DOI 10.1006/geno.1996.0233	18	145	146	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					630	633		10.1086/515501	http://dx.doi.org/10.1086/515501			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326328	Green Published, Bronze			2022-12-18	WOS:A1997XY52300020
J	Phillips, JC; DelBono, EA; Haines, JL; Pralea, AM; Cohen, JS; Greff, LJ; Wiggs, JL				Phillips, JC; DelBono, EA; Haines, JL; Pralea, AM; Cohen, JS; Greff, LJ; Wiggs, JL			A second locus for Rieger syndrome maps to chromosome 13q14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FORK HEAD DOMAIN; TRANSCRIPTION FACTORS; GENE FAMILY; EXPRESSION; DROSOPHILA; LINKAGE; REGION; DELETION; EMBRYO; ARM	Rieger syndrome is a genetically and phenotypically heterogeneous disorder typically characterized by malformations of the eyes, teeth, and umbilicus. The syndrome is inherited as an autosomal dominant trait and exhibits significant variable expressivity. One locus associated with this disorder has been mapped to 4q25. Using a large four-generation pedigree, we have identified a second locus for Rieger syndrome located on chromosome 13q14.	TUFTS UNIV NEW ENGLAND MED CTR,DEPT OPHTHALMOL,BOSTON,MA 02111; TUFTS UNIV,SACKLER SCH GRAD BIOMED SCI,BOSTON,MA 02111; TUFTS UNIV,SCH MED,DEPT OPHTHALMOL,BOSTON,MA 02111; MASSACHUSETTS GEN HOSP,MOL NEUROGENET UNIT,BOSTON,MA 02114; CINCINNATI EYE INST,CINCINNATI,OH	Tufts Medical Center; Tufts University; Tufts University; Harvard University; Massachusetts General Hospital			Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NATIONAL EYE INSTITUTE [R01EY009847, R29EY009847] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY009847, EY09847] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKAZAWA K, 1981, JPN J OPHTHALMOL, V25, P321; Alkemade P., 1969, DYSGENESIS MESODERMA; BAUMGARTNER S, 1987, GENE DEV, V1, P1247, DOI 10.1101/gad.1.10.1247; BREEBAART AC, 1966, ARCH OPHTHALMOL-CHIC, V76, P825; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; COTE S, 1987, EMBO J, V6, P2793, DOI 10.1002/j.1460-2075.1987.tb02575.x; DELMARCELLE Y, 1958, B SOC BELG OPHTHALM, V120, P638; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FITCH N, 1978, J MED GENET, V15, P30, DOI 10.1136/jmg.15.1.30; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; HACKER U, 1992, P NATL ACAD SCI USA, V89, P8754, DOI 10.1073/pnas.89.18.8754; HEINEMANN MH, 1979, BRIT J OPHTHALMOL, V63, P40, DOI 10.1136/bjo.63.1.40; HEON E, 1995, HUM MOL GENET, V4, P1435, DOI 10.1093/hmg/4.8.1435; HERVE J, 1984, ANN PEDIATR-PARIS, V31, P77; JUDISCH GF, 1979, ARCH OPHTHALMOL-CHIC, V97, P2120, DOI 10.1001/archopht.1979.01020020438004; KAESTNER KH, 1994, GENOMICS, V20, P377, DOI 10.1006/geno.1994.1191; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEGIUS E, 1994, J MED GENET, V31, P340, DOI 10.1136/jmg.31.4.340; LIGUTIC I, 1981, CLIN GENET, V20, P323; MILLER LM, 1993, GENE DEV, V7, P933, DOI 10.1101/gad.7.6.933; MITCHELL JA, 1981, AM J MED GENET, V8, P73, DOI 10.1002/ajmg.1320080110; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; NAKANO KE, 1985, J EMBRYOL EXP MORPH, V88, P1; SABA V, 1927, ANN ATTALMOLOGICA CL, V55, P446; SASAKI H, 1993, DEVELOPMENT, V118, P47; Shields M B, 1983, Trans Am Ophthalmol Soc, V81, P736; Stathacopoulos R A, 1987, J Pediatr Ophthalmol Strabismus, V24, P198; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; TABBARA KF, 1973, CAN J OPHTHALMOL, V8, P488; WIGGS JL, 1994, GENOMICS, V21, P299, DOI 10.1006/geno.1994.1269; Wolkowicz M I, 1971, Ann Ophthalmol, V3, P842	31	145	151	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					613	619						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751862				2022-12-18	WOS:A1996VN62500015
J	Meyers, GA; Day, D; Goldberg, R; Daentl, DL; Przylepa, KA; Abrams, LJ; Graham, JM; Feingold, M; Rawnsley, E; Scott, AF; Jabs, EW				Meyers, GA; Day, D; Goldberg, R; Daentl, DL; Przylepa, KA; Abrams, LJ; Graham, JM; Feingold, M; Rawnsley, E; Scott, AF; Jabs, EW			FCFR2 exon IIIa and IIIe mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: Evidence for missense changes, insertions, and a deletion due to alternative RNA splicing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Fibroblast growth factor receptor 2 (FGFR2) mutations have been associated with the craniosynostotic conditions Crouzon, Jackson-Weiss, and Pfeiffer syndromes. Previously, mutations were described in the exons IIIa and IIIc, which form the extracellular, third immunoglobulin-like domain (IgIII) and adjacent linker regions, both of which are normally involved in ligand binding;. For all three conditions, mutations were found in exon IIIc. Only in Crouzon syndrome were mutations identified in exon IIIa. In this study, 39 cases with one of these three conditions were screened for exon IIIa or IIIc mutations. Eleven mutations are reported in 17 unrelated cases. Mutations in exon IIIa are identified for not only Crouzon but also Jackson-Weiss and Pfeiffer syndromes. Four mutations in either exon IIIa or exon IIIc reported only in Crouzon syndrome are present also in one of the other two syndromes. Two insertions, one in exon IIIa in a Crouzon syndrome patient and the other in exon IIIc in a Pfeiffer syndrome patient, were observed. The latter mutation has the same alternative RNA splicing effect as a reported synonymous mutation for Crouzon syndrome. A missense mutation was detected in one Pfeiffer syndrome family in which two members had craniosynostosis without limb anomalies. The inter- and intrafamilial variability in expression of FGFR2 mutations suggests that these three syndromes, presumed to be clinically distinct, are instead representative of a spectrum of related craniosynostotic and digital disorders.	JOHNS HOPKINS UNIV HOSP,CTR MED GENET,BALTIMORE,MD 21287; TEXAS DEPT HLTH,GENET SCREENING & COUNSELING SERV,DENTON,TX; MONTEFIORE MED CTR,CTR CRANIOFACIAL DISORDERS,BRONX,NY 10467; SHRINERS HOSP CRIPPLED CHILDREN,SAN FRANCISCO,CA; CHILDRENS HOSP OAKLAND,MED CTR,DIV MED GENET,OAKLAND,CA; UNIV CALIF LOS ANGELES,SCH MED,CEDARS SINAI MED CTR,CTR MED GENET BIRTH DEFECTS,LOS ANGELES,CA 90024; NATL BIRTH DEFECTS CTR,WALTHAM,MA; DARTMOUTH HITCHCOCK MED CTR,CTR GENET & CHILD DEV,LEBANON,NH	Johns Hopkins University; Johns Hopkins Medicine; Texas Department of State Health Services; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Dartmouth College			Graham, John M./J-1429-2019	Jabs, Ethylin/0000-0001-8983-5466	NICHD NIH HHS [HD24061] Funding Source: Medline; NIDCR NIH HHS [DE101180, DE11131] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE011131] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Cohen, 1986, CRANIOSYNOSTOSIS DIA; GORRY MC, 1995, HUM MOL GENET, V4, P1387, DOI 10.1093/hmg/4.8.1387; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JACKSON CE, 1976, J PEDIATR-US, V88, P963, DOI 10.1016/S0022-3476(76)81050-5; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; OLDRIDGE M, 1995, HUM MOL GENET, V4, P1077; PARK WJ, 1995, AM J HUM GENET, V57, P321; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; PARK WJ, 1995, AM J HUM GENET, V57, P748; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	16	145	157	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					491	498						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644708				2022-12-18	WOS:A1996TV56400007
J	CALLEN, DF; EYRE, HJ; RINGENBERGS, ML; FREEMANTLE, CJ; WOODROFFE, P; HAAN, EA				CALLEN, DF; EYRE, HJ; RINGENBERGS, ML; FREEMANTLE, CJ; WOODROFFE, P; HAAN, EA			CHROMOSOMAL ORIGIN OF SMALL RING MARKER CHROMOSOMES IN MAN - CHARACTERIZATION BY MOLECULAR-GENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHOID REPETITIVE DNA; INSITU HYBRIDIZATION; PERICENTRIC REGIONS; SEQUENCES; LOCALIZATION	Ten cases of small ring chromosomes which did not stain with distamycinA/DAPI and did not possess satellite regions associated with nucleolus-organizing regions are described. In situ hybridization with a battery of biotinylated pericentric repeat probes specific either for individual chromosomes or for groups of chromosomes allowed the identification of the chromosomal origin of these marker chromosomes. There was one example of a marker derived from each of chromosomes 1, 3, 6, 14, 16, 18, 20, 13 or 21, and the X, and there were two examples of markers derived from chromosome 12. One case possessed two markers, one derived from chromosome 6, and one derived from the X. The mechanism of generation of ring marker chromosomes is discussed. Five of seven cases who could be phenotypically assessed were abnormal. Three of these - the first with a ring chromosome derived from chromosome 1; the second with two markers, one derived from chromosome 6 and the other from the X chromosome; and the third with a ring chromosome derived from chromosome 20 - each possessed distinctive facies. Additional cases with identified rings may allow the delineation of new chromosomal syndromes.	ADELAIDE CHILDRENS HOSP INC,DEPT MED GENET,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT NEUROSURG,ADELAIDE,SA 5006,AUSTRALIA		CALLEN, DF (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Callen, David F/G-1975-2012; Slagboom, P. Eline/R-4790-2016	Slagboom, P. Eline/0000-0002-2875-4723; Callen, David/0000-0002-6189-9991				CALLEN DF, 1990, J MED GENET, V27, P155, DOI 10.1136/jmg.27.3.155; CALLEN DF, 1987, HUM GENET, V77, P236, DOI 10.1007/BF00284476; CALLEN DF, 1990, AM J HUM GENET, V47, P493; CHOO KH, 1987, DNA-J MOLEC CELL BIO, V6, P297, DOI 10.1089/dna.1987.6.297; DEVILEE P, 1988, Genomics, V3, P1, DOI 10.1016/0888-7543(88)90151-6; DEVILEE P, 1986, CYTOGENET CELL GENET, V41, P193, DOI 10.1159/000132229; FOWLER JCS, 1989, CHROMOSOMA, V98, P266, DOI 10.1007/BF00327312; FOWLER JCS, UNPUB RESTRICTION EN; HAMERTON JL, 1971, HUMAN CYTOGENETICS; HULSEBOS T, 1988, CYTOGENET CELL GENET, V47, P144, DOI 10.1159/000132533; JABS EW, 1987, AM J HUM GENET, V41, P374; JORGENSEN AL, 1987, P NATL ACAD SCI USA, V84, P1075, DOI 10.1073/pnas.84.4.1075; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; METZDORF R, 1988, CHROMOSOMA, V97, P154, DOI 10.1007/BF00327372; MOYZIS RK, 1987, CHROMOSOMA, V95, P375, DOI 10.1007/BF00333988; Rooney D E, 1986, HUMAN CYTOGENETICS P, VFirst	16	145	148	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					769	782						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014800				2022-12-18	WOS:A1991FK47800017
J	MORNET, E; CRETE, P; KUTTENN, F; RAUXDEMAY, MC; BOUE, J; WHITE, PC; BOUE, A				MORNET, E; CRETE, P; KUTTENN, F; RAUXDEMAY, MC; BOUE, J; WHITE, PC; BOUE, A			DISTRIBUTION OF DELETIONS AND 7 POINT MUTATIONS ON CYP21B GENES IN 3 CLINICAL FORMS OF STEROID 21-HYDROXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; MAJOR-HISTOCOMPATIBILITY-COMPLEX; C-4 GENES; 17-HYDROXYPROGESTERONE DETERMINATION; PRENATAL-DIAGNOSIS; DNA PROBES; HAPLOTYPES; HLA; COMPONENT	To characterize mutations in the CYP21B gene that are responsible for congenital adrenal hyperplasia (CAH), DNA samples from 91 French patients have been studied by allelic-specific oligonucleotide hybridization and Southern blot analysis. Seven sites mostly found in the CYP21A pseudogene and deletions of the functional CYP21B gene have been screened. Gene conversions involving small DNA segments accounted for 57% of the tested mutations and probably cause 74% of the mutations responsible for the disease. Complete deletion of the CYP21B gene accounted for 18% of the CAH mutations in the whole sample and for 21% in the classical form of the disease. Three mutations were found associated with specific clinical forms of the disease: a G-C substitution in the seventh exon was associated with the late-onset form of the disease, and both an 8-bp depletion in the third exon and complete deletion of CYP21B were associated with the salt-wasting form.	HOP NECKER ENFANTS MALAD,ENDOCRINOL & MED REPROD LAB,PARIS,FRANCE; HOSP TROUSSEAU,EXPLORAT FONCTIONNELLES LAB,PARIS,FRANCE; CORNELL UNIV,MED CTR,COLL MED,DIV PEDIAT ENDOCRINOL,NEW YORK,NY 10021	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Cornell University	MORNET, E (corresponding author), INSERM,U73,CHATEAU LONGCHAMPS,F-75016 PARIS,FRANCE.							AMOR M, 1988, P NATL ACAD SCI USA, V85, P1600, DOI 10.1073/pnas.85.5.1600; CARROLL MC, 1985, P NATL ACAD SCI USA, V82, P521, DOI 10.1073/pnas.82.2.521; CHIOU SH, 1990, J BIOL CHEM, V265, P3549; COLLIER S, 1989, EMBO J, V8, P1393, DOI 10.1002/j.1460-2075.1989.tb03520.x; GARLEPP MJ, 1986, IMMUNOGENETICS, V23, P100, DOI 10.1007/BF00377968; GLOBERMAN H, 1988, J CLIN INVEST, V82, P139, DOI 10.1172/JCI113562; HARADA F, 1987, P NATL ACAD SCI USA, V84, P8091, DOI 10.1073/pnas.84.22.8091; HIGASHI Y, 1988, P NATL ACAD SCI USA, V85, P7486, DOI 10.1073/pnas.85.20.7486; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; MATTESON KJ, 1987, P NATL ACAD SCI USA, V84, P5858, DOI 10.1073/pnas.84.16.5858; MILLER WL, 1989, ANNU REV GENET, V23, P371, DOI 10.1146/annurev.ge.23.120189.002103; MOREL Y, 1989, J CLIN INVEST, V83, P527, DOI 10.1172/JCI113914; MORNET E, 1986, HUM GENET, V73, P358, DOI 10.1007/BF00279101; MORNET E, 1986, HUM GENET, V84, P402; OWERBACH D, 1990, MOL ENDOCRINOL, V4, P125, DOI 10.1210/mend-4-1-125; PARTANEN J, 1989, AM J HUM GENET, V44, P660; RAUM D, 1984, AM J HUM GENET, V36, P72; RAUXDEMAY M, 1989, PRENATAL DIAG, V9, P457, DOI 10.1002/pd.1970090702; RODRIGUES NR, 1987, EMBO J, V6, P1653, DOI 10.1002/j.1460-2075.1987.tb02414.x; RUMSBY G, 1986, J MED GENET, V23, P204, DOI 10.1136/jmg.23.3.204; SPEISER P, 1988, NEW ENGL J MED, V1, P19; TUSIELUNA MT, IN PRESS J BIOL CHEM; WERKMEISTER JW, 1986, AM J HUM GENET, V39, P461; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; WHITE PC, 1987, NEW ENGL J MED, V316, P1580, DOI 10.1056/NEJM198706183162506; WHITE PC, 1988, P NATL ACAD SCI USA, V85, P4436, DOI 10.1073/pnas.85.12.4436; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P1986, DOI 10.1073/pnas.81.7.1986; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111	28	145	148	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					79	88						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985465				2022-12-18	WOS:A1991ET18800011
J	Dannemann, M; Andres, AM; Kelso, J				Dannemann, Michael; Andres, Aida M.; Kelso, Janet			Introgression of Neandertal- and Denisovan-like Haplotypes Contributes to Adaptive Variation in Human Toll-like Receptors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POSITIVE SELECTION; GENETIC-VARIATION; GENOME SEQUENCE; EVOLUTION; ANCESTRY; RECOMBINATION; POPULATIONS; LANDSCAPE; DIVERSITY; MUTATION	Pathogens and the diseases they cause have been among the most important selective forces experienced by humans during their evolutionary history. Although adaptive alleles generally arise by mutation, introgression can also be a valuable source of beneficial alleles. Archaic humans, who lived in Europe and Western Asia for more than 200,000 years, were probably well adapted to this environment and its local pathogens. It is therefore conceivable that modern humans entering Europe and Western Asia who admixed with them obtained a substantial immune advantage from the introgression of archaic alleles. Here we document a cluster of three Toll-like receptors (TLR6-TLR1-TLR10) in modem humans that carries three distinct archaic haplotypes, indicating repeated introgression from archaic humans. Two of these haplotypes are most similar to the Neandertal genome, and the third haplotype is most similar to the Denisovan genome. The Toll-like receptors are key components of innate immunity and provide an important first line of immune defense against bacteria, fungi, and parasites. The unusually high allele frequencies and unexpected levels of population differentiation indicate that there has been local positive selection on multiple haplotypes at this locus. We show that the introgressed alleles have clear functional effects in modern humans; archaic-like alleles underlie differences in the expression of the TLR genes and are associated with reduced microbial resistance and increased allergic disease in large cohorts. This provides strong evidence for recurrent adaptive introgression at the TLR6-TLR1-TLR10 locus, resulting in differences in disease phenotypes in modem humans.	[Dannemann, Michael; Andres, Aida M.; Kelso, Janet] Max Planck Inst Evolutionare Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Dannemann, Michael] Univ Leipzig, Fac Med, D-04103 Leipzig, Germany	Max Planck Society; Leipzig University	Kelso, J (corresponding author), Max Planck Inst Evolutionare Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	kelso@eva.mpg.de	Kelso, Janet/N-1812-2019	Kelso, Janet/0000-0002-3618-322X	Max Planck Society; Deutsche Forschungsgemeinschaft [SFB1052]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Cesare de Filippo, Felix Key, Svante Paabo, Kay Prafer, Joao Teixeira, and two anonymous reviewers for helpful comments and discussions. We thank David Reich and Nick Patterson for access to the Simons Genome Diversity Panel data and Marike Schreiber for assistance with the figure preparation. Funding was provided by the Max Planck Society and the Deutsche Forschungsgemeinschaft SFB1052 "Obesity mechanisms" (project A02) (to J.K.).	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enard D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000840; Fay JC, 2000, GENETICS, V155, P1405; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Key FM, 2014, CURR OPIN GENET DEV, V29, P45, DOI 10.1016/j.gde.2014.08.001; Kim BY, 2015, AM J HUM GENET, V96, P454, DOI 10.1016/j.ajhg.2014.12.029; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Laayouni H, 2014, P NATL ACAD SCI USA, V111, P2668, DOI 10.1073/pnas.1317723111; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; Mendez FL, 2013, MOL BIOL EVOL, V30, P798, DOI 10.1093/molbev/mst004; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Qin PF, 2015, MOL BIOL EVOL, V32, P2665, DOI 10.1093/molbev/msv141; Quach H, 2013, HUM MOL GENET, V22, P4829, DOI 10.1093/hmg/ddt335; Quintana-Murci L, 2013, NAT REV IMMUNOL, V13, P280, DOI 10.1038/nri3421; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sanchez-Quinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047765; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Segurel L, 2014, CURR OPIN IMMUNOL, V30, P79, DOI 10.1016/j.coi.2014.08.002; TAJIMA F, 1989, GENETICS, V123, P585; Vernot B, 2015, AM J HUM GENET, V96, P448, DOI 10.1016/j.ajhg.2015.01.006; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	59	144	147	3	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					22	33		10.1016/j.ajhg.2015.11.015	http://dx.doi.org/10.1016/j.ajhg.2015.11.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26748514	hybrid, Green Submitted, Green Published			2022-12-18	WOS:000368050800002
J	Mayr, JA; Haack, TB; Graf, E; Zimmermann, FA; Wieland, T; Haberberger, B; Superti-Furga, A; Kirschner, J; Steinmann, B; Baumgartner, MR; Moroni, I; Lamantea, E; Zeviani, M; Rodenburg, RJ; Smeitink, J; Strom, TM; Meitinger, T; Sperl, W; Prokisch, H				Mayr, Johannes A.; Haack, Tobias B.; Graf, Elisabeth; Zimmermann, Franz A.; Wieland, Thomas; Haberberger, Birgit; Superti-Furga, Andrea; Kirschner, Janbernd; Steinmann, Beat; Baumgartner, Matthias R.; Moroni, Isabella; Lamantea, Eleonora; Zeviani, Massimo; Rodenburg, Richard J.; Smeitink, Jan; Strom, Tim M.; Meitinger, Thomas; Sperl, Wolfgang; Prokisch, Holger			Lack of the Mitochondrial Protein Acylglycerol Kinase Causes Sengers Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; ATP SYNTHASE DEFICIENCY; LACTIC-ACIDOSIS; HYPERTROPHIC CARDIOMYOPATHY; CONGENITAL CATARACT; 3-METHYLGLUTACONIC ACIDURIA; OXIDATIVE-PHOSPHORYLATION; SKELETAL-MUSCLE; MYOPATHY; EXPRESSION	Exome sequencing of an individual with congenital cataracts, hypertrophic cardiomyopathy, skeletal myopathy, and lactic acidosis, all typical symptoms of Sengers syndrome, discovered two nonsense mutations in the gene encoding mitochondrial acylglycerol kinase (AGK). Mutation screening of AGK in further individuals with congenital cataracts and cardiomyopathy identified numerous loss-of-function mutations in an additional eight families, confirming the causal nature of AGK deficiency in Sengers syndrome. The loss of AGK led to a decrease of the adenine nucleotide translocator in the inner mitochondrial membrane in muscle, consistent with a role of AGK in driving the assembly of the translocator as a result of its effects on phospholipid metabolism in mitochondria.	[Haack, Tobias B.; Graf, Elisabeth; Wieland, Thomas; Haberberger, Birgit; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Mayr, Johannes A.; Zimmermann, Franz A.; Sperl, Wolfgang] Paracelsus Med Univ Salzburg, Dept Paediat, A-5020 Salzburg, Austria; [Haack, Tobias B.; Haberberger, Birgit; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Superti-Furga, Andrea; Kirschner, Janbernd] Univ Med Ctr, Dept Neuropaediat & Muscle Disorders, D-79106 Freiburg, Germany; [Steinmann, Beat; Baumgartner, Matthias R.] Univ Childrens Hosp, Childrens Res Ctr, Div Metab, CH-8032 Zurich, Switzerland; [Moroni, Isabella; Lamantea, Eleonora; Zeviani, Massimo] Ist Ricovero & Cura Carattere Sci, Carlo Besta Neurol Inst Fdn, Div Mol Neurogenet, I-20126 Milan, Italy; [Rodenburg, Richard J.; Smeitink, Jan] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands; [Meitinger, Thomas] Munich Heart Alliance, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Paracelsus Private Medical University; Technical University of Munich; University of Freiburg; University Children's Hospital Zurich; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Radboud University Nijmegen; Munich Heart Alliance	Prokisch, H (corresponding author), Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.	prokisch@helmholtz-muenchen.de	Moroni, Isabella/AAL-1336-2021; Rodenburg, Richard/N-3579-2014; Baumgartner, Matthias R/Q-2855-2017; superti-furga, andrea/E-9162-2015; Kirschner, Janbernd/H-7418-2016; Prokisch, Holger/N-8964-2013; Zeviani, Massimo/K-2891-2014; Kirschner, Janbernd/Q-1493-2019; Smeitink, Jan/C-1351-2013; Zeviani, Massimo/AAU-2632-2021; Meitinger, Thomas/O-1318-2015; Lamantea, Eleonora/J-8339-2016	Moroni, Isabella/0000-0002-3322-1681; Rodenburg, Richard/0000-0001-5227-3527; Baumgartner, Matthias R/0000-0002-9270-0826; superti-furga, andrea/0000-0002-3543-7531; Kirschner, Janbernd/0000-0003-1618-7386; Kirschner, Janbernd/0000-0003-1618-7386; Zeviani, Massimo/0000-0002-9067-5508; Lamantea, Eleonora/0000-0001-5090-6028; Meitinger, Thomas/0000-0002-8838-8403; Mayr, Johannes/0000-0001-6970-336X; Prokisch, Holger/0000-0003-2379-6286	Helmholtz Association [HA-215]; German Federal Ministry of Education and Research (BMBF) [SysMBo 0315494A]; German Network for Mitochondrial Disorders [mitoNET 01GM0867]; BMBF; European Commission [N. 261123]; Genetic European Variation in Disease Consortium; German Ministry for Education and Research [01GR0804-4]; Austrian Paediatric Society (OGKJ); Jubilaumsfonds of Oesterreichische Nationalbank [12568]; Vereinigung zur Forderung padiatrischer Forschung und Fortbildung Salzburg; Telethon-Italy [GPP10005, GGP1011]; Fondazione Cariplo [2011-0526]; Italian Association of Mitochondrial Patients and Families (Mitocon); Fondazione Pierfranco e Luisa Mariani-Organizzazione Non Lucrativa di Utilita Sociale	Helmholtz Association(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Network for Mitochondrial Disorders; BMBF(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Genetic European Variation in Disease Consortium; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Austrian Paediatric Society (OGKJ); Jubilaumsfonds of Oesterreichische Nationalbank; Vereinigung zur Forderung padiatrischer Forschung und Fortbildung Salzburg; Telethon-Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Italian Association of Mitochondrial Patients and Families (Mitocon); Fondazione Pierfranco e Luisa Mariani-Organizzazione Non Lucrativa di Utilita Sociale	We are indebted to the subjects and their families involved in the study. We gratefully acknowledge the support of J. Schum, R. Hellinger, and A. Loschner in genotyping and cell-culture work. T.M. and M.P. were supported by the Impulse and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society (HA-215) and the German Federal Ministry of Education and Research (BMBF)-funded Systems Biology of Metabotypes grant (SysMBo 0315494A) and German Network for Mitochondrial Disorders (mitoNET 01GM0867). T.M. is supported by the BMBF-funded German Center for Heart Research. T.M. and T.M.S. were supported by the European Commission 7th Framework Program (N. 261123), the Genetic European Variation in Disease Consortium, and the German Ministry for Education and Research (01GR0804-4). J.A.M. was supported by the Wissenschaftspreis 2008 of the Austrian Paediatric Society (OGKJ), W.S. was supported by the Jubilaumsfonds of Oesterreichische Nationalbank (12568), and JAM., F.Z., and W.S. were supported by the Vereinigung zur Forderung padiatrischer Forschung und Fortbildung Salzburg. Telethon-Italy is gratefully acknowledged for grants GPP10005 and GGP1011 to M.Z.; M.Z. is also supported by Fondazione Cariplo (grant 2011-0526) and the Italian Association of Mitochondrial Patients and Families (Mitocon). E.L. is supported by Fondazione Pierfranco e Luisa Mariani-Organizzazione Non Lucrativa di Utilita Sociale.	BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; Cowell CF, 2009, J CELL SCI, V122, P919, DOI 10.1242/jcs.041061; CRUYSBERG JRM, 1986, AM J OPHTHALMOL, V102, P740, DOI 10.1016/0002-9394(86)90402-2; DEPINAY SL, 1986, KLIN MONATSBL AUGENH, V189, P482, DOI 10.1055/s-2008-1050858; Di Rosa G, 2006, J INHERIT METAB DIS, V29, P546, DOI 10.1007/s10545-006-0279-y; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Epand RM, 2009, BIOCHEMISTRY-US, V48, P12358, DOI 10.1021/bi901769r; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; Morava E, 2004, EUR J PEDIATR, V163, P467, DOI 10.1007/s00431-004-1465-2; SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4; SMEITINK JAM, 1989, EUR J PEDIATR, V148, P656, DOI 10.1007/BF00441527; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; VALSSON J, 1988, AM J CARDIOL, V61, P193, DOI 10.1016/0002-9149(88)91331-8; VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157; Zhao YT, 2009, CELL SIGNAL, V21, P367, DOI 10.1016/j.cellsig.2008.10.010	26	144	148	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					314	320		10.1016/j.ajhg.2011.12.005	http://dx.doi.org/10.1016/j.ajhg.2011.12.005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22284826	Green Published, Bronze			2022-12-18	WOS:000300742200013
J	Belostotsky, R; Seboun, E; Idelson, GH; Milliner, DS; Becker-Cohen, R; Rinat, C; Monico, CG; Feinstein, S; Ben-Shalom, E; Magen, D; Weissman, I; Charon, C; Frishberg, Y				Belostotsky, Ruth; Seboun, Eric; Idelson, Gregory H.; Milliner, Dawn S.; Becker-Cohen, Rachel; Rinat, Choni; Monico, Carla G.; Feinstein, Sofia; Ben-Shalom, Efrat; Magen, Daniella; Weissman, Irith; Charon, Celine; Frishberg, Yaacov			Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PURIFICATION; ALDOLASE; KIDNEY; ENZYME	Primary hyperoxaluria (PH) is an autosomal-recessive disorder of endogenous oxalate synthesis characterized by accumulation of calcium oxalate primarily in the kidney. Deficiencies of alanine-glyoxylate aminotransferase (AGT) or glyoxylate reductase (GRHPR) are the two known causes of the disease (PH I and II, respectively). To determine the etiology of an as yet uncharacterized type of PH, we selected a cohort of 15 non-PH I/PH II patients from eight unrelated families with calcium oxalate nephrolithiasis for high-density SNP microarray analysis. We determined that mutations in an uncharacterized gene, DHDPSL, on chromosome 10 cause a third type of PH (PH III). To overcome the difficulties in data analysis attributed to a state of compound heterozygosity, we developed a strategy of "heterozygosity mapping"-a search for long heterozygous patterns unique to all patients in a given family and overlapping between families, followed by reconstruction of haplotypes. This approach enabled us to determine an allelic fragment shared by all patients of Ashkenazi Jewish descent and bearing a 3 bp deletion in DHDPSL. Overall, six mutations were detected: four missense mutations, one in-frame deletion, and one splice-site mutation. Our assumption is that DHDPSL is the gene encoding 4-hydroxy-2-oxoglutarate aldolase, catalyzing the final step in the metabolic pathway of hydroxyproline.	[Belostotsky, Ruth; Idelson, Gregory H.; Becker-Cohen, Rachel; Rinat, Choni; Feinstein, Sofia; Ben-Shalom, Efrat; Frishberg, Yaacov] Shaare Zedek Med Ctr, Div Pediat Nephrol, IL-91031 Jerusalem, Israel; [Seboun, Eric] Univ Paris 06, Div Genet & Microbiol, F-75005 Paris, France; [Seboun, Eric] INSERM, Fac Med Pitie Salpetriere, U525, F-75634 Paris, France; [Milliner, Dawn S.; Monico, Carla G.] Mayo Clin, Div Nephrol, Rochester, MN 55905 USA; [Milliner, Dawn S.; Monico, Carla G.] Mayo Clin, Mayo Clin Hyperoxaluria Ctr, Rochester, MN 55905 USA; [Becker-Cohen, Rachel; Rinat, Choni; Feinstein, Sofia; Ben-Shalom, Efrat; Frishberg, Yaacov] Hadassah Hebrew Univ, Sch Med, IL-91120 Jerusalem, Israel; [Magen, Daniella] Rambam Hlth Care Campus, Pediatr Nephrol Unit, IL-31096 Haifa, Israel; [Weissman, Irith] Western Galilee Med Ctr, Pediat Nephrol Unit, IL-22100 Nahariyya, Israel; [Charon, Celine] Ctr Natl Genotypage, F-91057 Evry, France	Hebrew University of Jerusalem; Shaare Zedek Medical Center; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Mayo Clinic; Mayo Clinic; Hebrew University of Jerusalem; Hadassah University Medical Center; Rambam Health Care Campus; Western Galilee Hospital; CEA; UDICE-French Research Universities; Universite Paris Saclay	Frishberg, Y (corresponding author), Shaare Zedek Med Ctr, Div Pediat Nephrol, IL-91031 Jerusalem, Israel.	yaacovf@ekmd.huji.ac.il			Oxalosis and Hyperoxaluria Foundation; National Institute of Diabetes and Digestive and Kidney Diseases [DK073354, U54DK083908]; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK083908, R01DK073354] Funding Source: NIH RePORTER	Oxalosis and Hyperoxaluria Foundation; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Tsafi Danieli, Yael Keren, and Giora Morozov for excellent technical assistance. We are indebted to Karl Skorecki and Orly Reiner for critical review of the manuscript and for helpful suggestions. This work was supported in part by funding from the Oxalosis and Hyperoxaluria Foundation and by grants DK073354 and U54DK083908 from the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Health (D.S.M.).	Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; ANDERSON M, 1985, ARCH BIOCHEM BIOPHYS, V236, P82, DOI 10.1016/0003-9861(85)90608-3; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Cregeen DP, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9200; DANPURE CJ, 1986, FEBS LETT, V201, P20, DOI 10.1016/0014-5793(86)80563-4; Dekker E E, 1975, Methods Enzymol, V41, P115; DEKKER EE, 1992, J BIOL CHEM, V267, P10507; Ellard S, 2007, AM J HUM GENET, V81, P375, DOI 10.1086/519174; Hoppe B, 2009, KIDNEY INT, V75, P1264, DOI 10.1038/ki.2009.32; Jiang HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005280; LOWRY M, 1985, METABOLISM, V34, P955, DOI 10.1016/0026-0495(85)90145-3; Miyazawa H, 2007, AM J HUM GENET, V80, P1090, DOI 10.1086/518176; Monico CG, 2008, AM J KIDNEY DIS, V52, P1096, DOI 10.1053/j.ajkd.2008.07.041; Monico CG, 2002, KIDNEY INT, V62, P392, DOI 10.1046/j.1523-1755.2002.00468.x	15	144	155	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					392	399		10.1016/j.ajhg.2010.07.023	http://dx.doi.org/10.1016/j.ajhg.2010.07.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20797690	Green Published, Bronze			2022-12-18	WOS:000281923500009
J	Browning, BL; Yu, ZX				Browning, Brian L.; Yu, Zhaoxia			Simultaneous Genotype Calling and Haplotype Phasing Improves Genotype Accuracy and Reduces False-Positive Associations for Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIDDEN MARKOV-MODELS; SUSCEPTIBILITY LOCI; LARGE-SCALE; UNRELATED INDIVIDUALS; ARRAY DATA; INFERENCE; IMPUTATION; ALGORITHM; DISEASE; POLYMORPHISMS	We present a novel method for Simultaneous genotype calling and haplotype-phase inference. Our method employs the computationally efficient BEAGLE haplotype-frequency model, which can be applied to large-scale studies with millions of markers and thousands of samples. We compare genotype calls made with our method to genotype calls made with the BIRDSEED, CHIAMO, GenCall, and ILLUMINUS genotype-calling methods, using genotype data from the Illumina 550K and Affymetrix 500K arrays. We show that our method has higher genotype-call accuracy and yields fewer uncalled genotypes than competing methods. We perform single-marker analysis of data from the Wellcome Trust Case Control Consortium bipolar disorder and type 2 diabetes Studies. I or bipolar disorder, the genotype calls in the original study yield 25 markers with apparent false-positive association with bipolar disorder at a p < 10(-7) significance level, whereas genotype calls made with our method yield no associated markers at this significance threshold. Conversely, for markers with replicated association with type 2 diabetes, there is good concordance between genotype calls used in the original study and calls made by our method. Results from single-marker and haplotypic analysis of our method's genotype calls for the bipolar disorder study indicate that our method is highly effective at eliminating genotyping artifacts that cause false-positive associations in genome-wide association Studies. Our new genotype-calling methods are implemented in the BEAGLE and BEAGLECALL software packages.	[Browning, Brian L.] Univ Auckland, Dept Stat, Auckland 1142, New Zealand; [Yu, Zhaoxia] Univ Calif Irvine, Dept Stat, Irvine, CA 92697 USA	University of Auckland; University of California System; University of California Irvine	Browning, BL (corresponding author), Univ Auckland, Dept Stat, Auckland 1142, New Zealand.	b.browning@auckland.ac.nz	Browning, Brian L/A-1178-2010	Browning, Brian L/0000-0001-6454-6633	Wellcome Trust [076113]; New Zealand Marsden Fund [08-UOA-028]; NIH [R01HG004960]; National Human Genome Research Institute; New Zealand Marsden Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004960] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by New Zealand Marsden Fund award 08-UOA-028 and NIH award R01HG004960 from the National Human Genome Research Institute. The content of this study is solely the responsibility of the authors and does not necessary represent the official views of the National Human Genome Research Institute, the National Institutes of Health, or the New Zealand Marsden Fund.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning BL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-309; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Eronen L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-542; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Kang HS, 2004, AM J HUM GENET, V74, P495, DOI 10.1086/382284; Kennedy J, 2008, J COMPUT BIOL, V15, P1155, DOI 10.1089/cmb.2007.0133; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LONG JC, 1995, AM J HUM GENET, V56, P799; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sampson JN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-68; Scheet P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000147; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yu ZX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-63; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	39	144	151	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					847	861		10.1016/j.ajhg.2009.11.004	http://dx.doi.org/10.1016/j.ajhg.2009.11.004			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	19931040	Bronze, Green Published			2022-12-18	WOS:000272797100008
J	Meredith, C; Herrmann, R; Parry, C; Liyanage, K; Dye, DE; Durling, HJ; Duff, RM; Beckman, K; de Visser, M; van der Graaff, MM; Hedera, P; Fink, JK; Petty, EM; Lamont, P; Fabian, V; Bridges, L; Voit, T; Mastaglia, FL; Laing, NG				Meredith, C; Herrmann, R; Parry, C; Liyanage, K; Dye, DE; Durling, HJ; Duff, RM; Beckman, K; de Visser, M; van der Graaff, MM; Hedera, P; Fink, JK; Petty, EM; Lamont, P; Fabian, V; Bridges, L; Voit, T; Mastaglia, FL; Laing, NG			Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REGULATORY PHOSPHORYLATION SITE; TIBIAL MUSCULAR-DYSTROPHY; SARCOMERIC M-BAND; MISSENSE MUTATION; HYPERTROPHIC CARDIOMYOPATHY; BODY MYOPATHY; ROD DOMAIN; PROTEIN; LINKAGE; TITIN	We previously linked Laing-type early-onset autosomal dominant distal myopathy (MPD1) to a 22-cM region of chromosome 14. One candidate gene in the region, MYH7, which is mutated in cardiomyopathy and myosin storage myopathy, codes for the myosin heavy chain of type I skeletal muscle fibers and cardiac ventricles. We have identified five novel heterozygous mutations - Arg1500Pro, Lys1617del, Ala1663Pro, Leu1706Pro, and Lys1729del in exons 32, 34, 35, and 36 of MYH7 - in six families with early-onset distal myopathy. All five mutations are predicted, by in silico analysis, to locally disrupt the ability of the myosin tail to form the coiled coil, which is its normal structure. These findings demonstrate that heterozygous mutations toward the 3' end of MYH7 cause Laing-type early-onset distal myopathy. MYH7 is the fourth distal-myopathy gene to have been identified.	Univ Western Australia, Queen Elizabeth II Med Ctr, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia; Edith Cowan Univ, Ctr Human Genet, Perth, WA, Australia; Royal Perth Hosp, Dept Neurol, Perth, WA, Australia; Royal Perth Hosp, Dept Anat Pathol, Perth, WA, Australia; Univ Hosp Essen, Dept Pediat & Pediat Neurol, Essen, Germany; Univ Western Australia, Western Australian Inst Med Res, Med Res Ctr, Nedlands, WA 6009, Australia; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; Univ Michigan, Dept Neurol, Ann Arbor, MI USA; Univ Michigan, Dept Human Genet & Internal Med, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI USA	University of Western Australia; Edith Cowan University; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Duisburg Essen; University of Western Australia; University of Amsterdam; Academic Medical Center Amsterdam; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Laing, NG (corresponding author), Univ Western Australia, Queen Elizabeth II Med Ctr, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, 4th Floor,A Block, Nedlands, WA 6009, Australia.	nlaing@cyllene.uwa.edu.au	Dye, Danielle/B-8143-2013	Dye, Danielle/0000-0002-3564-6579; Laing, Nigel/0000-0001-5111-3732; Hedera, Peter/0000-0003-2699-4085	NINDS NIH HHS [R01NS38713, K08 NS042743, R01NS36177, K08NS42743, R01NS33645] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036177, R01NS038713, R01NS033645, K08NS042743] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahlberg G, 1999, ANN NEUROL, V46, P399, DOI 10.1002/1531-8249(199909)46:3<399::AID-ANA16>3.0.CO;2-Q; Askanas V, 1997, ANN NEUROL, V41, P421, DOI 10.1002/ana.410410403; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Blair E, 2002, CIRC RES, V90, P263, DOI 10.1161/hh0302.104532; Bohlega S, 2004, NEUROLOGY, V62, P1518, DOI 10.1212/01.WNL.0000123255.92062.37; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Craig R, 1994, MYOLOGY, P134; Feit H, 1998, AM J HUM GENET, V63, P1732, DOI 10.1086/302166; Felice KJ, 1999, NEUROMUSCULAR DISORD, V9, P59, DOI 10.1016/S0960-8966(98)00099-6; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Haravuori H, 2004, NEUROMUSCULAR DISORD, V14, P183, DOI 10.1016/j.nmd.2003.12.003; Hedera P, 2003, ARCH NEUROL-CHICAGO, V60, P1321, DOI 10.1001/archneur.60.9.1321; HOUMEIDA A, 1995, J CELL BIOL, V131, P1471, DOI 10.1083/jcb.131.6.1471; JAENICKE T, 1990, GENOMICS, V8, P194, DOI 10.1016/0888-7543(90)90272-V; Kayashima T, 2002, J HUM GENET, V47, P77, DOI 10.1007/s100380200004; LAING NG, 1995, AM J HUM GENET, V56, P422; Linssen WHJP, 1998, NEUROMUSCULAR DISORD, V8, P317, DOI 10.1016/S0960-8966(98)00020-0; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597; Mastaglia FL, 2002, NEUROMUSCULAR DISORD, V12, P350, DOI 10.1016/S0960-8966(01)00287-5; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1998, MOL BIOL CELL, V9, P829, DOI 10.1091/mbc.9.4.829; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; SCOPPETTA C, 1995, ACTA NEUROL SCAND, V92, P122; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sjoberg G, 1999, HUM MOL GENET, V8, P2191, DOI 10.1093/hmg/8.12.2191; Tajsharghi H, 2003, ANN NEUROL, V54, P494, DOI 10.1002/ana.10693; Tateyama M, 2002, NEUROLOGY, V58, P323, DOI 10.1212/WNL.58.2.323; Udd B, 2002, Neuromuscul Disord, V12, P897, DOI 10.1016/S0960-8966(02)00116-5; Udd B, 2001, CURR OPIN NEUROL, V14, P561, DOI 10.1097/00019052-200110000-00003; Van den Bergh PYK, 2003, ANN NEUROL, V54, P248, DOI 10.1002/ana.10647; Voit T, 2001, NEUROMUSCULAR DISORD, V11, P11, DOI 10.1016/S0960-8966(00)00158-9; VONDEIMLING F, 2001, NEUROMUSCULAR DISORD, V11, P653; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Zimprich F, 2000, MUSCLE NERVE, V23, P1876, DOI 10.1002/1097-4598(200012)23:12<1876::AID-MUS13>3.0.CO;2-A	41	144	148	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					703	708		10.1086/424760	http://dx.doi.org/10.1086/424760			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15322983	Green Published, Bronze			2022-12-18	WOS:000223634100017
J	Crawford, DC; Carlson, CS; Rieder, MJ; Carrington, DP; Yi, Q; Smith, JD; Eberle, MA; Kruglyak, L; Nickerson, DA				Crawford, DC; Carlson, CS; Rieder, MJ; Carrington, DP; Yi, Q; Smith, JD; Eberle, MA; Kruglyak, L; Nickerson, DA			Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN LIPOPROTEIN-LIPASE; CLASS-II REGION; LINKAGE-DISEQUILIBRIUM; HUMAN-GENOME; SEQUENCE VARIATION; COMMON DISEASE; ASSOCIATION; RECOMBINATION; BLOCKS	Recent studies have suggested that a significant fraction of the human genome is contained in blocks of strong linkage disequilibrium, ranging from similar to5 to >100 kb in length, and that within these blocks a few common haplotypes may account for >90% of the observed haplotypes. Furthermore, previous studies have suggested that common haplotypes in candidate genes are generally shared across populations and represent the majority of chromosomes in each population. The conclusions drawn from these preliminary studies, however, are based on an incomplete knowledge of the variation in the regions examined. To bridge this gap in knowledge, we have completely resequenced 100 candidate genes in a population of African descent and one of European descent. Although these genes have been well studied because of their medical importance, we demonstrate that a large amount of sequence variation has not yet been described. We also report that the average number of inferred haplotypes per gene, when complete data is used, is higher than in previous reports and that the number and proportion of all haplotypes represented by common haplotypes per gene is variable. Furthermore, we demonstrate that haplotypes shared between the two populations constitute only a fraction of the total number of haplotypes observed and that these shared haplotypes represent fewer of the African-descent chromosomes than was expected from previous studies. Finally, we show that restricting variation discovery to coding regions does not adequately describe all common haplotypes or the true haplotype block structure observed when all common variation is used to infer haplotypes. These data, derived from complete knowledge of genetic variation in these genes, suggest that the haplotype architecture of candidate genes across the human genome is more complex than previously suggested, with important implications for candidate gene and genomewide association studies.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Crawford, DC (corresponding author), Univ Washington, Dept Genome Sci, Box 357730, Seattle, WA 98195 USA.	dcrawfo@gs.washington.edu; debnick@u.washington.edu	Crawford, Dana/C-1054-2012; Crawford, Dana/O-5578-2019	Crawford, Dana/0000-0002-6437-6248; Eberle, Michael/0000-0001-8965-1253	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682, U01HL069757, U01HL066642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059520, R37MH059520] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL066682, U01 HL069757, U01 HL066642, HL66642, U01 HL69757, HL66682] Funding Source: Medline; NIMH NIH HHS [R37 MH059520, MH59520, R01 MH059520] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bonnen PE, 2002, GENOME RES, V12, P1846, DOI 10.1101/gr.483802; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Coronini R, 2003, NAT BIOTECHNOL, V21, P21, DOI 10.1038/nbt0103-21; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; EWENS WJ, 1964, GENETICS, V50, P891; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harding RM, 1997, AM J HUM GENET, V60, P772; Hartl DL, 1997, PRINCIPLES POPULATIO; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Kauppi L, 2003, HUM MOL GENET, V12, P33, DOI 10.1093/hmg/ddg008; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Li N, 2003, GENETICS, V165, P2213; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Nakajima T, 2002, AM J HUM GENET, V70, P108, DOI 10.1086/338454; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schneider JA, 2003, MECH AGEING DEV, V124, P17, DOI 10.1016/S0047-6374(02)00165-3; Schneider JA, 2002, HUM MOL GENET, V11, P207, DOI 10.1093/hmg/11.3.207; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Subrahmanyan L, 2001, AM J HUM GENET, V69, P381, DOI 10.1086/321297; Taylor JG, 2002, BLOOD, V100, P4303, DOI 10.1182/blood-2001-12-0306; Templeton AR, 2000, GENETICS, V156, P1259; Tiret L, 2002, HUM MOL GENET, V11, P419, DOI 10.1093/hmg/11.4.419; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Xu CF, 2002, HUM GENET, V110, P148, DOI 10.1007/s00439-001-0656-4; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142; Zhang K, 2003, HUM GENET, V113, P51, DOI 10.1007/s00439-003-0941-5	58	144	152	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					610	622		10.1086/382227	http://dx.doi.org/10.1086/382227			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15015130	Green Published, Bronze			2022-12-18	WOS:000220280800002
J	Senderek, J; Bergmann, C; Stendel, C; Kirfel, J; Verpoorten, N; De Jonghe, P; Timmerman, V; Chrast, R; Verheijen, MHG; Lemke, G; Battaloglu, E; Parman, Y; Erdem, S; Tan, E; Topaloglu, H; Hahn, A; Muller-Felber, W; Rizzuto, N; Fabrizi, GM; Stuhrmann, M; Rudnik-Schoneborn, S; Zuchner, S; Schroder, JM; Buchheim, E; Straub, V; Klepper, JR; Huehne, K; Rautenstrauss, B; Buttner, R; Nelis, E; Zerres, K				Senderek, J; Bergmann, C; Stendel, C; Kirfel, J; Verpoorten, N; De Jonghe, P; Timmerman, V; Chrast, R; Verheijen, MHG; Lemke, G; Battaloglu, E; Parman, Y; Erdem, S; Tan, E; Topaloglu, H; Hahn, A; Muller-Felber, W; Rizzuto, N; Fabrizi, GM; Stuhrmann, M; Rudnik-Schoneborn, S; Zuchner, S; Schroder, JM; Buchheim, E; Straub, V; Klepper, JR; Huehne, K; Rautenstrauss, B; Buttner, R; Nelis, E; Zerres, K			Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIFFERENTIATION-ASSOCIATED PROTEIN-1; SENSORY NEUROPATHY; HEREDITARY MOTOR; CHROMOSOME 5Q23-Q33; DEMYELINATING FORM; CELL-DEATH; DISEASE; FAMILIES; PERIAXIN	Charcot-Marie-Tooth disease type 4C (CMT4C) is a childhood-onset demyelinating form of hereditary motor and sensory neuropathy associated with an early-onset scoliosis and a distinct Schwann cell pathology. CMT4C is inherited as an autosomal recessive trait and has been mapped to a 13-cM linkage interval on chromosome 5q23-q33. By homozygosity mapping and allele-sharing analysis, we refined the CMT4C locus to a suggestive critical region of 1.7 Mb. We subsequently identified mutations in an uncharacterized transcript, KIAA1985, in 12 families with autosomal recessive neuropathy. We observed eight distinct protein-truncating mutations and three nonconservative missense mutations affecting amino acids conserved through evolution. In all families, we identified a mutation on each disease allele, either in the homozygous or in the compound heterozygous state. The CMT4C gene is strongly expressed in neural tissues, including peripheral nerve tissue. The translated protein defines a new protein family of unknown function with putative orthologues in vertebrates. Comparative sequence alignments indicate that members of this protein family contain multiple SH3 and TPR domains that are likely involved in the formation of protein complexes.	Rhein Westfal TH Aachen, Dept Human Genet, D-52074 Aachen, Germany; Rhein Westfal TH Aachen, Dept Neuropathol, Aachen, Germany; Univ Bonn, Inst Pathol, D-5300 Bonn, Germany; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA USA; Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; Istanbul Univ, Fac Med, Dept Neurol, Istanbul, Turkey; Hacettepe Univ, Dept Neurol, Ankara, Turkey; Hacettepe Univ, Neuromuscular Dis Res Lab, Ankara, Turkey; Hacettepe Childrens Hosp Med Ctr, Dept Pediat Neurol, Ankara, Turkey; Univ Giessen, Dept Neuropediat, Giessen, Germany; Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; Univ Verona, Dept Neurol & Visual Sci, Neurol Sect, I-37100 Verona, Italy; Hannover Med Sch, Inst Human Genet, D-3000 Hannover, Germany; Esslingen Community Hosp, Dept Paediat, Esslingen, Germany; Univ Hosp Essen, Dept Pediat & Pediat Neurol, Essen, Germany; Univ Erlangen Nurnberg, Dept Human Genet, Erlangen, Germany	RWTH Aachen University; RWTH Aachen University; University of Bonn; Flanders Institute for Biotechnology (VIB); University of Antwerp; Salk Institute; Bogazici University; Istanbul University; Hacettepe University; Hacettepe University; Hacettepe University; Justus Liebig University Giessen; University of Munich; University of Verona; Hannover Medical School; University of Duisburg Essen; University of Erlangen Nuremberg	Senderek, J (corresponding author), Rhein Westfal TH Aachen, Dept Human Genet, Pauwelsstr 30, D-52074 Aachen, Germany.	jsenderek@ukaachen.de	Senderek, Jan/F-8405-2015; Rudnik-Schöneborn, Sabine/F-8473-2015; Verheijen, Mark/GQY-5157-2022; Battaloğlu, Esra/AAF-1559-2020; Timmerman, Vincent/O-7283-2019; Verheijen, Mark/AAD-8112-2019; TOPALOGLU, HALUK AYDIN/I-9318-2013	Senderek, Jan/0000-0002-8263-1783; Timmerman, Vincent/0000-0002-2162-0933; Verheijen, Mark/0000-0002-3739-3755; Straub, Volker/0000-0001-9046-3540; Erdem Ozdamar, Sevim/0000-0001-9348-6457; Chrast, Roman/0000-0003-4189-3514				Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dyck P.J, 1993, PNP, P1094; *EUR CMT CONS ENMC, 1999, NEUROMUSCULAR DISORD, V9, P279; Fidzianska A, 2002, BRAIN DEV-JPN, V24, P727, DOI 10.1016/S0387-7604(02)00081-5; Gabreels-Festen A, 1999, J NEUROL NEUROSUR PS, V66, P569, DOI 10.1136/jnnp.66.5.569; Guilbot A, 1999, EUR J HUM GENET, V7, P849, DOI 10.1038/sj.ejhg.5200382; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; GUILBOT A, 2001, ACTA MYOL, V20, P21; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; Horiuchi T, 2000, BIOCHEM BIOPH RES CO, V272, P877, DOI 10.1006/bbrc.2000.2841; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kessali M, 1997, NEUROLOGY, V48, P867, DOI 10.1212/WNL.48.4.867; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; NELIS E, 2001, ACTA MYOL, V20, P39; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; SKRE H, 1974, CLIN GENET, V6, P98; Stoll R, 2001, EMBO J, V20, P340, DOI 10.1093/emboj/20.3.340; Thomas PK, 2000, CURR OPIN NEUROL, V13, P565, DOI 10.1097/00019052-200010000-00010; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382	30	144	149	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1106	1119		10.1086/379525	http://dx.doi.org/10.1086/379525			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14574644	Green Published, Bronze			2022-12-18	WOS:000186493400012
J	Reynisdottir, I; Thorleifsson, G; Benediktsson, R; Sigurdsson, G; Emilsson, V; Einarsdottir, AS; Hjorleifsdottir, EE; Orlygsdottir, GT; Bjornsdottir, GT; Saemundsdottir, J; Halldorsson, S; Hrafnkelsdottir, S; Sigurjonsdottir, SB; Steinsdottir, S; Martin, M; Kochan, JP; Rhees, BK; Grant, SFA; Frigge, ML; Kong, A; Gudnason, V; Stefansson, K; Gulcher, JR				Reynisdottir, I; Thorleifsson, G; Benediktsson, R; Sigurdsson, G; Emilsson, V; Einarsdottir, AS; Hjorleifsdottir, EE; Orlygsdottir, GT; Bjornsdottir, GT; Saemundsdottir, J; Halldorsson, S; Hrafnkelsdottir, S; Sigurjonsdottir, SB; Steinsdottir, S; Martin, M; Kochan, JP; Rhees, BK; Grant, SFA; Frigge, ML; Kong, A; Gudnason, V; Stefansson, K; Gulcher, JR			Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SEARCH; CALPAIN-10 GENE; INSULIN-SECRETION; GLUCOSE-TOLERANCE; LINKAGE ANALYSIS; ALPHA-GENE; MELLITUS; ONSET; SCAN; LOCUS	We report a genomewide linkage study of type 2 diabetes ( T2D [MIM 125853]) in the Icelandic population. A list of type 2 diabetics was cross-matched with a computerized genealogical database clustering 763 type 2 diabetics into 227 families. The diabetic patients and their relatives were genotyped with 906 microsatellite markers. A nonparametric multipoint linkage analysis yielded linkage to 5q34-q35.2 (LOD = 2.90, P = 1.29 x 10(-4)) in all diabetics. Since obesity, here defined as body mass index (BMI) greater than or equal to 30 kg/m(2), is a key risk factor for the development of T2D, we studied the data either independently of BMI or by stratifying the patient group as obese ( BMI greater than or equal to 30) or nonobese (BMI < 30). A nonparametric multipoint linkage analysis yielded linkage to 5q34 - q35.2 (LOD = 3.64, P = 2.12 x 10(-5)) in the nonobese diabetics. No linkage was observed in this region for the obese diabetics. Linkage analysis conditioning on maternal transmission to the nonobese diabetics resulted in a LOD score of 3.48 (P = 3.12 x 10(-5)) in the same region, whereas conditioning on paternal transmission led to a substantial drop in the LOD score. Finally, we observed potential interactions between the 5q locus and two T2D susceptibility loci, previously mapped in other populations.	deCODE Genet, Reykjavik, Iceland; Iceland Heart Assoc, Reykjavik, Iceland; Landspitali Univ Hosp, Reykjavik, Iceland; Hoffmann La Roche Inc, Nutley, NJ 07110 USA	Icelandic Heart Association; Landspitali National University Hospital; Roche Holding	Reynisdottir, I (corresponding author), Iceland Heart Assoc, Holtasmari 1, IS-201 Kopavogur, Iceland.	ingar@decode.is; rafn@efnaskipti.com	Gudnason, Vilmundur/AAE-7126-2019; Benediktsson, Rafn/R-2457-2018; Stefansson, Kari/AAE-7187-2019; Gudnason, Vilmundur/K-6885-2015	Gudnason, Vilmundur/0000-0001-5696-0084; Benediktsson, Rafn/0000-0002-2954-9801; Gudnason, Vilmundur/0000-0001-5696-0084; Reynisdottir, Inga/0000-0002-9730-7476; Emilsson, Valur/0000-0001-9982-0524				Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BRAY GA, 1987, ANN NY ACAD SCI, V499, P14, DOI 10.1111/j.1749-6632.1987.tb36194.x; Busfield F, 2002, AM J HUM GENET, V70, P349, DOI 10.1086/338626; Cassell PG, 2002, DIABETES, V51, P1622, DOI 10.2337/diabetes.51.5.1622; Ciccarese M, 1997, DIABETOLOGIA, V40, P1366, DOI 10.1007/s001250050835; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Foster D.W., 1998, HARRISONS PRINCIPLES, Vfourteenth, P2060; Frayling TM, 2003, DIABETES, V52, P872, DOI 10.2337/diabetes.52.3.872; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1992, NATURE, V357, P607, DOI 10.1038/357607c0; Garant MJ, 2002, DIABETES, V51, P231, DOI 10.2337/diabetes.51.1.231; Gardner RJ, 1999, J MED GENET, V36, P192; Gavin JR, 1997, DIABETES CARE, V20, P1183; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Hani EH, 1997, DIABETES, V46, P1225, DOI 10.2337/diab.46.7.1225; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Kahn CR, 1996, ANNU REV MED, V47, P509; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lindgren CM, 2002, DIABETES, V51, P1609, DOI 10.2337/diabetes.51.5.1609; Lindgren CM, 2002, AM J HUM GENET, V70, P509, DOI 10.1086/338629; Lindsay RS, 2001, DIABETES, V50, P2850, DOI 10.2337/diabetes.50.12.2850; Luo TH, 2001, DIABETOLOGIA, V44, P501, DOI 10.1007/s001250051649; Lynn S, 2002, DIABETES, V51, P247, DOI 10.2337/diabetes.51.1.247; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Malecki MT, 2001, DIABETES, V50, pA243; Medici F, 1999, DIABETOLOGIA, V42, P146, DOI 10.1007/s001250051132; Moneva MH, 2002, CURR DRUG TARGETS, V3, P203, DOI 10.2174/1389450023347803; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; Parker A, 2001, DIABETES, V50, P675, DOI 10.2337/diabetes.50.3.675; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; Rasmussen SK, 2002, DIABETES, V51, P3561, DOI 10.2337/diabetes.51.12.3561; REWERS M, 1995, DIABETES AM, P179; ROTTER JI, 1992, GENETIC BASIS COMMON, P413; Shaw JTE, 1998, DIABETES, V47, P1793, DOI 10.2337/diabetes.47.11.1793; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Thomas AW, 1997, HUM GENET, V101, P212, DOI 10.1007/s004390050617; THOMPSON DB, 1995, DIABETES, V44, P478, DOI 10.2337/diabetes.44.4.478; Tsai HJ, 2001, AM J HUM GENET, V69, P1236, DOI 10.1086/324646; Tuomi T, 1999, DIABETES, V48, P150, DOI 10.2337/diabetes.48.1.150; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vilbergsson S, 1997, DIABETIC MED, V14, P491, DOI 10.1002/(SICI)1096-9136(199706)14:6<491::AID-DIA365>3.0.CO;2-1; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Wang Yanqing, 2002, Zhonghua Yi Xue Za Zhi, V82, P613; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	70	144	151	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					323	335		10.1086/377139	http://dx.doi.org/10.1086/377139			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12851856	Bronze, Green Published			2022-12-18	WOS:000184223900009
J	Edelmann, L; Spiteri, E; Koren, K; Pulijaal, V; Bialer, MG; Shanske, A; Goldberg, R; Morrow, BE				Edelmann, L; Spiteri, E; Koren, K; Pulijaal, V; Bialer, MG; Shanske, A; Goldberg, R; Morrow, BE			AT-rich palindromes mediate the constitutional t(11;22) translocation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL SYNDROME; LOW-COPY REPEATS; MOLECULAR DEFINITION; 22Q11 BREAKPOINTS; DELETION SYNDROME; INVERTED REPEATS; CLUSTERED 11Q23; INSTABILITY; DIGEORGE; IDENTIFICATION	The constitutional t(11;22) translocation is the only known recurrent non-Robertsonian translocation in humans. Offspring are susceptible to der(22) syndrome, a severe congenital anomaly disorder caused by 3:1 meiotic nondisjunction events. We previously localized the t(11;22) translocation breakpoint to a region on 22q11 within a low-copy repeat termed "LCR22" and within an AT-rich repeat on 11q23. The LCR22s are implicated in mediating different rearrangements on 22q11, leading to velocardiofacial syndrome/DiGeorge syndrome and cat-eye syndrome by homologous recombination mechanisms. The LCR22s contain AT-rich repetitive sequences, suggesting that such repeats may mediate the t(11;22) translocation. To determine the molecular basis of the translocation, we cloned and sequenced the t(11;22) breakpoint in the derivative 11 and 22 chromosomes in 13 unrelated carriers, including two de novo cases and der(22) syndrome offspring. We found that, in all cases examined, the reciprocal exchange occurred between similar AT-rich repeats on both chromosomes 11q23 and 22q11. To understand the mechanism, we examined the sequence of the breakpoint intervals in the derivative chromosomes and compared this with the deduced normal chromosomal sequence. A palindromic AT-rich sequence with a near-perfect hairpin could form, by intrastrand base-pairing, on the parental chromosomes. The sequence of the breakpoint junction in both derivatives indicates that the exchange events occurred at the center of symmetry of the palindromes, and this resulted in small, overlapping staggered deletions in this region among the different carriers. On the basis of previous studies performed in diverse organisms, we hypothesize that double-strand breaks may occur in the center of the palindrome, the tip of the putative hairpin, leading to illegitimate recombination events between similar AT-rich sequences on chromosomes 11 and 22, resulting in deletions and loss of the palindrome, which then could stabilize the DNA structure.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Mt Sinai Med Ctr, Dept Human Genet, New York, NY 10029 USA; Montefiore Med Ctr, Dept Obstet & Gynecol, New York, NY USA; Montefiore Med Ctr, Ctr Craniofacial Disorders, New York, NY USA; N Shore Univ Hosp, Dept Pediat, Div Genet, Manhasset, NY 11030 USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Montefiore Medical Center; Montefiore Medical Center; Northwell Health; North Shore University Hospital	Morrow, BE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	morrow@aecom.yu.edu		Morrow, Bernice/0000-0002-8076-4726	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD034980] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009060, T32 CA09060] Funding Source: Medline; NICHD NIH HHS [P0-1 HD34980-02] Funding Source: Medline; NIGMS NIH HHS [T32 GM07491-25, T32 GM007491] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; CALABRETTA B, 1982, NATURE, V296, P219, DOI 10.1038/296219a0; CAMPANA M, 1986, AM J MED GENET, V24, P341, DOI 10.1002/ajmg.1320240214; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; Connelly JC, 1996, GENES CELLS, V1, P285, DOI 10.1046/j.1365-2443.1996.23024.x; Cromie GA, 2000, GENETICS, V154, P513; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V65, P1608, DOI 10.1086/302689; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; FIREMAN P, 1965, J PEDIATR-US, V67, P907; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; Funke B, 1999, AM J HUM GENET, V64, P747, DOI 10.1086/302284; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Graw SL, 2000, AM J HUM GENET, V66, P1138, DOI 10.1086/302821; GUANTI G, 1981, J MED GENET, V18, P108, DOI 10.1136/jmg.18.2.108; HENDERSON ST, 1993, GENETICS, V134, P57; Hill AS, 2000, HUM MOL GENET, V9, P1525, DOI 10.1093/hmg/9.10.1525; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; Krebs I, 1997, HUM MOL GENET, V6, P1079, DOI 10.1093/hmg/6.7.1079; Kurahashi H, 2000, AM J HUM GENET, V67, P763, DOI 10.1086/303054; Kurahashi H, 1998, HUM GENET, V103, P189, DOI 10.1007/s004390050805; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; LIN AE, 1986, CLIN GENET, V29, P269; LINDSAY EA, 1995, AM J MED GENET, V57, P514, DOI 10.1002/ajmg.1320570339; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; Megonigal MD, 1998, P NATL ACAD SCI USA, V95, P6413, DOI 10.1073/pnas.95.11.6413; MICHELS VV, 1982, AM J HUM GENET, V34, P507; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; MORROW B, 1995, AM J HUM GENET, V56, P1391; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; RUSKIN B, 1993, GENETICS, V134, P43; SCHINZEL A, 1981, HUM GENET, V56, P249, DOI 10.1007/BF00274675; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaikh TH, 1999, AM J HUM GENET, V65, P1595, DOI 10.1086/302666; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Sutherland HF, 1996, AM J HUM GENET, V59, P23; Tapia-Paez I, 2000, HUM GENET, V106, P506, DOI 10.1007/s004390000287; Viswanathan VK, 1999, BIOTECHNIQUES, V27, P508, DOI 10.2144/99273st04; WARBURTON D, 1991, AM J HUM GENET, V49, P995; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412	46	144	149	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					1	13		10.1086/316952	http://dx.doi.org/10.1086/316952			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11095996	Bronze, Green Published			2022-12-18	WOS:000166399900001
J	Stober, G; Saar, K; Ruschendorf, F; Meyer, J; Nurnberg, G; Jatzke, S; Franzek, E; Reis, A; Lesch, KP; Wienker, TF; Beckmann, H				Stober, G; Saar, K; Ruschendorf, F; Meyer, J; Nurnberg, G; Jatzke, S; Franzek, E; Reis, A; Lesch, KP; Wienker, TF; Beckmann, H			Splitting schizophrenia: Periodic catatonia-susceptibility locus on chromosome 15q15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; GENOME SCAN; NO EVIDENCE; GENETICS; CLASSIFICATION; HETEROGENEITY; INHERITANCE; DIAGNOSIS; DISORDERS; WORKSHOP	The nature of subtypes in schizophrenia and the meaning of heterogeneity in schizophrenia have been considered a principal controversy in psychiatric research. We addressed these issues in periodic catatonia, a clinical entity derived from Leonhard's classification of schizophrenias, in a genomewide linkage scan. Periodic catatonia is characterized by qualitative psychomotor disturbances during acute psychotic outbursts and by long-term outcome. On the basis of our previous findings of a lifetime morbidity risk of 26.9% of periodic catatonia in first-degree relatives, we conducted a genome scan in 12 multiplex pedigrees with 135 individuals, using 356 markers with an average spacing of 11 cM. In nonparametric multipoint linkage analyses (by GENEHUNTER-PLUS), significant evidence for linkage was obtained on chromosome 15q15 (P = 2.6 x 10(-5); nonparametric LOD score [LOD*] 3.57). A further locus on chromosome 22q13 with suggestive evidence for linkage (P = 1.8 x 10(-3); LOD* 1.85) was detected, which indicated genetic heterogeneity. Parametric linkage analysis under an autosomal dominant model (affecteds-only analysis) provided independent confirmation of nonparametric linkage results, with maximum LOD scores 2.75 (recombination fraction [theta] .04; two-point analysis) and 2.89 (theta = .029; four-point analysis), at the chromosome 15q candidate region. Splitting the complex group of schizophrenias on the basis of clinical observation and genetic analysis, we identified periodic catatonia as a valid nosological entity. Our findings provide evidence that periodic catatonia is associated with a major disease locus, which maps to chromosome 15q15.	Univ Wurzburg, Dept Psychiat & Psychotherapy, D-97080 Wurzburg, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany	University of Wurzburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Bonn	Stober, G (corresponding author), Univ Wurzburg, Dept Psychiat, Fuchsleinstr 15, D-97080 Wurzburg, Germany.		Reis, André/D-2309-2009; Lesch, Klaus-Peter/J-4906-2013	Reis, André/0000-0002-6301-6363; Lesch, Klaus-Peter/0000-0001-8348-153X; Saar, Kathrin/0000-0002-4483-1557				*AM PSYCH ASS, 1991, DIAGN STAT MAN MENT; ANDREASEN NC, 1993, SCHIZOPHRENIA BULL, V19, P199, DOI 10.1093/schbul/19.2.199; Beckmann H, 1996, AM J MED GENET, V67, P289, DOI 10.1002/(SICI)1096-8628(19960531)67:3<289::AID-AJMG5>3.0.CO;2-I; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; Craddock N, 1999, AM J MED GENET, V88, P244, DOI 10.1002/(SICI)1096-8628(19990618)88:3<244::AID-AJMG7>3.0.CO;2-1; Curtis L, 1999, AM J MED GENET, V88, P109, DOI 10.1002/(SICI)1096-8628(19990416)88:2<109::AID-AJMG1>3.0.CO;2-3; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Franzek E, 1995, PSYCHIAT RES, V59, P17, DOI 10.1016/0165-1781(95)02753-X; FRANZEK E, 1992, EUR J PSYCHIAT, V6, P97; Franzek E, 1996, BIOL PSYCHIAT, V40, P1255, DOI 10.1016/0006-3223(95)00623-0; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; GOTTESMAN I, 1991, SHIZOPHRENIA GENESIS; Karayiorgou M, 1997, MOL PSYCHIATR, V2, P211, DOI 10.1038/sj.mp.4000271; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; Knapp M, 1997, BRIT J PSYCHIAT, V171, P509, DOI 10.1192/bjp.171.6.509; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Leboyer M, 1998, TRENDS NEUROSCI, V21, P102, DOI 10.1016/S0166-2236(97)01187-9; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Leonard S, 1998, AM J MED GENET, V81, P308, DOI 10.1002/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P; Leonhard K., 1999, CLASSIFICATION ENDOG, V2nd; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; Myles-Worsley M, 1999, AM J MED GENET, V88, P544, DOI 10.1002/(SICI)1096-8628(19991015)88:5<544::AID-AJMG20>3.0.CO;2-V; Neves-Pereira M, 1998, AM J MED GENET, V81, P361, DOI 10.1002/(SICI)1096-8628(19980907)81:5<361::AID-AJMG3>3.0.CO;2-W; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; Oulis P, 1999, PSYCHOPATHOLOGY, V32, P187, DOI 10.1159/000029089; PERALTA V, 1992, BRIT J PSYCHIAT, V161, P335, DOI 10.1192/bjp.161.3.335; Pfuhlmann B, 1997, PSYCHOPATHOLOGY, V30, P100, DOI 10.1159/000285036; Pfuhlmann B, 1997, ACTA PSYCHIAT SCAND, V95, P357, DOI 10.1111/j.1600-0447.1997.tb09644.x; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; Saar K, 1997, AM J HUM GENET, V60, P605; Schwab SG, 1999, AM J MED GENET, V88, P276, DOI 10.1002/(SICI)1096-8628(19990618)88:3<276::AID-AJMG13>3.0.CO;2-N; STOBER G, 1995, EUR ARCH PSY CLIN N, V245, P135, DOI 10.1007/BF02193085; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TSUANG MT, 1995, SCHIZOPHR RES, V17, P161, DOI 10.1016/0920-9964(95)00057-S; Vogel F., 1997, HUMAN GENETICS PROBL; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729	44	144	151	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1201	1207		10.1086/321183	http://dx.doi.org/10.1086/321183			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	369WW	11001582	Green Published			2022-12-18	WOS:000165091600017
J	Hardy, C; Khanim, F; Torres, R; Scott-Brown, M; Seller, A; Poulton, J; Collier, D; Kirk, J; Polymeropoulos, M; Latif, F; Barrett, T				Hardy, C; Khanim, F; Torres, R; Scott-Brown, M; Seller, A; Poulton, J; Collier, D; Kirk, J; Polymeropoulos, M; Latif, F; Barrett, T			Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIABETES-MELLITUS; OPTIC ATROPHY; TRANSMEMBRANE PROTEIN; DIDMOAD SYNDROME; INSIPIDUS; DEAFNESS; AMPLIFICATION; LINKAGE; MTDNA	Wolfram syndrome is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and progressive optic atrophy. mtDNA deletions have been described, and a gene (WFS1) recently has been identified, on chromosome 4p16, encoding a predicted 830 amino acid transmembrane protein. Direct DNA sequencing was done to screen the entire coding region of the WFS1 gene in 30 patients from 19 British kindreds with Wolfram syndrome. DNA was also screened for structural rearrangements (deletions and duplications) and point mutations in mtDNA. No pathogenic mtDNA mutations were found in our cohort. We identified 24 mutations in the WFS1 gene: 8 nonsense mutations, 8 missense mutations, 3 in-frame deletions, 1 in-frame insertion, and 4 frameshift mutations. Of these, 23 were novel mutations, and most occurred in exon 8. The majority of patients were compound heterozygotes for two mutations, and there was no common founder mutation. The data were also analyzed for genotype-phenotype relationships. Although some interesting cases were noted, consideration of the small sample size and frequency of each mutation indicated no clear-cut correlations between any of the observed mutations and disease severity. There were no obvious mutation hot spots or clusters. Hence, molecular screening for Wolfram syndrome in affected families and for Wolfram syndrome-carrier status in subjects with psychiatric disorders or diabetes mellitus will require complete analysis of exon 8 and upstream exons.	Univ Birmingham, Sch Med, Div Reprod & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Birminghams Womens Hosp, Reg Genet Serv, Birmingham B15 2TT, W Midlands, England; Childrens Hosp, Dept Endocrinol, Birmingham B16 8ET, W Midlands, England; John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; Churchill Hosp, Genet Mol Lab, Oxford OX3 7LJ, England; Inst Psychiat, Genet Sect, London, England; Novartis Pharmaceut Corp, Gaithersburg, MD USA; George Washington Univ, Dept Genet, Washington, DC USA	University of Birmingham; Birmingham Women's Hospital; University of Birmingham; University of Oxford; University of Oxford; University of London; King's College London; Novartis; George Washington University	Barrett, T (corresponding author), Univ Birmingham, Sch Med, Div Reprod & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England.		Collier, David A/D-1649-2011; Barrett, Timothy/F-1682-2010	Collier, David A/0000-0003-4087-1559; Barrett, Timothy/0000-0002-6873-0750; Poulton, Joanna/0000-0002-2460-5587				BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Barrientos A, 1996, AM J HUM GENET, V58, P963; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; BLASI C, 1986, DIABETES CARE, V9, P521, DOI 10.2337/diacare.9.5.521; BUNDEY S, 1992, J INHERIT METAB DIS, V15, P315, DOI 10.1007/BF02435965; Collier DA, 1996, AM J HUM GENET, V59, P855; Concannon P, 1997, HUM MUTAT, V10, P100, DOI 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O; CRADDOCK N, 1993, HUM MOL GENET, V2, P1941, DOI 10.1093/hmg/2.11.1941; FRASER FC, 1977, J MED GENET, V14, P190, DOI 10.1136/jmg.14.3.190; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; JACKSON MJ, 1994, DIABETES CARE, V17, P728, DOI 10.2337/diacare.17.7.728; LI YY, 1995, BIOCHEM BIOPH RES CO, V210, P211, DOI 10.1006/bbrc.1995.1648; NORBY S, 1993, HUM MUTAT, V2, P309, DOI 10.1002/humu.1380020412; POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Swift RG, 1998, MOL PSYCHIATR, V3, P86, DOI 10.1038/sj.mp.4000344; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Wolfram DJ, 1938, P MAYO CLIN, V13, P715	19	144	156	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1279	1290		10.1086/302609	http://dx.doi.org/10.1086/302609			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521293	Green Published, Bronze			2022-12-18	WOS:000083531000009
J	Kosaki, K; Bassi, MT; Kosaki, R; Lewin, M; Belmont, J; Schauer, G; Casey, B				Kosaki, K; Bassi, MT; Kosaki, R; Lewin, M; Belmont, J; Schauer, G; Casey, B			Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NODAL EXPRESSION; BETA SUPERFAMILY; SITUS-INVERSUS; MOUSE; ASYMMETRY; MICE; HETEROTAXY; EMBRYOS	Members of the transforming growth factor (TGF)-beta family of cell-signaling molecules have been implicated recently in mammalian left-right (LR) axis development, the process by which vertebrates lateralize unpaired organs (e.g., heart, stomach, and spleen). Two family members, Lefty1 and Lefty2, are expressed exclusively on the left side of the mouse embryo by 8.0 days post coitum. This asymmetry is lost or reversed in two murine models of abnormal LR-axis specification, inversus viscerum (iv) and inversion of embryonic turning (inv). Furthermore, mice homozygous for a Lefty1 null allele manifest LR malformations and misexpress Lefty2. We hypothesized that Lefty mutations may be associated with human LR-axis malformations, We now report characterization of two Lefty homologues, LEFTY A and LEFTY B, separated by similar to 50 kb on chromosome lq42. Each comprises four exons spliced at identical positions. LEFTY A is identical to ebaf, a cDNA previously identified in a search for genes expressed in human endometrium. The deduced amino acid sequences of LEFTY A and LEFTY B are more similar to each other than to Lefty1 or Lefty2. Analysis of 126 human cases of LR-axis malformations showed one nonsense and one missense mutation in LEFTY A. Both mutations lie in the cysteine-knot region of the protein LEFTY A, and the phenotype of affected individuals is very similar to that typically seen in Lefty1(-/-) mice with LR-axis malformations.	Baylor Coll Med, Dept Pathol S230, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Childrens Hosp, Dept Pathol, Columbus, OH 43205 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Casey, B (corresponding author), Baylor Coll Med, Dept Pathol S230, Houston, TX 77030 USA.	bcasey@bcm.tmc.edu	Belmont, John W/AAI-2494-2019; Bassi, Maria Teresa T/A-3517-2014; Belmont, John/AAH-6084-2021; Kosaki, Kenjiro/K-5350-2013	Belmont, John W/0000-0001-7409-3578; Bassi, Maria Teresa T/0000-0002-8236-1197; 	NICHD NIH HHS [HD36003, HD01078, P30 HD24064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD036003, K08HD001078] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BALDINI A, 1994, IN SITU HYBRIDIZATIO, P75; Casey B, 1998, HUM MOL GENET, V7, P1565, DOI 10.1093/hmg/7.10.1565; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; CONLON FL, 1991, DEVELOPMENT, V111, P969; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Harvey RP, 1998, CELL, V94, P273, DOI 10.1016/S0092-8674(00)81468-3; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; IANNACCONE PM, 1992, DEV DYNAM, V194, P198, DOI 10.1002/aja.1001940305; ICARDO JM, 1991, CIRCULATION, V84, P2547, DOI 10.1161/01.CIR.84.6.2547; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Kim Sang-Hee, 1995, Journal of Korean Medical Science, V10, P250; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kothapalli R, 1997, J CLIN INVEST, V99, P2342, DOI 10.1172/JCI119415; LAYTON WM, 1993, TERATOLOGY, V47, P595, DOI 10.1002/tera.1420470611; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Melloy PG, 1998, DEV BIOL, V193, P77, DOI 10.1006/dbio.1997.8787; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Morishima M, 1996, TERATOLOGY, V54, P183, DOI 10.1002/(SICI)1096-9926(199610)54:4<183::AID-TERA2>3.0.CO;2-2; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Oulad-Abdelghani M, 1998, INT J DEV BIOL, V42, P23; Smith SM, 1997, DEV BIOL, V182, P162, DOI 10.1006/dbio.1996.8474; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van praagh R., 1972, BIRTH DEFECTS-ORIG, V8, P4; Yasui H, 1998, ANAT REC, V250, P210, DOI 10.1002/(SICI)1097-0185(199802)250:2<210::AID-AR11>3.0.CO;2-R; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	30	144	160	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					712	721		10.1086/302289	http://dx.doi.org/10.1086/302289			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053005	Green Published, Bronze			2022-12-18	WOS:000079204700008
J	Gelernter, J; Kranzler, H; Coccaro, E; Siever, L; New, A; Mulgrew, CL				Gelernter, J; Kranzler, H; Coccaro, E; Siever, L; New, A; Mulgrew, CL			D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRUCTURED CLINICAL INTERVIEW; GENE; ASSOCIATION; ALCOHOLISM; POLYMORPHISM; POPULATION; CLOZAPINE; VARIANTS; AFRICANS; REPEAT	Two reports have been published suggesting an association between the personality trait of novelty seeking and the DRD4*7R allele at the D4 dopamine-receptor locus (with heterozygotes or homozygotes for DRD4*7R having higher novelty seeking). We studied novelty seeking and four coding-sequence polymorphisms affecting protein structure in the D4 dopamine-receptor gene (DRD4) in a sample of 341 American subjects, of whom 224 are of primarily European ancestry and 117 are of primarily African ancestry. These subjects had diagnoses of substance dependence or personality disorder (PD) or were screened to exclude major psychiatric diagnosis. We found that, although the substance-dependent subjects had significantly higher novelty seeking than the control and PD subjects, they did not differ in DRD4*7R allele frequency. There was no association between any DRD4 polymorphism and novelty seeking in any population or diagnostic group, except for a significant association between the DRD4*7R allele and lower novelty seeking among European American females and African American substance abusers. The novelty seeking of subjects heterozygous for a null mutation did not differ from that of subjects with two functional alleles. We conclude that the most likely explanation of these results is that the DRD4 VNTR does not influence directly the trait of novelty seeking, in these samples.	YALE UNIV,SCH MED,DEPT PSYCHIAT,DIV MOL PSYCHIAT,W HAVEN,CT 06516; UNIV CONNECTICUT,CTR HLTH,DEPT PSYCHIAT,FARMINGTON,CT 06032; MED COLL PENN & HAHNEMANN UNIV,EASTERN PENN PSYCHIAT INST,PHILADELPHIA,PA 19129; MT SINAI SCH MED,NEW YORK,NY; BRONX VET ADM MED CTR,NEW YORK,NY	Yale University; University of Connecticut; Drexel University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Gelernter, J (corresponding author), VA CONNECTICUT HEALTHCARE SYST,PSYCHIAT 116A2,W HAVEN CAMPUS,950 CAMPBELL AVE,W HAVEN,CT 06516, USA.		kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450; Gelernter, Joel/0000-0002-4067-1859	NIMH NIH HHS [K02-MH01387, R29-MH50859, K20-MH00931] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050859, K20MH000931, K02MH001387] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMSON MD, 1995, AM J MED GENET, V60, P199, DOI 10.1002/ajmg.1320600306; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; ASGHARI V, 1994, MOL PHARMACOL, V46, P364; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; BRENT EE, 1993, EXSAMPLE EXPERT SYST; CATALANO M, 1993, BIOL PSYCHIAT, V34, P459, DOI 10.1016/0006-3223(93)90236-7; Chang FM, 1997, AM J MED GENET, V74, P91, DOI 10.1002/(SICI)1096-8628(19970221)74:1<91::AID-AJMG18>3.0.CO;2-M; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Coccaro EF, 1996, ARCH GEN PSYCHIAT, V53, P531; Cubells JF, 1997, AM J MED GENET, V74, P374, DOI 10.1002/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO;2-P; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; FENG D, 1994, BEHAV GENET, V24, P357, DOI 10.1007/BF01067537; FIRST MB, 1995, J PERS DISORD, V9, P83, DOI 10.1521/pedi.1995.9.2.83; GELERNTER J, 1992, GENOMICS, V13, P208, DOI 10.1016/0888-7543(92)90222-E; GEORGE SR, 1993, BIOCHEM BIOPH RES CO, V196, P107, DOI 10.1006/bbrc.1993.2222; Grice DE, 1996, AM J HUM GENET, V59, P644; Jonsson EG, 1997, AM J PSYCHIAT, V154, P697; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; Liu ISC, 1996, AM J MED GENET, V61, P277, DOI 10.1002/(SICI)1096-8628(19960122)61:3<277::AID-AJMG14>3.3.CO;2-5; Malhotra AK, 1996, MOL PSYCHIATR, V1, P388; MEADORWOODRUFF JH, 1994, NEUROPSYCHOPHARMACOL, V10, P239, DOI 10.1038/npp.1994.27; Muramatsu T, 1996, J MED GENET, V33, P113, DOI 10.1136/jmg.33.2.113; NOTHEN MM, 1994, HUM MOL GENET, V3, P2207, DOI 10.1093/hmg/3.12.2207; PETRONIS A, 1993, GENOMICS, V18, P161, DOI 10.1006/geno.1993.1445; Pfohl B., 1989, STRUCTURED INTERVIEW; SEEMAN P, 1994, AM J MED GENET, V54, P384, DOI 10.1002/ajmg.1320540419; Spitzer R.L., 1975, SCHEDULE AFFECTIVE D; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; VANTOL HHM, 1992, NATURE, V358, P149; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0	32	144	150	1	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1144	1152		10.1086/301595	http://dx.doi.org/10.1086/301595			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345090	Bronze, Green Published			2022-12-18	WOS:A1997YH01700021
J	Nolin, SL; Lewis, FA; Ye, LL; Houck, GE; Glicksman, AE; Limprasert, P; Li, SY; Zhong, N; Ashley, AE; Feingold, E; Sherman, SL; Brown, WT				Nolin, SL; Lewis, FA; Ye, LL; Houck, GE; Glicksman, AE; Limprasert, P; Li, SY; Zhong, N; Ashley, AE; Feingold, E; Sherman, SL; Brown, WT			Familial transmission of the FMR1 CGG repeat	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; TRINUCLEOTIDE REPEAT; MENTAL-RETARDATION; MYOTONIC-DYSTROPHY; CLINICAL PHENOTYPE; FULL MUTATION; GENE; EXPANSION; LENGTH; INSTABILITY	To better define the nature of FMR1 CGG-repeat expansions, changes in allele sizes fur 191 families with fragile X and for 33 families with gray-zone repeats (40-60) were analyzed. Expansion of the fragile X chromosome to the full mutation was seen in 13.4% of offspring from premutation mothers with 56-59 repeats, 20.6% of those with 60-69 repeats, 57.8% of those with 70-79 repeats, 72.9% of those with 80-89 repeats, and 97.3% of those with 90-199 repeats. Fur premutation fathers, the majority (62%) of their daughters had a larger repeat number, while a few had either a smaller (22%) or the same (16%) repeat number, compared with their fathers' sizes. However, daughters with a smaller repeat number were observed only if their fathers had greater than or equal to 80 repeats. Fifteen (39.5%) of 38 such daughters carried a smaller repeat than did their fathers. We observed that a similar repeat number was inherited more often than expected by chance, among the members of a sibship segregating fragile X. This familial clustering, observed in the offspring of both malts and females with a premutation, implies there may be an additional factor, independent of parental repeat size, that influences CGG-repeat instability. Instability in gray-zone allele transmissions was observed in 25% of alleles with 50-60 CGGs but in <8% of those with 40-49 CGGs. Examination of gray-zone allele organization revealed that long tracts of pul-e CGGs (>34) are not always unstably transmitted. These results raise new questions regarding the familial factors that nay determine transmission expansions.	NEW YORK STATE INST BASIC RES DEV DISABIL,DEPT HUMAN GENET,STATEN ISL,NY 10314; CSI IBR CTR DEV NEUROSCI,STATEN ISL,NY; CUNY,GRAD SCH PHD PROGRAM BIOL,STATEN ISL,NY; EMORY UNIV,SCH MED,DEPT GENET & MOL MED,ATLANTA,GA 30322; EMORY UNIV,ROLLINS SCH PUBL HLTH,DEPT BIOSTAT,ATLANTA,GA	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; City University of New York (CUNY) System; Emory University; Emory University; Rollins School Public Health			Limprasert, Pornprot/N-5236-2019; Limprasert, Pornprot/L-1820-2013; Brown, William/GXN-2777-2022	Limprasert, Pornprot/0000-0001-5022-5361; Limprasert, Pornprot/0000-0001-5022-5361; Ashley-Koch, Allison/0000-0001-5409-9155; Feingold, Eleanor/0000-0003-2898-6484	NICHD NIH HHS [HD29407] Funding Source: Medline; PHS HHS [MCJ360587] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029407] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASHLEY AE, 1995, AM J HUM GENET, V57, P1414; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Brown W T, 1992, Mol Genet Med, V2, P39; Brown WT, 1996, AM J MED GENET, V64, P191, DOI 10.1002/(SICI)1096-8628(19960712)64:1<191::AID-AJMG34>3.3.CO;2-G; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Brown WT, 1996, AM J MED GENET, V64, P287, DOI 10.1002/(SICI)1096-8628(19960809)64:2<287::AID-AJMG11>3.0.CO;2-B; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Eichler EE, 1996, HUM MOL GENET, V5, P319, DOI 10.1093/hmg/5.3.319; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FISCH GS, 1995, AM J HUM GENET, V56, P1147; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST M, 1995, AM J HUM GENET, V56, P67; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; KOCH MC, 1991, AM J HUM GENET, V48, P1084; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LOESCH DZ, 1995, AM J HUM GENET, V57, P1408; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; MACPHERSON JN, 1995, J MED GENET, V32, P236, DOI 10.1136/jmg.32.3.236; MEIJER H, 1994, HUM MOL GENET, V3, P615; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1994, HUM MOL GENET, V3, P393, DOI 10.1093/hmg/3.3.393; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; Rousseau F., 1994, American Journal of Human Genetics, V55, pA240; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VAISANEN ML, 1994, HUM GENET, V93, P143; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1992, AM J HUM GENET, V50, P968; ZHONG N, 1995, AM J HUM GENET, V57, P351	38	144	146	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1252	1261						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940270				2022-12-18	WOS:A1996VV31500011
J	McNally, EM; PassosBueno, MR; Bonnemann, CG; Vainzof, M; Moreira, ED; Lidov, HGW; BenOthmane, K; Denton, PH; Vance, JM; Zatz, M; Kunkel, LM				McNally, EM; PassosBueno, MR; Bonnemann, CG; Vainzof, M; Moreira, ED; Lidov, HGW; BenOthmane, K; Denton, PH; Vance, JM; Zatz, M; Kunkel, LM			Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADHALIN DEFICIENCY; BETA-SARCOGLYCAN; GENE; PROTEIN; LINKAGE; REGION	Autosomal recessive muscular dystrophy is genetically heterogeneous. One form of this disorder, limb-girdle muscular dystrophy type 2C (LGMD 2C), is prevalent in northern Africa and has been shown to be associated with a single mutation in the gene encoding the dystrophin-associated protein gamma-sarcoglycan, The previous mutation analysis of gamma-sarcoglycan required the availability of muscle biopsies. To establish a mutation assay for genomic DNA, the intron-exon structure of the gamma-sarcoglycan gene was determined, and primers were designed to amplify each of the exons encoding gamma-sarcoglycan. We studied a group of Brazilian muscular dystrophy patients for mutations in the gamma-sarcoglycan gene. These patients were selected on the basis of autosomal inheritance and/or the presence of normal dystrophin and/or deficiency of alpha-sarcoglycan immunostaining. Four of 19 patients surveyed had a single, homozygous mutation in the gamma-sarcoglycan gene. The mutation identified in these patients, all of African-Brazilian descent, is identical to that seen in the North African population, suggesting that even patients of remote African descent may carry this mutation. The phenotype in these patients varied considerably, Of four families with an identical mutation, three have a severe Duchenne-like muscular dystrophy. However, one family has much milder symptoms, suggesting that other loci may be present that modify the severity of the clinical course resulting from gamma-sarcoglycan gene mutations.	CHILDRENS HOSP, DIV GENET, BOSTON, MA 02115 USA; CHILDRENS HOSP, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DIV CARDIOVASC, BOSTON, MA 02115 USA; UNIV SAO PAULO, SAO PAULO, BRAZIL; DUKE UNIV, SCH MED, DEPT NEUROL, DURHAM, NC USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Universidade de Sao Paulo; Duke University			Zatz, Mayana/M-5338-2015; Vainzof, Mariz/J-7150-2012; McNally, Elizabeth/W-4909-2019; Vainzof, Mariz/Q-4787-2019; Passos-Bueno, Maria Rita/I-6796-2016; Moreira, Eloisa/K-9155-2014	Zatz, Mayana/0000-0003-3970-8025; Vainzof, Mariz/0000-0002-2797-0782; Vainzof, Mariz/0000-0002-2797-0782; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Vance, Jeffery/0000-0003-3815-8199; McNally, Elizabeth/0000-0002-1221-719X	NHLBI NIH HHS [HL03448] Funding Source: Medline; NINDS NIH HHS [NS23740, P01 NS26630] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023740, P01NS026630] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BENOTHMANE K, 1995, AM J HUM GENET, V57, P732; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; Dubowitz V., 1995, MUSCLE DISORDERS CHI; HAMIDA MB, 1983, MUSCLE NERVE, V6, P469, DOI 10.1002/mus.880060702; KAWAI H, 1995, J CLIN INVEST, V96, P1202, DOI 10.1172/JCI118152; LIEN LL, 1994, GENOMICS, V22, P273, DOI 10.1006/geno.1994.1384; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; LJUNGGREN A, 1995, ANN NEUROL, V38, P367, DOI 10.1002/ana.410380305; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; PassosBueno MR, 1996, J MED GENET, V33, P97, DOI 10.1136/jmg.33.2.97; PICCOLO F, 1995, NAT GENET, V10, P243, DOI 10.1038/ng0695-243; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; VAINZOF M, 1991, J NEUROL SCI, V101, P141, DOI 10.1016/0022-510X(91)90038-9; ZATZ M, 1995, HUM MOL GENET, V4, P401, DOI 10.1093/hmg/4.3.401	19	144	154	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1040	1047						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900232				2022-12-18	WOS:A1996VN90000011
J	Lohmann, DR; Brandt, B; Hopping, W; Passarge, E; Horsthemke, B				Lohmann, DR; Brandt, B; Hopping, W; Passarge, E; Horsthemke, B			The spectrum of RB1 germ-line mutations in hereditary retinoblastoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONCOGENIC POINT MUTATIONS; BASE-PAIR SUBSTITUTIONS; RNA SPLICE JUNCTIONS; GEL-ELECTROPHORESIS; GENE-EXPRESSION; MESSENGER-RNA; HEMOPHILIA-A; T-ANTIGEN; DELETIONS; PROTEIN	We have searched for germ-line RB1 mutations in 119 patients with hereditary retinoblastoma. Previous investigations by Southern blot hybridization and PCR fragment-length analysis had revealed mutations in 48 patients. Here we report on the analysis of the remaining 71 patients. By applying heteroduplex analysis, nonisotopic SSCP, and direct sequencing, we detected germ-line mutations resulting in premature termination codons or disruption of splice signals in 51 (72%) of the 71 patients. Four patients also showed rare sequence variants. No region of the RB1 gene was preferentially involved in single base substitutions. Recurrent transitions were observed at most of the 14 CGA codons within the RB1. No mutation was observed in exons 25-27, although this region contains two CGA codons. This suggests that mutations within the 3'-terminal region of the RB1 gene may not be oncogenic. When these data were combined with the results of our previous investigations, mutations were identified in a total of 99 (83%) of 119 patients. The spectrum comprises 15% large deletions, 26% small length alterations, and 42% base substitutions. No correlation between the location of frameshift or nonsense mutations and phenotypic features, including age at diagnosis, the number of tumor foci, and manifestation of nonocular tumors was observed.	UNIV KLINIKUM ESSEN,INST HUMANGENET,ESSEN,GERMANY; UNIV KLINIKUM ESSEN,ZENTRUM AUGENHEILKUNDE,ESSEN,GERMANY	University of Duisburg Essen; University of Duisburg Essen			Lohmann, Dietmar R/B-4041-2013; Lohmann, Dietmar R./X-4895-2019	Lohmann, Dietmar R/0000-0002-2624-9889; Lohmann, Dietmar R./0000-0002-2624-9889				BLANQUET V, 1995, HUM MOL GENET, V4, P383, DOI 10.1093/hmg/4.3.383; BLANQUET V, 1993, HUM MOL GENET, V2, P975, DOI 10.1093/hmg/2.7.975; BLANQUET V, 1991, AM J MED GENET, V39, P355, DOI 10.1002/ajmg.1320390321; BLANQUET V, 1994, HUM MOL GENET, V3, P1185, DOI 10.1093/hmg/3.7.1185; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHILLON M, 1995, AM J HUM GENET, V56, P623; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; COOPER DN, 1990, HUM GENET, V85, P55; Cowell John K., 1994, European Journal of Human Genetics, V2, P281; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; GREGER V, 1994, HUM GENET, V94, P491; HAMEL PA, 1992, TRENDS GENET, V8, P180, DOI 10.1016/0168-9525(92)90221-O; HASHIMOTO T, 1991, ONCOGENE, V6, P463; HOGG A, 1992, ONCOGENE, V7, P1445; HOGG A, 1993, P NATL ACAD SCI USA, V90, P7351, DOI 10.1073/pnas.90.15.7351; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; HUANG S, 1990, EMBO J, V9, P1815, DOI 10.1002/j.1460-2075.1990.tb08306.x; HUI ML, 1994, HUM MOL GENET, V3, P2231; KATO MV, 1994, HUM MUTAT, V3, P44, DOI 10.1002/humu.1380030108; KLOSS K, 1991, AM J MED GENET, V39, P196, DOI 10.1002/ajmg.1320390215; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KRAWCZAK M, 1992, HUM GENET, V90, P41; LOHMANN D, 1992, HUM GENET, V89, P49, DOI 10.1007/BF00207041; LOHMANN DR, 1994, HUM MOL GENET, V3, P2187, DOI 10.1093/hmg/3.12.2187; LOHMANN DR, 1994, HUM GENET, V94, P491; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; SAKAI T, 1991, AM J HUM GENET, V48, P880; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIMIZU T, 1994, AM J HUM GENET, V54, P793; STIRDIVANT SM, 1992, J BIOL CHEM, V267, P14846; TOGUCHIDA J, 1993, GENOMICS, V17, P535, DOI 10.1006/geno.1993.1368; WEIRTHOMPSON E, 1991, ONCOGENE, V6, P2353; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501; YANDELL DW, 1991, AM J HUM GENET, V49, P45; YANDELL DW, 1989, AM J HUM GENET S, V45, pA45; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	42	144	148	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					940	949						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651278				2022-12-18	WOS:A1996UH19200006
J	KWON, JM; ELLIOTT, JL; YEE, WC; IVANOVICH, J; SCAVARDA, NJ; MOOLSINTONG, PJ; GOODFELLOW, PJ				KWON, JM; ELLIOTT, JL; YEE, WC; IVANOVICH, J; SCAVARDA, NJ; MOOLSINTONG, PJ; GOODFELLOW, PJ			ASSIGNMENT OF A 2ND CHARCOT-MARIE-TOOTH TYPE-II LOCUS TO CHROMOSOME-3Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; NEUROPATHY TYPE-I; DISEASE TYPE-1A; GENETIC-HETEROGENEITY; HEREDITARY MOTOR; DUPLICATION; DNA; LOCALIZATION; HUMANS	Charcot-Marie-Tooth disease (CMT) is the most common inherited motor and sensory neuropathy. The neuronal form of this disorder is referred to as Charcot-Marie-Tooth type II disease (CMT2). CMT2 is usually inherited as an autosomal dominant trait with a variable age at onset of symptoms associated with progressive axonal neuropathy. In some families, the locus that predisposes to CMT2 has been demonstrated to map to the distal portion of the short arm of chromosome 1. Other families with CMT2 do not show linkage with Ip markers, suggesting genetic heterogeneity in CMT2. We investigated linkage in a single large kindred with autosomal dominant CMT2. The gene responsible for CMT2 in this kindred (CMT2B) was mapped to the interval between the microsatellite markers D3S1769 and D3S1744 in the 3q13-22 region. Study of additional CMT2 kindreds should serve to further refine the disease gene region and may ultimately lead to the identification of a gene defect that underlies the CMT2 phenotype.	WASHINGTON UNIV,SCH MED,DEPT SURG,DIV GEN SURG,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)					NINDS NIH HHS [5K12NS01690] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS001690] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENOTHMANE K, 1993, GENOMICS, V17, P370; Buetow K H, 1994, Science, V265, P2055, DOI 10.1126/science.8091228; CHANCE PF, 1990, AM J HUM GENET, V47, P915; CHANCE PF, 1992, NEUROLOGY, V42, P2037, DOI 10.1212/WNL.42.10.2037; Dyck P.J, 1993, PNP, P1094; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HAYASAKA K, 1993, GENOMICS, V17, P755, DOI 10.1006/geno.1993.1400; HAYASAKA K, 1993, BIOCHEM BIOPH RES CO, V194, P1317, DOI 10.1006/bbrc.1993.1968; HENTATI A, 1992, GENOMICS, V12, P155, DOI 10.1016/0888-7543(92)90419-S; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOPREST LJ, 1992, NEUROLOGY, V42, P597, DOI 10.1212/WNL.42.3.597; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; SKRE H, 1974, CLIN GENET, V6, P98; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171	20	144	149	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					853	858						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573046				2022-12-18	WOS:A1995RV79300016
J	STEVANIN, G; LEGUERN, E; RAVISE, N; CHNEIWEISS, H; DURR, A; CANCEL, G; VIGNAL, A; BOCH, AL; RUBERG, M; PENET, C; POTHIN, Y; LAGROUA, I; HAGUENAU, M; RANCUREL, G; WEISSENBACH, J; AGID, Y; BRICE, A				STEVANIN, G; LEGUERN, E; RAVISE, N; CHNEIWEISS, H; DURR, A; CANCEL, G; VIGNAL, A; BOCH, AL; RUBERG, M; PENET, C; POTHIN, Y; LAGROUA, I; HAGUENAU, M; RANCUREL, G; WEISSENBACH, J; AGID, Y; BRICE, A			A 3RD LOCUS FOR AUTOSOMAL-DOMINANT CEREBELLAR-ATAXIA TYPE-I MAPS TO CHROMOSOME 14Q24.3-QTER - EVIDENCE FOR THE EXISTENCE OF A 4TH LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; MACHADO-JOSEPH DISEASE; SPINOCEREBELLAR ATAXIA; MUSCULAR-ATROPHY; SHORT ARM; HLA; REPEAT; GENE; HETEROGENEITY; LOCALIZATION	The autosomal dominant cerebellar ataxias (ADCA) type I are a group of neurological disorders that are clinically and genetically heterogeneous. Two genes implicated in the disease, SCA1 (spinal cerebellar ataxia 1) and SCA2, are already localized. We have mapped a third locus to chromosome 14q24.3-qter, by linkage analysis in a non-SCA1/non-SCA2 family and have confirmed its existence in a second such family. We suggest designating this new locus ''SCA3.'' Combined analysis of the two families restricted the SCA3 locus to a 15-cM interval between markers D14S67 and D14S81. The gene for Machado-Joseph disease (MJD), a clinically different form of ADCA type I, has been recently assigned to chromosome 14q24.3-q32. Although the SCA3 locus is within the MJD region, linkage analyses cannot yet demonstrate whether they result from mutations of the same gene. Linkage to all three loci (SCA1, SCA2, and SCA3) was excluded in another family, which indicates the existence of a fourth ADCA type I locus.	COLL FRANCE, INSERM, U114, F-75231 PARIS 05, FRANCE; HOP LARIBOISIERE, SERV NEUROL, F-75475 PARIS 10, FRANCE; GENETHON, EVRY, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	STEVANIN, G (corresponding author), HOP LA PITIE SALPETRIERE, INSERM, U289, 47 BLVD HOP, F-75651 PARIS 13, FRANCE.		Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009; Vignal, Alain/I-6253-2017; brice, alexis/AAE-8275-2019; herve, chneiweiss/Q-6818-2019	Stevanin, Giovanni/0000-0001-9368-8657; Vignal, Alain/0000-0002-6797-2125; brice, alexis/0000-0002-0941-3990; herve, chneiweiss/0000-0001-7675-5061; Cancel-Tassin, Geraldine/0000-0002-9583-6382				AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; [Anonymous], 1992, Science, V258, P67; AUBURGER G, 1990, AM J HUM GENET, V46, P1163; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CARSON WJ, 1992, GENOMICS, V13, P852, DOI 10.1016/0888-7543(92)90168-R; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DURR A, IN PRESS BRAIN; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HARDING AE, 1984, HEREDITARY ATAXIAS R, P129; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KEATS BJB, 1991, AM J HUM GENET, V49, P972; KHATI C, 1993, NEUROLOGY, V43, P1131, DOI 10.1212/WNL.43.6.1131; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Ott J., 1991, ANAL HUMAN GENETIC L; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RANUM LPW, 1992, NEUROLOGY, V42, P344, DOI 10.1212/WNL.42.2.344; RICH SS, 1987, AM J HUM GENET, V41, P524; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; STEVANIN G, 1993, HUM MOL GENET, V2, P1483, DOI 10.1093/hmg/2.9.1483; TAKIYAMA Y, 1989, ACTA NEUROL SCAND, V79, P214, DOI 10.1111/j.1600-0404.1989.tb03741.x; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	36	144	144	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					11	20						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279460				2022-12-18	WOS:A1994MQ70000003
J	SCHORK, NJ				SCHORK, NJ			EXTENDED MULTIPOINT IDENTITY-BY-DESCENT ANALYSIS OF HUMAN QUANTITATIVE TRAITS - EFFICIENCY, POWER, AND MODELING CONSIDERATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANCE-COMPONENTS; ENVIRONMENTAL SOURCES; SERUM-CHOLESTEROL; LINKAGE; PEDIGREES; TECUMSEH; MICHIGAN; LOCUS	Goldgar introduced a novel marker-based method for partitioning the variation of a quantitative trait into specific chromosomal regions. Unlike traditional linkage mapping methods, Goldgar's method does not require the estimation of statistical quantities characterizing each locus thought to influence the trait under scrutiny (e.g., allele frequencies, penetrances, etc.). Goldgar's method is thus more flexible and less model dependent than many traditional marker-based genetic analysis techniques. Unfortunately, however, many of the properties of Goldgar's method have not been investigated. In this paper, the utility of an extended version of Goldgar's approach is studied in settings in which sibships are taken as the sampling unit of interest. The extensions discussed revolve around the incorporation of a wider variety of effects and factors into Goldgar's basic model. Analytic studies pertaining to power, sample-size requirements, and estimation procedures for the proposed extended version of Goldgar's method are described. Hypothesis-testing strategies are also discussed. The results of the analytic studies indicate that, although an extended sib-pair version of Goldgar's variance-partitioning approach to modeling the chromosomal determinants of a quantitative trait will be useful only for traits with high heritabilities or when fine-scale genetic maps can be employed, Goldgar's technique as a whole has promise, as it can be made relatively robust statistically, refined through some simple and intuitive extensions, and can be easily adapted to work with more complex sampling units. Further extensions of Goldgar's methods are proposed, and areas in need of additional research are discussed.	UNIV MICHIGAN,DEPT EPIDEMIOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	SCHORK, NJ (corresponding author), UNIV MICHIGAN,DEPT MED,R6592 KRESGE I,ANN ARBOR,MI 48109, USA.			Schork, Nicholas/0000-0003-0920-5013	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL048957] Funding Source: NIH RePORTER; NHLBI NIH HHS [NHLBI R03HL48957-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BLANGERO J, 1991, GENET EPIDEMIOL, V8, P299, DOI 10.1002/gepi.1370080503; BLANGERO J, 1990, AM J HUM GENET, V47, P414; CAREY G, 1988, BEHAV GENET, V18, P329, DOI 10.1007/BF01260933; CHESHER A, 1984, ECONOMETRICA, V52, P865, DOI 10.2307/1911188; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GOLDGAR DE, 1992, AM J HUM GENET, V50, P598; GOLDGAR DE, 1981, THESIS U COLORADO BO; GUMPERTZ ML, 1992, J AM STAT ASSOC, V87, P201, DOI 10.2307/2290470; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HULTEN M, 1974, HEREDITAS, V76, P55; KEMPTHORNE O, 1957, INTRO GENETIC STATIS; KENDALL MG, 1979, ADV THEORY STATISTIC, V2; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; LANGE K, 1978, J MATH BIOL, V6, P59, DOI 10.1007/BF02478517; LANGE K, 1976, ANN HUM GENET, V4, P171; Magnus J. R., 1988, WILEY SERIES PROBABI; MAGNUS JR, 1982, J ECONOMETRICS, V19, P239, DOI 10.1016/0304-4076(82)90005-7; MOLL PP, 1979, ANN HUM GENET, V42, P343, DOI 10.1111/j.1469-1809.1979.tb00668.x; NELSON SF, 1993, NAT GENET, V4, P11, DOI 10.1038/ng0593-11; ONIKI RS, 1991, THESIS U UTAH SALT L; Ott J., 1991, ANAL HUMAN GENETIC L; SANDA AI, 1986, NUCLEIC ACIDS RES, V14, P7265, DOI 10.1093/nar/14.18.7265; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SCHORK NJ, 1993, BIOMETRICAL J, V35, P387, DOI 10.1002/bimj.4710350402; SCHORK NJ, 1994, IN PRESS AM J HUM GE, V54; SCHORK NJ, UNPUB MAPPING COMPLE; Searle S. R., 1992, VARIANCE COMPONENTS; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SING CF, 1976, AM J HUM GENET, V28, P453; SING CF, 1992, ANN MED, V24, P529; THOMPSON EA, 1984, PEDIGREE ANAL HUMAN; TITTERINGTON DM, 1985, STATISTICAL ANAL FIN; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; WHITE H, 1982, J ECONOMETRICS, V19, P301, DOI 10.1016/0304-4076(82)90007-0	39	144	149	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1306	1319						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	MJ818	8250047				2022-12-18	WOS:A1993MJ81800018
J	ZEVIANI, M; BRESOLIN, N; GELLERA, C; BORDONI, A; PANNACCI, M; AMATI, P; MOGGIO, M; SERVIDEI, S; SCARLATO, G; DIDONATO, S				ZEVIANI, M; BRESOLIN, N; GELLERA, C; BORDONI, A; PANNACCI, M; AMATI, P; MOGGIO, M; SERVIDEI, S; SCARLATO, G; DIDONATO, S			NUCLEUS-DRIVEN MULTIPLE LARGE-SCALE DELETIONS OF THE HUMAN MITOCHONDRIAL GENOME - A NEW AUTOSOMAL DOMINANT DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MILAN, SCH MED, INST NEUROL, I-20122 MILAN, ITALY; UNIV CATTOLICA SACRO CUORE, SCH MED, DEPT NEUROL, I-00168 ROME, ITALY	University of Milan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	ZEVIANI, M (corresponding author), IST NEUROCHIRURG C BESTA, DEPT BIOCHEM & GENET, VIA CELORIA 11, I-20133 MILAN, ITALY.		Gellera, Cinzia/J-7887-2016; Zeviani, Massimo/K-2891-2014; Zeviani, Massimo/AAU-2632-2021; amati-bonneau, patrizia/K-6198-2015; Di Donato, Stefano/B-9717-2012; Servidei, Serenella/ABC-4262-2021	Gellera, Cinzia/0000-0002-3582-665X; Zeviani, Massimo/0000-0002-9067-5508; Bresolin, Nereo/0000-0001-6694-3595				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Battey, 1986, BASIC METHODS MOL BI; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DENSMORE LD, 1985, GENETICS, V110, P689; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HUSAIN M, 1983, BIOCHEM J, V209, P541, DOI 10.1042/bj2090541; HUTCHINSON SA, 1974, NATURE, V251, P536; JOHNS DR, 1989, LANCET, V1, P393; JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059; LOMBES A, 1989, REV NEUROL-FRANCE, V145, P671; MIGNOTTE B, 1985, NUCLEIC ACIDS RES, V13, P1703, DOI 10.1093/nar/13.5.1703; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.es.18.110187.001413; PALVA TK, 1985, FEBS LETT, V192, P267, DOI 10.1016/0014-5793(85)80122-8; RAND DM, 1989, GENETICS, V121, P551; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VANTUYLE GC, 1981, J BIOL CHEM, V256, P2772; Wallace D C, 1987, Birth Defects Orig Artic Ser, V23, P137; WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X; WALLACE DC, 1982, MICROBIOL REV, V46, P208, DOI 10.1128/MMBR.46.2.208-240.1982; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; YUZAKI M, 1989, BIOCHEM BIOPH RES CO, V164, P1352, DOI 10.1016/0006-291X(89)91818-4; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1989, NEUROL CLIN, V7, P123, DOI 10.1016/S0733-8619(18)30832-6; ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	35	144	146	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					904	914						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978558				2022-12-18	WOS:A1990EK40000005
J	BIAS, WB; REVEILLE, JD; BEATY, TH; MEYERS, DA; ARNETT, FC				BIAS, WB; REVEILLE, JD; BEATY, TH; MEYERS, DA; ARNETT, FC			EVIDENCE THAT AUTOIMMUNITY IN MAN IS A MENDELIAN DOMINANT TRAIT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21205; UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294; UNIV TEXAS,HLTH SCI CTR,DEPT MED,HOUSTON,TX 77225	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health Science Center Houston	BIAS, WB (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205, USA.				NCRR NIH HHS [RR-00722] Funding Source: Medline; NIADDK NIH HHS [AM-20656, AM-20558] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ADAMS DD, 1980, LANCET, V1, P396; ARNETT FC, 1984, SEMIN ARTHRITIS RHEU, V14, P24, DOI 10.1016/0049-0172(84)90006-4; BARTELS ED, 1941, HEREDITY GRAVES DISE; BELL DA, 1984, J RHEUMATOL, V11, P475; BERZOFSKY RN, 1977, ARTHRITIS RHEUM, V20, P1320, DOI 10.1002/art.1780200704; BIAS WB, 1981, HUM IMMUNOL, V2, P155, DOI 10.1016/0198-8859(81)90062-8; BLOCK SR, 1975, AM J MED, V59, P533, DOI 10.1016/0002-9343(75)90261-2; BUREK CL, 1982, CLIN IMMUNOL IMMUNOP, V25, P395, DOI 10.1016/0090-1229(82)90204-5; DATTA SK, 1978, J EXP MED, V147, P854, DOI 10.1084/jem.147.3.854; DEHORATIUS RJ, 1975, J CLIN INVEST, V56, P1149, DOI 10.1172/JCI108190; FIALKOW PJ, 1964, AM J MED, V36, P188, DOI 10.1016/0002-9343(64)90082-8; GERMAIN RN, 1981, SCAND J IMMUNOL, V13, P1, DOI 10.1111/j.1365-3083.1981.tb00104.x; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; HARLEY JB, 1986, SCIENCE, V232, P1145, DOI 10.1126/science.3458307; HARLEY JB, 1986, ARTHRITIS RHEUM, V29, P196, DOI 10.1002/art.1780290207; HASSTEDT SJ, 1981, 13 U UT TECHN REP; HOCHBERG MC, 1985, MEDICINE, V64, P285, DOI 10.1097/00005792-198509000-00001; HOLBOROW EJ, 1957, BMJ-BRIT MED J, V2, P732, DOI 10.1136/bmj.2.5047.732; HOLMAN H, 1960, ARTHRITIS RHEUM, V3, P244; Howie J B, 1968, Adv Immunol, V9, P215, DOI 10.1016/S0065-2776(08)60444-7; INMAN RD, 1979, ARTHRITIS RHEUM, V22, P624; JUNGERS P, 1982, ARTHRITIS RHEUM, V25, P454, DOI 10.1002/art.1780250415; KNIGHT JG, 1981, J CLIN LAB IMMUNOL, V5, P165; KNIGHT JG, 1982, CIBA F SYMP, V90, P35; LAHITA RG, 1983, ARTHRITIS RHEUM, V26, P39, DOI 10.1002/art.1780260107; LAHITA RG, 1982, ARTHRITIS RHEUM, V25, P843, DOI 10.1002/art.1780250726; LAHITA RG, 1981, J CLIN ENDOCR METAB, V53, P174, DOI 10.1210/jcem-53-1-174; LASTER AJ, 1982, NEW ENGL J MED, V307, P1495, DOI 10.1056/NEJM198212093072406; LAWLEY TJ, 1981, NEW ENGL J MED, V304, P185, DOI 10.1056/NEJM198101223040401; LERNER RA, 1976, J EXP MED, V143, P151, DOI 10.1084/jem.143.1.151; LEVY JA, 1975, J RHEUMATOL, V2, P135; LIPPMAN SM, 1982, AM J MED, V73, P827, DOI 10.1016/0002-9343(82)90773-2; MORTEO OG, 1961, ARTHRITIS RHEUM, V4, P356, DOI 10.1002/art.1780040404; OTT J, 1974, AM J HUM GENET, V26, P588; Pirofsky B, 1969, AUTOIMMUNIZATION AUT; REVEILLE JD, 1985, IMMUNOGENETICS, V21, P299, DOI 10.1007/BF00430796; REVEILLE JD, 1984, ANN INTERN MED, V101, P748, DOI 10.7326/0003-4819-101-6-748; ROITT IM, 1982, CIBA F S, V90, P35; ROUBINIAN JR, 1977, J CLIN INVEST, V59, P1066, DOI 10.1172/JCI108729; SCHANFIELD MS, 1978, BASIC CLIN IMMUNOL, P59; SNYDER LAURENCE H., 1932, OHIO JOUR SCI, V32, P436; STIMSON WH, 1980, J CLIN LAB IMMUNOL, V4, P27; YOSHIKI T, 1974, J EXP MED, V140, P1011, DOI 10.1084/jem.140.4.1011; [No title captured]	44	144	147	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1986	39	5					584	602						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F3032	3098096				2022-12-18	WOS:A1986F303200004
J	STEVENS, RL; FLUHARTY, AL; KIHARA, H; KABACK, MM; SHAPIRO, LJ; MARSH, B; SANDHOFF, K; FISCHER, G				STEVENS, RL; FLUHARTY, AL; KIHARA, H; KABACK, MM; SHAPIRO, LJ; MARSH, B; SANDHOFF, K; FISCHER, G			CEREBROSIDE SULFATASE ACTIVATOR DEFICIENCY INDUCED METACHROMATIC LEUKODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAX PLANCK INST PSYCHIAT,D-8000 MUNICH 40,FED REP GER; UNIV CALIF LOS ANGELES,HARBOR MED CTR,DEPT PEDIAT,DIV MED GENET,TORRANCE,CA 90509	Max Planck Society; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	STEVENS, RL (corresponding author), LANTERMAN STATE HOSP,MENTAL RETARDAT RES CTR GRP,UCLA SCH MED,POMONA,CA 91769, USA.				NICHD NIH HHS [HD-12178, HD-04612] Funding Source: Medline; NINDS NIH HHS [NS-11665] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011665] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARATON G, 1977, CLIN CHIM ACTA, V76, P339, DOI 10.1016/0009-8981(77)90160-7; CONZELMANN E, 1978, P NATL ACAD SCI USA, V75, P3979, DOI 10.1073/pnas.75.8.3979; DULANEY JT, 1978, METABOLIC BASIS INHE, P770; FISCHER G, 1977, BIOCHIM BIOPHYS ACTA, V481, P561, DOI 10.1016/0005-2744(77)90288-1; FISCHER G, 1978, BIOCHIM BIOPHYS ACTA, V528, P69, DOI 10.1016/0005-2760(78)90053-X; FISCHER G, 1975, H-S Z PHYSIOL CHEM, V356, P605, DOI 10.1515/bchm2.1975.356.1.605; FLUHARTY AL, 1978, J PEDIATR-US, V92, P782, DOI 10.1016/S0022-3476(78)80153-X; FLUHARTY AL, 1979, AM J HUM GENET, V31, P574; FLUHARTY AL, 1974, LIPIDS, V9, P865, DOI 10.1007/BF02532611; HECHTMAN P, 1980, AM J HUM GENET, V32, pA42; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; JATZKEWI.H, 1973, FEBS LETT, V32, P129, DOI 10.1016/0014-5793(73)80754-9; JERFY A, 1973, BIOCHIM BIOPHYS ACTA, V293, P178, DOI 10.1016/0005-2744(73)90389-6; KIHARA H, 1980, PEDIATR RES, V14, P224, DOI 10.1203/00006450-198003000-00009; LI SC, 1979, J BIOL CHEM, V254, P592; LI SC, 1976, J BIOL CHEM, V251, P1159; MEHL E, 1968, BIOCHIM BIOPHYS ACTA, V151, P619, DOI 10.1016/0005-2744(68)90008-9; MRAZ W, 1976, H-S Z PHYSIOL CHEM, V357, P1181, DOI 10.1515/bchm2.1976.357.2.1181; MRAZ W, 1976, FEBS LETT, V67, P105; PERCY AK, 1972, J NEUROCHEM, V19, P233, DOI 10.1111/j.1471-4159.1972.tb01273.x; PORTER MT, 1972, BIOCHIM BIOPHYS ACTA, V258, P769, DOI 10.1016/0005-2744(72)90178-7; PORTER MT, 1971, BIOCHEM BIOPH RES CO, V44, P660, DOI 10.1016/S0006-291X(71)80134-1; SHAPIRO LJ, 1979, PEDIATR RES, V13, P1179, DOI 10.1203/00006450-197910000-00021; STEVENS RL, 1975, J BIOL CHEM, V250, P2495	24	144	144	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					900	906						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199	6119902				2022-12-18	WOS:A1981MV19900007
J	PHELPS, VR				PHELPS, VR			RELATIVE INDEX FINGER LENGTH AS A SEX-INFLUENCED TRAIT IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALIX PHE, 1867, ANN SC NAT ZOO, V8, P295; BAKER F, 1888, AM ANTHROPOL, V1, P51, DOI DOI 10.1525/AA.1888.1.1.02A00040; Carus C. G., 1853, SYMBOLIK MENSCHLICHE; Ecker A, 1875, ARCH ANTHR, V8, P67; George R, 1930, ANAT REC, V46, P199, DOI 10.1002/ar.1090460210; Gerdy Pierre-Nicolas, 1829, ANATOMIE FORMES EXTE; GRUNING J, 1886, ARCH ANTHR BRAUNSCHW, V16, P511; HUIZINGA J, 1949, P K AKAD WET C, V52, P403; HUIZINGA J, 1949, P K AKAD WET C, V52, P587; Humphry GM, 1861, HUMAN FOOT HUMAN HAN; KLOEPFER HW, 1946, ANN EUGENIC, V13, P35, DOI 10.1111/j.1469-1809.1946.tb02342.x; LANGER C, 1865, LEHRBUCH ANATOMIE; MANTEGAZZA P, 1877, ARCH ANTROPOLOGIA ET, V7, P19; MOORE CR, 1948, EMBRYONIC SEX HORMON; PFITZNER W, 1892, MORPHOL ARB, V1, P1; PHELPS VR, 1948, THESIS U TEXAS; Schultz AH, 1926, Q REV BIOL, V1, P465, DOI 10.1086/394257; SNYDER L. H., 1935, HUMAN BIOL, V7, P608; SNYDER LAURENCE H., 1934, EUGENICAL NEWS, V19, P61; VOLOTZKOY M, 1924, RUSS ANTROP J, V8, P70; Wood-Jones F, 1920, PRINCIPLES ANATOMY S; WOODJONES F, 1941, PRINCIPLES ANATOMY S	22	144	146	1	11	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1952	4	2					72	89						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS397	14943709				2022-12-18	WOS:A1952XS39700002
J	Suls, A; Jaehn, JA; Kecskes, A; Weber, Y; Weckhuysen, S; Craiu, DC; Siekierska, A; Djemie, T; Afrikanova, T; Gormley, P; von Spiczak, S; Kluger, G; Iliescu, CM; Talvik, T; Talvik, I; Meral, C; Caglayan, HS; Giraldez, BG; Serratosa, J; Lemke, JR; Hoffman-Zacharska, D; Szczepanik, E; Barisic, N; Komarek, V; Hjalgrim, H; Moller, RS; Linnankivi, T; Dimova, P; Striano, P; Zara, F; Marini, C; Guerrini, R; Depienne, C; Baulac, S; Kuhlenbaumer, G; Crawford, AD; Lehesjoki, AE; de Witte, PAM; Palotie, A; Lerche, H; Esguerra, CV; De Jonghe, P; Helbig, I				Suls, Arvid; Jaehn, Johanna A.; Kecskes, Angela; Weber, Yvonne; Weckhuysen, Sarah; Craiu, Dana C.; Siekierska, Aleksandra; Djemie, Tania; Afrikanova, Tatiana; Gormley, Padhraig; von Spiczak, Sarah; Kluger, Gerhard; Iliescu, Catrinel M.; Talvik, Tiina; Talvik, Inga; Meral, Cihan; Caglayan, Hande S.; Giraldez, Beatriz G.; Serratosa, Jose; Lemke, Johannes R.; Hoffman-Zacharska, Dorota; Szczepanik, Elzbieta; Barisic, Nina; Komarek, Vladimir; Hjalgrim, Helle; Moller, Rikke S.; Linnankivi, Tarja; Dimova, Petia; Striano, Pasquale; Zara, Federico; Marini, Carla; Guerrini, Renzo; Depienne, Christel; Baulac, Stephanie; Kuhlenbaeumer, Gregor; Crawford, Alexander D.; Lehesjoki, Anna-Elina; de Witte, Peter A. M.; Palotie, Aarno; Lerche, Holger; Esguerra, Camila V.; De Jonghe, Peter; Helbig, Ingo		EuroEPINOMICS RES Consortium	De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM SPECTRUM DISORDERS; DNA-BINDING PROTEIN-2; GENE; PHENOTYPE; DELETION; DISEASE; MEMBER; RATES; SCN1A	Dravet syndrome is a severe epilepsy syndrome characterized by infantile onset of therapy-resistant, fever-sensitive seizures followed by cognitive decline. Mutations in SCN1A explain about 75% of cases with Dravet syndrome; 90% of these mutations arise de novo. We studied a cohort of nine Dravet-syndrome-affected individuals without an SCN1A mutation (these included some atypical cases with onset at up to 2 years of age) by using whole-exome sequencing in proband-parent trios. In two individuals, we identified a de novo loss-of-function mutation in CHD2 (encoding chromodomain helicase DNA binding protein 2). A third CHD2 mutation was identified in an epileptic proband of a second (stage 2) cohort. All three individuals with a CHD2 mutation had intellectual disability and fever-sensitive generalized seizures, as well as prominent myoclonic seizures starting in the second year of life or later. To explore the functional relevance of CHD2 haploinsufficiency in an in vivo model system, we knocked down chd2 in zebrafish by using targeted morpholino antisense oligomers. chd2-knockdown larvae exhibited altered locomotor activity, and the epileptic nature of this seizure-like behavior was confirmed by field-potential recordings that revealed epileptiform discharges similar to seizures in affected persons. Both altered locomotor activity and epileptiform discharges were absent in appropriate control larvae. Our study provides evidence that de novo loss-of-function mutations in CHD2 are a cause of epileptic encephalopathy with generalized seizures.	[Suls, Arvid; Weckhuysen, Sarah; Djemie, Tania; De Jonghe, Peter] VIB, Dept Mol Genet, Neurogenet Grp, B-2610 Antwerp, Belgium; [Suls, Arvid; Weckhuysen, Sarah; Djemie, Tania; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium; [Jaehn, Johanna A.; von Spiczak, Sarah; Helbig, Ingo] Univ Kiel, Univ Med Ctr Schleswig Holstein, D-24105 Kiel, Germany; [Kecskes, Angela; Siekierska, Aleksandra; Afrikanova, Tatiana; Crawford, Alexander D.; de Witte, Peter A. M.; Esguerra, Camila V.] Univ Louvain, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, B-3000 Louvain, Belgium; [Weber, Yvonne; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, D-72076 Tubingen, Germany; [Craiu, Dana C.; Iliescu, Catrinel M.] Carol Davila Univ Med, Dept Neurol, Pediat Neurol Clin 2, Bucharest 050474, Romania; [Craiu, Dana C.; Iliescu, Catrinel M.] Carol Davila Univ Med, Dept Pediat Neurol, Bucharest 050474, Romania; [Craiu, Dana C.; Iliescu, Catrinel M.] Carol Davila Univ Med, Dept Psychiat, Bucharest 050474, Romania; [Craiu, Dana C.; Iliescu, Catrinel M.] Carol Davila Univ Med, Dept Neurosurg, Bucharest 050474, Romania; [Craiu, Dana C.; Iliescu, Catrinel M.] Prof Doctor Alexandru Obregia Clin Hosp, Pediat Neurol Clin, Bucharest 041914, Romania; [Gormley, Padhraig; Palotie, Aarno] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Kluger, Gerhard] Schon Klin Vogtareuth, Tagesklin Neuropadiatrie, Epilepsiezentrum Kinder & Jugendliche, D-83569 Vogtareuth, Germany; [Talvik, Tiina; Talvik, Inga] Univ Tartu, Dept Pediat, EE-51014 Tartu, Estonia; [Talvik, Tiina; Talvik, Inga] Tartu Univ Hosp, Dept Neurol & Neurorehabil, Childrens Clin, EE-50406 Tartu, Estonia; [Meral, Cihan] GATA Haydarpasa Teaching Hosp, Dept Pediat Neurol, TR-34668 Istanbul, Turkey; [Caglayan, Hande S.] Bogazici Univ, Dept Mol Biol & Genet, TR-34342 Istanbul, Turkey; [Giraldez, Beatriz G.; Serratosa, Jose] Hosp Univ Fdn Jimenez Diaz, Epilepsy Unit, Madrid 28040, Spain; [Giraldez, Beatriz G.; Serratosa, Jose] Ctr Invest Biomed Red Enfermedades Raras, Madrid 28040, Spain; [Lemke, Johannes R.] Univ Childrens Hosp, Inselspital, Div Human Genet, CH-3010 Bern, Switzerland; [Hoffman-Zacharska, Dorota] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Szczepanik, Elzbieta] Inst Mother & Child Hlth, Clin Neurol Child & Adolescents, PL-01211 Warsaw, Poland; [Barisic, Nina] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Paediat, Zagreb 10000, Croatia; [Komarek, Vladimir] Univ Hosp Motol, Child Neurol Dept, Prague 15006, Czech Republic; [Hjalgrim, Helle; Moller, Rikke S.] Danish Epilepsy Ctr, DK-4293 Dianalund, Denmark; [Hjalgrim, Helle] Univ Southern Denmark, Inst Reg Hlth Res, DK-5230 Odense, Denmark; [Linnankivi, Tarja] Univ Helsinki, Childrens Hosp, Helsinki 00029, Finland; [Linnankivi, Tarja] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland; [Dimova, Petia] St Naum Univ Hosp Neurol & Psychiat, Clin Child Neurol, Sofia 1113, Bulgaria; [Striano, Pasquale] Univ Genoa, Dept Neurosci, Pediat Neurol & Muscular Dis Unit, I-16147 Genoa, Italy; [Striano, Pasquale] Univ Genoa, Dept Rehabil, I-16147 Genoa, Italy; [Striano, Pasquale] Univ Genoa, Dept Ophthalmol, I-16147 Genoa, Italy; [Striano, Pasquale] Univ Genoa, Dept Genet, I-16147 Genoa, Italy; [Striano, Pasquale] Univ Genoa, Dept Maternal & Child Hlth, I-16147 Genoa, Italy; [Striano, Pasquale] Gaslini Inst, I-16147 Genoa, Italy; [Zara, Federico] Gaslini Inst, Dept Neurosci, Neurogenet Lab, Pediat Neurol & Muscular Dis Unit, I-16147 Genoa, Italy; [Marini, Carla; Guerrini, Renzo] Univ Florence, Meyer Childrens Hosp, Pediat Neurol Unit, I-50132 Florence, Italy; [Marini, Carla; Guerrini, Renzo] Univ Florence, Meyer Childrens Hosp, Pediat Neurol Labs, I-50132 Florence, Italy; [Depienne, Christel; Baulac, Stephanie] Hop La Pitie Salpetriere, Ctr Rech, INSERM, Inst Cerveau & Moelle Epiniere,U975, F-75013 Paris, France; [Depienne, Christel; Baulac, Stephanie] Hop La Pitie Salpetriere, Ctr Rech, CNRS 7225, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France; [Baulac, Stephanie] Univ Paris 06, UMR S 975, F-75013 Paris, France; [Depienne, Christel] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Unite Fonct Neurogenet Mol & Cellulaire, F-75013 Paris, France; [Kuhlenbaeumer, Gregor] Univ Kiel, Inst Expt Med, Dept Neurol, D-24105 Kiel, Germany; [Crawford, Alexander D.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, L-4362 Esch Sur Alzette, Luxembourg; [Lehesjoki, Anna-Elina] Folkhalsan Inst Genet, Helsinki 00290, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, FIN-00290 Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Ctr Neurosci, FIN-00290 Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland, FIN-00290 Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Kiel; Schleswig Holstein University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Wellcome Trust Sanger Institute; University of Tartu; Gulhane Military Medical Academy; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Bogazici University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Bern; University Hospital of Bern; University of Zagreb; Motol University Hospital; University of Southern Denmark; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Medical University Sofia; University of Genoa; University of Genoa; University of Genoa; University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Kiel; University of Luxembourg; University of Helsinki; University of Helsinki; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	De Jonghe, P (corresponding author), VIB, Dept Mol Genet, Neurogenet Grp, B-2610 Antwerp, Belgium.	peter.dejonghe@molgen.vib-ua.be	Iliescu, Catrinel/AAL-3103-2021; Muhle, Hiltrud/F-5715-2010; Baulac, Stéphanie/O-2099-2016; Zara, Federico/U-3477-2017; Craiu, Dana/ABE-4886-2020; Craiu, Dana/ABC-2986-2020; Helbig, Ingo/G-8467-2018; Suls, Arvid/M-2694-2013; Depienne, Christel/AAL-3835-2021; Esguerra, Camila/D-7657-2014; Caglayan, Hande S/A-2368-2016; Weckhuysen, Sarah/HGB-9957-2022; Esguerra, Camila/N-6159-2015; Szczepanik, Elżbieta/X-6617-2018; Striano, Pasquale/F-9117-2014; Iliescu, Laura/S-2853-2018; Gormley, Padhraig/L-1949-2018; Marini, Carla/AAC-2413-2022	Baulac, Stéphanie/0000-0001-6430-4693; Zara, Federico/0000-0001-9744-5222; Helbig, Ingo/0000-0001-8486-0558; Suls, Arvid/0000-0003-0328-198X; Depienne, Christel/0000-0002-7212-9554; Esguerra, Camila/0000-0001-7891-1427; Caglayan, Hande S/0000-0001-6402-3306; Weckhuysen, Sarah/0000-0003-2878-1147; Esguerra, Camila/0000-0002-2271-8094; Szczepanik, Elżbieta/0000-0001-9942-8522; Striano, Pasquale/0000-0002-6065-1476; Iliescu, Laura/0000-0002-8800-4940; Gormley, Padhraig/0000-0002-8908-6968; Marini, Carla/0000-0002-9212-2691; Hoffman-Zacharska, Dorota/0000-0001-7367-512X; Selmer, Kaja Kristine/0000-0003-4871-112X; Linnankivi, Tarja/0000-0001-9190-2218; Moller, Rikke S./0000-0002-9664-1448; Guerrini, Renzo/0000-0002-7272-7079; Craiu, Dana/0000-0003-4156-6812; de Witte, Peter/0000-0002-9989-9567; Serratosa, Jose/0000-0003-2239-8948; Palotie, Aarno/0000-0002-2527-5874; Siekierska, Aleksandra/0000-0003-4907-605X; Appenzeller, Silke/0000-0002-5472-8692	European Science Foundation; state budget of Romania; Scientific and Technological Research Council of Turkey; National Science Centre Poland [800/N-ESF-EuroEPINOMICS/10/2011/0]; MH CZ-DRO, University Hospital Motol, Prague [00064203]; "Investissements d'avenir" [ANR-10-IAIHU-06]; Academy of Finland [141549, 251704]; Folkhalsan Research Foundation; Wellcome Trust [WT089062, 098051]; Academy of Finland Center of Excellence in Complex Disease Genetics grants [213506, 129680]; European Community [HEALTH-F4-2007-201413]; Synaptic Systems grant [242167]; Sigrid Juselius Foundation; European Commission [261123]; Federal Ministry of Education and Research [NGENplus/EMINet 01GS08123, IonNeurONet 01GM1105A]; German Research Foundation (DFG) [Le1030/11-1]; German Society for Epileptology; Fund for Scientific Research Flanders (FWO); Flemish government Methusalem excellence grant; University of Antwerp	European Science Foundation(European Science Foundation (ESF)European Commission); state budget of Romania; Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); National Science Centre Poland(National Science Centre, Poland); MH CZ-DRO, University Hospital Motol, Prague; "Investissements d'avenir"(French National Research Agency (ANR)); Academy of Finland(Academy of Finland); Folkhalsan Research Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland Center of Excellence in Complex Disease Genetics grants(Academy of Finland); European Community(European Commission); Synaptic Systems grant; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Society for Epileptology; Fund for Scientific Research Flanders (FWO)(FWO); Flemish government Methusalem excellence grant; University of Antwerp	We thank the probands and their families for their cooperation. The research was supported by the EUROCORES program EuroEPINOMICS of the European Science Foundation; funds from the state budget of Romania, managed by the Executive Agency for Higher Education, Research, Development, and Innovation Funding for Project 6-EUROC; the Scientific and Technological Research Council of Turkey; National Science Centre Poland funding for project 800/N-ESF-EuroEPINOMICS/10/2011/0; MH CZ-DRO, University Hospital Motol, Prague (00064203); "Investissements d'avenir" ANR-10-IAIHU-06; the Academy of Finland (grant 141549) and Folkhalsan Research Foundation; Wellcome Trust grants WT089062 and 098051; Academy of Finland grant 251704; Academy of Finland Center of Excellence in Complex Disease Genetics grants 213506 and 129680; the European Community's Seventh Framework Programme (FP7/2007-2013) ENGAGE Consortium (grant HEALTH-F4-2007-201413); Synaptic Systems grant 242167; the Sigrid Juselius Foundation; European Commission FP7 project 261123 (gEUVADIS); Federal Ministry of Education and Research NGENplus/EMINet 01GS08123; IonNeurONet 01GM1105A; German Research Foundation (DFG) Le1030/11-1; the German Society for Epileptology; the Fund for Scientific Research Flanders (FWO); the Flemish government Methusalem excellence grant; and the University of Antwerp. We thank the VIB Genetic Service Facility and the institute of Clinical Molecular Biology in Kiel for providing Sanger sequencing, supported in part by DFG Cluster of Excellence "Inflammation at Interfaces" and "Future Ocean." We thank technicians S. Greve, S. Arndt, and T. Henke for technical support. G.K. is a member of the DFG-funded Cluster of Excellence "Inflammation at Interfaces." A.S. is a FWO postdoctoral fellow. T.D. and A.K. are Institute of Science and Technology PhD fellows.	Afrikanova T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054166; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Capelli LP, 2012, EUR J MED GENET, V55, P132, DOI 10.1016/j.ejmg.2011.10.004; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cross JH, 2013, HAND CLINIC, V111, P619, DOI 10.1016/B978-0-444-52891-9.00064-6; de Ligt J, 2013, CURR OPIN GENET DEV, V23, P257, DOI 10.1016/j.gde.2013.01.007; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; Depienne C, 2011, HUM MUTAT, V32, pE1959, DOI 10.1002/humu.21373; Derchansky M, 2008, J PHYSIOL-LONDON, V586, P477, DOI 10.1113/jphysiol.2007.143065; Dhamija R, 2012, J CHILD NEUROL, V27, P663, DOI 10.1177/0883073811435829; Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x; Kearney JA, 2006, PEDIATR NEUROL, V34, P116, DOI 10.1016/j.pediatrneurol.2005.07.009; Kulkarni S, 2008, AM J MED GENET A, V146A, P1117, DOI 10.1002/ajmg.a.32178; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MM, 2008, AM J MED GENET A, V146A, P368, DOI 10.1002/ajmg.a.32116; Lund C, 2013, EPILEPSY RES, V105, P110, DOI 10.1016/j.eplepsyres.2013.01.009; Marfella CGA, 2006, J CELL PHYSIOL, V209, P162, DOI 10.1002/jcp.20718; Marfella CGA, 2008, KIDNEY BLOOD PRESS R, V31, P421, DOI 10.1159/000190788; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nagarajan P, 2009, ONCOGENE, V28, P1053, DOI 10.1038/onc.2008.440; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Suls A, 2006, HUM MUTAT, V27, P914, DOI 10.1002/humu.20350; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Veredice C, 2009, EPILEPSIA, V50, P1810, DOI 10.1111/j.1528-1167.2009.02078.x; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712	34	143	156	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					967	975		10.1016/j.ajhg.2013.09.017	http://dx.doi.org/10.1016/j.ajhg.2013.09.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24207121	Green Published, Bronze			2022-12-18	WOS:000326996600017
J	Puente, XS; Quesada, V; Osorio, FG; Cabanillas, R; Cadinanos, J; Fraile, JM; Ordonez, GR; Puente, DA; Gutierrez-Fernandez, A; Fanjul-Fernandez, M; Levy, N; Freije, JMP; Lopez-Otin, C				Puente, Xose S.; Quesada, Victor; Osorio, Fernando G.; Cabanillas, Ruben; Cadinanos, Juan; Fraile, Julia M.; Ordonez, Gonzalo R.; Puente, Diana A.; Gutierrez-Fernandez, Ana; Fanjul-Fernandez, Miriam; Levy, Nicolas; Freije, Jose M. P.; Lopez-Otin, Carlos			Exome Sequencing and Functional Analysis Identifies BANF1 Mutation as the Cause of a Hereditary Progeroid Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TO-AUTOINTEGRATION FACTOR; HUTCHINSON-GILFORD-PROGERIA; NUCLEAR-ENVELOPE; MOUSE MODEL; ZMPSTE24; BAF; CHROMATIN; PROTEIN; EMERIN; MICE	Accelerated aging syndromes represent a valuable source of information about the molecular mechanisms involved in normal aging. Here, we describe a progeroid syndrome that partially phenocopies Hutchinson-Gilford progeria syndrome (HGPS) but also exhibits distinctive features, including the absence of cardiovascular deficiencies characteristic of HGPS, the lack of mutations in LMNA and ZMPSTE24, and a relatively long lifespan of affected individuals. Exome sequencing and molecular analysis in two unrelated families allowed us to identify a homozygous mutation in BANF1 (c.34G>A [p.Ala12Thr]), encoding barrier-to-autointegration factor 1 (BAF), as the molecular abnormality responsible for this Mendelian disorder. Functional analysis showed that fibroblasts from both patients have a dramatic reduction in BAF protein levels, indicating that the p.Ala12Thr mutation impairs protein stability. Furthermore, progeroid fibroblasts display profound abnormalities in the nuclear lamina, including blebs and abnormal distribution of emerin, an interaction partner of BAE These nuclear abnormalities are rescued by ectopic expression of wild-type BANF1, providing evidence for the causal role of this mutation. These data demonstrate the utility of exome sequencing for identifying the cause of rare Mendelian disorders and underscore the importance of nuclear envelope alterations in human aging.	[Puente, Xose S.; Quesada, Victor; Osorio, Fernando G.; Fraile, Julia M.; Ordonez, Gonzalo R.; Puente, Diana A.; Gutierrez-Fernandez, Ana; Fanjul-Fernandez, Miriam; Freije, Jose M. P.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Cabanillas, Ruben; Cadinanos, Juan] Ctr Med Asturias, Inst Med Oncol & Mol Asturias, Oviedo 33193, Spain; [Levy, Nicolas] Univ Aix Marseille 2, INSERM, UMR S910, Fac Med Timone, F-13385 Marseille, France	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	clo@uniovi.es	López-Otín, Carlos/AAB-2106-2020; Quesada, Víctor/B-6557-2014; Puente, Xosé S./ADB-0672-2022; LEVY, Nicolas/J-1632-2014; Gutierrez-Fernandez, Ana/ABG-6678-2020; Gutierrez-Fernandez, Ana/AAS-9954-2021; Freije, José M.P./A-6535-2008	López-Otín, Carlos/0000-0001-6964-1904; Quesada, Víctor/0000-0002-8398-3457; Puente, Xosé S./0000-0001-9525-1483; LEVY, Nicolas/0000-0001-5171-6365; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; Freije, José M.P./0000-0002-4688-8266; Miriam, Fanjul Fernandez/0000-0002-0074-2325; Cadinanos, Juan/0000-0001-7561-7759	Ministerio de Ciencia e Innovacion-Spain; PCTI-FICYT Asturias; Fundacion Centro Medico de Asturias; Fundacion Maria Cristina Masaveu Peterson; European Union; Obra Social Cajastur; Accion Transversal del Cancer-RTICC	Ministerio de Ciencia e Innovacion-Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PCTI-FICYT Asturias; Fundacion Centro Medico de Asturias; Fundacion Maria Cristina Masaveu Peterson; European Union(European Commission); Obra Social Cajastur; Accion Transversal del Cancer-RTICC	We thank the atypical progeria patients and their families for participating in this study, and especially N.M.O. and G.R.P. for their courage and enthusiasm. We also thank Y. Espanol for help with confocal microscopy; A. Ramsay and G. Velasco for helpful comments; S. Alvarez, M. Fernandez, and R. Alvarez for excellent technical assistance; and the staff of the Centro Medico de Asturias for their kind assistance. This work has been supported by grants from Ministerio de Ciencia e Innovacion-Spain, PCTI-FICYT Asturias, Fundacion Centro Medico de Asturias, Fundacion Maria Cristina Masaveu Peterson, and the European Union (FP7 Micro-EnviMet). C.L-O. is an investigator in the Botin Foundation. The Instituto Universitario de Oncologia is supported by Obra Social Cajastur and Accion Transversal del Cancer-RTICC.	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bengtsson L, 2004, CURR OPIN CELL BIOL, V16, P73, DOI 10.1016/j.ceb.2003.11.012; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Cai ML, 2007, J BIOL CHEM, V282, P14525, DOI 10.1074/jbc.M700576200; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Haraguchi T, 2001, J CELL SCI, V114, P4575; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Haraguchi T, 2007, J CELL SCI, V120, P1967, DOI 10.1242/jcs.03461; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Ramirez CL, 2007, CELL MOL LIFE SCI, V64, P155, DOI 10.1007/s00018-006-6349-3; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679	36	143	149	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					650	656		10.1016/j.ajhg.2011.04.010	http://dx.doi.org/10.1016/j.ajhg.2011.04.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21549337	Green Published, Bronze			2022-12-18	WOS:000290832100014
J	Ding, J; Gudjonsson, JE; Liang, LM; Stuart, PE; Li, Y; Chen, W; Weichenthal, M; Ellinghaus, E; Franke, A; Cookson, W; Nair, RP; Elder, JT; Abecasis, GR				Ding, Jun; Gudjonsson, Johann E.; Liang, Liming; Stuart, Philip E.; Li, Yun; Chen, Wei; Weichenthal, Michael; Ellinghaus, Eva; Franke, Andre; Cookson, William; Nair, Rajan P.; Elder, James T.; Abecasis, Goncalo R.			Gene Expression in Skin and Lymphoblastoid Cells: Refined Statistical Method Reveals Extensive Overlap in cis-eQTL Signals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; REGULATORY VARIATION; PSORIASIS; DISCOVERY; CANDIDATE; TRAITS; LOCUS	Psoriasis, an immune-mediated, inflammatory disease of the skin and joints, provides an ideal system for expression quantitative trait locus (eQTL) analysis, because it has a strong genetic basis and disease-relevant tissue (skin) is readily accessible. To better understand the role of genetic variants regulating cutaneous gene expression, we identified 841 cis-acting eQTLs using RNA extracted from skin biopsies of 53 psoriatic individuals and 57 healthy controls. We found substantial overlap between cis-eQTLs of normal control, uninvolved psoriatic, and lesional psoriatic skin. Consistent with recent studies and with the idea that control of gene expression can mediate relationships between genetic variants and disease risk, we found that eQTL SNPs are more likely to be associated with psoriasis than are randomly selected SNPs. To explore the tissue specificity of these eQTLs and hence to quantify the benefits of studying eQTLs in different tissues, we developed a refined statistical method for estimating eQTL overlap and used it to compare skin eQTLs to a published panel of lymphoblastoid cell line (LCL) eQTLs. Our method accounts for the fact that most eQTL studies are likely to miss some true eQTLs as a result of power limitations and shows that similar to 70% of cis-eQTLs in LCLs are shared with skin, as compared with the naive estimate of <50% sharing. Our results provide a useful method for estimating the overlap between various eQTL studies and provide a catalog of cis-eQTLs in skin that can facilitate efforts to understand the functional impact of identified susceptibility variants on psoriasis and other skin traits.	[Ding, Jun; Liang, Liming; Li, Yun; Chen, Wei; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Gudjonsson, Johann E.; Stuart, Philip E.; Nair, Rajan P.; Elder, James T.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA; [Weichenthal, Michael] Univ Kiel, Dept Dermatol, D-24105 Kiel, Germany; [Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Cookson, William] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Elder, James T.] Ann Arbor VA Hlth Syst, Dept Dermatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Kiel; University of Kiel; Imperial College London	Ding, J (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	junding@umich.edu; goncalo@umich.edu	Franke, Andre/B-2151-2010; Abecasis, Goncalo R/B-7840-2010; Chen, Wei/AAX-5994-2020; Weichenthal, Michael/A-5692-2009; Cookson, William/HHC-1790-2022; Ding, Jun/G-3918-2011; Ellinghaus, Eva/E-6490-2012	Franke, Andre/0000-0003-1530-5811; Chen, Wei/0000-0001-7196-8703; Ellinghaus, Eva/0000-0003-2914-3382; Abecasis, Goncalo/0000-0003-1509-1825	National Institutes of Health [AR042742, AR050511, AR054966, HG002651, MH084698]; Ann Arbor Veterans Affairs Hospital; German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); Popgen Biobank; Forschungsgemeinschaft (DFG); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054966, R01AR042742, R01AR050511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084698] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ann Arbor Veterans Affairs Hospital; German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Popgen Biobank; Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank the psoriasis patients and healthy controls who participated in this study. This research was supported by grants AR042742, AR050511, AR054966, HG002651, and MH084698 from the National Institutes of Health and by the Ann Arbor Veterans Affairs Hospital. The authors thank Antigone Dimas and Emmanouil Dermitzakis for kindly sharing their eQTL results from fibroblasts, LCLs, and T cells. Genotyping of the German study panel was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the Popgen Biobank, and it received infrastructure support through the Deutsche Forschungsgemeinschaft (DFG) excellence cluster "Inflammation at Interfaces."	[Anonymous], ONLINE MENDELIAN INH; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, pS90; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Li Y, 2010, GENET EPIDEMIOL; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; *U MI CTR STAT GEN, U MICH CTR STAT GEN; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	38	143	145	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					779	789		10.1016/j.ajhg.2010.10.024	http://dx.doi.org/10.1016/j.ajhg.2010.10.024			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21129726	Green Published, Bronze			2022-12-18	WOS:000285564600004
J	Fiskerstrand, T; H'mida-Ben Brahim, D; Johanssond, S; M'zahem, A; Haukanes, BI; Drouot, N; Zimmermann, J; Cole, AJ; Vedeler, C; Bredrup, C; Assoum, M; Tazir, M; Klockgether, T; Hamri, A; Steen, VM; Boman, H; Bindoff, LA; Koenig, M; Knappskog, PM				Fiskerstrand, Torunn; H'mida-Ben Brahim, Dorra; Johanssond, Stefan; M'zahem, Abderrahim; Haukanes, Bjorn Ivar; Drouot, Nathalie; Zimmermann, Julian; Cole, Andrew J.; Vedeler, Christian; Bredrup, Cecilie; Assoum, Mirna; Tazir, Meriem; Klockgether, Thomas; Hamri, Abdelmadjid; Steen, Vidar M.; Boman, Helge; Bindoff, Laurence A.; Koenig, Michel; Knappskog, Per M.			Mutations in ABHD12 Cause the Neurodegenerative Disease PHARC: An Inborn Error of Endocannabinoid Metabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROGLIAL CELLS; 2-ARACHIDONOYLGLYCEROL; BLOCKADE; ENZYMES; SYSTEM; 2-AG; ACID	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC) is a neurodegenerative disease marked by early-onset cataract and hearing loss, retinitis pigmentosa, and involvement of both the central and peripheral nervous systems, including demyelinating sensorimotor polyneuropathy and cerebellar ataxia. Previously, we mapped this Refsum-like disorder to a 16 Mb region on chromosome 20. Here we report that mutations in the ABHD12 gene cause PHARC disease and we describe the clinical manifestations in a total of 19 patients from four different countries. The ABHD12 enzyme was recently shown to hydrolyze 2-arachidonoyl glycerol (2-AG), the main endocannabinoid lipid transmitter that acts on cannabinoid receptors CB1 and CB2. Our data therefore represent an example of an inherited disorder related to endocannabinoid metabolism. The endocannabinoid system is involved in a wide range of physiological processes including neurotransmission, mood, appetite, pain appreciation, addiction behavior, and inflammation, and several potential drugs targeting these pathways are in development for clinical applications. Our findings show that ABHD12 performs essential functions in both the central and peripheral nervous systems and the eye. Any future drug-mediated interference with this enzyme should consider the potential risk of long-term adverse effects.	[Fiskerstrand, Torunn; Johanssond, Stefan; Haukanes, Bjorn Ivar; Steen, Vidar M.; Boman, Helge; Knappskog, Per M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [H'mida-Ben Brahim, Dorra; Drouot, Nathalie; Assoum, Mirna; Koenig, Michel] Univ Strasbourg, CNRS, INSERM, IGBMC, F-67000 Illkirch Graffenstaden, France; [M'zahem, Abderrahim; Hamri, Abdelmadjid] Univ Benbadis, Ctr Hosp, Constantine 25000, Algeria; [Zimmermann, Julian; Klockgether, Thomas] Univ Klinikum, Klin & Poliklin Neurol, D-53105 Bonn, Germany; [Cole, Andrew J.] Massachusetts Gen Hosp, MGH Epilepsy Serv, Boston, MA 02114 USA; [Cole, Andrew J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Vedeler, Christian; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Vedeler, Christian; Steen, Vidar M.; Bindoff, Laurence A.; Knappskog, Per M.] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway; [Bredrup, Cecilie] Haukeland Hosp, Dept Ophthalmol, N-5021 Bergen, Norway; [Tazir, Meriem] Ctr Hosp Univ Mustapha, Serv Neurol, Algiers 16000, Algeria; [Klockgether, Thomas] DZNE, D-53105 Bonn, Germany; [H'mida-Ben Brahim, Dorra] CHU Farhat Hached, Serv Cytogenet Genet Mol & Biol Reprod, Sousse 4000, Tunisia	University of Bergen; Haukeland University Hospital; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Bonn; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Universite de Sousse; Hopital Farhat Hached	Fiskerstrand, T (corresponding author), Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway.	torunn.fiskerstrand@helse-bergen.no; mkoenig@igbmc.fr	Zimmermann, Julian/ABQ-0926-2022; Bredrup, Cecilie/GPK-4303-2022; Johansson, Stefan/C-4394-2011	Zimmermann, Julian/0000-0003-1964-0078; Johansson, Stefan/0000-0002-2298-7008; Bindoff, Laurence/0000-0003-0988-276X; Haukanes, Bjorn Ivar/0000-0003-1559-3366	Helse Vest (Western Norway Regional Health Authority) [911308]; Agence Nationale pour la Recherche-Maladies Rares, France [ANR-05-MRAR-013-01]; French association Connaitre les Syndromes Cerebelleux; Centre National de la Recherche Scientifique (CNRS)	Helse Vest (Western Norway Regional Health Authority); Agence Nationale pour la Recherche-Maladies Rares, France(French National Research Agency (ANR)); French association Connaitre les Syndromes Cerebelleux; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from Helse Vest (Western Norway Regional Health Authority, 911308, to P.K., T.F., H.B., V.M.S, and B.I.H.) and from the Agence Nationale pour la Recherche-Maladies Rares (ANR-05-MRAR-013-01, France, to M.K.). D.H.-B.B. was supported by the French association Connaitre les Syndromes Cerebelleux. M.A. was supported by a BDI fellowship from the Centre National de la Recherche Scientifique (CNRS). We thank John Walker and Andrew Su for the kind permission to replot (Figure 2) gene expression data from GNF: Mouse Gene Atlas V3. The technical assistance of Jorunn Skeie Bringsli, Guri Matre, Hilde Rusaas, Sigrid Erdal, Paal Borge, Christine Stansberg, Bard Kjersem, Christelle Thibault, Serge Vicaire, Jone Vignes, and Ingrid Bauer was highly appreciated. We thank the patients and their families for participating in this study.	Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Ebert S, 2009, J NEUROCHEM, V110, P1863, DOI 10.1111/j.1471-4159.2009.06286.x; Finsterer J, 2009, CAN J NEUROL SCI, V36, P543, DOI 10.1017/S0317167100008027; Fiskerstrand T, 2009, NEUROLOGY, V72, P20, DOI 10.1212/01.wnl.0000333664.90605.23; Guzman M, 2010, CHEM BIOL, V17, P4, DOI 10.1016/j.chembiol.2010.01.001; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kreutz S, 2009, GLIA, V57, P286, DOI 10.1002/glia.20756; Landreth GE, 2009, J NEUROIMMUNE PHARM, V4, P369, DOI 10.1007/s11481-009-9173-3; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; Marrs W, 2007, CHEM BIOL, V14, P1309, DOI 10.1016/j.chembiol.2007.12.004; Marrs W, 2009, AAPS J, V11, P307, DOI 10.1208/s12248-009-9109-0; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Straiker A, 2009, MOL PHARMACOL, V76, P1220, DOI 10.1124/mol.109.059030; Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8; Wanders RJA, 2007, BIOCHEM SOC T, V35, P865, DOI 10.1042/BST0350865; Wang J, 2009, PROSTAG OTH LIPID M, V89, P112, DOI 10.1016/j.prostaglandins.2008.12.002; Zhang J, 2008, J BIOL CHEM, V283, P22601, DOI 10.1074/jbc.M800524200	23	143	145	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					410	417		10.1016/j.ajhg.2010.08.002	http://dx.doi.org/10.1016/j.ajhg.2010.08.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20797687	Bronze, Green Published			2022-12-18	WOS:000281923500011
J	Rehman, AU; Morell, RJ; Belyantseva, IA; Khan, SY; Boger, ET; Shahzad, M; Ahmed, ZM; Riazuddin, S; Khan, SN; Riazuddin, S; Friedman, TB				Rehman, Atteeq Ur; Morell, Robert J.; Belyantseva, Inna A.; Khan, Shahid Y.; Boger, Erich T.; Shahzad, Mohsin; Ahmed, Zubair M.; Riazuddin, Saima; Khan, Shaheen N.; Riazuddin, Sheikh; Friedman, Thomas B.			Targeted Capture and Next-Generation Sequencing Identifies C9orf75, Encoding Taperin, as the Mutated Gene in Nonsyndromic Deafness DFNB79	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL RECESSIVE DEAFNESS; COCHLEAR HAIR-CELLS; ANKLE-LINK COMPLEX; MYOSIN-XVA; GAMMA-ACTIN; PROTEIN; STEREOCILIA; MUTATIONS; DNA; BUNDLE	Targeted genome capture combined with next-generation sequencing was used to analyze 2.9 Mb of the DFNB79 interval on chromosome 9q34.3, which includes 108 candidate genes. Genomic DNA from an affected member of a consanguineous family segregating recessive, nonsyndromic hearing loss was used to make a library of fragments covering the DFNB79 linkage interval defined by genetic analyses of four pedigrees. Homozygosity for eight previously unreported variants in transcribed sequences was detected by evaluating a library of 402,554 sequencing reads and was later confirmed by Sanger sequencing. Of these variants, six were determined to be polymorphisms in the Pakistani population, and one was in a noncoding gene that was subsequently excluded genetically from the DFNB79 linkage interval. The remaining variant was a nonsense mutation in a predicted gene, C9orf75, renamed TPRN. Evaluation of the other three DFNB79-linked families identified three additional frameshift Mutations, for a total of four truncating alleles of this gene. Although TPRN is expressed in many tissues, immunolocalization of the protein product in the mouse cochlea shows prominent expression in the taper region of hair cell stereocilia. Consequently, we named the protein taperin.	[Rehman, Atteeq Ur; Morell, Robert J.; Belyantseva, Inna A.; Boger, Erich T.; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA; [Rehman, Atteeq Ur; Khan, Shahid Y.; Shahzad, Mohsin; Khan, Shaheen N.] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; [Ahmed, Zubair M.] Cincinnati Childrens Hosp Res Fdn, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA; [Ahmed, Zubair M.] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Riazuddin, Saima] Childrens Hosp Res Fdn, Div Pediat Otolaryngol Head & Neck Surg, Cincinnati, OH 45229 USA; [Riazuddin, Saima] Childrens Hosp Res Fdn, Div Ophthalmol, Cincinnati, OH 45229 USA; [Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54550, Pakistan	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Health Science - Pakistan	Friedman, TB (corresponding author), Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov	Rehman, Atteeq/AAG-8342-2020; Nasim Khan, Shaheen/F-2135-2015; Morell, Robert James/Q-2042-2019	Morell, Robert/0000-0003-1537-7356; Shahzad, Mohsin/0000-0003-1537-3195	National Institute of Deafness and Other Communication Disorders [1 Z01 DC000039-12]; Higher Education Commission, Islamabad; Ministry of Science and Technology, Islamabad; International Center for Genetic Engineering and Biotechnology, Trieste [CRP/PAK08-01, 08/009]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000039, ZIADC000039, ZIADC000048] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Higher Education Commission, Islamabad; Ministry of Science and Technology, Islamabad; International Center for Genetic Engineering and Biotechnology, Trieste; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are thankful to the family members who helped make this study possible. We thank Jonathan Bird, Byung Yoon Choi, Dennis Drayna, Meghan Drummond, Karen Friderici, Andrew Griffith, Changsoo Kang, Sue Lee, M. Hashirn Raza, Mary Vendetti, and Barbara Zwiesler. This work was supported by National Institutes of Health intramural funds from the National Institute of Deafness and Other Communication Disorders (1 Z01 DC000039-12) to T.B.F; by the Higher Education Commission, Islamabad; the Ministry of Science and Technology, Islamabad; and by the International Center for Genetic Engineering and Biotechnology, Trieste, project CRP/PAK08-01 (contract 08/009), to S.R.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Ahmed ZM, 2008, NAT GENET, V40, P1335, DOI 10.1038/ng.245; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; D'Ascenzo M, 2009, MAMM GENOME, V20, P424, DOI 10.1007/s00335-009-9200-y; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Kao SC, 2007, BIOCHEM BIOPH RES CO, V356, P594, DOI 10.1016/j.bbrc.2007.03.026; Khan SY, 2007, HUM MUTAT, V28, P417, DOI 10.1002/humu.20469; Khan SY, 2010, EUR J HUM GENET, V18, P125, DOI 10.1038/ejhg.2009.121; Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lai NS, 2009, BIOCHEM BIOPH RES CO, V387, P676, DOI 10.1016/j.bbrc.2009.07.086; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; Mewborn SK, 2005, CYTOGENET GENOME RES, V108, P22, DOI 10.1159/000080798; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Nicholson P, 2009, CELL MOL LIFE SCI; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Volpi L, 2010, AM J HUM GENET, V86, P72, DOI 10.1016/j.ajhg.2009.11.014; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	36	143	164	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					378	388		10.1016/j.ajhg.2010.01.030	http://dx.doi.org/10.1016/j.ajhg.2010.01.030			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20170899	Green Published, Bronze			2022-12-18	WOS:000275678800009
J	Kung, AWC; Xiao, SM; Cherny, S; Li, GHY; Gao, Y; Tso, G; Lau, KS; Luk, KDK; Liu, JM; Cui, B; Zhang, MJ; Zhang, ZL; He, JW; Yue, H; Xia, WB; Luo, LM; He, SL; Kiel, DP; Karasik, D; Hsu, YH; Cupples, LA; Demissie, S; Styrkarsdottir, U; Halldorsson, BV; Sigurdsson, G; Thorsteinsdottir, U; Stefansson, K; Richards, JB; Zhai, GJ; Soranzo, N; Valdes, A; Spector, TD; Sham, PC				Kung, Annie W. C.; Xiao, Su-Mei; Cherny, Stacey; Li, Gloria H. Y.; Gao, Yi; Tso, Gloria; Lau, Kam S.; Luk, Keith D. K.; Liu, Jian-min; Cui, Bin; Zhang, Min-Jia; Zhang, Zhen-lin; He, Jin-wei; Yue, Hua; Xia, Wia-bo; Luo, Lian-mei; He, Shu-li; Kiel, Douglas P.; Karasik, David; Hsu, Yi-Hsiang; Cupples, L. Adrienne; Demissie, Serkalem; Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Sigurdsson, Gunnar; Thorsteinsdottir, Unnur; Stefansson, Kari; Richards, J. Brent; Zhai, Guangju; Soranzo, Nicole; Valdes, Ana; Spector, Tim D.; Sham, Pak C.			Association of JAG1 with Bone Mineral Density and Osteoporotic Fractures: A Genome-wide Association Study and Follow-up Replication Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHINESE WOMEN; ALAGILLE-SYNDROME; GENE POLYMORPHISMS; SOUTHERN CHINESE; MASS; DIFFERENTIATION; METAANALYSIS; LINKAGE; RISK; HERITABILITY	Bone mineral density (BMD), a diagnostic parameter for osteoporosis and a clinical predictor of fracture, is a polygenic trait with high heritability. To identify genetic variants that influence BMD in different ethnic groups, we performed a genome-wide association study (GWAS) on 800 unrelated Southern Chinese women with extreme BMD and carried out follow-up replication studies in six independent Study Populations of European descent and Asian Populations including 18,098 Subjects. In the meta-analysis, rs2273061 of the Jagged1 (JAG]) gene was associated with high BMD (p = 5.27 x 10(-8) for lumbar spine [LS] and p = 4.15 x 10(-5) for femoral neck [FN], n = 18,898). This SNP was further found to be associated with the low risk of osteoporotic fracture (p = 0.009, OR = 0.7, 95% Cl 0.57-0.93, n = 1881). Region-wide and haplotype analysis showed that the strongest association evidence was from the linkage disequilibrium block 5, which included rs2273061 of the JAG1 gene (1) = 8.52 x 10(-9) for LS and 3.47 x 10(-5) at FN). To assess the function of identified variants, an electrophoretic mobility shift assay demonstrated the binding of c-Myc to the "G" but not "N' allele of rs2273061. A mRNA expression Study in both human bone-derived cells and peripheral blood mononuclear cells confirmed association of the high BMD-related allele G of rs2273061 with higher JAG1 expression. Our results identify the JAG I gene as a candidate for BMD regulation in different ethnic groups, and it is a potential key factor for fracture pathogenesis.	[Kung, Annie W. C.; Xiao, Su-Mei; Li, Gloria H. Y.; Gao, Yi; Tso, Gloria; Lau, Kam S.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Kung, Annie W. C.; Xiao, Su-Mei] Univ Hong Kong, Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Cherny, Stacey; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Luk, Keith D. K.] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Liu, Jian-min; Cui, Bin; Zhang, Min-Jia] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Endocrine & Metab Dis, Shanghai 200025, Peoples R China; [Zhang, Zhen-lin; He, Jin-wei; Yue, Hua] Shanghai Jiao Tong Univ, Peoples Hosp 6, Osteoporosis Res Unit, Ctr Preventing & Treating Osteoporosis, Shanghai 200233, Peoples R China; [Xia, Wia-bo; Luo, Lian-mei; He, Shu-li] Peking Union Med Coll, Peking Union Med Coll Hosp, Minist Hlth, Dept Endocrinol,Key Lab Endocrinol, Beijing 100730, Peoples R China; [Xia, Wia-bo; Luo, Lian-mei; He, Shu-li] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Kiel, Douglas P.; Karasik, David; Hsu, Yi-Hsiang] Hebrew SeniorLife Inst Aging Res, Boston, MA 02131 USA; [Kiel, Douglas P.; Karasik, David; Hsu, Yi-Hsiang] Harvard Univ, Sch Med, Boston, MA 02131 USA; [Cupples, L. Adrienne; Demissie, Serkalem] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Cupples, L. Adrienne; Demissie, Serkalem] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Halldorsson, Bjarni V.] Reykjavik Univ, IS-103 Reykjavik, Iceland; [Sigurdsson, Gunnar] Univ Hosp, Dept Endocrinol & Metab, IS-108 Reykjavik, Iceland; [Sigurdsson, Gunnar; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Richards, J. Brent] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Richards, J. Brent] McGill Univ, Dept Human Genet, Montreal, PQ H3T 1E2, Canada; [Richards, J. Brent; Zhai, Guangju; Soranzo, Nicole; Valdes, Ana; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Soranzo, Nicole] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Reykjavik University; Landspitali National University Hospital; University of Iceland; McGill University; McGill University; University of London; King's College London; Wellcome Trust Sanger Institute	Kung, AWC (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	awckung@hkucc.hku.hk	Stefansson, Kari/AAE-7187-2019; Cherny, Stacey S/B-3315-2008; Li, Gloria/ABH-4759-2022; Richards, J Brent/AAF-4225-2019; TSO, Gloria HOI WAN/C-4749-2009	Cherny, Stacey S/0000-0002-0269-3352; Li, Gloria/0000-0003-0275-2356; Richards, J Brent/0000-0002-3746-9086; Karasik, David/0000-0002-8826-0530; Soranzo, Nicole/0000-0003-1095-3852; Kiel, Douglas/0000-0001-8474-0310; Demissie, Serkalem/0000-0002-8009-0987; Liu, Jian-min/0000-0002-0179-1751; Valdes, Ana M./0000-0003-1141-4471; Halldorsson, Bjarni/0000-0003-0756-0767; Cupples, L. Adrienne/0000-0003-0273-7965; Styrkarsdottir, Unnur/0000-0001-8146-8278	Hong Kong Research Grant Council; HKU Foundation; Matching Grant; CRCG; The University of Hong Kong; Wellcome Trust; European Community's Sixth and Seventh Framework Programmes [FP7/2007-2013]; ENGAGE [HEALTH-F4-2007-201413]; 1711-5 GenomEUtwin Project [QLG2-CT-2002-01254]; Department of Health via the National Institute for Health Research (NIHR); Biotechnology and Biological Sciences Research Council (BBSRC) [G20234]; National Eye Institute via an NIH/CIDR; US National Institute for Arthritis, Musculoskeletal and Skin Diseases; National Institute on Aging [R01 AR/AG 41398, R01 AR 050066]; National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195]; Affymetrix, Inc. [N02-HL-6-4278]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041398, R01AR050066] Funding Source: NIH RePORTER	Hong Kong Research Grant Council(Hong Kong Research Grants Council); HKU Foundation(University of Hong Kong); Matching Grant; CRCG; The University of Hong Kong(University of Hong Kong); Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Sixth and Seventh Framework Programmes; ENGAGE; 1711-5 GenomEUtwin Project; Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Eye Institute via an NIH/CIDR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute for Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc.; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project is supported by Hong Kong Research Grant Council; The Bone Health Fund of HKU Foundation; and Matching Grant, CRCG Grant, and The Osteoporosis Research Fund of The University of Hong Kong. The Twins UK Study was funded by the Wellcome Trust, European Community's Sixth and Seventh Framework Programmes (FP7/2007-2013), ENGAGE project HEALTH-F4-2007-201413, and the 1711-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives Support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & StThornas' NHS Foundation Trust in partnership with King's College London. T.D.S. is an NIHR senior Investigator. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). The authors acknowledge the funding and support of the National Eye Institute via an NIH/CIDR genotyping project (PI, Terri Young). For genotyping of the Twins UK study, we thank the staff from the Genotyping Facilities at the Wellcome Trust Sanger Institute for sample preparation, Quality Control and Genotyping led by Leena Peltonen and Panos Deloukas; Le Centre National de Genotypage, France, led by Mark Lathrop; Duke University, North Carolina, USA, led by David Goldstein; and the Finnish Institute of Molecular Medicine, Finnish Genome Center, University of Helsinki, led by Aarno Palotie. The Framingham Osteoporosis Study (FOS) study was funded by grants from the US National Institute for Arthritis, Musculoskeletal and Skin Diseases and National Institute oil Aging (R01 AR/AG 41398 to D.P.K. and R01 AR 050066 to D.K.). The Framingham Heart Study of the National Heart, Lung, and Blood Institute of the National Institutes of Health and Boston University School of Medicine were supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (N01-HC-25195) and its contract with Affymetrix, Inc. for genotyping services (N02-HL-6-4278). Analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research was conducted with the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The following are employees of deCODE Company, Iceland, and own stock or stock options of deCODE Company: U.S., B.V.H., U.T., and K.S.	ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; ALAGILLE D, 1975, J PEDIATR-US, V86, P63, DOI 10.1016/S0022-3476(75)80706-2; Arden NK, 1996, J BONE MINER RES, V11, P530; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BLACK DM, 1991, J BONE MINER RES, V6, P883; Cheung CL, 2009, HUM MOL GENET, V18, P679, DOI 10.1093/hmg/ddn397; DEQUEKER J, 1987, BONE, V8, P207, DOI 10.1016/8756-3282(87)90166-9; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dvornyk V, 2003, ANN HUM GENET, V67, P216, DOI 10.1046/j.1469-1809.2003.00037.x; Gartland Alison, 2005, Methods Mol Med, V107, P29; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Huang QY, 2006, MOL GENET METAB, V88, P295, DOI 10.1016/j.ymgme.2006.04.009; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Krantz ID, 1997, J MED GENET, V34, P152, DOI 10.1136/jmg.34.2.152; Krantz ID, 1997, AM J MED GENET, V70, P80, DOI 10.1002/(SICI)1096-8628(19970502)70:1<80::AID-AJMG15>3.0.CO;2-T; Kung AWC, 2007, J BONE MINER RES, V22, P1080, DOI [10.1359/jbmr.070320, 10.1359/JBMR.070320]; Kung AWC, 2006, BONE, V39, P1097, DOI 10.1016/j.bone.2006.04.029; Kung AWC, 1999, OSTEOPOROSIS INT, V10, P456, DOI 10.1007/s001980050254; Kung AWC, 1998, BONE, V22, P389, DOI 10.1016/S8756-3282(97)00301-3; Lambrinoudaki I, 2001, J ENDOCRINOL INVEST, V24, P499, DOI 10.1007/BF03343882; Li MX, 2007, BIOINFORMATICS, V23, P3105, DOI 10.1093/bioinformatics/btm458; Liu Jian-Min, 2004, Osteoporos Int, V15, P238, DOI 10.1007/s00198-003-1536-7; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Ng MYM, 2006, ANN HUM GENET, V70, P428, DOI 10.1111/j.1469-1809.2005.00242.x; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ralston SH, 2006, PLOS MED, V3, P515, DOI 10.1371/journal.pmed.0030090; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; THERNEAU T, 2008, KINSHIP MIXED EFFECT; Tran BNH, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-55; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang YW, 2007, INT J BIOCHEM CELL B, V39, P402, DOI 10.1016/j.biocel.2006.09.006; Weber JM, 2006, BONE, V39, P485, DOI 10.1016/j.bone.2006.03.002; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang Y, 2008, J CELL BIOCHEM, V105, P487, DOI 10.1002/jcb.21844; Zhao HY, 2008, OSTEOPOROSIS INT, V19, P221, DOI 10.1007/s00198-007-0440-y	47	143	158	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					229	239		10.1016/j.ajhg.2009.12.014	http://dx.doi.org/10.1016/j.ajhg.2009.12.014			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20096396	Green Published, Bronze			2022-12-18	WOS:000274637200012
J	Reiner, AP; Barber, MJ; Guan, Y; Ridker, PM; Lange, LA; Chasman, DI; Walston, JD; Cooper, GM; Jenny, NS; Rieder, MJ; Durda, JP; Smith, JD; Novembre, J; Tracy, RP; Rotter, JI; Stephens, M; Nickerson, DA; Krauss, RM				Reiner, Alexander P.; Barber, Mathew J.; Guan, Yongtao; Ridker, Paul M.; Lange, Leslie A.; Chasman, Daniel I.; Walston, Jeremy D.; Cooper, Gregory M.; Jenny, Nancy S.; Rieder, Mark J.; Durda, J. Peter; Smith, Joshua D.; Novembre, John; Tracy, Russell P.; Rotter, Jerome I.; Stephens, Matthew; Nickerson, Deborah A.; Krauss, Ronald M.			Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EPIDEMIOLOGIC APPLICATIONS; EXPRESSION; INFLAMMATION; CHOLESTEROL; VARIABILITY; AMERICANS; VARIANTS; PROMOTER; THERAPY	Data from the Pharmacogenomics and Risk of Cardiovascular Disease (PARC) study and the Cardiovascular Health Study (CHS) provide independent and confirmatory evidence for association between common polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-la and plasma C-reactive protein (CRP) concentration. Analyses with the use of imputation-based methods to combine genotype data from both studies and to test untyped SNPs from the HapMap database identified several SNPs within a 5 kb region of HNF1A intron 1 with the strongest evidence of association with CRP phenotype.	[Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Barber, Mathew J.; Guan, Yongtao; Novembre, John; Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Walston, Jeremy D.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Cooper, Gregory M.; Rieder, Mark J.; Smith, Joshua D.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Jenny, Nancy S.; Durda, J. Peter; Tracy, Russell P.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05446 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	University of Washington; University of Washington Seattle; University of Chicago; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Vermont; Cedars Sinai Medical Center; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Reiner, AP (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	apreiner@u.washington.edu	Rotter, Jerome/AAY-6598-2021; Novembre, John/G-1339-2011; Cooper, Gregory/D-6914-2011	Cooper, Gregory/0000-0001-5509-9923	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055222, N01HC085080, N01HC085079, N01HC085086, N01HC085082, N01HC015103, N01HC085084, N01HC085081, N01HC085083, N01HC085085, N01HC035129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071862, U01HL069757, U01HL080295, N01HV48195, U01HL084689] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG023122] Funding Source: NIH RePORTER; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NHLBI NIH HHS [HC-85084, N01HC85086, HC-85085, R01 HL-071862, N01-HV-48195, N01 HC035129, N01HV48195, N01HC85079, U01 HL084689, HC-85083, HC-85082, U01 HL-069757, HC-85080, N01 HC-55222, HC-85081, N01-HC-85079, U01 HL069757, HC-85086, N01 HC015103, N01HC55222, U01 HL080295, R01 HL071862] Funding Source: Medline; NIA NIH HHS [U19 AG023122] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491-019004, P30 DK063491-049004, P30 DK063491-039004, P30 DK063491-05, P30 DK063491, P30 DK063491-029004] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agrawal A, 2003, MOL IMMUNOL, V40, P373, DOI 10.1016/S0161-5890(03)00148-2; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Austin MA, 2004, ANN HUM GENET, V68, P179, DOI 10.1046/j.1529-8817.2004.00078.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chasman DI, 2006, GENES IMMUN, V7, P211, DOI 10.1038/sj.gene.6364289; de Maat MPM, 2004, ARTERIOSCL THROM VAS, V24, P2168, DOI 10.1161/01.ATV.0000143856.01669.e7; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Holmkvist J, 2006, DIABETOLOGIA, V49, P2882, DOI 10.1007/s00125-006-0450-x; Lange LA, 2008, J THROMB HAEMOST, V6, P654, DOI 10.1111/j.1538-7836.2008.02906.x; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Li SP, 1996, BIOCHEMISTRY-US, V35, P9060, DOI 10.1021/bi953033d; Macy EM, 1997, CLIN CHEM, V43, P52; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Roberts WL, 2001, CLIN CHEM, V47, P418; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; Voleti B, 2005, J IMMUNOL, V175, P3386, DOI 10.4049/jimmunol.175.5.3386; Zhang YY, 2007, ATHEROSCLEROSIS, V191, P121, DOI 10.1016/j.atherosclerosis.2006.02.043	26	143	147	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1193	1201		10.1016/j.ajhg.2008.03.017	http://dx.doi.org/10.1016/j.ajhg.2008.03.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18439552	Bronze, Green Published			2022-12-18	WOS:000255923600020
J	Prandini, P; Deutsch, S; Lyle, R; Gagnebin, M; Vivier, CD; Delorenzi, M; Gehrig, C; Descombes, P; Sherman, S; Bricarelli, FD; Baldo, C; Novelli, A; Dallapiccola, B; Antonarakis, SE				Prandini, Paola; Deutsch, Samuel; Lyle, Robert; Gagnebin, Maryline; Vivier, Celine Delucinge; Delorenzi, Mauro; Gehrig, Corinne; Descombes, Patrick; Sherman, Stephanie; Bricarelli, Franca Dagna; Baldo, Chiara; Novelli, Antonio; Dallapiccola, Bruno; Antonarakis, Stylianos E.			Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOUSE MODEL; SYNDROME BRAIN; OVER-EXPRESSION; CHROMOSOME-21; CELL; POPULATIONS; TRISOMY-21	Down syndrome (DS) is characterized by extensive phenotypic variability, with most traits occurring in only a fraction of affected individuals. Substantial gene-expression variation is present among unaffected individuals, and this variation has a strong genetic component. Since DS is caused by genomic-dosage imbalance, we hypothesize that gene-expression variation of human chromosome 21 (HSA21) genes in individuals with DS has an impact on the phenotypic variability among affected individuals. We studied gene-expression variation in 14 lymphoblastoid and 17 fibroblast cell lines from individuals with DS and an equal number of controls. Gene expression was assayed using quantitative real-time polymerase chain reaction on 100 and 106 HSA21 genes and 23 and 26 non-HSA21 genes in lymphoblastoid and fibroblast cell lines, respectively. Surprisingly, only 39% and 62% of HSA21 genes in lymphoblastoid and fibroblast cells, respectively, showed a statistically significant difference between DS and normal samples, although the average up-regulation of HSA21 genes was close to the expected 1.5-fold in both cell types. Gene-expression variation in DS and normal samples was evaluated using the Kolmogorov-Smirnov test. According to the degree of overlap in expression levels, we classified all genes into 3 groups: (A) nonoverlapping, (13) partially overlapping, and (C) extensively overlapping expression distributions between normal and DS samples. We hypothesize that, in each cell type, group A genes are the most dosage sensitive and are most likely involved in the constant DS traits, group B genes might be involved in variable DS traits, and group C genes are not dosage sensitive and are least likely to participate in DS pathological phenotypes. This study provides the first extensive data set on HSA21 gene-expression variation in DS and underscores its rote in modulating the outcome of gene-dosage imbalance.	Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Ghent Univ Hosp, CH-1211 Geneva, Switzerland; Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva, Switzerland; Ullevaal Univ Hosp, Dept Med Genet, Oslo, Norway; Swiss Inst Bioinformat, Lausanne, Switzerland; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Emory Univ, Sch Med, Atlanta, GA 30322 USA; Galliera Hosp, Genet Lab, Genoa, Italy; IRCCS, CSS, San Giovanni Rotondo, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy	University of Geneva; Ghent University; Ghent University Hospital; University of Geneva; University of Oslo; Swiss Institute of Bioinformatics; Swiss Institute Experimental Cancer Research; Emory University; Ente Ospedaliero Ospedali Galliera; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome	Antonarakis, SE (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Stylianos.Antonarakis@medecine.unige.ch	Novelli, Antonio/K-4035-2016; Baldo, Chiara/AAB-1435-2020; Antonarakis, Stylianos E/N-8866-2014; Dallapiccola, Bruno/K-8692-2016	Baldo, Chiara/0000-0001-7508-3953; Antonarakis, Stylianos E/0000-0001-8907-5823; Dallapiccola, Bruno/0000-0002-5031-1013; Novelli, Antonio/0000-0002-9037-4297; Deutsch, Samuel/0000-0001-9456-7101	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038979] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000039, M01 RR00039] Funding Source: Medline; NICHD NIH HHS [R01 HD38979, R01 HD038979] Funding Source: Medline; Telethon [GTF04003] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		Amano K, 2004, HUM MOL GENET, V13, P1333, DOI 10.1093/hmg/ddh154; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Chung IH, 2005, J KOREAN MED SCI, V20, P82, DOI 10.3346/jkms.2005.20.1.82; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Epstein C. J., 1989, METABOLIC BASIS INHE, P291; FitzPatrick DR, 2005, TRENDS GENET, V21, P249, DOI 10.1016/j.tig.2005.02.012; Ganesh L, 2006, MOL CELL BIOL, V26, P3864, DOI 10.1128/MCB.26.10.3864-3874.2006; Georgiades P, 2006, DEVELOPMENT, V133, P1059, DOI 10.1242/dev.02277; Gross SJ, 2002, AM J OBSTET GYNECOL, V187, P457, DOI 10.1067/mob.2002.123542; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hu W, 2007, NEUROLOGY, V68, P277, DOI 10.1212/01.wnl.0000250240.99311.9d; Johnson-Leger CA, 2002, BLOOD, V100, P2479, DOI 10.1182/blood-2001-11-0098; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; Mao R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r107; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Mittaz L, 1997, GENOMICS, V41, P210, DOI 10.1006/geno.1997.4655; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Reboul J, 1999, GENOME RES, V9, P242; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Roper RJ, 2006, P NATL ACAD SCI USA, V103, P1452, DOI 10.1073/pnas.0510750103; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sanchez-Font MF, 2003, NUCLEIC ACIDS RES, V31, P2769, DOI 10.1093/nar/gkg396; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; Shin JH, 2004, NEUROCHEM INT, V45, P73, DOI 10.1016/j.neuint.2003.12.004; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200; Takei Y, 2002, J BIOL CHEM, V277, P43121, DOI 10.1074/jbc.C200442200; Tang Y, 2004, ANN NEUROL, V56, P808, DOI 10.1002/ana.20291; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200	45	143	148	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					252	263		10.1086/519248	http://dx.doi.org/10.1086/519248			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668376	Bronze, Green Published			2022-12-18	WOS:000248540400006
J	Salonen, JT; Uimari, P; Aalto, JM; Pirskanen, M; Kaikkonen, J; Todorova, B; Hypponen, J; Korhonen, VP; Asikainen, J; Devine, C; Tuomainen, TP; Luedemann, J; Nauck, M; Kerner, W; Stephens, RH; New, JP; Ollier, WE; Gibson, JM; Payton, A; Horan, MA; Pendleton, N; Mahoney, W; Meyre, D; Delplanque, J; Froguel, P; Luzzatto, O; Yakir, B; Darvasi, A				Salonen, Jukka T.; Uimari, Pekka; Aalto, Juha-Matti; Pirskanen, Mia; Kaikkonen, Jari; Todorova, Boryana; Hypponen, Jelena; Korhonen, Veli-Pekka; Asikainen, Janne; Devine, Christopher; Tuomainen, Tomi-Pekka; Luedemann, Jan; Nauck, Matthias; Kerner, Wolfgang; Stephens, Richard H.; New, John P.; Ollier, William E.; Gibson, J. Martin; Payton, Antony; Horan, Michael A.; Pendleton, Neil; Mahoney, Walt; Meyre, David; Delplanque, Jerome; Froguel, Philippe; Luzzatto, Oren; Yakir, Benjamin; Darvasi, Ariel			Type 2 diabetes whole-genome association study in four populations: The DiaGen consortium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE ASSOCIATION; JOUBERT-SYNDROME; RISK; GENE; MELLITUS; POLYMORPHISMS; GLUCOSE; LINKAGE; VARIANT; TCF7L2	Type 2 diabetes (T2D)) is a common, polygenic chronic disease with high heritability. The purpose of this whole-genome association study was to discover novel T2D-associated genes. We genotyped 500 familial cases and 497 controls with >300,000 HapMap-derived tagging single-nucleotide-polymorphism (SNP) markers. When a stringent statistical correction for multiple testing was used, the only significant SNP was at TCF7L2, which has already been discovered and confirmed as a T2D-susceptibility gene. For a replication study, we selected 10 SNPs in six chromosomal regions with the strongest association (singly or as part of a haplotype) for retesting in an independent case-control set including 2,573 T2D cases and 2,776 controls. The most significant replicated result was found at the AH11-LOC441171 gene region.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Stat, IL-91904 Jerusalem, Israel; Univ Kuopio, Oy Jurilab, FIN-70211 Kuopio, Finland; Univ Kuopio, Publ Hlth Res Inst, FIN-70211 Kuopio, Finland; Univ Kuopio, Sch Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland; Univ Greifswald, Inst Clin Chem & Lab Med, D-17487 Greifswald, Germany; Ctr Cardiol & Diabet, Karlsburg, Germany; Univ Manchester, Hope Hosp, Vasc Res Grp, Salford M6 8HD, Lancs, England; Univ Manchester, Hope Hosp, Div Med & Neurosci, Salford M6 8HD, Lancs, England; Univ Manchester, Ctr Integrated Genom Med Res, Manchester M13 9PL, Lancs, England; Nanogen, San Diego, CA USA; Inst Pasteur, CNRS, UMR, F-59019 Lille, France; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Ernst Moritz Arndt Universitat Greifswald; University of Manchester; University of Manchester; University of Manchester; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Imperial College London	Darvasi, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	arield@cc.huji.ac.il	Meyre, David/D-7315-2011; Pendleton, Neil/F-2333-2015; FROGUEL, Philippe/O-6799-2017	Meyre, David/0000-0003-4850-7444; Pendleton, Neil/0000-0003-0794-2386; FROGUEL, Philippe/0000-0003-2972-0784; New, John/0000-0003-4146-025X; Stephens, Richard/0000-0001-6596-5434; gibson, martin/0000-0002-1331-1524; Payton, Antony/0000-0003-0335-152X	Medical Research Council [G0600331] Funding Source: Medline; MRC [G0600331] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Barroso I, 2005, DIABETIC MED, V22, P517, DOI 10.1111/j.1464-5491.2005.01550.x; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; ERONEN L, 2004, PAC S BIOCOMPUT, V9, P104; Eronen L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-542; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hansen L, 2005, DIABETES OBES METAB, V7, P122, DOI 10.1111/j.1463-1326.2004.00396.x; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Luedemann J, 2002, STROKE, V33, P2929, DOI 10.1161/01.STR.0000038422.57919.7F; Mayer BJ, 2001, J CELL SCI, V114, P1253; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; PERMUTT MA, 1991, BAILLIERE CLIN ENDOC, V5, P495, DOI 10.1016/S0950-351X(05)80144-2; Rabbitt PMA, 2004, AGING NEUROPSYCHOL C, V11, P245, DOI 10.1080/13825580490511116; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Toivonen HTT, 2000, AM J HUM GENET, V67, P133, DOI 10.1086/302954; Tsuchiya T, 2006, MOL GENET METAB, V89, P174, DOI 10.1016/j.ymgme.2006.05.013; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Xiang KS, 2004, DIABETES, V53, P228, DOI 10.2337/diabetes.53.1.228	28	143	152	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					338	345		10.1086/520599	http://dx.doi.org/10.1086/520599			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668382	Bronze, Green Published			2022-12-18	WOS:000248540400012
J	Siintola, E; Topcu, M; Aula, N; Lohi, H; Minassian, BA; Paterson, AD; Liu, XQ; Wilson, C; Lahtinen, U; Anttonen, AK; Lehesjoki, AE				Siintola, Eija; Topcu, Meral; Aula, Nina; Lohi, Hannes; Minassian, Berge A.; Paterson, Andrew D.; Liu, Xiao-Qing; Wilson, Callum; Lahtinen, Ulla; Anttonen, Anna-Kaisa; Lehesjoki, Anna-Elina			The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CATHEPSIN-D DEFICIENCY; STORAGE DISEASE; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; MUTANT MICE; MUTATIONS; CLN6; LEADS; DISRUPTION; RESIDENT	The late-infantile-onset forms are the most genetically heterogeneous group among the autosomal recessively inherited neurodegenerative disorders, the neuronal ceroid lipofuscinoses (NCLs). The Turkish variant was initially considered to be a distinct genetic entity, with clinical presentation similar to that of other forms of late- infantile-onset NCL (LINCL), including age at onset from 2 to 7 years, epileptic seizures, psychomotor deterioration, myoclonus, loss of vision, and premature death. However, Turkish variant LINCL was recently found to be genetically heterogeneous, because mutations in two genes, CLN6 and CLN8, were identified to underlie the disease phenotype in a subset of patients. After a genomewide scan with single-nucleotide-polymorphism markers and homozygosity mapping in nine Turkish families and one Indian family, not linked to any of the known NCL loci, we mapped a novel variant LINCL locus to chromosome 4q28.1-q28.2 in five families. We identified six different mutations in the MFSD8 gene ( previously denoted "MGC33302"), which encodes a novel polytopic 518-amino acid membrane protein that belongs to the major facilitator superfamily of transporter proteins. MFSD8 is expressed ubiquitously, with several alternatively spliced variants. Like the majority of the previously identified NCL proteins, MFSD8 localizes mainly to the lysosomal compartment. However, the function of MFSD8 remains to be elucidated. Analysis of the genome-scan data suggests the existence of at least three more genes in the remaining five families, further corroborating the great genetic heterogeneity of LINCLs.	Univ Helsinki, Biomed Helsinki, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Neurosci Ctr, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Hacettepe Univ, Fac Med, Sect Child Neurol, Dept Pediat, TR-06100 Ankara, Turkey; Univ Toronto, Hosp Sick Children, Toronto, ON M4X 1K9, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M4X 1K9, Canada; Starship Childrens Hosp, Auckland, New Zealand	University of Helsinki; University of Helsinki; University of Helsinki; Hacettepe University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Starship Children's Hospital	Lehesjoki, AE (corresponding author), Univ Helsinki, Biomed Helsinki, Folkhalsan Inst Genet, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	anna-elina.lehesjoki@helsinki.fi	Lohi, Hannes/F-4596-2011; Paterson, Andrew/AAQ-7511-2020; Paterson, Andrew D/A-4088-2011	Lohi, Hannes/0000-0003-1087-5532; Paterson, Andrew/0000-0002-9169-118X; Paterson, Andrew D/0000-0002-9169-118X; Lahtinen, Ulla Marketta/0000-0002-5798-8633; Liu, Xiao-Qing/0000-0002-4034-5156				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BERKOVIC SF, 1988, BRAIN, V111, P27, DOI 10.1093/brain/111.1.27; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Cannelli N, 2006, NEUROGENETICS, V7, P111, DOI 10.1007/s10048-005-0024-y; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Casal M, 1999, J BACTERIOL, V181, P2620, DOI 10.1128/JB.181.8.2620-2623.1999; Das AK, 1998, J CLIN INVEST, V102, P361, DOI 10.1172/JCI3112; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; Heine C, 2004, J BIOL CHEM, V279, P22347, DOI 10.1074/jbc.M400643200; Hellsten E, 1996, EMBO J, V15, P5240, DOI 10.1002/j.1460-2075.1996.tb00909.x; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Isosomppi J, 2002, HUM MOL GENET, V11, P885, DOI 10.1093/hmg/11.8.885; Jarvela I, 1998, HUM MOL GENET, V7, P85, DOI 10.1093/hmg/7.1.85; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; Lonka L, 2000, HUM MOL GENET, V9, P1691, DOI 10.1093/hmg/9.11.1691; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Patton-Vogt JL, 1998, GENETICS, V149, P1707; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; PRESS EM, 1960, BIOCHEM J, V74, P501, DOI 10.1042/bj0740501; Ranta S, 2004, HUM MUTAT, V23, P300, DOI 10.1002/humu.20018; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P105; Reece M, 1998, FEBS LETT, V433, P245, DOI 10.1016/S0014-5793(98)00907-7; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; Savukoski M, 1998, NAT GENET, V19, P286, DOI 10.1038/975; Schulz A, 2004, ANN NEUROL, V56, P342, DOI 10.1002/ana.20187; Siintola E, 2005, CLIN GENET, V68, P167, DOI 10.1111/j.1399-0004.2005.00471.x; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Soares-Silva I, 2003, BIOCHEM J, V376, P781, DOI 10.1042/BJ20031180; Steinfeld R, 2006, AM J HUM GENET, V78, P988, DOI 10.1086/504159; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Tang CH, 2006, MOL CELL BIOL, V26, P2309, DOI 10.1128/MCB.26.6.2309-2316.2006; Topcu M, 2004, TURKISH J PEDIATR, V46, P1; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Wheeler RB, 1999, MOL GENET METAB, V66, P337, DOI 10.1006/mgme.1999.2804; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; Williams RE, 1999, BIOM HLTH R, V33, P114; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x	49	143	149	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					136	146		10.1086/518902	http://dx.doi.org/10.1086/518902			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564970	Green Published, Bronze			2022-12-18	WOS:000247039700012
J	Reich, D; Patterson, N; Ramesh, V; De Jager, PL; McDonald, GJ; Tandon, A; Choy, E; Hu, DL; Tamraz, B; Pawlikowska, L; Wassel-Fyr, C; Huntsman, S; Waliszewska, A; Rossin, E; Li, RL; Garcia, M; Reiner, A; Ferrell, R; Cummings, S; Kwok, PY; Harris, T; Zmuda, JM; Ziv, E				Reich, David; Patterson, Nick; Ramesh, Vijaya; De Jager, Philip L.; McDonald, Gavin J.; Tandon, Arti; Choy, Edwin; Hu, Donglei; Tamraz, Bani; Pawlikowska, Ludmila; Wassel-Fyr, Christina; Huntsman, Scott; Waliszewska, Alicja; Rossin, Elizabeth; Li, Rongling; Garcia, Melissa; Reiner, Alexander; Ferrell, Robert; Cummings, Steve; Kwok, Pui-Yan; Harris, Tamara; Zmuda, Joseph M.; Ziv, Elad		Hlth ABC Study	Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; LINKAGE-DISEQUILIBRIUM; CARDIOVASCULAR EVENTS; INFLAMMATORY MARKERS; DISEASE; CORONARY; RISK; ASSOCIATION; POPULATIONS	Circulating levels of inflammatory markers can predict cardiovascular disease risk. To identify genes influencing the levels of these markers, we genotyped 1,343 single-nucleotide polymorphisms (SNPs) in 1,184 African Americans from the Health, Aging and Body Composition (Health ABC) Study. Using admixture mapping, we found a significant association of interleukin 6 soluble receptor (IL-6 SR) with European ancestry on chromosome 1 (LOD 4.59), in a region that includes the gene for this receptor (IL-6R). Genotyping 19 SNPs showed that the effect is largely explained by an allele at 4% frequency in West Africans and at 35% frequency in European Americans, first described as associated with IL-6 SR in a Japanese cohort. We replicate this association (P << 1.0 x 10(-12)) and also demonstrate a new association with circulating levels of a different molecule, IL-6 (P < 3.4 x 10(-5)). After replication in 1,674 European Americans from Health ABC, the combined result is even more significant: P << 1.0 x 10(-12) for IL-6 SR, and P < 2.0 x 10(-9) for IL-6. These results also serve as an important proof of principle, showing that admixture mapping can not only coarsely localize but can also fine map a phenotypically important variant.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Richard B Simches Res Ctr, Boston, MA 02114 USA; Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Partners Healthcare Ctr Genet & Genom, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02138 USA; MIT, Cambridge, MA 02139 USA; Univ Calif San Francisco, Div Gen Internal Med, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogenom, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Calif Pacific Med Ctr Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA; Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA; NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; Univ Washington, Sch Publ Hlth & Community Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Univ Pittsburgh, Dept Epidemiol & Human Genet, Pittsburgh, PA 15260 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, New Res Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu	Ziv, Elad/L-5396-2014; Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Choy, Edwin/0000-0001-9896-8084	NCI NIH HHS [K22 CA109351] Funding Source: Medline; NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NIA NIH HHS [R01 AG021024, N01 AG062106, N01 AG062103, N01 AG062101] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NINDS NIH HHS [P30 NS045776] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA109351] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG007390, N01AG062103, R01AG021024, N01AG062106, N01AG062101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Austin MA, 2004, ANN HUM GENET, V68, P179, DOI 10.1046/j.1529-8817.2004.00078.x; Best LG, 2004, HUM HERED, V58, P112, DOI 10.1159/000083032; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Collins-Schramm HE, 2003, HUM GENET, V113, P211, DOI 10.1007/s00439-003-0961-1; Curb JD, 2003, CIRCULATION, V107, P2016, DOI 10.1161/01.CIR.0000065228.20100.F7; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Maat MPM, 2004, ARTERIOSCL THROM VAS, V24, P2168, DOI 10.1161/01.ATV.0000143856.01669.e7; DEAN PN, 1990, CYTOMETRY, V11, P321, DOI 10.1002/cyto.990110302; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Finney D.J., 1971, PROBIT ANAL; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Galicia JC, 2004, GENES IMMUN, V5, P513, DOI 10.1038/sj.gene.6364120; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Jones R. A. C., 2001, Integrated Pest Management Reviews, V6, P15, DOI 10.1023/A:1020494604184; Kanaya AM, 2006, ARCH INTERN MED, V166, P350, DOI 10.1001/archinte.166.3.350; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; Kritchevsky SB, 2005, CARDIOVASC RES, V66, P265, DOI 10.1016/j.cardiores.2004.12.026; Kwok PY, 2002, HUM MUTAT, V19, P315, DOI 10.1002/humu.10058; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2005, PHILOS T ROY SOC B, V360, P1605, DOI 10.1098/rstb.2005.1691; Retterstol L, 2003, ATHEROSCLEROSIS, V169, P279, DOI 10.1016/S0021-9150(03)00192-8; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; RIFE DC, 1954, AM J HUM GENET, V6, P26; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Tuomisto K, 2006, THROMB HAEMOSTASIS, V95, P511, DOI 10.1160/TH05-08-0571; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Wiederhold T, 2004, ONCOGENE, V23, P8815, DOI 10.1038/sj.onc.1208110; Worns MA, 2006, GENES IMMUN, V7, P600, DOI 10.1038/sj.gene.6364330; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510	42	143	151	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					716	726		10.1086/513206	http://dx.doi.org/10.1086/513206			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357077	Green Published, Bronze			2022-12-18	WOS:000245465200012
J	Rosenberg, EH; Almeida, LS; Kleefstra, T; deGrauw, RS; Yntema, HG; Bahi, N; Moraine, C; Ropers, HH; Fryns, JP; deGrauw, TJ; Jakobs, C; Salomons, GS				Rosenberg, EH; Almeida, LS; Kleefstra, T; deGrauw, RS; Yntema, HG; Bahi, N; Moraine, C; Ropers, HH; Fryns, JP; deGrauw, TJ; Jakobs, C; Salomons, GS			High prevalence of SLC6A8 deficiency in X-linked mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY; TRANSPORTER GENE SLC6A8; BRAIN CREATINE DEFICIENCY; INBORN ERROR; METABOLISM; MUTATION; DEFECT; XQ28	A novel X-linked mental retardation (XLMR) syndrome was recently identified, resulting from creatine deficiency in the brain caused by mutations in the creatine transporter gene, SLC6A8. We have studied the prevalence of SLC6A8 mutations in a panel of 290 patients with nonsyndromic XLMR archived by the European XLMR Consortium. The full-length open reading frame and splice sites of the SLC6A8 gene were investigated by DNA sequence analysis. Six pathogenic mutations, of which five were novel, were identified in a total of 288 patients with XLMR, showing a prevalence of at least 2.1% (6/288). The novel pathogenic mutations are a nonsense mutation (p.Y317X) and four missense mutations. Three missense mutations (p. G87R, p. P390L, and p. P554L) were concluded to be pathogenic on the basis of conservation, segregation, chemical properties of the residues involved, as well as the absence of these and any other missense mutation in 276 controls. For the p. C337W mutation, additional material was available to biochemically prove (i.e., by increased urinary creatine: creatinine ratio) pathogenicity. In addition, we found nine novel polymorphisms (IVS1+26G-->A, IVS7+37G-->A, IVS7+ 87A-->G, IVS7-35G-->A, IVS12-3C-->T, IVS2+88G-->C, IVS9-36G-->A, IVS12-82G-->C, and p. Y498) that were present in the XLMR panel and/or in the control panel. Two missense variants (p.V629I and p. M560V) that were not highly conserved and were not associated with increased creatine: creatinine ratio, one translational silent variant (p.L472), and 10 intervening sequence variants or untranslated region variants (IVS6+9C-->T, IVS7-151_152delGA, IVS7-99C-->A, IVS8-35G-->A, IVS8+28C-->T, IVS10-18C-->T, IVS11+21G-->A, IVS12+15C-->T, *207G-->C, IVS12+32C-->A) were found only in the XLMR panel but should be considered as unclassified variants or as a polymorphism (p.M560V). Our data indicate that the frequency of SLC6A8 mutations in the XLMR population is close to that of CGG expansions in FMR1, the gene responsible for fragile-X syndrome.	Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Metab Unit, NL-1081 HV Amsterdam, Netherlands; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Childrens Hosp, Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; CHU Cochin, Inst Cochin Genet Mol, INSERM, CNRS, Paris, France; CHU Bretonneau, Serv Genet, INSERM, U316, F-37044 Tours, France; Max Planck Inst Mol Genet, Berlin, Germany; Catholic Univ Louvain, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; Cincinnati Children's Hospital Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Universite Catholique Louvain	Salomons, GS (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Metab Unit, 1Wbi2,Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	g.salomons@vumc.nl	Rosenberg, Efraim/C-7180-2008; Kleefstra, Tjitske/G-2619-2012; Yntema, H.G./L-4771-2015	Rosenberg, Efraim/0000-0002-3859-6941; Almeida, Ligia/0000-0003-1370-961X				Bauman PA, 2002, ARCH BIOCHEM BIOPHYS, V404, P80, DOI 10.1016/S0003-9861(02)00232-1; Bianchi MC, 2000, ANN NEUROL, V47, P511; Bizzi A, 2002, ANN NEUROL, V52, P227, DOI 10.1002/ana.10246; Brown A, 2004, AM J PHYSIOL-CELL PH, V286, pC1071, DOI 10.1152/ajpcell.00291.2003; Cecil KM, 2001, ANN NEUROL, V49, P401, DOI 10.1002/ana.79; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; DeGrauw TJ, 2002, NEUROPEDIATRICS, V33, P232, DOI 10.1055/s-2002-36743; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; deVries BBA, 1997, AM J HUM GENET, V61, P660, DOI 10.1086/515496; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; GREGOR P, 1995, GENOMICS, V25, P332, DOI 10.1016/0888-7543(95)80155-F; Hahn KA, 2002, AM J HUM GENET, V70, P1349, DOI 10.1086/340092; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Item CB, 2001, AM J HUM GENET, V69, P1127, DOI 10.1086/323765; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; Sandoval N, 1996, GENOMICS, V35, P383, DOI 10.1006/geno.1996.0373; Schulze A, 1997, J PEDIATR-US, V131, P626, DOI 10.1016/S0022-3476(97)70075-1; Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5; STOCKLER S, 1994, PEDIATR RES, V36, P409; Stockler S, 1996, AM J HUM GENET, V58, P914; Stromberger C, 2003, J INHERIT METAB DIS, V26, P299, DOI 10.1023/A:1024453704800; van der Knaap MS, 2000, ANN NEUROL, V47, P540, DOI 10.1002/1531-8249(200004)47:4<540::AID-ANA23>3.0.CO;2-K; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	26	143	150	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					97	105		10.1086/422102	http://dx.doi.org/10.1086/422102			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15154114	Green Published, Bronze			2022-12-18	WOS:000222031300012
J	De Vos, M; Hayward, BE; Picton, S; Sheridan, E; Bonthron, DT				De Vos, M; Hayward, BE; Picton, S; Sheridan, E; Bonthron, DT			Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA MISMATCH REPAIR; PRIMITIVE NEUROECTODERMAL TUMOR; GERM-LINE MUTATION; CELL-LINE; HEMATOLOGICAL MALIGNANCY; TYPE-1 NEUROFIBROMATOSIS; GENE; SUPRATENTORIAL; HPMS2; DEFICIENT	We investigated a family with an autosomal recessive syndrome of cafe-au-lait patches and childhood malignancy, notably supratentorial primitive neuroectodermal tumor. There was no cancer predisposition in heterozygotes; nor was there bowel cancer in any individual. However, autozygosity mapping indicated linkage to a region of 7p22 surrounding the PMS2 mismatch-repair gene. Sequencing of genomic PCR products initially failed to identify a PMS2 mutation. Genome searches then revealed a previously unrecognized PMS2 pseudogene, corresponding to exons 9-15, within a 100-kb inverted duplication situated 600 kb centromeric from PMS2 itself. This information allowed a redesigned sequence analysis, identifying a homozygous mutation (R802X) in PMS2 exon 14. Furthermore, in the family with Turcot syndrome, in which the first inherited PMS2 mutation (R134X) was described, a further truncating mutation was identified on the other allele, in exon 13. Further whole-genome analysis shows that the complexity of PMS2 pseudogenes is greater than appreciated and may have hindered previous mutation studies. Several previously reported PMS2 polymorphisms are, in fact, pseudogene sequence variants. Although PMS2 mutations may be rare in colorectal cancer, they appear, for the most part, to behave as recessive traits. For technical reasons, their involvement in childhood cancer, particularly in primitive neuroectodermal tumor, may have been underestimated.	Univ Leeds, Mol Med Unit, Leeds, W Yorkshire, England; St James Univ Hosp, Dept Paediat Oncol, Leeds, W Yorkshire, England; St James Univ Hosp, Dept Clin Genet, Leeds, W Yorkshire, England	University of Leeds; Saint James's University Hospital; Saint James's University Hospital	Bonthron, DT (corresponding author), Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England.	d.t.bonthron@leeds.ac.uk	De Vos, Michel/AAG-3014-2020	De Vos, Michel/0000-0001-5019-5924; Bonthron, David/0000-0001-8132-8179				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BAPTISTE M, 1989, NEUROLOGY, V39, P487, DOI 10.1212/WNL.39.4.487; Basil JB, 1999, GYNECOL ONCOL, V74, P395, DOI 10.1006/gyno.1999.5486; BURWELL RG, 1982, ARCH DIS CHILD, V57, P631, DOI 10.1136/adc.57.8.631; Chadwick R B, 2000, Hum Mutat, V16, P530; Chan GCF, 1996, MED PEDIATR ONCOL, V26, P215, DOI 10.1002/(SICI)1096-911X(199603)26:3<215::AID-MPO12>3.0.CO;2-F; De Rosa M, 2000, ONCOGENE, V19, P1719, DOI 10.1038/sj.onc.1203447; Dirks PB, 1996, J NEURO-ONCOL, V29, P75, DOI 10.1007/BF00165520; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; Glaab WE, 1998, J BIOL CHEM, V273, P26662, DOI 10.1074/jbc.273.41.26662; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Ho YS, 1996, CANCER LETT, V104, P103, DOI 10.1016/0304-3835(96)04238-3; HORII A, 1994, BIOCHEM BIOPH RES CO, V204, P1257, DOI 10.1006/bbrc.1994.2598; Jakacki RI, 1999, CHILD NERV SYST, V15, P586, DOI 10.1007/s003810050547; Kato T, 1998, MUTAT RES-FUND MOL M, V422, P279, DOI 10.1016/S0027-5107(98)00208-5; Kondo E, 1999, J BIOCHEM-TOKYO, V125, P818; Korf B R, 2000, Oncologist, V5, P477, DOI 10.1634/theoncologist.5-6-477; KORF BR, 1992, PEDIATRICS, V90, P924; KURAMOTO H, 1972, AM J OBSTET GYNECOL, V114, P1012, DOI 10.1016/0002-9378(72)90861-7; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Liu T, 2001, CANCER RES, V61, P7798; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Martinez-lage JF, 2002, NEUROCIRUGIA, V13, P128; Miyaki M, 1997, ONCOGENE, V15, P2877, DOI 10.1038/sj.onc.1201668; Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122; Nicolaides NC, 1998, MOL CELL BIOL, V18, P1635, DOI 10.1128/MCB.18.3.1635; NICOLAIDES NC, 1995, GENOMICS, V30, P195, DOI 10.1006/geno.1995.9885; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Orellana C, 1998, CANCER GENET CYTOGEN, V105, P103, DOI 10.1016/S0165-4608(98)00015-6; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Osborne LR, 1997, GENOMICS, V45, P402, DOI 10.1006/geno.1997.4923; Paulino AC, 1999, CANCER-AM CANCER SOC, V86, P135, DOI 10.1002/(SICI)1097-0142(19990701)86:1<135::AID-CNCR19>3.0.CO;2-0; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; PERILONGO G, 1993, LEUKEMIA, V7, P912; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; RAFFEL C, 1989, NEUROSURGERY, V25, P959, DOI 10.1227/00006123-198912000-00018; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Ricciardone MD, 1999, CANCER RES, V59, P290; RISINGER JI, 1995, J BIOL CHEM, V270, P18183, DOI 10.1074/jbc.270.31.18183; Risinger JI, 1998, CANCER RES, V58, P2978; Ruggieri M, 2001, NEUROLOGY, V56, P1433, DOI 10.1212/WNL.56.11.1433; Russo C, 1999, CANCER, V86, P331, DOI 10.1002/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Strother D, 2001, J CLIN ONCOL, V19, P2696, DOI 10.1200/JCO.2001.19.10.2696; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trimbath J D, 2001, Fam Cancer, V1, P101; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; Vilkki S, 2001, CANCER RES, V61, P4541; Wang Q, 1999, CANCER RES, V59, P294; Whiteside D, 2002, CANCER RES, V62, P359; Yamada NA, 2003, MUTAGENESIS, V18, P277, DOI 10.1093/mutage/18.3.277; Yang HJ, 1999, CHILD NERV SYST, V15, P377, DOI 10.1007/s003810050418	56	143	152	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					954	964		10.1086/420796	http://dx.doi.org/10.1086/420796			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15077197	Bronze, Green Published			2022-12-18	WOS:000220926100015
J	Keyser-Tracqui, C; Crubezy, E; Ludes, B				Keyser-Tracqui, C; Crubezy, E; Ludes, B			Nuclear and mitochondrial DNA analysis of a 2,000-year-old necropolis in the Egyin Gol Valley of Mongolia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANCIENT DNA; FORENSIC GENETICS; NEW-WORLD; POPULATIONS; SEQUENCE; REMAINS; REGION; LINEAGES; HISTORY; ORIGIN	DNA was extracted from the skeletal remains of 62 specimens excavated from the Egyin Gol necropolis, in northern Mongolia. This burial site is linked to the Xiongnu period and was used from the 3rd century B. C. to the 2nd century A. D. Three types of genetic markers were used to determine the genetic relationships between individuals buried in the Egyin Gol necropolis. Results from analyses of autosomal and Y chromosome short tandem repeats, as well as mitochondrial DNA, showed close relationships between several specimens and provided additional background information on the social organization within the necropolis as well as the funeral practices of the Xiongnu people. To the best of our knowledge, this is the first study using biparental, paternal, and maternal genetic systems to reconstruct partial genealogies in a protohistoric necropolis.	Inst Med Legale, Lab Anthropol Mol, F-67085 Strasbourg, France; Univ Toulouse 3, CNRS, UMR 8555, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Keyser-Tracqui, C (corresponding author), Inst Med Legale, Lab Anthropol Mol, 11 Rue Humann, F-67085 Strasbourg, France.		LUDES, Bertrand/AAB-6309-2022; Crubézy, Eric/AAB-5165-2022	Crubézy, Eric/0000-0001-9417-9053				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Burger J, 1999, ELECTROPHORESIS, V20, P1722; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Clisson I, 2002, INT J LEGAL MED, V116, P304, DOI 10.1007/s00414-002-0295-x; Collins MJ, 1999, PHILOS T R SOC B, V354, P51, DOI 10.1098/rstb.1999.0359; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; Cooper A, 2000, SCIENCE, V289, P1139; Crubezy E, 1996, ANTIQUITY, V70, P891, DOI 10.1017/S0003598X00084143; Crubezy E., 2000, ARCHEOLOGIE FUNERAIR; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; Fily ML, 1998, CR ACAD SCI III-VIE, V321, P79, DOI 10.1016/S0764-4469(97)89629-1; FRANCFORT HP, 2000, FOUILLE KOURGANE SCY, P775; Gabriel MN, 2001, J FORENSIC SCI, V46, P247; Gill P, 2001, INT J LEGAL MED, V114, P305, DOI 10.1007/s004140100232; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Henke J, 2001, CROAT MED J, V42, P292; Hummel S, 2000, Anthropol Anz, V58, P15; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; Kolman CJ, 1996, GENETICS, V142, P1321; Kolman CJ, 2000, AM J PHYS ANTHROPOL, V111, P5; KONOVALOV NB, 1976, KHUNY 5 ZABAYIKALE A; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; MARX I, 2000, XIONGNU CULTURE 3 CE; MINAJEV SS, 1996, DOSSIERS ARCHEOLOGIE, V212, P74; Murail P, 1999, INT J OSTEOARCHAEOL, V9, P39, DOI 10.1002/(SICI)1099-1212(199901/02)9:1<39::AID-OA458>3.3.CO;2-M; Murail P, 2000, ANTIQUITY, V74, P531, DOI 10.1017/S0003598X00059883; Nielsen-Marsh C, 2000, HUMAN OSTEOLOGY ARCH, P439; Person A, 1996, PALAEOGEOGR PALAEOCL, V126, P135, DOI 10.1016/S0031-0182(97)88906-7; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Rudenko Sergei, 1970, FROZEN TOMBS SIBERIA; Schultes T, 2000, Anthropol Anz, V58, P37; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Stone AC, 1999, PHILOS T R SOC B, V354, P153, DOI 10.1098/rstb.1999.0368; TORRONI A, 1993, AM J HUM GENET, V53, P563; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	38	143	156	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					247	260		10.1086/377005	http://dx.doi.org/10.1086/377005			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	702KW	12858290	Green Published, Bronze			2022-12-18	WOS:000184223900003
J	Zweers, MC; Bristow, J; Steijlen, PM; Dean, WB; Kucharekova, M; Boezeman, JB; Schalkwijk, J				Zweers, MC; Bristow, J; Steijlen, PM; Dean, WB; Kucharekova, M; Boezeman, JB; Schalkwijk, J			Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TENASCIN-X DEFICIENCY; JOINT HYPERMOBILITY; COLLAGEN		Univ Med Ctr Nijmegen, Dept Dermatol, POB 9101, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Human Genet, Nijmegen, Netherlands; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	Radboud University Nijmegen; Radboud University Nijmegen; University of California System; University of California San Francisco	Zweers, MC (corresponding author), Univ Med Ctr Nijmegen, Dept Dermatol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	m.zweers@derma.umcn.nl	Schalkwijk, Joost/N-1774-2013; Steijlen, Peter/X-2729-2019; Otero, M.E./L-4446-2015; Schalkwijk, Joost/R-7509-2019; Boezeman, J.B.M./L-4209-2015; Zweers, Manon/E-5090-2016	Schalkwijk, Joost/0000-0002-1308-1319; 	NHLBI NIH HHS [HL 60875] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060875] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; BYERS PH, 1994, J INVEST DERMATOL, V103, pS47, DOI 10.1038/jid.1994.9; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; Grahame R, 2000, J RHEUMATOL, V27, P1777; Grahame R, 1999, ARCH DIS CHILD, V80, P188, DOI 10.1136/adc.80.2.188; LARSSON LG, 1987, ARTHRITIS RHEUM, V30, P1426, DOI 10.1002/art.1780301216; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; NARCISI P, 1994, HUM MOL GENET, V3, P1617, DOI 10.1093/hmg/3.9.1617; RikkenBultman DGA, 1997, EUR J OBSTET GYN R B, V73, P189, DOI 10.1016/S0301-2115(97)02745-0; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9	13	143	149	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					214	217		10.1086/376564	http://dx.doi.org/10.1086/376564			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12865992	Green Published, Bronze			2022-12-18	WOS:000183904900020
J	Sung, SS; Brassington, AME; Grannatt, K; Rutherford, A; Whitby, FG; Krakowiak, PA; Jorde, LB; Carey, JC; Bamshad, M				Sung, SS; Brassington, AME; Grannatt, K; Rutherford, A; Whitby, FG; Krakowiak, PA; Jorde, LB; Carey, JC; Bamshad, M			Mutations in genes encoding fast-twitch contractile proteins cause distal arthrogryposis syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FREEMAN-SHELDON-SYNDROME; TROPONIN-I ISOFORMS; DROSOPHILA-MELANOGASTER; NEMALINE MYOPATHY; CLINICAL ANALYSIS; SKELETAL-MUSCLE; TROPOMYOSIN; CARDIOMYOPATHY; ABNORMALITIES; VARIANT	The distal arthrogryposes (DAs) are a group of disorders characterized by multiple congenital contractures of the limbs. We previously mapped a locus for DA type 2B (DA2B), the most common of the DAs, to chromosome 11. We now report that DA2B is caused by mutations in TNNI2 that are predicted to disrupt the carboxy-terminal domain of an isoform of troponin I (TnI) specific to the troponin-tropomyosin (Tc-Tm) complex of fast-twitch myofibers. Because the DAs are genetically heterogeneous, we sought additional candidate genes by examining modifiers of mutant Drosophila isoforms of TnI. One of these modifiers, Tm2, encodes tropomyosin, another component of the Tc-Tm complex. A human homologue of Tm2, TPM2, enocodes beta-tropomyosin and maps to the critical interval of DA type 1 (DA1). We discovered that DA1 is caused by substitution of a highly conserved amino acid residue in beta-tropomyosin. These findings suggest that DAs, in general, may be caused by mutations in genes encoding proteins of the contractile apparatus specific to fast-twitch myofibers. This provides a new opportunity to directly study the etiology and pathogenesis of multiple-congenital-contracture syndromes.	Univ Utah, Hlth Sci Ctr, Dept Human Genet, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84112 USA; Univ Utah, Hlth Sci Ctr, Dept Pediat, Salt Lake City, UT 84112 USA; Shriners Hosp Children, Intermt Unit, Salt Lake City, UT USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Arkansas System; University of Arkansas Medical Sciences	Bamshad, M (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Human Genet, Eccles Inst Human Genet, 15 North 2030 East, Salt Lake City, UT 84112 USA.				PHS HHS [M01-00064] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDRADE MD, 1998, AM J MED GENET, V79, P97; BAMSHAD M, 1994, AM J HUM GENET, V55, P1153; Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Bamshad M, 1996, AM J MED GENET, V65, P282, DOI 10.1002/(SICI)1096-8628(19961111)65:4<282::AID-AJMG7>3.0.CO;2-R; BARBAS JA, 1993, MOL CELL BIOL, V13, P1433, DOI 10.1128/MCB.13.3.1433; BEALL CJ, 1991, J CELL BIOL, V114, P941, DOI 10.1083/jcb.114.5.941; Burton D, 2002, BIOCHEM J, V362, P443, DOI 10.1042/0264-6021:3620443; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; DEAK II, 1982, J EMBRYOL EXP MORPH, V69, P61; DEAKII, 1977, J EMBRYOL EXP MORPHO, V40, P885; Digel J, 2001, ARCH BIOCHEM BIOPHYS, V387, P243, DOI 10.1006/abbi.2000.2259; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; Feldman L, 2002, MICROVASC RES, V63, P41, DOI 10.1006/mvre.2001.2364; Freeman E A, 1938, Arch Dis Child, V13, P277; FYRBERG E, 1990, J MOL BIOL, V216, P657, DOI 10.1016/0022-2836(90)90390-8; HALL JG, 1985, CLIN ORTHOP RELAT R, P44; HALL JG, 1982, AM J MED GENET, V11, P185, DOI 10.1002/ajmg.1320110208; HOTTA Y, 1972, NATURE, V240, P527, DOI 10.1038/240527a0; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; KLEMP P, 1995, AM J MED GENET, V55, P414, DOI 10.1002/ajmg.1320550406; Krakowiak PA, 1997, AM J HUM GENET, V60, P426; Krakowiak PA, 1998, AM J MED GENET, V76, P93, DOI 10.1002/(SICI)1096-8628(19980226)76:1<93::AID-AJMG17>3.0.CO;2-K; McDonough JL, 1999, CIRC RES, V84, P9; Moraczewska J, 2000, BIOPHYS J, V79, P3217, DOI 10.1016/S0006-3495(00)76554-4; Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645; Mullen AJ, 2000, GENE, V242, P313, DOI 10.1016/S0378-1119(99)00519-3; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Naimi B, 2001, MOL BIOL CELL, V12, P1529, DOI 10.1091/mbc.12.5.1529; Pieples K, 2000, BIOCHEMISTRY-US, V39, P8291, DOI 10.1021/bi000047x; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Squire JM, 1998, FASEB J, V12, P761, DOI 10.1096/fasebj.12.10.761; VANEK J, 1986, J MED GENET, V23, P231, DOI 10.1136/jmg.23.3.231; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Whitby FG, 2000, PROTEINS, V38, P49; ZHU L, 1995, DEV BIOL, V169, P487, DOI 10.1006/dbio.1995.1163	36	143	151	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					681	690		10.1086/368294	http://dx.doi.org/10.1086/368294			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12592607	Bronze, Green Published			2022-12-18	WOS:000181152600017
J	Kanetsky, PA; Swoyer, J; Panossian, S; Holmes, R; Guerry, D; Rebbeck, TR				Kanetsky, PA; Swoyer, J; Panossian, S; Holmes, R; Guerry, D; Rebbeck, TR			A polymorphism in the agouti signaling protein gene is associated with human pigmentation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STIMULATING-HORMONE-RECEPTOR; HUMAN MELANOCYTES; RED HAIR; MELANOCORTIN-1 RECEPTOR; HUMAN HOMOLOG; MUTATIONS; MELANOGENESIS; NOMENCLATURE; PHENOTYPE; MELANOMA	In mice and humans, binding of alpha-melanocyte-stimulating hormone to the melanocyte-stimulating-hormone receptor (MSHR), the protein product of melanocortin-1 receptor (MC1R) gene, leads to the synthesis of eumelanin. In the mouse, ligation of MSHR by agouti signaling protein (ASP) results in the production of pheomelanin. The role of ASP in humans is unclear. We sought to characterize the agouti signaling protein gene (ASIP) in a group of white subjects, to assess whether ASIP was a determinant of human pigmentation and whether this gene may be associated with increased melanoma risk. We found no evidence of coding-region sequence variation in ASIP, but detected a g. 8818A-->G polymorphism in the 3' untranslated region. We genotyped 746 participants in a study of melanoma susceptibility for g. 8818A-->G, by means of polymerase chain reaction and restriction fragment-length polymorphism analysis. Among the 147 healthy controls, the frequency of the G allele was .12. Carriage of the G allele was significantly associated with dark hair (odds ratio 1.8; 95% confidence interval [CI] 1.2-2.8) and brown eyes (odds ratio 1.9; 95% CI 1.3-2.8) after adjusting for age, gender, and disease status. ASIP g. 8818A-->G was not associated independently with disease status. This is the first report of an association of ASIP with specific human pigmentation characteristics. It remains to be investigated whether the interaction of MC1R and ASIP can enhance prediction of human pigmentation and melanoma risk.	Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Kanetsky, PA (corresponding author), Univ Penn, Dept Biostat & Epidemiol, 903 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.				NATIONAL CANCER INSTITUTE [P01CA075434] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA75434] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdel-Malek ZA, 2001, J CELL SCI, V114, P1019; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; Frandberg PA, 1998, BIOCHEM BIOPH RES CO, V245, P490, DOI 10.1006/bbrc.1998.8459; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; HUNT G, 1994, PIGM CELL RES, V7, P217, DOI 10.1111/j.1600-0749.1994.tb00052.x; HUSTAD CM, 1995, GENETICS, V140, P255; Kanetsky PA, 2001, CANCER EPIDEM BIOMAR, V10, P509; KWON HY, 1994, P NATL ACAD SCI USA, V91, P9760, DOI 10.1073/pnas.91.21.9760; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Norman RA, 1999, INT J OBESITY, V23, P163, DOI 10.1038/sj.ijo.0800786; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; Suzuki I, 1996, ENDOCRINOLOGY, V137, P1627, DOI 10.1210/en.137.5.1627; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Tucker MA, 1997, JAMA-J AM MED ASSOC, V277, P1439, DOI 10.1001/jama.277.18.1439; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; van der Velden PA, 2001, AM J HUM GENET, V69, P774, DOI 10.1086/323411; Voisey J, 2001, PIGM CELL RES, V14, P264, DOI 10.1034/j.1600-0749.2001.140406.x; WILSON BD, 1995, HUM MOL GENET, V4, P223, DOI 10.1093/hmg/4.2.223; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274	28	143	151	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					770	775		10.1086/339076	http://dx.doi.org/10.1086/339076			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11833005	Green Published, Bronze			2022-12-18	WOS:000173880000020
J	Le Saux, O; Beck, K; Sachsinger, C; Silvestri, C; Treiber, C; Goring, HHH; Johnson, EW; De Paepe, A; Pope, FM; Pasquali-Ronchetti, I; Bercovitch, L; Terry, S; Boyd, CD				Le Saux, O; Beck, K; Sachsinger, C; Silvestri, C; Treiber, C; Goring, HHH; Johnson, EW; De Paepe, A; Pope, FM; Pasquali-Ronchetti, I; Bercovitch, L; Terry, S; Boyd, CD			A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAINS; CYSTIC-FIBROSIS; STARGARDT-DISEASE; RETINITIS-PIGMENTOSA; GEL-ELECTROPHORESIS; TRANSPORTER GENE; TANGIER-DISEASE; P-GLYCOPROTEIN; ATP	To better understand the pathogenetics of pseudoxanthoma elasticum (PXE), we performed a mutational analysis of ATP-binding cassette subfamily C member 6 (ABCC6) in 122 unrelated patients with PXE, the largest cohort of patients yet studied. Thirty-six mutations were characterized, and, among these, 28 were novel variants (for a total of 43 PXE mutations known to date). Twenty-one alleles were missense variants, six were small insertions or deletions, five were nonsense, two were alleles likely to result in aberrant mRNA splicing, and two were large deletions involving ABCC6. Although most mutations appeared to be unique variants, two disease-causing alleles occurred frequently in apparently unrelated individuals. R1141X was found in our patient cohort at a frequency of 18.8% and was preponderant in European patients. ABCC6del23-29 occurred at a frequency of 12.9% and was prevalent in patients from the United States. These results suggested that R1141X and ABCC6del23-29 might have been derived regionally from founder alleles. Putative disease-causing mutations were identified in similar to 64% of the 244 chromosomes studied, and 85.2% of the 122 patients were found to have at least one disease-causing allele. Our results suggest that a fraction of the undetected mutant alleles could be either genomic rearrangements or mutations occurring in noncoding regions of the ABCC6 gene. The distribution pattern of ABCC6 mutations revealed a cluster of disease-causing variants within exons encoding a large C-terminal cytoplasmic loop and in the C-terminal nucleotide-binding domain (NBD2). We discuss the potential structural and functional significance of this mutation pattern within the context of the complex relationship between the PXE phenotype and the function of ABCC6.	Univ Hawaii, Pacific Biomed Res Ctr, Lab Matrix Pathobiol, Honolulu, HI 96822 USA; Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Barrow Neurol Inst, Phoenix, AZ 85013 USA; Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; Univ Wales Hosp, Inst Med Genet, MRC, Connect Tissue Genet Grp, Cardiff CF4 4XN, S Glam, Wales; Brown Med Sch, Dept Dermatol, Providence, RI USA; PXE Int Inc, Sharon, MA USA	University of Hawaii System; Universita di Modena e Reggio Emilia; Texas Biomedical Research Institute; Barrow Neurological Institute; Ghent University; Ghent University Hospital; Cardiff University; Brown University	Boyd, CD (corresponding author), Univ Hawaii, Pacific Biomed Res Ctr, Lab Matrix Pathobiol, 1993 East West Rd, Honolulu, HI 96822 USA.	cbkc08901@aol.com	Le Saux, Olivier/P-4668-2017	Le Saux, Olivier/0000-0002-5605-3617	NCRR NIH HHS [RR03061, G12 RR003061, P20 RR016453] Funding Source: Medline; NEI NIH HHS [EY13019] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016453] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013019] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Bacchelli B, 1999, MODERN PATHOL, V12, P1112; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Cai L, 2000, J MOL MED-JMM, V78, P36, DOI 10.1007/s001090000079; CHRISTIANO AM, 1992, J INVEST DERMATOL, V99, P660, DOI 10.1111/1523-1747.ep12668156; Contri MB, 1996, AM J PATHOL, V148, P569; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DARIER J, 1896, 3 C INT DERM LONDR, P289; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Germain DP, 2000, BIOCHEM BIOPH RES CO, V274, P297, DOI 10.1006/bbrc.2000.3101; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; HULL J, 1994, GENOMICS, V19, P362, DOI 10.1006/geno.1994.1070; JONES CT, 1992, HUM MOL GENET, V1, P11, DOI 10.1093/hmg/1.1.11; Kool M, 1999, CANCER RES, V59, P175; Le Saux O, 1999, GENOMICS, V62, P1, DOI 10.1006/geno.1999.5925; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; LEBWOHL M, 1993, ARCH DERMATOL RES, V285, P121, DOI 10.1007/BF01112912; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Madon J, 2000, MOL PHARMACOL, V57, P634, DOI 10.1124/mol.57.3.634; Maquat LE, 1996, AM J HUM GENET, V59, P279; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Messiaen L, 1997, HUM GENET, V101, P75, DOI 10.1007/s004390050590; Mickle JE, 1998, HUM MOL GENET, V7, P729, DOI 10.1093/hmg/7.4.729; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NELDNER KH, 1988, INT J DERMATOL, V27, P98, DOI 10.1111/j.1365-4362.1988.tb01280.x; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; NISHIDA H, 1990, ANN THORAC SURG, V49, P483, DOI 10.1016/0003-4975(90)90265-8; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Passi A, 1996, CELL BIOCHEM FUNCT, V14, P111, DOI 10.1002/(SICI)1099-0844(199606)14:2<111::AID-CBF653>3.0.CO;2-#; Pollet JF, 2000, BBA-MOL BASIS DIS, V1500, P59, DOI 10.1016/S0925-4439(99)00088-5; Rigal D., 1881, ANN DERMATOL SYPHIL, V2, P491; Ringpfeil F, 2001, AM J HUM GENET, V68, P642, DOI 10.1086/318807; Ringpfeil F, 2000, P NATL ACAD SCI USA, V97, P6001, DOI 10.1073/pnas.100041297; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Rubegni P, 2000, AM J CARDIOL, V85, P1268, DOI 10.1016/S0002-9149(00)00745-1; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Sherer DW, 2001, J AM ACAD DERMATOL, V44, P534, DOI 10.1067/mjd.2001.112401; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Struk B, 2000, J MOL MED, V78, P282, DOI 10.1007/s001090000114; Struk B, 1997, HUM MOL GENET, V6, P1823, DOI 10.1093/hmg/6.11.1823; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; TORRINGTON M, 1991, S AFR MED J, V79, P7; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Uitto J, 1998, J INVEST DERMATOL, V110, P840, DOI 10.1046/j.1523-1747.1998.00188.x; UITTO J, 1987, DERMATOL CLIN, V5, P63, DOI 10.1016/S0733-8635(18)30767-8; Uitto J, 2001, TRENDS MOL MED, V7, P13, DOI 10.1016/S1471-4914(00)01869-4; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; vanSoest S, 1997, GENOME RES, V7, P830, DOI 10.1101/gr.7.8.830; Weenink AC, 1996, NETH J MED, V49, P24, DOI 10.1016/0300-2977(95)00079-8	64	143	149	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					749	764		10.1086/323704	http://dx.doi.org/10.1086/323704			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11536079	Bronze, Green Published			2022-12-18	WOS:000171008200008
J	McKay, JD; Lesueur, F; Jonard, L; Pastore, A; Williamson, J; Hoffman, L; Burgess, J; Duffield, A; Papotti, M; Stark, M; Sobol, H; Maes, B; Murat, A; Kaariainen, H; Bertholon-Gregoire, M; Zini, M; Rossing, MA; Toubert, ME; Bonichon, F; Cavarec, M; Bernard, AM; Boneu, A; Leprat, F; Haas, O; Lasset, C; Schlumberger, M; Canzian, F; Goldgar, DE; Romeo, G				McKay, JD; Lesueur, F; Jonard, L; Pastore, A; Williamson, J; Hoffman, L; Burgess, J; Duffield, A; Papotti, M; Stark, M; Sobol, H; Maes, B; Murat, A; Kaariainen, H; Bertholon-Gregoire, M; Zini, M; Rossing, MA; Toubert, ME; Bonichon, F; Cavarec, M; Bernard, AM; Boneu, A; Leprat, F; Haas, O; Lasset, C; Schlumberger, M; Canzian, F; Goldgar, DE; Romeo, G			Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LINKAGE ANALYSIS; TUMORS; CANCER; PAPILLARY; MAPS; INHERITANCE; EXCLUSION; ACCOUNT; 19P13.2	The familial form of nonmedullary thyroid carcinoma (NMTC) is a complex genetic disorder characterized by multifocal neoplasia and a higher degree of aggressiveness than its sporadic counterpart. In a large Tasmanian pedigree (Tas1) with recurrence of papillary thyroid carcinoma (PTC), the most common form of NMTC, an extensive genomewide scan revealed a common haplotype on chromosome 2q21 in seven of the eight patients with PTC. To verify the significance of the 2q21 locus, we performed linkage analysis in an independent sample set of 80 pedigrees, yielding a multipoint heterogeneity LOD score (HLOD) of 3.07 (alpha = 0.42), nonparametric linkage (NPL) 3.19, () at marker D2S2271. Stratification based on the presence of at least one case of the follicular variant of PTC, the phenotype observed in the Tas1 family, identified 17 such pedigrees, yielding a maximal HLOD score of 4.17 (alpha = 0.80) and NPL = 4.99 (P = .00002) at markers AFMa272zg9 and D2S2271, respectively. These results indicate the existence of a susceptibility locus for familial NMTC on chromosome 2q21.	Int Agcy Res Canc, F-69372 Lyon 08, France; Hop Antiquaille, Clin Endocrinol Nutr & Diabet, Lyon, France; Ctr Leon Berard, Unite Oncol Genet, F-69373 Lyon, France; Royal Hobart Hosp, Hobart, Tas, Australia; Univ Turin, Dipartimento Anat Patol, Turin, Italy; Inst Jean Godinot, Unite Med Nucl & Biophys 2, Reims, France; Hop Hotel Dieu, Clin Endocrinol Malad Metab & Nutr, Nantes, France; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Arcispedale S Maria Nuova, Serv Endocrinol, Reggio Emilia, Italy; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Hop St Louis, Serv Cent Med Nucl, Paris, France; Inst Bergonie, Nucl Med Serv, Bordeaux, France; Hop Haut Leveque, Bordeaux, France; CHU Morvan, Nucl Med Serv, Brest, France; Ctr Eugene Marquis, Rennes, France; Inst Claudius Regaud, Nucl Med Serv, Toulouse, France; St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; Inst Gustave Roussy, Nucl Med Serv, Villejuif, France	World Health Organization; International Agency for Research on Cancer (IARC); CHU Lyon; UNICANCER; Centre Leon Berard; Royal Hobart Hospital; University of Turin; UNICANCER; Institut Jean Godinot; Nantes Universite; CHU de Nantes; University of Helsinki; IRCCS Arcispedale S. Maria Nuova; Fred Hutchinson Cancer Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Bergonie; CHU Bordeaux; CHU Brest; Universite de Bretagne Occidentale; UNICANCER; Centre Eugene Marquis; UNICANCER; Institut Claudius Regaud; Saint Anna Children's Hospital; UNICANCER; Gustave Roussy	Romeo, G (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	romeo@iarc.fr	Canzian, Federico/I-2804-2014; Zini, Michele/AAA-7306-2021; /AAR-7818-2021; Haas, Oskar/AAM-5794-2020; Lesueur, Fabienne/R-2178-2017; /AGZ-3814-2022	Zini, Michele/0000-0003-2971-8510; /0000-0002-3621-4807; Lesueur, Fabienne/0000-0001-7404-4549; /0000-0002-3621-4807; Burgess, John/0000-0003-4748-9571; Canzian, Federico/0000-0002-4261-4583; Jonard, Laurence/0000-0003-0369-0505				Alsanea O, 2001, CURR OPIN ONCOL, V13, P44, DOI 10.1097/00001622-200101000-00009; Bignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610; Bol S, 1999, CANCER GENET CYTOGEN, V114, P75, DOI 10.1016/S0165-4608(99)00028-X; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Burgess JR, 2000, J CLIN ENDOCR METAB, V85, P1513, DOI 10.1210/jc.85.4.1513; Burgess JR, 1997, J CLIN ENDOCR METAB, V82, P345, DOI 10.1210/jc.82.2.345; Canzian F, 1998, AM J HUM GENET, V63, P1743, DOI 10.1086/302164; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Franzen A, 1999, ENDOCRINOLOGY, V140, P4300, DOI 10.1210/en.140.9.4300; Gibson H.B., 1995, SURVEILLANCE IODINE; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; GROSSMAN RF, 1995, ARCH SURG-CHICAGO, V130, P892; Harach HR, 1999, J PATHOL, V189, P387, DOI 10.1002/(SICI)1096-9896(199911)189:3<387::AID-PATH443>3.0.CO;2-S; HEDINGER C, 1998, HISTOLOGICAL TYPING; HSIEH CL, 1990, SOMAT CELL MOLEC GEN, V16, P407, DOI 10.1007/BF01232469; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lesueur F, 1999, J CLIN ENDOCR METAB, V84, P2157, DOI 10.1210/jc.84.6.2157; Liu CX, 2000, CANCER RES, V60, P1961; MACHOFF CD, 2000, J CLIN ENDOCR METAB, V85, P1758; McKay JD, 1999, EUR J ENDOCRINOL, V141, P122, DOI 10.1530/eje.0.1410122; Neumann S, 1999, J CLIN ENDOCR METAB, V84, P3750, DOI 10.1210/jc.84.10.3750; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PARKIN DM, 1997, IARC SCI PUBLICATION, V143; Piao Z, 2001, GENE CHROMOSOME CANC, V30, P113, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1069>3.3.CO;2-Y; Rapley EA, 2000, NAT GENET, V24, P197, DOI 10.1038/72877; Richards PAC, 1995, MED J AUSTRALIA, V163, P628, DOI 10.5694/j.1326-5377.1995.tb124774.x; Richter J, 1997, CANCER RES, V57, P2860; ROGUE L, 1995, GENE CHROMOSOME CANC, V13, P157, DOI 10.1002/gcc.2870130304; ROUSSEAUMERCK MF, 1991, HUM GENET, V86, P350; Saretzki G, 1997, CANCER, V80, P1241, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1241::AID-CNCR7>3.0.CO;2-N; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; SOZZI G, 1992, CANCER GENET CYTOGEN, V64, P38, DOI 10.1016/0165-4608(92)90320-8; Tallini G, 1999, LAB INVEST, V79, P547; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Tung WS, 1997, GENE CHROMOSOME CANC, V19, P43, DOI 10.1002/(SICI)1098-2264(199705)19:1<43::AID-GCC7>3.0.CO;2-0; ZEDENIUS J, 1995, HUM GENET, V96, P27, DOI 10.1007/BF00214182	38	143	145	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					440	446		10.1086/321979	http://dx.doi.org/10.1086/321979			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11438887	Green Published, Bronze			2022-12-18	WOS:000170108200019
J	Rossetti, S; Strmecki, L; Gamble, V; Burton, S; Sneddon, V; Peral, B; Roy, S; Bakkaloglu, A; Komel, R; Winearls, CG; Harris, PC				Rossetti, S; Strmecki, L; Gamble, V; Burton, S; Sneddon, V; Peral, B; Roy, S; Bakkaloglu, A; Komel, R; Winearls, CG; Harris, PC			Mutation analysis of the entire PKD1 gene: Genetic and diagnostic implications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; COL4A5 COLLAGEN GENE; NONSENSE MUTATION; RNA SURVEILLANCE; REPEATED PART; 2-HIT MODEL; PROTEIN; IDENTIFICATION; CYSTS; CYSTOGENESIS	Mutation screening of the major autosomal dominant polycystic kidney disease (ADPKD) locus, PKD1, has proved difficult because of the large transcript and complex reiterated gene region. We have developed methods, employing long polymerase chain reaction (PCR) and specific reverse transcription-PCR, to amplify all of the PKD1 coding area. The gene was screened for mutations in 131 unrelated patients with ADPKD, using the protein-truncation test and direct sequencing. Mutations were identified in 57 families, and, including 24 previously characterized changes from this cohort, a detection rate of 52.3% was achieved in 155 families. Mutations were found in all areas of the gene, from exons 1 to 46, with no clear hotspot identified. There was no significant difference in mutation frequency between the single-copy and duplicated areas, but mutations were more than twice as frequent in the 3' half of the gene, compared with the 5' half. The majority of changes were predicted to truncate the protein through nonsense mutations (32%), insertions or deletions (29.6%) or splicing changes (6.2%), although the figures were biased by the methods employed, and, in sequenced areas, similar to 50% of all mutations were missense or in-frame. Studies elsewhere have suggested that gene conversion may be a significant cause of mutation at PKD1, but only 3 of 69 different mutations matched PKD1-like HG sequence. A relatively high rate of new PKD1 mutation was calculated, 1.8 x 10(-5) mutations per generation, consistent with the many different mutations identified (69 in 81 pedigrees) and suggesting significant selection against mutant alleles. The mutation detection rate, in this study, of >50% is comparable to that achieved for other large multiexon genes and shows the feasibility of genetic diagnosis in this disorder.	Mayo Clin & Mayo Fdn, Div Nephrol, Rochester, MN 55901 USA; John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England; Univ Oxford, John Radcliffe Hosp, Oxford Renal Unit, Oxford OX3 9DU, England; UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; Inst Child Hlth, London, England; Hacettepe Univ, Dept Pediat Nephrol, Ankara, Turkey; Inst Biochem, Med Ctr Mol Biol, Ljubljana, Slovenia	Mayo Clinic; University of Oxford; University of Oxford; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of London; University College London; Hacettepe University	Harris, PC (corresponding author), Mayo Clin & Mayo Fdn, Div Nephrol, 200 1st St SW, Rochester, MN 55901 USA.	harris.peter@mayo.edu	Peral, Belén/F-4562-2015	Peral, Belén/0000-0003-4984-4020; Sneddon, Tam Paterson/0000-0003-1137-8992; Strmecki, Lana/0000-0001-5534-9427				Blaszak RT, 1999, NUCLEIC ACIDS RES, V27, P2610, DOI 10.1093/nar/27.13.2610; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Cooper DN, 1995, METABOLIC MOL BASES, P259; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; Daniells C, 1998, HUM GENET, V102, P216, DOI 10.1007/s004390050681; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; DOBIN A, 1993, GENET EPIDEMIOL, V10, P189, DOI 10.1002/gepi.1370100305; DODE C, 1990, BRIT J HAEMATOL, V76, P275, DOI 10.1111/j.1365-2141.1990.tb07884.x; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; Giannelli F, 1999, AM J HUM GENET, V65, P1580, DOI 10.1086/302652; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Green PM, 1999, AM J HUM GENET, V65, P1572, DOI 10.1086/302651; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Hayward C, 1997, HUM MUTAT, V10, P280, DOI 10.1002/(SICI)1098-1004(1997)10:4<280::AID-HUMU3>3.3.CO;2-L; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Huan YH, 1999, J CLIN INVEST, V104, P1459, DOI 10.1172/JCI5111; Hughes J, 1999, HUM MOL GENET, V8, P543, DOI 10.1093/hmg/8.3.543; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; Knebelmann B, 1996, AM J HUM GENET, V59, P1221; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Koptides M, 1999, HUM MOL GENET, V8, P509, DOI 10.1093/hmg/8.3.509; Koptides M, 2000, HUM MOL GENET, V9, P447, DOI 10.1093/hmg/9.3.447; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; Martin P, 1998, J AM SOC NEPHROL, V9, P2291; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; Peral B, 1996, AM J HUM GENET, V58, P86; Peral B, 1997, AM J HUM GENET, V60, P1399, DOI 10.1086/515467; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; PERAL B, 1994, AM J HUM GENET, V54, P899; Perrichot RA, 1999, HUM GENET, V105, P231, DOI 10.1007/s004390051094; Phakdeekitcharoen B, 2000, KIDNEY INT, V58, P1400, DOI 10.1046/j.1523-1755.2000.00302.x; Ponting CP, 1999, CURR BIOL, V9, pR585, DOI 10.1016/S0960-9822(99)80379-0; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; Roelfsema JH, 1997, AM J HUM GENET, V61, P1044, DOI 10.1086/301600; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; Rossetti S, 1996, AM J MED GENET, V65, P155, DOI 10.1002/(SICI)1096-8628(19961016)65:2<155::AID-AJMG15>3.0.CO;2-P; Rowan AJ, 1997, HUM MUTAT, V9, P172, DOI 10.1002/(SICI)1098-1004(1997)9:2<172::AID-HUMU10>3.0.CO;2-#; Sandford R, 1997, HUM MOL GENET, V6, P1483, DOI 10.1093/hmg/6.9.1483; STEVENSON AC, 1967, MUTAT RES, V4, P339, DOI 10.1016/0027-5107(67)90029-2; Thomas R, 1999, AM J HUM GENET, V65, P39, DOI 10.1086/302460; Thongnoppakhun W, 1999, BIOTECHNIQUES, V26, P126, DOI 10.2144/99261rr01; Torra R, 1999, AM J HUM GENET, V65, P345, DOI 10.1086/302501; Torra R, 1998, HUM MUTAT, pS117; Van Raay T J, 1996, Microb Comp Genomics, V1, P317; Veldhuisen B, 1997, AM J HUM GENET, V61, P547, DOI 10.1086/515497; VOGEL F, 1997, HUM GENET, P1; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; WARD CJ, 1994, CELL, V77, P881; Watnick T, 1999, AM J HUM GENET, V65, P1561, DOI 10.1086/302657; Watnick T, 2000, NAT GENET, V25, P143, DOI 10.1038/75981; Watnick TJ, 1997, HUM MOL GENET, V6, P1473, DOI 10.1093/hmg/6.9.1473; Watnick TJ, 1998, HUM MOL GENET, V7, P1239, DOI 10.1093/hmg/7.8.1239; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; Wilson PD, 1999, LAB INVEST, V79, P1311; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585	71	143	167	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					46	63		10.1086/316939	http://dx.doi.org/10.1086/316939			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11115377	Bronze, Green Published			2022-12-18	WOS:000166399900005
J	Pearce, SHS; Cheetham, T; Imrie, H; Vaidya, B; Barnes, ND; Bilous, RW; Carr, D; Meeran, K; Shaw, NJ; Smith, CS; Toft, AD; Williams, G; Kendall-Taylor, P				Pearce, SHS; Cheetham, T; Imrie, H; Vaidya, B; Barnes, ND; Bilous, RW; Carr, D; Meeran, K; Shaw, NJ; Smith, CS; Toft, AD; Williams, G; Kendall-Taylor, P			A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE TYPE-I; LYMPHOPROLIFERATIVE SYNDROME; LINKAGE DISEQUILIBRIUM; POSITIONAL CLONING; MUTATIONS; LOCUS	Autoimmune polyendocrinopathy type 1 (APS1) is an autosomal recessive disorder characterized by autoimmune hypoparathyroidism, autoimmune adrenocortical failure, and mucocutaneous candidiasis. Recently, an autoimmune regulator gene (AIRE-1), which is located on chromosome 21q22.3, has been identified, and mutations in European kindreds with APS1 have been described. We used SSCP analysis and direct DNA sequencing to screen the entire 1,635-bp coding region of AIRE-1 in 12 British families with APS1. A 13-bp deletion (964del13) was found to account for 17 of the 24 possible mutant AIRE-1 alleles, in our kindreds. This mutation was found to occur de novo in one affected subject. A common haplotype spanning the AIRE-1 locus was found in chromosomes that carried the 964del13 mutation, suggesting a founder effect in our population. One of 576 normal subjects was also a heterozygous carrier of the 964del13 mutation. Six other point mutations were found in AIRE-1, including two 1-bp deletions, three missense mutations (R15L, L28P, and Y90C), and a nonsense mutation (R257*). The high frequency of the 964del13 allele and the clustering of the other AIRE-1 mutations may allow rapid molecular screening for APS1 in British kindreds. Furthermore, the prevalence of the 964del13 AIRE-1 mutation may have implications in the pathogenesis of the more common autoimmune endocrinopathies in our population.	Univ Newcastle Upon Tyne, Sch Med, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Dept Child Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Addenbrookes Hosp, Dept Paediat, Cambridge, England; Middlesbrough Gen Hosp, Ctr Diabet, Middlesbrough, Cleveland, England; N Tees Gen Hosp, Dept Med, Stockton On Tees, England; Hammersmith Hosp, Dept Endocrinol, London, England; Birmingham Childrens Hosp, Endocrine Unit, Birmingham, W Midlands, England; Alder Hey Hosp, Endocrine Unit, Liverpool, Merseyside, England; Fazakerley Dist Gen Hosp, Dept Med, Liverpool, Merseyside, England; Royal Infirm Edinburgh, Endocrine Unit, Edinburgh, Midlothian, Scotland	Newcastle University - UK; Newcastle University - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University Hospital of North Tees; Imperial College London; University of Birmingham; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; Royal Infirmary of Edinburgh	Pearce, SHS (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Dept Med, 4th Floor,Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	spearce@hgmp.mrc.ac.uk	Pearce, Simon/AAB-3692-2019; Vaidya, Bijay/AAF-1947-2020	Pearce, Simon/0000-0001-8384-8063; Vaidya, Bijay/0000-0002-2223-0494	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; Aaltonen J, 1997, GENOME RES, V7, P820, DOI 10.1101/gr.7.8.820; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; ARULANANTHAM K, 1979, NEW ENGL J MED, V300, P164, DOI 10.1056/NEJM197901253000403; Bjorses P, 1996, AM J HUM GENET, V59, P879; CANALE VC, 1967, J PEDIATR-US, V70, P891, DOI 10.1016/S0022-3476(67)80262-2; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FRIEDMAN TC, 1991, AM J MED, V91, P625, DOI 10.1016/0002-9343(91)90215-J; FUKUHARA Y, 1990, BIOCHEM BIOPH RES CO, V170, P296, DOI 10.1016/0006-291X(90)91273-U; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HONG R, 1981, LANCET, V1, P773; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; HUNG W, 1963, NEW ENGL J MED, V269, P658, DOI 10.1056/NEJM196309262691303; JORDE LB, 1995, AM J HUM GENET, V56, P11; KENDALLTAYLOR P, 1988, BRIT MED J, V296, P1489, DOI 10.1136/bmj.296.6635.1489; KENNY FM, 1964, NEW ENGL J MED, V271, P708, DOI 10.1056/NEJM196410012711404; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; NEUFELD M, 1981, MEDICINE, V60, P355, DOI 10.1097/00005792-198109000-00003; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; RICHMAN RA, 1975, ARCH DERMATOL, V111, P625, DOI 10.1001/archderm.111.5.625; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Scott HS, 1998, MOL ENDOCRINOL, V12, P1112, DOI 10.1210/me.12.8.1112; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	35	143	146	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1675	1684		10.1086/302145	http://dx.doi.org/10.1086/302145			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837820	Green Published, Bronze			2022-12-18	WOS:000077707700013
J	Wuyts, W; Van Hul, W; De Boulle, K; Hendrickx, J; Bakker, E; Vanhoenacker, F; Mollica, F; Ludecke, HJ; Sayli, BS; Pazzaglia, UE; Mortier, G; Hamel, B; Conrad, EU; Matsushita, M; Raskind, WH; Willems, PJ				Wuyts, W; Van Hul, W; De Boulle, K; Hendrickx, J; Bakker, E; Vanhoenacker, F; Mollica, F; Ludecke, HJ; Sayli, BS; Pazzaglia, UE; Mortier, G; Hamel, B; Conrad, EU; Matsushita, M; Raskind, WH; Willems, PJ			Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-11; HETEROZYGOSITY; CLONING; LINKAGE; MARKERS; LOCUS	Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant bone disorder characterized by the Presence of multiple benign cartilage-capped tumors (exostoses). Besides suffering complications caused by the pressure of these exostoses on the surrounding tissues, EXT patients are at an increased risk for malignant chondrosarcoma, which may develop from an exostosis. EXT is genetically heterogeneous, and three loci have been identified so far: EXT1, on chromosome 8q23-q24; EXT2, on 11p11-p12; and EXT3, on the short arm of chromosome 19. The EXT1 and EXT2 genes were cloned recently and they were shown to be homologous. We have now analyzed the EXT1 and EXT2 genes, in 26 EXT families originating from nine countries, to identify the underlying disease-causing mutation. Of the 26 families, 10 families had an EXT1 mutation, and 10 had an EXT2 mutation. Twelve of these mutations have never been described before, In addition, we have reviewed all EXT1 and EXT2 mutations reported so far, to determine the nature, frequency, and distribution. of mutations that cause EXT, From this analysis, we conclude that mutations in either the EXT1 or the EXT2 gene are responsible for the majority of EXT cases, Most of the mutations in EXT1 and EXT2 cause premature termination of the EXT proteins, whereas missense mutations are rare. The development is thus mainly due to loss of function of the EXT genes, consistent with the hypothesis that the EXT genes have a tumor-suppressor function.	Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; Univ Antwerp, Dept Radiol, B-2610 Antwerp, Belgium; Leiden Univ, Dept Human Genet, NL-2300 RA Leiden, Netherlands; Catania Univ, Dept Pediat, I-95126 Catania, Italy; Univ Essen Gesamthsch Klinikum, Inst Human Genet, D-4300 Essen, Germany; Ankara Univ, Fac Med, TR-06100 Ankara, Turkey; Univ Pavia, I-27100 Pavia, Italy; Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium; Univ Nijmegen, Dept Human Genet, Nijmegen, Netherlands; Univ Washington, Dept Orthoped, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Antwerp; University of Antwerp; Leiden University; Leiden University - Excl LUMC; University of Catania; University of Duisburg Essen; Ankara University; University of Pavia; Ghent University; Ghent University Hospital; Radboud University Nijmegen; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Van Hul, W (corresponding author), Univ Antwerp, Dept Med Genet, Univ Plein 1, B-2610 Antwerp, Belgium.	vhul@uia.ua.ac.be	wuyts, wim/B-1346-2012; wuyts, wim/B-6262-2017; Mortier, Geert/D-2542-2012; Bakker, Egbert/D-3525-2009	wuyts, wim/0000-0002-4349-9038; wuyts, wim/0000-0002-4349-9038; Mortier, Geert/0000-0001-9871-4578; Bakker, Egbert/0000-0002-2843-7357; Van Hul, Wim/0000-0002-5065-7858	NATIONAL CANCER INSTITUTE [R01CA016448] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA16448] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Blanton SH, 1996, AM J MED GENET, V62, P150; COOK A, 1993, AM J HUM GENET, V53, P71; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Hecht JT, 1997, AM J HUM GENET, V60, P80; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; LegeaiMallet L, 1997, HUM GENET, V99, P298, DOI 10.1007/s004390050361; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; Ludecke HJ, 1997, GENOMICS, V40, P351, DOI 10.1006/geno.1996.4577; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; MOLLICA F, 1984, AM J MED GENET, V19, P665, DOI 10.1002/ajmg.1320190406; Philippe C, 1997, AM J HUM GENET, V61, P520, DOI 10.1086/515505; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; RASKIND WH, IN PRESS HUM GENET; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SOLOMON L, 1964, AM J HUM GENET, V16, P351; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; VANHUL W, IN PRESS GENOMICS; Wells DE, 1997, HUM GENET, V99, P612, DOI 10.1007/s004390050415; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; Wuyts W, 1997, EUR J HUM GENET, V5, P382, DOI 10.1159/000484796; Wuyts W, 1996, HUM MOL GENET, V5, P1547, DOI 10.1093/hmg/5.10.1547; WUYTS W, 1995, AM J HUM GENET, V57, P382	24	143	152	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					346	354		10.1086/301726	http://dx.doi.org/10.1086/301726			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463333	Green Published, Bronze			2022-12-18	WOS:000072416000018
J	STRUEWING, JP; BRODY, LC; ERDOS, MR; KASE, RG; GIAMBARRESI, TR; SMITH, SA; COLLINS, FS; TUCKER, MA				STRUEWING, JP; BRODY, LC; ERDOS, MR; KASE, RG; GIAMBARRESI, TR; SMITH, SA; COLLINS, FS; TUCKER, MA			DETECTION OF 8 BRCA1 MUTATIONS IN 10 BREAST OVARIAN-CANCER FAMILIES, INCLUDING 1 FAMILY WITH MALE BREAST-CANCER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; REGION; PRONE	Genetic epidemiological evidence suggests that mutations in BRCA1 may be responsible for approximately one half of early onset familial breast cancer and the majority of familial breast/ovarian cancer. The recent cloning of BRCA1 allows for the direct detection of mutations, but the feasibility of presymptomatic screening for cancer susceptibility is unknown. We analyzed genomic DNA from one affected individual from each of 24 families with at least three cases of ovarian or breast cancer, using SSCP assays. Variant SSCP bands were subcloned and sequenced. Allele-specific oligonucleotide hybridization was used to verify sequence changes and to screen DNA from control individuals. Six frameshift and two missense mutations were detected in 10 different families. A frameshift mutation was detected in a male proband affected with both breast and prostate cancer. A 40-bp deletion was detected in a patient who developed intra-abdominal carcinomatosis 1 year after prophylactic oophorectomy. Mutations were detected throughout the gene, and only one was detected in more than a single family. These results provide further evidence that inherited breast and ovarian cancer can occur as a consequence of a wide array of BRCA1 mutations. These results suggests that development of a screening test for BRCA1 mutations will be technically challenging. The finding of a mutation in a family with male breast cancer, not previously thought to be related to BRCA1, also illustrates the potential difficulties of genetic counseling for individuals known to carry mutations.	NIH, NATL CTR HUMAN GENOME RES, GENE TRANSFER LAB, BETHESDA, MD USA; WESTAT RES INC, ROCKVILLE, MD USA; UNIV CAMBRIDGE, DEPT PATHOL, CRC, HUMAN CANC GENET GRP, CAMBRIDGE, ENGLAND	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Westat; University of Cambridge	STRUEWING, JP (corresponding author), NCI, GENET EPIDEMIOL BRANCH, BLDG EPN, ROOM 439, 6130 EXECUT BLVD MSC 7372, BETHESDA, MD 20892 USA.		Struewing, Jeffery P/I-7502-2013; Struewing, Jeffery P/C-3221-2008; Tucker, Margaret A/B-4297-2015	Struewing, Jeffery P/0000-0002-4848-3334; 				BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; COHEN MM, 1994, AM J HUM GENET, V55, pR1; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRAUMENI JF, 1975, CANCER-AM CANCER SOC, V36, P364, DOI 10.1002/1097-0142(197508)36:2<364::AID-CNCR2820360211>3.0.CO;2-C; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KELSEY JL, 1993, EPIDEMIOL REV, V15, P7, DOI 10.1093/oxfordjournals.epirev.a036118; LAMTURE JB, 1994, NUCLEIC ACIDS RES, V22, P2121, DOI 10.1093/nar/22.11.2121; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; LI FP, 1970, J AMER MED ASSOC, V214, P1559, DOI 10.1001/jama.214.8.1559; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROWELL S, 1994, AM J HUM GENET, V55, P861; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH SA, 1994, GENE CHROMOSOME CANC, V10, P71, DOI 10.1002/gcc.2870100112; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; STRATTON MR, 1994, NAT GENET, V7, P103, DOI 10.1038/ng0594-103; STRUEWING JP, IN PRESS J NAT CANCE; TOBACMAN JK, 1982, LANCET, V2, P795; WEBER BL, 1994, NEW ENGL J MED, V331, P1523, DOI 10.1056/NEJM199412013312214; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; 1994, JAMA-J AM MED ASSOC, V271, P785; 1994, PRESYMPTOMATIC GENET	37	143	150	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					1	7						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611277				2022-12-18	WOS:A1995RE62900001
J	VANHOVE, JLK; ZHANG, W; KAHLER, SG; ROE, CR; CHEN, YT; TERADA, N; CHACE, DH; IAFOLLA, AK; DING, JH; MILLINGTON, DS				VANHOVE, JLK; ZHANG, W; KAHLER, SG; ROE, CR; CHEN, YT; TERADA, N; CHACE, DH; IAFOLLA, AK; DING, JH; MILLINGTON, DS			MEDIUM-CHAIN ACYL-COA DEHYDROGENASE (MCAD) DEFICIENCY - DIAGNOSIS BY ACYLCARNITINE ANALYSIS IN BLOOD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-A DEHYDROGENASE; TANDEM MASS-SPECTROMETRY; FATTY-ACID OXIDATION; CIS-4-DECENOIC ACID; HUMAN-URINE; MUTATION; PLASMA; PURIFICATION; CARNITINE; SIBLINGS	Medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency is a disorder of fatty acid catabolism, with autosomal recessive inheritance. The disease is characterized by episodic illness associated with potentially fatal hypoglycemia and has a relatively high frequency. A rapid and reliable method for the diagnosis of MCAD deficiency is highly desirable. Analysis of specific acylcarnitines was performed by isotope-dilution tandem mass spectrometry on plasma or whole blood samples from 62 patients with MCAD deficiency. Acylcarnitines were also analyzed in 42 unaffected relatives of patients with MCAD deficiency and in other groups of patients having elevated plasma C8 acylcarnitine, consisting of 32 receiving valproic acid, 9 receiving medium-chain triglyceride supplement, 4 having multiple acyl-coenzyme A dehydrogenase deficiency, and 8 others with various etiologies. Criteria for the unequivocal diagnosis of MCAD deficiency by acylcarnitine analysis are an elevated C8-acylcarnitine concentration (>0.3 muM), a ratio of C8/C10 acylcarnitines of >5, and lack of elevated species of chain length >C10. These criteria were not influenced by clinical state, carnitine treatment, or underlying genetic mutation, and no false-positive or false-negative results were obtained. The same criteria were also successfully applied to profiles from neonatal blood spots retrieved from the original Guthrie cards of eight patients. Diagnosis of MCAD deficiency can therefore be made reliably through the analysis of acylcarnitines in blood, including presymptomatic neonatal recognition. Tandem mass spectrometry is a convenient method for fast and accurate determination of all relevant acylcarnitine species.			VANHOVE, JLK (corresponding author), DUKE UNIV,MED CTR,DEPT PEDIAT,DIV GENET & METAB,BOX 3028,DURHAM,NC 27710, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039078] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-30] Funding Source: Medline; NICHD NIH HHS [HD-24908] Funding Source: Medline; NIDDK NIH HHS [DK-39078] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BLAKEMORE AIF, 1991, LANCET, V337, P298, DOI 10.1016/0140-6736(91)90907-7; CATZEFLIS C, 1990, EUR J PEDIATR, V149, P577, DOI 10.1007/BF01957697; CHACE DH, 1993, CLIN CHEM, V39, P66; COATES PM, 1985, PEDIATR RES, V19, P671, DOI 10.1203/00006450-198507000-00007; DING JH, 1992, PROG CLIN BIOL RES, V375, P479; DOMMES V, 1984, J BIOL CHEM, V259, P1789; DURAN M, 1988, CLIN CHEM, V34, P548; HALE DE, 1992, J PEDIATR-US, V121, P1, DOI 10.1016/S0022-3476(05)82532-6; HEALES SJR, 1991, J INHERIT METAB DIS, V14, P661, DOI 10.1007/BF01799930; HEALES SJR, 1992, CLIN CHIM ACTA, V209, P61, DOI 10.1016/0009-8981(92)90333-L; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; KLER RS, 1991, J BIOL CHEM, V266, P22932; MATSUBARA Y, 1990, LANCET, V335, P1589, DOI 10.1016/0140-6736(90)91413-5; MATSUBARA Y, 1991, LANCET, V338, P552, DOI 10.1016/0140-6736(91)91110-G; MILLINGTON DS, 1992, PROG CLIN BIOL RES, V375, P339; MILLINGTON DS, 1991, INT J MASS SPECTROM, V111, P211, DOI 10.1016/0168-1176(91)85056-R; MILLINGTON DS, 1989, ANAL BIOCHEM, V180, P331, DOI 10.1016/0003-2697(89)90441-7; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; MORTON DH, 1990, J PEDIATR-US, V117, P439, DOI 10.1016/S0022-3476(05)81091-1; RINALDO P, 1989, BIOMED ENVIRON MASS, V18, P471, DOI 10.1002/bms.1200180705; Roe C, 1989, METABOLIC BASIS INHE, P889; ROE CR, 1986, J PEDIATR-US, V108, P13, DOI 10.1016/S0022-3476(86)80762-4; ROE CR, 1985, PEDIATR RES, V19, P459, DOI 10.1203/00006450-198505000-00011; ROE CR, 1990, PROG CLIN BIOL RES, V321, P383; SCHMIDTSOMMERFELD E, 1992, PROG CLIN BIOL RES, V375, P355; SEAKINS JWT, 1988, J INHERIT METAB DIS, V11, P221, DOI 10.1007/BF01804241; STANLEY CA, 1983, PEDIATR RES, V17, P877, DOI 10.1203/00006450-198311000-00008; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; 1992, PROG CLIN BIOL RES, V375, P499; 1991, LANCET, V338, P544	32	143	149	1	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					958	966						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488845				2022-12-18	WOS:A1993LB88900013
J	CAREY, AH; KELLY, D; HALFORD, S; WADEY, R; WILSON, D; GOODSHIP, J; BURN, J; PAUL, T; SHARKEY, A; DUMANSKI, J; NORDENSKJOLD, M; WILLIAMSON, R; SCAMBLER, PJ				CAREY, AH; KELLY, D; HALFORD, S; WADEY, R; WILSON, D; GOODSHIP, J; BURN, J; PAUL, T; SHARKEY, A; DUMANSKI, J; NORDENSKJOLD, M; WILLIAMSON, R; SCAMBLER, PJ			MOLECULAR GENETIC-STUDY OF THE FREQUENCY OF MONOSOMY 22Q11 IN DIGEORGE SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPECTRUM; DELETION	It is well established that DiGeorge syndrome (DGS) may be associated with monosomy of 22q11-pter. More recently, DNA probes have been used to detect hemizygosity for this region in patients with no visible karyotypic abnormality. However, DGS has also been described in cases where the cytogenetic abnormality does not involve 22q11; for instance, four cases of 10p - have been reported. In this study we have prospectively analyzed patients, by using DNA markers from 22q11, to assess the frequency of 22q11 rearrangements in DGS. Twenty-one of 22 cases had demonstrable hemizygosity for 22q11. Cytogenetic analysis had identified interstitial deletion in 6 of 16 cases tested; in 6 other cases no karyotype was available. When these results are combined with those from our previous studies, 33 of 35 DGS patients had chromosome 22q11 deletions detectable by DNA probes.	ST MARYS HOSP, SCH MED, DEPT BIOCHEM & MOLEC GENET, LONDON, ENGLAND; DIV HUMAN GENET, NEWCASTLE UPON TYNE, ENGLAND; MHH KINDERKLIN, HANNOVER, GERMANY; ROSIE MATERN HOSP, DEPT OBSTET & GYNAECOL, CAMBRIDGE, ENGLAND; KAROLINSKA INST, DEPT CLIN GENET, S-10401 STOCKHOLM 60, SWEDEN	Imperial College London; Hannover Medical School; Karolinska Institutet			Halford, Stephanie/AAJ-1375-2020; Scambler, Peter J/C-4998-2008; Scambler, Peter/AAZ-6026-2020; Wilson, David/A-6264-2010; Sharkey, Andrew M/H-7015-2013	Halford, Stephanie/0000-0003-2179-907X; Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Wilson, David/0000-0001-8779-2060; Sharkey, Andrew M/0000-0002-5072-7748; Burn, John/0000-0002-9823-2322; Dumanski, Jan Piotr/0000-0002-1489-1452				AMMANN AJ, 1982, AM J DIS CHILD, V136, P906, DOI 10.1001/archpedi.1982.03970460036008; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; CAREY AH, 1990, GENOMICS, V7, P299, DOI 10.1016/0888-7543(90)90161-M; CAREY JC, 1980, J PEDIATR-US, V96, P955, DOI 10.1016/S0022-3476(80)80599-3; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CONLEY ME, 1979, J PEDIATR-US, V94, P883, DOI 10.1016/S0022-3476(79)80207-3; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; EMANUEL BS, 1988, AM J HUM GENET, V43, P575; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; GREENBERG F, 1988, AM J HUM GENET, V43, P605; Lammer E J, 1986, Am J Med Genet Suppl, V2, P113, DOI 10.1002/ajmg.1320250615; LAMMER P, 1984, AM J HUM GENET S, V36, pS61; LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; RAMSAY M, 1990, GENOMICS, V6, P39, DOI 10.1016/0888-7543(90)90446-2; ROHN RD, 1984, J PEDIATR-US, V105, P47, DOI 10.1016/S0022-3476(84)80355-8; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SHARKEY AM, 1992, HUM GENET, V89, P73, DOI 10.1007/BF00207046; STEVENS CA, 1990, PEDIATRICS, V85, P526; WILSON DI, 1992, AM J HUM GENET, V51, P957; WILSON DI, 1991, BRIT HEART J, V66, P308	22	143	145	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					964	970						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415265				2022-12-18	WOS:A1992JU84000005
J	SPIRIO, L; OTTERUD, B; STAUFFER, D; LYNCH, H; LYNCH, P; WATSON, P; LANSPA, S; SMYRK, T; CAVALIERI, J; HOWARD, L; BURT, R; WHITE, R; LEPPERT, M				SPIRIO, L; OTTERUD, B; STAUFFER, D; LYNCH, H; LYNCH, P; WATSON, P; LANSPA, S; SMYRK, T; CAVALIERI, J; HOWARD, L; BURT, R; WHITE, R; LEPPERT, M			LINKAGE OF A VARIANT OR ATTENUATED FORM OF ADENOMATOUS POLYPOSIS-COLI TO THE ADENOMATOUS POLYPOSIS-COLI (APC) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-5; LOCALIZATION; INHERITANCE; CANCER; GENE	Adenomatous polyps are an intermediate in the pathway to colon carcinoma. An inherited disorder, familial adenomatous polyposis coli (APC), is characterized by hundreds to thousands of adenomatous polyps. A previously reported family had colon cancer associated with a low average but highly heterogenous number of colonic polyps, this phenotype mapped to the APC locus on 5q. Four new families have been ascertained in which the phenotypic pattern was different from classical polyposis but similar to that of the "prototype" kindred reported earlier. By multilocus linkage analysis, the gene responsible for the disease phenotype was mapped, with a high level of confidence, to the APC locus in two of the four families with the attenuated or variant form of polyposis (AAPC); the results for the two remaining kindreds were inconclusive. A combined maximum LOD score of approximately 7.6 at a recombination fraction of 0 was obtained when the results were summed over the four pedigrees with markers closest to the APC locus. The establishment of genetic linkage in such families may point to the APC locus as having a more significant role in inherited predispositions to colorectal cancer than was previously thought.	UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,DIV GASTROENTEROL,SALT LAKE CITY,UT 84112; CREIGHTON UNIV,SCH MED,DEPT PREVENTAT MED PUBL HLTH,OMAHA,NE 68178; CREIGHTON UNIV,SCH MED,DEPT MED GASTROENTEROL,OMAHA,NE 68178; CLARKSON MEM HOSP,DEPT PATHOL,OMAHA,NE; UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT MED ONCOL,GASTROINTESTINAL ONCOL & DIGEST DIS SECT,HOUSTON,TX 77030	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Creighton University; Creighton University; University of Texas System; UTMD Anderson Cancer Center	SPIRIO, L (corresponding author), UNIV UTAH,SCH MED,ECCLES INST HUMAN GENET,DEPT HUMAN GENET,BLDG 533,SUITE 6470A,SALT LAKE CITY,UT 84112, USA.		Lanspa, Stephen/AAM-1739-2020		NHGRI NIH HHS [8 RO1 HG00367] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BURT RW, 1985, NEW ENGL J MED, V312, P1540, DOI 10.1056/NEJM198506133122403; BURT RW, 1988, GASTROENTEROL CLIN N, V17, P657; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; DECOSSE JJ, 1989, JNCI-J NATL CANCER I, V81, P1290, DOI 10.1093/jnci/81.17.1290; GARDNER EJ, 1951, AM J HUM GENET, V3, P167; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LEPPERT M, 1990, NEW ENGL J MED, V322, P904, DOI 10.1056/NEJM199003293221306; LEWIS RA, 1984, OPHTHALMOLOGY, V91, P916; LYNCH H, IN PRESS DIS COLON R; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PETERSEN GM, 1991, GASTROENTEROLOGY, V100, P1658, DOI 10.1016/0016-5085(91)90666-9; WILLIAMSON R, 1990, CYTOGENET CELL GENET, V55, P457, DOI 10.1159/000133027	20	143	144	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					92	100						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1319115				2022-12-18	WOS:A1992JA46700010
J	CAMARGO, M; CERVENKA, J				CAMARGO, M; CERVENKA, J			PATTERNS OF DNA-REPLICATION OF HUMAN-CHROMOSOMES .2. REPLICATION MAP AND REPLICATION MODEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CAMARGO, M (corresponding author), UNIV MINNESOTA, DEPT ORAL PATHOL & GENET, DIV CYTOGENET & CELL GENET, MINNEAPOLIS, MN 55455 USA.				NCI NIH HHS [IR01-CA-29779] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGELL RR, 1975, CHROMOSOMA, V51, P301, DOI 10.1007/BF00326317; ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; BOBROW M, 1972, NATURE-NEW BIOL, V238, P122, DOI 10.1038/newbio238122a0; BOSTOCK CJ, 1974, CHROMOSOMA, V48, P73; BOSTOCK CJ, 1975, CHROMOSOMA, V51, P25, DOI 10.1007/BF00285804; BOSTOCK CJ, 1976, CHROMOSOMA, V56, P275, DOI 10.1007/BF00293191; BUHLER E, 1977, HEREDITAS, V86, P63; BUYS CHCM, 1981, HUM GENET, V57, P28, DOI 10.1007/BF00271162; CALDERON D, 1973, HUMANGENETIK, V18, P63; CAMARGO M, 1980, HUM GENET, V54, P47, DOI 10.1007/BF00279048; CAMARGO M, 1981, CYTOGENET CELL GENET, V31, P77, DOI 10.1159/000131628; CAMARGO M, 1980, AM J HUM GENET, V32, pA65; CAMARGO M, UNPUB CYTOGENET CELL; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; COMINGS DE, 1978, AM J HUM GENET, V30, P223; COMINGS DE, 1978, ANNU REV GENET, V12, P25, DOI 10.1146/annurev.ge.12.120178.000325; COMINGS DE, 1970, CHROMOSOMA, V29, P434; CRAIG AP, 1971, CHROMOSOMA, V32, P364; CRAIGHOLMES AP, 1973, AM J HUM GENET, V25, P181; DAS RK, 1978, CHROMOSOMA, V67, P165, DOI 10.1007/BF00293174; DISTECHE C, 1974, CHROMOSOMA, V47, P263, DOI 10.1007/BF00328861; DUTRILLAUX B, 1976, CHROMOSOMA, V58, P51, DOI 10.1007/BF00293440; DUTRILLAUX B, 1973, CR ACAD SCI D NAT, V276, P3179; EMANUEL BS, 1978, AM J HUM GENET, V30, P153; EPPLEN JT, 1975, CYTOGENET CELL GENET, V15, P177, DOI 10.1159/000130516; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; GALLOWAY SM, 1975, EXP CELL RES, V94, P454, DOI 10.1016/0014-4827(75)90517-0; GANNER E, 1971, CHROMOSOMA, V35, P326, DOI 10.1007/BF00326282; GHOSH PK, 1979, HUM GENET, V52, P79; GIANELLI F, 1970, MONOGRAPHS HUMAN GEN, V5, P1; GOSDEN JR, 1975, EXP CELL RES, V92, P148, DOI 10.1016/0014-4827(75)90648-5; GOTO K, 1978, CHROMOSOMA, V66, P351, DOI 10.1007/BF00328535; HILWIG I, 1972, EXP CELL RES, V75, P122, DOI 10.1016/0014-4827(72)90527-7; HOUSMAN D, 1975, J MOL BIOL, V94, P173, DOI 10.1016/0022-2836(75)90076-5; JALAL SM, 1974, CHROMOSOMA, V48, P391, DOI 10.1007/BF00290995; KATO H, 1974, NATURE, V251, P70, DOI 10.1038/251070a0; KIMURA S, 1980, CHROMOSOMA, V77, P309, DOI 10.1007/BF00286056; KNIGHT LA, 1973, CHROMOSOMA, V40, P153; KONDRA PM, 1978, HUM GENET, V43, P139, DOI 10.1007/BF00293591; KONGSUWAN K, 1980, CHROMOSOMA, V76, P151, DOI 10.1007/BF00293414; KORENBERG JR, 1974, CHROMOSOMA, V48, P355, DOI 10.1007/BF00290992; LATT SA, 1974, EXP CELL RES, V87, P425, DOI 10.1016/0014-4827(74)90510-2; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; LIMON J, 1979, HUM GENET, V51, P247; LIN MS, 1974, EXP CELL RES, V86, P392, DOI 10.1016/0014-4827(74)90727-7; MAGENIS RE, 1978, SCIENCE, V202, P64; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; MILLER OJ, 1970, ADV HUM GENET, P35; MOSES MJ, 1975, SCIENCE, V187, P363, DOI 10.1126/science.1111110; NAKAGOME Y, 1977, EXP CELL RES, V106, P457, DOI 10.1016/0014-4827(77)90203-8; PAINTER RB, 1971, J MOL BIOL, V58, P289, DOI 10.1016/0022-2836(71)90247-6; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; POPESCU NC, 1979, CYTOGENET CELL GENET, V24, P53, DOI 10.1159/000131356; REMINGTON JA, 1973, EXP CELL RES, V76, P410, DOI 10.1016/0014-4827(73)90393-5; SCHMID W, 1969, CYTOGENETICS, V8, P125, DOI 10.1159/000130029; SCHMIDT M, 1980, CHROMOSOMA, V76, P101, DOI 10.1007/BF00292230; SCHMIDTKE J, 1980, HUM GENET, V55, P255, DOI 10.1007/BF00291774; SCHNEDL W, 1977, HUM GENET, V36, P299, DOI 10.1007/BF00446280; SCHNEDL W, 1977, HUM GENET, V36, P167, DOI 10.1007/BF00273255; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; SEABRIGH.M, 1971, LANCET, V2, P971; STUBBLEFIELD E, 1970, CHROMOSOMA, V31, P79, DOI 10.1007/BF00321158; STUBBLEFIELD E, 1975, CHROMOSOMA, V53, P209, DOI 10.1007/BF00329172; VANDESANDE JH, 1977, SCIENCE, V195, P400, DOI 10.1126/science.63994; VEDBRAT S, 1979, CYTOGENET CELL GENET, V24, P201, DOI 10.1159/000131381; VIEGASPEQUIGNOT E, 1978, ANN GENET-PARIS, V21, P122; YUNIS JJ, 1975, HUMANGENETIK, V27, P167, DOI 10.1007/BF00278343; ZAKHAROV AF, 1976, BIOL ZBL, V95, P327; 1978, CYTOGENET CELL GENET, V21, P313	69	143	146	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1982	34	5					757	780						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PH242	7124731				2022-12-18	WOS:A1982PH24200008
J	REED, TE; NEEL, JV				REED, TE; NEEL, JV			GENETIC STUDY OF MULTIPLE POLYPOSIS OF THE COLON (WITH AN APPENDIX DERIVING A METHOD OF ESTIMATING RELATIVE FITNESS)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BACON HE, 1949, ANUS RECTUM SIGMOID; COCKAYNE EA, 1927, CANCER REV, V2, P337; CRIPPS H, 1882, T PATHOL SOC LOND, V33, P165; CROWE FW, AM LECTURES DERMATOL; Dublin L.I., 1949, LENGTH LIFE; DUKES CE, 1952, ANN EUGENIC, V17, P1; Fisher R., 1930, GENETICAL THEORY NAT; GARDNER EJ, 1952, CANCER, V5, P695, DOI 10.1002/1097-0142(195207)5:4<695::AID-CNCR2820050407>3.0.CO;2-5; GARDNER EJ, 1953, AM J HUM GENET, V5, P139; GIANTURCO C, 1953, JAMA-J AM MED ASSOC, V153, P1429, DOI 10.1001/jama.1953.02940330013004; HALDANE JBS, 1949, HEREDITAS          S, P267; HELWIG EB, 1947, SURG GYNECOL OBSTET, V84, P36; JEGHERS H, 1949, NEW ENGL J MED, V241, P993, DOI 10.1056/NEJM194912222412501; NACHTSHEIM H, 1954, NATURWISSENSCHAFTEN, V17, P385; NEEL JV, 1952, AM NAT, V86, P129, DOI 10.1086/281718; NEEL JV, 1954, GASTROENTEROLOGY, V26, P1; Neel JV, 1954, HUMAN HEREDITY; PANSE F, 1942, ERBCHOREA EINE KLINI; REED SC, 1951, SCIENCE, V113, P294, DOI 10.1126/science.113.2933.294; SWINTON N W, 1947, Lahey Clin Bull, V5, P84; VOGEL FRIEDRICH, 1954, ZEITSCHR MENSCHL VERERBUNGS U KONSTITUTIONSLEHRE, V32, P308	21	143	143	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1955	7	3					236	263						28	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA212	13258558				2022-12-18	WOS:A1955WA21200002
J	Kingsmore, SF; Cakici, JA; Clark, MM; Gaughran, M; Feddock, M; Batalov, S; Bainbridge, MN; Carroll, J; Caylor, SA; Clarke, C; Ding, Y; Ellsworth, K; Farnaes, L; Hildreth, A; Hobbs, C; James, K; Kint, CI; Lenberg, J; Nahas, S; Prince, L; Reyes, I; Salz, L; Sanford, E; Schols, P; Sweeney, N; Tokita, M; Veeraraghavan, N; Watkins, K; Wigby, K; Wong, T; Chowdhury, S; Wright, MS; Dimmock, D; Bezares, Z; Bloss, C; Braun, JJA; Diaz, C; Mashburn, D; Tamang, D; Orendain, D; Friedman, J; Gleeson, J; Barea, J; Chiang, G; Cohenmeyer, C; Coufal, NG; Evans, M; Honold, J; Hovey, RL; Kimball, A; Lane, B; Le, C; Le, J; Leibel, S; Moyer, L; Mulrooney, P; Oh, D; Ordonez, P; Oriol, A; Ortiz-Arechiga, M; Puckett, L; Speziale, M; Suttner, D; Van der Kraan, L; Knight, G; Sauer, C; Song, R; White, S; Wise, A; Yamada, C				Kingsmore, Stephen F.; Cakici, Julie A.; Clark, Michelle M.; Gaughran, Mary; Feddock, Michele; Batalov, Sergey; Bainbridge, Matthew N.; Carroll, Jeanne; Caylor, Sara A.; Clarke, Christina; Ding, Yan; Ellsworth, Katarzyna; Farnaes, Lauge; Hildreth, Amber; Hobbs, Charlotte; James, Kiely; Kint, Cyrielle I.; Lenberg, Jerica; Nahas, Shareef; Prince, Lance; Reyes, Iris; Salz, Lisa; Sanford, Erica; Schols, Peter; Sweeney, Nathaly; Tokita, Mari; Veeraraghavan, Narayanan; Watkins, Kelly; Wigby, Kristen; Wong, Terence; Chowdhury, Shimul; Wright, Meredith S.; Dimmock, David; Bezares, Zaira; Bloss, Cinnamon; Braun, Joshua J. A.; Diaz, Carlos; Mashburn, Dana; Tamang, Dorjee; Orendain, Daniken; Friedman, Jenni; Gleeson, Joe; Barea, Jaime; Chiang, George; Cohenmeyer, Casey; Coufal, Nicole G.; Evans, Marva; Honold, Jose; Hovey, Raymond L.; Kimball, Amy; Lane, Brian; Le, Crystal; Le, Jennie; Leibel, Sandra; Moyer, Laurel; Mulrooney, Patrick; Oh, Daeheon; Ordonez, Paulina; Oriol, Albert; Ortiz-Arechiga, Maria; Puckett, Laura; Speziale, Mark; Suttner, Denise; Van der Kraan, Lucitia; Knight, Gail; Sauer, Charles; Song, Richard; White, Sarah; Wise, Audra; Yamada, Catherine		RCIGM Investigators	A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in III Infants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARE; IDENTIFICATION; VARIANTS	The second Newborn Sequencing in Genomic Medicine and Public Health study was a randomized, controlled trial of the effectiveness of rapid whole-genome or -exome sequencing (rWGS or rWES, respectively) in seriously ill infants with diseases of unknown etiology. Here we report comparisons of analytic and diagnostic performance. Of 1,248 ill inpatient infants, 578 (46%) had diseases of unknown etiology. 213 infants (37% of those eligible) were enrolled within 96 h of admission. 24 infants (11%) were very ill and received ultrarapid whole-genome sequencing (urWGS). The remaining infants were randomized, 95 to rWES and 94 to rWGS. The analytic performance of rWGS was superior to rWES, including variants likely to affect protein function, and ClinVar pathogenic/likely pathogenic variants (p < 0.0001). The diagnostic performance of rWGS and rWES were similar (18 diagnoses in 94 infants [19%] versus 19 diagnoses in 95 infants [20%], respectively), as was time to result (median 11.0 versus 11.2 days, respectively). However, the proportion diagnosed by urWGS (11 of 24 [46%]) was higher than rWES/rWGS (p = 0.004) and time to result was less (median 4.6 days, p < 0.0001). The incremental diagnostic yield of reflexing to trio after negative proband analysis was 0.7% (1 of 147). In conclusion, rapid genomic sequencing can be performed as a first-tier diagnostic test in inpatient infants. urWGS had the shortest time to result, which was important in unstable infants, and those in whom a genetic diagnosis was likely to impact immediate management. Further comparison of urWGS and rWES is warranted because genomic technologies and knowledge of variant pathogenicity are evolving rapidly.	[Kingsmore, Stephen F.; Cakici, Julie A.; Clark, Michelle M.; Gaughran, Mary; Feddock, Michele; Batalov, Sergey; Bainbridge, Matthew N.; Carroll, Jeanne; Caylor, Sara A.; Clarke, Christina; Ding, Yan; Ellsworth, Katarzyna; Farnaes, Lauge; Hildreth, Amber; Hobbs, Charlotte; James, Kiely; Lenberg, Jerica; Nahas, Shareef; Reyes, Iris; Salz, Lisa; Sanford, Erica; Sweeney, Nathaly; Tokita, Mari; Veeraraghavan, Narayanan; Watkins, Kelly; Wigby, Kristen; Wong, Terence; Chowdhury, Shimul; Wright, Meredith S.; Dimmock, David] Rady Childrens Inst Genom Med, San Diego, CA 92123 USA; [Cakici, Julie A.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Carroll, Jeanne; Farnaes, Lauge; Hildreth, Amber; Prince, Lance; Sanford, Erica; Sweeney, Nathaly; Wigby, Kristen] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Hildreth, Amber] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kint, Cyrielle I.; Schols, Peter] Diploid, B-3001 Leuven, Belgium	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Kingsmore, SF (corresponding author), Rady Childrens Inst Genom Med, San Diego, CA 92123 USA.	skingsmore@rchsd.org	Cakici, Julie/ABC-3574-2021; Coufal, Nicole/ABA-9471-2021	Cakici, Julie/0000-0001-5672-3396; Sauer, Charles/0000-0002-2761-2344; Batalov, Sergey/0000-0002-0925-0554; Prince, Lawrence/0000-0002-7010-4548; Coufal, Nicole/0000-0001-6547-1733; Kingsmore, Stephen/0000-0001-7180-2527; Sanford Kobayashi, Erica/0000-0002-3622-8141; Carroll, Jeanne/0000-0003-3673-0323	NICHD [U19HD077693]; NHGRI; NCATS [UL1TR002550]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002550] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by grant U19HD077693 from NICHD and NHGRI to S.F.K., grant UL1TR002550 from NCATS to E.J. Topol, and gifts from the Liguori Family, John Motter and Effie Simanikas, Ernest and Evelyn Rady, and Rady Children's Hospital.	Alfares A, 2018, GENET MED, V20, P1328, DOI 10.1038/gim.2018.41; Ali H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40761-w; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arth AC, 2017, MMWR-MORBID MORTAL W, V66, P41, DOI 10.15585/mmwr.mm6602a1; Berg JS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2252; Berry MA, 2008, J PERINATOL, V28, P297, DOI 10.1038/sj.jp.7211904; Borghesi A, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0418-0; Briggs B, 2018, CSH MOL CASE STUD, V4, DOI 10.1101/mcs.a003525; Ceyhan-Birsoy O, 2019, AM J HUM GENET, V104, P76, DOI 10.1016/j.ajhg.2018.11.016; Chen DY, 2018, PEDIATR NEUROL, V86, P69, DOI 10.1016/j.pediatrneurol.2018.06.002; Clark MM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat6177; Clark MM, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0053-8; Daoud H, 2016, CAN MED ASSOC J, V188, pE254, DOI 10.1503/cmaj.150823; Farnaes L, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001776; Farnaes L, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0049-4; Flygare S, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2056-y; French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x; Friedman JM, 2019, GENET MED, V21, P498, DOI 10.1038/s41436-018-0055-z; Hildreth A, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001966; Jaganathan K, 2019, CELL, V176, P535, DOI 10.1016/j.cell.2018.12.015; Khan MJ, 2018, PAK J MED SCI, V34, P540, DOI 10.12669/pjms.343.14644; Lee M, 2017, AM J HUM GENET, V100, P751, DOI 10.1016/j.ajhg.2017.04.001; Lionel AC, 2018, GENET MED, V20, P435, DOI 10.1038/gim.2017.119; Malam F, 2017, AM J MED GENET A, V173, P1839, DOI 10.1002/ajmg.a.38250; Meng LY, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.3438; Mestek-Boukhibar L, 2018, J MED GENET, V55, P721, DOI 10.1136/jmedgenet-2018-105396; Meynert AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-247; Miller NA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0221-8; Murphy SL, 2018, NCHS DATA BRIEF; Petrikin JE, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0045-8; Petrikin JE, 2015, SEMIN PERINATOL, V39, P623, DOI 10.1053/j.semperi.2015.09.009; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sanford E. F., 2019, PEDIAT CRIT CARE MED, V19; Sanford E, 2018, CSH MOL CASE STUD, V4, DOI 10.1101/mcs.a003244; Sanford E, 2018, CSH MOL CASE STUD, V4, DOI 10.1101/mcs.a002485; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Shashi V, 2019, GENET MED, V21, P161, DOI 10.1038/s41436-018-0044-2; Smith LD, 2015, COLD SPRING HARB PER, V6; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Stark Z, 2019, AM J HUM GENET, V104, P13, DOI 10.1016/j.ajhg.2018.11.014; Stark Z, 2018, GENET MED, V20, P1554, DOI 10.1038/gim.2018.37; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; U. K. Department of Health and Social Care, 2018, M HANC ANN AMB MAP 5; van Diemen CC, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-2854; Wang Y, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0135-9; Weiner J, 2011, ARCH PEDIAT ADOL MED, V165, P630, DOI 10.1001/archpediatrics.2011.102; Wilfert AB, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0498-x; Willig LK, 2015, LANCET RESP MED, V3, P377, DOI 10.1016/S2213-2600(15)00139-3; Yip RKH, 2019, CURR TOP DEV BIOL, V133, P343, DOI 10.1016/bs.ctdb.2019.02.002	50	142	143	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2019	105	4					719	733		10.1016/j.ajhg.2019.08.009	http://dx.doi.org/10.1016/j.ajhg.2019.08.009			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC0EX	31564432	Green Published, Bronze			2022-12-18	WOS:000488953400004
J	Blok, LS; Madsen, E; Juusola, J; Gilissen, C; Baralle, D; Reijnders, MRF; Venselaar, H; Helsmoorte, C; Cho, MT; Hoischen, A; Vissers, LELM; Koemans, TS; Wissink-Lindhout, W; Eichler, EE; Romano, C; Van Esch, H; Stumpel, C; Vreeburg, M; Smeets, E; Obemdorff, K; van Bon, BWM; Shaw, M; Gecz, J; Haan, E; Bienek, M; Jensen, C; Loeys, BL; Van Diick, A; Innes, AM; Racher, H; Vermeer, S; Di Donato, N; Rump, A; Tatton-Brown, K; Parker, MJ; Henderson, A; Lynch, SA; Fryer, A; Ross, A; Vasudevan, P; Kini, U; Newbury-Ecob, R; Chandler, K; Male, A; Dijkstra, S; Schieving, J; Giltay, J; Van Gassen, KLI; Schuurs-Hoeijmakers, J; Tan, PL; Pediaditakis, I; Haas, SA; Retterer, K; Reed, P; Monaghan, KG; Haverfield, E; Natowicz, M; Myers, A; Kruer, MC; Stein, Q; Strauss, KA; Brigatti, KW; Keating, K; Burton, BK; Kim, KH; Charrow, J; Norman, J; Foster-Barber, A; Kline, AD; Kimball, A; Zackai, E; Harr, M; Fox, J; McLaughlin, J; Lindstrom, K; Haude, KM; van Roozendaal, K; Brunner, H; Chung, WK; Kooy, RF; Pfundt, R; Kalscheuer, V; Mehta, SG; Katsanis, N; Kleefstra, T				Blok, Lot Snijders; Madsen, Erik; Juusola, Jane; Gilissen, Christian; Baralle, Diana; Reijnders, Margot R. F.; Venselaar, Hanka; Helsmoorte, Celine; Cho, Megan T.; Hoischen, Alexander; Vissers, Lisenka E. L. M.; Koemans, Tom S.; Wissink-Lindhout, Willemijn; Eichler, Evan E.; Romano, Corrado; Van Esch, Hilde; Stumpel, Connie; Vreeburg, Maaike; Smeets, Eric; Obemdorff, Karin; van Bon, Bregje W. M.; Shaw, Marie; Gecz, Jozef; Haan, Eric; Bienek, Melanie; Jensen, Corinna; Loeys, Bart L.; Van Diick, Anke; Innes, A. Micheil; Racher, Hilary; Vermeer, Sascha; Di Donato, Nataliya; Rump, Andreas; Tatton-Brown, Katrina; Parker, Michael J.; Henderson, Alex; Lynch, Sally A.; Fryer, Alan; Ross, Alison; Vasudevan, Pradeep; Kini, Usha; Newbury-Ecob, Ruth; Chandler, Kate; Male, Alison; Dijkstra, Sybe; Schieving, Jolanda; Giltay, Jacques; Van Gassen, Koen L. I.; Schuurs-Hoeijmakers, Janneke; Tan, Perciliz L.; Pediaditakis, Igor; Haas, Stefan A.; Retterer, Kyle; Reed, Patrick; Monaghan, Kristin G.; Haverfield, Eden; Natowicz, Marvin; Myers, Angela; Kruer, Michael C.; Stein, Quinn; Strauss, Kevin A.; Brigatti, Karlla W.; Keating, Katherine; Burton, Barbara K.; Kim, Katherine H.; Charrow, Joel; Norman, Jennifer; Foster-Barber, Audrey; Kline, Antonie D.; Kimball, Amy; Zackai, Elaine; Harr, Margaret; Fox, Joyce; McLaughlin, Julie; Lindstrom, Kristin; Haude, Katrina M.; van Roozendaal, Kees; Brunner, Han; Chung, Wendy K.; Kooy, R. Frank; Pfundt, Rolph; Kalscheuer, Vera; Mehta, Sarju G.; Katsanis, Nicholas; Kleefstra, Tjitske		DDD Study	Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WNT/BETA-CATENIN; MENTAL-RETARDATION; CELL-CYCLE; DOMINANT; RNA; METHYLATION; VARIABILITY; MODULATION; EXPRESSION; DELETION	Intellectual disability (ID) affects approximately 1%-3% of humans with a gender bias toward males. Previous studies have identified mutations in more than 100 genes on the X chromosome in males with ID, but there is less evidence for de novo mutations on the X chromosome causing ID in females. In this study we present 35 unique deleterious de novo mutations in DDX3X identified by whole exome sequencing in 38 females with ID and various other features including hypotonia, movement disorders, behavior problems, corpus callosum hypoplasia, and epilepsy. Based on our findings, mutations in DDX3X are one of the more common causes of ID, accounting for 1%-3% of unexplained ID in females. Although no de novo DDX3X mutations were identified in males, we present three families with segregating missense mutations in DDX3X, suggestive of an X-linked recessive inheritance pattern. In these families, all males with the DDX3X variant had ID, whereas carrier females were unaffected. To explore the pathogenic mechanisms accounting for the differences in disease transmission and phenotype between affected females and affected males with DDX3X missense variants, we used canonical Wnt defects in zebrafish as a surrogate measure of DDX3X function in vivo. We demonstrate a consistent loss-of-function effect of all tested de novo mutations on the Wnt pathway, and we further show a differential effect by gender. The differential activity possibly reflects a dose-dependent effect of DDX3X expression in the context of functional mosaic females versus one-copy males, which reflects the complex biological nature of DDX3X mutations.	[Blok, Lot Snijders; Gilissen, Christian; Reijnders, Margot R. F.; Hoischen, Alexander; Vissers, Lisenka E. L. M.; Koemans, Tom S.; Wissink-Lindhout, Willemijn; van Bon, Bregje W. M.; Schuurs-Hoeijmakers, Janneke; Brunner, Han; Pfundt, Rolph; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Madsen, Erik; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Juusola, Jane; Cho, Megan T.; Tan, Perciliz L.; Pediaditakis, Igor; Retterer, Kyle; Reed, Patrick; Monaghan, Kristin G.; Haverfield, Eden] GeneDx, Gaithersburg, MD 20877 USA; [Baralle, Diana] Univ Southampton, Fac Med, Human Dev & Hlth, Southampton SO16 6YD, Hants, England; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Nijmegen Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; [Helsmoorte, Celine; Loeys, Bart L.; Van Diick, Anke; Kooy, R. Frank] Univ Antwerp, Dept Med Genet, B-2650 Antwerp, Belgium; [Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Romano, Corrado] IRCCS Assoc Oasi Maria Santissima, Pediat & Med Genet, I-94018 Troina, Italy; [Van Esch, Hilde] Univ Hosp Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Romano, Corrado; Van Esch, Hilde; Stumpel, Connie; van Roozendaal, Kees; Brunner, Han] Maastricht UMC, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Stumpel, Connie; Vreeburg, Maaike; Smeets, Eric; van Roozendaal, Kees; Brunner, Han] Maastricht UMC, Sch Oncol & Dev Biol GROW, NL-6202 AZ Maastricht, Netherlands; [Obemdorff, Karin] Atrium Orbis Med Ctr, Dept Pediat, NL-6162 BG Sittard, Netherlands; [van Bon, Bregje W. M.; Shaw, Marie; Gecz, Jozef; Haan, Eric] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5006, Australia; [van Bon, Bregje W. M.; Shaw, Marie; Gecz, Jozef; Haan, Eric] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5006, Australia; [Haan, Eric] SA Pathol, South Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Bienek, Melanie; Jensen, Corinna; Kalscheuer, Vera] Max Planck Inst Mol Genet, Dept Human Genet, D-14195 Berlin, Germany; [Innes, A. Micheil; Racher, Hilary] Univ Calgary, Cumming Sch Med, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Innes, A. Micheil; Racher, Hilary] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB T2N 4N1, Canada; [Vermeer, Sascha] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Di Donato, Nataliya; Rump, Andreas] Carl Gustav Carus TU Dresden, Fac Med, D-01307 Dresden, Germany; [Tatton-Brown, Katrina] Univ London St Georges Hosp, London SW17 0RE, England; [Parker, Michael J.] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Henderson, Alex] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northem Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Lynch, Sally A.] Temple St Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; [Fryer, Alan] Liverpool Womens Hosp, Dept Clin Genet, Liverpool L8 7SS, Merseyside, England; [Fryer, Alan] Alder Hey Childrens Hosp, Liverpool L8 7SS, Merseyside, England; [Ross, Alison] Clin Genet Ctr, North Scotland Reg Genet Serv, Aberdeen AB25 2ZA, Scotland; [Vasudevan, Pradeep] Leicester Royal Infirm, Univ Hosp Leicester, Dept Clin Genet, Leicester LE1 5WW, Leics, England; [Kini, Usha] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford OX3 7LE, England; [Newbury-Ecob, Ruth] Univ Hosp, Dept Clin Genet, Bristol BS1 3NU, Avon, England; [Chandler, Kate] St Marys Hosp, MAHSC, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Male, Alison] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Dijkstra, Sybe] Org People Intellectual Disabil, ORO, NL-5751 PH Deurne, Netherlands; [Schieving, Jolanda] Radboud Univ Nijmegen, Med Ctr, Dept Child Neurol, NL-6500 HB Nijmegen, Netherlands; [Giltay, Jacques; Van Gassen, Koen L. I.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [Haas, Stefan A.] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Natowicz, Marvin] Cleveland Clin, Pathol & Lab Med & Genom Med Inst, Cleveland, OH 44195 USA; [Myers, Angela; Kruer, Michael C.] Sanford Childrens Specialty Clin, Sioux Falls, SD 57105 USA; [Kruer, Michael C.; Stein, Quinn] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Kruer, Michael C.; Stein, Quinn] Phoenix Childrens Hosp, Ronald A Matricaria Inst Mol Med, Phoenix, AZ USA; [Strauss, Kevin A.; Brigatti, Karlla W.] Franklin & Marshall Coll, Clin Special Children, Lancaster, PA 17604 USA; [Keating, Katherine; Burton, Barbara K.; Kim, Katherine H.; Charrow, Joel] Ann & Robert H Lurie Childrens Hosp Chicago, Div Genet Birth Defects & Metab, Chicago, IL 60611 USA; [Norman, Jennifer] Integris Pediat Neurol, Oklahoma City, OK 73112 USA; [Foster-Barber, Audrey] Benioff Childrens Hosp, Child Neurol & Palliat Care, San Francisco, CA 94925 USA; [Kline, Antonie D.; Kimball, Amy] Greater Baltimore Med Ctr, Harvey Inst Human Genet, Baltimore, MD 21204 USA; [Zackai, Elaine; Harr, Margaret] Childrens Hosp Philadelphia, Div Human Genet, Dept Pediat, Philadelphia, PA 19104 USA; [Fox, Joyce; McLaughlin, Julie] Cohen Childrens Med Ctr, Div Med Genet, New Hyde Pk, NY 11040 USA; [Lindstrom, Kristin] Phoenix Childrens Hosp, Div Genet & Metab, Phoenix, AZ 85006 USA; [Haude, Katrina M.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Mehta, Sarju G.; Katsanis, Nicholas; Kleefstra, Tjitske] Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, East Anglian Reg Genet Serv, Cambridge CB2 0QQ, England	Radboud University Nijmegen; Duke University; University of Southampton; Radboud University Nijmegen; University of Antwerp; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; IRCCS Oasi Maria SS; KU Leuven; University Hospital Leuven; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Atrium Medical Center; Orbis Medical Center; University of Adelaide; Robinson Research Institute; University of Adelaide; SA Pathology; Max Planck Society; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Groningen; Technische Universitat Dresden; Carl Gustav Carus University Hospital; St Georges University London; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Oxford University Hospitals NHS Foundation Trust; University of Manchester; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Max Planck Society; Cleveland Clinic Foundation; Sanford Health; Barrow Neurological Institute; Phoenix Children's Hospital; Phoenix Children's Hospital; Franklin & Marshall College; Ann & Robert H. Lurie Children's Hospital of Chicago; Greater Baltimore Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Phoenix Children's Hospital; University of Rochester; Columbia University; Columbia University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Katsanis, N (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA.	nicholas.katsanis@duke.edu; tjitske.kleefstra@radboudumc.nl	Romano, Corrado/B-9695-2008; Stein, Quinn/AAJ-4738-2021; van Bon, Bregje/Q-2445-2015; Blok, Lot Snijders/P-9156-2015; innes, allan micheil/A-9955-2017; Gecz, Jozef/X-3469-2019; Van+Esch, Hilde/AAU-5688-2020; Schieving, J.H./L-4632-2015; Brunner, Han/C-9928-2013; Vissers, Lisenka ELM/A-2598-2015; Gilissen, Christian/E-5246-2012; Pfundt, Rolph/L-4576-2015; Kooy, Frank/F-5276-2014; Kleefstra, Tjitske/G-2619-2012; Hoischen, Alexander/AGF-7293-2022; Loeys, B.L./L-4493-2015; Di Donato, Nataliya/G-2357-2019; Venselaar, Hanka/D-2009-2016; Hoischen, Alexander/D-1282-2013; Loeys, Bart/B-3236-2017	Romano, Corrado/0000-0003-1049-0683; Stein, Quinn/0000-0002-7670-9281; van Bon, Bregje/0000-0003-2234-0105; Blok, Lot Snijders/0000-0002-9825-3625; Gecz, Jozef/0000-0002-7884-6861; Vissers, Lisenka ELM/0000-0001-6470-5497; Gilissen, Christian/0000-0003-1693-9699; Kooy, Frank/0000-0003-2024-0485; Hoischen, Alexander/0000-0002-8072-4476; Di Donato, Nataliya/0000-0001-9439-4677; Venselaar, Hanka/0000-0001-9824-6559; Hoischen, Alexander/0000-0002-8072-4476; Loeys, Bart/0000-0003-3703-9518; van Gassen, Koen/0000-0001-7934-0662; Kalscheuer, Vera/0000-0001-6898-3259; Van Dijck, Anke/0000-0002-6713-2943; Van Esch, Hilde/0000-0002-9604-5726; Baralle, Diana/0000-0003-3217-4833; Helsmoortel, Celine/0000-0001-7180-7707; Vermeer, Sascha/0000-0001-7625-1912; Lynch, Sally Ann/0000-0003-3540-1333; Innes, Micheil/0000-0001-9881-5467; Haas, Stefan/0000-0003-3418-3688	Netherlands Organization for Health Research and Development (ZonMw grant) [907-00-365]; Italian Ministry of Health and '5 per mille'; Alberta Children's Hospital Foundation; NIH Training Grant [5T32HD060558-04]; German Ministry of Education and Research [01GS08166]; EU FP7 project GENCODYS [241995]; Australian NHMRC grants [628952, 1041920]; Simons Foundation; Doris Duke Charitable Foundation Clinical Scientist Development Award; Marguerite-Marie Delacroix Foundation; FWO-Flanders; Fund for Scientific Research Flanders; ERC starting grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS083739] Funding Source: NIH RePORTER	Netherlands Organization for Health Research and Development (ZonMw grant); Italian Ministry of Health and '5 per mille'; Alberta Children's Hospital Foundation; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EU FP7 project GENCODYS; Australian NHMRC grants(National Health and Medical Research Council (NHMRC) of Australia); Simons Foundation; Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Marguerite-Marie Delacroix Foundation; FWO-Flanders(FWO); Fund for Scientific Research Flanders(FWO); ERC starting grant(European Research Council (ERC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their contribution. Drs. Jillian Parboosingh, Francois Bernier, and Ryan Lamont contributed to the study design, data interpretation, and X-inactivation studies of individual 8. Drs. Concetta Barone and Paolo Bosco were instrumental for clinical evaluation and X-inactivation studies in individual 13. Miriam Uppill provided technical assistance with investigations in family 1. This work was supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw grant 907-00-365 to T.K.), the Italian Ministry of Health and '5 per mille' funding (C.R.), a grant from the Alberta Children's Hospital Foundation (A.M.I.), a NIH Training Grant (5T32HD060558-04 to E.C.M.), German Ministry of Education and Research (01GS08166 to N.D.D. and A.R.), the EU FP7 project GENCODYS (grant number 241995 to V.M.K.), Australian NH&MRC grants 628952 and 1041920 to J.G., support from the Simons Foundation (W.K.C.), Doris Duke Charitable Foundation Clinical Scientist Development Award (M.C.K.), a grant from the Marguerite-Marie Delacroix Foundation (A.V.D.), and FWO-Flanders (H.V.E. and F.K.). B.L. is a senior clinical investigator supported by Fund for Scientific Research Flanders and holds an ERC starting grant. Acknowledgments of the DDD Study are included in the Supplemental Data.	Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Andoniadou CL, 2011, DEVELOPMENT, V138, P4931, DOI 10.1242/dev.066597; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Braun KVN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124120; Busque L, 1996, BLOOD, V88, P59; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cotton AM, 2015, HUM MOL GENET, V24, P1528, DOI 10.1093/hmg/ddu564; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Ditton HJ, 2004, HUM MOL GENET, V13, P2333, DOI 10.1093/hmg/ddh240; Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123; Ferlin A, 2003, J MED GENET, V40, P18, DOI 10.1136/jmg.40.1.18; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Garbelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019810; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Hu H., 2015, MOL PSYCHIAT; Kasim V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059445; Kelly C, 2000, DEVELOPMENT, V127, P3899; KELLY GM, 1995, MECH DEVELOP, V53, P261, DOI 10.1016/0925-4773(95)00442-4; Kuechler A, 2015, HUM GENET, V134, P97, DOI 10.1007/s00439-014-1498-1; Kumar S, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-44; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Li Q, 2014, J BIOMED RES, V28, P282, DOI 10.7555/JBR.27.20130047; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Mentink RA, 2014, DEV CELL, V31, P188, DOI 10.1016/j.devcel.2014.08.008; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Retterer K., 2014, GENET MED; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Schalock R. L., 2021, INTELLECTUAL DISABIL; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Sekiguchi T, 2004, EXP CELL RES, V300, P213, DOI 10.1016/j.yexcr.2004.07.005; Tucci V, 2014, J CLIN INVEST, V124, P1468, DOI 10.1172/JCI70372; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Westerfield M, 1995, ZEBRAFISH BOOK; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Zhang SW, 2014, DEVELOPMENT, V141, P4794, DOI 10.1242/dev.115691	45	142	147	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					343	352		10.1016/j.ajhg.2015.07.004	http://dx.doi.org/10.1016/j.ajhg.2015.07.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26235985	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000359328800015
J	Jenkinson, EM; Rehman, AU; Walsh, T; Clayton-Smith, J; Lee, K; Morell, RJ; Drummond, MC; Khan, SN; Naeem, MA; Rauf, B; Billington, N; Schultz, JM; Urquhart, JE; Lee, MK; Berry, A; Hanley, NA; Mehta, S; Cilliers, D; Clayton, PE; Kingston, H; Smith, MJ; Warner, TT; Black, GC; Trump, D; Davis, JRE; Ahmad, W; Leal, SM; Riazuddin, S; King, MC; Friedman, TB; Newman, WG				Jenkinson, Emma M.; Rehman, Atteeq U.; Walsh, Tom; Clayton-Smith, Jill; Lee, Kwanghyuk; Morell, Robert J.; Drummond, Meghan C.; Khan, Shaheen N.; Naeem, Muhammad Asif; Rauf, Bushra; Billington, Neil; Schultz, Julie M.; Urquhart, Jill E.; Lee, Ming K.; Berry, Andrew; Hanley, Neil A.; Mehta, Sarju; Cilliers, Deirdre; Clayton, Peter E.; Kingston, Helen; Smith, Miriam J.; Warner, Thomas T.; Black, Graeme C.; Trump, Dorothy; Davis, Julian R. E.; Ahmad, Wasim; Leal, Suzanne M.; Riazuddin, Sheikh; King, Mary-Claire; Friedman, Thomas B.; Newman, William G.		Univ Washington	Perrault Syndrome Is Caused by Recessive Mutations in CLPP, Encoding a Mitochondrial ATP-Dependent Chambered Protease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAUSE OVARIAN DYSGENESIS; ESCHERICHIA-COLI CLPP; HEARING-LOSS; SPASTIC PARAPLEGIA; SUBUNIT; RNA; ACTIVATION; EXPRESSION; MODULATOR; TERMINUS	Perrault syndrome is a genetically and clinically heterogeneous autosomal-recessive condition characterized by sensorineural hearing loss and ovarian failure. By a combination of linkage analysis, homozygosity mapping, and exome sequencing in three families, we identified mutations in CLPP as the likely cause of this phenotype. In each family, affected individuals were homozygous for a different pathogenic CLPP allele: c.433A>C (p.Thr145Pro), c.440G>C (p.Cys147Ser), or an experimentally demonstrated splice-donor-site mutation, c.270+4A>G. CLPP, a component of a mitochondrial ATP-dependent proteolytic complex, is a highly conserved endopeptidase encoded by CLPP and forms an element of the evolutionarily ancient mitochondrial unfolded-protein response (UPRmt) stress signaling pathway. Crystal-structure modeling suggests that both substitutions would alter the structure of the CLPP barrel chamber that captures unfolded proteins and exposes them to proteolysis. Together with the previous identification of mutations in HARS2, encoding mitochondrial histidyl-tRNA synthetase, mutations in CLPP expose dysfunction of mitochondrial protein homeostasis as a cause of Perrault syndrome.	[Jenkinson, Emma M.; Clayton-Smith, Jill; Urquhart, Jill E.; Kingston, Helen; Smith, Miriam J.; Black, Graeme C.; Trump, Dorothy; Newman, William G.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Ctr Genet Med, Manchester M13 9WL, Lancs, England; [Jenkinson, Emma M.; Clayton-Smith, Jill; Urquhart, Jill E.; Berry, Andrew; Hanley, Neil A.; Kingston, Helen; Smith, Miriam J.; Black, Graeme C.; Trump, Dorothy; Davis, Julian R. E.; Newman, William G.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester M13 9WL, Lancs, England; [Rehman, Atteeq U.; Morell, Robert J.; Drummond, Meghan C.; Schultz, Julie M.; Friedman, Thomas B.] NIDCD, Mol Genet Lab, NIH, Rockville, MD 20850 USA; [Walsh, Tom; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Lee, Kwanghyuk; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Khan, Shaheen N.; Naeem, Muhammad Asif; Rauf, Bushra; Riazuddin, Sheikh] Univ Punjab, Ctr Excellence Mol Biol, Lahore 54590, Pakistan; [Billington, Neil] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20824 USA; [Berry, Andrew; Hanley, Neil A.; Davis, Julian R. E.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Ctr Endocrinol & Diabet, Manchester M13 9WL, Lancs, England; [Mehta, Sarju] Addenbrookes Hosp, East Anglian Med Genet Serv, Cambridge CB2 0QQ, England; [Cilliers, Deirdre] Oxford Univ NHS Trust, Oxford Reg Genet Ctr, Oxford OX3 7LJ, England; [Clayton, Peter E.] Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester M13 9WL, Lancs, England; [Clayton, Peter E.] Cent Manchester Fdn NHS Trust, Manchester M13 9WL, Lancs, England; [Warner, Thomas T.] UCL, Inst Neurol, London WC1N 3BG, England; [Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad 45320, Pakistan; [Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54550, Pakistan	University of Manchester; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Washington; University of Washington Seattle; Baylor College of Medicine; University of Punjab; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Oxford University Hospitals NHS Foundation Trust; University of Manchester; University of London; University College London; Quaid I Azam University; University of Health Science - Pakistan	Friedman, TB (corresponding author), NIDCD, Mol Genet Lab, NIH, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov; william.newman@manchester.ac.uk	Warner, Thomas T/A-1454-2013; Morell, Robert James/Q-2042-2019; Davis, Julian R/G-8943-2014; Ahmad, Wasim/GSD-8904-2022; Ahmad, Wasim/E-9713-2015; Rehman, Atteeq/AAG-8342-2020; Urquhart, Jill/G-2282-2015; Black, Graeme/K-7374-2015	Warner, Thomas T/0000-0001-6195-6995; Davis, Julian R/0000-0003-0838-0557; Urquhart, Jill/0000-0002-5788-5511; Lee, Kwanghyuk/0000-0001-7781-9696; Walsh, Tom/0000-0002-8875-0310; Black, Graeme/0000-0001-8727-6592; King, Mary-Claire/0000-0001-9426-1743; Newman, William/0000-0002-6382-4678; Hanley, Neil/0000-0003-3234-4038; Lee, Kwanghyuk/0000-0003-1389-1220; Billington, Neil/0000-0003-2306-0228; Morell, Robert/0000-0003-1537-7356; Naeem, Muhammad Asif/0000-0001-8547-6419; Clayton, Peter/0000-0003-1225-4537	Infertility Research Trust; Manchester University Biomedical Research Centre; Wellcome Trust; National Institutes of Health (NIH) [R01 DC005641, R01 DC011651, R01 DC003594, N01 HG065403, U54 HG006493, N01-HG-65403]; Higher Education Commission; Ministry of Science and Technology of Pakistan; International Center for Genetic Engineering and Biotechnology, Trieste, Italy [CRP/PAK08-01, 08/009]; National Heart, Lung, and Blood Institute (NIH) [HL004232]; Genome Canada through the Ontario Genomics Institute [2007-OGI-TD-05]; Ontario Ministry of Research and Innovation;  [DC000039-15]; NATIONAL CANCER INSTITUTE [R01CA157744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004232, K08HL004232] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403, U54HG006493, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000039, R01DC005641, R01DC011651, R01DC003594, ZIADC000039, T32DC000039] Funding Source: NIH RePORTER	Infertility Research Trust; Manchester University Biomedical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Ministry of Science and Technology of Pakistan; International Center for Genetic Engineering and Biotechnology, Trieste, Italy; National Heart, Lung, and Blood Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the families for their participation in the study. We thank Inna Belyantseva, Dennis Drayna, and Andrew J. Griffith for their critique of this manuscript. This study was supported by the Infertility Research Trust; by the Manchester University Biomedical Research Centre; by the Wellcome Trust (N.A.H. is a Senior Fellow in Clinical Science); by National Institutes of Health (NIH) grants and contracts R01 DC005641, R01 DC011651, R01 DC003594, N01 HG065403, and U54 HG006493; by the Higher Education Commission and the Ministry of Science and Technology of Pakistan; and by the International Center for Genetic Engineering and Biotechnology, Trieste, Italy (CRP/PAK08-01 contract 08/009 to Sh.R). Genotyping of family DEM4395 was performed at the Center for Inherited Disease Research, which is funded through the NIH to The Johns Hopkins University (contract number N01-HG-65403). N.B. was supported by National Heart, Lung, and Blood Institute (NIH) intramural funds (HL004232) to James Sellers. Work at the National Institute on Deafness and Other Communication Disorders (NIH) was supported by intramural funds (DC000039-15) to T.B.F. The authors also acknowledge GeneMANIA, the development of which was funded by Genome Canada through the Ontario Genomics Institute (2007-OGI-TD-05) and which is now funded by the Ontario Ministry of Research and Innovation.	Bewley MC, 2006, J STRUCT BIOL, V153, P113, DOI 10.1016/j.jsb.2005.09.011; Bross P, 1995, FEBS LETT, V377, P249, DOI 10.1016/0014-5793(95)01353-9; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Cleeter M, 2011, AMYOTROPH LATERAL SC, V12, P148, DOI 10.3109/17482968.2010.543689; Daly SB, 2010, AM J HUM GENET, V87, P309, DOI 10.1016/j.ajhg.2010.07.010; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; Fiumara A, 2004, AM J MED GENET A, V128A, P246, DOI 10.1002/ajmg.a.20616; FLANAGAN JM, 1995, BIOCHEMISTRY-US, V34, P10910, DOI 10.1021/bi00034a025; FLORES O, 1991, P NATL ACAD SCI USA, V88, P9999, DOI 10.1073/pnas.88.22.9999; Gersch M, 2012, J BIOL CHEM, V287, P9484, DOI 10.1074/jbc.M111.336222; Gottschalk ME, 1996, AM J MED GENET, V65, P274, DOI 10.1002/(SICI)1096-8628(19961111)65:4<274::AID-AJMG5>3.0.CO;2-P; Guest SS, 1999, GENET MED, V1, P207; Hansen J, 2008, NEUROSCIENCE, V153, P474, DOI 10.1016/j.neuroscience.2008.01.070; Housset E., 1951, B MEM SOC MED HOP P, V67, P79; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Iscru E, 2009, MOL CELL NEUROSCI, V40, P62, DOI 10.1016/j.mcn.2008.09.002; Jenkinson EM, 2012, J NEUROL, V259, P974, DOI 10.1007/s00415-011-6285-5; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; Kim DY, 2008, J MOL BIOL, V379, P760, DOI 10.1016/j.jmb.2008.04.036; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Lenz DR, 2011, HEARING RES, V281, P3, DOI 10.1016/j.heares.2011.05.021; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; LINSSEN WHJP, 1994, AM J MED GENET, V51, P81, DOI 10.1002/ajmg.1320510117; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Motta P M, 2000, Hum Reprod, V15 Suppl 2, P129; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Pierson TM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002325; Rehman AU, 2011, HUM GENET, V130, P759, DOI 10.1007/s00439-011-1018-5; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Walton JC, 2012, CEREBELLUM, V11, P982, DOI 10.1007/s12311-012-0368-4; Wang JM, 1997, CELL, V91, P447, DOI 10.1016/S0092-8674(00)80431-6; WEAVER SP, 1994, HEARING RES, V72, P44, DOI 10.1016/0378-5955(94)90204-6; Willard FS, 2006, CELL SIGNAL, V18, P1226, DOI 10.1016/j.cellsig.2005.10.003; WOJTKOWIAK D, 1993, J BIOL CHEM, V268, P22609; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zhang XL, 2002, MOL BRAIN RES, V105, P1, DOI 10.1016/S0169-328X(02)00379-0	44	142	154	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					605	613		10.1016/j.ajhg.2013.02.013	http://dx.doi.org/10.1016/j.ajhg.2013.02.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23541340	Green Published, Bronze			2022-12-18	WOS:000317449700013
J	Kunishima, S; Okuno, Y; Yoshida, K; Shiraishi, Y; Sanada, M; Muramatsu, H; Chiba, K; Tanaka, H; Miyazaki, K; Sakai, M; Ohtake, M; Kobayashi, R; Iguchi, A; Niimi, G; Otsu, M; Takahashi, Y; Miyano, S; Saito, H; Kojima, S; Ogawa, S				Kunishima, Shinji; Okuno, Yusuke; Yoshida, Kenichi; Shiraishi, Yuichi; Sanada, Masashi; Muramatsu, Hideki; Chiba, Kenichi; Tanaka, Hiroko; Miyazaki, Koji; Sakai, Michio; Ohtake, Masatoshi; Kobayashi, Ryoji; Iguchi, Akihiro; Niimi, Gen; Otsu, Makoto; Takahashi, Yoshiyuki; Miyano, Satoru; Saito, Hidehiko; Kojima, Seiji; Ogawa, Seishi			ACTN1 Mutations Cause Congenital Macrothrombocytopenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRAY PLATELET SYNDROME; BERNARD-SOULIER-SYNDROME; ALPHA-ACTININ; THROMBOCYTOPENIA; NBEAL2; MEGAKARYOCYTES; DISEASE; ITGA2B; GENE	Congenital macrothrombocytopenia (CMTP) is a heterogeneous group of rare platelet disorders characterized by a congenital reduction of platelet counts and abnormally large platelets, for which CMTP-causing mutations are only found in approximately half the cases. We herein performed whole-exome sequencing and targeted Sanger sequencing to identify mutations that cause CMTP, in which a dominant mode of transmission had been suspected but for which no known responsible mutations have been documented. In 13 Japanese CMTP-affected pedigrees, we identified six (46%) affected by ACTN1 variants cosegregating with CMTP. In the entire cohort, ACNT1 variants accounted for 5.5% of the dominant forms of CMTP cases and represented the fourth most common cause in Japanese individuals. Individuals with ACTN1 variants presented with moderate macrothrombocytopenia with anisocytosis but were either asymptomatic or had only a modest bleeding tendency. ACTN1 encodes alpha-actinin-1, a member of the actin-crosslinking protein superfamily that participates in the organization of the cytoskeleton. In vitro transfection experiments in Chinese hamster ovary cells demonstrated that altered a-actinin-1 disrupted the normal actin-based cytoskeletal structure. Moreover, transduction of mouse fetal liver-derived megakaryocytes with disease-associated ACTN1 variants caused a disorganized actin-based cytoskeleton in megakaryocytes, resulting in the production of abnormally large proplatelet tips, which were reduced in number. Our findings provide an insight into the pathogenesis of CMTP.	[Kunishima, Shinji] Natl Hosp Org Nagoya Med Ctr, Dept Adv Diag, Clin Res Ctr, Nagoya, Aichi 4600001, Japan; [Okuno, Yusuke; Yoshida, Kenichi; Sanada, Masashi; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo 1138655, Japan; [Okuno, Yusuke; Muramatsu, Hideki; Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ, Dept Pediat, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo 1088639, Japan; [Miyazaki, Koji] Kitasato Univ, Dept Hematol, Sch Med, Sagamihara, Kanagawa 2288555, Japan; [Sakai, Michio] Univ Occupat & Environm Hlth, Sch Med, Dept Pediat, Kitakyushu, Fukuoka 8078555, Japan; [Ohtake, Masatoshi] Sendai City Hosp, Div Pediat, Sendai, Miyagi 9848501, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido 0030006, Japan; [Iguchi, Akihiro] Hokkaido Univ, Dept Pediat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Niimi, Gen] Fujita Hlth Univ, Electron Microscopy Lab, Joint Res Lab, Toyoake, Aichi 4701192, Japan; [Otsu, Makoto] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell & Regenerat Med, Tokyo 1088639, Japan; [Saito, Hidehiko] Natl Hosp Org Nagoya Med Ctr, Nagoya, Aichi 4600001, Japan	Nagoya Medical Center; University of Tokyo; Nagoya University; University of Tokyo; Kitasato University; University of Occupational & Environmental Health - Japan; Hokkaido University; Fujita Health University; University of Tokyo; Nagoya Medical Center	Kunishima, S (corresponding author), Natl Hosp Org Nagoya Med Ctr, Dept Adv Diag, Clin Res Ctr, Nagoya, Aichi 4600001, Japan.	kunishis@nnh.hosp.go.jp	Ogawa, Seishi/AAE-7088-2019; Muramatsu, Hideki/ABA-3376-2021; Takahashi, Yoshiyuki/I-1929-2012; Okuno, Yusuke/C-9082-2009; Muramatsu, Hideki/I-3763-2012	Muramatsu, Hideki/0000-0002-8801-0021; Okuno, Yusuke/0000-0003-3139-9272; Miyano, Satoru/0000-0002-1753-6616; Yoshida, Kenichi/0000-0003-4612-2778; Otsu, Makoto/0000-0002-9769-0217	Research on Measures for Intractable Diseases Project [H23-012]; Ministry of Health Labour and Welfare; Japan Society for the Promotion of Science [20591161, 23591429]; National Hospital Organization Research Fund (Network Research Grant for Congenital Thrombocytopenia)	Research on Measures for Intractable Diseases Project; Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Hospital Organization Research Fund (Network Research Grant for Congenital Thrombocytopenia)	This work was supported by Research on Measures for Intractable Diseases Project (H23-012), a matching fund subsidy from the Ministry of Health Labour and Welfare, the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research 20591161 and 23591429), and the National Hospital Organization Research Fund (Network Research Grant for Congenital Thrombocytopenia). The supercomputing resources were provided by the Human Genome Center, the Institute of Medical Science, The University of Tokyo. We thank R.C. Mulligan for the 293 gp and 293 gpg cells, M. Onodera for pGCDNsamIRES/EGFP, K. Oguri and Y. Kusano for discussions on the expression analysis, and Y. Kito for technical assistance.	Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Balduini CL, 2012, HUM GENET, V131, P1821, DOI 10.1007/s00439-012-1215-x; Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; Bender M, 2010, BLOOD, V116, P1767, DOI 10.1182/blood-2010-03-274340; Berndt MC, 2011, HAEMATOL-HEMATOL J, V96, P355, DOI 10.3324/haematol.2010.039883; Gunay-Aygun M, 2011, NAT GENET, V43, P732, DOI 10.1038/ng.883; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Hartwig JH, 2006, BLOOD CELL MOL DIS, V36, P99, DOI 10.1016/j.bcmd.2005.12.007; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Jackson SC, 2009, BLOOD, V113, P3348, DOI 10.1182/blood-2008-06-165233; Kahr WHA, 2011, NAT GENET, V43, P738, DOI 10.1038/ng.884; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Kunishima S, 2006, BLOOD REV, V20, P111, DOI 10.1016/j.blre.2005.08.001; Kunishima S, 2002, INT J HEMATOL, V76, P319, DOI 10.1007/BF02982690; Kunishima S, 2011, BLOOD, V117, P5479, DOI 10.1182/blood-2010-12-323691; Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c; Kunishima S, 2009, BLOOD, V113, P458, DOI 10.1182/blood-2008-06-162610; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Nabekura T, 2006, MOL THER, V13, P301, DOI 10.1016/j.ymthe.2005.09.021; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Nurden AT, 2012, HAEMOPHILIA, V18, P154, DOI 10.1111/j.1365-2516.2012.02856.x; Nurden AT, 2011, BLOOD, V118, P5996, DOI 10.1182/blood-2011-07-365635; Nurden P, 2011, BLOOD, V118, P5928, DOI 10.1182/blood-2011-07-365601; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Shiraga M, 1999, J CELL BIOL, V147, P1419, DOI 10.1083/jcb.147.7.1419; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Tadokoro S, 2011, BLOOD, V117, P250, DOI 10.1182/blood-2009-10-246751; Thon JN, 2012, BLOOD, V120, P1552, DOI 10.1182/blood-2012-04-408724; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	33	142	149	3	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					431	438		10.1016/j.ajhg.2013.01.015	http://dx.doi.org/10.1016/j.ajhg.2013.01.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23434115	Bronze, Green Published			2022-12-18	WOS:000316161700017
J	Bhattacharjee, S; Rajaraman, P; Jacobs, KB; Wheeler, WA; Melin, BS; Hartge, P; Yeager, M; Chung, CC; Chanock, SJ; Chatterjee, N				Bhattacharjee, Samsiddhi; Rajaraman, Preetha; Jacobs, Kevin B.; Wheeler, William A.; Melin, Beatrice S.; Hartge, Patricia; Yeager, Meredith; Chung, Charles C.; Chanock, Stephen J.; Chatterjee, Nilanjan		GliomaScan Consortium	A Subset-Based Approach Improves Power and Interpretation for the Combined Analysis of Genetic Association Studies of Heterogeneous Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TELOMERASE REVERSE-TRANSCRIPTASE; SUSCEPTIBILITY LOCI; COLORECTAL-CANCER; PROSTATE-CANCER; COMMON VARIANT; BREAST-CANCER; RISK; METAANALYSIS; TERT	Pooling genome-wide association studies (GWASs) increases power but also poses methodological challenges because studies are often heterogeneous. For example, combining GWASs of related but distinct traits can provide promising directions for the discovery of loci with small but common pleiotropic effects. Classical approaches for meta-analysis or pooled analysis, however, might not be suitable for such analysis because individual variants are likely to be associated with only a subset of the traits or might demonstrate effects in different directions. We propose a method that exhaustively explores subsets of studies for the presence of true association signals that are in either the same direction or possibly opposite directions. An efficient approximation is used for rapid evaluation of p values. We present two illustrative applications, one for a meta-analysis of separate case-control studies of six distinct cancers and another for pooled analysis of a case-control study of glioma, a class of brain tumors that contains heterogeneous subtypes. Both the applications and additional simulation studies demonstrate that the proposed methods offer improved power and more interpretable results when compared to traditional methods for the analysis of heterogeneous traits. The proposed framework has applications beyond genetic association studies.	[Bhattacharjee, Samsiddhi; Chatterjee, Nilanjan] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD 20852 USA; [Rajaraman, Preetha] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD 20852 USA; [Jacobs, Kevin B.; Yeager, Meredith] NCI, Core Genotyping Facil, NIH, Dept Hlth & Human Serv, Gaithersburg, MD 20877 USA; [Wheeler, William A.] Informat Management Serv Inc, Rockville, MD 20852 USA; [Melin, Beatrice S.] Umea Univ, Dept Radiat Sci, S-90187 Umea, Sweden; [Hartge, Patricia] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Chung, Charles C.; Chanock, Stephen J.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Umea University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chatterjee, N (corresponding author), NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, 6120 Execut Blvd, Rockville, MD 20852 USA.	chattern@mail.nih.gov	Wang, Zhaoming/R-5527-2018; Albanes, Demetrius/B-9749-2015; Yeager, Meredith/AAA-5322-2020; Freeman, Laura E. Beane/C-4468-2015; Ruder, Avima/I-4155-2012	Wang, Zhaoming/0000-0001-7556-3869; Freeman, Laura E. Beane/0000-0003-1294-4124; Ruder, Avima/0000-0003-0419-6664; Bhattacharjee, Samsiddhi/0000-0002-8549-1130; Jacobs, Kevin/0000-0002-4657-6473	National Cancer Institute, National Institutes of Health, USA; NATIONAL CANCER INSTITUTE [ZIACP010181, R01CA098661] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural program of the National Cancer Institute, National Institutes of Health, USA. The authors would like to thank the GliomaScan Consortium investigators (Demetrius Albanes, Ulrika Andersson, Laura Beane-Freeman, Christine D. Berg, Julie E. Buring, Mary Ann Butler, Tania Carreon, Helle Collatz Christensen, Maria Feychting, Susan M. Gapstur, J. Michael Gaziano, Graham G. Giles, Goran Hallmans, Susan E. Hankinson, Roger Henriksson, Jane Hoppin, Ann W. Hsing, Peter D. Inskip, Christoffer Johansen, Laurence N. Kolonel, Roberta McKean-Cowdin, Dominique Michaud, Ulrike Peters, Mark P. Purdue, Avima M. Ruder, Howard D. Sesso, Gianluca Seven, Victoria L. Stevens, Kala Visvanathan, Zhaoming Wang, Emily White, Walter C. Willett, and Anne Zeleniuch-Jacquotte) for providing data for the glioma example. The simulation experiments utilized the high-performance computational capabilities of the StatPro Linux cluster at the National Cancer Institute and the Biowulf Linux cluster at the National Institutes of Health, USA. We would also like to thank Alan Genz and Fabio Iwamoto for helpful discussions and two anonymous reviewers for comments and suggestions that helped improve the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Chung CC, 2010, CARCINOGENESIS, V31, P111, DOI 10.1093/carcin/bgp273; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Egan KM, 2011, J NEURO-ONCOL, V104, P535, DOI 10.1007/s11060-010-0506-0; Fisher RA, 1925, STAT METHODS RES WOR; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Genz A, 2000, J STAT COMPUT SIM, V68, P1, DOI 10.1080/00949650008812053; Genz A, 2009, COMPUTATION MULTIVAR; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Huang J, 2011, BIOINFORMATICS, V27, P1201, DOI 10.1093/bioinformatics/btr116; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jenkins RB, 2011, CANCER GENET-NY, V204, P13, DOI 10.1016/j.cancergencyto.2010.10.002; Kraft P, 2010, NAT GENET, V42, P819, DOI 10.1038/ng1010-819; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lee PH, 2011, HUM HERED, V72, P10, DOI 10.1159/000327158; Li J, 2011, ANN APPL STAT, V5, P994, DOI 10.1214/10-AOAS393; Lin DY, 2009, AM J HUM GENET, V85, P862, DOI 10.1016/j.ajhg.2009.11.001; Macgregor S, 2006, EUR J HUM GENET, V14, P529, DOI 10.1038/sj.ejhg.5201604; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Naiman DQ, 1997, ANN STAT, V25, P1954; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pfeiffer RM, 2009, STAT SCI, V24, P547, DOI 10.1214/09-STS286; Province MA, 2001, AM J HUM GENET, V69, P660, DOI 10.1086/323316; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; Roeder K, 2009, STAT SCI, V24, P398, DOI 10.1214/09-STS289; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Sanson M, 2011, HUM MOL GENET, V20, P2897, DOI 10.1093/hmg/ddr192; Schmidt S, 2008, HUM HERED, V65, P154, DOI 10.1159/000109732; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Simon M, 2010, CLIN CANCER RES, V16, P5252, DOI 10.1158/1078-0432.CCR-10-1502; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Taylor JE, 2007, BIOMETRIKA, V94, P1, DOI 10.1093/biomet/asm004; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zaykin DV, 2010, GENET EPIDEMIOL, V34, P725, DOI 10.1002/gepi.20536	56	142	145	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					821	835		10.1016/j.ajhg.2012.03.015	http://dx.doi.org/10.1016/j.ajhg.2012.03.015			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22560090	Green Published, Bronze			2022-12-18	WOS:000303907500006
J	Riazuddin, SA; Zaghloul, NA; Al-Saif, A; Davey, L; Diplas, BH; Meadows, DN; Eghrari, AO; Minear, MA; Li, YJ; Klintworth, GK; Afshari, N; Gregory, SG; Gottsch, JD; Katsanis, N				Riazuddin, S. Amer; Zaghloul, Norann A.; Al-Saif, Amr; Davey, Lisa; Diplas, Bill H.; Meadows, Danielle N.; Eghrari, Allen O.; Minear, Mollie A.; Li, Yi-Ju; Klintworth, Gordon K.; Afshari, Natalie; Gregory, Simon G.; Gottsch, John D.; Katsanis, Nicholas			Missense Mutations in TCF8 Cause Late-Onset Fuchs Corneal Dystrophy and Interact with FCD4 on Chromosome 9p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; LINKAGE; LOCUS; TRANSCRIPTION; POPULATION; FAMILY; MAPS	Fuchs corneal dystrophy (FCD) is a degenerative genetic disorder of the corneal endothelium that represents one of the most common causes of corneal transplantation in the United States. Despite its high prevalence (4%, over the age of 40), the underlying genetic basis of FCD is largely unknown. Here we report missense mutations in TCF8, a transcription factor whose haploinsufficiency causes posterior polymorphous corneal dystrophy (PPCD), in a cohort of late-onset FCD patients. In contrast to PPCD-causing mutations, all of which are null, FCD-associated mutations encode rare missense changes Suggested to cause loss of function by an in vivo complementation assay. Importantly, segregation of a recurring p.Q840P mutation in a large, multigenerational FCD pedigree showed this allele to be sufficient but not necessary for pathogenesis. Execution of a genome-wide scan conditioned for the presence of the 840P allele identified an additional late-onset FCD locus on chromosome 9p, whereas haplotype analysis indicated that the presence of the TCF8 allele and the disease haplotype on 9p leads to a severe FCD manifestation with poor prognosis. Our data suggest that PPCD and FCD are allele variants of the same disease Continuum and that genetic interaction between genes that cause corneal dystrophies can modulate the expressivity of the phenotype.	[Riazuddin, S. Amer; Zaghloul, Norann A.; Al-Saif, Amr; Davey, Lisa; Diplas, Bill H.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Meadows, Danielle N.; Eghrari, Allen O.; Gottsch, John D.] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Cornea & External Dis Serv, Ctr Corneal Genet, Baltimore, MD 21205 USA; [Minear, Mollie A.; Li, Yi-Ju; Gregory, Simon G.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Klintworth, Gordon K.; Afshari, Natalie] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modelling, Durham, NC 27710 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Duke University; Duke University; Duke University	Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@cellbio.duke.edu	Eghrari, Allen/AAI-9282-2021; Katsanis, Nicholas/E-1837-2012; Eghrari, Allen/ABH-4964-2020	Eghrari, Allen/0000-0003-2798-038X; Gregory, Simon/0000-0002-7805-1743; Li, Yi-Ju/0000-0001-6996-4834; Diplas, Bill/0000-0001-9248-7351; Katsanis, Nicholas/0000-0002-2480-0171	NATIONAL EYE INSTITUTE [R01EY016514, R01EY016835, P30EY005722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016514, P30 EY005722, R01EY016835, P30 EY005722-24, R01 EY016835, R01EY016514] Funding Source: Medline; NICHD NIH HHS [R01HD04260] Funding Source: Medline; NIDDK NIH HHS [P30 DK079637] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Goar E L, 1933, Trans Am Ophthalmol Soc, V31, P48; Gottsch JD, 2006, CORNEA, V25, P485, DOI 10.1097/01.ico.0000178726.11693.14; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; Mannis MJ, 2006, CORNEA, V25, P164; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; Muraoka O, 2000, DEV BIOL, V228, P29, DOI 10.1006/dbio.2000.9909; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P140, DOI 10.1167/iovs.05-0578; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; WILSON SE, 1988, CORNEA, V7, P2	23	142	147	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					45	53		10.1016/j.ajhg.2009.12.001	http://dx.doi.org/10.1016/j.ajhg.2009.12.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20036349	Green Published, Bronze			2022-12-18	WOS:000274471200004
J	Coene, KLM; Roepman, R; Doherty, D; Afroze, B; Kroes, HY; Letteboer, SJF; Ngu, LH; Budny, B; van Wijk, E; Gorden, NT; Azhimi, M; Thauvin-Robinet, C; Veltman, JA; Boink, M; Kleefstra, T; Cremers, FPM; van Bokhoven, H; de Brouwer, APM				Coene, Karlien L. M.; Roepman, Ronald; Doherty, Dan; Afroze, Bushra; Kroes, Hester Y.; Letteboer, Stef J. F.; Ngu, Lock H.; Budny, Bartlomiej; van Wijk, Erwin; Gorden, Nicholas T.; Azhimi, Malika; Thauvin-Robinet, Christel; Veltman, Joris A.; Boink, Mireille; Kleefstra, Tjitske; Cremers, Frans P. M.; van Bokhoven, Hans; de Brouwer, Arjan P. M.			OFD1 Is Mutated in X-Linked Joubert Syndrome and Interacts with LCA5-Encoded Lebercilin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASAL BODY PROTEIN; DIGITAL SYNDROME TYPE-1; PRIMARY CILIA FORMATION; GENE-EXPRESSION; RENAL SYNDROME; SENIOR-LOKEN; MUTATIONS; CEP290; DNA; NEPHRONOPHTHISIS	We ascertained a multi-generation Malaysian family with Joubert syndrome US). The presence of asymptomatic obligate carrier females suggested an X-linked recessive inheritance pattern. Affected males presented with mental retardation accompanied by postaxial polydactyly and retinitis pigmentosa. Brain MRIs showed the presence of a "molar tooth sign," which classifies this syndrome as classic JS with retinal involvement. Linkage analysis showed linkage to Xpter-Xp22.2 and a maximum LOD score of 2.06 for marker DXS8022. Mutation analysis revealed a frameshift mutation, p.K948NfsX8, in exon 21 of OFD1. In an isolated male with JS, a second frameshift mutation, p.E923KfsX3, in the same exon was identified. OFD1 has previously been associated with oral-facial-digital type 1 (OFD1) syndrome, a male-lethal X-linked dominant condition, and with X-linked recessive Simpson-Golabi-Behmel syndrome type 2 (SGBS2). In a yeast two-hybrid screen of a retinal cDNA library, we identified OFD1 as an interacting partner of the LCA5-encoded ciliary protein lebercilin. We show that X-linked recessive mutations in OFD1 reduce, but do not eliminate, the interaction with lebercilin, whereas X-linked dominant OFD1 mutations completely abolish binding to lebercilin. In addition, recessive mutations in OFD1 did not affect the pericentriolar localization of the recombinant protein in hTERT-RPE1. cells, whereas this localization was lost for dominant mutations. These findings offer a molecular explanation for the phenotypic spectrum observed for OFD1 mutations; this spectrum now includes OFD1 syndrome, SGBS2, and JS.	[Coene, Karlien L. M.; Roepman, Ronald; Letteboer, Stef J. F.; Azhimi, Malika; Veltman, Joris A.; Boink, Mireille; Kleefstra, Tjitske; Cremers, Frans P. M.; van Bokhoven, Hans; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Coene, Karlien L. M.; Roepman, Ronald; Veltman, Joris A.; Cremers, Frans P. M.; van Bokhoven, Hans; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [van Wijk, Erwin] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; [Doherty, Dan; Gorden, Nicholas T.] Univ Washington, Dept Pediat, Sch Med, Seattle, WA 98195 USA; [Doherty, Dan; Gorden, Nicholas T.] Seattle Childrens Hosp, Seattle, WA 98195 USA; [Afroze, Bushra; Ngu, Lock H.] Kuala Lumpur Hosp, Inst Pediat, Div Clin Genet, Kuala Lumpur 50586, Malaysia; [Kroes, Hester Y.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [Budny, Bartlomiej] Poznan Univ Med Sci, Dept Med Genet, PL-60352 Poznan, Poland; [Thauvin-Robinet, Christel] Hop Enfants, Ctr Genet, F-21079 Dijon, France	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Utrecht University; Utrecht University Medical Center; Poznan University of Medical Sciences; CHU Dijon Bourgogne	Roepman, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	r.roepman@antrg.umcn.nl	Budny, Bartlomiej/AIC-4615-2022; Roepman, Ronald/B-1339-2014; Ngu, Lock-Hock/Y-6055-2019; van Bokhoven, Hans/D-8764-2012; Veltman, Joris A/F-5128-2010; Budny, Bartlomiej/ABF-5760-2021; Letteboer, Stef JF/P-8272-2015; van Wijk, Erwin/J-8913-2014; Coene, Karlien/K-7583-2016; Bokhoven, J.H.L.M. van van/H-8015-2014; Cremers, Frans/A-5625-2014; de Brouwer, Arjan PM/P-5949-2015; Kleefstra, Tjitske/G-2619-2012; Ngu, Lock Hock/R-4473-2019	Budny, Bartlomiej/0000-0002-2860-395X; Roepman, Ronald/0000-0002-5178-8163; Veltman, Joris A/0000-0002-3218-8250; van Wijk, Erwin/0000-0002-5702-3460; Coene, Karlien/0000-0001-9873-1458; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Cremers, Frans/0000-0002-4954-5592; Ngu, Lock Hock/0000-0002-2396-1686	Netherlands Organization for Scientific Research [NWO Toptalent-021.001.014, NWO Vidi-91786396]; Foundation Fighting Blindness [BR-CMM-0808-0451-RAD]; United States National Institutes of Health [NCRR SKL2RR025015]; March of Dimes Endowment for Healthier Babies; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064077] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Foundation Fighting Blindness(European Commission); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Endowment for Healthier Babies(March of Dimes); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their valuable contribution to this research. We are also indebted to Lydie Burglen (Service de Genetique et Embryologie Medicales CHU Hopital d'Enfants Armand-Trousseau, Paris, France) for providing the cell lines of the female patient with the p.I171fs mutation and to Saskia van der Velde and Christel Beumer (Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands) for expert technical assistance with cell culturing. We thank Ian Glass and Melissa Parisi (Department of Pediatrics, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, USA) for providing clinical details on subject UW87. We also thank Uwe Wolfrum (Johannes-Gutenberg Universitat, Mainz, Germany) for providing the hTERT-RPE1 cell line and the a.-centrin monoclonal antibody, E. Nigg (Max-Planck Institut far Biochemie, Martinsried, Germany) for providing alpha-OFD1 serum, Carsten Janke (CNRS Centre de Recherches en Biochimie Macromoleculaire, Montpellier, France) for providing the GT335 monoclonal antibody, and Brunella Franco (TIGEM Telethon Institute of Genetics and Medicine, Naples, Italy) for providing the full-length OFD1 clone. This work was supported by The Netherlands Organization for Scientific Research (NWO Toptalent-021.001.014 to K.L.M.C. and NWO Vidi-91786396 to R.R.), the Foundation for Retinal Research (R.R. and F.P.M.C.), the Foundation Fighting Blindness (BR-CMM-0808-0451-RAD to R.R.), the United States National Institutes of Health (NCRR SKL2RR025015 to D.D.), and the March of Dimes Endowment for Healthier Babies (to D. D.).	Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; de Brouwer APM, 2006, MOL DIAGN THER, V10, P197; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Eley L, 2008, KIDNEY INT, V74, P1139, DOI 10.1038/ki.2008.377; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Gurrieri F, 2007, AM J MED GENET A, V143A, P3314, DOI 10.1002/ajmg.a.32032; Haug K, 2000, AM J MED GENET, V91, P135, DOI 10.1002/(SICI)1096-8628(20000313)91:2<135::AID-AJMG11>3.0.CO;2-1; Helou J, 2007, J MED GENET, V44, P657, DOI 10.1136/jmg.2007.052027; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; KING MD, 1984, ARCH DIS CHILD, V59, P709, DOI 10.1136/adc.59.8.709; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rakkolainen A, 2002, J MED GENET, V39, P292, DOI 10.1136/jmg.39.4.292; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; Romio L, 2003, J AM SOC NEPHROL, V14, P680, DOI 10.1097/01.ASN.0000054497.48394.D2; Rozen S, 2000, Methods Mol Biol, V132, P365; Satran D, 1999, AM J MED GENET, V86, P459; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Thauvin-Robinet C, 2006, J MED GENET, V43, P54, DOI 10.1136/jmg.2004.027672; Thauvin-Robinet C, 2009, HUM MUTAT, V30, pE320, DOI 10.1002/humu.20888; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003; VERLOES A, 1989, AM J MED GENET, V32, P227, DOI 10.1002/ajmg.1320320217; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; WALL FE, 1995, IN VITRO CELL DEV-AN, V31, P156	58	142	145	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					465	481		10.1016/j.ajhg.2009.09.002	http://dx.doi.org/10.1016/j.ajhg.2009.09.002			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19800048	Green Published, Bronze			2022-12-18	WOS:000270836000004
J	Hanein, S; Martin, E; Boukhris, A; Byrne, P; Goizet, C; Hamri, A; Benomar, A; Lossos, A; Denora, P; Fernandez, J; Elleuch, N; Forlani, S; Durr, A; Feki, I; Hutchinson, M; Santorelli, FM; Mhiri, C; Brice, A; Stevanin, G				Hanein, Sylvain; Martin, Elodie; Boukhris, Amir; Byrne, Paula; Goizet, Cyril; Hamri, Abdelmadjid; Benomar, Ali; Lossos, Alexander; Denora, Paola; Fernandez, Jose; Elleuch, Nizar; Forlani, Sylvie; Durr, Alexandra; Feki, Imed; Hutchinson, Michael; Santorelli, Filippo M.; Mhiri, Chokri; Brice, Alexis; Stevanin, Giovanni			Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THIN CORPUS-CALLOSUM; MESSENGER-RNA DECAY; HEREDITARY ATAXIAS; FYVE DOMAIN; EXCHANGE FACTOR; MUTATIONS; DEMENTIA; FAMILIES; NONSENSE; PROTEIN	Hereditary spastic paraplegias (HSPs) are genetically and phenotypically heterogeneous disorders. Both "uncomplicated" and "complicated" forms have been described with various modes of inheritance. Sixteen loci for autosomal-recessive "complicated" HSP have been mapped. The SPG15 locus was first reported to account for a rare form of spastic paraplegia variably associated with mental impairment, pigmented maculopathy, dysarthria, cerebellar signs, and distal amyotrophy, sometimes designated as Kjellin syndrome. Here, we report the refinement of SPG15 to a 2.64 Mb genetic interval on chromosome 14q23.3-q24.2 and the identification of ZFYVE26, which encodes a zinc-ftnger protein with a FYVE domain that we named spastizin, as the cause of SPG15. Six different truncating mutations were found to segregate with the disease in eight families with a phenotype that included variable clinical features of Kjellin syndrome. ZFYVE26 mRNA was widely distributed in human tissues, as well as in rat embryos, suggesting a possible role of this gene during embryonic development. In the adult rodent brain, its expression profile closely resembled that of SPG11, another gene responsible for complicated HSP. In cultured cells, spastizin colocalized partially with markers of endoplasmic reticulurn and endosomes, suggesting a role in intracellular trafficking.	[Hanein, Sylvain; Martin, Elodie; Boukhris, Amir; Goizet, Cyril; Denora, Paola; Fernandez, Jose; Forlani, Sylvie; Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni] INSERM, Unite Mixte Rech UMR S679, F-75013 Paris, France; [Hanein, Sylvain; Martin, Elodie; Boukhris, Amir; Goizet, Cyril; Denora, Paola; Fernandez, Jose; Forlani, Sylvie; Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni] UPMC, UMR S679, F-75013 Paris, France; [Boukhris, Amir; Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni] Grp Hosp Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, F-75013 Paris, France; [Boukhris, Amir; Elleuch, Nizar; Mhiri, Chokri] Hop Univ Habib Bourguiba, Serv Neurol, Sfax 3029, Tunisia; [Byrne, Paula] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Med & Med Serv, Dublin 4, Ireland; [Goizet, Cyril] Univ Victor Segalen Bordeaux 2, Serv Genet Med, Hop Pellegrin, Lab Genet Humaine, F-33076 Bordeaux, France; [Hamri, Abdelmadjid] Hop Benbadis, Constantine 25000, Algeria; [Benomar, Ali] Hop Specialit, Dept Neurol, Rabat, Morocco; [Benomar, Ali] Hop Specialit, Dept Neurogenet, Rabat, Morocco; [Lossos, Alexander] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Neurol, Jerusalem, Israel; [Denora, Paola; Santorelli, Filippo M.] IRCCS Bambino Gesu Childrens Hosp, Mol Med Unit, I-400165 Rome, Italy; [Hutchinson, Michael] Univ Coll Dublin, St Vincents Univ Hosp, Dept Neurol, Dublin 4, Ireland; [Brice, Alexis] Grp Hosp Pitie Salpetriere, AP HP, F-75013 Paris, France; [Brice, Alexis] Univ Paris 06, Fac Med Pitie Salpetriere, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Monastir; Hopital Fattouma Bourguiba; University College Dublin; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Hebrew University of Jerusalem; Hadassah University Medical Center; IRCCS Bambino Gesu; University College Dublin; Saint Vincent's University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Stevanin, G (corresponding author), INSERM, Unite Mixte Rech UMR S679, F-75013 Paris, France.	stevanin@ccr.jussieu.fr	brice, alexis/AAE-8275-2019; Stevanin, Giovanni/E-5038-2016; hanein, sylvain/AAG-4933-2019; GOIZET, Cyril/M-4576-2014; hutchinson, michael/H-3508-2019; Santorelli, Filippo M/ABE-5124-2020; MARTIN, Elodie/ABF-3563-2020; Brice, Alexis/A-2170-2009; MHIRI, Chokri/O-8801-2014	brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; hanein, sylvain/0000-0001-5817-6330; GOIZET, Cyril/0000-0002-1913-889X; Santorelli, Filippo M/0000-0002-1359-9062; MARTIN, Elodie/0000-0002-4494-9168; fernandez, jose-carlos/0000-0003-2410-6179; MHIRI, Chokri/0000-0001-7591-6994	Telethon [GGP06188] Funding Source: Medline	Telethon(Fondazione Telethon)		Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; BEHAN WMH, 1974, J NEUROL NEUROSUR PS, V37, P8, DOI 10.1136/jnnp.37.1.8; BOUKHRIS A, 2007, MOVEMENT DISORD, V23, P429; Casali C, 2004, NEUROLOGY, V62, P262, DOI 10.1212/WNL.62.2.262; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Elleuch N, 2007, NEUROGENETICS, V8, P307, DOI 10.1007/s10048-007-0097-x; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; FILLA A, 1992, J NEUROL, V239, P351, DOI 10.1007/BF00867594; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; HARDING AE, 1983, LANCET, V1, P1151; HAYAKAWA A, 2004, J BIOL CHEM, V13, P58; Hughes CA, 2001, NEUROLOGY, V56, P1230, DOI 10.1212/WNL.56.9.1230; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; KJELLIN K, 1959, ARCH NEUROL-CHICAGO, V1, P133, DOI 10.1001/archneur.1959.03840020007002; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; POLO JM, 1991, BRAIN, V114, P855, DOI 10.1093/brain/114.2.855; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; Stendel C, 2007, AM J HUM GENET, V81, P158, DOI 10.1086/518770; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Stevanin G, 2008, BRAIN, V131, P772, DOI 10.1093/brain/awm293; Stevanin G, 2007, NAT GENET, V39, P366, DOI 10.1038/ng1980; Webb S, 1997, J NEUROL NEUROSUR PS, V63, P628, DOI 10.1136/jnnp.63.5.628	31	142	148	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					992	1002		10.1016/j.ajhg.2008.03.004	http://dx.doi.org/10.1016/j.ajhg.2008.03.004			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18394578	Bronze, Green Published			2022-12-18	WOS:000255103900017
J	O'Reilly, M; Palfi, A; Chadderton, N; Millington-Ward, S; Ader, M; Cronin, T; Tuohy, T; Auricchio, A; Hildinger, M; Tivnan, A; McNally, N; Humphries, MM; Kiang, AS; Humphries, P; Kenna, PF; Farrar, GJ				O'Reilly, Mary; Palfi, Arpad; Chadderton, Naomi; Millington-Ward, Sophia; Ader, Marius; Cronin, Therese; Tuohy, Therese; Auricchio, Alberto; Hildinger, Markus; Tivnan, Amanda; McNally, Niamh; Humphries, Marian M.; Kiang, Anna-Sophia; Humphries, Pete; Kenna, Paul F.; Farrar, G. Jane			RNA interference-mediated suppression and replacement of human rhodopsin in vivo	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; ADENOASSOCIATED VIRUS VECTORS; GENE-THERAPY; MAMMALIAN-CELLS; RETINAL DEGENERATION; MOUSE MODEL; MUTATION; RIBOZYME; DISEASE; EXPRESSION	Mutational heterogeneity represents a significant barrier to development of therapies for many dominantly inherited diseases. For example, 1100 mutations in the rhodopsin gene (RHO) have been identified in patients with retinitis pigmentosa (RP). The development of therapies for dominant disorders that correct the primary genetic lesion and overcome mutational heterogeneity is challenging. Hence, therapeutics comprising two elements-gene suppression in conjunction with gene replacement-have been investigated. Suppression is targeted to a site independent of the mutation; therefore, both mutant and wild- type alleles are suppressed. In parallel with suppression, a codon- modified replacement gene refractory to suppression is provided. Both in vitro and in vivo validation of suppression and replacement for RHO- linked RP has been undertaken in the current study. RNA interference (RNAi) has been used to achieve similar to 90% in vivo suppression of RHO in photoreceptors, with use of adeno-associated virus (AAV) for delivery. Demonstration that codon- modifed RHO genes express functional wild- type protein has been explored transgenically, together with in vivo expression of AAV-delivered RHO-replacement genes in the presence of targeting RNAi molecules. Observation of potential therapeutic benefit from AAV-delivered suppression and replacement therapies has been obtained in Pro23His mice. Results provide the first in vivo indication that suppression and replacement can provide a therapeutic solution for dominantly inherited disorders such as RHO-linked RP and can be employed to circumvent mutational heterogeneity.	Trinity Coll Dublin, Smurfiti Inst Genet, Dublin 2, Ireland; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Federico 11 Univ, Telethon Inst Genet & Med, Naples, Italy; Federico 11 Univ, Dept Pediat, Naples, Italy	Trinity College Dublin; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	O'Reilly, M (corresponding author), Trinity Coll Dublin, Smurfiti Inst Genet, Dublin 2, Ireland.	oreillym@tcd.ie	Tuohy, Therese/A-8665-2009; Ader, Marius/E-7535-2010; Farrar, G Jane/B-9832-2011; Palfi, Arpad/C-5541-2009; chadderton, naomi/A-6953-2010; AURICCHIO, Alberto/AHE-7979-2022; Bateson, Jane Farrar/AAO-6147-2020	Ader, Marius/0000-0001-9467-7677; Palfi, Arpad/0000-0003-3517-3932; AURICCHIO, Alberto/0000-0002-0832-2472; Cronin, Therese/0000-0002-2938-2765; Chadderton, Naomi/0000-0002-1684-1598; Millington-Ward, Sophia/0000-0001-7470-0702	Telethon [TGM06S01, TGM03P04] Funding Source: Medline	Telethon(Fondazione Telethon)		Allocca M, 2006, EXPERT OPIN BIOL TH, V6, P1279, DOI 10.1517/14712598.6.12.1279; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Bennett Jean, 2004, Novartis Found Symp, V255, P195; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cashman SM, 2005, GENE THER, V12, P1223, DOI 10.1038/sj.gt.3302512; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; Gorbatyuk M, 2007, EXP EYE RES, V84, P44, DOI 10.1016/j.exer.2006.08.014; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hauswirth WW, 2000, PROG RETIN EYE RES, V19, P689, DOI 10.1016/S1350-9462(00)00007-0; Hildinger M, 2001, J VIROL, V75, P6199, DOI 10.1128/JVI.75.13.6199-6203.2001; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Kiang AS, 2005, MOL THER, V12, P555, DOI 10.1016/j.ymthe.2005.03.028; Kim DH, 2003, ANTISENSE NUCLEIC A, V13, P151, DOI 10.1089/108729003768247619; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McNally N, 1999, HUM MOL GENET, V8, P1309, DOI 10.1093/hmg/8.7.1309; Millington-Ward S, 2004, EUR J HUM GENET, V12, P864, DOI 10.1038/sj.ejhg.5201230; MillingtonWard S, 1997, HUM MOL GENET, V6, P1415, DOI 10.1093/hmg/6.9.1415; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Palfi A, 2006, HUM MUTAT, V27, P260, DOI 10.1002/humu.20287; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Rohr UP, 2002, J VIROL METHODS, V106, P81, DOI 10.1016/S0166-0934(02)00138-6; Rolling F, 2004, GENE THER, V11, pS26, DOI 10.1038/sj.gt.3302366; Stieger K, 2006, MOL THER, V13, P967, DOI 10.1016/j.ymthe.2005.12.001; Tessitore A, 2006, MOL THER, V14, P692, DOI 10.1016/j.ymthe.2006.07.008; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xia XG, 2005, J NEUROCHEM, V92, P362, DOI 10.1111/j.1471-4159.2004.02860.x; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998	31	142	171	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					127	135		10.1086/519025	http://dx.doi.org/10.1086/519025			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564969	Green Published, Bronze			2022-12-18	WOS:000247039700011
J	Lu, WN; van Eerde, AM; Fan, XP; Quintero-Rivera, F; Kulkarni, S; Ferguson, H; Kim, HG; Fan, YL; Xi, QC; Li, QG; Sanlaville, D; Andrews, W; Sundaresan, V; Bi, WM; Yan, J; Giltay, JC; Wijmenga, C; de Jong, TPVM; Feather, SA; Woolf, AS; Rao, Y; Lupski, JR; Eccles, MR; Quade, BJ; Gusella, JF; Morton, CC; Maas, RL				Lu, Weining; van Eerde, Albertien M.; Fan, Xueping; Quintero-Rivera, Fabiola; Kulkarni, Shashikant; Ferguson, Heather; Kim, Hyung-Goo; Fan, Yanli; Xi, Qiongchao; Li, Qing-Gang; Sanlaville, Damien; Andrews, William; Sundaresan, Vasi; Bi, Weimin; Yan, Jiong; Giltay, Jacques C.; Wijmenga, Cisca; de Jong, Tom P. V. M.; Feather, Sally A.; Woolf, Adrian S.; Rao, Yi; Lupski, James R.; Eccles, Michael R.; Quade, Bradley J.; Gusella, James F.; Morton, Cynthia C.; Maas, Richard L.			Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS-SYNDROME; CONGENITAL-ANOMALIES; NEURONAL MIGRATION; MICE; SLIT; DELETION; GENE; EXPRESSION; ROUNDABOUT; GUIDANCE	Congenital anomalies of the kidney and urinary tract (CAKUT) include vesicoureteral reflux (VUR). VUR is a complex, genetically heterogeneous developmental disorder characterized by the retrograde flow of urine from the bladder into the ureter and is associated with reflux nephropathy, the cause of 15% of end-stage renal disease in children and young adults. We investigated a man with a de novo translocation, 46, X, t(Y;3)(p11;p12)dn, who exhibits multiple congenital abnormalities, including severe bilateral VUR with ureterovesical junction defects. This translocation disrupts ROBO2, which encodes a transmembrane receptor for SLIT ligand, and produces dominant-negative ROBO2 proteins that abrogate SLIT-ROBO signaling in vitro. In addition, we identified two novel ROBO2 intracellular missense variants that segregate with CAKUT and VUR in two unrelated families. Adult heterozygous and mosaic mutant mice with reduced Robo2 gene dosage also exhibit striking CAKUT-VUR phenotypes. Collectively, these results implicate the SLIT-ROBO signaling pathway in the pathogenesis of a subset of human VUR.	Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Gynecol & Reprod Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Human Genet Res, Massachusetts Gen Hosp, Boston, MA 02115 USA; Boston Univ, Renal Sect, Boston, MA 02215 USA; Univ Utrecht, Ctr Med, Dept Med Genet, NL-3508 TC Utrecht, Netherlands; Univ Utrecht, Ctr Med, Dept Pediat Urol, NL-3508 TC Utrecht, Netherlands; Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA; Kings Coll London, Med Res Council Ctr Dev Neurobiol, London WC2R 2LS, England; Hop Necker Enfants Malad, Dept Genet, F-75730 Paris, France; UCL, Nephrourol Unit, Inst Child Hlth, London WC1E 6BT, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; St James Univ Hosp, Dept Pediat Nephrol, Leeds, W Yorkshire, England; Univ Otago, Dept Pathol, Dunedin, New Zealand	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Utrecht University; Utrecht University; Northwestern University; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Baylor College of Medicine; Saint James's University Hospital; University of Otago	Maas, RL (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, NRB 458,77 Ave Louis Pasteur, Boston, MA 02115 USA.	maas@genetics.med.harvard.edu	de Jong, Tom/AAG-5659-2020; Woolf, Adrian S./AAZ-1075-2020; Sanlaville, Damien/M-4716-2014; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Woolf, Adrian S./0000-0001-5541-1358; Sanlaville, Damien/0000-0001-9939-2849; Wijmenga, Cisca/0000-0002-5635-1614; de Jong, Tom P.V.M./0000-0002-9091-1099; van Eerde, Albertien M./0000-0001-5953-5956; Fan, Xueping/0000-0002-3715-6864; Lu, Weining/0000-0002-6570-3044; Yan, Jiong/0000-0003-0536-8130	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK063316] Funding Source: Medline; NIGMS NIH HHS [P01 GM061354] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey R R, 1973, Clin Nephrol, V1, P132; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Blanco P, 2000, MAMM GENOME, V11, P906, DOI 10.1007/s003350010177; CHAPMAN CJ, 1985, AM J MED GENET, V20, P577, DOI 10.1002/ajmg.1320200403; Chou IC, 2002, J FORMOS MED ASSOC, V101, P726; Dillon MJ, 1998, J AM SOC NEPHROL, V9, P2377; Eccles MR, 1996, HUM MOL GENET, V5, P1425, DOI 10.1093/hmg/5.Supplement_1.1425; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kincaid-Smith P S, 1984, Contrib Nephrol, V39, P94; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li XF, 2006, J BIOL CHEM, V281, P28430, DOI 10.1074/jbc.M604135200; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; MACKIE GG, 1975, J PEDIATR SURG, V10, P473, DOI 10.1016/0022-3468(75)90187-6; Nakanishi K, 2003, PEDIATR INT, V45, P610, DOI 10.1046/j.1442-200X.2003.01779.x; NOE HN, 1992, J UROLOGY, V148, P1869, DOI 10.1016/S0022-5347(17)37053-2; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Sanna-Cherchi S, 2005, J AM SOC NEPHROL, V16, P1781, DOI 10.1681/ASN.2004121034; Sargent MA, 2000, PEDIATR RADIOL, V30, P587, DOI 10.1007/s002470000263; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Srinivas S, 1999, DEV GENET, V24, P241; Stauss J, 2003, J UROLOGY, V170, P1966, DOI 10.1097/01.ju.0000092163.08445.e5; TANAGHO EA, 1969, J UROLOGY, V101, P824, DOI 10.1016/S0022-5347(17)62433-9; VANDENABBEELE AD, 1987, PEDIATRICS, V79, P147; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; Ward Michael E., 2004, V294, P137; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xian J, 2004, CANCER RES, V64, P6432, DOI 10.1158/0008-5472.CAN-04-2561; Xian J, 2001, P NATL ACAD SCI USA, V98, P15062, DOI 10.1073/pnas.251407098; Yan J, 2004, HUM MOL GENET, V13, P2613, DOI 10.1093/hmg/ddh288; Yue Y, 2006, GENOMICS, V88, P772, DOI 10.1016/j.ygeno.2006.05.011	44	142	154	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					616	632		10.1086/512735	http://dx.doi.org/10.1086/512735			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357069	Green Published, Bronze			2022-12-18	WOS:000245465200004
J	Perrault, I; Hanein, S; Gerber, S; Barbet, F; Ducroq, D; Dollfus, H; Hamel, C; Dufier, JL; Munnich, A; Kaplan, J; Rozet, JM				Perrault, I; Hanein, S; Gerber, S; Barbet, F; Ducroq, D; Dollfus, H; Hamel, C; Dufier, JL; Munnich, A; Kaplan, J; Rozet, JM			Retinal dehydrogenase 12 (RDH12) mutations in leber congenital amaurosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VERTEBRATE RETINA; GENE-MUTATIONS; MOUSE MODEL; CRB1 GENE; LOCUS; IDENTIFICATION; DYSTROPHY; PIGMENT; CRX	Leber congenital amaurosis (LCA), the most early-onset and severe form of all inherited retinal dystrophies, is responsible for congenital blindness. Ten LCA genes have been mapped, and seven of these have been identified. Because some of these genes are involved in the visual cycle, we regarded the retinal pigment epithelium and photoreceptor-specific retinal dehydrogenase (RDH) genes as candidate genes in LCA. Studying a series of 110 unrelated patients with LCA, we found mutations in the photoreceptor-specific RDH12 gene in a significant subset of patients (4.1%). Interestingly, all patients harboring RDH12 mutations had a severe yet progressive rod-cone dystrophy with severe macular atrophy but no or mild hyperopia.	Hop Necker Enfants Malad, Unite Rech Handicaps Genet Enfant, F-75743 Paris 15, France; Hop Necker Enfants Malad, Serv Ophtalmol, F-75743 Paris 15, France; Hop Univ Strasbourg, Clin Ophtalmol, Strasbourg, France; Serv Ophtalmol, Montpellier, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Montpellier	Kaplan, J (corresponding author), Hop Necker Enfants Malad, Unite Rech Handicaps Genet Enfant, 149 Rue Sevres, F-75743 Paris 15, France.	kaplan@necker.fr	hanein, sylvain/AAG-4933-2019; ROZET, Jean-Michel/E-5737-2016; perrault, isabelle/H-3047-2017; KAPLAN, Josseline/I-2622-2017	hanein, sylvain/0000-0001-5817-6330; ROZET, Jean-Michel/0000-0001-7951-7886; perrault, isabelle/0000-0002-8560-1379; Dollfus, Helene/0000-0002-2249-895X; GERBER, Sylvie/0000-0002-6827-1769; KAPLAN, Josseline/0000-0002-1849-8658				Bennett Jean, 2004, Novartis Found Symp, V255, P195; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Dharmaraj S, 2000, AM J HUM GENET, V66, P319, DOI 10.1086/302719; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Gerber S, 2001, EUR J HUM GENET, V9, P561, DOI 10.1038/sj.ejhg.5200689; Gerber Sylvie, 2002, Ophthalmic Genet, V23, P225, DOI 10.1076/opge.23.4.225.13879; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Keen TJ, 2003, EUR J HUM GENET, V11, P420, DOI 10.1038/sj.ejhg.5200981; Kuksa V, 2003, VISION RES, V43, P2959, DOI 10.1016/S0042-6989(03)00482-6; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; North MA, 1997, P NATL ACAD SCI USA, V94, P3128, DOI 10.1073/pnas.94.7.3128; Perrault I, 1999, AM J HUM GENET, V64, P1225, DOI 10.1086/302335; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Stockton DW, 1998, HUM GENET, V103, P328, DOI 10.1007/s004390050825; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200	24	142	145	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					639	646		10.1086/424889	http://dx.doi.org/10.1086/424889			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15322982	Bronze, Green Published			2022-12-18	WOS:000223634100009
J	Middleton, FA; Pato, MT; Gentile, KL; Morley, CP; Zhao, X; Eisener, AF; Brown, A; Petryshen, TL; Kirby, AN; Medeiros, H; Carvalho, C; Macedo, A; Dourado, A; Coelho, I; Valente, J; Soares, MJ; Ferreira, CP; Lei, M; Azevedo, MH; Kennedy, JL; Daly, MJ; Sklar, P; Pato, CN				Middleton, FA; Pato, MT; Gentile, KL; Morley, CP; Zhao, X; Eisener, AF; Brown, A; Petryshen, TL; Kirby, AN; Medeiros, H; Carvalho, C; Macedo, A; Dourado, A; Coelho, I; Valente, J; Soares, MJ; Ferreira, CP; Lei, M; Azevedo, MH; Kennedy, JL; Daly, MJ; Sklar, P; Pato, CN			Genomewide linkage analysis of bipolar disorder by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay: A comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE SCAN; NATIONAL-INSTITUTE; SCHIZOPHRENIA; GENETICS; GENES; NEUROGENESIS; METAANALYSIS; ILLNESS	We performed a linkage analysis on 25 extended multiplex Portuguese families segregating for bipolar disorder, by use of a high-density single-nucleotide-polymorphism (SNP) genotyping assay, the GeneChip Human Mapping 10K Array (HMA10K). Of these families, 12 were used for a direct comparison of the HMA10K with the traditional 10-cM microsatellite marker set and the more dense 4-cM marker set. This comparative analysis indicated the presence of significant linkage peaks in the SNP assay in chromosomal regions characterized by poor coverage and low information content on the microsatellite assays. The HMA10K provided consistently high information and enhanced coverage throughout these regions. Across the entire genome, the HMA10K had an average information content of 0.842 with 0.21-Mb intermarker spacing. In the 12-family set, the HMA10K-based analysis detected two chromosomal regions with genomewide significant linkage on chromosomes 6q22 and 11p11; both regions had failed to meet this strict threshold with the microsatellite assays. The full 25-family collection further strengthened the findings on chromosome 6q22, achieving genomewide significance with a maximum nonparametric linkage (NPL) score of 4.20 and a maximum LOD score of 3.56 at position 125.8 Mb. In addition to this highly significant finding, several other regions of suggestive linkage have also been identified in the 25-family data set, including two regions on chromosome 2 (57 Mb, NPL = 2.98; 145 Mb, NPL = 3.09), as well as regions on chromosomes 4 (91 Mb, NPL = 2.97), 16 (20 Mb, NPL = 2.89), and 20 (60 Mb, NPL = 2.99). We conclude that at least some of the linkage peaks we have identified may have been largely undetected in previous whole-genome scans for bipolar disorder because of insufficient coverage or information content, particularly on chromosomes 6q22 and 11p11.	Vet Adm Med Ctr, Washington, DC 20422 USA; SUNY Syracuse, Dept Neurosci & Physiol, Syracuse, NY USA; SUNY Syracuse, Ctr Psychiat & Mol Genet, Syracuse, NY USA; SUNY Syracuse, Dept Psychiat, Syracuse, NY USA; Whitehead Inst, Cambridge, MA 02142 USA; Broad Inst, Cambridge, MA USA; Harvard Med Sch, Psychiat & Neurodev Genet Unit, Charlestown, MA USA; Univ Coimbra, Coimbra, Portugal; Psychiat Serv, Ponta Delgada, Azores, Portugal; Ctr Addict & Mental Hlth, Clarke Div, Toronto, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) System; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidade de Coimbra; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Pato, CN (corresponding author), Vet Adm Med Ctr, 50 Irving St NW, Washington, DC 20422 USA.	cmpato@aol.com	Morley, Christopher P./W-5037-2019; Daly, Mark J/B-2453-2017; Petryshen, Tracey/X-5850-2019; Morley, Christopher P./K-1907-2014; macedo santos, antónio/M-5737-2013; macedo, antónio/AFQ-1570-2022; macedo, antónio/AFQ-1571-2022; Barreto Carvalho, Célia/AAY-8962-2021	Morley, Christopher P./0000-0003-0185-7148; Daly, Mark J/0000-0002-0949-8752; Petryshen, Tracey/0000-0002-7972-4612; Morley, Christopher P./0000-0003-0185-7148; macedo santos, antónio/0000-0003-2180-2718; macedo, antónio/0000-0003-2180-2718; macedo, antónio/0000-0003-2180-2718; de Oliveira Barreto Coimbra Carvalho, Celia Maria/0000-0003-4453-8139; Middleton, Frank/0000-0002-3107-7188; Soares, Maria Joao/0000-0002-4674-1045	NIMH NIH HHS [R01 MH058693, MH058693, MH52618] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052618] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; AMBELAS A, 1986, J NERV MENT DIS, V174, P693, DOI 10.1097/00005053-198611000-00009; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Pato CN, 1997, AM J MED GENET, V74, P286, DOI 10.1002/(SICI)1096-8628(19970531)74:3<286::AID-AJMG9>3.0.CO;2-O; Pato CN, 2000, AM J MED GENET, V96, P854; PATO CN, IN PRESS AM J MED GE; Peltonen L, 2000, HUM HERED, V50, P66, DOI 10.1159/000022892; Sakamoto M, 2003, J BIOL CHEM, V278, P44808, DOI 10.1074/jbc.M300448200; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Shao WL, 2002, MOL CELL BIOL, V22, P3358, DOI 10.1128/MCB.22.10.3358-3372.2002; Sklar P, 2004, MOL PSYCHIATR, V9, P213, DOI 10.1038/sj.mp.4001418; Sklar P, 2002, ANNU REV GENOM HUM G, V3, P371, DOI 10.1146/annurev.genom.3.022502.103141; Tsuang M, 1990, GENETICS MOOD DISORD; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202	24	142	146	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					886	897		10.1086/420775	http://dx.doi.org/10.1086/420775			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15060841	Green Published, Bronze			2022-12-18	WOS:000220926100010
J	Abkevich, V; Camp, NJ; Hensel, CH; Neff, CD; Russell, DL; Hughes, DC; Plenk, AM; Lowry, MR; Richards, RL; Carter, C; Frech, GC; Stone, S; Rowe, K; Chau, CA; Cortado, K; Hunt, A; Luce, K; O'Neil, G; Poarch, J; Potter, J; Poulsen, GH; Saxton, H; Bernat-Sestak, M; Thompson, V; Gutin, A; Skolnick, MH; Shattuck, D; Cannon-Albright, L				Abkevich, V; Camp, NJ; Hensel, CH; Neff, CD; Russell, DL; Hughes, DC; Plenk, AM; Lowry, MR; Richards, RL; Carter, C; Frech, GC; Stone, S; Rowe, K; Chau, CA; Cortado, K; Hunt, A; Luce, K; O'Neil, G; Poarch, J; Potter, J; Poulsen, GH; Saxton, H; Bernat-Sestak, M; Thompson, V; Gutin, A; Skolnick, MH; Shattuck, D; Cannon-Albright, L			Predisposition locus for major depression at chromosome 12q22-12q23.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SCAN; LINKAGE ANALYSIS; EARLY-ONSET; BIPOLAR DISORDER; FAMILIAL COSEGREGATION; GENETIC-LINKAGE; RECURRENT; SCHIZOPHRENIA; RISK; DISEASE	Major depression disorder is a common psychiatric disease with a major economic impact on society. In many cases, no effective treatment is available. The etiology of major depression is complex, but it is clear that the disease is, to a large extent, determined genetically, especially among individuals with a familial history of major depression, presumably through the involvement of multiple predisposition genes in addition to an environmental component. As a first step toward identification of chromosomal loci contributing to genetic predisposition to major depression, we have conducted a genomewide scan by using 628 microsatellite markers on 1,890 individuals from 110 Utah pedigrees with a strong family history of major depression. We identified significant linkage to major depression in males at marker D12S1300 (multipoint heterogeneity LOD score 4.6; P = .00003 after adjustment for multiple testing). With additional markers, the linkage evidence became highly significant, with the multipoint heterogeneity LOD score at marker D12S1706 increasing to 6.1 (P = .0000007 after adjustment for multiple testing). This study confirms the presence of one or more genes involved in psychiatric diseases on the q arm of chromosome 12 and provides strong evidence for the existence of a sex-specific predisposition gene to major depression at 12q22-q23.2.	Myriad Genet, Salt Lake City, UT 84108 USA; Intermt Hlth Care, Salt Lake City, UT USA; Childrens Ctr, Salt Lake City, UT USA; Valley Mental Hlth, Salt Lake City, UT USA	Myriad Genetics, Inc; Intermountain Healthcare	Abkevich, V (corresponding author), Myriad Genet, 320 Wakara Way, Salt Lake City, UT 84108 USA.	victor@myriad.com	Russell, Darryl L/I-6654-2012	Russell, Darryl L/0000-0002-4930-7658; Russell, Deanna/0000-0002-9650-2309; albright, lisa/0000-0003-2602-3668				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Angst J, 1999, J CLIN PSYCHIAT, V60, P57; Balciuniene J, 1998, MOL PSYCHIATR, V3, P162, DOI 10.1038/sj.mp.4000372; BERTELSEN A, 1977, BRIT J PSYCHIAT, V130, P330, DOI 10.1192/bjp.130.4.330; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Camp NJ, 2001, AM J HUM GENET, V69, P1278, DOI 10.1086/324590; COX N, 1989, J PSYCHIAT RES, V23, P109, DOI 10.1016/0022-3956(89)90002-2; CRADDOCK N, 1994, BRIT J PSYCHIAT, V164, P355, DOI 10.1192/bjp.164.3.355; Davidson JRT, 1999, J CLIN PSYCHIAT, V60, P4; Degn B, 2001, MOL PSYCHIATR, V6, P450, DOI 10.1038/sj.mp.4000882; Detera-Wadleigh SD, 1999, AM J MED GENET, V88, P255, DOI 10.1002/(SICI)1096-8628(19990618)88:3<255::AID-AJMG8>3.0.CO;2-V; Ekholm JM, 2001, AM J MED GENET, V105, P580; ENGLUND SA, 1990, J AFFECT DISORDERS, V18, P247, DOI 10.1016/0165-0327(90)90075-J; Ewald H, 2002, AM J MED GENET, V114, P760; Fullerton J, 2003, AM J HUM GENET, V72, P879, DOI 10.1086/374178; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; Hirschfield RMA, 1997, JAMA-J AM MED ASSOC, V277, P333, DOI 10.1001/jama.277.4.333; Jones I, 2002, MOL PSYCHIATR, V7, P424, DOI 10.1038/sj.mp.4000989; Jorde LB, 1981, INFORMATION SCI HUMA, V56, P105; Kelsoe JR, 2003, J AFFECT DISORDERS, V73, P183, DOI 10.1016/S0165-0327(02)00323-3; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kort EN, 2000, AM J HUM GENET, V66, P1845, DOI 10.1086/302945; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Marazita ML, 1997, AM J HUM GENET, V61, P1370, DOI 10.1086/301627; Maziade M, 2002, AM J MED GENET, V114, P858; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MOLDIN SO, 1991, BEHAV GENET, V21, P211, DOI 10.1007/BF01065817; Morissette J, 1999, AM J MED GENET, V88, P567, DOI 10.1002/(SICI)1096-8628(19991015)88:5<567::AID-AJMG24>3.0.CO;2-8; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pincus HA, 2001, J CLIN PSYCHIAT, V62, P5; Robins L.N., 1991, PSYCHIAT DISORDERS A; Samuels ME, 2001, CLIN GENET, V59, P88, DOI 10.1034/j.1399-0004.2001.590205.x; Spak L, 2000, ACTA PSYCHIAT SCAND, V102, P44, DOI 10.1034/j.1600-0447.2000.102001044.x; SPANER D, 1994, ACTA PSYCHIAT SCAND, V89, P7, DOI 10.1111/j.1600-0447.1994.tb05786.x; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; TANNA VL, 1976, BIOL PSYCHIAT, V11, P767; TANNA VL, 1989, J PSYCHIAT RES, V23, P99, DOI 10.1016/0022-3956(89)90001-0; Thomas A, 2000, STAT COMPUT, V10, P259, DOI 10.1023/A:1008947712763; TORGERSEN S, 1986, ARCH GEN PSYCHIAT, V43, P222; TSUANG MT, 1994, GENETIC STUDIES AFFE; Weissman MM, 1991, PSYCHIAT DISORDERS A, P53; Wilcox MA, 2002, BIOL PSYCHIAT, V52, P847, DOI 10.1016/S0006-3223(02)01465-8; World Health Organization, 1990, COMP INT DIAGN INT C; Zubenko GS, 2002, AM J MED GENET, V114, P980, DOI 10.1002/ajmg.b.10933; Zubenko GS, 2002, AM J MED GENET, V114, P413, DOI 10.1002/ajmg.10381; Zubenko GS, 2001, AM J MED GENET, V105, P690, DOI 10.1002/ajmg.1554	54	142	150	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1271	1281		10.1086/379978	http://dx.doi.org/10.1086/379978			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14606042	Green Published, Bronze			2022-12-18	WOS:000187491100005
J	Stankiewicz, P; Shaw, CJ; Dapper, JD; Wakui, K; Shaffer, LG; Withers, M; Elizondo, L; Park, SS; Lupski, JR				Stankiewicz, P; Shaw, CJ; Dapper, JD; Wakui, K; Shaffer, LG; Withers, M; Elizondo, L; Park, SS; Lupski, JR			Genome architecture catalyzes nonrecurrent chromosomal rearrangements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS-SYNDROME; ROBERTSONIAN TRANSLOCATION FORMATION; SEGMENTAL DUPLICATIONS; HOMOLOGOUS RECOMBINATION; PERICENTROMERIC HETEROCHROMATIN; MOLECULAR MECHANISMS; GENE CLUSTERS; X-CHROMOSOME; PMP22 GENE; DISORDERS	To investigate the potential involvement of genome architecture in nonrecurrent chromosome rearrangements, we analyzed the breakpoints of eight translocations and 18 unusual-sized deletions involving human proximal 17p. Surprisingly, we found that many deletion breakpoints occurred in low-copy repeats (LCRs); 13 were associated with novel large LCR17p structures, and 2 mapped within an LCR sequence ( middle SMS-REP) within the Smith-Magenis syndrome (SMS) common deletion. Three translocation breakpoints involving 17p11 were found to be located within the centromeric alpha-satellite sequence D17Z1, three within a pericentromeric segment, and one at the distal SMS-REP. Remarkably, our analysis reveals that LCRs constitute >23% of the analyzed genome sequence in proximal 17p - an experimental observation two-to fourfold higher than predictions based on virtual analysis of the genome. Our data demonstrate that higher-order genomic architecture involving LCRs plays a significant role not only in recurrent chromosome rearrangements but also in translocations and unusual-sized deletions involving 17p.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Room 604B,1 Baylor Plaza, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Stankiewicz, Paweł/AAP-7906-2021; Park, Sung Sup/J-2756-2012	Stankiewicz, Paweł/0000-0002-6456-7490; Park, Sung Sup/0000-0003-3754-4848	NICHD NIH HHS [P01 HD039420, P01 HD39420, HD24064, P30 HD024064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039420] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bandyopadhyay R, 2001, CHROMOSOME RES, V9, P235, DOI 10.1023/A:1016652621226; Beheshti B, 2000, MOL DIAGN, V5, P23, DOI 10.2165/00066982-200005010-00008; Berger R, 1999, LEUKEMIA, V13, P671, DOI 10.1038/sj.leu.2401365; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Briggs SD, 2002, NAT GENET, V30, P241, DOI 10.1038/ng0302-241; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Eichler EE, 1999, HUM MOL GENET, V8, P151, DOI 10.1093/hmg/8.2.151; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Elsea SH, 1997, CYTOGENET CELL GENET, V79, P276, DOI 10.1159/000134742; ELSEA SH, 1997, CYTOGENET CELL GENET, V81, P67; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Fauth C, 2001, AM J MED GENET, V103, P160, DOI 10.1002/ajmg.1520; Fioretos T, 1999, BLOOD, V94, P225, DOI 10.1182/blood.V94.1.225.413k24_225_232; Gao LI, 1997, NUCLEIC ACIDS RES, V25, P4740, DOI 10.1093/nar/25.23.4740; Giglio S, 2002, AM J HUM GENET, V71, P276, DOI 10.1086/341610; HAN JY, 1994, AM J HUM GENET, V55, P960; Horvath JE, 2001, HUM MOL GENET, V10, P2215, DOI 10.1093/hmg/10.20.2215; Hussain SZ, 2000, AM J MED GENET, V95, P99, DOI 10.1002/1096-8628(20001113)95:2<99::AID-AJMG2>3.0.CO;2-2; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Juyal RC, 1996, AM J HUM GENET, V58, P998; Katsanis N, 2001, NAT GENET, V29, P88, DOI 10.1038/ng0901-88; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; King PH, 1998, CLIN GENET, V54, P413; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; MERTENS F, 1994, GENE CHROMOSOME CANC, V10, P221, DOI 10.1002/gcc.2870100402; Morrow BE, 2002, AM J HUM GENET, V71, P296; Page SL, 1996, HUM MOL GENET, V5, P1279, DOI 10.1093/hmg/5.9.1279; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Rhodes CH, 1997, CYTOGENET CELL GENET, V78, P247, DOI 10.1159/000134667; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Roa BB, 1996, HUM GENET, V97, P642; Saglio G, 2002, P NATL ACAD SCI USA, V99, P9882, DOI 10.1073/pnas.152171299; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Sawyer JR, 1998, BLOOD, V91, P1732, DOI 10.1182/blood.V91.5.1732.1732_1732_1741; Scheurlen WG, 1999, GENE CHROMOSOME CANC, V25, P230, DOI 10.1002/(SICI)1098-2264(199907)25:3<230::AID-GCC5>3.0.CO;2-E; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2001, GENOME RES, V11, P1205, DOI 10.1101/gr.181101; Tumer Z, 1998, AM J MED GENET, V76, P45; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; Wolff DJ, 1996, AM J HUM GENET, V58, P154	66	142	153	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1101	1116		10.1086/374385	http://dx.doi.org/10.1086/374385			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12649807	Bronze, Green Published			2022-12-18	WOS:000182474400004
J	van Bokhoven, H; Brunner, HG				van Bokhoven, H; Brunner, HG			Splitting p63	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							LIMB-MAMMARY SYNDROME; P53 HOMOLOG P63; ADULT-SYNDROME; EEC-SYNDROME; ECTODERMAL DYSPLASIA; P53-RELATED PROTEIN; FOOT MALFORMATION; DOWN-REGULATION; CLEFT-LIP; GENE	Causative TP63 mutations have been identified in five distinct human developmental disorders that are characterized by various degrees of limb abnormalities, ectodermal dysplasia, and facial clefts. The distribution of mutations over the various p63 protein domains and the structural and functional implications of these mutations establish a clear genotype-phenotype correlation.	Univ Nijmegen, Med Ctr 417, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	van Bokhoven, H (corresponding author), Univ Nijmegen, Med Ctr 417, Dept Human Genet, Box 9101, NL-6500 HB Nijmegen, Netherlands.	H.vanbokhoven@antrg.azn.nl	Brunner, Han/C-9928-2013; Bokhoven, J.H.L.M. van van/H-8015-2014; van Bokhoven, Hans/D-8764-2012	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; 				Amiel J, 2001, EUR J HUM GENET, V9, P642, DOI 10.1038/sj.ejhg.5200676; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Bamberger C, 2002, J INVEST DERMATOL, V118, P133, DOI 10.1046/j.0022-202x.2001.01649.x; Bamberger C, 2001, FEBS LETT, V501, P121, DOI 10.1016/S0014-5793(01)02643-6; Bamshad M, 2000, AM J MED GENET, V90, P183, DOI 10.1002/(SICI)1096-8628(20000117)90:2<183::AID-AJMG22>3.0.CO;2-#; BARROW LL, IN PRESS AM J MED GE; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Calabro V, 2002, J BIOL CHEM, V277, P2674, DOI 10.1074/jbc.M107173200; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438; Chitayat D, 1996, AM J MED GENET, V61, P45, DOI 10.1002/(SICI)1096-8628(19960102)61:1<45::AID-AJMG9>3.0.CO;2-W; De Laurenzi V, 2000, BIOCHEM BIOPH RES CO, V273, P342, DOI 10.1006/bbrc.2000.2932; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Duijf PHG, 2002, HUM MOL GENET, V11, P799, DOI 10.1093/hmg/11.7.799; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; FRASER FC, 1970, AM J HUM GENET, V22, P336; Hagiwara K, 1999, CANCER RES, V59, P4165; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HAY RJ, 1976, BRIT J DERMATOL, V94, P277, DOI 10.1111/j.1365-2133.1976.tb04384.x; HOLLISTER DW, 1973, J PEDIATR-US, V83, P438, DOI 10.1016/S0022-3476(73)80268-9; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Jost CA, 1999, NATURE, V399, P817, DOI 10.1038/21710; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kadakia M, 2001, DNA CELL BIOL, V20, P321, DOI 10.1089/10445490152122433; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kosaki R, 2001, CLIN GENET, V60, P314, DOI 10.1034/j.1399-0004.2001.600411.x; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liefer KM, 2000, CANCER RES, V60, P4016; Little NA, 2001, ONCOGENE, V20, P4576, DOI 10.1038/sj.onc.1204615; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; OPITZ JM, 1980, EUR J PEDIATR, V133, P217, DOI 10.1007/BF00496079; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Ozaki T, 1999, CANCER RES, V59, P5902; Pochampally R, 2000, BIOCHEM BIOPH RES CO, V279, P1001, DOI 10.1006/bbrc.2000.4056; PROPPING P, 1993, AM J MED GENET, V45, P642, DOI 10.1002/ajmg.1320450525; Propping P, 2000, AM J MED GENET, V90, P179, DOI 10.1002/(SICI)1096-8628(20000117)90:2<179::AID-AJMG21>3.3.CO;2-D; RAPP R S, 1968, Journal of Medical Genetics, V5, P269, DOI 10.1136/jmg.5.4.269; RODINI ESO, 1990, AM J MED GENET, V37, P42, DOI 10.1002/ajmg.1320370112; Roelfsema NM, 1996, CLIN DYSMORPHOL, V5, P115, DOI 10.1097/00019605-199604000-00003; RUDIGER RA, 1970, AM J DIS CHILD, V120, P160; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; SCHECHTMAN M, 1994, PHILOS PSYCHOL, V7, P3, DOI 10.1080/09515089408573107; SCHINZEL A, 1986, J MED GENET, V23, P291, DOI 10.1136/jmg.23.4.291; Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500; Schultz J, 1997, PROTEIN SCI, V6, P249; Senoo M, 1998, BIOCHEM BIOPH RES CO, V248, P603, DOI 10.1006/bbrc.1998.9013; Shimada A, 1999, CANCER RES, V59, P2781; Sidow A, 1999, NAT GENET, V23, P104, DOI 10.1038/12709; Sidow A, 1997, NATURE, V389, P722, DOI 10.1038/39587; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; van Bokhoven H, 1999, AM J HUM GENET, V64, P538, DOI 10.1086/302246; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WALLIS CE, 1988, CLIN GENET, V34, P252; Wessagowit V, 2000, CLIN EXP DERMATOL, V25, P441, DOI 10.1046/j.1365-2230.2000.00683.x; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhu JH, 1999, ONCOGENE, V18, P2149, DOI 10.1038/sj.onc.1202533	67	142	146	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					1	13		10.1086/341450	http://dx.doi.org/10.1086/341450			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12037717	Green Published, Bronze			2022-12-18	WOS:000176307700001
J	Millat, G; Marcais, C; Tomasetto, C; Chikh, K; Fensom, AH; Harzer, K; Wenger, DA; Ohno, K; Vanier, MT				Millat, G; Marcais, C; Tomasetto, C; Chikh, K; Fensom, AH; Harzer, K; Wenger, DA; Ohno, K; Vanier, MT			Niemann-Pick C1 disease: Correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NIEMANN-PICK-DISEASE; C-DISEASE; FIBROBLASTS; GENE; COMPLEMENTATION; TRANSPORT; FORM	To obtain more information of the functional domains of the NPC1 protein, the mutational spectrum and the level of immunoreactive protein were investigated in skin fibroblasts from 30 unrelated patients with Niemann-Pick C1 disease. Nine of them were characterized by mild alterations of cellular cholesterol transport (the "variant" biochemical phenotype). The mutations showed a wide distribution to nearly all NPC1 domains, with a cluster (11/32) in a conserved NPC1 cysteine-rich luminal loop. Homozygous mutations in 14 patients and a phenotypically defined allele, combined with a new mutation, in a further 10 patients allowed genotype/phenotype correlations. Premature-termination-codon mutations, the three missense mutations in the sterol-sensing domain (SSD), and A1054T in the cysteine-rich luminal loop all occurred in patients with infantile neurological onset and "classic" (severe) cholesterol-trafficking alterations. By western blot, NPC1 protein was undetectable in the SSD missense mutations studied (L724P and Q775P) and essentially was absent in the A1054T missense allele. Our results thus enhance the functional significance of the SSD and demonstrate a correlation between the absence of NPC1 protein and the most severe neurological form. In the remaining missense mutations studied, corresponding to other disease presentations (including two adults with nonneurological disease), NPC1 protein was present in significant amounts of normal size, without clear-cut correlation with either the clinical phenotype or the "classic"/"variant" biochemical phenotype. Missense mutations in the cysteine-rich luminal loop resulted in a wide array of clinical and biochemical phenotypes. Remarkably, all five mutant alleles (I943M, V950M, G986S, G992R, and the recurrent P1007A) definitively correlated with the "variant" phenotype clustered within this loop, providing new insight on the functional complexity of the latter domain.	Ctr Hosp Lyon Sud, Lab Fdn Gillet Merieux, F-69495 Pierre Benite, France; Tottori Univ, Fac Med, Sch Life Sci, Dept Neurobiol, Yonago, Tottori 683, Japan; Thomas Jefferson Univ, Jefferson Med Coll, Dept Neurol, Philadelphia, PA 19107 USA; Univ Tubingen, Inst Hirnforsch, Neurochem Lab, Tubingen, Germany; Guys Hosp, Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London, England; Univ Louis Pasteur Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS,U184, INSERM,UPR 6520, Strasbourg, France; Lyon Sud Med Sch, INSERM, Unit 189, Oullins, France	CHU Lyon; Tottori University; Jefferson University; Eberhard Karls University of Tubingen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vanier, MT (corresponding author), Ctr Hosp Lyon Sud, Lab Fdn Gillet Merieux, Batiment 3B, F-69495 Pierre Benite, France.	vanier@univ-lyon1.fr	Tomasetto, Catherine Laure/J-2783-2014	Tomasetto, Catherine Laure/0000-0002-1811-5848; CHIKH, Karim/0000-0002-1217-4193				Baumkoetter J., 1998, Journal of Inherited Metabolic Disease, V21, P118; Blanchette-Mackie EJ, 2000, BBA-MOL CELL BIOL L, V1486, P171, DOI 10.1016/S1388-1981(00)00055-X; BYERS DM, 1989, BIOCHEM J, V262, P713, DOI 10.1042/bj2620713; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Christomanou H, 2000, MOL GENET METAB, V70, P196, DOI 10.1006/mgme.2000.3004; Cruz JC, 2000, J BIOL CHEM, V275, P41309, DOI 10.1074/jbc.M008272200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; DAWSON G, 1971, J PEDIATR-US, V79, P423, DOI 10.1016/S0022-3476(71)80151-8; DAWSON G, 1972, J LIPID RES, V13, P207; Fensom AH, 1999, J INHERIT METAB DIS, V22, P84, DOI 10.1023/A:1005463718823; FROHLICH E, 1990, ULTRASCHALL MED, V11, P119, DOI 10.1055/s-2007-1011543; Greer WL, 1998, AM J HUM GENET, V63, P52, DOI 10.1086/301931; Greer WL, 1999, AM J HUM GENET, V65, P1252, DOI 10.1086/302620; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; JAEKEN J, 1980, ACTA PAEDIATR BELG, V33, P43; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; KANOUN N, 1989, ANN PEDIATR-PARIS, V36, P335; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; MARTIN JJ, 1984, J NEUROL SCI, V66, P33, DOI 10.1016/0022-510X(84)90139-4; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; Morris JA, 1999, BIOCHEM BIOPH RES CO, V261, P493, DOI 10.1006/bbrc.1999.1070; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Ory DS, 2000, BBA-MOL CELL BIOL L, V1529, P331, DOI 10.1016/S1388-1981(00)00158-X; Patterson M. C., 2001, METABOLIC MOL BASES, VIII, P3611; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; RIBEIRO I, IN PRESS HUM GENET; STEINBERG SJ, 1994, J MED GENET, V31, P317, DOI 10.1136/jmg.31.4.317; Vanier Marie T., 2000, Journal of Inherited Metabolic Disease, V23, P232; VANIER MT, 1991, J INHERIT METAB DIS, V14, P580, DOI 10.1007/BF01797928; VANIER MT, 1988, CLIN GENET, V33, P331; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; Vanier MT, 1996, AM J HUM GENET, V58, P118; Vanier MT, 1998, BRAIN PATHOL, V8, P163; Vanier MT, 1999, NEUROCHEM RES, V24, P481, DOI 10.1023/A:1022575511354; Vanier MT, 1999, AM J HUM GENET, V65, pA495; VANIER MT, 1996, HDB CLIN NEUROLOGY, V66, P133; Watari H, 2000, EXP CELL RES, V259, P247, DOI 10.1006/excr.2000.4976; Watari H, 1999, J BIOL CHEM, V274, P21861, DOI 10.1074/jbc.274.31.21861; WENGER DA, 1975, SCIENCE, V188, P1310, DOI 10.1126/science.1145196; Yamamoto T, 2000, J MED GENET, V37, P707, DOI 10.1136/jmg.37.9.707; Yamamoto T, 1999, HUM GENET, V105, P10, DOI 10.1007/s004390051057; Yano T, 1996, P JPN ACAD B-PHYS, V72, P214, DOI 10.2183/pjab.72.214; Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200	45	142	148	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1373	1385		10.1086/320606	http://dx.doi.org/10.1086/320606			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11333381	Green Published, Bronze			2022-12-18	WOS:000169094600008
J	Dunning, AM; Durocher, F; Healey, CS; Teare, MD; McBride, SE; Carlomagno, F; Xu, CF; Dawson, E; Rhodes, S; Ueda, S; Lai, E; Luben, RN; Van Rensburg, EJ; Mannermaa, A; Kataja, V; Rennart, G; Dunham, I; Purvis, I; Easton, D; Ponder, BAJ				Dunning, AM; Durocher, F; Healey, CS; Teare, MD; McBride, SE; Carlomagno, F; Xu, CF; Dawson, E; Rhodes, S; Ueda, S; Lai, E; Luben, RN; Van Rensburg, EJ; Mannermaa, A; Kataja, V; Rennart, G; Dunham, I; Purvis, I; Easton, D; Ponder, BAJ			The extent of linkage disequilibrium in four populations with distinct demographic histories	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; MAPPING GENES; GENOME; SEQUENCE; SUSCEPTIBILITY; MUTATIONS; VARIANTS; BREAST; LOCUS	The design and feasibility of whole-genome-association studies are critically dependent on the extent of linkage disequilibrium (LD) between markers. Although there has been extensive theoretical discussion of this, few empirical data exist. The authors have determined the extent of LD among 38 biallelic markers with minor allele frequencies >.1, since these are most comparable to the common disease-susceptibility polymorphisms that association studies aim to detect. The markers come from three chromosomal regions-1,335 kb on chromosome 13q12-13, 380 kb on chromosome 19q13.2, and 120 kb on chromosome 22q13.3-which have been extensively mapped. These markers were examined in similar to1,600 individuals from four populations, all of European origin but with different demographic histories; Afrikaners, Ashkenazim, Finns, and East Anglian British. There are few differences, either in allele frequencies or in LD, among the populations studied. A similar inverse relationship was found between LD and distance in each genomic region and in each population. Mean D' is .68 for marker pairs <5 kb apart and is .24 for pairs separated by 10-20 kb, and the level of LD is not different from that seen in unlinked marker pairs separated by >500 kb. However, only 50% of marker pairs at distances <5 kb display sufficient LD (<Delta> > .3) to be useful in association studies. Results of the present study, if representative of the whole genome, suggest that a whole-genome scan searching for common disease-susceptibility alleles would require markers spaced less than or equal to5 kb apart.	Univ Cambridge, CRC, Dept Oncol, Strangeways Res Lab, Cambridge CB1 8RN, England; Univ Cambridge, CRC, Genet Epidemiol Grp, Cambridge CB1 8RN, England; Univ Cambridge, EPIC, Cambridge CB1 8RN, England; GlaxoWellcome Med Res Ctr, UK Mol Genet, Cambridge, England; Sanger Ctr, Cambridge, England; Glaxo Wellcome Inc, US Discovery Genet, Res Triangle Pk, NC 27709 USA; Univ Pretoria, Dept Human Genet, ZA-0002 Pretoria, South Africa; Kuopio Univ Hosp, Dept Clin Genet, SF-70210 Kuopio, Finland; Kuopio Univ Hosp, Dept Radiotherapy & Oncol, SF-70210 Kuopio, Finland; Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Dept Community Med & Epidemiol, Haifa, Israel	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; GlaxoSmithKline; University of Pretoria; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Dunning, AM (corresponding author), Univ Cambridge, CRC, Dept Oncol, Strangeways Res Lab, Worts Causeway, Cambridge CB1 8RN, England.		Luben, Robert N/H-5519-2015; van Rensburg, Elizabeth J./B-9104-2011	Luben, Robert N/0000-0002-5088-6343; Rennert, Gad/0000-0002-8512-068X; McBride, Simon/0000-0002-3090-5068; Kataja, Vesa/0000-0003-4846-4843; Dunham, Ian/0000-0003-2525-5598; Xu, Chun-Fang/0000-0002-8747-0683; Teare, Marion Dawn/0000-0003-3994-0051; Durocher, Francine/0000-0001-8012-4641; Dunning, Alison Margaret/0000-0001-6651-7166	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins A, 1998, P NATL ACAD SCI USA, V95, P1741, DOI 10.1073/pnas.95.4.1741; Day N, 1999, BRIT J CANCER, V80, P95; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Dunning AM, 1997, HUM MOL GENET, V6, P285, DOI 10.1093/hmg/6.2.285; Durocher F, 1996, HUM MOL GENET, V5, P835, DOI 10.1093/hmg/5.6.835; Eaves IA, 2000, NAT GENET, V25, P320; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Huttley GA, 1999, GENETICS, V152, P1711; JORDE LB, 1994, AM J HUM GENET, V54, P884; KOESTLER A, 1976, 13 TRIDE KAZAR EMPIR; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; Martin ER, 2000, GENOMICS, V63, P7, DOI 10.1006/geno.1999.6057; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; Roberts L, 2000, SCIENCE, V287, P1898, DOI 10.1126/science.287.5460.1898; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; THEAL GM, 1964, HIST S AFRICA, V4, P346; Weir B., 1996, GENETIC DATA ANAL; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	29	142	146	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1544	1554		10.1086/316906	http://dx.doi.org/10.1086/316906			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11078480	Green Published, Bronze			2022-12-18	WOS:000165607600018
J	Ostrander, EA; Stanford, JL				Ostrander, EA; Stanford, JL			Genetics of prostate cancer: Too many loci, too few genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							VITAMIN-D-RECEPTOR; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; FAMILY-HISTORY; CHROMOSOME 1Q; COMPLEX TRAITS; SRD5A2 GENE; RISK; ASSOCIATION; HPC1		Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Ostrander, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, D4-100,1100 Fairview Ave N,POB 19024, Seattle, WA 98109 USA.	eostrand@fhcrc.org		Ostrander, Elaine/0000-0001-6075-9738				BELLO MJ, 1995, INT J CANCER, V64, P207; BELLO MJ, 1995, CANCER GENET CYTOGEN, V83, P160, DOI 10.1016/0165-4608(95)00064-V; Berry R, 2000, AM J HUM GENET, V66, P539, DOI 10.1086/302771; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Cannon L., 1982, CANCER SURV, V1, P47; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Etzioni R, 1998, AM J EPIDEMIOL, V148, P775; FINCHAM SM, 1990, PROSTATE, V17, P189, DOI 10.1002/pros.2990170303; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Gibbs M, 2000, AM J HUM GENET, V67, P100, DOI 10.1086/302969; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P8272; Gleason DF, 1977, UROLOGIC PATHOLOGY P; Glover FE, 1998, UROLOGY, V52, P441, DOI 10.1016/S0090-4295(98)00200-3; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Goode EL, 2000, GENET EPIDEMIOL, V18, P251, DOI 10.1002/(SICI)1098-2272(200003)18:3<251::AID-GEPI5>3.0.CO;2-X; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Gronberg H, 1997, CANCER RES, V57, P4707; GRONBERG H, 1994, J UROLOGY, V152, P1484, DOI 10.1016/S0022-5347(17)32452-7; Gronberg H, 1999, AM J HUM GENET, V65, P134, DOI 10.1086/302447; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5; GRONBERG H, 1997, JAMA-J AM MED ASSOC, V278, P1284; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; ISAACS SD, 1995, J NATL CANCER I, V87, P991, DOI 10.1093/jnci/87.13.991; Jaffe JM, 2000, CANCER RES, V60, P1626; KRAUS JA, 1995, J NEUROPATH EXP NEUR, V54, P91, DOI 10.1097/00005072-199501000-00011; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lange EM, 1999, CLIN CANCER RES, V5, P4013; Laniado ME, 1998, JAMA-J AM MED ASSOC, V279, P507, DOI 10.1001/jama.279.7.507; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Makridakis NM, 1999, LANCET, V354, P975, DOI 10.1016/S0140-6736(98)11282-5; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; MORGANTI G, 1956, Acta Genet Stat Med, V6, P304; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Neuhausen SL, 1999, HUM MOL GENET, V8, P2437, DOI 10.1093/hmg/8.13.2437; Ott J, 1996, NATURE, V379, P772, DOI 10.1038/379772a0; Page WF, 1997, PROSTATE, V33, P240; Pearson JD, 1996, UROLOGY, V48, P4, DOI 10.1016/S0090-4295(96)00603-6; PETERS MA, 2000, IN PRESS HUM HERED; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; REICHARDT JKV, 1995, CANCER RES, V55, P3973; Ries L, 2000, SEER CANC STAT REV 1; Ries L. A. G., 1999, SEER CANC STAT REV 1; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; Stanford JL, 1997, CANCER RES, V57, P1194; STANFORD JL, 1999, NCI PUBLICATION; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Suarez BK, 2000, PROSTATE, V45, P106, DOI 10.1002/1097-0045(20001001)45:2<106::AID-PROS4>3.0.CO;2-H; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; TAVTIGIAN SV, 2000, AM J HUM GENET S, V67, pA7; Taylor JA, 1996, CANCER RES, V56, P4108; Walther MM, 1998, JAMA-J AM MED ASSOC, V279, P507; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Whittemore AS, 1999, AM J HUM GENET, V65, P254, DOI 10.1086/302457; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WHITTEMORE AS, 1995, J NATL CANCER I, V87, P354, DOI 10.1093/jnci/87.5.354; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; XU J, 2000, AM J HUM GENET, V67, P541; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807; Xu Jianfeng, 2000, Journal of Urology, V163, P55	73	142	148	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1367	1375		10.1086/316916	http://dx.doi.org/10.1086/316916			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11067781	Green Published, Bronze			2022-12-18	WOS:000165607600001
J	Hodges, M; Tissot, C; Howe, K; Grimwade, D; Freemont, PS				Hodges, M; Tissot, C; Howe, K; Grimwade, D; Freemont, PS			Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMAIN-10 ND10; GROWTH-SUPPRESSOR; BINDING DOMAINS; RAR-ALPHA; PML; DIFFERENTIATION; ONCOPROTEIN; GENE; LOCALIZATION; REPLICATION		Imperial Canc Res Fund, Mol Struct & Funct Lab, London WC2A 3PX, England; United Med & Dent Sch Guys & St Thomas, Guys Hosp, Div Med & Mol Genet, London SE1 7EH, England	Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Freemont, PS (corresponding author), Imperial Canc Res Fund, Mol Struct & Funct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	freemont@icrf.icnet.uk		Freemont, Paul/0000-0002-5658-8486				Ahn MJ, 1995, ONCOGENE, V11, P2357; Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Boddy MN, 1996, ONCOGENE, V13, P971; Boddy MN, 1997, J CELL SCI, V110, P2197; Borden KLB, 1998, J VIROL, V72, P758, DOI 10.1128/JVI.72.1.758-766.1998; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Cao TY, 1998, J CELL SCI, V111, P1319; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Desbois C, 1996, SCIENCE, V273, P951, DOI 10.1126/science.273.5277.951; Doucas V, 1996, BBA-REV CANCER, V1288, pM25, DOI 10.1016/S0304-419X(96)00028-5; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Fagioli M, 1998, ONCOGENE, V16, P2905, DOI 10.1038/sj.onc.1201811; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Gongora C, 1997, J BIOL CHEM, V272, P19457, DOI 10.1074/jbc.272.31.19457; Grande MA, 1996, J CELL BIOCHEM, V63, P280, DOI 10.1002/(SICI)1097-4644(19961201)63:3<280::AID-JCB3>3.0.CO;2-T; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Grignani F, 1996, EMBO J, V15, P4949, DOI 10.1002/j.1460-2075.1996.tb00875.x; Grimwade D, 1997, CURR TOP MICROBIOL, V220, P81; Grimwade D, 1997, BLOOD, V90, P4876; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; Guidez F, 1998, BLOOD, V91, P2634, DOI 10.1182/blood.V91.8.2634.2634_2634_2642; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Ishov AM, 1996, J CELL BIOL, V134, P815, DOI 10.1083/jcb.134.4.815; Ishov AM, 1997, J CELL BIOL, V138, P5, DOI 10.1083/jcb.138.1.5; JACKSON DA, 1995, BIOESSAYS, V17, P587, DOI 10.1002/bies.950170704; Kamei H, 1997, EXP CELL RES, V237, P207, DOI 10.1006/excr.1997.3790; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; KELLY C, 1995, J GEN VIROL, V76, P2887, DOI 10.1099/0022-1317-76-11-2887; KOKEN MHM, 1995, ONCOGENE, V10, P1315; Koken MHM, 1997, P NATL ACAD SCI USA, V94, P10255, DOI 10.1073/pnas.94.19.10255; Korioth F, 1996, EXP CELL RES, V229, P155, DOI 10.1006/excr.1996.0353; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Le XF, 1998, ONCOGENE, V16, P1839, DOI 10.1038/sj.onc.1201705; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Matera AG, 1998, AM J HUM GENET, V63, P317, DOI 10.1086/301992; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; Mu ZM, 1997, CARCINOGENESIS, V18, P2063, DOI 10.1093/carcin/18.11.2063; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Nickerson JA, 1995, INT REV CYTOL, V162A, P67; ONODERA M, 1995, ONCOGENE, V11, P1291; Pandolfi PP, 1996, HAEMATOLOGICA, V81, P472; Redner RL, 1997, BLOOD, V90, P1431; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHEER U, 1994, CURR OPIN CELL BIOL, V6, P354, DOI 10.1016/0955-0674(94)90026-4; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Skinner PJ, 1998, NATURE, V391, P307, DOI 10.1038/34701; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; STUURMAN N, 1997, CELL MOL BIOL LETT, V2, P137; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; TERRIS B, 1995, CANCER RES, V55, P1590; TSAI S, 1993, P NATL ACAD SCI USA, V90, P7153, DOI 10.1073/pnas.90.15.7153; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wells RA, 1997, NAT GENET, V17, P109, DOI 10.1038/ng0997-109; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	69	142	145	0	7	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					297	304		10.1086/301991	http://dx.doi.org/10.1086/301991			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683622	Green Published, Bronze			2022-12-18	WOS:000075360800002
J	BUETOW, KH				BUETOW, KH			INFLUENCE OF ABERRANT OBSERVATIONS ON HIGH-RESOLUTION LINKAGE ANALYSIS OUTCOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE CONVERSION; GLOBIN GENES; DNA SEGMENT; RECOMBINATION; DISEASE; HUMANS; GAMMA; LOCUS	Because of the availability of efficient, user-friendly computer analysis programs, the construction of multilocus human genetic maps has become commonplace. At the level of resolution at which most of these maps have been developed, the methods have proved to be robust. This may not be true in the construction of high-resolution linkage maps (3-cM interlocus resolution or less). High-resolution meiotic maps, by definition, have a low probability of recombination occurring in an interval. As such, even low frequencies of errors in typing (1.5% or less) may influence mapping outcomes. To investigate the influence of aberrant observations on high-resolution maps, a Monte Carlo simulation analysis of multipoint linkage data was performed. Introduction of error was observed to reduce power to discriminate orders, dramatically inflate map length, and provide significant support for incorrect over correct orders. These results appear to be due to the misclassification of nonrecombinant gametes as multiple recombinants. Chi-2-like goodness-of-fit analysis appears to be quite sensitive to the appearance of misclassified gametes, providing a simple test for aberrant data sets. Multiple pairwise likelihood analysis appears to be less sensitive than does multipoint analysis and may serve as a check for map validity.			BUETOW, KH (corresponding author), FOX CHASE CANC INST,DIV POPULAT SCI,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.				NCI NIH HHS [CA06925] Funding Source: Medline; NHGRI NIH HHS [HG00355, HG00206] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000355, P50HG000206] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BUETOW KH, 1991, AM J HUM GENET, V48, P911; CHAKRAVARTI A, UNPUB ESTIMATION CHR; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; FITCH DHA, 1990, J BIOL CHEM, V265, P781; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; MORTON NE, 1990, ANN HUM GENET, V54, P235, DOI 10.1111/j.1469-1809.1990.tb00381.x; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1990, BANB REPORT, V33, P327; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SHIELDS DC, IN PRESS P NATL ACAD; STARCK J, 1990, HUM GENET, V84, P179; URABE K, 1990, AM J HUM GENET, V46, P1178; WEBER JL, 1989, AM J HUM GENET, V44, P388	21	142	145	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					985	994						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928104				2022-12-18	WOS:A1991GM87300010
J	KOEBERL, DD; BOTTEMA, CDK; KETTERLING, RP; BRIDGE, PJ; LILLICRAP, DP; SOMMER, SS				KOEBERL, DD; BOTTEMA, CDK; KETTERLING, RP; BRIDGE, PJ; LILLICRAP, DP; SOMMER, SS			MUTATIONS CAUSING HEMOPHILIA-B - DIRECT ESTIMATE OF THE UNDERLYING RATES OF SPONTANEOUS GERM-LINE TRANSITIONS, TRANSVERSIONS, AND DELETIONS IN A HUMAN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAYO CLIN & MAYO FDN, DEPT BIOCHEM & MOLEC BIOL, ROCHESTER, MN 55905 USA; QUEENS UNIV, DEPT PATHOL, RICHARDSON LAB, KINGSTON K7L 3N6, ONTARIO, CANADA	Mayo Clinic; Queens University - Canada				Ketterling, Rhett/0000-0001-6479-7897; Bottema, Cynthia/0000-0001-6245-0099	NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039762] Funding Source: NIH RePORTER; NCI NIH HHS [CA15083.F1.3] Funding Source: Medline; NHLBI NIH HHS [HL39762-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1985, DNA REPAIR; ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; ANTONARAKIS SE, 1988, TRENDS GENET, V4, P233, DOI 10.1016/0168-9525(88)90156-4; ATTREE O, 1989, GENOMICS, V4, P266, DOI 10.1016/0888-7543(89)90330-3; BARRAI I, 1985, AM J HUM GENET, V37, P680; BECKMANN RJ, 1985, NUCLEIC ACIDS RES, V13, P5233, DOI 10.1093/nar/13.14.5233; BENTLEY AK, 1986, CELL, V45, P343, DOI 10.1016/0092-8674(86)90319-3; BOTTEMA CDK, IN PRESS BR J HAEMOT; BROWNLEE GG, 1989, RECENT ADV HAEMATOLO, V5, P251; CAMERINO G, 1984, P NATL ACAD SCI-BIOL, V81, P498, DOI 10.1073/pnas.81.2.498; CHAKRABORTY R, 1989, P NATL ACAD SCI USA, V86, P9407, DOI 10.1073/pnas.86.23.9407; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DRAKE JW, 1969, MOL BASIS MUTATION; EMI M, 1986, GENE, V41, P305; EVANS JP, 1989, BLOOD, V74, P207; EYSTER ME, 1980, AM J HEMATOL, V9, P277, DOI 10.1002/ajh.2830090306; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; FUCHS HE, 1984, J CLIN INVEST, V73, P1696, DOI 10.1172/JCI111377; FUNG MR, 1984, NUCLEIC ACIDS RES, V12, P4481, DOI 10.1093/nar/12.11.4481; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GEDDES VA, 1989, J BIOL CHEM, V264, P4689; GIANNELLI F, 1983, NATURE, V303, P181, DOI 10.1038/303181a0; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; HEDNER U, 1989, METABOLIC BASIS INHE, P2107; HUANG MN, 1989, BLOOD, V73, P718; IKKALA E, 1960, THESIS U HELSINKI; JACOB M, 1989, NUCLEIC ACIDS RES, V17, P2159, DOI 10.1093/nar/17.6.2159; KATAYAMA K, 1979, P NATL ACAD SCI USA, V76, P4990, DOI 10.1073/pnas.76.10.4990; KOEBERL DD, 1990, HUM GENET, V84, P387; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; KURACHI K, 1982, P NATL ACAD SCI-BIOL, V79, P6461, DOI 10.1073/pnas.79.21.6461; LARSSON SA, 1982, ACTA MED SCAND, V212, P195; LARSSON SA, 1985, BRIT J HAEMATOL, V59, P593, DOI 10.1111/j.1365-2141.1985.tb07353.x; LIDDELL MB, 1989, BRIT J HAEMATOL, V72, P208, DOI 10.1111/j.1365-2141.1989.tb07684.x; LONG GL, 1984, P NATL ACAD SCI-BIOL, V81, P5653, DOI 10.1073/pnas.81.18.5653; MANDEL JL, 1989, NATURE, V339, P584, DOI 10.1038/339584a0; MASYS DR, 1982, BLOOD, V60, P1143; MCGRAW RA, 1985, P NATL ACAD SCI USA, V82, P2847, DOI 10.1073/pnas.82.9.2847; MIKES O, 1966, BIOCHEM BIOPH RES CO, V24, P346, DOI 10.1016/0006-291X(66)90162-8; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NEEL JV, 1986, P NATL ACAD SCI USA, V83, P389, DOI 10.1073/pnas.83.2.389; NOYES CM, 1983, P NATL ACAD SCI-BIOL, V80, P4200, DOI 10.1073/pnas.80.14.4200; POORT SR, 1989, NUCLEIC ACIDS RES, V17, P3614, DOI 10.1093/nar/17.9.3614; REITSMA PH, 1989, BLOOD, V73, P743; SAKAI T, 1989, J BIOCHEM-TOKYO, V105, P756, DOI 10.1093/oxfordjournals.jbchem.a122740; SARKAR G, 1990, GENOMICS, V6, P133, DOI 10.1016/0888-7543(90)90458-7; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; SOMMER SS, 1980, J MOL EVOL, V15, P37, DOI 10.1007/BF01732582; SPITZER SG, 1988, J BIOL CHEM, V263, P10545; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; STOUT JT, 1989, METABOLIC BASIS INHE, P1007; SUGIMOTO M, 1988, J BIOCHEM-TOKYO, V104, P878, DOI 10.1093/oxfordjournals.jbchem.a122575; TOOMEY JR, 1988, BLOOD S, V72, pA312; TSANG TC, 1988, EMBO J, V7, P3009, DOI 10.1002/j.1460-2075.1988.tb03164.x; VOGEL F, 1975, ADV HUM GENET, V5, P223; VOGEL F, 1977, J MOL EVOL, V9, P159, DOI 10.1007/BF01732746; VOGEL F, 1986, HUMAN GENETICS PROBL, P433; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; WARE J, 1988, BLOOD, V72, P820; WARE J, 1989, J BIOL CHEM, V264, P11401; WHITFIELD HJ, 1966, J MOL BIOL, V21, P335, DOI 10.1016/0022-2836(66)90103-3; WINSHIP PR, 1984, NUCLEIC ACIDS RES, V12, P8861, DOI 10.1093/nar/12.23.8861; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	78	142	143	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					202	217						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2198809				2022-12-18	WOS:A1990DT87100005
J	KAJII, T; OHAMA, K; NIIKAWA, N; FERRIER, A; AVIRACHAN, S				KAJII, T; OHAMA, K; NIIKAWA, N; FERRIER, A; AVIRACHAN, S			BANDING ANALYSIS OF ABNORMAL KARYOTYPES IN SPONTANEOUS ABORTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV GENEVA, CLIN GYNECOL & OBSTET, LAB EMBRYOL & CYTOGENET, GENEVA, SWITZERLAND	University of Geneva								AVIRACHAN S, 1973, CLIN GENET, V4, P101; CASPERSSON T, 1972, J MED GENET, V9, P1, DOI 10.1136/jmg.9.1.1; HAMERTON JL, 1971, HUMAN CYTOGENETICS, V2; KAJII T, 1972, HUMANGENETIK, V15, P265, DOI 10.1007/BF00702364; KAJII T, 1972, LANCET, V2, P1311; LAURITSEN JG, 1972, HEREDITAS-GENETISK A, V71, P160; OHAMA K, 1972, HUMANGENETIK, V16, P267, DOI 10.1007/BF00273474; ROUX C, 1970, PRESSE MED, V78, P647; TAYLOR A I, 1968, Journal of Medical Genetics, V5, P227, DOI 10.1136/jmg.5.3.227	9	142	142	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	5					539	547						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q7858	4741848				2022-12-18	WOS:A1973Q785800006
J	Deschamps, M; Laval, G; Fagny, M; Itan, Y; Abel, L; Casanova, JL; Patin, E; Quintana-Murci, L				Deschamps, Matthieu; Laval, Guillaume; Fagny, Maud; Itan, Yuval; Abel, Laurent; Casanova, Jean-Laurent; Patin, Etienne; Quintana-Murci, Lluis			Genomic Signatures of Selective Pressures and Introgression from Archaic Hominins at Human Innate Immunity Genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; BALANCING SELECTION; WIDE ASSOCIATION; POPULATION DIFFERENTIATION; INBORN-ERRORS; CELL-SURFACE; ADAPTATION; SUSCEPTIBILITY; ANCIENT	Human genes governing innate immunity provide a valuable tool for the study of the selective pressure imposed by microorganisms on host genomes. A comprehensive, genome-wide study of how selective constraints and adaptations have driven the evolution of innate immunity genes is missing. Using full-genome sequence variation from the 1000 Genomes Project, we first show that innate immunity genes have globally evolved under stronger purifying selection than the remainder of protein-coding genes. We identify a gene set under the strongest selective constraints, mutations in which are likely to predispose individuals to life-threatening disease, as illustrated by STAT1 and TRAF3. We then evaluate the occurrence of local adaptation and detect 57 high-scoring signals of positive selection at innate immunity genes, variation in which has been associated with susceptibility to common infectious or autoimmune diseases. Furthermore, we show that most adaptations targeting coding variation have occurred in the last 6,000-13,000 years, the period at which populations shifted from hunting and gathering to farming. Finally, we show that innate immunity genes present higher Neandertal introgression than the remainder of the coding genome. Notably, among the genes presenting the highest Neandertal ancestry, we find the TLR6-TLR1-TLR10 cluster, which also contains functional adaptive variation in Europeans. This study identifies highly constrained genes that fulfill essential, non-redundant functions in host survival and reveals others that are more permissive to change containing variation acquired from archaic hominins or adaptive variants in specific populations improving our understanding of the relative biological importance of innate immunity pathways in natural conditions.	[Deschamps, Matthieu; Laval, Guillaume; Fagny, Maud; Patin, Etienne; Quintana-Murci, Lluis] Inst Pasteur, Unit Human Evolutionary Genet, F-75015 Paris, France; [Deschamps, Matthieu; Laval, Guillaume; Fagny, Maud; Patin, Etienne; Quintana-Murci, Lluis] CNRS, URA3012, F-75015 Paris, France; [Deschamps, Matthieu; Fagny, Maud] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France; [Itan, Yuval; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Abel, Laurent; Casanova, Jean-Laurent] INSERM, Necker Branch, Lab Human Genet Infect Dis, U1163, F-75015 Paris, France; [Abel, Laurent; Casanova, Jean-Laurent] Paris Descartes Univ, Imagine Inst, F-75015 Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Quintana-Murci, L (corresponding author), Inst Pasteur, Unit Human Evolutionary Genet, F-75015 Paris, France.	quintana@pasteur.fr	Fagny, Maud/AAF-5682-2019; Quintana-Murci, Lluis/AAB-7468-2022; Abel, Laurent/H-8888-2017	Fagny, Maud/0000-0002-7740-2521; Abel, Laurent/0000-0001-7016-6493; Patin, Etienne/0000-0002-9911-4459; Casanova, Jean-Laurent/0000-0002-7782-4169	Institut Pasteur; Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR) [ANR-12-BSV7-0012, ANR-14-CE14-0008-02, ANR-14-CE14-0007-02]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; European Research Council under the European Union/ERC [281297]	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); European Research Council under the European Union/ERC(European Research Council (ERC))	The authors thank Matthew Albert and Jean-Marc Cavaillon for useful advice and discussions. This work was supported by the Institut Pasteur, the Centre National de la Recherche Scientifique (CNRS), and the Agence Nationale de la Recherche (ANR) grants: "DEMOCHIPS" ANR-12-BSV7-0012, "IEIHSEER" ANR-14-CE14-0008-02, and "TBPATHGEN" ANR-14-CE14-0007-02. The laboratory of L.Q.-M. has received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant no. ANR-10-LABX-62-IBEID), and from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement No. 281297.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Aeschbacher S, 2012, GENETICS, V192, P1027, DOI 10.1534/genetics.112.143164; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Beaumont MA, 2002, GENETICS, V162, P2025; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cagliani R, 2014, GENOME BIOL EVOL, V6, P830, DOI 10.1093/gbe/evu066; Casals F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-202; Casanova JL, 2015, CELL, V160, P13, DOI 10.1016/j.cell.2014.12.029; Casanova JL, 2013, COLD SH Q B, V78, P157, DOI 10.1101/sqb.2013.78.019968; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Colonna V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r88; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Daub JT, 2013, MOL BIOL EVOL, V30, P1544, DOI 10.1093/molbev/mst080; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Eilertson KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002806; Enard D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000840; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fagny M, 2014, MOL BIOL EVOL, V31, P1850, DOI 10.1093/molbev/msu118; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Fornarino S, 2011, MOL BIOL EVOL, V28, P3087, DOI 10.1093/molbev/msr137; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fry AE, 2009, HUM MOL GENET, V18, P2683, DOI 10.1093/hmg/ddp192; Fumagalli M, 2014, CURR OPIN IMMUNOL, V30, P9, DOI 10.1016/j.coi.2014.05.001; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Fumagalli M, 2010, MOL BIOL EVOL, V27, P2555, DOI 10.1093/molbev/msq141; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hollox EJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-113; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Key FM, 2014, CURR OPIN GENET DEV, V29, P45, DOI 10.1016/j.gde.2014.08.001; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Laayouni H, 2014, P NATL ACAD SCI USA, V111, P2668, DOI 10.1073/pnas.1317723111; Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Mendez FL, 2013, MOL BIOL EVOL, V30, P798, DOI 10.1093/molbev/mst004; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; Newbold C, 1999, INT J PARASITOL, V29, P927, DOI 10.1016/S0020-7519(99)00049-1; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Peter BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003011; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pybus M., 2015, BIOINFORMATICS; Quintana-Murci L, 2013, NAT REV IMMUNOL, V13, P280, DOI 10.1038/nri3421; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shlyakhter I, 2014, BIOINFORMATICS, V30, P3427, DOI 10.1093/bioinformatics/btu562; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Vasseur E, 2012, AM J HUM GENET, V91, P27, DOI 10.1016/j.ajhg.2012.05.008; Vasseur E, 2011, HUM MOL GENET, V20, P4462, DOI 10.1093/hmg/ddr377; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775	98	141	142	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2016	98	1					5	21		10.1016/j.ajhg.2015.11.014	http://dx.doi.org/10.1016/j.ajhg.2015.11.014			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DA8JL	26748513	Green Published, Bronze			2022-12-18	WOS:000368050800001
J	Aschard, H; Vilhjalmsson, BJ; Joshi, AD; Price, AL; Kraft, P				Aschard, Hugues; Vilhjalmsson, Bjarni J.; Joshi, Amit D.; Price, Alkes L.; Kraft, Peter			Adjusting for Heritable Covariates Can Bias Effect Estimates in Genome-Wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINEAR MIXED-MODEL; BODY-MASS INDEX; IGF-I; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; GLYCEMIC TRAITS; LOCI; VARIANTS; ADJUSTMENT; PLEIOTROPY	In recent years, a number of large-scale genome-wide association studies have been published for human traits adjusted for other correlated traits with a genetic basis. In most studies, the motivation for such an adjustment is to discover genetic variants associated with the primary outcome independently of the correlated trait. In this report, we contend that this objective is fulfilled when the tested variants have no effect on the covariate or when the correlation between the covariate and the outcome is fully explained by a direct effect of the covariate on the outcome. For all other scenarios, an unintended bias is introduced with respect to the primary outcome as a result of the adjustment, and this bias might lead to false positives. Here, we illustrate this point by providing examples from published genome-wide association studies, including large meta-analysis of waist-to-hip ratio and waist circumference adjusted for body mass index (BMI), where genetic effects might be biased as a result of adjustment for body mass index. Using both theory and simulations, we explore this phenomenon in detail and discuss the ramifications for future genome-wide association studies of correlated traits and diseases.	[Aschard, Hugues; Vilhjalmsson, Bjarni J.; Joshi, Amit D.; Price, Alkes L.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Aschard, H (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	haschard@hsph.harvard.edu	Vilhjalmsson, Bjarni/K-3971-2014; Kraft, Peter/GQH-8448-2022; Vilhjálmsson, Bjarni/ABC-1369-2020	Vilhjalmsson, Bjarni/0000-0003-2277-9249; Vilhjálmsson, Bjarni/0000-0003-2277-9249	NIH [R21 ES020754, R03 HG006720, U19 CA148065]; NATIONAL CANCER INSTITUTE [U19CA148065] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG006720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020754] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to Sara Lindstrom, Gaurav Bhatia, Po-Ru Loh, Hilary Finucane, and Stephanie London for helpful discussions. This research was funded by NIH grants R21 ES020754, R03 HG006720, and U19 CA148065.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Chan JM, 2002, J NATL CANCER I, V94, P1099; Cole SR, 2002, INT J EPIDEMIOL, V31, P163, DOI 10.1093/ije/31.1.163; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P2534, DOI 10.1210/jc.80.8.2534; Kaplan RC, 2011, HUM MOL GENET, V20, P1241, DOI 10.1093/hmg/ddq560; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Loth DW, 2014, NAT GENET, V46, P669, DOI 10.1038/ng.3011; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mefford J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003096; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Murabito JM, 2006, AM J EPIDEMIOL, V164, P963, DOI 10.1093/aje/kwj295; PEARL J, 1995, ARTIF INTELL MED, V7, P561, DOI 10.1016/0933-3657(95)00027-3; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Post WS, 1997, HYPERTENSION, V30, P1025, DOI 10.1161/01.HYP.30.5.1025; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Stein CM, 2003, J INFECT DIS, V187, P1679, DOI 10.1086/375249; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; Stergiakouli E, 2014, OBESITY, V22, P2252, DOI 10.1002/oby.20840; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vansteelandt S, 2009, GENET EPIDEMIOL, V33, P394, DOI 10.1002/gepi.20393; Zaitlen N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003032; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/NMETH.2848, 10.1038/nmeth.2848]	37	141	141	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					329	339		10.1016/j.ajhg.2014.12.021	http://dx.doi.org/10.1016/j.ajhg.2014.12.021			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25640676	Bronze, Green Published			2022-12-18	WOS:000349276700015
J	Holmes, MV; Lange, LA; Palmer, T; Lanktree, MB; North, KE; Almoguera, B; Buxbaum, S; Chandrupatla, HR; Elbers, CC; Guo, YR; Hoogeveen, RC; Li, J; Li, YR; Swerdlow, DI; Cushman, M; Price, TS; Curtis, SP; Fornage, M; Hakonarson, H; Patel, SR; Redline, S; Siscovick, DS; Tsai, MY; Wilson, JG; van der Schouw, YT; FitzGerald, GA; Hingorani, AD; Casas, JP; de Bakker, PIW; Rich, SS; Schadt, EE; Asselbergs, FW; Reiner, AP; Keating, BJ				Holmes, Michael V.; Lange, Leslie A.; Palmer, Tom; Lanktree, Matthew B.; North, Kari E.; Almoguera, Berta; Buxbaum, Sarah; Chandrupatla, Hareesh R.; Elbers, Clara C.; Guo, Yiran; Hoogeveen, Ron C.; Li, Jin; Li, Yun R.; Swerdlow, Daniel I.; Cushman, Mary; Price, Tom S.; Curtis, Sean P.; Fornage, Myriam; Hakonarson, Hakon; Patel, Sanjay R.; Redline, Susan; Siscovick, David S.; Tsai, Michael Y.; Wilson, James G.; van der Schouw, Yvonne T.; FitzGerald, Garret A.; Hingorani, Aroon D.; Casas, Juan P.; de Bakker, Paul I. W.; Rich, Stephen S.; Schadt, Eric E.; Asselbergs, Folkert W.; Reiner, Alex P.; Keating, Brendan J.			Causal Effects of Body Mass Index on Cardiometabolic Traits and Events: A Mendelian Randomization Analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIFE-STYLE INTERVENTION; GENE-CENTRIC METAANALYSIS; C-REACTIVE PROTEIN; BLOOD-PRESSURE; CARDIOVASCULAR RISK; MORTALITY; DESIGN; LOCI; ASSOCIATION; VARIANTS	Elevated body mass index (BMI) associates with cardiometabolic traits on observational analysis, yet the underlying causal relationships remain unclear. We conducted Mendelian randomization analyses by using a genetic score (GS) comprising 14 BMI-associated SNPs from a recent discovery analysis to investigate the causal role of BMI in cardiometabolic traits and events. We used eight population-based cohorts, including 34,538 European-descent individuals (4,407 type 2 diabetes (T2D), 6,073 coronary heart disease (CHD), and 3,813 stroke cases). A 1 kg/m(2) genetically elevated BMI increased fasting glucose (0.18 mmol/l; 95% confidence interval (CI) = 0.12-0.24), fasting insulin (8.5%; 95% CI = 5.9-11.1), interleukin-6 (7.0%; 95% CI = 4.0-10.1), and systolic blood pressure (0.70 mmHg; 95% CI = 0.24-1.16) and reduced high-density lipoprotein cholesterol (-0.02 mmol/l; 95% CI = -0.03 to -0.01) and low-density lipoprotein cholesterol (LDL-C; -0.04 mmol/l; 95% CI = -0.07 to -0.01). Observational and causal estimates were directionally concordant, except for LDL-C. A 1 kg/m2 genetically elevated BMI increased the odds of T2D (odds ratio [OR] = 1.27; 95% CI = 1.18-1.36) but did not alter risk of CHD (OR 1.01; 95% CI = 0.94-1.08) or stroke (OR = 1.03; 95% CI = 0.95-1.12). A meta-analysis incorporating published studies reporting 27,465 CHD events in 219,423 individuals yielded a pooled OR of 1.04 (95% CI = 0.97-1.12) per 1 kg/m2 increase in BMI. In conclusion, we identified causal effects of BMI on several cardiometabolic traits; however, whether BMI causally impacts CHD risk requires further evidence.	[Holmes, Michael V.; Keating, Brendan J.] Univ Penn, Dept Surg, Div Transplantat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Holmes, Michael V.; Swerdlow, Daniel I.; Hingorani, Aroon D.; Casas, Juan P.] UCL, Genet Epidemiol Grp, Inst Cardiovasc Sci, Fac Populat Hlth Sci, London WC1E 6BT, England; [Lange, Leslie A.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27514 USA; [Palmer, Tom] Univ Warwick, Div Hlth Sci, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Lanktree, Matthew B.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [North, Kari E.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Almoguera, Berta; Chandrupatla, Hareesh R.; Guo, Yiran; Li, Jin; Li, Yun R.; Hakonarson, Hakon; Keating, Brendan J.] Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Buxbaum, Sarah] Jackson State Univ, Jackson Heart Study Coordinating Ctr, Jackson, MS 39213 USA; [Elbers, Clara C.] Univ Med Ctr Utrecht, Complex Genet Sect, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Hoogeveen, Ron C.] Baylor Coll Med, Dept Med, Div Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Cushman, Mary] Univ Vermont, Dept Med, Colchester, VT 05446 USA; [Cushman, Mary] Univ Vermont, Dept Pathol, Colchester, VT 05446 USA; [Price, Tom S.; FitzGerald, Garret A.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Curtis, Sean P.] Merck Res Labs, Rahway, NJ 07065 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Patel, Sanjay R.; Redline, Susan] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55414 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [van der Schouw, Yvonne T.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London WC1E 7HT, England; [de Bakker, Paul I. W.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Rich, Stephen S.; Reiner, Alex P.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Schadt, Eric E.] Mt Sinai Sch Med, Dept Genom, New York, NY 10029 USA; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, NL-3584 CX Utrecht, Netherlands; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, NL-3501 DG Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London WC1E 6BT, England; [Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Keating, Brendan J.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Warwick; McMaster University; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jackson State University; Utrecht University; Utrecht University Medical Center; Baylor College of Medicine; University of Vermont; University of Vermont; University of Pennsylvania; Pennsylvania Medicine; Merck & Company; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center; Utrecht University; Utrecht University Medical Center; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Brigham & Women's Hospital; University of Virginia; Icahn School of Medicine at Mount Sinai; Utrecht University; Utrecht University Medical Center; University of London; University College London; Fred Hutchinson Cancer Center; University of Pennsylvania; Pennsylvania Medicine	Holmes, MV (corresponding author), Univ Penn, Dept Surg, Div Transplantat, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	michael.holmes@uphs.upenn.edu; bkeating@mail.med.upenn.edu	Asselbergs, Folkert W./ABD-6752-2021; Cushman, Mary/K-1157-2019; Swerdlow, Daniel/A-3497-2009; Price, Thomas S./B-7372-2008; de Bakker, Paul IW/B-8730-2009; Guo, Yiran/H-4120-2011; van der Schouw, Yvonne T./F-8327-2014; Buxbaum, Sarah G./E-1970-2013; Palmer, Tom Michael/X-6807-2019; Lanktree, Matthew Bruce/I-9790-2019	Asselbergs, Folkert W./0000-0002-1692-8669; Cushman, Mary/0000-0002-7871-6143; Swerdlow, Daniel/0000-0002-7946-3459; Price, Thomas S./0000-0001-7356-2109; de Bakker, Paul IW/0000-0001-7735-7858; van der Schouw, Yvonne T./0000-0002-4605-435X; Buxbaum, Sarah G./0000-0002-4886-3564; Palmer, Tom Michael/0000-0003-4655-4511; Lanktree, Matthew Bruce/0000-0002-5750-6286; Tsai, Michael/0000-0001-7553-3408; Li, Yun Rose/0000-0002-8077-4975; Hingorani, Aroon/0000-0001-8365-0081; Patel, Sanjay/0000-0002-9142-5172; Hoogeveen, Ron/0000-0003-2399-4653; Rich, Stephen/0000-0003-3872-7793	National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER; British Heart Foundation [PG/09/022/26739] Funding Source: researchfish; Medical Research Council [MR/K006584/1, G0802432] Funding Source: researchfish; MRC [G0802432] Funding Source: UKRI	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Belalcazar LM, 2013, OBESITY, V21, P944, DOI 10.1002/oby.20431; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Cappola TP, 2010, CIRC-CARDIOVASC GENE, V3, P147, DOI 10.1161/CIRCGENETICS.109.898395; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Fall T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001474; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Global Health Observatory (GHO), 2013, OB SIT TRENDS; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Harris R., 2006, METAN STATA MODULE F; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kivimaki M, 2008, EUR HEART J, V29, P2552, DOI 10.1093/eurheartj/ehn252; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LamonFava S, 1996, ARTERIOSCL THROM VAS, V16, P1509, DOI 10.1161/01.ATV.16.12.1509; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lewis CE, 2009, CIRCULATION, V119, P3263, DOI 10.1161/CIRCULATIONAHA.109.192574; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Nichols A, 2007, STATA J, V7, P507, DOI 10.1177/1536867X0700700403; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Palmer TM, 2012, STAT METHODS MED RES, V21, P223, DOI 10.1177/0962280210394459; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Pierce BL, 2012, INT J EPIDEMIOL, V41, P1383, DOI 10.1093/ije/dys141; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; The Atherosclerosis Risk in Communities (ARIC), AM J EPIDEMIOL, V129, P687; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005; Welsh P, 2010, J CLIN ENDOCR METAB, V95, P93, DOI 10.1210/jc.2009-1064; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	54	141	144	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					198	208		10.1016/j.ajhg.2013.12.014	http://dx.doi.org/10.1016/j.ajhg.2013.12.014			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24462370	Bronze, Green Published			2022-12-18	WOS:000331419500004
J	Peyrard-Janvid, M; Leslie, EJ; Kousa, YA; Smith, TL; Dunnwald, M; Magnusson, M; Lentz, BA; Unneberg, P; Fransson, I; Koillinen, HK; Rautio, J; Pegelow, M; Karsten, A; Basel-Vanagaite, L; Gordon, W; Andersen, B; Svensson, T; Murray, JC; Cornell, RA; Kere, J; Schutte, BC				Peyrard-Janvid, Myriam; Leslie, Elizabeth J.; Kousa, Youssef A.; Smith, Tiffany L.; Dunnwald, Martine; Magnusson, Mans; Lentz, Brian A.; Unneberg, Per; Fransson, Ingegerd; Koillinen, Hannele K.; Rautio, Jorma; Pegelow, Marie; Karsten, Agneta; Basel-Vanagaite, Lina; Gordon, William; Andersen, Bogi; Svensson, Thomas; Murray, Jeffrey C.; Cornell, Robert A.; Kere, Juha; Schutte, Brian C.			Dominant Mutations in GRHL3 Cause Van der Woude Syndrome and Disrupt Oral Periderm Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPLITEAL PTERYGIUM SYNDROME; CLEFT-PALATE; GRAINY-HEAD; GENOME-WIDE; IRF6; VARIANTS; FAMILIES; DIFFERENTIATION; DROSOPHILA; EMBRYOS	Mutations in interferon regulatory factor 6 (IRF6) account for similar to 70% of cases of Van der Woude syndrome (VWS), the most common syndromic form of cleft lip and palate. In 8 of 45 VWS-affected families lacking a mutation in IRF6, we found coding mutations in grainyhead-like 3 (GRHL3). According to a zebrafish-based assay, the disease-associated GRHL3 mutations abrogated periderm development and were consistent with a dominant-negative effect, in contrast to haploinsufficiency seen in most VWS cases caused by IRF6 mutations. In mouse, all embryos lacking Grhl3 exhibited abnormal oral periderm and 17% developed a cleft palate. Analysis of the oral phenotype of double heterozygote (Irf6(+/-);Grhl3(+/-)) murine embryos failed to detect epistasis between the two genes, suggesting that they function in separate but convergent pathways during palatogenesis. Taken together, our data demonstrated that mutations in two genes, IRF6 and GRHL3, can lead to nearly identical phenotypes of orofacial cleft. They supported the hypotheses that both genes are essential for the presence of a functional oral periderm and that failure of this process contributes to VWS.	[Peyrard-Janvid, Myriam; Fransson, Ingegerd; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Peyrard-Janvid, Myriam; Fransson, Ingegerd; Kere, Juha] Ctr Biotechnol, S-14183 Huddinge, Sweden; [Leslie, Elizabeth J.; Dunnwald, Martine; Lentz, Brian A.; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Leslie, Elizabeth J.; Dunnwald, Martine; Lentz, Brian A.; Murray, Jeffrey C.] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Kousa, Youssef A.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Smith, Tiffany L.; Cornell, Robert A.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Magnusson, Mans; Svensson, Thomas; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Sci Life Lab, S-17121 Solna, Sweden; [Unneberg, Per] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-17121 Solna, Sweden; [Koillinen, Hannele K.] Helsinki Univ Hosp, Dept Clin Genet, Helsinki 00029, Finland; [Rautio, Jorma] Helsinki Univ Hosp, Dept Plast Surg, Cleft Palate & Craniofacial Ctr, Helsinki 00029, Finland; [Pegelow, Marie; Karsten, Agneta] Karolinska Inst, Inst Odontol, Stockholm Craniofacial Team, Dept Orthodont, S-17177 Stockholm, Sweden; [Basel-Vanagaite, Lina] Schneider Childrens Med Ctr Israel, Pediat Genet Unit, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Basel-Vanagaite, Lina] Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel; [Gordon, William; Andersen, Bogi] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Kere, Juha] Univ Helsinki, Res Programs Unit, FIN-00014 Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki 00014, Finland; [Schutte, Brian C.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Karolinska Institutet; University of Iowa; University of Iowa; Michigan State University; University of Iowa; Karolinska Institutet; Stockholm University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; University of California System; University of California Irvine; University of Helsinki; Michigan State University	Peyrard-Janvid, M (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden.	myriam.peyrard@ki.se; juha.kere@ki.se	Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Youssef A Kousa/AAR-3064-2020; Leslie, Elizabeth/AAP-8941-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Youssef A Kousa/0000-0001-6049-8144; Leslie, Elizabeth/0000-0002-5735-1712; Magnusson, Mans/0000-0002-0001-1047; Unneberg, Per/0000-0001-5735-3315; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Svensson, Thomas/0000-0002-9190-2979; Cornell, Robert/0000-0003-4207-9100	Swedish Research Council [521-2007-3133, 2009-5091]; National Institutes of Health [DE021071, DE13513, F31DE022696, DE08559, GM008629, AR061586, AR44882]; Sigrid Juselius Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061586, R01AR044882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023575, F31DE022696, R01DE021071, U01DE020057, R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559, R01DE013513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We greatly appreciate the many individuals affected with VWS, their family members, and clinicians for participating in this study. We would like to thank Arianna L. Smith and Mager Scientific for technical assistance; Nicole Patel for the artistic renderings of murine embryos at E13.5 and E15.5; Paivi Lahermo for providing the Finnish controls and Pat Venta for critiques. Financial support for this research was provided by the Swedish Research Council 521-2007-3133 (M.P.-J.) and 2009-5091 (J.K.), by National Institutes of Health grants DE021071 (R.A.C.), DE13513 (B.C.S.), F31DE022696 (Y.A.K.), DE08559 (J.C.M.), GM008629 (E.J.L.), AR061586 (M.D.), and AR44882 (B.A.), and by the Sigrid Juselius Foundation (J.K.).	Beaty TH, 2011, GENET EPIDEMIOL, V35, P469, DOI 10.1002/gepi.20595; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; BURDICK AB, 1985, J CRAN GENET DEV BIO, V5, P181; Chalmers AD, 2006, MECH DEVELOP, V123, P702, DOI 10.1016/j.mod.2006.04.006; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; de Lima RLLF, 2009, GENET MED, V11, P241, DOI 10.1097/GIM.0b013e318197a49a; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Koillinen H, 2001, EUR J HUM GENET, V9, P747, DOI 10.1038/sj.ejhg.5200713; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Krishnan L, 1996, J IMMUNOL, V156, P653; Leslie EJ, 2013, GENET MED, V15, P338, DOI 10.1038/gim.2012.141; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Malik S, 2010, CLIN GENET, V78, P247, DOI 10.1111/j.1399-0004.2010.01375.x; Mazzalupo S, 2001, MECH DEVELOP, V100, P65, DOI 10.1016/S0925-4773(00)00489-5; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Pegelow M, 2014, CLEFT PALATE-CRAN J, V51, P49, DOI 10.1597/11-220; Peyrard-Janvid M, 2005, EUR J HUM GENET, V13, P1261, DOI 10.1038/sj.ejhg.5201493; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Richardson RJ, 2009, HUM MOL GENET, V18, P2632, DOI 10.1093/hmg/ddp201; Sabel JL, 2009, DEV BIOL, V325, P249, DOI 10.1016/j.ydbio.2008.10.031; Schutte B.C., 2008, INBORN ERRORS DEV, P1069; Schutte BC, 2000, GENOME RES, V10, P81; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	33	141	151	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					23	32		10.1016/j.ajhg.2013.11.009	http://dx.doi.org/10.1016/j.ajhg.2013.11.009			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24360809	hybrid, Green Published			2022-12-18	WOS:000329888400003
J	Nakamura, K; Kodera, H; Akita, T; Shiina, M; Kato, M; Hoshino, H; Terashima, H; Osaka, H; Nakamura, S; Tohyama, J; Kumada, T; Furukawa, T; Iwata, S; Shiihara, T; Kubota, M; Miyatake, S; Koshimizu, E; Nishiyama, K; Nakashima, M; Tsurusaki, Y; Miyake, N; Hayasaka, K; Ogata, K; Fukuda, A; Matsumoto, N; Saitsu, H				Nakamura, Kazuyuki; Kodera, Hirofumi; Akita, Tenpei; Shiina, Masaaki; Kato, Mitsuhiro; Hoshino, Hideki; Terashima, Hiroshi; Osaka, Hitoshi; Nakamura, Shinichi; Tohyama, Jun; Kumada, Tatsuro; Furukawa, Tomonori; Iwata, Satomi; Shiihara, Takashi; Kubota, Masaya; Miyatake, Satoko; Koshimizu, Eriko; Nishiyama, Kiyomi; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Hayasaka, Kiyoshi; Ogata, Kazuhiro; Fukuda, Atsuo; Matsumoto, Naomichi; Saitsu, Hirotomo			De Novo Mutations in GNAO1, Encoding a G alpha(o) Subunit of Heterotrimeric G Proteins, Cause Epileptic Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OHTAHARA-SYNDROME; BINDING-PROTEIN; SUPPRESSION; INHIBITION; GABAPENTIN; CHANNELS	Heterotrimeric G proteins, composed of alpha, beta, and gamma subunits, can transduce a variety of signals from seven-transmembrane-type receptors to intracellular effectors. By whole-exome sequencing and subsequent mutation screening, we identified de novo heterozygous mutations in GNAO1, which encodes a G alpha(o) subunit of heterotrimeric G proteins, in four individuals with epileptic encephalopathy. Two of the affected individuals also showed involuntary movements. Somatic mosaicism (approximately 35% to 50% of cells, distributed across multiple cell types, harbored the mutation) was shown in one individual. By mapping the mutation onto three-dimensional models of the G alpha subunit in three different complexed states, we found that the three mutants (c.521A>G [p.Asp174Gly], c.836T>A [p.Ile279Asn], and c.572_592del [p.Thr191_Phe197del]) are predicted to destabilize the G alpha subunit fold. A fourth mutant (c.607G>A), in which the Gly203 residue located within the highly conserved switch II region is substituted to Arg, is predicted to impair GTP binding and/or activation of downstream effectors, although the p.Gly203Arg substitution might not interfere with G alpha binding to G-protein-coupled receptors. Transient-expression experiments suggested that localization to the plasma membrane was variably impaired in the three putatively destabilized mutants. Electrophysiological analysis showed that G alpha(o)-mediated inhibition of calcium currents by norepinephrine tended to be lower in three of the four G alpha(o) mutants. These data suggest that aberrant G alpha(o) signaling can cause multiple neurodevelopmental phenotypes, including epileptic encephalopathy and involuntary movements.	[Nakamura, Kazuyuki; Kodera, Hirofumi; Miyatake, Satoko; Koshimizu, Eriko; Nishiyama, Kiyomi; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Matsumoto, Naomichi; Saitsu, Hirotomo] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Nakamura, Kazuyuki; Kato, Mitsuhiro; Shiihara, Takashi; Hayasaka, Kiyoshi] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 9909585, Japan; [Akita, Tenpei; Kumada, Tatsuro; Furukawa, Tomonori; Iwata, Satomi; Fukuda, Atsuo] Hamamatsu Univ Sch Med, Dept Neurophysiol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Hoshino, Hideki; Terashima, Hiroshi; Kubota, Masaya] Natl Ctr Child Hlth & Dev, Div Neurol, Setagaya Ku, Tokyo 1578535, Japan; [Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Clin Res Inst, Div Neurol, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Nakamura, Shinichi] Nagano Red Cross Hosp, Dept Pediat, Nagano 3808582, Japan; [Tohyama, Jun] Nishi Niigata Chuo Natl Hosp, Epilepsy Ctr, Dept Pediat, Niigata 9502085, Japan	Yokohama City University; Yamagata University; Hamamatsu University School of Medicine; Yokohama City University; National Center for Child Health & Development - Japan; Nagano Red Cross Hospital	Matsumoto, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp; hsaitsu@yokohama-cu.ac.jp	Kumada, Tatsuro/AAY-9117-2020; Saitsu, Hirotomo/AAM-7131-2021; Hayasaka, Kiyoshi/H-5340-2012; Akita, Tenpei/AAE-9841-2020; Fukuda, Atsuo/ABA-6843-2020; Nakamura, Kazuyuki/B-6247-2012; Furukawa, Tomonori/G-7014-2014	Akita, Tenpei/0000-0003-4614-4504; Fukuda, Atsuo/0000-0001-7112-4834; Kubota, Masaya/0000-0002-8299-4867; Tsurusaki, Yoshinori/0000-0002-7240-6355; Saitsu, Hirotomo/0000-0003-0723-0960; Kato, Mitsuhiro/0000-0003-1485-8553	Ministry of Health, Labour, and Welfare of Japan; Japan Society for the Promotion of Science [25293085, 25293235, 13313587]; Takeda Science Foundation; Japan Science and Technology Agency; Strategic Research Program for Brain Sciences [11105137]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [12024421]; Grants-in-Aid for Scientific Research [23612008] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank the individuals and their families for their participation in this study. We also thank Aya Narita and Nobuko Watanabe for their technical assistance and Tohru Kozasa and Nobuchika Suzuki for their valuable comments. This work was supported by the Ministry of Health, Labour, and Welfare of Japan, the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research (B) [25293085 and 25293235] and a Grant-in-Aid for Scientific Research (A) [13313587]), the Takeda Science Foundation, the Japan Science and Technology Agency, the Strategic Research Program for Brain Sciences (11105137), and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (12024421).	DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dulac O, 2001, EPILEPSIA, V42, P23, DOI 10.1046/j.1528-1157.2001.042suppl.3023.x; Edvardson S, 2013, EPILEPSIA, V54, pe24, DOI 10.1111/epi.12050; Goldenstein BL, 2009, MOL PHARMACOL, V75, P1222, DOI 10.1124/mol.108.054296; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; HUFF RM, 1985, J BIOL CHEM, V260, P864; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Jurgens CWD, 2007, MOL PHARMACOL, V71, P1572, DOI 10.1124/mol.106.031773; Kato M, 2007, AM J HUM GENET, V81, P361, DOI 10.1086/518903; Kurian MA, 2010, BRAIN, V133, P2964, DOI 10.1093/brain/awq238; Marini C, 2011, EPILEPSIA, V52, P24, DOI 10.1111/j.1528-1167.2011.02997.x; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; Mills PB, 2005, HUM MOL GENET, V14, P1077, DOI 10.1093/hmg/ddi120; Molinari F, 2005, AM J HUM GENET, V76, P334, DOI 10.1086/427564; Nakata H, 2005, MOL PHARMACOL, V67, P695, DOI 10.1124/mol.104.003913; Ohtahara S, 2006, EPILEPSY RES, V70, pS58, DOI 10.1016/j.eplepsyres.2005.11.021; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saitsu H, 2011, CLIN GENET, V80, P484, DOI 10.1111/j.1399-0004.2010.01575.x; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Saitsu H, 2012, EPILEPSIA, V53, P1441, DOI 10.1111/j.1528-1167.2012.03548.x; Saitsu H, 2012, ANN NEUROL, V72, P298, DOI 10.1002/ana.23620; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Sills GJ, 2006, CURR OPIN PHARMACOL, V6, P108, DOI 10.1016/j.coph.2005.11.003; SLEPAK VZ, 1993, J BIOL CHEM, V268, P1414; Stefani A, 2001, EPILEPSY RES, V43, P239, DOI 10.1016/S0920-1211(00)00201-1; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Valenzuela D, 1997, P NATL ACAD SCI USA, V94, P1727, DOI 10.1073/pnas.94.5.1727; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Williams DJ, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00181; Zhang XL, 2000, EPILEPSIA, V41, pS52	36	141	149	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					496	505		10.1016/j.ajhg.2013.07.014	http://dx.doi.org/10.1016/j.ajhg.2013.07.014			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23993195	Green Published, Bronze			2022-12-18	WOS:000330268900008
J	Guo, DC; Regalado, E; Casteel, DE; Santos-Cortez, RL; Gong, LM; Kim, JJ; Dyack, S; Horne, SG; Chang, GJ; Jondeau, G; Boileau, C; Coselli, JS; Li, ZY; Leal, SM; Shendure, J; Rieder, MJ; Bamshad, MJ; Nickerson, DA; Kim, C; Milewicz, DM				Guo, Dong-Chuan; Regalado, Ellen; Casteel, Darren E.; Santos-Cortez, Regie L.; Gong, Limin; Kim, Jeong Joo; Dyack, Sarah; Horne, S. Gabrielle; Chang, Guijuan; Jondeau, Guillaume; Boileau, Catherine; Coselli, Joseph S.; Li, Zhenyu; Leal, Suzanne M.; Shendure, Jay; Rieder, Mark J.; Bamshad, Michael J.; Nickerson, Deborah A.; Kim, Choel; Milewicz, Dianna M.		GenTAC Registry Consortium; Natl Heart Lung Blood Inst Grand O	Recurrent Gain-of-Function Mutation in PRKG1 Causes Thoracic Aortic Aneurysms and Acute Aortic Dissections	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT PROTEIN-KINASES; BETA RECEPTOR; NITRIC-OXIDE; CGMP ACTION	Gene mutations that lead to decreased contraction of vascular smooth-muscle cells (SMCs) can cause inherited thoracic aortic aneurysms and dissections. Exome sequencing of distant relatives affected by thoracic aortic disease and subsequent Sanger sequencing of additional probands with familial thoracic aortic disease identified the same rare variant, PRKG1 c.530G>A (p.Arg177Gln), in four families. This mutation segregated with aortic disease in these families with a combined two-point LOD score of 7.88. The majority of affected individuals presented with acute aortic dissections (63%) at relatively young ages (mean 31 years, range 17-51 years). PRKG1 encodes type I cGMP-dependent protein kinase (PKG-1), which is activated upon binding of cGMP and controls SMC relaxation. Although the p.Arg177G1n alteration disrupts binding to the high-affinity cGMP binding site within the regulatory domain, the altered PKG-1 is constitutively active even in the absence of cGMP. The increased PKG-1 activity leads to decreased phosphorylation of the myosin regulatory light chain in fibroblasts and is predicted to cause decreased contraction of vascular SMCs. Thus, identification of a gain-of-function mutation in PRKG1 as a cause of thoracic aortic disease provides further evidence that proper SMC contractile function is critical for maintaining the integrity of the thoracic aorta throughout a lifetime.	[Guo, Dong-Chuan; Regalado, Ellen; Gong, Limin; Chang, Guijuan] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Casteel, Darren E.] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; [Santos-Cortez, Regie L.; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kim, Jeong Joo; Milewicz, Dianna M.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Dyack, Sarah] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4R2, Canada; [Horne, S. Gabrielle] Dalhousie Univ, Dept Med, Halifax, NS B3H 4R2, Canada; [Jondeau, Guillaume; Boileau, Catherine] Hop Bichat Claude Bernard, Inst Natl Sante & Rech Med, U698, F-75018 Paris, France; [Jondeau, Guillaume; Boileau, Catherine] Hop Bichat Claude Bernard, Ctr Reference Syndromes Marfan, F-75018 Paris, France; [Jondeau, Guillaume; Boileau, Catherine] Hop Bichat Claude Bernard, Apparentes Serv Cardiol, F-75018 Paris, France; [Jondeau, Guillaume] Hop Bichat Claude Bernard, AP HP, Serv Cardiol, F-75018 Paris, France; [Jondeau, Guillaume] Univ Paris 07, Unite Format & Rech Med, F-75010 Paris, France; [Boileau, Catherine] Hop Ambroise Pare, AP HP 9, Serv Biochim Hormonol & Genet Mol, F-92100 Boulogne, France; [Boileau, Catherine] Univ Versailles Saint Quentin En Yvelines, Unite Format & Rech Sci Sante, F-78280 Guyancourt, France; [Coselli, Joseph S.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Li, Zhenyu] Univ Kentucky, Dept Internal Med, Lexington, KY 40508 USA; [Shendure, Jay; Rieder, Mark J.; Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kim, Choel] Baylor Coll Med, Dept Biochem & Mol Biol, Dept Verna & Marrs McLean, Houston, TX 77030 USA; [Milewicz, Dianna M.] Mem Hermann Heart & Vasc Inst, Houston, TX 77030 USA; [Milewicz, Dianna M.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Diego; University of California System; University of California San Diego; Baylor College of Medicine; Baylor College of Medicine; Dalhousie University; Dalhousie University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Baylor College of Medicine; University of Kentucky; University of Washington; University of Washington Seattle; Baylor College of Medicine; Saint Lukes Episcopal Hospital; Texas Heart Institute	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.	dianna.m.milewicz@uth.tmc.edu	Shendure, Jay/AAU-3684-2021; Kim, Jeong Joo/GYJ-5589-2022; Barbalić, Maja/E-2161-2017; boileau, catherine/M-4482-2017; Dyack, Sarah/AAD-4347-2020; Altshuler, David M/A-4476-2009; de Bakker, Paul IW/B-8730-2009	Barbalić, Maja/0000-0001-8914-1691; boileau, catherine/0000-0002-0371-7539; Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Shendure, Jay/0000-0002-1516-1865; Regalado, Ellen/0000-0002-5859-218X; Turner, Emily/0000-0001-9040-9229; Akey, Joshua/0000-0002-4411-1330; Quinlan, Aaron/0000-0003-1756-0859; Caan, Bette/0000-0002-5803-310X; Ballantyne, Christie/0000-0002-6432-1730	Lung Cohorts Sequencing Project [HL-102923]; Women's Health Initiative Sequencing Project [HL-102924]; Heart Cohorts Sequencing Project [HL-103010]; Broad Institute Sequencing Project [HL-102925]; GenTAC Registry Consortium [HHSN268200648199C, HHSN268201000048C]; Northwest Genomics Center Sequencing Project [HL-102926]; Family Studies Project Team; University of Texas Health Science Center at Houston [RO1 HL62594, P50HL083794-01, P01HL110869-01, UL1 RR024148]; Vivian L. Smith Foundation; TexGen Foundation; Richard T. Pisani funds; Groupements d'Interet Scientifique Maladies Rares; PHRC [A0M09093]; PHRC AOM [10108]; ANR from the French National Research Agency [BLAN 1129]; European Union;  [RO1 GM090161]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170, RC2HL102924, UC2HL102926, RC2HL102923, UC2HL103010, P50HL083794, RC2HL102925, P01HL110869, RC2HL102926, UC2HL102924, UC2HL102925, R01HL062594, RC2HL103010, UC2HL102923, R01HL109942] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008122] Funding Source: NIH RePORTER	Lung Cohorts Sequencing Project; Women's Health Initiative Sequencing Project; Heart Cohorts Sequencing Project; Broad Institute Sequencing Project; GenTAC Registry Consortium; Northwest Genomics Center Sequencing Project; Family Studies Project Team; University of Texas Health Science Center at Houston; Vivian L. Smith Foundation; TexGen Foundation; Richard T. Pisani funds; Groupements d'Interet Scientifique Maladies Rares; PHRC; PHRC AOM; ANR from the French National Research Agency(French National Research Agency (ANR)); European Union(European Commission); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are extremely grateful to the families involved in this study, as well as the physicians and genetic counselors who aided in the collection of clinical data from the families (available in the Supplemental Data). We would like to thank the National Heart, Lung, and Blood Grand Opportunity Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung Cohorts Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Heart Cohorts Sequencing Project (HL-103010), the Broad Institute Sequencing Project (HL-102925), the GenTAC Registry Consortium (HHSN268200648199C and HHSN268201000048C), the Northwest Genomics Center Sequencing Project (HL-102926, D.A.N, M.J.R, and J.S.), and the Family Studies Project Team. We thank Z. Ren for technical assistance. The following sources provided funding for these studies: RO1 HL62594 (D.M.M.), P50HL083794-01 (D.M.M.), P01HL110869-01 (D.M.M.), UL1 RR024148 (University of Texas Health Science Center at Houston), the Vivian L. Smith Foundation (D.M.M.), the TexGen Foundation (D.M.M.), Richard T. Pisani funds (D.M.M.), RO1 GM090161 (C.K.), Groupements d'Interet Scientifique Maladies Rares (C.B.), PHRC A0M09093 (G.J.), PHRC AOM 10108 (C.B.), ANR 2010 BLAN 1129 from the French National Research Agency (G.J.), and the European Union 7th Framework Program integrated project "Fighting Aneurysmal Disease" (www.fighting-aneurysm.org) (J.B.M.).	Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; BRICKMAN E, 1973, J BACTERIOL, V116, P582, DOI 10.1128/JB.116.2.582-587.1973; Devereux RB, 2012, AM J CARDIOL, V110, P1189, DOI 10.1016/j.amjcard.2012.05.063; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Inamoto S, 2010, CARDIOVASC RES, V88, P520, DOI 10.1093/cvr/cvq230; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Moll D, 2006, J NEURAL TRANSM, V113, P1015, DOI 10.1007/s00702-006-0515-5; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Pape LA, 2007, CIRCULATION, V116, P1120, DOI 10.1161/CIRCULATIONAHA.107.702720; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Roh S, 2007, J INVEST DERMATOL, V127, P2533, DOI 10.1038/sj.jid.5700907; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Tran-Fadulu V, 2006, AM J MED GENET A, V140A, P1196, DOI 10.1002/ajmg.a.31236; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	21	141	147	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					398	404		10.1016/j.ajhg.2013.06.019	http://dx.doi.org/10.1016/j.ajhg.2013.06.019			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23910461	Green Published, Bronze			2022-12-18	WOS:000323186200020
J	Szpiech, ZA; Xu, JS; Pemberton, TJ; Peng, WP; Zollner, S; Rosenberg, NA; Li, JZ				Szpiech, Zachary A.; Xu, Jishu; Pemberton, Trevor J.; Peng, Weiping; Zoellner, Sebastian; Rosenberg, Noah A.; Li, Jun Z.			Long Runs of Homozygosity Are Enriched for Deleterious Variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WORLDWIDE HUMAN-POPULATIONS; DNA-SEQUENCING DATA; GENETIC-VARIATION; CODING VARIATION; HUMAN GENOME; MUTATIONS; VARIANTS; HAPLOTYPE; PATTERNS; DISEASE	Exome sequencing offers the potential to study the population-genomic variables that underlie patterns of deleterious variation. Runs of homozygosity (ROH) are long stretches of consecutive homozygous genotypes probably reflecting segments shared identically by descent as the result of processes such as consanguinity, population size reduction, and natural selection. The relationship between ROH and patterns of predicted deleterious variation can provide insight into the way in which these processes contribute to the maintenance of deleterious variants. Here, we use exome sequencing to examine ROH in relation to the distribution of deleterious variation in 27 individuals of varying levels of apparent inbreeding from 6 human populations. A significantly greater fraction of all genome-wide predicted damaging homozygotes fall in ROH than would be expected from the corresponding fraction of nondamaging homozygotes in ROH (p < 0.001). This pattern is strongest for long ROH (p < 0.05). ROH, and especially long ROH, harbor disproportionately more deleterious homozygotes than would be expected on the basis of the total ROH coverage of the genome and the genomic distribution of nondamaging homozygotes. The results accord with a hypothesis that recent inbreeding, which generates long ROH, enables rare deleterious variants to exist in homozygous form. Thus, just as inbreeding can elevate the occurrence of rare recessive diseases that represent homozygotes for strongly deleterious mutations, inbreeding magnifies the occurrence of mildly deleterious variants as well.	[Szpiech, Zachary A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Szpiech, Zachary A.; Pemberton, Trevor J.; Rosenberg, Noah A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Xu, Jishu; Peng, Weiping; Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Pemberton, Trevor J.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0J9, Canada; [Zoellner, Sebastian] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Zoellner, Sebastian] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; Stanford University; University of Michigan System; University of Michigan; University of Manitoba; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Szpiech, ZA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	zachary.szpiech@ucsf.edu	Pemberton, Trevor/F-9206-2018	Li, Jun/0000-0001-6727-0812; Pemberton, Trevor/0000-0003-1224-1146; Rosenberg, Noah/0000-0002-1829-8664	National Institutes of Health [R01 GM081441, R01 HG005855]; Burroughs Wellcome Fund; NARSAD Young Investigator Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NARSAD Young Investigator Award(NARSAD); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Brendan Tarrier, Christine Brennan, and Robert Lyons of the University of Michigan DNA Sequencing Core. Funding for this research was provided by National Institutes of Health R01 GM081441 and R01 HG005855, an NARSAD Young Investigator Award, and a grant from the Burroughs Wellcome Fund.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Cann HM, 2002, SCIENCE, V296, P261; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Curtis D, 2008, ANN HUM GENET, V72, P261, DOI 10.1111/j.1469-1809.2007.00411.x; Darwin CR, 1876, EFFECTS CROSS SELF F; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Fay JC, 2001, GENETICS, V158, P1227; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Garrod AE, 1902, LANCET, V2, P1616; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jorde LB, 2001, HUM HERED, V52, P61, DOI 10.1159/000053356; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Kiezun A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003301; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; KONDRASHOV AS, 1995, J THEOR BIOL, V175, P583, DOI 10.1006/jtbi.1995.0167; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lesecque Y, 2012, GENETICS, V191, P1321, DOI 10.1534/genetics.112.140343; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Lohmueller KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002326; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; McQuillan R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002655; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Necsulea A, 2011, HUM MUTAT, V32, P198, DOI 10.1002/humu.21407; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rudan I, 2003, J MED GENET, V40, P925, DOI 10.1136/jmg.40.12.925; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Sunyaev SR, 2012, HUM MOL GENET, V21, pR10, DOI 10.1093/hmg/dds385; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Torkamani Ali, 2012, Frontiers in Genetics, V3, P211, DOI 10.3389/fgene.2012.00211; Wang S, 2009, GENET EPIDEMIOL, V33, P172, DOI 10.1002/gepi.20344; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	53	141	145	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					90	102		10.1016/j.ajhg.2013.05.003	http://dx.doi.org/10.1016/j.ajhg.2013.05.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23746547	Green Published, Bronze			2022-12-18	WOS:000321804500008
J	Avenarius, MR; Hildebrand, MS; Zhang, Y; Meyer, NC; Sinith, LLH; Kahrizi, K; Najmabadi, H; Smith, RJH				Avenarius, Matthew R.; Hildebrand, Michael S.; Zhang, Yuzhou; Meyer, Nicole C.; Sinith, Luke L. H.; Kahrizi, Kimia; Najmabadi, Hossein; Smith, Richard J. H.			Human Male Infertility Caused by Mutations in the CATSPER1 Channel Protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIBROUS SHEATH; MALE-FERTILITY; SPERM; DYSPLASIA; MOTILITY	Male infertility, a common barrier that prevents successful conception, is a reproductive difficulty affecting 15% of couples. Heritable forms of nonsyndromic male infertility can arise from single-gene defects as well as chromosomal abnormalities. Although no CATSPER gene has been identified as causative for human male infertility, male mice deficient for members of the CatSper gene family are infertile. In this study, we used routine semen analysis to identify two consanguineous Iranian families segregating autosomal-recessive male infertility. Autozygosity by descent was demonstrated in both families for a similar to 11 cM region on chromosome 11q13.1, flanked by markers D11S1765 and D11S4139. This region contains the human CATSPER1 gene. Denaturing high-performance liquid chromatography (DHPLC) and bidirectional sequence analysis of CATSPER1 in affected family members revealed two separate insertion mutations (c.539-540insT and c.948-949insATGGC) that are predicted to lead to frameshifts and premature stop codons (p.Lys180LysfsX8 and p.Asp317MetfsX18). CATSPER1 is one of four members of the sperm-specific CATSPER voltage-gated calcium channel family known to be essential for normal male fertility in mice. These results suggest that CATSPER1 is also essential for normal male fertility in humans.	[Hildebrand, Michael S.; Zhang, Yuzhou; Meyer, Nicole C.; Sinith, Luke L. H.; Smith, Richard J. H.] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Smith, Richard J. H.] Univ Iowa, Interdisciplinary Ph D Program Genet, Iowa City, IA 52242 USA; [Avenarius, Matthew R.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Kahrizi, Kimia; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran 19834, Iran	University of Iowa; University of Iowa; University of Michigan System; University of Michigan	Smith, RJH (corresponding author), Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA.	r_chard-smith@uiowa.edu	Najmabadi, Hossein/P-8182-2017; Kahrizi, Kimia/D-7989-2017	Hildebrand, Michael/0000-0003-2739-0515; Smith, Richard/0000-0003-1201-6731; Avenarius, Matthew/0000-0001-9516-5163; Najmabadi, Hossein/0000-0002-6084-7778	Australian National Health and Medical Research (NHMRC) Overseas Biomedical Fellowship	Australian National Health and Medical Research (NHMRC) Overseas Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The authors sincerely thank the families for their participation in this study. R.J.H.S. is the Sterba Hearing Research Professor, University of Iowa College of Medicine. M.S.H. is supported by an Australian National Health and Medical Research (NHMRC) Overseas Biomedical Fellowship.	Arce B, 1980, Reproduccion, V4, P177; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; CHEMES HE, 1987, FERTIL STERIL, V48, P664; GRABSKI J, 1979, ANDROLOGIA, V11, P182; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Li HG, 2009, FERTIL STERIL, V92, P1141, DOI 10.1016/j.fertnstert.2008.07.1751; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; MOSHER W, 1990, FECUNDITY INFERTILIT; Prasad S, 2004, AM J MED GENET A, V124A, P1, DOI 10.1002/ajmg.a.20272; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; SKAKKEBAEK NE, 1994, LANCET, V343, P1473, DOI 10.1016/S0140-6736(94)92586-0; TEMPLETON A, 1990, BRIT MED J, V301, P148, DOI 10.1136/bmj.301.6744.148; Turner RMO, 2001, J ANDROL, V22, P302; World Health Organization, 1999, WHO LAB MANUAL EXAMI, V4th; Zuccarello D, 2008, HUM REPROD, V23, P1957, DOI 10.1093/humrep/den193	18	141	148	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					505	510		10.1016/j.ajhg.2009.03.004	http://dx.doi.org/10.1016/j.ajhg.2009.03.004			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19344877	Green Published, Bronze			2022-12-18	WOS:000265232800010
J	Giunta, C; Elcioglu, NH; Albrecht, B; Eich, G; Chambaz, C; Janecke, AR; Yeowell, H; Weis, M; Eyre, DR; Kraenzlin, M; Steinmann, B				Giunta, Cecilia; Elcioglu, Nursel H.; Albrecht, Beate; Eich, Georg; Chambaz, Celine; Janecke, Andreas R.; Yeowell, Heather; Weis, MaryAnn; Eyre, David R.; Kraenzlin, Marius; Steinmann, Beat			Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome - An autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-VI; LYSYL HYDROXYLASE-ACTIVITY; KYPHOSCOLIOTIC TYPE; OSTEOGENESIS IMPERFECTA; LIV-1 SUBFAMILY; SYNDROME EDS; SKIN FIBROBLASTS; 2 SIBLINGS; DIAGNOSIS; MECHANISM	We present clinical, radiological, biochemical, and genetic findings on six patients from two consanguineous families that show EDS-like features and radiological findings of a mild skeletal dysplasia. The EDS-like findings comprise hyperelastic, thin, and bruisable skin, hypermobility of the small joints with a tendency to contractures, protuberant eyes with bluish sclerae, hands with finely wrinkled palms, atrophy of the thenar muscles, and tapering fingers. The skeletal dysplasia comprises platyspondyly with moderate short stature, osteopenia, and widened metaphyses. Patients have an increased ratio of total urinary pyridinolines, lysyl pyridinoline/hydroxylysyl pyridinoline (LP/HP), of similar to 1 as opposed to similar to 6 in EDS VI or similar to 0.2 in controls. Lysyl and prolyl residues of collagens were underhydroxylated despite normal lysyl hydroxylase and prolyl 4-hydroxylase activities; underhydroxylation was a generalized process as shown by mass spectrometry of the alpha 1(I)- and alpha 2(I)-chain-derived peptides of collagen type I and involved at least collagen types I and II. A genome-wide SNP scan and sequence analyses identified in all patients a homozygous c.483_491 del9 SLC39A13 mutation that encodes for a membrane-bound zinc transporter SLC39A13. We hypothesize that an increased Zn2+ content inside the endoplasmic reticulum competes with Fe2+, a cofactor that is necessary for hydroxylation of lysyl and prolyl residues, and thus explains the biochemical findings. These data suggest an entity that we have designated "spondylocheiro dysplastic form of EDS (SCD-EDS)" to indicate a generalized skeletal dysplasia involving mainly the spine (spondylo) and striking clinical abnormalities of the hands (cheiro) in addition to the EDS-like features.	[Giunta, Cecilia; Chambaz, Celine; Steinmann, Beat] Univ Childrens Hosp, Div Metab & Mol Pediat, CH-8032 Zurich, Switzerland; [Elcioglu, Nursel H.] Marmara Univ Hosp, T-34600 Istanbul, Turkey; [Albrecht, Beate] Univ Klinikum, Inst Humangenet, Essen, Germany; [Albrecht, Beate] Univ Duisberg Essen, D-45122 Essen, Germany; [Eich, Georg] Kantonsspital, CH-5000 Aarau, Switzerland; [Janecke, Andreas R.] Innsbruck Med Univ, Div Clin Genet, A-6020 Innsbruck, Austria; [Yeowell, Heather] Duke Univ, Med Ctr, Div Dermatol, Durham, NC 27710 USA; [Eyre, David R.; Kraenzlin, Marius] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Steinmann, Beat] Univ Basel Hosp, Div Endocrinol & Diabet, CH-4031 Basel, Switzerland	University Children's Hospital Zurich; Marmara University; University of Duisburg Essen; University of Duisburg Essen; Kantonsspital Aarau AG (KSA); Medical University of Innsbruck; Duke University; University of Washington; University of Washington Seattle; University of Basel	Steinmann, B (corresponding author), Univ Childrens Hosp, Div Metab & Mol Pediat, CH-8032 Zurich, Switzerland.	beat.steinmann@kispi.uzh.ch	Giunta, Cecilia/T-8222-2019; Janecke, Andreas/AAA-5227-2019	Giunta, Cecilia/0000-0002-9313-8257; Janecke, Andreas/0000-0001-7155-0315	NIAMS NIH HHS [AR 36794, R37 AR037318, R01 AR036794, AR 37318, R01 AR037318, R37 AR036794] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R01AR037318, R37AR037318, R37AR036794] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BERG RA, 1983, ARCH BIOCHEM BIOPHYS, V226, P681, DOI 10.1016/0003-9861(83)90338-7; Clark AG, 2002, MATRIX BIOL, V21, P175, DOI 10.1016/S0945-053X(01)00193-7; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eyre D, 2002, MOL GENET METAB, V76, P211, DOI 10.1016/S1096-7192(02)00036-7; Giunta C, 2005, MOL GENET METAB, V86, P269, DOI 10.1016/j.ymgme.2005.04.014; Giunta C, 2005, AM J MED GENET A, V133A, P158, DOI 10.1002/ajmg.a.30529; Grant ME, 2002, COLLAGEN FAMILY STRU, P159, DOI DOI 10.1002/0471221929.CH2; Greulich W.W., 1993, RADIOGRAPHIC ATLAS S, V2nd ed.; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Heim P, 1998, ACTA PAEDIATR, V87, P708, DOI 10.1080/080352598750014184; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Jarisch A, 1998, AM J MED GENET, V78, P455, DOI 10.1002/(SICI)1096-8628(19980806)78:5<455::AID-AJMG11>3.0.CO;2-E; KRAENZLIN ME, CLIN CHEM IN PRESS; KRANE SM, 1984, EXTRACELLULAR MATRIX, P413; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; MURAD S, 1985, CONNECT TISSUE RES, V13, P181, DOI 10.3109/03008208509152396; NELLHAUS G, 1968, PEDIATRICS, V41, P106; NEYZI O, 1978, IST TIP FAK MECM S74, V41; Neyzi O, 2006, ACTA PAEDIATR, V95, P1635, DOI 10.1080/08035250600652013; PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901; PRADER A, 1988, HELV PAEDIATR ACTA S, V52, P1; PUISTOLA U, 1980, BIOCHIM BIOPHYS ACTA, V611, P51, DOI 10.1016/0005-2744(80)90041-8; Rajan DP, 1999, BIOCHEM BIOPH RES CO, V262, P762, DOI 10.1006/bbrc.1999.1272; STEINMANN B, 1986, J BIOL CHEM, V261, P8958; STEINMANN B, 1975, HELV PAEDIATR ACTA, V30, P255; STEINMANN B, 1984, J BIOL CHEM, V259, P1129; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; TUDERMAN L, 1977, EUR J BIOCHEM, V80, P341, DOI 10.1111/j.1432-1033.1977.tb11888.x; VOGEL A, 1979, LAB INVEST, V40, P201; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yis U, 2008, NEUROMUSCULAR DISORD, V18, P210, DOI 10.1016/j.nmd.2007.11.006	41	141	145	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1290	1305		10.1016/j.ajhg.2008.05.001	http://dx.doi.org/10.1016/j.ajhg.2008.05.001			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18513683	Green Published, Bronze			2022-12-18	WOS:000256647000007
J	Milunsky, JM; Maher, TA; Zhao, G; Roberts, AE; Stalkers, HJ; Zori, RT; Burch, MN; Clemens, M; Mulliken, JB; Smith, R; Lin, AE				Milunsky, Jeff M.; Maher, Tom A.; Zhao, Geping; Roberts, Amy E.; Stalkers, Heather J.; Zori, Roberto T.; Burch, Michelle N.; Clemens, Michele; Mulliken, John B.; Smith, Rosemarie; Lin, Angela E.			TFAP2A mutations result in branchio-oculo-facial syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AP-2-ALPHA TRANSCRIPTION FACTOR; NONSYNDROMIC CLEFT-LIP; FACTOR AP-2; DEFECTS; PALATE; IDENTIFICATION; MORPHOGENESIS; EXCLUSION; FAMILY; LOCUS	Branchio-oculo-facial syndrome (BOFS) is a rare autosomal-dominant cleft palate-craniofacial disorder with variable expressivity. The major features include cutaneous anomalies (cervical, infra- and/or supra-auricular defects, often with dermal thymus), ocular anomalies, characteristic facial appearance (malformed pinnae, oral clefts), and, less commonly, renal and ectodermal (dental and hair) anomalies. The molecular basis for this disorder is heretofore unknown. We detected a 3.2 Mb deletion by 500K SNP microarray in an affected mother and son with BOFS at chromosome 6p24.3. Candidate genes in this region were selected for sequencing on the basis of their expression patterns and involvement in developmental pathways associated with the clinical findings of BOFS. Four additional BOFS patients were found to have de novo missense mutations in the highly conserved exons 4 and 5 (basic region of the DNA binding domain) of the TFAP2A gene in the candidate deleted region. We conclude BOFS is caused by mutations involving TFAP2A. More patients need to be studied to determine possible genetic heterogeneity and to establish whether there are genotype-phenotype correlations.	[Milunsky, Jeff M.; Maher, Tom A.; Zhao, Geping] Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; [Milunsky, Jeff M.] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Milunsky, Jeff M.] Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; [Roberts, Amy E.] Childrens Hosp, Dept Cardiol, Boston, MA 02114 USA; [Stalkers, Heather J.; Zori, Roberto T.; Burch, Michelle N.] Univ Florida, Dept Pediat, Raymond C Philips Unit, Div Genet, Gainesville, FL 32610 USA; [Burch, Michelle N.] UPMC, Magee Womens Hosp, Dept Genet, Pittsburgh, PA USA; [Mulliken, John B.] Childrens Hosp, Div Plast Surg, Boston, MA 02118 USA; [Smith, Rosemarie] Maine Med Ctr, Barbara Bush Childrens Hosp, Portland, ME USA; [Lin, Angela E.] MassGen Hosp Children, Genet Unit, Boston, MA 02114 USA	Boston University; Boston University; Boston University; Harvard University; Boston Children's Hospital; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Boston Children's Hospital; Maine Medical Center; Harvard University; Massachusetts General Hospital	Milunsky, JM (corresponding author), Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA.	jmilunsk@bu.edu						Ahituv N, 2004, MAMM GENOME, V15, P424, DOI 10.1007/s00335-004-2334-z; Damberg M, 2005, J NEURAL TRANSM, V112, P1281, DOI 10.1007/s00702-005-0325-1; Davies AF, 1999, J MED GENET, V36, P708; Donnai D, 1992, Clin Dysmorphol, V1, P89; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Feng WG, 2008, MOL CELL BIOL, V28, P315, DOI 10.1128/MCB.01168-07; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Heimberger AB, 2005, CLIN CANCER RES, V11, P267; Jean D, 1998, J BIOL CHEM, V273, P16501, DOI 10.1074/jbc.273.26.16501; Juriloff DM, 2008, BIRTH DEFECTS RES A, V82, P63, DOI 10.1002/bdra.20430; Kaiser R, 2007, AM J MED GENET A, V143A, P2185, DOI 10.1002/ajmg.a.31875; LIN AE, 1991, CLEFT PALATE-CRAN J, V28, P96, DOI 10.1597/1545-1569(1991)028<0096:TBOFS>2.3.CO;2; LIN AE, 1995, AM J MED GENET, V56, P42, DOI 10.1002/ajmg.1320560112; LIN AE, 1992, CLIN GENET, V41, P221; Lin AE, 2000, AM J MED GENET, V91, P387, DOI 10.1002/(SICI)1096-8628(20000424)91:5<387::AID-AJMG13>3.0.CO;2-1; McPherson LA, 2002, J BIOL CHEM, V277, P45028, DOI 10.1074/jbc.M208924200; Moreno LM, 2004, AM J MED GENET A, V125A, P135, DOI 10.1002/ajmg.a.20425; MorrissKay GM, 1996, BIOESSAYS, V18, P785, DOI 10.1002/bies.950181004; Nelson DK, 2004, DEV BIOL, V267, P72, DOI 10.1016/j.ydbio.2003.10.033; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Orso F, 2007, ADV EXP MED BIOL, V604, P87, DOI 10.1007/978-0-387-69116-9_6; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schultz RE, 2004, AM J MED GENET A, V125A, P17, DOI 10.1002/ajmg.a.20424; Stabach PR, 2006, ONCOGENE, V25, P2148, DOI 10.1038/sj.onc.1209250; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; West-Mays JA, 1999, DEV BIOL, V206, P46, DOI 10.1006/dbio.1998.9132; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	28	141	145	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1171	1177		10.1016/j.ajhg.2008.03.005	http://dx.doi.org/10.1016/j.ajhg.2008.03.005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18423521	Green Published, Bronze			2022-12-18	WOS:000255923600017
J	Nathanson, KL; Kanetsky, PA; Hawes, R; Vaughn, DJ; Letrero, R; Tucker, K; Friedlander, M; Phillips, KA; Hogg, D; Jewett, MAS; Lohynska, R; Daugaard, G; Richard, S; Chompret, A; Bonati-Pellie, C; Heidenreich, A; Olah, E; Geczi, L; Bodrogi, I; Ormiston, WJ; Daly, PA; Oosterhuis, JW; Gillis, AJM; Looijenga, LHJ; Guilford, P; Fossa, SD; Heimdal, K; Tjulandin, SA; Liubchenko, L; Stoll, H; Weber, W; Huddart, R; Crockford, GP; Forman, D; Oliver, DT; Einhorn, L; Weber, BL; Kramer, J; McMaster, M; Greene, MH; Pike, M; Cortessis, V; Chen, C; Schwartz, SM; Bishop, DT; Easton, DF; Stratton, MR; Rapley, EA				Nathanson, KL; Kanetsky, PA; Hawes, R; Vaughn, DJ; Letrero, R; Tucker, K; Friedlander, M; Phillips, KA; Hogg, D; Jewett, MAS; Lohynska, R; Daugaard, G; Richard, S; Chompret, A; Bonati-Pellie, C; Heidenreich, A; Olah, E; Geczi, L; Bodrogi, I; Ormiston, WJ; Daly, PA; Oosterhuis, JW; Gillis, AJM; Looijenga, LHJ; Guilford, P; Fossa, SD; Heimdal, K; Tjulandin, SA; Liubchenko, L; Stoll, H; Weber, W; Huddart, R; Crockford, GP; Forman, D; Oliver, DT; Einhorn, L; Weber, BL; Kramer, J; McMaster, M; Greene, MH; Pike, M; Cortessis, V; Chen, C; Schwartz, SM; Bishop, DT; Easton, DF; Stratton, MR; Rapley, EA			The Y deletion gr/gr and susceptibility to testicular germ cell tumor	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MALE-SPECIFIC REGION; MALE-INFERTILITY; EUROPEAN COUNTRIES; GONADAL-FUNCTION; CANCER; CHROMOSOME; FAMILY; RISK; GENE; MEN	Testicular germ cell tumor (TGCT) is the most common cancer in young men. Despite a considerable familial component to TGCT risk, no genetic change that confers increased risk has been substantiated to date. The human Y chromosome carries a number of genes specifically involved in male germ cell development, and deletion of the AZFc region at Yq11 is the most common known genetic cause of infertility. Recently, a 1.6-Mb deletion of the Y chromosome that removes part of the AZFc region-known as the "gr/gr" deletion-has been associated with infertility. In epidemiological studies, male infertility has shown an association with TGCT that is out of proportion with what can be explained by tumor effects. Thus, we hypothesized that the gr/gr deletion may be associated with TGCT. Using logistic modeling, we analyzed this deletion in a large series of TGCT cases with and without a family history of TGCT. The gr/gr deletion was present in 3.0% (13/431) of TGCT cases with a family history, 2% (28/1,376) of TGCT cases without a family history, and 1.3% (33/2,599) of unaffected males. Presence of the gr/gr deletion was associated with a twofold increased risk of TGCT (adjusted odds ratio [aOR] 2.1; 95% confidence interval [CI] 1.3-3.6; P = .005) and a threefold increased risk of TGCT among patients with a positive family history (aOR 3.2; 95% CI 1.5-6.7; P = .0027). The gr/gr deletion was more strongly associated with seminoma (aOR 3.0; 95% CI 1.6-5.4; P = .0004) than with nonseminoma TGCT (aOR 1.5; 95% CI 0.72-3.0; P = .29). These data indicate that the Y microdeletion gr/gr is a rare, low-penetrance allele that confers susceptibility to TGCT.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; Univ New S Wales, Dept Med Oncol, Div Med, Sydney, NSW, Australia; Prince Wales Hosp Randwick, Sydney, NSW, Australia; Peter MacCallum Canc Ctr, Dept Haematol & Med Oncol, Melbourne, Vic, Australia; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Univ Toronto, Toronto, ON, Canada; Univ Hosp Prague, Dept Radiotherapy & Oncol, Prague, Czech Republic; Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; CHU Bicetre, EPHE, UMR 8125, Fac Med Paris Sud, Le Kremlin Bicetre, France; CHU Bicetre, Serv Urol, Le Kremlin Bicetre, France; Inst Gustave Roussy, Villejuif, France; Hop Paul Brousse, INSERM U535, Villejuif, France; Univ Marburg, Dept Urol Oncol, Marburg, Germany; Natl Inst Oncol, Dept Mol Genet, Budapest, Hungary; Natl Inst Oncol, Dept Chemotherapy, Budapest, Hungary; St James Hosp, Dept Med Oncol, Dublin 8, Ireland; Erasmus Univ, Med Ctr, Dept Pathol, Rotterdam, Netherlands; Dr Daniel Den Hoed Canc Ctr, Josphine Nefkens Inst, NL-3008 AE Rotterdam, Netherlands; Univ Otago, Canc Genet Lab, Dunedin, New Zealand; Natl Hosp Norway, Radiumhosp Trust, Dept Clin Canc Res & Genet, Oslo, Norway; NN Blokhin Russian Canc Res Ctr, Lab Clin Genet, Inst Clin Oncol, Moscow, Russia; Univ Basel Hosp, Familial Canc Clin, CH-4031 Basel, Switzerland; St James Univ Hosp, Genet Epidemiol Div, Canc Res UK Clin Ctr, Leeds, W Yorkshire, England; Barts & London Queen Marys Sch Med & Dent, Dept Med Oncol, London, England; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46204 USA; NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; Univ So Calif, Dept Preventat Med, Keck Sch Med, Los Angeles, CA USA; Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA; Univ Cambridge, Canc Res UK, Genet Epidemiol Unit, Cambridge, England	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of London; Institute of Cancer Research - UK; University of New South Wales Sydney; Peter Maccallum Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; General University Hospital Prague; Rigshospitalet; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Philipps University Marburg; National Institute of Oncology Hungary; National Institute of Oncology Hungary; Trinity College Dublin; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Otago; University of Oslo; National Hospital Norway; N.N. Blokhin Russian Cancer Research Center; University of Basel; Cancer Research UK; Saint James's University Hospital; University of Leeds; University of London; Queen Mary University London; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; Fred Hutchinson Cancer Center; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Nathanson, KL (corresponding author), Univ Penn, Sch Med, Dept Med, 513 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	knathans@mail.med.upenn.edu	Looijenga, Leendert/B-8145-2019; friedlander, michael l/G-3490-2013; RICHARD, Stéphane/O-1005-2017; Heimdal, Ketil Riddervold/H-3038-2019; Pillay, Nischalan/F-9536-2012; Lohynska, Radka/AAC-7908-2019; Daugaard, Gedske/AAD-4009-2019; Tjulandin, Sergei/Y-5069-2018	Looijenga, Leendert/0000-0002-8146-1911; friedlander, michael l/0000-0002-6488-0604; RICHARD, Stéphane/0000-0002-9859-9773; Heimdal, Ketil Riddervold/0000-0002-8911-3508; Lohynska, Radka/0000-0003-1379-9264; Cortessis, Victoria/0000-0002-2339-1089; Daugaard, Gedske/0000-0002-9618-9180; huddart, robert/0000-0003-3604-1990; Bishop, Tim/0000-0002-8752-8785; Guilford, Parry/0000-0002-7256-9576; Nathanson, Katherine/0000-0002-6740-0901; Phillips, Kelly-Anne/0000-0002-0475-1771	NCI NIH HHS [R01 CA085914-01, R01CA085914, R01 CA085914-05, R01 CA085914-07, R01 CA085914-08, R01 CA085914-04, R01 CA085914, R01 CA085914-09, R01 CA085914-06, R01 CA085914-02, R01 CA085914-03, R01 CA085914-10, R01 CA10204] Funding Source: Medline; NIDCD NIH HHS [R01 DC010204] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085914, Z01CP010144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010204] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMI HO, 1994, INT J CANCER, V59, P33, DOI 10.1002/ijc.2910590108; Akre O, 1999, EPIDEMIOLOGY, V10, P364, DOI 10.1097/00001648-199907000-00005; Bergstrom R, 1996, J NATL CANCER I, V88, P727, DOI 10.1093/jnci/88.11.727; Bosl George J., 1997, P1397; DAVIES JM, 1981, LANCET, V1, P928; de Llanos M, 2005, HUM REPROD, V20, P216, DOI 10.1093/humrep/deh582; Dorus S, 2003, HUM MOL GENET, V12, P1643, DOI 10.1093/hmg/ddg185; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Ferlin A, 2005, J MED GENET, V42, P209, DOI 10.1136/jmg.2004.025833; FORMAN D, 1992, BRIT J CANCER, V65, P255, DOI 10.1038/bjc.1992.51; Frydelund-Larsen L, 2003, MOL HUM REPROD, V9, P517, DOI 10.1093/molehr/gag069; Ginalski K, 2004, P NATL ACAD SCI USA, V101, P2305, DOI 10.1073/pnas.0306306101; Heimdal K, 1996, BRIT J CANCER, V73, P964, DOI 10.1038/bjc.1996.173; Hemminki K, 2004, J MED GENET, V41, P801, DOI 10.1136/jmg.2004.022731; Hemminki K, 2004, BRIT J CANCER, V90, P1765, DOI 10.1038/sj.bjc.6601714; Huyghe E, 2003, J UROLOGY, V170, P5, DOI 10.1097/01.ju.0000053866.68623.da; Jacobsen R, 2000, BMJ-BRIT MED J, V321, P789, DOI 10.1136/bmj.321.7264.789; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kleiman SE, 2003, HUM GENET, V113, P486, DOI 10.1007/s00439-003-0990-9; Kucklenbroich K, 2005, HUM REPROD, V20, P191, DOI 10.1098/humrep/deh558; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; LILFORD R, 1994, BMJ-BRIT MED J, V309, P570, DOI 10.1136/bmj.309.6954.570; Lynch M, 2005, MOL HUM REPROD, V11, P507, DOI 10.1093/molehr/gah191; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; Moller H, 1999, BMJ-BRIT MED J, V318, P559, DOI 10.1136/bmj.318.7183.559; Moller H, 1996, INT J CANCER, V66, P287, DOI 10.1002/(SICI)1097-0215(19960503)66:3<287::AID-IJC2>3.0.CO;2-V; Petersen PM, 1998, APMIS, V106, P24, DOI 10.1111/j.1699-0463.1998.tb01316.x; Petersen PM, 1998, SEMIN ONCOL, V25, P224; Quintana-Murci L, 2003, J Med Genet, V40, pe20, DOI 10.1136/jmg.40.3.e20; Rapley EA, 2000, NAT GENET, V24, P197, DOI 10.1038/72877; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Repping S, 2004, AM J HUM GENET, V75, P514, DOI 10.1086/423394; Reynolds N, 2005, REPROD BIOMED ONLINE, V10, P72, DOI 10.1016/S1472-6483(10)60806-1; Richiardi L, 2004, J NATL CANCER I, V96, P145, DOI 10.1093/jnci/djh012; Ries L, 2004, SEER CANC STAT REV 1; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; SCHOTTENFELD D, 1980, AM J EPIDEMIOL, V112, P232, DOI 10.1093/oxfordjournals.aje.a112989; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sonneveld DJA, 1999, EUR J CANCER, V35, P1368, DOI 10.1016/S0959-8049(99)00140-9; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Westergaard T, 1996, INT J CANCER, V66, P627, DOI 10.1002/(SICI)1097-0215(19960529)66:5<627::AID-IJC8>3.3.CO;2-Y	45	141	146	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1034	1043		10.1086/498455	http://dx.doi.org/10.1086/498455			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380914	Green Published, Bronze			2022-12-18	WOS:000233241200012
J	Elson, JL; Turnbull, DM; Howell, N				Elson, JL; Turnbull, DM; Howell, N			Comparative Genomics and the evolution of human mitochondrial DNA: Assessing the effects of selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CODON-SUBSTITUTION MODELS; PHYLOGENETIC NETWORK; NONNEUTRAL EVOLUTION; REGION SEQUENCES; HUMAN MTDNA; DROSOPHILA; MUTATIONS; AFRICAN; POLYMORPHISM; POPULATIONS	This article provides evidence that selection has been a significant force during the evolution of the human mitochondrial genome. Both gene-by-gene and whole-genome approaches were used here to assess selection in the 560 mitochondrial DNA (mtDNA) coding-region sequences that were used previously for reduced-median-network analysis. The results of the present analyses were complex, in that the action of selection was not indicated by all tests, but this is not surprising, in view of the characteristics and limitations of the different analytical methods. Despite these limitations, there is evidence for both gene-specific and lineage-specific variation in selection. Whole-genome sliding-window approaches indicated a lack of selection in large-scale segments of the coding region. In other tests, we analyzed the ratio of nonsynonymous-to-synonymous substitutions in the 13 protein-encoding mtDNA genes. The most straightforward interpretation of those results is that negative selection has acted on the mtDNA during evolution. Single-gene analyses indicated significant departures from neutrality in the CO1, ND4, and ND6 genes, although the data also suggested the possible operation of positive selection on the AT6 gene. Finally, our results and those of other investigators do not support a simple model in which climatic adaptation has been a major force during human mtDNA evolution.	MitoKor Inc, San Diego, CA 92121 USA; Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77550 USA	Newcastle University - UK; University of Texas System; University of Texas Medical Branch Galveston	Howell, N (corresponding author), MitoKor Inc, 11494 Sorrento Valley Rd, San Diego, CA 92121 USA.	howelln@mitokor.com		/0000-0002-3551-5624				Ballard JWO, 2000, J MOL EVOL, V51, P64, DOI 10.1007/s002390010067; Ballard JWO, 2000, J MOL EVOL, V51, P48, DOI 10.1007/s002390010066; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; Grassly NC, 1997, MOL BIOL EVOL, V14, P239, DOI 10.1093/oxfordjournals.molbev.a025760; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moilanen JS, 2003, MOL BIOL EVOL, V20, P2132, DOI 10.1093/molbev/msg230; Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121; Nachman MW, 1998, GENETICA, V102-3, P61, DOI 10.1023/A:1017030708374; Nachman MW, 1996, GENETICS, V142, P953; NACHMAN MW, 1994, P NATL ACAD SCI USA, V91, P6364, DOI 10.1073/pnas.91.14.6364; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Templeton AR, 1996, GENETICS, V144, P1263; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Weiss G, 2003, MOL BIOL EVOL, V20, P572, DOI 10.1093/molbev/msg073; Wise CA, 1998, GENETICS, V148, P409; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Zeng LW, 1998, GENETICA, V102-3, P369, DOI 10.1023/A:1017035109224	31	141	149	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					229	238		10.1086/381505	http://dx.doi.org/10.1086/381505			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14712420	Green Published, Bronze			2022-12-18	WOS:000188860000004
J	Ahmed, ZM; Morell, RJ; Riazuddin, S; Gropman, A; Shaukat, S; Ahmad, MM; Mohiddin, SA; Fananapazir, L; Caruso, RC; Husnain, T; Khan, SN; Riazuddin, S; Griffith, AJ; Friedman, TB; Wilcox, ER				Ahmed, ZM; Morell, RJ; Riazuddin, S; Gropman, A; Shaukat, S; Ahmad, MM; Mohiddin, SA; Fananapazir, L; Caruso, RC; Husnain, T; Khan, SN; Riazuddin, S; Griffith, AJ; Friedman, TB; Wilcox, ER			Mutations of MYO6 are associated with recessive deafness, DFNB37	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNCONVENTIONAL MYOSIN-VI; HUMAN HOMOLOG; HEARING-LOSS; ISOFORM; MICE	Cosegregation of profound, congenital deafness with markers on chromosome 6q13 in three Pakistani families defines a new recessive deafness locus, DFNB37. Haplotype analyses reveal a 6-cM linkage region, flanked by markers D6S1282 and D6S1031, that includes the gene encoding unconventional myosin VI. In families with recessively inherited deafness, DFNB37, our sequence analyses of MYO6 reveal a frameshift mutation (36-37insT), a nonsense mutation (R1166X), and a missense mutation (E216V). These mutations, along with a previously published missense allele linked to autosomal dominant progressive hearing loss (DFNA22), provide an allelic spectrum that probes the relationship between myosin VI dysfunction and the resulting phenotype.	Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Genet Mol Lab, NIH, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Sect Gene Struct & Funct, Genet Mol Lab, NIH, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Hearing Sect, NIH, Rockville, MD 20850 USA; Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; NINDS, Neurogenet Branch, Washington, DC USA; Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; NHLBI, Clin Cardiol Sect, NIH, Bethesda, MD 20892 USA; NEI, Sect Ophthalm Mol Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Friedman, TB (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Genet Mol Lab, NIH, 5 Res Court,2A-19, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov	Husnain, Tayyab/AAE-9033-2019; Morell, Robert James/Q-2042-2019; Nasim Khan, Shaheen/F-2135-2015; Husnain, Tayyab/G-3805-2015	Morell, Robert/0000-0003-1537-7356; Mohiddin, Saidi/0000-0002-1031-4084	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000064, Z01DC000035, Z01DC000060, Z01DC000039] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DC000039, Z01 DC000064] Funding Source: Medline; NIDCD NIH HHS [ZO1 DC00035-06, ZO1 DC000064-02, T32 DC000035, ZO1 DC000039-06] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahituv N, 2000, GENE, V261, P269, DOI 10.1016/S0378-1119(00)00535-7; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bohrmann J, 1997, CELL MOL LIFE SCI, V53, P652, DOI 10.1007/s000180050084; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Breckler J, 2000, EXP EYE RES, V70, P121, DOI 10.1006/exer.1999.0758; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Friedman T, 2000, CURR OPIN NEUROBIOL, V10, P487, DOI 10.1016/S0959-4388(00)00120-3; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GRIFFITH AJ, 2002, SPR HDB AUD, V14, P121; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; MERMALL V, 1995, J CELL BIOL, V129, P1575, DOI 10.1083/jcb.129.6.1575; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Sellers J. R., 1999, MYOSINS; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835	30	141	148	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1315	1322		10.1086/375122	http://dx.doi.org/10.1086/375122			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12687499	Green Published, Bronze			2022-12-18	WOS:000182474400025
J	Baser, ME; Friedman, JM; Aeschliman, D; Joe, H; Wallace, AJ; Ramsden, RT; Evans, DGR				Baser, ME; Friedman, JM; Aeschliman, D; Joe, H; Wallace, AJ; Ramsden, RT; Evans, DGR			Predictors of the risk of mortality in neurofibromatosis 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	49th Annual Meeting of the American-Society-of-Human-Genetics	OCT 19-23, 1999	SAN FRANCISCO, CALIFORNIA	Amer Soc Human Genet			GERM-LINE MUTATIONS; TYPE-2 NEUROFIBROMATOSIS; NF2 GENE; PHENOTYPIC VARIABILITY; TUMOR-SUPPRESSOR; LEARNING-CURVE; DISEASE; SEVERITY; SURGERY; IDENTIFICATION	To evaluate clinical and molecular predictors of the risk of mortality in people with neurofibromatosis 2 (NF2), we analyzed the mortality experience of 368 patients from 261 families in the United Kingdom NF2 registry, using the Cox proportional-hazards model and the jackknife method. Age at diagnosis, intracranial meningiomas, and type of treatment center were informative predictors of the risk of mortality. In Cox models, the relative risk of mortality increased 1.13-fold per year decrease in age at diagnosis (95% confidence interval [CI] 1.08-1.18) and was 2.51-fold greater in people with meningiomas compared with those without meningiomas (95% CI 1.38-4.57). The relative risk of mortality in patients treated at specialty centers was 0.34 compared with those treated at nonspecialty centers (95% CI 0.12-0.98). In a separate model, the relative risk of mortality in people with constitutional NF2 missense mutations was very low compared with those with other types of mutations (nonsense or frameshift mutations, splice-site mutations, and large deletions), but the Cl could not be well quantified because there was only one death among people with missense mutations. We conclude that age at diagnosis, the strongest single predictor of the risk of mortality, is a useful index for patient counseling and clinical management (as are intracranial meningiomas). To ensure optimal care, we recommend that people with NF2 be referred to specialty treatment centers.	Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Univ British Columbia, Dept Biostat, Vancouver, BC, Canada; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Manchester Royal Infirm, Dept Otolaryngol, Manchester M13 9WL, Lancs, England	University of British Columbia; University of British Columbia; University of Manchester; University of Manchester	Baser, ME (corresponding author), 2257 Fox Hills Dr, Los Angeles, CA 90064 USA.		Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784; Friedman, Jan/0000-0002-7482-9570				Antinheimo J, 2000, NEUROLOGY, V54, P71, DOI 10.1212/WNL.54.1.71; Baser ME, 1996, AM J MED GENET, V64, P563, DOI 10.1002/(SICI)1096-8628(19960906)64:4<563::AID-AJMG7>3.3.CO;2-0; Baser ME, 2002, J NEUROSURG, V96, P217, DOI 10.3171/jns.2002.96.2.0217; Baser ME, 1999, AM J HUM GENET, V65, pA61; Bruder CEG, 1999, HUM GENET, V104, P418, DOI 10.1007/s004390050978; Bruder CEG, 1999, GENE CHROMOSOME CANC, V25, P184, DOI 10.1002/(SICI)1098-2264(199906)25:2<184::AID-GCC15>3.0.CO;2-B; Buchman CA, 1996, LARYNGOSCOPE, V106, P1406, DOI 10.1097/00005537-199611000-00019; CHARABI S, 1992, ACTA OTO-LARYNGOL, V112, P810, DOI 10.3109/00016489209137478; Evans DA, 1998, KLUW S INF, V2, P63; EVANS DGR, 1993, J LARYNGOL OTOL, V107, P401, DOI 10.1017/S002221510012328X; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; Evans DGR, 1998, J MED GENET, V35, P450, DOI 10.1136/jmg.35.6.450; EVANS DGR, 1992, Q J MED, V84, P603; Evans DGR, 2000, J MED GENET, V37, P897, DOI 10.1136/jmg.37.12.897; Gutmann DH, 1998, HUM MOL GENET, V7, P335, DOI 10.1093/hmg/7.3.335; Jackler RK, 1998, AM J OTOL, V19, P691; Kino T, 2001, GENES CELLS, V6, P441, DOI 10.1046/j.1365-2443.2001.00432.x; Kluwe L, 1998, AM J MED GENET, V77, P228, DOI 10.1002/(SICI)1096-8628(19980518)77:3<228::AID-AJMG8>3.3.CO;2-1; Kluwe L, 1996, HUM GENET, V98, P534, DOI 10.1007/s004390050255; Kluwe L, 1998, HUM MOL GENET, V7, P2051, DOI 10.1093/hmg/7.13.2051; MacCollin M, 1998, Semin Pediatr Neurol, V5, P243, DOI 10.1016/S1071-9091(98)80003-X; MAUTNER VF, 1993, NEUROSURGERY, V33, P92; MAUTNER VF, 1995, AM J ROENTGENOL, V165, P951, DOI 10.2214/ajr.165.4.7676998; Mautner VF, 2002, J NEUROSURG, V96, P223, DOI 10.3171/jns.2002.96.2.0223; Mautner VF, 1996, NEUROSURGERY, V38, P880, DOI 10.1097/00006123-199605000-00004; McCarthy BJ, 1998, J NEUROSURG, V88, P831, DOI 10.3171/jns.1998.88.5.0831; MEREL P, 1995, GENE CHROMOSOME CANC, V12, P117, DOI 10.1002/gcc.2870120206; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; NAROD SA, 1992, AM J HUM GENET, V51, P486; PARRY DM, 1994, AM J MED GENET, V52, P450, DOI 10.1002/ajmg.1320520411; Parry DM, 1996, AM J HUM GENET, V59, P529; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Ruttledge MH, 1996, AM J HUM GENET, V59, P331; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; VENABLES WN, 1997, MODERN APPL STAT S P; Welling DB, 1999, AM J OTOL, V20, P644; Zucman-Rossi J, 1998, HUM MOL GENET, V7, P2095, DOI 10.1093/hmg/7.13.2095	38	141	149	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					715	723		10.1086/342716	http://dx.doi.org/10.1086/342716			9	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12235555	Green Published, Bronze			2022-12-18	WOS:000178613800002
J	Chen, YS; Olckers, A; Schurr, TG; Kogelnik, AM; Huoponen, K; Wallace, DC				Chen, YS; Olckers, A; Schurr, TG; Kogelnik, AM; Huoponen, K; Wallace, DC			mtDNA variation in the South African Kung and Khwe - and their genetic relationships to other African populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; ENDONUCLEASE CLEAVAGE PATTERNS; CONTROL-REGION SEQUENCE; ANALYSIS REVEALS; POLYMORPHISMS; ORIGIN; ANCIENT; HAPLOGROUPS; MIGRATIONS; EVOLUTION	The mtDNA variation of 74 Khoisan-speaking individuals (Kung and Khwe) from Schmidtsdrift, in the Northern Cape Province of South Africa, was examined by high-resolution RFLP analysis and control region (CR) sequencing. The resulting data were combined with published RFLP haplotype and CR sequence data from sub-Saharan African populations and then were subjected to phylogenetic analysis to deduce the evolutionary relationships among them. More than 77% of the Kung and Khwe mtDNA samples were found to belong to the major mtDNA lineage, macrohaplogroup L* (defined by a HpaI site at nucleotide position 3592), which is prevalent in sub-Saharan African populations. Additional sets of RFLPs subdivided macrohaplogroup L* into two extended haplogroups-L1 and L2-both of which appeared in the Kung and Khwe. Besides revealing the significant substructure of macrohaplogroup L* in African populations, these data showed that the Biaka Pygmies have one of the most ancient RFLP sublineages observed in African mtDNA and, thus, that they could represent one of the oldest human populations. In addition, the Kung exhibited a set of related haplotypes that were positioned closest to the root of the human mtDNA phylogeny, suggesting that they, too, represent one of the most ancient African populations. Comparison of Kung and Khwe CR sequences with those from other African populations confirmed the genetic association of the Kung with other Khoisan-speaking peoples, whereas the Khwe were more closely linked to non-Khoisan-speaking (Bantu) populations. Finally, the overall sequence divergence of 214 African RFLP haplotypes defined in both this and an earlier study was 0.364%, giving an estimated age, for all African mtDNAs, of 125,500-165,500 years before the present, a dare that is concordant with all previous estimates derived from mtDNA and other genetic data, for the time of origin of modern humans in Africa.	Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; Georgia Inst Technol, Coll Comp, Biomed Engn Program, Atlanta, GA 30332 USA; Univ Pretoria, Dept Human Genet, ZA-0002 Pretoria, South Africa	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; University of Pretoria	Wallace, DC (corresponding author), Emory Univ, Sch Med, Ctr Mol Med, 1462 Clifton Rd NE, Atlanta, GA 30322 USA.		Olckers, Antonel/AAW-8903-2020; Schurr, Theodore G/A-1336-2007	Olckers, Antonel/0000-0002-4974-5666; 	NCRR NIH HHS [MO1-RR-00039, M01 RR000039] Funding Source: Medline; NIA NIH HHS [R01 AG013154, AG13154] Funding Source: Medline; NINDS NIH HHS [R01 NS021328, NS 21328] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; BALLINGER SW, 1992, GENETICS, V130, P139; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHEN YS, 1995, AM J HUM GENET, V57, P133; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; DELAMEIDA A, 1965, BUSHMEN OTHER NONBAN; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; GREENBERG JH, 1963, LANGUAGES AFRICA; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HORAI S, 1990, AM J HUM GENET, V46, P828; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; NEI M, 1983, GENETICS, V105, P207; NURSE GT, 1977, HUM HERED, V27, P81, DOI 10.1159/000152855; NURSE GT, 1985, RES MONOGRAPHS HUMAN, V3; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; RITTE U, 1993, HUM BIOL, V65, P359; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; SCOZZARI R, 1994, HUM BIOL, V66, P1; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SOODYALL H, 1993, ANN HUM BIOL, V20, P477, DOI 10.1080/03014469300002872; Soodyall H, 1996, AM J HUM GENET, V58, P595; SOODYALL H, 1993, THESIS U WITWATERSAN; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; SWOFFORD DL, 1994, PHYLOGENETIC ANAL US; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VIGILANT L, 1990, THESIS U CALIFORNIA; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	46	141	151	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1362	1383		10.1086/302848	http://dx.doi.org/10.1086/302848			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739760	Bronze, Green Published			2022-12-18	WOS:000088373400018
J	Sirianni, N; Naidu, S; Pereira, J; Fernando, R; Hoffman, EP				Sirianni, N; Naidu, S; Pereira, J; Fernando, R; Hoffman, EP			Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CHROMOSOME INACTIVATION; LINKAGE ANALYSIS; MAP		Johns Hopkins Med Inst, Kennedy Krieger Inst Neurol, Baltimore, MD 21205 USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA USA; Hosp Gen do Portao, Curitiba, Parana, Brazil; Univ Fed Parana, Med Genet Unit, Clin Hosp, BR-80060000 Curitiba, Parana, Brazil	Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade Federal do Parana	Naidu, S (corresponding author), Johns Hopkins Med Inst, Kennedy Krieger Inst Neurol, 707 N Broadway,5th Floor Tower, Baltimore, MD 21205 USA.			Hoffman, Eric/0000-0001-6470-5139	NIGMS NIH HHS [GM08540] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ELLISON KA, 1992, AM J HUM GENET, V50, P278; FAIN PR, 1995, NAT GENET, V9, P261, DOI 10.1038/ng0395-261; Hoffman EP, 1996, AM J MED GENET, V63, P573, DOI 10.1002/(SICI)1096-8628(19960628)63:4<573::AID-AJMG11>3.0.CO;2-F; KOYBAYASHI H, 1995, HUM GENET, V95, P483; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Naidu S, 1997, ANN NEUROL, V42, P3, DOI 10.1002/ana.410420104; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Schanen NC, 1997, AM J HUM GENET, V61, P634, DOI 10.1086/515525; Xiang FQ, 1998, J MED GENET, V35, P297, DOI 10.1136/jmg.35.4.297; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X	12	141	145	0	8	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1552	1558		10.1086/302105	http://dx.doi.org/10.1086/302105			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792883	Green Published, Bronze			2022-12-18	WOS:000076985200033
J	Naumova, AK; Plenge, RM; Bird, LM; Leppert, M; Morgan, K; Willard, HF; Sapienza, C				Naumova, AK; Plenge, RM; Bird, LM; Leppert, M; Morgan, K; Willard, HF; Sapienza, C			Heritability of X chromosome-inactivation phenotype in a large family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNBALANCED INACTIVATION; EXPRESSION; MOUSE; GENE; MUTATIONS; MEMBRANES; DELETION; REPEATS; DISEASE; FEMALES	One of the two X chromosomes in each somatic cell of normal human females becomes inactivated very early in embryonic development. Although the inactivation of an X chromosome in any particular somatic cell of the embryonic lineage is thought to be a stochastic and epigenetic event, a strong genetic influence on this process has been described in the mouse. We have attempted to uncover evidence for genetic control of X-chromosome inactivation in the human by examining X chromosome-inactivation patterns in 255 females from 36 three-generation pedigrees, to determine whether this quantitative character exhibits evidence of heritability. We have found one family in which all seven daughters of one male and the mother of this male have highly skewed patterns of X-chromosome inactivation, suggesting strongly that this quantitative character is controlled by one or more X-linked genes in some families.	TEMPLE UNIV,SCH MED,FELS INST CANC RES & MOL BIOL,PHILADELPHIA,PA 19140; TEMPLE UNIV,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19140; CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV CLEVELAND HOSP,CLEVELAND,OH 44106; CHILDRENS HOSP & HLTH CTR,SAN DIEGO,CA; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA; MONTREAL GEN HOSP,RES INST,MONTREAL,PQ H3G 1A4,CANADA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Case Western Reserve University; Case Western Reserve University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; McGill University; McGill University; McGill University			Bird, Lynne/AAG-9533-2021	Bird, Lynne/0000-0003-4833-3747; Naumova, Anna K./0000-0001-8481-5765				ALLEN RC, 1994, AM J HUM GENET, V54, P25; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ARIEL M, 1995, NAT GENET, V9, P312, DOI 10.1038/ng0395-312; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BROWN RM, 1993, J MED GENET, V30, P177, DOI 10.1136/jmg.30.3.177; Cattanach B. M., 1991, Mouse Genome, V89, P565; CATTANACH BM, 1972, GENET RES, V19, P229, DOI 10.1017/S001667230001449X; CHOMCZYNSKI P, 1989, CINNA BIOTECX B, V3; CLARKE JTR, 1991, AM J HUM GENET, V49, P289; CLARKE JTR, 1992, AM J HUM GENET, V51, P316; CLARKE JTR, 1993, AM J HUM GENET, V52, P433; DAHL N, 1995, AM J HUM GENET, V56, P1108; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FAIN PR, 1995, NAT GENET, V9, P261, DOI 10.1038/ng0395-261; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; HARRISON KB, 1986, CYTOGENET CELL GENET, V41, P163, DOI 10.1159/000132221; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; HEARD E, 1994, HUM MOL GENET, V3, P1481, DOI 10.1093/hmg/3.suppl_1.1481; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEISTI JT, 1975, AM J HUM GENET, V27, P441; LYON MF, 1988, AM J HUM GENET, V42, P8; MATTEI MG, 1981, HUM GENET, V56, P401, DOI 10.1007/BF00274702; MIGEON BR, 1993, AM J HUM GENET, V52, P431; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; NAUMOVA AK, 1995, DEV GENET, V17, P198, DOI 10.1002/dvg.1020170304; ORSTAVIK RE, 1995, AM J MED GENET, V56, P210; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; PUCK JM, 1992, AM J HUM GENET, V50, P742; ROPERS HH, 1978, HUM GENET, V43, P265, DOI 10.1007/BF00278833; Rupert JL, 1995, EUR J HUM GENET, V3, P333; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; SCHMIDT M, 1992, AM J MED GENET, V42, P161, DOI 10.1002/ajmg.1320420205; SCHMIDT M, 1990, HUM GENET, V84, P347, DOI 10.1007/BF00196232; SIMMLER MC, 1993, MAMM GENOME, V4, P523, DOI 10.1007/BF00364788; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; WENGLER G, 1995, BLOOD, V85, P2471, DOI 10.1182/blood.V85.9.2471.bloodjournal8592471; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; WEST JD, 1978, GENET RES, V32, P91, DOI 10.1017/S0016672300018565; Willard H, 1995, METABOLIC MOL BASES, P719; ZABEL BU, 1978, AM J MED GENET, V1, P309, DOI 10.1002/ajmg.1320010307; ZUCCOTTI M, 1995, NAT GENET, V9, P316, DOI 10.1038/ng0395-316	48	141	142	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1111	1119						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651287				2022-12-18	WOS:A1996UM27100003
J	MOUNTAIN, JL; HEBERT, JM; BHATTACHARYYA, S; UNDERHILL, PA; OTTOLENGHI, C; GADGIL, M; CAVALLISFORZA, LL				MOUNTAIN, JL; HEBERT, JM; BHATTACHARYYA, S; UNDERHILL, PA; OTTOLENGHI, C; GADGIL, M; CAVALLISFORZA, LL			DEMOGRAPHIC HISTORY OF INDIA AND MTDNA-SEQUENCE DIVERSITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; NUCLEOTIDE-SEQUENCES; POPULATIONS; EVOLUTION; INHERITANCE	The demographic history of India was examined by comparing mtDNA sequences obtained from members of three culturally divergent Indian subpopulations (endogamous caste groups). While an inferred tree revealed some clustering according to caste affiliation, there was no clear separation into three genetically distinct groups along caste lines. Comparison of pairwise nucleotide difference distributions, however, did indicate a difference in growth patterns between two of the castes. The Brahmin population appears to have undergone either a rapid expansion or steady growth. The low-ranking Mukri caste, however, may have either maintained a roughly constant population size or undergone multiple bottlenecks during that period. Comparison of the Indian sequences to those obtained from other populations, using a tree, revealed that the Indian sequences, along with ah other non-African samples, form a starlike cluster. This cluster may represent a major expansion, possibly originating in southern Asia, taking place at some point after modern humans initially left Africa.	STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; INDIAN INST SCI,CTR ECOL SCI,BANGALORE 560012,KARNATAKA,INDIA	Stanford University; Indian Institute of Science (IISC) - Bangalore			Ottolenghi, Chris/H-3745-2017	Ottolenghi, Chris/0000-0002-0734-344X	NIGMS NIH HHS [GM 28428] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AQUADRO CF, 1983, GENETICS, V103, P287; AVISE JC, 1984, J MOL EVOL, V20, P99, DOI 10.1007/BF02257369; BALLINGER SW, 1992, GENETICS, V130, P139; BAMSHAD M, 1994, AM J PHS ANTHR S, V18, P53; BHATTACHARYYA S, 1993, THESIS INDIAN I SCI; BRAUER G, 1989, HUMAN REVOLUTION, P123; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CLARK JD, 1989, HUMAN REVOLUTION, P565; DAQUILA RT, 1991, NUCLEIC ACIDS RES, V19, P3749, DOI 10.1093/nar/19.13.3749; Efron B, 1982, JACKKNIFE BOOTSTRAP; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gadgil M., 1989, Common property resources. Ecology and community-based sustainable development., P240; Gadgil Madhav, 1993, FISSURED LAND ECOLOG; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Goudet J., 2001, CLADISTICS; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Hartl D. L., 1989, PRINCIPLES POPULATIO; Herre W, 1977, ORIGINS AGR, P245; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; HOEH WR, 1991, SCIENCE, V251, P1488, DOI 10.1126/science.1672472; JHA DN, 1974, INDIAN SC HIST PROBI; JOSHI NV, 1993, CURR SCI INDIA, V64, P10; KARVE I, 1968, CURR ANTHROPOL, V9, P109, DOI 10.1086/200976; Karve Irawati Karmarkar, 1961, HINDU SOC INTERPRETA; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klein RG, 1989, HUMAN CAREER HUMAN B; KLEIN RG, 1994, ORIGINS ANATOMICALLY, P3; LUM JK, 1994, HUM BIOL, V66, P567; Malhotra KC, 1984, PEOPLE S ASIA, P295; Nei M., 1987, MOL EVOLUTIONARY GEN; PIAZZA A, 1981, BIOMETRICS, V37, P635, DOI 10.2307/2530147; POWELL BHB, 1896, INDIAN VILLAGE COMMU; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROGERS AR, IN PRESS EVOLUTION; ROYCHOUDHURY AK, 1984, PEOPLE S ASIA BIOL A, P283; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SLATKIN M, 1991, GENETICS, V129, P555; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; VIDYARTHI LP, 1983, PEOPLES INDIA SOME G, P85; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Wolfram S., 1988, MATH SYSTEM DOING MA	50	141	145	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					979	992						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717409				2022-12-18	WOS:A1995QP66300020
J	MCCONKIEROSELL, A; LACHIEWICZ, AM; SPIRIDIGLIOZZI, GA; TARLETON, J; SCHOENWALD, S; PHELAN, MC; GOONEWARDENA, P; DING, XH; BROWN, WT				MCCONKIEROSELL, A; LACHIEWICZ, AM; SPIRIDIGLIOZZI, GA; TARLETON, J; SCHOENWALD, S; PHELAN, MC; GOONEWARDENA, P; DING, XH; BROWN, WT			EVIDENCE THAT METHYLATION OF THE FMR-I LOCUS IS RESPONSIBLE FOR VARIABLE PHENOTYPIC-EXPRESSION OF THE FRAGILE-X SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; HUMAN-CHROMOSOMES; CPG ISLAND; DNA; SITE; INSTABILITY; GENE; MECHANISM; REPEAT; MALES	DNA at the FMR-1 locus was analyzed by Southern blot using probe StB12.3 in an unusual fragile X family with six brothers, three of whom are affected with fragile X to varying degrees, two of whom are nonpenetrant carriers, and one of whom is unaffected. Fragile X chromosome studies, detailed physical examinations, and psychological testing were completed on all six. Two of the affected brothers and the two nonpenetrant brothers were found to be methylation mosaics. The three affected males spanned the phenotypic and cognitive spectrum of the fragile X syndrome. A correlation was seen between the degree of methylation and the phenotypic expression identified in the three affected males. The two males initially classified as nonpenetrant were found to have mild phenotypic expression which consisted of minor cognitive deficits and a partial physical phenotype. These two, who were negative on fragile X chromosome studies, were found on DNA analysis to have large broad smears, with approximately 97% of the DNA unmethylated. The results described here indicate that some ''nonpenetrant'' carrier males may have varying amounts of methylation of the FMR-1 region, which can result in mild expression of the fragile X syndrome. The apparently mild phenotypic and cognitive expression of the fragile X syndrome in the two males, initially classified as nonpenetrant, who are mosaic for hypermethylation of an expansion of the CGG repeat in the premutation range, indicates that expression of the syndrome is not confined to males with large, hypermethylated expansions (full mutation) but has instead a gradient effect with a threshold for the full expression of the phenotype.	GREENWOOD GENET CTR,GREENWOOD,SC 29646; KAISER PERMANENTE,DEPT GENET,SAN JOSE,CA; NEW YORK STATE INST BASIC RES DEV DISABIL,STATEN ISL,NY 10314	Greenwood Genetic Center; Kaiser Permanente; Institute for Basic Research in Developmental Disabilities	MCCONKIEROSELL, A (corresponding author), DUKE UNIV,MED CTR,DEPT PEDIAT,BOX 3028,DURHAM,NC 27710, USA.		Brown, William/GXN-2777-2022		PHS HHS [MCJ360587] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; Brown W T, 1992, Mol Genet Med, V2, P39; BROWN WT, 1991, AM J MED GENET, V38, P292, DOI 10.1002/ajmg.1320380226; CHUDLEY AE, 1987, AM J MED GENET, V28, P13, DOI 10.1002/ajmg.1320280103; CIANCHETTI C, 1991, AM J MED GENET, V40, P234, DOI 10.1002/ajmg.1320400222; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GLOVER TW, 1981, AM J HUM GENET, V33, P234; Goodman R.M., 1983, MALFORMED INFANT CHI; HAGERMAN R, 1985, AM J DIS CHILD, V139, P674, DOI 10.1001/archpedi.1985.02140090036021; Hagerman R J, 1987, Curr Probl Pediatr, V17, P621; Hagerman R. J., 1991, FRAGILE X SYNDROME D, P173; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; HOWARDPEEBLES PN, 1980, AM J MED GENET, V7, P497, DOI 10.1002/ajmg.1320070410; KEMPER MB, 1988, AM J MED GENET, V30, P191, DOI 10.1002/ajmg.1320300118; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LAIRD CD, 1987, GENETICS, V117, P587; LOESCH DZ, 1988, J MED GENET, V25, P407, DOI 10.1136/jmg.25.6.407; LOESCH DZ, 1987, AM J MED GENET, V27, P401, DOI 10.1002/ajmg.1320270219; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; PLOMIN R, 1980, INTELLIGENCE, V4, P15, DOI 10.1016/0160-2896(80)90003-3; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SEABRIGH.M, 1971, LANCET, V2, P971; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; Sparrow SS, 1984, VINELAND ADAPTIVE BE; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; VEENEMA H, 1987, J MED GENET, V24, P32, DOI 10.1136/jmg.24.1.32; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; WOHRLE D, 1992, AM J HUM GENET, V51, P299; WOLFF G, 1978, AM J MED GENET, V2, P217, DOI 10.1002/ajmg.1320020302; WOODCOCK RW, 1989, WOODCOCKJOHNSON PSYC; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; ZACHMANN M, 1974, HELV PAEDIATR ACTA, V29, P61; [No title captured]	41	141	142	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					800	809						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213810				2022-12-18	WOS:A1993LY62700002
J	CASSIDY, SB; LAI, LW; ERICKSON, RP; MAGNUSON, L; THOMAS, E; GENDRON, R; HERRMANN, J				CASSIDY, SB; LAI, LW; ERICKSON, RP; MAGNUSON, L; THOMAS, E; GENDRON, R; HERRMANN, J			TRISOMY-15 WITH LOSS OF THE PATERNAL-15 AS A CAUSE OF PRADER-WILLI SYNDROME DUE TO MATERNAL DISOMY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNIPARENTAL DISOMY; PARENTAL ORIGIN; CHROMOSOME-15 DELETION; ANGELMAN SYNDROME; RECURRENCE RISK; POLYMORPHISMS; ISODISOMY; LOCUS; 15Q	Uniparental disomy has recently been recognized to cause human disorders, including Prader-Willi syndrome (PWS). We describe a particularly instructive case which raises important issues concerning the mechanisms producing uniparental disomy and whose evaluation provides evidence that trisomy may precede uniparental disomy in a fetus. Chorionic villus sampling performed for advanced maternal age revealed trisomy 15 in all direct and cultured cells, though the fetus appeared normal. Chromosome analysis of amniocytes obtained at 15 wk was normal in over 100 cells studied. The child was hypotonic at birth, and high-resolution banding failed to reveal the deletion of 15q11-13, a deletion which is found in 50%-70% of patients with PWS. Over time, typical features of PWS developed. Molecular genetic analysis using probes for chromosome 15 revealed maternal disomy. Maternal nondisjunction with fertilization of a disomic egg by a normal sperm, followed by loss of the paternal 15, is a likely cause of confined placental mosaicism and uniparental disomy in this case of PWS, and advanced maternal age may be a predisposing factor.	UNIV ARIZONA,COLL MED,STEELE MEM CHILDRENS RES CTR,DEPT PEDIAT,TUCSON,AZ 85724; GREAT LAKES GENET,MILWAUKEE,WI; GREAT LAKES GENET,KINGSPORT,TN	University of Arizona	CASSIDY, SB (corresponding author), UNIV ARIZONA,COLL MED,GENET DYSMORPHOL SECT,TUCSON,AZ 85724, USA.							ANVRET M, 1992, AM J MED GENET, V42, P256; ARMOUR JAL, 1990, GENOMICS, V8, P501, DOI 10.1016/0888-7543(90)90037-U; BUTLER MG, 1983, LANCET, V1, P1285; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CASSIDY SB, 1987, AM J MED GENET, V28, P59, DOI 10.1002/ajmg.1320280109; CASSIDY SB, 1992, AM J MED GENET, V42, P220, DOI 10.1002/ajmg.1320420221; CLARREN SK, 1977, AM J DIS CHILD, V131, P798, DOI 10.1001/archpedi.1977.02120200080018; COX NJ, 1988, AM J HUM GENET, V43, P954; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P6964; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FRANCOMANO CA, 1991, HUM GENET, V87, P162, DOI 10.1007/BF00204174; HALL JG, 1990, AM J HUM GENET, V46, P857; HASSOLD T, 1984, AM J HUM GENET, V36, P1349; HULTEN M, 1991, LANCET, V338, P638, DOI 10.1016/0140-6736(91)90652-6; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEDBETTER DH, 1988, PRADERWILLI SYNDROME, P13; LUBINSKY M, 1987, AM J MED GENET, V28, P37, DOI 10.1002/ajmg.1320280106; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; Maniatis T., 1982, MOL CLONING; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P10073, DOI 10.1093/nar/15.23.10073; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NICHOLLS RD, 1992, NATO ASI SER, V61, P41; PURVISSMITH SG, 1992, AM J HUM GENET, V50, P1348; RICH DC, 1988, NUCLEIC ACIDS RES, V16, P8740, DOI 10.1093/nar/16.17.8740; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROGAN PK, 1991, AM J HUM GENET S, V49, pA287; SIMONI G, 1983, HUM GENET, V63, P349, DOI 10.1007/BF00274761; SMEETS DFC, 1992, NATO ASI SER, V61, P95; SPENCE JE, 1988, AM J HUM GENET, V42, P217; WARBURTON D, 1991, CHROMOSOME ANOMALIES, P57; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2835; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308	39	141	141	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					701	708						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1357962				2022-12-18	WOS:A1992JQ66700002
J	FARRER, LA; GRUNDFAST, KM; AMOS, J; ARNOS, KS; ASHER, JH; BEIGHTON, P; DIEHL, SR; FEX, J; FOY, C; FRIEDMAN, TB; GREENBERG, J; HOTH, C; MARAZITA, M; MILUNSKY, A; MORELL, R; NANCE, W; NEWTON, V; RAMESAR, R; SANAGUSTIN, TB; SKARE, J; STEVENS, CA; WAGNER, RG; WILCOX, ER; WINSHIP, I; READ, AP				FARRER, LA; GRUNDFAST, KM; AMOS, J; ARNOS, KS; ASHER, JH; BEIGHTON, P; DIEHL, SR; FEX, J; FOY, C; FRIEDMAN, TB; GREENBERG, J; HOTH, C; MARAZITA, M; MILUNSKY, A; MORELL, R; NANCE, W; NEWTON, V; RAMESAR, R; SANAGUSTIN, TB; SKARE, J; STEVENS, CA; WAGNER, RG; WILCOX, ER; WINSHIP, I; READ, AP			WAARDENBURG SYNDROME (WS) TYPE-I IS CAUSED BY DEFECTS AT MULTIPLE LOCI, ONE OF WHICH IS NEAR ALPP ON CHROMOSOME-2 - 1ST REPORT OF THE WS CONSORTIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGMENT LENGTH POLYMORPHISMS; ALKALINE-PHOSPHATASE GENE; LINKAGE ANALYSIS; HIRSCHSPRUNG MEGACOLON; DISEASE; HETEROGENEITY; HUMANS; RFLP; MAP; STRATEGIES	Previous studies have localized the gene for Waardenburg syndrome (WS) type I to the distal portion of chromosome 2q, near the ALPP locus. We pooled linkage data obtained from 41 WS type I and 3 WS type II families which were typed for six polymorphic loci on chromosome 2q in order to refine the location of the WS locus (WS1) and evaluate the extent of genetic heterogeneity. In the course of this work, we developed diagnostic criteria for genetic and phenotypic studies. Our findings, based on two-locus and multilocus analysis using a linkage map established from reference pedigrees, suggest that there are two or more mutations causing WS, one of which (i.e., WS1) is located on chromosome 2q, between the ALPP and FN1 loci, at distances of 7.8 cM and 11.2 cM for each marker, respectively. The results also indicate that WS1 is responsible for the illness in approximately 45% of all families in this sample. However, the odds favoring this position over a location between ALPP and SAG are only 2:1 when alternate assumptions about the proportion of linked families are considered. We conclude that a more saturated map of this region of chromosome 2q, including highly polymorphic markers, will be needed to accurately distinguish linked families and, ultimately, isolate the mutant gene.	BOSTON UNIV,SCH PUBL HLTH,BOSTON,MA 02215; NATL INST DEAFNESS & OTHER COMMUNICAT DISORDERS,MOLEC CYTOL LAB,BETHESDA,MD; GALLAUDET UNIV,WASHINGTON,DC; MICHIGAN STATE UNIV,DEPT ZOOL,E LANSING,MI 48824; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHIAT,RICHMOND,VA 23298; BOSTON UNIV,CTR HUMAN GENET,BOSTON,MA 02215; MICHIGAN STATE UNIV,GENET GRAD PROGRAM,E LANSING,MI 48824; UNIV CAPE TOWN,DEPT HUMAN GENET,CAPE TOWN,SOUTH AFRICA; UNIV MANCHESTER,DEPT MED GENET,MANCHESTER M13 9PL,LANCS,ENGLAND; UNIV MANCHESTER,CTR AUDIOL,MANCHESTER M13 9PL,LANCS,ENGLAND	Boston University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Michigan State University; Virginia Commonwealth University; Virginia Commonwealth University; Boston University; Michigan State University; University of Cape Town; University of Manchester; University of Manchester	FARRER, LA (corresponding author), BOSTON UNIV,SCH MED,DEPT NEUROL,80 E CONCORD ST,BOSTON,MA 02118, USA.		Ramesar, Raj S/I-6941-2015; Winship, Ingrid M/D-7204-2016; Morell, Robert James/Q-2042-2019; Farrer, Lindsay/AAS-1035-2020	Ramesar, Raj S/0000-0001-5688-1634; Milunsky, Aubrey/0000-0003-2114-4823; Winship, Ingrid/0000-0001-8535-6003; Farrer, Lindsay/0000-0001-5533-4225; Morell, Robert/0000-0003-1537-7356	NIDCD NIH HHS [DC00038] Funding Source: Medline; NIMHD NIH HHS [263-MD-117512] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		AMBANI LM, 1983, J PEDIATR-US, V102, P802, DOI 10.1016/S0022-3476(83)80267-4; ARIAS S, 1978, J GENET HUM, V26, P103; ARIAS S, 1971, Birth Defects Original Article Series, V7, P87; ASHER JH, 1990, J MED GENET, V27, P618, DOI 10.1136/jmg.27.10.618; ASHER JH, 1991, AM J HUM GENET, V48, P43; BADNER JA, 1990, AM J MED GENET, V35, P100, DOI 10.1002/ajmg.1320350119; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; COLOMBI M, 1988, NUCLEIC ACIDS RES, V16, P9074, DOI 10.1093/nar/16.18.9074; COLOMBI M, 1987, NUCLEIC ACIDS RES, V16, P6761; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COTTERMAN CW, 1951, AM J HUM GENET, V3, P254; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FARRER LA, 1986, AM J HUM GENET, V39, P146; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOY C, 1990, AM J HUM GENET, V46, P1017; GARDELLA R, 1988, NUCLEIC ACIDS RES, V16, P1651, DOI 10.1093/nar/16.4.1651; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; GOODMAN RM, 1982, AM J MED GENET, V11, P425, DOI 10.1002/ajmg.1320110407; HAGEMAN MJ, 1977, AM J HUM GENET, V29, P468; ISHIKIRIYAMA S, 1989, AM J MED GENET, V33, P505, DOI 10.1002/ajmg.1320330419; KELLEY RI, 1981, AM J HUM GENET, V33, pA65; KLEIN D, 1983, AM J MED GENET, V14, P231, DOI 10.1002/ajmg.1320140205; KUMLINWOLFF E, 1987, NUCLEIC ACIDS RES, V15, P10076, DOI 10.1093/nar/15.23.10076; LALOUEL JM, 1985, AM J HUM GENET, V37, P700; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LANGE K, 1983, HUM HERED, V33, P291, DOI 10.1159/000153393; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MARTIN D, 1987, NUCLEIC ACIDS RES, V15, P9104, DOI 10.1093/nar/15.21.9104; MARTIN D, 1987, ANN HUM GENET, V51, P145, DOI 10.1111/j.1469-1809.1987.tb01056.x; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MEAKIN SO, 1985, MOL CELL BIOL, V5, P1408, DOI 10.1128/MCB.5.6.1408; MEIRE F, 1987, AM J MED GENET, V27, P683, DOI 10.1002/ajmg.1320270322; MORTON NE, 1956, AM J HUM GENET, V8, P80; OCONNELL P, 1989, GENOMICS, V5, P738, DOI 10.1016/0888-7543(89)90115-8; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; OMOTADE OO, 1990, J MED GENET, V27, P358, DOI 10.1136/jmg.27.6.358; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L; PAKSTIS AJ, IN PRESS CYTOGENET C; PARTINGTON MW, 1964, CAN MED ASSOC J, V90, P1008; RINGENS PJ, 1990, INVEST OPHTH VIS SCI, V31, P1421; RISCH N, 1988, AM J HUM GENET, V42, P353; SELLARS S, 1983, J LARYNGOL OTOL, V97, P885, DOI 10.1017/S0022215100095736; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SU Y, 1991, THESIS VIRGINIA COMM; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WINSHIP I, IN PRESS CLIN GENET	55	141	166	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					902	913						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1349198				2022-12-18	WOS:A1992HR47300004
J	SPRITZ, RA; GIEBEL, LB; HOLMES, SA				SPRITZ, RA; GIEBEL, LB; HOLMES, SA			DOMINANT NEGATIVE AND LOSS OF FUNCTION MUTATIONS OF THE C-KIT (MAST STEM-CELL GROWTH-FACTOR RECEPTOR) PROTOONCOGENE IN HUMAN PIEBALDISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERSTITIAL DELETION; TYROSINE KINASE; RETARDED-CHILD; SI-LOCUS; W-LOCUS; LIGAND; TRAIT; MOUSE; GENE; DNA	Piebaldism is an autosomal dominant disorder of melanocyte development and is characterized by congenital white patches of skin and hair from which melanocytes are completely absent. A similar disorder of the mouse, "dominant white spotting" (W), results from mutations of the c-kit proto-oncogene, which encodes the cellular tyrosine kinase receptor for the mast/stem cell growth factor. We have identified c-kit gene mutations in three patients with piebaldism. A missense substitution (Phe --> Leu) at codon 584, within the tyrosine kinase domain, is associated with a severe piebald phenotype, whereas two different frameshifts, within codons 561 and 642, are both associated with a variable and relatively mild piebald phenotype. This is consistent with a possible "dominant negative" effect of missense c-kit polypeptides on the function of the dimeric receptor.	UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	SPRITZ, RA (corresponding author), UNIV WISCONSIN,DEPT MED GENET,GENET LAB 317,445 HENRY MALL,MADISON,WI 53706, USA.				NIAMS NIH HHS [AR 39892] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BREATHNACH AS, 1965, J INVEST DERMATOL, V45, P28, DOI 10.1038/jid.1965.87; COOKE JV, 1952, J PEDIATR-US, V41, P1, DOI 10.1016/S0022-3476(52)80022-8; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FROGGAT P, 1951, IRISH J MED SCI, V398, P86; FUNDERBURK SJ, 1974, AM J HUM GENET, V26, P715; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; HAYASHI SI, 1991, NUCLEIC ACIDS RES, V19, P1267, DOI 10.1093/nar/19.6.1267; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HOO JJ, 1986, HUM GENET, V73, P230, DOI 10.1007/BF00401233; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; HULTEN MA, 1987, J MED GENET, V24, P568, DOI 10.1136/jmg.24.9.568; JIMBOW K, 1975, J INVEST DERMATOL, V64, P50, DOI 10.1111/1523-1747.ep12540914; Keeler CE, 1934, J AMER MED ASSOC, V103, P0179, DOI 10.1001/jama.1934.72750290001009; KOGAN SC, 1990, PCR PROTOCOLS, P288; LACASSIE Y, 1977, AM J HUM GENET, V29, P641; LUCIAN, 1905, WORKS LUCIAN SAMOSAT, V1; Lyon M., 1989, GENETIC VARIANTS STR; MAHAKRISHNAN A, 1980, ARCH DERMATOL, V116, P1102, DOI 10.1001/archderm.1980.01640340012007; MORGAN J, 1786, T AM PHILOS SOC PHIL, V2, P392; Muller H.J, 1932, P 6 INT C GEN, V1, P213; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; OTT J, 1974, AM J HUM GENET, V26, P588; PAWSON T, 1990, TRENDS GENET, V6, P350, DOI 10.1016/0168-9525(90)90276-C; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Selmanowitz V J, 1977, J Dermatol Surg Oncol, V3, P615; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; YAMAMOTO Y, 1989, AM J MED GENET, V32, P520, DOI 10.1002/ajmg.1320320419; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	35	141	152	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					261	269						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1370874				2022-12-18	WOS:A1992HD00100002
J	ZOGHBI, HY; JODICE, C; SANDKUIJL, LA; KWIATKOWSKI, TJ; MCCALL, AE; HUNTOON, SA; LULLI, P; SPADARO, M; LITT, M; CANN, HM; FRONTALI, M; TERRENATO, L				ZOGHBI, HY; JODICE, C; SANDKUIJL, LA; KWIATKOWSKI, TJ; MCCALL, AE; HUNTOON, SA; LULLI, P; SPADARO, M; LITT, M; CANN, HM; FRONTALI, M; TERRENATO, L			THE GENE FOR AUTOSOMAL DOMINANT SPINOCEREBELLAR ATAXIA (SCAI) MAPS TELOMERIC TO THE HLA COMPLEX AND IS CLOSELY LINKED TO THE D6S89-LOCUS IN 3 LARGE KINDREDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; HEREDITARY ATAXIA; CHROMOSOME-6; LOCUS; POLYMORPHISM; ONSET; AGE	We studied three large kindreds with the HLA-linked form of spinocerebellar ataxia (SCA1) in order to localize the SCA1 locus on the short arm of chromosome 6 (6p). Two loci containing highly informative dinucleotide repeat sequences were used for linkage analysis. These two loci are D6S89, which is telomeric to the HLA region, and T complex-associated testes-expressed 1 (TCTE1), centromeric to HLA. Pairwise linkage analysis of SCA1 and D6S89 revealed a maximum lod score of 5.86 in the Houston SCA1 (HSCA1) kindred and of 8.08 in the Calabrian SCA1 (SCA1) kindreds, at recombination fractions of .050 and .022, respectively. A maximum pairwise lod score of 4.54 at a recombination frequency of .100 was obtained for SCA1 and TCTE1 in the HSCA1 kindred. No evidence for linkage was detected between TCTE1 and SCA1 in the CSCA1 kindreds. Multilocus linkage analysis of SCA1, HLA, and D6S89 in all three kindreds provided strong evidence for localization of the SCA1 locus telomeric to the HLA regions. However, multilocus linkage analysis of SCA1, HLA, and TCTE1 with HSCA1 family genotypes indicated the possibility of a location of the SCA1 locus centromeric to HLA. An analysis of HSCA1 recombinants in this region of chromosome 6 revealed relatively high recombination frequencies between HLA and each of the other two markers and relatively low frequencies between the latter and SCA1, predicting that the SCA1 locus would tend to segregate away from HLA together with D6S89 or TCTE1, as found with the three-point linkage analyses for this family. The results of the pairwise linkage analysis in HSCA1 and CSCA1 and of multilocus linkage analysis in the Calabrian kindreds support a single SCA1 locus telomeric to the HLA region on 6p.	BAYLOR UNIV, INST MOLEC GENET, HOUSTON, TX 77030 USA; TOR VERGATA UNIV, DIPARTIMENTO BIOL, ROME, ITALY; UNIV ROME LA SAPIENZA, DIPARTIMENTO MED SPERIMENTALE, I-00185 ROME, ITALY; UNIV ROME LA SAPIENZA, IST CLIN MALATTIE NERVOSE & MENTALI, I-00185 ROME, ITALY; CNR, IST MED SPERIMENTALE, ROME, ITALY; ACAD HOSP ROTTERDAM DIJKZIGT, DEPT CLIN GENET, ROTTERDAM, NETHERLANDS; OREGON HLTH SCI UNIV, DEPT BIOCHEM & MOLEC GENET, PORTLAND, OR 97201 USA; CTR ETUD POLYMORPHISME HUMAIN, PARIS, FRANCE	Baylor College of Medicine; Baylor University; University of Rome Tor Vergata; Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Erasmus University Rotterdam; Erasmus MC; Oregon Health & Science University	ZOGHBI, HY (corresponding author), BAYLOR UNIV, DEPT PEDIAT, HOUSTON, TX 77030 USA.			iodice, carla/0000-0002-1549-5005; Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER; NICHD NIH HHS [K11 HD00684] Funding Source: Medline; NINDS NIH HHS [R01 NS27699] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAUR MP, 1990, HISTOCOMPATIBILITY T, P994; BIBBINS KB, 1989, GENOMICS, V5, P139, DOI 10.1016/0888-7543(89)90098-0; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; CURRIER RD, 1972, NEUROLOGY, V22, P1040, DOI 10.1212/WNL.22.9.1040; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; FRONTALI M, 1991, ANN HUM GENET, V55, P7, DOI 10.1111/j.1469-1809.1991.tb00393.x; Greenfield JG, 1954, SPINOCEREBELLAR DEGE; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KOEPPEN AH, 1984, OLIVOPONTOCEREBELLAR, P13; KWIATKOWSKI TJ, IN PRESS GENOMICS; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; PEDERSEN L, 1980, HUM GENET, V54, P371, DOI 10.1007/BF00291585; PIAZZA A, 1982, RES CLIN LAB, P1; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RICH SS, 1987, AM J HUM GENET, V41, P524; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; SPADARO M, UNPUB HLA LINKED SPI; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609	26	141	142	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					23	30						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063871				2022-12-18	WOS:A1991FW51100004
J	GERMAN, J; SCHONBERG, S; LOUIE, E; CHAGANTI, RSK				GERMAN, J; SCHONBERG, S; LOUIE, E; CHAGANTI, RSK			BLOOMS SYNDROME .4. SISTER-CHROMATID EXCHANGES IN LYMPHOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK BLOOD CTR,NEW YORK,NY 10021	New York Blood Center								BARTRAM CR, 1976, ANN HUM GENET, V40, P79, DOI 10.1111/j.1469-1809.1976.tb00166.x; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; GERMAN J, 1969, AM J HUM GENET, V21, P196; GERMAN J, 1974, CHROMOSOMA, V48, P361, DOI 10.1007/BF00290993; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GERMAN J, 1974, CHROMOSOMES CANCER, P601; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; MARSH W L, 1975, Transfusion (Bethesda), V15, P589; NICHOLS WW, 1975, HEREDITAS, V81, P225; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; RUTTEN FJ, 1976, EXCERPTA MEDICA  397, P97; SHIRAISHI Y, 1976, CYTOGENET CELL GENET, V17, P162, DOI 10.1159/000130710; SPERLING K, 1976, HUM GENET, V31, P47, DOI 10.1007/BF00270398	13	141	142	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	3					248	255						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG794	868871				2022-12-18	WOS:A1977DG79400004
J	ALLDERDICE, PW; DAVIS, JG; MILLER, OJ; KLINGER, HP; WARBURTON, D; MILLER, DA; ALLEN, FH; ABRAMS, CAL; MCGILVRAY, E				ALLDERDICE, PW; DAVIS, JG; MILLER, OJ; KLINGER, HP; WARBURTON, D; MILLER, DA; ALLEN, FH; ABRAMS, CAL; MCGILVRAY, E			13Q- DELETION SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAMS MS, 1965, LANCET, V2, P494; BAIN AD, 1963, LANCET, V2, P304; BLOOM GE, 1967, SCIENCE, V156, P1746, DOI 10.1126/science.156.3783.1746; GERALD PS, 1967, J PEDIATR-US, V70, P172, DOI 10.1016/S0022-3476(67)80411-6; GEY W, 1967, MAMMALIAN CHROMOSOME, V8, P267; GIANNELLI F, 1966, CYTOGENETICS, V5, P186, DOI 10.1159/000129897; HOLLOWELL JG, 1967, SOUTH MED J, V60, P1355; JACOBSEN P, 1966, HEREDITAS-GENETISK A, V55, P188; LAURENT C, 1967, ANN GENET-PARIS, V10, P25; LEJEUNE J, 1968, ANN GENET-PARIS, V11, P79; LELE KP, 1963, ANN HUM GENET, V27, P171, DOI 10.1111/j.1469-1809.1963.tb00209.x; LEWIS KB, 1965, J AMER MED ASSOC, V193, P1080, DOI 10.1001/jama.193.13.1080; MCDONALD R, 1960, ARCH DIS CHILD, V35, P367, DOI 10.1136/adc.35.182.367; MIKEL'SAAR A. V. N., 1967, GENETIKA, V4, P142; REISMAN LE, 1965, LANCET, V2, P445; SCHMID W, 1965, HUMAN CHROMOSOME MET; SPARKES RS, 1967, AM J HUM GENET, V19, P644; TAYLOR A I, 1968, Journal of Medical Genetics, V5, P227, DOI 10.1136/jmg.5.3.227; TEPLITZ RL, 1967, J PEDIATR-US, V70, P936, DOI 10.1016/S0022-3476(67)80266-X; THOMPSON H, 1965, HUM CHROMOSOME NEWSL, P21; WANG HC, 1962, NATURE, V195, P733, DOI 10.1038/195733a0; ZETTERQVIST P, 1963, ACTA PAEDIATR, V52, P115, DOI 10.1111/j.1651-2227.1963.tb04085.x	22	141	147	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	5					499	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7549	5347076				2022-12-18	WOS:A1969E754900008
J	SCHULL, WJ				SCHULL, WJ			EMPIRICAL RISKS IN CONSANGUINEOUS MARRIAGES - SEX RATIO, MALFORMATION, AND VIABILITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AOYAMA M, 1948, NIHON KAZOKU SEIDO N; BEARDSLEY RK, VILLAGE JAPAN STUDY; Embree John F., 1939, SUYE MURA JAPANESE V; HALDANE JBS, 1950, ANN EUGENIC, V15, P15, DOI 10.1111/j.1469-1809.1949.tb02418.x; HOZUMI S, 1933, SHINZOKU HO; ICHIBA M, 1953, NIHON IKA DAIGAKU ZA, V20, P916; ICHIBA M, 1954, NIHON IKA DAIGAKU ZA, V21, P113; ICHIBA M, 1953, NIHON IKA DAIGAKU ZA, V20, P798; ICHIBA M, 1954, NIHON IKA DAIGAKU ZA, V21, P119; IKEMI T, 1936, IKAI JIHO, P2188; KANOKOGI T, 1952, TAISHITSU IGAKU KENK, V2, P214; KANOKOGI T, 1952, TAISHITSU IGAKU KENK, V2, P221; KIDA F, 1949, TAISHITSU IGAKU KENK, V3, P135; KOMAI T, 1957, EUGEN QUART, V4, P99, DOI 10.1080/19485565.1957.9987314; KROOTH RS, 1957, AM J HUM GENET, V9, P170; KUBOTA Y, 1950, MINZOKU EISEI, V17, P114; MACKLIN MT, 1952, AM J HUM GENET, V4, P14; MARUYAMA M, 1935, MINZOKU EISEI, V4, P54; MILLIS J, 1954, ANN HUM GENET, V19, P58, DOI 10.1111/j.1469-1809.1954.tb01263.x; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MORTON NE, 1955, ANN HUM GENET, V20, P125; MORTON NE, 1955, ANN HUM GENET, V20, P116; MURDOCH J, 1926, HISTORY JAPAN; NAGASHIMA T, 1949, MINZOKU EISEI, V16, P76; NAKAGAWA Z, 1953, CHUSHAKU SHINZOKU HO; NEEL JV, 1956, 461 NAT AC SCI NAT R; NEEL JV, AM J HUMAN GENET; OKAZAKI A, 1941, KEKKON TO JINKO; ROBSON EB, 1955, ANN HUM GENET, V19, P262, DOI 10.1111/j.1469-1809.1955.tb01352.x; ROY SN, 1956, BIOMETRIKA, V43, P361; ROY SN, 1956, ANN MATH STAT, V27, P749, DOI 10.1214/aoms/1177728181; Schull WJ, 1953, AM ANTHROPOL, V55, P74, DOI 10.1525/aa.1953.55.1.02a00060; SCHULL WJ, PEDIATRICS; SHINOZAKI N, 1955, JINKO MONDAI KENKYUS, P102; SHINOZAKI N, 1951, JINKO MONDAI KENKYUS, V7, P105; SHINOZAKI N, 1951, JINKO MONDAI KENKYUS, V7, P52; SHIROYAMA E, 1953, TAISHITSU IGAKU KENK, V3, P462; SHIROYAMA E, 1953, TAISHITSU IGAKU KENK, V3, P465; SLATIS HM, 1954, AM J HUM GENET, V6, P412; STEINER C, 1950, FAR EASTERN Q, V9, P169; Sutter J, 1953, POPULATION, V8, P511, DOI 10.2307/1525212; Sutter J, 1954, POPULATION, V9, P425, DOI 10.2307/1524555; Sutter J, 1952, POPULATION, V7, P249, DOI 10.2307/1524207; TANAKA K, 1955, POPULATION, V9, P12; TANAKA Y, 1952, POPULATION, V6, P8; TANIGUCHI T, 1951, POPULATION, V5, P419; YANASE T, 1949, POPULATION, V3, P132; YANASE T, 1951, IGAKU KENKYU, V21, P183; YERUSHALMY J., 1938, AMER JOUR HYG, V28, P244; Yerushalmy J., 1945, HUMAN BIOL, V17, P65	50	141	141	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1958	10	3					294	343						50	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA220	13571221				2022-12-18	WOS:A1958WA22000005
J	Mancuso, N; Shi, H; Goddard, P; Kichaev, G; Gusev, A; Pasaniuc, B				Mancuso, Nicholas; Shi, Huwenbo; Goddard, Page; Kichaev, Gleb; Gusev, Alexander; Pasaniuc, Bogdan			Integrating Gene Expression with Summary Association Statistics to Identify Genes Associated with 30 Complex Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; MENDELIAN RANDOMIZATION; EDUCATIONAL-ATTAINMENT; CARDIOVASCULAR RISK; COMMON VARIANTS; HUMAN HEIGHT; FINNISH MEN; YOUNG FINNS; DISEASE	Although genome-wide association studies (GWASs) have identified thousands of risk loci for many complex traits and diseases, the causal variants and genes at these loci remain largely unknown. Here, we introduce a method for estimating the local genetic correlation between gene expression and a complex trait and utilize it to estimate the genetic correlation due to predicted expression between pairs of traits. We integrated gene expression measurements from 45 expression panels with summary GWAS data to perform 30 multi-tissue transcriptome-wide association studies (TWASs). We identified 1,196 genes whose expression is associated with these traits; of these, 168 reside more than 0.5 Mb away from any previously reported GWAS significant variant. We then used our approach to find 43 pairs of traits with significant genetic correlation at the level of predicted expression; of these, eight were not found through genetic correlation at the SNP level. Finally, we used bi-directional regression to find evidence that BMI causally influences triglyceride levels and that triglyceride levels causally influence low-density lipoprotein. Together, our results provide insight into the role of gene expression in the susceptibility of complex traits and diseases.	[Mancuso, Nicholas; Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Shi, Huwenbo; Kichaev, Gleb; Pasaniuc, Bogdan] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA; [Goddard, Page] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [Gusev, Alexander] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Gusev, Alexander] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Gusev, Alexander] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mancuso, N; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA.	nmancuso@mednet.ucla.edu; bpasaniuc@mednet.ucla.edu	Mancuso, Nicholas/GLQ-8627-2022	Pasaniuc, Bogdan/0000-0002-0227-2056	Biomedical Big Data Training Program [NIH-NCI T32CA201160]; Takeda Pharmaceuticals; F. Hoffman-La Roche; NIH [GM105857, GM053275, HG009120, R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, MH06692]; NATIONAL CANCER INSTITUTE [T32CA201160] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105857, R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, P50MH084053, R01MH075916, R01MH085542, R01MH097276, R01MH093725, P50MH066392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138, P01AG002219] Funding Source: NIH RePORTER	Biomedical Big Data Training Program; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); F. Hoffman-La Roche; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Valerie Arboleda, Robert Brown, Kathy Burch, and Malika Kumar for helpful discussions and feedback. We also thank Dr. Nicole Soranzo for sharing summary data for the platelet traits. This research was funded in part by NIH awards GM105857, GM053275, and HG009120. G.K. is supported by the Biomedical Big Data Training Program (NIH-NCI T32CA201160). CMC data were generated as part of the CommonMind Consortium, supported by funding from Takeda Pharmaceuticals, F. Hoffman-La Roche, and NIH grants R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, and MH06692. Brain tissue for the study was obtained from the following brain bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimer Disease Core Center, the University of Pittsburgh NeuroBioBank and Brain and Tissue Repositories, and the National Institute of Mental Health (NIMH) Human Brain Collection Core. CommonMind Consortium leadership includes Pamela Sklar, Joseph Buxbaum (Icahn School of Medicine at Mount Sinai), Bernie Devlin, David Lewis (University of Pittsburgh), Raquel Gur, Chang-Gyu Hahn (University of Pennsylvania), Keisuke Hirai, Hiroyoshi Toyoshiba (Takeda Pharmaceuticals), Enrico Domenici, Laurent Essioux (F. Hoffman-La Roche), Lara Mangravite, Mette Peters (Sage Bionetworks), Thomas Lehner, Barbara Lipska (NIMH).	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fall T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001474; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Gusev A., 2016, BIORXIV; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Gutierrez-Arcelus M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004958; Hosokawa Y, 1999, GENOMICS, V61, P326, DOI 10.1006/geno.1999.5949; Kennedy JM, 2014, J EXP MED, V211, P2519, DOI 10.1084/jem.20140455; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nuotio J, 2014, SCAND J PUBLIC HEALT, V42, P563, DOI 10.1177/1403494814541597; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pavlides JMW, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0338-4; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pickrell J., 2015, BIORXIV; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shi H., 2016, BIORXIV; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Stancakova A, 2012, DIABETES, V61, P1895, DOI 10.2337/db11-1378; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Wang JB, 2016, AM J HUM GENET, V98, P697, DOI 10.1016/j.ajhg.2016.02.020; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.1093/biomet/34.1-2.28; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	63	140	141	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					473	487		10.1016/j.ajhg.2017.01.031	http://dx.doi.org/10.1016/j.ajhg.2017.01.031			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28238358	Green Published, Bronze			2022-12-18	WOS:000395851900013
J	Sanna-Cherchi, S; Kiryluk, K; Burgess, KE; Bodria, M; Sampson, MG; Hadley, D; Nees, SN; Verbitsky, M; Perry, BJ; Sterken, R; Lozanovski, VJ; Materna-Kiryluk, A; Barlassina, C; Kini, A; Corbani, V; Carrea, A; Somenzi, D; Murtas, C; Ristoska-Bojkovska, N; Izzi, C; Bianco, B; Zaniew, M; Flogelova, H; Weng, PL; Kacak, N; Giberti, S; Gigante, M; Arapovic, A; Drnasin, K; Caridi, G; Curioni, S; Allegri, F; Ammenti, A; Ferrettio, S; Goj, V; Bernardo, L; Jobanputra, V; Chung, WK; Lifton, RP; Sanders, S; State, M; Clark, LN; Saraga, M; Padmanabhan, S; Dominiczak, AF; Foroud, T; Gesualdo, L; Gucev, Z; Allegri, L; Latos-Bielenska, A; Cusi, D; Scolari, F; Tasic, V; Hakonarson, H; Ghiggeri, GM; Gharavi, AG				Sanna-Cherchi, Simone; Kiryluk, Krzysztof; Burgess, Katelyn E.; Bodria, Monica; Sampson, Matthew G.; Hadley, Dexter; Nees, Shannon N.; Verbitsky, Miguel; Perry, Brittany J.; Sterken, Roel; Lozanovski, Vladimir J.; Materna-Kiryluk, Anna; Barlassina, Cristina; Kini, Akshata; Corbani, Valentina; Carrea, Alba; Somenzi, Danio; Murtas, Corrado; Ristoska-Bojkovska, Nadica; Izzi, Claudia; Bianco, Beatrice; Zaniew, Marcin; Flogelova, Hana; Weng, Patricia L.; Kacak, Nilgun; Giberti, Stefania; Gigante, Maddalena; Arapovic, Adela; Drnasin, Kristina; Caridi, Gianluca; Curioni, Simona; Allegri, Franca; Ammenti, Anita; Ferrettio, Stefania; Goj, Vinicio; Bernardo, Luca; Jobanputra, Vaidehi; Chung, Wendy K.; Lifton, Richard P.; Sanders, Stephan; State, Matthew; Clark, Lorraine N.; Saraga, Marijan; Padmanabhan, Sandosh; Dominiczak, Anna F.; Foroud, Tatiana; Gesualdo, Loreto; Gucev, Zoran; Allegri, Landino; Latos-Bielenska, Anna; Cusi, Daniele; Scolari, Francesco; Tasic, Velibor; Hakonarson, Hakon; Ghiggeri, Gian Marco; Gharavi, Ali G.			Copy-Number Disorders Are a Common Cause of Congenital Kidney Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOMIC REARRANGEMENTS; RENAL HYPODYSPLASIA; MUTATIONS; ANOMALIES; ABNORMALITIES; DUPLICATIONS; CHILDREN; AUTISM; MODEL; 17Q12	We examined the burden of large, rare, copy-number variants (CNVs) in 192 individuals with renal hypodysplasia (RHD) and replicated findings in 330 RHD cases from two independent cohorts. CNV distribution was significantly skewed toward larger gene-disrupting events in RHD cases compared to 4,733 ethnicity-matched controls (p = 4.8 x 10(-11)). This excess was attributable to known and novel (i.e., not present in any database or in the literature) genomic disorders. All together, 55/522 (10.5%) RHD cases harbored 34 distinct known genomic disorders, which were detected in only 0.2% of 13,839 population controls (p = 1.2 x 10(-58)). Another 32 (6.1%) RHD cases harbored large gene-disrupting CNVs that were absent from or extremely rare in the 13,839 population controls, identifying 38 potential novel or rare genomic disorders for this trait. Deletions at the HNF1B locus and the DiGeorge/velocardiofacial locus were most frequent. However, the majority of disorders were detected in a single individual. Genomic disorders were detected in 22.5% of individuals with multiple malformations and 14.5% of individuals with isolated urinary-tract defects; 14 individuals harbored two or more diagnostic or rare CNVs. Strikingly, the majority of the known CNV disorders detected in the RHD cohort have previous associations with developmental delay or neuropsychiatric diseases. Up to 16.6% of individuals with kidney malformations had a molecular diagnosis attributable to a copy-number disorder, suggesting kidney malformations as a sentinel manifestation of pathogenic genomic imbalances. A search for pathogenic CNVs should be considered in this population for the diagnosis of their specific genomic disorders and for the evaluation of the potential for developmental delay.	[Sanna-Cherchi, Simone; Kiryluk, Krzysztof; Burgess, Katelyn E.; Nees, Shannon N.; Verbitsky, Miguel; Perry, Brittany J.; Sterken, Roel; Weng, Patricia L.; Kacak, Nilgun; Gharavi, Ali G.] Columbia Univ, Div Nephrol, New York, NY 10023 USA; [Sanna-Cherchi, Simone] St Lukes Roosevelt Hosp, Dept Internal Med, New York, NY 10019 USA; [Bodria, Monica; Carrea, Alba; Murtas, Corrado; Caridi, Gianluca; Ghiggeri, Gian Marco] G Gaslini Inst Children, Div Nephrol Dialysis & Transplantat, I-16147 Genoa, Italy; [Hadley, Dexter; Kini, Akshata; Hakonarson, Hakon] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Sampson, Matthew G.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Lozanovski, Vladimir J.; Ristoska-Bojkovska, Nadica; Gucev, Zoran] Univ Childrens Hosp, Div Pediat Nephrol, Skopje 1000, Macedonia; [Materna-Kiryluk, Anna; Latos-Bielenska, Anna] Polish Registry Congenital Malformat, PL-60352 Poznan, Poland; [Barlassina, Cristina; Curioni, Simona; Cusi, Daniele] San Paolo Hosp, Div Nephrol, I-20142 Milan, Italy; [Barlassina, Cristina] Univ Milan, Dept Med Surg & Dent, I-20142 Milan, Italy; [Corbani, Valentina] St Andrea Hosp, SC Nephrol & Dialysis, I-19100 La Spezia, Italy; [Somenzi, Danio; Bianco, Beatrice; Giberti, Stefania; Allegri, Landino] Univ Parma, Dept Clin Med Nephrol & Hlth Sci, I-43100 Parma, Italy; [Izzi, Claudia; Scolari, Francesco] Univ Brescia, Chair Nephrol, I-25018 Montichiari, Italy; [Izzi, Claudia; Scolari, Francesco] Montichiari Hosp, Div Nephrol, I-25018 Montichiari, Italy; [Zaniew, Marcin] Dist Children Hosp, Dept Pediat Nephrol & Toxicol, PL-70111 Szczecin, Poland; [Flogelova, Hana] Palacky Univ, Fac Med, Olomouc 77200, Czech Republic; [Gigante, Maddalena; Gesualdo, Loreto] Univ Foggia, Dept Biomed Sci, I-71100 Foggia, Italy; [Arapovic, Adela; Saraga, Marijan] Univ Hosp Split, Dept Pediat, Split 21000, Croatia; [Drnasin, Kristina] Pediat Outpatient Clin, Solin 21210, Croatia; [Allegri, Franca] Univ Parma, Dept Clin Sci, I-43100 Parma, Italy; [Ammenti, Anita] Univ Parma, Dept Pediat, I-43100 Parma, Italy; [Ferrettio, Stefania] Parma Univ Hosp, Div Urol, I-43100 Parma, Italy; [Goj, Vinicio; Bernardo, Luca] Fatebenefratelli Hosp, SC Pediat, I-21121 Milan, Italy; [Jobanputra, Vaidehi] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Div Clin Genet, Dept Pediat, New York, NY 10032 USA; [Lifton, Richard P.; Sanders, Stephan; State, Matthew] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Clark, Lorraine N.] Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Saraga, Marijan] Univ Split, Sch Med, Split 21000, Croatia; [Padmanabhan, Sandosh; Dominiczak, Anna F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Foroud, Tatiana] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Pennsylvania; University of Pennsylvania; San Paolo-Polo Universitaria Hospital; University of Milan; University of Parma; University of Brescia; Palacky University Olomouc; University of Foggia; University of Split; University of Parma; University of Parma; University of Parma; University Hospital of Parma; Columbia University; Columbia University; Yale University; University of Split; University of Glasgow; Indiana University System; Indiana University Bloomington	Gharavi, AG (corresponding author), Columbia Univ, Div Nephrol, New York, NY 10023 USA.	ag2239@columbia.edu	Padmanabhan, Sandosh/S-3963-2016; Izzi, Claudia/GZG-8769-2022; Murtas, Corrado/N-4981-2019; bodria, monica/K-2115-2016; scolari, francesco/AAC-5957-2022; Lozanovski, Vladimir J/AAP-9781-2020; Caridi, Gianluca/F-7052-2010; Arapovic, Adela/D-7022-2017; State, Matthew/W-2256-2019; Saraga, Marijan/E-7647-2017; Dominiczak, Anna F/P-9390-2017; Ghiggeri, Gian Marco/N-4712-2015; Tasic, Velibor/H-8714-2019; Sanders, Stephan/S-8645-2019; Hadley, Dexter/ABB-7568-2021; Gigante, Maddalena/R-4369-2016; Izzi, Claudia/AAB-7004-2022; Gesualdo, Loreto/K-7751-2016; Sampson, Matthew/U-4501-2017	Murtas, Corrado/0000-0001-7801-6596; bodria, monica/0000-0001-9690-9945; Lozanovski, Vladimir J/0000-0002-7332-3973; Caridi, Gianluca/0000-0001-6700-3001; Dominiczak, Anna F/0000-0003-4913-3608; Ghiggeri, Gian Marco/0000-0003-3659-9062; Tasic, Velibor/0000-0002-3377-1245; Hadley, Dexter/0000-0003-0990-4674; Gigante, Maddalena/0000-0001-8228-7639; Gesualdo, Loreto/0000-0002-4861-0911; Barlassina, Cristina/0000-0001-7407-2697; Padmanabhan, Sandosh/0000-0003-3869-5808; Sanders, Stephan/0000-0001-9112-5148; Scolari, Francesco/0000-0003-0233-9705; Izzi, Claudia/0000-0001-6253-3185; Nees, Shannon/0000-0003-4046-3942; Arapovic, Adela/0000-0002-2462-039X; State, Matthew/0000-0003-1624-8302; Sampson, Matthew/0000-0001-9560-076X; Ferretti, Stefania/0000-0002-2292-5632	Italian Telethon Foundation [GGP08050]; American Heart Association [0930151N]; American Society of Nephrology (ASN); National Institute of Diabetes and Digestive and Kidney Diseases [K23-DK090207]; Fondazione Malattie Renali nel Bambino; ASN; Doris Duke Charitable Foundation; Polish Ministry of Health.; National Institutes of Health [NS050487, NS060113]; Parkinson's Disease Foundation; British Heart Foundation (BHF) Chair [CH/98001]; BHF program [RG/07/005/23633]; BHF Special Project [SP/08/005/25115]; European Community;  [1R01DK080099]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080099, K23DK090207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS050487, R01NS060113] Funding Source: NIH RePORTER	Italian Telethon Foundation(Fondazione Telethon); American Heart Association(American Heart Association); American Society of Nephrology (ASN); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fondazione Malattie Renali nel Bambino; ASN; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Polish Ministry of Health.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; British Heart Foundation (BHF) Chair(British Heart Foundation); BHF program; BHF Special Project; European Community(European Commission); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all patients and family members for their participation. This study was supported by 1R01DK080099 (A.G.G.) and Italian Telethon Foundation grant GGP08050 (G.M.G.). S.S.C. is supported by American Heart Association grant 0930151N and the American Society of Nephrology (ASN) Carl W. Gottschalk Research Scholar Grant. K.K. is supported by National Institute of Diabetes and Digestive and Kidney Diseases K23-DK090207. G.M.G. is supported by the Fondazione Malattie Renali nel Bambino. S.N.N. is supported by the ASN and Doris Duke Charitable Foundation. A.M.K., A.L.B., and The Polish Registry of Congenital Malformations are supported by the Polish Ministry of Health. We thank the HYPERGENES Consortium (HEALTH-F4-2007-201550; INTEROMICS: MIUR-CNR Italian Flagship Project) for sharing genotyping data. L.N.C. is supported by National Institutes of Health grants NS050487 and NS060113 and the Parkinson's Disease Foundation. The Glasgow-Malmo Hypertension study was funded by the British Heart Foundation (BHF) Chair CH/98001 (A.F.D.), the BHF program RG/07/005/23633 (A.F.D. and S.P.), the BHF Special Project grant SP/08/005/25115 (A.F.D. and S.P.), and the European Community Framework 6 Network of Excellence InGenious HyperCare. The Children's Hospital of Philadelphia (CHOP) Control Copy Number Variation dataset was supplied by the Center for Applied Genomics at CHOP through dbGaP accession number phs000199.v1.p1. The Genetic Consortium for Late Onset Alzheimer's Disease was provided through the Division of Neuroscience at the National Institute on Aging through dbGaP accession number phs000168.v1.p1. This study used DECHIPER-generated data, provided by the Wellcome Trust. A full list of contributing centers is available at http://decipher.sanger.ac.uk or by email to decipher@sanger.ac.uk.	[Anonymous], 1993, TERATOLOGY, V48, P658; Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Ashraf S, 2010, NEPHROL DIAL TRANSPL, V25, P1496, DOI 10.1093/ndt/gfp650; Bingham C, 2004, NEPHROL DIAL TRANSPL, V19, P2703, DOI 10.1093/ndt/gfh348; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Burtey Stephane, 2008, Nat Clin Pract Nephrol, V4, pE1, DOI 10.1038/ncpneph0906; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P918; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Eccles MR, 1999, CLIN GENET, V56, P1, DOI 10.1034/j.1399-0004.1999.560101.x; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Galasso C, 2008, J CHILD NEUROL, V23, P802, DOI 10.1177/0883073808314150; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; LIVERA LN, 1989, BRIT MED J, V298, P1421, DOI 10.1136/bmj.298.6685.1421; Loane M, 2011, BIRTH DEFECTS RES A, V91, pS31, DOI 10.1002/bdra.20778; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Nagamani SCS, 2010, EUR J HUM GENET, V18, P278, DOI 10.1038/ejhg.2009.174; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sanna-Cherchi S, 2007, AM J HUM GENET, V80, P539, DOI 10.1086/512248; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; SHPRINTZEN RJ, 1994, J MED GENET, V31, P423, DOI 10.1136/jmg.31.5.423-b; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Thomas R, 2011, PEDIATR NEPHROL, V26, P897, DOI 10.1007/s00467-011-1826-9; Ulinski T, 2006, J AM SOC NEPHROL, V17, P497, DOI 10.1681/ASN.2005101040; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Weng PL, 2009, J AM SOC NEPHROL, V20, P1633, DOI 10.1681/ASN.2008111199	36	140	150	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					987	997		10.1016/j.ajhg.2012.10.007	http://dx.doi.org/10.1016/j.ajhg.2012.10.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23159250	Green Published, Bronze			2022-12-18	WOS:000312417400002
J	Stuiver, M; Lainez, S; Will, C; Terryn, S; Gunzel, D; Debaix, H; Sommer, K; Kopplin, K; Thumfart, J; Kampik, NB; Querfeld, U; Willnow, TE; Nemec, V; Wagner, CA; Hoenderop, JG; Devuyst, O; Knoers, NVAM; Bindels, RJ; Meij, IC; Muller, D				Stuiver, Marchel; Lainez, Sergio; Will, Constanze; Terryn, Sara; Guenzel, Dorothee; Debaix, Huguette; Sommer, Kerstin; Kopplin, Kathrin; Thumfart, Julia; Kampik, Nicole B.; Querfeld, Uwe; Willnow, Thomas E.; Nemec, Vladimir; Wagner, Carsten A.; Hoenderop, Joost G.; Devuyst, Olivier; Knoers, Nine V. A. M.; Bindels, Rene J.; Meij, Iwan C.; Mueller, Dominik			CNNM2, Encoding a Basolateral Protein Required for Renal Mg2+ Handling, Is Mutated in Dominant Hypomagnesemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISTAL CONVOLUTED TUBULE; THICK ASCENDING LIMB; CONE-ROD DYSTROPHY; MAGNESIUM TRANSPORT; GENE FAMILY; AMELOGENESIS IMPERFECTA; SECONDARY HYPOCALCEMIA; MOLECULAR-CLONING; MUTATIONS; EXPRESSION	Familial hypomagnesemia is a rare human disorder caused by renal or intestinal magnesium (Mg2+) wasting, which may lead to symptoms of Mg2+ depletion such as tetany, seizures, and cardiac arrhythmias. Our knowledge of the physiology of Mg2+ (re)absorption, particularly the luminal uptake of Mg2+ along the nephron, has benefitted from positional cloning approaches in families with Mg2+ reabsorption disorders; however, basolateral Mg2+ transport and its regulation are still poorly understood. Here, by using a candidate screening approach, we identified CNNM2 as a gene involved in renal Mg2+ handling in patients of two unrelated families with unexplained dominant hypomagnesemia. In the kidney, CNNM2 was predominantly found along the basolateral membrane of distal tubular segments involved in Mg2+ reabsorption. The basolateral localization of endogenous and recombinant CNNM2 was confirmed in epithelial kidney cell lines. Electrophysiological analysis showed that CNNM2 mediated Mg2+-sensitive Na+ currents that were significantly diminished in mutant protein and were blocked by increased extracellular Mg2+ concentrations. Our data support the findings of a recent genome-wide association study showing the CNNM2 locus to be associated with serum me, concentrations. The mutations found in CNNM2, its observed sensitivity to extracellular Mg2+, and its basolateral localization signify a critical role for CNNM2 in epithelial Mg2+ transport.	[Stuiver, Marchel; Will, Constanze; Sommer, Kerstin; Kopplin, Kathrin; Thumfart, Julia; Querfeld, Uwe; Mueller, Dominik] Charite, Dept Pediat Nephrol, D-13353 Berlin, Germany; [Stuiver, Marchel; Will, Constanze; Sommer, Kerstin; Kopplin, Kathrin; Thumfart, Julia; Querfeld, Uwe; Mueller, Dominik] Charite, Cardiovasc Res Ctr, D-10115 Berlin, Germany; [Lainez, Sergio; Hoenderop, Joost G.; Bindels, Rene J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Terryn, Sara; Debaix, Huguette; Devuyst, Olivier] Catholic Univ Louvain, Sch Med, Div Nephrol, B-1200 Brussels, Belgium; [Guenzel, Dorothee] Charite, Inst Clin Physiol, D-12200 Berlin, Germany; [Kampik, Nicole B.; Wagner, Carsten A.; Devuyst, Olivier] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Kampik, Nicole B.; Wagner, Carsten A.; Devuyst, Olivier] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Willnow, Thomas E.; Meij, Iwan C.] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Nemec, Vladimir] Pardubice Reg Hosp, Dept Pediat, Pardubice 53203, Czech Republic; [Knoers, Nine V. A. M.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Radboud University Nijmegen; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Utrecht University; Utrecht University Medical Center	Muller, D (corresponding author), Charite, Dept Pediat Nephrol, D-13353 Berlin, Germany.	dominik.mueller@charite.de	Thumfart, Julia/T-7828-2017; Hoenderop, Joost G.J./H-8047-2014; Querfeld, Uwe/AAF-6330-2020; Bindels, René JM/B-9824-2013	Thumfart, Julia/0000-0003-1162-5295; Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; Willnow, Thomas/0000-0001-9515-7921; Kampik Kijewski, Nicole Beate/0000-0002-2278-5940; Devuyst, Olivier/0000-0003-3744-4767; Gunzel, Dorothee/0000-0002-7998-7164; Stuiver, Marchel/0000-0003-3437-4468; Querfeld, Uwe/0000-0001-6783-3822	European Community [EUNEFRON 201590]; Deutsche Forschungsgemeinschaft [DFG FOR721]; Fonds National de la Recherche Scientifique; Fonds de la Recherche Scientifique Medicale; Fondation Alphonse and Jean Forton; Concerted Research Action [10/15-029]; Interuniversity Attraction Pole [IUAP P6/05]; Communaute Francaise de Belgique; Swiss National Science Foundation [3100A0-122217]; Netherlands Organization for Scientific Research [ZonMw 9120.6110, ZonMw 9120.8026, NWO ALW 818.02.001]; European Young Investigator award (EURYI)	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fondation Alphonse and Jean Forton; Concerted Research Action; Interuniversity Attraction Pole(Belgian Federal Science Policy Office); Communaute Francaise de Belgique(Australian Research Council); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Young Investigator award (EURYI)(European Science Foundation (ESF))	The authors are grateful to the members of the affected families for their participation in this study. We thank D.H. Ellison and P.A. Friedman for providing the anti-NCC antibody and the mDCT cells, respectively. We also thank F. van Zeeland for her excellent technical support. This work was supported by grants from the European Community, FP7 (EUNEFRON 201590) to C.A.W., O.D., N.V.A.M.K., I.C.M. and D.M., and the Deutsche Forschungsgemeinschaft (DFG FOR721) to D.G. and D.M. In addition, O.D. was financially supported by the Belgian agencies Fonds National de la Recherche Scientifique and Fonds de la Recherche Scientifique Medicale, the Fondation Alphonse and Jean Forton, a Concerted Research Action (10/15-029), an Interuniversity Attraction Pole (IUAP P6/05), and the programme d'excellence Marshall DIANE convention from the Region Wallonne, Belgium (Communaute Francaise de Belgique). C.A.W. was further supported by the Swiss National Science Foundation (3100A0-122217). R.J.B. and J.G.H. were supported by grants of the Netherlands Organization for Scientific Research (ZonMw 9120.6110; ZonMw 9120.8026; NWO ALW 818.02.001) and a European Young Investigator award (EURYI) 2006.	Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; Belge H, 2007, P NATL ACAD SCI USA, V104, P14849, DOI 10.1073/pnas.0702810104; Dahan K, 2003, J AM SOC NEPHROL, V14, P2883, DOI 10.1097/01.ASN.0000092147.83480.B5; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; GIBSON MM, 1991, MOL MICROBIOL, V5, P2753, DOI 10.1111/j.1365-2958.1991.tb01984.x; Glaudemans B, 2010, KIDNEY INT, V77, P17, DOI 10.1038/ki.2009.358; Glaudemans B, 2009, J CLIN INVEST, V119, P936, DOI 10.1172/JCI36948; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Gunzel D, 2009, J PHYSIOL-LONDON, V587, P3777, DOI 10.1113/jphysiol.2009.173401; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meij IC, 2003, NEPHROL DIAL TRANSPL, V18, P512, DOI 10.1093/ndt/18.3.512; Meij IC, 1999, AM J HUM GENET, V64, P180, DOI 10.1086/302199; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; PIZZONIA JH, 1991, IN VITRO CELL DEV B, V27, P409; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; QUAMME GA, 1989, AM J PHYSIOL, V256, pF197, DOI 10.1152/ajprenal.1989.256.2.F197; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schweigel M, 2000, FRONT BIOSCI-LANDMRK, V5, pD666, DOI 10.2741/Schweigel; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Sponder G, 2010, MAGNESIUM RES, V23, P105, DOI 10.1684/mrh.2010.0206; Trouet D, 1997, PFLUG ARCH EUR J PHY, V434, P632, DOI 10.1007/s004240050445; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wang CY, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-7; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Will C, 2010, AM J PHYSIOL-RENAL, V298, pF1152, DOI 10.1152/ajprenal.00499.2009	38	140	143	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					333	343		10.1016/j.ajhg.2011.02.005	http://dx.doi.org/10.1016/j.ajhg.2011.02.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21397062	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000288589000010
J	Guernsey, DL; Jiang, HY; Hussin, J; Arnold, M; Bouyakdan, K; Perry, S; Babineau-Sturk, T; Beis, J; Dumas, N; Evans, SC; Ferguson, M; Matsuoka, M; Macgillivray, C; Nightingale, M; Patry, L; Rideout, AL; Thomas, A; Orr, A; Hoffmann, I; Michaud, JL; Awadalla, P; Meek, DC; Ludman, M; Samuels, ME				Guernsey, Duane L.; Jiang, Haiyan; Hussin, Julie; Arnold, Marc; Bouyakdan, Khalil; Perry, Scott; Babineau-Sturk, Tina; Beis, Jill; Dumas, Nadine; Evans, Susan C.; Ferguson, Meghan; Matsuoka, Makoto; Macgillivray, Christine; Nightingale, Mathew; Patry, Lysanne; Rideout, Andrea L.; Thomas, Aidan; Orr, Andrew; Hoffmann, Ingrid; Michaud, Jacques L.; Awadalla, Philip; Meek, David C.; Ludman, Mark; Samuels, Mark E.			Mutations in Centrosomal Protein CEP152 in Primary Microcephaly Families Linked to MCPH4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROTUBULE GENERATION; GENE; ASPM; PREDICTION; HETEROGENEITY; EVOLUTION; ASTERLESS; ALIGNMENT; CDK5RAP2; PANTHER	Primary microcephaly is a rare condition in which brain size is substantially diminished without other syndromic abnormalities. Seven autosomal loci have been genetically mapped, and the underlying causal genes have been identified for MCPH1, MCPH3, MCPH5, MCPH6, and MCPH7 but not for MCPH2 or MCPH4. The known genes play roles in mitosis and cell division. We ascertained three families from an Eastern Canadian subpopulation, each with one microcephalic child. Homozygosity analysis in two families using genome-wide dense SNP genotyping supported linkage to the published MCPH4 locus on chromosome 15q21.1. Sequencing of coding exons of candidate genes in the interval identified a nonconservative amino acid change in a highly conserved residue of the centrosomal protein CEP152. The affected children in these two families were both homozygous for this missense variant. The third affected child was compound heterozygous for the missense mutation plus a second, premature-termination mutation truncating a third of the protein and preventing its localization to centrosomes in transfected cells. CEP152 is the putative mammalian ortholog of Drosphila asterless, mutations in which affect mitosis in the fly. Published data from zebrafish are also consistent with a role of CEP152 in centrosome function. By RT-PCR, CEP152 is expressed in the embryonic mouse brain, similar to other MCPH genes. Like some other MCPH genes, CEP152 shows signatures of positive selection in the human lineage. CEP152 is a strong candidate for the causal gene underlying MCPH4 and may be an important gene in the evolution of human brain size.	[Guernsey, Duane L.; Jiang, Haiyan; Arnold, Marc; Perry, Scott; Evans, Susan C.; Matsuoka, Makoto; Macgillivray, Christine; Nightingale, Mathew; Samuels, Mark E.] Dalhousie Univ, Dept Pathol, Halifax, NS B3H 1X5, Canada; [Babineau-Sturk, Tina; Beis, Jill; Dumas, Nadine; Ferguson, Meghan; Rideout, Andrea L.; Thomas, Aidan; Ludman, Mark] IWK Hlth Ctr, Maritime Med Genet Serv, Halifax, NS B3K 6R8, Canada; [Guernsey, Duane L.; Orr, Andrew] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS B3H 2Y9, Canada; [Ludman, Mark] IWK Hlth Ctr, Div Med Genet, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Ludman, Mark] Dalhousie Univ, Halifax, NS B3K 6R8, Canada; [Hussin, Julie; Bouyakdan, Khalil; Patry, Lysanne; Michaud, Jacques L.; Awadalla, Philip; Samuels, Mark E.] Univ Montreal, Ctr Rech, CHU Ste Justine, Montreal, PQ H3T 1C5, Canada; [Meek, David C.] St Johns Hosp, Dept Pediat, St John, NB E2L 4L2, Canada; [Meek, David C.] Dalhousie Univ, St John, NB E2L 4L2, Canada; [Arnold, Marc; Hoffmann, Ingrid] German Canc Res Ctr, Dept Cell Cycle Control & Carcinogenesis, D-69120 Heidelberg, Germany	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Universite de Montreal; Dalhousie University; Helmholtz Association; German Cancer Research Center (DKFZ)	Samuels, ME (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS B3H 1X5, Canada.	mark.e.samuels@umontreal.ca	Awadalla, Philip/AAC-4896-2021	Orr, Andrew/0000-0002-9388-9034; Nightingale, Mat/0000-0003-1465-7911; Ludman, Mark/0000-0002-9658-6784	Genome Canada; Genome Atlantic; Nova Scotia Health Research Foundation; Nova Scotia Research and Innovation Trust; IWK Health Centre Foundation; Dalhousie Medical Research Fund; Capital Health Research Fund; Centre de Recherche du CHU Ste-Justine; Canadian Institutes of Health Research; Ministry of Economic Development, Innovation and Export Trade [PSR-SIIRI-195]; Genome Quebec Chair of Population and Medical Genomics; Deutsche Jose Carreras-Leukamie Stiftung [DJCLC R07/21v]	Genome Canada(Genome Canada); Genome Atlantic; Nova Scotia Health Research Foundation; Nova Scotia Research and Innovation Trust; IWK Health Centre Foundation; Dalhousie Medical Research Fund; Capital Health Research Fund; Centre de Recherche du CHU Ste-Justine; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade; Genome Quebec Chair of Population and Medical Genomics; Deutsche Jose Carreras-Leukamie Stiftung	Foremost, we thank the families who generously contributed their time and materials to this research study. Thanks to Monica Bettencourt-Dias for helpful discussions regarding centrosome function and evolution. D.L.G. and M.E.S. were supported by Genome Canada, Genome Atlantic, Nova Scotia Health Research Foundation, Nova Scotia Research and Innovation Trust, IWK Health Centre Foundation, Dalhousie Medical Research Fund, and Capital Health Research Fund. M.E.S. was supported by the Centre de Recherche du CHU Ste-Justine. J.L.M. is a senior scientist of the Fonds pour la Recherche en Sante du Quebec and was supported by an operating grant from the Canadian Institutes of Health Research. P.A. was supported by a Ministry of Economic Development, Innovation and Export Trade (PSR-SIIRI-195) grant and a Genome Quebec Chair of Population and Medical Genomics. I.H. was supported by the Deutsche Jose Carreras-Leukamie Stiftung (DJCLC R07/21v).	Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Evans PD, 2006, GENE, V375, P75, DOI 10.1016/j.gene.2006.02.019; Faivre L, 2002, AM J MED GENET, V112, P379, DOI 10.1002/ajmg.10677; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Graham JM, 2004, AM J MED GENET A, V128A, P235, DOI 10.1002/ajmg.a.30060; Guernsey DL, 2010, J NEUROL SCI, V288, P79, DOI 10.1016/j.jns.2009.09.034; Guernsey DL, 2009, AM J HUM GENET, V85, P120, DOI 10.1016/j.ajhg.2009.06.008; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gul A, 2006, NEUROGENETICS, V7, P105, DOI 10.1007/s10048-006-0042-4; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Khan SH, 1998, GLYCOCONJUGATE J, V15, P1125, DOI 10.1023/A:1006955604501; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Lupas A, 1997, CURR OPIN STRUC BIOL, V7, P388, DOI 10.1016/S0959-440X(97)80056-5; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pD175, DOI 10.1093/nar/gkn815; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Raymond FL, 2009, HUM MOL GENET, V18, pR60, DOI 10.1093/hmg/ddp071; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Ropers HH, 2007, AM J HUM GENET, V81, P199, DOI 10.1086/520679; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tanizawa H., 2009, CHEM BIO INFORM J, V9, P12; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Vallender EJ, 2008, TRENDS NEUROSCI, V31, P637, DOI 10.1016/j.tins.2008.08.010; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	58	140	145	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					40	51		10.1016/j.ajhg.2010.06.003	http://dx.doi.org/10.1016/j.ajhg.2010.06.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598275	Bronze, Green Published			2022-12-18	WOS:000280029200004
J	van der Lelij, P; Chrzanowska, KH; Godthelp, BC; Rooimans, MA; Ostra, AB; Stumm, M; Zdzienicka, MZ; Joenje, H; de Winter, JP				van der Lelij, Petra; Chrzanowska, Krystyna H.; Godthelp, Barbara C.; Rooimans, Martin A.; Ostra, Anneke B.; Stumm, Markus; Zdzienicka, Malgorzata Z.; Joenje, Hans; de Winter, Johan P.			Warsaw Breakage Syndrome, a Cohesinopathy Associated with Mutations in the XPD Helicase Family Member DDX11/ChIR1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SISTER-CHROMATID COHESION; DNA HELICASE; CELLS; YEAST; CHLR1	The iron-sulfur-containing DNA helicases XPD, FANCJ, DDX11, and RTEL represent a small subclass of superfamily 2 helicases. XPD and FANCJ have been connected to the genetic instability syndromes xeroderma pigmentosum and Fanconi anemia. Here, we report a human individual with biallelic mutations in DDX11. Defective DDX11 is associated with a unique cellular phenotype in which features of Fanconi anemia (drug-induced chromosomal breakage) and Roberts syndrome (sister chromatid cohesion defects) coexist. The DDX11-deficient patient represents another cohesinopathy, besides Cornelia de Lange syndrome and Roberts syndrome, and shows that DDX11 functions at the interface between DNA repair and sister chromatid cohesion.	[Chrzanowska, Krystyna H.] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland; [van der Lelij, Petra; Rooimans, Martin A.; Ostra, Anneke B.; Joenje, Hans; de Winter, Johan P.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; [Godthelp, Barbara C.] Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 ZC Leiden, Netherlands; [Stumm, Markus] Otto VonGuericke Univ Magdegurg, Inst Human Genet, D-39120 Magdeburg, Germany; [Zdzienicka, Malgorzata Z.] Nicholas Copernicus Univ, Coll Med, Dept Mol Cell Genet, PL-85094 Bydgoszcz, Poland	Children's Memorial Health Institute; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Otto von Guericke University; Nicolaus Copernicus University; Ludwik Rydygier Collegium Medicum	Chrzanowska, KH (corresponding author), Childrens Mem Hlth Inst, Dept Med Genet, Al Dzieci Polskich 20, PL-04730 Warsaw, Poland.	k.chrzanowska@czd.pl; j.dewinter@vumc.nl		van der Lelij, Petra/0000-0002-7461-9645; Chrzanowska, Krystyna/0000-0003-3888-0624				Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6	8	140	144	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					262	266		10.1016/j.ajhg.2010.01.008	http://dx.doi.org/10.1016/j.ajhg.2010.01.008			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20137776	Green Published, Bronze			2022-12-18	WOS:000274637200016
J	Edvardson, S; Hama, H; Shaag, A; Gomori, JM; Berger, I; Soffer, D; Korman, SH; Taustein, I; Saada, A; Elpeleg, O				Edvardson, Simon; Hama, Hiroko; Shaag, Avraham; Gomori, John Moshe; Berger, Itai; Soffer, Dov; Korman, Stanley H.; Taustein, Ilana; Saada, Ann; Elpeleg, Orly			Mutations in the Fatty Acid 2-Hydroxylase Gene Are Associated with Leukodystrophy with Spastic Paraparesis and Dystonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRAIN CEREBROSIDES; RAT; HYDROXYLATION; MYELINATION; PARAPLEGIA; LOCUS; FA2H	Myelination is a complex, developmentally regulated process whereby myelin proteins and lipids are coordinately expressed by myelinating glial cells. Homozygosity mapping in nine patients with childhood onset spasticity, dystonia, cognitive dysfunction, and periventricular white matter disease revealed inactivating mutations in the FA2H gene. FA2H encodes the enzyme fatty acid 2-hydroxylase that catalyzes the 2-hydroxylation of myelin galactolipids, galactosylceramide, and its sulfated form, sulfatide. To our knowledge, this is the first identified deficiency of a lipid component ofniyelin and the clinical phenotype underscores the importance of the 2-hydroxylation of galactolipids for myelin maturation. In patients with autosomal-recessive unclassified leukodystrophy or complex spastic paraparesis, sequence analysis of the FA2H gene is warranted.	[Edvardson, Simon; Shaag, Avraham; Korman, Stanley H.; Saada, Ann; Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; [Edvardson, Simon; Berger, Itai; Taustein, Ilana] Hadassah Hebrew Univ, Med Ctr, Pediat Neurol Unit, IL-91120 Jerusalem, Israel; [Gomori, John Moshe] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, IL-91120 Jerusalem, Israel; [Soffer, Dov] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel; [Hama, Hiroko] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Medical University of South Carolina	Elpeleg, O (corresponding author), Hadassah Hebrew Univ, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel.	elpeleg@acc.huji.ac.il	Saada, Ann/J-6864-2017; Berger, Itai/D-9729-2017	Saada, Ann/0000-0003-2951-0656; Berger, Itai/0000-0002-7577-4444; Edvardson, Simon/0000-0003-2878-1278	Hebrew University; Hadassah Medical Organization; National Institute of Health [NS060807]	Hebrew University; Hadassah Medical Organization; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledge the collaboration of the patients' families. This work was supported by the Joint Research Fund of the Hebrew University and Hadassah Medical Organization and by the National Institute of Health grant NS060807.	Alderson NL, 2006, J LIPID RES, V47, P2772, DOI 10.1194/jlr.M600362-JLR200; Alderson NL, 2005, J LIPID RES, V46, P1569, DOI 10.1194/jlr.D500013-JLR200; Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; BOGGS JM, 1988, BIOCHIM BIOPHYS ACTA, V938, P361, DOI 10.1016/0005-2736(88)90134-4; CAMPAGNONI AT, 2004, NEUROGLIA, P253; Croes K, 2000, J LIPID RES, V41, P629; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Dick KJ, 2008, NEUROLOGY, V71, P248, DOI 10.1212/01.wnl.0000319610.29522.8a; Eckhardt M, 2005, BIOCHEM J, V388, P245, DOI 10.1042/BJ20041451; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Hein S, 2008, HUM MOL GENET, V17, P1750, DOI 10.1093/hmg/ddn066; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSHI M, 1973, J NEUROCHEM, V21, P709, DOI 10.1111/j.1471-4159.1973.tb06017.x; IGISU H, 1984, SCIENCE, V224, P753, DOI 10.1126/science.6719111; KINNEY HC, 1994, NEUROCHEM RES, V19, P983, DOI 10.1007/BF00968708; KISHIMOTO Y, 1959, J LIPID RES, V1, P72; LIPPEL K, 1969, LIPIDS, V4, P129, DOI 10.1007/BF02531931; Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016; Matsunaga I, 2000, LIPIDS, V35, P365, DOI 10.1007/s11745-000-533-y; Morell Pierre, 1999, P69; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Uchida Y, 2007, J BIOL CHEM, V282, P13211, DOI 10.1074/jbc.M611562200; WEBSTER HD, 1980, INSERM S SER, V14, P73	24	140	145	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					643	648		10.1016/j.ajhg.2008.10.010	http://dx.doi.org/10.1016/j.ajhg.2008.10.010			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	19068277	Green Published, Bronze			2022-12-18	WOS:000261006900011
J	Kim, JW; Lee, SK; Lee, ZH; Park, JC; Lee, KE; Lee, MH; Park, JT; Seo, BM; Hu, JCC; Simmer, JP				Kim, Jung-Wook; Lee, Sook-Kyung; Lee, Zang Hee; Park, Joo-Cheol; Lee, Kyung-Eun; Lee, Myoung-Hwa; Park, Jong-Tae; Seo, Byoung-Moo; Hu, Jan C. -C.; Simmer, James P.			FAM83H mutations in families with autosomal-dominant hypocalcified amelogenesis imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENAMEL MATRIX; DENTAL ENAMEL; CANDIDATE GENES; MICE DISPLAY; PROTEIN; CLONING; AMELOBLASTIN; SHAPE	Amelogenesis imperfecta (AT) is a collection of diverse inherited disorders featuring dental-enamel defects in the absence of significant nondental symptoms. AT phenotypes vary and are categorized as hypoplastic, hypocalcified, and hypomaturation types. Phenotypic specificity to enamel has focused research on genes encoding enamel-matrix proteins. We studied two families with autosomal-dominant hypocalcified AT and have identified nonsense mutations (R325X and Q398X) in the FAM83H gene on chromosome 8q24.3. The mutations perfectly cosegregate with the disease phenotype and demonstrate that FAM83H is required for proper dental-enamel calcification.	[Kim, Jung-Wook; Lee, Sook-Kyung; Lee, Zang Hee; Park, Joo-Cheol; Lee, Kyung-Eun] Seoul Natl Univ, Sch Dent, Dept Cell & Dev Biol, Seoul 110768, South Korea; [Kim, Jung-Wook; Lee, Sook-Kyung; Lee, Zang Hee; Park, Joo-Cheol; Lee, Kyung-Eun; Seo, Byoung-Moo] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 110768, South Korea; [Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul 110768, South Korea; [Seo, Byoung-Moo] Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Seoul 110768, South Korea; [Lee, Myoung-Hwa; Park, Jong-Tae] Chosun Univ, Coll Dent, Dept Oral Histol, Kwangju 501759, South Korea; [Hu, Jan C. -C.; Simmer, James P.] Univ Michigan, Dent Res Lab, Dept Biol & Mat Sci, Ann Arbor, MI 48108 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chosun University; University of Michigan System; University of Michigan	Kim, JW (corresponding author), Seoul Natl Univ, Sch Dent, Dept Cell & Dev Biol, 275 1 Yongon Dong, Seoul 110768, South Korea.	pedoman@snu.ac.kr	Hu, Jan C-C./F-5679-2015; Park, Joo Cheol/D-6437-2012	Hu, Jan C-C./0000-0002-9294-0248; Park, Joo Cheol/0000-0002-3162-7557; Simmer, James/0000-0002-7192-6105				Bartlett JD, 1996, GENE, V183, P123, DOI 10.1016/S0378-1119(96)00525-2; Bartlett JD, 2006, CURR TOP DEV BIOL, V74, P57, DOI 10.1016/S0070-2153(06)74003-0; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; DACULSI G, 1978, J ULTRA MOL STRUCT R, V65, P163, DOI 10.1016/S0022-5320(78)90053-9; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hart PS, 2003, EUR J ORAL SCI, V111, P326, DOI 10.1034/j.1600-0722.2003.00046.x; Hu CC, 2000, J DENT RES, V79, P912, DOI 10.1177/00220345000790040501; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Hu JCC, 2005, CELLS TISSUES ORGANS, V181, P219, DOI 10.1159/000091383; Iwasaki K, 2005, J DENT RES, V84, P1127, DOI 10.1177/154405910508401207; Kim JH, 2005, J KOREAN MED SCI, V20, P42, DOI 10.3346/jkms.2005.20.1.42; Kim JW, 2006, EUR J ORAL SCI, V114, P3, DOI 10.1111/j.1600-0722.2006.00278.x; Kim JW, 2004, J DENT RES, V83, P378, DOI 10.1177/154405910408300505; Kim JW, 2005, J DENT RES, V84, P278, DOI 10.1177/154405910508400314; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Mendoza G, 2007, HUM GENET, V120, P653, DOI 10.1007/s00439-006-0246-6; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Seedorf H, 2007, J DENT RES, V86, P764, DOI 10.1177/154405910708600815; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Toyosawa S, 2000, GENE, V256, P1, DOI 10.1016/S0378-1119(00)00379-6; WARSHAWSKY H, 1987, ANAT REC, V218, P380, DOI 10.1002/ar.1092180405; WITKOP CJ, 1988, J ORAL PATHOL MED, V17, P547, DOI 10.1111/j.1600-0714.1988.tb01332.x; Witkop CJ, 1976, ORAL FACIAL GENETICS, P151; Yamakoshi Y, 2006, EUR J ORAL SCI, V114, P266, DOI 10.1111/j.1600-0722.2006.00279.x	28	140	146	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					489	494		10.1016/j.ajhg.2007.09.020	http://dx.doi.org/10.1016/j.ajhg.2007.09.020			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252228	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000253223900020
J	Nalls, MA; Wilson, JG; Patterson, NJ; Tandon, A; Zmuda, JM; Huntsman, S; Garcia, M; Hu, DL; Li, RL; Beamer, BA; Patel, KV; Akylbekova, EL; Files, JC; Hardy, CL; Buxbaum, SG; Taylor, HA; Reich, D; Harris, TB; Ziv, E				Nalls, Michael A.; Wilson, James G.; Patterson, Nick J.; Tandon, Arti; Zmuda, Joseph M.; Huntsman, Scott; Garcia, Melissa; Hu, Donglei; Li, Rongling; Beamer, Brock A.; Patel, Kushang V.; Akylbekova, Ermeg L.; Files, Joe C.; Hardy, Cheryl L.; Buxbaum, Sarah G.; Taylor, Herman A.; Reich, David; Harris, Tamara B.; Ziv, Elad			Admixture mapping of white cell count: Genetic locus responsible for lower white blood cell count in the health ABC and Jackson Heart Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE-SCLEROSIS SUSCEPTIBILITY; MULTILOCUS GENOTYPE DATA; ADMIXED POPULATIONS; LINKAGE DISEQUILIBRIUM; CHEMOKINE RECEPTOR; ETHNIC-DIFFERENCES; DISEASE GENES; RISK; AFRICAN; ASSOCIATION	White blood cell count (WBC) is an important clinical marker that varies among different ethnic groups. African Americans are known to have a lower WBC than European Americans. We surveyed the entire genome for loci underlying this difference in WBC by using admixture mapping. We analyzed data from African American participants in the Health, Aging, and Body Composition Study and the Jackson Heart Study. Participants of both studies were genotyped across >= 1322 single nucleotide polymorphisms that were preselected to be informative for African versus European ancestry and span the entire genome. We used these markers to estimate genetic ancestry in each chromosomal region and then tested the association between WBC and genetic ancestry at each locus. We found a locus on chromosome 1q strongly associated with WBC (P < 10(-12)). The strongest association was with a marker known to affect the expression of the Duffy blood group antigen. Participants who had both copies of the common West African allele had a mean WBC of 4.9 (SD 1.3); participants who had both common European alleles had a mean WBC of 7.1 (SD 1.3). This variant explained similar to 20% of population variation in WBC. We used admixture mapping, a novel method for conducting genetic-association studies, to find a region that was significantly associated with WBC on chromosome 1q. Additional studies are needed to determine the biological mechanism for this effect and its clinical implications.	[Nalls, Michael A.; Garcia, Melissa; Patel, Kushang V.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Wilson, James G.] Vet Adm Med Ctr, Jackson, MS 39216 USA; [Patterson, Nick J.; Tandon, Arti; Reich, David] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA; [Zmuda, Joseph M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Huntsman, Scott; Hu, Donglei; Ziv, Elad] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Inst Human Genet, San Francisco, CA 94143 USA; [Li, Rongling] Univ Tennessee, Dept Prevent Med, Div Biostat & Epidemiol, Memphis, TN 38163 USA; [Beamer, Brock A.] Johns Hopkins Univ, Sch Med, Div Geriatr Med & Gerontol, Baltimore, MD 21287 USA; [Akylbekova, Ermeg L.; Buxbaum, Sarah G.] Jackson State Univ, Jackson Heart Study Coordinating Ctr, Jackson, MS 39213 USA; [Wilson, James G.; Files, Joe C.; Hardy, Cheryl L.; Taylor, Herman A.] Univ Mississippi, Med Ctr, Dept Med, Div Hematol, Jackson, MS 39216 USA; [Taylor, Herman A.] Jackson State Univ, Tougaloo Coll, Jackson, MS 39216 USA; [Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of Tennessee System; University of Tennessee Health Science Center; Johns Hopkins University; Jackson State University; University of Mississippi; University of Mississippi Medical Center; Jackson State University; Tougaloo College; Harvard University; Harvard Medical School	Harris, TB (corresponding author), NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA.	harris99@nia.nih.gov	Ziv, Elad/L-5396-2014; Buxbaum, Sarah G./E-1970-2013	Buxbaum, Sarah G./0000-0002-4886-3564	NATIONAL INSTITUTE ON AGING [ZIAAG007390] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-95172, N01HC95170, R01 HL084107, N01-HC-95170, N01-HC-95171, R01 HL084107-02, N01HC95171, N01HC95172] Funding Source: Medline; NIA NIH HHS [N01-AG-6-2103, N01-AG-6-2101, N01-AG-6-2106] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAIN B, 1984, J CLIN PATHOL, V37, P188, DOI 10.1136/jcp.37.2.188; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; DROBYSKI WR, 1993, BLOOD, V82, P2310; Falush D, 2003, GENETICS, V164, P1567; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Garner C, 2000, BLOOD, V95, P342; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 1997, AM J HUM GENET, V60, P188; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; *ON NURS SOC, 2005, CHEM BIOTH GUID REC, P246; Parasol N, 1998, BLOOD, V92, P2237, DOI 10.1182/blood.V92.7.2237.2237_2237_2243; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pollitt RA, 2007, EUR J EPIDEMIOL, V22, P55, DOI 10.1007/s10654-006-9082-1; Pritchard JK, 2000, GENETICS, V155, P945; RAMSAY S, 2007, IN PRESS ATHEROSCLER; REED WW, 1991, ARCH INTERN MED, V151, P501, DOI 10.1001/archinte.151.3.501; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2005, PHILOS T ROY SOC B, V360, P1605, DOI 10.1098/rstb.2005.1691; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; Shankar A, 2006, ARCH INTERN MED, V166, P188, DOI 10.1001/archinte.166.2.188; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; Taylor Jr HA, 2005, ETHN DIS, V15; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; *US DEP HHS, 2006, GUID US ANT AG HIV 1, P116; Weijenberg MP, 1996, ARTERIOSCL THROM VAS, V16, P499, DOI 10.1161/01.ATV.16.4.499	37	140	142	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					81	87		10.1016/j.ajhg.2007.09.003	http://dx.doi.org/10.1016/j.ajhg.2007.09.003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179887	Green Published, Bronze			2022-12-18	WOS:000253223800009
J	Yang, T; Vidarsson, H; Rodrigo-Blomqvist, S; Rosengren, SS; Enerback, S; Smith, RJH				Yang, Tao; Vidarsson, Hilmar; Rodrigo-Blomqvist, Sandra; Rosengren, Sally S.; Enerback, Sven; Smith, Richard J. H.			Transcriptional control of SLC26A4 is involved in pendred syndrome and nonsyndromic enlargement of vestibular aqueduct (DFNB4)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME GENE PDS; HEARING-LOSS; FACTOR FOXI1; DNA-BINDING; INNER-EAR; MUTATIONS; EXPRESSION; DEAFNESS; IDENTIFICATION; SPECIFICITY	Although recessive mutations in the anion transporter gene SLC26A4 are known to be responsible for Pendred syndrome (PS) and nonsyndromic hearing loss associated with enlarged vestibular aqueduct (EVA), also known as "DFNB4," a large percentage of patients with this phenotype lack mutations in the SLC26A4 coding region in one or both alleles. We have identified and characterized a key transcriptional regulatory element in the SLC26A4 promoter that binds FOX11, a transcriptional activator of SLC26A4. In nine patients with PS or nonsyndromic EVA, a novel c.- 103T -> C mutation in this regulatory element interferes with FOXI1 binding and completely abolishes FOXI1-mediated transcriptional activation. We have also identified six patients with mutations in FOXI1 that compromise its ability to activate SLC26A4 transcription. In one family, the EVA phenotype segregates in a double-heterozygous mode in the affected individual who carries single mutations in both SLC26A4 and FOXI1. This finding is consistent with our observation that EVA occurs in the Slc26a4(+/-); Foxi1(+/-) double-heterozygous mouse mutant. These results support a novel dosage-dependent model for the molecular pathogenesis of PS and nonsyndromic EVA that involves SLC26A4 and its transcriptional regulatory machinery.	Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; Univ Iowa, Interdept PhD Program Genet, Iowa City, IA 52242 USA; Univ Gothenburg, Dept Biochem Med, Gothenburg, Sweden; Univ Connecticut Hlth Partners, Hartford, CT USA	University of Iowa; University of Iowa; University of Gothenburg; University of Connecticut	Smith, RJH (corresponding author), Univ Iowa, Dept Otolaryngol Head & Neck Surg, 200 Hawkins Dr,21151 PFP, Iowa City, IA 52242 USA.	richard-smith@uiowa.edu		Smith, Richard/0000-0003-1201-6731; Yang, Tao/0000-0001-6011-987X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002842] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002842, R01 DC02842] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BATSAKIS JG, 1962, ARCHIV OTOLARYNGOL, V76, P401; Bidart JM, 2000, J CLIN ENDOCR METAB, V85, P2028, DOI 10.1210/jc.85.5.2028; Blomqvist SR, 2006, EMBO J, V25, P4131, DOI 10.1038/sj.emboj.7601272; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Blons H, 2004, CLIN GENET, V66, P333, DOI 10.1111/j.1399-0004.2004.00296.x; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; DEKOK YJM, 1995, HUM MOL GENET, V4, P2145; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Hulander M, 2003, DEVELOPMENT, V130, P2013, DOI 10.1242/dev.00376; Hulander M, 1998, NAT GENET, V20, P374, DOI 10.1038/3850; Kurth I, 2006, BIOCHEM J, V393, P277, DOI 10.1042/BJ20051094; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; Pallares-Ruiz N, 2002, EUR J HUM GENET, V10, P72, DOI 10.1038/sj.ejhg.5200762; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Prasad S, 2004, AM J MED GENET A, V124A, P1, DOI 10.1002/ajmg.a.20272; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Usami S, 1999, HUM GENET, V104, P188, DOI 10.1007/s004390050933; Wilch E, 2006, AM J HUM GENET, V79, P174, DOI 10.1086/505333	26	140	158	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1055	1063		10.1086/518314	http://dx.doi.org/10.1086/518314			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503324	Green Published, Bronze			2022-12-18	WOS:000246553800005
J	Hegele, RA; Cao, HN; Liu, DM; Costain, GA; Charlton-Menys, V; Rodger, NW; Durrington, PN				Hegele, Robert A.; Cao, Henian; Liu, Dora M.; Costain, Gary A.; Charlton-Menys, Valentine; Rodger, N. Wilson; Durrington, Paul N.			Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL PARTIAL LIPODYSTROPHY; OF-THE-LITERATURE; CLINICAL-FEATURES; HUMAN DNA; S-PHASE; LAMIN; DISEASE; DERANGEMENTS; REPLICATION; ORIGIN	The etiology of acquired partial lipodystrophy (APL, also called "Barraquer-Simons syndrome") is unknown. Genomic DNA mutations affecting the nuclear lamina protein lamin A cause inherited partial lipodystrophy but are not found in patients with APL. Because it also encodes a nuclear lamina protein (lamin B2) and its genomic structure was recently reannotated, we sequenced LMNB2 as a candidate gene in nine white patients with APL. In four patients, we found three new rare mutations in LMNB2: intron 1 - 6G -> T, exon 5 c.643G -> A (p. R215Q; in two patients), and exon 8 c.1218G -> A (p.A407T). The combined frequency of these mutations was 0.222 in the patients with APL, compared with 0.0018 in a multiethnic control sample of 1,100 subjects (P = 2.1 x 10(-7)) and 0.0045 in a sample of 330 white controls (P = 2.1 x 10(-s)). These novel heterozygous mutations are the first reported for LMNB2, are the first reported among patients with APL, and indicate how sequencing of a reannotated candidate gene can reveal new disease-associated mutations.	Univ Western Ontario, Vasc Biol Grp, Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Schulich Sch Med & Dent, Div Endocrinol, London, ON N6A 5K8, Canada; St Johns Hosp, St John, NB, Canada; Manchester Royal Infirm, Div Cardiovasc & Endocrine Sci, Manchester M13 9WL, Lancs, England	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Manchester	Hegele, RA (corresponding author), Univ Western Ontario, Vasc Biol Grp, Robarts Res Inst, 406-100 Perth Dr, London, ON N6A 5K8, Canada.	hegele@robarts.ca	Hegele, Robert/AAF-6482-2020; Hegele, Robert/G-3301-2011	Hegele, Robert/0000-0003-2861-5325; 				BARRAQUERFERRE L, 1935, PRESSE MED, V86, P1672; Bhayana S, 2002, CLIN GENET, V61, P283, DOI 10.1034/j.1399-0004.2002.610407.x; BIAMONTI G, 1992, MOL CELL BIOL, V12, P3499, DOI 10.1128/MCB.12.8.3499; Biasi D, 1999, RHEUMATOL INT, V19, P75, DOI 10.1007/s002960050106; BIER DM, 1978, J CLIN ENDOCR METAB, V46, P800, DOI 10.1210/jcem-46-5-800; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Capeau J, 2005, BIOCHEM SOC T, V33, P1073, DOI 10.1042/BST0331073; Ferrarini A, 2004, AM J MED GENET A, V126A, P427, DOI 10.1002/ajmg.a.20623; Frey BJ, 2005, NAT GENET, V37, P991, DOI 10.1038/ng1630; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; Hegele RA, 2005, INT J OBESITY, V29, pS31, DOI 10.1038/sj.ijo.0802911; Hegele RA, 2005, CLIN GENET, V68, P31, DOI 10.1111/j.1399-0004.2005.00447.x; Hegele RA, 2004, TRENDS CARDIOVAS MED, V14, P133, DOI 10.1016/j.tcm.2004.02.001; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Hegele RA, 2001, J HUM GENET, V46, P351, DOI 10.1007/s100380170072; HOGER TH, 1990, CHROMOSOMA, V99, P379, DOI 10.1007/BF01726689; Jeune M, 1965, Ann Pediatr (Paris), V12, P749; Kusic J, 2005, J BIOL CHEM, V280, P9848, DOI 10.1074/jbc.M408310200; LANGHOF H, 1960, Arch Klin Exp Dermatol, V210, P313; Misra A, 2004, MEDICINE, V83, P18, DOI 10.1097/01.md.0000111061.69212.59; Misra A, 2003, MEDICINE, V82, P129, DOI 10.1097/00005792-200303000-00007; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Quecedo E, 1996, PEDIATR DERMATOL, V13, P477, DOI 10.1111/j.1525-1470.1996.tb00728.x; REICHEL W, 1976, KLIN WOCHENSCHR, V54, P75, DOI 10.1007/BF01468772; TRIBIOLI C, 1987, NUCLEIC ACIDS RES, V15, P10211, DOI 10.1093/nar/15.24.10211; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Worman Howard J., 2005, V264, P35, DOI 10.1002/0470093765.ch4	28	140	151	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					383	389		10.1086/505885	http://dx.doi.org/10.1086/505885			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826530	Green Published, Bronze			2022-12-18	WOS:000239040400021
J	Theuns, J; Brouwers, N; Engelborghs, S; Sleegers, K; Bogaerts, V; Corsmit, E; De Pooter, T; van Duijn, CM; De Deyn, PP; Van Broeckhoven, C				Theuns, Jessie; Brouwers, Nathalie; Engelborghs, Sebastiaan; Sleegers, Kristel; Bogaerts, Veerle; Corsmit, Ellen; De Pooter, Tim; van Duijn, Cornelia M.; De Deyn, Peter P.; Van Broeckhoven, Christine			Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR AP-2; APP GENE PROMOTER; BETA-PROTEIN; PARKINSONS-DISEASE; REGULATORY REGION; CONFERS SUSCEPTIBILITY; TRANSGENIC MICE; SENILE PLAQUES; DOWNS-SYNDROME; GENOME SCREEN	Genetic variations in promoter sequences that alter gene expression play a prominent role in increasing susceptibility to complex diseases. Also, expression levels of APP are essentially regulated by its core promoter and 5' upstream regulatory region and correlate with amyloid beta levels in Alzheimer disease ( AD) brains. Here, we systematically sequenced the proximal promoter (-766/+204) and two functional distal regions (-2634/-2159 and -2096/-1563) of APP in two independent AD series with onset ages <= 70 years (Belgian sample n = 180; Dutch sample, n = 111) and identified eight novel sequence variants. Three mutations (-118C -> A, -369C -> G, and -534G -> A) identified only in patients with AD showed, in vitro, a nearly twofold neuron- specific increase in APP transcriptional activity, similar to what is expected from triplication of APP in Down syndrome. These mutations either abolished (AP-2 and HES-1) or created (Oct1) transcription-factor binding sites involved in the development and differentiation of neuronal systems. Also, two of these clustered in the 200-bp region (-540/-340) of the APP promoter that showed the highest degree of species conservation. The present study provides evidence that APP-promoter mutations that significantly increase APP expression levels are associated with AD.	Univ Antwerp VIB, Neurodegenerat Brain Dis Grp, Lab Neurogenet, Dept Mol Genet, B-2610 Antwerp, Belgium; Univ Antwerp, Lab Neurochem & Behav, Inst Born Bunge, B-2610 Antwerp, Belgium; Middelheim Hosp, Dept Neurol, Memory Clin, Antwerp, Belgium; Erasmus MC, Dept Biostat & Epidemiol, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; ZNA Middelheim Hospital; Erasmus University Rotterdam; Erasmus MC	Van Broeckhoven, C (corresponding author), Univ Antwerp VIB, Neurodegenerat Brain Dis Grp, Lab Neurogenet, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	christine.vanbroeckhoven@ua.ac.be	Brouwers, Nathalie/L-2089-2014; Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019	Brouwers, Nathalie/0000-0002-9808-9394; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Duijn, Cornelia/0000-0002-2374-9204; Theuns, Jessie/0000-0001-5087-7650				Athan ES, 2002, ARCH NEUROL-CHICAGO, V59, P1793, DOI 10.1001/archneur.59.11.1793; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Brouwers N, 2006, NEUROSCI LETT, V392, P72, DOI 10.1016/j.neulet.2005.08.064; BURDICK D, 1992, J BIOL CHEM, V267, P546; CHERNAK JM, 1993, GENE, V133, P255, DOI 10.1016/0378-1119(93)90648-M; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; Damberg M, 2000, LIFE SCI, V68, P669, DOI 10.1016/S0024-3205(00)00969-3; Dermaut B, 2003, ANN NEUROL, V53, P409, DOI 10.1002/ana.10507; Dewji NN, 1996, MOL BRAIN RES, V35, P325, DOI 10.1016/0169-328X(95)00214-D; Engelborghs S, 2006, NEUROBIOL AGING, V27, P285, DOI 10.1016/j.neurobiolaging.2005.02.005; Engelborghs S, 2003, J NEUROL NEUROSUR PS, V74, P1148, DOI 10.1136/jnnp.74.8.1148; FIDANI L, 1992, HUM MOL GENET, V1, P165, DOI 10.1093/hmg/1.3.165; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GRILLI M, 1995, J BIOL CHEM, V270, P26774, DOI 10.1074/jbc.270.45.26774; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IZUMI R, 1992, GENE, V112, P189, DOI 10.1016/0378-1119(92)90375-Y; Kabos P, 2002, NEUROREPORT, V13, P2385, DOI 10.1097/00001756-200212200-00002; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; LAFAUCI G, 1989, BIOCHEM BIOPH RES CO, V159, P297, DOI 10.1016/0006-291X(89)92437-6; Lahiri DK, 2005, NEUROBIOL AGING, V26, P1329, DOI 10.1016/j.neurobiolaging.2004.11.005; LAHIRI DK, 1995, MOL BRAIN RES, V32, P233, DOI 10.1016/0169-328X(95)00078-7; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; LIDDELL MB, 1995, HUM MOL GENET, V4, P853, DOI 10.1093/hmg/4.5.853; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Myers A, 2002, AM J MED GENET, V114, P235, DOI 10.1002/ajmg.10183; Olson JM, 2002, AM J HUM GENET, V71, P154, DOI 10.1086/341034; Olson JM, 2001, AM J HUM GENET, V69, P895, DOI 10.1086/323472; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; POLLWEIN P, 1992, NUCLEIC ACIDS RES, V20, P63, DOI 10.1093/nar/20.1.63; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Querfurth HW, 1999, GENE, V232, P125, DOI 10.1016/S0378-1119(99)00091-8; Quitschke WW, 1996, J BIOL CHEM, V271, P22231, DOI 10.1074/jbc.271.36.22231; ROGAEV EI, 1993, NEUROLOGY, V43, P2275, DOI 10.1212/WNL.43.11.2275; ROOKE K, 1992, NEURODEGENERATION, V1, P237; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SOLA C, 1993, MOL BRAIN RES, V17, P41, DOI 10.1016/0169-328X(93)90071-V; Song WH, 1998, GENE, V217, P165, DOI 10.1016/S0378-1119(98)00340-0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Theuns J, 2000, HUM MOL GENET, V9, P325, DOI 10.1093/hmg/9.3.325; Theuns J, 2003, HUM MOL GENET, V12, P869, DOI 10.1093/hmg/ddg098; Theuns J, 2000, HUM MOL GENET, V9, P2383, DOI 10.1093/hmg/9.16.2383; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wavrant-De Vrieze F, 1999, NEUROSCI LETT, V269, P67, DOI 10.1016/S0304-3940(99)00417-6; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; West AB, 2002, HUM MOL GENET, V11, P2787, DOI 10.1093/hmg/11.22.2787; WIRAK DO, 1991, EMBO J, V10, P289, DOI 10.1002/j.1460-2075.1991.tb07949.x; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957; YAMADA T, 1989, BIOCHEM BIOPH RES CO, V158, P906, DOI 10.1016/0006-291X(89)92808-8; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N	64	140	148	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					936	946		10.1086/504044	http://dx.doi.org/10.1086/504044			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685645	Green Published, Bronze			2022-12-18	WOS:000237553800004
J	Hillmer, AM; Hanneken, S; Ritzmann, S; Becker, T; Freudenberg, J; Brockschmidt, FF; Flaquer, A; Freudenberg-Hua, Y; Abou Jamra, R; Metzen, C; Heyn, U; Schweiger, N; Betz, RC; Blaumeiser, B; Hampe, J; Schreiber, S; Schulze, TG; Hennies, HC; Schumacher, J; Propping, P; Ruzicka, T; Cichon, S; Wienker, TF; Kruse, R; Nothen, MM				Hillmer, AM; Hanneken, S; Ritzmann, S; Becker, T; Freudenberg, J; Brockschmidt, FF; Flaquer, A; Freudenberg-Hua, Y; Abou Jamra, R; Metzen, C; Heyn, U; Schweiger, N; Betz, RC; Blaumeiser, B; Hampe, J; Schreiber, S; Schulze, TG; Hennies, HC; Schumacher, J; Propping, P; Ruzicka, T; Cichon, S; Wienker, TF; Kruse, R; Nothen, MM			Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MALE PATTERN BALDNESS; PROSTATE-CANCER RISK; BULBAR MUSCULAR-ATROPHY; TIGHTLY LINKED MARKERS; HAIRLESS GENE; REPEAT; CAG; POLYMORPHISM; ASSOCIATION; EXPRESSION	Androgenetic alopecia ( AGA), or male- pattern baldness, is the most common form of hair loss. Its pathogenesis is androgen dependent, and genetic predisposition is the major requirement for the phenotype. We demonstrate that genetic variability in the androgen receptor gene ( AR) is the cardinal prerequisite for the development of early-onset AGA, with an etiological fraction of 0.46. The investigation of a large number of genetic variants covering the AR locus suggests that a polyglycine- encoding GGN repeat in exon 1 is a plausible candidate for conferring the functional effect. The X- chromosomal location of AR stresses the importance of the maternal line in the inheritance of AGA.	Univ Bonn, Dept Genom, Life & Brain Ctr, D-53127 Bonn, Germany; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; Cent Inst Mental Hlth, Div Genet Epidemiol Psychiat, D-6800 Mannheim, Germany; Max Delbruck Ctr Mol Med, Dept Mol Genet, Berlin, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany	University of Bonn; University of Bonn; University of Bonn; Heinrich Heine University Dusseldorf; University of Antwerp; University of Kiel; Central Institute of Mental Health; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Nothen, MM (corresponding author), Univ Bonn, Dept Genom, Life & Brain Ctr, Siegmund Freud Str 25, D-53127 Bonn, Germany.	markus.noethen@uni-bonn.de	Hampe, Jochen/A-2555-2010; Cichon, Sven/H-8803-2013; Betz, Regina C/E-8591-2011; Nöthen, Markus/B-2027-2009; Cichon, Sven/B-9618-2014; Hillmer, Axel M/B-7485-2015; Hennies, Hans C/G-9424-2014; Hillmer, Axel M/N-2927-2014; Jamra, Rami Abou/I-2350-2012; Abou Jamra, Rami/AAC-8192-2019; Schumacher, Johannes/F-4970-2015; Jamra, Rami Abou/I-4805-2015; Schulze, Thomas G/H-2157-2013	Hampe, Jochen/0000-0002-2421-6127; Cichon, Sven/0000-0002-9475-086X; Betz, Regina C/0000-0001-5024-3623; Nöthen, Markus/0000-0002-8770-2464; Cichon, Sven/0000-0002-9475-086X; Hillmer, Axel M/0000-0002-3381-7266; Hennies, Hans C/0000-0001-7210-2389; Hillmer, Axel M/0000-0002-3381-7266; Jamra, Rami Abou/0000-0002-1542-1399; Abou Jamra, Rami/0000-0002-1542-1399; Schumacher, Johannes/0000-0001-9217-6457; Jamra, Rami Abou/0000-0002-1542-1399; Becker, Tim/0000-0002-6573-1109				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Becker T, 2004, AM J HUM GENET, V75, P561, DOI 10.1086/424390; Becker T, 2004, GENET EPIDEMIOL, V27, P21, DOI 10.1002/gepi.10323; Beilin J, 2000, J MOL ENDOCRINOL, V25, P85, DOI 10.1677/jme.0.0250085; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chang BL, 2002, HUM GENET, V110, P122, DOI 10.1007/s00439-001-0662-6; Choong CS, 1996, MOL ENDOCRINOL, V10, P1527, DOI 10.1210/me.10.12.1527; Ding DC, 2005, PROSTATE, V62, P133, DOI 10.1002/pros.20128; Ding DC, 2004, PROSTATE, V58, P23, DOI 10.1002/pros.10316; Ellis JA, 1998, J INVEST DERMATOL, V110, P849, DOI 10.1046/j.1523-1747.1998.00224.x; Ellis JA, 1999, CLIN SCI, V96, P659, DOI 10.1042/CS19990005; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; FABER PW, 1991, J BIOL CHEM, V266, P10743; FABER PW, 1993, J BIOL CHEM, V268, P9296; Grad JM, 2001, ENDOCRINOLOGY, V142, P1107, DOI 10.1210/en.142.3.1107; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Hawk E, 2000, CANCER EPIDEM BIOMAR, V9, P523; Hillmer AM, 2002, BRIT J DERMATOL, V146, P601, DOI 10.1046/j.1365-2133.2002.04766.x; Hillmer AM, 2001, AM J HUM GENET, V69, P235, DOI 10.1086/321273; Hsing AW, 2000, CANCER RES, V60, P5111; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; Knapp M, 2003, HUM HERED, V56, P2, DOI 10.1159/000073727; KUSTER W, 1984, J AM ACAD DERMATOL, V11, P921, DOI 10.1016/S0190-9622(84)80498-3; LA SA, 1991, NATURE, V352, P77; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Lotufo PA, 2000, ARCH INTERN MED, V160, P165, DOI 10.1001/archinte.160.2.165; Lower KM, 2004, HORM RES, V62, P208, DOI 10.1159/000081064; Matilainen V, 2000, LANCET, V356, P1165, DOI 10.1016/S0140-6736(00)02763-X; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; Nakajima H, 1996, J NEUROL SCI, V142, P12, DOI 10.1016/0022-510X(96)00142-6; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Oh BR, 1998, UROLOGY, V51, P744, DOI 10.1016/S0090-4295(98)00108-3; Sasaki M, 2005, BIOCHEM BIOPH RES CO, V329, P100, DOI 10.1016/j.bbrc.2005.01.104; SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400; Zeegers MP, 2004, CANCER EPIDEM BIOMAR, V13, P1765; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073	41	140	152	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					140	148		10.1086/431425	http://dx.doi.org/10.1086/431425			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15902657	Green Published, Bronze			2022-12-18	WOS:000229794500014
J	Rainier, S; Chai, JH; Tokarz, D; Nicholls, RD; Fink, JK				Rainier, S; Chai, JH; Tokarz, D; Nicholls, RD; Fink, JK			NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN	The hereditary spastic paraplegias (HSPs) are genetically heterogeneous disorders characterized by progressive lower-extremity weakness and spasticity. The molecular pathogenesis is poorly understood. We report discovery of a dominant negative mutation in the NIPA1 gene in a kindred with autosomal dominant HSP (ADHSP), linked to chromosome 15q11-q13 (SPG6 locus); and precisely the same mutation in an unrelated kindred with ADHSP that was too small for meaningful linkage analysis. NIPA1 is highly expressed in neuronal tissues and encodes a putative membrane transporter or receptor. Identification of the NIPA1 function and ligand will aid an understanding of axonal neurodegeneration in HSP and may have important therapeutic implications.	Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI USA; Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Fink, JK (corresponding author), Univ Michigan, Dept Neurol, Room 5214 CCGCB,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jkfink@umich.edu			NICHD NIH HHS [R01 HD031491, HD31491] Funding Source: Medline; NIEHS NIH HHS [ES10631, R01 ES010631] Funding Source: Medline; NINDS NIH HHS [R01NS36177, R01NS38713, R01NS33645] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033645, R01NS036177, R01NS038713] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; FINK JK, 1995, NEUROLOGY, V45, P325, DOI 10.1212/WNL.45.2.325; FINK JK, 1995, AM J HUM GENET, V56, P188; Fink JK, 2002, ANN NEUROL, V51, P669, DOI 10.1002/ana.10258; Fink JK, 1999, SEMIN NEUROL, V19, P301, DOI 10.1055/s-2008-1040846; FINK JK, 2001, EMERY RIMOINS PRINCI, P3124; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hedera P, 2000, NEUROLOGY, V55, P1591, DOI 10.1212/WNL.55.10.1591; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Rainier SR, 2000, AM J HUM GENET, V67, P391; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758	17	140	155	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					967	971		10.1086/378817	http://dx.doi.org/10.1086/378817			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	14508710	Green Published, Bronze			2022-12-18	WOS:000185676100022
J	Zhao, LP; Li, SYS; Khalid, N				Zhao, LP; Li, SYS; Khalid, N			A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; HUMAN GENOME; POPULATION; SEQUENCE; MODELS; RISK; GENE; CASE/CONTROL; FREQUENCIES; DIVERSITY	The rough draft of the human genome map has been used to identify most of the functional genes in the human genome, as well as to identify nucleotide variations, known as "single-nucleotide polymorphisms" (SNPs), in these genes. By use of advanced biotechnologies, researchers are beginning to genotype thousands of SNPs from biological samples. Among the many possible applications, one of them is the study of SNP associations with complex human diseases, such as cancers or coronary heart diseases, by using a case-control study design. Through the gathering of environmental risk factors and other lifestyle factors, such a study can be effectively used to investigate interactions between genes and environmental factors in their associations with disease phenotype. Earlier, we developed a method to statistically construct individuals' haplotypes and to estimate the distribution of haplotypes of multiple SNPs in a defined population, by use of estimating-equation techniques. Extending this idea, we describe here an analytic method for assessing the association between the constructed haplotypes along with environmental factors and the disease phenotype. This method is also robust to the model assumptions and is scalable to a large number of SNPs. Asymptotic properties of estimations in the method are proved theoretically and are tested for finite sample sizes by use of simulations. To demonstrate the use of the method, we applied it to assess the possible association between apolipoprotein CIII (six coding SNPs) and restenosis by using a case-control data set. Our analysis revealed two haplotypes that may reduce the risk of restenosis.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Enodar Biolog Corp, Issaquah, WA USA	Fred Hutchinson Cancer Center	Zhao, LP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,Mailstop MW-805, Seattle, WA 98109 USA.	lzhao@fhcrc.org						Breslow NE, 1980, STAT METHODS CANC RE; Britton JA, 2002, AM J EPIDEMIOL, V156, P507, DOI 10.1093/aje/kwf065; Chakravarti A, 1998, NAT GENET, V19, P216, DOI 10.1038/885; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; COX DR, 1972, J ROY STAT SOC C-APP, V21, P113, DOI 10.2307/2346482; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; GODAMBE VP, 1960, ANN MATH STAT, V31, P1208, DOI 10.1214/aoms/1177705693; Hallman DM, 1999, ANN HUM GENET, V63, P499, DOI 10.1017/S000348009900785X; Hartl DL, 1997, PRINCIPLES POPULATIO; HAVILAND MB, 1995, ANN HUM GENET, V59, P211, DOI 10.1111/j.1469-1809.1995.tb00742.x; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Khoury M, 1993, FUNDAMENTALS GENETIC; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI S, IN PRESS BIOSTATISTI; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; PRENTICE RL, 1986, BIOMETRICS, V42, P109, DOI 10.2307/2531247; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schlesselman James J., 1982, CASE CONTROL STUDIES; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogelstein B., 1998, GENETIC BASIS HUMAN; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WESTON A, 1992, CANCER EPIDEM BIOMAR, V1, P481; Whittemore Alice S., 1995, Biometrika, V82, P57, DOI 10.1093/biomet/82.1.57; WIJSMAN EM, 1987, AM J HUM GENET, V41, P356; Zee R. Y. L., 2002, Pharmacogenomics Journal, V2, P197, DOI 10.1038/sj.tpj.6500101; Zheng CX, 1999, GENET EPIDEMIOL, V17, P79, DOI 10.1002/(SICI)1098-2272(1999)17:2<79::AID-GEPI1>3.0.CO;2-N	43	140	151	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1231	1250		10.1086/375140	http://dx.doi.org/10.1086/375140			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12704570	Bronze, Green Published			2022-12-18	WOS:000182474400015
J	Lin, S; Cutler, DJ; Zwick, ME; Chakravarti, A				Lin, S; Cutler, DJ; Zwick, ME; Chakravarti, A			Haplotype inference in random population samples	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FREQUENCY ESTIMATION; RECONSTRUCTION; SUSCEPTIBILITY	Contemporary genotyping and sequencing methods do not provide information on linkage phase in diploid organisms. The application of statistical methods to infer and reconstruct linkage phase in samples of diploid sequences is a potentially time- and labor-saving method. The Stephens-Smith-Donnelly (SSD) algorithm is one such method, which incorporates concepts from population genetics theory in a Markov chain-Monte Carlo technique. We applied a modified SSD method, as well as the expectation-maximization and partition-ligation algorithms, to sequence data from eight loci spanning >1 Mb on the human X chromosome. We demonstrate that the accuracy of the modified SSD method is better than that of the other algorithms and is superior in terms of the number of sites that may be processed. Also, we find phase reconstructions by the modified SSD method to be highly accurate over regions with high linkage disequilibrium (LD). If only polymorphisms with a minor allele frequency >0.2 are analyzed and scored according to the fraction of neighbor relations correctly called, reconstructions are 95.2% accurate over entire 100-kb stretches and are 98.6% accurate within blocks of high LD.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA	Johns Hopkins University	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA.	aravinda@jhmi.edu		Lin, Shin/0000-0003-0118-0413; Zwick, Michael/0000-0001-9772-8257	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG002343, R01HG001847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060007] Funding Source: NIH RePORTER; NHGRI NIH HHS [F32 HG002343-02, F32 HG002343, F32 HG002343-03, HG01847, F32 HG002343-01] Funding Source: Medline; NIGMS NIH HHS [GM07309, T32 GM007309] Funding Source: Medline; NIMH NIH HHS [MH60007, R01 MH060007] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Lazzeroni LC, 2001, STAT METHODS MED RES, V10, P57, DOI 10.1191/096228001666442347; LEWONTIN RC, 1988, GENETICS, V120, P849; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; PUFFETT D, 1994, MUSIC ANAL, V13, P3; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sokal R.R., 1981, BIOMETRY, V2nd ed.; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stephens M, 2001, AM J HUM GENET, V69, P912, DOI 10.1086/323623; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254; Zhang SL, 2001, AM J HUM GENET, V69, P906, DOI 10.1086/323622; [No title captured]	24	140	147	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1129	1137		10.1086/344347	http://dx.doi.org/10.1086/344347			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12386835	Bronze, Green Published			2022-12-18	WOS:000178884300010
J	Evans, JC; Frayling, TM; Cassell, PG; Saker, PJ; Hitman, GA; Walker, M; Levy, JC; O'Rahilly, S; Rao, PVS; Bennett, AJ; Jones, EC; Menzel, S; Prestwich, P; Simecek, N; Wishart, M; Dhillon, R; Fletcher, C; Millward, A; Demaine, A; Wilkin, T; Horikawa, Y; Cox, NJ; Bell, GI; Ellard, S; McCarthy, MI; Hattersley, AT				Evans, JC; Frayling, TM; Cassell, PG; Saker, PJ; Hitman, GA; Walker, M; Levy, JC; O'Rahilly, S; Rao, PVS; Bennett, AJ; Jones, EC; Menzel, S; Prestwich, P; Simecek, N; Wishart, M; Dhillon, R; Fletcher, C; Millward, A; Demaine, A; Wilkin, T; Horikawa, Y; Cox, NJ; Bell, GI; Ellard, S; McCarthy, MI; Hattersley, AT			Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; POLYMORPHISM; MUTATIONS	Variation in CAPN10, the gene encoding the ubiquitously expressed cysteine protease calpain-10, has been associated with type 2 diabetes in Mexican Americans and in two northern-European populations, from Finland and Germany. We have studied CAPN10 in white subjects of British/Irish ancestry, using both family-based and case-control studies. In 743 sib pairs, there was no evidence of linkage at the CAPN10 locus, which thereby excluded it as a diabetes-susceptibility gene, with an overall sib recurrence risk, lambda (S), of 1.25. We examined four single-nucleotide polymorphisms (SNP-44, -43, -19, and -63) previously either associated with type 2 diabetes or implicated in transcriptional regulation of calpain-10 expression. We did not find any association between SNP-43, -19, and -63, either individually or as part of the previously described risk haplotypes. We did, however, observe significantly increased (P = .033) transmission of the less common C allele at SNP-44, to affected offspring in parents-offspring trios (odds ratio 1.6). An independent U.K. case-control study and a small discordant-sib study did not show significant association individually. In a combined analysis of all U.K. studies (P = .015) and in combination with a Mexican American study (P = .004), the C allele at SNP-44 is associated with type 2 diabetes. Sequencing of the coding region of CAPN10 in a group of U.K. subjects revealed four coding polymorphisms-L34V, T504A, R555C, and V666I. The T504A polymorphism was in perfect linkage disequilibrium with the diabetes-associated C allele at SNP-44, suggesting that the synthesis of a mutant protein and/or altered transcriptional regulation could contribute to diabetes risk. In conclusion, we were not able to replicate the association of the specific calpain-10 alleles identified by Horikawa et al. but suggest that other alleles at this locus may increase type 2 diabetes risk in the U.K. population.	Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Diabet & Vasc Med, Exeter EX2 5AX, Devon, England; Univ London, Queen Mary, St Bartholomews & Royal London Sch Med & Dent, Dept Diabet & Metab Med, London, England; Univ London Imperial Coll Sci Technol & Med, Imperial Coll Genet, London, England; Univ London Imperial Coll Sci Technol & Med, Genom Res Inst, London, England; Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; Univ Newcastle Upon Tyne, Sch Med, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Radcliffe Infirm, Diabet Res Labs, Oxford OX2 6HE, England; Wellcome Trust Ctr Human Genet, Oxford, England; Univ Cambridge, Dept Med & Clin Biochem, Cambridge, England; Univ Plymouth, Plymouth Postgrad Med Sch, Plymouth PL4 8AA, Devon, England; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Exeter; University of London; Queen Mary University London; Imperial College London; Imperial College London; Imperial College London; Newcastle University - UK; Radcliffe Infirmary; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; University of Plymouth; University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Hattersley, AT (corresponding author), Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Diabet & Vasc Med, Barrack Rd, Exeter EX2 5AX, Devon, England.	A.T.Hattersley@exeter.ac.uk	Menzel, Stephan/U-6906-2019; O'Rahilly, Stephen/ABF-6509-2020; McCarthy, Mark/M-3763-2015	O'Rahilly, Stephen/0000-0003-2199-4449; Levy, Jonathan/0000-0002-9486-1885; Frayling, Timothy/0000-0001-8362-2603; Hattersley, Andrew/0000-0001-5620-473X; Menzel, Stephan/0000-0002-1590-9108; Ellard, Sian/0000-0002-7620-5526; McCarthy, Mark/0000-0002-4393-0510; bennett, amanda/0000-0003-2140-8710				Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Frayling TM, 2000, J CLIN ENDOCR METAB, V85, P853, DOI 10.1210/jc.85.2.853; Frayling TM, 1999, DIABETES, V48, P2475, DOI 10.2337/diabetes.48.12.2475; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Macfarlane WM, 1999, J CLIN INVEST, V104, pR33, DOI 10.1172/JCI7449; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714	14	140	147	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					544	552		10.1086/323315	http://dx.doi.org/10.1086/323315			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11481585	Green Published, Bronze			2022-12-18	WOS:000170271400007
J	Bovee, JVMG; Cleton-Jansen, AM; Wuyts, W; Caethoven, G; Taminiau, AHM; Bakker, E; Van Hul, W; Cornelisse, CJ; Hogendoorn, PCW				Bovee, JVMG; Cleton-Jansen, AM; Wuyts, W; Caethoven, G; Taminiau, AHM; Bakker, E; Van Hul, W; Cornelisse, CJ; Hogendoorn, PCW			EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; CYTOMETRIC DNA ANALYSIS; MULTIPLE EXOSTOSES; BREAST-CARCINOMA; MARKERS; POLYMORPHISMS; CHROMOSOME-11; HETEROGENEITY; CLONING; CELLS	Osteochondromas occur as sporadic solitary lesions or as multiple lesions, characterizing the hereditary multiple exostoses syndrome (EXT). Approximately 15% of all chondrosarcomas arise within the cartilaginous cap of an osteochondroma. EXT is genetically heterogeneous, and two genes, EXT1 and EXT2, located on 8q24 and 11p11-p12, respectively, have been cloned. It is still unclear whether osteochondroma is a developmental disorder or a true neoplasm. Furthermore, it is unclear whether inactivation of both alleles of an EXT gene, according to the tumor-suppressor model, is required for osteochondroma development, or whether a single EXT germline mutation acts in a dominant negative way. We therefore studied loss of heterozygosity and DNA ploidy in eight sporadic and six hereditary osteochondromas. EXT1- and EXT2-mutation analysis was performed in a total of 34 sporadic and hereditary osteochondromas and secondary peripheral chondrosarcomas. We demonstrated osteochondroma to be a true neoplasm, since aneuploidy was found in 4 of 10 osteochondromas. Furthermore, LOH was almost exclusively found at the EXT1 locus in 5 of 14 osteochondromas. Four novel constitutional cDNA alterations were detected in exon I of EXT1. Two patients with multiple osteochondromas demonstrated a germline mutation combined with loss of the remaining wild-type allele in three osteochondromas, indicating that, in cartilaginous cells of the growth plate, inactivation of both copies of the EXT1 gene is required for osteochondroma formation in hereditary cases. In contrast, no somatic EXT1 cDNA alterations were found in sporadic osteochondromas. No mutations were found in the EXT2 gene.	Leiden Univ, Ctr Med, Dept Pathol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Ctr Med, Dept Orthoped Surg, NL-2300 RC Leiden, Netherlands; Leiden Univ, Ctr Med, Dept Human Genet, NL-2300 RC Leiden, Netherlands; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Antwerp	Bovee, JVMG (corresponding author), Leiden Univ, Ctr Med, Dept Pathol, POB 9600,L1-Q, NL-2300 RC Leiden, Netherlands.	JBovee@Pat.azl.nl	Bakker, Egbert/D-3525-2009; Hogendoorn, Pancras/O-6494-2019; Hogendoorn, Pancras C.W./H-5859-2015; wuyts, wim/B-1346-2012; wuyts, wim/B-6262-2017	Bakker, Egbert/0000-0002-2843-7357; Hogendoorn, Pancras/0000-0002-1513-8104; Hogendoorn, Pancras C.W./0000-0002-1513-8104; wuyts, wim/0000-0002-4349-9038; wuyts, wim/0000-0002-4349-9038; Bovee, Judith/0000-0003-1155-0481; Van Hul, Wim/0000-0002-5065-7858				AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BOVEE JVM, IN PRESS GENES CHROM; Bridge JA, 1998, CANCER-AM CANCER SOC, V82, P1657, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1657::AID-CNCR10>3.0.CO;2-3; CONRAD M, 1983, BIOSYSTEMS, V16, P101, DOI 10.1016/0303-2647(83)90031-X; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; DEVILEE P, 1991, CANCER RES, V51, P1020; DEVILEE P, 1991, ONCOGENE, V6, P311; Dorfman H.D., 1998, BONE TUMORS; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GRUIS NA, 1993, BRIT J CANCER, V68, P308, DOI 10.1038/bjc.1993.333; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Hecht JT, 1997, AM J HUM GENET, V60, P80; HIDDEMANN W, 1984, CANCER GENET CYTOGEN, V13, P181, DOI 10.1016/0165-4608(84)90059-1; Huvos A, 1991, BONE TUMORS DIAGNOSI; ISOLA J, 1994, AM J PATHOL, V145, P1301; Jagasia AA, 1996, CANCER LETT, V105, P91, DOI 10.1016/0304-3835(96)04274-7; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LegeaiMallet L, 1997, CLIN GENET, V52, P12; LegeaiMallet L, 1997, HUM GENET, V99, P298, DOI 10.1007/s004390050361; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; MCCORD JM, 1998, OXIDAT STRESS DIS, V1, P1; MERTENS F, 1994, GENE CHROMOSOME CANC, V9, P8, DOI 10.1002/gcc.2870090103; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mulder JD, 1993, RADIOLOGIC ATLAS BON; Philippe C, 1997, AM J HUM GENET, V61, P520, DOI 10.1086/515505; Raskind WH, 1996, GENE CHROMOSOME CANC, V16, P138, DOI 10.1002/(SICI)1098-2264(199606)16:2<138::AID-GCC8>3.0.CO;2-0; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Raskind WH, 1998, HUM MUTAT, V11, P231, DOI 10.1002/(SICI)1098-1004(1998)11:3<231::AID-HUMU8>3.0.CO;2-K; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; Springfield DS, 1996, J BONE JOINT SURG AM, V78A, P141, DOI 10.2106/00004623-199601000-00019; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; VINDELOV LL, 1983, CYTOMETRY, V3, P328, DOI 10.1002/cyto.990030504; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; WEBER JL, 1989, AM J HUM GENET, V44, P388; Wells DE, 1997, HUM GENET, V99, P612, DOI 10.1007/s004390050415; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; Willms R, 1997, INT ORTHOP, V21, P133, DOI 10.1007/s002640050136; Wuyts W, 1996, HUM MOL GENET, V5, P1547, DOI 10.1093/hmg/5.10.1547; Wuyts W, 1998, AM J HUM GENET, V62, P346, DOI 10.1086/301726; Yamaguchi T, 1996, ANTICANCER RES, V16, P2009	44	140	147	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					689	698		10.1086/302532	http://dx.doi.org/10.1086/302532			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441575	Green Published, Bronze			2022-12-18	WOS:000082426400013
J	Starikovskaya, YB; Sukernik, RI; Schurr, TG; Kogelnik, AM; Wallace, DC				Starikovskaya, YB; Sukernik, RI; Schurr, TG; Kogelnik, AM; Wallace, DC			mtDNA diversity in Chukchi and Siberian Eskimos: Implications for the genetic history of ancient Beringia and the peopling of the New World	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA ANALYSIS; NATIVE-AMERICAN; NORTHEASTERN SIBERIA; EVOLUTIONARY HISTORY; MAXIMUM-LIKELIHOOD; CONTROL REGION; POPULATIONS; POLYMORPHISMS; HAPLOGROUPS; REVEALS	The mtDNAs of 145 individuals representing the aboriginal populations of Chukotka-the Chukchi and Siberian Eskimos-were subjected to RFLP analysis and control-region sequencing. This analysis showed that the core of the genetic makeup of the Chukchi and Siberian Eskimos consisted of three (A, C, and D) of the four primary mtDNA haplotype groups (haplogroups) (A-D) observed in Native Americans, with haplogroup A being the most prevalent in both Chukotkan populations. Two unique haplotypes belonging to haplogroup G (formerly called "other" mtDNAs) were also observed in a, few Chukchi, and these have apparently been;acquired through gene flow from adjacent Kamchatka, where haplogroup G is prevalent in the Koryak and Itel'men. In addition, a 16111C-->T transition appears to delineate an "American" enclave of haplogroup A mtDNAs in northeastern Siberia, whereas the 16192C-->T transition demarcates a "northern Pacific Rim" cluster within this haplogroup. Furthermore, the sequence-divergence estimates for haplogroups A, C, and D of Siberian and Native American populations indicate that the earliest inhabitants of Beringia possessed a limited number of founding mtDNA haplotypes and that the first humans expanded into the New World similar to 34,000 years before present (YBP). Subsequent migration 16,000-13,000 YBP apparently brought a restricted number of haplogroup B haplotypes to the Americas. For millennia, Beringia may have been the repository of the respective founding sequences that selectively penetrated into northern North America from western Alaska.	Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Anthropol, Atlanta, GA 30322 USA; Russian Acad Sci, Lab Human Mol Genet, Inst Cytol & Genet, Novosibirsk, Russia; Russian Acad Sci, Chukotkan Res Ctr, Far Eastern Div, Anadyr, Chukotkan Auton, Russia	Emory University; Emory University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Sciences	Wallace, DC (corresponding author), Emory Univ, Sch Med, Ctr Mol Med, 1462 Clifton Rd NE, Atlanta, GA 30322 USA.	dwallace@gmm.gen.emory.edu	Starikovskaya, Elena/N-5636-2015; Schurr, Theodore G/A-1336-2007; Sukernik, Rem I/N-6990-2015		NHLBI NIH HHS [HL45572] Funding Source: Medline; NIA NIH HHS [AG13154] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ARUTIUNOV SA, 1982, WHALE ALLEY; BALLINGER SW, 1992, GENETICS, V130, P139; Bendall KE, 1996, AM J HUM GENET, V59, P1276; BOGORAS W, 1910, PUBLICATION JESUP 1, V8; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Bonnichsen R., 1991, CLOVIS ORIGINS ADAPT, P309; Bryan AlanL., 1991, CLOVIS ORIGINS ADAPT, P15; BUTZER KW, 1991, 1 AM SEARCH RES, P137; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHEN YS, 1995, AM J HUM GENET, V57, P133; DELAGUNA F, 1988, CROSSROADS CONTINENT, P58; DIKOV NN, 1994, ANTHR PACIFIC RIM, P87; Dillehay Thomas D., 1997, MONTE VERDE LATE PLE, V2; DOLGIKH BO, 1960, AN SSSR T I ETNOGRAF, V55; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Forster P, 1996, AM J HUM GENET, V59, P935; Fox CL, 1996, HUM BIOL, V68, P855; GOEBEL T, 1995, ANTIQUITY, V69, P349, DOI 10.1017/S0003598X00064747; GONDATTI NL, 1897, P AMUR DIVISION RU 1, V3, P166; HARPER AB, 1980, ANN HUM BIOL, V7, P547, DOI 10.1080/03014468000004661; HAYNES CV, 1992, RADIOCARBON AFTER FOUR DECADES, P355; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Horai S, 1996, AM J HUM GENET, V59, P579; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Howell N, 1996, AM J HUM GENET, V59, P501; Huoponen K, 1997, EUR J HUM GENET, V5, P25, DOI 10.1159/000484728; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; JUKES T H, 1969, P21; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King ML, 1996, SCIENCE, V273, P634, DOI 10.1126/science.273.5275.634; Kolman CJ, 1996, GENETICS, V142, P1321; Krauss ME, 1988, CROSSROADS CONTINENT, P145; Krauss N., 1994, ANTHR PACIFIC RIM, P365; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; Lorenz JG, 1996, AM J PHYS ANTHROPOL, V101, P307, DOI 10.1002/(SICI)1096-8644(199611)101:3<307::AID-AJPA1>3.0.CO;2-W; MENOVSHCHIKOV GA, 1959, ESKIMOSI MAGADANSKOE; Merriwether DA, 1996, AM J HUM GENET, V59, P204; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; NEEL JV, 1994, P NATL ACAD SCI USA, V91, P10737, DOI 10.1073/pnas.91.22.10737; NEI M, 1983, GENETICS, V105, P207; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; ROGERS RA, 1991, J BIOGEOGR, V18, P623, DOI 10.2307/2845543; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Rudenko Sergei I., 1947, ANCIENT CULTURE BERI; SAITOU N, 1989, MOL BIOL EVOL, V6, P514; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SCHURR TG, IN PRESS AM J PHYS A; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; STANFORD D, 1991, 1 AM SEARCH RES, P1; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Sukernik RI, 1996, GENETIKA+, V32, P432; SUKERNIK RI, 1986, GENETIKA+, V22, P2369; SUKERNIK RI, 1992, SOC ST HUM, V33, P107; SWOFFORD D. L., 1994, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; VIGILANT L, 1990, THESIS U CALIFORNIA; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLNER AS, 1995, J APPL POLYM SCI, V57, P1, DOI 10.1002/app.1995.070570101; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WRIGHT HE, 1991, 1 AM SEARCH RES, P113; YOUNG SB, 1988, CROSSROADS CONTINENT, P106	74	140	146	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1473	1491		10.1086/302087	http://dx.doi.org/10.1086/302087			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	138QZ	9792876	Green Published, Bronze			2022-12-18	WOS:000076985200025
J	RaveHarel, N; Kerem, E; NissimRafinia, M; Madjar, I; Goshen, R; Augarten, A; Rahat, A; Hurwitz, A; Darvasi, A; Kerem, B				RaveHarel, N; Kerem, E; NissimRafinia, M; Madjar, I; Goshen, R; Augarten, A; Rahat, A; Hurwitz, A; Darvasi, A; Kerem, B			The molecular basis of partial penetrance of splicing mutations in cystic fibrosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL BILATERAL ABSENCE; TRANSMEMBRANE CONDUCTANCE REGULATOR; VAS-DEFERENS; CFTR GENE; IDENTIFICATION; EXPRESSION; MEN; DNA; ASSOCIATION; NUCLEOTIDE	The splicing variant, 5T allele, in intron 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene was shown to be associated with partial penetrance of the clinical expression, This splicing variant leads to two possible transcripts: one normal and the other aberrantly spliced that lacks exon 9. The aim of this study was to analyze the molecular basis of the partial penetrance in individuals carrying the 5T allele, We analyzed the level of the correctly spliced RNA transcribed from the 5T allele in nasal and epididymal epithelium and correlated it with disease expression. Semiquantitative nondifferential reverse-transcriptase-PCR showed a considerable variability (6%-37%) in the total level of correctly spliced RNA transcribed from the 5T allele in nasal epithelium from 11 patients, A significant nonlinear correlation (r = .82, P = .002) between the level of the normal CFTR transcripts and the severity of lung disease was shown, No individuals with normal lung function and minimal or no lung disease (FEV(1) >80% predicted) had <25% of normal transcripts, and individuals with <15% of normal transcripts did not have FEV(1) >80%, The level of normal transcripts in epididymal epithelial cells from four infertile males with congenital bilateral absence of the vas deferens was low (6%-24%), In infertile males with normal lung function the level of correctly spliced transcripts in the nasal epithelium was higher than the level in the epididymal epithelium. These results indicate that there is variability in the efficiency of the splicing mechanism, among different individuals and between different organs of the same individual, This variability provides the molecular basis of the partial penetrance of cystic fibrosis disease in patients carrying the 5T allele.	HEBREW UNIV JERUSALEM, INST LIFE SCI, DEPT GENET, IL-91904 JERUSALEM, ISRAEL; HEBREW UNIV JERUSALEM, INST LIFE SCI, DEPT BIOCHEM, IL-91904 JERUSALEM, ISRAEL; SHAARE ZEDEK MED CTR, DEPT PEDIAT, JERUSALEM, ISRAEL; SHAARE ZEDEK MED CTR, CYST FIBROSIS CLIN, JERUSALEM, ISRAEL; HADASSAH UNIV HOSP, DEPT OBSTET & GYNAECOL, IL-91120 JERUSALEM, ISRAEL; CHAIM SHEBA MED CTR, DEPT UROL, RAMAT GAN, ISRAEL; CHAIM SHEBA MED CTR, DEPT PEDIAT, RAMAT GAN, ISRAEL	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Chaim Sheba Medical Center								ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; ARREDONDOVEGA FX, 1994, AM J HUM GENET, V54, P820; CASALS T, 1995, HUM GENET, V95, P205; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; CHILLON M, 1995, AM J HUM GENET, V56, P623; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; COSTES B, 1995, EUR J HUM GENET, V3, P285; CULARD JF, 1994, HUM GENET, V93, P467; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; JARVI K, 1995, LANCET, V345, P1578, DOI 10.1016/S0140-6736(95)91131-6; Kerem B, 1996, EUR J HUM GENET, V4, P65; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM BS, 1989, AM J HUM GENET, V44, P827; KEREM E, 1995, HUM GENET, V96, P193, DOI 10.1007/BF00207378; KEREM E, IN PRESS AM J RESP C; KISHIMOTO TK, 1989, J BIOL CHEM, V264, P3588; MCINNES B, 1992, J CLIN INVEST, V90, P306, DOI 10.1172/JCI115863; MERCIER B, 1995, AM J HUM GENET, V56, P272; OATES RD, 1994, J ANDROL, V15, P1; OSBORNE L, 1991, AM J HUM GENET, V48, P608; OSBORNE LR, 1993, HUM MOL GENET, V2, P1605, DOI 10.1093/hmg/2.10.1605; PATRIZIO P, 1993, HUM REPROD, V8, P215, DOI 10.1093/oxfordjournals.humrep.a138025; Pignatti PF, 1996, AM J HUM GENET, V58, P889; Polgar G, 1971, PULMONARY FUNCTION T; RAVEHAREL N, 1995, AM J HUM GENET, V56, P1359; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; *SAS I, 1985, SAS US GUID; SCHELLEN TMCM, 1980, FERTIL STERIL, V34, P401; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; TIZZANO EF, 1994, AM J PATHOL, V144, P906; TREZISE AEO, 1993, HUM MOL GENET, V2, P213, DOI 10.1093/hmg/2.3.213; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; WEATHERALL DJ, 1989, METABOLIC BASIS INHE, P2281; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	39	140	143	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					87	94						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981951				2022-12-18	WOS:A1997WA81800014
J	MERCIER, B; VERLINGUE, C; LISSENS, W; SILBER, SJ; NOVELLI, G; BONDUELLE, M; AUDREZET, MP; FEREC, C				MERCIER, B; VERLINGUE, C; LISSENS, W; SILBER, SJ; NOVELLI, G; BONDUELLE, M; AUDREZET, MP; FEREC, C			IS CONGENITAL BILATERAL ABSENCE OF VAS-DEFERENS A PRIMARY FORM OF CYSTIC-FIBROSIS - ANALYSES OF THE CFTR GENE IN 67 PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; GRADIENT GEL-ELECTROPHORESIS; IDENTIFICATION; MUTATIONS; SEQUENCE; POLYMORPHISM; POPULATION; REGIONS; CLONING; MEN	Congenital bilateral absence of the vas deferens (CBAVD) is an important cause of sterility in men. Although the genetic basis of this condition is still unclear, it has been shown recently that some of these patients carry mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) genes. To extend this observation, we have analyzed the entire coding sequence of the CFTR gene in a cohort of 67 men with CBAVD, who are otherwise healthy. We have identified four novel missense mutations (A800G, G149R, R258G, and E193K). We have shown that 42% of subjects were carriers of one CFTR allele and that 24% are compound heterozygous for CFTR alleles. Thus, we have been unable to identify 76% of these patients as carrying two CFTR mutations. Furthermore, we have described the segregation of CFTR haplotypes in the family of one CBAVD male; in this family are two male siblings, with identical CFTR loci but displaying different phenotypes, one of them being fertile and the other sterile. The data presented in this family, indicating a discordance between the CBAVD phenotype and a marked carrier (Delta F508) chromosome, support the involvement of another gene(s), in the etiology of CBAVD.	CTR DEPT TRANSFUS SANGUINE, CTR BIOGENET, F-29275 BREST, FRANCE; VRIJE UNIV BRUSSELS HOSP, BRUSSELS, BELGIUM; ST LUKES HOSP, ST LOUIS, MO USA; UNIV CATTOLICA SACRO CUORE, ROME, ITALY	Vrije Universiteit Brussel; Saint Luke's Hospital - Missouri; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli			Lissens, Willy/B-2892-2013; Novelli, Giuseppe/A-5195-2013; Ferec, Claude/ABG-9699-2020; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/GQB-3329-2022	Lissens, Willy/0000-0003-3875-9955; Novelli, Giuseppe/0000-0002-7781-602X; Ferec, Claude/0000-0002-2325-0710; Novelli, Giuseppe/0000-0002-7781-602X				ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; AUDREZET MP, 1993, HUM MOL GENET, V2, P51, DOI 10.1093/hmg/2.1.51; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CLAUSTRES M, 1993, HUM MOL GENET, V2, P1209, DOI 10.1093/hmg/2.8.1209; CULARD JF, 1994, HUM GENET, V93, P467; CUPPENS H, 1993, GENOMICS, V18, P693, DOI 10.1016/S0888-7543(05)80376-3; DORK T, 1991, HUM GENET, V87, P441; DUMUR V, 1990, LANCET, V336, P512, DOI 10.1016/0140-6736(90)92066-Q; FANEN P, 1992, GENOMICS, V13, P770, DOI 10.1016/0888-7543(92)90152-I; FEIGELSON J, 1969, ARCH FR PEDIATR, V26, P937; FEREC C, 1992, NAT GENET, V1, P188, DOI 10.1038/ng0692-188; FODDE R, 1994, HUM MUTAT, V3, P83, DOI 10.1002/humu.1380030202; GAUCHER C, 1992, BRIT J HAEMATOL, V82, P73, DOI 10.1111/j.1365-2141.1992.tb04596.x; GERVAIS R, 1993, NEW ENGL J MED, V328, P446, DOI 10.1056/NEJM199302113280619; HOLSCLAW DS, 1971, J UROLOGY, V106, P568, DOI 10.1016/S0022-5347(17)61343-0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; MERCIER B, 1993, GENOMICS, V16, P296, DOI 10.1006/geno.1993.1183; MERCIER B, 1993, HUM MUTAT, V2, P16, DOI 10.1002/humu.1380020104; MORRAL N, 1992, GENOMICS, V13, P1362, DOI 10.1016/0888-7543(92)90071-Y; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; MORRAL N, 1992, HUM GENET, V88, P356; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; OSBORNE LR, 1993, HUM MOL GENET, V2, P1605, DOI 10.1093/hmg/2.10.1605; PATRIZIO P, 1993, HUM REPROD, V8, P215, DOI 10.1093/oxfordjournals.humrep.a138025; RIGOT JM, 1991, NEW ENGL J MED, V325, P64; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SILBER SJ, 1990, NEW ENGL J MED, V323, P1788, DOI 10.1056/NEJM199012273232602; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; Tucker Stephen J., 1992, Human Molecular Genetics, V1, P77, DOI 10.1093/hmg/1.2.77; VERLINGUE C, 1993, PRENATAL DIAG, V13, P1143, DOI 10.1002/pd.1970131210; YORIFUJI T, 1991, GENOMICS, V10, P547, DOI 10.1016/0888-7543(91)90434-G	35	140	141	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					272	277						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7529962				2022-12-18	WOS:A1995QC10100035
J	NYSTROMLAHTI, M; PARSONS, R; SISTONEN, P; PYLKKANEN, L; AALTONEN, LA; LEACH, FS; HAMILTON, SR; WATSON, P; BRONSON, E; CAVALIERI, J; LYNCH, J; LANSPA, S; SMYRK, T; LYNCH, P; DROUHARD, T; KINZLER, KW; VOGELSTEIN, B; LYNCH, HT; DELACHAPELLE, A; PELTOMAKI, P				NYSTROMLAHTI, M; PARSONS, R; SISTONEN, P; PYLKKANEN, L; AALTONEN, LA; LEACH, FS; HAMILTON, SR; WATSON, P; BRONSON, E; CAVALIERI, J; LYNCH, J; LANSPA, S; SMYRK, T; LYNCH, P; DROUHARD, T; KINZLER, KW; VOGELSTEIN, B; LYNCH, HT; DELACHAPELLE, A; PELTOMAKI, P			MISMATCH REPAIR GENES ON CHROMOSOMES 2P AND 3P ACCOUNT FOR A MAJOR SHARE OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER FAMILIES EVALUABLE BY LINKAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYNCH-SYNDROME-II; MICROSATELLITE INSTABILITY; ENDOMETRIAL CARCINOMA; TUMOR SPECTRUM; COLON-CANCER; MUTATIONS; DIAGNOSIS; HOMOLOG	Two susceptibility loci for hereditary nonpolyposis colerectal cancer (HNPCC) have been identified, and each contains a mismatch repair gene: MSH2 on chromosome 2p and MLH1 on chromosome 3p. We studied the involvement of these loci in 13 large HNPCC kindreds originating from three different continents. Six families showed close linkage to the 2p locus, and a heritable mutation of the MSH2 gene was subsequently found in four. The 2p-linked kindreds included a family characterized by the lack of extracolonic manifestations (Lynch I syndrome), as well as two families with cutaneous manifestations typical of the Muir-Torre syndrome. Four families showed evidence for linkage to the 3p locus, and a heritable mutation of the MLH1 gene was later detected in three. One 3p-linked kindred was of Amerindian origin. Of the remaining three families studied for linkage, one showed lod scores compatible with exclusion of both MSH2. and MLH1, while led scores obtained in the other two families suggested exclusion of one HNPCC locus (MSH2 or MLH1) but were uninformative for markers flanking the other locus. Our results suggest that mismatch repair genes on 2p and 3p account for a major share of HNPCC in kindreds that can be evaluated by linkage analysis.	UNIV HELSINKI,DEPT MED GENET,SF-00014 HELSINKI,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,SF-00310 HELSINKI,FINLAND; JOHNS HOPKINS UNIV,SCH MED,JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; CLARKSON HOSP,OMAHA,NE; CREIGHTON UNIV,SCH MED,OMAHA,NE 68178; NAVAJO AREA INDIAN HLTH SERV,TUBA CITY,AZ; UNIV TEXAS,MD ANDERSON CANC CTR,HOUSTON,TX	University of Helsinki; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Creighton University; University of Texas System; UTMD Anderson Cancer Center			Lanspa, Stephen/AAM-1739-2020; Aaltonen, Lauri/A-5375-2010	Aaltonen, Lauri/0000-0001-6839-4286; Nystrom, Minna/0000-0003-0827-0243; Peltomaki, Paivi/0000-0001-8819-2980; Parsons, Ramon/0000-0002-6656-3514	NCI NIH HHS [CA 47527, CA 57435, CA 35494] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047527, R01CA035494, R37CA035494] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FUJII H, 1989, J BIOL CHEM, V264, P10057; HAKALA T, 1991, CANCER, V68, P1656, DOI 10.1002/1097-0142(19911001)68:7<1656::AID-CNCR2820680732>3.0.CO;2-7; HALL NR, IN PRESS EUR J CANCE; HONCHEL R, 1994, CANCER RES, V54, P1159; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jones Michael H., 1992, Human Molecular Genetics, V1, P131, DOI 10.1093/hmg/1.2.131; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LYNCH HT, 1990, J UROLOGY, V143, P24, DOI 10.1016/S0022-5347(17)39853-1; LYNCH HT, 1990, CANCER, V66, P2233, DOI 10.1002/1097-0142(19901115)66:10<2233::AID-CNCR2820661033>3.0.CO;2-A; LYNCH HT, 1981, ARCH INTERN MED, V141, P607, DOI 10.1001/archinte.141.5.607; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; LYNCH HT, 1988, DIS COLON RECTUM, V31, P372, DOI 10.1007/BF02564888; LYNCH HT, 1991, DIS COLON RECTUM, V34, P891, DOI 10.1007/BF02049703; LYNCH HT, 1985, CANCER GENET CYTOGEN, V15, P209, DOI 10.1016/0165-4608(85)90164-5; LYNCH HT, 1988, CANCER, V62, P1007, DOI 10.1002/1097-0142(19880901)62:5<1007::AID-CNCR2820620528>3.0.CO;2-X; LYNCH HT, 1991, CANCER GENET CYTOGEN, V52, P161; LYNCH HT, 1988, BASIC CLIN PERSPECTI, P177; LYNCH HT, IN PRESS AM J GASTRO; MECKLIN JP, 1991, CANCER, V68, P1109, DOI 10.1002/1097-0142(19910901)68:5<1109::AID-CNCR2820680535>3.0.CO;2-S; NEW L, 1993, MOL GEN GENET, V239, P97, DOI 10.1007/BF00281607; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; PAPADOPOULOS N, 1994, SCIENCE, V263, P1825; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; PELTOMAKI P, 1993, CANCER RES, V53, P5853; RISINGER JI, 1993, CANCER RES, V53, P5100; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	36	140	144	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					659	665						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942843				2022-12-18	WOS:A1994PJ02700008
J	SIBILLE, A; ENG, CM; KIM, SJ; PASTORES, G; GRABOWSKI, GA				SIBILLE, A; ENG, CM; KIM, SJ; PASTORES, G; GRABOWSKI, GA			PHENOTYPE GENOTYPE CORRELATIONS IN GAUCHER DISEASE TYPE-I - CLINICAL AND THERAPEUTIC IMPLICATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID BETA-GLUCOSIDASE; HUMAN GLUCOCEREBROSIDASE; MARROW TRANSPLANTATION; GENETIC-HETEROGENEITY; REPLACEMENT THERAPY; HIGH-FREQUENCY; MUTATION; ALLELES; IDENTIFICATION; ENZYME	Gaucher disease is the most frequent lysosomal storage disease and the most prevalent genetic disease among Ashkenazi Jews. Gaucher disease type 1 is characterized by marked variability of the phenotype and by the absence of neuronopathic involvement. To test the hypothesis that this phenotypic variability was due to genetic compounds of several different mutant alleles, 161 symptomatic patients with Gaucher disease type 1 (> 90% Ashkenazi Jewish) were analyzed for clinical involvement, and their genotypes were determined. Qualitative and quantitative measures of disease involvement included age at onset of the disease manifestations, hepatic and splenic volumes, age at splenectomy, and severity of bony disease. Highly statistically significant differences (P < .005) were found in each clinical parameter in patients with the N370S/N370S genotype compared with those patients with the N370S/84GG, N370S/L444P, and N370S/? genotypes. The symptomatic N370S homozygotes had onset of their disease two to three decades later than patients with the other genotypes. In addition, patients with the latter genotypes have much more severely involved livers' spleens, and bones and had a higher incidence of splenectomy at an earlier age. These predictive genotype analyses provide the basis for genetic care delivery and therapeutic recommendations in patients affected with Gaucher disease type 1.	UNIV CINCINNATI, CHILDRENS HOSP,MED CTR,DIV HUMAN GENET, ELLAND & BETHESDA AVE, CINCINNATI, OH 45229 USA; CUNY MT SINAI SCH MED, DIV MED & MOLEC GENET, NEW YORK, NY 10029 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai			Pastores, Gregory M./AAE-8647-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 36729] Funding Source: Medline; PHS HHS [2 M01 00071] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Beighton P, 1982, Prog Clin Biol Res, V95, P107; BEUTLER E, 1990, CLIN CHIM ACTA, V194, P161, DOI 10.1016/0009-8981(90)90130-K; BEUTLER E, 1992, BLOOD, V79, P1662; BEUTLER E, 1991, NEW ENGL J MED, V325, P1354; BEUTLER E, 1992, SCIENCE, V256, P794, DOI 10.1126/science.1589760; BEUTLER E, 1991, P NATL ACAD SCI USA, V88, P10544, DOI 10.1073/pnas.88.23.10544; BEUTLER E, 1991, BLOOD, V78, P1183; BEUTLER E, IN PRESS METABOLIC B; CHOY FYM, 1991, AM J MED GENET, V41, P469, DOI 10.1002/ajmg.1320410418; ERIKSON A, 1990, ACTA PAEDIATR SCAND, V79, P680, DOI 10.1111/j.1651-2227.1990.tb11535.x; FALLET S, 1992, PEDIATR RES, V31, P496, DOI 10.1203/00006450-199205000-00018; FIRON N, 1990, AM J HUM GENET, V46, P527; GLEW RH, 1988, LAB INVEST, V58, P5; GRABOWSKI GA, 1990, CRIT REV BIOCHEM MOL, V25, P385, DOI 10.3109/10409239009090616; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRABOWSKI GA, 1992, HORIZONS, V1, P3; GRACE ME, 1990, J BIOL CHEM, V265, P6827; GRACE ME, 1991, AM J HUM GENET, V49, P646; HE GS, 1992, AM J HUM GENET, V51, P810; HERMANN G, 1986, AM J ROENTGENOL, V147, P943, DOI 10.2214/ajr.147.5.943; HONG CM, 1990, DNA CELL BIOL, V9, P233, DOI 10.1089/dna.1990.9.233; LATHAM T, 1990, AM J HUM GENET, V47, P79; LATHAM TE, 1991, DNA CELL BIOL, V10, P15, DOI 10.1089/dna.1991.10.15; Lee R E, 1982, Prog Clin Biol Res, V95, P177; Ludwig J., 1979, CURRENT METHODS AUTO; MASUNO M, 1990, HUM GENET, V84, P203; OHASHI T, 1991, J BIOL CHEM, V266, P3661; SIDRANSKY E, 1992, AM J MED GENET, V42, P331, DOI 10.1002/ajmg.1320420315; STARER F, 1987, BRIT J RADIOL, V60, P1189, DOI 10.1259/0007-1285-60-720-1189; TARAO K, 1989, HEPATOLOGY, V9, P589, DOI 10.1002/hep.1840090413; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TSAI P, 1992, PEDIATR RES, V31, P503, DOI 10.1203/00006450-199205000-00019; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P5708; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; ZIMRAN A, 1989, LANCET, V2, P349; ZIMRAN A, 1991, AM J HUM GENET, V49, P855	39	140	146	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1094	1101						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503443				2022-12-18	WOS:A1993LG13300010
J	CAREY, G; WILLIAMSON, J				CAREY, G; WILLIAMSON, J			LINKAGE ANALYSIS OF QUANTITATIVE TRAITS - INCREASED POWER BY USING SELECTED SAMPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARKER LOCUS; PEDIGREES; FAMILY	Although a number of methods have been developed for linkage analysis of quantitative traits, power is relatively poor unless there is a single major locus of very large effect. Here it is demonstrated that the use of selected samples (i.e., ascertainment of a proband with an extreme score on the quantitative measure) can dramatically increase power, especially when proband selection is performed on the tail of a distribution with an infrequent recessive gene. Depending on gene action and allele frequency, selected samples permit detection of a major locus that accounts for as little as 10%-20% of the phenotypic variation. The judicious use of selected samples can make an appreciable difference in the feasibility of linkage studies for quantitative traits.	UNIV COLORADO, DEPT PSYCHOL, BOULDER, CO 80309 USA; UNIV COLORADO, DEPT MATH, BOULDER, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	CAREY, G (corresponding author), UNIV COLORADO, INST BEHAV GENET, BOX 447, BOULDER, CO 80309 USA.				NIDA NIH HHS [DA05131] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AMOS CI, 1989, GENET EPIDEMIOL, V6, P349, DOI 10.1002/gepi.1370060205; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; BOEHNKE M, 1989, AM J HUM GENET, V44, P216; COCKERHAM CC, 1983, AM J HUM GENET, V35, P263; DEFRIES JC, 1988, ACTA GENET MED GEMEL, V37, P205, DOI 10.1017/S0001566000003810; DEMENAIS FM, 1989, PROG CLIN BIOL RES, V329, P201; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; JAYAKAR SD, 1984, HUM GENET, V67, P143, DOI 10.1007/BF00272989; LANGE K, 1976, AM J HUM GENET, V28, P167; NANCE WE, 1989, BEHAV GENET, V19, P143, DOI 10.1007/BF01065889; RAO DC, 1988, AM J HUM GENET, V42, P506; SMITH CAB, 1975, ANN HUM GENET, V38, P451, DOI 10.1111/j.1469-1809.1975.tb00634.x	15	140	142	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					786	796						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897525				2022-12-18	WOS:A1991GG66500010
J	JACOBS, PA; HUNT, PA; MAYER, M; BART, RD				JACOBS, PA; HUNT, PA; MAYER, M; BART, RD			DUCHENNE MUSCULAR-DYSTROPHY (DMD) IN A FEMALE WITH AN X-AUTOSOME TRANSLOCATION - FURTHER EVIDENCE THAT THE DMD LOCUS IS AT XP21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,JOHN A BURNS SCH MED,DEPT PEDIAT,HONOLULU,HI 96822	University of Hawaii System	JACOBS, PA (corresponding author), UNIV HAWAII,JOHN A BURNS SCH MED,DEPT ANAT & REPROD BIOL,HONOLULU,HI 96822, USA.				NICHD NIH HHS [HD-07879] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CANKI N, 1979, ANN GENET-PARIS, V22, P35; CARPENTER NJ, 1980, J MED GENET, V17, P216, DOI 10.1136/jmg.17.3.216; DEMEYER R, 1977, 5TH INT C BIRTH DEF, P42; GERALD P S, 1974, Birth Defects Original Article Series, V10, P29; GREENSTEIN RM, 1980, CYTOGENET CELL GENET, V27, P268, DOI 10.1159/000131496; KEATS BJB, 1979, SOURCE BOOK LINKAGE; LINDENBAUM RH, 1979, J MED GENET, V16, P389, DOI 10.1136/jmg.16.5.389; Race R. R, 1968, BLOOD GROUPS MAN; VERELLEN C, 1978, AM J HUM GENET, V30, pA97; WILLARD HF, 1976, AM J HUM GENET, V28, P213	10	140	141	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	4					513	518						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ348	7258185				2022-12-18	WOS:A1981LZ34800002
J	RICE, J; CLONINGER, CR; REICH, T				RICE, J; CLONINGER, CR; REICH, T			MULTIFACTORIAL INHERITANCE WITH CULTURAL TRANSMISSION AND ASSORTATIVE MATING .1. DESCRIPTION AND BASIC PROPERTIES OF THE UNITARY MODELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JEWISH HOSP ST LOUIS, ST LOUIS, MO 63110 USA	Barnes-Jewish Hospital	RICE, J (corresponding author), WASHINGTON UNIV, SCH MED, DEPT PSYCHIAT, ST LOUIS, MO 63110 USA.		Cloninger, Claude/F-5357-2012	Cloninger, Claude/0000-0003-3096-4807				CARTER CO, 1969, LANCET, V1, P1252; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CAVALLIS.LL, 1973, AM J HUM GENET, V25, P618; CAVALLISFORZA L, 1973, THEOR POPUL BIOL, V4, P42, DOI 10.1016/0040-5809(73)90005-1; CLONINGER CR, AM J HUM GENET; CRITTENDEN L, 1961, ANN NY ACAD SCI, V91, P769, DOI 10.1111/j.1749-6632.1961.tb31106.x; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; CROW JF, 1968, EUGEN QUART, V15, P85, DOI 10.1080/19485565.1968.9987760; CURNOW RN, 1975, J ROY STAT SOC A STA, V138, P131, DOI 10.2307/2984646; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Galton F., 1894, NATURAL INHERITANCE; KAPLAN EB, 1972, 823 U N CAR I STAT M; KENDALL MG, 1973, ADV THEORY STATISTIC, V2; LEWONTIN R, 1968, EUGEN QUART, V15, P141, DOI 10.1080/19485565.1968.9987764; Li C., 1975, PATH ANAL A PRIMER; MORAN PAP, 1966, EUGENICS LABORATORY, V41; MORTON NE, 1974, AM J HUM GENET, V26, P318; Pearson K, 1902, BIOMETRIKA, V2, P357; Pearson K., 1896, PHILOS T ROYAL SOC A, V187, P253, DOI [10.1098/rsta.1896.0007, DOI 10.1098/RSTA.1896.0007]; RAO DC, 1976, AM J HUM GENET, V28, P228; RAO DC, 1974, AM J HUM GENET, V26, P331; RAO DC, 1975, AM J HUM GENET, V27, P509; REICH T, 1975, BRIT J PSYCHIAT, V127, P1, DOI 10.1192/bjp.127.1.1; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; REICH T, ANN HUM GENET; SPUHLER JN, 1968, EUGEN QUART, V15, P128, DOI 10.1080/19485565.1968.9987763; SPUHLER JN, 1967, GENETIC DIVERSITY HU, P241; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; VETTA A, 1974, ANN HUM GENET, V38, P243, DOI 10.1111/j.1469-1809.1974.tb01954.x; WILSON SR, 1974, ANN HUM GENET, V38, P225, DOI 10.1111/j.1469-1809.1974.tb01952.x; WILSON SR, 1973, ANN HUM GENET, V37, P189, DOI 10.1111/j.1469-1809.1973.tb01826.x; WOLKIND SN, 1974, BRIT J PSYCHIAT, V125, P125, DOI 10.1192/bjp.125.2.125; Wright S, 1920, J AGRIC RES, V20, P0557; Wright S., 1968, EVOLUTION GENETICS P, P373	35	140	141	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1978	30	6					618	643						26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GK656	747189				2022-12-18	WOS:A1978GK65600006
J	Couto, JA; Huang, AY; Konczyk, DJ; Goss, JA; Fishman, SJ; Mulliken, JB; Warman, ML; Greenel, AK				Couto, Javier A.; Huang, August Y.; Konczyk, Dennis J.; Goss, Jeremy A.; Fishman, Steven J.; Mulliken, John B.; Warman, Matthew L.; Greenel, Arin K.			Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER CELL-LINES; LUNG ADENOCARCINOMA; SIGNALING PATHWAY; GENETIC-VARIATION; MEK1; KINASE; ACTIVATION; MANAGEMENT; SEQUENCES; MELANOMA	Arteriovenous malformation (AVM) is a fast-flow, congenital vascular anomaly that may arise anywhere in the body. AVMs typically progress, causing destruction of surrounding tissue and, sometimes, cardiac overload. AVMs are difficult to control; they often re-expand after embolization or resection, and pharmacologic therapy is unavailable. We studied extracranial AVMs in order to identify their biological basis. We performed whole-exome sequencing (WES) and whole-genome sequencing (WGS) on AVM tissue from affected individuals. Endothelial cells were separated from non-endothelial cells by immune-affinity purification. We used droplet digital PCR (ddPCR) to confirm mutations found by WES and WGS, to determine whether mutant alleles were enriched in endothelial or non-endothelial cells, and to screen additional AVM specimens. In seven of ten specimens, WES and WGS detected and ddPCR confirmed somatic mutations in mitogen activated protein kinase kinase 1 (MAP2K1), the gene that encodes MAP-extracellular signal-regulated kinase 1 (MEK1). Mutant alleles were enriched in endothelial cells and were not present in blood or saliva. 9 of 15 additional AVM specimens contained mutant MAP2K1 alleles. Mutations were missense or small in-frame deletions that affect amino acid residues within or adjacent to the protein's negative regulatory domain. Several of these mutations have been found in cancers and shown to increase MEK1 activity. In summary, somatic mutations in MAP2K1 are a common cause of extracranial AVM. The likely mechanism is endothelial cell dysfunction due to increased MEK1 activity. MEK1 inhibitors, which are approved to treat several forms of cancer, are potential therapeutic agents for individuals with extracranial AVM.	[Couto, Javier A.; Konczyk, Dennis J.; Goss, Jeremy A.; Mulliken, John B.; Greenel, Arin K.] Harvard Med Sch, Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA; [Huang, August Y.; Warman, Matthew L.] Harvard Med Sch, Boston Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Fishman, Steven J.] Harvard Med Sch, Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Warman, Matthew L.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Greenel, AK (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA.	arin.greene@childrens.harvard.edu	Huang, August Yue/E-9983-2016	Huang, August Yue/0000-0002-0416-2854; Konczyk, Dennis/0000-0002-2657-0680	NIH [NICHD-81004, NICHD-82606, NHLBI-12703, NIAMS AR-64231]; Translational Research Program Career Award Boston Children's Hospital; American Society of Plastic Surgeons/Plastic Surgery Foundation [PSF-71190]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD081004, R21HD082606] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Research Program Career Award Boston Children's Hospital; American Society of Plastic Surgeons/Plastic Surgery Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Mr. Matthew P. Vivero and Dr. Steven Hann for their scientific expertise, Dr. Katherine A. Rauen for sharing unpublished data regarding MAP2K1 mutations in CFC, the study participants, and the members of the Vascular Anomalies Center at Boston Children's Hospital. Research reported in this manuscript was supported by the NIH awards NICHD-81004 (A.K.G.), NICHD-82606 (A.K.G.), NHLBI-12703 (A.K.G.), and NIAMS AR-64231 (M.L.W.), the Translational Research Program Career Award Boston Children's Hospital (A.K.G.), and the American Society of Plastic Surgeons/Plastic Surgery Foundation (grant PSF-71190 to A.K.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aoki Y, 2013, INT J HEMATOL, V97, P30, DOI 10.1007/s12185-012-1239-y; Arcila ME, 2015, CLIN CANCER RES, V21, P1935, DOI 10.1158/1078-0432.CCR-14-2124; Bansal A, 1997, ONCOGENE, V14, P1231, DOI 10.1038/sj.onc.1200947; Bayrak-Toydemir P, 1993, RASA1 RELATED DISORD; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Choi YL, 2012, CARCINOGENESIS, V33, P956, DOI 10.1093/carcin/bgs099; Couto JA, 2015, AM J HUM GENET, V96, P480, DOI 10.1016/j.ajhg.2015.01.007; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Greene AK, 2011, J PEDIATR SURG, V46, P1784, DOI 10.1016/j.jpedsurg.2011.05.006; Greene AK, 2011, CLIN PLAST SURG, V38, P95, DOI 10.1016/j.cps.2010.08.005; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; Huang AY, 2014, CELL RES, V24, P1311, DOI 10.1038/cr.2014.131; Knight T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00160; Kohout MP, 1998, PLAST RECONSTR SURG, V102, P643, DOI 10.1097/00006534-199809030-00006; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim YH, 2016, AM J HUM GENET, V99, P443, DOI 10.1016/j.ajhg.2016.06.010; Lim YH, 2015, J INVEST DERMATOL, V135, P1698, DOI 10.1038/jid.2015.55; Lin RZ, 2013, ANGIOGENESIS, V16, P735, DOI 10.1007/s10456-013-9350-0; Liu AS, 2010, PLAST RECONSTR SURG, V125, P1185, DOI 10.1097/PRS.0b013e3181d18070; Luks VL, 2015, J PEDIATR-US, V166, P1048, DOI 10.1016/j.jpeds.2014.12.069; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Marks JL, 2008, CANCER RES, V68, P5524, DOI 10.1158/0008-5472.CAN-08-0099; McDonald J, 1993, HEREDITARY HEMORRHAG; Morris C.A., 1993, GENEREVIEWS; Mulliken JB., 2013, MULLIKEN YOUNGS VASC; Nava C, 2007, J MED GENET, V44, P763, DOI 10.1136/jmg.2007.050450; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Rauen K. A., 1993, CARDIOFACIOCUTANEOUS; Roberts AE, 1993, NOONAN SYNDROME; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Sherry ST, 2000, HUM MUTAT, V15, P68, DOI 10.1002/(SICI)1098-1004(200001)15:1<68::AID-HUMU14>3.0.CO;2-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Solus JF, 2013, ADV ANAT PATHOL, V20, P217, DOI 10.1097/PAP.0b013e3182976c94; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Zenker M, 2011, CURR OPIN PEDIATR, V23, P443, DOI 10.1097/MOP.0b013e32834881dd	43	139	148	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					546	554		10.1016/j.ajhg.2017.01.018	http://dx.doi.org/10.1016/j.ajhg.2017.01.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28190454	Bronze, Green Published			2022-12-18	WOS:000395851900018
J	Jang, MA; Kim, EK; Now, H; Nguyen, NTH; Kim, WJ; Yoo, JY; Lee, J; Jeong, YM; Kim, CH; Kim, OH; Sohn, S; Nam, SH; Hong, Y; Lee, YS; Chang, SA; Jang, SY; Kim, JW; Lee, MS; Lim, SY; Sung, KS; Park, KT; Kim, BJ; Lee, JH; Kim, DK; Kee, C; Ki, CS				Jang, Mi-Ae; Kim, Eun Kyoung; Now, Hesung; Nguyen, Nhung T. H.; Kim, Woo-Jong; Yoo, Joo-Yeon; Lee, Jinhyuk; Jeong, Yun-Mi; Kim, Cheol-Hee; Kim, Ok-Hwa; Sohn, Seongsoo; Nam, Seong-Hyeuk; Hong, Yoojin; Lee, Yong Seok; Chang, Sung-A; Jang, Shin Yi; Kim, Jong-Won; Lee, Myung-Shik; Lim, So Young; Sung, Ki-Sun; Park, Ki-Tae; Kim, Byoung Joon; Lee, Joo-Heung; Kim, Duk-Kyung; Kee, Changwon; Ki, Chang-Seok			Mutations in DDX58, which Encodes RIG-I, Cause Atypical Singleton-Merten Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPEN-ANGLE GLAUCOMA; CALCIFICATION; RNA; GENE; IDENTIFICATION; ACTIVATION; SPECTRUM; SENSOR; GAIN; MDA5	Singleton-Merten syndrome (SMS) is an autosomal-dominant multi-system disorder characterized by dental dysplasia, aortic calcification, skeletal abnormalities, glaucoma, psoriasis, and other conditions. Despite an apparent autosomal-dominant pattern of inheritance, the genetic background of SMS and information about its phenotypic heterogeneity remain unknown. Recently, we found a family affected by glaucoma, aortic calcification, and skeletal abnormalities. Unlike subjects with classic SMS, affected individuals showed normal dentition, suggesting atypical SMS. To identify genetic causes of the disease, we performed exome sequencing in this family and identified a variant (c.1118A>C [p.GLu373Ala]) of DDX58, whose protein product is also known as RIG-I. Further analysis of DDX58 in 100 individuals with congenital glaucoma identified another variant (c.803G>T [p.Cys268Phe]) in a family who harbored neither dental anomalies nor aortic calcification but who suffered from glaucoma and skeletal abnormalities. Cys268 and Glu373 residues of DDX58 belong to ATP-binding motifs I and II, respectively, and these residues are predicted to be located closer to the ADP and RNA molecules than other nonpathogenic missense variants by protein structure analysis. Functional assays revealed that DDX58 alterations confer constitutive activation and thus lead to increased interferon (IFN) activity and IFN-stimulated gene expression. In addition, when we transduced primary human trabecular meshwork cells with c.803G>T (p.Cys268Phe) and c.1118A>C (p.Glu373A1a) mutants, cytopathic effects and a significant decrease in cell number were observed. Taken together, our results demonstrate that DDX58 mutations cause atypical SMS manifesting with variable expression of glaucoma, aortic calcification, and skeletal abnormalities without dental anomalies.	[Jang, Mi-Ae; Kim, Jong-Won; Ki, Chang-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul 135710, South Korea; [Jang, Mi-Ae; Kim, Jong-Won; Ki, Chang-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Genet, Seoul 135710, South Korea; [Kim, Eun Kyoung; Chang, Sung-A; Jang, Shin Yi; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, Seoul 135710, South Korea; [Now, Hesung; Nguyen, Nhung T. H.; Kim, Woo-Jong; Yoo, Joo-Yeon] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Lee, Jinhyuk] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon 305806, South Korea; [Lee, Jinhyuk] Univ Sci & Technol, Dept Bioinformat, Taejon 305350, South Korea; [Jeong, Yun-Mi; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea; [Kim, Ok-Hwa] Woorisoa Childrens Hosp, Dept Radiol, Seoul 152862, South Korea; [Sohn, Seongsoo; Kee, Changwon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul 135710, South Korea; [Nam, Seong-Hyeuk; Hong, Yoojin; Lee, Yong Seok] Samsung SDS, Seoul 138240, South Korea; [Lee, Myung-Shik] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul 135710, South Korea; [Lim, So Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Plast Surg, Seoul 135710, South Korea; [Sung, Ki-Sun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthoped Surg, Seoul 135710, South Korea; [Park, Ki-Tae] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat Dent, Seoul 135710, South Korea; [Kim, Byoung Joon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul 135710, South Korea; [Lee, Joo-Heung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Dermatol, Seoul 135710, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Pohang University of Science & Technology (POSTECH); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kee, C (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul 135710, South Korea.	ckee@skku.edu; changski@skku.edu	Kim, Duk Kyung/F-4613-2014; Jang, Mi-Ae/P-1228-2019; Ki, Chang-Seok/G-7559-2014; ki, cs/O-5931-2014	Ki, Chang-Seok/0000-0001-7679-8731; Chang, Sung-A/0000-0001-5124-605X; Jang, Shin Yi/0000-0003-4319-7029; Jang, Mi-Ae/0000-0002-6558-5236; Kim, Duk-Kyung/0000-0002-2348-8948; Kim, Cheol-Hee/0000-0002-3019-0699; Kee, Changwon/0000-0002-7419-0316	Samsung Medical Center Clinical Research fund [CRO112031]; National Research Foundation of Korea - Korean Ministry of Science, ICT, and Future Planning [NRF-2012R1A4A1028200]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Samsung Medical Center Clinical Research fund(Samsung); National Research Foundation of Korea - Korean Ministry of Science, ICT, and Future Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This study was supported by the Samsung Medical Center Clinical Research fund (CRO112031) and by a National Research Foundation of Korea grant (no. NRF-2012R1A4A1028200) funded by the Korean Ministry of Science, ICT, and Future Planning. J.L. was supported by the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program.	Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Feigenbaum A, 2013, AM J MED GENET A, V161A, P360, DOI 10.1002/ajmg.a.35732; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; GAY BB, 1976, RADIOLOGY, V118, P389, DOI 10.1148/118.2.389; Hwang SY, 2012, NUCLEIC ACIDS RES, V40, P2724, DOI 10.1093/nar/gkr1098; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Kim HJ, 2011, MOL VIS, V17, P2093; Kohlway A, 2013, EMBO REP, V14, P772, DOI 10.1038/embor.2013.108; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Liu F, 2011, PROTEIN CELL, V2, P351, DOI 10.1007/s13238-011-1045-y; Minin AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1453, DOI 10.1134/S0006297908130063; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Singleton E B, 1973, Pediatr Radiol, V1, P2, DOI 10.1007/BF00972817; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Valverde I, 2010, J AM COLL CARDIOL, V56, P1760, DOI 10.1016/j.jacc.2010.02.078; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	23	139	146	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					266	274		10.1016/j.ajhg.2014.11.019	http://dx.doi.org/10.1016/j.ajhg.2014.11.019			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25620203	Green Published, Bronze			2022-12-18	WOS:000349276700008
J	Arnaud, L; Saison, C; Helias, V; Lucien, N; Steschenko, D; Giarratana, MC; Prehu, C; Foliguet, B; Montout, L; de Brevern, AG; Francina, A; Ripoche, P; Fenneteau, O; Da Costa, L; Peyrard, T; Coghlan, G; Illum, N; Birgens, H; Tamary, H; Iolascon, A; Delaunay, J; Tchernia, G; Cartron, JP				Arnaud, Lionel; Saison, Carole; Helias, Virginie; Lucien, Nicole; Steschenko, Dominique; Giarratana, Marie-Catherine; Prehu, Claude; Foliguet, Bernard; Montout, Lory; de Brevern, Alexandre G.; Francina, Alain; Ripoche, Pierre; Fenneteau, Odile; Da Costa, Lydie; Peyrard, Thierry; Coghlan, Gail; Illum, Niels; Birgens, Henrik; Tamary, Hannah; Iolascon, Achille; Delaunay, Jean; Tchernia, Gil; Cartron, Jean-Pierre			A Dominant Mutation in the Gene Encoding the Erythroid Transcription Factor KLF1 Causes a Congenital Dyserythropoietic Anemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INHERITED MUTATION; BETA-THALASSEMIA; GLOBAL ROLE; BLOOD; EKLF; ERYTHROPOIESIS; PHENOTYPE; CD44; MICE; FORM	The congenital dyserythropoietic anemias (CDAs) are inherited red blood cell disorders whose hallmarks are ineffective erythropoiesis, hemolysis, and morphological abnormalities of erythroblasts in bone marrow We have identified a missense mutation in KLF1 of patients with a hitherto unclasified CDA KLF1 is an erythroid transcription factor and extensive studies in mouse models have shown that it plays a critical role in the expression of globin genes, but also in the expression of a wide spectrum of genes potentially essential for erythropoiesis The unique features of this CDA confirm the key role of KLF1 during human erythroid differentiation Furthermore, we show that the mutation has a dominant negative effect on KLF1 transcriptional activity and unexpectedly abolishes the expression of the water channel AQP1 and the adhesion molecule CD44 Thus, the study of this disease causing mutation in KLF1 provides further insights into the roles of this transcription factor during erythropoiesis in humans	[Arnaud, Lionel; Saison, Carole; Helias, Virginie; Lucien, Nicole; Montout, Lory; de Brevern, Alexandre G.; Ripoche, Pierre; Peyrard, Thierry; Cartron, Jean-Pierre] Natl Inst Blood Transfus, F-75015 Paris, France; [Steschenko, Dominique] Ctr Hosp Univ Nancy, Hop Enfants Brabois, F-54511 Vandoeuvre Les Nancy, France; [Giarratana, Marie-Catherine] Univ Paris 06, UMR S 938, INSERM, Fac Med Pierre & Marie Curie, F-75012 Paris, France; [Prehu, Claude] CHU Henri Mondor, Lab Biochim & Genet, F-94010 Creteil, France; [Foliguet, Bernard] Univ Nancy, Serv Commun Microscopie Elect, Fac Med, F-54506 Vandoeuvre Les Nancy, France; [Montout, Lory; de Brevern, Alexandre G.] Dynam Struct & Interact Macromol Biol, F-75015 Paris, France; [Montout, Lory; de Brevern, Alexandre G.; Ripoche, Pierre] Univ Paris 07, UMR S 665, INSERM, Inst Natl Transfus Sanguine, F-75015 Paris, France; [Francina, Alain] Hop Edouard Herriot, Hosp Civils Lyon, Unite Pathol Mol Globule Rouge, F-69003 Lyon, France; [Fenneteau, Odile; Da Costa, Lydie] Hop Robert Debre, Lab Hematol Biol, Ctr Hosp, F-75019 Paris, France; [Da Costa, Lydie; Tchernia, Gil] Hop Bicetre, Hematol Lab, F-94275 Le Kremlin Bicetre, France; [Peyrard, Thierry] Ctr Natl Reference Grp Sanguins, F-75011 Paris, France; [Coghlan, Gail] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1S1, Canada; [Illum, Niels] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, DK-5000 Odense, Denmark; [Birgens, Henrik] Univ Copenhagen, Herlev Hosp, DK-2730 Herlev, Denmark; [Tamary, Hannah] Schneider Childrens Med Ctr, Pediat Hematol Unit, IL-49202 Petah Tiqwa, Israel; [Iolascon, Achille] Univ Naples Federico II, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy; [Iolascon, Achille] Ctr Ingn Genet Biotecnol Avanzate, I-80145 Naples, Italy; [Delaunay, Jean] Univ Paris 11, UMR S 779, INSERM, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France	CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Manitoba; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Naples Federico II; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Arnaud, L (corresponding author), Natl Inst Blood Transfus, F-75015 Paris, France.		Iolascon, Achille/A-4461-2014; de Brevern, Alexandre G./B-4788-2009	de Brevern, Alexandre G./0000-0001-7112-5626; Illum, Niels Ove/0000-0003-2679-2117; iolascon, achille/0000-0002-9558-0356; PEYRARD, THIERRY/0000-0002-7715-568X; Saison, Carole/0000-0001-5898-7176	National Institute of Blood Transfusion (INTS); National Institute for Health and Medical Research (INSERM); Pans Diderot University; Winnipeg Rh Institute Foundation; Israel Science Foundation [699/_03 18 4]; Israeli Ministry of Science Culture and Sport; Israeli Ministry of Science; Italian Ministry of University and Research [MUR PS 35 126/Ind]; Italian Telethon Foundation [GGP09044]; Regione Campania [DGRC 1901/2009]	National Institute of Blood Transfusion (INTS); National Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Pans Diderot University; Winnipeg Rh Institute Foundation; Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Science Culture and Sport; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Telethon Foundation(Fondazione Telethon); Regione Campania(Regione Campania)	First we would like to thank the patients and patient ME s relatives for providing blood samples for this study We would like also to thank D Sommelet, J Buisme, L Douay, M Goossens, C Etchebest Y Colin, T Zelinski P Cane, T Cynober M Feneant Ihibault, C Schmitt R Russo M R Esposito C Menanteau S Kappler Gratias, B N Pham, P Y Le Pennec, E. Vera C Verheyde, G Nicolas, B A Ballif and M Le Gall for their contributions to this study L A and J PC were supported by the National Institute of Blood Transfusion (INTS) the National Institute for Health and Medical Research (INSERM), and Pans Diderot University (Pans 7) G C was supported by an operating grant from the Winnipeg Rh Institute Foundation to T Zelinski H T was supported by an Israel Science Foundation grant (No 699/_03 18 4), by an Israeli Ministry of Science Culture and Sport grant in the framework of the Israel France Program and by an Israeli Ministry of Science Eshkol Fellowship A I was supported by the Italian Ministry of University and Research (grant MUR PS 35 126/Ind) the Italian Telethon Foundation (project GGP09044) and Regione Campania (DGRC 1901/2009)	Bianchi P, 2009, HUM MUTAT, V30, P1292, DOI 10.1002/humu.21077; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Dgany O, 2002, AM J HUM GENET, V71, P1467, DOI 10.1086/344781; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; FENG WC, 1994, J BIOL CHEM, V269, P1493; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; HEIMPEL H., 1968, ARCH KLIN MED, V215, P174; Heimpel H, 2010, HAEMATOL-HEMATOL J, V95, P1034, DOI 10.3324/haematol.2009.014563; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hollanda LM, 2006, NAT GENET, V38, P807, DOI 10.1038/ng1825; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PARSONS SF, 1994, BLOOD, V83, P860; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; PERKINS AC, 1995, NATURE, V375, P318; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; Renella R, 2009, HEMATOL ONCOL CLIN N, V23, P283, DOI 10.1016/j.hoc.2009.01.010; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Siatecka M, 2010, P NATL ACAD SCI USA, V107, P15151, DOI 10.1073/pnas.1004996107; Singleton BK, 2008, BLOOD, V112, P2081, DOI 10.1182/blood-2008-03-145672; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; TANG WZ, 1993, BLOOD, V81, P1636; WICKRAMASINGHE SN, 1991, BRIT J HAEMATOL, V79, P322, DOI 10.1111/j.1365-2141.1991.tb04541.x	29	139	141	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					721	727		10.1016/j.ajhg.2010.10.010	http://dx.doi.org/10.1016/j.ajhg.2010.10.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21055716	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000284668400020
J	Asher, JE; Lamb, JA; Brocklebank, D; Cazier, JB; Maestrini, E; Addis, L; Sen, M; Baron-Cohen, S; Monaco, AP				Asher, Julian E.; Lamb, Janine A.; Brocklebank, Denise; Cazier, Jean-Baptiste; Maestrini, Elena; Addis, Laura; Sen, Mallika; Baron-Cohen, Simon; Monaco, Anthony P.			A Whole-Genome Scan and Fine-Mapping Linkage Study of Auditory-Visual Synesthesia Reveals Evidence of Linkage to Chromosomes 2q24, 5q33, 6p12, and 12p12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEONATAL-INFANTILE SEIZURES; NEURONAL SODIUM-CHANNEL; READING-DISABILITY; SYNAESTHESIA; COLOR; MUTATIONS; MEMORY; AUTISM; EXPRESSION; BRAIN	Synesthesia, a neurological condition affecting between 0.05%-1% of the population, is characterized by anomalous sensory perception and associated alterations in cognitive function due to interference from synesthetic percepts. A stimulus in one sensory modality triggers an automatic, consistent response in either another modality or a different aspect of the same modality. Familiality studies show evidence of a strong genetic predisposition; whereas initial pedigree analyses Supported a single-gene X-linked dominant mode of inheritance with a skewed F:M ratio and a notable absence of male-to-male transmission, subsequent analyses in larger samples indicated that the mode of inheritance was likely to be more complex. Here, we report the results of a whole-genome linkage scan for auditory-visual synesthesia with 410 microsatellite markers at 9.05 cM density in 43 multiplex families (n = 196) with potential candidate regions fine-mapped at 5 cM density. Using NPL and HLOD analysis, we identified four candidate regions. Significant linkage at the genome-wide level was detected to chromosome 2q24 (HLOD = 3.025, empirical genome-wide p = 0.047). Suggestive linkage was found to chromosomes 5q33, 6p12, and 12p12. No support was found for linkage to the X chromosome; furthermore, we have identified two confirmed cases of male-to-male transmission of synesthesia. Our results demonstrate that auditory-visual synesthesia is likely to be an oligogenic disorder subject to multiple modes of inheritance and locus heterogeneity. This study comprises a significant step toward identifying the genetic substrates underlying synesthesia, with important implications for our understanding of the role of genes in human cognition and perception.	[Asher, Julian E.; Brocklebank, Denise; Cazier, Jean-Baptiste; Addis, Laura; Sen, Mallika; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Asher, Julian E.; Baron-Cohen, Simon] Univ Cambridge, Sect Dev Psychiat, Dept Psychiat, Cambridge CB2 8AH, England; [Lamb, Janine A.] Univ Manchester, Ctr Integrated Genom Med Res, Manchester M13 9PT, Lancs, England; [Maestrini, Elena] Univ Bologna, Dept Biol, I-40126 Bologna, Italy	University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; University of Manchester; University of Bologna	Asher, JE (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	j.asher@imperial.ac.uk	Monaco, Anthony P/A-4495-2010; Cazier, Jean-Baptiste/F-2369-2010; Maestrini, Elena/K-7508-2012; Cazier, Jean-Baptiste/GLR-2949-2022; Addis, Laura/R-1385-2016	Monaco, Anthony P/0000-0001-7480-3197; Cazier, Jean-Baptiste/0000-0001-7581-9051; Maestrini, Elena/0000-0001-5924-3179; Cazier, Jean-Baptiste/0000-0001-7581-9051; Addis, Laura/0000-0001-8455-4278; Lamb, Janine/0000-0002-7248-0539	Cambridge Overseas Trust; Max Planck Institute; Trinity College Cambridge; Nancy Lurie Marks Family Foundation; Wellcome Trust; MRC Target Autism Genome; NLM Family Foundation	Cambridge Overseas Trust; Max Planck Institute(Foundation CELLEX); Trinity College Cambridge; Nancy Lurie Marks Family Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); MRC Target Autism Genome; NLM Family Foundation	This work was submitted by J.E.A. in part fulfilment of a PhD at the University of Cambridge. J.E.A. was supported by the Cambridge Overseas Trust, the Max Planck Institute, and Trinity College Cambridge. J.A.L. was supported by the Nancy Lurie Marks Family Foundation. D.B., J.-B.C., and A.P.M. were supported by the Wellcome Trust. L.A. was Supported by the MRC. S.B.-C. was supported by the MRC Target Autism Genome, Trinity College Cambridge, and the NLM Family Foundation. We are grateful to John Harrison, Patrick Bolton, Shibley Rahman, and Hannah Waine for assistance with sample collection and to Wentian Li for statistical discussions.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Asher JE, 2006, CORTEX, V42, P137, DOI 10.1016/S0010-9452(08)70337-X; Ashwin E, 2009, BIOL PSYCHIAT, V65, P17, DOI 10.1016/j.biopsych.2008.06.012; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bailey M. E. S., 1997, SYNAESTHESIA CLASSIC, P182; Barnett KJ, 2008, COGNITION, V106, P871, DOI 10.1016/j.cognition.2007.05.003; Baron-Cohen S, 2007, J CONSCIOUSNESS STUD, V14, P237; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Berkovic SF, 2004, ANN NEUROL, V55, P550, DOI 10.1002/ana.20029; Brockschnieder D, 2006, J NEUROSCI, V26, P757, DOI 10.1523/JNEUROSCI.4317-05.2006; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Choi YL, 2005, J NEURO-ONCOL, V73, P19, DOI 10.1007/s11060-004-3013-3; Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Galton F., 1983, INQUIRY HUMAN FACULT; Glicksohn J, 1999, PERCEPTION, V28, P109, DOI 10.1068/p2755; Gray JA, 2002, J CONSCIOUSNESS STUD, V9, P5; Green JAK, 2008, COGNITION, V106, P463, DOI 10.1016/j.cognition.2007.01.013; Harrison J, 2004, J AUTISM DEV DISORD, V34, P727, DOI 10.1007/s10803-004-5293-z; Herlenius E, 2007, EPILEPSIA, V48, P1138, DOI 10.1111/j.1528-1167.2007.01049.x; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Kaplan DE, 2002, AM J HUM GENET, V70, P1287, DOI 10.1086/340449; KEMNER C, 1995, BIOL PSYCHIAT, V38, P150, DOI 10.1016/0006-3223(94)00247-Z; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levitin DJ, 2005, J CHILD PSYCHOL PSYC, V46, P514, DOI 10.1111/j.1469-7610.2004.00376.x; Luria A.R, 1968, MIND MNEMONIST LITTL; Martin D, 2007, EUR J MIGR LAW, V9, P141, DOI 10.1163/138836407X179346; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Newbury DF, 2005, TRENDS COGN SCI, V9, P528, DOI 10.1016/j.tics.2005.09.002; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palferman S, 2001, AM J HUM GENET, V69, P570; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.3.CO;2-S; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; RIZZO M, 1989, NEUROLOGY, V39, P781, DOI 10.1212/WNL.39.6.781; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Rozen S, 2000, Methods Mol Biol, V132, P365; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Simner J, 2005, COGN NEUROPSYCHOL, V22, P1069, DOI 10.1080/02643290500200122; Simner J, 2006, PERCEPTION, V35, P1024, DOI 10.1068/p5469; Smilek D, 2002, PSYCHOL SCI, V13, P548, DOI 10.1111/1467-9280.00496; Suzuki T, 2004, NAT GENET, V36, P842, DOI 10.1038/ng1393; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Ward J, 2005, PERCEPTION, V34, P611, DOI 10.1068/p5250; Ward J, 2006, CORTEX, V42, P264, DOI 10.1016/S0010-9452(08)70352-6; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; Whitaker WRJ, 2000, J COMP NEUROL, V422, P123, DOI 10.1002/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X; Whitaker WRJ, 2001, MOL BRAIN RES, V88, P37, DOI 10.1016/S0169-328X(00)00289-8; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yaro C, 2007, Q J EXP PSYCHOL, V60, P681, DOI 10.1080/17470210600785208; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200; [No title captured]	66	139	143	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					279	285		10.1016/j.ajhg.2009.01.012	http://dx.doi.org/10.1016/j.ajhg.2009.01.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19200526	Green Published, Bronze			2022-12-18	WOS:000263799700018
J	Pey, AL; Stricher, F; Serrano, L; Martinez, A				Pey, Angel L.; Stricher, Francois; Serrano, Luis; Martinez, Aurora			Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							HUMAN PHENYLALANINE-HYDROXYLASE; IN-VITRO EXPRESSION; AMYOTROPHIC-LATERAL-SCLEROSIS; RESOLUTION CRYSTAL-STRUCTURES; 2.0 ANGSTROM RESOLUTION; CATALYTIC DOMAIN; STRUCTURAL BASIS; PROTEIN AGGREGATION; PAH GENE; BIOCHEMICAL PHENOTYPE	Phenylketonuria (PKU) is a genetic disease caused by mutations in human phenylalanine hydroxylase (PAH). Most missense mutations result in misfolding of PAH, increased protein turnover, and a loss of enzymatic function. We studied the prediction of the energetic impact on PAH native-state stability of 318 PKU-associated missense mutations, using the protein-design algorithm FoldX. For the 80 mutations for which expression analyses have been performed in eukaryote systems, in most cases we found substantial overall correlations between the mutational energetic impact and both in vitro residual activities and patient metabolic phenotype. This finding confirmed that the decrease in protein stability is the main molecular pathogenic mechanism in PKU and the determinant for phenotypic outcome. Metabolicphenotypes have been shown to be better predicted than in vitro residual activities, probably because of greater stringency in the phenotyping process. Finally, all the remaining 238 PKU missense mutations compiled at the PAH locus knowledgebase (PAHdb) were analyzed, and their phenotypic outcomes were predicted on the basis of the energetic impact provided by FoldX. Residues in exons 7-9 and in interdomain regions within the subunit appear to play an important structural role and constitute hotspots for destabilization. FoldX analysis will be useful for predicting the phenotype associated with rare or new mutations detected in patients with PKU. However, additional factors must be considered that may contribute to the patient phenotype, such as possible effects on catalysis and interindividual differences in physiological and metabolic processes.	Univ Bergen, Dept Biomed, NO-5009 Bergen, Norway; European Mol Biol Lab, Heidelberg, Germany; EMBL Syst Biol Unit, Ctr Regulac Genom, Barcelona, Spain	University of Bergen; European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Martinez, A (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, NO-5009 Bergen, Norway.	aurora.martinez@biomed.uib.no	Serrano, Luis/B-3355-2013; Stricher, François/L-2688-2015; Martinez, Aurora/M-3088-2019	Serrano, Luis/0000-0002-5276-1392; Stricher, François/0000-0003-0150-0878; Martinez, Aurora/0000-0003-1643-6506; Pey, Angel Luis/0000-0001-7706-3243				ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Acosta AX, 2001, HUM MUTAT, V17, P122, DOI 10.1002/1098-1004(200102)17:2<122::AID-HUMU4>3.0.CO;2-C; Aguado C, 2006, FEBS LETT, V580, P1697, DOI 10.1016/j.febslet.2006.02.005; Andersen OA, 2003, J MOL BIOL, V333, P747, DOI 10.1016/j.jmb.2003.09.004; Andersen OA, 2002, J MOL BIOL, V320, P1095, DOI 10.1016/S0022-2836(02)00560-0; Andersen OA, 2001, J MOL BIOL, V314, P279, DOI 10.1006/jmbi.2001.5061; Aulehla-Scholz C, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9116; Bjorgo E, 1998, EUR J BIOCHEM, V257, P1, DOI 10.1046/j.1432-1327.1998.2570001.x; Blau N, 2004, MOL GENET METAB, V82, P101, DOI 10.1016/j.ymgme.2004.03.006; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; BURGARD P, 2006, PKU BH4 ADV PHENYLKE, P251; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2004, BIOINFORMATICS, V20, P63, DOI 10.1093/bioinformatics/bth928; Cellmer T, 2007, TRENDS BIOTECHNOL, V25, P254, DOI 10.1016/j.tibtech.2007.03.011; Chao HK, 2001, HUM GENET, V108, P14, DOI 10.1007/s004390000435; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cooper A, 1999, CURR OPIN CHEM BIOL, V3, P557, DOI 10.1016/S1367-5931(99)00008-3; Daniele A, 2007, ANN HUM GENET, V71, P185, DOI 10.1111/j.1469-1809.2006.00328.x; Daubner SC, 1999, BIOCHEMISTRY-US, V38, P4448, DOI 10.1021/bi983012u; De Lucca M, 1998, HUM MUTAT, V11, P354; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Desviat LR, 1999, EUR J HUM GENET, V7, P386, DOI 10.1038/sj.ejhg.5200312; Desviat LR, 2004, MOL GENET METAB, V83, P157, DOI 10.1016/j.ymgme.2004.06.007; Desviat LR, 1997, EUR J HUM GENET, V5, P196, DOI 10.1159/000484763; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Doskeland AP, 1996, BIOCHEM J, V319, P941, DOI 10.1042/bj3190941; Dumoulin M, 2006, ACCOUNTS CHEM RES, V39, P603, DOI 10.1021/ar050070g; Eiken HG, 1996, HUM MUTAT, V7, P228, DOI 10.1002/(SICI)1098-1004(1996)7:3<228::AID-HUMU7>3.0.CO;2-6; Elliott BA, 1997, QUAL LIFE RES, V6, P96; Erlandsen H, 2000, BIOCHEMISTRY-US, V39, P2208, DOI 10.1021/bi992531+; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; Erlandsen H, 1998, BIOCHEMISTRY-US, V37, P15638, DOI 10.1021/bi9815290; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Gamez A, 2000, J BIOL CHEM, V275, P29737, DOI 10.1074/jbc.M003231200; GIBBS BS, 1993, J BIOL CHEM, V268, P8046; Gjetting T, 2001, MOL GENET METAB, V72, P132, DOI 10.1006/mgme.2000.3118; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Guldberg P, 1998, AM J HUM GENET, V63, P71, DOI 10.1086/301920; Guttler F, 1999, PEDIATRICS, V104, P258, DOI 10.1542/peds.104.2.258; GUTTLER F, 2006, PKU BH4 ADV PHENYLKE, P311; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Jennings IG, 2000, EUR J HUM GENET, V8, P683, DOI 10.1038/sj.ejhg.5200518; Kayaalp E, 1997, AM J HUM GENET, V61, P1309, DOI 10.1086/301638; Kemsley JN, 2003, J AM CHEM SOC, V125, P5677, DOI 10.1021/ja029106f; Kim SW, 2006, CLIN CHIM ACTA, V365, P279, DOI 10.1016/j.cca.2005.09.019; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Lindner M., 2006, PKU BH4 ADV PHENYLKE, P180; Liu RJ, 2000, J MOL BIOL, V295, P127, DOI 10.1006/jmbi.1999.3300; MARSDEN D, 2006, PKU BH4 ADV PHENYLKE, P92; MATALON R, 2006, PKU BH4 ADV PHENYLKE, P201; MICHALSMATALON K, 2006, PKU BH4 ADV PHENYLKE, P220; MUNOZ V, 1994, PROTEINS, V20, P301, DOI 10.1002/prot.340200403; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Petukhov M, 1999, PROTEIN SCI, V8, P1982, DOI 10.1110/ps.8.10.1982; Pey AL, 2005, MOL GENET METAB, V86, pS43, DOI 10.1016/j.ymgme.2005.04.008; Pey AL, 2004, HUM MUTAT, V24, P388, DOI 10.1002/humu.20097; Pey AL, 2003, HUM MUTAT, V21, P370, DOI 10.1002/humu.10198; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Scavelli R, 2005, MOL GENET METAB, V86, pS153, DOI 10.1016/j.ymgme.2005.09.015; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; SCRIVER CR, 1994, ANNU REV GENET, V28, P141; Scriver CR, 2003, HUM MUTAT, V21, P333, DOI 10.1002/humu.10200; Scriver CR, 2002, J PEDIATR-US, V140, P502, DOI 10.1067/mpd.2002.124316; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; SCRIVER CR, 2001, METABOLIC MOL BASES, P1667; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Teigen K, 1999, J MOL BIOL, V294, P807, DOI 10.1006/jmbi.1999.3288; Thony B, 2004, FEBS LETT, V577, P507, DOI 10.1016/j.febslet.2004.10.056; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Thusberg J, 2006, HUM MUTAT, V27, P1230, DOI 10.1002/humu.20407; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Urbanc B, 2006, METHOD ENZYMOL, V412, P314, DOI 10.1016/S0076-6879(06)12019-4; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; Ventura S, 2002, NAT STRUCT BIOL, V9, P485, DOI 10.1038/nsb799; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Waters PJ, 1999, J INHERIT METAB DIS, V22, P208, DOI 10.1023/A:1005533825980; Waters PJ, 2000, MOL GENET METAB, V69, P101, DOI 10.1006/mgme.2000.2965; Waters PJ, 2003, HUM MUTAT, V21, P357, DOI 10.1002/humu.10197; Waters PJ, 2006, PKU BH4 ADV PHENYLKE, P277; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Yip YL, 2006, HUM MUTAT, V27, P926, DOI 10.1002/humu.20379; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zekanowski C, 2000, ACTA BIOCHIM POL, V47, P365, DOI 10.18388/abp.2000_4016; Zschocke J, 2003, HUM MUTAT, V21, P345, DOI 10.1002/humu.10192	101	139	145	3	22	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					1006	1024		10.1086/521879	http://dx.doi.org/10.1086/521879			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924342	Bronze, Green Published			2022-12-18	WOS:000250480900012
J	Millstein, J; Conti, DV; Gilliland, FD; Gauderman, WJ				Millstein, J; Conti, DV; Gilliland, FD; Gauderman, WJ			A testing framework for identifying susceptibility genes in the presence of epistasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; S-TRANSFERASE M1; OXIDATIVE STRESS; CANCER RISK; POLYMORPHISMS; HYPERTENSION; COMPLEXITY; RECEPTOR; MODEL; MOUSE	An efficient testing strategy called the "focused interaction testing framework" (FITF) was developed to identify susceptibility genes involved in epistatic interactions for case-control studies of candidate genes. In the FITF approach, likelihood-ratio tests are performed in stages that increase in the order of interaction considered. Joint tests of main effects and interactions are performed conditional on significant lower-order effects. A reduction in the number of tests performed is achieved by prescreening gene combinations with a goodness-of-fit x 2 statistic that depends on association among candidate genes in the pooled case-control group. Multiple testing is accounted for by controlling false-discovery rates. Simulation analysis demonstrated that the FITF approach is more powerful than marginal tests of candidate genes. FITF also outperformed multifactor dimensionality reduction when interactions involved additive, dominant, or recessive genes. In an application to asthma case-control data from the Children's Health Study, FITF identified a significant multilocus effect between the nicotinamide adenine dinucleotide ( phosphate) reduced: quinone oxidoreductase gene (NQO1), myeloperoxidase gene (MPO), and catalase gene ( CAT) (unadjusted P = .00026), three genes that are involved in the oxidative stress pathway. In an independent data set consisting primarily of African American and Asian American children, these three genes also showed a significant association with asthma status (P = .0008).	NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; Univ So Calif, Dept Prevent Med, Div Biostat, Los Angeles, CA 90089 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Southern California	Millstein, J (corresponding author), NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, 7600 Sand Point Way NE,Bldg 4,1133B, Seattle, WA 98115 USA.	josh.millstein@noaa.gov			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010421] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES10421, R01 ES010421] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ambrosone CB, 2005, CANCER RES, V65, P1105; Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Aston CE, 2005, HUM GENET, V116, P208, DOI 10.1007/s00439-004-1206-7; Balmain A, 2000, CARCINOGENESIS, V21, P371, DOI 10.1093/carcin/21.3.371; Barlassina C, 2002, J AM SOC NEPHROL, V13, pS155, DOI 10.1097/01.ASN.0000032524.13069.88; Bastone L, 2004, HUM HERED, V58, P82, DOI 10.1159/000083029; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Ccok NR, 2004, STAT MED, V23, P1439, DOI 10.1002/sim.1749; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Coffey CS, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-49; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; David GL, 2003, AM J RESP CRIT CARE, V168, P1199, DOI 10.1164/rccm.200305-684OC; De Miglio MR, 2004, INT J CANCER, V111, P9, DOI 10.1002/ijc.20225; Devlin B, 2003, GENET EPIDEMIOL, V25, P36, DOI 10.1002/gepi.10237; Dong CH, 2005, EUR J HUM GENET, V13, P102, DOI 10.1038/sj.ejhg.5201292; Forsberg L, 2001, FREE RADICAL BIO MED, V30, P500, DOI 10.1016/S0891-5849(00)00487-1; Foulkes AS, 2005, STAT MED, V24, P775, DOI 10.1002/sim.1965; Foulkes AS, 2004, J ROY STAT SOC C-APP, V53, P311, DOI 10.1046/j.1467-9876.2003.05094.x; Gilliland FD, 1999, ENVIRON HEALTH PERSP, V107, P403, DOI 10.1289/ehp.99107s3403; Hahn Lance W, 2004, In Silico Biol, V4, P183; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Hsueh WC, 2001, DIABETES CARE, V24, P672, DOI 10.2337/diacare.24.4.672; Kim JH, 2001, GENOMICS, V74, P273, DOI 10.1006/geno.2001.6569; Kuida S, 2000, GENOME RES, V10, P49; Longmate JA, 2001, AM J HUM GENET, V68, P1229, DOI 10.1086/320106; MacNee W, 2001, EUR J PHARMACOL, V429, P195, DOI 10.1016/S0014-2999(01)01320-6; Mak JCW, 2004, J ALLERGY CLIN IMMUN, V114, P260, DOI 10.1016/j.jaci.2004.05.013; Moore Jason H, 2002, Pac Symp Biocomput, P53; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Naber CK, 2000, HYPERTENSION, V36, P986, DOI 10.1161/01.HYP.36.6.986; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Ritchie MD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-28; Roldan V, 2005, HAEMATOLOGICA, V90, P421; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Sindhu RK, 2005, BBA-MOL CELL RES, V1743, P86, DOI 10.1016/j.bbamcr.2004.08.013; Soares ML, 2005, HUM MOL GENET, V14, P543, DOI 10.1093/hmg/ddi051; Staessen JA, 2001, J HYPERTENS, V19, P1349, DOI 10.1097/00004872-200108000-00002; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tripodis N, 2001, J NATL CANCER I, V93, P1484, DOI 10.1093/jnci/93.19.1484; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Turan NN, 2000, PHARMACOL RES, V41, P589, DOI 10.1006/phrs.1999.0628; Ukkola O, 2001, INT J OBESITY, V25, P1332, DOI 10.1038/sj.ijo.0801735; Williams SM, 2000, HYPERTENSION, V36, P2, DOI 10.1161/01.HYP.36.1.2; Williams SM, 2004, HUM HERED, V57, P28, DOI 10.1159/000077387; Yanchina ED, 2004, B EXP BIOL MED+, V137, P64, DOI 10.1023/B:BEBM.0000024389.16247.0a; Yang P, 2004, CARCINOGENESIS, V25, P1935, DOI 10.1093/carcin/bgh203	51	139	142	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					15	27		10.1086/498850	http://dx.doi.org/10.1086/498850			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385446	Bronze, Green Published			2022-12-18	WOS:000233930400003
J	Hurles, ME; Sykes, BC; Jobling, MA; Forster, P				Hurles, ME; Sykes, BC; Jobling, MA; Forster, P			The dual origin of the Malagasy in Island Southeast Asia and East Africa: Evidence from maternal and paternal lineages	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; SLAVE-TRADE; MTDNA; ADMIXTURE; POPULATIONS; MADAGASCAR; AMPLIFICATION; HAPLOTYPE; TREE; DNA	Linguistic and archaeological evidence about the origins of the Malagasy, the indigenous peoples of Madagascar, points to mixed African and Indonesian ancestry. By contrast, genetic evidence about the origins of the Malagasy has hitherto remained partial and imprecise. We defined 26 Y-chromosomal lineages by typing 44 Y-chromosomal polymorphisms in 362 males from four different ethnic groups from Madagascar and 10 potential ancestral populations in Island Southeast Asia and the Pacific. We also compared mitochondrial sequence diversity in the Malagasy with a manually curated database of 19,371 hypervariable segment I sequences, incorporating both published and unpublished data. We could attribute every maternal and paternal lineage found in the Malagasy to a likely geographic origin. Here, we demonstrate approximately equal African and Indonesian contributions to both paternal and maternal Malagasy lineages. The most likely origin of the Asia-derived paternal lineages found in the Malagasy is Borneo. This agrees strikingly with the linguistic evidence that the languages spoken around the Barito River in southern Borneo are the closest extant relatives of Malagasy languages. As a result of their equally balanced admixed ancestry, the Malagasy may represent an ideal population in which to identify loci underlying complex traits of both anthropological and medical interest.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; Univ Oxford, Weatherall Inst Mol Med, Oxford, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Oxford; University of Leicester	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	meh@sanger.ac.uk		Jobling, Mark/0000-0002-8061-1308	Wellcome Trust [057559] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adelaar A, 1995, BIJDR TAAL-LAND-V, V151, P325, DOI 10.1163/22134379-90003036; Belgrader P, 1996, GENOME SCI TECHNOLOG, V1, P77, DOI [DOI 10.1089/GST.1996.1.77, 10.1089/gst.1996.1.77]; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; Dahl O. C., 1988, ETUDES OCEAN INDIEN, V9, P91; DAHL OC, 1951, MALGACHE MAANYAN UNE; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; DEWAR RE, 1993, J WORLD PREHIST, V7, P417, DOI 10.1007/BF00997802; Duplantier JM, 2002, HEREDITY, V89, P154, DOI 10.1038/sj.hdy.6800122; Ellis N, 2002, GENOME RES, V12, P339; FIX AG, 1999, MIGRATION COLONISATI; Forster L, 2002, P NATL ACAD SCI USA, V99, P13950, DOI 10.1073/pnas.202400499; Forster P, 2002, INT J LEGAL MED, V116, P99, DOI 10.1007/s00414-001-0261-z; Halder Indrani, 2003, Human Genomics, V1, P52; Hewitt R, 1996, AM J HUM GENET, V58, P1303; Hurles ME, 2003, TRENDS ECOL EVOL, V18, P531, DOI 10.1016/S0169-5347(03)00245-3; Hurles ME, 2003, AM J HUM GENET, V72, P1282, DOI 10.1086/374827; Hurles ME, 2002, GENETICS, V160, P289; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; LONG JC, 1991, GENETICS, V127, P417; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; MIGOT F, 1995, TISSUE ANTIGENS, V46, P131, DOI 10.1111/j.1399-0039.1995.tb02490.x; Paracchini S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e27; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; ROBERTS D. F., 1962, AMER JOUR HUMAN GENET, V14, P261; Rohl A, 2001, INT J LEGAL MED, V115, P29, DOI 10.1007/s004140100217; SOODYALL H, 1995, NAT GENET, V10, P377, DOI 10.1038/ng0895-377; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; VERIN P, 1999, INDOPACIFIC PREHISTO, V18, P35; Wang JL, 2003, GENETICS, V164, P747	34	139	141	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					894	901		10.1086/430051	http://dx.doi.org/10.1086/430051			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15793703	Bronze, Green Published			2022-12-18	WOS:000228198300017
J	Lowe, N; Kirley, A; Hawi, Z; Sham, P; Wickham, H; Kratochvil, CJ; Smith, SD; Lee, SY; Levy, F; Kent, L; Middle, F; Rohde, LA; Roman, T; Tahir, E; Yazgan, Y; Asherson, P; Mill, J; Thapar, A; Payton, A; Todd, RD; Stephens, T; Ebstein, RP; Manor, I; Barr, CL; Wigg, KG; Sinke, RJ; Buitelaar, JK; Smalley, SL; Nelson, SF; Biederman, J; Faraone, SV; Gill, M				Lowe, N; Kirley, A; Hawi, Z; Sham, P; Wickham, H; Kratochvil, CJ; Smith, SD; Lee, SY; Levy, F; Kent, L; Middle, F; Rohde, LA; Roman, T; Tahir, E; Yazgan, Y; Asherson, P; Mill, J; Thapar, A; Payton, A; Todd, RD; Stephens, T; Ebstein, RP; Manor, I; Barr, CL; Wigg, KG; Sinke, RJ; Buitelaar, JK; Smalley, SL; Nelson, SF; Biederman, J; Faraone, SV; Gill, M			Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIT HYPERACTIVITY DISORDER; DOPAMINE TRANSPORTER; DIAGNOSTIC INTERVIEW; POPULATION-SAMPLE; SYSTEM GENES; CHILDREN; ADHD; LINKAGE; METAANALYSIS; ADULTS	Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable, heterogeneous disorder of early onset, consisting of a triad of symptoms: inattention, hyperactivity, and impulsivity. The disorder has a significant genetic component, and theories of etiology include abnormalities in the dopaminergic system, with DRD4, DAT1, SNAP25, and DRD5 being implicated as major susceptibility genes. An initial report of association between ADHD and the common 148-bp allele of a microsatellite marker located 18.5 kb from the DRD5 gene has been followed by several studies showing nonsignificant trends toward association with the same allele. To establish the postulated association of the (CA)(n) repeat with ADHD, we collected genotypic information from 14 independent samples of probands and their parents, analyzed them individually and, in the absence of heterogeneity, analyzed them as a joint sample. The joint analysis showed association with the DRD5 locus (P=.00005; odds ratio 1.24; 95% confidence interval 1.12-1.38). This association appears to be confined to the predominantly inattentive and combined clinical subtypes.	Trinity Coll Dublin, Dept Genet, Dublin 2, Ireland; Trinity Coll Dublin, Dept Psychiat, Dublin 2, Ireland; Inst Psychiat, Social Genet & Dev Res Ctr, London, England; Univ Nebraska, Med Ctr, Psychopharmacol Res Ctr, Omaha, NE USA; Univ New S Wales, Prince Wales Hosp, Sch Psychiat, Sydney, NSW, Australia; Univ Cambridge, Cambridge CB2 1TN, England; Univ Birmingham, Dept Psychiat, Birmingham, W Midlands, England; Univ Fed Rio Grande do Sul, Fed Sch Med Sci Porto Alegre, ADHD Outpatient Program, Porto Alegre, RS, Brazil; Univ Fed Rio Grande do Sul, Fed Sch Med Sci Porto Alegre, Dept Genet, Porto Alegre, RS, Brazil; TUBITAK, Res Inst Genet & Biotechnol, Marmara Res Ctr, Kocaeli, Turkey; Cardiff Univ, Dept Psychol Med, Cardiff CF4 4XN, S Glam, Wales; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63130 USA; Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; Herzog Hosp, Jerusalem, Israel; Geha Mental Hlth Ctr, Petak Tikvah, Israel; Univ Hlth Network, Toronto Western Res Inst, Div Cell & Mol Biol, Toronto, ON, Canada; Hosp Sick Children, Brain & Behav Programme, Toronto, ON M5G 1X8, Canada; Univ Med Ctr Utrecht, Dept Biomed Genet, Utrecht, Netherlands; Univ Nijmegen, Med Ctr, Dept Psychiat, Nijmegen, Netherlands; Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Los Angeles, CA USA; Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA	Trinity College Dublin; Trinity College Dublin; University of London; King's College London; University of Nebraska System; University of Nebraska Medical Center; University of New South Wales Sydney; University of Cambridge; University of Birmingham; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Cardiff University; Washington University (WUSTL); Washington University (WUSTL); Hebrew University of Jerusalem; Hebrew University of Jerusalem; Herzog Medical Center; Tel Aviv University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lowe, N (corresponding author), Trinity Coll Dublin, Dept Genet, Dublin 2, Ireland.	lowen@tcd.ie	Sinke, Richard J/A-1462-2009; Mill, Jonathan S/B-3276-2010; Tahir Turanli, Eda/D-4989-2009; Thapar, Anita/AAH-5555-2020; Tahir Turanli, Eda/GNP-2451-2022; Buitelaar, Jan K/E-4584-2012; MANOR, IRIS/ADP-6397-2022; Rohde, Luis Augusto P/A-6426-2008; Faraone, Stephen V/O-7239-2018; Faraone, Stephen/AAE-7334-2019; Roman, Tatiana/C-1300-2010; Turanli, Eda Tahir/AAF-6837-2020; Nelson, Stanley F/D-4771-2009; Buitelaar, J.K./AAY-7522-2020; Mill, Jonathan/B-5678-2014	Mill, Jonathan S/0000-0003-1115-3224; Thapar, Anita/0000-0002-3689-737X; Tahir Turanli, Eda/0000-0002-0789-0398; Buitelaar, Jan K/0000-0001-8288-7757; MANOR, IRIS/0000-0002-0642-0028; Rohde, Luis Augusto P/0000-0002-4552-4188; Faraone, Stephen V/0000-0002-9217-3982; Faraone, Stephen/0000-0002-9217-3982; Nelson, Stanley F/0000-0002-2082-3114; Mill, Jonathan/0000-0003-1115-3224; Barr, Cathy/0000-0003-0361-0106; Ebstein, Richard/0000-0002-3626-541X; Kent, Lindsey/0000-0002-5315-3399; Gill, Michael/0000-0003-0206-5337; Hawi, Ziarih/0000-0002-0814-9112; Asherson, Philip/0000-0003-2667-2254; Payton, Antony/0000-0003-0335-152X	NICHD NIH HHS [R01 HD37694, R01 HD36317, P50 HD027802, R01 HD037694, R01 HD037999, R01 HD37999, R01 HD036317] Funding Source: Medline; NIMH NIH HHS [MH58277, R01 MH52812, R01 MH058277, R13 MH059126, R01 MH052813, R13 MH59126, R01 MH050657] Funding Source: Medline; NINDS NIH HHS [R01 NS43762, R01 NS043762] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037694, R01HD036317, R01HD037999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R13MH059126, R01MH058277, R01MH052813, R01MH050657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043762] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ANDERSON JC, 1987, ARCH GEN PSYCHIAT, V44, P69; ANGOLD A, 1995, PSYCHOL MED, V25, P739, DOI 10.1017/S003329170003498X; Barkley RA, 2002, J INT NEUROPSYCH SOC, V8, P655, DOI 10.1017/S1355617702801345; Barro RJ, 2000, J ECON GROWTH, V5, P5, DOI 10.1023/A:1009850119329; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; Brophy K, 2002, MOL PSYCHIATR, V7, P913, DOI 10.1038/sj.mp.4001092; CADORET RJ, 1991, COMPR PSYCHIAT, V32, P73, DOI 10.1016/0010-440X(91)90072-K; Clarke AR, 2003, CLIN NEUROPHYSIOL, V114, P319, DOI 10.1016/S1388-2457(02)00364-4; Curran S, 2001, AM J MED GENET, V105, P387, DOI 10.1002/ajmg.1366; CURTIS D, 1995, AM J HUM GENET, V56, P811; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Davids E, 2003, BRAIN RES REV, V42, P1, DOI 10.1016/S0165-0173(02)00274-6; Davies W, 2001, ANN MED, V33, P428, DOI 10.3109/07853890108995956; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Faraone SV, 2000, BIOL PSYCHIAT, V48, P9, DOI 10.1016/S0006-3223(00)00889-1; FARAONE SV, IN PRESS WORLD PSYCH; Flory K, 2003, PSYCHOL ADDICT BEHAV, V17, P151, DOI 10.1037/0893-164X.17.2.151; Glatt SJ, 2003, AM J MED GENET B, V121B, P14, DOI 10.1002/ajmg.b.20048; Hartung CM, 2002, J CLIN CHILD ADOLESC, V31, P453, DOI 10.1207/S15374424JCCP3104_5; Hawi Z, 2003, MOL PSYCHIATR, V8, P299, DOI 10.1038/sj.mp.4001290; Hawi Ziarih, 2003, Expert Rev Neurother, V3, P453, DOI 10.1586/14737175.3.4.453; HAY D, 2001, ATTENTION GENES ADHD, P35; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kirley A, 2002, NEUROPSYCHOPHARMACOL, V27, P607; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; KUSTANOVICH V, IN PRESS MOL PSYCHIA; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; LOU HC, 1990, LANCET, V335, P8, DOI 10.1016/0140-6736(90)90136-S; Maher BS, 2002, PSYCHIATR GENET, V12, P207, DOI 10.1097/00041444-200212000-00003; Mannuzza S, 2000, CHILD ADOL PSYCH CL, V9, P711; Orvaschel H, 1987, SCHEDULE AFFECTIVE D; Payton A, 2001, AM J MED GENET, V105, P464, DOI 10.1002/ajmg.1407; Rasmussen ER, 2002, J CHILD PSYCHOL PSYC, V43, P1018, DOI 10.1111/1469-7610.00229; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; RUBIA K, 1997, NEUROIMAGE; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Silberg J, 1996, J CHILD PSYCHOL PSYC, V37, P803, DOI 10.1111/j.1469-7610.1996.tb01476.x; Spencer T, 1996, J AM ACAD CHILD PSY, V35, P409, DOI 10.1097/00004583-199604000-00008; *STAT, 1999, REF MAN STAT VERS 6; Tahir E, 2000, MOL PSYCHIATR, V5, P396, DOI 10.1038/sj.mp.4000744; Thapar A, 1999, BRIT J PSYCHIAT, V174, P105, DOI 10.1192/bjp.174.2.105; Todd RD, 2001, AM J PSYCHIAT, V158, P1891, DOI 10.1176/appi.ajp.158.11.1891; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; ZAMETKIN AJ, 1990, NEW ENGL J MED, V323, P1361, DOI 10.1056/NEJM199011153232001	50	139	149	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					348	356		10.1086/381561	http://dx.doi.org/10.1086/381561			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	772UM	14732906	Green Published, Bronze			2022-12-18	WOS:000188860000015
J	Zhu, M; Yang, T; Wei, S; DeWan, AT; Morell, RJ; Elfenbein, JL; Fisher, RA; Leal, SM; Smith, RJH; Friderici, KH				Zhu, M; Yang, T; Wei, S; DeWan, AT; Morell, RJ; Elfenbein, JL; Fisher, RA; Leal, SM; Smith, RJH; Friderici, KH			Mutations in the gamma-actin gene (ACTG1) are associated with dominant progressive deafness (DFNA20/26)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BINDING-SITE; HEARING-LOSS; HAIR CELL; COCHLEAR PATHOLOGY; CUTICULAR PLATE; 2 GENOTYPES; LATE-ONSET; FILAMENTS; PROTEIN; DEGENERATION	Age-related hearing loss (presbycusis) is a significant problem in the population. The genetic contribution to age-related hearing loss is estimated to be 40%-50%. Gene mutations that cause nonsyndromic progressive hearing loss with early onset may provide insight into the etiology of presbycusis. We have identified four families segregating an autosomal dominant, progressive, sensorineural hearing loss phenotype that has been linked to chromosome 17q25.3. The critical interval containing the causative gene was narrowed to similar to2 million bp between markers D17S914 and D17S668. Cochlear-expressed genes were sequenced in affected family members. Sequence analysis of the gamma-actin gene (ACTG1) revealed missense mutations in highly conserved actin domains in all four families. These mutations change amino acids that are conserved in all actins, from protozoa to mammals, and were not found in 1100 chromosomes from normal hearing individuals. Much of the specialized ultrastructural organization of the cells in the cochlea is based on the actin cytoskeleton. Many of the mutations known to cause either syndromic or nonsyndromic deafness occur in genes that interact with actin (e.g., the myosins, espin, and harmonin). The mutations we have identified are in various binding domains of actin and are predicted to mildly interfere with bundling, gelation, polymerization, or myosin movement and may cause hearing loss by hindering the repair or stability of cochlear cell structures damaged by noise or aging. This is the first description of a mutation in cytoskeletal, or nonmuscle, actin.	Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; Michigan State Univ, Dept Audiol & Speech Sci, E Lansing, MI 48824 USA; Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; Univ Iowa, Interdept Genet Program, Iowa City, IA USA; Univ Iowa, Dept Otolaryngol, Iowa City, IA USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Natl Inst Deafness & Other Commun Disorders, Genet Mol Lab, NIH, Rockville, MD USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; University of Iowa; University of Iowa; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Baylor College of Medicine	Friderici, KH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 5163 Biomed Phys Sci Bldg, E Lansing, MI 48824 USA.	frideric@msu.edu	Morell, Robert James/Q-2042-2019	Smith, Richard/0000-0003-1201-6731; Morell, Robert/0000-0003-1537-7356; Yang, Tao/0000-0001-6011-987X; DeWan, Andrew/0000-0002-7679-8704	Intramural NIH HHS [Z01 DC000039] Funding Source: Medline; NIDCD NIH HHS [R01 DC003544, R01-DC03544, R29 DC003594, R01 DC004568, 1Z01DC00039-06, R01-DC04568, DC03594, R01 DC003594] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003594, Z01DC000039, R01DC004568, R01DC003544, R29DC003594] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMS AEM, 1989, SCIENCE, V243, P231, DOI 10.1126/science.2643162; Anagnostopoulos AV, 2002, TRENDS GENET, V18, P499; [Anonymous], 1984, 7029 ISO; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; DEROSIER DJ, 1989, J CELL BIOL, V109, P2853, DOI 10.1083/jcb.109.6.2853; DeStefano AL, 2003, ARCH OTOLARYNGOL, V129, P285, DOI 10.1001/archotol.129.3.285; DeWan AT, 2003, CLIN GENET, V63, P39, DOI 10.1034/j.1399-0004.2003.630106.x; Elfenbein JL, 2001, EAR HEARING, V22, P279, DOI 10.1097/00003446-200108000-00003; FABBRIZIO E, 1993, BIOCHEMISTRY-US, V32, P10457, DOI 10.1021/bi00090a023; Feinberg J, 1997, BIOCHEM BIOPH RES CO, V233, P61, DOI 10.1006/bbrc.1997.6402; Fransen E, 2003, EXP GERONTOL, V38, P353, DOI 10.1016/S0531-5565(03)00032-9; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; HIROKAWA N, 1982, J CELL BIOL, V95, P249, DOI 10.1083/jcb.95.1.249; Hofer D, 1997, J CELL SCI, V110, P765; HONTS JE, 1994, J CELL BIOL, V126, P413, DOI 10.1083/jcb.126.2.413; Hu BH, 1997, HEARING RES, V110, P209, DOI 10.1016/S0378-5955(97)00075-0; Hu BH, 2002, HEARING RES, V166, P62, DOI 10.1016/S0378-5955(02)00286-1; HULTCRANTZ M, 1995, ORL J OTO-RHINO-LARY, V57, P1, DOI 10.1159/000276695; Ilkovski B, 2001, AM J HUM GENET, V68, P1333, DOI 10.1086/320605; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Karlsson KK, 1997, EAR HEARING, V18, P114, DOI 10.1097/00003446-199704000-00003; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Kikkawa Y, 2003, HUM MOL GENET, V12, P453, DOI 10.1093/hmg/ddg042; LI HS, 1994, ORL J OTO-RHINO-LARY, V56, P61, DOI 10.1159/000276611; MCGOUGH A, 1994, J CELL BIOL, V126, P433, DOI 10.1083/jcb.126.2.433; Morell RJ, 2000, GENOMICS, V63, P1, DOI 10.1006/geno.1999.6058; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Olson TM, 2000, J MOL CELL CARDIOL, V32, P1687, DOI 10.1006/jmcc.2000.1204; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Raphael Y, 2002, BRIT MED BULL, V63, P25, DOI 10.1093/bmb/63.1.25; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; Sheterline P, 1998, ACTIN; SOUCEK S, 1987, ACTA OTO-LARYNGOL, P93; Steel KP, 1998, SCIENCE, V279, P1870, DOI 10.1126/science.279.5358.1870; TILNEY LG, 1983, J CELL BIOL, V96, P822, DOI 10.1083/jcb.96.3.822; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; Yang T, 2000, AM J HUM GENET, V67, P300; Zuo J, 2002, J NEUROBIOL, V53, P286, DOI 10.1002/neu.10128	41	139	154	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1082	1091		10.1086/379286	http://dx.doi.org/10.1086/379286			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	13680526	Green Published, Bronze			2022-12-18	WOS:000186493400010
J	Coffee, B; Zhang, FP; Ceman, S; Warren, ST; Reines, D				Coffee, B; Zhang, FP; Ceman, S; Warren, ST; Reines, D			Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile X syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION; CGG REPEAT; LYSINE 9; H3; HP1; TRANSCRIPTION; LOCUS; SITE; REACTIVATION; RECOGNITION	Fragile X syndrome is caused by an expansion of a polymorphic CGG triplet repeat that results in silencing of FMR1 expression. This expansion triggers methylation of FMR1's CpG island, hypoacetylation of associated histones, and chromatin condensation, all characteristics of a transcriptionally inactive gene. Here, we show that there is a graded spectrum of histone H4 acetylation that is proportional to CGG repeat length and that correlates with responsiveness of the gene to DNA demethylation but not with chromatin condensation. We also identify alterations in patient cells of two recently identified histone H3 modifications: methylation of histone H3 at lysine 4 and methylation of histone H3 at lysine 9, which are marks for euchromatin and heterochromatin, respectively. In fragile X cells, there is a decrease in methylation of histone H3 at lysine 4 with a large increase in methylation at lysine 9, a change that is consistent with the model of FMR1's switch from euchromatin to heterochromatin in the disease state. The high level of histone H3 methylation at lysine 9 may account for the failure of H3 to be acetylated after treatment of fragile X cells with inhibitors of histone deacetylases, a treatment that fully restores acetylation to histone H4. Using 5-aza-2'-deoxycytidine, we show that DNA methylation is tightly coupled to the histone modifications associated with euchromatin but not to the heterochromatic mark of methylation of historic H3 at lysine 9, consistent with recent findings that this histone modification may direct DNA methylation. Despite the drug-induced accumulation of mRNA in patient cells to 35% of the wild-type level, FMR1 protein remained undetectable. The identification of intermediates in the heterochromatinization of FA4R1 has enabled us to begin to dissect the epigenetics of silencing of a disease-related gene in its natural chromosomal context.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Howard Hughes Med Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Howard Hughes Medical Institute	Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.		excellency, Your/R-2357-2019; Warren, Stephen T/A-2498-2012	excellency, Your/0000-0003-0832-6243; 	NICHD NIH HHS [P01 HD035576, HD35576] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035576] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bestor TH, 1998, NATURE, V393, P311, DOI 10.1038/30613; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Chiurazzi P, 1999, HUM MOL GENET, V8, P2317, DOI 10.1093/hmg/8.12.2317; Chiurazzi P, 1998, HUM MOL GENET, V7, P109, DOI 10.1093/hmg/7.1.109; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Eberhart DE, 1996, SOMAT CELL MOLEC GEN, V22, P435, DOI 10.1007/BF02369435; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gregory RI, 2001, MOL CELL BIOL, V21, P5426, DOI 10.1128/MCB.21.16.5426-5436.2001; HORNSTRA IK, 1993, HUM MOL GENET, V2, P1659; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li E, 1999, NAT GENET, V23, P5, DOI 10.1038/12595; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Mills R P, 1988, J Laryngol Otol Suppl, V16, P1; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SNOW K, 1993, AM J HUM GENET, V53, P1217; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 2001, METABOLIC MOL BASES, P1257; Xin ZH, 2001, AM J HUM GENET, V69, P1389, DOI 10.1086/324469	37	139	143	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					923	932		10.1086/342931	http://dx.doi.org/10.1086/342931			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12232854	Green Published, Bronze			2022-12-18	WOS:000178613800018
J	Pendleton, A; Johnson, MD; Hughes, A; Gurley, KA; Ho, AM; Doherty, M; Dixey, J; Gillet, P; Loeuille, D; McGrath, R; Reginato, A; Shiang, R; Wright, G; Netter, P; Williams, C; Kingsley, DM				Pendleton, A; Johnson, MD; Hughes, A; Gurley, KA; Ho, AM; Doherty, M; Dixey, J; Gillet, P; Loeuille, D; McGrath, R; Reginato, A; Shiang, R; Wright, G; Netter, P; Williams, C; Kingsley, DM			Mutations in ANKH cause chondrocalcinosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIHYDRATE CRYSTAL DEPOSITION; INORGANIC PYROPHOSPHATE; PROGRESSIVE ANKYLOSIS; ARTICULAR CHONDROCALCINOSIS; CRANIOMETAPHYSEAL DYSPLASIA; OSTEO-ARTHRITIS; CHROMOSOME 5P; CALCIUM; DISEASE; MOUSE	Chondrocalcinosis (CC) is a common cause of joint pain and arthritis that is caused by the deposition of calcium-containing crystals within articular cartilage. Although most cases are sporadic, rare familial forms have been linked to human chromosomes 8 (CCAL1) or 5p (CCAL2) (Baldwin et al. 1995; Hughes et al. 1995; Andrew et al. 1999). Here, we show that two previously described families with CCAL2 have mutations in the human homolog of the mouse progressive ankylosis gene (ANKH). One of the human mutations results in the substitution of a highly conserved amino acid residue within a predicted transmembrane segment. The other creates a new ATG start site that adds four additional residues to the ANKH protein. Both mutations segregate completely with disease status and are not found in control subjects. In addition, 1 of 95 U.K. patients with sporadic CC showed a deletion of a single codon in the ANKH gene. The same change was found in a sister who had bilateral knee replacement for osteoarthritis. Each of the three human mutations was reconstructed in a full-length ANK expression construct previously shown to regulate pyrophosphate levels in cultured cells in vitro. All three of the human mutations showed significantly more activity than a previously described nonsense mutation that causes severe hydroxyapatite mineral deposition and widespread joint ankylosis in mice. These results suggest that small sequence changes in ANKH are one cause of CC and joint disease in humans. Increased ANK activity may explain the different types of crystals commonly deposited in human CCAL2 families and mutant mice and may provide a useful pharmacological target for treating some forms of human CC.	Stanford Univ, Beckman Ctr B300, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; Queens Univ Belfast, Dept Med Genet, Belfast BT7 1NN, Antrim, North Ireland; Royal Victoria Hosp, Dept Rheumatol, Belfast BT12 6BA, Antrim, North Ireland; Stanford Univ, HHMI, Sch Med, Stanford, CA 94305 USA; City Hosp, Nottingham NG5 1PB, England; Robert Jones & Agnes Hunt Orthopaed Hosp, Oswestry SY10 7AG, Shrops, England; Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Biochem Mol Pharmacol, Philadelphia, PA 19107 USA; Univ Henri Poincare, UMR 7561, CNRS, Nancy, France; Rhumatol Clin, Nancy, France; Univ Med & Dent New Jersey, Div Rheumatol, Camden, NJ USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA	Stanford University; Queens University Belfast; Howard Hughes Medical Institute; Stanford University; University of Nottingham; Keele University; Jefferson University; Jefferson University; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Virginia Commonwealth University	Kingsley, DM (corresponding author), Stanford Univ, Beckman Ctr B300, Dept Dev Biol, Sch Med, 279 Campus Dr, Stanford, CA 94305 USA.	kingsley@cmgm.stanford.edu		Doherty, Michael/0000-0002-5763-8326	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044360] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR044360, R01 AR44360] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andrew LJ, 1999, AM J HUM GENET, V64, P136, DOI 10.1086/302186; BALDWIN CT, 1995, AM J HUM GENET, V56, P692; DIEPPE P, 1985, CLIN RHEUM DIS, V11, P367; DOHERTY M, 1991, BRIT J RHEUMATOL, V30, P10; DOHERTY M, 1988, RHEUM DIS CLIN N AM, V14, P395; DOHERTY M, 1991, ARTHRITIS RHEUM, V34, P1297, DOI 10.1002/art.1780341014; FELSON DT, 1989, J RHEUMATOL, V16, P1241; FLEISCH H, 1981, METAB BONE DIS RELAT, V3, P279, DOI 10.1016/0221-8747(81)90044-8; GAUCHER A, 1977, SCAND J RHEUMATOL, V6, P217, DOI 10.3109/03009747709095453; Guo Y, 2002, J CELL BIOCHEM, V84, P27, DOI 10.1002/jcb.1263; HAKIM FT, 1984, ARTHRITIS RHEUM, V27, P1411, DOI 10.1002/art.1780271212; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; HUGHES AE, 1995, HUM MOL GENET, V4, P1225, DOI 10.1093/hmg/4.7.1225; JONES AC, 1992, SEMIN ARTHRITIS RHEU, V22, P188, DOI 10.1016/0049-0172(92)90019-A; KOHN NN, 1962, ANN INTERN MED, V56, P738, DOI 10.7326/0003-4819-56-5-738; MCCARTY DJ, 1976, ARTHRITIS RHEUM, V19, P275, DOI 10.1002/1529-0131(197605/06)19:3+<275::AID-ART1780190702>3.0.CO;2-0; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/88236; RACHOW JW, 1988, RHEUM DIS CLIN N AM, V14, P289; Reichenberger E, 2001, AM J HUM GENET, V68, P1321, DOI 10.1086/320612; RICHARDSON BC, 1983, ARTHRITIS RHEUM, V26, P1387, DOI 10.1002/art.1780261112; ROSENTHAL AK, 1994, J RHEUMATOL, V21, P896; ROSENTHAL AK, 1991, ARTHRITIS RHEUM, V34, P904, DOI 10.1002/art.1780340717; SWEET HO, 1981, J HERED, V72, P87, DOI 10.1093/oxfordjournals.jhered.a109459; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; VANDENBOOMGAARD J, 1976, SOLID STATE COMMUN, V19, P405, DOI 10.1016/0038-1098(76)91177-7; VANDERKORST JK, 1974, AM J MED, V56, P307, DOI 10.1016/0002-9343(74)90612-3	26	139	144	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					933	940		10.1086/343054	http://dx.doi.org/10.1086/343054			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12297987	Bronze, Green Published			2022-12-18	WOS:000178613800019
J	Jawaheer, D; Li, WT; Graham, RR; Chen, W; Damle, A; Xiao, XL; Monteiro, J; Khalili, H; Lee, A; Lundsten, R; Begovich, A; Bugawan, T; Erlich, H; Elder, JT; Criswell, LA; Seldin, MF; Amos, CI; Behrens, TW; Gregersen, PK				Jawaheer, D; Li, WT; Graham, RR; Chen, W; Damle, A; Xiao, XL; Monteiro, J; Khalili, H; Lee, A; Lundsten, R; Begovich, A; Bugawan, T; Erlich, H; Elder, JT; Criswell, LA; Seldin, MF; Amos, CI; Behrens, TW; Gregersen, PK			Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHARED EPITOPE HYPOTHESIS; SUSCEPTIBILITY LOCUS; AMERICAN PATIENTS; HUMAN MHC; HLA; HLA-DRB1; REGION; SEVERITY; PROMOTER; LINKAGE	Rheumatoid arthritis (RA) is an inflammatory disease with a complex genetic component. An association between RA and the human leukocyte antigen (HLA) complex has long been observed in many different populations, and most studies have focused on a direct role for the HLA-DRB1 "shared epitope" in disease susceptibility. We have performed an extensive haplotype analysis, using 54 markers distributed across the entire HLA complex, in a set of 469 multicase families with RA. The results show that, in addition to associations with the DRB1 alleles, at least two additional genetic effects are present within the major histocompatibility complex. One of these lies within a 497-kb region in the central portion of the HLA complex, an interval that excludes DRB1. This genetic risk factor is present on a segment of a highly conserved ancestral A1-B8-DRB1*03 (8.1) haplotype. Additional risk genes may also be present in the HLA class I region in a subset of DRB1*0404 haplotypes. These data emphasize the importance of defining haplotypes when trying to understand the HLA associations with disease, and they clearly demonstrate that such associations with RA are complex and cannot be completely explained by the DRB1 locus.	N Shore LIJ Res Inst, Ctr Genom & Human Genet, Manhasset, NY 11030 USA; Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA; Roche Mol Syst, Berkeley, CA USA; Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthritis, Dept Med, Div Rheumatol, San Francisco, CA USA; Univ Calif Davis, Dept Biol Chem, Davis, CA 95616 USA	Northwell Health; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Roche Holding; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California Davis	Gregersen, PK (corresponding author), N Shore LIJ Res Inst, Ctr Genom & Human Genet, 350 Commun Dr, Manhasset, NY 11030 USA.	peterg@nshs.edu	Peng, Bo/A-6920-2009; Jawaheer, Damini/AFR-8556-2022	Peng, Bo/0000-0001-8225-2284; Jawaheer, Damini/0000-0003-4954-874X; Li, Wentian/0000-0003-1155-110X	NCRR NIH HHS [5-M01-RR-00079, M01 RR000079] Funding Source: Medline; NIAMS NIH HHS [N01-AR7-2232, P01-AR45231-SCOR, R01-AR44222, R01-AR43274, R01 AR043274] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR045231, R01AR043274, N01AR072232] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALPER CA, 1989, NEW ENGL J MED, V321, P708, DOI 10.1056/NEJM198909143211103; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; CANDORE G, 1994, AUTOIMMUNITY, V18, P121, DOI 10.3109/08916939409007985; CARUSO C, 1993, IMMUNOL INVEST, V22, P41, DOI 10.3109/08820139309066192; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; DEIGHTON CM, 1989, CLIN GENET, V36, P178; DIZIER MH, 1993, AM J HUM GENET, V53, P715; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Gregersen PK, 1998, ARTHRIT CARE RES, V11, P1, DOI 10.1002/art.1790110102; Hall FC, 1996, QJM-MON J ASSOC PHYS, V89, P821, DOI 10.1093/qjmed/89.11.821; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; KASLOW RA, 1990, LANCET, V335, P927, DOI 10.1016/0140-6736(90)90995-H; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lio D, 2001, HUM IMMUNOL, V62, P705, DOI 10.1016/S0198-8859(01)00264-6; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; MCDANIEL DO, 1995, ANN INTERN MED, V123, P181, DOI 10.7326/0003-4819-123-3-199508010-00004; Milner CM, 2001, FRONT BIOSCI-LANDMRK, V6, pD914, DOI 10.2741/Milner; Moxley G, 2002, RHEUM DIS CLIN N AM, V28, P39, DOI 10.1016/S0889-857X(03)00068-1; Mulcahy B, 1996, AM J HUM GENET, V59, P676; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; NEPOM GT, 1986, LANCET, V2, P1002; OLLIER W, 1992, RHEUM DIS CLIN N AM, V18, P741; Ota M, 2001, GENOMICS, V71, P263, DOI 10.1006/geno.2000.6371; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; RONNINGEN KS, 1992, TISSUE ANTIGENS, V39, P280, DOI 10.1111/j.1399-0039.1992.tb01949.x; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sobel E, 1996, AM J HUM GENET, V58, P1323; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; Teller K, 1996, J RHEUMATOL, V23, P1363; Thomson W, 1999, ARTHRITIS RHEUM, V42, P757, DOI 10.1002/1529-0131(199904)42:4<757::AID-ANR20>3.0.CO;2-X; TOSATO G, 1981, NEW ENGL J MED, V305, P1238, DOI 10.1056/NEJM198111193052102; UDALOVA IA, 1993, GENOMICS, V16, P180, DOI 10.1006/geno.1993.1156; Waldron-Lynch F, 2001, GENES IMMUN, V2, P82, DOI 10.1038/sj.gene.6363738; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159; Zanelli E, 2001, HUM IMMUNOL, V62, P75, DOI 10.1016/S0198-8859(00)00227-5	41	139	146	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					585	594		10.1086/342407	http://dx.doi.org/10.1086/342407			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12181776	Bronze, Green Published			2022-12-18	WOS:000177489600012
J	Hart, TC; Zhang, YZ; Gorry, MC; Hart, PS; Cooper, M; Marazita, ML; Marks, JM; Cortelli, JR; Pallos, D				Hart, TC; Zhang, YZ; Gorry, MC; Hart, PS; Cooper, M; Marazita, ML; Marks, JM; Cortelli, JR; Pallos, D			A mutation in the SOS1 gene causes hereditary gingival fibromatosis type	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXCHANGE PROTEIN; LINKAGE ANALYSIS; EGF RECEPTOR; SH3 DOMAIN; SON; GRB2; IDENTIFICATION; HETEROGENEITY; PLECKSTRIN; SCORES	Hereditary gingival fibromatosis (HGF) is a rare, autosomal dominant form of gingival overgrowth. Affected individuals have a benign, slowly progressive, nonhemorrhagic, fibrous enlargement of the oral masticatory mucosa. Genetic loci for autosomal dominant forms of HGF have been localized to chromosome 2p21-p22 (HGF1) and chromosome 5q13-q22 (HGF2). To identify the gene responsible for HGF1, we extended genetic linkage studies to refine the chromosome 2p21-p22 candidate interval to similar to2.3 Mb. Development of an integrated physical and genetic map of the interval identified 16 genes. Sequencing of these genes, in affected and unaffected HGF1 family members, identified a mutation in the Son of sevenless-1 (SOS1) gene in affected individuals. In this report, we describe the genomic structure of the SOS1 gene and present evidence that insertion of a cytosine between nucleotides 126,142 and 126,143 in codon 1083 of the SOS1 gene is responsible for HGF1. This insertion mutation, which segregates in a dominant manner over four generations, introduces a frameshift and creates a premature stop codon, abolishing four functionally important proline-rich SH3 binding domains normally present in the carboxyl-terminal region of the SOS1 protein. The resultant protein chimera contains the wild-type SOS1 protein for the N-terminal amino acids 1-1083 fused to a novel 22-amino acid carboxyl terminus. Similar SOS1 deletion constructs are functional in animal models, and a transgenic mouse construct with a comparable SOS1 chimera produces a phenotype with skin hypertrophy. Clarification of the functional role of this SOS1 mutant has implications for understanding other forms of gingival fibromatosis and corrective gingival-tissue management.	Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Div Oral Biol & Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Taubate, Sch Dent, Dept Periodont, Taubate, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade de Taubate	Hart, PS (corresponding author), Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Div Oral Biol & Pathol, 614 Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.	hart@sdmgenetics.pitt.edu	Cortelli, Jose R/D-1771-2011; cortelli, jose/AGP-8091-2022; Pallos, Debora/H-7844-2012; Pallos, Debora/AAW-5258-2021	Cortelli, Jose R/0000-0001-5147-0705; Pallos, Debora/0000-0001-7426-1041; 	NIDCR NIH HHS [DE 10990] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		[Anonymous], 1998, J PERIODONTOL, V69, P841; Antonarakis SE, 1998, HUM MUTAT, V11, P1; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Chen JM, 1999, J PROTEIN CHEM, V18, P867, DOI 10.1023/A:1020631313180; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Fryns JP, 1996, ANN GENET-PARIS, V39, P54; Gao Z, 1992, Epithelial Cell Biol, V1, P156; Gorlin R. J., 1990, SYNDROMES HEAD NECK, P847; Hart TC, 1998, AM J HUM GENET, V62, P876, DOI 10.1086/301797; Hart TC, 2000, J DENT RES, V79, P1758, DOI 10.1177/00220345000790100501; HASSELL T M, 1991, Critical Reviews in Oral Biology and Medicine, V2, P103; Hu YL, 1996, ONCOGENE, V12, P1865; JORGENSO.RJ, 1974, J PERIODONTOL, V45, P472, DOI 10.1902/jop.1974.45.7.472; Kim MJ, 2000, BIOCHEMISTRY-US, V39, P8674, DOI 10.1021/bi992558t; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; MACIASFLORES MA, 1984, HUM GENET, V66, P66, DOI 10.1007/BF00275189; MCCOLLAM L, 1995, J BIOL CHEM, V270, P15954, DOI 10.1074/jbc.270.27.15954; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Park C, 1998, MOL CELLS, V8, P518; RAESTE AM, 1978, SCAND J DENT RES, V86, P357; RIVERA H, 1992, ANN GENET-PARIS, V35, P97; Rojas JM, 1996, ONCOGENE, V12, P2291; Seymour RA, 1996, J CLIN PERIODONTOL, V23, P165, DOI 10.1111/j.1600-051X.1996.tb02072.x; Shashi V, 1999, J MED GENET, V36, P683; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Smith RG, 1997, J CLIN PERIODONTOL, V24, P201, DOI 10.1111/j.1600-051X.1997.tb00492.x; Sobel E, 1996, AM J HUM GENET, V58, P1323; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Terwilliger J., 1994, HDB HUMAN GENETIC LI; Wasiak S, 2001, J BIOL CHEM, V276, P26622, DOI 10.1074/jbc.M100591200; WITKOP C J JR, 1971, Birth Defects Original Article Series, V7, P210; Xiao SX, 2001, GENOMICS, V74, P180, DOI 10.1006/geno.2001.6542; Xiao SX, 2000, GENOMICS, V68, P247, DOI 10.1006/geno.2000.6285; Zhang Y, 2001, J MED GENET, V38, P96, DOI 10.1136/jmg.38.2.96; ZHANG Y, IN PRESS CYTOGENET G	41	139	151	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					943	954		10.1086/339689	http://dx.doi.org/10.1086/339689			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11868160	Green Published, Bronze			2022-12-18	WOS:000174252100011
J	Weston, MD; Eudy, JD; Fujita, S; Yao, SF; Usami, S; Cremers, C; Greenburg, J; Ramesar, R; Martini, A; Moller, C; Smith, RJ; Sumegi, J; Kimberling, WJ				Weston, MD; Eudy, JD; Fujita, S; Yao, SF; Usami, S; Cremers, C; Greenburg, J; Ramesar, R; Martini, A; Moller, C; Smith, RJ; Sumegi, J; Kimberling, WJ			Genomic structure and identification of novel mutations in Usherin, the gene responsible for Usher syndrome type IIa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; EPIDERMOLYSIS-BULLOSA; MUSCULAR-DYSTROPHY; C-ELEGANS; LAMININ; LOCUS; CHAIN; MAPS; PREVALENCE; MIGRATIONS	Usher syndrome type IIa (USHIIa) is an autosomal recessive disorder characterized by moderate to severe sensorineural hearing loss and progressive retinitis pigmentosa, This disorder maps to human chromosome 1q41. Recently, mutations in USHIIa patients were identified in a novel gene isolated from this chromosomal region. The USH2A gene encodes a protein with a predicted molecular weight of 171.5 kD and possesses laminin epidermal growth factor as well as fibronectin type III domains. These domains are observed in other protein components of the basal lamina and extracellular matrixes; they may also be observed in cell-adhesion molecules. The intron/exon organization of the gene whose protein we name "Usherin" was determined by direct sequencing of PCR products and cloned genomic DNA with cDNA-specific primers. The gene is encoded by 21 exons and spans a minimum of 105 kb. A mutation search of 57 independent USHIIa probands was performed with a combination of direct sequencing and heteroduplex analysis of PCR-amplified exons. Fifteen new mutations were found. Of 114 independent USH2A alleles, 58 harbored probable pathologic mutations. Ten cases of USHIIa were true homozygotes and 10 were compound heterozygotes; 18 heterozygotes with only one identifiable mutation were observed. Sixty-five percent (38/58) of cases had at least one mutation, and 51% (58/114) of the total number of possible mutations were identified. The allele 2299delG (previously reported as 2314delG) was the most frequent mutant allele observed (16%; 31/192). Three new missense mutations (C319Y, N346H, and C419F) were discovered; all were restricted to the previously unreported laminin domain VI region of Usherin. The possible significance of this domain, known to be necessary for laminin network assembly, is discussed in the context of domain VI mutations from other proteins.	Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA; Univ Nebraska, Med Ctr, Monroe Meyer Inst Genet & Rehabil, Ctr Genet Mol, Omaha, NE USA; Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 036, Japan; Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; Katholieke Univ Nijmegen, Nijmegen, Netherlands; Univ Cape Town, Sch Med, Dept Genet, ZA-7925 Cape Town, South Africa; Univ Ferrara, ENT Dept, I-44100 Ferrara, Italy; Univ Gothenburg, Dept Audiol, Gothenburg, Sweden; Univ Iowa, Dept Otolaryngol Head & Neck Surg, Mol Otolaryngol Res Labs, Iowa City, IA 52242 USA	Boys Town National Research Hospital; University of Nebraska System; University of Nebraska Medical Center; Hirosaki University; Shinshu University; Radboud University Nijmegen; University of Cape Town; University of Ferrara; University of Gothenburg; University of Iowa	Kimberling, WJ (corresponding author), Boys Town Natl Res Hosp, Dept Genet, 555 N 30th St, Omaha, NE 68131 USA.		Ramesar, Raj S/I-6941-2015; Cremers, C.W.R.J./L-4254-2015; Martini, Alessandro/K-2513-2018	Ramesar, Raj S/0000-0001-5688-1634; Martini, Alessandro/0000-0002-2003-6348; Smith, Richard/0000-0003-1201-6731	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002842] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01DC02824, R01 DC002842] Funding Source: Medline; NIDDK NIH HHS [5PO1DK01813] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Culligan KG, 1998, INT J MOL MED, V2, P639; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Hmani M, 1999, EUR J HUM GENET, V7, P363, DOI 10.1038/sj.ejhg.5200307; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KEATS BJB, 1994, AM J HUM GENET, V54, P681; KIMBERLING W, 1992, OTOLARYNG CLIN N AM, V25, P923; KIMBERLING WJ, 1990, GENOMICS, V7, P245, DOI 10.1016/0888-7543(90)90546-7; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Liu XZ, 1999, AM J HUM GENET, V64, P1221, DOI 10.1086/302332; Mellerio JE, 1998, BRIT J DERMATOL, V139, P325; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PIEKEDAHL SA, IN PRESS J MED GENET; PIEKEDAHL SA, 1997, ASS RES OTOLARYNGOL, V20, pA874; Pulkkinen L, 1999, MATRIX BIOL, V18, P29, DOI 10.1016/S0945-053X(98)00005-5; SANKILA EM, 1995, HUM MOL GENET, V4, P93, DOI 10.1093/hmg/4.1.93; SMITH RJH, 1992, ARCH OTOLARYNGOL, V118, P1085; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wayne S, 1997, AM J HUM GENET, V61, pA300; WAYNE S, 1996, HUM MOL GENET, V10, P1689; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286	32	139	149	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1199	1210		10.1086/302855	http://dx.doi.org/10.1086/302855			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10729113	Green Published, Bronze			2022-12-18	WOS:000088373400004
J	Jiang, YH; Lev-Lehman, E; Bressler, J; Tsai, TF; Beaudet, AL				Jiang, YH; Lev-Lehman, E; Bressler, J; Tsai, TF; Beaudet, AL			Genetics of Angelman syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG-TERM POTENTIATION; PRADER-WILLI; UBIQUITIN; UBE3A; MICE; ANTISENSE; MUTATION; LIGASE; MEMORY; MOUSE		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room T619, Houston, TX 77030 USA.	abeaudet@bcm.tmc.edu			NICHD NIH HHS [HD 37283] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Harbers K, 1996, P NATL ACAD SCI USA, V93, P12412, DOI 10.1073/pnas.93.22.12412; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; JAY V, 1991, NEUROLOGY, V41, P416, DOI 10.1212/WNL.41.3.416; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; JIANG Y, 1909, CURR OPIN GENE DEV, V8, P334; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; JOHNSON DK, 1995, GENETICS, V141, P1563; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; KYRIAKIDES T, 1992, ACTA NEUROPATHOL, V83, P675, DOI 10.1007/BF00299421; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; LEDBETTER DH, 1995, METABOLIC MOL BASES, P811; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; Meiri N, 1998, P NATL ACAD SCI USA, V95, P15037, DOI 10.1073/pnas.95.25.15037; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; SCHETS FM, 1993, LETT APPL MICROBIOL, V16, P75, DOI 10.1111/j.1472-765X.1993.tb00347.x; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; WU TH, 1997, NAT GENET, V17, P12; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158	35	139	143	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					1	6		10.1086/302473	http://dx.doi.org/10.1086/302473			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364509	Bronze, Green Published			2022-12-18	WOS:000081224300001
J	Chance, PF; Rabin, BA; Ryan, SG; Ding, Y; Scavina, M; Crain, B; Griffin, JW; Cornblath, DR				Chance, PF; Rabin, BA; Ryan, SG; Ding, Y; Scavina, M; Crain, B; Griffin, JW; Cornblath, DR			Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; PYRAMIDAL FEATURES; HUMAN GENOME; MAP; NEUROPATHY; DISEASE; SYSTEM; REGION; LIMB	We performed genetic mapping studies of an le-generation pedigree with an autosomal dominant, juvenile-onset motor-systems disease. The disorder is characterized by slow progression, distal limb amyotrophy, and pyramidal tract signs associated with severe loss of motor neurons in the brain stem and spinal cord. The gene for this disorder, classified as a form of juvenile amyotrophic lateral sclerosis (ALS), is designated "ALS4." We performed a genomewide search and detected strong evidence for linkage of the ALS4 locus to markers from chromosome 9q34. The highest LOD score (Z) was obtained with D9S1847 (Z = 18.8, recombination fraction of .00). An analysis of recombinant events identified D9S1831 and D9S164 as flanking markers, on chromosome 9q34, that define an similar to 5-cM interval that harbors the ALS4 gene. These results extend the degree of heterogeneity within familial ALS syndromes, and they implicate a gene on chromosome 9q34 as critical for motor-neuron function.	Childrens Hosp, Div Neurol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chance, PF (corresponding author), Univ Washington, Dept Pediat, Box 356320, Seattle, WA 98195 USA.	pchance@u.washington.edu	Chance, Phillip/AAX-5826-2020					BENHAMIDA M, 1990, BRAIN, V113, P347; BRETT PM, 1994, ANN HUM GENET, V58, P95, DOI 10.1111/j.1469-1809.1994.tb01879.x; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; BROWN RH, 1995, CELL, V80, P687, DOI 10.1016/0092-8674(95)90346-1; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; CHRISTODOULOU K, 1995, HUM MOL GENET, V4, P1629, DOI 10.1093/hmg/4.9.1629; CROSS HE, 1967, ARCH NEUROL-CHICAGO, V16, P473, DOI 10.1001/archneur.1967.00470230025003; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIRONG S, 1995, GENOMICS, V30, P605; ENGEL WK, 1959, BRAIN, V82, P203, DOI 10.1093/brain/82.2.203; FEINSTEIN E, 1995, GENOMICS, V29, P305, DOI 10.1006/geno.1995.1255; Furlong RA, 1996, GENOMICS, V33, P421, DOI 10.1006/geno.1996.0217; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1984, J NEUROL NEUROSUR PS, V47, P168, DOI 10.1136/jnnp.47.2.168; Hentati A, 1997, AM J HUM GENET, V61, pA279; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; HIRANO A, 1967, ARCH NEUROL-CHICAGO, V16, P232, DOI 10.1001/archneur.1967.00470210008002; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Kimura J., 1989, ELECTRODIAGNOSIS DIS, V2nd; LANDER CM, 1976, J NEUROL SCI, V28, P389, DOI 10.1016/0022-510X(76)90032-0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; MCCARTHY BG, 1995, NEUROLOGY, V45, P1848, DOI 10.1212/WNL.45.10.1848; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; MYRIANTHOPOULOS NC, 1964, BRAIN, V87, P589, DOI 10.1093/brain/87.4.589; OTT J, 1985, ANAL HUMAN GENET LIN; Pellegrino JE, 1996, NEUROLOGY, V46, P1128, DOI 10.1212/WNL.46.4.1128; PERICAKVANCE MA, 1995, ANN HUM GENET, V59, P347, DOI 10.1111/j.1469-1809.1995.tb00756.x; REFSUM S, 1954, NEUROLOGY, V4, P40, DOI 10.1212/WNL.4.1.40; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; SILVER JR, 1966, J NEUROL NEUROSUR PS, V29, P135, DOI 10.1136/jnnp.29.2.135; STRONG MJ, 1991, CAN J NEUROL SCI, V18, P45, DOI 10.1017/S0317167100031280; TANAKA J, 1984, ACTA NEUROPATHOL, V64, P22, DOI 10.1007/BF00695602; VANGENT EM, 1985, J NEUROL NEUROSUR PS, V48, P266, DOI 10.1136/jnnp.48.3.266; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLIAMS DB, 1991, MAYO CLIN PROC, V66, P54, DOI 10.1016/S0025-6196(12)61175-6; WIRTH B, 1994, GENOMICS, V20, P84, DOI 10.1006/geno.1994.1130	42	139	142	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					633	640		10.1086/301769	http://dx.doi.org/10.1086/301769			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497266	hybrid, Green Submitted, Green Published			2022-12-18	WOS:000072894400017
J	Morton, NE				Morton, NE			Significance levels in complex inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAITS; GENETIC DISSECTION; LOD SCORE; LINKAGE; ASTHMA; TESTS; LOCI; MAP	A LOD score greater than or equal to 3 is necessary but not sufficient to make a linkage test reliable, anti this applies to complex inheritance as well as to major loci. Factors that affect this threshold are considered here, A LOD score as small as 2 is suggestive but is unreliable except as confirmation of either a significant linkage or a strong candidate locus, A threshold as great as 4 is unnecessarily conservative if multipoint tests are used sensibly. Marker density is not a major factor; and biases in the evaluation of LOD scores-especially inadequate allowance for estimation of nuisance parameters in multiple models-are paramount. Allelic association increases resolution for oligogenes within a candidate region and remains the only practical method to Locate polygenes, The method sketched here combines multipoint linkage and allelic association to test efficiently for a regional candidate locus.	Univ Southampton, Princess Anne Hosp, Southampton SO16 5YA, Hants, England	University of Southampton	Morton, NE (corresponding author), Univ Southampton, Princess Anne Hosp, Coxford Rd,Level G, Southampton SO16 5YA, Hants, England.							Barnes KC, 1996, GENOMICS, V37, P41, DOI 10.1006/geno.1996.0518; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Collins A, 1996, P NATL ACAD SCI USA, V93, P9177, DOI 10.1073/pnas.93.17.9177; COLLINS A, 1995, HUM HERED, V45, P311, DOI 10.1159/000154299; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Curtis D, 1996, NAT GENET, V12, P356, DOI 10.1038/ng0496-356; Daly MJ, 1996, NAT GENET, V14, P131, DOI 10.1038/ng1096-131; Fisher R. A., 1935, ANN EUGEN, V6, P187; GENIN E, 1995, ANN HUM GENET, V59, P123, DOI 10.1111/j.1469-1809.1995.tb01610.x; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALDANE JBS, 1947, ANN EUGEN, V14, P20; Hodge SE, 1997, AM J HUM GENET, V60, P217; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; LAWRENCE S, 1994, ANN HUM GENET, V58, P359, DOI 10.1111/j.1469-1809.1994.tb00732.x; Lio P, 1997, P NATL ACAD SCI USA, V94, P5344, DOI 10.1073/pnas.94.10.5344; MORTON NE, 1991, ANN HUM GENET, V55, P301, DOI 10.1111/j.1469-1809.1991.tb00857.x; Morton NE, 1996, P NATL ACAD SCI USA, V93, P3471, DOI 10.1073/pnas.93.8.3471; MORTON NE, 1955, AM J HUM GENET, V7, P277; RAO DC, 1978, AM J HUM GENET, V30, P516; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RISCH N, 1991, AM J HUM GENET, V48, P1058; SKOLNICK M H, 1984, Genetic Epidemiology, V1, P363, DOI 10.1002/gepi.1370010408; Spielman RS, 1996, AM J HUM GENET, V59, P983; Wald A., 1947, SEQUENTIAL ANAL; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; Wright S., 1968, EVOLUTION GENETICS P, P373; ZENG ZB, 1994, GENETICS, V136, P1457	31	139	142	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					690	697		10.1086/301741	http://dx.doi.org/10.1086/301741			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497238	Green Published, Bronze			2022-12-18	WOS:000072894400023
J	Yoon, PW; Freeman, SB; Sherman, SL; Taft, LF; Gu, YC; Pettay, D; Flanders, WD; Khoury, MJ; Hassold, TJ				Yoon, PW; Freeman, SB; Sherman, SL; Taft, LF; Gu, YC; Pettay, D; Flanders, WD; Khoury, MJ; Hassold, TJ			Advanced maternal age and the risk of down syndrome characterized by the meiotic stage of the chromosomal furor: A population-based study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA POLYMORPHISMS; TRISOMY-21; NONDISJUNCTION; ABNORMALITIES; AMNIOCENTESIS; EPIDEMIOLOGY; RATES	The identification of DNA polymorphisms makes it possible to classify trisomy 21 according to the parental origin and stage (meiosis I [MI], meiosis II [MII], or postzygotic mitotic) of the chromosomal error. Studying the effect of parental age on these subgroups could shed light on parental exposures and their timing. From 1989 through 1993, 270 infants with trisomy 21 and 267 randomly selected control infants were ascertained in a population-based, case-control study in metropolitan Atlanta. Blood samples for genetic studies were obtained from case infants and their parents. Using logistic regression, we independently examined the association between maternal and paternal age and subgroups of trisomy 21 defined by parental origin and meiotic stage. The distribution of trisomy 21 by origin was 86% maternal (75% MI and 25% MII), 3% paternal (50% MI and 50% MII), and 5% mitotic. Compared with women <25 years of age, women greater than or equal to 40 years old had an odds ratio of 5.2 (95% confidence interval, 1.0-27.4) for maternal MI (MMI) errors and 51.4 (95% confidence interval, 2.3-333.0) for maternal MII (MMII) errors. Birth-prevalence rates for women greater than or equal to 40 years old were 4.2/1,000 births for MMI errors and 1.9/1,000 births for MMII errors. These results support an association between advanced maternal age and both MMI and MMII errors. The association with MI does not pinpoint the timing of the error; however, the association with MII implies that there is at least one maternal age-related mechanism acting around the time of conception.	EMORY UNIV,DEPT MOLEC & MED GENET,SCH MED,ATLANTA,GA 30322; EMORY UNIV,DEPT PEDIAT,SCH MED,DIV MED GENET,ATLANTA,GA 30322; EMORY UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,ATLANTA,GA; UNIV HOSP CLEVELAND,CLEVELAND,OH; CASE WESTERN RESERVE UNIV,SCH MED,DEPT HUMAN GENET,CLEVELAND,OH; CASE WESTERN RESERVE UNIV,SCH MED,CTR HUMAN GENET,CLEVELAND,OH; CTR DIS CONTROL & PREVENT,NATL CTR ENVIRONM HLTH,DIV BIRTH DEFECTS & DEV DISABIL,ATLANTA,GA 30341	Emory University; Emory University; Emory University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Centers for Disease Control & Prevention - USA					NICHD NIH HHS [N01 HD92707, R01 HD21341, P01 HD32111] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341, P01HD032111] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS MM, 1981, AM J OBSTET GYNECOL, V139, P673, DOI 10.1016/0002-9378(81)90483-X; ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; DRUGAN A, 1990, PRENATAL DIAG, V10, P483, DOI 10.1002/pd.1970100802; ERICKSON JD, 1978, ANN HUM GENET, V41, P289, DOI 10.1111/j.1469-1809.1978.tb01896.x; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HOOK EB, 1988, AM J HUM GENET, V42, P797; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; HOOK EB, 1990, AM J EPIDEMIOL, V111, P75; JANERICH DT, 1986, J CHRON DIS, V39, P1079, DOI 10.1016/0021-9681(86)90141-4; KRIVCHENIA E, 1993, AM J EPIDEMIOL, V137, P815, DOI 10.1093/oxfordjournals.aje.a116743; LYNBERG MC, 1992, PUBLIC HEALTH SURVEILLANCE, P157; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; 1991, CONGENITAL MALFORMAT, P157	16	139	144	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					628	633						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644722				2022-12-18	WOS:A1996TV56400021
J	NICHOLLS, RD				NICHOLLS, RD			NEW INSIGHTS REVEAL COMPLEX MECHANISMS INVOLVED IN GENOMIC IMPRINTING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							PRADER-WILLI SYNDROME; FAMILIAL ANGELMAN SYNDROME; GENE; RECEPTOR; REGION; SHOWS		CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,CLEVELAND,OH 44106	Case Western Reserve University	NICHOLLS, RD (corresponding author), CASE WESTERN RESERVE UNIV,DEPT GENET,10900 EUCLID AVE,CLEVELAND,OH 44106, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031491] Funding Source: NIH RePORTER; NICHD NIH HHS [1RO1 HD31491] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BEAUDET AL, 1994, J CELL BIOCH A S, V18, P205; BUITING K, 1993, HUM MOL GENET, V2, P1991; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; CLAYTONSMITH J, 1992, J MED GENET, V29, P412, DOI 10.1136/jmg.29.6.412; DITTRICH B, 1993, HUM MOL GENET, V2, P1995, DOI 10.1093/hmg/2.12.1995; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; FEINBERG AP, 1993, NAT GENET, V4, P110, DOI 10.1038/ng0693-110; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FILSON AJ, 1993, DEVELOPMENT, V118, P731; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; HAAS OA, 1992, NATURE, V359, P414, DOI 10.1038/359414a0; HALL JG, 1990, AM J HUM GENET, V46, P857; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; HATADA I, 1993, NUCLEIC ACIDS RES, V21, P5577, DOI 10.1093/nar/21.24.5577; HOLM VA, 1993, PEDIATRICS, V91, P398; JONG MTC, UNPUB IDENTIFICATION; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; Junien C, 1992, CURR OPIN GENET DEV, V2, P431, DOI 10.1016/S0959-437X(05)80154-6; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1993, P NATL ACAD SCI USA, V90, P2050, DOI 10.1073/pnas.90.5.2050; NICHOLLS RD, 1993, CURR OPIN GENET DEV, V3, P445, DOI 10.1016/0959-437X(93)90119-A; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OGAWA O, 1993, HUM MOL GENET, V2, P2163, DOI 10.1093/hmg/2.12.2163; OGAWA O, 1993, NAT GENET, V5, P408, DOI 10.1038/ng1293-408; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; RAZIN A, IN PRESS CELL; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; REIS A, 1994, AM J HUM GENET, V54, P741; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; SCHNEID H, 1993, J MED GENET, V30, P353, DOI 10.1136/jmg.30.5.353; STEWART CL, 1993, ADV DEV BIOL, V2, P73; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SURANI MA, 1993, NATURE, V366, P302, DOI 10.1038/366302a0; WATSTAFF J, 1992, NAT GENET, V1, P291; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; ZEMAL S, 1992, NAT GENET, V2, P61; ZHANG YH, 1993, AM J HUM GENET, V53, P113	55	139	139	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					733	740						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178814				2022-12-18	WOS:A1994NH39400001
J	OLSCHWANG, S; LAURENTPUIG, P; GRODEN, J; WHITE, R; THOMAS, G				OLSCHWANG, S; LAURENTPUIG, P; GRODEN, J; WHITE, R; THOMAS, G			GERM-LINE MUTATIONS IN THE 1ST 14 EXONS OF THE ADENOMATOUS POLYPOSIS-COLI (APC) GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; SINGLE-BASE CHANGES; DNA FRAGMENTS; GC-CLAMP; CHROMOSOME-5; IDENTIFICATION; LOCUS; SUBSTITUTIONS; LOCALIZATION; MARKERS	The first 14 exons of the APC gene have been screened by the denaturation gradient gel electrophoresis method in 160 unrelated patients with familial adenomatous polyposis coli (APC) syndrome. Four polymorphic variants corresponding to silent mutations not associated with the disease phenotype were observed. Mutations predicted to alter the coding property of the APC gene were observed in 26 patients. All these mutations are expected to lead either to aberrant splicing, to synthesis of a truncated APC protein because of the emergence of a stop codon, or to a change in the translation reading frame. Single-base-pair substitutions were observed on 21 occasions. The most frequent mutation (eight cases) was a C-to-T change which exclusively occurred on the nontranscribed strand within a CG dinucleotide.	INST CURIE,GENET TUMEURS LAB,26 RUE ULM,F-75231 PARIS 05,FRANCE; UNIV UTAH,HOWARD HUGHES MED INST,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah			Olschwang, Sylviane/G-2716-2013; Laurent-Puig, Pierre/K-3641-2019; laurent-puig, pierre/B-2226-2013	Olschwang, Sylviane/0000-0001-7078-3029; Laurent-Puig, Pierre/0000-0001-8475-5459; laurent-puig, pierre/0000-0001-8475-5459				ABRAMS ES, 1990, GENOMICS, V7, P463, DOI 10.1016/0888-7543(90)90188-Z; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BULOW S, 1986, SCAND J SOC MED, V14, P67; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DUNLOP MG, 1990, AM J HUM GENET, V47, P982; DUNLOP MG, 1991, LANCET, V337, P313, DOI 10.1016/0140-6736(91)90940-Q; FISCHER SG, 1983, P NATL ACAD SCI-BIOL, V80, P1579, DOI 10.1073/pnas.80.6.1579; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Herrera L, 1990, FAMILIAL ADENOMATOUS; JONES PA, IN PRESS BIOESSAYS; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; OLSCHWANG S, 1991, GASTROENTEROLOGY, V101, P154, DOI 10.1016/0016-5085(91)90472-W; OLSCHWANG S, 1992, HUM GENET, V90, P161; Sambrook J., 1989, MOL CLONING LABORATO, P31; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232	23	139	139	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					273	279						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8381580				2022-12-18	WOS:A1993KN27500004
J	RASKIND, WH; WILLIAMS, CA; HUDSON, LD; BIRD, TD				RASKIND, WH; WILLIAMS, CA; HUDSON, LD; BIRD, TD			COMPLETE DELETION OF THE PROTEOLIPID PROTEIN GENE (PLP) IN A FAMILY WITH X-LINKED PELIZAEUS-MERZBACHER DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATION; MICE; CHROMOSOME; DISORDER; MOUSE; EXON	Pelizaeus-Merzbacher disease (PMD) is an X-linked neurologic disorder characterized by dysmyelination in the central nervous system. Proteolipid protein (PLP), a major structural protein of myelin, is coded on the X chromosome. It has been postulated that a defect in the PLP gene is responsible for PMD. Different single-nucleotide substitutions have been found in conserved regions of the PLP gene of four unrelated PMD patients. Novel Southern blot patterns suggested a complex rearrangement in a fifth family. Linkage to PLP has been shown in others. We evaluated the PLP locus in a four-generation family with two living males affected with X-linked PMD. Analysis of DNA from the affected males revealed complete absence of a band, with PLP probes encompassing the promoter region, the entire coding region, and the 3' untranslated region and spanning at least 29 kb of genomic DNA. DNA from unaffected relatives gave the expected band pattern. Two obligate and one probable carrier women were hemizygous for the PLP locus by dosage analysis. Although it is unlikely, the previously described point mutations in PLP could represent polymorphisms. The finding of complete deletion of the PLP gene in our family is a stronger argument that mutations in PLP are responsible for X-linked PMD.	UNIV WASHINGTON,SCH MED,DEPT MED,DIV MOLEC GENET,SEATTLE,WA 98195; VET AFFAIRS HOSP,DIV NEUROL,SEATTLE,WA; UNIV FLORIDA,DEPT PEDIAT,DIV GENET,GAINESVILLE,FL 32611; NINCDS,VIRAL & MOLEC PATHOGENESIS LAB,BETHESDA,MD 20892	University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	RASKIND, WH (corresponding author), UNIV WASHINGTON,SCH MED,DEPT MED,DIV GEN INTERNAL MED,RG-20,SEATTLE,WA 98195, USA.				NCI NIH HHS [CA 16448] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA016448, R01CA016448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRAUN PE, 1984, MYELIN, P98; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; FAHIM S, 1986, J NEUROSCI RES, V16, P303, DOI 10.1002/jnr.490160125; GENCIC S, 1990, J NEUROSCI, V10, P117; GENCIC S, 1989, AM J HUM GENET, V45, P435; HUDSON LD, 1987, P NATL ACAD SCI USA, V84, P1454, DOI 10.1073/pnas.84.5.1454; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; IKENAKA K, 1988, J MOL BIOL, V199, P587, DOI 10.1016/0022-2836(88)90303-8; MACKLIN WB, 1987, FEBS LETT, V223, P417, DOI 10.1016/0014-5793(87)80331-9; MAENPAA J, 1990, CLIN GENET, V37, P141; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; Merzbacher L., 1910, Z F R GESAMTE NEUROL, V3, P1, DOI [10.1007/BF02893591, DOI 10.1007/BF02893591]; NAVE KA, 1987, J NEUROCHEM, V49, P1873, DOI 10.1111/j.1471-4159.1987.tb02449.x; PRATT VM, 1991, AM J MED GENET, V38, P136, DOI 10.1002/ajmg.1320380129; PRATT VM, 1990, AM J MED GENET S, V47, pA233; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; RAPIN I, 1989, MERRITTS TXB NEUROLO, P557; RASKIND WH, 1991, AM J HUM GENET, V48, P335; ROUSSEL G, 1987, J NEUROCYTOL, V16, P195, DOI 10.1007/BF01795303; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; TYLER HR, 1958, ARCH NEURO PSYCHIATR, V80, P162, DOI 10.1001/archneurpsyc.1958.02340080032004; WILLARD HF, 1987, CYTOGENET CELL GENET, V46, P716	22	139	140	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1355	1360						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1720927				2022-12-18	WOS:A1991GU67200023
J	BOLHUIS, PA; HENSELS, GW; HULSEBOS, TJM; BAAS, F; BARTH, PG				BOLHUIS, PA; HENSELS, GW; HULSEBOS, TJM; BAAS, F; BARTH, PG			MAPPING OF THE LOCUS FOR X-LINKED CARDIOSKELETAL MYOPATHY WITH NEUTROPENIA AND ABNORMAL MITOCHONDRIA (BARTH SYNDROME) TO XQ28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; FACTOR-VIII GENE; CARNITINE METABOLISM; LINKAGE ANALYSIS; DXS52 LOCUS; CHROMOSOME; RECOMBINATION; COMMITTEE; DNA; CARDIOMYOPATHY	X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria is clinically characterized by congenital dilated cardiomyopathy, skeletal myopathy, recurrent bacterial infections, and growth retardation. We analyzed linkage between the disease locus and X-chromosomal markers in a family with seven carriers, four patients, and eight unaffected sons of carriers. Highest lod scores obtained by two-point linkage analysis were 2.70 for St14.1 (DXS52, TaqI) at a recombination fraction of zero and 2.53 for cpX67 (DXS134) at a recombination fraction of zero. Multipoint linkage analysis resulted in a maximum lod score of 5.24 at the position of St35.691 (DXS305). The most distal recombination detected in this family was located between the markers II-10 (DXS466) and DX13 (DXS15). These data indicate the location of the mutated gene at Xq28.	UNIV AMSTERDAM,ACAD MED CTR,DEPT PEDIAT,1105 AZ AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT ANTHROPOGENET,1105 AZ AMSTERDAM,NETHERLANDS	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	BOLHUIS, PA (corresponding author), UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,1105 AZ AMSTERDAM,NETHERLANDS.		Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428; Barth, Peter/0000-0002-9025-5677				BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BELL MV, 1989, HUM GENET, V82, P27, DOI 10.1007/BF00288266; BOWTELL DDL, 1987, ANAL BIOCHEM, V162, P463, DOI 10.1016/0003-2697(87)90421-0; BROWN WT, 1988, HUM GENET, V78, P201, DOI 10.1007/BF00291662; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; FEIL R, 1990, AM J HUM GENET, V46, P720; HODGSON S, 1986, HUM GENET, V74, P409, DOI 10.1007/BF00280495; HODGSON S, 1987, J MED GENET, V24, P210, DOI 10.1136/jmg.24.4.210; HULSEBOS TJM, UNPUB NEW DISTAL MAR; INO T, 1988, J AM COLL CARDIOL, V11, P1301, DOI 10.1016/0735-1097(88)90296-3; INO T, 1988, J PEDIATR-US, V113, P511, DOI 10.1016/S0022-3476(88)80642-5; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KELLEY R I, 1989, American Journal of Human Genetics, V45, pA7; KENWRICK S, 1989, AM J HUM GENET, V45, P873; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MCKUSICK VA, 1988, MENDELIAN INHERITANC, P1276; MULLIGAN LM, 1987, AM J MED GENET, V26, P751, DOI 10.1002/ajmg.1320260334; NEUSTEIN HB, 1979, PEDIATRICS, V64, P24; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; OTT J, 1974, AM J HUM GENET, V26, P588; PATTERSON M, 1988, AM J MED GENET, V30, P581, DOI 10.1002/ajmg.1320300159; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; THOMAS NST, 1987, CYTOGENET CELL GENET, V46, P704; VINCENT A, 1989, HUM GENET, V82, P85, DOI 10.1007/BF00288280; WARREN ST, 1989, GENOME MAPPING SEQUE, P126; YATES JRW, 1986, J MED GENET, V23, P587, DOI 10.1136/jmg.23.6.587	28	139	140	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					481	485						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998334				2022-12-18	WOS:A1991FK47000007
J	Okada, Y; Han, B; Tsoi, LC; Stuart, PE; Ellinghaus, E; Tejasvi, T; Chandran, V; Pellett, F; Pollock, R; Bowcock, AM; Krueger, GG; Weichenthal, M; Voorhees, JJ; Rahman, P; Gregersen, PK; Franke, A; Nair, RP; Abecasis, GR; Gladman, DD; Elder, JT; de Bakker, PIW; Raychaudhuri, S				Okada, Yukinori; Han, Buhm; Tsoi, Lam C.; Stuart, Philip E.; Ellinghaus, Eva; Tejasvi, Trilokraj; Chandran, Vinod; Pellett, Fawnda; Pollock, Remy; Bowcock, Anne M.; Krueger, Gerald G.; Weichenthal, Michael; Voorhees, John J.; Rahman, Proton; Gregersen, Peter K.; Franke, Andre; Nair, Rajan P.; Abecasis, Goncalo R.; Gladman, Dafna D.; Elder, James T.; de Bakker, Paul I. W.; Raychaudhuri, Soumya			Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SEROPOSITIVE RHEUMATOID-ARTHRITIS; ANALYSIS IDENTIFIES 3; HLA-C; SUSCEPTIBILITY LOCI; JOINT MANIFESTATIONS; DISEASE; RISK; VARIANTS; ALLELES	Psoriasis vulgaris (PsV) risk is strongly associated with variation within the major histocompatibility complex (MHC) region, but its genetic architecture has yet to be fully elucidated. Here, we conducted a large-scale fine-mapping study of PsV risk in the MHC region in 9,247 PsV-affected individuals and 13,589 controls of European descent by imputing class I and II human leukocyte antigen (HLA) genes from SNP genotype data. In addition, we imputed sequence variants for MICA, an MHC HLA-like gene that has been associated with PsV, to evaluate association at that locus as well. We observed that HLA-C*06:02 demonstrated the lowest p value for overall PsV risk (p = 1.7 x 10(-364)). Stepwise analysis revealed multiple HLA-C*06:02-independent risk variants in both class I and class II HLA genes for PsV susceptibility (HLA-C*12:03, HLA-B amino acid positions 67 and 9, HLA-A amino acid position 95, and HLA-DQ alpha 1 amino acid position 53; p < 5.0 x 10(-8)), but no apparent risk conferred by MICA. We further evaluated risk of two major clinical subtypes of PsV, psoriatic arthritis (PsA; n = 3,038) and cutaneous psoriasis (PsC; n = 3,098). We found that risk heterogeneity between PsA and PsC might be driven by HLA-B amino acid position 45 (P-omnibus = 2.2 x 10(-11)), indicating that different genetic factors underlie the overall risk of PsV and the risk of specific PsV subphenotypes. Our study illustrates the value of high-resolution HLA and MICA imputation for fine mapping causal variants in the MHC.	[Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Div, Tokyo 1130085, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Okada, Yukinori; Han, Buhm; Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Okada, Yukinori; Han, Buhm; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Okada, Yukinori; Han, Buhm; Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Okada, Yukinori; Han, Buhm; Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Tsoi, Lam C.; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Tsoi, Lam C.; Abecasis, Goncalo R.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Stuart, Philip E.; Tejasvi, Trilokraj; Voorhees, John J.; Nair, Rajan P.; Elder, James T.] Univ Michigan, Dept Dermatol, Sch Med, Ann Arbor, MI 48109 USA; [Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Chandran, Vinod; Gladman, Dafna D.] Univ Toronto, Div Rheumatol, Dept Med, Toronto, ON M5T 2S8, Canada; [Chandran, Vinod; Pellett, Fawnda; Pollock, Remy; Gladman, Dafna D.] Univ Toronto, Ctr Prognosis Studies Rheumat Dis, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada; [Bowcock, Anne M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Krueger, Gerald G.] Univ Utah, Dept Dermatol, Salt Lake City, UT 84112 USA; [Weichenthal, Michael] Univ Kiel, Dept Dermatol, D-24105 Kiel, Germany; [Rahman, Proton] Mem Univ Newfoundland, St John, NF A1C 5S7, Canada; [Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Gladman, Dafna D.] Univ Toronto, Toronto Western Res Inst, Toronto, ON M5G 2M9, Canada; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI 48105 USA; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands; [Raychaudhuri, Soumya] Univ Manchester, Arthrit Res UK Epidemiol Unit, Ctr Musculoskeletal Res, Inst Inflammat & Repair, Manchester M13 9PT, Lancs, England	Tokyo Medical & Dental University (TMDU); RIKEN; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Kiel; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Imperial College London; Utah System of Higher Education; University of Utah; University of Kiel; Memorial University Newfoundland; Northwell Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Manchester	de Bakker, PIW (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands.	pdebakker@umcutrecht.nl; soumya@broadinstitute.org	Franke, Andre/B-2151-2010; Han, Buhm/AAQ-9672-2020; Ellinghaus, Eva/E-6490-2012; Voorhees, John/AAM-9966-2020; de Bakker, Paul IW/B-8730-2009	Franke, Andre/0000-0003-1530-5811; Ellinghaus, Eva/0000-0003-2914-3382; Voorhees, John/0000-0003-1856-785X; de Bakker, Paul IW/0000-0001-7735-7858; Tsoi, Lam Cheung/0000-0003-1627-5722; Bowcock, Anne/0000-0001-8691-9090; Raychaudhuri, Soumya/0000-0002-1901-8265	NIH [1R01AR062886, R01AR042742, R01AR050511, R01AR062382, 5U01GM092691-04, 1R01AR063759-01A1, 2R01AR050266]; Arthritis Foundation; Doris Duke Foundation; Japan Society of the Promotion of Science; Japan Science and Technology Agency; Ann Arbor Veterans Affairs Hospital; Canadian Institute of Health Research; Krembil Foundation; Arthritis Society; Vernieuwingsimpuls VIDI Award, Netherlands Organization for Scientific Research [016.126.354]; Babcock Memorial Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050266, R01AR062886, R01AR063611, R01AR063759, R01AR065183, R01AR050511, R01AR042742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ann Arbor Veterans Affairs Hospital; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Arthritis Society; Vernieuwingsimpuls VIDI Award, Netherlands Organization for Scientific Research; Babcock Memorial Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (1R01AR062886, R01AR042742, R01AR050511, R01AR062382, 5U01GM092691-04, 1R01AR063759-01A1, and 2R01AR050266), the Arthritis Foundation, a Clinical Scientist Development Award to S.R. from the Doris Duke Foundation, the Japan Society of the Promotion of Science, the Japan Science and Technology Agency, the Ann Arbor Veterans Affairs Hospital, the Canadian Institute of Health Research, the Krembil Foundation, the Arthritis Society, a Vernieuwingsimpuls VIDI Award (project 016.126.354) from the Netherlands Organization for Scientific Research, and the Babcock Memorial Trust.	Asahina A, 1996, J DERMATOL SCI, V13, P125, DOI 10.1016/S0923-1811(96)00518-X; BUXTON SE, 1992, J EXP MED, V175, P809, DOI 10.1084/jem.175.3.809; Chandran V, 2013, HUM IMMUNOL, V74, P1333, DOI 10.1016/j.humimm.2013.07.014; Choy MK, 2010, TRENDS MOL MED, V16, P97, DOI 10.1016/j.molmed.2010.01.002; Christophers E, 2001, CLIN EXP DERMATOL, V26, P314, DOI 10.1046/j.1365-2230.2001.00832.x; Clop A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071690; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Eder L, 2012, ANN RHEUM DIS, V71, P1361, DOI 10.1136/annrheumdis-2012-201308; Eder L, 2012, ANN RHEUM DIS, V71, P50, DOI 10.1136/ard.2011.155044; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; FitzGerald O, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2580; Foo JN, 2013, AM J HUM GENET, V93, P167, DOI 10.1016/j.ajhg.2013.05.020; Gregersen PK, 2012, ANN NEUROL, V72, P927, DOI 10.1002/ana.23691; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Knight J, 2012, HUM MOL GENET, V21, P5185, DOI 10.1093/hmg/dds344; Lo PHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061279; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollock R, 2011, TISSUE ANTIGENS, V77, P554, DOI 10.1111/j.1399-0039.2011.01670.x; Pollock RA, 2013, TISSUE ANTIGENS, V82, P43, DOI 10.1111/tan.12126; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Rich SS, 2006, ANN NY ACAD SCI, V1079, P1, DOI 10.1196/annals.1375.001; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Stewart-Jones GBE, 2005, J IMMUNOL, V175, P2459, DOI 10.4049/jimmunol.175.4.2459; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1134, DOI 10.1002/art.33415	40	138	141	2	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					162	172		10.1016/j.ajhg.2014.07.002	http://dx.doi.org/10.1016/j.ajhg.2014.07.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25087609	Green Published, hybrid			2022-12-18	WOS:000340076000003
J	Lee, S; Teslovich, TM; Boehnke, M; Lin, XH				Lee, Seunggeun; Teslovich, Tanya M.; Boehnke, Michael; Lin, Xihong			General Framework for Meta-analysis of Rare Variants in Sequencing Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; LOCI; DISEASES; ROBUST; TESTS; MAP	We propose a general statistical framework for meta-analysis of gene- or region-based multimarker rare variant association tests in sequencing association studies. In genome-wide association studies, single-marker meta-analysis has been widely used to increase statistical power by combining results via regression coefficients and standard errors from different studies. In analysis of rare variants in sequencing studies, region-based multimarker tests are often used to increase power. We propose meta-analysis methods for commonly used gene- or region-based rare variants tests, such as burden tests and variance component tests. Because estimation of regression coefficients of individual rare variants is often unstable or not feasible, the proposed method avoids this difficulty by calculating score statistics instead that only require fitting the null model for each study and then aggregating these score statistics across studies. Our proposed meta-analysis rare variant association tests are conducted based on study-specific summary statistics, specifically score statistics for each variant and between-variant covariance-type (linkage disequilibrium) relationship statistics for each gene or region. The proposed methods are able to incorporate different levels of heterogeneity of genetic effects across studies and are applicable to meta-analysis of multiple ancestry groups. We show that the proposed methods are essentially as powerful as joint analysis by directly pooling individual level genotype data. We conduct extensive simulations to evaluate the performance of our methods by varying levels of heterogeneity across studies, and we apply the proposed methods to meta-analysis of rare variant effects in a multicohort study of the genetics of blood lipid levels.	[Lee, Seunggeun; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Teslovich, Tanya M.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Teslovich, Tanya M.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lin, XH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	xlin@hsph.harvard.edu			National Institutes of Health [K99 HL113264, R01 HG000376, R37 CA076404, P01 CA134294]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants K99 HL113264 (S.L.), R01 HG000376 (M.B.), and R37 CA076404 and P01 CA134294 (X.L.) from the National Institutes of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255; DAVIES R. B., 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025; Fisher R., 1970, STAT METHODS RES WOR; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2010, GENET EPIDEMIOL, V34, P60, DOI 10.1002/gepi.20435; Liu D. J., 2013, ARXIV13051318; Liu L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003443; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stouffer S, 1949, STUDIES SOCIAL PSYCH, V1; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57	37	138	141	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					42	53		10.1016/j.ajhg.2013.05.010	http://dx.doi.org/10.1016/j.ajhg.2013.05.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23768515	Green Published, Bronze			2022-12-18	WOS:000321804500004
J	Paternoster, L; Zhurov, AI; Toma, AM; Kemp, JP; Pourcain, BS; Timpson, NJ; McMahon, G; McArdle, W; Ring, SM; Smith, GD; Richmond, S; Evans, DM				Paternoster, Lavinia; Zhurov, Alexei I.; Toma, Arshed M.; Kemp, John P.; Pourcain, Beate St.; Timpson, Nicholas J.; McMahon, George; McArdle, Wendy; Ring, Susan M.; Smith, George Davey; Richmond, Stephen; Evans, David M.			Genome-wide Association Study of Three-Dimensional Facial Morphology Identifies a Variant in PAX3 Associated with Nasion Position	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHILDREN; PARENTS	Craniofacial morphology is highly heritable, but little is known about which genetic variants influence normal facial variation in the general population. We aimed to identify genetic variants associated with normal facial variation in a population-based cohort of 15-year-olds from the Avon Longitudinal Study of Parents and Children. 3D high-resolution images were obtained with two laser scanners, these were merged and aligned, and 22 landmarks were identified and their x, y, and z coordinates used to generate 54 3D distances reflecting facial features. 14 principal components (PCs) were also generated from the landmark locations. We carried out genome-wide association analyses of these distances and PCs in 2,185 adolescents and attempted to replicate any significant associations in a further 1,622 participants. In the discovery analysis no associations were observed with the PCs, but we identified four associations with the distances, and one of these, the association between rs7559271 in PAX3 and the nasion to midendocanthion distance (n-men), was replicated (p = 4 x 10(-7)). In a combined analysis, each G allele of rs7559271 was associated with an increase in n-men distance of 0.39 mm (p = 4 x 10(-16)), explaining 1.3% of the variance. Independent associations were observed in both the z (nasion prominence) and y (nasion height) dimensions (p = 9 x 10(-9) and p = 9 x 10(-1), respectively), suggesting that the locus primarily influences growth in the yz plane. Rare variants in PAX3 are known to cause Waardenburg syndrome, which involves deafness, pigmentary abnormalities, and facial characteristics including a broad nasal bridge. Our findings show that common variants within this gene also influence normal craniofacial development.	[Paternoster, Lavinia; Kemp, John P.; Timpson, Nicholas J.; McMahon, George; Smith, George Davey; Evans, David M.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Bristol BS8 2BN, Avon, England; [Paternoster, Lavinia; Kemp, John P.; Pourcain, Beate St.; Timpson, Nicholas J.; McMahon, George; McArdle, Wendy; Ring, Susan M.; Smith, George Davey; Evans, David M.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Zhurov, Alexei I.; Toma, Arshed M.; Richmond, Stephen] Cardiff Univ, Dept Appl Clin Res & Publ Hlth, Cardiff CF14 4XY, S Glam, Wales	University of Bristol; University of Bristol; Cardiff University	Paternoster, L (corresponding author), Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Bristol BS8 2BN, Avon, England.	l.paternoster@bristol.ac.uk	Evans, David M/H-6325-2013; Kemp, John P./R-3091-2018; Davey Smith, George/A-7407-2013; St Pourcain, Beate/K-8004-2017; Zhurov, Alexei I/P-4410-2014; Attrill, Lauren/V-1688-2018; Timpson, Nicholas John/O-7548-2015; wang, edwin/G-5372-2010; Richmond, Steve/K-6696-2012; Fox, Laura J/C-6249-2016; Paternoster, Lavinia/C-1292-2015	Evans, David M/0000-0003-0663-4621; Kemp, John P./0000-0002-9105-2249; Davey Smith, George/0000-0002-1407-8314; St Pourcain, Beate/0000-0002-4680-3517; Zhurov, Alexei I/0000-0002-5594-0740; Timpson, Nicholas John/0000-0002-7141-9189; Richmond, Steve/0000-0001-5449-5318; Paternoster, Lavinia/0000-0003-2514-0889; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	UK Medical Research Council; Wellcome Trust [092731, WT083431MA]; University of Bristol; ALSPAC; Cardiff University; Medical Research Council [MRC G0800582]; Medical Research Council [G0600705, G0800582] Funding Source: researchfish; MRC [G0600705, G0800582] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Bristol; ALSPAC; Cardiff University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are extremely grateful to all the individuals who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. We thank the Sanger Centre, Centre National de Genotypage, and 23andMe for generating the ALSPAC GWA data. The publication is the work of the authors and L.P. will serve as guarantor for the contents of this paper. The UK Medical Research Council, the Wellcome Trust (grant ref: 092731), and the University of Bristol provide core support for the Avon Longitudinal Study of Parents and their Children. The collection of the face data was funded by ALSPAC and Cardiff University. L.P., D.M.E., and this work were supported by a Medical Research Council New Investigator Award (MRC G0800582 to D.M.E.). A.M.T. was funded by a Cardiff University 3-year PhD program. J.P.K. was funded by a Wellcome Trust 4-year PhD studentship in molecular, genetic, and life course epidemiology (WT083431MA).	Benson PE, 1997, EUR J ORTHODONT, V19, P397, DOI 10.1093/ejo/19.4.397; Boehringer S, 2011, EUR J HUM GENET, V19, P1192, DOI 10.1038/ejhg.2011.110; Bozic M, 2009, ANGLE ORTHOD, V79, P640, DOI 10.2319/081608-432.1; Dryden I.L., 1998, STAT SHAPE ANAL, DOI [DOI 10.5555/1046920.1088707, 10.1002/9781119072492]; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Hochheiser H, 2011, DEV BIOL, V355, P175, DOI 10.1016/j.ydbio.2011.02.033; Johannsdottir B, 2005, AM J ORTHOD DENTOFAC, V127, P200, DOI 10.1016/j.ajodo.2004.07.033; Kau CH, 2005, AM J ORTHOD DENTOFAC, V128, P424, DOI 10.1016/j.ajodo.2004.06.037; KAU CH, 2010, AM J ORTHOD DENTOF S, V137, pE1; KAU CH, 2010, AM J ORTHOD DENTOF S, V9, pS56; Kau CH, 2010, AM J ORTHOD DENTOFAC, V137, DOI [10.1016/j.ajodo.2009.04.022, 10.1016/j.ajodo.2010.01.022]; Kau CH, 2008, AM J ORTHOD DENTOFAC, V134, P751, DOI 10.1016/j.ajodo.2007.01.037; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; KOHN LAP, 1991, ANNU REV ANTHROPOL, V20, P261, DOI 10.1146/annurev.an.20.100191.001401; Leamy LJ, 2008, HEREDITY, V101, P518, DOI 10.1038/hdy.2008.79; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; NAKATA M, 1973, AM J ORTHOD DENTOFAC, V63, P471, DOI 10.1016/0002-9416(73)90160-7; Oh J, 2007, J DENT RES, V86, P1203, DOI 10.1177/154405910708601212; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Sherwood RJ, 2008, GENETICS, V180, P619, DOI 10.1534/genetics.108.090407; Tanner J. M., 1962, GROWTH ADOLESCENCE, V2nd; Toma AM, 2009, ORTHOD CRANIOFAC RES, V12, P33, DOI 10.1111/j.1601-6343.2008.01435.x; TOMA AM, 2011, EUR J ORTHO IN PRESS, V20, P2011; Tsukamoto Kazuhiro, 1992, Human Molecular Genetics, V1, P315, DOI 10.1093/hmg/1.5.315; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552; Zhurov A, 2010, 3 DIMENSIONAL IMAGIN, P126	29	138	146	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					478	485		10.1016/j.ajhg.2011.12.021	http://dx.doi.org/10.1016/j.ajhg.2011.12.021			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22341974	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000301762800013
J	Zhao, H; Chen, ZJ; Qin, YY; Shi, YH; Wang, S; Choi, Y; Simpson, JL; Rajkovic, A				Zhao, Han; Chen, Zi-Jiang; Qin, Yingying; Shi, Yuhua; Wang, Shan; Choi, Youngsok; Simpson, Joe Leigh; Rajkovic, Aleksandar			Transcription factor FIGLA is mutated in patients with Premature Ovarian Failure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FOLLICLE-STIMULATING-HORMONE; HUMAN MENSTRUAL-CYCLE; HELIX-LOOP-HELIX; CANDIDATE GENES; DIMERIC INHIBIN; INDIAN WOMEN; EXPRESSION; ALPHA; DIFFERENTIATION; DISRUPTION	Premature Ovarian Failure (POF) is a genetically heterogenous disorder that leads to hypergonadotropic ovarian failure and infertility. We screened 100 Chinese women with POF for mutations in the oocyte-specific gene FIGLA and identified three variants in four women: missense mutation c.11C -> A (p.A4E) was found in two women; deletion c. 15-36 del (p.G6fsX66), resulting in a frameshift that leads to haploinsufficiency, was found in one woman; and deletion c.419-421 delACA (p.140 delN) was found in one. Functional analyses by the yeast two-hybrid assay demonstrated that the p.140 delN mutation disrupted FIGLA binding to the TCF3 helix-loop-helix (HLH) domain. Our findings show that a subset of Chinese women with sporadic, premature ovarian failure harbor mutations in FIGLA.	[Zhao, Han; Choi, Youngsok; Rajkovic, Aleksandar] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Zhao, Han; Chen, Zi-Jiang; Qin, Yingying; Shi, Yuhua; Wang, Shan] Shandong Univ, Shandong Prov Hosp Affiliated, Ctr Reprod Med, Jinan 250021, Shandong, Peoples R China; [Simpson, Joe Leigh] Florida Int Univ, Coll Med, Dept Obstet & Gynecol, Dept Human & Mol Genet, Miami, FL 33199 USA	Baylor College of Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; State University System of Florida; Florida International University	Rajkovic, A (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	raikovic@bcm.edu	Li, Yuan/GXV-1310-2022; Yan, Junhao/AAH-8310-2019; Chen, Zi-Jiang/GOE-6119-2022	Chen, Zi-Jiang/0000-0001-6637-6631; Choi, Youngsok/0000-0002-3862-4105	NICHD NIH HHS [HD44858, HD058125, R01 HD044858, R21 HD058125] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044858] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD058125] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Athanikar JN, 1998, P NATL ACAD SCI USA, V95, P4935, DOI 10.1073/pnas.95.9.4935; Bayne RAL, 2004, MOL HUM REPROD, V10, P373, DOI 10.1093/molehr/gah056; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Bione S, 2004, HUM REPROD, V19, P2759, DOI 10.1093/humrep/deh502; Bodega B, 2006, HUM REPROD, V21, P952, DOI 10.1093/humrep/dei432; Chand AL, 2006, FERTIL STERIL, V86, P1009, DOI 10.1016/j.fertnstert.2006.02.107; Conway GS, 1996, FERTIL STERIL, V65, P337, DOI 10.1016/S0015-0282(16)58095-9; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; CRAMER DW, 1995, FERTIL STERIL, V64, P740, DOI 10.1016/S0015-0282(16)57849-2; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Dixit H, 2006, HUM REPROD, V21, P1643, DOI 10.1093/humrep/del129; Dixit H, 2005, MENOPAUSE, V12, P749, DOI 10.1097/01.gme.0000184424.96437.7a; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; GROOME NP, 1994, CLIN ENDOCRINOL, V40, P717, DOI 10.1111/j.1365-2265.1994.tb02504.x; Groome NP, 1996, J CLIN ENDOCR METAB, V81, P1401, DOI 10.1210/jc.81.4.1401; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Huntriss J, 2002, MOL HUM REPROD, V8, P1087, DOI 10.1093/molehr/8.12.1087; Jiang N, 1998, J CLIN ENDOCR METAB, V83, P4338, DOI 10.1210/jc.83.12.4338; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kovanci E, 2007, FERTIL STERIL, V87, P143, DOI 10.1016/j.fertnstert.2006.05.079; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lacombe A, 2006, AM J HUM GENET, V79, P113, DOI 10.1086/505406; Laissue P, 2006, EUR J ENDOCRINOL, V154, P739, DOI 10.1530/eje.1.02135; Liang LF, 1997, DEVELOPMENT, V124, P4939; LITTLEWOOD TD, 1995, PROTEIN PROFILE, V2, P621; Marozzi A, 2002, HUM REPROD, V17, P1741, DOI 10.1093/humrep/17.7.1741; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Pietrobono R, 2005, HUM MOL GENET, V14, P267, DOI 10.1093/hmg/ddi024; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Shelling AN, 2000, HUM REPROD, V15, P2644, DOI 10.1093/humrep/15.12.2644; Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Suzumori N, 2007, CURR MED CHEM, V14, P353, DOI 10.2174/092986707779941087; Terracciano A, 2005, AM J MED GENET C, V137C, P32, DOI 10.1002/ajmg.c.30062; Toniolo D, 2007, SEMIN REPROD MED, V25, P264, DOI 10.1055/s-2007-980220; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004; Woad KJ, 2006, AUST NZ J OBSTET GYN, V46, P242, DOI 10.1111/j.1479-828X.2006.00585.x; Yatsenko AN, 2006, HUM MOL GENET, V15, P3411, DOI 10.1093/hmg/ddl417; Zhao H, 2007, FERTIL STERIL, V88, P1474, DOI 10.1016/j.fertnstert.2007.01.021	47	138	158	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1342	1348		10.1016/j.ajhg.2008.04.018	http://dx.doi.org/10.1016/j.ajhg.2008.04.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18499083	Green Published, Bronze			2022-12-18	WOS:000256647000011
J	Valente, L; Tiranti, V; Marsano, RM; Malfatti, E; Fernandez-Vizarra, E; Donnini, C; Mereghetti, P; De Gioia, L; Burlina, A; Castellan, C; Comi, GP; Savasta, S; Ferrero, I; Zeviani, M				Valente, Lucia; Tiranti, Valeria; Marsano, Rene Massimiliano; Malfatti, Edoardo; Fernandez-Vizarra, Erika; Donnini, Claudia; Mereghetti, Paolo; De Gioia, Luca; Burlina, Alberto; Castellan, Claudio; Comi, Giacomo P.; Savasta, Salvatore; Ferrero, Iliana; Zeviani, Massimo			Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIDEROBLASTIC ANEMIA MLASA; SACCHAROMYCES-CEREVISIAE; OXIDATIVE-PHOSPHORYLATION; MISSENSE MUTATION; CRYSTAL-STRUCTURE; LEIGHS SYNDROME; FACTOR-TU; DISEASE; YEAST; DEFICIENCY	Mitochondrial protein translation is a complex process performed within mitochondria by an apparatus composed of mitochondrial DNA (mtDNA)-encoded RNAs and nuclear DNA -encoded proteins. Although the latter by far outnumber the former, the vast majority of mitochondrial translation defects in humans have been associated with mutations in RNA-encoding mtDNA genes, whereas mutations in protein-encoding nuclear genes have been identified in a handful of cases. Genetic investigation involving patients with defective mitochondrial translation led us to the discovery of novel mutations in the mitochondrial elongation factor G1 (EFG1) in one affected baby and, for the first time, in the mitochondrial elongation factor Tu (EFTu) in another one. Both patients were affected by severe lactic acidosis and rapidly progressive, fatal encephalopathy. The EFG1-mutant patient had early-onset Leigh syndrome, whereas the EFTu-mutant patient had severe infantile macrocystic leukodystrophy with micropolygyria. Structural modeling enabled us to make predictions about the effects of the mutations at the molecular level. Yeast and mammalian cell systems proved the pathogenic role of the mutant alleles by functional complementation in vivo. Nuclear-gene abnormalities causing mitochondrial translation defects represent a new, potentially broad field of mitochondrial medicine. Investigation of these defects is important to expand the molecular characterization of mitochondrial disorders and also may contribute to the elucidation of the complex control mechanisms, which regulate this fundamental pathway of mtDNA homeostasis.	IRCCS Fdn, Natl Neurol Inst Carlo Besta, Div Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Res Childrens Mito, I-20126 Milan, Italy; Univ Milan, Dept Biosci & Biotechnol, Milan, Italy; Univ Milan, Osped Maggiore Policlin, IRCCS Fdn, Dept Neurol Sci,Dino Ferrari Ctr, Milan, Italy; Univ Parma, Dept Genet Biol Microrganisms Anthropol & Evolut, I-43100 Parma, Italy; Univ Siena, Dept Neurol, I-53100 Siena, Italy; Univ Padua, Dept Paediat, Padua, Italy; Reg Publ Hlth Hosp, Serv Genet, Bolzano, Italy; Univ Pavia, Dept Paediat, I-27100 Pavia, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Parma; University of Siena; University of Padua; University of Pavia	Zeviani, M (corresponding author), IRCCS Fdn, Natl Neurol Inst Carlo Besta, Div Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Res Childrens Mito, Via Temolo 4, I-20126 Milan, Italy.	zeviani@istituto-besta.it	Tiranti, Valeria/AFN-5783-2022; Tiranti, Valeria/J-8233-2016; Fernandez-Vizarra, Erika/AAE-5600-2020; Zeviani, Massimo/AAU-2632-2021; Marsano, René Massimiliano/B-9640-2012; De Gioia, Luca/K-6439-2016; burlina, alberto/AHE-6095-2022; Comi, Giacomo P/K-5702-2016; Zeviani, Massimo/K-2891-2014; Donnini, Claudia/B-5548-2015	Tiranti, Valeria/0000-0002-3584-7338; Tiranti, Valeria/0000-0002-3584-7338; Zeviani, Massimo/0000-0002-9067-5508; Marsano, René Massimiliano/0000-0001-8450-1010; Comi, Giacomo P/0000-0002-1383-5248; Donnini, Claudia/0000-0002-4901-2358; SAVASTA, Salvatore/0000-0001-9238-0749; Fernandez-Vizarra, Erika/0000-0002-2469-142X; Mereghetti, Paolo/0000-0001-6012-592X				Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; COTTRELL SF, 1975, J BIOL CHEM, V250, P4087; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; DEFONTAINE A, 1991, NUCLEIC ACIDS RES, V19, P185, DOI 10.1093/nar/19.1.185; Farina L, 2002, AM J NEURORADIOL, V23, P1095; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; FERNOW CL, 1806, ROMISCHE STUDIEN, V1, P1; Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hammarsund M, 2001, HUM GENET, V109, P542, DOI 10.1007/s00439-001-0610-5; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter SE, 2004, MITOCHONDRION, V4, P21, DOI 10.1016/j.mito.2004.04.003; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; Jeppesen MG, 2005, J BIOL CHEM, V280, P5071, DOI 10.1074/jbc.M411782200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; MOUNOLOU JC, 1966, BIOCHEM BIOPH RES CO, V24, P218, DOI 10.1016/0006-291X(66)90723-6; Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NAGATA S, 1983, P NATL ACAD SCI-BIOL, V80, P6192, DOI 10.1073/pnas.80.20.6192; Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200; Sambrook J, 2001, MOL CLONING LAB MANU; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sherman F, 1986, LAB COURSE MANUAL ME; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; Sylvester JE, 2004, GENET MED, V6, P73, DOI 10.1097/01.GIM.0000117333.21213.17; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017; VAMBUTAS A, 1991, EUR J BIOCHEM, V201, P643, DOI 10.1111/j.1432-1033.1991.tb16325.x; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Woriax VL, 1997, BBA-GENE STRUCT EXPR, V1352, P91, DOI 10.1016/S0167-4781(97)00002-X	39	138	148	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					44	58		10.1086/510559	http://dx.doi.org/10.1086/510559			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160893	Bronze, Green Published			2022-12-18	WOS:000243102500005
J	Treloar, SA; Wicks, J; Nyholt, DR; Montgomery, GW; Bahlo, M; Smith, V; Dawson, G; Mackay, IJ; Weeks, DE; Bennett, ST; Carey, A; Ewen-White, KR; Duffy, DL; O'Connor, DT; Barlow, DH; Martin, NG; Kennedy, SH				Treloar, SA; Wicks, J; Nyholt, DR; Montgomery, GW; Bahlo, M; Smith, V; Dawson, G; Mackay, IJ; Weeks, DE; Bennett, ST; Carey, A; Ewen-White, KR; Duffy, DL; O'Connor, DT; Barlow, DH; Martin, NG; Kennedy, SH			Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; PERITONEAL ENDOMETRIOSIS; DETECT LINKAGE; MODEL-FREE; LOD-SCORE; ASSOCIATION; DISEASE; POWER; HERITABILITY; INFORMATION	Endometriosis is a common gynecological disease that affects up to 10% of women in their reproductive years. It causes pelvic pain, severe dysmenorrhea, and subfertility. The disease is defined as the presence of tissue resembling endometrium in sites outside the uterus. Its cause remains uncertain despite 150 years of hypothesis-driven research, and thus the therapeutic options are limited. Disease predisposition is inherited as a complex genetic trait, which provides an alternative route to understanding the disease. We seek to identify susceptibility loci, using a positional-cloning approach that starts with linkage analysis to identify genomic regions likely to harbor these genes. We conducted a linkage study of 1,176 families ( 931 from an Australian group and 245 from a U. K. group), each with at least two members-mainly affected sister pairs-with surgically diagnosed disease. We have identified a region of significant linkage on chromosome 10q26 ( maximum LOD score [MLS] of 3.09; genomewide P = .047) and another region of suggestive linkage on chromosome 20p13 MLS p 2.09). Minor peaks with MLS > 1.0) were found on chromosomes 2, 6, 7, 8, 12, 14, 15, and 17. This is the first report of linkage to a major locus for endometriosis. The findings will facilitate discovery of novel positional genetic variants that influence the risk of developing this debilitating disease. Greater understanding of the aberrant cellular and molecular mechanisms involved in the etiology and pathophysiology of endometriosis should lead to better diagnostic methods and targeted treatments.	Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Cooperat Res Ctr Discovery Genes Common Human Dis, Melbourne, Vic, Australia; Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; Australian Genome Res Facil, Melbourne, Vic, Australia; Queensland Endometriosis Res Inst, Brisbane, Qld, Australia; Oxagen, Abingdon, Oxon, England; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Walter & Eliza Hall Institute; Oxagen Limited; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford	Treloar, SA (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	Sue.Treloar@qimr.edu.au	Weeks, Daniel E/B-2995-2012; Barlow, David/F-8738-2011; Duffy, David L/B-7392-2013; Montgomery, Grant W/B-7148-2008; Nyholt, Dale Robert/J-3174-2017; Kennedy, Stephen/B-8950-2009; Smith, Vicki E/F-6972-2010	Weeks, Daniel E/0000-0001-9410-7228; Duffy, David L/0000-0001-7227-632X; Montgomery, Grant W/0000-0002-4140-8139; Nyholt, Dale Robert/0000-0001-7159-3040; Smith, Vicki E/0000-0003-0757-7198; Martin, Nicholas/0000-0003-4069-8020; Bahlo, Melanie/0000-0001-5132-0774				Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; *AM FERT SOC, 1985, FERTIL STERIL, V43, P351; Bischoff FZ, 2000, HUM REPROD UPDATE, V6, P37, DOI 10.1093/humupd/6.1.37; Cordell HJ, 2004, AM J HUM GENET, V74, P1294, DOI 10.1086/421476; Daftary GS, 2004, J CLIN ENDOCR METAB, V89, P2390, DOI 10.1210/jc.2003-031389; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; DUFFY DL, 2001, SIB PAIR RELEASE 0 9; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; FLORES I, 2004, AM SOC HUM GEN 2004; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Hadfield RM, 2001, MOL HUM REPROD, V7, P1073, DOI 10.1093/molehr/7.11.1073; Healy DL, 1998, HUM REPROD UPDATE, V4, P736, DOI 10.1093/humupd/4.5.736; Hodge SE, 1997, AM J HUM GENET, V60, P217; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Huang J, 2001, HUM HERED, V51, P217, DOI 10.1159/000053345; Kennedy S, 2003, SEMIN REPROD MED, V21, P111; KENNEDY S, 1995, J ASSIST REPROD GEN, V12, P32, DOI 10.1007/BF02214126; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; *NAT I CHILD HLTH, 2002, END; Nisolle M, 1997, FERTIL STERIL, V68, P585, DOI 10.1016/S0015-0282(97)00191-X; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pal DK, 2001, EUR J HUM GENET, V9, P855, DOI 10.1038/sj.ejhg.5200724; PEIFFER SL, 1995, CANCER RES, V55, P1922; Peiffer-Schneider S, 1998, GENOMICS, V52, P9, DOI 10.1006/geno.1998.5399; RISCH N, 1990, AM J HUM GENET, V46, P229; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Sato N, 2000, CANCER RES, V60, P7052; Simpson JL, 2002, ANN NY ACAD SCI, V955, P239, DOI 10.1111/j.1749-6632.2002.tb02785.x; Song KK, 2004, GENET EPIDEMIOL, V26, P88, DOI 10.1002/gepi.10296; Stefanson H, 2002, HUM REPROD, V17, P555, DOI 10.1093/humrep/17.3.555; Stefansson H, 2001, FERTIL STERIL, V76, P1019, DOI 10.1016/S0015-0282(01)02862-X; SUAREZ BK, 1979, CLIN GENET, V15, P126; Treloar S, 2002, FERTIL STERIL, V78, P679, DOI 10.1016/S0015-0282(02)03341-1; Treloar SA, 1999, FERTIL STERIL, V71, P701, DOI 10.1016/S0015-0282(98)00540-8; Varma R, 2004, REPRODUCTION, V127, P293, DOI 10.1530/rep.1.00020; Vinatier D, 2001, EUR J OBSTET GYN R B, V96, P21, DOI 10.1016/S0301-2115(00)00405-X; Walling GA, 2000, GENETICS, V155, P1369; Wicks J, 2004, TWIN RES, V7, P211, DOI 10.1375/136905204323016195; Zondervan KT, 2001, CURR OPIN OBSTET GYN, V13, P309, DOI 10.1097/00001703-200106000-00011; Zondervan KT, 2004, HUM REPROD, V19, P448, DOI 10.1093/humrep/deh052	50	138	143	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					365	376		10.1086/432960	http://dx.doi.org/10.1086/432960			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080113	Green Published, Bronze			2022-12-18	WOS:000231314100004
J	Velagaleti, GVN; Bien-Willner, GA; Northup, JK; Lockhart, LH; Hawkins, JC; Jalal, SM; Withers, M; Lupski, JR; Stankiewicz, P				Velagaleti, GVN; Bien-Willner, GA; Northup, JK; Lockhart, LH; Hawkins, JC; Jalal, SM; Withers, M; Lupski, JR; Stankiewicz, P			Position effects due to chromosome breakpoints that map similar to 900 Kb upstream and similar to 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL SEX REVERSAL; HUMAN GENETIC-DISEASE; SRY-RELATED GENE; STICKLER-SYNDROME; 5-GENERATION FAMILY; STOP CODON; ODS MICE; TRANSLOCATION; EXPRESSION; MUTATION	Campomelic dysplasia ( CD) is a semilethal skeletal malformation syndrome with or without XY sex reversal. In addition to the multiple mutations found within the sex-determining region Y - related high-mobility group box gene (SOX9) on 17q24.3, several chromosome anomalies ( translocations, inversions, and deletions) with breakpoints scattered over 1 Mb upstream of SOX9 have been described. Here, we present a balanced translocation, t(4; 17)( q28.3; q24.3), segregating in a family with a mild acampomelic CD with Robin sequence. Both chromosome breakpoints have been identified by fluorescence in situ hybridization and have been sequenced using a somatic cell hybrid. The 17q24.3 breakpoint maps similar to 900 kb upstream of SOX9, which is within the same bacterial artificial chromosome clone as the breakpoints of two other reported patients with mild CD. We also report a prenatal identification of acampomelic CD with male-to-female sex reversal in a fetus with a de novo balanced complex karyotype, 46, XY, t( 4; 7; 8; 17)( 4qter --> 4p15.1:: 17q25.1 --> 17qter --> 7qterr7p15.3:: 4p15.1 --> 4pter; 8pter --> 8q12.1:: 7p15.3 --> 7pter; 17pter --> 17q25.1:: 8q12.1 --> 8qter). Surprisingly, the 17q breakpoint maps similar to 1.3 Mb downstream of SOX9, making this the longest-range position effect found in the field of human genetics and the first report of a patient with CD with the chromosome breakpoint mapping 3' of SOX9. By using the Regulatory Potential score in conjunction with analysis of the rearrangement breakpoints, we identified a candidate upstream cis-regulatory element, SOX9cre1. We provide evidence that this 1.1-kb evolutionarily conserved element and the downstream breakpoint region colocalize with SOX9 in the interphase nucleus, despite being located 1.1 Mb upstream and 1.3 Mb downstream of it, respectively. The potential molecular mechanism responsible for the position effect is discussed.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Pediat, Galveston, TX 77550 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; Mayo Clinic	Stankiewicz, P (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room T821, Houston, TX 77030 USA.	pawels@bcm.tmc.edu	Stankiewicz, Paweł/AAP-7906-2021	Stankiewicz, Paweł/0000-0002-6456-7490	NICHD NIH HHS [P01 HD039420, HD24064, P01 HD39420, P30 HD024064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039420] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bickmore WA, 2003, HUM MOL GENET, V12, pR207, DOI 10.1093/hmg/ddg260; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Cameron FJ, 1996, HUM MOL GENET, V5, P1625, DOI 10.1093/hmg/5.10.1625; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cho KS, 2004, CURR OPIN GENET DEV, V14, P308, DOI 10.1016/j.gde.2004.04.015; Davies AF, 1999, J MED GENET, V36, P708; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; Donoso LA, 2002, AM J OPHTHALMOL, V134, P720, DOI 10.1016/S0002-9394(02)01638-0; ERDEL M, 2004, EUR J HUM GENET, V12, P136; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Goji K, 1998, HUM MUTAT, pS114; Hageman RM, 1998, HUM MUTAT, pS112; Hill-Harfe KL, 2005, AM J HUM GENET, V76, P663, DOI 10.1086/429254; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Jamshidi N, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010157; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kleinjan DA, 2003, NAT GENET, V34, P125, DOI 10.1038/ng0603-125; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; MANSOUR S, 1995, J MED GENET, V32, P415, DOI 10.1136/jmg.32.6.415; MARAIA R, 1991, CLIN GENET, V39, P401; MAUMENEE IH, 1979, AM J OPHTHALMOL, V88, P432, DOI 10.1016/0002-9394(79)90645-7; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Poirier C, 2004, GENETICS, V168, P1557, DOI 10.1534/genetics.104.032177; Pop R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013185; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Stalker HJ, 1997, AM J MED GENET, V73, P247; Stalker HJ, 2001, AM J MED GENET, V103, P339, DOI 10.1002/ajmg.1559; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TOMMERUP N, 1993, NAT GENET, V4, P170, DOI 10.1038/ng0693-170; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; VINTINER GM, 1991, AM J MED GENET, V41, P44, DOI 10.1002/ajmg.1320410113; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Williams CJ, 1996, AM J MED GENET, V63, P461, DOI 10.1002/(SICI)1096-8628(19960614)63:3<461::AID-AJMG9>3.0.CO;2-U; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; YOUNG ID, 1992, J MED GENET, V29, P251, DOI 10.1136/jmg.29.4.251; Zhang P, 2003, J BIOL CHEM, V278, P117, DOI 10.1074/jbc.M208049200	52	138	142	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					652	662		10.1086/429252	http://dx.doi.org/10.1086/429252			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15726498	Green Published, Bronze			2022-12-18	WOS:000227516000011
J	Fernandes, S; Paracchini, S; Meyer, LH; Floridia, G; Smith, CT; Vogt, PH				Fernandes, S; Paracchini, S; Meyer, LH; Floridia, G; Smith, CT; Vogt, PH			A large AZFc deletion removes DAZ3/DAZ4 and nearby genes from men in Y haplogroup N	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMOLOGOUS RECOMBINATION; CHROMOSOME; NOMENCLATURE; HISTORY; REGION; TREE	Deletion of the entire AZFc locus on the human Y chromosome leads to male infertility. The functional roles of the individual gene families mapped to AZFc are, however, still poorly understood, since the analysis of the region is complicated by its repeated structure. We have therefore used single-nucleotide variants (SNVs) across similar to 3 Mb of the AZFc sequence to identify 17 AZFc haplotypes and have examined them for deletion of individual AZFc gene copies. We found five individuals who lacked SNVs from a large segment of DNA containing the DAZ3/ DAZ4 and BPY2.2/BPY2.3 gene doublets in distal AZFc. Southern blot analyses showed that the lack of these SNVs was due to deletion of the underlying DNA segment. Typing 118 binary Y markers showed that all five individuals belonged to Y haplogroup N, and 15 of 15 independently ascertained men in haplogroup N carried a similar deletion. Haplogroup N is known to be common and widespread in Europe and Asia, and there is no indication of reduced fertility in men with this Y chromosome. We therefore conclude that a common variant of the human Y chromosome lacks the DAZ3/ DAZ4 and BPY2.2/BPY2.3 doublets in distal AZFc and thus that these genes cannot be required for male fertility; the gene content of the AZFc locus is likely to be genetically redundant. Furthermore, the observed deletions cannot be derived from the GenBank reference sequence by a single recombination event; an origin by homologous recombination from such a sequence organization must be preceded by an inversion event. These data confirm the expectation that the human Y chromosome sequence and gene complement may differ substantially between individuals and more variations are to be expected in different Y chromosomal haplogroups.	Heidelberg Univ, Dept Gynecol Endocrinol & Reprod Med, Sect Mol Genet & Infertil, D-69115 Heidelberg, Germany; Univ Porto, Fac Med, Dept Human Genet, P-4100 Oporto, Portugal; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Ruprecht Karls University Heidelberg; Universidade do Porto; University of Oxford	Vogt, PH (corresponding author), Heidelberg Univ, Dept Gynecol Endocrinol & Reprod Med, Sect Mol Genet & Infertil, Vossstr 9, D-69115 Heidelberg, Germany.	peter_vogt@med.uni-heidelberg.de	Paracchini, Silvia/AAU-6813-2021; FLORIDIA, GIOVANNA/A-6640-2015; Fernandes, Susana/B-4499-2008; Fernandes, Susana/AAM-5888-2020	Paracchini, Silvia/0000-0001-9934-8602; FLORIDIA, GIOVANNA/0000-0003-4187-8816; Fernandes, Susana/0000-0003-1128-833X				Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Ellis N, 2002, GENOME RES, V12, P339; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Floridia G, 2000, CHROMOSOMA, V109, P318, DOI 10.1007/s004120000081; Hammer MF, 2002, ANNU REV ANTHROPOL, V31, P303, DOI 10.1146/annurev.anthro.31.040402.085413; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Krausz C, 2000, HUM REPROD, V15, P1431, DOI 10.1093/humrep/15.7.1431; Krausz C, 2001, HUM MOL GENET, V10, P1873, DOI 10.1093/hmg/10.18.1873; Krausz C, 1999, FRONT BIOSCI, V4, P1; Paracchini S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e27; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Simoni M, 2001, HUM REPROD, V16, P402, DOI 10.1093/humrep/16.3.402; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Vogt PH, 1998, MOL HUM REPROD, V4, P739, DOI 10.1093/molehr/4.8.739; Zerjal T, 1997, AM J HUM GENET, V60, P1174; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P8326, DOI 10.1073/pnas.151008498	19	138	150	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					180	187		10.1086/381132	http://dx.doi.org/10.1086/381132			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14639527	Bronze, Green Published			2022-12-18	WOS:000187723500018
J	White, S; Kalf, M; Liu, Q; Villerius, M; Engelsma, D; Kriek, M; Vollebregt, E; Bakker, B; van Ommen, GJB; Breuning, MH; den Dunnen, JT				White, S; Kalf, M; Liu, Q; Villerius, M; Engelsma, D; Kriek, M; Vollebregt, E; Bakker, B; van Ommen, GJB; Breuning, MH; den Dunnen, JT			Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; INTRAGENIC DELETIONS; MUTATIONS; CDNA; CARRIERS; LOCUS; MOSAICISM; FREQUENCY; DIAGNOSIS	Duplications and deletions are known to cause a number of genetic disorders, yet technical difficulties and financial considerations mean that screening for these mutations, especially duplications, is often not performed. We have adapted multiplex amplifiable probe hybridization (MAPH) for the screening of the DMD gene, mutations in which cause Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy. MAPH involves the quantitative recovery of specifically designed probes following hybridization to immobilized genomic DNA. We have engineered probes for each of the 79 exons of the DMD gene, and we analyzed them by using a 96-capillary sequencer. We screened 24 control individuals, 102 patients, and 23 potential carriers and detected a large number of novel rearrangements, especially small, one- and two-exon duplications. A duplication of exon 2 alone was the most frequently occurring mutation identified. Our analysis indicates that duplications occur in 6% of patients with DMD. The MAPH technique as modified here is simple, quick, and accurate; furthermore, it is based on existing technology (i.e., hybridization, PCR, and electrophoresis) and should not require new equipment. Together, these features should allow easy implementation in routine diagnostic laboratories. Furthermore, the methodology should be applicable to any genetic disease, it should be easily expandable to cover 1 200 probes, and its characteristics should facilitate high-throughput screening.	Leiden Univ, Med Ctr, NL-2333 AL Leiden, Netherlands; City Hope Natl Med Ctr, Dept Mol Genet, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Dept Mol Diagnosis, Duarte, CA 91010 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; City of Hope; City of Hope	den Dunnen, JT (corresponding author), Leiden Univ, Med Ctr, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.		Bakker, Egbert/D-3525-2009; dunnen, johan den/ABH-4228-2020	Bakker, Egbert/0000-0002-2843-7357; dunnen, johan den/0000-0002-6304-1710				ABBS S, 1991, J MED GENET, V28, P304, DOI 10.1136/jmg.28.5.304; Armour JAL, 2000, NUCLEIC ACIDS RES, V28, P605, DOI 10.1093/nar/28.2.605; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; BEGGS AH, 1990, HUM GENET, V86, P45; Bennett RR, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-17; Bosserhoff AK, 2000, COMB CHEM HIGH T SCR, V3, P455; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; FORREST SM, 1987, NATURE, V329, P638, DOI 10.1038/329638a0; GILLARD EF, 1989, AM J HUM GENET, V45, P507; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; HU XY, 1990, AM J HUM GENET, V46, P682; IOANNOU P, 1992, NEUROLOGY, V42, P1783, DOI 10.1212/WNL.42.9.1783; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MANSFIELD ES, 1993, AM J MED GENET, V48, P200, DOI 10.1002/ajmg.1320480406; Mendell JR, 2001, NEUROLOGY, V57, P645, DOI 10.1212/WNL.57.4.645; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Morgan NV, 1999, AM J HUM GENET, V65, P1330, DOI 10.1086/302627; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Roest PAM, 1996, J MED GENET, V33, P935, DOI 10.1136/jmg.33.11.935; Sismani C, 2001, EUR J HUM GENET, V9, P527, DOI 10.1038/sj.ejhg.5200670; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; Whittock NV, 1997, GENET TEST, V1, P115, DOI 10.1089/gte.1997.1.115; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; WOOD S, 1988, HUM GENET, V78, P282, DOI 10.1007/BF00291677; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125; Yamagishi H, 1996, J MED GENET, V33, P1027, DOI 10.1136/jmg.33.12.1027; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550	32	138	154	1	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					365	374		10.1086/341942	http://dx.doi.org/10.1086/341942			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12111668	Green Published, Bronze			2022-12-18	WOS:000176977700014
J	Goddard, KAB; Witte, JS; Suarez, BK; Catalona, WJ; Olson, JM				Goddard, KAB; Witte, JS; Suarez, BK; Catalona, WJ; Olson, JM			Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANDROGEN RECEPTOR GENE; SUSCEPTIBILITY LOCUS; ASYMPTOTIC PROPERTIES; HIGH-RISK; FAMILIES; 1Q42.2-43; 1Q24-25; REPEAT; HPC1; 1Q	As with many complex genetic diseases, genome scans for prostate cancer have given conflicting results, often failing to provide replication of previous findings. One factor contributing to the lack of consistency across studies is locus heterogeneity, which can weaken or even eliminate evidence for linkage that is present only in a subset of families. Currently, most analyses either fail to account for locus heterogeneity or attempt to account for it only by partitioning data sets into smaller and smaller portions. In the present study, we model locus heterogeneity among affected sib pairs with prostate cancer by including covariates in the linkage analysis that serve as surrogate measures of between-family linkage differences. The model is a modification of the Olson conditional logistic model for affected relative pairs. By including Gleason score, age at onset, male-to-male transmission, and/or number of affected first-degree family members as covariates, we detected linkage near three locations that were previously identified by linkage (1q24-25 [HPC1; LOD score 3.25, P = .00012], 1q42.2-43 [PCAP; LOD score 2.84, P = .0030], and 4q [LOD score 2.80, P = .00038]), near the androgen-receptor locus on Xq12-13 (AR; LOD score 3.06, P = .00053), and at five new locations (LOD score > 2.5). Without covariates, only a few weak-to-moderate linkage signals were found, none of which replicate findings of previous genome scans. We conclude that covariate-based linkage analysis greatly improves the likelihood that linked regions will be found by incorporation of information about heterogeneity within the sample.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Rammelkamp Ctr Res & Educ, Cleveland, OH 44109 USA; Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Case Western Reserve University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Goddard, KAB (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Rammelkamp Ctr Res & Educ, 2500 Metrohlth Dr,Metrohlth Campus, Cleveland, OH 44109 USA.				NCI NIH HHS [CA88164, R01 CA088164] Funding Source: Medline; NCRR NIH HHS [RR03655, P41 RR003655] Funding Source: Medline; NHGRI NIH HHS [R01 HG001577, HG01577, R29 HG001577] Funding Source: Medline; NIMH NIH HHS [T32 MH014677, MH14677] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001577, R29HG001577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014677] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berry R, 2000, AM J HUM GENET, V66, P539, DOI 10.1086/302771; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Gauderman W. James, 2000, Genetic Epidemiology, V19, P248; Gibbs M, 2000, AM J HUM GENET, V67, P100, DOI 10.1086/302969; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Gibbs M, 1999, AM J HUM GENET, V64, P1087, DOI 10.1086/302342; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; GODDARD KAB, 1999, THESIS U WASHINGTON; Good H.G., 1925, Annals of the Entomological Society of America, V18, P251; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Greenwood CMT, 1999, AM J HUM GENET, V64, P871, DOI 10.1086/302288; Gronberg H, 1997, CANCER RES, V57, P4707; Gronberg H, 1999, AM J HUM GENET, V65, P134, DOI 10.1086/302447; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Hsing AW, 2000, CANCER RES, V60, P5111; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; KEETCH DW, 1995, J UROLOGY, V154, P2100, DOI 10.1016/S0022-5347(01)66705-3; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lange EM, 1999, CLIN CANCER RES, V5, P4013; LKANGE EM, 2000, CANCER EPIDEM BIOMAR, V9, P439; McCarthy MI, 1998, GENET EPIDEMIOL, V15, P317, DOI 10.1002/(SICI)1098-2272(1998)15:4<317::AID-GEPI1>3.0.CO;2-#; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; RISCH N, 1990, AM J HUM GENET, V46, P229; Schaid DJ, 2001, AM J HUM GENET, V68, P1189, DOI 10.1086/320102; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stanford JL, 1997, CANCER RES, V57, P1194; Suarez BK, 2000, AM J HUM GENET, V66, P933, DOI 10.1086/302818; Tavtigian SV, 2000, AM J HUM GENET, V67, P11; Whittemore AS, 1999, AM J HUM GENET, V65, P254, DOI 10.1086/302457; Whittemore AS, 1998, AM J HUM GENET, V62, P1228, DOI 10.1086/301820; WHITTEMORE AS, 1994, CANCER SURV, V20, P309; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2000, AM J HUM GENET, V66, P945, DOI 10.1086/302807; Yuan B, 1997, AM J HUM GENET, V60, P459	48	138	140	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1197	1206		10.1086/320103	http://dx.doi.org/10.1086/320103			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309685	Green Published, Bronze			2022-12-18	WOS:000168171200013
J	Lai, CSL; Fisher, SE; Hurst, JA; Levy, ER; Hodgson, S; Fox, M; Jeremiah, S; Povey, S; Jamison, DC; Green, ED; Vargha-Khadem, F; Monaco, AP				Lai, CSL; Fisher, SE; Hurst, JA; Levy, ER; Hodgson, S; Fox, M; Jeremiah, S; Povey, S; Jamison, DC; Green, ED; Vargha-Khadem, F; Monaco, AP			The SPCH1 region on human 7q31: Genomic characterization of the critical interval and localization of translocations associated with speech and language disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; MAP; CHROMOSOME; DISEASE; AUTISM	The KE family is a large three-generation pedigree in which half the members are affected with a severe speech and language disorder that is transmitted as an autosomal dominant monogenic trait. In previously published work, we localized the gene responsible (SPCH1) to a 5.6-cM region of 7q31 between D7S2459 and D7S643. In the present study, we have employed bioinformatic analyses to assemble a derailed BAC-/PAC-based sequence map of this interval, containing 152 sequence tagged sites (STSs), 20 known genes, and >7.75 Mb of completed genomic sequence. We screened the affected chromosome 7 from the KE family with 120 of these STSs (average spacing <100 kb), but we did not detect any evidence of a microdeletion. Novel polymorphic markers were generated from the sequence and were used to further localize critical recombination breakpoints in the KE family. This allowed refinement of the SPCH1 interval to a region between new markers 013A and 330B, containing similar to 6.1 Mb of completed sequence. In addition, we have studied two unrelated patients with a similar speech and language disorder, who have de novo translocations involving 7q31. Fluorescence in situ hybridization analyses with BACs/PACs from the sequence map localized the t(5;7)(q22;q31.2) breakpoint in the first patient (CS) to a single clone within the newly refined SPCH1 interval. This clone contains the CAGH44 gene, which encodes a brain-expressed protein containing a large polyglutamine stretch. However, we found that the t(2;7)(p23;q31.3) breakpoint in the second patient (BRD) resides within a BAC clone mapping >3.7 Mb distal to this, outside the current SPCH1 critical interval. Finally, we investigated the CAGH44 gene in affected individuals of the KE family, but we found no mutations in the currently known coding sequence. These studies represent further steps toward the isolation of the first gene to be implicated in the development of speech and language.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Oxford Radcliffe Hosp, Dept Clin Genet, Oxford, England; UCL, Guys Hosp, Genet Ctr, London WC1E 6BT, England; UCL, MRC, Human Biochem Genet Unit, London WC1E 6BT, England; Inst Child Hlth, Cognit Neurosci Unit, London, England; NHGRI, NIH, Bethesda, MD 20892 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk	Vargha-Khadem, Faraneh/C-2558-2008; Monaco, Anthony P/A-4495-2010; Fisher, Simon E./E-9130-2012	Monaco, Anthony P/0000-0001-7480-3197; Fisher, Simon E./0000-0002-3132-1996; vargha-khadem, faraneh/0000-0003-4890-8379	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, HUM MOL GENET, V7, P571; Barrett S, 1999, AM J MED GENET, V88, P609; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; GOPNIK M, 1990, NATURE, V344, P715, DOI 10.1038/344715a0; GOPNIK M, 1991, COGNITION, V39, P1, DOI 10.1016/0010-0277(91)90058-C; *INT MOL GEN STUD, 1999, MOL PSYCH, V4, pS14; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; Millwood IY, 1997, GENOMICS, V40, P253, DOI 10.1006/geno.1996.4555; MUNROE DJ, 1994, GENOMICS, V19, P506, DOI 10.1006/geno.1994.1100; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; VARGHAKHADEM F, 1990, NATURE, V346, P226, DOI 10.1038/346226c0; Vincent JB, 1999, MOL PSYCHIATR, V4, pS65; Warburton P, 2000, AM J MED GENET, V96, P228, DOI 10.1002/(SICI)1096-8628(20000403)96:2<228::AID-AJMG20>3.0.CO;2-G; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; [No title captured]	24	138	144	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					357	368		10.1086/303011	http://dx.doi.org/10.1086/303011			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10880297	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000089357800012
J	Richard, I; Roudaut, C; Saenz, A; Pogue, R; Grimbergen, JEMA; Anderson, LVB; Beley, C; Cobo, AM; de Diego, C; Eymard, B; Gallano, P; Ginjaar, HB; Lasa, A; Pollitt, C; Topaloglu, H; Urtizberea, JA; de Visser, M; van der Kooi, A; Bushby, K; Bakker, E; de Munain, AL; Fardeau, M; Beckmann, JS				Richard, I; Roudaut, C; Saenz, A; Pogue, R; Grimbergen, JEMA; Anderson, LVB; Beley, C; Cobo, AM; de Diego, C; Eymard, B; Gallano, P; Ginjaar, HB; Lasa, A; Pollitt, C; Topaloglu, H; Urtizberea, JA; de Visser, M; van der Kooi, A; Bushby, K; Bakker, E; de Munain, AL; Fardeau, M; Beckmann, JS			Calpainopathy - A survey of mutations and polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; BETA-SARCOGLYCAN; REUNION-ISLAND; GENE; EXPRESSION; CALPAIN-3; REGION; MAPS; CHROMOSOME-15; LINKAGE	Limb-girdle muscular dystrophy-type 2A (LGMD2A) is an autosomal recessive disorder characterized mainly by symmetrical and selective atrophy of the proximal limb muscles. It derives, from defects in the, human CAPN3 gene, which encodes the skeletal muscle-specific member of the calpain family. This report represents a compilation of the mutations and variants identified so far in this gene. To date, 97 distinct pathogenic calpain 3 mutations have been identified (4 nonsense mutations, 32 deletions/insertions 8 splice-site mutations,and 53 missense mutations), 56 of which have not been described previously, together with 12 polymorphisms and 5 non-classified variants. The mutations are distributed along the entire length of the CAPN3 gene. Thus far, most mutations identified represent private variants, although particular mutations have been found more frequently. Knowledge of the mutation spectrum occurring in the CAPN3 gene may contribute significantly to structure/ function and pathogenesis studies. It may also help in the design of efficient mutation-screening strategies: for calpainopathies.	Genethon, CNRS, URA 1922, F-91000 Evry, France; Hosp Ntra Sra Aranzazu, Dept Neurol, San Sebastian, Spain; Hosp Ntra Sra Aranzazu, Expt Unit, San Sebastian, Spain; Newcastle Univ, Sch Biochem & Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Leiden Univ, Med Ctr, MGC Dept Human & Clin Genet, Leiden, Netherlands; Hop La Pitie Salpetriere, INSERM, U153, Inst Myol, Paris, France; Hosp Santa Creu & Sant Pau, Unitat Genet Mol, Barcelona, Spain; Hacettepe Univ, Dept Med Biol, Ankara, Turkey; Amsterdam Med Ctr, Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); Newcastle University - UK; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hospital of Santa Creu i Sant Pau; Hacettepe University; University of Amsterdam; Academic Medical Center Amsterdam	Beckmann, JS (corresponding author), Genethon, CNRS, URA 1922, 1 Rue Int, F-91000 Evry, France.	beckmann@genethon.fr	DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Bakker, Egbert/D-3525-2009; Richard, isabelle/J-8298-2013; Sáenz, Amets/E-4761-2019; Pogue, Robert/C-3860-2016; Beckmann, Jacques S/A-9772-2008; TOPALOGLU, HALUK AYDIN/I-9318-2013; Lasa, Adriana/H-4745-2017	Bakker, Egbert/0000-0002-2843-7357; Sáenz, Amets/0000-0002-0704-1150; Pogue, Robert/0000-0002-8789-3512; Beckmann, Jacques S/0000-0002-9741-1900; Lasa, Adriana/0000-0001-9957-9646; van der Kooi, Anneke/0000-0002-5261-5512; /0000-0002-9509-4032				ALLAMAND V, 1995, AM J HUM GENET, V56, P1417; Anderson LVB, 1998, AM J PATHOL, V153, P1169, DOI 10.1016/S0002-9440(10)65661-1; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; Beckmann J, 1998, NEUROMUSCULAR DISORD, P123; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; CHIANNILKULCHAI N, 1995, HUM MOL GENET, V4, P717, DOI 10.1093/hmg/4.4.717; Dincer P, 1997, ANN NEUROL, V42, P222, DOI 10.1002/ana.410420214; Eymard B, 1997, NEUROLOGY, V48, P1227, DOI 10.1212/WNL.48.5.1227; Fardeau M, 1996, BRAIN, V119, P295, DOI 10.1093/brain/119.1.295; Fardeau M, 1996, NEUROMUSCULAR DISORD, V6, P447, DOI 10.1016/S0960-8966(96)00387-2; FOUGEROUSSE F, 1994, HUM MOL GENET, V3, P285, DOI 10.1093/hmg/3.2.285; Gardner-Medwin D., 1974, DISORDERS VOLUNTARY, P517; Haffner K, 1998, HUM MUTAT, pS298; HERASSE M, CELL; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Moreira ES, 1997, AM J HUM GENET, V61, P151, DOI 10.1086/513889; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; RICHARD I, 1995, NAT GENET, V10, P259, DOI 10.1038/ng0795-259; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Topaloglu H, 1997, NEUROPEDIATRICS, V28, P212, DOI 10.1055/s-2007-973702; Urtasun M, 1998, BRAIN, V121, P1735, DOI 10.1093/brain/121.9.1735; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; Weiler T, 1998, AM J HUM GENET, V63, P140, DOI 10.1086/301925	30	138	146	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1524	1540		10.1086/302426	http://dx.doi.org/10.1086/302426			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330340	Green Published, Bronze			2022-12-18	WOS:000080696200005
J	Yue, Q; Jen, JC; Nelson, SF; Baloh, RW				Yue, Q; Jen, JC; Nelson, SF; Baloh, RW			Progressive ataxia due to a missense mutation in a calcium-channel gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; MACHADO-JOSEPH DISEASE; SODIUM-CHANNEL; CA2+ CHANNELS; FUNCTIONAL EXPRESSION; POINT MUTATIONS; FAMILIES; IDENTIFICATION; DEFECTS; KCNA1	We describe a family with severe progressive cerebellar ataxia involving the trunk, the extremities, and speech. The proband, who has prominent atrophy of the cerebellum, shown by magnetic resonance imaging, was confined to a wheelchair at the age of 44 years. Two sons have episodes of vertigo and ataxia that are not responsive to acetazolamide. Quantitative eye-movement testing showed a consistent pattern of abnormalities localizing to the cerebellum. Genotyping suggested linkage to chromosome 19p, and SSCP showed an aberrant migrating fragment in exon 6 of the calcium-channel gene CACNA1A, which cosegregated with the disease. Sequencing of exon 6 identified a G --> A transposition in one allele, at nucleotide 1152, resulting in a predicted glycine-to-arginine substitution at codon 293. The CAG-repeat expansion associated with spinocerebellar ataxia 6 was not present in any family members. This family is unique in having a non-CAG-repeat mutation that leads to severe progressive ataxia. Since a great deal is known about the function of calcium channels, we speculate on how this missense mutation leads to the combination of clinical symptoms and signs.	UNIV CALIF LOS ANGELES,DEPT NEUROL,SCH MED,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT HEMATOL & ONCOL,LOS ANGELES,CA; UNIV CALIF LOS ANGELES,SCH MED,DEPT SURG HEAD & NECK,LOS ANGELES,CA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA			Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114	NATIONAL INSTITUTE ON AGING [R01AG009063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002952] Funding Source: NIH RePORTER; NIA NIH HHS [AG9063] Funding Source: Medline; NIDCD NIH HHS [P01 DC02952, DC00008-21] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; BAIN PG, 1992, ANN NEUROL, V31, P146; BALOH RW, 1980, AVIAT SPACE ENVIR MD, V51, P563; BALOH RW, 1986, BRAIN, V109, P159, DOI 10.1093/brain/109.1.159; Baloh RW, 1997, ANN NEUROL, V41, P8, DOI 10.1002/ana.410410105; BROWNE DL, 1995, HUM MOL GENET, V4, P1671, DOI 10.1093/hmg/4.9.1671; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; CANNON SC, 1993, J PHYSIOL-LONDON, V466, P501; CANNON SC, 1993, NEURON, V10, P317, DOI 10.1016/0896-6273(93)90321-H; Cannon SC, 1996, ANNU REV NEUROSCI, V19, P141, DOI 10.1146/annurev.ne.19.030196.001041; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ducros A, 1996, AM J HUM GENET, V58, P171; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Higgins JJ, 1996, NEUROLOGY, V46, P208, DOI 10.1212/WNL.46.1.208; Hille B., 1992, IONIC CHANNELS EXCIT; Junck L, 1996, NEUROLOGY, V46, P4, DOI 10.1212/WNL.46.1.4; KOH JY, 1992, BRAIN RES, V587, P233, DOI 10.1016/0006-8993(92)91002-V; Ludwig A, 1997, J NEUROSCI, V17, P1339; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MOSCHNER C, 1994, BRAIN, V117, P15, DOI 10.1093/brain/117.1.15; MOSKOWITZ MA, 1990, NEUROL CLIN, V8, P801, DOI 10.1016/S0733-8619(18)30318-9; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Peixoto AA, 1997, GENETICS, V145, P1003; PTACEK L, 1994, NAT GENET, V8, P111, DOI 10.1038/ng1094-111; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1994, CELL, V77, P863; RAVNIKGLAVAC M, 1994, HUM MOL GENET, V3, P801, DOI 10.1093/hmg/3.5.801; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; STEA A, 1995, LIGAND VOLTAGE GATED, P113; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; Volsen SG, 1995, MOL BRAIN RES, V34, P271, DOI 10.1016/0169-328X(95)00234-J; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	39	138	141	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1078	1087		10.1086/301613	http://dx.doi.org/10.1086/301613			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345107	Green Published, Bronze			2022-12-18	WOS:A1997YH01700012
J	StoppaLyonnet, D; LaurentPuig, P; Essioux, L; Pages, S; Ithier, G; Ligot, L; Fourquet, A; Salmon, RJ; Clough, KB; Pouillart, P; Alapetite, C; Alepee, B; Klijanienko, J; Asselain, B; Beuzeboc, P; Bourgeois, D; Bourgeois, H; Bourstyn, E; Brunin, F; Campana, F; Chauveinc, F; Cosset, JM; deCremoux, P; delaRochefordiere, A; Delattre, C; deMargerie, V; deStGaudens, AB; Dieras, V; Dorval, T; Dubray, B; Durand, JC; Falcou, MC; Fitoussi, F; GarciaGiralt, E; Giraud, P; Gautier, C; Guglielmina, JN; Hamelin, JP; Hoffman, H; Jaulerry, C; Jouve, M; Labeta, C; Legall, M; Magdelenat, H; Meunier, M; Mosseri, V; NGuyen, TT; Natali, JC; Neuenschwander, S; Nos, C; Olivier, L; Palangie, T; Pierga, JY; Pontvert, D; Roge, P; SastreGareau, X; Schlienger, P; Scholl, S; Selinger, R; Thibault, F; This, P; Trophilme, D; Validire, P; Vielh, P; Vilcoq, JR; VincentSalomon, A; Voillemot, N; Zafrani, B; BonaitiPellie, C; Thomas, G				StoppaLyonnet, D; LaurentPuig, P; Essioux, L; Pages, S; Ithier, G; Ligot, L; Fourquet, A; Salmon, RJ; Clough, KB; Pouillart, P; Alapetite, C; Alepee, B; Klijanienko, J; Asselain, B; Beuzeboc, P; Bourgeois, D; Bourgeois, H; Bourstyn, E; Brunin, F; Campana, F; Chauveinc, F; Cosset, JM; deCremoux, P; delaRochefordiere, A; Delattre, C; deMargerie, V; deStGaudens, AB; Dieras, V; Dorval, T; Dubray, B; Durand, JC; Falcou, MC; Fitoussi, F; GarciaGiralt, E; Giraud, P; Gautier, C; Guglielmina, JN; Hamelin, JP; Hoffman, H; Jaulerry, C; Jouve, M; Labeta, C; Legall, M; Magdelenat, H; Meunier, M; Mosseri, V; NGuyen, TT; Natali, JC; Neuenschwander, S; Nos, C; Olivier, L; Palangie, T; Pierga, JY; Pontvert, D; Roge, P; SastreGareau, X; Schlienger, P; Scholl, S; Selinger, R; Thibault, F; This, P; Trophilme, D; Validire, P; Vielh, P; Vilcoq, JR; VincentSalomon, A; Voillemot, N; Zafrani, B; BonaitiPellie, C; Thomas, G			BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; OVARIAN-CANCER; BREAST-CANCER; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; DNA FRAGMENTS; IDENTIFICATION; LOCALIZATION	An account of familial aggregation in breast/ovarian cancer has become possible with the identification of BRCA1 germ-line mutations. We evaluated, for 249 individuals registered with the Institut Curie in Paris, the prior probability that an individual carried a mutation that predisposes to these diseases. We chose 160 women for BRCA1 analysis: 103 with a family history of breast cancer and 57 with a family history of breast-ovarian cancer. To detect small mutations, we generated and analyzed 35 overlapping genomic PCR products that cover the coding portion of the gene, by using denaturing gradient gel electrophoresis. Thirty-eight truncating mutations (32 frameshifts, 4 nonsense mutations, and 2 splice variants) were observed in 15% of women with a family history of breast cancer only and in 40% of those with a history of breast-ovarian cancer. Twelve of 25 distinct truncating mutations identified were novel and unique. Most BRCA1 mutations that had been reported more than five times in the Breast Cancer Information Core were present in our series. One mutation (5149del4) observed in two apparently unrelated families most likely originates from a common ancestor. The position of truncating mutations did not significantly affect the ratio of the risk of breast cancer to that of ovarian cancer. In addition, 15 DNA variants (14 missense mutations and 1 neutral mutation) were identified, 9 of which were novel. Indirect evidence suggests that seven of these mutations are deleterious.	INST CURIE,INSERM,U434,F-75231 PARIS 05,FRANCE; INST CURIE,DEPT RADIOTHERAPY,F-75231 PARIS 05,FRANCE; INST CURIE,DEPT CHIRURG,F-75231 PARIS 05,FRANCE; INST CURIE,DEPT MED ONCOL,F-75231 PARIS 05,FRANCE; INST GUSTAVE ROUSSY,INSERM,U351,UNITE RECH EPIDEMIOL CANC,F-94805 VILLEJUIF,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	StoppaLyonnet, D (corresponding author), INST CURIE,UNITE GENET ONCOL,26 RUE ULM,F-75231 PARIS 05,FRANCE.		laurent-puig, pierre/B-2226-2013; Laurent-Puig, Pierre/K-3641-2019	laurent-puig, pierre/0000-0001-8475-5459; Laurent-Puig, Pierre/0000-0001-8475-5459				ABEL KJ, 1995, HUM MOL GENET, V4, P2265, DOI 10.1093/hmg/4.12.2265; Bienstock RJ, 1996, CANCER RES, V56, P2539; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Durocher F, 1996, HUM MOL GENET, V5, P835, DOI 10.1093/hmg/5.6.835; EASTON DF, 1993, AM J HUM GENET, V52, P678; FISCHER SG, 1983, P NATL ACAD SCI-BIOL, V80, P1579, DOI 10.1073/pnas.80.6.1579; FORD D, 1995, BRIT J CANCER, V72, P805, DOI 10.1038/bjc.1995.417; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HAMELIN R, 1993, ONCOGENE, V8, P2213; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MOYRET C, 1994, ONCOGENE, V9, P1739; NAROD SA, 1995, AM J HUM GENET, V56, P254; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Peelen T, 1996, EUR J HUM GENET, V4, P225; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Serova O, 1996, AM J HUM GENET, V58, P42; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; SOBOL H, 1994, LANCET, V344, P1151, DOI 10.1016/S0140-6736(94)90655-6; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430	33	138	142	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1021	1030						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150149				2022-12-18	WOS:A1997WX76000002
J	TORRONI, A; CHEN, YS; SEMINO, O; SANTACHIARABENECERETTI, AS; SCOTT, CR; LOTT, MT; WINTER, M; WALLACE, DC				TORRONI, A; CHEN, YS; SEMINO, O; SANTACHIARABENECERETTI, AS; SCOTT, CR; LOTT, MT; WINTER, M; WALLACE, DC			MTDNA AND Y-CHROMOSOME POLYMORPHISMS IN 4 NATIVE-AMERICAN POPULATIONS FROM SOUTHERN MEXICO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; AFRICAN POPULATIONS; RESTRICTION SITES; LENGTH MUTATIONS; AMERINDIAN TRIBE; NEW-GUINEA; PROBE; HAPLOTYPES; MIGRATIONS; DIVERSITY	mtDNA sequence variation was examined in 60 Native Americans (Mixtecs from the Alta, Mixtecs from the Baja, Valley Zapotecs, and Highland Mire) from southern Mexico by PCR amplification and high-resolution restriction endonuclease analysis. Four groups of mtDNA haplotypes (haplogroups A, B, C, and D) characterize Amerind populations, but only three (haplogroups A, B, and C) were observed in these Mexican populations. The comparison of their mtDNA variation with that observed in other populations from Mexico and Central America permits a clear distinction among the different Middle American tribes and raises questions about some of their linguistic affiliations. The males of these population samples were also analyzed for Y-chromosome RFLPs with the probes 49a, 49f, and 12f2. This analysis suggests that certain Y-chromosome haplotypes were brought from Asia during the colonization of the Americas, and a differential gene flow was introduced into Native American populations from European males and females.	EMORY UNIV, SCH MED, DEPT GENET & MOLEC MED, ATLANTA, GA 30322 USA; EMORY UNIV, SCH MED, DEPT ANTHROPOL, ATLANTA, GA 30322 USA; UNIV PAVIA, DIPARTIMENTO GENET & MICROBIOL, PAVIA, ITALY; UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98195 USA; INST NACL ANTROPOL & HIST, CTR REG OAXACA, OAXACA, MEXICO	Emory University; Emory University; University of Pavia; University of Washington; University of Washington Seattle			Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478; SEMINO, Ornella/0000-0002-9675-9403; Lott, Marie/0000-0003-2035-479X	NCRR NIH HHS [M01-RR-00039] Funding Source: Medline; NIGMS NIH HHS [GM 46915] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046915] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; Barabas Alicia M., 1990, ETNICIDAD PLURALISMO; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BARRANTES R, 1990, AM J HUM GENET, V46, P63; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; Brega A, 1987, Gene Geogr, V1, P201; BREUIL S, 1987, ANN GENET-PARIS, V30, P209; CANN RL, 1983, GENETICS, V104, P699; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; CHAGNON NA, 1970, AM J PHYS ANTHROPOL, V32, P339, DOI 10.1002/ajpa.1330320304; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; DIAMOND JM, 1990, NATURE, V344, P589, DOI 10.1038/344589a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Greenberg J. H, 1987, LANGUAGE AM; GUERIN P, 1988, NUCLEIC ACIDS RES, V16, P7759, DOI 10.1093/nar/16.15.7759; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1986, HUM GENET, V72, P105; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Josserand J.K, 1984, VANDERBILT U PUBLICA, V31; KIDD JR, 1991, HUM BIOL, V63, P775; Lucotte G, 1990, Gene Geogr, V4, P21; LUCOTTE G, 1992, HUM BIOL, V64, P757; LUCOTTE G, 1989, AM J HUM GENET, V45, P16; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; MITCHELL RJ, 1993, HUM BIOL, V65, P387; NEEL JV, 1978, ANNU REV GENET, V12, P365, DOI 10.1146/annurev.ge.12.120178.002053; NEEL JV, 1980, POPULATION STRUCTURE, P173; NEI M, 1983, GENETICS, V105, P207; NGO KY, 1986, AM J HUM GENET, V38, P407; NICHOLS J, 1990, LANGUAGE, V66, P475, DOI 10.2307/414609; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; QUACK B, 1988, CYTOGENET CELL GENET, V47, P232, DOI 10.1159/000132557; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANTACHIARABENE.AS, 1992, GENETIC DIVERSITY JE, P45; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; SPURDLE A, 1992, AM J HUM GENET, V50, P107; STONE AC, IN PRESS AM J PHYS A; STONEKING M, 1990, GENETICS, V124, P717; SWOFFORD D, 1992, PHYLOGENETIC ANAL US; TORRONI A, 1990, ANN HUM GENET, V54, P287; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TORRONI A, UNPUB MITOCHONDRIAL; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1992, HUM BIOL, V64, P403; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	56	138	143	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					303	318						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304347				2022-12-18	WOS:A1994MU31500015
J	ABEL, L; DEMENAIS, F; PRATA, A; SOUZA, AE; DESSEIN, A				ABEL, L; DEMENAIS, F; PRATA, A; SOUZA, AE; DESSEIN, A			EVIDENCE FOR THE SEGREGATION OF A MAJOR GENE IN HUMAN SUSCEPTIBILITY RESISTANCE TO INFECTION BY SCHISTOSOMA-MANSONI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTECTIVE IMMUNITY; REGRESSIVE MODELS; IRRADIATED CERCARIAE; SURFACE-ANTIGEN; UNIFIED MODEL; MICE; IDENTIFICATION; TRAITS; MECHANISMS; COMPLEX	Severe clinical disease caused by the major human parasite Schistosoma mansoni is the consequence of high and prolonged infections. Epidemiological studies indicate that, for individuals having frequent contacts with cercaria-infested waters, both infection intensities and reinfection after treatment depend, in large part, on their intrinsic susceptibility/resistance to infection, suggesting the role of genetic factors in human resistance to S. mansoni. To investigate whether a major gene controls human susceptibility/resistance to infection by S. mansoni, segregation analysis of infection intensities, adjusted for the factors relevant in schistosomiasis (water contact, age, sex), was performed on 20 Brazilian pedigrees (269 individuals), using both the unified mixed model and the regressive model of analysis. The results are consistent with the hypothesis that there is a codominant major gene controlling human susceptibility/resistance to infection by S. mansoni. Parameter estimates indicate a frequency of .20-.25 for the deleterious allele; thus, about 5% of the population is predisposed to high infections, 60% is resistant, and 35% has an intermediate, although fairly good, level of resistance. These findings provide a genetic basis for earlier observations on the lower resistance and the predisposition to reinfection of certain individuals. In addition to the detection of a major gene effect, the data suggest that immunity to S. mansoni develops progressively during childhood to reach a maximum around the age of puberty. The implications of these results for the strategy to be used in endemic areas to reduce morbidity and to control parasite transmission are discussed.	HOWARD UNIV,CTR CANC,DIV EPIDEMIOL & BIOSTAT,WASHINGTON,DC 20059; FAC MED TRIANGULO MINEIRO,UBERABA,BRAZIL; CTR SAUDE CAATINGA MOURA,JACOBINA,BRAZIL; CTR IMMUNOL MARSEILLE LUMINY,MARSEILLE,FRANCE	Howard University; Universidade Federal do Triangulo Mineiro; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	ABEL, L (corresponding author), UNIV PARIS 07,INSERM,U155,ANTHROPOL BIOL LAB,TOUR 16,2 PL JUSSIEU,F-75221 PARIS 05,FRANCE.		Demenais, Florence/G-3298-2013; Abel, Laurent/H-8888-2017	Demenais, Florence/0000-0001-8361-0936; Abel, Laurent/0000-0001-7016-6493				ABEL L, 1988, AM J HUM GENET, V42, P256; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BUTTERWORTH A, 1988, BIOCHIMIE, V70, P1053, DOI 10.1016/0300-9084(88)90268-4; BUTTERWORTH AE, 1985, T ROY SOC TROP MED H, V79, P393, DOI 10.1016/0035-9203(85)90391-8; BUTTERWORTH AE, 1987, PARASITOLOGY, V94, P281, DOI 10.1017/S0031182000053956; BYRAM JE, 1977, AM J TROP MED HYG, V26, P944, DOI 10.4269/ajtmh.1977.26.944; CHENSUE SW, 1980, J EXP MED, V151, P1398, DOI 10.1084/jem.151.6.1398; CLAAS FHJ, 1979, J IMMUNOGENET, V6, P167; CORREAOLIVEIRA R, 1988, INFECT IMMUN, V56, P708, DOI 10.1128/IAI.56.3.708-710.1988; CORREAOLIVEIRA R, 1986, J IMMUNOL, V137, P2014; CROMBIE JA, 1985, NATURE, V315, P491, DOI 10.1038/315491a0; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; DEMENAIS FM, 1990, GENET EPIDEMIOL, V7, P319, DOI 10.1002/gepi.1370070503; DESSEIN AJ, 1988, J IMMUNOL, V140, P2727; DESSEIN AJ, 1984, CELL IMMUNOL, V85, P100, DOI 10.1016/0008-8749(84)90282-X; ELSTON RC, 1986, 7TH INT C HUM GEN BE; FANNING MM, 1981, J INFECT DIS, V144, P148, DOI 10.1093/infdis/144.2.148; GOUDOTCROZEL V, 1989, J EXP MED, V170, P2065, DOI 10.1084/jem.170.6.2065; JAMES SL, 1983, PARASITE IMMUNOL, V5, P567, DOI 10.1111/j.1365-3024.1983.tb00773.x; JONES JT, 1983, PARASITOLOGY, V86, P19, DOI 10.1017/S0031182000057139; JOSE MV, 1989, J MATH BIOL, V27, P707, DOI 10.1007/BF00276952; Katz N., 1978, Revista do Instituto de Medicina Tropical de Sao Paulo, V20, P273; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; MACLEAN CJ, 1976, BIOMETRICS, V32, P694; MARTIN LK, 1968, AM J TROP MED HYG, V17, P382, DOI 10.4269/ajtmh.1968.17.382; Mims C. A., 1982, Immunology of parasitic infections.  2nd edition., P3; Morton N.E., 1983, METHODS GENETIC EPID; PRATA A, 1967, Gazeta Medica da Bahia, V67, P93; SALAM EA, 1979, J IMMUNOL, V123, P1829; SCHURR E, 1989, J IMMUNOL, V142, P4507; SHER A, 1984, PARASITE IMMUNOL, V6, P319, DOI 10.1111/j.1365-3024.1984.tb00804.x; SKAMENE E, GENETIC CONTROL HOST; TINGLEY GA, 1988, T ROY SOC TROP MED H, V82, P448, DOI 10.1016/0035-9203(88)90159-9; WAKELIN D, 1985, Parasitology Today, V1, P17, DOI 10.1016/0169-4758(85)90101-2; WARREN KS, 1967, AM J PATHOL, V51, P735; WARREN KS, 1976, J INVEST DERMATOL, V47, P464; WRIGHT MD, 1988, J PARASITOL, V74, P618, DOI 10.2307/3282180; 1985, TROPICAL DISEASE RES	41	138	147	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					959	970						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1902058				2022-12-18	WOS:A1991FK89700015
J	SHAW, MW; FALLS, HF; NEEL, JV				SHAW, MW; FALLS, HF; NEEL, JV			CONGENITAL ANIRIDIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEATTIE PH, 1947, BRIT J OPHTHALMOL, V31, P649, DOI 10.1136/bjo.31.11.649; BELL J, 1932, TREASURY HUMAN INHER, V2; Crowe FW, 1956, CLIN PATHOLOGICAL GE; DUKEELDER W, 1941, TXB OPHTHALMOLOGY; FALLS HF, 1949, AM J OPHTHALMOL, V32, P41, DOI 10.1016/S0002-9394(14)78356-4; FRANCESCHETTI A, 1935, HEREDITARY DISEASES; FRANCOIS J, 1955, ADV OPHTHALMOL, V4, P19; GLICK PC, 1957, AM FAMILIES; GROVE JH, ARCH OPHTH; HALDANE JBS, 1948, ANN EUGENIC, V14, P117; HEATH P, 1953, T AM OPHTHAL SOC, V51, P167; Mann I, 1937, DEV ABNORMALITIES EY; MOLLENBACH CJ, 1947, OPERA DOMO BIOL HERI, V15; Neel JV, 1954, HUMAN HEREDITY; PAGANELLI VX, 1951, THESIS GENEVE; PENROSELS, 1955, LANCET, V2, P312; PINCUS MH, 1948, ARCH OPHTHALMOL-CHIC, V39, P60, DOI 10.1001/archopht.1948.00900020063006; REED TE, 1955, AM J HUM GENET, V7, P28; REED TE, 1959, AM J HUM GENET, V11, P107; SORSBY A, 1951, GENETICS OPHTHALMOLO; WAARDENBURG PJ, 1932, MENSCHLICHE AUGE SEI	21	138	142	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	4					389	415						27	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF080	17948455				2022-12-18	WOS:A1960WF08000001
J	CLARK, PJ				CLARK, PJ			THE HERITABILITY OF CERTAIN ANTHROPOMETRIC CHARACTERS AS ASCERTAINED FROM MEASUREMENTS OF TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Cummins H, 1943, FINGERPRINTS PALMS S, P71; DAHLBERG G, 1926, TWIN BIRTHS TWINS HE, P149; Holzinger KJ, 1929, J EDUC PSYCHOL, V20, P241, DOI 10.1037/h0072484; Martin R., 1928, LEHRBUCH ANTHR, V1; NEWMAN HH, 1937, TWINS STUDY HEREDITY, P117; PRICE B, 1950, AM J HUM GENET, V2, P293; SUTTON HE, UNPUBLISHED; TANIGUCHI T, 1955, ZWILLINGSANATOMIE, P14; VONVERSCHUER O, 1927, ERG INN MED KINDERHK, V31, P35	9	138	140	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1956	8	1					49	54						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF068	13302199				2022-12-18	WOS:A1956WF06800006
J	Watson, CT; Steinberg, KM; Huddleston, J; Warren, RL; Malig, M; Schein, J; Willsey, AJ; Joy, JB; Scott, JK; Graves, TA; Wilson, RK; Holt, RA; Eichler, EE; Breden, F				Watson, Corey T.; Steinberg, Karyn M.; Huddleston, John; Warren, Rene L.; Malig, Maika; Schein, Jacqueline; Willsey, A. Jeremy; Joy, Jeffrey B.; Scott, Jamie K.; Graves, Tina A.; Wilson, Richard K.; Holt, Robert A.; Eichler, Evan E.; Breden, Felix			Complete Haplotype Sequence of the Human Immunoglobulin Heavy-Chain Variable, Diversity, and Joining Genes and Characterization of Allelic and Copy-Number Variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; IUIS NOMENCLATURE SUBCOMMITTEE; CELL-RECEPTORS REPORT; V-H GENES; HUMAN-GENOME; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; AUTOIMMUNE-DISEASES; REGION GENE; HOMOZYGOUS DELETION	The immunoglobulin heavy-chain locus (IGH) encodes variable (IGHV), diversity (IGHD), joining (IGHJ), and constant (IGHC) genes and is responsible for antibody heavy-chain biosynthesis, which is vital to the adaptive immune response. Programmed V-(D)-J somatic rearrangement and the complex duplicated nature of the locus have impeded attempts to reconcile its genomic organization based on traditional B-lymphocyte derived genetic material. As a result, sequence descriptions of germline variation within IGHV are lacking, haplotype inference using traditional linkage disequilibrium methods has been difficult, and the human genome reference assembly is missing several expressed IGHV genes. By using a hydatidiform mole BAC clone resource, we present the most complete haplotype of IGHV, IGHD, and IGHJ gene regions derived from a single chromosome, representing an alternate assembly of similar to 1 Mbp of high-quality finished sequence. From this we add 101 kbp of previously uncharacterized sequence, including functional IGHV genes, and characterize four large gemiline copy-number variants (CNVs). In addition to this germline reference, we identify and characterize eight CNV-containing haplotypes from a panel of nine diploid genomes of diverse ethnic origin, discovering previously unmapped IGHV genes and an additional 121 kbp of insertion sequence. We genotype four of these CNVs by using PCR in 425 individuals from nine human populations. We find that all four are highly polymorphic and show considerable evidence of stratification (F-st = 0.3-0.5), with the greatest differences observed between African and Asian populations. These CNVs exhibit weak linkage disequilibrium with SNPs from two commercial arrays in most of the populations tested.	[Watson, Corey T.; Willsey, A. Jeremy; Joy, Jeffrey B.; Breden, Felix] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Scott, Jamie K.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Steinberg, Karyn M.; Huddleston, John; Malig, Maika; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Warren, Rene L.; Schein, Jacqueline; Holt, Robert A.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Graves, Tina A.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	Simon Fraser University; Simon Fraser University; University of Washington; University of Washington Seattle; British Columbia Cancer Agency; Washington University (WUSTL); Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu; breden@sfu.ca	Wilson, Richard K./AAF-4139-2019; Schein, Jacquie E/G-3674-2015; Holt, Robert A/C-3303-2009; Willsey, A Jeremy/H-3001-2019; Warren, Rene/R-7681-2016	Wilson, Richard K./0000-0002-1992-1358; Holt, Robert A/0000-0002-7259-1247; Willsey, A Jeremy/0000-0002-9922-3612; Meltz Steinberg, Karyn/0000-0002-8676-3337; Joy, Jeffrey/0000-0002-7013-1482; Watson, Corey/0000-0001-7248-8787; Warren, Rene/0000-0002-9890-2293; Breden, Felix/0000-0001-9762-6314	Simon Fraser University; Ruth L. Kirschstein National Research Service Award (NRSA) training grant [T32HG00035]; NRSA Fellowship [F32GM097807]; US National Institutes of Health [HG002385, HG004120]; National Science and Engineering Research Council of Canada; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385, P01HG004120, T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097807] Funding Source: NIH RePORTER	Simon Fraser University; Ruth L. Kirschstein National Research Service Award (NRSA) training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to T. Brown for assistance with manuscript preparation. We are grateful to Marie-Paule Lefranc and to the IMGT Nomenclature Committee for their help in defining IGHV genes and alleles and for providing the IMGT standardized rules for descriptions of CNVs. C.T.W. was supported in part by a President's Research Stipend and graduate fellowship awarded by Simon Fraser University. K.M.S. was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) training grant to the University of Washington (T32HG00035) and an individual NRSA Fellowship (F32GM097807). This work was supported by the US National Institutes of Health (grants HG002385 and HG004120 to E.E.E.) and a National Science and Engineering Research Council of Canada grant to F.B. E.E.E. is an Investigator of the Howard Hughes Medical Institute. E.E.E. is on the scientific advisory boards for Pacific Biosciences, SynapDx, and DNAnexus.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Ballana E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-14; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; Chen LJ, 2008, LEUKEMIA RES, V32, P1491, DOI 10.1016/j.leukres.2008.02.005; Chimge NO, 2005, GENES IMMUN, V6, P186, DOI 10.1038/sj.gene.6364176; Cho ML, 2003, LUPUS, V12, P400, DOI 10.1191/0961203303lu385oa; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; COOK GP, 1994, NAT GENET, V7, P162, DOI 10.1038/ng0694-162; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Feeney AJ, 1996, J CLIN INVEST, V97, P2277, DOI 10.1172/JCI118669; Field LL, 2002, GENES IMMUN, V3, P338, DOI 10.1038/sj.gene.6363857; Gazave E, 2011, GENOME RES, V21, P1626, DOI 10.1101/gr.117242.110; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hollox EJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-113; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Johnson TA, 1997, J IMMUNOL, V158, P235; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; KEYEUX G, 1989, GENOMICS, V5, P431, DOI 10.1016/0888-7543(89)90006-2; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Kidd MJ, 2012, J IMMUNOL, V188, P1333, DOI 10.4049/jimmunol.1102097; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; LEFRANC G, 1983, EUR J IMMUNOL, V13, P240, DOI 10.1002/eji.1830130312; Lefranc M P, 1983, Mol Biol Med, V1, P207; LEFRANC M-P, 1991, Immunodeficiency Reviews, V2, P265; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; Lefranc MP, 2007, IMMUNOGENETICS, V59, P899, DOI 10.1007/s00251-007-0260-4; Lefranc Marie-Paule, 2012, Methods Mol Biol, V882, P635, DOI 10.1007/978-1-61779-842-9_34; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P604, DOI 10.1101/pdb.ip82; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P627, DOI 10.1101/pdb.ip84; Lefranc MP, 2008, DEV COMP IMMUNOL, V32, P461, DOI 10.1016/j.dci.2007.09.008; Lefranc MP, 2001, NUCLEIC ACIDS RES, V29, P207, DOI 10.1093/nar/29.1.207; LEFRANC MP, 1982, NATURE, V300, P760, DOI 10.1038/300760a0; Lefranc MP, 2001, CURR PROTOC IMMUNOL, V1; Lerner RA, 2011, MOL BIOSYST, V7, P1004, DOI 10.1039/c0mb00310g; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; Mamtani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011458; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mefford HC, 2011, ANN NEUROL, V70, P974, DOI 10.1002/ana.22645; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Milner ECB, 1995, ANN NY ACAD SCI, V764, P50; Mo L, 1996, AUTOIMMUNITY, V24, P257, DOI 10.3109/08916939608994718; Ohm-Laursen L, 2005, IMMUNOGENETICS, V57, P621, DOI 10.1007/s00251-005-0035-8; OLEE T, 1991, J CLIN INVEST, V88, P193, DOI 10.1172/JCI115277; Pallares N, 1999, EXP CLIN IMMUNOGENET, V16, P36, DOI 10.1159/000019095; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Pelak K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001208; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pramanik S, 2002, AM J HUM GENET, V71, P1342, DOI 10.1086/344713; Pramanik S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-78; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruiz M, 1999, EXP CLIN IMMUNOGENET, V16, P173, DOI 10.1159/000019109; Sasso EH, 1996, J CLIN INVEST, V97, P2074, DOI 10.1172/JCI118644; Schrider DR, 2010, MOL BIOL EVOL, V27, P103, DOI 10.1093/molbev/msp210; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; SHIN EK, 1993, IMMUNOGENETICS, V38, P304; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Traherne JA, 2010, HUM MOL GENET, V19, P737, DOI 10.1093/hmg/ddp538; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; WALTER G, 1993, NUCLEIC ACIDS RES, V21, P4524, DOI 10.1093/nar/21.19.4524; Watson CT, 2012, GENES IMMUN, V13, P363, DOI 10.1038/gene.2012.12; WIEBE V, 1994, HUM GENET, V93, P520; YANG PM, 1990, P NATL ACAD SCI USA, V87, P7907, DOI 10.1073/pnas.87.20.7907	83	137	152	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					530	546		10.1016/j.ajhg.2013.03.004	http://dx.doi.org/10.1016/j.ajhg.2013.03.004			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23541343	Green Published, Bronze			2022-12-18	WOS:000317449700005
J	Walczak-Sztulpa, J; Eggenschwiler, J; Osborn, D; Brown, DA; Emma, F; Klingenberg, C; Hennekam, RC; Torre, G; Garshasbi, M; Tzschach, A; Szczepanska, M; Krawczynski, M; Zachwieja, J; Zwolinska, D; Beales, PL; Ropers, HH; Latos-Bielenska, A; Kuss, AW				Walczak-Sztulpa, Joanna; Eggenschwiler, Jonathan; Osborn, Daniel; Brown, Desmond A.; Emma, Francesco; Klingenberg, Claus; Hennekam, Raoul C.; Torre, Giuliano; Garshasbi, Masoud; Tzschach, Andreas; Szczepanska, Malgorzata; Krawczynski, Marian; Zachwieja, Jacek; Zwolinska, Danuta; Beales, Philip L.; Ropers, Hans-Hilger; Latos-Bielenska, Anna; Kuss, Andreas W.			Cranioectodermal Dysplasia, Sensenbrenner Syndrome, Is a Ciliopathy Caused by Mutations in the IFT122 Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPHYXIATING THORACIC DYSTROPHY; RIB-POLYDACTYLY SYNDROME; INTRAFLAGELLAR TRANSPORT; CILIA; ZEBRAFISH; MOUSE; EXPRESSION; DYNC2H1; PROTEIN; FAMILY	Cranioectodermal dysplasia (CED) is a disorder characterized by craniofacial, skeletal, and ectodermal abnormalities. Most cases reported to date are sporadic, but a few familial cases support an autosomal-recessive inheritance pattern. Aiming at the elucidation of the genetic basis of CED, we collected 13 patients with CED symptoms from 12 independent families. In one family with consanguineous parents two siblings were affected, permitting linkage analysis and homozygosity mapping. This revealed a single region of homozygosity with a significant LOD score (3.57) on chromosome 3q2-3q24. By sequencing candidate genes from this interval we found a homozygous missense mutation in the IFT122 (WDR10) gene that cosegregated with the disease. Examination of IFT122 in our patient cohort revealed one additional homozygous missense change in the patient from a second consanguineous family. In addition, we found compound heterozygosity for a donor splice-site change and a missense change in one sporadic patient. All mutations were absent in 340 control chromosomes. Because 117122 plays an important role in the assembly and maintenance of eukaryotic cilia, we investigated patient fibroblasts and found significantly reduced frequency and length of primary cilia as compared to controls. Furthermore, we transiently knocked clown ift122 in zebrafish embryos and observed the typical phenotype found in other models of ciliopathies. Because not all of our patients harbored mutations in IFT122, CED seems to be genetically heterogeneous. Still, by identifying CED as a ciliary disorder, our study suggests that the causative mutations in the unresolved cases most likely affect primary cilia function too.	[Walczak-Sztulpa, Joanna; Garshasbi, Masoud; Tzschach, Andreas; Ropers, Hans-Hilger; Kuss, Andreas W.] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Walczak-Sztulpa, Joanna; Latos-Bielenska, Anna] Karol Marcinkowski Univ Med Sci, Dept Med Genet, PL-60352 Poznan, Poland; [Eggenschwiler, Jonathan; Brown, Desmond A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Osborn, Daniel; Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Emma, Francesco] Childrens Hosp & Res Inst Bambino Gesu, Div Nephrol & Dialysis, I-00165 Rome, Italy; [Klingenberg, Claus] Univ Hosp N Norway, Dept Paediat, N-9038 Tromso, Norway; [Klingenberg, Claus] Univ Tromso, N-9038 Tromso, Norway; [Hennekam, Raoul C.] UCL, Great Ormond St Hosp Children, Inst Child Hlth, London WC1N 1EH, England; [Hennekam, Raoul C.] Univ Amsterdam, Dept Paediat, NL-1105 AZ Amsterdam, Netherlands; [Torre, Giuliano] Childrens Hosp & Res Inst Bambino Gesu, Div Hepatogastroenterol, I-00165 Rome, Italy; [Szczepanska, Malgorzata] Karol Marcinkowski Univ Med Sci, Div Reprod, Dept Gynecol & Obstet, PL-60535 Poznan, Poland; [Krawczynski, Marian] Karol Marcinkowski Univ Med Sci, Dept Gastroenterol & Metab, PL-60572 Poznan, Poland; [Zachwieja, Jacek] Karol Marcinkowski Univ Med Sci, Dept Paediat Cardiol & Nephrol, PL-60572 Poznan, Poland; [Zwolinska, Danuta] Wroclaw Med Univ, Dept Paediat Nephrol, PL-50369 Wroclaw, Poland; [Zwolinska, Danuta] Wroclaw Med Univ, Clin Paediat Nephrol, PL-50369 Wroclaw, Poland; [Latos-Bielenska, Anna] Ctr Med Genet, PL-60601 Poznan, Poland	Max Planck Society; Poznan University of Medical Sciences; Princeton University; University of London; University College London; IRCCS Bambino Gesu; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Amsterdam; IRCCS Bambino Gesu; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Wroclaw Medical University; Wroclaw Medical University	Walczak-Sztulpa, J (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	jsztulpa@umed.poznan.pl; kuss_a@molgen.mpg.de	Brown, Desmond/AAP-7304-2020; Beales, Philip L/C-7367-2009; Osborn, Daniel/ABG-6699-2020; Klingenberg, Claus/AAH-4467-2019; Tzschach, Andreas/I-2648-2019; Emma, Francesco/H-2116-2012	Brown, Desmond/0000-0002-2896-1722; Tzschach, Andreas/0000-0002-6840-965X; Emma, Francesco/0000-0002-0383-3468; eggenschwiler, jonathan/0000-0001-6444-8865; Kuss, Andreas/0000-0002-9401-4627; Osborn, Daniel/0000-0002-5266-404X; Zachwieja, Jacek/0000-0002-7365-553X; Garshasbi, Masoud/0000-0002-5508-7903	EU [HEALTH-F2-2007-201804]; Max-Planck-Innovation; MRC [G0801843] Funding Source: UKRI; Medical Research Council [G0801843] Funding Source: researchfish	EU(European Commission); Max-Planck-Innovation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to all affected individuals and their families for their participation in the study. We thank Daniela Pilz, Ian D. Young, Krystyna Chrzanowska, Satoshi Sasaki, Han Brunner, Helen Fryssira, and Ewa Obersztyn for providing DNA samples. We thank Lia Abbasi Moheb and Lars Riff Jensen for continuous support, Marianne Schlicht and Susanne Freier for technical assistance, and Joseph Goodhouse for help with confocal microscopy. This work was supported by grants from the EU Framework 7 EUCILIA (HEALTH-F2-2007-201804) and the Max-Planck-Innovation funds. Philip Beales is a Wellcome Trust Senior Research Fellow.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Eke T, 1996, BRIT J OPHTHALMOL, V80, P490, DOI 10.1136/bjo.80.5.490; Fry AE, 2009, AM J MED GENET A, V149A, P2212, DOI 10.1002/ajmg.a.33027; Garshasbi M, 2006, HUM GENET, V118, P708, DOI 10.1007/s00439-005-0104-y; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Konstantinidou AE, 2009, AM J MED GENET A, V149A, P2206, DOI 10.1002/ajmg.a.33013; Lehman JM, 2008, DEV DYNAM, V237, P1960, DOI 10.1002/dvdy.21515; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Niedermaier M, 2005, J CLIN INVEST, V115, P900, DOI 10.1172/JCI200523675; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Tobin JL, 2008, PEDIATR NEPHROL, V23, P2095, DOI 10.1007/s00467-008-0898-7; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tsao CC, 2008, J CELL SCI, V121, P428, DOI 10.1242/jcs.015826; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385; Zaffanello M, 2006, AM J MED GENET A, V140A, P2336, DOI 10.1002/ajmg.a.31464	24	137	140	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					949	956		10.1016/j.ajhg.2010.04.012	http://dx.doi.org/10.1016/j.ajhg.2010.04.012			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20493458	Green Published, Bronze			2022-12-18	WOS:000278948900012
J	Bush, WS; Sawcer, SJ; de Jager, PL; Oksenberg, JR; McCauley, JL; Pericak-Vance, MA; Haines, JL				Bush, William S.; Sawcer, Stephen J.; de Jager, Philip L.; Oksenberg, Jorge R.; McCauley, Jacob L.; Pericak-Vance, Margaret A.; Haines, Jonathan L.		IMSGC	Evidence for Polygenic Susceptibility to Multiple Sclerosis-The Shape of Things to Come	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INTERLEUKIN-7 RECEPTOR; GENETIC EPIDEMIOLOGY; COMPLEX DISEASES; RISK; PREDICTION; LINKAGE; MODELS; LOCUS	It is well established that the risk of developing multiple sclerosis is substantially increased in the relatives of affected individuals and that most of this increase is genetically determined. The observed pattern of familial recurrence risk has long suggested that multiple variants are involved, but it has proven difficult to identify individual risk variants and little has been established about the genetic architecture underlying susceptibility. By using data from two independent genome-wide association studies (GWAS), we demonstrate that a substantial proportion of the thousands of variants that individually fail to show statistically significant evidence of association have allele frequencies in cases that are skewed away from the null distribution through the effects of multiple as-yet-unidentified risk loci. The collective effect of 12,627 SNPs with Cochran-Mantel-Haenszel test (p < 0.2) in our discovery GWAS set optimally explains similar to 3% of the variance in MS risk in our independent target GWAS set, estimated by Nagelkerke's pseudo-R(2). This model has a highly significant fit (p = 9.90E-19). These results statistically demonstrate a polygenic component to MS susceptibility and suggest that the risk alleles identified to date represent just the tip of an iceberg of risk variants likely to include hundreds of modest effects and possibly thousands of very small effects.	[Bush, William S.; Haines, Jonathan L.] Vanderbilt Univ, Nashville, TN 37203 USA; [Sawcer, Stephen J.] Univ Cambridge, Cambridge CB2 1TN, England; [de Jager, Philip L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [de Jager, Philip L.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [McCauley, Jacob L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA	Vanderbilt University; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; University of Miami	Bush, WS (corresponding author), Vanderbilt Univ, Nashville, TN 37203 USA.	wbush@chgr.mc.vanderbilt.edu	Bush, Will/B-9797-2012; Haines, Jonathan/C-3374-2012; Bush, William/N-1369-2019	Haines, Jonathan/0000-0002-4351-4728; Bush, William/0000-0002-9729-6519	National Institutes of Health [NS049477, NS032830, MH065215]; Wellcome Trust [0847021Z/08/Z]; Cambridge NIHR Biomedical Research Centre; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032830, R01NS049477] Funding Source: NIH RePORTER; Medical Research Council [G0801418B] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institutes of Health (NS049477, NS032830, MH065215), the Wellcome Trust (0847021Z/08/Z), and the Cambridge NIHR Biomedical Research Centre. This study makes use of data generated by the WTCCC and NIMH. Study participants were recruited in agreement with protocols of the institutional review board at each institution.	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Lindsey JW, 2005, AM J MED GENET A, V135A, P53, DOI 10.1002/ajmg.a.30702; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; RISCH N, 1990, AM J HUM GENET, V46, P222; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Sadovnick AD, 1997, EPIDEMIOL REV, V19, P99, DOI 10.1093/oxfordjournals.epirev.a017951; SADOVNICK AD, 1995, NEUROL CLIN, V13, P99, DOI 10.1016/S0733-8619(18)30063-X; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Willer CJ, 2007, J HUM GENET, V52, P955, DOI 10.1007/s10038-007-0194-6; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063	28	137	139	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					621	625		10.1016/j.ajhg.2010.02.027	http://dx.doi.org/10.1016/j.ajhg.2010.02.027			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20362272	Green Published, Bronze			2022-12-18	WOS:000276716800013
J	Lohr, NJ; Molleston, JP; Strauss, KA; Torres-Martinez, W; Sherman, EA; Squires, RH; Rider, NL; Chikwava, KR; Cummings, OW; Morton, DH; Puffenberger, EG				Lohr, Naomi J.; Molleston, Jean P.; Strauss, Kevin A.; Torres-Martinez, Wilfredo; Sherman, Eric A.; Squires, Robert H.; Rider, Nicholas L.; Chikwava, Kudakwashe R.; Cummings, Oscar W.; Morton, D. Holmes; Puffenberger, Erik G.			Human ITCH E3 Ubiquitin Ligase Deficiency Causes Syndromic Multisystem Autoimmune Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONSPECIFIC INTERSTITIAL PNEUMONIA; CELL	Ubiquitin ligases play an important role in the regulation of the immune system. Absence of Itch E3 ubiquitin ligase in mice has been shown to cause severe autoimmune disease. Using autozygosity mapping in a large Amish kindred, we identified a linkage region on chromosome 20 and selected candidate genes for screening. We describe, in ten patients, identification of a mutation resulting in truncation of ITCH. These patients represent the first reported human phenotype associated with ITCH deficiency. These patients not only have multisystem autoimmune disease but also display morphologic and developmental abnormalities. This disorder underscores the importance of ITCH ubiquitin ligase in many cellular processes.	[Molleston, Jean P.] Indiana Univ, Sch Med, Dept Pediat, Sect Pediat Gastroenterol Hepatol & Nutr, Indianapolis, IN 46202 USA; [Lohr, Naomi J.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Strauss, Kevin A.; Sherman, Eric A.; Rider, Nicholas L.; Morton, D. Holmes; Puffenberger, Erik G.] Clin Special Children, Strasburg, PA USA; [Torres-Martinez, Wilfredo] Indiana Univ, Sch Med, Dept Med Genet, Indianapolis, IN 46202 USA; [Squires, Robert H.] Childrens Hosp Pittsburgh, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; [Cummings, Oscar W.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Strauss, Kevin A.; Morton, D. Holmes; Puffenberger, Erik G.] Franklin & Marshall Coll, Lancaster, PA 17604 USA; [Strauss, Kevin A.; Rider, Nicholas L.; Morton, D. Holmes; Puffenberger, Erik G.] Lancaster Gen Hosp, Lancaster, PA USA; [Chikwava, Kudakwashe R.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University-Purdue University Indianapolis; Franklin & Marshall College; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Molleston, JP (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Sect Pediat Gastroenterol Hepatol & Nutr, Indianapolis, IN 46202 USA.	jpmolles@iupui.edu		Sherman, Erin/0000-0002-1835-8604; Puffenberger, Erik/0000-0002-6388-9148	American Academy of Pediatrics Resident Research	American Academy of Pediatrics Resident Research	Naomi Lohr was funded by an American Academy of Pediatrics Resident Research Grant. The authors thank Vicki Haviland-Wilhite and Sharon McPheeters for expert secretarial assistance. They also thank the Amish families who shared their medical histories and allowed physical examinations and blood draws. jean Molleston receives research funding support from Hoffman LaRoche.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Burt RK, 2002, BLOOD, V99, P768, DOI 10.1182/blood.V99.3.768; EICHER BJ, 1990, SCHWATZ BUCH DESCEND, P17529; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Katzenstein ALA, 2000, AM J SURG PATHOL, V24, P1, DOI 10.1097/00000478-200001000-00001; Kinder BW, 2007, AM J RESP CRIT CARE, V176, P691, DOI 10.1164/rccm.200702-220OC; Lorick K. L., 2006, CURRENT PROTOCOLS CE; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Martinez A, 2010, BRAIN PATHOL, V20, P281, DOI 10.1111/j.1750-3639.2009.00326.x; Matesic LE, 2008, CURR TOP MICROBIOL, V321, P185; Matesic LE, 2006, HUM MOL GENET, V15, P3485, DOI 10.1093/hmg/ddl425; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Parravicini V, 2008, BLOOD, V111, P4273, DOI 10.1182/blood-2007-10-115667; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Strauss KA, 2009, ANNU REV GENOM HUM G, V10, P513, DOI 10.1146/annurev-genom-082908-150040; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Zhang M, 2007, J IMMUNOL, V179, P4435, DOI 10.4049/jimmunol.179.7.4435	22	137	147	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					447	453		10.1016/j.ajhg.2010.01.028	http://dx.doi.org/10.1016/j.ajhg.2010.01.028			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20170897	Green Published, Bronze			2022-12-18	WOS:000275678800016
J	Xu, SH; Huang, W; Qian, J; Jin, L				Xu, Shuhua; Huang, Wei; Qian, Ji; Jin, Li			Analysis of genomic admixture in Uyghur and its implication in mapping strategy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-POLYMORPHISM PANEL; LINKAGE DISEQUILIBRIUM; AFRICAN-AMERICAN; ADMIXED POPULATIONS; ETHNIC-DIFFERENCES; DISEASE RISK; GENES; MARKERS; MAP; INFERENCE	The Uyghur (UIG) population, settled in Xinjiang, China, is a population presenting a typical admixture of Eastern and Western anthropometric traits. We dissected its genomic structure at population level, individual level, and chromosome level by using 20,177 SNPS spanning nearly the entire chromosome 21. Our results showed that UIG was formed by two-way admixture, with 60% European ancestry and 40% East Asian ancestry. Overall linkage disequilibrium (LD) in UIG was similar to that in its parental populations represented in East Asia and Europe with regard to common alleles, and UIG manifested elevation of LD only within 500 kb and at a level of 0.1 < r(2) < 0.8 when ancestry-informative markers (AIMs) were used. The size of chromosomal segments that were derived from East Asian and European ancestries averaged 2.4 cM and 4.1 cM, respectively. Both the magnitude of LD and fragmentary ancestral chromosome segments indicated a long history of Uyghur. Under the assumption of a hybrid isolation (HI) model, we estimated that the admixture event of UIG occurred about 126 [107 similar to 146] generations ago, or 2520 [2140 similar to 2920] years ago assuming 20 years per generation. In spite of the long history and short LD of Uyghur compared with recent admixture populations such as the African-American population, we suggest that mapping by admixture LD (MALD) is still applicable in the Uyghur population but similar to 10-fold AIMs are necessary for a whole-genome scan.	[Xu, Shuhua; Jin, Li] Chinese Acad Sci, Shanghai 200031, Peoples R China; [Xu, Shuhua; Jin, Li] Max Planck Soc CAS MPG, Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Xu, Shuhua; Qian, Ji; Jin, Li] Fudan Univ, Minist Educ, MOE, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Xu, Shuhua; Qian, Ji; Jin, Li] Fudan Univ, Ctr Evolut Biol, Sch Life Sci, Shanghai 200433, Peoples R China; [Xu, Shuhua; Qian, Ji; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Huang, Wei] Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Fudan University; Fudan University; Fudan University	Jin, L (corresponding author), Chinese Acad Sci, Shanghai 200031, Peoples R China.	ljin007@gmail.com	XU, SHUHUA/D-5345-2009; Xu, Shuhua/AAH-7620-2020; Jin, Li/C-1468-2009; Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/M-5063-2019	XU, SHUHUA/0000-0002-1975-1002; Xu, Shuhua/0000-0002-1975-1002; Jin, Li/0000-0002-4546-2415; 				AI Q, 1993, ACTA ANTHR SINICA, V12, P357; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barnes Kathleen C, 2007, Proc Am Thorac Soc, V4, P58, DOI 10.1513/pats.200607-146JG; BRISCOE D, 1994, J HERED, V85, P59; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Collins-Schramm HE, 2003, HUM GENET, V113, P211, DOI 10.1007/s00439-003-0961-1; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Cui Y. Q., 2004, J CENTRAL U NATIONAL, V31, P34; Darvasi A, 2005, NAT GENET, V37, P118, DOI 10.1038/ng0205-118; Falush D, 2003, GENETICS, V164, P1567; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Huang W, 2006, P NATL ACAD SCI USA, V103, P1418, DOI 10.1073/pnas.0510360103; Karafev TM, 2005, HUM BIOL, V77, P93, DOI 10.1353/hub.2005.0030; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lai S P, 1999, Yi Chuan Xue Bao, V26, P447; LEWONTIN RC, 1964, GENETICS, V50, P757; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2005, AM J HUM GENET, V76, P1, DOI 10.1086/426949; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2005, PHILOS T ROY SOC B, V360, P1605, DOI 10.1098/rstb.2005.1691; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Risch NJ, 1992, AM J HUM GENET S, V51, P13; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rybicki BA, 2002, HUM HERED, V53, P187, DOI 10.1159/000066193; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Seldin MF, 2007, CURR OPIN GENET DEV, V17, P177, DOI 10.1016/j.gde.2007.03.002; Shriver MD, 2006, ADV EXP MED BIOL, V588, P89; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; WASSEL F, 2007, HUM GENET, V121, P615; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Xiao FX, 2002, HUM BIOL, V74, P555, DOI 10.1353/hub.2002.0050; Xu SH, 2007, MOL BIOL EVOL, V24, P2049, DOI 10.1093/molbev/msm135; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329; Zhu XF, 2006, HUM GENET, V120, P431, DOI 10.1007/s00439-006-0224-z	61	137	159	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					883	894		10.1016/j.ajhg.2008.01.017	http://dx.doi.org/10.1016/j.ajhg.2008.01.017			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18355773	Green Published, Bronze			2022-12-18	WOS:000255103900007
J	Ruiz-Perez, VL; Tompson, SWJ; Blair, HJ; Espinoza-Valdez, C; Lapunzina, P; Silva, EO; Hamel, B; Gibbs, JL; Young, ID; Wright, MJ; Goodship, JA				Ruiz-Perez, VL; Tompson, SWJ; Blair, HJ; Espinoza-Valdez, C; Lapunzina, P; Silva, EO; Hamel, B; Gibbs, JL; Young, ID; Wright, MJ; Goodship, JA			Mutations in two nonhomologous genes in a head-to-head configuration cause Ellis-van Creveld syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOOTH AGENESIS; SEQUENCE; SITOSTEROLEMIA; LOCUS	Ellis-van Creveld syndrome (EvC) is an autosomal recessive skeletal dysplasia. Elsewhere, we described mutations in EVC in patients with this condition (Ruiz-Perez et al. 2000). We now report that mutations in EVC2 also cause EvC. These two genes lie in a head-to-head configuration that is conserved from fish to man. Affected individuals with mutations in EVC and EVC2 have the typical spectrum of features and are phenotypically indistinguishable.	Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Hosp Univ Catolico, Cuenca, Ecuador; Hosp Univ La Paz, Madrid, Spain; Inst Maternoinfantil Pernambuco, Recife, PE, Brazil; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Leeds Gen Infirm, Leeds, W Yorkshire, England; Leicester Royal Infirm, Leicester, Leics, England	Newcastle University - UK; Hospital Universitario La Paz; Radboud University Nijmegen; Leeds General Infirmary; University of Leeds; University of Leicester	Goodship, JA (corresponding author), Newcastle Univ, Int Ctr Life, Inst Human Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	j.a.goodship@ncl.ac.uk	Ruiz-Perez, Victor L/K-6066-2014; Lapunzina, Pablo/L-7075-2014	Ruiz-Perez, Victor L/0000-0003-0635-3619; Lapunzina, Pablo/0000-0002-6324-4825; Tompson, Stuart/0000-0001-9788-6730				Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Carlock L, 1996, MOL BRAIN RES, V42, P202, DOI 10.1016/S0169-328X(96)00115-5; Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713; Ide SE, 1996, HUM GENET, V98, P572, DOI 10.1007/s004390050261; Jumlongras D, 2001, AM J HUM GENET, V69, P67, DOI 10.1086/321271; Lu KM, 2001, AM J HUM GENET, V69, P278, DOI 10.1086/321294; MORITOMO Y, 1992, J VET MED SCI, V54, P453, DOI 10.1292/jvms.54.453; OLIVEIRADASILVA E, 1980, J MED GENET, V17, P349, DOI 10.1136/jmg.17.5.349; Platzer M, 1997, GENOME RES, V7, P592, DOI 10.1101/gr.7.6.592; Ruiz-Perez VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508; SHIMADA T, 1989, J BIOL CHEM, V264, P20171; Takeda H, 2002, P NATL ACAD SCI USA, V99, P10549, DOI 10.1073/pnas.152337899; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	16	137	138	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					728	732		10.1086/368063	http://dx.doi.org/10.1086/368063			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12571802	Green Published, Bronze			2022-12-18	WOS:000181152600023
J	Shao, YJ; Raiford, KL; Wolpert, CM; Cope, HA; Ravan, SA; Ashley-Koch, AA; Abramson, RK; Wright, HH; DeLong, RG; Gilbert, JR; Cuccaro, ML; Pericak-Vance, MA				Shao, YJ; Raiford, KL; Wolpert, CM; Cope, HA; Ravan, SA; Ashley-Koch, AA; Abramson, RK; Wright, HH; DeLong, RG; Gilbert, JR; Cuccaro, ML; Pericak-Vance, MA			Phenotypic homogeneity provides increased support for linkage on chromosome 2 in autistic disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Autistic disorder (AutD) is a neurodevelopmental disorder characterized by significant disturbances in social, communicative, and behavioral functioning. A two-stage genomic screen analysis of 99 families with AutD revealed suggestive evidence for linkage to chromosome 2q (D2S116 nonparametric sib-pair LOD score [MLS] 1.12 at 198 cM). In addition, analysis of linkage disequilibrium for D2S116 showed an allele-specific P value of <.01. Recently, linkage to the same region of 2q was reported in an independent genome screen. This evidence for linkage increased when analysis was restricted to the subset of patients with AutD who had delayed onset (>36 mo) of phrase speech (PSD). We similarly classified our data set of 82 sib pairs with AutD, identifying 45 families with AutD and PSD. Analysis of this PSD subset increased our support for linkage to 2q (MLS 2.86 and HLOD 2.12 for marker D2S116). These data support evidence for a gene on chromosome 2 contributing to risk of AutD, and they suggest that phenotypic homogeneity increases the power to find susceptibility genes for AutD.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Univ S Carolina, WS Hall Psychiat Inst, Columbia, SC 29208 USA	Duke University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, CARL Bldg,Box 3445, Durham, NC 27710 USA.			Cope, Heidi/0000-0003-0586-9277; Ashley-Koch, Allison/0000-0001-5409-9155	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, R01NS036768] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD 36701] Funding Source: Medline; NINDS NIH HHS [P01 NS026630, R01 NS036768, NS 36768, NS 26630] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; Bass MP, 2000, AM J HUM GENET, V67, P349; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Leal SM, 2000, AM J HUM GENET, V66, P567, DOI 10.1086/302748; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MacLean JE, 1999, J AM ACAD CHILD PSY, V38, P746, DOI 10.1097/00004583-199906000-00023; Ott J, 1999, ANAL HUMAN GENETIC L; Palferman S, 2001, HUM MOL GENET, V10, P973; PERICAKVANCE MA, IN PRESS BEHAV GENET; Rutter M., 1994, CHILD ADOLESCENT PSY, V3, P569; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Szatmari P, 2000, AM J PSYCHIAT, V157, P1980, DOI 10.1176/appi.ajp.157.12.1980	16	137	144	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1058	1061		10.1086/339765	http://dx.doi.org/10.1086/339765			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11875756	Green Published, Bronze			2022-12-18	WOS:000174252100027
J	Martin, ER; Bass, MP; Kaplan, NL				Martin, ER; Bass, MP; Kaplan, NL			Correcting for a potential bias in the pedigree disequilibrium test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ASSOCIATION; LINKAGE		Duke Univ, Med Ctr, Ctr Human Genet, Dept Med, Durham, NC 27710 USA; NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Martin, ER (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Dept Med, Box 3468, Durham, NC 27710 USA.				NIMH NIH HHS [R01 MH-98-017] Funding Source: Medline; NINDS NIH HHS [NS-99-004] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES044004] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Teng J, 1999, GENOME RES, V9, P234	5	137	140	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					1065	1067		10.1086/319525	http://dx.doi.org/10.1086/319525			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254459	Green Published, Bronze			2022-12-18	WOS:000167666000028
J	Forbes, JR; Cox, DW				Forbes, JR; Cox, DW			Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; IRON UPTAKE; GOLGI-APPARATUS; MENKES DISEASE; GENE HOMOLOG; COPPER; YEAST; TRANSPORT; ATPASE; CERULOPLASMIN	Wilson disease is an autosomal recessive disorder of copper transport that causes hepatic and/or neurological disease resulting from copper accumulation in the liver and brain. The protein defective in this disorder is a putative copper-transporting P-type ATPase, ATP7B. More than 100 mutations have been identified in the ATP7B gene of patients with Wilson disease. To determine the effect of Wilson disease missense mutations on ATP7B function, we have developed a yeast complementation assay based on the ability of ATP7B to complement the high-affinity iron-uptake deficiency of the yeast mutant ccc2. We characterized missense mutations found in the predicted membrane-spanning segments of ATP7B. Ten mutations have been made in the ATP7B cDNA by site-directed mutagenesis: five Wilson disease missense mutations, two mutations originally classified as possible disease-causing mutations, two putative ATP7B normal variants, and mutation of the cysteineproline-cysteine (CPC) motif conserved in heavymetal-transporting P-type ATPases. All seven putative Wilson disease mutants tested were able to at least partially complement ccc2 mutant yeast, indicating that they retain some ability to transport copper. One mutation was a temperature-sensitive mutation that was able to complement ccc2 mutant yeast at 30 degrees C but was unable to complement at 37 degrees C. Mutation of the CPC motif resulted in a nonfunctional protein, which demonstrates that this motif is essential for copper transport by ATP7B. Of the two putative ATP7B normal variants tested, one resulted in a nonfunctional protein, which suggests that it is a disease-causing mutation.	Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada	University of Alberta	Cox, DW (corresponding author), Univ Alberta, Dept Med Genet, 8-39 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	diane.cox@ualberta.ca						[Anonymous], 1995, METABOLIC BASIS INHE; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BROWN NL, 1992, PLASMID, V27, P41, DOI 10.1016/0147-619X(92)90005-U; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; Chuang LM, 1996, J MED GENET, V33, P521, DOI 10.1136/jmg.33.6.521; COX DW, 1998, SLEISENGER FORDTRANS, P1104; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; FARRER LA, 1991, NEUROLOGY, V41, P992, DOI 10.1212/WNL.41.7.992; FIGUS A, 1995, AM J HUM GENET, V57, P1318; GROSS JB, 1989, J CLIN INVEST, V83, P30, DOI 10.1172/JCI113873; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Iida M, 1998, FEBS LETT, V428, P281, DOI 10.1016/S0014-5793(98)00546-8; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Lutsenko S, 1998, P NATL ACAD SCI USA, V95, P6004, DOI 10.1073/pnas.95.11.6004; MACLENNAN DH, 1992, ACTA PHYSIOL SCAND, V146, P141; MURATA Y, 1995, BIOCHEM BIOPH RES CO, V209, P349, DOI 10.1006/bbrc.1995.1510; Nanji MS, 1997, AM J HUM GENET, V60, P1423, DOI 10.1086/515459; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Payne AS, 1998, J BIOL CHEM, V273, P3765, DOI 10.1074/jbc.273.6.3765; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Sambongi Y, 1997, J BIOCHEM-TOKYO, V121, P1169, DOI 10.1093/oxfordjournals.jbchem.a021711; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SCHILSKY ML, 1994, AM J PHYSIOL, V266, pG907, DOI 10.1152/ajpgi.1994.266.5.G907; SILVER S, 1992, PLASMID, V27, P1, DOI 10.1016/0147-619X(92)90001-Q; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; SOLIOZ M, 1998, ADV MOL CEL A&B, V23, P167; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Waldenstrom E, 1996, GENOMICS, V37, P303, DOI 10.1006/geno.1996.0564; Yoshimizu T, 1998, BIOSCI BIOTECH BIOCH, V62, P1258, DOI 10.1271/bbb.62.1258; Yuan DS, 1997, J BIOL CHEM, V272, P25787, DOI 10.1074/jbc.272.41.25787; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; ZUBENKO GS, 1980, GENETICS, V96, P137	40	137	142	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1663	1674		10.1086/302163	http://dx.doi.org/10.1086/302163			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837819	Bronze, Green Published			2022-12-18	WOS:000077707700012
J	Honsho, M; Tamura, S; Shimozawa, N; Suzuki, Y; Kondo, N; Fujiki, Y				Honsho, M; Tamura, S; Shimozawa, N; Suzuki, Y; Kondo, N; Fujiki, Y			Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; TARGETING SIGNAL-1 RECEPTOR; MAMMALIAN-CELL MUTANT; ASSEMBLY FACTOR-II; BIOGENESIS DISORDERS; PTS2 RECEPTOR; 3-KETOACYL-COA THIOLASE; MEMBRANE-PROTEIN; REPRESENT 2; GENE	Peroxisome-biogenesis disorders (PBDs), including Zellweger syndrome (ZS), are autosomal recessive diseases caused by a deficiency in peroxisome assembly as well as by a malfunction of peroxisomes, among which >10 genotypes have been identified. We have isolated a human PEX16 cDNA (HsPEX16) by performing an expressed-sequence-tag homology search on a human DNA database, by using yeast PEX16 from Yarrowia lipolytica and then screening the human liver cDNA library. This cDNA encodes a peroxisomal protein (a peroxin Pex16p) made up of 336 amino acids. Among 13 peroxisome-deficiency complementation groups (CGs), HsPEX16 expression morphologically and biochemically restored peroxisome biogenesis only in fibroblasts from a CG-D patient with ZS in Japan (the same group as CG-IX in the United States). Pex16p was localized to peroxisomes through expression study of epitope-tagged Pex16p. One patient (PBDD-01) possessed a homozygous, inactivating nonsense mutation, C-->T at position 526 ina codon ((C) under bar GA) for (176)Arg, that resulted in a termination codon ((T) under bar GA). This implies that the C-terminal half is required for the biological function of Pex16p. PBDD-01-derived PEX16 cDNA was defective in peroxisome-restoring activity when expressed in the patient's fibroblasts. These results demonstrate that mutation in PEX16 is the genetic cause of CC-D PBDs.	Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Gifu Univ, Sch Med, Dept Pediat, Gifu 500, Japan	Kyushu University; Japan Science & Technology Agency (JST); Gifu University	Fujiki, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.			Honsho, Masanori/0000-0001-6165-4516; Shimozawa, Nobuyuki/0000-0003-3040-5458				Abe I, 1998, FEBS LETT, V431, P468, DOI 10.1016/S0014-5793(98)00815-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Eitzen GA, 1997, J CELL BIOL, V137, P1265, DOI 10.1083/jcb.137.6.1265; Fujiki Y, 1997, BBA-MOL BASIS DIS, V1361, P235, DOI 10.1016/S0925-4439(97)00051-3; Fukuda S, 1996, AM J HUM GENET, V59, P1210; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Okumoto K, 1997, EXP CELL RES, V233, P11, DOI 10.1006/excr.1997.3552; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; SANTOS MJ, 1992, J CELL PHYSIOL, V151, P103, DOI 10.1002/jcp.1041510115; SANTOS MJ, 1988, SCIENCE, V239, P1536, DOI 10.1126/science.3281254; Shimozawa N, 1998, BIOCHEM BIOPH RES CO, V243, P368, DOI 10.1006/bbrc.1997.8067; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; Shimozawa N, 1998, AM J HUM GENET, V63, P1898, DOI 10.1086/302142; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; Subramani S, 1997, NAT GENET, V15, P331, DOI 10.1038/ng0497-331; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Tateishi K, 1997, EUR J CELL BIOL, V73, P352; Titorenko VI, 1998, MOL CELL BIOL, V18, P2789, DOI 10.1128/MCB.18.5.2789; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V230, P402, DOI 10.1006/bbrc.1996.5971; TSUKAMOTO T, 1994, MOL CELL BIOL, V14, P5458, DOI 10.1128/MCB.14.8.5458; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; WENDLAND M, 1993, J CLIN INVEST, V92, P2462, DOI 10.1172/JCI116854; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; WIEMER EAC, 1989, EUR J CELL BIOL, V50, P407; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; YAJIMA S, 1992, HUM GENET, V88, P491, DOI 10.1007/BF00219334; ZOELLER RA, 1989, J BIOL CHEM, V264, P21872	47	137	139	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1622	1630		10.1086/302161	http://dx.doi.org/10.1086/302161			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837814	Green Published, Bronze			2022-12-18	WOS:000077707700007
J	Yu, CE; Oshima, J; Wijsman, EM; Nakura, J; Miki, T; Piussan, C; Matthews, S; Fu, YH; Mulligan, J; Martin, GM; Schellenberg, GD; Burg, G; Epstein, CJ; Fischer, W; Fujiwara, Y; Fukuchi, KI; Hoehn, H; Hurlimann, AF; Kiso, S; Matthews, J; Melaragno, MI; Murano, S; Ouais, S; Poot, M; Rizzo, M; Saida, T; Tannock, TCA; Uyeno, B				Yu, CE; Oshima, J; Wijsman, EM; Nakura, J; Miki, T; Piussan, C; Matthews, S; Fu, YH; Mulligan, J; Martin, GM; Schellenberg, GD; Burg, G; Epstein, CJ; Fischer, W; Fujiwara, Y; Fukuchi, KI; Hoehn, H; Hurlimann, AF; Kiso, S; Matthews, J; Melaragno, MI; Murano, S; Ouais, S; Poot, M; Rizzo, M; Saida, T; Tannock, TCA; Uyeno, B			Mutations in the consensus helicase domains of the Werner syndrome gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PIGMENTOSUM GROUP-D; COMPLEMENTATION GROUP-D; XERODERMA-PIGMENTOSUM; DNA-REPAIR; COCKAYNE-SYNDROME; PUTATIVE HELICASES; CELL-LINES; S-PHASE; LYMPHOCYTES; FIBROBLASTS	Werner syndrome (WS) is an autosomal recessive disease with a complex phenotype that is suggestive of accelerated aging. WS is caused by mutations in a gene, WRN, that encodes a predicted 1,432-amino-acid protein with homology to DNA and RNA helicases. Previous work identified four WS mutations in the 3' end of the gene, which resulted in predicted truncated protein products of 1,060-1,247 amino acids but did not disrupt the helicase domain region (amino acids 569-859). Here, additional WS subjects were screened for mutations, and the intron-exon structure of the gene was determined. A total of 35 exons were defined, with the coding sequences beginning in the second exon. Five new WS mutations were identified: two nonsense mutations at codons 369 and 889; a mutation at a splice-junction site, resulting in a predicted truncated protein of 760 amino acids; a 1-bp deletion causing a frameshift; and a predicted truncated protein of 391 amino acids. Another deletion is >15 kb of genomic DNA, including exons 19-23; the predicted protein is 1,186 amino acids long. Four of these new mutations either partially disrupt the helicase domain region or result in predicted protein products completely missing the helicase region. These results confirm that mutations in the WRN gene are responsible for WS. Also, the location of the mutations indicates that the presence or absence of the helicase domain does not influence the WS phenotype and suggests that WS is the result of complete loss of function of the WRN gene product.	VET AFFAIRS PUGET SOUND HLTH CARE SYST, CTR GERIATR RES EDUC & CLIN 182B, SEATTLE DIV, SEATTLE, WA 98108 USA; WASHINGTON UNIV, DEPT MED, DIV MED GENET, SEATTLE, WA USA; WASHINGTON UNIV, DEPT PATHOL, SEATTLE, WA USA; WASHINGTON UNIV, DEPT BIOSTAT, SEATTLE, WA USA; WASHINGTON UNIV, DEPT NEUROL & PHARMACOL, SEATTLE, WA USA; OSAKA UNIV, SCH MED, DEPT GERIATR MED, OSAKA 553, JAPAN; UNIV AMIENS, AMIENS, FRANCE; DARWIN MOL CORP, BOTHELL, WA USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Osaka University; Picardie Universites; Universite de Picardie Jules Verne (UPJV)			Melaragno, Maria I/F-9013-2012; Melaragno, Maria Isabel/W-8714-2019; Poot, Martin/F-9427-2010		NIA NIH HHS [AG08303, T32 AG00057, R01 AG12019] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG012019, R37AG008303, T32AG000057] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMEMIYA CT, 1992, NUCLEIC ACIDS RES, V20, P2559, DOI 10.1093/nar/20.10.2559; Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; ARLETT CF, 1980, CANCER RES, V40, P926; BROUGHTON BC, 1994, NAT GENET, V7, P189, DOI 10.1038/ng0694-189; BROUGHTON BC, 1995, AM J HUM GENET, V56, P167; CHENG RZ, 1990, MUTAT RES, V237, P259, DOI 10.1016/0921-8734(90)90008-F; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; FREDERICK GD, 1994, HUM MOL GENET, V3, P1783, DOI 10.1093/hmg/3.10.1783; FUJIWARA Y, 1977, J CELL PHYSIOL, V92, P365, DOI 10.1002/jcp.1040920305; FUKUCHI K, 1985, SOMAT CELL MOLEC GEN, V11, P303, DOI 10.1007/BF01534688; FUKUCHI K, 1990, HUM GENET, V84, P249; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GAWKRODGER DJ, 1985, ARCH DERMATOL, V121, P636, DOI 10.1001/archderm.1985.01660050088021; GEBHART E, 1985, HUM GENET, V70, P324, DOI 10.1007/BF00295370; GEBHART E, 1988, HUM GENET, V80, P135, DOI 10.1007/BF00702855; Goddard KAB, 1996, AM J HUM GENET, V58, P1286; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GOTO M, 1978, J AM GERIATR SOC, V26, P341, DOI 10.1111/j.1532-5415.1978.tb03681.x; GOTO M, 1981, CLIN GENET, V19, P8; GOTO M, 1996, EPIDEMIOL BIOMARKERS, V5, P239; HANAOKA F, 1983, EXP CELL RES, V144, P463, DOI 10.1016/0014-4827(83)90425-1; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; HIGASHIKAWA T, 1978, EXP CELL RES, V113, P438, DOI 10.1016/0014-4827(78)90386-5; HOEHN H, 1975, CYTOGENET CELL GENET, V15, P282, DOI 10.1159/000130526; Ion A, 1996, AM J HUM GENET, V58, P1185; KAKIGI R, 1992, NEUROLOGY, V42, P922, DOI 10.1212/WNL.42.4.922; KIERAS FJ, 1986, BIOCHEM MED METAB B, V36, P276, DOI 10.1016/0885-4505(86)90136-2; MARTIN GM, 1970, LAB INVEST, V23, P86; MONNAT RJ, 1992, GENOMICS, V13, P777, DOI 10.1016/0888-7543(92)90153-J; NAKURA J, 1994, GENOMICS, V23, P600, DOI 10.1006/geno.1994.1548; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; REED R, 1953, BRIT J DERMATOL, V65, P165, DOI 10.1111/j.1365-2133.1953.tb13193.x; RILEY TR, 1965, ANN INTERN MED, V63, P285, DOI 10.7326/0003-4819-63-2-285; RUNGER TM, 1994, J INVEST DERMATOL, V102, P45, DOI 10.1111/1523-1747.ep12371730; RUNGER TM, 1993, TOXICOL LETT, V67, P309, DOI 10.1016/0378-4274(93)90064-5; SAITO H, 1991, EXP CELL RES, V192, P373, DOI 10.1016/0014-4827(91)90054-X; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; SALK D, 1985, ADV EXP MED BIOL, V190, P541; SALK D, 1981, HUM GENET, V58, P310, DOI 10.1007/BF00294930; SCAPPATICCI S, 1982, HUM GENET, V62, P16, DOI 10.1007/BF00295599; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; STAYTON CL, 1994, HUM MOL GENET, V3, P1957, DOI 10.1093/hmg/3.11.1957; STEFANINI M, 1989, MUTAT RES, V219, P179, DOI 10.1016/0921-8734(89)90013-1; SUMI SM, 1985, ADV EXP MED BIOL, V190, P215; Takayama K, 1996, AM J HUM GENET, V58, P263; TAKAYAMA K, 1995, CANCER RES, V55, P5656; TAKEUCHI F, 1982, HUM GENET, V60, P365, DOI 10.1007/BF00569220; TAKEUCHI F, 1982, EXP GERONTOL, V17, P473, DOI 10.1016/S0531-5565(82)80009-0; THANNHAUSER SJ, 1945, ANN INTERN MED, V23, P559, DOI 10.7326/0003-4819-23-4-559; TOLLEFSBOL TO, 1984, AGE, V7, P75, DOI 10.1007/BF02432205; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; UMEHARA F, 1993, NEUROLOGY, V43, P1252, DOI 10.1212/WNL.43.6.1252; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WERNER CWO, 1904, UDBER KATARCT VERBIN; WOOD S, 1992, CYTOGENET CELL GENET, V59, P243, DOI 10.1159/000133260; YU CE, 1994, AM J HUM GENET, V55, P356; Yu CE, 1996, GENOMICS, V35, P431, DOI 10.1006/geno.1996.0382; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	63	137	139	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					330	341						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012406				2022-12-18	WOS:A1997WE93100012
J	FIGUS, A; ANGIUS, A; LOUDIANOS, G; BERTINI, C; DESSI, V; LOI, A; DEIANA, M; LOVICU, M; OLLA, N; SOLE, G; DEVIRGILIIS, S; LILLIU, F; FARCI, AMG; NURCHI, A; GIACCHINO, R; BARABINO, A; MARAZZI, M; ZANCAN, L; GREGGIO, NA; MARCELLINI, M; SOLINAS, A; DEPLANO, A; BARBERA, C; DEVOTO, M; OZSOYLU, S; KOCAK, N; AKAR, N; KARAYALCIN, S; MOKINI, V; CULLUFI, P; BALESTRIERI, A; CAO, A; PIRASTU, M				FIGUS, A; ANGIUS, A; LOUDIANOS, G; BERTINI, C; DESSI, V; LOI, A; DEIANA, M; LOVICU, M; OLLA, N; SOLE, G; DEVIRGILIIS, S; LILLIU, F; FARCI, AMG; NURCHI, A; GIACCHINO, R; BARABINO, A; MARAZZI, M; ZANCAN, L; GREGGIO, NA; MARCELLINI, M; SOLINAS, A; DEPLANO, A; BARBERA, C; DEVOTO, M; OZSOYLU, S; KOCAK, N; AKAR, N; KARAYALCIN, S; MOKINI, V; CULLUFI, P; BALESTRIERI, A; CAO, A; PIRASTU, M			MOLECULAR PATHOLOGY AND HAPLOTYPE ANALYSIS OF WILSON DISEASE IN MEDITERRANEAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPPER-TRANSPORTING ATPASE; MENKES DISEASE; POLYACRYLAMIDE GELS; CANDIDATE GENE; CHROMOSOME-13; LOCUS; PROTEIN; ENCODES; LINKAGE; THERAPY	We analyzed mutations and defined the chromosomal haplotype in 127 patients of Mediterranean descent who were affected by Wilson disease (WD), 39 Sardinians, 49 Italians, 33 Turks, and 6 Albanians. Haplotypes were derived by use of the microsatellite markers D13S301, D13S296, D135297, and D13S298, which are linked to the WD locus. There were five common haplotypes in Sardinians, three in Italians, and two in Turks, which accounted for 85%, 32%, and 30% of the WD chromosomes, respectively. We identified 16 novel mutations: 8 frameshifts, 7 missense mutations, and 1 splicing defect. In addition, we detected the previously described mutations: 2302insC, 3404delC, Arg1320ter, Gly944Ser, and His1070Gin. Of the new mutations detected, two, the 1515insT on haplotype I and 2464delC on haplotype XVI, accounted for 6% and 13%, respectively, of the mutations in WD chromosomes in the Sardinian population. Mutations H1070Q, 2302insC, and 2533delA represented 13%, 8%, and 8%, respectively, of the mutations in WD chromosomes in other Mediterranean populations. The remaining mutations were rare and limited to one or two patients from different populations. Thus, WD results from some frequent mutations and many rare defects.	UNIV CAGLIARI,IST MED INTERNA,MED CLIN 1,CAGLIARI,ITALY; UNIV CAGLIARI,IST CLIN & BIOL ETA EVOLUT,I-09100 CAGLIARI,ITALY; OSPED REG MICROCITEMIE,USL 21,CAGLIARI,ITALY; IST GIANNINA GASLINI,DIV MALATTIE INFETT,I-16148 GENOA,ITALY; IST GIANNINA GASLINI,DIV PEDIAT 3,I-16148 GENOA,ITALY; IST GIANNINA GASLINI,MALATTIE INFETT CLIN 2,I-16148 GENOA,ITALY; UNIV PADUA,DIPARTIMENTO PEDIAT,PEDIAT CLIN 1,PADUA,ITALY; OSPED PEDIAT BAMBIN GESU,ROME,ITALY; UNIV SASSARI,IST PATOL MED,I-07100 SASSARI,ITALY; IST DISCIPLINE PEDIAT,TURIN,ITALY; COLUMBIA UNIV COLL PHYS & SURG,NEW YORK STATE PSYCHIAT INST,NEW YORK,NY 10032; TURKISH HLTH & THERAPY FDN,ANKARA,TURKEY; ISHAN DOGRAMARE CHILDRENS HOSP HACETTEPE,ANKARA,TURKEY; ANKARA UNIV,DEPT PEDIAT MOLEC PATHOL,ANKARA,TURKEY; ANKARA UNIV,DEPT GASTROENTEROL,ANKARA,TURKEY; CTR HOSP UNIV TIRANA,SERV MED GENET,TIRANE,ALBANIA; CTR HOSP UNIV TIRANA,DEPT SPECIAL PEDIAT,PEDIAT GASTROENTEROL CLIN,TIRANE,ALBANIA	University of Cagliari; University of Cagliari; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Padua; IRCCS Bambino Gesu; University of Sassari; Columbia University; New York State Psychiatry Institute; Selcuk University; Turkish Health & Therapy Foundation; Hacettepe University; Ankara University; Ankara University			Solinas, Antonio/AAU-9023-2020; Sole, Gabriella/I-4820-2013; Devoto, Marcella/AAP-7595-2021; Akar, Nejat/H-2949-2019; Angius, Andrea/B-8966-2015; Angius, Andrea/P-9549-2015	Sole, Gabriella/0000-0001-5292-5038; Angius, Andrea/0000-0003-2596-6461; Solinas, Antonio/0000-0002-5537-6692; DEVOTO, MARCELLA/0000-0002-4431-5114	Telethon [E.0129] Funding Source: Medline	Telethon(Fondazione Telethon)		BERRY MJ, 1982, ANAL BIOCHEM, V124, P180, DOI 10.1016/0003-2697(82)90235-4; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BOWCOCK AM, 1994, AM J HUM GENET, V54, P79; BREWER G, 1994, ARCH NEUROL-CHICAGO, V51, P545, DOI 10.1001/archneur.1994.00540180023009; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, 1993, GENOMICS, V16, P593, DOI 10.1006/geno.1993.1235; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; Danks DM, 1989, METABOLIC BASIS INHE, V1, P1416; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; GOLDMAN D, 1982, ELECTROPHORESIS, V3, P24, DOI 10.1002/elps.1150030105; HOOGENRAAD TU, 1983, ACTA NEUROL SCAND, V67, P356; KOOY RF, 1993, HUM GENET, V91, P504, DOI 10.1007/BF00217780; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEINBERG IH, 1987, NEW ENGL J MED, V317, P209, DOI 10.1056/NEJM198707233170405; Scheinberg IH, 1984, MAJOR PROBLEMS INTER, VXXIII; SILVER S, 1992, MICROBIOL REV, V56, P195, DOI 10.1128/MMBR.56.1.195-228.1992; STEWART EA, 1993, AM J HUM GENET, V53, P864; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; THOMAS GR, 1993, HUM MOL GENET, V2, P1401, DOI 10.1093/hmg/2.9.1401; THOMAS GR, 1994, AM J HUM GENET, V54, P71; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Walshe JM, 1986, ORPHAN DIS ORPHAN DR, P76	28	137	145	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1318	1324						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533760				2022-12-18	WOS:A1995TE65500008
J	BROWN, S; RUSSO, J; CHITAYAT, D; WARBURTON, D				BROWN, S; RUSSO, J; CHITAYAT, D; WARBURTON, D			THE 13Q(-) SYNDROME - THE MOLECULAR DEFINITION OF A CRITICAL DELETION REGION IN BAND 13Q32	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; HUMAN CHROMOSOME-13; DNA-SEQUENCES; LINKAGE MAP; POLYMORPHISMS; ASSIGNMENT; CHAIN; GENE	Patients with interstitial deletions of the long arm of chromosome 13 may have widely varying phenotypes. From cytogenetic analysis, we have postulated that there is a discrete region in 13q32 where deletion leads to a syndrome of severe malformations, including digital and brain anomalies. To test this hypothesis at the molecular level, we have studied the deletions in 17 patients; 5 had severe malformations, while the remaining 12 had only minor malformations. Our results indicate that the deletions in the severely affected patients all involve an overlapping region in q32, while the deletions in the mildly affected patients include some, but not all, of this overlapping region. Our findings are consistent with the hypothesis that the severely malformed 13q(-) phenotype results from the deletion of a critical region in 13q32. This region is presently defined as lying between D13S136 and D13S147 and is on the order of 1 Mb in size.	COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT PEDIAT,NEW YORK,NY 10032; HOSP SICK CHILDREN,TORONTO,ON M5G 1X8,CANADA	Columbia University; Columbia University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	BROWN, S (corresponding author), COLUMBIA UNIV,DEPT OBSTET & GYNECOL,630 W 168TH ST,NEW YORK,NY 10032, USA.			NOIRI, Eisei/0000-0002-9515-7582	NICHD NIH HHS [HD00916] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000916] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOTTANI A, 1991, HUM GENET, V87, P748; BROWN S, 1993, AM J MED GENET, V45, P52, DOI 10.1002/ajmg.1320450115; CARMICHAEL A, 1977, ARCH DIS CHILD, V52, P972, DOI 10.1136/adc.52.12.972; COWELL JK, 1989, CYTOGENET CELL GENET, V52, P1, DOI 10.1159/000132827; FISCHER SG, 1994, GENOMICS, V21, P525, DOI 10.1006/geno.1994.1311; HENNIES HC, 1993, HUM MOL GENET, V2, P87, DOI 10.1093/hmg/2.1.87; KENNERKNECHT I, 1992, GENOMICS, V14, P550, DOI 10.1016/S0888-7543(05)80269-1; KORENBERG JR, 1994, PHENOTYPIC MAPPING D, P87; NEIBUHR E, 1977, NEW CHROMOSOMAL SYND, P273; NICHOLS WW, 1979, HUM GENET, V52, P169; PETRUKHIN KE, 1993, GENOMICS, V15, P76, DOI 10.1006/geno.1993.1012; SAMEC S, 1994, HUM MOL GENET, V3, P214, DOI 10.1093/hmg/3.1.214-a; SCHINZEL A, 1994, PHENOTYPIC MAPPING D, P19; SLATER H, 1994, J MED GENET, V31, P644, DOI 10.1136/jmg.31.8.644; STALLARD R, 1993, AM J HUM GENET, V53, P256; TAKAHASHI E, 1992, JPN J CANCER RES, V83, P1117, DOI 10.1111/j.1349-7006.1992.tb02731.x; TRANEBJAERG L, 1988, AM J MED GENET, V29, P739, DOI 10.1002/ajmg.1320290403; TRASK BJ, 1991, AM J HUM GENET, V48, P1; Washington S S, 1995, Cytogenet Cell Genet, V70, P1; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Wilroy R S Jr, 1976, Birth Defects Orig Artic Ser, V12, P161	22	137	143	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					859	866						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573047				2022-12-18	WOS:A1995RV79300017
J	KORENBERG, JR; BRADLEY, C; DISTECHE, CM				KORENBERG, JR; BRADLEY, C; DISTECHE, CM			DOWN-SYNDROME - MOLECULAR MAPPING OF THE CONGENITAL HEART-DISEASE AND DUODENAL STENOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN CHROMOSOME-21; ALZHEIMER-DISEASE; DOWNS-SYNDROME; MESSENGER-RNA; REGION; GENE; LOCUS; MAPS; MARKERS	Down syndrome (DS) is a major cause of congenital heart and gut disease and mental retardation. DS individuals also have characteristic facies, hands, and dermatoglyphics, in addition to abnormalities of the immune system, an increased risk of leukemia, and an Alzheimer-like dementia. Although their molecular basis is unknown, recent work on patients with DS and partial duplications of chromosome 21 has suggested small chromosomal regions located in band q22 that are likely to contain the genes for some of these features. We now extend these analyses to define molecular markers for the congenital heart disease, the duodenal stenosis, and an "overlap" region for the facial and some of the skeletal features. We report the clinical, cytogenetic, and molecular analysis of two patients. The first is DUP21JS, who carries both a partial duplication of chromosome 21, including the region 21q21.1-q22.13, or proximal q22.2, and DS features including duodenal stenosis. Using quantitative Southern blot dosage analysis and 15 DNA sequences unique to chromosome 21, we have defined the molecular extent of the duplication. This includes the region defined by DNA sequences for APP (amyloid precursor protein), SOD1 (CuZn superoxide dismutase), D21S47, SF57, D21S17, D21S55, D21S3, and D21S15 and excludes the regions defined by DNA sequences for D21S16, D21S46, D21S1, D21S19, BCE I (breast cancer estrogen-inducible gene), D21S39, and D21S44. Using similar techniques, we have also defined the region duplicated in the second case occurring in a family carrying a translocation associated with DS and congenital heart disease. This region includes DNA sequences for D21S55 and D21S3 and excludes DNA sequences for D21S47 and D21S17. The DS molecular-overlap region is defined by the three DNA sequences duplicated in both patients and includes D21S55, D21S3, and D21S15. These studies provide the molecular basis for the construction of a DS phenotypic map and focus the search for genes responsible for the physical features, congenital heart disease, and duodenal stenosis of DS.	UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,AHMANSON DEPT PEDIAT,LOS ANGELES,CA 90048; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle	KORENBERG, JR (corresponding author), UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,DEPT MED GENET,CTR MED GENET BIRTH DEFECTS,SSB-3,LOS ANGELES,CA 90048, USA.							CHENG SV, 1988, P NATL ACAD SCI USA, V85, P6032, DOI 10.1073/pnas.85.16.6032; Epstein C.J, 1986, CONSEQUENCES CHROMOS; FERENCZ C, 1989, J PEDIATR-US, V114, P79, DOI 10.1016/S0022-3476(89)80605-5; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; KORENBERG JR, 1987, AM J HUM GENET, V41, P963; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KORENBERG JR, 1989, GENOMICS, V5, P124, DOI 10.1016/0888-7543(89)90095-5; LYNN HB, 1969, PEDIAT SURG, P800; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MIYABARA S, 1982, TERATOLOGY, V25, P369, DOI 10.1002/tera.1420250314; MIYAZAKI K, 1987, CLIN GENET, V32, P383; MOISAN JP, 1985, CYTOGENET CELL GENET, V40, P701; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NIEBUHR E, 1974, HUMANGENETIK, V21, P99, DOI 10.1007/BF00278575; OWEN MJ, 1990, AM J HUM GENET, V46, P316; PARK JP, 1987, CLIN GENET, V32, P342; POISSONNIER M, 1976, ANN GENET-PARIS, V19, P69; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; REEVES RH, 1989, GENOMICS, V5, P522, DOI 10.1016/0888-7543(89)90018-9; SHERMAN L, 1983, P NATL ACAD SCI-BIOL, V80, P5465, DOI 10.1073/pnas.80.18.5465; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P7168, DOI 10.1093/nar/13.19.7168; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; WATKINS P, 1985, CYTOGENET CELL GENET, V40, P701; WATKINS PC, 1985, NUCLEIC ACIDS RES, V13, P6075, DOI 10.1093/nar/13.17.6075; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	26	137	141	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					294	302						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1531166				2022-12-18	WOS:A1992HD00100006
J	FEENER, CA; BOYCE, FM; KUNKEL, LM				FEENER, CA; BOYCE, FM; KUNKEL, LM			RAPID DETECTION OF CA POLYMORPHISMS IN CLONED DNA - APPLICATION TO THE 5' REGION OF THE DYSTROPHIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; DMD GENE; CDNA; MARKERS; AMPLIFICATION; ORGANIZATION; DELETIONS; SEQUENCE; REPEAT	To identify CA repeats in genomic sequences which had been previously subcloned into plasmids, we performed PCR using a (CA)n primer and a flanking vector primer on the genomic inserts. By incorporation of a restriction enzyme site into the (CA)n primer, we have been able to subclone the genomic DNA so that the sequence flanking the CA repeat is readily determined. Primers can then be designed to amplify across the CA repeat in patient DNA samples. Application of this technique to genomic DNAs surrounding the upstream "brain" promoter of the dystrophin gene has led to the discovery of four new CA repeats. Three of these repeats are highly polymorphic, with PICs ranging from .586 to .768. The location of these markers at the extreme 5' terminus of the dystrophin gene, together with their high degree of polymorphism and ease of assay, makes them ideal for linkage analysis in families with Duchenne muscular dystrophy.	CHILDRENS HOSP MED CTR,HOWARD HUGHES MED INST,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute								ABBS S, 1990, GENOMICS, V7, P602, DOI 10.1016/0888-7543(90)90205-9; BAKKER E, 1985, LANCET, V1, P655; BEGGS AH, 1990, HUM GENET, V86, P45; BEGGS AH, 1990, NUCLEIC ACIDS RES, V18, P1931, DOI 10.1093/nar/18.7.1931; BOYCE FM, IN PRESS P NATL ACAD; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; DARRAS BT, 1988, AM J HUM GENET, V43, P612; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; FORREST S M, 1988, Genomics, V2, P109, DOI 10.1016/0888-7543(88)90091-2; HAMADA H, 1984, MOL CELL BIOL, V4, P2610, DOI 10.1128/MCB.4.12.2610; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LITT M, 1989, AM J HUM GENET, V44, P397; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; OUDET C, 1990, HUM GENET, V84, P283; ROBERTS RG, 1989, NUCLEIC ACIDS RES, V17, P5961, DOI 10.1093/nar/17.15.5961; SMEETS HJM, 1989, HUM GENET, V83, P245, DOI 10.1007/BF00285165; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388	24	137	145	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					621	627						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998344				2022-12-18	WOS:A1991FK47000023
J	SCHILDKRAUT, JM; RISCH, N; THOMPSON, WD				SCHILDKRAUT, JM; RISCH, N; THOMPSON, WD			EVALUATING GENETIC ASSOCIATION AMONG OVARIAN, BREAST, AND ENDOMETRIAL CANCER - EVIDENCE FOR A BREAST OVARIAN-CANCER RELATIONSHIP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University; Yale University	SCHILDKRAUT, JM (corresponding author), UNIV N CAROLINA,SCH PUBL HLTH,DEPT EPIDEMIOL,CB 7400,ROSNEAU HALL,CHAPEL HILL,NC 27599, USA.				NCI NIH HHS [CA09279] Funding Source: Medline; NICHD NIH HHS [3-Y01-HD-8-1037] Funding Source: Medline; PHS HHS [200-80-0561] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081037] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009279] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON DE, 1977, CANCER-AM CANCER SOC, V40, P1855, DOI 10.1002/1097-0142(197710)40:4+<1855::AID-CNCR2820400814>3.0.CO;2-1; BAILEYWILSON JE, 1986, GENET EPIDEMIOL, V3, P27, DOI 10.1002/gepi.1370030104; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; COX DR, 1972, J R STAT SOC B, V105, P488; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711; GO RCP, 1983, J NATL CANCER I, V71, P455; HILDRETH NG, 1981, AM J EPIDEMIOL, V114, P398, DOI 10.1093/oxfordjournals.aje.a113207; KAPLAN EB, 1972, I STATISTICS MIMEOGR, V823; KELSEY JL, 1982, AM J EPIDEMIOL, V116, P333, DOI 10.1093/oxfordjournals.aje.a113417; LYNCH HT, 1982, OBSTET GYNECOL, V59, P589; MURPHREE AL, 1984, SCIENCE, V223, P1028, DOI 10.1126/science.6320372; NEWELL GR, 1977, CANCER, V40, P1812, DOI 10.1002/1097-0142(197710)40:4+<1812::AID-CNCR2820400807>3.0.CO;2-6; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P1; PRIOR P, 1981, BRIT J CANCER, V44, P628, DOI 10.1038/bjc.1981.247; REIMER RR, 1978, J NATL CANCER I, V61, P1195, DOI 10.1093/jnci/61.5.1195; RISCH N, 1983, BIOMETRICS, V39, P929, DOI 10.2307/2531328; RISCH N, 1986, UNPUB; Salmi T, 1979, Acta Obstet Gynecol Scand Suppl, V86, P1; SCHILDKRAUT JM, 1988, GENET EPIDEMIOL, V5, P355, DOI 10.1002/gepi.1370050506; SCHILDKRAUT JM, 1988, AM J EPIDEMIOL, V128, P456, DOI 10.1093/oxfordjournals.aje.a114994; SCHOENBERG BS, 1977, MULTIPLE PRIMARY MAL; SCHWARTZ AG, 1985, JNCI-J NATL CANCER I, V75, P665; SHOTTENFELD D, 1971, JNCI-J NATL CANCER I, V46, P161; SMITH C, 1976, ANN HUM GENET, V39, P281, DOI 10.1111/j.1469-1809.1976.tb00132.x; STRONG LC, 1977, CANCER, V40, P1861, DOI 10.1002/1097-0142(197710)40:4+<1861::AID-CNCR2820400815>3.0.CO;2-9; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104; WINGO PA, 1988, AM J EPIDEMIOL, V128, P206, DOI 10.1093/oxfordjournals.aje.a114942; YOUNG JL, 1981, NIH812330 DEP HLTH H	29	137	138	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					521	529						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2491011				2022-12-18	WOS:A1989AW39500005
J	BREWER, GJ				BREWER, GJ			ACHROMATIC REGIONS OF TETRAZOLIUM STAINED STARCH GELS - INHERITED ELECTROPHORETIC VARIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOYER PD, 1963, ENZYMES           ED, P97; BOYER PD, 1963, ENZYMES           ED, P41; BREWER GJ, 1967, ACTA GENET STAT MED, V17, P97; DERN RJ, 1966, J LAB CLIN MED, V67, P255; EATON EM, 1966, NATURE, V212, P944, DOI 10.1038/212944b0; PALEUS S, 1963, ENZYMES, P97; SHOWS TB, 1964, SCIENCE, V145, P1056, DOI 10.1126/science.145.3636.1056; SPENCER N, 1964, NATURE, V204, P742, DOI 10.1038/204742a0; YONETANI T, 1963, ENZYMES, P41	9	137	137	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	5					674	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	99950	4292999				2022-12-18	WOS:A19679995000006
J	Twigg, SRF; Wilkie, AOM				Twigg, Stephen R. F.; Wilkie, Andrew O. M.			A Genetic-Pathophysiological Framework for Craniosynostosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GROWTH-FACTOR RECEPTOR-3; CREST-MESODERM BOUNDARY; OF-FUNCTION MUTATION; DYSPLASIA TYPE-I; CYTOCHROME-P450 OXIDOREDUCTASE; CROUZON-SYNDROME; APERT-SYNDROME; MOUSE MODEL; SIGNALING PATHWAYS; FGFR2 MUTATIONS	Craniosynostosis; the premature fusion of one or more cranial sutures of the skull, provides a paradigm for investigating the interplay of genetic and environmental factors leading to malformation. Over the past 20 years molecular genetic techniques have provided a new approach to dissect the underlying causes; success has mostly come from investigation of clinical samples, and recent advances in high-throughput DNA sequencing have dramatically enhanced the study of the human as the preferred "model organism." In parallel, however, we need a pathogenetic classification to describe the pathways and processes that lead to cranial suture fusion. Given the prenatal onset of most craniosynostosis, investigation of mechanisms requires more conventional model organisms; principally the mouse, because of similarities in cranial suture development. We present a framework for classifying genetic causes of craniosynostosis based on current understanding of cranial suture biology and molecular and developmental pathogenesis. Of note, few pathologies result from complete loss of gene function. Instead, biochemical mechanisms involving haploinsufficiency, dominant gain-of-function and recessive hypomorphic mutations, and an unusual X-linked cellular interference process have all been implicated. Although few of the genes involved could have been predicted based on expression patterns alone (because the genes play much wider roles in embryonic development or cellular homeostasis), we argue that they fit into a limited number of functional modules active at different stages of cranial suture development. This provides a useful approach both when defining the potential role of new candidate genes in craniosynostosis and, potentially, for devising pharmacological approaches to therapy.	[Twigg, Stephen R. F.; Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Wilkie, Andrew O. M.] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Dept Plast & Reconstruct Surg, Craniofacial Unit, Oxford OX3 9DU, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	andrew.wilkie@imm.ox.ac.uk	Twigg, Stephen/AAU-1135-2021; Wilkie, Andrew/AAC-3820-2020	Twigg, Stephen/0000-0001-5024-049X; Wilkie, Andrew/0000-0002-2972-5481	Wellcome Trust [102731]; NIHR Oxford Biomedical Research Centre; NIH	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Aimee Fenwick, Anne Goriely, Deborah Lloyd, and anonymous referees for helpful comments on the manuscript, Simeon Boyd and Wanda Lattanzi for suggesting genes to include in Table 51, and Ryan McAllister (http://www.handjazz.com) for artwork. We are grateful to Steven Wall and David Johnson, lead surgeons at the Oxford Craniofacial Unit, for facilitating genetic research in their patients, and to the Wellcome Trust for sustained funding over a period of more than 20 years, which has made this work possible. The laboratory is currently supported by the Wellcome Trust (Senior Investigator Award to A.O.M.W., ref. 102731), the NIHR Oxford Biomedical Research Centre, and the NIH.	Babbs C, 2011, HUM MUTAT, V32, P930, DOI 10.1002/humu.21521; Badve CA, 2013, PEDIATR RADIOL, V43, P728, DOI 10.1007/s00247-013-2673-6; Behr B, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00037; Behr B, 2010, DEV BIOL, V344, P922, DOI 10.1016/j.ydbio.2010.06.009; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Boulet SL, 2008, AM J MED GENET A, V146A, P984, DOI 10.1002/ajmg.a.32208; Carver EA, 2002, ANAT REC, V268, P90, DOI 10.1002/ar.10124; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Cohen MM, 1996, AM J MED GENET, V62, P339, DOI 10.1002/(SICI)1096-8628(19960424)62:4<339::AID-AJMG3>3.0.CO;2-M; Cohen MM, 2000, CRANIOSYNOSTOSIS DIA, V2nd; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Connolly JP, 2004, PLAST RECONSTR SURG, V113, P1313, DOI 10.1097/01.PRS.0000111593.96440.30; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Deckelbaum RA, 2012, DEVELOPMENT, V139, P1346, DOI 10.1242/dev.076729; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Eggenschwiler JT, 2006, DEV BIOL, V290, P1, DOI 10.1016/j.ydbio.2005.09.022; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; ElGhouzzi V, 1997, NAT GENET, V15, P42; Eswarakumar VP, 2006, P NATL ACAD SCI USA, V103, P18603, DOI 10.1073/pnas.0609157103; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Forrest CR, 2013, PLAST RECONSTR SURG, V131, p86E, DOI 10.1097/PRS.0b013e318272c12b; Fukami M, 2010, MOL GENET METAB, V100, P269, DOI 10.1016/j.ymgme.2010.03.023; Fukami M, 2009, J CLIN ENDOCR METAB, V94, P1723, DOI 10.1210/jc.2008-2816; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Gong SG, 2012, CHILD NERV SYST, V28, P1495, DOI 10.1007/s00381-012-1792-y; Goodnough LH, 2012, DEVELOPMENT, V139, P4428, DOI 10.1242/dev.081679; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Hajihosseini MK, 2002, MECH DEVELOP, V113, P79, DOI 10.1016/S0925-4773(01)00656-6; Hajihosseini MK, 2001, P NATL ACAD SCI USA, V98, P3855, DOI 10.1073/pnas.071586898; Hajihosseini MK, 2009, DEV DYNAM, V238, P376, DOI 10.1002/dvdy.21648; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hatch NE, 2006, J BIOL CHEM, V281, P27292, DOI 10.1074/jbc.M600448200; Herring Susan W., 2008, V12, P41, DOI 10.1159/000115031; Hoefkens MF, 2004, J CRANIOFAC SURG, V15, P233, DOI 10.1097/00001665-200403000-00013; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Holmes G, 2012, CHILD NERV SYST, V28, P1471, DOI 10.1007/s00381-012-1844-3; Holmes G, 2012, DEV BIOL, V368, P283, DOI 10.1016/j.ydbio.2012.05.026; Holmes G, 2009, DEV BIOL, V328, P273, DOI 10.1016/j.ydbio.2009.01.026; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Iseki S, 1999, DEVELOPMENT, V126, P5611; Iseki S, 1997, DEVELOPMENT, V124, P3375; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Jacob S, 2007, ANN PLAS SURG, V58, P215, DOI 10.1097/01.sap.0000232833.41739.a5; Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Jin H, 2009, CURR BIOL, V19, pR472, DOI 10.1016/j.cub.2009.04.015; Johnson D, 2000, MECH DEVELOP, V91, P341, DOI 10.1016/S0925-4773(99)00278-6; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Justice CM, 2012, NAT GENET, V44, P1360, DOI 10.1038/ng.2463; Khonsari RH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2670; Khonsari RH, 2013, HUM MOL GENET, V22, P1873, DOI 10.1093/hmg/ddt041; Khonsari RH, 2012, AM J MED GENET A, V158A, P2797, DOI 10.1002/ajmg.a.35598; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Kirmi O, 2009, SEMIN ULTRASOUND CT, V30, P492, DOI 10.1053/j.sult.2009.08.002; Klopocki E, 2011, AM J HUM GENET, V88, P70, DOI 10.1016/j.ajhg.2010.11.006; Krone N, 2012, J CLIN ENDOCR METAB, V97, pE257, DOI 10.1210/jc.2011-0640; Kuo JS, 1998, DEVELOPMENT, V125, P2867; Lajeunie E, 2006, EUR J HUM GENET, V14, P289, DOI 10.1038/sj.ejhg.5201558; Lajeunie E, 2005, J NEUROSURG, V103, P353, DOI 10.3171/ped.2005.103.4.0353; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; Lajeunie E, 2001, J NEUROSURG, V95, P778, DOI 10.3171/jns.2001.95.5.0778; LAJEUNIE E, 1995, AM J MED GENET, V55, P500, DOI 10.1002/ajmg.1320550422; Lana-Elola E, 2007, DEV BIOL, V311, P335, DOI 10.1016/j.ydbio.2007.08.028; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Lenton K, 2011, GENESIS, V49, P784, DOI 10.1002/dvg.20768; Levi B, 2012, J CRANIOFAC SURG, V23, P13, DOI 10.1097/SCS.0b013e318240c6c0; Lievens PMJ, 2004, J BIOL CHEM, V279, P43254, DOI 10.1074/jbc.M405247200; Liu B, 2014, REPROD TOXICOL, V48, P88, DOI 10.1016/j.reprotox.2014.05.009; Liu B, 2014, J DENT RES, V93, P475, DOI 10.1177/0022034514528211; Liu J, 2013, CALCIFIED TISSUE INT, V92, P451, DOI 10.1007/s00223-013-9701-2; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Lomri A, 1998, J CLIN INVEST, V101, P1310; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Mansour SL, 2013, GENE DEV, V27, P2320, DOI 10.1101/gad.228957.113; Marucci DD, 2008, PLAST RECONSTR SURG, V122, P217, DOI 10.1097/PRS.0b013e3181774240; Mathieu PS, 2014, J BIOMECH, V47, P2211, DOI 10.1016/j.jbiomech.2014.04.004; Mathijssen IMJ, 1999, J CRAN GENET DEV BIO, V19, P57; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Melville H, 2010, AM J MED GENET A, V152A, P3007, DOI 10.1002/ajmg.a.33703; Merrill AE, 2006, HUM MOL GENET, V15, P1319, DOI 10.1093/hmg/ddl052; Merrill AE, 2012, AM J HUM GENET, V90, P550, DOI 10.1016/j.ajhg.2012.02.005; Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Minegishi Y, 2007, CURR OPIN ALLERGY CL, V7, P506, DOI 10.1097/ACI.0b013e3282f1baea; Mishina Y, 2014, EXP CELL RES, V325, P138, DOI 10.1016/j.yexcr.2014.01.019; Miura T, 2009, J ANAT, V215, P642, DOI 10.1111/j.1469-7580.2009.01148.x; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Neben CL, 2014, HUM MOL GENET, V23, P5659, DOI 10.1093/hmg/ddu282; Nieman BJ, 2012, PHYSIOL GENOMICS, V44, P992, DOI 10.1152/physiolgenomics.00093.2012; Nieminen P, 2011, AM J HUM GENET, V89, P67, DOI 10.1016/j.ajhg.2011.05.024; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Pandey AV, 2013, PHARMACOL THERAPEUT, V138, P229, DOI 10.1016/j.pharmthera.2013.01.010; Passos-Bueno MR, 2011, MONOGR HUM GENET, V19, P152; Placone J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046678; Plaisancie J., 2014, OPHTHALMIC GENET; Przylepa KA, 1996, NAT GENET, V13, P492, DOI 10.1038/ng0896-492; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Ribes V, 2007, DEV BIOL, V303, P66, DOI 10.1016/j.ydbio.2006.10.032; Rice David P., 2008, V12, P1, DOI 10.1159/000115028; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; Sanchez-Lara PA, 2010, AM J MED GENET A, V152A, P394, DOI 10.1002/ajmg.a.33246; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; Schmidt K, 2009, MOL CELL BIOL, V29, P2716, DOI 10.1128/MCB.01638-08; Sharma VP, 2013, NAT GENET, V45, P304, DOI 10.1038/ng.2531; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Tabler JM, 2013, DEV CELL, V25, P623, DOI 10.1016/j.devcel.2013.05.021; Takenouchi T, 2014, AM J MED GENET A, V164, P2869, DOI 10.1002/ajmg.a.36705; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Ting MC, 2009, DEVELOPMENT, V136, P855, DOI 10.1242/dev.028605; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Twigg SRF, 2015, AM J HUM GENET, V97, P378, DOI 10.1016/j.ajhg.2015.07.007; Twigg SRF, 2013, NAT GENET, V45, P308, DOI 10.1038/ng.2539; Twigg SRF, 2012, AM J HUM GENET, V91, P897, DOI 10.1016/j.ajhg.2012.08.027; Twigg SRF, 2009, DEV DYNAM, V238, P331, DOI 10.1002/dvdy.21790; Varvagiannis K, 2013, AM J MED GENET A, V161A, P343, DOI 10.1002/ajmg.a.35727; Vu HL, 2001, J CRANIOFAC SURG, V12, P527, DOI 10.1097/00001665-200111000-00005; Wang YL, 2012, J CLIN INVEST, V122, P2153, DOI 10.1172/JCI62644; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Wieland I, 2004, AM J HUM GENET, V74, P1209, DOI 10.1086/421532; Wilkie AOM, 2007, NAT GENET, V39, P1057, DOI 10.1038/ng0907-1057; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Yen HY, 2010, DEV BIOL, V347, P258, DOI 10.1016/j.ydbio.2010.08.010; Yin L, 2008, BONE, V42, P631, DOI 10.1016/j.bone.2007.11.019; Yokota M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101693; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Yu JC, 2001, J CRANIOFAC SURG, V12, P391, DOI 10.1097/00001665-200107000-00018; Yu K, 2001, P NATL ACAD SCI USA, V98, P3641, DOI 10.1073/pnas.081082498; Zhao H, 2015, NAT CELL BIOL, V17, P386, DOI 10.1038/ncb3139; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	152	136	140	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					359	377		10.1016/j.ajhg.2015.07.006	http://dx.doi.org/10.1016/j.ajhg.2015.07.006			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26340332	Bronze, Green Published			2022-12-18	WOS:000361084700001
J	Oda, H; Nakagawa, K; Abe, J; Awaya, T; Funabiki, M; Hijikata, A; Nishikomori, R; Funatsuka, M; Ohshima, Y; Sugawara, Y; Yasumi, T; Kato, H; Shirai, T; Ohara, O; Fujita, T; Heike, T				Oda, Hirotsugu; Nakagawa, Kenji; Abe, Junya; Awaya, Tomonari; Funabiki, Masahide; Hijikata, Atsushi; Nishikomori, Ryuta; Funatsuka, Makoto; Ohshima, Yusei; Sugawara, Yuji; Yasumi, Takahiro; Kato, Hiroki; Shirai, Tsuyoshi; Ohara, Osamu; Fujita, Takashi; Heike, Toshio			Aicardi-Goutieres Syndrome Is Caused by IFIH1 Mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; EXONUCLEASE TREX1; INTERFERON; MDA5; RECOGNITION; PHENOTYPE; FILAMENT; SPECTRUM	Aicardi-Goutieres syndrome (AGS) is a rare, genetically determined early-onset progressive encephalopathy. To date, mutations in six genes have been identified as etiologic for AGS. Our Japanese nationwide AGS survey identified six AGS-affected individuals without a molecular diagnosis; we performed whole-exome sequencing on three of these individuals. After removal of the common polymorphisms found in SNP databases, we were able to identify IFIH1 heterozygous missense mutations in all three. In vitro functional analysis revealed that IFIH1 mutations increased type I interferon production, and the transcription of interferon-stimulated genes were elevated. IFIH1 encodes MDA5, and mutant MDA5 lacked ligand-specific responsiveness, similarly to the dominant Ifih1 mutation responsible for the SLE mouse model that results in type I interferon overproduction. This study suggests that the IFIH1 mutations are responsible for the AGS phenotype due to an excessive production of type I interferon.	[Oda, Hirotsugu; Nakagawa, Kenji; Abe, Junya; Awaya, Tomonari; Nishikomori, Ryuta; Yasumi, Takahiro; Heike, Toshio] Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto 6068507, Japan; [Oda, Hirotsugu; Ohara, Osamu] RIKEN Ctr Integrat Med Sci, Lab Integrat Genom, Yokohama, Kanagawa 2300045, Japan; [Abe, Junya] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Pediat, Osaka 5308480, Japan; [Funabiki, Masahide; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Lab Mol Genet, Kyoto 6068507, Japan; [Hijikata, Atsushi; Shirai, Tsuyoshi] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama 5260829, Japan; [Funatsuka, Makoto] Tokyo Womens Med Univ, Dept Pediat, Tokyo 1628666, Japan; [Ohshima, Yusei] Univ Fukui, Dept Pediat, Fac Med Sci, Fukui 9108507, Japan; [Sugawara, Yuji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Tokyo 1138510, Japan; [Kato, Hiroki] Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dept Human Genome Res, Kisarazu 2920818, Japan	Kyoto University; RIKEN; Kitano Hospital; Kyoto University; Tokyo Women's Medical University; University of Fukui; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Kazusa DNA Research Institute	Nishikomori, R (corresponding author), Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto 6068507, Japan.	mishiko@kuhp.kyoto-u.ac.jp	Nishikomori, Ryuta/N-4039-2018; Ohara, Osamu/G-5448-2015; Nishikomori, Ryuta/AAM-5771-2020; Awaya, Tomonari/O-2757-2015	Nishikomori, Ryuta/0000-0002-9407-6158; Ohara, Osamu/0000-0002-3328-9571; Nishikomori, Ryuta/0000-0002-9407-6158; Awaya, Tomonari/0000-0002-9004-3172; Ohshima, Yusei/0000-0002-4488-0308; Yasumi, Takahiro/0000-0003-3257-5071; Sugawara, Yuji/0000-0002-2671-7945; Hijikata, Atsushi/0000-0003-4297-8368; Shirai, Tsuyoshi/0000-0002-2506-5738	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japanese Ministry of Health, Labor and Welfare; Japanese Ministry of Education, Culture, Sports, Science, Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science, Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are very grateful to Y. Takaoka (Kyoto University) and E. Abe (RIKEN Center for Integrative Medical Sciences) for their technical assistance on Sanger sequencing, to E. Hirano (Kyoto University) for her technical assistance on functional analyses of the AGS mutants, to M. Takazawa (Kazusa DNA Research Institute) for his contribution to exome data analysis, and to T. Taylor for his critical reading of the manuscript. This work was supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was supported by Grants-in-aid for Scientific Research from the Japanese Ministry of Health, Labor and Welfare and the Japanese Ministry of Education, Culture, Sports, Science, Technology (MEXT).	Abe J, 2014, RHEUMATOLOGY, V53, P448, DOI 10.1093/rheumatology/ket372; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Blau N, 2003, NEUROLOGY, V61, P642, DOI 10.1212/01.WNL.0000082726.08631.E7; Chahwan C, 2012, CLIN GENET, V81, P413, DOI 10.1111/j.1399-0004.2011.01825.x; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Orcesi S, 2009, BRIT MED BULL, V89, P183, DOI 10.1093/bmb/ldn049; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	23	136	141	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2014	95	1					121	125		10.1016/j.ajhg.2014.06.007	http://dx.doi.org/10.1016/j.ajhg.2014.06.007			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AL1RP	24995871	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000338904100011
J	Pierce, SB; Gersak, K; Michaelson-Cohen, R; Walsh, T; Lee, MK; Malach, D; Klevit, RE; King, MC; Levy-Lahad, E				Pierce, Sarah B.; Gersak, Ksenija; Michaelson-Cohen, Rachel; Walsh, Tom; Lee, Ming K.; Malach, Daniel; Klevit, Rachel E.; King, Mary-Claire; Levy-Lahad, Ephrat			Mutations in LARS2, Encoding Mitochondrial Leucyl-tRNA Synthetase, Lead to Premature Ovarian Failure and Hearing Loss in Perrault Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYSGENESIS; PROTEIN; GENE; INVOLVEMENT; BINDING	The genetic causes of premature ovarian failure (POP) are highly heterogeneous, and causative mutations have been identified in more than ten genes so far. In two families affected by POP accompanied by hearing loss (together, these symptoms compose Perrault syndrome), exome sequencing revealed mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase: homozygous c.1565C>A (p.Thr522Asn) in a consanguineous Palestinian family and compound heterozygous c.1077delT and c.1886C>T (p.Thr629Met) in a nonconsanguineous Slovenian family. LARS2 c.1077delT leads to a frameshift at codon 360 of the 901 residue protein. LARS2 p.Thr522Asn occurs in the LARS2 catalytic domain at a site conserved from bacteria through mammals. LARS2 p.Thr629Met occurs in the LARS2 leucine-specific domain, which is adjacent to a catalytic loop critical in all species but for which primary sequence is not well conserved. A recently developed method of detecting remote homologies revealed threonine at this site in consensus sequences derived from multiple-species alignments seeded by human and E. coli residues at this region. Yeast complementation indicated that LARS2 c.1077delT is nonfunctional and that LARS2 p.Thr522Asn is partially functional. LARS2 p.Thr629Met was functional in this assay but might be insufficient as a heterozygote with the fully nonfunctional LARS2 c.1077delT allele. A known C. elegans strain with the protein-truncating alteration LARS-2 p.Trp247Ter was confirmed to be sterile. After HARS2, LARS2 is the second gene encoding mitochondrial tRNA synthetase to be found to harbor mutations leading to Perrault syndrome, further supporting a critical role for mitochondria in the maintenance of ovarian function and hearing.	[Pierce, Sarah B.; Walsh, Tom; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Pierce, Sarah B.; Walsh, Tom; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Gersak, Ksenija] Univ Med Ctr, Inst Med Genet, Ljubljana 1000, Slovenia; [Michaelson-Cohen, Rachel; Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel; [Malach, Daniel] Clalit Hlth Serv, Womens Hlth Ctr, IL-91999 Jerusalem, Israel; [Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University Medical Centre Ljubljana; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Clalit Health Services; University of Washington; University of Washington Seattle	Pierce, SB (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	sbpierce@uw.edu	Klevit, Rachel/AAI-7038-2021; Levy-Lahad, Ephrat/F-2186-2018	Klevit, Rachel/0000-0002-3476-969X; Levy-Lahad, Ephrat/0000-0002-2637-1921; Pierce, Sarah/0000-0001-6739-7135; Walsh, Tom/0000-0002-8875-0310; King, Mary-Claire/0000-0001-9426-1743	National Institutes of Health National Institute on Deafness and Other Communication Disorders [R01DC005641]; US Agency for International Development program for Middle East Research Cooperation [TA-MOU-10-M30-021]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005641] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); US Agency for International Development program for Middle East Research Cooperation(United States Agency for International Development (USAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to Sergey Ovchinnikov for advice on the analysis of protein homology, to Stephen Cusack (European Molecular Biology Laboratory, University of Grenoble, Centre National de la Recherche Scientifique) for providing structural coordinates prior to publication, to Karen Avraham and Zippora Brownstein for technical advice, and to Anne Thornton for technical assistance. This work was supported by National Institutes of Health National Institute on Deafness and Other Communication Disorders grant R01DC005641 (to M.C.K.) and a grant from the US Agency for International Development program for Middle East Research Cooperation (TA-MOU-10-M30-021 to E.L.L.).	AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Angermuller C, 2012, BIOINFORMATICS, V28, P3240, DOI 10.1093/bioinformatics/bts622; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Boumela I, 2011, REPRODUCTION, V141, P549, DOI 10.1530/REP-10-0504; Bullard JM, 2000, BBA-GENE STRUCT EXPR, V1490, P245, DOI 10.1016/S0167-4781(99)00240-7; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294; Harris SE, 2002, MOL HUM REPROD, V8, P729, DOI 10.1093/molehr/8.8.729; HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x; Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013; JONES BA, 1992, GENE DEV, V6, P380, DOI 10.1101/gad.6.3.380; Lacombe A, 2006, AM J HUM GENET, V79, P113, DOI 10.1086/505406; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/nmeth.1818, 10.1038/NMETH.1818]; Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836; Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Zangen D, 2011, AM J HUM GENET, V89, P572, DOI 10.1016/j.ajhg.2011.09.006; Zhao H, 2008, AM J HUM GENET, V82, P1342, DOI 10.1016/j.ajhg.2008.04.018	31	136	152	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					614	620		10.1016/j.ajhg.2013.03.007	http://dx.doi.org/10.1016/j.ajhg.2013.03.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23541342	Green Published, Bronze			2022-12-18	WOS:000317449700014
J	Simpson, MA; Hsu, R; Keir, LS; Hao, J; Sivapalan, G; Ernst, LM; Zackai, EH; Al-Gazali, LI; Hulskamp, G; Kingston, HM; Prescott, TE; Ion, A; Patton, MA; Murday, V; George, A; Crosby, AH				Simpson, M. A.; Hsu, R.; Keir, L. S.; Hao, J.; Sivapalan, G.; Ernst, L. M.; Zackai, E. H.; Al-Gazali, L. I.; Hulskamp, G.; Kingston, H. M.; Prescott, T. E.; Ion, A.; Patton, M. A.; Murday, V.; George, A.; Crosby, A. H.			Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOPLASTIC NOSE; DELINEATION; FAMILY	The generation and homeostasis of bone tissue throughout development and maturity is controlled by the carefully balanced processes of bone formation and resorption. Disruption of this balance can give rise to a broad range of skeletal pathologies. Lethal osteosclerotic bone dysplasia (or, Raine syndrome) is an autosomal recessive disorder characterized by generalized osteosclerosis with periosteal bone formation and a distinctive facial phenotype. Affected individuals survive only days or weeks. We have identified and defined a chromosome 7 uniparental isodisomy and a 7p telomeric microdeletion in an affected subject. The extent of the deleted region at the 7p telomere was established by genotyping microsatellite markers across the telomeric region. The region is delimited by marker D7S2563 and contains five transcriptional units. Sequence analysis of FAM20C, located within the deleted region, in six additional affected subjects revealed four homozygous mutations and two compound heterozygotes. The identified mutations include four nonsynonymous base changes, all affecting evolutionarily conserved residues, and four splice-site changes that are predicted to have a detrimental effect on splicing. FAM20C is a member of the FAM20 family of secreted proteins, and its mouse orthologue (DMP4) has demonstrated calcium-binding properties; we also show by in situ hybridization its expression profile in mineralizing tissues during development. This study defines the causative role of FAM20C in this lethal osteosclerotic disorder and its crucial role in normal bone development.	St Georges Univ London, Dept Med Genet, London SW17 0RE, England; Univ Illinois, Dept Oral Biol, Chicago, IL USA; Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; Univ Munster, Klin & Poliklin Kinderheilkunde, D-4400 Munster, Germany; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Univ Oslo, Rikshosp, Univ Hosp, Dept Med Genet, N-0027 Oslo, Norway; Royal Hosp Sick Children, Dept Clin Genet, Glasgow G3 8SJ, Lanark, Scotland	St Georges University London; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; United Arab Emirates University; University of Munster; University of Manchester; University of Oslo; National Hospital Norway; University of Glasgow	Crosby, AH (corresponding author), St Georges Univ London, Dept Med Genet, Cranmer Terrace, London SW17 0RE, England.	acrosby@sgul.ac.uk	Crosby, Andrew H/E-2218-2015; Simpson, Michael/F-4737-2011	Crosby, Andrew H/0000-0003-3667-9054; Simpson, Michael/0000-0002-8539-8753; Ernst, Linda/0000-0003-0104-5107; GEORGE, ANNE/0000-0002-9008-7642; Hsu, Ray/0000-0002-0959-1666				Acosta AX, 2000, CLIN DYSMORPHOL, V9, P99, DOI 10.1097/00019605-200009020-00004; Al-Gazali LI, 2003, CLIN DYSMORPHOL, V12, P89, DOI 10.1097/00019605-200304000-00003; AlMane K, 1996, PEDIATR RADIOL, V26, P55, DOI 10.1007/BF01403707; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Hao JJ, 2007, J BIOL CHEM, V282, P15357, DOI 10.1074/jbc.M701547200; Hulskamp G, 2003, CLIN DYSMORPHOL, V12, P153, DOI 10.1097/01.mcd.0000080413.95344.60; KAN AE, 1992, AM J MED GENET, V43, P860, DOI 10.1002/ajmg.1320430522; KINGSTON HM, 1991, SKELETAL RADIOL, V20, P117; Mahafza T, 2001, CLIN DYSMORPHOL, V10, P227, DOI 10.1097/00019605-200107000-00015; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; Nalla VK, 2005, HUM MUTAT, V25, P334, DOI 10.1002/humu.20151; PATEL PJ, 1992, EUR J PEDIATR, V151, P827, DOI 10.1007/BF01957934; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Rejjal A, 1998, AM J MED GENET, V78, P382, DOI 10.1002/(SICI)1096-8628(19980724)78:4<382::AID-AJMG17>3.0.CO;2-E; Shalev SA, 1999, AM J MED GENET, V86, P274, DOI 10.1002/(SICI)1096-8628(19990917)86:3<274::AID-AJMG15>3.0.CO;2-R; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483	16	136	138	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					906	912		10.1086/522240	http://dx.doi.org/10.1086/522240			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924334	Green Published, Bronze			2022-12-18	WOS:000250480900004
J	Feuk, L; Kalervo, A; Lipsanen-Nyman, M; Skaug, J; Nakabayashi, K; Finucane, B; Hartung, D; Innes, M; Kerem, B; Nowaczyk, MJ; Rivlin, J; Roberts, W; Senman, L; Summers, A; Szatmari, P; Wong, V; Vincent, JB; Zeesman, S; Osborne, LR; Cardy, JO; Kere, J; Scherer, SW; Hannula-Jouppi, K				Feuk, Lars; Kalervo, Aino; Lipsanen-Nyman, Marita; Skaug, Jennifer; Nakabayashi, Kazuhiko; Finucane, Brenda; Hartung, Danielle; Innes, Micheil; Kerem, Batsheva; Nowaczyk, Malgorzata J.; Rivlin, Joseph; Roberts, Wendy; Senman, Lili; Summers, Anne; Szatmari, Peter; Wong, Virginia; Vincent, John B.; Zeesman, Susan; Osborne, Lucy R.; Cardy, Janis Oram; Kere, Juha; Scherer, Stephen W.; Hannula-Jouppi, Katariina			Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL UNIPARENTAL DISOMY; SILVER-RUSSELL-SYNDROME; LANGUAGE IMPAIRMENT; SEVERE SPEECH; CHROMOSOME-7; AUTISM; GROWTH; ISODISOMY; DELETION; ORIGIN	Mutations in FOXP2 cause developmental verbal dyspraxia (DVD), but only a few cases have been described. We characterize 13 patients with DVD-5 with hemizygous paternal deletions spanning the FOXP2 gene, 1 with a translocation interrupting FOXP2, and the remaining 7 with maternal uniparental disomy of chromosome 7 (UPD7), who were also given a diagnosis of Silver-Russell Syndrome (SRS). Of these individuals with DVD, all 12 for whom parental DNA was available showed absence of a paternal copy of FOXP2. Five other individuals with deletions of paternally inherited FOXP2 but with incomplete clinical information or phenotypes too complex to properly assess are also described. Four of the patients with DVD also meet criteria for autism spectrum disorder. Individuals with paternal UPD7 or with partial maternal UPD7 or deletion starting downstream of FOXP2 do not have DVD. Using quantitative real-time polymerase chain reaction, we show the maternally inherited FOXP2 to be comparatively underexpressed. Our results indicate that absence of paternal FOXP2 is the cause of DVD in patients with SRS with maternal UPD7. The data also point to a role for differential parent-of-origin expression of FOXP2 in human speech development.	Hosp Sick Children, Ctr Appl Genom, Dept Genet, N York Gen Hosp, Toronto, ON M5G 1L7, Canada; Hosp Sick Children, Program Genet & Genom Biol, Dept Genet, N York Gen Hosp, Toronto, ON M5G 1L7, Canada; Hosp Sick Children, Child Dev Ctr, Dept Genet, N York Gen Hosp, Toronto, ON M5G 1L7, Canada; Univ Toronto, Ctr Addict & Mental Hlth, Clarke Inst, Toronto, ON, Canada; Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Helsinki, Dept Med Genet, Biomedicum, Helsinki, Finland; Hosp Children & Adolescents, Helsinki, Finland; Elwyn Inc, Genet Serv, Elwyn, PA USA; Childrens Mem Hosp, Chicago, IL 60614 USA; Alberta Childrens Prov Gen Hosp, Dept Med Genet, Calgary, AB, Canada; Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; McMaster Univ, Dept Pediat, Hamilton, ON, Canada; McMaster Univ, Dept Psychiat & Behave Neurosci, Hamilton, ON, Canada; Carmel Hosp, Cyst Fibrosis Ctr, Haifa, Israel; Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; Univ Western Ontario, Sch Commun Sci & Disorders, London, ON, Canada; Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; Karolinska Inst, Clin Res Ctr, Stockholm, Sweden	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); North York General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); North York General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); North York General Hospital; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University of Helsinki; Ann & Robert H. Lurie Children's Hospital of Chicago; Alberta Childrens Hospital; University of Calgary; Hebrew University of Jerusalem; McMaster University; McMaster University; Clalit Health Services; Carmel Medical Center; University of Hong Kong; Western University (University of Western Ontario); Karolinska Institutet; Karolinska Institutet	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, Dept Genet, N York Gen Hosp, MaRS Ctr E Tower,101 Coll St,Room 14-701, Toronto, ON M5G 1L7, Canada.	steve@genet.sickkids.on.ca	innes, allan micheil/A-9955-2017; Scherer, Stephen W./B-3785-2013; Hannula-Jouppi, Katariina SE/F-4476-2011; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Cardy, Janis Oram/AAF-4147-2019	Scherer, Stephen W./0000-0002-8326-1999; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Cardy, Janis Oram/0000-0002-7170-6145; Lipsanen-Nyman, Marita/0000-0003-4959-2310; Finucane, Brenda/0000-0003-4841-669X; Hannula-Jouppi, Katariina/0000-0003-3864-2853; Innes, Micheil/0000-0001-9881-5467				Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bruce HA, 2002, HUM GENET, V111, P136, DOI 10.1007/s00439-002-0768-5; CHAMBERLIN J, 1980, HUM GENET, V53, P343, DOI 10.1007/BF00287054; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Hannula K, 2002, PEDIATRICS, V109, P441, DOI 10.1542/peds.109.3.441; Hannula K, 2001, J MED GENET, V38, P273, DOI 10.1136/jmg.38.4.273; Hannula K, 2001, AM J HUM GENET, V68, P247, DOI 10.1086/316937; Hitchins MP, 2001, J MED GENET, V38, P810, DOI 10.1136/jmg.38.12.810; HOGLUND P, 1994, AM J HUM GENET, V55, P747; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; Lamb JA, 2005, J MED GENET, V42, P132, DOI 10.1136/jmg.2004.025668; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Nakabayashi K, 2002, GENOMICS, V79, P186, DOI 10.1006/geno.2002.6695; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; O'Brien EK, 2003, AM J HUM GENET, V72, P1536, DOI 10.1086/375403; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Palferman S, 2001, AM J HUM GENET, V69, P570; Pan YZ, 1998, AM J HUM GENET, V62, P1551, DOI 10.1086/301857; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Varela MC, 2004, EUR J HUM GENET, V12, P987, DOI 10.1038/sj.ejhg.5201264; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Warburton P, 2000, AM J MED GENET, V96, P228, DOI 10.1002/(SICI)1096-8628(20000403)96:2<228::AID-AJMG20>3.0.CO;2-G; Wassink TH, 2002, AM J MED GENET, V114, P566, DOI 10.1002/ajmg.10415; Xu Jie, 2004, Current Genomics, V5, P347, DOI 10.2174/1389202043349246; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110	34	136	142	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					965	972		10.1086/508902	http://dx.doi.org/10.1086/508902			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033973	Green Published, Bronze			2022-12-18	WOS:000241667400018
J	Weedon, MN; Schwarz, PEH; Horikawa, Y; Iwasaki, N; Illig, T; Holle, R; Rathmann, W; Selisko, T; Schulze, J; Owen, KR; Evans, J; Bosque-Plata, LD; Hitman, G; Walker, M; Levy, JC; Sampson, M; Bell, GI; McCarthy, MI; Hattersley, AT; Frayling, TM				Weedon, MN; Schwarz, PEH; Horikawa, Y; Iwasaki, N; Illig, T; Holle, R; Rathmann, W; Selisko, T; Schulze, J; Owen, KR; Evans, J; Bosque-Plata, LD; Hitman, G; Walker, M; Levy, JC; Sampson, M; Bell, GI; McCarthy, MI; Hattersley, AT; Frayling, TM			Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							INSULIN-RESISTANCE; GENE POLYMORPHISMS; GLUCOSE-TOLERANCE; INCREASED RISK; E23K VARIANT; CAUCASIANS; MELLITUS; CAPN10; JAPANESE		Peninsula Med Sch, Dept Diabet Res & Vasc Med, Exeter, Devon, England; Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Endocrinopathies & Metab Dis, D-8027 Dresden, Germany; Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Gunma, Japan; Tokyo Womens Med Univ, Ctr Diabet, Tokyo, Japan; GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; German Diabet Res Inst, Dept Biometry & Epidemiol, Dusseldorf, Germany; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ London, Queen Mary Sch Med & Dent, Barts & London, Dept Diabet & Metab Med, London, England; Med Sch Newcastle Upon Tyne, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Oxford, Radcliffe Infirm, Diabet Res Labs, Oxford OX2 6HE, England; Ctr Diabet, Norwich, Norfolk, England	University of Exeter; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Gunma University; Tokyo Women's Medical University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); University of Chicago; University of London; Queen Mary University London; Newcastle University - UK; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford	Frayling, TM (corresponding author), Royal Devon & Exeter Hosp, Barrack Rd, Exeter EX2 5DW, Devon, England.	T.M.Frayling@exeter.ac.uk	Holle, Rolf/D-9333-2013; McCarthy, Mark/M-3763-2015	Holle, Rolf/0000-0001-5395-2695; del Bosque-Plata, Laura/0000-0003-3224-378X; McCarthy, Mark/0000-0002-4393-0510; Levy, Jonathan/0000-0002-9486-1885; Weedon, Michael/0000-0002-6174-6135; Hattersley, Andrew/0000-0001-5620-473X; Frayling, Timothy/0000-0001-8362-2603	NIDDK NIH HHS [P30 DK020595, R01 DK047486, P60 DK020595] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Cassell PG, 2002, DIABETES, V51, P1622, DOI 10.2337/diabetes.51.5.1622; Daimon M, 2002, DIABETES RES CLIN PR, V56, P147, DOI 10.1016/S0168-8227(01)00372-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elbein SC, 2002, J CLIN ENDOCR METAB, V87, P650, DOI 10.1210/jc.87.2.650; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Fingerlin TE, 2002, DIABETES, V51, P1644, DOI 10.2337/diabetes.51.5.1644; Garant MJ, 2002, DIABETES, V51, P231, DOI 10.2337/diabetes.51.1.231; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Gonzalez A, 2002, J CLIN ENDOCR METAB, V87, P3971, DOI 10.1210/jc.87.8.3971; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hegele RA, 2001, DIABETES CARE, V24, P1498, DOI 10.2337/diacare.24.8.1498-a; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Horikawa Y, 2003, J CLIN ENDOCR METAB, V88, P244, DOI 10.1210/jc.2002-020847; Love-Gregory L, 2003, DIABETOLOGIA, V46, P136, DOI 10.1007/s00125-002-0947-x; Malecki MT, 2002, EUR J ENDOCRINOL, V146, P695, DOI 10.1530/eje.0.1460695; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; Rasmussen SK, 2002, DIABETES, V51, P3561, DOI 10.2337/diabetes.51.12.3561; Tsai HJ, 2001, AM J HUM GENET, V69, P1236, DOI 10.1086/324646; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; Wang Yanqing, 2002, Zhonghua Yi Xue Za Zhi, V82, P613; Xiang K, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P426	24	136	143	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1208	1212		10.1086/379285	http://dx.doi.org/10.1086/379285			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14574648	Green Published, Bronze			2022-12-18	WOS:000186493400022
J	Kayser, M; Brauer, S; Weiss, G; Schiefenhovel, W; Underhill, P; Shen, PD; Oefner, P; Tommaseo-Ponzetta, M; Stoneking, M				Kayser, M; Brauer, S; Weiss, G; Schiefenhovel, W; Underhill, P; Shen, PD; Oefner, P; Tommaseo-Ponzetta, M; Stoneking, M			Reduced Y-chromosome, but not mitochondrial DNA, diversity in human populations from West New Guinea	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN OCCUPATION; SEQUENCE VARIATION; EAST-ASIA; ORIGINS; HISTORY; MTDNA; HAPLOTYPES; POLYNESIANS; MIGRATION; DELETION	To investigate the paternal population history of New Guinea, 183 individuals from 11 regional populations of West New Guinea (WNG) and 131 individuals from Papua New Guinea (PNG) were analyzed at 26 binary markers and seven short-tandem-repeat loci from the nonrecombining part of the human Y chromosome and were compared with 14 populations of eastern and southeastern Asia, Polynesia, and Australia. Y-chromosomal diversity was low in WNG compared with PNG and with most other populations from Asia/Oceania; a single haplogroup (M-M4) accounts for 75% of WNG Y chromosomes, and many WNG populations have just one Y haplogroup. Four Y-chromosomal lineages (haplogroups M-M4, C-M208, C-M38, and K-M230) account for 94% of WNG Y chromosomes and 78% of all Melanesian Y chromosomes and were identified to have most likely arisen in Melanesia. Haplogroup C-M208, which in WNG is restricted to the Dani and Lani, two linguistically closely related populations from the central and western highlands of WNG, was identified as the major Polynesian Y-chromosome lineage. A network analysis of associated Y-chromosomal short-tandem-repeat haplotypes suggests two distinct population expansions involving C-M208-one in New Guinea and one in Polynesia. The observed low levels of Y-chromosome diversity in WNG contrast with high levels of mtDNA diversity reported for the same populations. This most likely reflects extreme patrilocality and/or biased male reproductive success (polygyny). Our data further provide evidence for primarily female-mediated gene flow within the highlands of New Guinea but primarily male-mediated gene flow between highland and lowland/coastal regions.	Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; Max Planck Inst Behav Physiol, Andechs, Germany; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Stanford Genome Technol Ctr, Palo Alto, CA USA; Univ Bari, Dept Zool, Bari, Italy	Max Planck Society; Max Planck Society; Stanford University; Stanford University; Universita degli Studi di Bari Aldo Moro	Kayser, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Inselstr 22, D-04103 Leipzig, Germany.	kayser@eva.mpg.de						ALLEN J, 1988, NATURE, V331, P707, DOI 10.1038/331707a0; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bellwood P., 1978, MANS CONQUEST PACIFI; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; BROWN P, 1978, HIGHLAND PEOPLES NEW; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; de Knijff P, 2000, AM J HUM GENET, V67, P1055; de Vries Lourens, 1993, PACIFIC LINGUISTIC B, VB-108; Ellis N, 2002, GENOME RES, V12, P339; Feil D.K., 1987, EVOLUTION HIGHLAND P; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Foley William A., 1986, PAPUAN LANGUAGES NEW; Gardner Robert, 1969, GARDENS WAR LIFE DEA; Grimes B.F., 2000, ETHNOLOGUE LANGUAGES, V14th ed.; GROUBE L, 1986, NATURE, V324, P453, DOI 10.1038/324453a0; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; HAYS TE, 1991, ENCY WORLD CULTURES, V2; Heeschen V, 1998, ETHNOGRAPHIC GRAMMAR; Heider Karl G., 1970, DUGUM DANI PAPUAN CU; HEIDER KG, 1997, CASE STUDIES CULTURA; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Hurles ME, 2002, GENETICS, V160, P289; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kayser M, 2001, CURR BIOL, V11, pU3; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; MELTON T, 1995, AM J HUM GENET, V57, P403; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITTON R, 1983, LOST WORLD IRIAN JAY; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; OSMOND M, IN PRESS T NEW GUINE, V1; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PAVLIDES C, 1994, ANTIQUITY, V68, P604, DOI 10.1017/S0003598X00047104; POSPISIL L, 1963, CASE STUDIES CULTURA; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Redd AJ, 2002, CURR BIOL, V12, P673, DOI 10.1016/S0960-9822(02)00789-3; ROSS M, IN PRESS T NEW GUINE, V1; Ross Malcolm, 1995, TALES CONCAVE WORLD, P139; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; SCHIEFENHOVEL W, 1988, MENSCH KULTUR UMWELT, V16; Schneider S, 2000, ARLEQUIN 2 000 SOFTW; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; SYKES B, 1995, AM J HUM GENET, V57, P1463; Tommaseo-Ponzetta M, 2002, AM J PHYS ANTHROPOL, V117, P49, DOI 10.1002/ajpa.10010; TOMMASEOPONZETT.M, 1986, CENTRO STUDI RICERCH, P125; TRENKENSCHUH FA, 1970, ASMAT SKETCH BOOK, V1, P4; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; van Enk Gerrit J., 1997, OXFORD STUDIES ANTHR, V9; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; WICKLER S, 1988, ANTIQUITY, V62, P703, DOI 10.1017/S0003598X00075104	65	136	139	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					281	302		10.1086/346065	http://dx.doi.org/10.1086/346065			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12532283	Green Published, Bronze			2022-12-18	WOS:000180680000010
J	Wheeler, RB; Sharp, JD; Schultz, RA; Joslin, JM; Williams, RE; Mole, SE				Wheeler, RB; Sharp, JD; Schultz, RA; Joslin, JM; Williams, RE; Mole, SE			The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; 15Q21-23; DISEASE	The neuronal ceroid lipofuscinoses (NCLs) are a group of autosomal recessive neurodegenerative diseases characterized by the accumulation of autofluorescent lipopigment in various tissues and by progressive cell death in the brain and retina. The gene for variant late-infantile NCL (vLINCL), CLN6, was previously mapped to chromosome 15q21-23 and is predicted to be orthologous to the genes underlying NCL in nclf mice and in South Hampshire and Merino sheep. The gene underlying this disease has been identified with six different mutations found in affected patients and with a 1-bp insertion in the orthologous Cln6 gene in the nclf mouse. CLN6 encodes a novel 311-amino acid protein with seven predicted transmembrane domains, is conserved across vertebrates and has no homologies with proteins of known function. One vLINCL mutation, affecting a conserved amino acid residue within the predicted third hydrophilic loop of the protein, has been identified, suggesting that this domain may play an important functional role.	UCL, Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, Rayne Inst, London WC1E 6JJ, England; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA	University of London; King's College London; University College London; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wheeler, RB (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, Rayne Inst, 5 Univ St, London WC1E 6JJ, England.	ruth.wheeler@ucl.ac.uk; j.sharp@ucl.ac.uk	Mole, Sara/C-2024-2008	Mole, Sara/0000-0003-4385-4957				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Broom M F, 2001, Eur J Paediatr Neurol, V5 Suppl A, P33, DOI 10.1053/ejpn.2000.0431; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Goebel H, 1999, NEURONAL CEROID LIPO; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; Savukoski M, 1998, NAT GENET, V19, P286, DOI 10.1038/975; Sharp J D, 2001, Eur J Paediatr Neurol, V5 Suppl A, P29, DOI 10.1053/ejpn.2000.0430; Sharp JD, 1999, MOL GENET METAB, V66, P329, DOI 10.1006/mgme.1999.2806; Sharp JD, 1997, HUM MOL GENET, V6, P591, DOI 10.1093/hmg/6.4.591; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Tammen I, 2001, Eur J Paediatr Neurol, V5 Suppl A, P37, DOI 10.1053/ejpn.2000.0432; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyynela J, 2000, EMBO J, V19, P2786, DOI 10.1093/emboj/19.12.2786; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4	20	136	138	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					537	542		10.1086/338708	http://dx.doi.org/10.1086/338708			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11727201	Green Published, Bronze			2022-12-18	WOS:000173254300025
J	Poloni, ES; Semino, O; Passarino, G; SantachiaraBenerecetti, AS; Dupanloup, I; Langaney, A; Excoffier, L				Poloni, ES; Semino, O; Passarino, G; SantachiaraBenerecetti, AS; Dupanloup, I; Langaney, A; Excoffier, L			Human genetic affinities for Y-chromosome P49a,f/TaqI haplotypes show strong correspondence with linguistics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							MITOCHONDRIAL-DNA POLYMORPHISMS; FRAGMENT LENGTH POLYMORPHISM; SOUTHERN AFRICAN POPULATIONS; SUB-SAHARAN AFRICA; HUMAN-EVOLUTION; MICROSATELLITE LOCI; JEWISH COMMUNITIES; HOMOZYGOSITY TEST; FREQUENCIES; HISTORY	Numerous population samples from around the world have been tested for Y chromosome-specific p49a, f/TaqI restriction polymorphisms. Here we review the literature as well as unpublished data on Y-chromosome p49a, f/ TaqI haplotypes and provide a new nomenclature unifying the notations used by different laboratories. We use this large data set to study worldwide genetic variability of human populations for this paternally transmitted chromosome segment. We observe, for the Y chromosome, an important level of population genetic structure among human populations (F-ST = .230, P < .001), mainly due to genetic differences among distinct linguistic groups of populations (F-ST = .246, P < .001). A multivariate analysis based on genetic distances between populations shows that human population structure inferred from the Y chromosome corresponds broadly to language families (r = .567, P < .001), in agreement with autosomal and mitochondrial data. Times of divergence of linguistic families, estimated from their internal level of genetic differentiation, are fairly concordant with current archaeological and linguistic hypotheses. Variability of the p49a, f/TaqI polymorphic marker is also significantly correlated with the geographic location of the populations (r = .613, P < .001), reflecting the fact that distinct linguistic groups generally also occupy distinct geographic areas. Comparison of Y-chromosome and mtDNA RFLPs in a restricted set of populations shows a globally high level of congruence, but it also allows identification of unequal maternal and paternal contributions to the gene pool of several populations.	MUSEE HOMME PARIS, LAB ANTHROPOL BIOL, PARIS, FRANCE; UNIV PAVIA, DIPARTIMENTO GENET & MICROBIOL A BUZZATI TRAVERSO, I-27100 PAVIA, ITALY; UNIV CALABRIA, DIPARTIMENTO BIOL CELLULARE, Arcavacata Di Rende, ITALY	Museum National d'Histoire Naturelle (MNHN); University of Pavia; University of Calabria	Poloni, ES (corresponding author), UNIV GENEVA, DEPT ANTHROPOL & ECOL, LAB GENET & BIOMETRIE, CASE POSTALE 511, CH-1211 GENEVA 24, SWITZERLAND.		Dupanloup, Isabelle/AAD-5372-2020; Excoffier, Laurent/D-3498-2013; Dupanloup, Isabelle/O-8609-2017	Excoffier, Laurent/0000-0002-7507-6494; Dupanloup, Isabelle/0000-0002-9258-6963; Poloni, Estella S./0000-0002-8465-003X; SEMINO, Ornella/0000-0002-9675-9403				Ammerman A.J., 1984, NEOLITHIC TRANSITION; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; ASTRINIDIS A, 1994, HUM BIOL, V66, P601; BALLINGER SW, 1992, GENETICS, V130, P139; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BISHOP CE, 1983, NATURE, V303, P831, DOI 10.1038/303831a0; Bomhard A, 1994, NOSTRATIC MACROFAMIL; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; BREUIL S, 1987, ANN GENET-PARIS, V30, P209; CALAFELL F, 1994, AM J PHYS ANTHROPOL, V93, P201, DOI 10.1002/ajpa.1330930205; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Ciminelli BM, 1995, J MOL EVOL, V41, P966; De Benedictis G, 1989, Gene Geogr, V3, P33; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; DEBENEDICTIS G, 1994, INT J ANTHR, V9, P129; Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177; Dolgopolsky Aaron, 1989, RECONSTRUCTING LANGU, P90; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; Ehret Christopher, 1984, HUNTERS FARMERS, P26; ELLIS N, 1990, NATURE, V344, P663, DOI 10.1038/344663a0; EXCOFFIER L, 1991, HUM BIOL, V63, P273; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; EXCOFFIER L, 1992, GENETICS, V131, P479; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GOMOLKA M, 1994, HUM GENET, V93, P592; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; GREENBERG JH, 1963, LANGUAGES AFRICA; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1997, GENETICS, V145, P787; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; JOBLING MA, 1994, HUM MOL GENET, V3, P107, DOI 10.1093/hmg/3.1.107; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KAISER M, 1988, ANNU REV ANTHROPOL, V17, P309; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Linares AR, 1996, ANN HUM GENET, V60, P401, DOI 10.1111/j.1469-1809.1996.tb00438.x; LIU A, 1994, 26 ANN M EUR SOC HUM; LUCOTTE G, 1994, HUM BIOL, V66, P519; Lucotte G, 1990, Gene Geogr, V4, P21; LUCOTTE G, 1993, HUM BIOL, V65, P835; LUCOTTE G, 1992, HUM BIOL, V64, P757; Lucotte G, 1991, Gene Geogr, V5, P131; LUCOTTE G, 1989, AM J HUM GENET, V45, P16; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; MANTEL N, 1967, CANCER RES, V27, P209; MARUYAMA T, 1985, GENETICS, V111, P675; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Michalakis Y, 1996, GENETICS, V142, P1061; MULLER S, 1994, HUM HERED, V44, P298, DOI 10.1159/000154233; NEI M, 1993, MOL BIOL EVOL, V10, P927; NGO KY, 1986, AM J HUM GENET, V38, P407; OAKEY R, 1990, GENOMICS, V7, P325, DOI 10.1016/0888-7543(90)90165-Q; PAABO S, 1995, SCIENCE, V268, P1141, DOI 10.1126/science.7761828; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; Phillipson D.W., 1977, LATER PREHISTORY E S; Relethford John H., 1995, Evolutionary Anthropology, V4, P53, DOI 10.1002/evan.1360040207; Renfrew C, 1991, CAMB ARCHAEOL J, V1, P3, DOI DOI 10.1017/S0959774300000238; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; REYNOLDS J, 1983, GENETICS, V105, P767; RITTE U, 1993, HUM BIOL, V65, P359; RITTE U, 1993, J MOL EVOL, V37, P435; ROEWER L, 1992, HUM GENET, V89, P389; Rohlf FJ, 1990, NTSYS PC NUMERICAL T; Ruhlen M., 1987, GUIDE WORLDS LANGUAG, V1; Salem AH, 1996, AM J HUM GENET, V59, P741; SANCHEZMAZAS A, 1994, HUM BIOL, V66, P27; SANTACHIARABENE.AS, 1992, GENETIC DIVERSITY JE, P45; Santos FR, 1996, HUM GENET, V97, P309, DOI 10.1007/BF02185760; SANTOS FR, 1993, HUM GENET, V90, P655; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; SCOZZARI R, 1994, HUM BIOL, V66, P1; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 1996, AM J HUM GENET, V59, P964; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; SMITH JM, 1990, NATURE, V344, P591, DOI 10.1038/344591b0; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SOODYALL H, 1993, ANN HUM BIOL, V20, P477, DOI 10.1080/03014469300002872; SPURDLE A, 1992, AM J HUM GENET, V50, P107; SPURDLE A, 1992, HUM MOL GENET, V1, P169, DOI 10.1093/hmg/1.3.169; SPURDLE AB, 1994, ANN HUM GENET, V58, P251, DOI 10.1111/j.1469-1809.1994.tb01889.x; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; Spurdle AB, 1996, AM J HUM GENET, V59, P1126; Spurdle AB, 1992, CURR OPIN GENET DEV, V2, P487, DOI 10.1016/S0959-437X(05)80162-5; Tavare S, 1997, GENETICS, V145, P505; TIERCY JM, 1992, AM J HUM GENET, V51, P592; TORRONI A, 1990, ANN HUM GENET, V54, P287; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1990, INT J ANTHR, V5, P97; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; VANSINA J, 1984, J AFR HIST, V25, P129, DOI 10.1017/S0021853700022829; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1986, GENETICS, V112, P899; WHITFIELD LS, 1995, GENOMICS, V27, P306, DOI 10.1006/geno.1995.1047; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zerjal T, 1997, AM J HUM GENET, V60, P1174; ZOOSSMANNDISKIN A, 1991, ISRAEL J MED SCI, V27, P245; [No title captured]	107	136	139	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1015	1035		10.1086/301602	http://dx.doi.org/10.1086/301602			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9346874	Bronze, Green Published			2022-12-18	WOS:A1997YH01700006
J	Blok, RB; Gook, DA; Thorburn, DR; Dahl, HHM				Blok, RB; Gook, DA; Thorburn, DR; Dahl, HHM			Skewed segregation of the mtDNA nt 8993 (T->G) mutation in human oocytes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; RAGGED-RED FIBERS; MITOCHONDRIAL-DNA; POINT MUTATION; RAPID SEGREGATION; PROTEIN-SYNTHESIS; LEIGH-SYNDROME; SEQUENCE; DEFECTS; CRYOPRESERVATION	Rapid changes in mtDNA variants between generations have led to the bottleneck theory, which proposes a dramatic reduction in mtDNA numbers during early oogenesis. We studied oocytes from a woman with heteroplasmic expression of the mtDNA nt 8993 (T-->G) mutation. Of seven oocytes analyzed, one showed no evidence of the mutation, and the remaining six had a mutant load >95%. This skewed expression of the mutation in oocytes is not compatible with the conventional bottleneck theory. A possible explanation is that, during amplification of mtDNA in the developing oocyte, mtDNA from one mitochondrion is preferentially amplified. Thus, subsequent mature oocytes may contain predominantly wild-type or mutant mitochondrial genomes.	ROYAL CHILDRENS HOSP,MURDOCH INST,PARKVILLE,VIC 3052,AUSTRALIA; ROYAL HOSP WOMEN,MELBOURNE,VIC,AUSTRALIA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne			Thorburn, David R/G-6266-2013	Gook, Debra/0000-0002-2564-8386; thorburn, david/0000-0002-7725-9470				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BLOK RB, 1995, HUM GENET, V95, P75; BLOK RB, 1995, BIOCHEM MOL MED, V56, P26, DOI 10.1006/bmme.1995.1052; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; CHEN X, 1995, AM J HUM GENET, V57, P239; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; deCoo IFM, 1996, AM J HUM GENET, V58, P636; DiMauro S, 1993, MOL GENETIC BASIS NE, P665; GOOK DA, 1994, HUM REPROD, V9, P684, DOI 10.1093/oxfordjournals.humrep.a138572; GOOK DA, 1993, HUM REPROD, V8, P1101, DOI 10.1093/oxfordjournals.humrep.a138201; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HOWELL N, 1992, HUM GENET, V90, P117; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; KOEHLER CM, 1991, GENETICS, V129, P247; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; MORTEN KJ, 1993, HUM MOL GENET, V2, P2081, DOI 10.1093/hmg/2.12.2081; MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099; Nagley Phillip, 1993, P137; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; PENISSONBESNIER I, 1992, J NEUROL SCI, V110, P144, DOI 10.1016/0022-510X(92)90021-C; PIKO L, 1973, J CELL BIOL, V58, P357, DOI 10.1083/jcb.58.2.357; POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; SCHMITT K, 1994, AM J HUM GENET, V55, P423; SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168; SHOFFNER JM, 1995, METABOLIC MOL BASES, P1535; STONEKING M, 1991, AM J HUM GENET, V48, P370; SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; TULINIUS MH, 1995, HUM GENET, V96, P290; VAILLANT F, 1995, HUM MOL GENET, V4, P903, DOI 10.1093/hmg/4.5.903	42	136	137	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1495	1501		10.1086/515453	http://dx.doi.org/10.1086/515453			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199572	Green Published, Bronze			2022-12-18	WOS:A1997XE29400029
J	Johannsson, O; Ostermeyer, EA; Hakansson, S; Friedman, LS; Johansson, U; Sellberg, C; BrondumNielsen, K; Sele, V; Olsson, H; King, MC; Borg, A				Johannsson, O; Ostermeyer, EA; Hakansson, S; Friedman, LS; Johansson, U; Sellberg, C; BrondumNielsen, K; Sele, V; Olsson, H; King, MC; Borg, A			Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE; 17Q	Nine different germ-line mutations in the BRCA1 breast and ovarian cancer susceptibility gene were identified in 15 of 47 kindreds from southern Sweden, by use of SSCP and heteroduplex analysis of all exons and flanking intron region and by a protein-truncation test for exon 11, followed by direct sequencing. All but one of the mutations are predicted to give rise to premature translation termination and include seven frameshift insertions or deletions, a nonsense mutation, and a splice acceptor site mutation. The remaining mutation is a missense mutation (Cys61Gly) in the zinc-binding motif. Four novel Swedish founding mutations were identified: the nucleotide 2595 deletion A was found in five families, the C 1806 T nonsense mutation in three families, the 3166 insertion TGAGA in three families, and the nucleotide 1201 deletion 11 in two families. Analysis of the intragenic polymorphism D17S855 supports common origins of the mutations. Eleven of the 15 kindreds manifesting BRCA1 mutations were breast-ovarian cancer families, several of them with a predominant ovarian cancer phenotype. The set of 32 families in which no BRCA1 alterations were detected included 1 breast-ovarian cancer kindred manifesting clear linkage to the BRCA1 region and loss of the wild-type chromosome in associated tumors. Other tumor types found in BRCA1 mutation/haplotype carriers included prostatic, pancreas, skin, and lung cancer, a malignant melanoma, an oligodendroglioma, and a carcinosarcoma. In all, 12 of 16 kindreds manifesting BRCA1 mutation or linkage contained ovarian cancer, as compared with only 6 of the remaining 31 families (P < .001). The present study confirms the involvement of BRCA1 in disease predisposition for a subset of hereditary breast cancer families often characterized by ovarian cancers.	UNIV LUND HOSP, DEPT ONCOL, S-22185 LUND, SWEDEN; UNIV CALIF BERKELEY, SCH PUBL HLTH, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA; JOHN F KENNEDY INST, COPENHAGEN, DENMARK; CENT HOSP HILLEROD, DEPT OBSTET & GYNECOL, HILLEROD, DENMARK	Lund University; Skane University Hospital; University of California System; University of California Berkeley				King, Mary-Claire/0000-0001-9426-1743; Olsson, Hakan/0000-0002-8794-9635	NCI NIH HHS [R01 CA27632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABERLE H, 1995, P NATL ACAD SCI USA, V92, P6384, DOI 10.1073/pnas.92.14.6384; BROWN MA, 1994, NATURE, V372, P733, DOI 10.1038/372733a0; CAMPBELL IG, 1994, HUM MOL GENET, V3, P589, DOI 10.1093/hmg/3.4.589; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CLAUS EB, 1991, AM J HUM GENET, V48, P232; EASTON DF, 1994, LANCET, V344, P761, DOI 10.1016/S0140-6736(94)92256-X; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; LINDBLOM A, 1993, AM J HUM GENET, V52, P749; LYNCH HT, 1990, BREAST CANCER RES TR, V15, P63, DOI 10.1007/BF01810778; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; PELTOKETO H, 1994, GENOMICS, V23, P250, DOI 10.1006/geno.1994.1487; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; SAITO H, 1993, CANCER RES, V53, P3382; SCHILDKRAUT JM, 1995, AM J OBSTET GYNECOL, V172, P908, DOI 10.1016/0002-9378(95)90020-9; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	28	136	136	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					441	450						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644702				2022-12-18	WOS:A1996TV56400001
J	BENNETT, RL; STEINHAUS, KA; UHRICH, SB; OSULLIVAN, CK; RESTA, RG; LOCHNERDOYLE, D; MARKEL, DS; VINCENT, V; HAMANISHI, J				BENNETT, RL; STEINHAUS, KA; UHRICH, SB; OSULLIVAN, CK; RESTA, RG; LOCHNERDOYLE, D; MARKEL, DS; VINCENT, V; HAMANISHI, J			RECOMMENDATIONS FOR STANDARDIZED HUMAN PEDIGREE NOMENCLATURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								The construction of an accurate family pedigree is a fundamental component of a clinical genetic evaluation and of human genetic research. Previous surveys of genetic counselors and human genetic publications have demonstrated significant inconsistencies in the usage of common pedigree symbols representing situations such as pregnancy, termination of pregnancy, miscarriage, and adoption, as well as less common scenarios such as pregnancies conceived through assisted reproductive technologies. The Pedigree Standardization Task Force (PSTF) was organized through the Professional Issues Committee of the National Society of Genetic Counselors, to establish recommendations for universal standards in human pedigree nomenclature. Nomenclature was chosen based on current usage, consistency among symbols, computer compatibility, and the adaptability of symbols to reflect the rapid technical advances in human genetics. Preliminary recommendations were presented for review at three national meetings of human genetic professionals and sent to >100 human genetic professionals for review. On the basis of this review process, the recommendations of the PSTF for standardized human pedigree nomenclature are presented here. By incorporating these recommendations into medical genetics professional training programs, board examinations, genetic publications, and pedigree software, the adoption of uniform pedigree nomenclature can begin. Usage of standardized pedigree nomenclature will reduce the chances for incorrect interpretation of patient and family medical and genetic information. It may also improve the quality of patient care provided by genetic professionals and facilitate communication between researchers involved with genetic family studies.	UNIV WASHINGTON,MED CTR,DEPT OBSTET & GYNECOL,SEATTLE,WA 98195; SWEDISH MED CTR,CTR PERINATAL STUDIES,SEATTLE,WA; DEPT HLTH,CTR GENET SERV,SEATTLE,WA; UNIV CALIF IRVINE,DIV HUMAN GENET,ORANGE,CA 92668; UNIV MICHIGAN,CTR HUMAN GENOME,ANN ARBOR,MI 48109; UNIV S CAROLINA,SCH MED,DIV GENET,COLUMBIA,SC	University of Washington; University of Washington Seattle; Swedish Medical Center; University of California System; University of California Irvine; University of Michigan System; University of Michigan; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	BENNETT, RL (corresponding author), UNIV WASHINGTON,MED CTR,DIV MED GENET,RG-25,SEATTLE,WA 98195, USA.		O'Sullivan, Ciara K/G-2428-2019; Hamanishi, Junzo/AAX-3318-2020; Resta, Bob/HCH-7871-2022	O'Sullivan, Ciara K/0000-0003-2603-2230; Markel, Dorene/0000-0002-3382-6779; Resta, Robert/0000-0001-7120-0673	PHS HHS [MCJ-411002-10] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bennett R L, 1993, J Genet Couns, V2, P261, DOI 10.1007/BF00961575; FRANKEL MS, 1993, ETHICAL LEGAL ISSUES; Galton F., 1889, NATURAL INHERITANCE; GLASS R, 1994, CBE VIEWS, V17, P70; Resta R G, 1993, J Genet Couns, V2, P235, DOI 10.1007/BF00961574; STEINHAUS KA, IN PRESS AM J MED GE; 1975, BIRTH DEFECTS ORG 11, V9	7	136	140	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					745	752						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887430	Green Published			2022-12-18	WOS:A1995QK91800025
J	FULKER, DW; CARDON, LR				FULKER, DW; CARDON, LR			A SIB-PAIR APPROACH TO INTERVAL MAPPING OF QUANTITATIVE TRAIT LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE-REGRESSION ANALYSIS; LINKAGE ANALYSIS; RELATIVE PAIRS; MARKER LOCI; POWER; CROSSES	An interval mapping procedure based on the sib-pair method of Haseman and Elston is developed, and simulation studies are carried out to explore its properties. The procedure is analogous to other interval mapping procedures used with experimental material, such as plants and animals, and yields very similar results in terms of the location and effect size of a quantitative trait locus (QTL). The procedure offers an advantage over the conventional Haseman and Elston approach, in terms of power, and provides useful information concerning the location of a QTL. Because of its simplicity, the method readily lends itself to the analysis of selected samples for increased power and the evaluation of multilocus models of complex phenotypes.	STANFORD UNIV,DEPT MATH,STANFORD,CA 94305; SRI INT,HLTH SCI SECT,STANFORD,CA	Stanford University; SRI International	FULKER, DW (corresponding author), UNIV COLORADO,INST BEHAV GENET,BOULDER,CO 80309, USA.				NHGRI NIH HHS [HG00085-01] Funding Source: Medline; NICHD NIH HHS [NICHD HD-11681, NICHD HD-27802] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD011681] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000085] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AMOS CI, 1989, GENET EPIDEMIOL, V6, P349, DOI 10.1002/gepi.1370060205; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; CAREY G, 1993, GENET EPIDEMIOL, V10, P103, DOI 10.1002/gepi.1370100203; CAREY G, 1991, AM J HUM GENET, V49, P786; DEFRIES JC, 1988, ACTA GENET MED GEMEL, V37, P205, DOI 10.1017/S0001566000003810; EAVES LJ, IN PRESS HEREDITY; ELSTON R C, 1985, Genetic Epidemiology, V2, P211, DOI 10.1002/gepi.1370020217; FULKER DW, 1991, READ WRIT, V3, P299, DOI 10.1007/BF00354964; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASEMAN JK, 1970, THESIS U N CAROLINA; LANDER ES, 1989, GENETICS, V121, P185; LITTLE R, 1987, STATISTICAL ANAL MIS; Mather K, 1971, BIOMETRICAL GENETICS; OLSON JM, 1993, GENET EPIDEMIOL, V10, P87, DOI 10.1002/gepi.1370100202; OTT J, 1985, ANAL HUMAN GENETIC L; RISCH N, 1990, AM J HUM GENET, V46, P229; ROBERTSON A, 1973, BEHAV GENET, V3, P389, DOI 10.1007/BF01070222; SAKS K, 1923, GENETICS, V8, P552; SOLLER M, 1976, THEOR APPL GENET, V47, P35, DOI 10.1007/BF00277402; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WILSON AF, 1991, AM J HUM GENET, V48, P862; 1989, STATISTICAL ANAL GEN	26	136	142	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					1092	1103						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198132				2022-12-18	WOS:A1994NP05300019
J	SURTI, U; HOFFNER, L; CHAKRAVARTI, A; FERRELL, RE				SURTI, U; HOFFNER, L; CHAKRAVARTI, A; FERRELL, RE			GENETICS AND BIOLOGY OF HUMAN OVARIAN TERATOMAS .1. CYTOGENETIC ANALYSIS AND MECHANISM OF ORIGIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	SURTI, U (corresponding author), MAGEE WOMENS HOSP,DEPT PATHOL,FORBES & HALKET ST,PITTSBURGH,PA 15213, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K04HD000774] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER; NCI NIH HHS [CA43881] Funding Source: Medline; NICHD NIH HHS [HD00774] Funding Source: Medline; NIGMS NIH HHS [GM 33771] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARRITT B, 1982, P NATL ACAD SCI-BIOL, V79, P7400, DOI 10.1073/pnas.79.23.7400; CHAKRAVARTI A, 1986, American Journal of Human Genetics, V39, pA150; CHAKRAVARTI A, 1989, MOL CYTOGENETIC STUD, P45; CLIMIE ARW, 1968, CANCER, V22, P824, DOI 10.1002/1097-0142(196810)22:4<824::AID-CNCR2820220421>3.0.CO;2-J; Damjanov I, 1983, HUMAN TERATOMAS EXPT, P23; DEKA R, 1990, AM J HUM GENET, V47, P644; EICHER EM, 1978, CYTOGENETICS CELL GE, V10, P232; EPPIG JT, 1983, GENETICS, V103, P797; EPPIG JT, 1988, J HERED, V79, P425, DOI 10.1093/oxfordjournals.jhered.a110545; HARNDEN DG, 1985, IN PRESS BIRTH DEFEC, V21; LINDER D, 1975, NEW ENGL J MED, V292, P63, DOI 10.1056/NEJM197501092920202; LINDER D, 1969, P NATL ACAD SCI USA, V63, P699, DOI 10.1073/pnas.63.3.699; LINDER D, 1970, ANN HUM GENET, V34, P21, DOI 10.1111/j.1469-1809.1970.tb00216.x; MA S, 1989, FERTIL STERIL, V51, P992; MANGOLD T, 1988, KARYOGRAM, V14, P15; OHAMA K, 1985, AM J OBSTET GYNECOL, V152, P869; Ohama K., 1987, HUM GENET, P245; OTT J, 1976, CYTOGENET CELL GENET, V16, P396, DOI 10.1159/000130641; PARRINGTON JM, 1984, J MED GENET, V21, P4, DOI 10.1136/jmg.21.1.4; Patil S R, 1978, Birth Defects Orig Artic Ser, V14, P297; PETERSON WF, 1955, AM J OBSTET GYNECOL, V70, P368, DOI 10.1016/S0002-9378(16)37681-5; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SURTI U, 1988, American Journal of Human Genetics, V43, pA34; WHEELER JE, 1983, HUMAN TERATOMAS EXPT, P1; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611	25	136	139	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					635	643						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	2220805				2022-12-18	WOS:A1990EB31900008
J	KALOUSEK, DK; BARRETT, IJ; MCGILLIVRAY, BC				KALOUSEK, DK; BARRETT, IJ; MCGILLIVRAY, BC			PLACENTAL MOSAICISM AND INTRAUTERINE SURVIVAL OF TRISOMIE-13 AND TRISOMIE-18	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA,DEPT PATHOL,VANCOUVER V6T 1W5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA	University of British Columbia; University of British Columbia								Bond D, 1983, OXFORD MONOGRAPHS ME, P198; BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; COX DM, 1974, PEDIATR RES, V8, P679, DOI 10.1203/00006450-197406000-00009; de Grouchy J, 1982, ATLAS MALADIES CHROM; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; EIBEN B, 1987, HUM GENET, V77, P137, DOI 10.1007/BF00272380; EICHENBAUM SZ, 1986, LANCET, V2, P391; GARDNER R L, 1978, P205; GARTNER A, 1988, GENOME S1, V30, P257; Jacobs P.A., 1987, HUM GENET, P233; JOHNSON A, 1988, 4TH INT C CHOR VILL; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; KALOUSEK DK, 1987, HUM GENET, V77, P163, DOI 10.1007/BF00272385; KALOUSEK DK, 1984, PATHOLOGY PLACENTA, P37; KALOUSEK DK, 1988, 4TH INT C CHOR VILL; KALOUSEK DK, 1985, 1ST TRIMESTER FETAL, P130; Kline JS, 1985, REPROD TOXICOL, V1985, P251; LINTON G, 1986, LANCET, V2, P630; MACAFEE J, 1970, OBSTET GYNECOL, V36, P735; MARKERT CL, 1978, SCIENCE, V202, P56, DOI 10.1126/science.694518; MARTIN AO, 1986, LANCET, V2, P391; MARTIN RH, 1987, HUM GENET, V77, P108, DOI 10.1007/BF00272374; MIKKELSENN M, 1987, HUM GENET, P598; SIMONI G, 1987, PRENATAL DIAG, V7, P671, DOI 10.1002/pd.1970070911; Simoni G, 1985, 1ST TRIMESTER FETAL, P137; Stein Z, 1981, Birth Defects Orig Artic Ser, V17, P95; STENE J, 1981, AM J HUM GENET, V33, P484; VEKEMANS MJJ, 1986, HUM GENET, V72, P307, DOI 10.1007/BF00290954; VEKEMANS MJJ, 1987, AM J MED GENET, V76, P763; WARBURTON D, 1983, AM J HUM GENET, V35, P1059; WIRTZ A, 1988, PRENATAL DIAG, V8, P321, DOI 10.1002/pd.1970080414; WRAMSBY H, 1987, NEW ENGL J MED, V316, P121, DOI 10.1056/NEJM198701153160301; YU CY, 1987, J AM HUM GENET S, V41, pA147	33	136	137	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					338	343						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2916579				2022-12-18	WOS:A1989T353500005
J	Rutsch, F; MacDougall, M; Lu, CM; Buers, I; Mamaeva, O; Nitschke, Y; Rice, GI; Erlandsen, H; Kehl, HG; Thiele, H; Nurnberg, P; Hohne, W; Crow, YJ; Feigenbaum, A; Hennekam, RC				Rutsch, Frank; MacDougall, Mary; Lu, Changming; Buers, Insa; Mamaeva, Olga; Nitschke, Yvonne; Rice, Gillian I.; Erlandsen, Heidi; Kehl, Hans Gerd; Thiele, Holger; Nuernberg, Peter; Hoehne, Wolfgang; Crow, Yanick J.; Feigenbaum, Annette; Hennekam, Raoul C.			A Specific IFIH1 Gain-of-Function Mutation Causes Singleton-Merten Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CHINESE POPULATION; RNA HELICASES; PSORIASIS; RESPONSES; VIRUSES; MOTIFS; MDA5	Singleton-Merten syndrome (SMS) is an infrequently described autosomal-dominant disorder characterized by early and extreme aortic and valvular calcification, dental anomalies (early-onset periodontitis and root resorption), osteopenia, and acro-osteolysis. To determine the molecular etiology of this disease, we performed whole-exome sequencing and targeted Sanger sequencing. We identified a common missense mutation, c.2465G>A (p.Arg822Gln), in interferon induced with helicase C domain 1 (IFIH1, encoding melanoma differentiation-associated protein 5 [MDA5]) in four SMS subjects from two families and a simplex case. IFIH1 has been linked to a number of autoimmune disorders, including Aicardi-Goutieres syndrome. Immunohistochemistry demonstrated the localization of MDA5 in all affected target tissues. In vitro functional analysis revealed that the IFIH1 c.2465G>A mutation enhanced MDA5 function in interferon beta induction. Interferon signature genes were upregulated in SMS individuals' blood and dental cells. Our data identify a gain-of-function IFIH1 mutation as causing SMS and leading to early arterial calcification and dental inflammation and resorption.	[Rutsch, Frank; Buers, Insa; Nitschke, Yvonne] Univ Munster, Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany; [MacDougall, Mary; Lu, Changming; Mamaeva, Olga; Erlandsen, Heidi] Univ Alabama Birmingham, Sch Dent, Inst Oral Hlth Res, Birmingham, AL 35294 USA; [Rice, Gillian I.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England; [Kehl, Hans Gerd] Univ Munster, Childrens Hosp, Dept Pediat Cardiol, D-48149 Munster, Germany; [Thiele, Holger; Nuernberg, Peter; Hoehne, Wolfgang] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Crow, Yanick J.] INSERM, UMR 1163, Lab Neurogenet & Neuroinflammat, F-75015 Paris, France; [Crow, Yanick J.] Paris Descartes Sorbonne Pads Cite Univ, Inst Imagine, F-75006 Paris, France; [Feigenbaum, Annette] Univ San Diego, Hosp Sick Children, Div Clin & Metab Genet, San Diego, CA 92123 USA; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands	University of Munster; University of Alabama System; University of Alabama Birmingham; University of Manchester; University of Munster; University of Cologne; University of Cologne; University of Cologne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of San Diego; University of Amsterdam; Academic Medical Center Amsterdam	Rutsch, F (corresponding author), Univ Munster, Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany.	rutschf@ukmuenster.de; macdougall@uab.edu	Thiele, Holger/ABE-6792-2020; Crow, Yanick J/N-6120-2014; MacDougall, Mary/ABG-8212-2021; Rice, Gillian I/G-3128-2015; Kehl, Hans Gerd/A-1624-2012; Lauschner, Flavia H/P-2457-2018	Thiele, Holger/0000-0002-0169-998X; Crow, Yanick J/0000-0001-7211-7564; Rice, Gillian I/0000-0002-4223-0571; Kehl, Hans Gerd/0000-0002-6555-8174; 	Arbeitsgemeinschaft Padiatrische Stoffwechselstorungen (Germany); University of Alabama at Birmingham School of Dentistry Institute of Oral Health Research; Global Center for Craniofacial Oral and Dental Disorders	Arbeitsgemeinschaft Padiatrische Stoffwechselstorungen (Germany); University of Alabama at Birmingham School of Dentistry Institute of Oral Health Research; Global Center for Craniofacial Oral and Dental Disorders	We thank the participating families for their generous support, all clinicians for contributing samples, and the University of Alabama at Birmingham School of Dentistry Institute of Oral Health Research and Global Center for Craniofacial Oral and Dental Disorders for partial funding. F.R. and I.B. received funding from the Arbeitsgemeinschaft Padiatrische Stoffwechselstorungen (Germany). We thank Ulrike Botschen for expert technical assistance and Christine Muller and Juan Dong for data collection. We also thank Johannes Roth, Helmut Wittkowski, and Katazyrna Barczik for fruitful discussions on the immunologic phenotype of the affected individuals.	Bijlmakers MJ, 2011, HUM MOL GENET, V20, P3129, DOI 10.1093/hmg/ddr215; Cen H, 2013, INFLAMMATION, V36, P444, DOI 10.1007/s10753-012-9564-0; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Dou QY, 2014, IMMUNOL INVEST, V43, P627, DOI 10.3109/08820139.2014.909455; Feigenbaum A, 2013, AM J MED GENET A, V161A, P360, DOI 10.1002/ajmg.a.35732; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu CM, 2014, CONNECT TISSUE RES, V55, P57, DOI 10.3109/03008207.2014.923880; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sheng Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5331; Singleton E B, 1973, Pediatr Radiol, V1, P2, DOI 10.1007/BF00972817; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	23	135	141	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					275	282		10.1016/j.ajhg.2014.12.014	http://dx.doi.org/10.1016/j.ajhg.2014.12.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25620204	Green Published, Bronze			2022-12-18	WOS:000349276700009
J	Harbuz, R; Zouari, R; Pierre, V; Ben Khelifa, M; Kharouf, M; Coutton, C; Merdassi, G; Abada, F; Escoffier, J; Nikas, Y; Vialard, F; Koscinski, I; Triki, C; Sermondade, N; Schweitzer, T; Zhioua, A; Zhioua, F; Latrous, H; Halouani, L; Ouafi, M; Makni, M; Jouk, PS; Sele, B; Hennebicq, S; Satre, V; Viville, S; Arnoult, C; Lunardi, J; Ray, PF				Harbuz, Radu; Zouari, Raoudha; Pierre, Virginie; Ben Khelifa, Mariem; Kharouf, Mahmoud; Coutton, Charles; Merdassi, Ghaya; Abada, Farid; Escoffier, Jessica; Nikas, Yorgos; Vialard, Francois; Koscinski, Isabelle; Triki, Chema; Sermondade, Nathalie; Schweitzer, Therese; Zhioua, Amel; Zhioua, Fethi; Latrous, Habib; Halouani, Lazhar; Ouafi, Marrakchi; Makni, Mounir; Jouk, Pierre-Simon; Sele, Bernard; Hennebicq, Sylviane; Satre, Veronique; Viville, Stephane; Arnoult, Christophe; Lunardi, Joel; Ray, Pierre F.			A Recurrent Deletion of DPY19L2 Causes Infertility in Man by Blocking Sperm Head Elongation and Acrosome Formation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTRACYTOPLASMIC SPERM; HOMOZYGOUS MUTATION; OOCYTE ACTIVATION; HUMAN GENOME; SPERMATOZOA; MEN; GLOBOZOOSPERMIA; INJECTION; GENE; FERTILIZATION	An increasing number of couples require medical assistance to achieve a pregnancy, and more than 2% of the births in Western countries now result from assisted reproductive technologies. To identify genetic variants responsible for male infertility, we performed a whole-genome SNP scan on patients presenting with total globozoospermia, a primary infertility phenotype characterized by the presence of 100% round acrosomeless spermatozoa in the ejaculate. This strategy allowed us to identify in most patients (15/20) a 200 kb homozygous deletion encompassing only DPY19L2, which is highly expressed in the testis. Although there was no known function for DPY19L2 in humans, previous work indicated that its ortholog in C. elegans is involved in cell polarity. In man, the DPY19L2 region has been described as a copy-number variant (CNV) found to be duplicated and heterozygously deleted in healthy individuals. We show here that the breakpoints of the deletions are located on a highly homologous 28 kb low copy repeat (LCR) sequence present on each side of DPY19L2, indicating that the identified deletions were probably produced by nonallelic homologous recombination (NAHR) between these two regions. We demonstrate that patients with globozoospermia have a homozygous deletion of DPY19L2, thus indicating that DPY19L2 is necessary in men for sperm head elongation and acrosome formation. A molecular diagnosis can now be proposed to affected men; the presence of the deletion confirms the diagnosis of globozoospermia and assigns a poor prognosis for the success of in vitro fertilization.	[Harbuz, Radu; Ben Khelifa, Mariem; Coutton, Charles; Abada, Farid; Jouk, Pierre-Simon; Sele, Bernard; Hennebicq, Sylviane; Satre, Veronique; Lunardi, Joel; Ray, Pierre F.] Univ Grenoble 1, Fac Med Pharm Grenoble, F-38706 Grenoble, France; [Harbuz, Radu; Pierre, Virginie; Ben Khelifa, Mariem; Coutton, Charles; Abada, Farid; Jouk, Pierre-Simon; Satre, Veronique; Arnoult, Christophe; Ray, Pierre F.] Equipe Genet Infertil & Therapeut GIT, Lab AGIM, CNRS, UJF,FRE 3405, F-38706 Grenoble, France; [Harbuz, Radu; Ben Khelifa, Mariem; Coutton, Charles; Abada, Farid; Lunardi, Joel; Ray, Pierre F.] CHU Grenoble, DBTP, UM Biochim & Genet Mol, F-38700 Grenoble, France; [Zouari, Raoudha; Kharouf, Mahmoud; Latrous, Habib; Halouani, Lazhar; Ouafi, Marrakchi; Makni, Mounir] Clin Reprod Jasmins, Tunis 1002, Tunisia; [Pierre, Virginie; Escoffier, Jessica; Arnoult, Christophe; Lunardi, Joel] INSERM, Grenoble Inst Neurosci, U836, F-38042 Grenoble, France; [Merdassi, Ghaya; Zhioua, Amel; Zhioua, Fethi] Hop Aziza Othmana, Unite Procreat Medicalement Assistee, Tunis 1004, Tunisia; [Nikas, Yorgos] Athens Innovat Microscopy Skra 36, Athens, Greece; [Vialard, Francois] Ctr Hosp Poissy St Germain, Dept Reprod Biol, F-78300 Poissy, France; [Koscinski, Isabelle; Viville, Stephane] CHU Strasbourg, Serv Biol Reprod, F-67000 Strasbourg, France; [Koscinski, Isabelle; Viville, Stephane] Univ Strasbourg, IGBMC, INSERM, CNRS,U964,UMR 1704, F-67404 Illkirch Graffenstaden, France; [Triki, Chema] CMRDP, Tunis Beledere 1002, Tunisia; [Sermondade, Nathalie] CHU Jean Verdier, Histol Embryol Cytogenet CECOS, F-93143 Bondy, France; [Schweitzer, Therese] Hop Matern Metz, Ctr AMP, F-57045 Metz, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Tunis-El-Manar; Hopital Aziza Othmana; Hospital Chi of Poissy Saint Germain; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CHR Metz-Thionville	Ray, PF (corresponding author), Univ Grenoble 1, Fac Med Pharm Grenoble, F-38706 Grenoble, France.	pray@chu-grenoble.fr	Jouk, Pierre-Simon/M-7367-2014; Escoffier, jessica/E-9498-2017; hennebicq, sylviane/A-6564-2012; Ray, Pierre/B-9326-2012; COUTTON, Charles/G-2859-2014; Jouk, Pierre-Simon/AAB-5262-2022; Escoffier, jessica/T-9857-2019; Ray, Pierre F/D-7315-2019; SATRE, Veronique/G-2864-2014; ARNOULT, christophe/E-8312-2013	Escoffier, jessica/0000-0001-8166-5845; hennebicq, sylviane/0000-0002-1851-6932; Jouk, Pierre-Simon/0000-0001-8301-320X; Ray, Pierre F/0000-0003-1544-7449; Vialard, Francois/0000-0002-5774-2756; Viville, Stephane/0000-0002-5088-3003; SATRE, Veronique/0000-0001-7852-8591; Coutton, Charles/0000-0002-8873-8098; ARNOULT, christophe/0000-0002-3753-5901	French Research Agency (ANR); Rhone Alpes Region	French Research Agency (ANR)(French National Research Agency (ANR)); Rhone Alpes Region(Region Auvergne-Rhone-Alpes)	This work was part of the project Identification and Characterization of Genes Involved in Infertility (IGG2I) funded by the program GENOPAT 2009 from the French Research Agency (ANR). This work was also funded in part by program CIBLE 2009 from the Rhone Alpes Region.	AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Battaglia DE, 1997, FERTIL STERIL, V68, P118, DOI 10.1016/S0015-0282(97)81486-0; Bechoua S, 2009, ANDROLOGIA, V41, P55, DOI 10.1111/j.1439-0272.2008.00884.x; Carson AR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-45; Dam AHDM, 2007, HUM REPROD UPDATE, V13, P63, DOI 10.1093/humupd/dml047; Dam AHDM, 2007, AM J HUM GENET, V81, P813, DOI 10.1086/521314; Dieterich K, 2007, NAT GENET, V39, P661, DOI 10.1038/ng2027; Dieterich K, 2009, HUM MOL GENET, V18, P1301, DOI 10.1093/hmg/ddp029; ESCALIER D, 1990, International Journal of Developmental Biology, V34, P287; FLORKEGERLOFF S, 1984, ANDROLOGIA, V16, P187; Force A, 1999, GENETICS, V151, P1531; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Harbuz R, 2009, GYNECOL OBSTET FERTI, V37, P546, DOI 10.1016/j.gyobfe.2009.04.002; Heytens E, 2009, HUM REPROD, V24, P2417, DOI 10.1093/humrep/dep207; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kilani ZM, 1998, HUM REPROD, V13, P2177, DOI 10.1093/humrep/13.8.2177; KULLANDER S, 1975, INT J FERTIL, V20, P33; Kurokawa Kiyoshi, 2005, Medical Molecular Morphology, V38, P79, DOI 10.1007/s00795-004-0280-1; LIU J, 1995, HUM REPROD, V10, P626, DOI 10.1093/oxfordjournals.humrep.a136000; Lu L, 2006, ASIAN J ANDROL, V8, P53, DOI 10.1111/j.1745-7262.2006.00089.x; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Morel F, 2004, MOL HUM REPROD, V10, P835, DOI 10.1093/molehr/gah111; Moretti E., 2005, Journal of Submicroscopic Cytology and Pathology, V37, P297; NISTAL M, 1978, ANDROLOGIA, V10, P234; OHTA T, 1987, GENETICS, V115, P207; RAY PF, 2009, Patent No. 0957963; RAY PF, 2010, HUM REPROD S1, V25; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Viville S, 2000, HUM REPROD, V15, P2563, DOI 10.1093/humrep/15.12.2563; World Health Organization, 1999, WHO LAB MANUAL EXAMI, V4th; Xu M, 2003, MOL HUM REPROD, V9, P9, DOI 10.1093/molehr/gag005; Yoon SY, 2008, J CLIN INVEST, V118, P3671, DOI 10.1172/JCI36942	38	135	149	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					351	361		10.1016/j.ajhg.2011.02.007	http://dx.doi.org/10.1016/j.ajhg.2011.02.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21397064	Green Published, Bronze			2022-12-18	WOS:000288589000012
J	Sugiana, C; Pagliarini, DJ; McKenzie, M; Kirby, DM; Salemi, R; Abu-Amero, KK; Dahl, HHM; Hutchison, WM; Vascotto, KA; Smith, SM; Newbold, RF; Christodoulou, J; Calvo, S; Mootha, VK; Ryan, MT; Thorburn, DR				Sugiana, Canny; Pagliarini, David J.; McKenzie, Matthew; Kirby, Denise M.; Salemi, Renato; Abu-Amero, Khaled K.; Dahl, Hans-Henrik M.; Hutchison, Wendy M.; Vascotto, Katherine A.; Smith, Stacey M.; Newbold, Robert F.; Christodoulou, John; Calvo, Sarah; Mootha, Vamsi K.; Ryan, Michael T.; Thorburn, David R.			Mutation of C20orf7 Disrupts Complex I Assembly and Causes Lethal Neonatal Mitochondrial Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESPIRATORY-CHAIN DISORDERS; CYTOCHROME-C-OXIDASE; LEIGH-SYNDROME; ENCODED SUBUNITS; DEFICIENCY; GENE; PROTEIN; ENCEPHALOMYOPATHY; SUPERCOMPLEXES; ENCEPHALOPATHY	Complex I (NADH:ubiquinone oxidoreductase) is the first and largest multimeric complex of the mitochondrial respiratory chain. Human complex I comprises seven Subunits encoded by mitochondrial DNA and 38 nuclear-encoded subunits that are assembled together in a process that is only partially understood. To date, Mutations causing complex I deficiency have been described in all 14 core subunits, five supernumerary Subunits, and four assembly factors. We describe complex I deficiency caused by mutation of the putative complex I assembly factor C20orf7. A candidate region for a lethal neonatal form of complex I deficiency was identified by homozygosity mapping of an Egyptian family with one affected child and two affected pregnancies predicted by enzyme-based prenatal diagnosis. The region was confirmed by microcell-mediated chromosome transfer, and 11 candidate genes encoding potential mitochondrial proteins were sequenced. A homozygous missense mutation in C20orf7 segregated with disease in the family. We show that C20orf7 is peripherally associated with the matrix face of the mitochondrial inner membrane and that silencing its expression with RNAi decreases complex I activity. C20orf7 patient fibroblasts showed an almost cornplete absence of complex I holoenzyme and were defective at all early stage of complex I assembly, but in a manner distinct from the assembly defects caused by mutations in the assembly factor NDUFAF1. Our results indicate that C20orf7 is crucial in the assembly of complex I and that mutations in C20orf7 cause mitochondrial disease.	[Sugiana, Canny; Kirby, Denise M.; Salemi, Renato; Vascotto, Katherine A.; Smith, Stacey M.; Thorburn, David R.] Royal Childrens Hosp, Mitochondrial & Metab Res Grp, Parkville, Vic 3052, Australia; [Dahl, Hans-Henrik M.; Hutchison, Wendy M.] Royal Childrens Hosp, Murdoch Childresn Res Inst, Genet Hearing Res Grp, Parkville, Vic 3052, Australia; [Sugiana, Canny; Thorburn, David R.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Pagliarini, David J.; Calvo, Sarah; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Pagliarini, David J.; Calvo, Sarah; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02446 USA; [Pagliarini, David J.; Calvo, Sarah; Mootha, Vamsi K.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Pagliarini, David J.; Calvo, Sarah; Mootha, Vamsi K.] Harvard Univ, Cambridge, MA 02142 USA; [McKenzie, Matthew; Ryan, Michael T.] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Kirby, Denise M.; Thorburn, David R.] Royal Childrens Hosp, Genet Hlth Serv Victoria, Melbourne, Vic 3052, Australia; [Abu-Amero, Khaled K.] King Saud Univ, Coll Med, Mol Genet Lab, Riyadh 11461, Saudi Arabia; [Newbold, Robert F.] Brunel Univ, Inst Cancer Genet & Pharmacogenom, Uxbridge UB8 3PH, Middx, England; [Christodoulou, John] Childrens Hosp, Western Sydney Genet Program, Westmead, NSW 2145, Australia; [Christodoulou, John] Univ Sydney, Discipline Paediat, Westmead, NSW 2145, Australia; [Christodoulou, John] Univ Sydney, Discipline Child Hlth & Genet Med, Westmead, NSW 2145, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; La Trobe University; Royal Children's Hospital Melbourne; King Saud University; Brunel University; University of Sydney; University of Sydney; University of Sydney	Thorburn, DR (corresponding author), Royal Childrens Hosp, Mitochondrial & Metab Res Grp, Flemington Rd, Parkville, Vic 3052, Australia.	david.thorburn@mcri.edu.au	Ryan, Michael T/C-6673-2011; Thorburn, David R/G-6266-2013; Christodoulou, John/E-5866-2015; McKenzie, Matthew/H-4926-2019; Ryan, Michael/X-2152-2019; Christodoulou, John/M-3628-2019	Ryan, Michael T/0000-0003-2586-8829; McKenzie, Matthew/0000-0001-7508-1800; Ryan, Michael/0000-0003-2586-8829; Christodoulou, John/0000-0002-8431-0641; thorburn, david/0000-0002-7725-9470; Pagliarini, David J./0000-0002-0001-0087	Australian National Health; Medical Research Council; Australian Research Council; University of Melbourne; Muscular Dystrophy Association; Ramaciotti Foundation; National Institutes of Health [GM077465]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne); Muscular Dystrophy Association(Muscular Dystrophy Association); Ramaciotti Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Andrew Cuthbert for advice on monochromosomal transfer. This work was supported by grants (D.R.T. and M.T.R.), postdoctoral fellowships (M.McK. and D.M.K.), and a principal research fellowship (D.R.T.) from the Australian National Health and Medical Research Council and a grant from the Australian Research Council (M.T.R.). C.S. was supported by a University of Melbourne postgraduate research scholarship. Grant funding was also received from the Muscular Dystrophy Association (D.R.T.), the Ramaciotti Foundation (M.McK.), and the National Institutes of Health (GM077465) (V.K.M.).	Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Benit P, 2003, HUM GENET, V112, P563, DOI 10.1007/s00439-002-0884-2; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Bradshaw TD, 2005, CANCER RES, V65, P3911, DOI 10.1158/0008-5472.CAN-04-4141; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Ellaway C, 1998, J INHERIT METAB DIS, V21, P72, DOI 10.1023/A:1005367515701; Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Grad LI, 2004, HUM MOL GENET, V13, P303, DOI 10.1093/hmg/ddh027; Harlow, 1999, USING ANTIBODIES LAB; Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Karp CM, 2007, ONCOGENE, V26, P1780, DOI 10.1038/sj.onc.1209980; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683; KIRBY DM, 2008, HUM GENET, V11, P395; Lamande SR, 1998, HUM MOL GENET, V7, P981, DOI 10.1093/hmg/7.6.981; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896; Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M; Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.0.CO;2-P; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006; Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6; Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397; Tsuneoka M, 2005, J BIOL CHEM, V280, P19977, DOI 10.1074/jbc.M501231200; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; Vogel RO, 2007, MOL GENET METAB, V91, P176, DOI 10.1016/j.ymgme.2007.02.007; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	58	135	141	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					468	478		10.1016/j.ajhg.2008.09.009	http://dx.doi.org/10.1016/j.ajhg.2008.09.009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18940309	Green Published, Bronze			2022-12-18	WOS:000260239200004
J	Valdmanis, PN; Meijer, IA; Reynolds, A; Lei, A; MacLeod, P; Schlesinger, D; Zatz, M; Reid, E; Dion, PA; Drapeau, P; Rouleau, GA				Valdmanis, Paul N.; Meijer, Inge A.; Reynolds, Annie; Lei, Adrienne; MacLeod, Patrick; Schlesinger, David; Zatz, Mayana; Reid, Evan; Dion, Patrick A.; Drapeau, Pierre; Rouleau, Guy A.			Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOSKELETAL PROTEIN; SPECTRIN REPEAT; ZEBRAFISH; ATAXIAS; MAPS; PREVALENCE; EXPRESSION; DROSOPHILA; SEQUENCE; 8Q	Hereditary spastic paraplegia (HSP) is a progressive upper-motor neurodegenerative disease. The eighth HSP locus, SPG8, is on chromosome 8p24.13. The three families previously linked to the SPG8 locus present with relatively severe, pure spastic paraplegia. We have identified three mutations in the KIAA0196 gene in six families that map to the SPG8 locus. One mutation, V626F, segregated in three large North American families with European ancestry and in one British family. An L619F mutation was found in a Brazilian family. The third mutation, N471D, was identified in a smaller family of European origin and lies in a spectrin domain. None of these mutations were identified in 500 control individuals. Both the L619 and V626 residues are strictly conserved across species and likely have a notable effect on the structure of the protein product strumpellin. Rescue studies with human mRNA injected in zebrafish treated with morpholino oligonucleotides to knock down the endogenous protein showed that mutations at these two residues impaired the normal function of the KIAA0196 gene. However, the function of the 1,159-aa strumpellin protein is relatively unknown. The identification and characterization of the KIAA0196 gene will enable further insight into the pathogenesis of HSP.	Univ Montreal, Notre Dame Hosp, CHUm, Fac Med, Montreal, PQ H2L 4M1, Canada; Univ Montreal, Fac Med, Dept Pathol & Biol Cellulaire, Montreal, PQ H2L 4M1, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 2T5, Canada; Childrens & Womens Hlth Ctr BC, Vancouver, BC, Canada; Univ Sao Paulo, Inst Biosci, Human Genome Res Ctr, BR-05508 Sao Paulo, Brazil; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 1TN, England; Univ Cambridge, Dept Med Genet, Cambridge CB2 1TN, England	Universite de Montreal; Universite de Montreal; McGill University; McGill University; BC Women's Hospital & Health Centre; Universidade de Sao Paulo; University of Cambridge; University of Cambridge	Rouleau, GA (corresponding author), Univ Montreal, Notre Dame Hosp, CHUm, Fac Med, 1560 Sherbrooke E,Room Y-3633, Montreal, PQ H2L 4M1, Canada.	guy.rouleau@umontreal.ca	Reid, Evan/F-3250-2010; Meijer, Inge/AAL-5157-2020; Zatz, Mayana/M-5338-2015	Reid, Evan/0000-0003-1623-7304; Zatz, Mayana/0000-0003-3970-8025; Valdmanis, Paul/0000-0001-8840-6969	Wellcome Trust [073483] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEHAN WMH, 1974, J NEUROL NEUROSUR PS, V37, P8, DOI 10.1136/jnnp.37.1.8; Bourgeois S, 2004, ANAL BIOCHEM, V324, P309, DOI 10.1016/j.ab.2003.10.006; Brand M, 1996, DEVELOPMENT, V123, P129; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DeLuca GC, 2004, NEUROPATH APPL NEURO, V30, P576, DOI 10.1111/j.1365-2990.2004.00587.x; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Fink JK, 1997, CURR OPIN NEUROL, V10, P313, DOI 10.1097/00019052-199708000-00006; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARDING AE, 1983, LANCET, V1, P1151; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hedera P, 1999, AM J HUM GENET, V64, P563, DOI 10.1086/302258; HIROSE F, 1993, J BIOL CHEM, V268, P2092; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Klebe S, 2006, BRAIN, V129, P1456, DOI 10.1093/brain/awl012; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Labuda D, 1999, ANAL BIOCHEM, V275, P84, DOI 10.1006/abio.1999.4293; Mc Monagle P, 2002, J NEUROL NEUROSUR PS, V72, P43, DOI 10.1136/jnnp.72.1.43; Meijer IA, 2002, ARCH NEUROL-CHICAGO, V59, P281, DOI 10.1001/archneur.59.2.281; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; POLO JM, 1991, BRAIN, V114, P855, DOI 10.1093/brain/114.2.855; Porkka KP, 2004, GENE CHROMOSOME CANC, V39, P1, DOI 10.1002/gcc.10289; Reid E, 1999, NEUROLOGY, V53, P1844, DOI 10.1212/WNL.53.8.1844; Rocco P, 2000, AM J MED GENET, V92, P122, DOI 10.1002/(SICI)1096-8628(20000515)92:2<122::AID-AJMG8>3.0.CO;2-B; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Silva MC, 1997, J CLIN EPIDEMIOL, V50, P1377, DOI 10.1016/S0895-4356(97)00202-3; Soderblom C, 2006, PHARMACOL THERAPEUT, V109, P42, DOI 10.1016/j.pharmthera.2005.06.001; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385; Wood JD, 2006, HUM MOL GENET, V15, P2763, DOI 10.1093/hmg/ddl212; Ylanne Jari, 2001, Cell Mol Biol Lett, V6, P234; Zuchner S, 2006, NEUROGENETICS, V7, P127, DOI 10.1007/s10048-006-0029-1	36	135	145	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					152	161		10.1086/510782	http://dx.doi.org/10.1086/510782			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160902	Bronze, Green Published			2022-12-18	WOS:000243102500014
J	Smeitink, JAM; Elpeleg, O; Antonicka, H; Diepstra, H; Saada, A; Smits, P; Sasarman, F; Vriend, G; Jacob-Hirsch, J; Shaag, A; Rechavi, G; Welling, B; Horst, J; Rodenburg, RJ; van den Heuvel, B; Shoubridge, EA				Smeitink, Jan A. M.; Elpeleg, Orly; Antonicka, Hana; Diepstra, Heleen; Saada, Ann; Smits, Paulien; Sasarman, Florin; Vriend, Gert; Jacob-Hirsch, Jasmine; Shaag, Avraham; Rechavi, Gideon; Welling, Brigitte; Horst, Jurgen; Rodenburg, Richard J.; van den Heuvel, Bert; Shoubridge, Eric A.			Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLUE-NATIVE-ELECTROPHORESIS; OXIDATIVE-PHOSPHORYLATION; PROTEIN-SYNTHESIS; FACTOR TU; EXPRESSION; DISEASE; CLONING; DISORDERS; COMPLEXES; RIBOSOME	The 13 polypeptides encoded in mitochondrial DNA ( mtDNA) are synthesized in the mitochondrial matrix on a dedicated protein-translation apparatus that resembles that found in prokaryotes. Here, we have investigated the genetic basis for a mitochondrial protein-synthesis defect associated with a combined oxidative phosphorylation enzyme deficiency in two patients, one of whom presented with encephalomyopathy and the other with hypertrophic cardiomyopathy. Sequencing of candidate genes revealed the same homozygous mutation (C997T) in both patients in TSFM, a gene coding for the mitochondrial translation elongation factor EFTs. EFTs functions as a guanine nucleotide exchange factor for EFTu, another translation elongation factor that brings aminoacylated transfer RNAs to the ribosomal A site as a ternary complex with guanosine triphosphate. The mutation predicts an Arg333Trp substitution at an evolutionarily conserved site in a subdomain of EFTs that interacts with EFTu. Molecular modeling showed that the substitution disrupts local subdomain structure and the dimerization interface. The steady-state levels of EFTs and EFTu in patient fibroblasts were reduced by 75% and 60%, respectively, and the amounts of assembled complexes I, IV, and V were reduced by 35%-91% compared with the amounts in controls. These phenotypes and the translation defect were rescued by retroviral expression of either EFTs or EFTu. These data clearly establish mutant EFTs as the cause of disease in these patients. The fact that the same mutation is associated with distinct clinical phenotypes suggests the presence of genetic modifiers of the mitochondrial translation apparatus.	Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; Hebrew Univ Jerusalem, Hadassah Med Ctr, Div Pediat, Metab Dis Unit, Jerusalem, Israel; McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Chaim Sheba Med Ctr, Inst Haematol, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; Univ Munster, Inst Human Genet, D-4400 Munster, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Hebrew University of Jerusalem; Hadassah University Medical Center; McGill University; McGill University; Chaim Sheba Medical Center; University of Munster	Smeitink, JAM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, Geert Grootepl 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.	J.Smeitink@cukz.umcn.nl	Rodenburg, Richard/N-3579-2014; Vriend, G./H-8112-2014; Vriend, Gert/D-6730-2011; Smeitink, Jan A.M./D-6064-2011; Smeitink, Jan/C-1351-2013; van den Heuvel, Lambertus/AAM-1772-2021; Saada, Ann/J-6864-2017	Rodenburg, Richard/0000-0001-5227-3527; van den Heuvel, Lambertus/0000-0003-3917-6727; Saada, Ann/0000-0003-2951-0656; Smits, Paulien/0000-0002-0371-3933; Antonicka, Hana/0000-0002-2525-2867				Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; BOULET L, 1992, AM J HUM GENET, V51, P1187; Chiron S, 2005, GENETICS, V169, P1891, DOI 10.1534/genetics.104.037473; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; DEFILIPPIS V, 1994, PROTEIN ENG, V7, P1203, DOI 10.1093/protein/7.10.1203; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285; Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114; Jeppesen MG, 2005, J BIOL CHEM, V280, P5071, DOI 10.1074/jbc.M411782200; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; O'Brien TW, 2002, GENE, V286, P73, DOI 10.1016/S0378-1119(01)00808-3; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800; Spremulli LL, 2004, PROG NUCLEIC ACID RE, V77, P211, DOI 10.1016/S0079-6603(04)77006-3; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Woriax VL, 1995, BBA-GENE STRUCT EXPR, V1264, P347, DOI 10.1016/0167-4781(95)00176-X; XIN H, 1995, J BIOL CHEM, V270, P17243, DOI 10.1074/jbc.270.29.17243; Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	26	135	138	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					869	877		10.1086/508434	http://dx.doi.org/10.1086/508434			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033963	Green Published, Bronze			2022-12-18	WOS:000241667400008
J	Merla, G; Howald, C; Henrichsen, CN; Lyle, R; Wyss, C; Zabot, MT; Antonarakis, SE; Reymond, A				Merla, Giuseppe; Howald, Cedric; Henrichsen, Charlotte N.; Lyle, Robert; Wyss, Carine; Zabot, Marie-Therese; Antonarakis, Stylianos E.; Reymond, Alexandre			Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; SYNDROME CRITICAL REGION; ATYPICAL 7Q11.23 DELETION; COPY-NUMBER VARIATION; LARGE-SCALE VARIATION; HUMAN GENOME; BINDING-PROTEIN; DOWN-SYNDROME; MOUSE MODEL; ELASTIN GENE	Genomic imbalance is a common cause of phenotypic abnormalities. We measured the relative expression level of genes that map within the microdeletion that causes Williams-Beuren syndrome and within its flanking regions. We found, unexpectedly, that not only hemizygous genes but also normal-copy neighboring genes show decreased relative levels of expression. Our results suggest that not only the aneuploid genes but also the flanking genes that map several megabases away from a genomic rearrangement should be considered possible contributors to the phenotypic variation in genomic disorders.	Univ Lausanne, Ctr Integrat Gen, Lausanne, Switzerland; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; IRCCS, Gen Med Serv, San Giovanni Rotondo, Italy; Hop Debrousse, Ctr Biotechnol Cellulaire, Hosp Civils Lyon, Lyon, France; Interdisciplinary Grp Study ELN Gene, Lyon, France	University of Lausanne; University of Geneva; IRCCS Casa Sollievo Della Sofferenza; CHU Lyon	Reymond, A (corresponding author), Univ Lausanne, Ctr Integrat Gen, Genopode Bldg, Lausanne, Switzerland.	alexandre.reymond@unil.ch	Hor, Charlotte/H-5908-2015; merla, giuseppe/K-4627-2012; Antonarakis, Stylianos E/N-8866-2014; Hor, Charlotte/AAB-4850-2020	Hor, Charlotte/0000-0002-5361-2372; merla, giuseppe/0000-0001-5078-928X; Antonarakis, Stylianos E/0000-0001-8907-5823; Hor, Charlotte/0000-0002-5361-2372; Reymond, Alexandre/0000-0003-1030-8327				Amano K, 2004, HUM MOL GENET, V13, P1333, DOI 10.1093/hmg/ddh154; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Botta A, 1999, J MED GENET, V36, P478; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Doll A, 2001, CYTOGENET CELL GENET, V95, P20, DOI 10.1159/000057012; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Frazer KA, 2003, GENOME RES, V13, P341, DOI 10.1101/gr.554603; Gagliardi C, 2003, J MED GENET, V40, P526, DOI 10.1136/jmg.40.7.526; Heller R, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e99; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Howald C, 2006, J MED GENET, V43, P266, DOI 10.1136/jmg.2005.034009; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Karmiloff-Smith A, 2003, J MED GENET, V40, P136, DOI 10.1136/jmg.40.2.136; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; Muller S, 2004, GENOMICS, V84, P458, DOI 10.1016/j.ygeno.2004.05.005; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Osborne LR, 1999, MOL GENET METAB, V67, P1, DOI 10.1006/mgme.1999.2844; Pankau R, 2001, AM J MED GENET, V98, P324, DOI 10.1002/1096-8628(20010201)98:4<324::AID-AJMG1103>3.0.CO;2-5; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urban Z, 2000, HUM GENET, V106, P577, DOI 10.1007/s004390050028; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang MS, 1999, AM J MED GENET, V86, P34, DOI 10.1002/(SICI)1096-8628(19990903)86:1<34::AID-AJMG7>3.3.CO;2-W	57	135	136	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					332	341		10.1086/506371	http://dx.doi.org/10.1086/506371			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826523	Green Published, Bronze			2022-12-18	WOS:000239040400014
J	Funke, B; Finn, CT; Plocik, AM; Lake, S; DeRosse, P; Kane, JM; Kucherlapati, R; Malhotra, AK				Funke, B; Finn, CT; Plocik, AM; Lake, S; DeRosse, P; Kane, JM; Kucherlapati, R; Malhotra, AK			Association of the DTNBP1 locus with schizophrenia in a US population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE DTNBP1; DYSBINDIN GENE; MUSCULAR-DYSTROPHY; RISK HAPLOTYPE; LINKAGE PHASE; 6P22.3 GENE; BRAIN; COMPLEX; IDENTIFICATION; SUBDIVISION	Linkage and association studies have recently implicated dystrobrevin-binding protein 1 (DTNBP1) in the etiology of schizophrenia. We analyzed seven previously tested DTNBP1 single-nucleotide polymorphisms (SNPs) in a cohort of 524 individuals with schizophrenia or schizoaffective disorder and 573 control subjects. The minor alleles of three SNPs (P1578, P1763, and P1765) were positively associated with the diagnosis of schizophrenia or schizoaffective disorder in the white subset of the study cohort (258 cases, 467 controls), with P1578 showing the most significant association (odds ratio 1.76, P = .0026). The same three SNPs were also associated in a smaller Hispanic subset (51 cases, 32 controls). No association was observed in the African American subset (215 cases, 74 controls). A stratified analysis of the white and Hispanic subsets showed association with the minor alleles of four SNPs (P1578, P1763, P1320, and P1765). Again, the most significant association was observed for P1578 (P = .0006). Haplotype analysis supported these findings, with a single risk haplotype significantly overrepresented in the white sample (P = .005). Our study provides further evidence for a role of the DTNBP1 gene in the genetic etiology of schizophrenia.	Harvard Univ, Sch Med, Partners Ctr Genet & Genom, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Zucker Hillside Hosp, Glen Oaks, NY USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Northwell Health	Kucherlapati, R (corresponding author), Harvard Univ, Sch Med, Partners Ctr Genet & Genom, 77 Ave Louis Pasteur,Suite 250, Boston, MA 02115 USA.	rkucherlapati@partners.org		Plocik, Alex/0000-0001-9489-6466	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD034980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH001760] Funding Source: NIH RePORTER; NICHD NIH HHS [HD034980-09] Funding Source: Medline; NIMH NIH HHS [K23MH001760, K23 MH001760] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Anderson JL, 2002, BRAIN, V125, P4, DOI 10.1093/brain/awf012; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Avila MT, 2002, J NERV MENT DIS, V190, P479, DOI 10.1097/00005053-200207000-00010; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U; Collier DA, 2003, EUR J PHARMACOL, V480, P177, DOI 10.1016/j.ejphar.2003.08.105; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Hinton VJ, 2000, NEUROLOGY, V54, P2127, DOI 10.1212/WNL.54.11.2127; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Levinson D.F., 2000, GENETIC INFLUENCES N, P47; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lui Fausta, 2001, Documenta Ophthalmologica, V103, P219, DOI 10.1023/A:1013041713837; MCGUFFIN P, 1995, LANCET, V346, P678, DOI 10.1016/S0140-6736(95)92285-7; Mehler MF, 2000, BRAIN RES REV, V32, P277, DOI 10.1016/S0165-0173(99)00090-9; Morris DW, 2003, SCHIZOPHR RES, V60, P167, DOI 10.1016/S0920-9964(02)00527-3; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; North KN, 1996, NEUROLOGY, V46, P461, DOI 10.1212/WNL.46.2.461; Pankow JS, 2002, AM J HUM GENET, V71, P1478, DOI 10.1086/344582; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336	34	135	137	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					891	898		10.1086/425279	http://dx.doi.org/10.1086/425279			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15362017	Green Published, Bronze			2022-12-18	WOS:000224303500015
J	Urban, Z; Riazi, S; Seidl, TL; Katahira, J; Smoot, LB; Chitayat, D; Boyd, CD; Hinek, A				Urban, Z; Riazi, S; Seidl, TL; Katahira, J; Smoot, LB; Chitayat, D; Boyd, CD; Hinek, A			Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMOOTH-MUSCLE CELLS; ELASTIN/LAMININ-BINDING-PROTEIN; BETA-GALACTOSIDASE; EXTRACELLULAR-MATRIX; DUCTUS-ARTERIOSUS; SPLICED VARIANT; POINT MUTATIONS; GENE; TROPOELASTIN; FIBER	To elucidate the pathomechanism leading to obstructive vascular disease in patients with elastin deficiency, we compared both elastogenesis and proliferation rate of cultured aortic smooth-muscle cells (SMCs) and skin fibroblasts from five healthy control subjects, four patients with isolated supravalvular aortic stenosis (SVAS), and five patients with Williams-Beuren syndrome (WBS). Mutations were determined in each patient with SVAS and in each patient with WBS. Three mutations found in patients with SVAS were shown to result in null alleles. RNA blot hybridization, immunostaining, and metabolic labeling experiments demonstrated that SVAS cells and WBS cells have reduced elastin mRNA levels and that they consequently deposit low amounts of insoluble elastin. Although SVAS cells laid down similar to50% of the elastin made by normal cells, WBS cells deposited only 15% of the elastin made by normal cells. The observed difference in elastin-gene expression was not caused by a difference in the stability of elastin mRNA in SVAS cells compared with WBS cells, but it did indicate that gene-interaction effects may contribute to the complex phenotype observed in patients with WBS. Abnormally low levels of elastin deposition in SVAS cells and in WBS cells were found to coincide with an increase in proliferation rate, which could be reversed by addition of exogenous insoluble elastin. We conclude that insoluble elastin is an important regulator of cellular proliferation. Thus, the reduced net deposition of insoluble elastin in arterial walls of patients with either SVAS or WBS leads to the increased proliferation of arterial SMCs. This results in the formation of multilayer thickening of the tunica media of large arteries and, consequently, in the development of hyperplastic intimal lesions leading to segmental arterial occlusion.	Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada; Univ Hawaii, Pacific Biomed Res Ctr, Honolulu, HI 96822 USA; Hosp Sick Children, Div Clin Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Hawaii System; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Hinek, A (corresponding author), Hosp Sick Children, Div Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	alek.hinek@sickkids.ca	Urban, Zsolt/A-2018-2013; Urban, Zsolt/B-1977-2008; Hinek, Aleksander/V-8790-2019	Urban, Zsolt/0000-0003-3890-1843; Riazi, Sheila/0000-0002-0670-1516	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR016453, RR16453] Funding Source: Medline; NIAMS NIH HHS [AR 467379] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BASHIR MM, 1989, J BIOL CHEM, V264, P8887; BEUREN AJ, 1962, CIRCULATION, V26, P1235, DOI 10.1161/01.CIR.26.6.1235; Boeckel T, 1999, AM J CARDIOL, V83, P1141, DOI 10.1016/S0002-9149(99)00032-6; BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149; CONWAY EE, 1990, J PEDIATR-US, V117, P593, DOI 10.1016/S0022-3476(05)80696-1; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; de Chalain T, 1999, J BIOMED MATER RES, V44, P280, DOI 10.1002/(SICI)1097-4636(19990305)44:3<280::AID-JBM6>3.0.CO;2-H; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; Dedic J, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<81::AID-HUMU30>3.0.CO;2-X; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Dridi SM, 1999, AM J MED GENET, V87, P134, DOI 10.1002/(SICI)1096-8628(19991119)87:2<134::AID-AJMG4>3.3.CO;2-I; EISENBERG R, 1964, AM J DIS CHILD, V108, P341, DOI 10.1001/archpedi.1964.02090010343002; EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057; EWART AK, 1993, P NATL ACAD SCI USA, V90, P3226, DOI 10.1073/pnas.90.8.3226; FAZIO MJ, 1991, AM J HUM GENET, V48, P696; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Fryssira H, 1997, J MED GENET, V34, P306, DOI 10.1136/jmg.34.4.306; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GARVEY W, 1986, STAIN TECHNOL, V61, P60, DOI 10.3109/10520298609110708; Hinek A, 2000, AM J HUM GENET, V66, P859, DOI 10.1086/302829; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436; HINEK A, 1993, J BIOL CHEM, V268, P1405; HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hinek A, 2000, AM J HUM GENET, V67, P23, DOI 10.1086/302968; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Hinek A, 1996, BIOL CHEM, V377, P471; Hinek A, 1996, EXP CELL RES, V225, P122, DOI 10.1006/excr.1996.0163; Iwasaki H, 2000, AM J PHYSIOL-HEART C, V278, pH521, DOI 10.1152/ajpheart.2000.278.2.H521; Ju HS, 1996, CAN J CARDIOL, V12, P1259; Jung S, 1999, GLIA, V25, P179, DOI 10.1002/(SICI)1098-1136(19990115)25:2<179::AID-GLIA8>3.0.CO;2-B; Jung S, 1998, J NEUROPATH EXP NEUR, V57, P439, DOI 10.1097/00005072-199805000-00007; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kamoun A, 1995, CELL ADHES COMMUN, V3, P273, DOI 10.3109/15419069509081013; KAPLAN P, 1995, J PEDIATR-US, V126, P943, DOI 10.1016/S0022-3476(95)70216-4; KUMAR A, 1993, AM J MED GENET, V45, P739, DOI 10.1002/ajmg.1320450614; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; MACLEOD DC, 1994, J AM COLL CARDIOL, V23, P59, DOI 10.1016/0735-1097(94)90502-9; Metcalfe K, 2000, EUR J HUM GENET, V8, P955, DOI 10.1038/sj.ejhg.5200564; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; OAKES BW, 1982, EUR J CELL BIOL, V27, P34; OCONNOR WN, 1985, ARCH PATHOL LAB MED, V109, P179; OLSON TM, 1995, HUM MOL GENET, V4, P1677, DOI 10.1093/hmg/4.9.1677; PasqualiRonchetti I, 1997, MICROSC RES TECHNIQ, V38, P428, DOI 10.1002/(SICI)1097-0029(19970815)38:4<428::AID-JEMT10>3.0.CO;2-L; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; PROSSER IW, 1991, CONNECT TISSUE RES, V25, P265, DOI 10.3109/03008209109029162; REIN AJJT, 1993, J AM COLL CARDIOL, V21, P1727, DOI 10.1016/0735-1097(93)90394-G; Rodems SM, 1998, J VIROL, V72, P2697, DOI 10.1128/JVI.72.4.2697-2707.1998; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; Urban Z, 1999, HUM GENET, V104, P135, DOI 10.1007/s004390050926; Urban Z, 2000, HUM GENET, V106, P577, DOI 10.1007/s004390050028; Urban Z, 2001, HUM GENET, V109, P512, DOI 10.1007/s00439-001-0608-z; Urban Z, 2000, PEDIATR DERMATOL, V17, P12, DOI 10.1046/j.1525-1470.2000.01703.x; von Dadelszen P, 2000, AM J MED GENET, V90, P270, DOI 10.1002/(SICI)1096-8628(20000214)90:4<270::AID-AJMG2>3.0.CO;2-R; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; WACHI H, 1995, BIOCHEM J, V309, P575, DOI 10.1042/bj3090575; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311; ZHANG MC, 1995, J CLIN INVEST, V95, P986, DOI 10.1172/JCI117808	66	135	147	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					30	44		10.1086/341035	http://dx.doi.org/10.1086/341035			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12016585	Green Published, Bronze			2022-12-18	WOS:000176307700004
J	Deng, HW; Deng, HY; Liu, YJ; Liu, YZ; Xu, FH; Shen, H; Conway, T; Li, JL; Huang, QY; Davies, KM; Recker, RR				Deng, HW; Deng, HY; Liu, YJ; Liu, YZ; Xu, FH; Shen, H; Conway, T; Li, JL; Huang, QY; Davies, KM; Recker, RR			A genomewide linkage scan for quantitative-trait loci for obesity phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; AUTOSOMAL GENOMIC SCAN; POSTMENOPAUSAL CAUCASIAN WOMEN; ASSESSING GENETIC-LINKAGE; BONE-MINERAL DENSITY; FAT MASS; UNITED-STATES; DIABETES-MELLITUS; PIMA-INDIANS; FAMILIAL RESEMBLANCE	Obesity is an increasingly serious health problem in the world. Body mass index (BMI), percentage fat mass, and body fat mass are important indices of obesity. For a sample of pedigrees that contains >10,000 relative pairs (including 1,249 sib pairs) that are useful for linkage analyses, we performed a whole-genome linkage scan, using 380 microsatellite markers to identify genomic regions that may contain quantitative-trait loci (QTLs) for obesity. Each pedigree was ascertained through a proband who has extremely low bone mass, which translates into a low BMI. A major QTL for BMI was identified on 2q14 near the marker D2S347 with a LOD score of 4.04 in two-point analysis and a maximum LOD score (MLS) of 4.44 in multipoint analysis. The genomic region near 2q14 also achieved an MLS >2.0 for percentage of fat mass and body fat mass. For the putative QTL on 2q14, as much as 28.2% of BMI variation (after adjustment for age and sex) may be attributable to this locus. In addition, several other genomic regions that may contain obesity-related QTLs are suggested. For example, 1p36 near the marker D1S468 may contain a QTL for BMI variation, with a LOD score of 2.75 in two-point analysis and an MLS of 2.09 in multipoint analysis. The genomic regions identified in this and earlier reports are compared for further exploration in extension studies that use larger samples and/or denser markers for confirmation and fine-mapping studies, to eventually identify major functional genes involved in obesity.	Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68131 USA; Creighton Univ, Dept Biomed Sci, Omaha, NE 68131 USA; Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Peoples R China	Creighton University; Creighton University; Hunan Normal University	Deng, HW (corresponding author), Creighton Univ, Osteoporosis Res Ctr, 601 N 30th St,Suite 6787, Omaha, NE 68131 USA.		Xu, Fuhua/B-8937-2014; Liu, Yaozhong/ABD-5544-2020	XU, FUHUA/0000-0002-8318-1825; Deng, Hong-Wen/0000-0002-0387-8818	NIAMS NIH HHS [R01 AR45349-01, K01 AR002170, K01 AR02170-01] Funding Source: Medline; NIDCD NIH HHS [P01 DC01813-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM60402-01A1, R01 GM060402] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045349, K01AR002170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC001813] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Allison DB, 1996, INT J OBESITY, V20, P501; Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194; Allison DB, 1997, AM J HUM GENET, V60, P676; Allison DB, 2000, MED CLIN N AM, V84, P305, DOI 10.1016/S0025-7125(05)70223-6; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; BOUCHARD C, 1988, INT J OBESITY, V12, P205; Brockmann GA, 1998, GENETICS, V150, P369; Bulik C M, 2001, Obes Rev, V2, P107, DOI 10.1046/j.1467-789x.2001.00030.x; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chagnon YC, 2000, METABOLISM, V49, P203, DOI 10.1016/S0026-0495(00)91299-X; Cheverud JM, 1996, GENETICS, V142, P1305; Chung WK, 1997, GENOMICS, V41, P332, DOI 10.1006/geno.1997.4672; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; de Andrade M, 2000, GENET EPIDEMIOL, V19, P333, DOI 10.1002/1098-2272(200012)19:4<333::AID-GEPI5>3.3.CO;2-R; de Andrade M, 1997, GENET EPIDEMIOL, V14, P773, DOI 10.1002/(SICI)1098-2272(1997)14:6<773::AID-GEPI35>3.0.CO;2-L; Deng HW, 2001, J CLIN DENSITOM, V4, P353, DOI 10.1385/JCD:4:4:353; Deng HW, 2001, J CLIN ENDOCR METAB, V86, P3735, DOI 10.1210/jc.86.8.3735; Deng HW, 2002, GENET EPIDEMIOL, V22, P12, DOI 10.1002/gepi.1040; Deng HW, 2000, GENET EPIDEMIOL, V19, P160, DOI 10.1002/1098-2272(200009)19:2<160::AID-GEPI4>3.0.CO;2-H; Deng HW, 2000, BIOTECHNIQUES, V29, P298, DOI 10.2144/00292st05; Deng HW, 1999, OSTEOPOROSIS INT, V9, P499, DOI 10.1007/s001980050268; Deng HW, 2000, J CLIN ENDOCR METAB, V85, P2748, DOI 10.1210/jc.85.8.2748; DENG HW, IN PRESS GENET RES; DENG HW, IN PRESS ANN HUM GEN; Echwald SM, 1999, J INTERN MED, V245, P653, DOI 10.1046/j.1365-2796.1999.00494.x; Faith MS, 1999, PEDIATRICS, V104, P61, DOI 10.1542/peds.104.1.61; Feitosa MF, 2002, AM J HUM GENET, V70, P72, DOI 10.1086/338144; Fernandez-Real JM, 2000, DIABETES CARE, V23, P831, DOI 10.2337/diacare.23.6.831; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; FORBES GB, 1995, METABOLISM, V44, P1442, DOI 10.1016/0026-0495(95)90144-2; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; GunayAygun M, 1997, BEHAV GENET, V27, P307, DOI 10.1023/A:1025683829856; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; HARRIS JR, 1995, GENET EPIDEMIOL, V12, P251, DOI 10.1002/gepi.1370120303; Hinney A, 2000, J CLIN ENDOCR METAB, V85, P2962, DOI 10.1210/jc.85.8.2962; Hirayama I, 1999, DIABETES, V48, P1183, DOI 10.2337/diabetes.48.5.1183; Horvat S, 2000, MAMM GENOME, V11, P2, DOI 10.1007/s003350010002; Hsueh WC, 2001, J CLIN ENDOCR METAB, V86, P1199, DOI 10.1210/jc.86.3.1199; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Keightley PD, 1996, GENETICS, V142, P227; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kovacs P, 1997, ANN NY ACAD SCI, V827, P94, DOI 10.1111/j.1749-6632.1997.tb51824.x; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lecomte E, 1997, GENET EPIDEMIOL, V14, P51, DOI 10.1002/(SICI)1098-2272(1997)14:1<51::AID-GEPI4>3.0.CO;2-8; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Li JL, 2001, GENOME RES, V11, P1304, DOI 10.1101/gr.159701; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Mitchell BD, 1999, DIABETES, V48, P1863, DOI 10.2337/diabetes.48.9.1863; MOLL PP, 1991, AM J HUM GENET, V49, P1243; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nguyen TV, 1998, AM J EPIDEMIOL, V147, P3; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Perusse L, 1999, NUTR REV, V57, pS31, DOI 10.1111/j.1753-4887.1999.tb01785.x; Perusse L, 2001, OBES RES, V9, P135, DOI 10.1038/oby.2001.17; Pomp D, 1997, BEHAV GENET, V27, P285, DOI 10.1023/A:1025631813018; Rice T, 1997, INT J OBESITY, V21, P1024, DOI 10.1038/sj.ijo.0800511; Rice T, 1999, GENET EPIDEMIOL, V16, P316; RICE T, 1993, AM J HUM GENET, V52, P967; Rice T, 1997, OBES RES, V5, P557; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Sakurai Y, 1997, EUR J EPIDEMIOL, V13, P893, DOI 10.1023/A:1007416322031; Samaras K, 1997, J CLIN ENDOCR METAB, V82, P781, DOI 10.1210/jc.82.3.781; Seidell JC, 1999, ACTA PAEDIATR, V88, P46, DOI 10.1111/j.1651-2227.1999.tb14350.x; SELBY JV, 1991, GENET EPIDEMIOL, V8, P371, DOI 10.1002/gepi.1370080603; Sham PC, 2000, GENET EPIDEMIOL, V19, pS22, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI4>3.0.CO;2-S; Sokal R. R., 1995, BIOMETRY; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Terwilliger JD, 1990, AM J HUM GENET S, V47, pA201; Vaughn TT, 1999, GENET RES, V74, P313, DOI 10.1017/S0016672399004103; VOGLER GP, 1995, INT J OBESITY, V19, P40; Walder K, 2000, INT J OBESITY, V24, P559, DOI 10.1038/sj.ijo.0801197; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; WILSON AF, 1991, AM J HUM GENET, V48, P862; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	95	135	140	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1138	1151		10.1086/339934	http://dx.doi.org/10.1086/339934			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11923910	Green Published, Bronze			2022-12-18	WOS:000175012400006
J	Lunetta, KL; Faraone, SV; Biederman, J; Laird, NM				Lunetta, KL; Faraone, SV; Biederman, J; Laird, NM			Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIT HYPERACTIVITY DISORDER; DOPAMINE TRANSPORTER GENE; TRANSMISSION/DISEQUILIBRIUM TESTS; RECEPTOR POLYMORPHISM; QUANTITATIVE TRAITS; DRD4 GENE; TRANSMISSION; DISEQUILIBRIUM; ADHD; LOCI	We extend the methodology for family-based tests of association and linkage to allow for both variation in the phenotypes of subjects and incorporation of covariates into general-score tests of association. We use standard association models for a phenotype and any number of predictors. Fire then construct a score statistic, using likelihoods for the distribution of phenotype, given genotype. The distribution of the score is computed as a function of offspring genotypes, conditional on parental genotypes and trait values for offspring and parents. This approach provides a natural extension of the transmission/disequilibrium test to any phenotype and to multiple genes or environmental factors and allows the study of gene-gene and gene-environment interaction. When the trait varies among subjects or when covariates are included in the association model, the score statistic depends on one or more nuisance parameters. We suggest two approaches for obtaining parameter estimates: (1) choosing the estimate that minimizes the variance of the test statistic and (2) maximizing the statistic over a nuisance parameter and using a corrected P value. We apply our methods to a sample of families with attention-deficit/hyperactivity disorder and provide examples of how covariates and gene-environment and gene-gene interactions can be incorporated.	Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Massachusetts Gen Hosp, Child Psychiat Serv, Psychopharmacol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Mental Hlth Ctr, Dept Psychiat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lunetta, KL (corresponding author), Dana Farber Canc Inst, Dept Biostat Sci, 44 Binney St, Boston, MA 02115 USA.		Faraone, Stephen/AAE-7334-2019; Faraone, Stephen V/O-7239-2018	Faraone, Stephen/0000-0002-9217-3982; Faraone, Stephen V/0000-0002-9217-3982; Lunetta, Kathryn/0000-0002-9268-810X	NICHD NIH HHS [R01 HD037694] Funding Source: Medline; NIMH NIH HHS [R01 MH057934, R01MH59532, R01MH57934, R01 MH059532, R01MH41314] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH041314, R01MH057934, R01MH059532] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DB, 1997, AM J HUM GENET, V60, P676; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Asherson P, 1998, AM J MED GENET, V81, P549; Castellanos FX, 1998, MOL PSYCHIATR, V3, P431, DOI 10.1038/sj.mp.4000430; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Comings DE, 1999, AM J MED GENET, V88, P358, DOI 10.1002/(SICI)1096-8628(19990820)88:4<358::AID-AJMG13>3.0.CO;2-G; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; COOK EH, 1995, AM J HUM GENET, V56, P993; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Daly G, 1998, AM J MED GENET, V81, P501; DAVIES RB, 1977, BIOMETRIKA, V64, P247, DOI 10.2307/2335690; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Faraone SV, 1999, AM J PSYCHIAT, V156, P768; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Kaplan NL, 1997, AM J HUM GENET, V60, P691; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; Poulton K, 1998, AM J MED GENET, V81, P458; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; RABINOWITZ D, IN PRESS HUM HERED; Rowe DC, 1998, MOL PSYCHIATR, V3, P419, DOI 10.1038/sj.mp.4000432; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Smalley SL, 1998, MOL PSYCHIATR, V3, P427, DOI 10.1038/sj.mp.4000457; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Swanson JM, 1998, MOL PSYCHIATR, V3, P38, DOI 10.1038/sj.mp.4000354; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; Whittaker JC, 1998, AM J HUM GENET, V63, P889, DOI 10.1086/302008	36	135	141	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					605	614		10.1086/302782	http://dx.doi.org/10.1086/302782			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677320	Green Published, Bronze			2022-12-18	WOS:000088373100027
J	Millat, G; Marcais, C; Rafi, MA; Yamamoto, T; Morris, JA; Pentchev, PG; Ohno, K; Wenger, DA; Vanier, MT				Millat, G; Marcais, C; Rafi, MA; Yamamoto, T; Morris, JA; Pentchev, PG; Ohno, K; Wenger, DA; Vanier, MT			Niemann-Pick C1 disease: The I1061T substitutions a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NIEMANN-PICK-DISEASE; CHOLESTEROL ESTERIFICATION; C-DISEASE; HETEROGENEITY	Niemann-Pick type C (NPC) disease is an autosomal recessive lipid-storage disorder usually characterized by hepatosplenomegaly and severe progressive neurological dysfunction, resulting from mutations affecting either the NPC1 gene (in 95% of the patients) or the yet-to-be-identified NPC2 gene. Our initial study of 25 patients with NPC1 identified a T-3182-->C transition that leads to an I1061T substitution in three patients. The mutation, located in exon 21, affects a putative transmembrane domain of the protein. PCR-based tests with genomic DNA were used to survey 115 unrelated patients from around the world with all known clinical and biochemical phenotypes of the disease. The I1061T allele constituted 33 (14.3%) of the 230 disease-causing alleles and was never found in controls (>200 alleles). The mutation was particularly frequent in patients with NPC from Western Europe, especially France (11/62 alleles) and the United Kingdom (9/32 alleles), and in Hispanic patients whose roots were in the Upper Rio Grande valley of the United States. The I1061T mutation originated in Europe and the high frequency in northern Rio Grande Hispanics results from a founder effect. All seven unrelated patients who were homozygous for the mutation and their seven affected siblings had a juvenile-onset neurological disease and severe alterations of intracellular LDL-cholesterol processing. The mutation was not found (0/40 alleles) in patients with the severe infantile neurological form of the disease. Testing for this mutation therefore has important implications for genetic counseling of families affected by NPC.	Ctr Hosp Lyon Sud, Lab Fdn Gillet Merieux, F-69495 Pierre Benite, France; Lyon Sud Sch Med, INSERM, U189, Oullins, France; Thomas Jefferson Univ, Jefferson Med Coll, Dept Neurol, Philadelphia, PA 19107 USA; Tottori Univ, Fac Med, Ctr Gene Res, Yonago, Tottori 683, Japan; Tottori Univ, Fac Med, Dept Neurobiol, Yonago, Tottori 683, Japan; NINDS, Dev & Metab Neurol Branch, Bethesda, MD 20892 USA	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Jefferson University; Tottori University; Tottori University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Vanier, MT (corresponding author), Ctr Hosp Lyon Sud, Lab Fdn Gillet Merieux, Batiment 3B, F-69495 Pierre Benite, France.	vanier@univ-lyon1.fr	MILLAT, Gilles/GWZ-2688-2022					BOWLER LM, 1990, J NEUROSCI RES, V27, P505, DOI 10.1002/jnr.490270411; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CEUTERICK C, 1986, NEUROPEDIATRICS, V17, P111; Fensom AH, 1999, J INHERIT METAB DIS, V22, P84, DOI 10.1023/A:1005463718823; Greer WL, 1998, AM J HUM GENET, V63, P52, DOI 10.1086/301931; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Lange Y, 1998, CURR OPIN STRUC BIOL, V8, P435, DOI 10.1016/S0959-440X(98)80119-X; MACONOCHIE IK, 1989, ARCH DIS CHILD, V64, P1391, DOI 10.1136/adc.64.10_Spec_No.1391; Morris JA, 1999, BIOCHEM BIOPH RES CO, V261, P493, DOI 10.1006/bbrc.1999.1070; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; PATTERSON MC, IN PRESS METABOLIC M; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; Pons G, 1976, Ann Pediatr (Paris), V23, P503; STEINBERG SJ, 1994, J MED GENET, V31, P317, DOI 10.1136/jmg.31.4.317; VANIER MT, 1988, CLIN GENET, V33, P331; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; VANIER MT, 1991, DEV NEUROSCI-BASEL, V13, P307, DOI 10.1159/000112178; Vanier MT, 1996, AM J HUM GENET, V58, P118; Vanier MT, 1998, BRAIN PATHOL, V8, P163; VANIER MT, 1996, NEURODYSTROPHIES NEU, P133; Watari H, 1999, P NATL ACAD SCI USA, V96, P805, DOI 10.1073/pnas.96.3.805; WENGER DA, 1977, AM J DIS CHILD, V131, P955, DOI 10.1001/archpedi.1977.02120220021002; WINSOR EJT, 1978, AM J HUM GENET, V30, P530; Yamamoto T, 1999, HUM GENET, V105, P10, DOI 10.1007/s004390051057	24	135	146	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1321	1329		10.1086/302626	http://dx.doi.org/10.1086/302626			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521297	Green Published, Bronze			2022-12-18	WOS:000083531000013
J	Mastroianni, N; Bettinelli, A; Bianchetti, M; Colussi, G; DeFusco, M; Sereni, F; Ballabio, A; Casari, C				Mastroianni, N; Bettinelli, A; Bianchetti, M; Colussi, G; DeFusco, M; Sereni, F; Ballabio, A; Casari, C			Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHANNEL	A hereditary defect of the distal tubule accounts for the clinical features of Gitelman syndrome (GS), an autosomal recessive disease characterized by hypokalemia, hypomagnesemia, metabolic alkalosis, and hypocalciuria. Recently, we cloned the cDNA coding for the human Na-Cl thiazide-sensitive cotransporter (TSC; also known as ''NCCT'' or ''SLC12A3'') as a possible candidate for GS, and Simon et al., independently, described mutations in patients with GS. Now, we show 12 additional mutations consistent with a loss of function of the Na-CI cotransporter in GS. Two missense replacements, R209W and P349L, are common to both studies and could represent ancient mutations. The other mutations include three deletions, two insertions, and six missense mutations. When all mutations from both studies are considered, missense mutations seem to be more frequently localized within the intracellular domains of the molecule, rather than in transmembrane or extracellular domains. One family, previously reported as a GS form with dominant inheritance, has proved to be recessive, with the affected child being a compound heterozygote. A highly informative intragenic tetranucleotide marker, useful for molecular diagnostic studies, has been identified at the acceptor splice site of exon 9.	TELETHON INST GENET & MED,I-20132 MILAN,ITALY; UNIV MILAN,CLIN PEDIAT 2,MILAN,ITALY; OSPED NIGUARDA CA GRANDA,DIV NEFROL & DIALISI,MILAN,ITALY; UNIV BERN,INSELSPITAL,KINDERKLIN,CH-3010 BERN,SWITZERLAND; UNIV SIENA,DEPT MOL BIOL,I-53100 SIENA,ITALY	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Bern; University Hospital of Bern; University of Siena			Colussi, Giacomo/AFV-2812-2022; BALLABIO, Andrea/AAL-2672-2020; Casari, Giorgio/J-3070-2018; De Fusco, Maurizio/AAN-7358-2020	Colussi, Giacomo/0000-0001-6133-1899; BALLABIO, Andrea/0000-0003-1381-4604; Casari, Giorgio/0000-0002-0115-8980; 	Telethon [TGM94000, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		BETTINELLI A, 1995, KIDNEY INT, V47, P547, DOI 10.1038/ki.1995.68; BETTINELLI A, 1992, J PEDIATR-US, V120, P38, DOI 10.1016/S0022-3476(05)80594-3; COLUSSI G, 1994, MINER ELECTROL METAB, V20, P294; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; KAUPPINEN R, 1995, HUM MOL GENET, V4, P215, DOI 10.1093/hmg/4.2.215; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Mastroianni N, 1996, GENOMICS, V35, P486, DOI 10.1006/geno.1996.0388; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTSU K, 1993, J BIOL CHEM, V268, P3184; PFAFFINGER PJ, 1995, J BIOL CHEM, V270, P28595, DOI 10.1074/jbc.270.48.28595; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; SUTTON RAL, 1992, MINER ELECTROL METAB, V18, P43	12	135	142	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1019	1026						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900229				2022-12-18	WOS:A1996VN90000008
J	SAJANTILA, A; BUDOWLE, B; STROM, M; JOHNSSON, V; LUKKA, M; PELTONEN, L; EHNHOLM, C				SAJANTILA, A; BUDOWLE, B; STROM, M; JOHNSSON, V; LUKKA, M; PELTONEN, L; EHNHOLM, C			PCR AMPLIFICATION OF ALLELES AT THE DIS80-LOCUS - COMPARISON OF A FINNISH AND A NORTH-AMERICAN CAUCASIAN POPULATION-SAMPLE, AND FORENSIC CASEWORK EVALUATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; APOLIPOPROTEIN-B GENE; HYPERVARIABLE REGION; GEL-ELECTROPHORESIS; VARIABLE NUMBER; HUMAN DNA; FINGERPRINTS; DIAGNOSIS; SEQUENCES; LOCI	Allele and genotype frequencies for the highly polymorphic D1S80 locus were determined in a Finnish population sample by using PCR followed by high-resolution PAGE and silver staining, a procedure called the amplified-fragment-length polymorphism (Amp-FLP) technique. In 140 unrelated Finnish individuals 15 alleles and 43 phenotypes were observed. The D1S80 locus demonstrated a heterozygosity of .77, and the power of discrimination was .92 in this sample representing a genetically isolated Finnish population. The distribution of observed genotypes conformed to Hardy-Weinberg expectations. In 36 mother-child pairs Mendelian inheritance for the alleles at the D1S80 locus could be demonstrated in all cases, and no mutations were observed. The usefulness of the D1S80 locus for forensic casework was assessed by using Amp-FLP analysis of the D1S80 locus in 36 forensic cases including 18 rapes, 14 homicides, and 4 other violent crimes. In most cases valuable information was obtained using the Amp-FLP technique, and in no case was there indication of either false-positive or false-negative results.	UNIV HELSINKI,DEPT FORENS MED,SF-00100 HELSINKI 10,FINLAND; FED BUR INVEST ACAD,CTR FORENS SCI RES & TRAINING,QUANTICO,VA	University of Helsinki	SAJANTILA, A (corresponding author), NATL PUBL HLTH INST,MOLEC GENET & FORENS SEROL LABS,MANNERHEIMINTIE 166,SF-00300 HELSINKI,FINLAND.		Sajantila, Antti/AAY-9084-2021	Sajantila, Antti/0000-0003-4117-5248				ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; BUGAWAN TL, 1988, BIO-TECHNOL, V6, P943, DOI 10.1038/nbt0888-943; COMEY CT, 1991, J FORENSIC SCI, V36, P1633; DAQUILA RT, 1991, NUCLEIC ACIDS RES, V19, P3749, DOI 10.1093/nar/19.13.3749; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; HELMINEN P, IN PRESS MOL CELL PR; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; HOCHMEISTER MN, 1991, INT J LEGAL MED, V104, P229, DOI 10.1007/BF01369812; HOCHMEISTER MN, 1991, J FORENSIC SCI, V36, P1649; HORN GT, 1989, NUCLEIC ACIDS RES, V17, P2140, DOI 10.1093/nar/17.5.2140; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; KASAI K, 1990, J FORENSIC SCI, V35, P1196; LUDWIG EH, 1989, AM J HUM GENET, V45, P458; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEI M, 1974, GENETICS, V76, P379; ODELBERG SJ, 1989, GENOMICS, V5, P915, DOI 10.1016/0888-7543(89)90134-1; REYNOLDS R, 1991, ANAL CHEM, V63, P2, DOI 10.1021/ac00001a002; REYNOLDS R, 1991, MAY INT SEM FOR APPL; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAJANTILA A, 1991, FORENSIC SCI INT, V51, P23, DOI 10.1016/0379-0738(91)90203-U; SAJANTILA A, 1991, INT J LEGAL MED, V104, P181, DOI 10.1007/BF01369802; SAJANTILA A, 1992, BIOTECHNIQUES, V12, P16; SINGERSAM J, 1989, AMPLIFICATIONS; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VIHKO P, 1981, AM J CLIN PATHOL, V75, P219; VONBEROLDINGEN CH, 1989, PCR TECHNOLOGY PRINC, P209; VUORIO AF, 1990, BIOCHEM BIOPH RES CO, V170, P616, DOI 10.1016/0006-291X(90)92136-N; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x	32	135	138	0	35	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					816	825						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1347970				2022-12-18	WOS:A1992HL84800018
J	WEIL, D; MATTEI, MG; PASSAGE, E; VANCONG, N; PRIBULACONWAY, D; MANN, K; DEUTZMANN, R; TIMPL, R; CHU, ML				WEIL, D; MATTEI, MG; PASSAGE, E; VANCONG, N; PRIBULACONWAY, D; MANN, K; DEUTZMANN, R; TIMPL, R; CHU, ML			CLONING AND CHROMOSOMAL LOCALIZATION OF HUMAN GENES ENCODING THE 3 CHAINS OF TYPE-VI COLLAGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									THOMAS JEFFERSON UNIV HOSP,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,1020 LOCUST ST,PHILADELPHIA,PA 19107; INSERM,U12,UNITE RECH GENET MED,F-75005 PARIS,FRANCE; INSERM,U242,CTR GENET MED,F-13258 MARSEILLE 09,FRANCE; MAX PLANCK INST BIOCHEM,D-8033 MARTINSRIED,FED REP GER	Jefferson University; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society			Mann, Karlheinz/C-4254-2008		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038912, P01AR038188, R01AR028450] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-28450, AR-38912, AR-38188] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BERNARD MP, 1985, BIOCHEMISTRY-US, V24, P2698, DOI 10.1021/bi00332a016; BOEDTKER H, 1985, ANN NY ACAD SCI, V460, P85, DOI 10.1111/j.1749-6632.1985.tb51159.x; BRUNS RR, 1986, J CELL BIOL, V103, P393, DOI 10.1083/jcb.103.2.393; CARTER WG, 1982, J BIOL CHEM, V257, P13805; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU ML, 1982, NUCLEIC ACIDS RES, V10, P5925, DOI 10.1093/nar/10.19.5925; CHU ML, 1987, EUR J BIOCHEM, V168, P309, DOI 10.1111/j.1432-1033.1987.tb13422.x; CHU ML, 1985, J BIOL CHEM, V260, P2315; DECROMBRUGGHE B, 1985, ANN NY ACAD SCI, V460, P142; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; EMANUEL BS, 1985, AM J HUM GENET, V37, P873; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; GIBSON MA, 1985, J BIOL CHEM, V260, P1149; GRIFFIN CA, 1987, P NATL ACAD SCI USA, V84, P512, DOI 10.1073/pnas.84.2.512; GROBLERRABIE AF, 1985, EMBO J, V4, P1745, DOI 10.1002/j.1460-2075.1985.tb03845.x; GUSELLA JF, 1986, ANNU REV BIOCHEM, V55, P831, DOI 10.1146/annurev.biochem.55.1.831; HELLERHARRISON RA, 1984, J BIOL CHEM, V259, P6858; HENRY I, 1985, CYTOGENET CELL GENET, V40, P650; HESSLE H, 1984, J BIOL CHEM, V259, P3955; HUERRE C, 1982, P NATL ACAD SCI-BIOL, V79, P6627, DOI 10.1073/pnas.79.21.6627; HUERREJEANPIERRE C, 1986, HUM GENET, V73, P64, DOI 10.1007/BF00292666; HUERREJEANPIERRE C, 1986, AM J HUM GENET, V38, P26; JANDER R, 1984, BIOCHEMISTRY-US, V23, P3675, DOI 10.1021/bi00311a016; JANDER R, 1983, EUR J BIOCHEM, V133, P39, DOI 10.1111/j.1432-1033.1983.tb07427.x; JHANWAR SC, 1986, CYTOGENET CELL GENET, V41, P47, DOI 10.1159/000132195; JUNIEN C, 1982, AM J HUM GENET, V34, P381; KNIGHT KR, 1984, BIOCHEM J, V220, P395, DOI 10.1042/bj2200395; KUHN K, 1985, ANN NY ACAD SCI, V460, P14, DOI 10.1111/j.1749-6632.1985.tb51153.x; KURKINEN M, 1985, NATURE, V317, P177, DOI 10.1038/317177a0; LEHRACH H, 1978, P NATL ACAD SCI USA, V75, P5417, DOI 10.1073/pnas.75.11.5417; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LOZANO G, 1985, P NATL ACAD SCI USA, V82, P4050, DOI 10.1073/pnas.82.12.4050; MANIATIS T, 1982, MOL CLONING LABORATO, P280; MARTIN GR, 1985, TRENDS BIOCHEM SCI, V10, P285, DOI 10.1016/0968-0004(85)90089-1; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MYERS JC, 1985, J BIOL CHEM, V260, P5533; NGUYEN VC, 1986, ANN GENET-PARIS, V29, P20; NINOMIYA Y, 1986, J BIOL CHEM, V261, P5041; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; ODERMATT E, 1983, BIOCHEM J, V211, P295, DOI 10.1042/bj2110295; OLSEN BR, 1985, ANN NY ACAD SCI, V460, P141, DOI 10.1111/j.1749-6632.1985.tb51162.x; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; PROWSE KR, 1986, CYTOGENET CELL GENET, V41, P42, DOI 10.1159/000132194; RAMIREZ F, 1985, ANN NY ACAD SCI, V460, P117, DOI 10.1111/j.1749-6632.1985.tb51160.x; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SAKURAI Y, 1986, J BIOL CHEM, V261, P6654; SOININEN R, 1986, EMBO J, V5, P2821, DOI 10.1002/j.1460-2075.1986.tb04574.x; SOLOMON E, 1983, CYTOGENET CELL GENET, V35, P64, DOI 10.1159/000131838; SOLOMON E, 1985, P NATL ACAD SCI USA, V82, P3330, DOI 10.1073/pnas.82.10.3330; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STGEORGEHYSLOP, 1987, SCIENCE, V235, P885; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; Timpl R., 1987, STRUCTURE FUNCTION C, P105, DOI [10.1016/B978--0--12--481280-2.50008---8, DOI 10.1016/B978--0--12--481280-2.50008---8]; TRUEB B, 1985, J CELL BIOL, V100, P638, DOI 10.1083/jcb.100.2.638; TRUEB B, 1986, EMBO J, V5, P2815, DOI 10.1002/j.1460-2075.1986.tb04573.x; TRUEB B, 1984, J BIOL CHEM, V259, P8597; TSIPOURAS P, 1986, HUM GENET, V74, P41; TSIPOURAS P, 1987, J MED GENET, V24, P2, DOI 10.1136/jmg.24.1.2; TSIPOURAS P, 1983, J CLIN INVEST, V72, P1261; UPHOLT WB, 1985, ANN NY ACAD SCI, V46, P130; VONDERMARK H, 1984, EUR J BIOCHEM, V142, P493; WEIL D, 1980, ANN HUM GENET, V44, P11, DOI 10.1111/j.1469-1809.1980.tb00941.x; WEIL D, 1987, NUCLEIC ACIDS RES, V12, P9383; WENSTRUP RJ, 1986, J CLIN INVEST, V78, P1449, DOI 10.1172/JCI112735; WILLIAMS JD, 1975, AM J HUM GENET, V27, P478	67	135	142	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1988	42	3					435	445						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6206	3348212				2022-12-18	WOS:A1988M620600005
J	RAO, DC; LASKARZEWSKI, PM; MORRISON, JA; KHOURY, P; KELLY, K; WETTE, R; RUSSELL, J; GLUECK, CJ				RAO, DC; LASKARZEWSKI, PM; MORRISON, JA; KHOURY, P; KELLY, K; WETTE, R; RUSSELL, J; GLUECK, CJ			THE CINCINNATI LIPID RESEARCH CLINIC FAMILY STUDY - CULTURAL AND BIOLOGICAL DETERMINANTS OF LIPIDS AND LIPOPROTEIN CONCENTRATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CINCINNATI,COLL MED,CLINFO CTR,GEN CLIN RES CTR,LIPID RES CLIN,CINCINNATI,OH 45267	University System of Ohio; University of Cincinnati	RAO, DC (corresponding author), WASHINGTON UNIV,SCH MED,DIV BIOSTAT,ST LOUIS,MO 63110, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH031302, P50MH031302] Funding Source: NIH RePORTER; NHLBI NIH HHS [N0-1-HV-2-2914L] Funding Source: Medline; NIGMS NIH HHS [GM-28719] Funding Source: Medline; NIMH NIH HHS [MH-31302] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ELSTON RC, 1975, BIOMETRIKA, V62, P133, DOI 10.2307/2334495; Fisher R.A., 1921, METRON, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; GARN SM, 1980, CHILDHOOD PREVENTION; GLUECK CJ, 1982, COMPLICATIONS CORONA; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GULBRANDSEN CL, 1977, SOC BIOL, V24, P289, DOI 10.1080/19485565.1977.9988299; GULBRANDSEN CL, 1979, HUM GENET, V50, P307, DOI 10.1007/BF00399397; HEISS G, 1980, CIRCULATION, V61, P302, DOI 10.1161/01.CIR.61.2.302; KELLY KK, 1982, UNPUB COLLABORATIVE; KRIEGER H, 1980, HUMAN GENETICS, V53, P261; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LASKARZEWSKI PM, 1983, HUM HERED; MORRISON JA, 1978, PEDIATRICS, V62, P468; MORRISON JA, 1982, METABOLISM, V131, P158; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1980, HUM GENET, V53, P261; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; RAO DC, 1979, GENET RES, V33, P175, DOI 10.1017/S0016672300018310; RAO DC, 1979, AM J MED GENET, V4, P39, DOI 10.1002/ajmg.1320040106; TYROLER HA, 1979, GENETIC ANAL COMMON, P647	20	135	135	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					888	903						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	PU211	7180846				2022-12-18	WOS:A1982PU21100007
J	Carss, KJ; Stevens, E; Foley, AR; Cirak, S; Riemersma, M; Torelli, S; Hoischen, A; Willer, T; van Scherpenzeel, M; Moore, SA; Messina, S; Bertini, E; Bonnemann, CG; Abdenur, JE; Grosmann, CM; Kesari, A; Punetha, J; Quinlivan, R; Waddell, LB; Young, HK; Wraige, E; Yau, S; Brodd, L; Feng, L; Sewry, C; MacArthur, DG; North, KN; Hoffinan, E; Stemple, DL; Hurles, ME; van Bokhoven, H; Campbell, KP; Lefeber, DJ; Lin, YY; Muntoni, F				Carss, Keren J.; Stevens, Elizabeth; Foley, A. Reghan; Cirak, Sebahattin; Riemersma, Moniek; Torelli, Silvia; Hoischen, Alexander; Willer, Tobias; van Scherpenzeel, Monique; Moore, Steven A.; Messina, Sonia; Bertini, Enrico; Boennemann, Carsten G.; Abdenur, Jose E.; Grosmann, Carla M.; Kesari, Akanchha; Punetha, Jaya; Quinlivan, Ros; Waddell, Leigh B.; Young, Helen K.; Wraige, Elizabeth; Yau, Shu; Brodd, Lina; Feng, Lucy; Sewry, Caroline; MacArthur, Daniel G.; North, Kathryn N.; Hoffinan, Eric; Stemple, Derek L.; Hurles, Matthew E.; van Bokhoven, Hans; Campbell, Kevin P.; Lefeber, Dirk J.; Lin, Yung-Yao; Muntoni, Francesco		UK10K consortium	Mutations in GDP-Mannose Pyrophosphorylase B Cause Congenital and Limb-Girdle Muscular Dystrophies Associated with Hypoglycosylation of alpha-Dystroglycan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-WALL INTEGRITY; O-GLYCAN STRUCTURES; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; GENE; ZEBRAFISH; EXPRESSION; FORM; IDENTIFICATION; DEFICIENCY	Congenital muscular dystrophies with hypoglycosylation of alpha-dystroglycan (alpha-DG) are a heterogeneous group of disorders often associated with brain and eye defects in addition to muscular dystrophy. Causative variants in 14 genes thought to be involved in the glycosylation of alpha-DG have been identified thus far. Allelic mutations in these genes might also cause milder limb-girdle muscular dystrophy phenotypes. Using a combination of exome and Sanger sequencing in eight unrelated individuals, we present evidence that mutations in guanosine diphosphate mannose (GDP-mannose) pyrophosphorylase B (GMPPB) can result in muscular dystrophy variants with hypoglycosylated alpha-DG. GMPPB catalyzes the formation of GDP-mannose from GTP and mannose-l-phosphate. GDP-mannose is required for O-mannosylation of proteins, including alpha-DG, and it is the substrate of cytosolic mannosyltransferases. We found reduced alpha-DG glycosylation in the muscle biopsies of affected individuals and in available fibroblasts. Overexpression of wild-type GMPPB in fibroblasts from an affected individual partially restored glycosylation of alpha-DG. Whereas wild-type GMPPB localized to the cytoplasm, five of the identified missense mutations caused formation of aggregates in the cytoplasm or near membrane protrusions. Additionally, knockdown of the GMPPB ortholog in zebrafish caused structural muscle defects with decreased motility, eye abnormalities, and reduced glycosylation of alpha-DG. Together, these data indicate that GMPPB mutations are responsible for congenital and limb-girdle muscular dystrophies with hypoglycosylation of alpha-DG.	[Carss, Keren J.; Stemple, Derek L.; Hurles, Matthew E.; Lin, Yung-Yao] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Stevens, Elizabeth; Foley, A. Reghan; Cirak, Sebahattin; Torelli, Silvia; Quinlivan, Ros; Feng, Lucy; Sewry, Caroline; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Cirak, Sebahattin; Kesari, Akanchha; Punetha, Jaya; Hoffinan, Eric] Childrens Natl Med Ctr, Res Ctr Genet Med, Washington, DC 20010 USA; [Riemersma, Moniek; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Neurol, NL-6525 HB Nijmegen, Netherlands; [Riemersma, Moniek; van Scherpenzeel, Monique; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Lab Med, NL-6525 HB Nijmegen, Netherlands; [Riemersma, Moniek; Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Human Genet,Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Willer, Tobias; Campbell, Kevin P.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Moore, Steven A.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Messina, Sonia] Univ Messina, Azienda Osped Univ Policlin G Martino, Dept Neurosci, I-98125 Messina, Italy; [Bertini, Enrico] Bambino Gesu Childrens Res Hosp, Mol Med Lab, I-00146 Rome, Italy; [Boennemann, Carsten G.] NINDS, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Abdenur, Jose E.] Childrens Hosp Orange Cty, Div Metab Disorders, Orange, CA 92868 USA; [Abdenur, Jose E.] Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA 92697 USA; [Grosmann, Carla M.] Univ Calif San Diego, Rady Childrens Hosp, Sch Med, Dept Neurosci, San Diego, CA 92123 USA; [Grosmann, Carla M.] Univ Calif San Diego, Rady Childrens Hosp, Sch Med, Dept Pediat, San Diego, CA 92123 USA; [Punetha, Jaya; Hoffinan, Eric] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20037 USA; [Quinlivan, Ros] Natl Hosp Neurol & Neurosurg, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Waddell, Leigh B.; North, Kathryn N.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia; [Young, Helen K.] Childrens Hosp Westmead, Dept Neurogenet, Sydney, NSW 2145, Australia; [Young, Helen K.] Univ Sydney, Royal N Shore Hosp, Northern Clin Sch, St Leonards, NSW 2065, Australia; [Wraige, Elizabeth] Guys & St Thomas NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat Neurol, London SE1 7EH, England; [Yau, Shu; Brodd, Lina] GSTS Pathol, DNA Lab, London SE1 9RT, England; [Sewry, Caroline] Robert Jones & Agnes Hunt Orthopaed Hosp NHS Fdn, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry SY10 7AG, Shrops, England; [MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [MacArthur, Daniel G.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [North, Kathryn N.] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [North, Kathryn N.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Lin, Yung-Yao] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England	Wellcome Trust Sanger Institute; University of London; University College London; Children's National Health System; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; AOU Policlinico Gaetano Martino; University of Messina; IRCCS Bambino Gesu; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Childrens Hospital of Orange County; University of California System; University of California Irvine; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; George Washington University; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; Guy's & St Thomas' NHS Foundation Trust; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Sydney; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Radboud University Nijmegen; Radboud University Nijmegen; University of London; Queen Mary University London	Muntoni, F (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England.	f.muntoni@ucl.ac.uk	McQuillin, Andrew/C-1623-2008; Cirak, Sebahattin/AAZ-6829-2020; Asimit, Jennifer/P-7567-2017; Bertini, Enrico/ABG-1278-2020; van Bokhoven, Hans/D-8764-2012; Jamshidi, Yalda/AAL-1377-2020; Zheng, Houfeng/K-4424-2012; Waddell, Leigh/L-3037-2017; Schmidts, Miriam/A-3777-2012; Hoischen, Alexander/AGF-7293-2022; Cirak, Sebahattin/AAX-9593-2020; Bokhoven, J.H.L.M. van van/H-8015-2014; van Scherpenzeel, Monique/N-7008-2015; Hoischen, Alexander/D-1282-2013; Lefeber, Dirk DJ/A-2146-2014; Bertini, Enrico/A-2284-2014; North, Kathryn N/K-6476-2012; Moayyeri, Alireza/N-3332-2014; Collier, David/D-1649-2011; Scambler, Peter/C-4998-2008	McQuillin, Andrew/0000-0003-1567-2240; Asimit, Jennifer/0000-0002-4857-2249; Jamshidi, Yalda/0000-0003-0151-6482; Zheng, Houfeng/0000-0001-5681-8598; Waddell, Leigh/0000-0003-2970-6624; Schmidts, Miriam/0000-0002-1714-6749; Hoischen, Alexander/0000-0002-8072-4476; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; van Scherpenzeel, Monique/0000-0002-9696-4562; Hoischen, Alexander/0000-0002-8072-4476; Bertini, Enrico/0000-0001-9276-4590; North, Kathryn N/0000-0003-0841-8009; Moayyeri, Alireza/0000-0002-9143-2161; Ritchie, Graham/0000-0002-6456-9736; Quinlivan, Rosaline/0000-0002-2306-4782; Bochukova, Elena/0000-0003-0275-1548; Zeggini, Eleftheria/0000-0003-4238-659X; Lin, Yung-Yao/0000-0002-0435-7694; Kelly, Kirsten/0000-0003-4234-543X; Hoffman, Eric/0000-0001-6470-5139; McKechanie, Andrew/0000-0003-4273-9906; Campbell, Kevin/0000-0003-2066-5889; Futema, Marta/0000-0002-2120-2088; Lee, Irene O./0000-0003-0004-6802; Savage, David Bousfield/0000-0002-7857-7032; Moore, Steven/0000-0002-6353-7900; Suvisaari, Jaana/0000-0001-7167-0990; Messina, Sonia/0000-0001-7994-3391; Farooqi, Sadaf/0000-0001-7609-3504; Collier, David/0000-0003-4087-1559; Punetha, Jaya/0000-0002-6774-4464; Scambler, Peter/0000-0002-1487-4628; Walter, Klaudia/0000-0003-4448-0301; MacArthur, Daniel/0000-0002-5771-2290; Wilson, Scott/0000-0002-0357-1373; Anney, Richard/0000-0002-6083-407X; Humphries, Stephen E/0000-0002-8221-6547; Semple, Robert Kenneth/0000-0001-6539-3069; Carss, Keren/0000-0003-4939-156X; Grosmann, Carla/0000-0002-4752-0797	Wellcome Trust [WT091310]; MRC [MR/K000608/1] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129, R01NS029525] Funding Source: NIH RePORTER; Medical Research Council [MR/K000608/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/924, RA4/0924] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK	This study makes use of data generated by the UK10K Consortium. A full list of the investigators who contributed to the generation of the data is available at http://www.uk10k.org/publications_and_posters.html. Funding for UK10K was provided by the Wellcome Trust under award WT091310. We are grateful to the UK10K consortium for making this study possible. Acknowledgments are continued in the Supplemental Data.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Barone R, 2012, ANN NEUROL, V72, P550, DOI 10.1002/ana.23632; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bouchet C, 2007, HUM MUTAT, V28, P1020, DOI 10.1002/humu.20561; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Chiba A, 1997, J BIOL CHEM, V272, P2156; Cirak S, 2013, BRAIN, V136, P269, DOI 10.1093/brain/aws312; Clement EM, 2008, ARCH NEUROL-CHICAGO, V65, P137, DOI 10.1001/archneurol.2007.2; Davis AJ, 2004, J BIOL CHEM, V279, P12462, DOI 10.1074/jbc.M312365200; Denton H, 2010, BIOCHEM J, V425, P603, DOI 10.1042/BJ20090896; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P16; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; Endo T, 2003, BIOL PHARM BULL, V26, P1641, DOI 10.1248/bpb.26.1641; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Herzog C, 2004, J INVEST DERMATOL, V122, P1372, DOI 10.1111/j.0022-202X.2004.22605.x; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jiang HC, 2008, MICROBIOL-SGM, V154, P2730, DOI 10.1099/mic.0.2008/019240-0; Keller R, 1999, PLANT J, V19, P131, DOI 10.1046/j.1365-313X.1999.00507.x; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lefeber DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002427; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YY, 2011, HUM MOL GENET, V20, P1763, DOI 10.1093/hmg/ddr059; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Maeda Y, 2008, BBA-GEN SUBJECTS, V1780, P861, DOI 10.1016/j.bbagen.2008.03.005; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Manzini MC, 2008, HUM MUTAT, V29, pE231, DOI 10.1002/humu.20844; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mercuri E, 2009, NEUROLOGY, V72, P1802, DOI 10.1212/01.wnl.0000346518.68110.60; Messina S, 2009, NEUROLOGY, V73, P1599, DOI 10.1212/WNL.0b013e3181c0d47a; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mostacciuolo ML, 1996, HUM GENET, V97, P277, DOI 10.1007/BF02185752; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; Parsons MJ, 2002, DEVELOPMENT, V129, P3505; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Rafiq MA, 2011, AM J HUM GENET, V89, P176, DOI 10.1016/j.ajhg.2011.06.006; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; SCHULER F, 1995, J CELL SCI, V108, P3795; Sharma V, 2011, J BIOL CHEM, V286, P39431, DOI 10.1074/jbc.M111.285502; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Warit S, 2000, MOL MICROBIOL, V36, P1156, DOI 10.1046/j.1365-2958.2000.01944.x; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Wright KM, 2012, NEURON, V76, P931, DOI 10.1016/j.neuron.2012.10.009; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhang NS, 1999, MICROBIOL-UK, V145, P309, DOI 10.1099/13500872-145-2-309	63	134	138	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					29	41		10.1016/j.ajhg.2013.05.009	http://dx.doi.org/10.1016/j.ajhg.2013.05.009			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23768512	Green Published, hybrid			2022-12-18	WOS:000321804500003
J	Palamara, PF; Lencz, T; Darvasi, A; Pe'er, I				Palamara, Pier Francesco; Lencz, Todd; Darvasi, Ariel; Pe'er, Itsik			Length Distributions of Identity by Descent Reveal Fine-Scale Demographic History	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETECTING ANCIENT ADMIXTURE; ALLELE FREQUENCY-SPECTRUM; LINKAGE DISEQUILIBRIUM; STATISTICAL-MODEL; GENOME; RARE; INFERENCE; VARIANTS; STRATIFICATION; HOMOZYGOSITY	Data-driven studies of identity by descent (IBD) were recently enabled by high-resolution genomic data from large cohorts and scalable algorithms for IBD detection. Yet, haplotype sharing currently represents an underutilized source of information for population-genetics research. We present analytical results on the relationship between haplotype sharing across purportedly unrelated individuals and a population's demographic history. We express the distribution of IBD sharing across pairs of individuals for segments of arbitrary length as a function of the population's demography, and we derive an inference procedure to reconstruct such demographic history. The accuracy of the proposed reconstruction methodology was extensively tested on simulated data. We applied this methodology to two densely typed data sets: 500 Ashkenazi Jewish (AJ) individuals and 56 Kenyan Maasai (MKK) individuals (HapMap 3 data set). Reconstructing the demographic history of the AJ cohort, we recovered two subsequent population expansions, separated by a severe founder event, consistent with previous analysis of lower-throughput genetic data and historical accounts of AJ history. In the MKK cohort, high levels of cryptic relatedness were detected. The spectrum of IBD sharing is consistent with a demographic model in which several small-sized denies intermix through high migration rates and result in enrichment of shared long-range haplotypes. This scenario of historically structured demographies might explain the unexpected abundance of runs of homozygosity within several populations.	[Palamara, Pier Francesco; Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Lencz, Todd] N Shore Long Isl Jewish Hlth Syst, Zucker Hillside Hosp Div, Div Res, Div Psychiat, Glen Oaks, NY 11004 USA; [Darvasi, Ariel] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Pe'er, Itsik] Columbia Univ, Columbia Initiat Syst Biol, New York, NY 10032 USA	Columbia University; Northwell Health; Hebrew University of Jerusalem; Columbia University	Pe'er, I (corresponding author), Columbia Univ, Dept Comp Sci, New York, NY 10027 USA.	itsik@cs.columbia.edu	Lencz, Todd/J-3418-2014	Lencz, Todd/0000-0001-8586-338X; Palamara, Pier Francesco/0000-0002-7999-1972	National Science Foundation [08929882, 0845677]; National Institutes of Health [U54 CA121852-06]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank Sharon Browning and two anonymous reviewers for their comments on a submitted draft. P.P. and I.P. were supported by National Science Foundation grants 08929882 and 0845677 and National Institutes of Health grant U54 CA121852-06.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bonnen PE, 2010, EUR J HUM GENET, V18, P309, DOI 10.1038/ejhg.2009.180; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Coast E, 2001, THESIS U LONDON; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Griffiths R., 1991, IMS LECT NOTES MONOG, V18, P100; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Gusev A, 2012, MOL BIOL EVOL, V29, P473, DOI 10.1093/molbev/msr133; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Henn BM, 2010, HUM MOL GENET, V19, pR221, DOI 10.1093/hmg/ddq403; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Liang LM, 2007, BIOINFORMATICS, V23, P1565, DOI 10.1093/bioinformatics/btm138; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McEvoy BP, 2011, GENOME RES, V21, P821, DOI 10.1101/gr.119636.110; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Slatkin M, 2004, AM J HUM GENET, V75, P282, DOI 10.1086/423146; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wall JD, 2000, GENETICS, V154, P1271; Wall JD, 2006, CURR OPIN GENET DEV, V16, P606, DOI 10.1016/j.gde.2006.09.006; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; Waxman M., 1950, JEWISH SOC STUD, V12, P385; Wegmann D, 2010, MOL BIOL EVOL, V27, P1425, DOI 10.1093/molbev/msq028; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1943, GENETICS, V28, P114; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	58	134	138	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					809	822		10.1016/j.ajhg.2012.08.030	http://dx.doi.org/10.1016/j.ajhg.2012.08.030			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23103233	Green Published, Bronze			2022-12-18	WOS:000311011400004
J	Huang, LJ; Szymanska, K; Jensen, VL; Janecke, AR; Innes, AM; Davis, EE; Frosk, P; Li, CM; Willer, JR; Chodirker, BN; Greenberg, CR; McLeod, DR; Bernier, FP; Chudley, AE; Muller, T; Shboul, M; Logan, CV; Loucks, CM; Beaulieu, CL; Bowie, RV; Bell, SM; Adkins, J; Zuniga, FI; Ross, KD; Wang, J; Ban, MR; Becker, C; Nurnberg, P; Douglas, S; Craft, CM; Akimenko, MA; Hegele, RA; Ober, C; Utermann, G; Bolz, HJ; Bulman, DE; Katsanis, N; Blacque, OE; Doherty, D; Parboosingh, JS; Leroux, MR; Johnson, CA; Boycott, KM				Huang, Lijia; Szymanska, Katarzyna; Jensen, Victor L.; Janecke, Andreas R.; Innes, A. Micheil; Davis, Erica E.; Frosk, Patrick; Li, Chunmei; Willer, Jason R.; Chodirker, Bernard N.; Greenberg, Cheryl R.; McLeod, D. Ross; Bernier, Francois P.; Chudley, Albert E.; Mueller, Thomas; Shboul, Mohammad; Logan, Clare V.; Loucks, Catrina M.; Beaulieu, Chandree L.; Bowie, Rachel V.; Bell, Sandra M.; Adkins, Jonathan; Zuniga, Freddi I.; Ross, Kevin D.; Wang, Jian; Ban, Matthew R.; Becker, Christian; Nuernberg, Peter; Douglas, Stuart; Craft, Cheryl M.; Akimenko, Marie-Andree; Hegele, Robert A.; Ober, Carole; Utermann, Gerd; Bolz, Hanno J.; Bulman, Dennis E.; Katsanis, Nicholas; Blacque, Oliver E.; Doherty, Dan; Parboosingh, Jillian S.; Leroux, Michel R.; Johnson, Colin A.; Boycott, Kym M.			TMEM237 Is Mutated in Individuals with a Joubert Syndrome Related Disorder and Expands the Role of the TMEM Family at the Ciliary Transition Zone	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARDET-BIEDL-SYNDROME; MECKEL-GRUBER-SYNDROME; BASAL BODY PROTEIN; PLANAR CELL POLARITY; OCULO-RENAL SYNDROME; CAENORHABDITIS-ELEGANS; CENTROSOMAL PROTEIN; ACTIN CYTOSKELETON; DISEASE GENES; MUTATIONS	Joubert syndrome related disorders (JSRDs) have broad but variable phenotypic overlap with other ciliopathies. The molecular etiology of this overlap is unclear but probably arises from disrupting common functional module components within primary cilia. To identify additional module elements associated with JSRDs, we performed homozygosity mapping followed by next-generation sequencing (NGS) and uncovered mutations in TMEM237 (previously known as ALS2CR4). We show that loss of the mammalian TMEM237, which localizes to the ciliary transition zone (TZ), results in defective ciliogenesis and deregulation of Wnt signaling. Furthermore, disruption of Dania redo (zebrafish) tmem237 expression produces gastrulation defects consistent with ciliary dysfunction, and Caenorhabditis elegans jbts-14 genetically interacts with nphp-4, encoding another TZ protein, to control basal body-TZ anchoring to the membrane and cilio-genesis. Both mammalian and C. elegans TMEM237/JBTS-14 require RPGRIP1L/MKS5 for proper TZ localization, and we demonstrate additional functional interactions between C. elegans JBTS-14 and MKS-2/TMEM216, MKSR-1/B9D1, and MKSR-2/B9D2. Collectively, our findings integrate TMEM237/JBTS-14 in a complex interaction network of TZ-associated proteins and reveal a growing contribution of a TZ functional module to the spectrum of ciliopathy phenotypes.	[Jensen, Victor L.; Li, Chunmei; Leroux, Michel R.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Huang, Lijia; Beaulieu, Chandree L.; Douglas, Stuart; Boycott, Kym M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Szymanska, Katarzyna; Logan, Clare V.; Bell, Sandra M.; Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Janecke, Andreas R.; Mueller, Thomas] Innsbruck Med Univ, Dept Pediat 2, A-6020 Innsbruck, Austria; [Janecke, Andreas R.; Utermann, Gerd] Innsbruck Med Univ, Div Human Genet, A-6020 Innsbruck, Austria; [Innes, A. Micheil; McLeod, D. Ross; Bernier, Francois P.; Loucks, Catrina M.; Parboosingh, Jillian S.] Univ Calgary, Dept Med Genet, Calgary, AB T3B 6A8, Canada; [Davis, Erica E.; Willer, Jason R.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Med Ctr, Durham, NC 27710 USA; [Frosk, Patrick; Chodirker, Bernard N.; Greenberg, Cheryl R.; Chudley, Albert E.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3R 0J9, Canada; [Shboul, Mohammad] Inst Med Biol Human Embryol, Singapore 138648, Singapore; [Bowie, Rachel V.; Blacque, Oliver E.] Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Adkins, Jonathan; Doherty, Dan] Univ Washington, Div Med Genet, Dept Pediat, Seattle, WA 98195 USA; [Zuniga, Freddi I.; Craft, Cheryl M.] Doheny Eye Inst, Mary D Allen Lab Vis Res, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Zuniga, Freddi I.; Craft, Cheryl M.] Doheny Eye Inst, Mary D Allen Lab Vis Res, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Ross, Kevin D.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Wang, Jian; Ban, Matthew R.; Hegele, Robert A.] Robarts Res Inst, London, ON N6A 5C1, Canada; [Wang, Jian; Ban, Matthew R.; Hegele, Robert A.] Univ Western Ontario, London, ON N6A 5C1, Canada; [Becker, Christian; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Akimenko, Marie-Andree] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; [Bolz, Hanno J.] Ctr Human Genet, D-55218 Ingelheim, Germany; [Bolz, Hanno J.] Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Bulman, Dennis E.] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Bulman, Dennis E.] Univ Ottawa, Ottawa, ON K1H 8L6, Canada	Simon Fraser University; University of Ottawa; Children's Hospital of Eastern Ontario; Saint James's University Hospital; University of Leeds; Medical University of Innsbruck; Medical University of Innsbruck; University of Calgary; Duke University; University of Manitoba; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University College Dublin; University of Washington; University of Washington Seattle; Doheny Eye Institute; Doheny Eye Institute; University of Chicago; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Cologne; University of Cologne; University of Ottawa; University of Cologne; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Leroux, MR (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	leroux@sfu.ca; kboycott@cheo.on.ca	Bernier, Francois/AAP-2174-2020; innes, allan micheil/A-9955-2017; Douglas, Stuart/K-6292-2019; Hegele, Robert/AAF-6482-2020; Katsanis, Nicholas/E-1837-2012; Janecke, Andreas/AAA-5227-2019; Hegele, Robert/G-3301-2011; Blacque, Oliver/AAL-8860-2021; Bernier, Francois/V-7150-2018	Hegele, Robert/0000-0003-2861-5325; Katsanis, Nicholas/0000-0002-2480-0171; Loucks, Catrina/0000-0003-1167-3721; Innes, Micheil/0000-0001-9881-5467; Jensen, Victor/0000-0002-9039-4319; Willer, Jason/0000-0002-5869-3992; Janecke, Andreas/0000-0001-7155-0315; Bernier, Francois/0000-0001-7063-4269; Frosk, Patrick/0000-0002-9673-795X; Blacque, Oliver/0000-0003-1598-2695; Davis, Erica/0000-0002-2412-8397; Johnson, Colin/0000-0002-2979-8234; Bell, Sandra/0000-0002-3022-9864; Ober, Carole/0000-0003-4626-9809; Logan, Clare/0000-0003-4323-1602	Genome Canada; National Human Genome Research Institute [HG 005921]; Michael Smith Foundation for Health Research (MSFHR); Austrian Science Foundation (FWF) [P18470]; Dr.-Legerlotz foundation Austria; National Institutes of Health (NIH) [R01EY021872]; Canadian Insitutes of Health Research (CIHR); Tiroler Wissenschaftsfonds; NIH [EY015851, EY03040, 1F31GM079910, R01HD04260, R01DK072301, R01DK075972, KL2RR025015, R01NS064077]; Gertrud-Kusen-Stiftung; Science Foundation Ireland President of Ireland [06/Y12/B928]; Alberta Children's Hospital Foundation; March of Dimes; MSFHR; Sir Jules Thorn Charitable Trust [09/JTA]; European Community [241955]; SickKids Foundation/CIHR IHDCYH [NI10-008]; CIHR Institute of Genetics; Genome British Columbia; Canadian Insitutes of Health Research [CIHR]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021872, R01EY015851, P30EY003040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM079910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064077] Funding Source: NIH RePORTER; MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Genome Canada(Genome Canada); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Dr.-Legerlotz foundation Austria; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Insitutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tiroler Wissenschaftsfonds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gertrud-Kusen-Stiftung; Science Foundation Ireland President of Ireland(Science Foundation Ireland); Alberta Children's Hospital Foundation; March of Dimes(March of Dimes); MSFHR(Michael Smith Foundation for Health Research); Sir Jules Thorn Charitable Trust; European Community(European Commission); SickKids Foundation/CIHR IHDCYH(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Genetics(Canadian Institutes of Health Research (CIHR)); Genome British Columbia; Canadian Insitutes of Health Research [CIHR](Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust	We thank the families for participation in this study, L. Racacho (D.E.B.) and J. Zhang (M.-A.A.) for technical support, R.T. Moon at University of Washington for the Topflash and Fopflash constructs, and D.G. Moerman (University of British Columbia; funded by Genome Canada, Genome British Columbia, and Canadian Insitutes of Health Research [CIHR]) and R. Waterston (University of Washington; funded by American Recovery and Reinvestment Act grant HG 005921 from the National Human Genome Research Institute) for the C. elegans jbts-14 mutant strain. V.L.J. was supported by a postdoctoral fellowship from the Michael Smith Foundation for Health Research (MSFHR). A.R.J. received funding from the Austrian Science Foundation (FWF grant P18470) and the Dr.-Legerlotz foundation Austria. E.E.D. is supported by National Institutes of Health (NIH) grant R01EY021872. P.F. and C.M.L. were supported by the Canadian Insitutes of Health Research (CIHR) Training Program in Genetics, Child Development, and Health. T.M. received funding from the Tiroler Wissenschaftsfonds. C.M.C. is the Mary D. Allen Chair and acknowledges funding from NIH EY015851, EY03040, 1F31GM079910, and Research to Prevent Blindness. H.J.B. received funding from the Gertrud-Kusen-Stiftung. N.K. acknowledges funding from NIH R01HD04260, R01DK072301, and R01DK075972 and is the Distinguished George W. Brumley Professor. O.E.B. acknowledges a Science Foundation Ireland President of Ireland Young Researcher Award (06/Y12/B928). D.D. is funded by the NIH grants KL2RR025015 and R01NS064077. J.S.P acknowledges funding from the Alberta Children's Hospital Foundation. M.R.L. is funded by the March of Dimes and a senior scholar award from the MSFHR. C.A.J. acknowledges funding from a Sir Jules Thorn Charitable Trust Biomedical Research Award (09/JTA). C.A.J. and N.K. are supported by the European Community's Seventh Framework Programme FP7/2009 under grant agreement 241955, SYSCILIA. K.M.B. is funded by the SickKids Foundation/CIHR IHDCYH (NI10-008), and a Clinical Investigatorship Award from the CIHR Institute of Genetics.	[Anonymous], NCBI NUCL DAT; [Anonymous], 2010, NCBI PROT DAT; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Bialas NJ, 2009, J CELL SCI, V122, P611, DOI 10.1242/jcs.028621; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Boulin T, 2007, NAT PROTOC, V2, P1276, DOI 10.1038/nprot.2007.192; Boycott KM, 2007, AM J MED GENET A, V143A, P1715, DOI 10.1002/ajmg.a.31832; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; CULOTTI JG, 1978, GENETICS, V90, P243; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dowdle WE, 2011, AM J HUM GENET, V89, P94, DOI 10.1016/j.ajhg.2011.06.003; Edvardson S, 2010, AM J HUM GENET, V86, P93, DOI 10.1016/j.ajhg.2009.12.007; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Hopp K, 2011, HUM MOL GENET, V20, P2524, DOI 10.1093/hmg/ddr151; INGLIS PN, 2007, C ELEGANS RES COMMUN, DOI DOI 10.1895/WORMBOOK.1.126.2; Janecke AR, 2004, J PEDIATR-US, V144, P264, DOI 10.1016/j.jpeds.2003.11.010; Jauregui AR, 2005, EXP CELL RES, V305, P333, DOI 10.1016/j.yexcr.2005.01.008; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Johnson JLF, 2010, TRENDS CELL BIOL, V20, P435, DOI 10.1016/j.tcb.2010.05.005; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Logan CV, 2011, MOL NEUROBIOL, V43, P12, DOI 10.1007/s12035-010-8154-0; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; NCBI, NAT CTR BIOT INF NCB; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Parisi MA, 2009, AM J MED GENET C, V151C, P326, DOI 10.1002/ajmg.c.30229; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; SCHURIG V, 1980, AM J MED GENET, V5, P373, DOI 10.1002/ajmg.1320050408; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Williams CL, 2010, J AM SOC NEPHROL, V21, P782, DOI 10.1681/ASN.2009060597; Winkelbauer ME, 2005, J CELL SCI, V118, P5575, DOI 10.1242/jcs.02665; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wolf MTF, 2011, PEDIATR NEPHROL, V26, P181, DOI 10.1007/s00467-010-1585-z; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; *ZEBR, ZEBR MOD ORG DAT; Zuniga FI, 2010, INVEST OPHTH VIS SCI, V51, P4407, DOI 10.1167/iovs.10-5251; ENTREZ GENE	74	134	144	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					713	730		10.1016/j.ajhg.2011.11.005	http://dx.doi.org/10.1016/j.ajhg.2011.11.005			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22152675	Green Published, Bronze			2022-12-18	WOS:000298208700003
J	Bown, MJ; Jones, GT; Harrison, SC; Wright, BJ; Bumpstead, S; Baas, AF; Gretarsdottir, S; Badger, SA; Bradley, DT; Burnand, K; Child, AH; Clough, RE; Cockerill, G; Hafez, H; Scott, DJA; Futers, S; Johnson, A; Sohrabi, S; Smith, A; Thompson, MM; van Bockxmeer, FM; Waltham, M; Matthiasson, SE; Thorleifsson, G; Thorsteinsdottir, U; Blankensteijn, JD; Teijink, JAW; Wijmenga, C; de Graaf, J; Kiemeney, LA; Assimes, TL; McPherson, R; Folkersen, L; Franco-Cereceda, A; Palmen, J; Smith, AJ; Sylvius, N; Wild, JB; Refstrup, M; Edkins, S; Gwilliam, R; Hunt, SE; Potter, S; Lindholt, JS; Frikke-Schmidt, R; Tybjaerg-Hansen, A; Hughes, AE; Golledge, J; Norman, PE; van Rij, A; Powel, JT; Eriksson, P; Stefansson, K; Thompson, JR; Humphries, SE; Sayers, RD; Deloukas, P; Samani, NJ				Bown, Matthew J.; Jones, Gregory T.; Harrison, Seamus C.; Wright, Benjamin J.; Bumpstead, Suzannah; Baas, Annette F.; Gretarsdottir, Solveig; Badger, Stephen A.; Bradley, Declan T.; Burnand, Kevin; Child, Anne H.; Clough, Rachel E.; Cockerill, Gillian; Hafez, Hany; Scott, D. Julian A.; Futers, Simon; Johnson, Anne; Sohrabi, Soroush; Smith, Alberto; Thompson, Matthew M.; van Bockxmeer, Frank M.; Waltham, Matthew; Matthiasson, Stefan E.; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Blankensteijn, Jan D.; Teijink, Joep A. W.; Wijmenga, Cisca; de Graaf, Jacqueline; Kiemeney, Lambertus A.; Assimes, Themistocles L.; McPherson, Ruth; Folkersen, Lasse; Franco-Cereceda, Anders; Palmen, Jutta; Smith, Andrew J.; Sylvius, Nicolas; Wild, John B.; Refstrup, Mette; Edkins, Sarah; Gwilliam, Rhian; Hunt, Sarah E.; Potter, Simon; Lindholt, Jes S.; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne; Hughes, Anne E.; Golledge, Jonathan; Norman, Paul E.; van Rij, Andre; Powel, Janet T.; Eriksson, Per; Stefansson, Karl; Thompson, John R.; Humphries, Steve E.; Sayers, Robert D.; Deloukas, Panos; Samani, Nilesh J.		CARDIoGRAM Consortium; Global BPgen Consortium; DIAGRAM Consortium; VRCNZ Consortium	Abdominal Aortic Aneurysm Is Associated with a Variant in Low-Density Lipoprotein Receptor-Related Protein 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; SEQUENCE VARIANT; VASCULAR WALL; DISEASE; METALLOPROTEINASE; IDENTIFICATION; GELATINASE; EXPRESSION; MUTATIONS	Abdominal aortic aneurysm (AAA) is a common cause of morbidity and mortality and has a significant heritability. We carried out a genome-wide association discovery study of 1866 patients with AAA and 5435 controls and replication of promising signals (lead SNP with a p value < 1 x 10(-5)) in 2871 additional cases and 32,687 controls and performed further follow-up in 1491 AAA and 11,060 controls. In the discovery study, nine loci demonstrated association with AAA (p < 1 x 10(-5)). In the replication sample, the lead SNP at one of these loci, rs1466535, located within intron 1 of low-density-lipoprotein receptor-related protein 1 (LRP1) demonstrated significant association (p = 0.0042). We confirmed the association of rs1466535 and AAA in our follow-up study (p = 0.035). In a combined analysis (6228 AAA and 49182 controls), rs1466535 had a consistent effect size and direction in all sample sets (combined p = 4.52 x 10(-10), odds ratio 1.15 [1.10-1.21]). No associations were seen for either rs1466535 or the 12q13.3 locus in independent association studies of coronary artery disease, blood pressure, diabetes, or hyperlipidaemia, suggesting that this locus is specific to AAA. Gene-expression studies demonstrated a trend toward increased LRP1 expression for the rs1466535 CC genotype in arterial tissues; there was a significant (p = 0.029) 1.19-fold (1.04-1.36) increase in LRP1 expression in CC homozygotes compared to TT homozygotes in aortic adventitia. Functional studies demonstrated that rs1466535 might alter a SREBP-1 binding site and influence enhancer activity at the locus. In conclusion, this study has identified a biologically plausible genetic variant associated specifically with AAA, and we suggest that this variant has a possible functional role in LRP1 expression.	[Bown, Matthew J.; Wright, Benjamin J.; Sylvius, Nicolas; Wild, John B.; Sayers, Robert D.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England; [Jones, Gregory T.; van Rij, Andre] Univ Otago, Dept Anat, Dunedin 9054, New Zealand; [Harrison, Seamus C.; Palmen, Jutta; Smith, Andrew J.; Humphries, Steve E.] UCL, London WC1E 6JF, England; [Bumpstead, Suzannah; Edkins, Sarah; Gwilliam, Rhian; Hunt, Sarah E.; Potter, Simon; Deloukas, Panos] Wellcome Trust Sanger Inst, Genet Complex Traits Humans Grp, Cambridge CB10 1SA, England; [Baas, Annette F.] Univ Med Ctr Utrecht, Med Genet Res Sect, NL-3584 CG Utrecht, Netherlands; [Gretarsdottir, Solveig; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Karl] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Gretarsdottir, Solveig; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Karl] deCODE Genet, IS-101 Reykjavik, Iceland; [Badger, Stephen A.; Bradley, Declan T.; Hughes, Anne E.] Queens Univ, Sch Med, Belfast BT7 1NN, Antrim, North Ireland; [Burnand, Kevin; Clough, Rachel E.; Smith, Alberto; Waltham, Matthew] Kings Coll London, Dept Vasc Surg, London WC2R 2LS, England; [Child, Anne H.; Cockerill, Gillian; Thompson, Matthew M.] St Georges Univ London, Dept Vasc Surg, London SW17 0RE, England; [Hafez, Hany] St Richards Hosp, Dept Vasc Surg, Chichester PO19 6SE, England; [Scott, D. Julian A.; Futers, Simon; Johnson, Anne; Sohrabi, Soroush] Univ Leeds, Leeds Inst Genet Hlth & Tech, Leeds LS2 9JT, W Yorkshire, England; [van Bockxmeer, Frank M.; Norman, Paul E.] Univ Western Australia, Dept Surg, Crawley, WA 6009, Australia; [Matthiasson, Stefan E.] Laekning Med Clin, IS-108 Reykjavik, Iceland; [Blankensteijn, Jan D.] Vrije Univ Amsterdam, Med Ctr, Dept Vasc Surg, NL-1007 MB Amsterdam, Netherlands; [Teijink, Joep A. W.] Catharina Hosp, Dept Vasc Surg, NL-5623 EJ Eindhoven, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [de Graaf, Jacqueline; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands; [Assimes, Themistocles L.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada; [Folkersen, Lasse; Franco-Cereceda, Anders; Eriksson, Per] Karolinska Inst, SE-17177 Stockholm, Sweden; [Refstrup, Mette; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Lindholt, Jes S.] Viborg Hosp, Dept Vasc Surg, DK-8800 Viborg, Denmark; [Golledge, Jonathan] James Cook Univ, Vasc Biol Unit, Townsville, Qld 4811, Australia; [Powel, Janet T.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester LE2 7LX, Leics, England	University of Leicester; University of Otago; University of London; University College London; Wellcome Trust Sanger Institute; Utrecht University; Utrecht University Medical Center; University of Iceland; Queens University Belfast; University of London; King's College London; St Georges University London; University of Leeds; University of Western Australia; Vrije Universiteit Amsterdam; Catharina Hospital; University of Groningen; Radboud University Nijmegen; Stanford University; University of Ottawa; University of Ottawa Heart Institute; Karolinska Institutet; University of Copenhagen; Aarhus University; James Cook University; Imperial College London; University of Leicester	Bown, MJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England.	m.bown@le.ac.uk	Hughes, Anne/A-1307-2012; Lambrechts, Diether/AAJ-3167-2020; Beckmann, Jacques S/A-9772-2008; Stefansson, Kari/AAE-7187-2019; Blankensteijn, Jan D/Q-9291-2016; Hide, Winston Hide/C-7217-2009; Palmer, Colin NA/C-7053-2008; Erdmann, Jeanette/P-7513-2014; Benediktsson, Rafn/R-2457-2018; Martinelli, Nicola/J-5622-2016; Bown, Matthew/P-1957-2016; Norman, Paul E/C-5485-2013; Laan, Maris/A-4100-2011; Powell, Janet/AAW-8669-2021; Bradley, Declan/AFN-7904-2022; Bradley, Declan T/AFO-1353-2022; Peyvandi, Flora/AAK-7437-2020; Panico, Salvatore/K-6506-2016; Meitinger, Thomas/O-1318-2015; Hide, Winston/R-3815-2019; Prokopenko, Inga/H-3241-2014; Assimes, Themistocles Leonard/D-9696-2015; Kiemeney, Lambertus A./D-3357-2009; golledge, jonathan/I-2371-2013; Olivieri, Oliviero/A-9126-2008; Ricceri, Fulvio/I-9910-2018; Wijmenga, Cisca/AAE-7719-2019; Ye, Shu/R-6384-2017; Wijmenga, Cisca/D-2173-2009; Hide, Winston A/V-2727-2017; Aulchenko, Yurii/M-8270-2013; Deloukas, Panos/B-2922-2013; de Graaf, J./H-8038-2014; van Dam, Rob M/F-9674-2010; Lindholt, Jes/J-2907-2014; Griffin, Simon/K-3106-2013; Dehghan, Abbas/B-9896-2008; McCarthy, Mark/M-3763-2015; Loos, Ruth/Q-2862-2016; Rudan, Igor/I-1467-2012; Sijbrands, Eric/A-1065-2009; van der Schouw, Yvonne/F-8327-2014; Doney, Alexander/P-7437-2017; Luben, Robert/H-5519-2015; MATULLO, Giuseppe/K-6383-2016	Lambrechts, Diether/0000-0002-3429-302X; Beckmann, Jacques S/0000-0002-9741-1900; Blankensteijn, Jan D/0000-0002-2062-8749; Hide, Winston Hide/0000-0002-8621-3271; Palmer, Colin NA/0000-0002-6415-6560; Erdmann, Jeanette/0000-0002-4486-6231; Benediktsson, Rafn/0000-0002-2954-9801; Martinelli, Nicola/0000-0001-6465-5119; Bown, Matthew/0000-0002-6180-3611; Norman, Paul E/0000-0003-3406-0506; Laan, Maris/0000-0002-8519-243X; Powell, Janet/0000-0002-3905-1468; Peyvandi, Flora/0000-0001-7423-9864; Panico, Salvatore/0000-0002-5498-8312; Hide, Winston/0000-0002-8621-3271; Prokopenko, Inga/0000-0003-1624-7457; Assimes, Themistocles Leonard/0000-0003-2349-0009; Kiemeney, Lambertus A./0000-0002-2368-1326; Olivieri, Oliviero/0000-0001-8209-9056; Ricceri, Fulvio/0000-0001-8749-9737; Wijmenga, Cisca/0000-0002-5635-1614; Ye, Shu/0000-0002-4126-4278; Hide, Winston A/0000-0002-8621-3271; Aulchenko, Yurii/0000-0002-7899-1575; Deloukas, Panos/0000-0001-9251-070X; van Dam, Rob M/0000-0002-7354-8734; Lindholt, Jes/0000-0001-9536-4488; Meitinger, Thomas/0000-0002-8838-8403; Meisinger, Christa/0000-0002-9026-6544; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hafez, Hany/0000-0001-5234-724X; Bradley, Declan/0000-0003-1468-1823; Soranzo, Nicole/0000-0003-1095-3852; Griffin, Simon/0000-0002-2157-4797; Engert, James/0000-0001-8411-4790; Dehghan, Abbas/0000-0001-6403-016X; Amin, Najaf/0000-0002-8944-1771; Pankow, James/0000-0001-7076-483X; Stewart, Alexandre/0000-0003-2673-9164; Johnson, Toby/0000-0002-5998-3270; Williams, Frances/0000-0002-2998-2744; Smith, Andrew/0000-0003-1141-2978; Polidoro, Silvia/0000-0003-2968-0575; McCarthy, Mark/0000-0002-4393-0510; s, hema/0000-0002-3440-9475; Preuss, Michael/0000-0001-5266-8465; Folkersen, Lasse/0000-0003-0708-9530; Loos, Ruth/0000-0002-8532-5087; Goodall, Alison/0000-0002-7883-9645; Gieger, Christian/0000-0001-6986-9554; Sacerdote, Carlotta/0000-0002-8008-5096; Rudan, Igor/0000-0001-6993-6884; Reilly, Muredach/0000-0002-3035-9386; UDA, MANUELA/0000-0002-4890-6456; GIRELLI, Domenico/0000-0001-9684-1899; Humphries, Stephen E/0000-0002-8221-6547; Sijbrands, Eric/0000-0001-8857-7389; Wain, Louise/0000-0003-4951-1867; Marrugat, Jaume/0000-0003-3320-554X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Hunt, Sarah/0000-0002-8350-1235; Tang, W. H. Wilson/0000-0002-8335-735X; Eyheramendy, Susana/0000-0003-4723-9660; solinas, emilia/0000-0003-3532-1317; Sylvius, Nicolas/0000-0002-3470-3711; Waeber, Gerard/0000-0003-4193-788X; Topless, Ruth/0000-0002-9343-8911; ELOSUA, ROBERTO/0000-0001-8235-0095; Wallace, Chris/0000-0001-9755-1703; van der Schouw, Yvonne/0000-0002-4605-435X; Doney, Alexander/0000-0002-6210-5620; Forouhi, Nita/0000-0002-5041-248X; Voight, Benjamin/0000-0002-6205-9994; Marre, Michel/0000-0002-3071-1837; Willer, Cristen/0000-0001-5645-4966; Raychaudhuri, Soumya/0000-0002-1901-8265; Luben, Robert/0000-0002-5088-6343; Eriksson, Per/0000-0002-5635-2692; Merriman, Tony/0000-0003-0844-8726; van Gilst, Wiek/0000-0003-2968-8585; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Pramstaller, Peter P/0000-0002-9831-8302; Jones, Gregory T/0000-0002-6950-4210; Lucas, Gavin/0000-0003-4166-9416; Wild, Philipp/0000-0003-4413-9752; Hall, Alistair/0000-0003-0306-7887; Caulfield, Mark/0000-0001-9295-3594; SCUTERI, ANGELO/0000-0003-4784-5441; MATULLO, Giuseppe/0000-0003-0674-7757; Kraft, Peter/0000-0002-4472-8103; Tomaszewski, Maciej/0000-0001-8215-6567; Tobin, Martin/0000-0002-3596-7874	Wellcome Trust [084695, 076113, 085475]; Higher Education Funding Council for England; Health Research Council of New Zealand (Vascular Research Consortium of New Zealand) [08/075]; National Health Medical Research Council (NHMRC); Office of Health and Medical Research; Swedish Research Council; Swedish Heart-Lung foundation; European Commission [Health-F2-2008-200647]; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; NHMRC (Australia); The Dunhill Medical Trust (Leicester); Garfield Weston Trust for Medical Research into Heart Surgery (Leeds); European Community [Health-F2-2008-200647, FP7/2007-2013]; St George's Hospital NHS Trust Special Trustees; Peter and Sonia Field Charitable Trust; British Heart Foundation [FS/11/16/28696, RG2008/08]; Netherlands Heart Foundation [2009T001]; British Heart Foundation chairs; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; MRC [MC_U127592696, MC_PC_U127592696] Funding Source: UKRI; British Heart Foundation [PG/10/001/28098] Funding Source: researchfish; Medical Research Council [MC_PC_U127592696, MC_U127592696] Funding Source: researchfish; Public Health Agency [EAT/3976/08] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Health Research Council of New Zealand (Vascular Research Consortium of New Zealand)(Health Research Council of New Zealand); National Health Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Office of Health and Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' National Health Service (NHS) Foundation Trust(National Institute for Health Research (NIHR)); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); The Dunhill Medical Trust (Leicester)(Dunhill Medical Trust); Garfield Weston Trust for Medical Research into Heart Surgery (Leeds); European Community(European Commission); St George's Hospital NHS Trust Special Trustees; Peter and Sonia Field Charitable Trust; British Heart Foundation(British Heart Foundation); Netherlands Heart Foundation(Netherlands Heart Foundation); British Heart Foundation chairs; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Public Health Agency	This study was funded by the Wellcome Trust (number 084695). This study makes use of data generated by the WTCCC. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the WTCCC project was provided by the Wellcome Trust under award 076113 and 085475. Further funding was provided by the Higher Education Funding Council for England (M.J.B.), Health Research Council of New Zealand (08/075) (Vascular Research Consortium of New Zealand), National Health Medical Research Council (NHMRC) and the Office of Health and Medical Research (J.G.); Swedish Research Council, Swedish Heart-Lung foundation, the European Commission (FAD, Health-F2-2008-200647), a donation by Fredrik Lundberg (for the expression study); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' National Health Service (NHS) Foundation Trust (R.C.), NHMRC (Australia), The Dunhill Medical Trust (Leicester), and the Garfield Weston Trust for Medical Research into Heart Surgery (Leeds) (provided additional funding for source cohorts); the European Community's Seventh Framework Programme (FP7/2007-2013); Fighting Aneurysmal Disease Project grant agreement HEALTH-F2-2008-200647 (provided replication data sets from Iceland and Netherlands); St George's Hospital NHS Trust Special Trustees and the Peter and Sonia Field Charitable Trust (A.H.C.); British Heart Foundation Clinical Training Fellowship (FS/11/16/28696) (S.E.H.); British Heart Foundation (RG2008/08) (S.E.H., A.J.S., J.P.); Netherlands Heart Foundation (2009T001) (A.F.B.); British Heart Foundation chairs (S.E.H and N.J.S.); and Leicester NIHR Biomedical Research Unit in Cardiovascular Disease (M.J.B., R.D.S. and N.J.S.). deCODE genetics is a biotechnology company, and authors employed by deCODE own stock or stock options in the company.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], LOCUSZOOM; [Anonymous], GEN WID ASS SCANS TO; Ashton H, 2001, J MED SCREEN, V8, P46; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Costales P, 2010, ATHEROSCLEROSIS, V213, P458, DOI 10.1016/j.atherosclerosis.2010.09.034; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gretarsdottir S, 2010, NAT GENET, V42, P692, DOI 10.1038/ng.622; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Inamoto S, 2010, CARDIOVASC RES, V88, P520, DOI 10.1093/cvr/cvq230; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; JOHANSEN K, 1986, JAMA-J AM MED ASSOC, V256, P1934, DOI 10.1001/jama.256.14.1934; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Larsson E, 2009, J VASC SURG, V49, P47, DOI 10.1016/j.jvs.2008.08.012; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; MAJUMDER PP, 1991, AM J HUM GENET, V48, P164; Milewicz DM, 2010, GENET MED, V12, P196, DOI 10.1097/GIM.0b013e3181cdd687; NEWMAN KM, 1994, CONNECT TISSUE RES, V30, P265, DOI 10.3109/03008209409015042; NEWMAN KM, 1994, ARTERIOSCLER THROMB, V14, P1315, DOI 10.1161/01.ATV.14.8.1315; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Powell J T, 1987, Eur J Vasc Surg, V1, P29, DOI 10.1016/S0950-821X(87)80020-8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson AR, 2008, EUR J VASC ENDOVASC, V35, P19, DOI 10.1016/j.ejvs.2007.07.022; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wahlgren CM, 2010, J VASC SURG, V51, P3, DOI 10.1016/j.jvs.2009.08.036; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wilmink ABM, 1998, BRIT J SURG, V85, P155; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	41	134	138	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					619	627		10.1016/j.ajhg.2011.10.002	http://dx.doi.org/10.1016/j.ajhg.2011.10.002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	22055160	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-18	WOS:000297090100003
J	Li, Z; Sergouniotis, PI; Michaelides, M; Mackay, DS; Wright, GA; Devery, S; Moore, AT; Holder, GE; Robson, AG; Webster, AR				Li, Zheng; Sergouniotis, Panagiotis I.; Michaelides, Michel; Mackay, Donna S.; Wright, Genevieve A.; Devery, Sophie; Moore, Anthony T.; Holder, Graham E.; Robson, Anthony G.; Webster, Andrew R.			Recessive Mutations of the Gene TRPM1 Abrogate ON Bipolar Cell Function and Cause Complete Congenital Stationary Night Blindness in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RICH PROTEOGLYCAN NYCTALOPIN; PROTEIN; ELECTRORETINOGRAM; RECEPTOR; CHANNEL; RETINA; MGLUR6; NYX; LOCALIZATION; EXPRESSION	Complete congenital stationary night blindness (cCSNB) is associated with loss of function of rod and cone ON bipolar cells in the mammalian retina. In humans, mutations in NYX and GRM6 have been shown to cause the condition. Through the analysis of a consanguineous family and screening of nine additional pedigrees, we have identified three families with recessive mutations in the gene TRPM1 encoding transient receptor potential cation channel, subfamily M, member 1, also known as melastatin. A number of other variants of unknown significance were found. All patients had myopia, reduced central vision, nystagmus, and electroretinographic evidence of ON bipolar cell dysfunction. None had abnormalities of skin pigmentation, although other skin conditions were reported. RNA derived from human retina and skin was analyzed and alternate 5' exons were determined. The most 5' exon is likely to harbor an initiation codon, and the protein sequence is highly conserved across vertebrate species. These findings suggest an important role of this specific cation channel for the normal function of ON bipolar cells in the human retina.	[Li, Zheng; Sergouniotis, Panagiotis I.; Michaelides, Michel; Mackay, Donna S.; Moore, Anthony T.; Holder, Graham E.; Robson, Anthony G.; Webster, Andrew R.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Michaelides, Michel; Wright, Genevieve A.; Devery, Sophie; Moore, Anthony T.; Holder, Graham E.; Robson, Anthony G.; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Webster, AR (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	andrew.webster@ucl.ac.uk		Mackay, Donna/0000-0002-2499-1203; Li, Zheng/0000-0002-7060-2213; Sergouniotis, Panos/0000-0003-0986-4123; Robson, Anthony/0000-0002-8391-6123	British Retinitis Pigmentosa Society; Foundation Fighting Blindness USA; Fight for Sight; National Institute for Health Research UK	British Retinitis Pigmentosa Society; Foundation Fighting Blindness USA; Fight for Sight; National Institute for Health Research UK(National Institute for Health Research (NIHR))	This study was supported by grants from the British Retinitis Pigmentosa Society, Foundation Fighting Blindness USA, Fight for Sight, and the National Institute for Health Research UK to the Biomedical Research Centre for Ophthalmology (Moorfields Eye Hospital [MEH] and the University College London [UCL] Institute of Ophthalmology). We are grateful to colleagues who referred patients to us at MEH and to Priya Banerjee and Jacob Raby of the UCL Genomics Microarray Facility for technical assistance. We acknowledge the cooperation and help provided by the family members in this study.	Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 2005, MAMM GENOME, V16, P815, DOI 10.1007/s00335-005-0018-y; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; BOJANG P, 2009, ARVO 2009 ANN M FL U; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Dhingra A, 2004, J NEUROSCI, V24, P5684, DOI 10.1523/JNEUROSCI.0492-04.2004; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Duncan LM, 1998, CANCER RES, V58, P1515; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hunter JJ, 1998, GENOMICS, V54, P116, DOI 10.1006/geno.1998.5549; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; MIYAKE Y, 1987, JPN J OPHTHALMOL, V31, P81; Nawy S, 1999, J NEUROSCI, V19, P2938; O'Connor E, 2005, HUM MOL GENET, V14, P1877, DOI 10.1093/hmg/ddi194; Pesch K, 2003, INVEST OPHTH VIS SCI, V44, P2260, DOI 10.1167/iovs.02-0115; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Scott K, 1998, CURR OPIN NEUROBIOL, V8, P383, DOI 10.1016/S0959-4388(98)80065-2; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SLAUGHTER MM, 1985, J NEUROSCI, V5, P224; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Zeitz C, 2003, INVEST OPHTH VIS SCI, V44, P4184, DOI 10.1167/iovs.03-0251	26	134	137	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					711	719		10.1016/j.ajhg.2009.10.003	http://dx.doi.org/10.1016/j.ajhg.2009.10.003			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19878917	Green Published, Bronze			2022-12-18	WOS:000271916500018
J	Leslie, S; Donnelly, P; McVean, G				Leslie, Stephen; Donnelly, Peter; McVean, Gil			A statistical method for predicting classical HLA alleles from SNP data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; DISEASE ASSOCIATION; HAPLOTYPE MAP; GENOTYPE DATA; IMPUTATION; GENETICS; HOTSPOTS; MODEL; MHC	Genetic variation at classical HLA alleles is a crucial determinant of transplant success and susceptibility to a large number of infectious and autoimmune diseases. However, large-scale studies involving classical type I and type II HLA alleles might be limited by the cost of allele-typing technologies. Although recent studies have shown that some common HLA alleles can be tagged with small numbers of markers, 1,2 SNP-based tagging does not offer a complete solution to predicting HLA alleles. We have developed a new statistical methodology to use SNP variation within the region to predict alleles at key class I (HLA-A, HLA-B, and HLA-C) and class II (HLA-DRB1, HLA-DQA1, and HLA-DQB1) loci. Our results indicate that a single panel of similar to 100 SNPs typed across the region is sufficient for predicting both rare and common HLA alleles with up to 95% accuracy in both African and non-African populations. Furthermore, we show that HLA alleles can be successfully predicted by using previously genotyped SNPs that are within the MHC and that had not been chosen for their ability to predict HLA alleles, such as those included on genome-wide products. These results indicate that our methodology, combined with an extended database of reference haplotypes, will facilitate large-scale experiments, including disease-association studies and vaccine trials, in which detailed information about HLA type is valuable.	[Leslie, Stephen; Donnelly, Peter; McVean, Gil] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford	McVean, G (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	mcvean@stats.ox.ac.uk		Donnelly, Peter/0000-0001-9495-3408	Wellcome Trust [068545/Z/02] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eyheramendy S, 2007, GENOME RES, V17, P88, DOI 10.1101/gr.5675406; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Halperin E, 2005, BIOINFORMATICS, V21, pI195, DOI 10.1093/bioinformatics/bti1021; Li N, 2003, GENETICS, V165, P2213; Malkki M, 2005, TISSUE ANTIGENS, V66, P114, DOI 10.1111/j.1399-0039.2005.00453.x; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI 10.1093/nar/GKG070; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	19	134	137	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					48	56		10.1016/j.ajhg.2007.09.001	http://dx.doi.org/10.1016/j.ajhg.2007.09.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179884	Green Published, Bronze			2022-12-18	WOS:000253223800006
J	Huang, RS; Duan, S; Shukla, SJ; Kistner, EO; Clark, TA; Chen, TX; Schweitzer, AC; Blume, JE; Dolan, ME				Huang, R. Stephanie; Duan, Shiwei; Shukla, Sunita J.; Kistner, Emily O.; Clark, Tyson A.; Chen, Tina X.; Schweitzer, Anthony C.; Blume, John E.; Dolan, M. Eileen			Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CENTROSOME SEPARATION; CANCER; DNA; CHEMOTHERAPY; POLYMORPHISM; INHIBITION; TOXICITY; DAMAGE; NEK2A	Cisplatin, a platinating agent commonly used to treat several cancers, is associated with nephrotoxicity, neurotoxicity, and ototoxicity, which has hindered its utility. To gain a better understanding of the genetic variants associated with cisplatin-induced toxicity, we present a stepwise approach integrating genotypes, gene expression, and sensitivity of HapMap cell lines to cisplatin. Cell lines derived from 30 trios of European descent (CEU) and 30 trios of African descent (YRI) were used to develop a preclinical model to identify genetic variants and gene expression that contribute to cisplatin-induced cytotoxicity in two different populations. Cytotoxicity was determined as cell-growth inhibition at increasing concentrations of cisplatin for 48 h. Gene expression in 176 HapMap cell lines (87 CEU and 89 YRI) was determined using the Affymetrix GeneChip Human Exon 1.0 ST Array. We identified six, two, and nine representative SNPs that contribute to cisplatin-induced cytotoxicity through their effects on 8, 2, and 16 gene expressions in the combined, Centre d'Etude du Polymorphisme Humain (CEPH), and Yoruban populations, respectively. These genetic variants contribute to 27%, 29%, and 45% of the overall variation in cell sensitivity to cisplatin in the combined, CEPH, and Yoruban populations, respectively. Our whole-genome approach can be used to elucidate the expression of quantitative trait loci contributing to a wide range of cellular phenotypes.	Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Dolan, ME (corresponding author), Univ Chicago, 5841 S Maryland Ave Box MC2115, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu	Duan, Shiwei/AAA-4782-2022; Duan, Shiwei/J-9633-2012	Duan, Shiwei/0000-0001-7682-2877; Huang, R. Stephanie/0000-0002-9862-0368; Clark, Tyson/0000-0002-7779-3227; Blume, John/0000-0003-3026-953X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61393, U01 GM061374, R24 GM061374, U01 GM061393, GM61374] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; DAUGAARD G, 1990, DAN MED BULL, V37, P1; Decatris MP, 2005, CLIN ONCOL-UK, V17, P249, DOI 10.1016/j.clon.2005.04.001; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Fishel ML, 2006, BIOCHEM PHARMACOL, V71, P239, DOI 10.1016/j.bcp.2005.10.039; Fletcher L, 2005, BBA-MOL CELL RES, V1744, P89, DOI 10.1016/j.bbamcr.2005.01.007; Fletcher L, 2004, RADIAT RES, V162, P128, DOI 10.1667/RR3211; Huang RS, 2007, MOL CANCER THER, V6, P31, DOI 10.1158/1535-7163.MCT-06-0591; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Medeiros Rui, 2003, Int J Clin Oncol, V8, P156, DOI 10.1007/s10147-003-0318-8; Rybak Leonard P, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P328, DOI 10.1097/00020840-200310000-00004; Sakamoto K, 2006, ONCOL REP, V16, P381; *SAS I, 1997, SAS STAT SORTW REL 9; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Suk R, 2005, CLIN CANCER RES, V11, P1534, DOI 10.1158/1078-0432.CCR-04-1953; Verstappen CCP, 2003, DRUGS, V63, P1549, DOI 10.2165/00003495-200363150-00003; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Yim EK, 2006, INT J GYNECOL CANCER, V16, P690, DOI 10.1111/j.1525-1438.2006.00586.x; Zhang W, 2005, J BIOL CHEM, V280, P42994, DOI 10.1074/jbc.M505450200; Zhou W, 2004, CLIN CANCER RES, V10, P4939, DOI 10.1158/1078-0432.CCR-04-0247; Zorbas H, 2005, CHEMBIOCHEM, V6, P1157, DOI 10.1002/cbic.200400427	28	134	144	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					427	437		10.1086/519850	http://dx.doi.org/10.1086/519850			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701890	Green Published, Bronze			2022-12-18	WOS:000249128200001
J	Basel-Vanagaite, L; Attia, R; Ishida-Yamamoto, A; Rainshtein, L; Ben Amitai, D; Lurie, R; Pasmanik-Chor, M; Indelman, M; Zvulunov, A; Saban, S; Magal, N; Sprecher, E; Shohat, M				Basel-Vanagaite, Lina; Attia, Revital; Ishida-Yamamoto, Akemi; Rainshtein, Limor; Ben Amitai, Dan; Lurie, Raziel; Pasmanik-Chor, Metsada; Indelman, Margarita; Zvulunov, Alex; Saban, Shirley; Magal, Nurit; Sprecher, Eli; Shohat, Mordechai			Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ICHTHYOSIS; FOLLICULAR ATROPHODERMA; BARRIER FUNCTION; HAIR; GENE; IDENTIFICATION; LOCUS; EXPRESSION; ABCA12; SKIN	In this article, we describe a novel autosomal recessive ichthyosis with hypotrichosis syndrome, characterized by congenital ichthyosis associated with abnormal hair. Using homozygosity mapping, we mapped the disease locus to 11q24.3-q25. We screened the ST14 gene, which encodes matriptase, since transplantation of skin from matriptase(-/-)- knockout mice onto adult athymic nude mice has been shown elsewhere to result in an ichthyosislike phenotype associated with almost complete absence of erupted pelage hairs. Mutation analysis revealed a missense mutation, G827R, in the highly conserved peptidase S1-S6 domain. Marked skin hyperkeratosis due to impaired degradation of the stratum corneum corneodesmosomes was observed in the affected individuals, which suggests that matriptase plays a significant role in epidermal desquamation.	Rabin Med Ctr, Dept Med Genet, IL-49100 Petah Tiqwa, Israel; Rabin Med Ctr, Pediat Dermatol Unit, IL-49100 Petah Tiqwa, Israel; Rabin Med Ctr, Schneider Childrens Med Ctr Israel, IL-49100 Petah Tiqwa, Israel; Felsenstein Med Res Ctr, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Bioinformat Unit, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 078, Japan; Technion Israel Inst Technol, Dept Dermatol, Haifa, Israel; Technion Israel Inst Technol, Lab Mol Dermatol, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Haifa, Israel; Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel; Weizmann Inst Sci, Dept Biol Serv, Microarray Facil, IL-76100 Rehovot, Israel	Rabin Medical Center; Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Asahikawa Medical College; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Weizmann Institute of Science	Basel-Vanagaite, L (corresponding author), Rabin Med Ctr, Dept Med Genet, Beilinson Campus, IL-49100 Petah Tiqwa, Israel.	basel@post.tau.ac.il		Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157				Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Broughton BC, 2001, HUM MOL GENET, V10, P2539, DOI 10.1093/hmg/10.22.2539; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; ELSAYEDALL H, 1992, BRIT J DERMATOL, V126, P24, DOI 10.1111/j.1365-2133.1992.tb08398.x; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; ITO M, 1984, J INVEST DERMATOL, V83, P1, DOI 10.1111/1523-1747.ep12261618; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Konig A, 1999, AM J MED GENET, V85, P365, DOI 10.1002/(SICI)1096-8628(19990806)85:4<365::AID-AJMG12>3.0.CO;2-#; Krebsova A, 2001, AM J HUM GENET, V69, P216, DOI 10.1086/321284; Lefevre C, 2006, HUM MOL GENET, V15, P767, DOI 10.1093/hmg/ddi491; Lefevre C, 2004, HUM MOL GENET, V13, P2473, DOI 10.1093/hmg/ddh263; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Lestringant GG, 1998, AM J MED GENET, V75, P186, DOI 10.1002/(SICI)1096-8628(19980113)75:2<186::AID-AJMG12>3.0.CO;2-L; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; LURIE R, 1995, CUTIS, V55, P349; Mizrachi-Koren M, 2005, J INVEST DERMATOL, V125, P456, DOI 10.1111/j.0022-202X.2005.23777.x; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Olson LE, 2005, P NATL ACAD SCI USA, V102, P3708, DOI 10.1073/pnas.0500519102; Sambrook J, 1987, MOL CLONING LAB MANU; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Sprecher E, 2005, CLIN DERMATOL, V23, P47, DOI 10.1016/j.clindermatol.2004.09.009; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tursen U, 2002, BRIT J DERMATOL, V147, P604, DOI 10.1046/j.1365-2133.2002.48461.x; Virolainen E, 2000, AM J HUM GENET, V66, P1132, DOI 10.1086/302813; Weeda G, 1997, AM J HUM GENET, V60, P320; YESUDIAN P, 1977, BRIT J DERMATOL, V96, P199, DOI 10.1111/j.1365-2133.1977.tb12544.x; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388	43	134	141	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					467	477		10.1086/512487	http://dx.doi.org/10.1086/512487			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273967	Green Published, Bronze			2022-12-18	WOS:000244403300007
J	Tian, C; Hinds, DA; Shigeta, R; Kittles, R; Ballinger, DG; Seldin, MF				Tian, Chao; Hinds, David A.; Shigeta, Russell; Kittles, Rick; Ballinger, Dennis G.; Seldin, Michael F.			A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; ADMIXED POPULATIONS; GENETIC-MARKERS; COMPLEX DISEASE; MAP; RECOMBINATION; INFERENCE; GUIDELINES	Admixture mapping requires a genomewide panel of relatively evenly spaced markers that can distinguish the ancestral origins of chromosomal segments in admixed individuals. Through use of the results of the International HapMap Project and specific selection criteria, the current study has examined the ability of selected single-nucleotide polymorphisms ( SNPs) to extract continental ancestry information in African American subjects and to explore parameters for admixture mapping. Genotyping of two linguistically diverse West African populations (Bini and Kanuri Nigerians, who are Niger-Congo [Bantu] and Nilo-Saharan speakers, respectively), European Americans, and African Americans validated a genomewide set of 14,000 SNP ancestry-informative markers with mean and median F-ST values > 0.59 and mean and median Fisher's information content 12.5. This set of SNPs extracted a larger amount of ancestry information in African Americans than previously reported SNP panels and provides nearly uniform coverage of the genome. Moreover, in the current study, simulations show that this more informative panel improves power for admixture mapping in African Americans when ethnicity risk ratios are modest. This is particularly important in the application of admixture mapping in complex genetic diseases for which only modest ethnicity risk ratios of relevant susceptibility genes are expected.	Univ Calif Davis, Rowe Program Human Genet, Dept Biochem, Davis, CA 95616 USA; Univ Calif Davis, Rowe Program Human Genet, Dept Med, Davis, CA 95616 USA; Perlegen Sci, Mountain View, CA USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH USA	University of California System; University of California Davis; University of California System; University of California Davis; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Seldin, MF (corresponding author), Univ Calif Davis, Dept Biol Chem Med, Room 4453,1 Shields Ave, Davis, CA 95616 USA.	mfseldin@ucdavis.edu		Hinds, David/0000-0002-4911-803X	NIAMS NIH HHS [R01 AR050267] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050267] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Collins-Schramm HE, 2004, HUM GENET, V114, P263, DOI 10.1007/s00439-003-1058-6; Collins-Schramm HE, 2003, HUM GENET, V113, P211, DOI 10.1007/s00439-003-0961-1; Collins-Schramm HE, 2002, HUM GENET, V111, P566, DOI 10.1007/s00439-002-0818-z; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Falush D, 2003, GENETICS, V164, P1567; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; LONG JC, 1991, GENETICS, V127, P417; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2005, AM J HUM GENET, V76, P1, DOI 10.1086/426949; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2005, PHILOS T ROY SOC B, V360, P1605, DOI 10.1098/rstb.2005.1691; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Seldin MF, 2004, GENOME RES, V14, P1076, DOI 10.1101/gr.2165904; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhang C, 2004, GENET EPIDEMIOL, V27, P225, DOI 10.1002/gepi.20021; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329	37	134	139	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					640	649		10.1086/507954	http://dx.doi.org/10.1086/507954			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960800	Green Published, Bronze			2022-12-18	WOS:000240855900005
J	Shi, H; Dong, YL; Wen, B; Xiao, CJ; Underhill, PA; Shen, PD; Chakraborty, R; Jin, L; Su, B				Shi, H; Dong, YL; Wen, B; Xiao, CJ; Underhill, PA; Shen, PD; Chakraborty, R; Jin, L; Su, B			Y-chromosome evidence of southern origin of the East Asian - Specific haplogroup O3-M122	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIVERGENCE TIME; MUTATION-RATE; GENE FLOW; SEQUENCE VARIATION; MITOCHONDRIAL-DNA; HUMAN-POPULATIONS; HAN CHINESE; HAPLOTYPES; HISTORY; EUROPE	The prehistoric peopling of East Asia by modern humans remains controversial with respect to early population migrations. Here, we present a systematic sampling and genetic screening of an East Asian-specific Y-chromosome haplogroup (O3-M122) in 2,332 individuals from diverse East Asian populations. Our results indicate that the O3-M122 lineage is dominant in East Asian populations, with an average frequency of 44.3%. The microsatellite data show that the O3-M122 haplotypes in southern East Asia are more diverse than those in northern East Asia, suggesting a southern origin of the O3-M122 mutation. It was estimated that the early northward migration of the O3-M122 lineages in East Asia occurred similar to 25,000-30,000 years ago, consistent with the fossil records of modern humans in East Asia.	Chinese Acad Sci, Kunming Inst Zool, Key Lab Cellular & Mol Evolut, Kunming, Peoples R China; Chinese Acad Sci, Kunming Primate Res Ctr, Kunming, Peoples R China; Yunnan Univ, Key Lab Bioresouces Conservat, Kunming 650091, Peoples R China; Yunnan Univ, Utilitzat & Human Genet Ctr, Kunming 650091, Peoples R China; Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; Fudan Univ, Sch Life Sci, Ctr Anthropol Studies, Shanghai 200433, Peoples R China; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; Univ Cincinnati, Ctr Genome Informat, Cincinnati, OH USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Yunnan University; Yunnan University; Fudan University; Fudan University; Stanford University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University System of Ohio; University of Cincinnati	Su, B (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Cellular & Mol Evolut, Kunming, Peoples R China.	sub@mail.kiz.ac.cn	Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/C-1468-2009; Wen, Bo/P-5332-2019; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Wen, Bo/0000-0003-0394-7366; 				BALLINGER SW, 1992, GENETICS, V130, P139; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; DU RF, 1998, SCI CHINA SER C, P83; Dupuy BM, 2004, HUM MUTAT, V23, P117, DOI 10.1002/humu.10294; Ellis N, 2002, GENOME RES, V12, P339; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Ke YH, 2001, SCI CHINA SER C, V44, P225, DOI 10.1007/BF02879329; Ke YH, 2001, CHINESE SCI BULL, V46, P935, DOI 10.1007/BF02900470; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Nachman MW, 2000, GENETICS, V156, P297; Piazza A, 1998, NATURE, V395, P636, DOI 10.1038/27071; Qian YP, 2000, HUM GENET, V106, P453, DOI 10.1007/s004390000259; Ramakrishnan U, 2004, MOL BIOL EVOL, V21, P1960, DOI 10.1093/molbev/msh212; Ramana GV, 2001, EUR J HUM GENET, V9, P695, DOI 10.1038/sj.ejhg.5200708; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; SCHNEIDER S, 1998, ARLEQUIN SOFTWARE PO; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WANG Z, 1994, HIST NATIONALITIES C; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Wen B, 2005, MOL BIOL EVOL, V22, P725, DOI 10.1093/molbev/msi055; WENG ZL, 1989, J ACTA ANTHR SIN, V8, P261; WU HC, 1995, HUMAN EVOLUTION CHIN; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; ZHAO T, 1986, ACTA ANTHR SIN, V6, P1; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	44	134	153	5	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					408	419		10.1086/444436	http://dx.doi.org/10.1086/444436			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080116	Bronze, Green Published			2022-12-18	WOS:000231314100007
J	Jiao, XD; Ventruto, V; Trese, MT; Shastry, BS; Hejtmancik, JF				Jiao, XD; Ventruto, V; Trese, MT; Shastry, BS; Hejtmancik, JF			Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR-RELATED PROTEIN-5; CANDIDATE GENE ANALYSIS; MISSENSE MUTATIONS; LINKAGE ANALYSIS; BONE-DENSITY; LOCUS; HETEROGENEITY; D11S533; MICE; MAPS	Familial exudative vitreoretinopathy (FEVR) is a hereditary eye disorder that affects both the retina and vitreous body. Autosomal recessive FEVR was diagnosed in multiple individuals from three consanguineous families of European descent. A candidate-locus-directed genome scan shows linkage to the region on chromosome 11q flanked by markers D11S905 and D11S1314. The maximum LOD score of 3.6 at theta = 0 is obtained with marker D11S987. Haplotype analysis confirms that the critical region is the 22-cM (311-Mb) interval flanked by markers D11S905 and D11S1314. This region contains LRP5 but not FZD4; mutations in both of these genes cause autosomal dominant FEVR. Sequencing of LRP5 shows, in all three families, homozygous mutations R570Q, R752G, and E1367K. This suggests that mutations in this gene can cause autosomal recessive as well as autosomal dominant FEVR.	NEI, NIH, Opthalm Genet & Visual Funct Branch, Bethesda, MD 20892 USA; CNR, Int Inst Genet & Biophys, I-80125 Naples, Italy; William Beaumont Hosp, Royal Oak, MI 48072 USA; Oakland Univ, Dept Biol Sci, Rochester, MI USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Beaumont Health; Oakland University	Hejtmancik, JF (corresponding author), NEI, NIH, Opthalm Genet & Visual Funct Branch, Bldg 10,Room 10B10,10 Ctr Dr MSC 1860, Bethesda, MD 20892 USA.	f3h@helix.nih.gov	Mackey AO, David/H-5340-2014	Mackey AO, David/0000-0001-7914-4709	NATIONAL EYE INSTITUTE [ZIAEY000272, Z01EY000272] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BEIGHTON P, 1985, CLIN GENET, V28, P69; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRISWICK VG, 1969, AM J OPHTHALMOL, V68, P578, DOI 10.1016/0002-9394(69)91237-9; de Crecchio G, 1998, CLIN GENET, V54, P315, DOI 10.1034/j.1399-0004.1998.5440409.x; DEPAEPE A, 1993, AM J MED GENET, V45, P30, DOI 10.1002/ajmg.1320450110; Downey LM, 2001, AM J HUM GENET, V68, P778, DOI 10.1086/318790; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; FULLWOOD P, 1993, BRIT J OPHTHALMOL, V77, P168, DOI 10.1136/bjo.77.3.168; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Jiao XD, 2000, AM J HUM GENET, V67, P1309; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kondo H, 2001, HUM GENET, V108, P368, DOI 10.1007/s004390100503; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LI Y, 1992, AM J HUM GENET, V51, P749; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mizuguchi T, 2004, J HUM GENET, V49, P80, DOI 10.1007/s10038-003-0111-6; MULLER B, 1994, GENOMICS, V20, P317, DOI 10.1006/geno.1994.1176; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Price SM, 1996, OPHTHALMIC GENET, V17, P53, DOI 10.3109/13816819609057871; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Shastry Barkur S., 2000, Current Genomics, V1, P259, DOI 10.2174/1389202003351445; Shastry BS, 1997, GENOMICS, V44, P247, DOI 10.1006/geno.1997.4863; Shastry BS, 2000, CLIN GENET, V58, P329, DOI 10.1034/j.1399-0004.2000.580412.x; Shastry BS, 1997, HUM MUTAT, V9, P396, DOI 10.1002/(SICI)1098-1004(1997)9:5<396::AID-HUMU3>3.3.CO;2-8; SHASTRY BS, 1995, GENOMICS, V27, P341, DOI 10.1006/geno.1995.1052; Shastry BS, 1997, AM J MED GENET, V69, P217, DOI 10.1002/(SICI)1096-8628(19970317)69:2<217::AID-AJMG19>3.0.CO;2-O; SMITH RJH, 1989, CYTOGENET CELL GENET, V50, P102, DOI 10.1159/000132733; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	34	134	148	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					878	884		10.1086/425080	http://dx.doi.org/10.1086/425080			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15346351	Green Published, Bronze			2022-12-18	WOS:000224303500013
J	Li, AR; Davila, S; Furu, L; Qian, Q; Tian, X; Kamath, PS; King, BF; Torres, VE; Somlo, S				Li, AR; Davila, S; Furu, L; Qian, Q; Tian, X; Kamath, PS; King, BF; Torres, VE; Somlo, S			Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHOMANNOSE ISOMERASE DEFICIENCY; GLUCOSIDASE-II; KIDNEY-DISEASE; GLYCOPROTEIN SYNDROME; ALPHA-SUBUNITS; BETA-SUBUNITS; IDENTIFICATION; PROTEINS; RECEPTORS; CELLS	Autosomal dominant polycystic liver disease (ADPLD) is a distinct clinical and genetic entity that can occur independently from autosomal dominant polycystic kidney disease (ADPKD). We previously studied two large kindreds and reported localization of a gene for ADPLD to an similar to8-Mb region, flanked by markers D19S586/ D19S583 and D19S593/D19S579, on chromosome 19p13.2-13.1. Expansion of these kindreds and identification of an additional family allowed us to define flanking markers CA267 and CA048 in an similar to3-Mb region containing > 70 candidate genes. We used a combination of denaturing high-performance liquid chromatography (DHPLC) heteroduplex analysis and direct sequencing to screen a panel of 15 unrelated affected individuals for mutations in genes from this interval. We found sequence variations in a known gene, PRKCSH, that were not observed in control individuals, that segregated with the disease haplotype, and that were predicted to be chain-terminating mutations. In contrast to PKD1, PKD2, and PKHD1, PRKCSH encodes a previously described human protein termed "protein kinase C substrate 80K-H" or "noncatalytic beta-subunit of glucosidase II." This protein is highly conserved, is expressed in all tissues tested, and contains a leader sequence, an LDLa domain, two EF-hand domains, and a conserved C-terminal HDEL sequence. Its function may be dependent on calcium binding, and its putative actions include the regulation of N-glycosylation of proteins and signal transduction via fibroblast growth-factor receptor. In light of the focal nature of liver cysts in ADPLD, the apparent loss-of-function mutations in PRKCSH, and the two-hit mechanism operational in dominant polycystic kidney disease, ADPLD may also occur by a two-hit mechanism.	Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06519 USA; Mayo Clin, Dept Med, Rochester, MN USA; Mayo Clin, Dept Radiol, Rochester, MN USA	Yale University; Yale University; Mayo Clinic; Mayo Clinic	Somlo, S (corresponding author), Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, 295 Congress Ave, New Haven, CT 06519 USA.	stefan.somlo@yale.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007356, P50DK057328, R01DK051041] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00585, M01 RR000585] Funding Source: Medline; NIDDK NIH HHS [DK51041, P50 DK57328, R01 DK051041, T32 DK007356, T32 DK07356, P50 DK057328] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arendt CW, 1997, J BIOL CHEM, V272, P13117, DOI 10.1074/jbc.272.20.13117; Arendt CW, 2000, GLYCOBIOLOGY, V10, P487, DOI 10.1093/glycob/10.5.487; BELLEFROID EJ, 1995, P NATL ACAD SCI USA, V92, P10757, DOI 10.1073/pnas.92.23.10757; Brule S, 2000, BIOL REPROD, V62, P642, DOI 10.1095/biolreprod62.3.642; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; COMFORT MW, 1952, GASTROENTEROLOGY, V20, P60; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Freeze HH, 1998, J PEDIATR-US, V133, P593, DOI 10.1016/S0022-3476(98)70096-4; Goh KC, 1996, J BIOL CHEM, V271, P5832, DOI 10.1074/jbc.271.10.5832; HIRAI M, 1990, BIOCHEM J, V270, P583, DOI 10.1042/bj2700583; Iglesias DM, 1999, DIGEST DIS SCI, V44, P385, DOI 10.1023/A:1026623005401; Jaeken J, 1998, AM J HUM GENET, V62, P1535, DOI 10.1086/301873; Kanai M, 1997, J BIOL CHEM, V272, P6621, DOI 10.1074/jbc.272.10.6621; KARHUNEN PJ, 1986, CLIN GENET, V30, P29; KIDA T, 1992, HEPATOLOGY, V16, P334, DOI 10.1002/hep.1840160209; Li YM, 1996, P NATL ACAD SCI USA, V93, P11047, DOI 10.1073/pnas.93.20.11047; MELNICK PJ, 1955, ARCH PATHOL, V59, P162; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; OUE F, 1995, GASTROENTEROLOGY, V108, P487, DOI 10.1016/0016-5085(95)90078-0; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pirson Y, 1996, HEPATOLOGY, V23, P249, DOI 10.1002/hep.510230208; Qian Q, 2003, HEPATOLOGY, V37, P164, DOI 10.1053/jhep.2003.50006; RAMOS A, 1990, ARCH PATHOL LAB MED, V114, P180; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; Reynolds DM, 2000, AM J HUM GENET, V67, P1598, DOI 10.1086/316904; SHAOUL E, 1995, ONCOGENE, V10, P1553; SOMLO S, 1995, J AM SOC NEPHROL, V6, P727; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; TORRES VE, 1994, J AM SOC NEPHROL, V5, P1186; TORRES VE, 1996, POLYCYSTIC KIDNEY DI; Treml K, 2000, GLYCOBIOLOGY, V10, P493, DOI 10.1093/glycob/10.5.493; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; Westphal V, 2001, MOL GENET METAB, V73, P77, DOI 10.1006/mgme.2001.3161; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6	39	134	138	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					691	703		10.1086/368295	http://dx.doi.org/10.1086/368295			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12529853	Bronze, Green Published			2022-12-18	WOS:000181152600018
J	Semino, O; Santachiara-Benerecetti, AS; Falaschi, F; Sforza, LLC; Underhill, PA				Semino, O; Santachiara-Benerecetti, AS; Falaschi, F; Sforza, LLC; Underhill, PA			Ethiopians and Khoisan share the deepest clades of the human Y-chromosome phylogeny	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFRICAN POPULATIONS; SEQUENCE VARIATION; DNA POLYMORPHISMS; HISTORY; MARKERS	The genetic structure of 126 Ethiopian and 139 Senegalese Y chromosomes was investigated by a hierarchical analysis of 30 diagnostic biallelic markers selected from the worldwide Y-chromosome genealogy. The present study reveals that (1) only the Ethiopians share with the Khoisan the deepest human Y-chromosome clades (the African-specific Groups I and II) but with a repertoire of very different haplotypes; (2) most of the Ethiopians and virtually all the Senegalese belong to Group III, whose precursor is believed to be involved in the first migration out of Africa; and (3) the Ethiopian Y chromosomes that fall into Groups VI, VIII, and IX may be explained by back migrations from Asia. The first observation confirms the ancestral affinity between the Ethiopians and the Khoisan, which has previously been suggested by both archaeological and genetic findings.	Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; IRCCS Policlin San Mateo, Serv Pronto Soccorso, Pavia, Italy; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Pavia; IRCCS Fondazione San Matteo; Stanford University	Semino, O (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	semino@ipvgen.unipv.it		SEMINO, Ornella/0000-0002-9675-9403	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428, R01GM055273] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 55273, GM 28428, P01 GM028428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; EXCOFFIER L, 1987, YEARB PHYS ANTHROPOL, V30, P151; GREENBERG JH, 1963, LANGUAGES AFRICA; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Hiernaux J., 1975, PEOPLE AFRICA; Levine D.N, 1974, GREATER ETHIOPIA; Nurse GT., 1985, PEOPLES SO AFRICA TH; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; RITTE U, 1993, J MOL EVOL, V37, P435; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 1996, AM J HUM GENET, V59, P964; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SPURDLE A, 1992, AM J HUM GENET, V50, P107; TORRONI A, 1990, ANN HUM GENET, V54, P287; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0	27	134	139	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					265	268		10.1086/338306	http://dx.doi.org/10.1086/338306			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11719903	Green Published, Bronze			2022-12-18	WOS:000172571900025
J	Zhao, HY; Zhang, SL; Merikangas, KR; Trixler, M; Wildenauer, DB; Sun, FZ; Kidd, KK				Zhao, HY; Zhang, SL; Merikangas, KR; Trixler, M; Wildenauer, DB; Sun, FZ; Kidd, KK			Transmission/disequilibrium tests using multiple tightly linked markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE RELATIVE RISK; COMPLEX HUMAN-DISEASES; LINKAGE DISEQUILIBRIUM; TEST TDT; SIBSHIP TEST; ASSOCIATION; TRANSMISSION; ALLELES; LOCI	Transmission/disequilibrium tests have attracted much attention in genetic studies of complex traits because (a) their power to detect genes having small to moderate effects may be greater than that of other linkage methods and (b) they are robust against population stratification. Highly polymorphic markers have become available throughout the human genome, and many such markers can be studied within short physical distances. Studies using multiple tightly linked markers are more informative than those using single markers. However, such information has not been fully utilized by existing statistical methods, resulting in possibly substantial loss of information in the identification of genes underlying complex traits. In this article, we propose novel statistical methods to analyze multiple tightly linked markers. Simulation studies comparing our methods versus existing methods suggest that our methods are more powerful. Finally, we apply the proposed methods to study genetic linkage between the dopamine D2 receptor locus and alcoholism.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Univ Pecs, Sch Med, Dept Psychiat, Pecs, Hungary; Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; Univ So Calif, Dept Math, Los Angeles, CA 90089 USA	Yale University; Yale University; University of Pecs; University of Bonn; University of Southern California	Zhao, HY (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.		Sun, Fengzhu/G-4373-2010	Sun, Fengzhu/0000-0002-8552-043X; Merikangas, Kathkeen/0000-0002-4667-2414	NIAAA NIH HHS [AA09379, R01 AA009379] Funding Source: Medline; NICHD NIH HHS [HD36834] Funding Source: Medline; NIGMS NIH HHS [R01 GM059507, GM59507] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; EWENS WJ, 1997, CURRENT PROTOCOLS S, V15; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SETHURAMAN B, 1997, THESIS U CALIFORNIA; Sham P, 1997, AM J HUM GENET, V61, P774; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; TEMPLETON AR, 1987, GENETICS, V117, P343; Teng J, 1999, GENOME RES, V9, P234; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMSON G, 1995, AM J HUM GENET, V57, P487; WEIR BS, 1978, GENETICS, V88, P633; Wilson SR, 1997, ANN HUM GENET, V61, P151, DOI 10.1017/S0003480097006040; Zhao HY, 1999, AM J HUM GENET, V64, P326, DOI 10.1086/302208; ZOUROS E, 1977, GENETICS, V85, P543	30	134	141	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					936	946		10.1086/303073	http://dx.doi.org/10.1086/303073			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10968775	Green Published, Bronze			2022-12-18	WOS:000089651100015
J	Bamshad, M; Le, T; Watkins, WS; Dixon, ME; Kramer, BE; Roeder, AD; Carey, JC; Root, S; Schinzel, A; Van Maldergem, L; Gardner, RJM; Lin, RC; Seidman, CE; Seidman, JG; Wallerstein, R; Moran, E; Sutphen, R; Campbell, CE; Jorde, LB				Bamshad, M; Le, T; Watkins, WS; Dixon, ME; Kramer, BE; Roeder, AD; Carey, JC; Root, S; Schinzel, A; Van Maldergem, L; Gardner, RJM; Lin, RC; Seidman, CE; Seidman, JG; Wallerstein, R; Moran, E; Sutphen, R; Campbell, CE; Jorde, LB			The spectrum of mutations in TBX3: Genotype phenotype relationship in ulnar-mammary syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							T-BOX GENES; HOLT-ORAM SYNDROME; BRACHYURY GENE; MESODERM FORMATION; MOUSE; FAMILY; LIMB; EXPRESSION; SPECIFICATION; IDENTITY	Ulnar-mammary syndrome (UMS) is a pleiotropic disorder affecting limb, apocrine-gland, tooth, hair, and genital development. Mutations that disrupt the DNA-binding-domain of the T-box gene, TBX3, have been demonstrated-to cause UMS. However, the 3' terminus of the open reading frame(ORF) of TBX3 was not identified, and mutations were detected in only two families with UMS. Furthermore, no substantial homology outside the T-box was found among TBX3 and its orthologues. The subsequent cloning of new TBX3 cDNAs allowed us to complete the characterization of TBX3 and to identify alternatively transcribed TBX3 transcripts, including one that interrupts the T-box. The complete ORF of TBX3 is predicted to encode a 723-residue protein, of which 255 amino acids are encoded by newly identified exons. Comparison of other T-box genes to TBX3 indicates regions of substantial homology outside the DNA-binding domain. Novel mutations have been found in all-of eight newly reported families with UMS, including five mutations downstream of the region encoding the T-box. This suggests that a domain(s) outside the T-box is highly conserved and important for the function of TBX3. We found no obvious phenotypic differences between those who have missense mutations and those who have deletions or frameshifts.	Univ Utah, Hlth Sci Ctr, Eccles Inst Human Genet, Dept Pediat, Salt Lake City, UT 84112 USA; Shriners Hosp Crippled Children, Intermt Unit, Salt Lake City, UT USA; Univ New Mexico, Div Genet & Dysmorphol, Albuquerque, NM 87131 USA; Univ Zurich, Inst Med Genet, Zurich, Switzerland; Inst Pathol & Genet, Ctr Genet Humaine, Loverval, Belgium; Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia; Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; NYU, Med Ctr, Dept Pediat, Human Genet Program, New York, NY 10016 USA; NYU, Hosp Joint Dis, Ctr Nervous & Dev Disorders, Inst Orthoped, New York, NY 10003 USA; Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Utah System of Higher Education; University of Utah; University of New Mexico; University of Zurich; Royal Children's Hospital Melbourne; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; New York University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; State University System of Florida; University of South Florida; Cleveland Clinic Foundation	Bamshad, M (corresponding author), Univ Utah, Hlth Sci Ctr, Eccles Inst Human Genet, Dept Pediat, 15 North 1030 East,Room 2100, Salt Lake City, UT 84112 USA.		Van Maldergem, Lionel/G-9849-2017; Van Maldergem, Lionel/O-3242-2019	Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214				Agulnik SI, 1996, GENETICS, V144, P249; Agulnik SI, 1998, GENOMICS, V51, P68, DOI 10.1006/geno.1998.5278; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, PEDIATR RES, V45, P291, DOI 10.1203/00006450-199903000-00001; Bamshad M, 1996, AM J MED GENET, V65, P325, DOI 10.1002/(SICI)1096-8628(19961111)65:4<325::AID-AJMG15>3.0.CO;2-W; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; BASSON CT, 1994, NEW ENGL J MED, V330, P1627; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; CHARIOT A, 1995, BIOCHEM BIOPH RES CO, V215, P713, DOI 10.1006/bbrc.1995.2522; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; FRANCESCHINI P, 1992, AM J MED GENET, V44, P807, DOI 10.1002/ajmg.1320440618; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; KISPERT A, 1994, GENE DEV, V8, P2137, DOI 10.1101/gad.8.18.2137; Kopp A, 1997, DEVELOPMENT, V124, P3715; Li QY, 1997, NAT GENET, V15, P21; Logan M, 1998, DEVELOPMENT, V125, P2825; MACMURRAY A, 1988, GENETICS, V120, P545; MAQUAT LE, 1995, RNA, V1, P453; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Ohuchi H, 1998, DEVELOPMENT, V125, P51; OREILLY MAJ, 1995, DEVELOPMENT, V121, P1351; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Ruvinsky I, 1997, GENOMICS, V40, P262, DOI 10.1006/geno.1996.4591; SCHINZEL A, 1987, CLIN GENET, V32, P160; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Schwabe JWR, 1998, TRENDS GENET, V14, P229, DOI 10.1016/S0168-9525(98)01477-2; Simon HG, 1997, DEVELOPMENT, V124, P1355; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; Wattler S, 1998, GENOMICS, V48, P24, DOI 10.1006/geno.1997.5150; Willing MC, 1996, AM J HUM GENET, V59, P799	41	134	142	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1550	1562		10.1086/302417	http://dx.doi.org/10.1086/302417			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330342	Green Published, Bronze			2022-12-18	WOS:000080696200007
J	Rochette, J; Pointon, JJ; Fisher, CA; Perera, G; Arambepola, M; Arichchi, DSK; De Silva, S; Vandwalle, JL; Monti, JP; Old, JM; Merryweather-Clarke, AT; Weatherall, DJ; Robson, KJH				Rochette, J; Pointon, JJ; Fisher, CA; Perera, G; Arambepola, M; Arichchi, DSK; De Silva, S; Vandwalle, JL; Monti, JP; Old, JM; Merryweather-Clarke, AT; Weatherall, DJ; Robson, KJH			Multicentric origin of hemochromatosis gene (HFE) mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY HEMOCHROMATOSIS; TRANSFERRIN RECEPTOR; HLA-H; D6S105; PREVALENCE; MARKERS	Genetic hemochromatosis (GH) is believed to be a disease restricted to those of European ancestry. In northwestern Europe, >80% of GH patients are homozygous for one mutation, the substitution of tyrosine for cysteine at position 282 (C282Y) in the unprocessed protein. In a proportion of GH patients, two mutations are present, C282Y and H63D. The clinical significance of this second mutation is such that it appears to predispose 1%-2% of compound heterozygotes to expression of the disease. The distribution of the two mutations differ, C282Y being limited to those of northwestern European ancestry and H63D being found at allele frequencies >5%, in Europe, in countries bordering the Mediterranean, in; the Middle East, and in the Indian subcontinent. The C282Y mutation occurs on a haplotype that extends less than or equal to 6 Mb, suggesting that this mutation has arisen during the past 2,000 years. The H63D mutation is older and does not occur on such a large extended haplotype, the haplotype in this case extending less than or equal to 700 kb. Here we report the finding of the H63D and C282Y mutations on new haplotypes. In Sri Lanka we have found H63D on three new haplotypes and have found C282Y on one new haplotype, demonstrating that these mutations have arisen independently on this island. These results suggest that the HFE gene has been the subject of selection pressure. These selection pressures could be due to infectious diseases, environmental conditions, or other genetic disorders such as anemia.	MRC, Mol Haematol Unit, Inst Mol Med, Oxford OX3 9DS, England; MRC, Natl Haemoglobinopathy Reference Serv, Inst Mol Med, Oxford OX3 9DS, England; Univ Picardie, Lab Biomol, Amiens, France; Anuradhapura Gen Hosp, Anuradhapura, Sri Lanka; Kurenegala Gen Hosp, Kurenagala, Sri Lanka	University of Oxford; University of Oxford; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Robson, KJH (corresponding author), MRC, Mol Haematol Unit, Inst Mol Med, Headley Way, Oxford OX3 9DS, England.	krobson@hammer.imm.ox.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beutler E, 1997, BLOOD CELL MOL DIS, V23, P219, DOI 10.1006/bcmd.1997.0139; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Borot N, 1997, IMMUNOGENETICS, V45, P320, DOI 10.1007/s002510050211; BOTHWELL TH, 1995, METABOLIC MOL BASES, P2237; Chang JG, 1997, BLOOD, V89, P3492, DOI 10.1182/blood.V89.9.3492; Cullen LM, 1998, AM J HUM GENET, V62, P1403, DOI 10.1086/301878; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ENRIQUEZ CMD, 1978, RACES BURMA; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; FLINT J, 1993, J HEPATOL S1, V26, P57; JAZWINSKA EC, 1993, AM J HUM GENET, V53, P347; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; Porto G, 1998, IMMUNOGENETICS, V47, P404, DOI 10.1007/s002510050376; RAHACHOWDHURY R, 1995, HUM MOL GENET, V4, P1869, DOI 10.1093/hmg/4.10.1869; Robson KJH, 1997, GUT, V41, P841; Rothengatter T, 1997, APPL PSYCHOL-INT REV, V46, P221, DOI 10.1111/j.1464-0597.1997.tb01226.x; VARAWALLA NY, 1992, HUM GENET, V90, P443; WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968; WORWOOD M, 1994, BRIT J HAEMATOL, V86, P863, DOI 10.1111/j.1365-2141.1994.tb04843.x	27	134	138	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1056	1062		10.1086/302318	http://dx.doi.org/10.1086/302318			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090890	Green Published, Bronze			2022-12-18	WOS:000079632900016
J	Allison, DB; Thiel, B; St Jean, P; Elston, RC; Infante, MC; Schork, NJ				Allison, DB; Thiel, B; St Jean, P; Elston, RC; Infante, MC; Schork, NJ			Multiple phenotype modeling in gene-mapping studies of quantitative traits: Power advantages	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISCORDANT SIB PAIRS; LINKAGE ANALYSIS; MULTIVARIATE-ANALYSIS; COMPLEX TRAITS; SIBLING PAIRS; LOCI; OBESITY; SEGREGATION; PEDIGREE; EFFICIENCY	Genomewide searches for loci influencing complex human traits and diseases such as diabetes, hypertension, and obesity are often plagued by low power and interpretive difficulties. Attempts to remedy these difficulties have typically relied on, and have promoted the use of, novel subject-ascertainment schemes, larger sample sizes, a greater density of DNA markers, and more-sophisticated statistical modeling and analysis strategies. Many of these remedies can be costly to implement. We investigate the utility of a simple statistical model for the mapping of quantitative-trait loci that incorporates multiple phenotypic or diagnostic endpoints into a gene-mapping analysis. The approach considers finding a linear combination of multiple phenotypic values that maximizes the evidence for linkage to a locus. Our results suggest that substantial increases in the power to map loci can be obtained with the proposed technique, although the increase in power obtained is a function of the size and direction of the residual correlation among the phenotypes used in the analysis. Extensive simulation studies are described that justify these claims, for cases in which two phenotypic measures are analyzed. This approach can be easily extended to cover more-complex situations and may provide a basis for more insightful genetic-analysis paradigms.	Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY USA; Case Western Reserve Univ, Dept Epidemiol & Stat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Case Western Reserve University; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Jackson Laboratory	Schork, NJ (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Metrohlth Med Ctr, R215 Rammelkamp Bldg,2500 MetroHealth Dr, Cleveland, OH 44106 USA.	njs2@po.cwru.edu		Allison, David/0000-0003-3566-9399; Schork, Nicholas/0000-0003-0920-5013	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK051716] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1996, INT J OBESITY, V20, P553; Allison DB, 1997, BEHAV GENET, V27, P401, DOI 10.1023/A:1025696232582; Allison DB, 1998, GENET EPIDEMIOL, V15, P87, DOI 10.1002/(SICI)1098-2272(1998)15:1<87::AID-GEPI7>3.0.CO;2-1; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1990, AM J HUM GENET, V47, P247; AMOS CI, 1986, GENET EPIDEMIOL, V3, P255, DOI 10.1002/gepi.1370030406; AMOS CI, 1993, GENET EPIDEMIOL, V10, P671, DOI 10.1002/gepi.1370100657; BAILEY KD, 1973, AM SOCIOL REV, V38, P18, DOI 10.2307/2094327; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; BLANGERO J, 1993, GENET EPIDEMIOL, V10, P617, DOI 10.1002/gepi.1370100648; BLANGERO J, 1991, GENET EPIDEMIOL, V8, P299, DOI 10.1002/gepi.1370080503; BONNEY GE, 1988, AM J HUM GENET, V43, P29; Boomsma DI, 1996, BEHAV GENET, V26, P161, DOI 10.1007/BF02359893; CHURCHILL GA, 1994, GENETICS, V138, P963; Doerge RW, 1996, GENETICS, V142, P285; Duggirala R, 1996, AM J HUM GENET, V59, P694; DUPUIS J, 1995, GENETICS, V140, P843; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; EAVES LJ, 1994, HEREDITY, V72, P175, DOI 10.1038/hdy.1994.25; ELSTON RC, 1995, CLIN EXP ALLERGY, V25, P103, DOI 10.1111/j.1365-2222.1995.tb00434.x; ELSTON RC, 1991, EPILEPSY RES, P161; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; GOLDIN LR, 1980, AM J MED GENET, V6, P279, DOI 10.1002/ajmg.1320060405; GROVE WM, 1994, PSYCHOL REP, V75, P467, DOI 10.2466/pr0.1994.75.1.467; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hochberg Y., 1987, WILEY SERIES PROBABI; JIANG CJ, 1995, GENETICS, V140, P1111; JONES MB, 1971, PSYCHOL BULL, V75, P92, DOI 10.1037/h0030297; KOROL AB, 1995, GENETICS, V140, P1137; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; Markel P. D., 1994, Psychiatric Genetics, V4, P205, DOI 10.1097/00041444-199400440-00003; MCGUFFIN P, 1993, TWINS TOOL BEHAV GEN, P243; Moldin SO, 1995, GENET EPIDEMIOL, V12, P801, DOI 10.1002/gepi.1370120645; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; OLSON JM, 1995, GENET EPIDEMIOL, V12, P177, DOI 10.1002/gepi.1370120206; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; REED DR, 1995, INT J OBESITY, V19, P599; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch NJ, 1996, AM J HUM GENET, V58, P836; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; Schork NJ, 1997, DIABETES REV, V5, P116; SCHORK NJ, 1994, AM J HUM GENET, V54, P361; SCHORK NJ, 1990, GENET EPIDEMIOL, V7, P427, DOI 10.1002/gepi.1370070605; Tiwari HK, 1997, ANN HUM GENET, V61, P253, DOI 10.1017/S0003480097006167; Todorov AA, 1997, HUM HERED, V47, P1, DOI 10.1159/000154381; ZLOTNIK LH, 1983, AM J MED GENET, V15, P307, DOI 10.1002/ajmg.1320150214; [No title captured]; [No title captured]	54	134	139	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1190	1201		10.1086/302038	http://dx.doi.org/10.1086/302038			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758596	Green Published, hybrid			2022-12-18	WOS:000076577800033
J	Farrington, SM; Lin-Goerke, J; Ling, J; Wang, YT; Burczak, JD; Robbins, DJ; Dunlop, MG				Farrington, SM; Lin-Goerke, J; Ling, J; Wang, YT; Burczak, JD; Robbins, DJ; Dunlop, MG			Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; REPAIR-GENE-MUTATIONS; HNPCC GENE; MICROSATELLITE INSTABILITY; FAMILY HISTORY; HOMOLOG; RISK; MSH2; POLYPOSIS; KINDREDS	Germ-line mutations in DNA mismatch-repair genes impart a markedly elevated cancer risk, often presenting as autosomal dominant hereditary nonpolyposis colorectal cancer (HNPCC). However, there are no pathognomonic features of HNPCC, not all gene carriers have a family history of the disease, and families fulfilling the Amsterdam criteria are relatively uncommon. Genetic testing of probands with early-onset colorectal cancer, irrespective of family history, is one approach that would allow predictive genetic testing of at-risk relatives. We cloned and sequenced hMSH2 and hMLH1 introns, to optimize genomic sequencing. We then systematically analyzed the entire hMSH2, and hMLH1 genes, by genomic sequencing and in vitro synthesized-protein-truncation assay (IVSP), in 50 colorectal cancer patients <30 years of age at diagnosis. To determine polymorphic variants, 26 anonymous donors also were sequenced. All subjects analyzed had at least 1 of 37 different polymorphic or pathogenic variants. IVSP complemented genomic sequencing, by detection of mutations not identified by genomic analysis. Fourteen cancer patients (28%) had pathogenic mutations, and a number of other variants also may have had a pathogenic significance that remains to be elucidated. Tumor replication-error status was useful in targeting sequencing efforts for this cohort of young patients: sensitivity was 86%, specificity 73%, and positive and negative predictive values 63% and 90%, respectively. These data indicate that an appreciable proportion of young colon cancer probands carry a germ-line mutation in a DNA mismatch-repair gene.	Univ Edinburgh, Dept Surg, Edinburgh EH4 2UX, Midlothian, Scotland; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2UX, Midlothian, Scotland; SmithKline Beecham Pharmaceut, Collegeville, PA USA	University of Edinburgh; University of Edinburgh; GlaxoSmithKline	Dunlop, MG (corresponding author), Univ Edinburgh, Dept Surg, Edinburgh EH4 2UX, Midlothian, Scotland.	Malcolm.Dunlop@hgu.mrc.ac.uk	Farrington, Susan M/C-7319-2013; Dunlop, Malcolm G/F-1973-2011; Farrington, Susan M/Q-2710-2019	Dunlop, Malcolm G/0000-0002-3033-5851; Farrington, Susan M/0000-0001-5955-7389				Akiyama Y, 1997, CANCER RES, V57, P3920; BORRESEN AL, 1995, HUM MOL GENET, V4, P2065, DOI 10.1093/hmg/4.11.2065; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Bubb VJ, 1996, ONCOGENE, V12, P2641; BUERSTEDDE JM, 1995, J MED GENET, V32, P909, DOI 10.1136/jmg.32.11.909; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Dunlop M, 1997, BRIT MED J, V314, P1779, DOI 10.1136/bmj.314.7097.1779; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Giardiello FM, 1997, NEW ENGL J MED, V336, P823, DOI 10.1056/NEJM199703203361202; Kane MF, 1997, CANCER RES, V57, P808; KohonenCorish M, 1996, AM J HUM GENET, V59, P818; KOLODNER RD, 1994, GENOMICS, V24, P516, DOI 10.1006/geno.1994.1661; KOLODNER RD, 1995, CANCER RES, V55, P242; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LIU B, 1994, CANCER RES, V54, P4590; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; LOTHE RA, 1993, CANCER RES, V53, P5849; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MARY JL, 1994, HUM MOL GENET, V3, P2067; Mauillon JL, 1996, CANCER RES, V56, P5728; Moslein G, 1996, HUM MOL GENET, V5, P1245, DOI 10.1093/hmg/5.9.1245; NAN HJ, 1995, HUM MOL GENET, V4, P237, DOI 10.1093/hmg/4.2.237; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Parker LT, 1996, BIOTECHNIQUES, V21, P694; Parker SL, 1996, CA-CANCER J CLIN, V46, P5, DOI 10.3322/canjclin.46.1.5; Plummer SJ, 1996, NAT MED, V2, P156, DOI 10.1038/nm0296-156; Scherer SJ, 1996, BIOCHEM BIOPH RES CO, V221, P722, DOI 10.1006/bbrc.1996.0663; SHARP L, 1993, CANC REGISTRATION ST; TANNERGARD P, 1995, CANCER RES, V55, P6092; Tomlinson IPM, 1997, J MED GENET, V34, P39, DOI 10.1136/jmg.34.1.39; Vasen HFA, 1996, GASTROENTEROLOGY, V110, P1020, DOI 10.1053/gast.1996.v110.pm8612988; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WIJNEN J, 1994, HUM MOL GENET, V3, P2268, DOI 10.1093/hmg/3.12.2268-a; WIJNEN J, 1995, AM J HUM GENET, V56, P1060; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847	39	134	142	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					749	759		10.1086/301996	http://dx.doi.org/10.1086/301996			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718327	Green Published, Bronze			2022-12-18	WOS:000075919000012
J	Peelen, T; vanVliet, M; PetrijBosch, A; Mieremet, R; Szabo, C; vandenOuweland, AMW; Hogervorst, F; Brohet, R; Ligtenberg, MJL; Teugels, E; vanderLuijt, R; vanderHout, AH; Gille, JJP; Pals, G; Jedema, I; Olmer, R; vanLeeuwen, I; Newman, B; Plandsoen, M; vanderEst, M; Brink, G; Hageman, S; Arts, PJW; Bakker, MM; Willems, HW; vanderLooij, E; Neyns, B; Bonduelle, M; Jansen, R; Oosterwijk, JC; Sijmons, R; Smeets, HJM; vanAsperen, CJ; MeijersHeijboer, H; Klijn, JGM; deGreve, J; King, MC; Menko, FH; Brunner, HG; Halley, D; vanOmmen, GJB; Vasen, HFA; Cornelisse, CJ; vantVeer, LJ; deKnijff, P; Bakker, E; Devilee, P				Peelen, T; vanVliet, M; PetrijBosch, A; Mieremet, R; Szabo, C; vandenOuweland, AMW; Hogervorst, F; Brohet, R; Ligtenberg, MJL; Teugels, E; vanderLuijt, R; vanderHout, AH; Gille, JJP; Pals, G; Jedema, I; Olmer, R; vanLeeuwen, I; Newman, B; Plandsoen, M; vanderEst, M; Brink, G; Hageman, S; Arts, PJW; Bakker, MM; Willems, HW; vanderLooij, E; Neyns, B; Bonduelle, M; Jansen, R; Oosterwijk, JC; Sijmons, R; Smeets, HJM; vanAsperen, CJ; MeijersHeijboer, H; Klijn, JGM; deGreve, J; King, MC; Menko, FH; Brunner, HG; Halley, D; vanOmmen, GJB; Vasen, HFA; Cornelisse, CJ; vantVeer, LJ; deKnijff, P; Bakker, E; Devilee, P			A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN TRUNCATION TEST; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; RAPID DETECTION; DNA; FREQUENCY; CARRIERS; 185DELAG; LINKAGE	We have identified 79 mutations in BRCA1 in a set of 643 Dutch and 23 Belgian hereditary breast and ovarian cancer families collected either for research or for clinical diagnostic purposes. Twenty-eight distinct mutations have been observed, 18 of them not previously reported and 12 of them occurring more than once. Most conspicuously, a 2804delAA mutation has been found 19 times and has never been reported outside the Netherlands. A common haplotype spanning greater than or equal to 375 kb could be identified for each of the nine examined recurrent mutations, indicating the presence of multiple BRCA1 founder mutations in the Dutch population. The 2804delAA mutation has been estimated to have originated similar to 32 generations ago, No specific breast or ovarian cancer phenotype could be assigned to any of the common mutations, and the ovarian cancer incidence among 18 families with the 2804delAA mutation was heterogeneous.	LEIDEN UNIV, MED CTR, DEPT HUMAN GENET, NL-2333 AL LEIDEN, NETHERLANDS; LEIDEN UNIV, MED CTR, DEPT PATHOL, NL-2333 AL LEIDEN, NETHERLANDS; LEIDEN UNIV, MED CTR, DEPT CLIN GENET, NL-2333 AL LEIDEN, NETHERLANDS; FDN DETECT HEREDITARY TUMORS, LEIDEN, NETHERLANDS; UNIV WASHINGTON, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA; ERASMUS UNIV ROTTERDAM, DEPT CLIN GENET, NL-3000 DR ROTTERDAM, NETHERLANDS; UNIV HOSP, ROTTERDAM, NETHERLANDS; DANIEL DEN HOED CANC CLIN, ROTTERDAM, NETHERLANDS; NETHERLANDS CANC INST, DEPT PATHOL, NL-1066 CX AMSTERDAM, NETHERLANDS; NETHERLANDS CANC INST, DEPT EPIDEMIOL, AMSTERDAM, NETHERLANDS; FREE UNIV AMSTERDAM, DEPT CLIN GENET, AMSTERDAM, NETHERLANDS; UNIV HOSP, DEPT HUMAN GENET, NIJMEGEN, NETHERLANDS; UNIV HOSP, DEPT PATHOL, NIJMEGEN, NETHERLANDS; FREE UNIV BRUSSELS, ACAD HOSP, DEPT MED GENET & ONCOL, MOL ONCOL LAB, B-1090 BRUSSELS, BELGIUM; UNIV UTRECHT, DEPT HUMAN GENET, UTRECHT, NETHERLANDS; UNIV GRONINGEN, UNIV HOSP GRONINGEN, DEPT MED GENET, GRONINGEN, NETHERLANDS; UNIV N CAROLINA, CHAPEL HILL, NC USA; DEPT CLIN GENET, MAASTRICHT, NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Utrecht University; University of Groningen; University of North Carolina; University of North Carolina Chapel Hill; Maastricht University			DEVILEE, PETER/ABR-2140-2022; Ligtenberg, Marjolijn/N-9666-2013; Oosterwijk, Jan C./G-5770-2011; Neyns, Bart/ABG-3145-2021; Pals, Gerard/A-5198-2011; van Asperen, Christi J/D-3970-2012; Neyns, Bart/AAA-8267-2021; De Greve, Jacques/J-4939-2012; Sijmons, Rolf/E-5829-2012; Bakker, Egbert/D-3525-2009; de Knijff, Peter/Y-2519-2018; Brunner, Han/C-9928-2013	Ligtenberg, Marjolijn/0000-0003-1290-1474; Neyns, Bart/0000-0003-0658-5903; van Asperen, Christi J/0000-0002-1436-7650; De Greve, Jacques/0000-0002-2389-0742; Sijmons, Rolf/0000-0001-8446-2779; Bakker, Egbert/0000-0002-2843-7357; de Knijff, Peter/0000-0002-0899-771X; Gille, Johan/0000-0003-4526-298X; Pals, Gerard/0000-0003-4091-7115; Bonduelle, Mary-Louise/0000-0002-1805-9962; Teugels, Erik/0000-0002-7828-4555	NCI NIH HHS [P50 CA58223, R01-CA27632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058223, R01CA027632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; Anderson TI, 1996, AM J HUM GENET, V59, P486; Berman DB, 1996, AM J HUM GENET, V58, P1166; Beutler E, 1996, HUM MUTAT, V8, P203, DOI 10.1002/(SICI)1098-1004(1996)8:3<203::AID-HUMU1>3.3.CO;2-C; Caligo MA, 1996, ONCOGENE, V13, P1483; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CORNELIS RS, 1995, HUM GENET, V95, P539, DOI 10.1007/BF00223866; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1995, AM J HUM GENET, V57, P1457; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FORD D, 1995, BRIT J CANCER, V72, P805, DOI 10.1038/bjc.1995.417; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; Johannsson O, 1996, AM J HUM GENET, V58, P441; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Peelen T, 1996, EUR J HUM GENET, V4, P225; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; Serova O, 1996, AM J HUM GENET, V58, P42; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; TONIN P, 1995, AM J HUM GENET, V57, P189; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; Wagner TMU, 1996, LANCET, V347, P1263, DOI 10.1016/S0140-6736(96)90781-3; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	35	134	143	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1041	1049						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150151				2022-12-18	WOS:A1997WX76000004
J	Schubert, EK; Lee, MK; Mefford, HC; Argonza, RH; Morrow, JE; Hull, J; Dann, JL; King, MC				Schubert, EK; Lee, MK; Mefford, HC; Argonza, RH; Morrow, JE; Hull, J; Dann, JL; King, MC			BRCA2 in American families with four or more cases of breast or ovarian cancer: Recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENE	In order to evaluate the role of inherited BRCA2 mutations in American families-particularly the appearance in America of European founder mutations-the BRCA2 coding sequence, 5' UTR, and 3' UTR were screened in 22 Caucasian American kindreds with four or more cases of breast or ovarian cancer. Six mutations were found that cause a premature-termination codon; four of them have been reported elsewhere, and two are novel. In the four families with previously seen mutations, the distinct lineages at high risk of cancer were of Dutch, German, Irish, and Ashkenazi Jewish ancestry; mutations in Europe reflect these ancestries. The families with novel mutations were Puerto Rican Hispanic (exon 9 deletion 995delCAAAT) and Ashkenazi Jewish (exon 11 deletion 6425delTT). Among female BRCA2-mutation carriers, risks of breast cancer were 32% by age 50 years, 67% by age 70 years, and 80% by age 90 years, yielding a lifetime risk similar to that for BRCA1 but an older distribution of ages at onset. BRCA2 families also included multiple cases of cancers of the male breast (six cases), ovary (three cases), fallopian tube (mio cases), pancreas (three cases), bladder (two cases), and prostate (two cases). Among 17 Ashkenazi Jewish families with four or more breast or ovarian cancers, 9 families (including 3 with ovarian cancer and 1 with male breast cancer) carried none of the three ancient mutations in BRCA1 or BRCA2. To date, both BRCA2 and BRCA1 have been screened by SSCA, supplemented by the protein-truncation test, in 48 families with four or more breast or ovarian cancers. Mutations have been detected in BRCA1 in 33 families, in BRCA2 in 6 families, and in neither gene in 9 families, suggesting both the probable cryptic nature of some mutations and the likelihood of at least one other BRCA gene.	UNIV WASHINGTON,DIV MED GENET,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle				King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [R01CA27632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CLAUS EB, 1991, AM J HUM GENET, V48, P232; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Foster KA, 1996, CANCER RES, V56, P3622; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; Friedman LS, 1997, AM J HUM GENET, V60, P313; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P684; KALBFLEISCH JD, 1980, ANAL FAILURE TIME DA; Katagiri T, 1996, CANCER RES, V56, P4575; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Puget N, 1997, CANCER RES, V57, P828; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; *SAS I, 1997, SAS REL 6 12; Serova OM, 1997, AM J HUM GENET, V60, P486; Stratton MR, 1996, HUM MOL GENET, V5, P1515, DOI 10.1093/hmg/5.Supplement_1.1515; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Takahashi H, 1996, CANCER RES, V56, P2738; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	28	134	137	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1031	1040						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150150				2022-12-18	WOS:A1997WX76000003
J	Narod, SA; Hawkins, MM; Robertson, CM; Stiller, CA				Narod, SA; Hawkins, MM; Robertson, CM; Stiller, CA			Congenital anomalies and childhood cancer in Great Britain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RUBINSTEIN-TAYBI SYNDROME; PAIRED BOX GENE; WILMS-TUMOR; INTERSTITIAL DELETION; BIRTH-DEFECTS; CHILDREN; ASSOCIATION; RHABDOMYOSARCOMA; MALFORMATIONS; MALIGNANCY	The presence of cancer and a congenital anomaly in the same child may be explained in certain cases by an underlying genetic abnormality. The study of these associations may lead to the identification of genes that are important in both processes. We have examined the records of 20,304 children with cancer in Britain, who were entered into the National Registry of Childhood Tumors (NRCT) during 1971-86, for the presence of congenital anomalies. The frequency of anomalies was much higher among children with solid tumors (4.4%) than among those with leukemia or lymphoma (2.6%; P <.0001). The types of cancer,vith the highest rates of anomalies were Wilms tumor (8.1%), Ewing sarcoma (5.8%), hepatoblastoma (6.4%), and gonadal and germ-cell tumors (6.4%), Cases of spina bifida and abnormalities of the eye, ribs, and spine were more common in children with cancer than among population-based controls. Future studies may be directed toward identifying the developmental pathways and the relevant genes that are involved in the overlap between pediatric cancer and malformation.	UNIV OXFORD,DEPT PEDIAT,CHILDHOOD CANC RES GRP,OXFORD,ENGLAND	University of Oxford	Narod, SA (corresponding author), UNIV TORONTO,WOMENS COLL HOSP,DEPT PREVENT MED & BIOSTAT,790 BAY ST,TORONTO,ON M5G 1N8,CANADA.		Narod, Steven A/AAA-6112-2022	Stiller, Charles/0000-0002-3006-7869				ATWELL JD, 1981, J PEDIATR SURG, V16, P1029, DOI 10.1016/S0022-3468(81)80870-6; BAIRD PA, 1987, CAN MED ASSOC J, V36, P109; BAPTISTE M, 1989, NEUROLOGY, V39, P487, DOI 10.1212/WNL.39.4.487; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BERRY CL, 1970, ARCH DIS CHILD, V45, P229, DOI 10.1136/adc.45.240.229; BIRCH JM, 1982, CARCINOGENESIS, V3, P75, DOI 10.1093/carcin/3.1.75; BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; BLOT WJ, 1980, LANCET, V1, P722; BONAITIPELLIE C, 1992, MED PEDIATR ONCOL, V20, P284, DOI 10.1002/mpo.2950200404; BUNIN GR, 1993, NEW ENGL J MED, V329, P536, DOI 10.1056/NEJM199308193290804; CHAO LY, 1993, NAT GENET, V3, P127, DOI 10.1038/ng0293-127; CICH JA, 1993, CAUSES CHILDHOOD CAN, V4, P1; EVANS G, 1993, MED PEDIATR ONCOL, V21, P433, DOI 10.1002/mpo.2950210608; FRAUMENI JF, 1973, J NATL CANCER I, V51, P1425, DOI 10.1093/jnci/51.5.1425; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; KLENERMAN L., 1967, J BONE JOINT SUR B BRIT, V49, P314; LYNCH HT, 1968, AM J DIS CHILD, V115, P723, DOI 10.1001/archpedi.1968.02100010725016; Mann J R, 1990, Paediatr Perinat Epidemiol, V4, P276, DOI 10.1111/j.1365-3016.1990.tb00651.x; MANN JR, 1993, BRIT J CANCER, V68, P357, DOI 10.1038/bjc.1993.340; MCKEEN EA, 1983, NEW ENGL J MED, V309, P1522; MEHES K, 1985, EUR J PEDIATR, V144, P243, DOI 10.1007/BF00451951; MILI F, 1993, AM J EPIDEMIOL, V137, P629, DOI 10.1093/oxfordjournals.aje.a116720; MILLER RW, 1964, NEW ENGL J MED, V270, P922, DOI 10.1056/NEJM196404302701802; MILLER RW, 1968, J NATL CANCER I, V40, P1079; MILLER RW, 1963, NEW ENGL J MED, V268, P393, DOI 10.1056/NEJM196302212680801; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; MOTEGI T, 1983, HUM GENET, V64, P160, DOI 10.1007/BF00327116; MULINARE J, 1988, JAMA-J AM MED ASSOC, V260, P3141, DOI 10.1001/jama.260.21.3141; MULVIHILL JJ, 1977, CANCER, V40, P3115, DOI 10.1002/1097-0142(197712)40:6<3115::AID-CNCR2820400655>3.0.CO;2-4; NAROD SA, 1991, BRIT J CANCER, V63, P993, DOI 10.1038/bjc.1991.216; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; RICCARDI VM, 1978, PEDIATRICS, V61, P604; ROBISON LL, 1982, NEW ENGL J MED, V307, P1086; RUYMANN FB, 1988, MED PEDIATR ONCOL, V16, P33, DOI 10.1002/mpo.2950160109; SCHUMACHER R, 1992, EUR J PEDIATR, V151, P432, DOI 10.1007/BF01959357; STILLER CA, 1987, CARCINOGENESIS, V8, P129, DOI 10.1093/carcin/8.1.129; Stiller CA, 1995, EUR J CANCER, V31A, P2028, DOI 10.1016/0959-8049(95)00428-9; SY WM, 1968, CANCER-AM CANCER SOC, V22, P234, DOI 10.1002/1097-0142(196807)22:1<234::AID-CNCR2820220127>3.0.CO;2-W; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; VANDERWIEL HJ, 1960, INHERITANCE GLIOMA G; VIEREGGE P, 1987, J NEUROL, V234, P220, DOI 10.1007/BF00618254; WEKSBERG R, 1993, HUM MOL GENET, V2, P549, DOI 10.1093/hmg/2.5.549; WIEDEMANN HR, 1983, EUR J PEDIATR, V141, P129, DOI 10.1007/BF00496807; WINDHAM GC, 1985, AM J EPIDEMIOL, V121, P49, DOI 10.1093/oxfordjournals.aje.a113982	46	134	136	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					474	485						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042906				2022-12-18	WOS:A1997WK40300003
J	MARTIN, RH; SPRIGGS, E; KO, E; RADEMAKER, AW				MARTIN, RH; SPRIGGS, E; KO, E; RADEMAKER, AW			THE RELATIONSHIP BETWEEN PATERNAL AGE, SEX-RATIOS, AND ANEUPLOIDY FREQUENCIES IN HUMAN SPERM, AS ASSESSED BY MULTICOLOR FISH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEW-YORK-STATE; NONRADIOACTIVE INSITU HYBRIDIZATION; IN-SITU HYBRIDIZATION; DOWNS-SYNDROME; BIRTH-ORDER; PARENTAL AGE; MATERNAL AGE; CHROMOSOME; NUCLEI; DNA	We studied the frequencies of X- and Y-chromosome-bearing sperm, diploidy and disomy for chromosomes 1, 12, X, and Y in sperm from 10 normal men aged 21-52 years, to determine whether there was any relationship between donor age and any of these variables. Multicolor FISH was used to control for lack of probe hybridization and to distinguish diploid sperm from disomic sperm. A minimum of 10,000 sperm per donor was evaluated for each chromosome, for a total of 225,846 sperm studied. Sperm were considered disomic if two fluorescent signals were separated by a minimal distance of one signal domain. The mean frequencies of X- and Y-bearing sperm were 50.1% and 49.0%, respectively; not significantly different from 50%. There was no correlation between paternal age and ''sex ratio'' in sperm. Similarly, there was no association between the frequency of diploid sperm (mean, .16%; range, .06%-.42%) and donor age. For disomy frequencies, there was no relationship between donor age and disomy 12 (mean, .16%; range, .10%-.25%), XX (mean, .07%; range, .03%-.17%), and XY sperm (mean, .16%; range, .08%-.24%). There was a significant increase in the frequency of YY sperm (P = .04; mean, .18%; range, .10%-.43%) and disomy 1 sperm (P = .01; mean, .11%; range, .05%-.18%) with donor age. In summary, our results do not support a correlation between paternal age and sex ratio or diploidy. A relationship between paternal age and disomy was observed for disomy 1 and YY sperm but not for disomy 12, XX or XY sperm.	UNIV CALGARY,DEPT MED GENET,CALGARY,AB,CANADA; ALBERTA CHILDRENS PROV GEN HOSP,DEPT GENET,CALGARY,AB T2T 5C7,CANADA; NORTHWESTERN UNIV,SCH MED,CTR CANC,BIOMETRY SECT,CHICAGO,IL 60611	University of Calgary; Alberta Childrens Hospital; University of Calgary; Northwestern University								BALDINI A, 1990, AM J HUM GENET, V46, P784; CAROTHERS AD, 1984, HUM GENET, V68, P248, DOI 10.1007/BF00418395; CAROTHERS AD, 1978, ANN HUM GENET, V41, P277, DOI 10.1111/j.1469-1809.1978.tb01895.x; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; CROSS PK, 1987, HUM GENET, V77, P307, DOI 10.1007/BF00291415; CURTSINGER JW, 1983, AM J HUM GENET, V35, P951; ERICKSON JD, 1978, ANN HUM GENET, V41, P289, DOI 10.1111/j.1469-1809.1978.tb01896.x; ERICKSON JD, 1976, ANN HUM GENET, V40, P205, DOI 10.1111/j.1469-1809.1976.tb00182.x; Griffin D. K., 1994, American Journal of Human Genetics, V55, pA44; GUTTENBACH M, 1994, HUM GENET, V93, P421; GUTTENBACH M, 1994, HUM GENET, V93, P7; GUTTENBACH M, 1990, AM J HUM GENET, V46, P553; GUTTENBACH M, 1991, HUM GENET, V87, P261; HATCH M, 1990, HUM GENET, V85, P355; HOLMES JM, 1993, HUM GENET, V91, P20; HOOK EB, 1982, HUM GENET, V62, P167; HOOK EB, 1984, AM J HUM GENET, V36, P413; JABS EW, 1989, P NATL ACAD SCI USA, V86, P202, DOI 10.1073/pnas.86.1.202; JAMES WH, 1985, J BIOSOC SCI, V17, P47, DOI 10.1017/S0021932000015467; MARTIN R, 1992, HUM HERED, V42, P333, DOI 10.1159/000154095; MARTIN RH, 1987, AM J HUM GENET, V41, P484; MARTIN RH, 1993, CYTOGENET CELL GENET, V64, P23, DOI 10.1159/000133552; MATSUNAGA E, 1978, HUM GENET, V40, P259, DOI 10.1007/BF00272186; MIHARU N, 1994, AM J HUM GENET S, V55, pA581; PIETERS MHEC, 1990, CYTOGENET CELL GENET, V53, P15, DOI 10.1159/000132886; REGAL RR, 1980, AM J EPIDEMIOL, V112, P650, DOI 10.1093/oxfordjournals.aje.a113037; Robinson W. P., 1993, European Journal of Human Genetics, V1, P280; ROECKER GO, 1983, AM J HUM GENET, V35, P1297; RUDER A, 1985, AM J HUM GENET, V37, P362; STENE J, 1981, HUM GENET, V59, P119, DOI 10.1007/BF00293059; STENE J, 1977, ANN HUM GENET, V40, P259; WATT JL, 1987, J MED GENET, V24, P60, DOI 10.1136/jmg.24.1.60; WILLIAMS BJ, 1993, HUM MOL GENET, V2, P1929, DOI 10.1093/hmg/2.11.1929; Wyrobek A. J., 1994, American Journal of Human Genetics, V55, pA122; WYROBEK AJ, 1990, MOL REPROD DEV, V27, P200, DOI 10.1002/mrd.1080270304; ZARUTSKIE PW, 1989, FERTIL STERIL, V52, P891	36	134	135	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1395	1399						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533769				2022-12-18	WOS:A1995TE65500017
J	BISHOP, DT; WILLIAMSON, JA				BISHOP, DT; WILLIAMSON, JA			THE POWER OF IDENTITY-BY-STATE METHODS FOR LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,DEPT MATH,BOULDER,CO 80309	University of Colorado System; University of Colorado Boulder	BISHOP, DT (corresponding author), IMPERIAL CANC RES FUND,GENET EPIDEMIOL LAB,3K SPRINGFIELD HOUSE,HYDE TERRACE,LEEDS LS2 9LU,ENGLAND.			Bishop, Tim/0000-0002-8752-8785	NATIONAL CANCER INSTITUTE [R23CA036362, R01CA036362, R01CA028854] Funding Source: NIH RePORTER; NCI NIH HHS [CA-36362, CA-28854] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CAMPBELL MA, 1971, ANN HUM GENET, V35, P225, DOI 10.1111/j.1469-1809.1956.tb01395.x; CANTOR R M, 1987, American Journal of Human Genetics, V41, pA252; COTTMAN CW, 1940, THESIS OHIO STATE U; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HODGE SE, 1981, AM J HUM GENET, V33, P381; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; LANGE K, 1986, AM J HUM GENET, V39, P148; LANGE K, 1974, THEOR POPUL BIOL, V6, P92, DOI 10.1016/0040-5809(74)90033-1; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; PENROSE LS, 1935, ANN EUGEN, V6, P133; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; SMITH CAB, 1953, J R STAT SOC B, V15, P153; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; Thompson EA, 1986, PEDIGREE ANAL HUMAN; THOMSON G, 1986, AM J HUM GENET, V39, P207; WEEKS DE, 1988, AM J HUM GENET, V42, P315	21	134	137	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					254	265						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301395				2022-12-18	WOS:A1990CM93800005
J	GLOVER, TW; STEIN, CK				GLOVER, TW; STEIN, CK			INDUCTION OF SISTER CHROMATID EXCHANGES AT COMMON FRAGILE SITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	GLOVER, TW (corresponding author), UNIV MICHIGAN,SCH MED,DEPT PEDIAT,D1225,MED PROFESS BLDG,BOX 0718,ANN ARBOR,MI 48109, USA.				NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA43222] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERGER R, 1985, CYTOGENET CELL GENET, V40, P490, DOI 10.1159/000132181; DANIEL A, 1984, AM J MED GENET, V18, P483, DOI 10.1002/ajmg.1320180318; GLOVER TW, 1986, CANCER GENET CYTOGEN, V19, P141, DOI 10.1016/0165-4608(86)90381-X; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GLOVER TW, 1985, FRAGILE SITES HUMAN, P80; HECHT F, 1984, CANCER GENET CYTOGEN, V13, P185, DOI 10.1016/0165-4608(84)90060-8; HECHT F, 1984, CANCER GENET CYTOGEN, V12, P189; ISHII Y, 1980, MUTAT RES, V79, P19, DOI 10.1016/0165-1218(80)90144-5; KUNZ BA, 1986, GENETICS, V114, P375; LATT SA, 1975, P NATL ACAD SCI USA, V72, P4066, DOI 10.1073/pnas.72.10.4066; LEBEAU MM, 1984, NATURE, V308, P607, DOI 10.1038/308607a0; LEDBETTER DH, 1986, NATURE, V324, P161, DOI 10.1038/324161a0; LEDBETTER DH, 1986, AM J MED GENET, V23, P445, DOI 10.1002/ajmg.1320230136; PAINTER RB, 1980, MUTAT RES, V70, P337, DOI 10.1016/0027-5107(80)90023-8; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; SCHIMKE RT, 1986, P NATL ACAD SCI USA, V83, P2157, DOI 10.1073/pnas.83.7.2157; SONO A, 1978, CELL STRUCT FUNCT, V3, P341, DOI 10.1247/csf.3.341; TOMMERUP N, 1986, 7TH P INT C HUM GEN; WENGER SL, 1987, AM J MED GENET, V26, P909, DOI 10.1002/ajmg.1320260419; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375	20	134	134	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					882	890						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	3674017				2022-12-18	WOS:A1987K936100009
J	HECHT, JT; FRANCOMANO, CA; HORTON, WA; ANNEGERS, JF				HECHT, JT; FRANCOMANO, CA; HORTON, WA; ANNEGERS, JF			MORTALITY IN ACHONDROPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,HLTH SCI CTR,SCH PUBL HLTH,HOUSTON,TX 77225; JOHNS HOPKINS UNIV HOSP,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV HOSP,DEPT PEDIAT,BALTIMORE,MD 21205	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	HECHT, JT (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,POB 20708,HOUSTON,TX 77225, USA.				NICHD NIH HHS [HD20691] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020691] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BLAND JD, 1982, DEV MED CHILD NEUROL, V24, P489; CHAPMAN RWG, 1982, J CLIN PATHOL, V35, P487, DOI 10.1136/jcp.35.5.487; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; HACKLER RH, 1977, J UROLOGY, V117, P486, DOI 10.1016/S0022-5347(17)58506-7; HAENSZEL W, 1962, J NATL CANCER I, V28, P1001; HECHT JT, 1985, AM J MED GENET, V20, P355, DOI 10.1002/ajmg.1320200219; HECHT JT, 1984, EUR J PEDIATR, V143, P58, DOI 10.1007/BF00442750; Marin-Padilla M, 1977, Birth Defects Orig Artic Ser, V13, P7; Nelson M A, 1970, Ann R Coll Surg Engl, V47, P185; PAULI RM, 1984, J PEDIATR-US, V104, P342, DOI 10.1016/S0022-3476(84)81092-6; Scott C I Jr, 1977, Birth Defects Orig Artic Ser, V13, P29; YANG SS, 1977, AM J CLIN PATHOL, V68, P68; 1977, VITAL STATISTICS US, V2	13	134	139	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1987	41	3					454	464						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K0191	3631079				2022-12-18	WOS:A1987K019100010
J	THERMAN, E; SARTO, GE; PATAU, K				THERMAN, E; SARTO, GE; PATAU, K			APPARENTLY ISODICENTRIC BUT FUNCTIONALLY MONOCENTRIC X-CHROMOSOME IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WISCONSIN, DEPT MED GENET, MADISON, WI 53706 USA; UNIV WISCONSIN, DEPT GYNECOL & OBSTET, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison								COHEN MM, 1972, AM J HUM GENET, V24, P583; CONTE FA, 1969, OCT AM SOC HUM GEN A, P53; CRAIGHOLMES AP, 1973, AM J HUM GENET, V25, P181; De MARS ROBERT, 1964, WE3TAR INST SYMP MONOGR, V1, P35; DEMARS R, 1967, 26 NAT CANC I MON, P327; DISTECHE C, 1972, CLIN GENET, V3, P388; EDWARDS JH, 1961, LANCET, V1, P616; EMERIT I, 1970, ANN GENET-PARIS, V13, P245; ENGEL W, 1971, CYTOGENETICS, V10, P87, DOI 10.1159/000130131; GERMAN J, 1967, 3 P INT C HUM GEN, P123; Hamerton JL, 1971, HUMAN CYTOGENETICS, V1; HUGHJONES K, 1965, ARCH DIS CHILD, V40, P274, DOI 10.1136/adc.40.211.274; JONES GH, 1969, CHROMOSOMA, V26, P105, DOI 10.1007/BF00319501; LIE GW, 1964, CYTOGENETICS, V3, P427, DOI 10.1159/000129831; MITTWOCH U, 1967, SEX CHROMOSOMES; MUKERJEE D, 1966, NATURE, V212, P153, DOI 10.1038/212153a0; NEUHAUSER G, 1967, HUMANGENETIK, V3, P300; NEURATH PW, 1972, CYTOGENETICS, V11, P457, DOI 10.1159/000130213; NIEBUHR E, 1972, HUMANGENETIK, V16, P217, DOI 10.1007/BF00273467; NIEBUHR E, 1972, CYTOGENETICS, V11, P165, DOI 10.1159/000130186; SARTO GE, 1973, AM J HUM GENET, V25, P262; THORBURN M J, 1967, Journal of Medical Genetics, V4, P283, DOI 10.1136/jmg.4.4.283; WARBURTON D, 1973, AM J HUM GENET, V25, P439; 1972, BIRTH DEFECTS OAS, V8	24	134	134	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	1					83	92						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S0166	4130093				2022-12-18	WOS:A1974S016600010
J	CHU, EHY; GILES, NH				CHU, EHY; GILES, NH			HUMAN CHROMOSOME COMPLEMENTS IN NORMAL SOMATIC CELLS IN CULTURE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARR ML, 1950, ANAT REC, V107, P283, DOI 10.1002/ar.1091070307; BENDER MA, 1957, SCIENCE, V126, P974, DOI 10.1126/science.126.3280.974; CHU EHY, 1958, J NATL CANCER I, V20, P383; CHU EHY, 1957, AM NAT, V91, P273, DOI 10.1086/281989; CHU EHY, 1958, 10 P INT C GEN MONTR, V2, P50; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; EAGLE H, 1956, SCIENCE, V123, P845, DOI 10.1126/science.123.3202.845-a; FORD CE, 1958, NATURE, V181, P1565, DOI 10.1038/1811565a0; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; HSU T. C., 1957, JOUR NATL CANCER INST, V19, P867; HSU TC, 1952, J HERED, V43, P167, DOI 10.1093/oxfordjournals.jhered.a106296; HSU TC, 1953, TEX REP BIOL MED, V11, P585; KODANI M, 1958, AM J HUM GENET, V10, P125; KODANI M, 1958, SCIENCE, V127, P1339, DOI 10.1126/science.127.3310.1339; KODANI M, 1957, P NATL ACAD SCI USA, V43, P285, DOI 10.1073/pnas.43.3.285; KODANI M, 1956, P INT GENET S, P103; MOORE KL, 1953, SURG GYNECOL OBSTET, V96, P641; PUCK TT, 1958, P NATL ACAD SCI USA, V44, P772, DOI 10.1073/pnas.44.8.772; RAPPAPORT C, 1956, Bull World Health Organ, V14, P147; REITALU J, 1957, Acta Genet Med Gemellol (Roma), V6, P393; ROTHFELS KH, 1958, CHROMOSOMA, V9, P163; SACHS L, 1954, ANN EUGENIC, V18, P255; SYVERTON JT, 1957, SPEC PUBL NY ACAD SC, V5, P331; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]; TJIO JH, 1958, J EXP MED, V108, P259, DOI 10.1084/jem.108.2.259; TJIO JH, 1958, 10TH INT C GEN MONTR	26	134	134	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	1					63	79						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF072	13626937				2022-12-18	WOS:A1959WF07200006
J	Tian, Y; Wang, JL; Huang, W; Zeng, S; Jiao, B; Liu, Z; Chen, Z; Li, YJ; Wang, Y; Min, HX; Wang, XJ; You, Y; Zhang, RX; Chen, XY; Yi, F; Zhou, YF; Long, HY; Zhou, CJ; Hou, X; Wang, JP; Xie, B; Liang, F; Yang, ZY; Sun, QY; Allen, EG; Shafik, AM; Kong, HE; Guo, JF; Yan, XX; Hu, ZM; Xia, K; Jiang, H; Xu, HW; Duan, RH; Jin, P; Tang, BS; Shen, L				Tian, Yun; Wang, Jun-Ling; Huang, Wen; Zeng, Sheng; Jiao, Bin; Liu, Zhen; Chen, Zhao; Li, Yujing; Wang, Ying; Min, Hao-Xuan; Wang, Xue-Jing; You, Yong; Zhang, Ru-Xu; Chen, Xiao-Yu; Yi, Fang; Zhou, Ya-Fang; Long, Hong-Yu; Zhou, Chao-Jun; Hou, Xuan; Wang, Jun-Pu; Xie, Bin; Liang, Fan; Yang, Zhuan-Yi; Sun, Qi-Ying; Allen, Emily G.; Shafik, Andrew Mark; Kong, Ha Eun; Guo, Ji-Feng; Yan, Xin-Xiang; Hu, Zheng-Mao; Xia, Kun; Jiang, Hong; Xu, Hong-Wei; Duan, Ran-Hui; Jin, Peng; Tang, Bei-Sha; Shen, Lu			Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE SYSTEM ATROPHY; FRAGILE-X; TRINUCLEOTIDE REPEAT; BODY DISEASE; HEXANUCLEOTIDE REPEAT; HYALINE INCLUSIONS; CAG TRINUCLEOTIDE; GENE; REGION; POLYGLUTAMINE	Neuronal intranuclear inclusion disease (NIID) is a slowly progressing neurodegenerative disease characterized by eosinophilic intranuclear inclusions in the nervous system and multiple visceral organs. The clinical manifestation of NIID varies widely, and both familial and sporadic cases have been reported. Here we have performed genetic linkage analysis and mapped the disease locus to 1p13.3-q23.1; however, whole-exome sequencing revealed no potential disease-causing mutations. We then performed long-read genome sequencing and identified a large GGC repeat expansion within human-specific NOTCH2NLC. Expanded GGC repeats as the cause of NIID was further confirmed in an additional three NIID-affected families as well as five sporadic NIID-affected case subjects. Moreover, given the clinical heterogeneity of NIID, we examined the size of the GGC repeat among 456 families with a variety of neurological conditions with the known pathogenic genes excluded. Surprisingly, GGC repeat expansion was observed in two Alzheimer disease (AD)-affected families and three parkinsonism-affected families, implicating that the GGC repeat expansions in NOTCH2NLC could also contribute to the pathogenesis of both AD and PD. Therefore, we suggest defining a term NIID-related disorders (NIIDRD), which will include NIID and other related neurodegenerative diseases caused by the expanded GGC repeat within human-specific NOTCH2NLC.	[Tian, Yun; Yi, Fang; Zhou, Ya-Fang; Sun, Qi-Ying; Xu, Hong-Wei; Tang, Bei-Sha] Cent S Univ, Xiangya Hosp, Dept Geriatr, Changsha 410008, Hunan, Peoples R China; [Wang, Jun-Ling; Zeng, Sheng; Jiao, Bin; Liu, Zhen; Chen, Zhao; Long, Hong-Yu; Zhou, Chao-Jun; Hou, Xuan; Guo, Ji-Feng; Yan, Xin-Xiang; Jiang, Hong; Tang, Bei-Sha; Shen, Lu] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Tian, Yun; Tang, Bei-Sha; Shen, Lu] Cent S Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Hunan, Peoples R China; [Huang, Wen; Hu, Zheng-Mao; Xia, Kun; Duan, Ran-Hui] Cent S Univ, Sch Life Sci, Ctr Med Genet, Changsha 410008, Hunan, Peoples R China; [Li, Yujing; Allen, Emily G.; Shafik, Andrew Mark; Kong, Ha Eun; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Whitehead Res Bldg,Room 305A,615 Michael St, Atlanta, GA 30322 USA; [Wang, Ying; Wang, Jun-Pu; Xie, Bin] Cent S Univ, Xiangya Hosp, Dept Pathol, Changsha 410008, Hunan, Peoples R China; [Min, Hao-Xuan; Liang, Fan] GrandOm Biosci, Beijing 100000, Peoples R China; [Wang, Xue-Jing] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China; [You, Yong] Univ South China, Affiliated Hosp 1, Dept Neurol, Hengyang 421000, Hunan, Peoples R China; [Zhang, Ru-Xu] Cent S Univ, Xiangya Hosp 3, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Chen, Xiao-Yu; Yang, Zhuan-Yi] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China; [Hu, Zheng-Mao; Xia, Kun; Duan, Ran-Hui] Cent S Univ, Hunan Key Lab Med Genet, Changsha 410008, Hunan, Peoples R China; [Jiang, Hong] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Emory University; Central South University; Zhengzhou University; University of South China; Central South University; Central South University; Central South University; Central South University	Shen, L (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.; Shen, L (corresponding author), Cent S Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Hunan, Peoples R China.; Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Whitehead Res Bldg,Room 305A,615 Michael St, Atlanta, GA 30322 USA.	peng.jin@emory.edu; shenlu@csu.edu.cn	XIA, KUN/AAO-3525-2020; yi, fang/ABE-1152-2021; Liang, Fan/HGA-0248-2022; Li, Yujing/AAJ-1411-2020; Li, yujing/GQA-4109-2022; Shafik, Andrew/AAZ-3372-2021; peng, zijuan/AAA-9342-2020	Li, Yujing/0000-0002-4363-2484; Tang, Beisha/0000-0003-2120-1576; Shafik, Andrew/0000-0002-8460-1553	National Key R&D Program of China [2018YFC1312003]; National Natural Science Foundation of China [81430023, 81701263, 81671075, 81771366, 81671120]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We would like to thank the affected individuals for permitting us to publish this information and NIH NeuroBioBank for providing human brain tissues. This work was funded by National Key R&D Program of China (Grant2018YFC1312003) and National Natural Science Foundation of China (Grant81430023, Grant81701263, Grant81671075, Grant81771366, and Grant81671120).	Abe K, 2017, BMJ CASE REP, V2017; Araki K, 2016, INTERNAL MED, V55, P2281, DOI 10.2169/internalmedicine.55.5544; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051; Fujita K, 2017, NEUROL-CLIN PRACT, V7, pE39, DOI 10.1212/CPJ.0000000000000389; Gelpi E, 2017, BRAIN, V140, pE51, DOI 10.1093/brain/awx156; Glineburg MR, 2018, BRAIN RES, V1693, P43, DOI 10.1016/j.brainres.2018.02.006; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Ishikawa K, 1997, AM J HUM GENET, V61, P336, DOI 10.1086/514867; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kimber TE, 1998, J NEUROL SCI, V160, P33, DOI 10.1016/S0022-510X(98)00169-5; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; Kong HE, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00128; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Lacroix AJ, 2019, AM J HUM GENET, V104, P35, DOI 10.1016/j.ajhg.2018.11.005; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; LINDENBERG R, 1968, ACTA NEUROPATHOL, V10, P54, DOI 10.1007/BF00690510; Liu Y, 2008, ACTA NEUROPATHOL, V116, P615, DOI 10.1007/s00401-008-0442-7; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MICHAUD J, 1981, ACTA NEUROPATHOL, V54, P113, DOI 10.1007/BF00689403; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Mori F, 2012, NEUROPATH APPL NEURO, V38, P322, DOI 10.1111/j.1365-2990.2011.01217.x; Mori F, 2011, NEUROPATHOLOGY, V31, P188, DOI 10.1111/j.1440-1789.2010.01150.x; Motoki M, 2018, NEUROLOGY, V91, P884, DOI 10.1212/WNL.0000000000006480; MUNOZGARCIA D, 1986, NEUROLOGY, V36, P785, DOI 10.1212/WNL.36.6.785; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Nakamura M, 2018, J NEUROL SCI, V392, P89, DOI 10.1016/j.jns.2018.07.012; Nakamura Masataka, 2014, Am J Neurodegener Dis, V3, P93; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; O'Sullivan JD, 2000, MOVEMENT DISORD, V15, P990, DOI 10.1002/1531-8257(200009)15:5<990::AID-MDS1035>3.0.CO;2-I; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PATEL H, 1985, J NEUROL SCI, V67, P57, DOI 10.1016/0022-510X(85)90022-X; Pountney DL, 2003, EXP NEUROL, V184, P436, DOI 10.1016/j.expneurol.2003.07.004; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; SCHUFFLER MD, 1978, GASTROENTEROLOGY, V75, P889; Sellier C, 2017, NEURON, V93, P331, DOI 10.1016/j.neuron.2016.12.016; Sone J, 2005, NEUROLOGY, V65, P1538, DOI 10.1212/01.wnl.0000184490.22527.90; Sone J, 2011, NEUROLOGY, V76, P1372, DOI 10.1212/WNL.0b013e3182166e13; Sone J, 2017, BRAIN, V140, pE52, DOI 10.1093/brain/awx158; Sone J, 2016, BRAIN, V139, P3170, DOI 10.1093/brain/aww249; Sone J, 2014, J NEUROL NEUROSUR PS, V85, P354, DOI 10.1136/jnnp-2013-306084; Sugiyama A, 2017, AM J NEURORADIOL, V38, P2100, DOI 10.3174/ajnr.A5336; Suzuki IK, 2018, CELL, V173, P1370, DOI 10.1016/j.cell.2018.03.067; Takahashi J, 2001, J NEUROPATH EXP NEUR, V60, P369, DOI 10.1093/jnen/60.4.369; Takahashi-Fujigasaki J, 2003, NEUROPATHOLOGY, V23, P351, DOI 10.1046/j.1440-1789.2003.00524.x; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Toyota T, 2015, NEUROL CLIN NEUROSCI, V3, P238, DOI 10.1111/ncn3.12016; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; Wang T, 2012, HUM MOL GENET, V21, P5500, DOI 10.1093/hmg/dds394; WEIDENHEIM KM, 1995, CLIN NEUROPATHOL, V14, P93; Zeng S, 2019, J MED GENET, V56, P265, DOI 10.1136/jmedgenet-2018-105484	61	133	149	9	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 3	2019	105	1					166	176		10.1016/j.ajhg.2019.05.013	http://dx.doi.org/10.1016/j.ajhg.2019.05.013			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG3RM	31178126	Green Published, hybrid			2022-12-18	WOS:000473723000013
J	Wood-Trageser, MA; Gurbuz, F; Yatsenko, SA; Jeffries, EP; Kotan, LD; Surti, U; Ketterer, DM; Matic, J; Chipkin, J; Jiang, HY; Trakselis, MA; Topaloglu, AK; Rajkovic, A				Wood-Trageser, Michelle A.; Gurbuz, Fatih; Yatsenko, Svetlana A.; Jeffries, Elizabeth P.; Kotan, L. Damla; Surti, Urvashi; Ketterer, Deborah M.; Matic, Jelena; Chipkin, Jacqueline; Jiang, Huaiyang; Trakselis, Michael A.; Topaloglu, A. Kemal; Rajkovic, Aleksandar			MCM9 Mutations Are Associated with Ovarian Failure, Short Stature, and Chromosomal Instability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							READ ALIGNMENT; MENOPAUSE; COMPLEX; WOMEN; IDENTIFICATION; FOXL2; LOCI; GENE; REPLICATION; SYNAPSIS	Premature ovarian failure (POP) is genetically heterogeneous and manifests as hypergonadotropic hypogonadism either as part of a syndrome or in isolation. We studied two unrelated consanguineous families with daughters exhibiting primary amenorrhea, short stature, and a 46,XX karyotype. A combination of SNP arrays, comparative genomic hybridization arrays, and whole-exome sequencing analyses identified homozygous pathogenic variants in MCM9, a gene implicated in homologous recombination and repair of double-stranded DNA breaks. In one family, the MCM9 c.1732 2T>C variant alters a splice donor site, resulting in abnormal alternative splicing and truncated forms of MCM9 that are unable to be recruited to sites of DNA damage. In the second family, MCM9 c.394C>T (p.Arg132*) results in a predicted loss of functional MCM9. Repair of chromosome breaks was impaired in lymphocytes from affected, but not unaffected, females in both families, consistent with MCM9 function in homologous recombination. Autosomal-recessive variants in MCM9 cause a genomic-instability syndrome associated with hypergonadotropic hypogonadism and short stature. Preferential sensitivity of germline meiosis to MCM9 functional deficiency and compromised DNA repair in the somatic component most likely account for the ovarian failure and short stature.	[Wood-Trageser, Michelle A.; Yatsenko, Svetlana A.; Surti, Urvashi; Ketterer, Deborah M.; Matic, Jelena; Chipkin, Jacqueline; Jiang, Huaiyang; Rajkovic, Aleksandar] Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Gurbuz, Fatih; Topaloglu, A. Kemal] Cukurova Univ, Div Pediat Endocrinol, Fac Med, TR-01330 Adana, Turkey; [Yatsenko, Svetlana A.; Surti, Urvashi; Rajkovic, Aleksandar] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Jeffries, Elizabeth P.; Trakselis, Michael A.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Kotan, L. Damla] Culcurova Univ, Inst Sci, Dept Biotechnol, TR-01330 Adana, Turkey; [Rajkovic, Aleksandar] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Cukurova University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rajkovic, A (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.	rajkovic@upmc.edu	Kotan, Leman Damla/A-2474-2015; Trakselis, Michael/V-3806-2019; TOPALOGLU, ALI/O-1408-2015; Gürbüz, Fatih/J-2700-2013; Wood-Trageser, Michelle/GPG-1868-2022	Kotan, Leman Damla/0000-0001-6176-8986; Gürbüz, Fatih/0000-0003-2160-9838; Wood-Trageser, Michelle/0000-0002-1880-4926; Trakselis, Michael/0000-0001-7054-8475	National Institute of Child Health and Human Development [R01HD070647, R21HD074278]; Magee-Womens Research Institute; Cukurova University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070647, R21HD074278] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Magee-Womens Research Institute(University of Pittsburgh); Cukurova University(Cukurova University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the affected individuals and their families for their participation in this research study on the genetics of premature ovarian failure. We thank the Cytogenetics Laboratory at Magee-Womens Hospital for their assistance with the chromosomal-breakage studies, the Cell Culture and Cytogenetics Facility at the University of Pittsburgh Cancer Institute for producing the Epstein-Barr virus cell line, and the Clinical Genomics Laboratory for whole-exome sequencing. Funding was provided by the National Institute of Child Health and Human Development (R01HD070647 and R21HD074278 to A.R.), the Magee-Womens Research Institute Postdoctoral Fellowship (M.A.W.-T.), and Cukurova University Scientific Research Projects.	Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS219, DOI 10.1016/j.fertnstert.2008.08.038; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bolcun-Filas E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000393; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Caburet S, 2014, NEW ENGL J MED, V370, P943, DOI 10.1056/NEJMoa1309635; Carty CL, 2013, HUM REPROD, V28, P1695, DOI 10.1093/humrep/det071; Chen CTL, 2012, HUM MOL GENET, V21, P1419, DOI 10.1093/hmg/ddr570; de Vries L, 2014, J CLIN ENDOCR METAB, V99, pE2129, DOI 10.1210/jc.2014-1268; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Giri N, 2007, J CLIN ENDOCR METAB, V92, P2624, DOI 10.1210/jc.2007-0135; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Harris SE, 2002, MOL HUM REPROD, V8, P729, DOI 10.1093/molehr/8.8.729; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; Jeffries EP, 2013, GENE, V519, P41, DOI 10.1016/j.gene.2013.01.054; Kinoshita Y, 2008, MICROSC RES TECHNIQ, V71, P288, DOI 10.1002/jemt.20553; Kuo FT, 2011, ENDOCRINOLOGY, V152, P3917, DOI 10.1210/en.2010-0989; Lakhal B, 2012, GENE, V509, P298, DOI 10.1016/j.gene.2012.08.007; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lutzmann M, 2012, MOL CELL, V47, P523, DOI 10.1016/j.molcel.2012.05.048; Mandon-Pepin B, 2008, EUR J ENDOCRINOL, V158, P107, DOI 10.1530/EJE-07-0400; MARASCHIO P, 1986, CLIN GENET, V30, P353; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Ni F, 2010, GYNECOL ENDOCRINOL, V26, P246, DOI 10.3109/09513590903225358; Nishimura K, 2012, MOL CELL, V47, P511, DOI 10.1016/j.molcel.2012.05.047; Oostra AB, 2012, ANEMIA, V2012, DOI 10.1155/2012/238731; Park J, 2013, MOL CELL BIOL, V33, P1632, DOI 10.1128/MCB.01503-12; Rafique S, 2012, OBSTET GYN CLIN N AM, V39, P567, DOI 10.1016/j.ogc.2012.09.007; Schuh-Huerta SM, 2012, HUM GENET, V131, P1709, DOI 10.1007/s00439-012-1184-0; Spencer KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055258; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Vegetti W, 1998, HUM REPROD, V13, P1796, DOI 10.1093/humrep/13.7.1796; Vijayraghavan Sriram, 2012, Subcell Biochem, V62, P113, DOI 10.1007/978-94-007-4572-8_7; Volkening M, 2005, MOL CELL BIOL, V25, P1560, DOI 10.1128/MCB.25.4.1560-1568.2005; Wong JCY, 2003, HUM MOL GENET, V12, P2063, DOI 10.1093/hmg/ddg219; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2	38	133	141	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					754	762		10.1016/j.ajhg.2014.11.002	http://dx.doi.org/10.1016/j.ajhg.2014.11.002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25480036	Bronze, Green Published			2022-12-18	WOS:000346623100012
J	Pingault, V; Bodereau, V; Baral, V; Marcos, S; Watanabe, Y; Chaoui, A; Fouveaut, C; Leroy, C; Verier-Mine, O; Francannet, C; Dupin-Deguine, D; Archambeaud, F; Kurtz, FJ; Young, J; Bertherat, J; Marlin, S; Goossens, M; Hardelin, JP; Dode, C; Bondurand, N				Pingault, Veronique; Bodereau, Virginie; Baral, Viviane; Marcos, Severine; Watanabe, Yuli; Chaoui, Asma; Fouveaut, Corinne; Leroy, Chrystel; Verier-Mine, Odile; Francannet, Christine; Dupin-Deguine, Delphine; Archambeaud, Francoise; Kurtz, Francois-Joseph; Young, Jacques; Bertherat, Jerome; Marlin, Sandrine; Goossens, Michel; Hardelin, Jean-Pierre; Dode, Catherine; Bondurand, Nadege			Loss-of-Function Mutations in SOX10 Cause Kallmann Syndrome with Deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR SOX10; ENTERIC NERVOUS-SYSTEM; NEURAL CREST CELLS; WAARDENBURG-SYNDROME; INNER-EAR; GENE; EXPRESSION; IDENTIFICATION; DEFICIENCY; HORMONE	Transcription factor SOX10 plays a role in the maintenance of progenitor cell multipotency, lineage specification, and cell differentiation and is a major actor in the development of the neural crest. It has been implicated in Waardenburg syndrome (WS), a rare disorder characterized by the association between pigmentation abnormalities and deafness, but SOX10 mutations cause a variable phenotype that spreads over the initial limits of the syndrome definition. On the basis of recent findings of olfactory-bulb agenesis in WS individuals, we suspected SOX10 was also involved in Kallmann syndrome (KS). KS is defined by the association between anosmia and hypogonadotropic hypogonadism due to incomplete migration of neuroendocrine gonadotropin-releasing hormone (GnRH) cells along the olfactory, vomeronasal, and terminal nerves. Mutations in any of the nine genes identified to date account for only 30% of the KS cases. KS can be either isolated or associated with a variety of other symptoms, including deafness. This study reports SOX10 loss-of-function mutations in approximately one-third of KS individuals with deafness, indicating a substantial involvement in this clinical condition. Study of SOX10-null mutant mice revealed a developmental role of SOX10 in a subpopulation of glial cells called olfactory ensheathing cells. These mice indeed showed an almost complete absence of these cells along the olfactory nerve pathway, as well as defasciculation and misrouting of the nerve fibers, impaired migration of GnRH cells, and disorganization of the olfactory nerve layer of the olfactory bulbs.	[Pingault, Veronique; Baral, Viviane; Watanabe, Yuli; Chaoui, Asma; Goossens, Michel; Bondurand, Nadege] INSERM, U955, Equipe 11, F-94000 Creteil, France; [Pingault, Veronique; Baral, Viviane; Watanabe, Yuli; Chaoui, Asma; Goossens, Michel; Bondurand, Nadege] Univ Paris Est Creteil Val de Marne, UMR S955, F-94000 Creteil, France; [Pingault, Veronique; Bodereau, Virginie; Goossens, Michel] Hop Henri Mondor, Lab Biochim & Genet, F-94000 Creteil, France; [Marcos, Severine; Dode, Catherine] Univ Paris 05, INSERM, U1016, Inst Cochin,Dept Genet & Dev, F-75014 Paris, France; [Fouveaut, Corinne; Leroy, Chrystel; Dode, Catherine] Hop Cochin, AP HP, Lab Biochim & Genet Mol, F-75014 Paris, France; [Verier-Mine, Odile] Ctr Hosp Valenciennes, Serv Endocrinol, F-59322 Valenciennes, France; [Francannet, Christine] Hop Hotel Dieu, Serv Genet Med, F-63058 Clermont Ferrand, France; [Dupin-Deguine, Delphine] Hop Purpan, Serv Genet Med, F-31059 Toulouse, France; [Archambeaud, Francoise] Hop Cluzeau, Serv Med & Endocrinol, F-87042 Limoges, France; [Kurtz, Francois-Joseph] Hop Belair, Serv Pediat, F-57126 Thionville, France; [Young, Jacques] Hop Bicetre, Serv Endocrinol, F-94275 Le Kremlin Bicetre, France; [Bertherat, Jerome] Hop Cochin, Serv Endocrinol, F-75014 Paris, France; [Marlin, Sandrine] Hop Armand Trousseau, AP HP, INSERM, Serv Genet,Ctr Reference Surdites Genet,U587, F-75012 Paris, France; [Hardelin, Jean-Pierre] Univ Paris 06, INSERM, U587, Dept Neurosci,Inst Pasteur, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CH de Valenciennes; CHU Clermont Ferrand; CHU de Toulouse; CHU Limoges; CHR Metz-Thionville; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Pingault, V (corresponding author), INSERM, U955, Equipe 11, F-94000 Creteil, France.	veronique.pingault@inserm.fr	Watanabe, Yuli/R-6082-2018; Young, Jacques/N-5251-2019; Young, Jacques/T-2976-2018; Bondurand, Nadege/H-4737-2017	Young, Jacques/0000-0001-9286-5631; Young, Jacques/0000-0001-9286-5631; Bondurand, Nadege/0000-0002-1531-1544; marlin, sandrine/0000-0002-4115-9806; Watanabe, Yuli/0000-0003-2264-4731; BERTHERAT, Jerome/0000-0003-2551-3008; Pingault, Veronique/0000-0001-7064-0765	Institut de la Sante et de la Recherche Medicale; Agence Nationale de la Recherche [ANR-JCJC-2010, ANR-2009-GENOPAT-017]; Fondation pour la Recherche Medicale	Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank the index cases and family members for their contribution to the study. We thank Fabien Guimiot for providing sections of human fetuses and Michael Wegner for providing us with the Sox10<SUP>lacZ</SUP> mice. We thank the Hopital Henri Mondor sequencing facility, Marjorie Collery for animal husbandry, and Xavier Ducrouy for confocal imaging. This work was supported by the Institut de la Sante et de la Recherche Medicale and the Agence Nationale de la Recherche (ANR-JCJC-2010 to N.B. and ANR-2009-GENOPAT-017 to C.D.). A.C. is a recipient of a fellowship from the Fondation pour la Recherche Medicale. S.M. is receiving a salary from the ANR-2009-GENOPAT-017 grant.	Barnett CP, 2009, AM J MED GENET A, V149A, P431, DOI 10.1002/ajmg.a.32657; Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; Bergman JEH, 2012, J CLIN ENDOCR METAB, V97, pE858, DOI 10.1210/jc.2011-2652; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bondurand N, 2003, DEVELOPMENT, V130, P6387, DOI 10.1242/dev.00857; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Breuskin I, 2010, J NEUROCHEM, V114, P1827, DOI 10.1111/j.1471-4159.2010.06897.x; Breuskin I, 2009, DEV BIOL, V335, P327, DOI 10.1016/j.ydbio.2009.09.007; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Chaoui A, 2011, HUM MUTAT, V32, P1436, DOI 10.1002/humu.21583; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode Catherine, 2007, Hum Mutat, V28, P97, DOI 10.1002/humu.9470; Dode C, 2009, EUR J HUM GENET, V17, P139, DOI 10.1038/ejhg.2008.206; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Ekberg JAK, 2012, NEUROSIGNALS, V20, P147, DOI 10.1159/000330895; Elmaleh-Berges M., 2012, AJNR AM J N IN PRESS; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hanchate NK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002896; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; Jiang L, 2011, BIOCHEM BIOPH RES CO, V408, P620, DOI 10.1016/j.bbrc.2011.04.072; Kapur RP, 1999, PEDIATR DEVEL PATHOL, V2, P559, DOI 10.1007/s100249900162; Katoh H, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-34; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Le Douarin NM, 1999, NEURAL CREST; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Lee MJ, 2001, DEV DYNAM, V222, P40, DOI 10.1002/dvdy.1165; Maka M, 2005, DEV BIOL, V277, P155, DOI 10.1016/j.ydbio.2004.09.014; Malki S, 2010, INT J BIOCHEM CELL B, V42, P411, DOI 10.1016/j.biocel.2009.09.020; Massin N, 2003, J CLIN ENDOCR METAB, V88, P2003, DOI 10.1210/jc.2002-021981; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Paratore C, 2001, DEVELOPMENT, V128, P3949; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Quinton R, 2001, CLIN ENDOCRINOL, V55, P163, DOI 10.1046/j.1365-2265.2001.01277.x; Reiprich S, 2008, MOL BIOL CELL, V19, P1575, DOI 10.1091/mbc.E07-08-0782; Sanchez-Mejias A, 2010, J MOL MED, V88, P507, DOI 10.1007/s00109-010-0592-7; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Soderlund D, 2002, J CLIN ENDOCR METAB, V87, P2589, DOI 10.1210/jc.87.6.2589; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Su ZD, 2010, PROG NEUROBIOL, V92, P517, DOI 10.1016/j.pneurobio.2010.08.008; Sznajer Y, 2008, AM J MED GENET A, V146A, P1038, DOI 10.1002/ajmg.a.32247; Teixeira L, 2010, J CLIN INVEST, V120, P3668, DOI 10.1172/JCI43699; Trarbach EB, 2010, J CLIN ENDOCR METAB, V95, P3491, DOI [10.1210/jc.2010-0176, 10.1210/endo.151.6.9992]; Verloes A, 2005, AM J MED GENET A, V133A, P306, DOI 10.1002/ajmg.a.30559; Watanabe K, 2000, MOL BRAIN RES, V84, P141, DOI 10.1016/S0169-328X(00)00236-9; Wegner M, 2005, PIGM CELL RES, V18, P74, DOI 10.1111/j.1600-0749.2005.00218.x; Wray S, 2010, J NEUROENDOCRINOL, V22, P743, DOI 10.1111/j.1365-2826.2010.02034.x; Zhang H, 2012, HUM GENET, V131, P491, DOI 10.1007/s00439-011-1098-2; Zhu L, 2004, NAT GENET, V36, P732, DOI 10.1038/ng1371	58	133	137	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					707	724		10.1016/j.ajhg.2013.03.024	http://dx.doi.org/10.1016/j.ajhg.2013.03.024			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23643381	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000318582800007
J	Wise, AL; Gyi, L; Manolio, TA				Wise, Anastasia L.; Gyi, Lin; Manolio, Teri A.			eXclusion: Toward Integrating the X Chromosome in Genome-wide Association Analyses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER SUSCEPTIBILITY LOCI; VARIANTS	The X chromosome lags behind autosomal chromosomes in genome-wide association study (GWAS) findings. Indeed, the X chromosome is commonly excluded from GWAS analyses despite being assayed on all current GWAS microarray platforms. This raises the question: why are so few hits reported on the X chromosome? This commentary aims to examine this question through review of the current X chromosome results in the National Human Genome Research Institute Catalog of Published Genome-Wide Association Studies (NHGRI GWAS Catalog). It will also investigate commonly cited reasons for exclusion of the X chromosome from GWAS and review the tools currently available for X chromosome analysis. It will conclude with recommendations for incorporating X chromosome analyses in future studies.	[Wise, Anastasia L.; Gyi, Lin; Manolio, Teri A.] NHGRI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Wise, AL (corresponding author), NHGRI, Bethesda, MD 20892 USA.	anastasia.wise@nih.gov						Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carty CL, 2012, HUM MOL GENET, V21, P711, DOI 10.1093/hmg/ddr489; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Hickey PF, 2011, GENET EPIDEMIOL, V35, P664, DOI 10.1002/gepi.20616; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kennedy RB, 2012, HUM GENET, V131, P1403, DOI 10.1007/s00439-012-1174-2; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; N'Diaye A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002298; Pillas D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000856; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Sanna S, 2009, HUM MOL GENET, V18, P2711, DOI 10.1093/hmg/ddp203; Thornton T, 2012, GENET EPIDEMIOL, V36, P438, DOI 10.1002/gepi.21638; Turnbull C, 2012, NAT GENET, V44, P681, DOI 10.1038/ng.2251; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Zheng G, 2007, GENET EPIDEMIOL, V31, P834, DOI 10.1002/gepi.20244	24	133	133	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					643	647		10.1016/j.ajhg.2013.03.017	http://dx.doi.org/10.1016/j.ajhg.2013.03.017			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23643377	Bronze, Green Published			2022-12-18	WOS:000318582800001
J	Tesson, C; Nawara, M; Salih, MAM; Rossignol, R; Zaki, MS; Al Balwi, M; Schule, R; Mignot, C; Obre, E; Bouhouche, A; Santorelli, FM; Durand, CM; Oteyza, AC; El-Hachimi, KH; Al Drees, A; Bouslam, N; Lamari, F; Elmalik, SA; Kabiraj, MM; Seidahmed, MZ; Esteves, T; Gaussen, M; Monin, ML; Gyapay, G; Lechner, D; Gonzalez, M; Depienne, C; Mochel, F; Lavie, J; Schols, L; Lacombe, D; Yahyaoui, M; Al Abdulkareem, I; Zuchner, S; Yamashita, A; Benomar, A; Goizet, C; Durr, A; Gleeson, JG; Darios, F; Brice, A; Stevanin, G				Tesson, Christelle; Nawara, Magdalena; Salih, Mustafa A. M.; Rossignol, Rodrigue; Zaki, Maha S.; Al Balwi, Mohammed; Schule, Rebecca; Mignot, Cyril; Obre, Emilie; Bouhouche, Ahmed; Santorelli, Filippo M.; Durand, Christelle M.; Oteyza, Andres Caballero; El-Hachimi, Khalid H.; Al Drees, Abdulmajeed; Bouslam, Naima; Lamari, Foudil; Elmalik, Salah A.; Kabiraj, Mohammad M.; Seidahmed, Mohammed Z.; Esteves, Typhaine; Gaussen, Marion; Monin, Marie-Lorraine; Gyapay, Gabor; Lechner, Doris; Gonzalez, Michael; Depienne, Christel; Mochel, Fanny; Lavie, Julie; Schols, Ludger; Lacombe, Didier; Yahyaoui, Mohamed; Al Abdulkareem, Ibrahim; Zuchner, Stephan; Yamashita, Atsushi; Benomar, Ali; Goizet, Cyril; Durr, Alexandra; Gleeson, Joseph G.; Darios, Frederic; Brice, Alexis; Stevanin, Giovanni			Alteration of Fatty-Acid-Metabolizing Enzymes Affects Mitochondrial Form and Function in Hereditary Spastic Paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREFERRING PHOSPHOLIPASE A(1); MUTATIONS; CYTOCHROME-P450; PROTEIN; IDENTIFICATION; COMPLEX; BRAIN; GENE; LYSOPHOSPHATIDYLINOSITOL; VASOCONSTRICTOR	Hereditary spastic paraplegia (HSP) is considered one of the most heterogeneous groups of neurological disorders, both clinically and genetically. The disease comprises pure and complex forms that clinically include slowly progressive lower-limb spasticity resulting from degeneration of the corticospinal tract. At least 48 loci accounting for these diseases have been mapped to date, and mutations have been identified in 22 genes, most of which play a role in intracellular trafficking. Here, we identified mutations in two functionally related genes (DDHD1 and CYP2U1) in individuals with autosomal-recessive forms of HSP by using either the classical positional cloning or a combination of whole-genome linkage mapping and next-generation sequencing. Interestingly, three subjects with CYP2U1 mutations presented with a thin corpus callosum, white-matter abnormalities, and/or calcification of the basal ganglia. These genes code for two enzymes involved in fatty-acid metabolism, and we have demonstrated in human cells that the HSP pathophysiology includes alteration of mitochondrial architecture and bioenergetics with increased oxidative stress. Our combined results focus attention on lipid metabolism as a critical HSP pathway with a deleterious impact on mitochondrial bioenergetic function.	[Tesson, Christelle; Nawara, Magdalena; El-Hachimi, Khalid H.; Esteves, Typhaine; Gaussen, Marion; Monin, Marie-Lorraine; Depienne, Christel; Mochel, Fanny; Durr, Alexandra; Darios, Frederic; Brice, Alexis; Stevanin, Giovanni] INSERM, U975, F-75013 Paris, France; [Tesson, Christelle; Nawara, Magdalena; El-Hachimi, Khalid H.; Esteves, Typhaine; Gaussen, Marion; Monin, Marie-Lorraine; Depienne, Christel; Mochel, Fanny; Durr, Alexandra; Darios, Frederic; Brice, Alexis; Stevanin, Giovanni] Univ Paris 06, Pitie Salpetriere Hosp, Ctr Rech, Inst Cerveau & Moelle Epiniere,Unite Mixte Rech S, F-75013 Paris, France; [Tesson, Christelle; Nawara, Magdalena; El-Hachimi, Khalid H.; Esteves, Typhaine; Gaussen, Marion; Monin, Marie-Lorraine; Depienne, Christel; Mochel, Fanny; Durr, Alexandra; Darios, Frederic; Brice, Alexis; Stevanin, Giovanni] CNRS, Unite Mixte Rech 7225, F-75013 Paris, France; [Tesson, Christelle; El-Hachimi, Khalid H.; Stevanin, Giovanni] Ecole Prat Hautes Etud, Neurogenet Lab, F-75013 Paris, France; [Salih, Mustafa A. M.] King Saud Univ, Coll Med, Div Pediat Neurol, Riyadh 11461, Saudi Arabia; [Rossignol, Rodrigue; Obre, Emilie; Durand, Christelle M.; Lavie, Julie; Lacombe, Didier; Goizet, Cyril] Univ Bordeaux Segalen, Lab Malad Rares Genet & Metab, Equipe Accueil 4576, F-33076 Bordeaux, France; [Zaki, Maha S.] Natl Res Ctr, Cairo 12311, Egypt; [Al Balwi, Mohammed] King Abdul Aziz Med City, Riyadh 11426, Saudi Arabia; [Al Balwi, Mohammed; Al Abdulkareem, Ibrahim] King Abdullah Int Med Res Ctr, Riyadh 11426, Saudi Arabia; [Schule, Rebecca; Oteyza, Andres Caballero; Schols, Ludger] Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Schule, Rebecca; Oteyza, Andres Caballero; Schols, Ludger] Ctr Neurol, D-72076 Tubingen, Germany; [Bouhouche, Ahmed; Bouslam, Naima; Yahyaoui, Mohamed; Benomar, Ali] Univ Mohammed V Souissi, Fac Med & Pharm Rabat, Equipe Rech Malad Neurodegenerat, Rabat 6402, Morocco; [Santorelli, Filippo M.] Fdn Stella Maris, Ist Ricovero & Cura Carattere Sci, I-56018 Pisa, Italy; [Al Drees, Abdulmajeed; Elmalik, Salah A.] King Saud Univ, Coll Med, Dept Physiol, Riyadh 11461, Saudi Arabia; [Lamari, Foudil] Hop La Pitie Salpetriere, AP HP, Serv Biochim, F-75013 Paris, France; [Kabiraj, Mohammad M.] Armed Forces Hosp, Dept Neurosci, Riyadh 11159, Saudi Arabia; [Seidahmed, Mohammed Z.] Secur Forces Hosp, Dept Pediat, Riyadh 11481, Saudi Arabia; [Gyapay, Gabor] Genoscope, F-91057 Evry, France; [Lechner, Doris] Ctr Natl Genotypage, F-91057 Evry, France; [Gonzalez, Michael; Zuchner, Stephan] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Gonzalez, Michael; Zuchner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Schols, Ludger] German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Lacombe, Didier; Goizet, Cyril] Ctr Hosp Univ Bordeaux, Serv Genet Med, F-33076 Bordeaux, France; [Yamashita, Atsushi] Teikyo Univ, Fac Pharmaceut Sci, Dept Life & Hlth Sci, Itabashi Ku, Tokyo 1738605, Japan; [Benomar, Ali] Univ Mohammed V Souissi, Ctr Rech Epidemiol Clin & Essai Therapeut, Fac Med & Pharm Rabat, Rabat 6402, Morocco; [Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); King Saud University; UDICE-French Research Universities; Universite de Bordeaux; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Mohammed V University in Rabat; IRCCS Fondazione Stella Maris; King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Prince Sultan Military Medical City; Security Forces Hospital - Saudi Arabia; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Miami; University of Miami; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); CHU Bordeaux; Teikyo University; Mohammed V University in Rabat; Howard Hughes Medical Institute; University of California System; University of California San Diego	Brice, A (corresponding author), INSERM, U975, F-75013 Paris, France.	alexis.brice@upmc.fr; giovanni.stevanin@upmc.fr	Schüle, Rebecca/B-5763-2019; brice, alexis/AAE-8275-2019; Zaki, Maha S/B-9361-2013; lacombe, didier/K-7967-2014; GOIZET, Cyril/M-4576-2014; Brice, Alexis/A-2170-2009; Depienne, Christel/AAL-3835-2021; Stevanin, Giovanni/E-5038-2016; Schöls, Ludger/ABB-2482-2021; AL-DREES, ABDULMAJEED A/N-9534-2016; Santorelli, Filippo M/ABE-5124-2020; Rossignol, Rodrigue/K-7821-2014; Salih, Mustafa/C-1222-2014	Schüle, Rebecca/0000-0002-7781-2766; brice, alexis/0000-0002-0941-3990; GOIZET, Cyril/0000-0002-1913-889X; Depienne, Christel/0000-0002-7212-9554; Stevanin, Giovanni/0000-0001-9368-8657; Schöls, Ludger/0000-0001-7774-5025; AL-DREES, ABDULMAJEED A/0000-0002-3125-050X; Santorelli, Filippo M/0000-0002-1359-9062; Lacombe, Didier/0000-0002-8956-2207; Al Balwi, Mohammed/0000-0003-2910-0390; Darios, Frederic/0000-0001-9800-5990; Caballero Garcia de Oteyza, Andres/0000-0002-8892-1255; Zaki, Maha/0000-0001-7840-0002; Bouhouche, Ahmed/0000-0001-5279-8649; Salih, Mustafa/0000-0002-4379-2111; Lavie, Julie/0000-0002-7208-3154; Yamashita, Atsushi/0000-0002-2544-2134	Association Strumpell-Lorrain; Association contre les Maladies Mitochondriales; Agence Nationale de la Recherche; Association Francaise contre les Myopathies; European Union; University of Tubingen; Conseil Regional d'Aquitaine; Verum Foundation; College of Medicine Research Center at King Saud University, Saudi Arabia [07-581]; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Neuroscience Research Pole in Ile de France; French Ministry of Research; Fondazione Telethon [GGP10121A]; program "Investissements d'avenir" [ANR-10-IAIHU-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248] Funding Source: NIH RePORTER	Association Strumpell-Lorrain; Association contre les Maladies Mitochondriales; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Union(European Commission); University of Tubingen; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Verum Foundation; College of Medicine Research Center at King Saud University, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Neuroscience Research Pole in Ile de France; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Fondazione Telethon(Fondazione TelethonEuropean Commission); program "Investissements d'avenir"(French National Research Agency (ANR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the affected family members and their relatives who participated in this study. We thank S. Rivaud-Pechoux and C. Gautier for their advice and D. Zelenika, E. Mundwiller, L. Orlando, D. Bouteiller, A. Rastetter, A. Meneret, the DNA and Cell Bank of the Centre de Recherche de l'Institut du Cerveau et de la Moelle Epiniere, and the Plateforme d'Imagerie de la Pitie-Salpetriere for their contribution. We also thank J.-P. Azulay, A. Lossos, and A. Cherif, who referred some of the affected individuals. This work was supported by the Association Strumpell-Lorrain (to the Spastic Paraplegia and Ataxia Network and C.G.), the Association contre les Maladies Mitochondriales (to C.G. and R.R.), the Agence Nationale de la Recherche (to A.D., G.S., and C.G.), the Association Francaise contre les Myopathies (to C.G. and G.S.), the European Union E-Rare program (to A.Br.), the University of Tubingen (to R.S.), the Conseil Regional d'Aquitaine (to C.G.), and the Verum Foundation (to A.Br.). M.A.M.S. was supported by the College of Medicine Research Center (project 07-581) at King Saud University, Saudi Arabia. M.Al.B. and I.Al.A. were supported by the King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. M.N. and C.T. were recipients of fellowships from the Neuroscience Research Pole in Ile de France and the French Ministry of Research, respectively. F.M.S. was supported by Fondazione Telethon project GGP10121A. This study also received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06 (to the Institut du Cerveau et de la Moelle Epiniere).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Anavi-Goffer S, 2012, J BIOL CHEM, V287, P91, DOI 10.1074/jbc.M111.296020; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Benard G, 2008, AM J PHYSIOL-CELL PH, V294, pC1123, DOI 10.1152/ajpcell.00143.2008; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Boukhris A, 2009, CLIN GENET, V75, P527, DOI 10.1111/j.1399-0004.2009.01176.x; Bouslam N, 2005, ANN NEUROL, V57, P567, DOI 10.1002/ana.20416; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Brown M, 2010, MICROVASC RES, V80, P75, DOI 10.1016/j.mvr.2009.12.010; Carroll MA, 2000, THORAX, V55, pS13, DOI 10.1136/thorax.55.suppl_2.S13; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chang PA, 2010, INT J BIOCHEM CELL B, V42, P573, DOI 10.1016/j.biocel.2009.12.007; Chevrollier A, 2012, INT J BIOCHEM CELL B, V44, P980, DOI 10.1016/j.biocel.2012.03.006; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Coutinho P, 1999, ARCH NEUROL-CHICAGO, V56, P943, DOI 10.1001/archneur.56.8.943; Darios F, 2003, J NEUROCHEM, V84, P643, DOI 10.1046/j.1471-4159.2003.01590.x; Dutheil F, 2009, DRUG METAB DISPOS, V37, P1528, DOI 10.1124/dmd.109.027011; Fink JK, 2003, EXP NEUROL, V184, pS106, DOI 10.1016/j.expneurol.2003.08.005; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Gebremedhin D, 1998, J PHYSIOL-LONDON, V507, P771, DOI 10.1111/j.1469-7793.1998.771bs.x; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Goizet C, 2011, HUM MUTAT, V32, P1118, DOI 10.1002/humu.21542; Goizet C, 2009, BRAIN, V132, P1589, DOI 10.1093/brain/awp073; Gregory A, 2011, CURR NEUROL NEUROSCI, V11, P254, DOI 10.1007/s11910-011-0181-3; Gucuyener K, 2010, BRAIN DEV-JPN, V32, P130, DOI 10.1016/j.braindev.2008.12.014; Hanein S, 2008, AM J HUM GENET, V82, P992, DOI 10.1016/j.ajhg.2008.03.004; HARDING AE, 1983, LANCET, V1, P1151; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; Imig JD, 2000, HYPERTENSION, V35, P307, DOI 10.1161/01.HYP.35.1.307; Jose C, 2011, BBA-BIOENERGETICS, V1807, P707, DOI 10.1016/j.bbabio.2010.12.002; Karlgren M, 2004, BIOCHEM BIOPH RES CO, V315, P679, DOI 10.1016/j.bbrc.2004.01.110; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Klebe S, 2012, EUR J HUM GENET, V20, P645, DOI 10.1038/ejhg.2011.261; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012; Murmu RP, 2011, MOL CELL NEUROSCI, V47, P191, DOI 10.1016/j.mcn.2011.04.004; Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, BIOCHEM BIOPH RES CO, V395, P232, DOI 10.1016/j.bbrc.2010.03.169; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; Rimmerman N, 2009, PROSTAG OTH LIPID M, V88, P10, DOI 10.1016/j.prostaglandins.2008.08.004; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schule R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Stevanin G, 2008, CURR NEUROL NEUROSCI, V8, P198, DOI 10.1007/s11910-008-0032-z; Stevanin G, 2008, BRAIN, V131, P772, DOI 10.1093/brain/awm293; Stevanin G, 2007, NAT GENET, V39, P366, DOI 10.1038/ng1980; Tallaksen CME, 2001, CURR OPIN NEUROL, V14, P457, DOI 10.1097/00019052-200108000-00005; Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505; Tsaousidou MK, 2008, AM J HUM GENET, V82, P510, DOI 10.1016/j.ajhg.2007.10.001; Wen HR, 2012, J BIOL CHEM, V287, P13868, DOI 10.1074/jbc.M111.334896; Yamashita A, 2010, BBA-MOL CELL BIOL L, V1801, P711, DOI 10.1016/j.bbalip.2010.03.012	64	133	136	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1051	1064		10.1016/j.ajhg.2012.11.001	http://dx.doi.org/10.1016/j.ajhg.2012.11.001			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23176821	Green Published, Bronze			2022-12-18	WOS:000312417400008
J	Lao, O; van Duijn, K; Kersbergen, P; de Knijff, P; Kayser, M				Lao, O; van Duijn, K; Kersbergen, P; de Knijff, P; Kayser, M			Proportioning whole-genome single-nucleotide-polymorphism diversity for the identification of geographic population structure and genetic ancestry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT POSITIVE SELECTION; HUMAN Y-CHROMOSOME; MICROSATELLITE LOCI; NATURAL-SELECTION; INFERENCE; ADMIXTURE; PATTERNS; MARKERS; DETECT; STRATIFICATION	The identification of geographic population structure and genetic ancestry on the basis of a minimal set of genetic markers is desirable for a wide range of applications in medical and forensic sciences. However, the absence of sharp discontinuities in the neutral genetic diversity among human populations implies that, in practice, a large number of neutral markers will be required to identify the genetic ancestry of one individual. We showed that it is possible to reduce the amount of markers required for detecting continental population structure to only 10 single-nucleotide polymorphisms ( SNPs), by applying a newly developed ascertainment algorithm to Affymetrix GeneChip Mapping 10K SNP array data that we obtained from samples of globally dispersed human individuals ( the Y Chromosome Consortium panel). Furthermore, this set of SNPs was able to recover the genetic ancestry of individuals from all four continents represented in the original data set when applied to an independent, much larger, worldwide population data set ( Centre d'Etude du Polymorphisme Humain-Human Genome Diversity Project Cell Line Panel). Finally, we provide evidence that the unusual patterns of genetic variation we observed at the respective genomic regions surrounding the five most informative SNPs is in agreement with local positive selection being the explanation for the striking SNP allele-frequency differences we found between continental groups of human populations.	Erasmus Univ, Med Ctr, Dept Forens Mol Biol, NL-3000 DR Rotterdam, Netherlands; Netherlands Forens Inst, Dept Biol, The Hague, Netherlands; Leiden Univ, Med Ctr, Dept Human & Clin Genet, Forens Lab DNA Res, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kayser, M (corresponding author), Erasmus Univ, Med Ctr, Dept Forens Mol Biol, POB 1738, NL-3000 DR Rotterdam, Netherlands.	m.kayser@erasmusmc.nl	de Knijff, Peter/Y-2519-2018; Schneider, Peter M./A-6661-2011; Lao, Oscar/N-9930-2017	de Knijff, Peter/0000-0002-0899-771X; Lao, Oscar/0000-0002-8525-9649				Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; EXCOFFIER L, 1992, GENETICS, V131, P479; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hao K, 2004, EUR J HUM GENET, V12, P1001, DOI 10.1038/sj.ejhg.5201273; *HAPM, 2003, NATURE; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Haupt R.L., 2004, PRACTICAL GENETIC AL, V2nd, DOI DOI 10.1002/0471671746; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Holtkemper U, 2001, HUM MOL GENET, V10, P629, DOI 10.1093/hmg/10.6.629; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kayser M, 2003, MOL BIOL EVOL, V20, P893, DOI 10.1093/molbev/msg092; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kruskal J., 1978, SAGE U PAPER SERIES, V11; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; McKeigue PM, 2005, AM J HUM GENET, V76, P1, DOI 10.1086/426949; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Mountain Joanna L., 2005, Human Genomics, V2, P4; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 2000, GENETICS, V155, P945; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ray DA, 2005, FORENSIC SCI INT, V153, P117, DOI 10.1016/j.forsciint.2004.10.017; Roessli D, 2000, ARLEQUIN VERSION 2 0; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; ROSENBERG NA, 2005, PLOS GENET, V1, P1; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2004, NAT REV GENET, V5, P43, DOI 10.1038/nrg1247; Sellick GS, 2003, DIABETES, V52, P2636, DOI 10.2337/diabetes.52.10.2636; Shriver Mark D., 2005, Human Genomics, V2, P81; Shriver Mark D, 2004, Hum Genomics, V1, P274; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Statsoft, 2001, STATISTICA DAT AN SO; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Turakulov R, 2003, HUM HERED, V55, P37, DOI 10.1159/000071808; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Xu HY, 2004, GENETICS, V166, P555, DOI 10.1534/genetics.166.1.555; Yang N, 2005, HUM GENET, V118, P382, DOI 10.1007/s00439-005-0012-1; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758	53	133	139	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					680	690		10.1086/501531	http://dx.doi.org/10.1086/501531			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532397	Green Published, Bronze			2022-12-18	WOS:000236755900013
J	Xue, YL; Daly, A; Yngvadottir, B; Liu, MN; Coop, G; Kim, Y; Sabeti, P; Chen, Y; Stalker, J; Huckle, E; Burton, J; Leonard, S; Rogers, J; Tyler-Smith, C				Xue, YL; Daly, A; Yngvadottir, B; Liu, MN; Coop, G; Kim, Y; Sabeti, P; Chen, Y; Stalker, J; Huckle, E; Burton, J; Leonard, S; Rogers, J; Tyler-Smith, C			Spread of an inactive form of caspase-12 in humans is due to recent positive selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; HAPLOTYPE RECONSTRUCTION; ADAPTIVE EVOLUTION; STATISTICAL-METHOD; MAJOR DETERMINANT; NATURAL-SELECTION; HUMAN-POPULATIONS; DNA POLYMORPHISM; BRAIN SIZE; GENE	The human caspase-12 gene is polymorphic for the presence or absence of a stop codon, which results in the occurrence of both active ( ancestral) and inactive ( derived) forms of the gene in the population. It has been shown elsewhere that carriers of the inactive gene are more resistant to severe sepsis. We have now investigated whether the inactive form has spread because of neutral drift or positive selection. We determined its distribution in a worldwide sample of 52 populations and resequenced the gene in 77 individuals from the HapMap Yoruba, Han Chinese, and European populations. There is strong evidence of positive selection from low diversity, skewed allele-frequency spectra, and the predominance of a single haplotype. We suggest that the inactive form of the gene arose in Africa similar to 100 - 500 thousand years ago ( KYA) and was initially neutral or almost neutral but that positive selection beginning similar to 60 - 100 KYA drove it to near fixation. We further propose that its selective advantage was sepsis resistance in populations that experienced more infectious diseases as population sizes and densities increased.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; European Bioinformat Inst, Hinxton, Cambs, England; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Rochester, Dept Biol, Rochester, NY 14627 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02138 USA	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of Chicago; University of Rochester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	cts@sanger.ac.uk	Sabeti, Pardis/GQH-8610-2022	Coop, Graham/0000-0001-8431-0302	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Cann HM, 2002, SCIENCE, V296, P261; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Coop G, 2004, THEOR POPUL BIOL, V66, P219, DOI 10.1016/j.tpb.2004.06.006; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DOBSON A, 1992, CAMBRIDGE ENCY HUMAN, P411; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Fay JC, 2000, GENETICS, V155, P1405; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Griffiths RC, 2003, THEOR POPUL BIOL, V64, P241, DOI 10.1016/S0040-5809(03)00075-3; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Kayser M, 2003, MOL BIOL EVOL, V20, P893, DOI 10.1093/molbev/msg092; Kim Y, 2002, GENETICS, V160, P765; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Ronald James, 2005, Human Genomics, V2, P113; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Saunders MA, 2002, GENETICS, V162, P1849; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Wall JD, 2000, GENETICS, V155, P1865; Watson R Scott, 2005, Pediatr Crit Care Med, V6, pS3; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhang JZ, 2003, GENETICS, V165, P2063; Zhang JZ, 2002, GENETICS, V162, P1825	56	133	139	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					659	670		10.1086/503116	http://dx.doi.org/10.1086/503116			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532395	Green Published, Bronze			2022-12-18	WOS:000236755900011
J	Benayed, R; Gharani, N; Rossman, I; Mancuso, V; Lazar, G; Kamdar, S; Bruse, SE; Tischfield, S; Smith, BJ; Zimmerman, RA; DiCicco- Bloom, E; Brzustowicz, LM; Millonig, JH				Benayed, R; Gharani, N; Rossman, I; Mancuso, V; Lazar, G; Kamdar, S; Bruse, SE; Tischfield, S; Smith, BJ; Zimmerman, RA; DiCicco- Bloom, E; Brzustowicz, LM; Millonig, JH			Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; GENOMEWIDE SCREEN; INFANTILE-AUTISM; BRAIN-STEM; CELL LOSS; CEREBELLAR; LINKAGE; ASSOCIATION; PATTERNS; DISEQUILIBRIUM	Our previous research involving 167 nuclear families from the Autism Genetic Resource Exchange (AGRE) demonstrated that two intronic SNPs, rs1861972 and rs1861973, in the homeodomain transcription factor gene ENGRAILED 2 (EN2) are significantly associated with autism spectrum disorder (ASD). In this study, significant replication of association for rs1861972 and rs1861973 is reported for two additional data sets: an independent set of 222 AGRE families (rs1861972-rs1861973 haplotype,) and a separate sample of 129 National P=.0016 Institutes of Mental Health families (rs1861972-rs1861973 haplotype,). Association analysis of the P =.0431 haplotype in the combined sample of both AGRE data sets ( 389 families) produced a P value of .0000033, whereas combining all three data sets ( 518 families) produced a P value of .00000035. Population-attributable risk calculations for the associated haplotype, performed using the entire sample of 518 families, determined that the risk allele contributes to as many as 40% of ASD cases in the general population. Linkage disequilibrium (LD) mapping with the use of polymorphisms distributed throughout the gene has shown that only intronic SNPs are in strong LD with rs1861972 and rs1861973. Resequencing and association analysis of all intronic SNPs have identified alleles associated with ASD, which makes them candidates for future functional analysis. Finally, to begin defining the function of EN2 during development, mouse En2 was ectopically expressed in cortical precursors. Fewer En2 transfected cells than controls displayed a differentiated phenotype. Together, these data provide further genetic evidence that EN2 might act as an ASD susceptibility locus, and they suggest that a risk allele that perturbs the spatial/temporal expression of EN2 could significantly alter normal brain development.	Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Dept Neurosci & Cell Biol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Millonig, JH (corresponding author), Univ Med & Dent New Jersey, Ctr Adv Biotechnol & Med, Robert Wood Johnson Med Sch, 679 Hoes Lane, Piscataway, NJ 08854 USA.	Millonig@CABM.rutgers.edu			NIEHS NIH HHS [P01 ES011256, P30 ES005022, P01 ES11256] Funding Source: Medline; NIMH NIH HHS [R01 MH070366, U24 MH068457, MH52708, T32 MH019957, MH39437, R01 MH70366, MH068457, MH/AG-19957, MH00980, MH00219] Funding Source: Medline; NINDS NIH HHS [1 F30 NS48649-01, F30 NS048649] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022, P01ES011256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052708, R01MH070366, P01MH039437, T32MH019957, U24MH068457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS048649] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Akshoomoff NA, 1997, INT REV NEUROBIOL, V41, P575, DOI 10.1016/S0074-7742(08)60371-2; Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Baader SL, 1998, J NEUROSCI, V18, P1763; Baader SL, 1999, J NEUROSCI, V19, P5370; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Bartlett CW, 2005, INT J DEV NEUROSCI, V23, P221, DOI 10.1016/j.ijdevneu.2004.10.004; BAUMAN M, 1985, NEUROLOGY, V35, P866, DOI 10.1212/WNL.35.6.866; Bauman M.L, 1994, NEUROBIOLOGY AUTISM, P119; BAUMAN ML, 1986, NEUROLOGY, V36, P190; Carey RG, 2002, J NEUROSCI, V22, P1583, DOI 10.1523/JNEUROSCI.22-05-01583.2002; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Corina DP, 2003, J COGNITIVE NEUROSCI, V15, P718, DOI 10.1162/jocn.2003.15.5.718; Courchesne E, 1997, LEARN MEMORY, V4, P1, DOI 10.1101/lm.4.1.1; Courchesne E, 1997, CURR OPIN NEUROBIOL, V7, P269, DOI 10.1016/S0959-4388(97)80016-5; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; GAFFNEY GR, 1987, BRIT J PSYCHIAT, V151, P831, DOI 10.1192/bjp.151.6.831; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Garner C, 2003, GENET EPIDEMIOL, V24, P57, DOI 10.1002/gepi.10217; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gharani N, 2004, MOL PSYCHIATR, V9, P474, DOI 10.1038/sj.mp.4001498; GUNTHER CV, 1994, MOL CELL BIOL, V14, P7569, DOI 10.1128/MCB.14.11.7569; HASHIMOTO T, 1995, J AUTISM DEV DISORD, V25, P1, DOI 10.1007/BF02178163; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Iannone MA, 2000, CYTOMETRY, V39, P131, DOI 10.1002/(SICI)1097-0320(20000201)39:2<131::AID-CYTO6>3.3.CO;2-L; KEMPER TL, 1993, NEUROL CLIN, V11, P175, DOI 10.1016/S0733-8619(18)30176-2; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; KLEIMAN MD, 1992, NEUROLOGY, V42, P753, DOI 10.1212/WNL.42.4.753; Kuemerle B, 1997, J NEUROSCI, V17, P7881; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; LOGAN C, 1989, NUCLEIC ACIDS RES, V17, P2879, DOI 10.1093/nar/17.7.2879; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; Millen KJ, 1995, DEVELOPMENT, V121, P3935; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; MURAKAMI JW, 1989, ARCH NEUROL-CHICAGO, V46, P689, DOI 10.1001/archneur.1989.00520420111032; Nicot A, 2001, P NATL ACAD SCI USA, V98, P4758, DOI 10.1073/pnas.071465398; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; PETIT E, 1995, J MED GENET, V32, P269, DOI 10.1136/jmg.32.4.269; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Riley B, 2004, NEUROTOX RES, V6, P17, DOI 10.1007/BF03033293; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch N, 2001, THEOR POPUL BIOL, V60, P215, DOI 10.1006/tpbi.2001.1538; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1986, AM J PSYCHIAT, V143, P862; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Serrano N, 1997, DEVELOPMENT, V124, P2527; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Terwilliger JD, 2001, ADV GENET, V42, P351, DOI 10.1016/S0065-2660(01)42032-3; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	66	133	148	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					851	868		10.1086/497705	http://dx.doi.org/10.1086/497705			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	974CT	16252243	Green Published, Bronze			2022-12-18	WOS:000232569600013
J	Barnby, G; Abbott, A; Sykes, N; Morris, A; Weeks, DE; Mott, R; Lamb, J; Bailey, AJ; Monaco, AP				Barnby, G; Abbott, A; Sykes, N; Morris, A; Weeks, DE; Mott, R; Lamb, J; Bailey, AJ; Monaco, AP		IMGSAC	Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: Evidence of association at GRIN2A and ABAT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PERVASIVE DEVELOPMENTAL DISORDERS; LINKAGE DISEQUILIBRIUM; COMMON DISEASE; FOLLOW-UP; MUTATIONS; PROTEIN; TESTS; HAPLOTYPES; PREDICTION	Autism is a highly heritable neurodevelopmental disorder whose underlying genetic causes have yet to be identified. To date, there have been eight genome screens for autism, two of which identified a putative susceptibility locus on chromosome 16p. In the present study, 10 positional candidate genes that map to 16p11-13 were examined for coding variants: A2BP1, ABAT, BFAR, CREBBP, EMP2, GRIN2A, MRTF-B, SSTR5, TBX6, and UBN1. Screening of all coding and regulatory regions by denaturing high-performance liquid chromatography identified seven non-synonymous changes. Five of these mutations were found to cosegregate with autism, but the mutations are not predicted to have deleterious effects on protein structure and are unlikely to represent significant etiological variants. Selected variants from candidate genes were genotyped in the entire International Molecular Genetics Study of Autism Consortium collection of 239 multiplex families and were tested for association with autism by use of the pedigree disequilibrium test. Additionally, genotype frequencies were compared between 239 unrelated affected individuals and 192 controls. Patterns of linkage disequilibrium were investigated, and the transmission of haplotypes across candidate genes was tested for association. Evidence of single-marker association was found for variants in ABAT, CREBBP, and GRIN2A. Within these genes, 12 single-nucleotide polymorphisms (SNPs) were subsequently genotyped in 91 autism trios (one affected individual and two unaffected parents), and the association was replicated within GRIN2A (Fisher's exact test, P < .0001). Logistic regression analysis of SNP data across GRIN2A and ABAT showed a trend toward haplotypic differences between cases and controls.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Pk Hosp Children, Univ Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford, England; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk	Bailey, Anthony/J-2860-2014; Weeks, Daniel E/B-2995-2012; Monaco, Anthony P/A-4495-2010	Bailey, Anthony/0000-0003-4257-972X; Weeks, Daniel E/0000-0001-9410-7228; Monaco, Anthony P/0000-0001-7480-3197; Lamb, Janine/0000-0002-7248-0539; Simpson, Nuala/0000-0003-3390-9993; Mott, Richard/0000-0002-1022-9330; Green, Jonathan/0000-0002-0143-181X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U19HD035482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001389, K05MH001196] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR006022, MO1 RR06022] Funding Source: Medline; NICHD NIH HHS [U19 HD35482, U19 HD035482] Funding Source: Medline; NIMH NIH HHS [K05 MH01196, K02 MH01389] Funding Source: Medline; Telethon [GGP030227] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission)		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bannerman DM, 2004, BEHAV NEUROSCI, V118, P643, DOI 10.1037/0735-7044.118.3.643; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bonora E, 2005, EUR J HUM GENET, V13, P198, DOI 10.1038/sj.ejhg.5201315; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; DEBIASE D, 1995, EUR J BIOCHEM, V227, P476; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Finelli P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016311; Fombonne E, 2002, MOL PSYCHIATR, V7, pS4, DOI 10.1038/sj.mp.4001162; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Hellings JA, 2002, AM J MED GENET, V114, P190, DOI 10.1002/ajmg.10156; ITOH N, 1993, J IMMUNOL, V151, P621; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kulp D, 1997, Pac Symp Biocomput, P232; Lamb JA, 2005, J MED GENET, V42, P132, DOI 10.1136/jmg.2004.025668; Lamb JA, 2002, NEUROMOL MED, V2, P11; Lauritsen MB, 2003, AM J MED GENET B, V121B, P100, DOI 10.1002/ajmg.b.20050; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Martin ER, 2003, AM J HUM GENET, V73, P1016, DOI 10.1086/378779; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; Mukhopadhyay N, 1999, AM J HUM GENET, V65, pA436; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ogdie MN, 2004, AM J HUM GENET, V75, P661, DOI 10.1086/424387; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Palferman S, 2001, AM J HUM GENET, V69, P570; Papapetrou C, 1999, GENOMICS, V55, P238, DOI 10.1006/geno.1998.5646; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Pickles A, 2000, J CHILD PSYCHOL PSYC, V41, P491, DOI 10.1017/S0021963099005557; PICKLES A, 1995, AM J HUM GENET, V57, P717; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Smalley SL, 2002, AM J HUM GENET, V71, P959, DOI 10.1086/342732; Sparrow SS, 1984, VINELAND ADAPTIVE BE; STONE JL, 2003, AM SOC HUM GEN LOS A; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Turic D, 2004, MOL PSYCHIATR, V9, P169, DOI 10.1038/sj.mp.4001387; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Vincent JB, 2004, AM J MED GENET B, V129B, P82, DOI 10.1002/ajmg.b.30069; Wallenstein S, 1998, GENET EPIDEMIOL, V15, P173, DOI 10.1002/(SICI)1098-2272(1998)15:2<173::AID-GEPI5>3.0.CO;2-7; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	64	133	138	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					950	966		10.1086/430454	http://dx.doi.org/10.1086/430454			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15830322	Green Published, Bronze			2022-12-18	WOS:000229047900004
J	McKeigue, PM				McKeigue, PM			Prospects for admixture mapping of complex traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							LINKAGE DISEQUILIBRIUM; ADMIXED POPULATIONS; ETHNIC-DIFFERENCES; HIGH PREVALENCE; DISEASE RISK; ASSOCIATION; GENES; INFERENCE; MARKERS; LIMITS	Admixture mapping extends to human populations the principles that underlie linkage analysis of an experimental cross. For detecting genes that contribute to ethnic variation in disease risk, admixture mapping has greater statistical power than family-linkage studies. In comparison with association studies, admixture mapping requires far fewer markers to search the genome and is less affected by allelic heterogeneity. Statistical-analysis programs for admixture mapping are now available, and a genomewide panel of markers for admixture mapping in populations formed by West African - European admixture has been assembled. Some of the remaining technical challenges include the ability to ensure that the statistical methods are robust and to develop marker panels for other admixed populations. Where admixed populations and panels of markers informative for ancestry are available, admixture mapping can be applied to localize genes that contribute to ethnic variation in any measurable trait.	Univ Coll Dublin, Conway Inst, Dublin 4, Ireland	University College Dublin	McKeigue, PM (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 4, Ireland.	paul.mckeigue@ucd.ie	Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284	NIMH NIH HHS [MH 60343] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060343] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Al-Mahroos F, 1998, DIABETES CARE, V21, P936, DOI 10.2337/diacare.21.6.936; BABRON MC, 1993, GENET EPIDEMIOL, V10, P389, DOI 10.1002/gepi.1370100610; BRISCOE D, 1994, J HERED, V85, P59; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Falush D, 2003, GENETICS, V164, P1567; FREIMER NB, 1993, AM J HUM GENET, V52, P1102; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Juengst ET, 1998, KENNEDY INST ETHIC J, V8, P183, DOI 10.1353/ken.1998.0010; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 1997, AM J HUM GENET, V60, P188; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Molokhia M, 2003, HUM GENET, V112, P310, DOI 10.1007/s00439-002-0883-3; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; OTT J, 1992, AM J HUM GENET, V51, P283; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; RIFE DC, 1954, AM J HUM GENET, V6, P26; Risch NJ, 1992, AM J HUM GENET S, V51, P13; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Terwilliger JD, 2000, HUM BIOL, V72, P63; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Weijer C, 1999, NAT GENET, V23, P275, DOI 10.1038/15455; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; WISE PH, 1976, AUST NZ J MED, V6, P191, DOI 10.1111/j.1445-5994.1976.tb03653.x; Zhang C, 2004, GENET EPIDEMIOL, V27, P225, DOI 10.1002/gepi.20021; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329; ZIMMET P, 1977, DIABETOLOGIA, V13, P111, DOI 10.1007/BF00745137	41	133	142	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					1	7		10.1086/426949	http://dx.doi.org/10.1086/426949			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15540159	Bronze, Green Published			2022-12-18	WOS:000225643600001
J	Stone, JL; Merriman, B; Cantor, RM; Yonan, AL; Gilliam, TC; Geschwind, DH; Nelson, SF				Stone, JL; Merriman, B; Cantor, RM; Yonan, AL; Gilliam, TC; Geschwind, DH; Nelson, SF			Evidence for sex-specific risk alleles in autism spectrum disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCI; X-CHROMOSOME; GENDER; BRAIN; DIMORPHISM; FAMILIES; LINKAGE	We investigated the genetic aspects of the large sex bias in the prevalence of autism spectrum disorder by monitoring changes in linkage when the family set for an affected sibling pair genome scan is subdivided on the basis of the sex of affected children. This produces a significant excess in the total number of linkage peaks (P = 1.3 x 10(-8)) and identifies a major male-specific linkage peak at chromosome 17q11 (P < .01). These results suggest that sexual dichotomy is an important factor in the genetics of autism; the same strategy can be used to explore this possibility in other complex disorders that exhibit significant sex biases.	Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Columbia Univ, Dept Genet & Dev, New York, NY USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University	Nelson, SF (corresponding author), Univ Calif Los Angeles, Dept Human Genet, 695 Charles Young Dr S,Gonda Bldg,Room 5554, Los Angeles, CA 90095 USA.	snelson@ucla.edu	Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114	NIMH NIH HHS [R01 MH064547, MH64547] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P3290, DOI 10.1210/jc.83.9.3290; Conroy J, 2004, MOL PSYCHIATR, V9, P587, DOI 10.1038/sj.mp.4001459; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Giedd JN, 1997, PROG NEURO-PSYCHOPH, V21, P1185, DOI 10.1016/S0278-5846(97)00158-9; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Lambe EK, 1999, NEUROPSYCHOLOGIA, V37, P521, DOI 10.1016/S0028-3932(98)00146-8; McCauley JL, 2004, AM J MED GENET B, V127B, P104, DOI 10.1002/ajmg.b.20151; REISERT I, 1991, TRENDS NEUROSCI, V14, P468, DOI 10.1016/0166-2236(91)90047-X; Rhodes ME, 1999, BRAIN RES REV, V30, P135, DOI 10.1016/S0165-0173(99)00011-9; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Skuse DH, 1999, J LAB CLIN MED, V133, P23, DOI 10.1053/lc.1999.v133.a94575; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Wisniewski AB, 1998, PSYCHONEUROENDOCRINO, V23, P519, DOI 10.1016/S0306-4530(98)00019-5; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	18	133	141	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1117	1123		10.1086/426034	http://dx.doi.org/10.1086/426034			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15467983	Bronze, Green Published			2022-12-18	WOS:000224866400016
J	Hauser, ER; Crossman, DC; Granger, CB; Haines, JL; Jones, CJH; Mooser, V; McAdam, B; Winkelmann, BR; Wiseman, AH; Muhlestein, JB; Bartel, AG; Dennis, CA; Dowdy, E; Estabrooks, S; Eggleston, K; Francis, S; Roche, K; Clevenger, PW; Huang, L; Pedersen, B; Shah, S; Schmidt, S; Haynes, C; West, S; Asper, D; Booze, M; Sharma, S; Sundseth, S; Middleton, L; Roses, AD; Hauser, MA; Vance, JM; Pericak-Vance, MA; Kraus, WE				Hauser, ER; Crossman, DC; Granger, CB; Haines, JL; Jones, CJH; Mooser, V; McAdam, B; Winkelmann, BR; Wiseman, AH; Muhlestein, JB; Bartel, AG; Dennis, CA; Dowdy, E; Estabrooks, S; Eggleston, K; Francis, S; Roche, K; Clevenger, PW; Huang, L; Pedersen, B; Shah, S; Schmidt, S; Haynes, C; West, S; Asper, D; Booze, M; Sharma, S; Sundseth, S; Middleton, L; Roses, AD; Hauser, MA; Vance, JM; Pericak-Vance, MA; Kraus, WE			A genomewide scan for early-onset coronary artery disease in 438 families: The GENECARD Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCI; CARDIOVASCULAR RISK-FACTORS; MELLITUS GENETICS FUSION; WIDE LINKAGE ANALYSIS; HEART-DISEASE; MYOCARDIAL-INFARCTION; SUSCEPTIBILITY LOCUS; METABOLIC SYNDROME; COMPLEX TRAITS; LIPOPROTEIN ABNORMALITIES	A family history of coronary artery disease (CAD), especially when the disease occurs at a young age, is a potent risk factor for CAD. DNA collection in families in which two or more siblings are affected at an early age allows identification of genetic factors for CAD by linkage analysis. We performed a genomewide scan in 1,168 individuals from 438 families, including 493 affected sibling pairs with documented onset of CAD before 51 years of age in men and before 56 years of age in women. We prospectively defined three phenotypic subsets of families: (1) acute coronary syndrome in two or more siblings; (2) absence of type 2 diabetes in all affected siblings; and (3) atherogenic dyslipidemia in any one sibling. Genotypes were analyzed for 395 microsatellite markers. Regions were defined as providing evidence for linkage if they provided parametric two-point LOD scores >1.5, together with nonparametric multipoint LOD scores >1.0. Regions on chromosomes 3q13 (multipoint LOD=3.3; empirical P value <.001) and 5q31 (multipoint LOD=1.4; empirical P value <.081) met these criteria in the entire data set, and regions on chromosomes 1q25, 3q13, 7p14, and 19p13 met these criteria in one or more of the subsets. Two regions, 3q13 and 1q25, met the criteria for genomewide significance. We have identified a region on chromosome 3q13 that is linked to early-onset CAD, as well as additional regions of interest that will require further analysis. These data provide initial areas of the human genome where further investigation may reveal susceptibility genes for early-onset CAD.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; GlaxoSmithKline, Res Triangle Pk, NC USA; Univ Lausanne Hosp, Lausanne, Switzerland; Univ Sheffield, Sheffield, S Yorkshire, England; Vanderbilt Univ, Nashville, TN USA; Univ Wales Coll Med, Cardiff CF4 4XN, S Glam, Wales; Ludwigshafen Heart Ctr, Ludwigshafen, Germany; Univ Heidelberg, Cooperat Unit Pharmacogen Appl Gen, Dept Internal Med 6, Heidelberg, Germany; Univ Heidelberg, Coordinat Ctr Clin Trials, Heidelberg, Germany; Baystate Med Ctr, Springfield, MA USA; Latter Day St Hosp, Salt Lake City, UT 84143 USA; Cardiovasc Associates, Norfolk, VA USA; Deborah Heart & Lung Ctr, Browns Mills, NJ USA	Duke University; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Sheffield; Vanderbilt University; Cardiff University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Baystate Medical Center	Hauser, ER (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, POB 3445, Durham, NC 27710 USA.	Elizabeth.Hauser@duke.edu	Granger, Christopher B/D-3458-2014; Haines, Jonathan/C-3374-2012; Huang, Liling/I-8457-2018	Granger, Christopher B/0000-0002-0045-3291; Haines, Jonathan/0000-0002-4351-4728; Huang, Liling/0000-0002-7558-603X; Vance, Jeffery/0000-0003-3815-8199; Hauser, Elizabeth/0000-0003-0367-9189; Kraus, William E/0000-0003-1930-9684; Joubert, Bonnie/0000-0001-7952-1180; Francis, Sheila/0000-0001-6552-0339; Sharma, Sanjay/0000-0001-5232-3272	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059528] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL073389, R01 HL073389] Funding Source: Medline; NIMH NIH HHS [R01 MH059528, MH059528] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; American Heart Association, 2004, HEART STROK STAT UPD; BASS MP, 2004, PAC S BIOC 2004; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Breslow JL, 2000, ANNU REV GENET, V34, P233, DOI 10.1146/annurev.genet.34.1.233; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 2001, GENET EPIDEMIOL, V20, P307, DOI 10.1002/gepi.2; Chiodini BD, 2003, ARTERIOSCL THROM VAS, V23, P1863, DOI 10.1161/01.ATV.0000093281.10213.DB; Coon H, 2001, ARTERIOSCL THROM VAS, V21, P1969, DOI 10.1161/hq1201.100228; Du WN, 2001, CHINESE MED J-PEKING, V114, P876; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; GRUNDY SM, 1995, AM J CARDIOL, V75, pB45, DOI 10.1016/0002-9149(95)80011-G; Harrap SB, 2000, AM J EPIDEMIOL, V152, P704, DOI 10.1093/aje/152.8.704; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hauser ER, 2003, AM HEART J, V145, P602, DOI 10.1067/mhj.2003.13; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Holmans P, 1997, AM J HUM GENET, V60, P657; Hsueh WC, 2003, DIABETES, V52, P550, DOI 10.2337/diabetes.52.2.550; Imperatore G, 2000, ARTERIOSCL THROM VAS, V20, P2651, DOI 10.1161/01.ATV.20.12.2651; Jomini V, 2002, J AM COLL CARDIOL, V40, P676, DOI 10.1016/S0735-1097(02)02017-X; Katzmarzyk PT, 2000, AM J HUM BIOL, V12, P395, DOI 10.1002/(SICI)1520-6300(200005/06)12:3<395::AID-AJHB10>3.0.CO;2-J; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; LUSIS AJ, 1992, MOL GENETICS CORONAR; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Naoumova RP, 2003, ARTERIOSCL THROM VAS, V23, P2070, DOI 10.1161/01.ATV.0000095975.35247.9F; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3263, DOI 10.1161/01.ATV.17.11.3263; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Rainwater DL, 1999, ARTERIOSCL THROM VAS, V19, P777, DOI 10.1161/01.ATV.19.3.777; Rice T, 1997, INT J OBESITY, V21, P1024, DOI 10.1038/sj.ijo.0800511; RISSANEN AM, 1979, AM J CARDIOL, V44, P60, DOI 10.1016/0002-9149(79)90251-0; SCHNEIDER S, 2000, ARLEQUIN V 2 000 SOF; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; Shearman AM, 2000, HUM MOL GENET, V9, P1315, DOI 10.1093/hmg/9.9.1315; Tang WH, 2003, DIABETES, V52, P2840, DOI 10.2337/diabetes.52.11.2840; Vance J. M., 1996, American Journal of Human Genetics, V59, pA239; VANCE JM, 1998, APPROACHES GENE MAPP; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Xiang KS, 2004, DIABETES, V53, P228, DOI 10.2337/diabetes.53.1.228; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445	55	133	139	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					436	447		10.1086/423900	http://dx.doi.org/10.1086/423900			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15272420	Bronze, Green Published			2022-12-18	WOS:000223272200008
J	Iyengar, SK; Song, DH; Klein, BEK; Klein, R; Schick, JH; Humphrey, J; Millard, C; Liptak, R; Russo, K; Jun, G; Lee, KE; Fijal, B; Elston, RC				Iyengar, SK; Song, DH; Klein, BEK; Klein, R; Schick, JH; Humphrey, J; Millard, C; Liptak, R; Russo, K; Jun, G; Lee, KE; Fijal, B; Elston, RC			Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BEAVER-DAM-EYE; STARGARDT-DISEASE GENE; VISUAL IMPAIRMENT; MALATTIA LEVENTINESE; QUANTITATIVE TRAIT; 10-YEAR INCIDENCE; 5-YEAR INCIDENCE; COMPLEX TRAITS; GRADING SYSTEM; VISION LOSS	To examine the genetic basis of age-related macular degeneration (ARMD), a degenerative disease of the retinal pigment epithelium and neurosensory retina, we conducted a genomewide scan in 34 extended families ( 297 individuals, 349 sib pairs) ascertained through index cases with neovascular disease or geographic atrophy. Family and medical history was obtained from index cases and family members. Fundus photographs were taken of all participating family members, and these were graded for severity by use of a quantitative scale. Model-free linkage analysis was performed, and tests of heterogeneity and epistasis were conducted. We have evidence of a major locus on chromosome 15q (GATA50C03 multipoint P = 1.98 x 10(-7); empirical P less than or equal to 1.0 x 10(-5); single-point P = 3.6 x 10(-7)). This locus was present as a weak linkage signal in our previous genome scan for ARMD, in the Beaver Dam Eye Study sample (D15S659, multipoint P = .047), but is otherwise novel. In this genome scan, we observed a total of 13 regions on 11 chromosomes (1q31, 2p21, 4p16, 5q34, 9p24, 9q31, 10q26, 12q13, 12q23, 15q21, 16p12, 18p11, and 20q13), with a nominal multipoint significance level of P less than or equal to .01 or LOD greater than or equal to 1.18. Family-by-family analysis of the data, performed using model-free linkage methods, suggests that there is evidence of heterogeneity in these families. For example, a single family ( family 460) individually shows linkage evidence at 8 loci, at the level of P < .0001. We conducted tests for heterogeneity, which suggest that ARMD susceptibility loci on chromosomes 9p24, 10q26, and 15q21 are not present in all families. We tested for mutations in linked families and examined SNPs in two candidate genes, hemicentin-1 and EFEMP1, in subsamples (145 and 189 sib pairs, respectively) of the data. Mutations were not observed in any of the 11 exons of EFEMP1 nor in exon 104 of hemicentin-1. The SNP analysis for hemicentin-1 on 1q31 suggests that variants within or in very close proximity to this gene cause ARMD pathogenesis. In summary, we have evidence for a major ARMD locus on 15q21, which, coupled with numerous other loci segregating in these families, suggests complex oligogenic patterns of inheritance for ARMD.	Case Western Reserve Univ, Metrohlth Med Ctr, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; Univ Wisconsin, Sch Med, Dept Ophthalmol & Visual Sci, Madison, WI USA	Case Western Reserve University; MetroHealth System; University of Wisconsin System; University of Wisconsin Madison	Iyengar, SK (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Dept Epidemiol & Biostat, Rammelkamp Bldg,R215,2500 Metrohlth Dr, Cleveland, OH 44109 USA.		/S-1190-2019	/0000-0001-7488-250X; Jun, Gyungah/0000-0002-3230-8697	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010605, U10EY006594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028356, R37GM028356] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NEI NIH HHS [EY10605, U10 EY006594, U10-EY06594] Funding Source: Medline; NHLBI NIH HHS [T32 HL007567, HL07567] Funding Source: Medline; NIGMS NIH HHS [R37 GM028356, GM28356, R01 GM028356] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Balatsoukas D D, 1995, J R Coll Surg Edinb, V40, P49; Bernstein PS, 2002, INVEST OPHTH VIS SCI, V43, P466; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bressler Neil M, 2002, J Am Board Fam Pract, V15, P142; Buch H, 2001, ACTA OPHTHALMOL SCAN, V79, P441, DOI 10.1034/j.1600-0420.2001.790503.x; Cordell HJ, 2001, ANN HUM GENET, V65, P491, DOI 10.1017/S0003480001008831; CRUICKSHANKS KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P514, DOI 10.1001/archopht.1993.01090040106042; DeBlack Susan Sanders, 2003, Optometry, V74, P99; DelaPaz MA, 1997, INVEST OPHTH VIS SCI, V38, P1060; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Evans J, 1996, BRIT J OPHTHALMOL, V80, P9, DOI 10.1136/bjo.80.1.9; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gensler G, 2002, J NUTR, V132, P697; Gorin MB, 2001, ARCH OPHTHALMOL-CHIC, V119, P752, DOI 10.1001/archopht.119.5.752; Guymer RH, 2002, CLIN EXP OPHTHALMOL, V30, P419, DOI 10.1046/j.1442-9071.2002.00572.x; Guymer RH, 2001, ARCH OPHTHALMOL-CHIC, V119, P745, DOI 10.1001/archopht.119.5.745; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; Harvey PT, 2003, GERONTOLOGY, V49, P1, DOI 10.1159/000066507; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Hunt DWC, 2003, IDRUGS, V6, P464; Jacques PF, 1999, INT J VITAM NUTR RES, V69, P198, DOI 10.1024/0300-9831.69.3.198; Jonasson F, 1987, Acta Ophthalmol Suppl, V182, P40; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Keverline MR, 1998, OPHTHALMIC GENET, V19, P19, DOI 10.1076/opge.19.1.19.2176; Klein BEK, 2001, AM J EPIDEMIOL, V154, P207, DOI 10.1093/aje/154.3.207; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Klein R, 1998, AM J EPIDEMIOL, V147, P103; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2001, OPHTHALMOLOGY, V108, P1757, DOI 10.1016/S0161-6420(01)00769-2; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Klein R, 2002, AM J EPIDEMIOL, V156, P589, DOI 10.1093/aje/kwf092; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1203; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 1995, PB95273827; Klein R, 1991, PB91149823; KLEIN R, 1991, PB91184267AS; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; MaresPerlman JA, 1996, ARCH OPHTHALMOL-CHIC, V114, P991, DOI 10.1001/archopht.1996.01100140199014; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mittra Robert A, 2003, Minn Med, V86, P40; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; SCHMIDT S, 2003, ASS RES VIS OPHTH M; SCHULTZ DW, 2003, ASS RES VIS OPHTH M; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; SEDDON JM, 2003, ASS RES VIS OPHTH M; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2001, HUM MOL GENET, V10, P2285, DOI 10.1093/hmg/10.20.2285; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tiwari HK, 1997, ANN HUM GENET, V61, P253, DOI 10.1017/S0003480097006167; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; VanNewkirk MR, 2001, OPHTHALMOLOGY, V108, P960, DOI 10.1016/S0161-6420(01)00554-1; VanNewkirk MR, 2000, OPHTHALMOLOGY, V107, P2203, DOI 10.1016/S0161-6420(00)00459-0; VINDING T, 1990, ACTA OPHTHALMOL, V68, P162; Vogel BE, 2001, DEVELOPMENT, V128, P883; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4; WILSON AF, 1993, GENET EPIDEMIOL, V10, P593, DOI 10.1002/gepi.1370100644; WILSON AF, 1991, AM J HUM GENET, V48, P862; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Yoshida A, 2000, JPN J OPHTHALMOL, V44, P290, DOI 10.1016/S0021-5155(99)00227-0	74	133	141	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					20	39		10.1086/380912	http://dx.doi.org/10.1086/380912			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14691731	Green Published, Bronze			2022-12-18	WOS:000187723500003
J	Robinson, SW; Morris, CD; Goldmuntz, E; Reller, MD; Jones, MA; Steiner, RD; Maslen, CL				Robinson, SW; Morris, CD; Goldmuntz, E; Reller, MD; Jones, MA; Steiner, RD; Maslen, CL			Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL HEART-DISEASE; DOWN-SYNDROME; CRITICAL REGION; CANAL DEFECT; GENE; EXCLUSION; IDENTIFICATION; CHROMOSOME-21; MORPHOGENESIS; DATABASE	Atrioventricular septal defects (AVSD) are common cardiovascular malformations, occurring in 3.5/10,000 births. Although frequently associated with trisomy 21, autosomal dominant AVSD has also been described. Recently we identified and characterized the cell adhesion molecule CRELD1 ( previously known as "cirrin") as a candidate gene for the AVSD2 locus mapping to chromosome 3p25. Analysis of the CRELD1 gene from individuals with non-trisomy 21-associated AVSD identified heterozygous missense mutations in nearly 6% of this population, including mutations in isolated AVSD and AVSD associated with heterotaxy syndrome. CRELD1 is the first human gene to be implicated in the pathogenesis of isolated AVSD and AVSD in the context of heterotaxy, which provides an important step in unraveling the pathogenesis of AVSD.	Oregon Hlth & Sci Univ, Dept Med, Div Endocrinol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Cardiol, Portland, OR USA; Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR USA; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat,Div Cardiol, Philadelphia, PA 19104 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Maslen, CL (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Endocrinol, 3181 SW Sam Jackson Pk Rd,L-465, Portland, OR 97239 USA.		Steiner, Robert D./AAJ-5756-2020	Steiner, Robert D./0000-0003-4177-4590	NCRR NIH HHS [M01 RR000334, 5 M01 RR00334] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000334] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMATI F, 1995, AM J MED GENET, V57, P483, DOI 10.1002/ajmg.1320570325; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Barlow GM, 2001, GENET MED, V3, P91, DOI 10.1097/00125817-200103000-00002; Collod-Beroud G, 1998, NUCLEIC ACIDS RES, V26, P229, DOI 10.1093/nar/26.1.229; COUSINEAU AJ, 1994, HUM GENET, V93, P103; Digilio MC, 1999, AM J MED GENET, V85, P140, DOI 10.1002/(SICI)1096-8628(19990716)85:2<140::AID-AJMG8>3.3.CO;2-1; Drumheller T, 1996, J MED GENET, V33, P842, DOI 10.1136/jmg.33.10.842; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; EMANUEL R, 1983, BRIT HEART J, V49, P144; Ferencz C, 1997, PERSPECTIVES PEDIAT; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Green EK, 2000, J MED GENET, V37, P581, DOI 10.1136/jmg.37.8.581; Jacobs J P, 2000, Ann Thorac Surg, V69, pS36; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; KUMAR A, 1994, BRIT HEART J, V71, P79; MARKWALD RR, 1981, SCAN ELECTRON MICROS, P261; O'Nuallain S, 1977, Birth Defects Orig Artic Ser, V13, P143; PHIPPS ME, 1994, HUM MOL GENET, V3, P903, DOI 10.1093/hmg/3.6.903; Pierpont MEM, 2000, AM J MED GENET, V97, P289, DOI 10.1002/1096-8628(200024)97:4<289::AID-AJMG1279>3.0.CO;2-U; RAMER JC, 1989, AM J MED GENET, V33, P108, DOI 10.1002/ajmg.1320330115; Rupp PA, 2002, GENE, V293, P47, DOI 10.1016/S0378-1119(02)00696-0; Sheffield VC, 1997, HUM MOL GENET, V6, P117, DOI 10.1093/hmg/6.1.117; Wessels A, 2000, METH MOL B, V136, P239; WILSON L, 1993, AM J HUM GENET, V53, P1262	24	133	147	2	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1047	1052		10.1086/374319	http://dx.doi.org/10.1086/374319			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12632326	Green Published, Bronze			2022-12-18	WOS:000181972600027
J	Karason, A; Gudjonsson, JE; Upmanyu, R; Antonsdottir, AA; Hauksson, VB; Runasdottir, EH; Jonsson, HH; Gudbjartsson, DF; Frigge, ML; Kong, A; Stefansson, K; Valdimarsson, H; Gulcher, JR				Karason, A; Gudjonsson, JE; Upmanyu, R; Antonsdottir, AA; Hauksson, VB; Runasdottir, EH; Jonsson, HH; Gudbjartsson, DF; Frigge, ML; Kong, A; Stefansson, K; Valdimarsson, H; Gulcher, JR			A susceptibility gene for psoriatic arthritis maps to chromosome 16q: Evidence for imprinting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SEARCH; LINKAGE ANALYSIS; FRAMESHIFT MUTATION; FAMILIAL PSORIASIS; CROHNS-DISEASE; MICA RATHER; HLA; TRANSMISSION; ORIGIN; LOCUS	Several genetic loci have been reported for psoriasis, but none has been specifically linked to psoriatic arthritis (PsA), a condition that affects >10% of patients with psoriasis. A genetic component for PsA is suggested by segregation within families and high concordance among identical twins. We performed a linkage scan to map genes contributing to PsA. We identified 178 patients with PsA out of 906 patients who were included in our genetic study of psoriasis. Using a comprehensive genealogy database, we were able to connect 100 of these into 39 families. We genotyped the patients using a framework marker set of 1,000 microsatellite markers, with an average density of 3 cM, and performed multipoint, affected-only, allele-sharing linkage analysis using the Allegro program. On the basis of the initial results, we genotyped more markers for the most prominent loci. A linkage with a LOD score of 2.17 was observed on chromosome 16q. The linkage analysis, conditioned on paternal transmission to affected individuals, gave a LOD score of 4.19, whereas a LOD score of only 1.03 was observed when conditioned for maternal transmission. A suggestive locus on chromosome 16q has previously been implicated in psoriasis. Our data indicate that a gene at this locus may be involved in paternal transmission of PsA.	DeCODE Genet, IS-101 Reykjavik, Iceland; Univ Natl Hosp, Dept Immunol, Reykjavik, Iceland	Landspitali National University Hospital	Karason, A (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	akarason@decode.is; helgiv@landspitali.is	Stefansson, Kari/AAE-7187-2019	Gudbjartsson, Daniel/0000-0002-5222-9857				Akolkar PN, 1997, AM J GASTROENTEROL, V92, P2241; Al-Heresh AM, 2002, RHEUMATOLOGY, V41, P525, DOI 10.1093/rheumatology/41.5.525; Alcolado JC, 2002, DIABETIC MED, V19, P89, DOI 10.1046/j.1464-5491.2002.00675.x; BAKER BS, 1984, BRIT J DERMATOL, V110, P555; Balendran N, 1999, J INVEST DERMATOL, V113, P322, DOI 10.1046/j.1523-1747.1999.00710.x; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bruce IN, 2001, RHEUMATOLOGY, V40, P363, DOI 10.1093/rheumatology/40.4.363; Burden AD, 1998, J INVEST DERMATOL, V110, P958, DOI 10.1046/j.1523-1747.1998.00213.x; Christian SL, 1998, GENOME RES, V8, P146, DOI 10.1101/gr.8.2.146; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; Costello P, 2001, Curr Rheumatol Rep, V3, P419, DOI 10.1007/s11926-996-0013-7; DeLisi LE, 2002, AM J PSYCHIAT, V159, P803, DOI 10.1176/appi.ajp.159.5.803; Eapen V, 1997, NEUROLOGY, V48, P934, DOI 10.1212/WNL.48.4.934; EASTMOND CJ, 1994, BAILLIERE CLIN RHEUM, V8, P263, DOI 10.1016/S0950-3579(94)80018-9; Elder JT, 2001, ARCH DERMATOL, V137, P1447; FARBER EM, 1974, ARCH DERMATOL, V109, P207, DOI 10.1001/archderm.109.2.207; Fearon U, 2001, CLIN EXP DERMATOL, V26, P333, DOI 10.1046/j.1365-2230.2001.00792.x; Gladman DD, 2001, HUM IMMUNOL, V62, P1239, DOI 10.1016/S0198-8859(01)00337-8; Gonzalez S, 2002, J RHEUMATOL, V29, P973; Gonzalez S, 2001, HUM IMMUNOL, V62, P632, DOI 10.1016/S0198-8859(01)00242-7; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gudjonsson JE, 2002, J INVEST DERMATOL, V118, P362, DOI 10.1046/j.0022-202x.2001.01656.x; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Haghighi F, 1999, AM J MED GENET, V88, P131, DOI 10.1002/(SICI)1096-8628(19990416)88:2<131::AID-AJMG7>3.3.CO;2-C; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jenisch S, 1998, AM J HUM GENET, V63, P191, DOI 10.1086/301899; Kato T, 1996, AM J MED GENET, V67, P546, DOI 10.1002/(SICI)1096-8628(19961122)67:6<546::AID-AJMG6>3.0.CO;2-F; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEE FI, 1990, AM J GASTROENTEROL, V85, P962; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; LICHTER DG, 1995, NEUROLOGY, V45, P924, DOI 10.1212/WNL.45.5.924; Lindsay RS, 2002, HUM GENET, V110, P503, DOI 10.1007/s00439-002-0718-2; Lindsay RS, 2001, DIABETES, V50, P2850, DOI 10.2337/diabetes.50.12.2850; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; MOLL JMH, 1973, ANN RHEUM DIS, V32, P181, DOI 10.1136/ard.32.3.181; Nair RP, 2001, J INVEST DERMATOL, V117, P1671, DOI 10.1046/j.0022-202x.2001.01620.x; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; Naumova AK, 2001, GENOME, V44, P311, DOI 10.1139/gen-44-3-311; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; Patel S, 2001, RHEUMATOLOGY, V40, P243, DOI 10.1093/rheumatology/40.3.243; Paterson AD, 1999, HUM HERED, V49, P197, DOI 10.1159/000022875; Prinz JC, 1999, CLIN EXP DERMATOL, V24, P291; Rahman P, 1999, ARTHRITIS RHEUM, V42, P1228, DOI 10.1002/1529-0131(199906)42:6<1228::AID-ANR20>3.0.CO;2-3; Rahman P, 2000, CLIN EXP RHEUMATOL, V18, P7; Samuelsson L, 1999, HUM GENET, V105, P523, DOI 10.1007/s004390051141; Strauch K, 2001, GENET EPIDEMIOL, V21, pS204, DOI 10.1002/gepi.2001.21.s1.s204; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; VALDIMARSSON H, 1995, IMMUNOL TODAY, V16, P145, DOI 10.1016/0167-5699(95)80132-4; Vandenbroeck K, 2002, J NEUROIMMUNOL, V125, P141, DOI 10.1016/S0165-5728(02)00023-1; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WINCHESTER R, 1995, DERMATOL CLIN, V13, P779	64	133	138	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					125	131		10.1086/345646	http://dx.doi.org/10.1086/345646			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12474146	Bronze, Green Published			2022-12-18	WOS:000180186800012
J	Ranade, K; Jorgenson, E; Sheu, WHH; Pei, D; Hsiung, CA; Chiang, FT; Chen, YDI; Pratt, R; Olshen, RA; Curb, D; Cox, DR; Botstein, D; Risch, N				Ranade, K; Jorgenson, E; Sheu, WHH; Pei, D; Hsiung, CA; Chiang, FT; Chen, YDI; Pratt, R; Olshen, RA; Curb, D; Cox, DR; Botstein, D; Risch, N			A polymorphism in the beta 1 adrenergic receptor is associated with resting heart rate	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; BETA(1)-ADRENERGIC RECEPTOR; BLOOD-PRESSURE; FOLLOW-UP; GENE; MORTALITY; FAILURE; HYPERTENSION; DISEASE; MICE	Resting heart rate is significantly associated with cardiovascular morbidity and mortality. However, the extent to which resting heart rate is genetically determined is poorly understood, and no genes have been found that contribute to variation in resting heart rate. Because signaling through the beta1 adrenergic receptor is a key determinant of cardiac function, we tested whether polymorphisms in this receptor are associated with resting heart rate. A cohort of 1 1,000 individuals of Chinese and Japanese descent, from nuclear families, was genotyped for two polymorphisms, resulting in a serine/glycine substitution at amino acid 49 (Ser49Gly) and an arginine/glycine substitution at residue 389 (Arg389Gly), in the beta1 adrenergic receptor. For comparison, polymorphisms in the beta2 and beta3 adrenergic receptors were also evaluated. The Ser49Gly polymorphism was significantly associated (P = .0004) with resting heart rate, independent of other variables, such as body-mass index, age, sex, ethnicity, exercise, smoking, alcohol intake, hypertension status, and treatment with beta blockers. The data support an additive model in which individuals heterozygous for the Ser49Gly polymorphism had mean heart rates intermediate to those of either type of homozygote, with Ser homozygotes having the highest mean heart rate and with Gly homozygotes having the lowest. Neither the Arg389Gly polymorphism in the beta1 adrenergic receptor nor polymorphisms in the beta2 and beta3 adrenergic receptors were associated with resting heart rate. The heritability of heart rate was 39.7% +/- 7.1% (P < 10(-7)).	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Div Endocrinol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Taichung Vet Gen Hosp, Div Endocrinol & Metab, Taichung, Taiwan; Tri Serv Gen Hosp, Taipei, Taiwan; Natl Hlth Res Inst, Div Biostat & Bioinformat, Taipei, Taiwan; Natl Taiwan Univ Hosp, Taipei, Taiwan; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Hawaii Ctr Hlth Res, Honolulu, HI USA	Stanford University; Stanford University; Stanford University; Taichung Veterans General Hospital; Tri-Service General Hospital; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; Harvard University; Brigham & Women's Hospital	Ranade, K (corresponding author), Bristol Myers Squibb Co, Pharmaceut Res Inst, POB 5400, Princeton, NJ 08543 USA.		Hsiung, Chao Agnes/E-3994-2010	CHIANG, FU-TIEN/0000-0003-4936-8968	NHLBI NIH HHS [U01 HL 54527-0151] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL054527] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Bengtsson K, 2001, CIRCULATION, V104, P187, DOI 10.1161/01.CIR.104.2.187; BLACKBURN H, 1960, ANN NY ACAD SCI, V90, P277, DOI 10.1111/j.1749-6632.1960.tb32642.x; Borjesson M, 2000, EUR HEART J, V21, P1853, DOI 10.1053/euhj.1999.1994; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; BRISTOW MR, 1993, J CLIN INVEST, V92, P2737, DOI 10.1172/JCI116891; DITTO B, 1993, PSYCHOPHYSIOLOGY, V30, P635, DOI 10.1111/j.1469-8986.1993.tb02089.x; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; GILLMAN MW, 1993, AM HEART J, V125, P1148, DOI 10.1016/0002-8703(93)90128-V; GILLUM RF, 1988, AM HEART J, V116, P163, DOI 10.1016/0002-8703(88)90262-1; GOLDBOURT U, 1977, AM J EPIDEMIOL, V105, P75, DOI 10.1093/oxfordjournals.aje.a112358; Greenland P, 1999, AM J EPIDEMIOL, V149, P853; HIGGINS MW, 1967, AM J EPIDEMIOL, V86, P60, DOI 10.1093/oxfordjournals.aje.a120734; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Kristal-Boneh E, 2000, EUR HEART J, V21, P116, DOI 10.1053/euhj.1999.1741; LEWONTIN RC, 1964, GENETICS, V49, P49; MANUCK SB, 1980, PHYSIOL BEHAV, V24, P621, DOI 10.1016/0031-9384(80)90261-9; Maqbool A, 1999, LANCET, V353, P897, DOI 10.1016/S0140-6736(99)00549-8; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; McGraw DW, 1998, J CLIN INVEST, V102, P1927, DOI 10.1172/JCI4862; Podlowski S, 2000, J MOL MED-JMM, V78, P87, DOI 10.1007/s001090000080; Ranade K, 2000, AM J HYPERTENS, V13, P704, DOI 10.1016/S0895-7061(00)00238-7; Ranade K, 2001, GENOME RES, V11, P1262; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Singh JP, 1999, CIRCULATION, V99, P2251, DOI 10.1161/01.CIR.99.17.2251; Tesson F, 1999, J MOL CELL CARDIOL, V31, P1025, DOI 10.1006/jmcc.1999.0947; THOMAS CB, 1960, ANN INTERN MED, V53, P697, DOI 10.7326/0003-4819-53-4-697; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603	34	133	154	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					935	942		10.1086/339621	http://dx.doi.org/10.1086/339621			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11854867	Green Published, Bronze			2022-12-18	WOS:000174252100010
J	Bailey, JA; Yavor, AM; Viggiano, L; Misceo, D; Horvath, JE; Archidiacono, N; Schwartz, S; Rocchi, M; Eichler, EE				Bailey, JA; Yavor, AM; Viggiano, L; Misceo, D; Horvath, JE; Archidiacono, N; Schwartz, S; Rocchi, M; Eichler, EE			Human-specific duplication and mosaic transcripts: The recent paralogous structure of chromosome 22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR GENE FAMILY; LOW-COPY REPEATS; GENOME DUPLICATIONS; DNA-SEQUENCE; GREAT APES; EVOLUTION; CLUSTER; ORGANIZATION; MECHANISM; DELETION	In recent decades, comparative chromosomal banding, chromosome painting, and gene-order studies have shown strong conservation of gross chromosome structure and gene order in mammals. However, findings from the human genome sequence suggest an unprecedented degree of recent (<35 million years ago) segmental duplication. This dynamism of segmental duplications has important implications in disease and evolution. Here we present a chromosome-wide view of the structure and evolution of the most highly homologous duplications (<greater than or equal to>1 kb and greater than or equal to 90%) on chromosome 22. Overall, 10.8% (3.7/33.8 Mb) of chromosome 22 is duplicated, with an average sequence identity of 95.4%. To organize the duplications into tractable units, intron-exon structure and well-defined duplication boundaries were used to define 78 duplicated modules (minimally shared evolutionary segments) with 157 copies on chromosome 22. Analysis of these modules provides evidence for the creation or modification of 11 novel transcripts. Comparative FISH analyses of human, chimpanzee, gorilla, orangutan, and macaque reveal qualitative and quantitative differences in the distribution of these duplications-consistent with their recent origin. Several duplications appear to be human specific, including a similar to 400-kb duplication (99.4%-99.8% sequence identity) that transposed from chromosome 14 to the most proximal pericentromeric region of chromosome 22. Experimental and in silico data further support a pericentromeric gradient of duplications where the most recent duplications transpose adjacent to the centromere. Taken together, these data suggest that segmental duplications have been an ongoing process of primate genome evolution, contributing to recent gene innovation and the dynamic transformation of genome architecture within and among closely related species.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Computat Genom, Cleveland, OH 44106 USA; Dipartimento Anat Patol & Genet, Sez Genet, Bari, Italy	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University	Eichler, EE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, BRB720,10900 Euclid Ave, Cleveland, OH 44106 USA.	eee@cwru.edu	Misceo, Doriana/AAR-9085-2020; archidiacono, nicoletta/B-8471-2011; Rocchi, Mariano/B-8451-2011	Misceo, Doriana/0000-0002-6594-5801; archidiacono, nicoletta/0000-0002-1439-9521; Viggiano, Luigi/0000-0002-2067-5166	NHGRI NIH HHS [R01 HG002385, HG002385] Funding Source: Medline; NIGMS NIH HHS [R01 GM058815, GM58815] Funding Source: Medline; Telethon [E.0962] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058815] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Edelmann L, 2001, GENOME RES, V11, P208, DOI 10.1101/gr.GR-1431R; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Eichler EE, 1998, GENOME RES, V8, P791, DOI 10.1101/gr.8.8.791; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Footz TK, 2001, GENOME RES, V11, P1053, DOI 10.1101/gr.154901; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Gratacos M, 2001, CELL, V106, P367, DOI 10.1016/S0092-8674(01)00447-0; Guy J, 2000, HUM MOL GENET, V9, P2029, DOI 10.1093/hmg/9.13.2029; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Hughes AL, 2001, GENOME RES, V11, P771, DOI 10.1101/gr.GR-1600R; Jackson MS, 1999, HUM MOL GENET, V8, P205, DOI 10.1093/hmg/8.2.205; JAUCH A, 1992, P NATL ACAD SCI USA, V89, P8611, DOI 10.1073/pnas.89.18.8611; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; JORGENSEN A L, 1988, Genomics, V3, P100, DOI 10.1016/0888-7543(88)90139-5; Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Luijten M, 2000, EUR J HUM GENET, V8, P209, DOI 10.1038/sj.ejhg.5200434; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Muller S, 1999, CHROMOSOMA, V108, P393, DOI 10.1007/s004120050391; MURPHY WJ, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-6-REVIEWS0005; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nadeau JH, 1998, TRENDS GENET, V14, P495, DOI 10.1016/S0168-9525(98)01607-2; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohno S., 1970, EVOLUTION GENE DUPLI; Patthy L, 1996, MATRIX BIOL, V15, P301, DOI 10.1016/S0945-053X(96)90131-6; Regnier V, 1997, HUM MOL GENET, V6, P9, DOI 10.1093/hmg/6.1.9; Ruault M, 1999, GENE, V239, P55, DOI 10.1016/S0378-1119(99)00381-9; Seroussi E, 1999, GENOME RES, V9, P803, DOI 10.1101/gr.9.9.803; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Skrabanek L, 1998, CURR OPIN GENET DEV, V8, P694, DOI 10.1016/S0959-437X(98)80039-7; Stankiewicz P, 2001, GENOME RES, V11, P1205, DOI 10.1101/gr.181101; TEGLUND S, 1994, GENOMICS, V23, P669, DOI 10.1006/geno.1994.1556; TOMLINSON IM, 1994, HUM MOL GENET, V3, P853; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wienberg J, 1997, CYTOGENET CELL GENET, V77, P211, DOI 10.1159/000134579; WIENBERG J, 1992, CHROMOSOMA, V101, P265, DOI 10.1007/BF00346004; Wong ACC, 1999, GENOMICS, V59, P326, DOI 10.1006/geno.1999.5889; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zimonjic DB, 1997, P NATL ACAD SCI USA, V94, P11461, DOI 10.1073/pnas.94.21.11461	61	133	139	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					83	100		10.1086/338458	http://dx.doi.org/10.1086/338458			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11731936	Green Published, Bronze			2022-12-18	WOS:000172571900009
J	Anikster, Y; Kleta, R; Shaag, A; Gahl, WA; Elpeleg, O				Anikster, Y; Kleta, R; Shaag, A; Gahl, WA; Elpeleg, O			Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): Identification of the OPA3 gene and its founder mutation in Iraqi Jews	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOMYOPATHY; PEROXISOMES; DEFICIENCY; PROTEIN	Type III 3-methylglutaconic aciduria (MGA) (MIM 258501) is a neuro-ophthalmologic syndrome that consists of early-onset bilateral optic atrophy and later-onset spasticity, extrapyramidal dysfunction, and cognitive deficit. Urinary excretion of 3-methylglutaconic acid and of 3-methylglutaric acid is increased. The disorder has been reported in 40 patients of Iraqi Jewish origin, allowing the mapping of the disease to chromosome 19q13.2-q13.3, by linkage analysis. To isolate the causative gene, OPA3, we sequenced four genes within the critical interval and identified, in the intronic sequence of a gene corresponding to cDNA clone FLJ22187, a point mutation that segregated with the type III MGA phenotype. The FLJ22187-cDNA clone, which we identified as the OPA3 gene, consists of two exons and encodes a peptide of 179 amino acid residues. Northern blot analysis revealed a primary transcript of similar to5.0 kb that was ubiquitously expressed, most prominently in skeletal muscle and kidney. Within the brain, the cerebral cortex, the medulla, the cerebellum, and the frontal lobe, compared to other parts of the brain, had slightly increased expression. The intronic G -->C mutation abolished mRNA expression in fibroblasts from affected patients and was detected in 8 of 85 anonymous Israeli individuals of Iraqi Jewish origin. Milder mutations in OPA3 should be sought in patients with optic atrophy with later onset, even in the absence of additional neurological abnormalities.	Hebrew Univ Jerusalem, Fac Med, Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel; NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	Hebrew University of Jerusalem; Shaare Zedek Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Elpeleg, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel.							ASHMARINA LI, 1994, J BIOL CHEM, V269, P31929; BESLEY GTN, 1995, J INHERIT METAB DIS, V18, P221, DOI 10.1007/BF00711772; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; COSTEFF H, 1989, NEUROLOGY, V39, P595, DOI 10.1212/WNL.39.4.595; Costeff H, 1998, BRAIN DEV-JPN, V20, P33, DOI 10.1016/S0387-7604(97)00096-X; COSTEFF H, 1993, ANN NEUROL, V33, P103, DOI 10.1002/ana.410330117; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; EDMOND J, 1974, J BIOL CHEM, V249, P66; ELPELEG ON, 1994, DEV MED CHILD NEUROL, V36, P167; GIBSON KM, 1993, PEDIATR NEUROL, V9, P120, DOI 10.1016/0887-8994(93)90046-F; GIBSON KM, 1992, J PEDIATR-US, V121, P940, DOI 10.1016/S0022-3476(05)80348-8; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; HOLME E, 1992, PEDIATR RES, V32, P731, DOI 10.1203/00006450-199212000-00022; IBEL H, 1993, EUR J PEDIATR, V152, P665, DOI 10.1007/BF01955244; KELLEY RI, 1995, PEDIATR RES, V37, P671, DOI 10.1203/00006450-199505000-00020; Nystuen A, 1997, HUM MOL GENET, V6, P563, DOI 10.1093/hmg/6.4.563; RIORDANEVA P, 1995, J MED GENET, V32, P81, DOI 10.1136/jmg.32.2.81; Scaglia F, 2001, J CHILD NEUROL, V16, P136, DOI 10.2310/7010.2001.7015; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHPILBERG O, 1995, BLOOD, V85, P429, DOI 10.1182/blood.V85.2.429.bloodjournal852429; Stoffman N, 2000, EUR J HUM GENET, V8, P307, DOI 10.1038/sj.ejhg.5200446; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; WANDERS RJA, 1992, ANN M SOC STUD INB E; Zlotogora J, 2000, MOL GENET METAB, V69, P169, DOI 10.1006/mgme.2000.2969	24	133	138	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1218	1224		10.1086/324651	http://dx.doi.org/10.1086/324651			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11668429	Green Published, Bronze			2022-12-18	WOS:000172086900006
J	Watkins, WS; Ricker, CE; Bamshad, MJ; Carroll, ML; Nguyen, SV; Batzer, MA; Harpending, HC; Rogers, AR; Jorde, LB				Watkins, WS; Ricker, CE; Bamshad, MJ; Carroll, ML; Nguyen, SV; Batzer, MA; Harpending, HC; Rogers, AR; Jorde, LB			Patterns of ancestral human diversity: An analysis of Alu-insertion and restriction-site polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; HUMAN-EVOLUTION; HUMAN-POPULATIONS; LINKAGE-DISEQUILIBRIUM; SEQUENCE VARIATION; GENETIC-EVIDENCE; HIGH-RESOLUTION; AFRICAN ORIGIN; LOCUS; CHROMOSOME	We have analyzed 35 widely distributed, polymorphic Alu loci in 715 individuals from 31 world populations. The average frequency of Alu insertions (the derived state) is lowest in Africa (.42) but is higher and similar in India (.55), Europe (.56), and Asia (.57). A comparison with 30 restriction-site polymorphisms (RSPs) for which the ancestral state has been determined shows that the frequency of derived RSP alleles is also lower in Africa (. 35) than it is in Asia (.45) and in Europe (.46). Neighbor-joining networks based on Alu insertions or RSPs are rooted in Africa and show African populations as separate from other populations, with high statistical support. Correlations between genetic distances based on Alu and nuclear RSPs, short tandem-repeat polymorphisms, and mtDNA, in the same individuals, are high and significant. For the 35 loci, Alu gene diversity and the diversity attributable to population subdivision is highest in Africa but is lower and similar in Europe and Asia. The distribution of ancestral alleles is consistent with an origin of early modern human populations in sub-Saharan Africa, the isolation and preservation of ancestral alleles within Africa, and an expansion out of Africa into Eurasia. This expansion is characterized by increasing frequencies of Alu inserts and by derived RSP alleles with reduced genetic diversity in non-African populations.	Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Hlth Sci Ctr, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, Stanley S Scott Canc Ctr,Dept Pathol, New Orleans, LA USA; Louisiana State Univ, Biol Computat & Visualizat Ctr, Dept Biol Sci, Baton Rouge, LA 70803 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University	Jorde, LB (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA.				NCRR NIH HHS [RR-00064, M01 RR000064] Funding Source: Medline; NIGMS NIH HHS [GM-59290, R01 GM059290] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCOT SS, 1995, GENE, V163, P273, DOI 10.1016/0378-1119(95)00317-Y; ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Arcot SS, 1998, J MOL BIOL, V281, P843, DOI 10.1006/jmbi.1998.1984; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BATZER MA, 1995, J MOL BIOL, V247, P418, DOI 10.1006/jmbi.1994.0150; Batzer MA, 1996, J MOL EVOL, V42, P22, DOI 10.1007/BF00163207; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Crawford DC, 2000, AM J HUM GENET, V66, P480, DOI 10.1086/302762; DEININGER PL, 1993, EVOL BIOL, V27, P157; DEKA R, 1995, AM J HUM GENET, V56, P461; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hawks J, 2000, J HUM EVOL, V39, P1, DOI 10.1006/jhev.1999.0384; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Lewis P.O., 2000, GENETIC DATA ANAL CO; Melton T, 1998, AM J HUM GENET, V63, P1807, DOI 10.1086/302131; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Nei M, 1996, MOL BIOL EVOL, V13, P170, DOI 10.1093/oxfordjournals.molbev.a025553; Nei M., 1987, MOL EVOLUTIONARY GEN; Novick GE, 1998, HUM BIOL, V70, P23; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Pang H, 1999, ANN HUM GENET, V63, P277, DOI 10.1046/j.1469-1809.1999.6340277.x; PENNY D, 1995, MOL BIOL EVOL, V12, P863; Purandare SM, 1996, AM J HUM GENET, V59, P159; Rana BK, 1999, GENETICS, V151, P1547; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Rogers AR, 1996, AM J HUM GENET, V58, P1033; Roy AM, 1999, GENETICA, V107, P149, DOI 10.1023/A:1003941704138; Roy AM, 2000, GENOME RES, V10, P1485, DOI 10.1101/gr.152300; Seielstad M, 1999, GENOME RES, V9, P558; Sherry ST, 1997, GENETICS, V147, P1977; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Stoneking M, 1996, CURR OPIN GENET DEV, V6, P731, DOI 10.1016/S0959-437X(96)80028-1; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Watkins WS, 1999, AM J PHYS ANTHROPOL, V109, P147, DOI 10.1002/(SICI)1096-8644(199906)109:2<147::AID-AJPA1>3.0.CO;2-C; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	60	133	141	0	16	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					738	752		10.1086/318793	http://dx.doi.org/10.1086/318793			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179020	Green Published, Bronze			2022-12-18	WOS:000166994200017
J	De Praeter, CM; Gerwig, GJ; Bause, E; Nuytinck, LK; Vliegenthart, JFG; Breuer, W; Kamerling, JP; Espeel, MF; Martin, JJR; De Paepe, AM; Chan, NWC; Dacremont, GA; Van Coster, RN				De Praeter, CM; Gerwig, GJ; Bause, E; Nuytinck, LK; Vliegenthart, JFG; Breuer, W; Kamerling, JP; Espeel, MF; Martin, JJR; De Paepe, AM; Chan, NWC; Dacremont, GA; Van Coster, RN			A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-D-MANNOSIDASE; GLYCOPROTEIN-SYNDROME; PIG-LIVER; PROTEIN GLYCOSYLATION; PURIFICATION; DISEASES; CHROMATOGRAPHY; INHIBITION; CHAINS	Glucosidase I is an important enzyme in N-linked glycoprotein processing, removing specifically distal alpha-1,2-linked glucose from the Glc(3)Man(9)GlcNAc(2) precursor after its en bloc transfer from dolichyl diphosphate to a nascent polypeptide chain in the endoplasmic reticulum. We have identified a glucosidase I defect in a neonate with severe generalized hypotonia and dysmorphic features. The clinical course was progressive and was characterized by the occurrence of hepatomegaly, hypoventilation, feeding problems, seizures, and fatal outcome at age 74 d, The accumulation of the tetrasaccharide Glc(alpha 1-2)Glc(alpha 1-3)Glc(alpha 1-3)Man in the patient's urine indicated a glycosylation disorder, Enzymological studies on liver tissue and cultured skin fibroblasts revealed a severe glucosidase I deficiency. The residual activity was <3% of that of controls, Glucosidase I activities in cultured skin fibroblasts from both parents were found to be 50% of those of controls. Tissues from the patient subjected to SDS-PAGE followed by immunoblotting revealed strongly decreased amounts of glucosidase I protein in the homogenate of the liver, and a less-severe decrease in cultured skin fibroblasts. Molecular studies showed that the patient was a compound heterozygote for two missense mutations in the glucosidase I gene: (1) one allele harbored a G-->C transition at nucleotide (nt) 1587, resulting in the substitution of Arg at. position 486 by Thr (R486T), and (2) on the other allele a T-->C transition at nt 2085 resulted in the substitution of Phe at position 652 by Leu (F652L), The mother was heterozygous for the G-->C transition, whereas the father was heterozygous for the T-->C transition, These base changes were not seen in 100 control DNA samples, A causal relationship between the alpha-glucosidase I deficiency and the disease is postulated.	State Univ Ghent Hosp, Dept Pediat, Div Pediat Neurol, B-9000 Ghent, Belgium; State Univ Ghent Hosp, Dept Pediat, Div Neonatal Intens Care, B-9000 Ghent, Belgium; State Univ Ghent Hosp, Dept Pediat, Div Pediat Neurol, B-9000 Ghent, Belgium; State Univ Ghent Hosp, Dept Pediat, Dept Metab Dis, B-9000 Ghent, Belgium; State Univ Ghent Hosp, Ctr Genet Med, B-9000 Ghent, Belgium; State Univ Ghent, Dept Histol & Embryol, B-9000 Ghent, Belgium; Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Bioorg Chem, Utrecht, Netherlands; Univ Bonn, Inst Physiol Chem, D-5300 Bonn, Germany; Univ Antwerp, Born Bunge Fdn, B-2020 Antwerp, Belgium; Univ Alberta, Dept Chem, Edmonton, AB, Canada	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Utrecht University; University of Bonn; University of Antwerp; University of Alberta	Van Coster, RN (corresponding author), State Univ Ghent Hosp, Dept Pediat, Div Pediat Neurol, De Pintelaan 185, B-9000 Ghent, Belgium.			Nuytinck, Lieve/0000-0002-5165-6937				BAUSE E, 1989, EUR J BIOCHEM, V183, P661, DOI 10.1111/j.1432-1033.1989.tb21096.x; BAUSE E, 1992, EUR J BIOCHEM, V208, P451, DOI 10.1111/j.1432-1033.1992.tb17207.x; BAUSE E, 1986, FEBS LETT, V206, P208, DOI 10.1016/0014-5793(86)80982-6; Bause E, 1996, BIOL CHEM, V377, P639, DOI 10.1515/bchm3.1996.377.10.639; BRAMHALL S, 1969, ANAL BIOCHEM, V31, P146, DOI 10.1016/0003-2697(69)90251-6; Ceuterick-De Groote C, 1998, BRAIN PATHOL, V8, P121; de Koning TJ, 1998, BIOCHEM BIOPH RES CO, V245, P38, DOI 10.1006/bbrc.1998.8385; DeCauwer H, 1997, CLIN NEUROPATHOL, V16, P237; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; EYSKENS F, 1994, ACTA PAEDIATR, V83, P892, DOI 10.1111/j.1651-2227.1994.tb13166.x; FUJIMOTO K, 1991, J BIOL CHEM, V266, P3571; FUKUDA M N, 1990, Glycobiology, V1, P9, DOI 10.1093/glycob/1.1.9; GERWIG GJ, 1993, J BIOL CHEM, V268, P26956; HARD K, 1993, GLYCOBIOLOGY PRACTIC, P223; Hentges A, 1997, BIOL CHEM, V378, P1031, DOI 10.1515/bchm.1997.378.9.1031; HETTKAMP H, 1984, EUR J BIOCHEM, V142, P85, DOI 10.1111/j.1432-1033.1984.tb08253.x; HETTKAMP H, 1982, BIOSCIENCE REP, V2, P899, DOI 10.1007/BF01114896; HUMBEL R, 1975, CLIN CHIM ACTA, V60, P143, DOI 10.1016/0009-8981(75)90119-9; JAEKEN J, 1994, ARCH DIS CHILD, V71, P123, DOI 10.1136/adc.71.2.123; KALZFULLER B, 1995, EUR J BIOCHEM, V231, P344, DOI 10.1111/j.1432-1033.1995.tb20706.x; KalzFuller B, 1996, GENOMICS, V34, P442, DOI 10.1006/geno.1996.0313; Kamerling JP, 1989, CLIN BIOCH PRINCIPLE, V1, P176; Keir G, 1999, ANN CLIN BIOCHEM, V36, P20, DOI 10.1177/000456329903600103; Korner C, 1998, P NATL ACAD SCI USA, V95, P13200, DOI 10.1073/pnas.95.22.13200; Kornfeld S, 1998, J CLIN INVEST, V101, P1293, DOI 10.1172/JCI3140; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUBAS WA, 1988, J BIOL CHEM, V263, P3990; Martin JJ, 1995, J INHERIT METAB DIS, V18, P19, DOI 10.1007/BF00711426; MONTREUIL J, 1996, GLYCOPROTEINS 2 NE B, V29; MONTREUIL J, 1996, GLYCOPROTEINS DIS NE, V30; Montreuil J, 1995, GLYCOPROTEINS NEW A, V29A; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; OGAWA T, 1984, PURE APPL CHEM, V56, P779, DOI 10.1351/pac198456070779; PHILIPS MJ, 1993, DIS LIVER, P189; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; Roels F, 1995, J INHERIT METAB DIS, V18, P155, DOI 10.1007/BF00711437; RONIN C, 1987, GLYCOCONJUGATE J, V4, P247, DOI 10.1007/BF01048430; Rosse WF, 1997, MEDICINE, V76, P63, DOI 10.1097/00005792-199703000-00001; Scaman CH, 1996, CARBOHYD RES, V296, P203, DOI 10.1016/S0008-6215(96)00242-X; SCHAILUBHAI K, 1987, BIOCHEM J, V247, pS55; SCHWEDEN J, 1986, ARCH BIOCHEM BIOPHYS, V248, P335, DOI 10.1016/0003-9861(86)90429-7; SCHWEDEN J, 1986, EUR J BIOCHEM, V157, P563, DOI 10.1111/j.1432-1033.1986.tb09703.x; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1	45	133	138	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1744	1756		10.1086/302948	http://dx.doi.org/10.1086/302948			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10788335	Green Published, Bronze			2022-12-18	WOS:000088373800003
J	Goring, HHH; Terwilliger, JD				Goring, HHH; Terwilliger, JD			Linkage analysis in the presence of errors IV: Joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE RELATIVE RISK; DEPENDENT DIABETES-MELLITUS; GENOME-WIDE SEARCH; COMPLEX TRAITS; SUSCEPTIBILITY LOCI; NUCLEAR FAMILIES; DISEASE; TESTS; ASSOCIATIONS; INFORMATION	There is a lot of confusion in the literature about the "differences" between "model-based" and "model-free" methods and about which approach is better suited for detection of the genes predisposing to complex multifactorial phenotypes. By starting from first principles, we demonstrate that the differences between the two approaches have more to do with study design than statistical analysis. When simple data structures are repeatedly ascertained, no assumptions about the genotype-phenotype relationship need to be made for the analysis to be powerful, since simple data structures admit only a small number of df. When more complicated and/or heterogeneous data structures are ascertained, however, the number of df in the underlying probability model is too large to have a powerful, truly "model-free" test. So-called "model-free" methods typically simplify the underlying probability model by implicitly assuming that, in some sense, all meioses connecting two affected individuals are informative for linkage with identical probability and that the affected individuals in a pedigree share as many disease-predisposing alleles as possible. By contrast, "model-based" methods add structure to the underlying parameter space by making assumptions about the genotype-phenotype relationship, making it possible to probabilistically assign disease-locus genotypes to all individuals in the data set on the basis of the observed phenotypes. In this study, we demonstrate the equivalence of these two approaches in a variety of situations and exploit this equivalence to develop more powerful and efficient likelihood-based analogues of "model-free" tests of linkage and/or linkage disequilibrium. Through the use of a "pseudomarker" locus to structure the space of observations, sib-pairs, triads, and singletons can be analyzed jointly, which will lead to tests that are more well-behaved, efficient, and powerful than traditional "model-free" tests such as the affected sib-pair, transmission/disequilibrium, haplotype relative risk, and case-control tests. Also described is an extension of this approach to large pedigrees, which, in practice, is equivalent to affected relative-pair analysis. The proposed methods are equally applicable to two-point and multipoint analysis (using complex-valued recombination fractions).	Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Genet, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; New York State Psychiat Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Terwilliger, JD (corresponding author), Columbia Univ, Dept Psychiat, 1150 St Nicholas Ave,Room 548,Unit 109, New York, NY 10032 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG000008, R01HG000008] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG000008, HG00008] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AGARWALA R, IN PRESS DISCRETE AP; Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CHASE GA, 1977, TRANSPLANT P, V1, P167; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVIS S, 1997, AM J HUM GENET S, V59, pA216; DEMOIVRE A, 1956, DOCTRINE CHANCES; DUPUIS J, 1995, GENETICS, V140, P843; EDWARDS JH, 1976, HGM, V3, P289; Excoffier L, 1998, AM J HUM GENET, V62, P171, DOI 10.1086/301674; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Farrall M, 1997, AM J HUM GENET, V60, P735; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Greenberg DA, 1996, AM J HUM GENET, V58, P892; Hartl DL, 1997, PRINCIPLES POPULATIO; Hartsfield N., 1994, PEARLSINGRAPH THEOR; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1999, NAT GENET, V21, P360, DOI 10.1038/7687; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; HYER RN, 1991, AM J HUM GENET, V48, P243; Joy C. Turner, 1955, COMMUNISTS NEGOTIATE; Kainulainen K, 1999, HYPERTENSION, V33, P844, DOI 10.1161/01.HYP.33.3.844; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kruglyak L, 1997, AM J HUM GENET, V61, P254; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1996, EMORY RIMOINS PRINCI; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; NORDHEIM EV, 1984, BIOMETRICS, V40, P785, DOI 10.2307/2530922; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; PENROSE LS, 1935, ANN EUGEN, V6, P133; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; *SAGE, 1994, STAT AN GEN EP; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1979, CLIN GENET, V15, P126; TAI J J, 1989, Proceedings of the National Science Council Republic of China Part B Life Sciences, V13, P38; Teng J, 1997, AM J HUM GENET, V60, P979; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TERWILLIGER JD, 1998, ENCY BIOSTATISTICS; TERWILLIGER JD, IN PRESS HUM BIOL; TIENARI PJ, 1994, GENOMICS, V19, P320, DOI 10.1006/geno.1994.1064; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Whittemore AS, 1996, AM J HUM GENET, V59, P704; Wilks SS, 1935, ANN MATH STAT, V6, P190, DOI 10.1214/aoms/1177732564; Zhao LP, 1998, AM J HUM GENET, V63, P225, DOI 10.1086/301909	57	133	138	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1310	1327		10.1086/302845	http://dx.doi.org/10.1086/302845			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10731466	Green Published, Bronze			2022-12-18	WOS:000088373400014
J	Knapp, M				Knapp, M			A note on power approximations for the transmission/disequilibrium test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM; GENE	The transmission/disequilibrium test (TDT) is a popular method for detection of the genetic basis of a disease. Investigators planning such studies require computation of sample size and power, allowing for a general genetic model. Here, a rigorous method is presented for obtaining the power approximations of the TDT for samples consisting of families with either a single affected child or affected sib pairs. Power calculations based on simulation show that these approximations are quite precise. By this method, it is also shown that a previously published power approximation of the TDT is erroneous.	Univ Bonn, Inst Med Stat, D-53105 Bonn, Germany	University of Bonn	Knapp, M (corresponding author), Univ Bonn, Inst Med Stat, Sigmund Freud Str 25, D-53105 Bonn, Germany.							Baur MP, 1997, GENETIC MAPPING OF DISEASE GENES, P159; Bellivier F, 1998, ARCH GEN PSYCHIAT, V55, P33, DOI 10.1001/archpsyc.55.1.33; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Camp NJ, 1997, AM J HUM GENET, V61, P1424, DOI 10.1086/301648; Johnson N. L., 1972, DISTRIBUTIONS STAT C; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; RAO CR, 1972, LINEAR STAT INFERENC; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaid DJ, 1998, AM J HUM GENET, V63, P935, DOI 10.1086/302077; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506	10	133	134	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1177	1185		10.1086/302334	http://dx.doi.org/10.1086/302334			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090903	Green Published, Bronze			2022-12-18	WOS:000079632900029
J	Bendall, KE; Macaulay, VA; Baker, JR; Sykes, BC				Bendall, KE; Macaulay, VA; Baker, JR; Sykes, BC			Heteroplasmic point mutations in the human mtDNA control region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; HEREDITARY OPTIC NEUROPATHY; REPEAT POLYMORPHISM; D-LOOP; SEQUENCE; SEGREGATION; GENE; EVOLUTION; LINEAGE; FAMILY	As part of an investigation of the fixation mechanisms of mtDNA mutations in humans, we sequenced the first hypervariable segment of the control region in 180 twin pairs and found evidence of site heteroplasmy in 4 pairs. Significant levels of two mitochondrial haplotypes differing by a single point mutation were found in two MZ pairs, and within each pair, both members had similar levels of heteroplasmy. Two DZ pairs were found in which the predominant mitochondrial haplotype differed within the pair. We measured proportions of mitochondrial haplotypes within two twin pairs and their maternal relatives, using primer extension. In both maternal lineages, most family members were heteroplasmic, and the proportions of each genotype varied widely in different individuals. We used the changes in haplotype proportions within mother-offspring pairs to calculate The size range of potential bottlenecks in mitochondrial numbers occurring during development of the offspring. In most individuals, the most likely effective bottleneck sizes ranged from 3 to 20 segregating units, though in two individuals a small bottleneck was very unlikely and there was no upper limit on its possible size. We also used the data from this study, together with unpublished data from other populations, to estimate the frequency of site heteroplasmy in normal human populations. From this, we calculated that the rate of mutation and fixation in the first hypervariable segment of the human mtDNA control region is between 1.2 x 10(-6) and 2.7 x 10(-5) per site per generation. This range is in good agreement with published estimates calculated by other methods.	ST THOMAS HOSP, TWIN RES UNIT, LONDON, ENGLAND	Guy's & St Thomas' NHS Foundation Trust	Bendall, KE (corresponding author), JOHN RADCLIFFE HOSP, INST MOL MED, DEPT CELLULAR SCI, OXFORD OX3 9DU, ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BENDALL KE, 1995, AM J HUM GENET, V57, P248; BERG ES, 1993, GENOMICS, V16, P350, DOI 10.1006/geno.1993.1196; Bernoulli Jacob, 1713, WERKE J BERNOULLI, V3, P107; CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; DECORTE R, 1990, DNA CELL BIOL, V9, P461, DOI 10.1089/dna.1990.9.461; Forster P, 1996, AM J HUM GENET, V59, P935; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASEGAWA M, 1991, J MOL EVOL, V32, P37, DOI 10.1007/BF02099927; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HAYASHI JI, 1985, EXP CELL RES, V160, P387, DOI 10.1016/0014-4827(85)90185-5; HOWELL N, 1992, HUM GENET, V90, P117; HOWELL N, 1994, AM J HUM GENET, V55, P203; HOWELL N, 1992, AM J HUM GENET, V50, P443; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; Jeffreys H., 1961, THEORY PROBABILITY, V3; KOEHLER CM, 1991, GENETICS, V129, P247; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; MAKELA TP, 1992, HUM MOL GENET, V1, P217, DOI 10.1093/hmg/1.3.217-a; Marchington DR, 1996, HUM MOL GENET, V5, P473, DOI 10.1093/hmg/5.4.473; MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; PIKO L, 1976, DEV BIOL, V49, P1, DOI 10.1016/0012-1606(76)90253-0; RILEY R, 1993, HUM MOL GENET, V2, P1512; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; STOHR H, 1994, HUM MOL GENET, V3, P2086; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VILKKI J, 1990, AM J HUM GENET, V47, P95; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WARMAN ML, 1993, GENOMICS, V17, P694, DOI 10.1006/geno.1993.1391; ZHU DP, 1992, AM J MED GENET, V42, P173, DOI 10.1002/ajmg.1320420208	44	133	140	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1276	1287						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940273				2022-12-18	WOS:A1996VV31500014
J	Telatar, M; Wang, ZJ; Udar, N; Liang, T; BernatowskaMatuszkiewicz, E; Lavin, M; Shiloh, Y; Concannon, P; Good, RA; Gatti, RA				Telatar, M; Wang, ZJ; Udar, N; Liang, T; BernatowskaMatuszkiewicz, E; Lavin, M; Shiloh, Y; Concannon, P; Good, RA; Gatti, RA			Ataxia-telangiectasia: Mutations in ATM cDNA detected by protein-truncation screening	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAPID DETECTION; GENE; FAMILIES; CANCER	We have examined the distal half of the ataxia-telangiectasia (A-T) gene transcript for truncation mutations in 48 A-T affecteds, We found 21 mutations; 4 of the mutations were seen in more than one individual. Genotyping of the individuals sharing mutations, by using nearby microsatellite markers, established that three of the four groups shared common haplotypes, indicating that these were probably founder effects, not public mutations. The one public mutation was found in two American families, one of Ashkenazi Jewish background and the other not, Most truncations deleted the PI3-kinase domain, although some exceptions to this were found in patients with typical A-T phenotypes. All patients not previously known to be consanguineous were found to be compound heterozygotes when mutations could be identified-that is, normal and abnormal protein segments were seen on SDS-PAGE gels. All 48 patients gave RT-PCR products, indicating the presence of relatively stable mRNAs despite their mutations. These results suggest that few public mutations or hot spots can be expected in the A-T gene and that epidemiological studies of A-T carrier status and associated health risks will have to be designed around populations with frequent founder-effect mutations, despite the obvious limitations of this approach.	UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90095; CHILDRENS MEM HOSP,WARSAW,POLAND; QUEENSLAND INST MED RES,BRISBANE,QLD 4006,AUSTRALIA; TEL AVIV UNIV,IL-69978 TEL AVIV,ISRAEL; VIRGINIA MASON RES CTR,SEATTLE,WA 98101; UNIV WASHINGTON,SCH MED,DEPT IMMUNOL,SEATTLE,WA 98195; UNIV S FLORIDA,ALL CHILDRENS HOSP,ST PETERSBURG,FL 33701	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Memorial Health Institute; QIMR Berghofer Medical Research Institute; Tel Aviv University; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; State University System of Florida; University of South Florida			Lavin, Martin F/F-5961-2014	Lavin, Martin F/0000-0002-5940-4769; Udar, Nitin/0000-0001-8533-9190; Concannon, Patrick/0000-0002-5801-1859; Bernatowska, Ewa/0000-0002-0125-266X	NCI NIH HHS [CA57569] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057569] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GATTI RA, 1994, INT J RADIAT BIOL, V66, pS57, DOI 10.1080/09553009414551861; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; LANGE E, 1995, AM J HUM GENET, V57, P112; LAVIN MF, 1995, TRENDS BIOCHEM SCI, V20, P382, DOI 10.1016/S0968-0004(00)89083-0; LEHMANN AR, 1995, TRENDS GENET, V11, P375, DOI 10.1016/S0168-9525(00)89112-X; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; SVEDMYR EAJ, 1975, TISSUE ANTIGENS, V5, P186; SWIFT M, 1976, CANCER RES, V36, P209; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; UHRHAMMER N, 1995, AM J HUM GENET, V57, P103; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8	20	133	141	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					40	44						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659541				2022-12-18	WOS:A1996VL45500007
J	TOKINO, T; TAKAHASHI, E; MORI, M; TANIGAMI, A; GLASER, T; PARK, JW; JONES, C; HORI, TA; NAKAMURA, Y				TOKINO, T; TAKAHASHI, E; MORI, M; TANIGAMI, A; GLASER, T; PARK, JW; JONES, C; HORI, TA; NAKAMURA, Y			ISOLATION AND MAPPING OF 62 NEW RFLP MARKERS ON HUMAN CHROMOSOME-11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOCRINE NEOPLASIA TYPE-1; GENETIC-LINKAGE MAP; VNTR MARKERS; LOCALIZATION; CARCINOMAS; CANCER; TUMOR	To obtain new RFLP markers on human chromosome 11 for a high-resolution map, we constructed a cosmid library from a Chinese hamster X human somatic hybrid cell line that retains only human chromosome 11 in a Chinese hamster genomic background. A total of 3,500 cosmids were isolated by colony hybridization with labeled human genomic DNA. DNA was prepared from 130 of these cosmid clones and examined for RFLP. In 62 of them, polymorphism was detected with one or more enzymes; four RFLPs were VNTR systems. All polymorphic clones were assigned to one of 22 intervals obtained by mapping on a deletion panel of 15 somatic hybrid cell lines containing parts of chromosome 11; 11 clones were finely mapped by in situ hybridization. Although RFLP markers were scattered on the whole chromosome, they were found predominantly in the regions of R-banding. These DNA markers will contribute to fine mapping of genes causing inherited disorders and tumor-suppressor genes that reside on chromosome 11. Furthermore, as one-third of the cosmid clones revealed a band or bands in Chinese hamster DNA, indicating sequence conservation, this subset of clones may be useful for isolating biologically important genes on chromosome 11.	JAPANESE FDN CANC RES,INST CANC,DIV BIOCHEM,1-37-1 KAMI IKEBUKURO,TOKYO 170,JAPAN; MIT,CTR CANC RES,CAMBRIDGE,MA 02139; NATL INST RADIOL SCI,DIV GENET,CHIBA 260,JAPAN; HARVARD UNIV,SCH MED,BOSTON,MA 02115; ELEANOR ROOSEVELT INST,DENVER,CO	Japanese Foundation for Cancer Research; Massachusetts Institute of Technology (MIT); National Institutes for Quantum Science & Technology; Harvard University; Harvard Medical School			Tokino, Takashi/AAI-9887-2021					ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; COOKSON WOCM, 1989, LANCET, V1, P1292; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GLASER T, 1989, THESIS MIT CAMBRIDGE; GRIFFIN CA, 1986, P NATL ACAD SCI USA, V83, P6122, DOI 10.1073/pnas.83.16.6122; HORI T, IN PRESS HUM GENET; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; JUNIEN C, 1989, CYTOGENET CELL GENET, V51, P226, DOI 10.1159/000132793; KAO FT, 1976, P NATL ACAD SCI USA, V73, P193, DOI 10.1073/pnas.73.1.193; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LAWRENCE JB, 1988, CELL, V52, P51; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P648; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MACKAY J, 1988, BRIT J CANCER, V58, P710, DOI 10.1038/bjc.1988.295; NAKAMURA Y, 1988, AM J HUM GENET, V43, P854; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, 1989, AM J HUM GENET, V44, P751; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; TAKAHASHI E, 1989, JPN J HUM GENET, V34, P307, DOI 10.1007/BF01929213; TAKAHASHI E, IN PRESS HUM GENET; THEILLET C, 1986, CANCER RES, V46, P4776; TSAI YC, 1990, CANCER RES, V50, P44; WAHL GM, 1987, P NATL ACAD SCI USA, V84, P2160, DOI 10.1073/pnas.84.8.2160; WANG HP, 1988, CYTOGENET CELL GENET, V48, P72, DOI 10.1159/000132593; YUNIS JJ, 1989, GENOMICS, V6, P48	31	133	134	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					258	268						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1671318				2022-12-18	WOS:A1991EV74400010
J	KURNIT, DM; LAYTON, WM; MATTHYSSE, S				KURNIT, DM; LAYTON, WM; MATTHYSSE, S			GENETICS, CHANCE, AND MORPHOGENESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DARTMOUTH COLL, HITCHCOCK MED CTR, DARTMOUTH MED SCH, DEPT ANAT, HANOVER, NH 03756 USA; HARVARD UNIV, MCLEAN HOSP, SCH MED, BELMONT, MA 02178 USA	Dartmouth College; Harvard University; McLean Hospital	KURNIT, DM (corresponding author), UNIV MICHIGAN, MED CTR,HOWARD HUGHES MED INST,1150 W MED CTR DR, MSRBI, ROOM 3520, ANN ARBOR, MI 48109 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020118] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037703] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37703] Funding Source: Medline; NICHD NIH HHS [R01 HD20118] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AFZELIUS B A, 1976, Science (Washington D C), V193, P317; ARNOLD GL, 1983, AM J MED GENET, V16, P35, DOI 10.1002/ajmg.1320160107; BODENSTEIN LA, IN PRESS CELL DIFFER; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURT RW, 1985, NEW ENGL J MED, V312, P1540, DOI 10.1056/NEJM198506133122403; CARTER C. O., 1965, PROGR MED GENET, V4, P59; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Cockayne EA, 1938, Q J MED, V7, P479; COLECLOUGH C, 1983, NATURE, V303, P23, DOI 10.1038/303023a0; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; EDELMAN GM, 1984, P NATL ACAD SCI-BIOL, V81, P1460, DOI 10.1073/pnas.81.5.1460; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FELDMAN W. M., 1935, PROC ROY SOC MED, V28, P753; FRASER SE, 1980, DEV BIOL, V79, P453, DOI 10.1016/0012-1606(80)90130-X; GUSELLA J, 1976, CELL, V9, P221, DOI 10.1016/0092-8674(76)90113-6; HAY DA, 1972, AM J ANAT, V133, P1, DOI 10.1002/aja.1001330102; HOLLIDAY R, 1977, SCIENCE, V198, P366, DOI 10.1126/science.910134; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; Hummel K. P., 1959, Journal of Heredity, V50, P9; IVEMARK BI, 1955, ACTA PAEDIATR S S104, V44, P590; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KAPLAN LC, 1985, AM J MED GENET, V21, P187, DOI 10.1002/ajmg.1320210128; Kartagener M., 1933, BEITR KLIN ERFORSCH, V83, P489, DOI DOI 10.1007/BF02141468; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; KURNIT DM, 1985, J CELL PHYSIOL, V123, P55, DOI 10.1002/jcp.1041230110; KURNIT DM, 1985, AM J MED GENET, V20, P385, DOI 10.1002/ajmg.1320200222; LAYTON WM, 1976, J HERED, V67, P336, DOI 10.1093/oxfordjournals.jhered.a108749; LAYTON WM, IN PRESS AM J CARDIO; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; MATTHYSSE S, 1986, J PSYCHIAT RES, V20, P57, DOI 10.1016/0022-3956(86)90023-3; MIYABARA S, 1984, CONGENIT ANOM, V24, P283; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; NEWMAN TB, 1985, PEDIATRICS, V76, P741; NIIKAWA N, 1983, AM J MED GENET, V16, P43, DOI 10.1002/ajmg.1320160108; NORA JJ, 1968, CIRCULATION, V38, P604, DOI 10.1161/01.CIR.38.3.604; OZATO K, 1985, P NATL ACAD SCI USA, V82, P2427, DOI 10.1073/pnas.82.8.2427; PENROSE L S, 1953, Acta Genet Stat Med, V4, P257; RABINOVITCH PS, 1983, P NATL ACAD SCI-BIOL, V80, P2951, DOI 10.1073/pnas.80.10.2951; REHDER H, 1981, TRISOMY 21, P57; RIKVOLD PA, 1982, PHYS REV A, V26, P647, DOI 10.1103/PhysRevA.26.647; ROSENQUIST GC, 1974, J PEDIATR-US, V85, P490, DOI 10.1016/S0022-3476(74)80450-6; Ruelle D., 1980, MATH INTELLIGENCER, V2, P126, DOI [10.1007/BF03023053, DOI 10.1007/BF03023053]; Smith, 1982, RECOGNIZABLE PATTERN; SMITH C, 1971, AM J HUM GENET, V23, P578; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; SMITH JR, 1980, SCIENCE, V207, P82; SOKOL R, 1981, STATISTICAL TABLES; SOLOMON E, 1984, NATURE, V309, P111, DOI 10.1038/309111a0; STAMATOYANNOPOULOS G, 1981, P NATL ACAD SCI-BIOL, V78, P7005, DOI 10.1073/pnas.78.11.7005; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; VANPRAAGH R, 1977, HEART DISEASE INFANT, P422; WRIGHT TC, 1984, P NATL ACAD SCI-BIOL, V81, P2426, DOI 10.1073/pnas.81.8.2426	58	133	133	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					979	995						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	3687945				2022-12-18	WOS:A1987L298400002
J	MUELLER, RF; HORNUNG, S; FURLONG, CE; ANDERSON, J; GIBLETT, ER; MOTULSKY, AG				MUELLER, RF; HORNUNG, S; FURLONG, CE; ANDERSON, J; GIBLETT, ER; MOTULSKY, AG			PLASMA PARAOXONASE POLYMORPHISM - A NEW ENZYME ASSAY, POPULATION, FAMILY, BIOCHEMICAL, AND LINKAGE STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; PUGET SOUND BLOOD CTR,SEATTLE,WA 98104	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Puget Sound Blood Center	MUELLER, RF (corresponding author), UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015253] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-15253] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE WN, 1953, BIOCHEM J, V53, P110, DOI 10.1042/bj0530110; CARROCIAMPI G, 1981, CAN J PHYSIOL PHARM, V59, P904, DOI 10.1139/y81-138; DOWD JE, 1965, J BIOL CHEM, V240, P863; ECKERSON HW, 1979, AM J HUM GENET, V31, pA46; EIBERG H, 1981, ANN HUM GENET, V45, P323, DOI 10.1111/j.1469-1809.1981.tb00345.x; ERDOES EG, 1961, NATURE, V190, P716, DOI 10.1038/190716a0; FENICHEL GM, 1972, NEUROLOGY, V22, P1026, DOI 10.1212/WNL.22.9.1026; FLUGEL M, 1978, KLIN WOCHENSCHR, V56, P911, DOI 10.1007/BF01489217; Fukuto T R, 1969, Ann N Y Acad Sci, V160, P97, DOI 10.1111/j.1749-6632.1969.tb15830.x; GELDMACH.M, 1969, ARCH TOXIKOL, V25, P223; GELDMACHERVONMALLINCKRODT M, 1979, HUM GENET, V50, P313, DOI 10.1007/BF00399398; KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41; MAIN AR, 1960, BIOCHEM J, V75, P188, DOI 10.1042/bj0750188; OTT J, 1974, AM J HUM GENET, V26, P588; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; SKRINJAR.M, 1968, BIOCHIM BIOPHYS ACTA, V165, P289, DOI 10.1016/0304-4165(68)90059-7; SPEAR RC, 1977, J OCCUP ENVIRON MED, V19, P411, DOI 10.1097/00043764-197706000-00009; Taylor W J, 1965, Can Med Assoc J, V93, P966; WECKER L, 1976, EXP NEUROL, V51, P281, DOI 10.1016/0014-4886(76)90253-3; WECKER L, 1978, J PHARMACOL EXP THER, V206, P97; ZECH R, 1974, COMP BIOCHEM PHYSIOL, V48, P427, DOI 10.1016/0305-0491(74)90277-6	21	133	134	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					393	408						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QS160	6305189				2022-12-18	WOS:A1983QS16000005
J	MIKLOS, GLG; JOHN, B				MIKLOS, GLG; JOHN, B			HETEROCHROMATIN AND SATELLITE DNA IN MAN - PROPERTIES AND PROSPECTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											MIKLOS, GLG (corresponding author), AUSTRALIAN NATL UNIV,RES SCH BIOL SCI,DEPT POPULAT BIOL,CANBERRA 2600,ACT,AUSTRALIA.							ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; ARRIGHI FE, 1974, CYTOGENET CELL GENET, V13, P268, DOI 10.1159/000130278; Beadle GW, 1932, P NATL ACAD SCI USA, V18, P160, DOI 10.1073/pnas.18.2.160; BOSTOCK CJ, 1978, NATURE, V272, P324, DOI 10.1038/272324a0; BRUTLAG D, 1977, J MOL BIOL, V112, P31, DOI 10.1016/S0022-2836(77)80154-X; Comings D E, 1972, Adv Hum Genet, V3, P237; COOKE H, 1976, NATURE, V262, P182, DOI 10.1038/262182a0; COOKE HJ, 1978, CELL, V13, P453, DOI 10.1016/0092-8674(78)90319-7; CORNEO G, 1970, J MOL BIOL, V48, P319, DOI 10.1016/0022-2836(70)90163-4; CORNEO G, 1976, Evolutionary Theory, V1, P261; CORNEO G, 1968, J MOL BIOL, V33, P331, DOI 10.1016/0022-2836(68)90301-X; CORNEO G, 1971, BIOCHIM BIOPHYS ACTA, V247, P528, DOI 10.1016/0005-2787(71)90689-7; CORNEO G, 1972, BIOCHIM BIOPHYS ACTA, V269, P201, DOI 10.1016/0005-2787(72)90427-3; CRAIGHOLMES AP, 1975, AM J HUM GENET, V27, P178; CRAIGHOLMES AP, 1973, AM J HUM GENET, V25, P181; DEV VG, 1975, CHROMOSOMA, V53, P335, DOI 10.1007/BF00294081; ENDOW SA, 1975, J MOL BIOL, V96, P665, DOI 10.1016/0022-2836(75)90145-X; Evans H J, 1977, Adv Hum Genet, V8, P347; EVANS HJ, 1974, NATURE, V251, P346, DOI 10.1038/251346a0; FRY K, 1977, CELL, V12, P1069, DOI 10.1016/0092-8674(77)90170-2; GERAEDTS JP, 1974, CLIN GENET, V6, P247; GERAEDTS JPM, 1975, EXP CELL RES, V95, P9, DOI 10.1016/0014-4827(75)90602-3; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GOSDEN JR, 1975, EXP CELL RES, V92, P148, DOI 10.1016/0014-4827(75)90648-5; GROPP A, 1972, CYTOGENETICS, V11, P259, DOI 10.1159/000130196; GROPP A, 1969, CHROMOSOMA, V27, P288, DOI 10.1007/BF00326166; HEARST JE, 1973, COLD SPRING HARB SYM, V38, P329, DOI 10.1101/SQB.1974.038.01.036; HILLIKER AJ, 1976, GENETICS, V83, P765; HOEHN H, 1977, HUM GENET, V35, P163, DOI 10.1007/BF00393965; HORZ W, 1977, EUR J BIOCHEM, V73, P383, DOI 10.1111/j.1432-1033.1977.tb11329.x; HOTTA Y, 1978, CHROMOSOMA, V69, P323, DOI 10.1007/BF00332135; HSU TC, 1972, P NATL ACAD SCI USA, V69, P1464, DOI 10.1073/pnas.69.6.1464; HSU TC, 1975, GENETICS, V79, P137; HULTEN M, 1974, HEREDITAS, V76, P55; JOHN B, 1973, CHROMOSOMA, V44, P123, DOI 10.1007/BF00329114; John B, 1979, Int Rev Cytol, V58, P1, DOI 10.1016/S0074-7696(08)61473-4; JOHN B, 1976, CHROMOSOMA, V54, P295, DOI 10.1007/BF00292812; JONES KW, 1973, CHROMOSOMA, V42, P445, DOI 10.1007/BF00399411; JONES KW, 1971, NATURE-NEW BIOL, V233, P268, DOI 10.1038/newbio233268a0; JONES KW, 1974, CHROMOSOMA, V49, P161, DOI 10.1007/BF00348888; JONES KW, 1977, MOL STRUCTURE HUMAN, P295; JONES KW, Z MORPHOL ANTHR; KLASTERSKA I, 1974, CHROMOSOMA, V44, P393, DOI 10.1007/BF00284899; LUBS HA, 1971, NATURE, V233, P134, DOI 10.1038/233134a0; LUBS HA, 1977, MOL HUMAN CYTOGENETI, P443; MAIO JJ, 1977, J MOL BIOL, V117, P637, DOI 10.1016/0022-2836(77)90062-6; MANTEUIL S, 1975, CELL, V5, P413, DOI 10.1016/0092-8674(75)90060-4; MANUELIDIS L, 1978, CHROMOSOMA, V66, P23, DOI 10.1007/BF00285813; MANUELIDIS L, 1978, CHROMOSOMA, V66, P1, DOI 10.1007/BF00285812; MARX KA, 1976, BIOCHIM BIOPHYS ACTA, V425, P129, DOI 10.1016/0005-2787(76)90019-8; MARX KA, 1976, CHROMOSOMA, V59, P23, DOI 10.1007/BF00327707; Mather K, 1939, GENETICS, V24, P413; MCKAY RDG, 1978, CYTOGENET CELL GENET, V21, P19, DOI 10.1159/000130875; MIKLOS GLG, 1976, CHROMOSOMA, V56, P143; MULLER H, 1975, CYTOGENET CELL GENET, V15, P239, DOI 10.1159/000130522; MULLER IH, 1976, CHROMOSOMES TODAY, V5, P249; NANKIVELL RN, 1976, CHROMOSOMA, V56, P127, DOI 10.1007/BF00293112; NATARAJAN AT, 1971, CHROMOSOMA, V35, P143, DOI 10.1007/BF00285734; NOVITSKI E, 1952, GENETICS, V37, P270; PARKER JS, 1976, CURRENT CHROMOSOME R, P133; PEACOCK WJ, 1977, INT CELL BIOL, P494; REES H, 1961, BOT REV, V27, P288, DOI 10.1007/BF02860084; RICE NR, 1973, P NATL ACAD SCI USA, V70, P3546, DOI 10.1073/pnas.70.12.3546; ROSENBERG H, 1978, SCIENCE, V200, P394, DOI 10.1126/science.205944; SALSER W, 1976, FED PROC, V35, P23; SANCHEZ O, 1976, BIOCHIM BIOPHYS ACTA, V435, P417, DOI 10.1016/0005-2787(76)90206-9; SAUNDERS GF, 1972, NATURE-NEW BIOL, V236, P244, DOI 10.1038/newbio236244a0; SAUNDERS GF, 1972, J MOL BIOL, V63, P323, DOI 10.1016/0022-2836(72)90430-5; SCHILDKRAUT CL, 1969, J MOL BIOL, V46, P305, DOI 10.1016/0022-2836(69)90423-9; SOUTHERN EM, 1975, J MOL BIOL, V94, P51, DOI 10.1016/0022-2836(75)90404-0; Sturtevant AH, 1936, GENETICS, V21, P554; SUZUKI DT, 1963, GENETICS, V48, P1605; THIERY JP, 1976, J MOL BIOL, V108, P219, DOI 10.1016/S0022-2836(76)80104-0; TSAI MY, 1977, BIOCHIM BIOPHYS ACTA, V475, P417, DOI 10.1016/0005-2787(77)90057-0; VISTORIN G, 1977, CYTOGENET CELL GENET, V18, P24, DOI 10.1159/000130745; WILLEY AM, 1975, EXP CELL RES, V91, P223, DOI 10.1016/0014-4827(75)90098-1; YAMAMOTO M, 1978, CHROMOSOMA, V66, P71, DOI 10.1007/BF00285817; YAMAMOTO M, CHROMOSOMA; [No title captured]	79	133	136	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	3					264	280						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HE538	111544				2022-12-18	WOS:A1979HE53800002
J	OPITZ, JM; STILES, FC; WISE, D; RACE, RR; SANGER, R; VONGEMMI.GR; KIERLAND, RR; CROSS, EG; DEGROOT, WP				OPITZ, JM; STILES, FC; WISE, D; RACE, RR; SANGER, R; VONGEMMI.GR; KIERLAND, RR; CROSS, EG; DEGROOT, WP			GENETICS OF ANGIOKERATOMA CORPORIS DIFFUSUM (FABRYS DISEASE) AND ITS LINKAGE RELATIONS WITH XG LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review																		ADAM A, 1963, ANN HUM GENET, V26, P187, DOI 10.1111/j.1469-1809.1963.tb01974.x; Anderson W., 1898, BRIT J DERMATOL, V10, P113, DOI [10.1111/j.1365-2133.1898.tb16317.x, DOI 10.1111/J.1365-2133.1898.TB16317.X]; BETHUNE JE, 1961, NEW ENGL J MED, V264, P1280, DOI 10.1056/NEJM196106222642503; BROWN A, 1952, Glasgow Med J, V33, P361; CALAS E, 1957, Bull Soc Fr Dermatol Syphiligr, V64, P682; CARTER TC, 1951, J GENET, V50, P307, DOI 10.1007/BF02996226; CLARK JI, 1963, AM J HUM GENET, V15, P292; CROSS EG, 1962, CAN MED ASSOC J, V87, P1; CURRY HB, 1961, JAMA-J AM MED ASSOC, V175, P864, DOI 10.1001/jama.1961.03040100028008; DAVIES SH, 1963, AM J HUM GENET, V15, P481; DEGROOT WP, 1964, DERMATOLOGICA, V128, P321, DOI 10.1159/000254765; DEGROOT WP, 1961, THESIS AMSTERDAM; DUPERRAT B, 1960, B SOC FRANC DERM SYP, V67, P874; Fabry J, 1916, ARCH DERMATOL SYPH-G, V123, P294, DOI 10.1007/BF01825509; Fabry J., 1898, ARCH DERMATOL SYPHIL, V43, P187; GUNTHER H, 1913, Z KLIN MED, V78, P53; Haldane JBS, 1919, J GENET, V8, P299; HEAD GD, 1917, ARCH INTERN MED, V20, P24; HENRY EW, 1963, CAN MED ASSOC J, V89, P206; HOFMANN A, 1962, Dtsch Z Nervenheilkd, V183, P351; HORNBOSTEL H, 1952, Helv Med Acta, V19, P388; HORNBOSTEL H, 1953, KLIN WOCHENSCHR, V31, P68, DOI 10.1007/BF01478472; HORNBOSTEL H, 1951, Arztl Wochensch, V6, P49; HORNBOSTEL H, 1950, HAUTARZT, V1, P183; JEFFRIES JL, 1963, SOUTHERN MED J, V56, P518, DOI 10.1097/00007611-196305000-00014; KARR WJ, 1959, AM J MED, V27, P829, DOI 10.1016/0002-9343(59)90200-1; KOCH H, 1949, BER DTSCH OPHTHAL GE, V55, P357; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KUSKE H, 1962, DERMATOLOGICA, V124, P298; Madden JF, 1934, J AMER MED ASSOC, V102, P442, DOI 10.1001/jama.1934.02750060024005; MORTON NE, 1955, AM J HUM GENET, V7, P277; PITTELKOW RB, 1957, ARCH DERMATOL, V76, P59, DOI 10.1001/archderm.1957.01550190063012; PITTELKOW RB, 1955, ARCH DERMATOL, V72, P556, DOI 10.1001/archderm.1955.03730360062007; POMPEN AW, 1958, NED TIJDSCHR GENEES, V102, P1941; POMPEN AWM, 1947, ACTA MED SCAND, V128, P234; PRICE JH, 1955, BRIT J DERMATOL, V67, P105, DOI 10.1111/j.1365-2133.1955.tb12700.x; RAHMAN AN, 1961, T ASSOC AM PHYSICIAN, V74, P366; RAHMAN AN, 1963, ARCH NEUROL-CHICAGO, V9, P373, DOI 10.1001/archneur.1963.00460100061007; RAHMAN AN, 1963, ARCH OPHTHALMOL-CHIC, V69, P708, DOI 10.1001/archopht.1963.00960040714005; RAHMAN AN, 1962, CLIN RES, V10, P393; Ruiter M, 1939, ARCH DERMATOL SYPH-G, V179, P165, DOI 10.1007/BF01949466; RUITER M, 1958, Hautarzt, V9, P15; RUITER M, 1959, Excerpta Med (Dermatol), V13, P61; RUITER M, 1952, Hautarzt, V3, P557; RUITER M, 1954, Dermatologica, V109, P273; RUITER M, 1939, NED TIJDSCHR GENEES, V83, P1801; RUITER M, 1957, ARCH KLIN EXP DERM, V206, P205; RUITER M, 1947, DERMATOLOGICA, V94, P1; SANGER R, 1964, ANN HUM GENET, V27, P271, DOI 10.1111/j.1469-1809.1963.tb00794.x; Scriba K, 1951, VERHANDL DEUTSCH GES, V34, P221; SIBLEY WK, 1918, P ROY SOC MED, V2, P101; SIBLEY WK, 1918, P ROY SOC MED, V2, P70; SIGUIER F, 1956, Bull Mem Soc Med Hop Paris, V72, P291; SMITH SM, 1961, MATHEMATICAL TABLES; STANBURY JB, 1965, METABOLIC BASIS INHE, pCH29; STILES F, IN PREPARATION; Stumpke G, 1916, ARCH DERMATOL SYPH-G, V121, P291; SWEELEY CC, 1963, J BIOL CHEM, V238, P3148; SWEELEY CC, 1965, METABOLIC BASIS INHE, pCH29; VINEYARD WR, 1960, ARCH DERMATOL, V82, P817, DOI 10.1001/archderm.1960.01580050159024; VONGEMMI.G, 1965, ARCH DERMATOL, V91, P206, DOI 10.1001/archderm.1965.01600090014003; Weicksel J, 1925, DEUT MED WOCHENSCHR, V51, P898; WISE D, 1962, Q J MED, V31, P177; WISE D, 1964, JADASSOHNS HDB HAUT, V7; WISE D, 1960, THESIS U CAMBRIDGE; 1881, HISTORY MARION COUNT	66	133	136	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1965	17	4					325	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	66220	17948499				2022-12-18	WOS:A19656622000005
J	Groza, T; Kohler, S; Moldenhauer, D; Vasilevsky, N; Baynam, G; Zemojtel, T; Schriml, LM; Kibbe, WA; Schofield, PN; Beck, T; Vasant, D; Brookes, AJ; Zankl, A; Washington, NL; Mungall, CJ; Lewis, SE; Haendel, MA; Parkinson, H; Robinson, PN				Groza, Tudor; Koehler, Sebastian; Moldenhauer, Dawid; Vasilevsky, Nicole; Baynam, Gareth; Zemojtel, Tomasz; Schriml, Lynn Marie; Kibbe, Warren Alden; Schofield, Paul N.; Beck, Tim; Vasant, Drashtti; Brookes, Anthony J.; Zankl, Andreas; Washington, Nicole L.; Mungall, Christopher J.; Lewis, Suzanna E.; Haendel, Melissa A.; Parkinson, Helen; Robinson, Peter N.			The Human Phenotype Ontology: Semantic Unification of Common and Rare Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RISK LOCI; GENETIC-VARIANTS; DATABASE; SUSCEPTIBILITY; DISORDERS; MEDICINE; RESOURCE; BIOLOGY; NETWORK	The Human Phenotype Ontology (HPO) is widely used in the rare disease community for differential diagnostics, phenotype-driven analysis of next-generation sequence-variation data, and translational research, but a comparable resource has not been available for common disease. Here, we have developed a concept-recognition procedure that analyzes the frequencies of HPO disease annotations as identified in over five million Pub Med abstracts by employing an iterative procedure to optimize precision and recall of the identified terms. We derived disease models for 3,145 common human diseases comprising a total of 132,006 HPO annotations. The HPO now comprises over 250,000 phenotypic annotations for over 10,000 rare and common diseases and can be used for examining the phenotypic overlap among common diseases that share risk alleles, as well as between Mendelian diseases and common diseases linked by genomic location. The annotations, as well as the HPO itself, are freely available.	[Groza, Tudor] Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld 4072, Australia; [Groza, Tudor; Zankl, Andreas] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Koehler, Sebastian; Moldenhauer, Dawid; Zemojtel, Tomasz; Robinson, Peter N.] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Moldenhauer, Dawid] Univ Appl Sci, D-35390 Giessen, Germany; [Vasilevsky, Nicole] Oregon Hlth & Sci Univ, Lib, Portland, OR 97239 USA; [Baynam, Gareth] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6840, Australia; [Baynam, Gareth] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA 6150, Australia; [Baynam, Gareth] Off Populat Hlth Genom, Publ Hlth & Clin Serv Div, Dept Hlth, Perth, WA 6004, Australia; [Baynam, Gareth] King Edward Mem Hosp, Genet Serv Western Australia, Perth, WA 6008, Australia; [Baynam, Gareth] Telethon Kids Inst, Perth, WA 6008, Australia; [Zemojtel, Tomasz] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland; [Schriml, Lynn Marie] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Schriml, Lynn Marie] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Kibbe, Warren Alden] NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20850 USA; [Schofield, Paul N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Schofield, Paul N.] Jackson Lab, Bar Harbor, ME 04609 USA; [Beck, Tim; Brookes, Anthony J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Vasant, Drashtti; Parkinson, Helen] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Zankl, Andreas] Childrens Hosp Westmead, Acad Dept Med Genet, Sydney, NSW 2145, Australia; [Zankl, Andreas] Univ Sydney, Discipline Genet Med, Sydney Med Sch, Sydney, NSW 2145, Australia; [Washington, Nicole L.; Mungall, Christopher J.; Lewis, Suzanna E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Robinson, Peter N.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Robinson, Peter N.] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Robinson, Peter N.] Free Univ Berlin, Dept Math & Comp Sci, Inst Bioinformat, D-14195 Berlin, Germany	University of Queensland; Garvan Institute of Medical Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Oregon Health & Science University; University of Western Australia; Murdoch University; King Edward Memorial Hospital; University of Western Australia; Telethon Kids Institute; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; Jackson Laboratory; University of Leicester; European Molecular Biology Laboratory (EMBL); University of Sydney; University of Sydney; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Robinson, PN (corresponding author), Charite, Inst Med & Human Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	peter.robinson@charite.de	Schofield, Paul/AAA-9414-2020; Köhler, Sebastian/H-3301-2019; Schriml, Lynn/AFO-9472-2022; Mungall, Chris/I-6006-2019; Vasilevsky, Nicole A/AAB-7589-2019; Kibbe, Warren/B-2106-2010	Schofield, Paul/0000-0002-5111-7263; Köhler, Sebastian/0000-0002-5316-1399; Mungall, Chris/0000-0002-6601-2165; Vasilevsky, Nicole A/0000-0001-5208-3432; Kibbe, Warren/0000-0001-5622-7659; Groza, Tudor/0000-0003-2267-8333; Schriml, Lynn/0000-0001-8910-9851; Lewis, Suzanna/0000-0002-8343-612X; Beck, Tim/0000-0002-0292-7972; Parkinson, Helen/0000-0003-3035-4195; Haendel, Melissa/0000-0001-9114-8737	Bundesministerium fur Bildung und Forschung [0313911]; European Commission [602300]; Raine Clinician Research Fellowship [20140101]; National Health and Medical Research Council of Australia [APP1055319, 305444]; NIH Office of the Director [1R24OD011883-01]; Australian Research Council Discovery Early Career Researcher Award [DE120100508]; BioMedBridges project - Research Infrastructures of the FP7 [284209]; European Molecular Biology Laboratory Core Funds; Basic Energy Sciences, Office of Science, US Department of Energy [DE-AC02-05CH11231]; NIH [1R24OD011883-01]; US Government; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011883] Funding Source: NIH RePORTER	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Raine Clinician Research Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); BioMedBridges project - Research Infrastructures of the FP7; European Molecular Biology Laboratory Core Funds; Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Government; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Bundesministerium fur Bildung und Forschung (project 0313911), the European Commission Seventh Framework Programme (FP7; grant 602300; SYBIL project), the Raine Clinician Research Fellowship (20140101), and the National Health and Medical Research Council of Australia (grant APP1055319, which is partnered with FP7 grant 305444). Oregon Health and Science University acknowledges the support of grant 1R24OD011883-01 from the NIH Office of the Director. T.G. was supported by an Australian Research Council Discovery Early Career Researcher Award (DE120100508). D.V. was supported in part by the BioMedBridges project funded by Research Infrastructures of the FP7 (grant 284209). H.P. was supported by European Molecular Biology Laboratory Core Funds. This work was supported by the director, Basic Energy Sciences, Office of Science, US Department of Energy under contract DE-AC02-05CH11231 and NIH contract 1R24OD011883-01. This document was prepared as an account of work sponsored by the US Government. While this document is believed to contain correct information, neither the US Government nor any agency thereof, nor the Regents of the University of California, nor any of their employees makes any warranty, express or implied, or assumes any legal responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed or represents that its use would not infringe privately owned rights. The views and opinions of authors expressed herein do not necessarily state or reflect those of the US Government or any agency thereof or the Regents of the University of California.	Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Batet M, 2011, J BIOMED INFORM, V44, P118, DOI 10.1016/j.jbi.2010.09.002; Bauer S, 2012, BIOINFORMATICS, V28, P2502, DOI 10.1093/bioinformatics/bts471; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Beck T, 2014, EUR J HUM GENET, V22, P949, DOI 10.1038/ejhg.2013.274; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Campos D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-281; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Chen YC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003825; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; Collier N, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav104; Demchak Barry, 2014, F1000Res, V3, P151, DOI 10.12688/f1000research.4492.2; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Doecke JD, 2013, INFLAMM BOWEL DIS, V19, P240, DOI 10.1097/MIB.0b013e3182810041; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Esplin ED, 2014, PHARMACOGENOMICS, V15, P1771, DOI 10.2217/pgs.14.117; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Haendel MA, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-21; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048; Javed A, 2014, NAT METHODS, V11, P935, DOI [10.1038/NMETH.3046, 10.1038/nmeth.3046]; Jonquet Clement, 2009, Summit Transl Bioinform, V2009, P56; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Kim DK, 2012, AM J RESP CRIT CARE, V186, P1238, DOI 10.1164/rccm.201206-1013OC; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kohler S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-418; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Kohler Sebastian, 2013, F1000Res, V2, P30, DOI 10.12688/f1000research.2-30.v1; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Lambert JC, 2001, J MED GENET, V38, P353, DOI 10.1136/jmg.38.6.353; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Li YZ, 2013, NAT GENET, V45, P1361, DOI 10.1038/ng.2779; Liakath-Ali K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4540; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lusis AJ, 2008, NAT GENET, V40, P129, DOI 10.1038/ng0208-129; Masino AJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-248; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Petrovski S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010272; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078; Renkema KY, 2014, NAT REV NEPHROL, V10, P433, DOI 10.1038/nrneph.2014.95; Richard-Miceli C, 2012, GENOME MED, V4, DOI 10.1186/gm305; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Robinson P.N., 2011, INTRO BIOL ONTOLOGIE; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Robinson PN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004268; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Sana ME, 2014, AM J MED GENET A, V164, P2069, DOI 10.1002/ajmg.a.36588; Saunders CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004041; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Sifrim A, 2013, NAT METHODS, V10, P1083, DOI [10.1038/NMETH.2656, 10.1038/nmeth.2656]; Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010; Smedley D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat025; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Tsai CT, 2015, J MED GENET, V52, P28, DOI 10.1136/jmedgenet-2014-102618; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Voros S, 2014, J CARDIOVASC COMPUT, V8, P442, DOI 10.1016/j.jcct.2014.08.006; Vulto-van Silfhout AT, 2013, EUR J MED GENET, V56, P471, DOI 10.1016/j.ejmg.2013.06.010; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Zemojtel T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009262; Zhang W, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav025; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	85	132	135	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					111	124		10.1016/j.ajhg.2015.05.020	http://dx.doi.org/10.1016/j.ajhg.2015.05.020			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26119816	Green Published, hybrid			2022-12-18	WOS:000358189500010
J	Franceschini, N; Fox, E; Zhang, Z; Edwards, TL; Nalls, MA; Sung, YJ; Tayo, BO; Sun, YV; Gottesman, O; Adeyemo, A; Johnson, AD; Young, JH; Rice, K; Duan, Q; Chen, F; Li, Y; Tang, H; Fornage, M; Keene, KL; Andrews, JS; Smith, JA; Fau, JD; Guangfa, Z; Guo, W; Liu, Y; Murray, SS; Musani, SK; Srinivasan, S; Edwards, DRV; Wang, H; Becker, LC; Bovet, P; Bochud, M; Broecke, U; Burnier, M; Carty, C; Chasman, DI; Ehret, G; Chen, WM; Chen, G; Chen, W; Ding, J; Dreisbach, AW; Evans, MK; Guo, X; Garcia, ME; Jensen, R; Keller, ME; Lettre, G; Lotay, V; Martin, LW; Moore, JH; Morrison, AC; Mosley, TH; Ogunniyi, A; Palmas, W; Papanicolaou, G; Penman, A; Polak, JF; Ridker, PM; Salako, B; Singleton, AB; Shriner, D; Taylor, KD; Vasan, R; Wiggins, K; Williams, SM; Yanek, LR; Zhao, W; Zonderman, AB; Becker, DM; Berenson, G; Boerwinkle, E; Bottinger, E; Cushman, M; Eaton, C; Nyberg, F; Heiss, G; Hirschhron, JN; Howard, VJ; Karczewsk, KJ; Lanktree, MB; Liu, K; Liu, YM; Loos, R; Margolis, K; Snyder, M; Psaty, BM; Schork, NJ; Weir, DR; Rotimi, CN; Sale, MM; Harris, T; Kardia, SLR; Hunt, SC; Arnett, D; Redline, S; Cooper, RS; Risch, NJ; Rao, DC; Rotter, JI; Chakravarti, A; Reiner, AP; Levy, D; Keating, BJ; Zhu, XO				Franceschini, Nora; Fox, Ervin; Zhang, Zhaogong; Edwards, Todd L.; Nalls, Michael A.; Sung, Yun Ju; Tayo, Bamidele O.; Sun, Yan V.; Gottesman, Omri; Adeyemo, Adebawole; Johnson, Andrew D.; Young, J. Hunter; Rice, Ken; Duan, Qing; Chen, Fang; Li, Yun; Tang, Hua; Fornage, Myriam; Keene, Keith L.; Andrews, Jeanette S.; Smith, Jennifer A.; Fau, Jessica D.; Guangfa, Zhang; Guo, Wei; Liu, Yu; Murray, Sarah S.; Musani, Solomon K.; Srinivasan, Sathanur; Edwards, Digna R. Velez; Wang, Heming; Becker, Lewis C.; Bovet, Pascal; Bochud, Murielle; Broecke, Ulrich; Burnier, Michel; Carty, Cara; Chasman, Daniel I.; Ehret, Georg; Chen, Wei-Min; Chen, Guanjie; Chen, Wei; Ding, Jingzhong; Dreisbach, Albert W.; Evans, Michele K.; Guo, Xiuqing; Garcia, Melissa E.; Jensen, Rich; Keller, Margaux E.; Lettre, Guillaume; Lotay, Vaneet; Martin, Lisa W.; Moore, Jason H.; Morrison, Alanna C.; Mosley, Thomas H.; Ogunniyi, Adesola; Palmas, Walter; Papanicolaou, George; Penman, Alan; Polak, Joseph F.; Ridker, Paul M.; Salako, Babatunde; Singleton, Andrew B.; Shriner, Daniel; Taylor, Kent D.; Vasan, Ramachandran; Wiggins, Kerni; Williams, Scott M.; Yanek, Lisa R.; Zhao, Wei; Zonderman, Alan B.; Becker, Diane M.; Berenson, Gerald; Boerwinkle, Eric; Bottinger, Erwin; Cushman, Mary; Eaton, Charles; Nyberg, Fredrik; Heiss, Gerardo; Hirschhron, Joel N.; Howard, Virginia J.; Karczewsk, Konrad J.; Lanktree, Matthew B.; Liu, Kiang; Liu, Yongmei; Loos, Ruth; Margolis, Karen; Snyder, Michael; Psaty, Bruce M.; Schork, Nicholas J.; Weir, David R.; Rotimi, Charles N.; Sale, Michele M.; Harris, Tamara; Kardia, Sharon L. R.; Hunt, Steven C.; Arnett, Donna; Redline, Susan; Cooper, Richard S.; Risch, Neil J.; Rao, D. C.; Rotter, Jerome I.; Chakravarti, Aravinda; Reiner, Alex P.; Levy, Daniel; Keating, Brendan J.; Zhu, Xiaofeng		Asian Genetic Epidemiology Network	Genome-wide Association Analysis of Blood-Pressure Traits in African-Ancestry Individuals Reveals Common Associated Genes in African and Non-African Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INCIDENT HYPERTENSION; LOCI; VARIANTS; METAANALYSIS; ANNOTATION; PREVENTION; DISEASE; COHORTS; ASIANS; CARE	High blood pressure (BP) is more prevalent and contributes to more severe manifestations of cardiovascular disease (CVD) in African Americans than in any other United States ethnic group. Several small African-ancestry (AA) BP genome-wide association studies (GWASs) have been published, but their findings have failed to replicate to date. We report on a large AA BP GWAS meta-analysis that includes 29,378 individuals from 19 discovery cohorts and subsequent replication in additional samples of AA (n = 10,386), European ancestry (EA) (n = 69,395), and East Asian ancestry (n = 19,601). Five loci (EVX1-HOXA, ULK4, RSPO3, PLEKHG1, and SOX6) reached genome-wide significance (p < 1.0 x 10(-8)) for either systolic or diastolic BP in a transethnic meta-analysis after correction for multiple testing. Three of these BP loci (EVX1-HOXA, RSPO3, and PLEKHG1) lack previous associations with BP. We also identified one independent signal in a known BP locus (SOX6) and provide evidence for fine mapping in four additional validated BP loci. We also demonstrate that validated EA BP GWAS loci, considered jointly, show significant effects in AA samples. Consequently, these findings suggest that BP loci might have universal effects across studied populations, demonstrating that multiethnic samples are an essential component in identifying, fine mapping, and understanding their trait variability.	[Franceschini, Nora; Heiss, Gerardo] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Musani, Solomon K.; Dreisbach, Albert W.; Mosley, Thomas H.; Penman, Alan] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39126 USA; [Zhang, Zhaogong; Guo, Wei; Wang, Heming; Zhu, Xiaofeng] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Zhang, Zhaogong] Heilongjiang Univ, Sch Comp Sci & Technol, Harbin 150080, Peoples R China; [Edwards, Todd L.; Williams, Scott M.] Vanderbilt Univ, Dept Med, Vanderbilt Epidemiol Ctr, Ctr Human Genet Res, Nashville, TN 37212 USA; [Sung, Yun Ju; Rao, D. C.] Natl Inst Aging, Natl Inst Hlth, Neurogenet Lab, Bethesda, MD 20892 USA; [Tayo, Bamidele O.; Cooper, Richard S.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Sun, Yan V.] Loyola Univ Chicago Stritch, Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; [Gottesman, Omri; Lotay, Vaneet; Bottinger, Erwin; Loos, Ruth] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Adeyemo, Adebawole; Chen, Guanjie; Shriner, Daniel; Rotimi, Charles N.] Charles Bronfman Inst Personalized Med, Mt Sinai Sch Med, New York, NY 10029 USA; [Johnson, Andrew D.; Levy, Daniel] Natl Human Genome Res Inst, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Young, J. Hunter; Yanek, Lisa R.; Becker, Diane M.] Natl Heart Lung & Blood Inst, Ctr Populat Studies, Framingham, MA 01702 USA; [Rice, Ken] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Duan, Qing] Univ Washington, Dept Biostat, Seattle, WA 98101 USA; [Chen, Fang; Chen, Wei-Min] Univ N Carolina, Bioinformat & Computat Biol Program, Chapel Hill, NC 27599 USA; [Li, Yun] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Tang, Hua; Karczewsk, Konrad J.; Snyder, Michael] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Fornage, Myriam] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Keene, Keith L.] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA; [Andrews, Jeanette S.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Smith, Jennifer A.; Zhao, Wei; Kardia, Sharon L. R.] Wake Forest Sch Med, Dept Biostat Sci Publ Hlth Sci, Winston Salem, NC 27157 USA; [Fau, Jessica D.; Weir, David R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Guangfa, Zhang; Schork, Nicholas J.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI 48104 USA; [Liu, Yu] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Murray, Sarah S.; Srinivasan, Sathanur; Chen, Wei; Berenson, Gerald] Scripps Res Inst, La Jolla, CA 92037 USA; [Edwards, Digna R. Velez] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Becker, Lewis C.] Tulane Univ, Tulane Ctr Cardiovasc Hlth, New Orleans, LA 70112 USA; [Bovet, Pascal; Bochud, Murielle] Vanderbilt Univ, Dept Obstet & Gynecol, Vanderbilt Epidemiol Ctr, Ctr Human Genet Res, Nashville, TN 37212 USA; Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland; [Bovet, Pascal] Minist Hlth, Victoria, Seychelles; [Broecke, Ulrich] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Burnier, Michel] Univ Lausanne Hosp, Serv Nephrol & Hypertens, CH-1010 Lausanne, Switzerland; [Carty, Cara] Univ Lausanne Hosp, Serv Nephrol & Hypertens, CH-1010 Lausanne, Switzerland; [Chasman, Daniel I.; Ridker, Paul M.] Fred Hutchinson Canc Res Ctr, Dept Biostat & Biomath, Seattle, WA 98109 USA; [Ehret, Georg] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Ehret, Georg; Chakravarti, Aravinda] Univ Hosp Geneva, Dept Specialties Internal Med, CH-1211 Geneva, Switzerland; [Ding, Jingzhong] Johns Hopkins Univ, Sch Med, McKusickNathans Inst Genet Med, Ctr Complex Dis Gen, Baltimore, MD 21205 USA; [Evans, Michele K.] Wake Forest Sch Med, Dept Internal Med, Sect Gerontol & Geriatr Med, Winston Salem, NC 27157 USA; [Guo, Xiuqing; Taylor, Kent D.; Rotter, Jerome I.] Natl Inst Aging, Natl Inst Hlth, Hlth Dispar Unit, Bethesda, MD 20892 USA; [Garcia, Melissa E.] Inst Med Genet, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Jensen, Rich; Wiggins, Kerni; Psaty, Bruce M.] Natl Inst Aging, Intramural Res Program, Lab Cellular & Mol Biol, Bethesda, MD 20892 USA; [Keller, Margaux E.] Univ Washington, Dept Med, Cardiovascular Hlth Res Unit, Epidemiol & Hlth Serv, Seattle, WA 98101 USA; [Lettre, Guillaume] Temple Univ, Dept Biol Anthropol, Philadelphia, PA 19122 USA; [Moore, Jason H.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Moore, Jason H.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Morrison, Alanna C.; Salako, Babatunde; Boerwinkle, Eric] George Washington Univ, Cardiovasc Inst, Washington, DC 20037 USA; [Ogunniyi, Adesola] Dartmouth Coll, Geisel Sch Med, Dept Genet, Inst Quantitat Biomed Sci, Hanover, NH 03756 USA; [Palmas, Walter] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Inst Quantitat Biomed Sci, Hanover, NH 03756 USA; [Papanicolaou, George] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA; [Polak, Joseph F.] Univ Ibadan, Dept Med, Ibadan, Oyo, Nigeria; [Vasan, Ramachandran] Columbia Univ, Dept Med, New York, NY 10032 USA; [Zonderman, Alan B.] NHLBI, NIH, Div Prevent & Populat Sci, Bethesda, MD 20892 USA; [Cushman, Mary] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA; [Eaton, Charles] Boston Univ, Sch Med, Boston, MA 02118 USA; [Nyberg, Fredrik] NIA, NIH, Lab Personal & Cognit, Bethesda, MD 20892 USA; [Hirschhron, Joel N.] Univ Vermont, Coll Med, Burlington, VT 05446 USA; Brown Univ, Alpert Med Sch, Dept Family Med & Epidemiol, Providence, RI 02912 USA; Global Epidemiol AstraZeneca Res & Dev, SE-43183 Molndal, Sweden; [Hirschhron, Joel N.] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Hirschhron, Joel N.] MIT, Cambridge, MA 02141 USA; [Hirschhron, Joel N.] Boston Childrens Hosp, Div Genet & Endocrinol, Boston, MA 02115 USA; [Hirschhron, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Howard, Virginia J.; Arnett, Donna] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Lanktree, Matthew B.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Liu, Kiang] Northwestern Univ Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Liu, Yongmei] Wake Forest Sch Med, Dept Epidemiol & Prevent Publ Hlth Sci, Winston Salem, NC 27157 USA; [Margolis, Karen] Hennepin Cty Med Ctr, Div Clin Epidemiol, Minneapolis, MN 55415 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA 98101 USA; [Sale, Michele M.] Univ Virginia Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Harris, Tamara] Natl Inst Aging, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Hunt, Steven C.] Univ Utah, Cardiovasc Genet, Salt Lake City, UT 84132 USA; [Redline, Susan] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Risch, Neil J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Inst Human Genet, San Francisco, CA 94143 USA; [Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci, Seattle, WA 98109 USA; [Levy, Daniel] Framingham Heart Study Natl Heart Lung & Blood In, Framingham, MA 01702 USA; [Keating, Brendan J.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Keating, Brendan J.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Mississippi; University of Mississippi Medical Center; Case Western Reserve University; Heilongjiang University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Washington University (WUSTL); Loyola University Chicago; Emory University; Rollins School Public Health; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Virginia; Wake Forest University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Scripps Research Institute; Scripps Research Institute; Case Western Reserve University; Tulane University; Vanderbilt University; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Medical College of Wisconsin; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Fred Hutchinson Cancer Center; Harvard University; Brigham & Women's Hospital; University of Geneva; Johns Hopkins University; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universite de Montreal; Universite de Montreal; George Washington University; Dartmouth College; Dartmouth College; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Ibadan; Columbia University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts Medical Center; Tufts University; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Vermont; Brown University; AstraZeneca; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; Western University (University of Western Ontario); Northwestern University; Feinberg School of Medicine; Wake Forest University; Hennepin County Medical Center; Group Health Cooperative; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Franceschini, N (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	noraf@unc.edu; xiaofeng.zhu@case.edu	Cushman, Mary/K-1157-2019; Levy, Daniel/ABF-6873-2021; EHRET, Georg B/A-9532-2009; Levy, Daniel/ABB-2752-2021; Bovet, Pascal/F-4477-2011; Singleton, Andrew B/C-3010-2009; Loos, Ruth/GON-5877-2022; Zhu, Xiaofeng/O-6874-2019; Zonderman, Alan B/A-5807-2013; Rotter, Jerome/AAY-6598-2021; Loos, Ruth J F/Q-2862-2016; Bochud, Murielle/A-3981-2010; Williams, Scott/Q-4812-2019; Evans, Michele Kim/AAE-4776-2019; Ramachandran, Vasan/Y-2527-2019; Johnson, Andrew D/G-6520-2013; Liu, Jianjun/AAK-4989-2020; Lanktree, Matthew Bruce/I-9790-2019; Moore, Jason H./AAV-9645-2021; Lee, Jong-Young/M-6319-2013	Cushman, Mary/0000-0002-7871-6143; Levy, Daniel/0000-0003-1843-8724; EHRET, Georg B/0000-0002-5730-0675; Bovet, Pascal/0000-0002-0242-4259; Zonderman, Alan B/0000-0003-3530-2319; Loos, Ruth J F/0000-0002-8532-5087; Bochud, Murielle/0000-0002-5727-0218; Williams, Scott/0000-0002-4835-9544; Ramachandran, Vasan/0000-0001-7357-5970; Johnson, Andrew D/0000-0001-6369-5178; Liu, Jianjun/0000-0002-3255-3019; Lanktree, Matthew Bruce/0000-0002-5750-6286; Moore, Jason H./0000-0002-5015-1099; Margolis, Karen/0000-0003-1862-7402; Morrison, Alanna/0000-0001-6381-4296; Smith, Jennifer Ann/0000-0002-3575-5468; Eaton, Charles/0000-0002-7723-9461; Martin, Lisa Warsinger/0000-0003-4352-0914; Shriner, Daniel/0000-0003-1928-5520; Schork, Nicholas/0000-0003-0920-5013; Evans, Michele/0000-0002-8546-2831; Faul, Jessica/0000-0002-6969-6478; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Adeyemo, Adebowale/0000-0002-3105-3231; Zonderman, Alan B/0000-0002-6523-4778; Zhou, Xueya/0000-0003-2350-081X; Nyberg, Fredrik/0000-0003-0892-5668; Snyder, Michael/0000-0003-0784-7987; Lee, Jong-Young/0000-0002-0092-9958; Zhu, Xiaofeng/0000-0003-0037-411X	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055673, R01HL105756, ZIAHL006170, ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362, R01HG003054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Primatesta P, 2001, HYPERTENSION, V37, P187, DOI 10.1161/01.HYP.37.2.187; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Saraiva RM, 2006, CURR OPIN CARDIOL, V21, P221, DOI 10.1097/01.hco.0000221584.56372.dc; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stevens J, 2008, AM J EPIDEMIOL, V167, P1365, DOI 10.1093/aje/kwn060; TAJIMA F, 1989, GENETICS, V123, P585; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zhu XF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001244; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113	41	132	134	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					545	554		10.1016/j.ajhg.2013.07.010	http://dx.doi.org/10.1016/j.ajhg.2013.07.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23972371	Bronze, Green Published			2022-12-18	WOS:000330268900014
J	Orloff, MS; He, X; Peterson, C; Chen, FS; Chen, JL; Mester, JL; Eng, C				Orloff, Mohammed S.; He, Xin; Peterson, Charissa; Chen, Fusong; Chen, Jin-Lian; Mester, Jessica L.; Eng, Charis			Germline PIK3CA and AKT1 Mutations in Cowden and Cowden-like Syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PTEN; DISEASE; KINASE; GENE; ASSOCIATION; SPECTRUM; PROTEUS; PATHWAY; BREAST; GROWTH	Cowden syndrome (CS) is a difficult-to-recognize multiple hamartoma syndrome with high risks of breast, thyroid, and other cancers. Germ line mutations in PTEN on 10q23 were found to cause 85% of CS when accrued from tertiary academic centers, but prospective accrual from the community over the last 12 years has revealed a 25% PTEN mutation frequency. PTEN is the phosphatase that has been implicated in a heritable cancer syndrome and subsequently in multiple sporadic cancers and developmental processes. PTEN antagonizes the AKT1/PI3K signaling pathway and has roles in cell cycle, migration, cell polarity, and apoptosis. We report that 8 of 91 (8.8%) unrelated CS individuals without germline PTEN mutations carried 10 germline PIK3CA mutations (7 missense, 1 nonsense, and 2 indels) and 2 (2.2%) AKT1 mutations. These mutations result in significantly increased P-Thr308-AKT and increased cellular PIP3. Our observations suggest that PIK3cA and AKT1 are CS susceptibility genes.	[Orloff, Mohammed S.; He, Xin; Peterson, Charissa; Chen, Fusong; Chen, Jin-Lian; Mester, Jessica L.; Eng, Charis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Orloff, Mohammed S.; He, Xin; Peterson, Charissa; Chen, Fusong; Chen, Jin-Lian; Mester, Jessica L.; Eng, Charis] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Orloff, Mohammed S.; Mester, Jessica L.; Eng, Charis] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA.	engc@ccf.org		Eng, Charis/0000-0002-3693-5145	NCI [P01CA124570]; American Cancer Society Clinical Research Professorship; NATIONAL CANCER INSTITUTE [P01CA124570] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Clinical Research Professorship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We are deeply grateful to all of our research participants and their families, clinicians, and genetic professionals who have contributed one way or the other to our studies over the many years, especially the last 6 years. This study is funded, in part, by NCI grant P01CA124570 and the American Cancer Society Clinical Research Professorship (both to C.E.). C.E. is the Sondra J. and Stephen R. Hardis Chair in Cancer Genomic Medicine at the Cleveland Clinic.	Bennett KL, 2010, JAMA-J AM MED ASSOC, V304, P2724, DOI 10.1001/jama.2010.1877; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Du L, 2012, J ONCOL, V2012, DOI 10.1155/2012/450179; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Furnari FB, 1998, CANCER RES, V58, P5002; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Ni Y, 2012, HUM MOL GENET, V21, P300, DOI 10.1093/hmg/ddr459; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rodriguez-Escudero I, 2009, J BIOL CHEM, V284, P13373, DOI 10.1074/jbc.M807867200; Smith JM, 2002, J MED GENET, V39, P937, DOI 10.1136/jmg.39.12.937; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Tan MH, 2011, AM J HUM GENET, V88, P42, DOI 10.1016/j.ajhg.2010.11.013; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; WHITMAN M, 1992, NATURE, V357, P252, DOI 10.1038/357252a0; WHITMAN M, 1987, BIOCHEM J, V247, P165, DOI 10.1042/bj2470165; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5	23	132	137	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					76	80		10.1016/j.ajhg.2012.10.021	http://dx.doi.org/10.1016/j.ajhg.2012.10.021			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23246288	Bronze, Green Published			2022-12-18	WOS:000313759000007
J	Lessard, CJ; Adrianto, I; Ice, JA; Wiley, GB; Kelly, JA; Glenn, SB; Adler, AJ; Li, H; Rasmussen, A; Williams, AH; Ziegler, J; Comeau, ME; Marion, M; Wakeland, BE; Liang, CY; Ramos, PS; Grundahl, KM; Gallant, CJ; Alarcon-Riquelme, ME; Alarcon, GS; Anaya, JM; Bae, SC; Boackle, SA; Brown, EE; Chang, DM; Cho, SK; Criswell, LA; Edberg, JC; Freedman, BI; Gilkeson, GS; Jacob, CO; James, JA; Kamen, DL; Kimberly, RP; Kim, JH; Martin, J; Merrill, JT; Niewold, TB; Park, SY; Petri, MA; Pons-Este, BA; Ramsey-Goldman, R; Reveille, JD; Scofield, RH; Song, YW; Stevens, AM; Tsao, BP; Vila, LM; Vyse, TJ; Yu, CY; Guthridge, JM; Kaufman, KM; Harley, JB; Wakeland, EK; Langefeld, CD; Gaffney, PM; Montgomery, CG; Moser, KL				Lessard, Christopher J.; Adrianto, Indra; Ice, John A.; Wiley, Graham B.; Kelly, Jennifer A.; Glenn, Stuart B.; Adler, Adam J.; Li, He; Rasmussen, Astrid; Williams, Adrienne H.; Ziegler, Julie; Comeau, Mary E.; Marion, Miranda; Wakeland, Benjamin E.; Liang, Chaoying; Ramos, Paula S.; Grundahl, Kiely M.; Gallant, Caroline J.; Alarcon-Riquelme, Marta E.; Alarcon, Graciela S.; Anaya, Juan-Manuel; Bae, Sang-Cheol; Boackle, Susan A.; Brown, Elizabeth E.; Chang, Deh-Ming; Cho, Soo-Kyung; Criswell, Lindsey A.; Edberg, Jeffrey C.; Freedman, Barry I.; Gilkeson, Gary S.; Jacob, Chaim O.; James, Judith A.; Kamen, Diane L.; Kimberly, Robert P.; Kim, Jae-Hoon; Martin, Javier; Merrill, Joan T.; Niewold, Timothy B.; Park, So-Yeon; Petri, Michelle A.; Pons-Estel, Bernardo A.; Ramsey-Goldman, Rosalind; Reveille, John D.; Scofield, R. Hal; Song, Yeong Wook; Stevens, Anne M.; Tsao, Betty P.; Vila, Luis M.; Vyse, Timothy J.; Yu, Chack-Yung; Guthridge, Joel M.; Kaufman, Kenneth M.; Harley, John B.; Wakeland, Edward K.; Langefeld, Carl D.; Gaffney, Patrick M.; Montgomery, Courtney G.; Moser, Kathy L.		BIOLUPUS Network; GENLES Network	Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as Susceptibility Loci for Systemic Lupus Erythematosus in a Large-Scale Multiracial Replication Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; PRIMARY BILIARY-CIRRHOSIS; RHEUMATOID-ARTHRITIS; RISK LOCI; GENETIC SUSCEPTIBILITY; FAMILIAL AGGREGATION; IMMUNE-RESPONSE; CROHNS-DISEASE; FOLLOW-UP; VARIANTS	Systemic lupus erythematosus (SLE) is a chronic heterogeneous autoimmune disorder characterized by the loss of tolerance to self-antigens and dysregulated interferon responses. The etiology of SLE is complex, involving both heritable and environmental factors. Candidate-gene studies and genome-wide association (GWA) scans have been successful in identifying new loci that contribute to disease susceptibility; however, much of the heritable risk has yet to be identified. In this study, we sought to replicate 1,580 variants showing suggestive association with SLE in a previously published GWA scan of European Americans; we tested a multiethnic population consisting of 7,998 SLE cases and 7,492 controls of European, African American, Asian, Hispanic, Gullah, and Amerindian ancestry to find association with the disease. Several genes relevant to immunological pathways showed association with SLE. Three loci exceeded the genome-wide significance threshold: interferon regulatory factor 8 (IRF8; rs11644034; p(meta-Euro) = 2.08 x 10(-10)), transmembrane protein 39A (TMEM39A; rs1132200; p(meta-all) 8.62 x 10(-9)), and 17q21 (rs1453560; p(meta-all) = 3.48 x 10(-10)) between IKAROS family of zinc finger 3 (AIOLOS; IKZF3) and zona pellucida binding protein 2 (ZPBP2). Fine mapping, resequencing, imputation, and haplotype analysis of IRF8 indicated that three independent effects tagged by rs8046526, rs450443, and rs4843869, respectively, were required for risk in individuals of European ancestry. Eleven additional replicated effects (5 x 10(-8) < p(meta-Euro) < 9.99 x 10(-5)) were observed with CFHR1, CADM2, LOC730109/IL12A, LPP, LOC63920, SLU7, ADAMTSL1, C10orf64, OR8D4 FAM19A2, and STXBP6. The results of this study increase the number of confirmed SLE risk loci and identify others warranting further investigation.	[Lessard, Christopher J.; Adrianto, Indra; Ice, John A.; Wiley, Graham B.; Kelly, Jennifer A.; Glenn, Stuart B.; Adler, Adam J.; Li, He; Rasmussen, Astrid; Grundahl, Kiely M.; Alarcon-Riquelme, Marta E.; James, Judith A.; Scofield, R. Hal; Guthridge, Joel M.; Kaufman, Kenneth M.; Gaffney, Patrick M.; Montgomery, Courtney G.; Moser, Kathy L.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Lessard, Christopher J.; Li, He; James, Judith A.; Scofield, R. Hal; Gaffney, Patrick M.; Moser, Kathy L.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Williams, Adrienne H.; Ziegler, Julie; Comeau, Mary E.; Marion, Miranda; Langefeld, Carl D.] Wake Forest Univ Hlth Sci, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Wakeland, Benjamin E.; Liang, Chaoying; Wakeland, Edward K.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Ramos, Paula S.; Gilkeson, Gary S.; Kamen, Diane L.] Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA; [Gallant, Caroline J.] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, S-75105 Uppsala, Sweden; [Alarcon-Riquelme, Marta E.; BIOLUPUS Network; GENLES Network] Pfizer Univ Granada Junta Andalucia, Ctr Genom & Invest Oncol, Granada 18100, Spain; [Alarcon, Graciela S.; Brown, Elizabeth E.; Edberg, Jeffrey C.; Kimberly, Robert P.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Anaya, Juan-Manuel] Univ Rosario, Ctr Autoimmune Dis Res, Bogota, Colombia; [Bae, Sang-Cheol; Cho, Soo-Kyung; Kim, Jae-Hoon; Park, So-Yeon] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul 133792, South Korea; [Boackle, Susan A.] Univ Colorado Denver, Div Rheumatol, Aurora, CO 80045 USA; [Chang, Deh-Ming] Natl Def Med Ctr, Taipei 114, Taiwan; [Criswell, Lindsey A.] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Freedman, Barry I.] Wake Forest Sch Med, Dept Internal Med, Nephrol Sect, Winston Salem, NC 27157 USA; [Jacob, Chaim O.] Univ So Calif, Dept Med, Los Angeles, CA 90089 USA; [James, Judith A.; Scofield, R. Hal] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Niewold, Timothy B.] Univ Chicago, Rheumatol Sect, Chicago, IL 60637 USA; [Niewold, Timothy B.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [Pons-Estel, Bernardo A.] Sanatorio Parque, RA-2000 Rosario, Santa Fe, Argentina; [Ramsey-Goldman, Rosalind] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Reveille, John D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Scofield, R. Hal] US Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Song, Yeong Wook] Seoul Natl Univ, Div Rheumatol, Seoul 110799, South Korea; [Stevens, Anne M.] Univ Washington, Dept Pediat, Div Rheumatol, Seattle, WA 98105 USA; [Tsao, Betty P.] Univ Calif Los Angeles, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA; [Stevens, Anne M.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98105 USA; [Vila, Luis M.] Univ Puerto Rico, Dept Med, Div Rheumatol, San Juan, PR 00936 USA; [Vyse, Timothy J.] Kings Coll London, Div Genet & Mol Med, London SE1 9RT, England; [Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London SE1 9RT, England; [Yu, Chack-Yung] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; [Yu, Chack-Yung] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Kaufman, Kenneth M.; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA; [Kaufman, Kenneth M.; Harley, John B.] US Dept Vet Affairs Med Ctr, Cincinnati, OH 45220 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Wake Forest University; Wake Forest University School of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of South Carolina; Uppsala University; Pfizer; University of Granada; University of Alabama System; University of Alabama Birmingham; Universidad del Rosario; Hanyang University; Hanyang University Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Defense Medical Center; University of California System; University of California San Francisco; Wake Forest University; University of Southern California; University of Oklahoma System; University of Oklahoma Health Sciences Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Chicago; University of Chicago; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Oklahoma System; University of Oklahoma Health Sciences Center; Seoul National University (SNU); University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; Seattle Children's Hospital; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of London; King's College London; University of London; King's College London; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Moser, KL (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	moserk@omrf.org	Scofield, Robert Hal/AEJ-8314-2022; Anaya, Juan-Manuel/J-1960-2016; Martín, María/HDL-9512-2022; Martin, Javier/B-8141-2008; Martín, Javier/AAV-5209-2021; Rasmussen, Astrid/A-4878-2013; Bae, Sang-Cheol/P-2051-2015; Alarcón-Riquelme, Marta E./ABF-8163-2020; Merrill, Joan/HDL-9141-2022; Adrianto, Indra/D-4214-2013; Yu, Chack-Yung/E-4360-2011; Song, Yeong-Wook/J-2765-2012; Niewold, Timothy/D-2669-2018	Anaya, Juan-Manuel/0000-0002-6444-1249; Martin, Javier/0000-0002-2202-0622; Rasmussen, Astrid/0000-0001-7744-2948; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Adrianto, Indra/0000-0002-9973-3057; Niewold, Timothy/0000-0003-3532-6660; Tsao, Betty/0000-0001-7938-5975; Kelly, Jennifer/0000-0002-3203-2467; Guthridge, Joel/0000-0002-9308-237X; Yu, Chack-Yung/0000-0002-5218-7503; Ramos, Paula/0000-0002-9433-6634; Universidad del Rosario, Biblioteca/0000-0003-3491-9392; Montgomery, Courtney/0000-0002-9606-3772; Gaffney, Patrick/0000-0002-1580-869X; Li, He (Hurley)/0000-0002-1766-5311; Kim, Jae-Hoon/0000-0002-4756-1281; Kimberly, Robert/0000-0002-5330-3086; Lessard, Christopher J./0000-0003-2440-3843; Bae, Sang-Cheol/0000-0003-4658-1093; Pons-Estel, Bernardo/0000-0003-2518-0266	NCATS NIH HHS [UL1 TR000154, UL1 TR000062] Funding Source: Medline; NCI NIH HHS [R01 CA141700] Funding Source: Medline; NCRR NIH HHS [UL1 RR024999, I ULI RR025014-02, 1U54 RR23417-01, UL1 RR029882, P20 RR015577, P30 RR031152, P20 RR020143, M01 RR-00079, UL1 RR025741] Funding Source: Medline; NIAID NIH HHS [K08 AI083790, K24 AI078004, P01 AI083194, R01 AI070983, R21 AI070304, N01 AI50026, R01 AI063274, AI071651] Funding Source: Medline; NIAMS NIH HHS [K24 AR002138, R01 AR054459, AR042460, P60 2 AR30692, P30 AR053483, P60 AR053308, R01 AR43814, P30 AR055385, R01 AR057172, R01 AR043814, N01 AR62277, P01 AR49084, RC1 AR058621, R01 AR043274, R01 AR051545-01A2, P60 AR062755, P60 AR049459, R01 AR33062] Funding Source: Medline; PHS HHS [R3724717] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA141700] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154, UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031152, UL1RR025741, UL1RR029882, P20RR015577, M01RR000079, P20RR020143, UL1RR025014, UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070983, R21AI070304, R01AI063274, K08AI083790, P01AI083194, N01AI050026, K24AI078004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049084, R01AR043274, P60AR030692, R01AR051545, R01AR042460, R01AR043814, R01AR057172, R01AR033062, P60AR049459, RC1AR058621, P60AR053308, R01AR054459, K24AR002138, P30AR053483] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anaya JM, 2006, J RHEUMATOL, V33, P2227; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Arora-Singh RK, 2010, J AUTOIMMUN, V35, P52, DOI 10.1016/j.jaut.2010.02.001; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2006, IMMUNOL REV, V210, P120, DOI 10.1111/j.0105-2896.2006.00367.x; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Esposito F, 2010, GENES IMMUN, V11, P397, DOI 10.1038/gene.2010.28; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirschfield GM, 2010, NAT GENET, V42, P655, DOI 10.1038/ng.631; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lessard CJ, 2011, AM J HUM GENET, V88, P83, DOI 10.1016/j.ajhg.2010.11.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; MCCULLOCH DK, 1990, DIABETES, V39, P549, DOI 10.2337/diabetes.39.5.549; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; NIES KM, 1974, ARTHRITIS RHEUM-US, V17, P397, DOI 10.1002/art.1780170409; Peluso I, 2006, WORLD J GASTROENTERO, V12, P5606, DOI 10.3748/wjg.v12.i35.5606; Petri M, 2002, BEST PRACT RES CL RH, V16, P847, DOI 10.1053/berh.2002.0259; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REINERTSEN JL, 1978, NEW ENGL J MED, V299, P515, DOI 10.1056/NEJM197809072991004; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanchez E, 2011, ANN RHEUM DIS, V70, P1752, DOI 10.1136/ard.2011.154104; Sestak AL, 1999, J RHEUMATOL, V26, P1495; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tan WF, 2011, ARTHRITIS RHEUM-US, V63, P2755, DOI 10.1002/art.30452; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079	66	132	139	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					648	660		10.1016/j.ajhg.2012.02.023	http://dx.doi.org/10.1016/j.ajhg.2012.02.023			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22464253	Green Published, Bronze			2022-12-18	WOS:000302833400007
J	Lines, MA; Huang, LJ; Schwartzentruber, J; Douglas, SL; Lynch, DC; Beaulieu, C; Guion-Almeida, ML; Zechi-Ceide, RM; Gener, B; Gillessen-Kaesbach, G; Nava, C; Baujat, G; Horn, D; Kini, U; Caliebe, A; Alanay, Y; Utine, GE; Lev, D; Kohlhase, J; Grix, AW; Lohmann, DR; Hehr, U; Bohm, D; Majewski, J; Bulman, DE; Wieczorek, D; Boycott, KM				Lines, Matthew A.; Huang, Lijia; Schwartzentruber, Jeremy; Douglas, Stuart L.; Lynch, Danielle C.; Beaulieu, Chandree; Guion-Almeida, Maria Leine; Zechi-Ceide, Roseli Maria; Gener, Blanca; Gillessen-Kaesbach, Gabriele; Nava, Caroline; Baujat, Genevieve; Horn, Denise; Kini, Usha; Caliebe, Almuth; Alanay, Yasemin; Utine, Gulen Eda; Lev, Dorit; Kohlhase, Jurgen; Grix, Arthur W.; Lohmann, Dietmar R.; Hehr, Ute; Boehm, Detlef; Majewski, Jacek; Bulman, Dennis E.; Wieczorek, Dagmar; Boycott, Kym M.		FORGE Canada Consortium	Haploinsufficiency of a Spliceosomal GTPase Encoded by EFTUD2 Causes Mandibulofacial Dysostosis with Microcephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; TREACHER-COLLINS-SYNDROME; RIBOSOMAL TRANSLOCASE; CLEFT-PALATE; RNA; MUTATIONS; PROTEIN; HOMOLOG; SNU114P; GENE	Mandibulofacial dysostosis with microcephaly (MFDM) is a rare sporadic syndrome comprising craniofacial malformations, microcephaly, developmental delay, and a recognizable dysmorphic appearance. Major sequelae, including choanal atresia, sensorineural hearing loss, and cleft palate, each occur in a significant proportion of affected individuals. We present detailed clinical findings in 12 unrelated individuals with MFDM; these 12 individuals compose the largest reported cohort to date. To define the etiology of MFDM, we employed whole-exome sequencing of four unrelated affected individuals and identified heterozygous mutations or deletions of EFTUD2 in all four. Validation studies of eight additional individuals with MFDM demonstrated causative EFTUD2 mutations in all affected individuals tested. A range of EPTUD2-mutation types, including null alleles and frameshifts, is seen in MFDM, consistent with haploinsufficiency; segregation is de novo in all cases assessed to date. U5-116kD, the protein encoded by EFTUD2, is a highly conserved spliceosomal GTPase with a central regulatory role in catalytic splicing and post-splicing-complex disassembly. MFDM is the fast multiple-malformation syndrome attributed to a defect of the major spliceosome. Our findings significantly extend the range of reported spliceosomal phenotypes in humans and pave the way for further investigation in related conditions such as Treacher Collins syndrome.	[Lines, Matthew A.; Huang, Lijia; Douglas, Stuart L.; Lynch, Danielle C.; Beaulieu, Chandree; Boycott, Kym M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Schwartzentruber, Jeremy] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Guion-Almeida, Maria Leine; Zechi-Ceide, Roseli Maria] Univ Sao Paulo, Hosp Rehabil Craniofacial Anomalies, Dept Clin Genet, BR-17012900 Bauru, Brazil; [Gener, Blanca] Hosp Univ Cruces, Dept Pediat, Baracaldo 48903, Vizcaya, Spain; [Gillessen-Kaesbach, Gabriele] Univ Klinikum Schleswig Holstein, D-23538 Lubeck, Germany; [Nava, Caroline; Baujat, Genevieve] Hop Necker Enfants Malad, Ctr Reference Malad Osseuses Constitut, Dept Genet, F-75015 Paris, France; [Horn, Denise] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Kini, Usha] Oxford Radcliffe Hosp Natl Hlth Serv Trust, Dept Clin Genet, Oxford OX3 7LJ, England; [Kini, Usha] Oxford Radcliffe Hosp Natl Hlth Serv Trust, Spires Cleft Lip & Palate Ctr, Oxford OX3 7LJ, England; [Caliebe, Almuth] Univ Kiel, Inst Human Genet, D-24105 Kiel, Germany; [Alanay, Yasemin; Utine, Gulen Eda] Hacettepe Univ, Fac Med, Dept Pediat, Pediat Genet Unit, TR-06532 Ankara, Turkey; [Alanay, Yasemin] Acibadem Univ, Dept Pediat, Pediat Genet Unit, TR-34457 Istanbul, Turkey; [Lev, Dorit] Wolfson Med Ctr, Inst Med Genet, IL-58100 Holon, Israel; [Kohlhase, Jurgen; Boehm, Detlef] Ctr Human Genet Freiburg, D-79100 Freiburg, Germany; [Grix, Arthur W.] Kaiser Permanente, Sacramento, CA 95815 USA; [Lohmann, Dietmar R.; Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, D-45147 Essen, Germany; [Hehr, Ute] Univ Regensburg, Dept Human Genet, D-93053 Regensburg, Germany; [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Bulman, Dennis E.] Ottawa Hosp, Res Inst, Ottawa, ON K1Y 4E9, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; McGill University; Universidade de Sao Paulo; Hospital Universitario Cruces; University of Kiel; Schleswig Holstein University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Hacettepe University; Acibadem University; Kaiser Permanente; University of Duisburg Essen; University of Regensburg; McGill University; University of Ottawa; Ottawa Hospital Research Institute	Boycott, KM (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.	kboycott@cheo.on.ca	Gener, Blanca/E-4310-2012; Wieczorek, Dagmar/AAU-6008-2021; Zechi-Ceide, Roseli/I-8178-2013; Caliebe, Almuth/G-1248-2018; Lohmann, Dietmar R./X-4895-2019; Douglas, Stuart/K-6292-2019; Lines, Matthew/M-4540-2018; Scherer, Stephen W./B-3785-2013; Lohmann, Dietmar R/B-4041-2013; Alanay, Yasemin/A-1516-2016; , Ivan/D-6804-2012	Wieczorek, Dagmar/0000-0003-2812-6492; Zechi-Ceide, Roseli/0000-0002-4526-3336; Caliebe, Almuth/0000-0003-2157-425X; Lohmann, Dietmar R./0000-0002-2624-9889; Scherer, Stephen W./0000-0002-8326-1999; Lohmann, Dietmar R/0000-0002-2624-9889; Alanay, Yasemin/0000-0003-0683-9731; , Ivan/0000-0002-3108-058X; Nava, Caroline/0000-0003-1272-0518; Schwartzentruber, Jeremy/0000-0002-6183-2092	government of Canada through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; Physicians' Services Incorporated Foundation; German Ministry of Research and Education [BMBF 01GM0802]; CIHR Institute of Genetics	government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; Physicians' Services Incorporated Foundation; German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF)); CIHR Institute of Genetics(Canadian Institutes of Health Research (CIHR))	The authors would first like to thank the study participants and their families, without whose participation this work would not be possible. This work was funded by the government of Canada through Genome Canada, the Canadian Institutes of Health Research (CIHR), and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec, Genome British Columbia, and the Physicians' Services Incorporated Foundation. This work was part of the CRANIRARE Network funded through a grant from the German Ministry of Research and Education to D.R.L. and D.W. (BMBF 01GM0802). K.M.B. is supported by a Clinical Investigatorship Award from the CIHR Institute of Genetics. This work was selected for study by the FORGE Canada Steering Committee, consisting of K. Boycott (University of Ottawa), J. Friedman (University of British Columbia), J. Michaud (University of Montreal), F. Bernier (University of Calgary), M. Brudno (University of Toronto), B. Fernandez (Memorial University), B. Knoppers (McGill University), M. Samuels (Universite de Montreal), and S. Scherer (University of Toronto). We would like to thank Janet Marcadier (clinical coordinator) for her contribution to the infrastructure of the FORGE Canada Consortium. We also wish to acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre, Montreal, Canada.	Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Bartels C, 2003, J BIOL CHEM, V278, P28324, DOI 10.1074/jbc.M303043200; Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Brenner TJ, 2005, GENETICS, V170, P1063, DOI 10.1534/genetics.105.042044; Dauwerse JG, 2011, NAT GENET, V43, P20, DOI 10.1038/ng.724; Dixon J, 1996, NAT GENET, V12, P130; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Guion-Almeida ML, 2006, CLIN DYSMORPHOL, V15, P171, DOI 10.1097/01.mcd.0000220603.09661.7e; Guion-Almeida ML, 2009, AM J MED GENET A, V149A, P2762, DOI 10.1002/ajmg.a.32816; Hacker I, 2008, NAT STRUCT MOL BIOL, V15, P1206, DOI 10.1038/nsmb.1506; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Schneider C, 2002, MOL CELL BIOL, V22, P3219, DOI 10.1128/MCB.22.10.3219-3229.2002; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Tanackovic G, 2011, AM J HUM GENET, V88, P643, DOI 10.1016/j.ajhg.2011.04.008; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wieczorek D, 2009, AM J MED GENET A, V149A, P837, DOI 10.1002/ajmg.a.32747; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020	25	132	139	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					369	377		10.1016/j.ajhg.2011.12.023	http://dx.doi.org/10.1016/j.ajhg.2011.12.023			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22305528	Green Published, hybrid			2022-12-18	WOS:000300742200020
J	Tavtigian, SV; Oefner, PJ; Babikyan, D; Hartmann, A; Healey, S; Le Calvez-Kelm, F; Lesueur, F; Byrnes, GB; Chuang, SC; Forey, N; Feuchtinger, C; Gioia, L; Hall, J; Hashibe, M; Herte, B; McKay-Chopin, S; Thomas, A; Vallee, MP; Voegele, C; Webb, PM; Whiteman, DC; Sangrajrang, S; Hopper, JL; Southey, MC; Andrulis, IL; John, EM; Chenevix-Trench, G				Tavtigian, Sean V.; Oefner, Peter J.; Babikyan, Davit; Hartmann, Anne; Healey, Sue; Le Calvez-Kelm, Florence; Lesueur, Fabienne; Byrnes, Graham B.; Chuang, Shu-Chun; Forey, Nathalie; Feuchtinger, Corinna; Gioia, Lydie; Hall, Janet; Hashibe, Mia; Herte, Barbara; McKay-Chopin, Sandrine; Thomas, Alun; Vallee, Maxime P.; Voegele, Catherine; Webb, Penelope M.; Whiteman, David C.; Sangrajrang, Suleeporn; Hopper, John L.; Southey, Melissa C.; Andrulis, Irene L.; John, Esther M.; Chenevix-Trench, Georgia		Australian Canc Study; BCFR; Kathleen Cuningham Fdn Consortium	Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATAXIA-TELANGIECTASIA GENE; RESOLUTION MELTING ANALYSIS; AFFECT PROTEIN FUNCTION; EARLY-ONSET; ALLELIC VARIANTS; FAMILIAL BREAST; TRUNCATING MUTATIONS; DNA-DAMAGE; SUSCEPTIBILITY ALLELES; GERMLINE MUTATIONS	The susceptibility gene for ataxia telangiectasia, ATM, is also an intermediate-risk breast-cancer-susceptibility gene. However, the spectrum and frequency distribution of ATM mutations that confer increased risk of breast cancer have been controversial. To assess the contribution of rare variants in this gene to risk of breast cancer, we pooled data from seven published ATM case-control mutation-screening studies, including a total of 1544 breast cancer cases and 1224 controls, with data from our own mutation screening of an additional 987 breast cancer cases and 1021 controls. Using an in silico missense-substitution analysis that provides a ranking of missense substitutions from evolutionarily most likely to least likely, we carried out analyses of protein-truncating variants, splice-junction variants, and rare missense variants. We found marginal evidence that the combination of ATM protein-truncating and splice-junction variants contribute to breast cancer risk. There was stronger evidence that a subset of rare, evolutionarily unlikely missense substitutions confer increased risk. On the basis of subset analyses, we hypothesize that rare missense substitutions falling in and around the FAT, kinase, and FATC domains of the protein may be disproportionately responsible for that risk and that a subset of these may confer higher risk than do protein-truncating variants. We conclude that a comparison between the graded distributions of missense substitutions in cases versus controls can complement analyses of truncating variants and help identify susceptibility genes and that this approach will aid interpretation of the data emerging from new sequencing technologies.	[Healey, Sue; Webb, Penelope M.; Whiteman, David C.; Chenevix-Trench, Georgia; Australian Canc Study] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Tavtigian, Sean V.; Babikyan, Davit; Le Calvez-Kelm, Florence; Lesueur, Fabienne; Byrnes, Graham B.; Chuang, Shu-Chun; Forey, Nathalie; Gioia, Lydie; Hashibe, Mia; McKay-Chopin, Sandrine; Vallee, Maxime P.; Voegele, Catherine] Int Agcy Res Canc, F-69372 Lyon, France; [Oefner, Peter J.; Hartmann, Anne; Feuchtinger, Corinna; Herte, Barbara] Univ Regensburg, Inst Funct Gen, D-93053 Regensburg, Germany; [Hall, Janet] INSERM, Inst Curie Rech, U612, F-91405 Orsay, France; [Thomas, Alun] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT 84112 USA; [Kathleen Cuningham Fdn Consortium] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Sangrajrang, Suleeporn] Natl Canc Inst, Div Res, Bangkok 10400, Thailand; [Hopper, John L.; Southey, Melissa C.] Univ Melbourne, Ctr MEGA Epidemiol, Carlton, Vic 3010, Australia; [Andrulis, Irene L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [John, Esther M.] No Calif Canc Ctr, Fremont, CA 94538 USA; [John, Esther M.; BCFR] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	QIMR Berghofer Medical Research Institute; World Health Organization; International Agency for Research on Cancer (IARC); University of Regensburg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Utah System of Higher Education; University of Utah; Peter Maccallum Cancer Center; National Cancer Institute - Thailand; University of Melbourne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Stanford University	Chenevix-Trench, G (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	georgia.trench@qimr.edu.au	Webb, Penelope/D-5736-2013; Chenevix-Trench, Georgia/AAV-2014-2020; hall, janet/G-1372-2013; Andrulis, Irene L./E-7267-2013; Whiteman, David C/P-2728-2014; Chuang, Shu-Chun/N-3358-2013; Lesueur, Fabienne/R-2178-2017	Webb, Penelope/0000-0003-0733-5930; Chenevix-Trench, Georgia/0000-0002-1878-2587; hall, janet/0000-0002-4397-6295; Whiteman, David C/0000-0003-2563-9559; Lesueur, Fabienne/0000-0001-7404-4549; Byrnes, Graham/0000-0003-3893-7539; Thorne, Heather/0000-0003-3610-2511; Southey, Melissa/0000-0002-6313-9005; Vallee, Maxime/0000-0002-3616-9508; Thomas, Alun/0000-0001-5650-7044; Le Calvez-Kelm, Florence/0000-0003-0063-5068	NATIONAL CANCER INSTITUTE [U01CA069638, R01CA121245, R01CA100352, U01CA069467, U01CA069417] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA69467, U01 CA069638, U01 CA69417, U01 CA069417, U01 CA069467, R01 CA121245, R01-CA121245, R01 CA100352, R01-CA100352, U01 CA69638] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTMAN DG, 1991, BRIT J CANCER, V64, P975, DOI 10.1038/bjc.1991.441; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angele S, 2003, CANCER RES, V63, P8717; Atencio DP, 2001, ENVIRON MOL MUTAGEN, V38, P200, DOI 10.1002/em.1072; Bebb DG, 1999, BRIT J CANCER, V80, P1979, DOI 10.1038/sj.bjc.6690630; Becker-Catania SG, 2000, MOL GENET METAB, V70, P122, DOI 10.1006/mgme.2000.2998; Bernstein JL, 2003, HUM MUTAT, V21, P542, DOI 10.1002/humu.10206; BOGDANOVA N, 2009, BREAST CANC IN PRESS; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; Broeks A, 2008, BREAST CANCER RES TR, V107, P243, DOI 10.1007/s10549-007-9543-6; Broeks A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1668; Brunet J, 2008, CLIN GENET, V73, P465, DOI 10.1111/j.1399-0004.2008.00987.x; Buchholz TA, 2004, CANCER, V100, P1345, DOI 10.1002/cncr.20133; Chen JD, 1998, CANCER RES, V58, P1376; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; Concannon P, 2008, CANCER RES, V68, P6486, DOI 10.1158/0008-5472.CAN-08-0134; Couch FJ, 2008, HUM MUTAT, V29, P1314, DOI 10.1002/humu.20899; Dork T, 2001, CANCER RES, V61, P7608; Drumea KC, 2000, BREAST CANCER RES TR, V61, P79, DOI 10.1023/A:1006463730337; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Fernandes N, 2005, J BIOL CHEM, V280, P15158, DOI 10.1074/jbc.M412065200; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Gonzalez-Hormazabal P, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-117; Goudet J., 2001, CLADISTICS; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Guthery SL, 2007, AM J HUM GENET, V81, P1221, DOI 10.1086/522239; Heikkinen K, 2005, INT J CANCER, V116, P69, DOI 10.1002/ijc.20996; Hirsch AE, 2008, BREAST CANCER RES TR, V107, P139, DOI 10.1007/s10549-007-9531-x; Ho AY, 2007, INT J RADIAT ONCOL, V69, P677, DOI 10.1016/j.ijrobp.2007.04.012; Iannuzzi CM, 2002, INT J RADIAT ONCOL, V52, P606, DOI 10.1016/S0360-3016(01)02684-0; Izatt L, 1999, GENE CHROMOSOME CANC, V26, P286, DOI 10.1002/(SICI)1098-2264(199912)26:4<286::AID-GCC2>3.0.CO;2-X; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lim DS, 1998, P NATL ACAD SCI USA, V95, P10146, DOI 10.1073/pnas.95.17.10146; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Maillet P, 2002, J MED GENET, V39, P751, DOI 10.1136/jmg.39.10.751; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Mitui M, 2009, HUM MUTAT, V30, P12, DOI 10.1002/humu.20805; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nguyen-Dumont T, 2009, HUM MUTAT, V30, P884, DOI 10.1002/humu.20949; Offit K, 2002, CLIN CANCER RES, V8, P3813; Oppitz U, 1999, INT J RADIAT ONCOL, V44, P981, DOI 10.1016/S0360-3016(99)00108-X; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Pylkas K, 2007, CARCINOGENESIS, V28, P1040, DOI 10.1093/carcin/bgl237; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Ramsay J, 1998, RADIOTHER ONCOL, V47, P125, DOI 10.1016/S0167-8140(98)00014-0; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Rodriguez C, 2002, GENE CHROMOSOME CANC, V33, P141, DOI 10.1002/gcc.1222; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sangrajrang S, 2007, BIOMARKERS, V12, P523, DOI 10.1080/13547500701395602; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Scott SP, 2002, P NATL ACAD SCI USA, V99, P925, DOI 10.1073/pnas.012329699; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shafman TD, 2000, GENE CHROMOSOME CANC, V27, P124, DOI 10.1002/(SICI)1098-2264(200002)27:2<124::AID-GCC2>3.0.CO;2-M; Shayeghl M, 1998, BRIT J CANCER, V78, P922, DOI 10.1038/bjc.1998.602; Sodha N, 2006, CANCER RES, V66, P8966, DOI 10.1158/0008-5472.CAN-06-1990; Sommer SS, 2003, CANCER GENET CYTOGEN, V145, P115, DOI 10.1016/S0165-4608(03)00119-5; Soukupova J, 2008, ONCOL REP, V19, P1505; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Spring K, 2001, CANCER RES, V61, P4561; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Takano EA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-59; Tapia T, 2008, BREAST CANCER RES TR, V107, P281, DOI 10.1007/s10549-007-9544-5; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; TAVTIGIAN SV, 1997, ACCOMPLISHMENTS CANC, P189; TAVTIGIAN SV, 2007, HEREDITARY BREAST CA, P179; Teraoka SN, 2001, CANCER-AM CANCER SOC, V92, P479, DOI 10.1002/1097-0142(20010801)92:3<479::AID-CNCR1346>3.0.CO;2-G; Thompson D, 2004, J MAMMARY GLAND BIOL, V9, P221, DOI 10.1023/B:JOMG.0000048770.90334.3b; Thorstenson YR, 2003, CANCER RES, V63, P3325; Thorstenson YR, 2001, AM J HUM GENET, V69, P396, DOI 10.1086/321296; Uziel T, 1996, GENOMICS, V33, P317, DOI 10.1006/geno.1996.0201; Voegele C, 2007, BIOINFORMATICS, V23, P2504, DOI 10.1093/bioinformatics/btm365; Vorechovsky I, 1996, CANCER RES, V56, P4130; Vorechovsky I, 1996, CANCER RES, V56, P2726; Waddell N, 2006, GENE CHROMOSOME CANC, V45, P1169, DOI 10.1002/gcc.20381; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375	94	132	136	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					427	446		10.1016/j.ajhg.2009.08.018	http://dx.doi.org/10.1016/j.ajhg.2009.08.018			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19781682	Green Published, Bronze			2022-12-18	WOS:000270836000001
J	Adams, SM; Bosch, E; Balaresque, PL; Ballereau, SJ; Lee, AC; Arroyo, E; Lopez-Parra, AM; Aler, M; Grifo, MSG; Brion, M; Carracedo, A; Lavinha, J; Martinez-Jarreta, B; Quintana-Murci, L; Picornell, A; Ramon, M; Skorecki, K; Behar, DM; Calafell, F; Jobling, MA				Adams, Susan M.; Bosch, Elena; Balaresque, Patricia L.; Ballereau, Stephane J.; Lee, Andrew C.; Arroyo, Eduardo; Lopez-Parra, Ana M.; Aler, Mercedes; Grifo, Marina S. Gisbert; Brion, Maria; Carracedo, Angel; Lavinha, Joao; Martinez-Jarreta, Begona; Quintana-Murci, Lluis; Picornell, Antonia; Ramon, Misericordia; Skorecki, Karl; Behar, Doron M.; Calafell, Francesc; Jobling, Mark A.			The Genetic Legacy of Religious Diversity and Intolerance: Paternal Lineages of Christians, Jews, and Muslims in the Iberian Peninsula	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; INFERRING ADMIXTURE PROPORTIONS; SEQUENCE VARIATION; MOLECULAR-DATA; DNA VARIATION; NORTH-AFRICA; EUROPE; MTDNA; POPULATION; POOL	Most studies of European genetic diversity have focused on large-scale variation and interpretations based on events in prehistory, but migrations and invasions in historical times could also have had profound effects on the genetic landscape. The Iberian Peninsula provides a suitable region for examination of the demographic impact of such recent events, because its complex recent history has involved the long-term residence of two very different populations with distinct geographical origins and their own particular cultural and religious characteristics-North African Muslims and Sephardic Jews. To address this issue, we analyzed Y chromosome haplotypes, which provide the necessary phylogeographic resolution, in 1140 males from the Iberian Peninsula and Balearic Islands. Admixture analysis based on binary and Y-STR haplotypes indicates a high mean proportion of ancestry from North African (10.6%) and Sephardic Jewish (19.8%) sources. Despite alternative possible sources for lineages ascribed a Sephardic Jewish origin, these proportions attest to a high level of religious conversion (whether voluntary or enforced), driven by historical episodes of social and religious intolerance, that ultimately led to the integration of descendants. In agreement with the historical record, analysis of haplotype sharing and diversity within specific haplogroups suggests that the Sephardic Jewish component is the more ancient. The geographical distribution of North African ancestry in the peninsula does not reflect the initial colonization and subsequent withdrawal and is likely to result from later enforced Population movement-more marked in some regions than in others-plus the effects of genetic drift.	[Adams, Susan M.; Bosch, Elena; Balaresque, Patricia L.; Ballereau, Stephane J.; Lee, Andrew C.; Jobling, Mark A.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Arroyo, Eduardo; Lopez-Parra, Ana M.] Univ Complutense Madrid, Fac Med, Dept Toxicol & Legislac Sanitaria, Lab Genet Forense & Genet Poblac, E-28040 Madrid, Spain; [Aler, Mercedes; Grifo, Marina S. Gisbert] Univ Valencia, Fac Med, Secc Biol Forense, Unidad Docente Med Legal, Valencia 46010, Spain; [Brion, Maria; Carracedo, Angel] Univ Santiago, Fac Med, Xenom Hosp Clin Univ, Inst Med Legal, Santiago De Compostela 15706, Spain; [Lavinha, Joao] Inst Nacl Saude Dr Ricardo Jorge, Ctr Genet Humana, P-1649016 Lisbon, Portugal; [Martinez-Jarreta, Begona] Univ Zaragoza, Unidad Docente Med Legal & Forense, E-50009 Zaragoza, Spain; [Quintana-Murci, Lluis] Inst Pasteur, CNRS, URA3012, Unit Human Evolutionary Genet, F-75015 Paris, France; [Picornell, Antonia; Ramon, Misericordia] Univ Illes Balears, IUNICS, Genet Lab, Palma de Mallorca 07122, Spain; [Picornell, Antonia; Ramon, Misericordia] Univ Illes Balears, Dept Biol, Palma de Mallorca 07122, Spain; [Skorecki, Karl; Behar, Doron M.] Mol Med Lab, IL-31096 Haifa, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Calafell, Francesc] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Inst Evolutionary Biol, UPF CSIC, Barcelona 08003, Spain	University of Leicester; Complutense University of Madrid; University of Valencia; Universidade de Santiago de Compostela; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Zaragoza; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Universitat de les Illes Balears; Universitat de les Illes Balears; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Jobling, MA (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	rnaj4@leicester.ac.uk	RAMON, M MISERICORDIA/Y-2497-2018; Ballereau, Stephane/AAM-4883-2020; Picornell, Antonia/H-5072-2017; Quintana-Murci, Lluis/AAB-7468-2022; Pardo, Eduardo Arroyo/L-2240-2014; BALARESQUE, Patricia/G-3731-2010; Bosch, Elena/D-8681-2014; PARRA, ANA MARIA LOPEZ/L-1911-2014; Carracedo, Angel/D-4257-2012; Brion, Maria/J-8059-2014; Calafell, Francesc/C-8595-2014; Bosch, Elena/N-7603-2019; Lopez, Ana/T-7670-2019; Martinez-Jarreta, Begona/AAE-5805-2020	RAMON, M MISERICORDIA/0000-0003-1234-3337; Ballereau, Stephane/0000-0002-8479-3110; Picornell, Antonia/0000-0003-4454-5304; Pardo, Eduardo Arroyo/0000-0003-1851-0589; Bosch, Elena/0000-0003-2848-103X; PARRA, ANA MARIA LOPEZ/0000-0001-8974-1005; Carracedo, Angel/0000-0003-1085-8986; Brion, Maria/0000-0001-7463-2148; Calafell, Francesc/0000-0002-1083-9438; Bosch, Elena/0000-0003-2848-103X; Lopez, Ana/0000-0001-8974-1005; Martinez-Jarreta, Begona/0000-0001-6469-9189; Lavinha, Joao/0000-0002-7474-6871; Jobling, Mark/0000-0002-8061-1308; Quintana-Murci, Lluis/0000-0003-2429-6320; BALARESQUE, Patricia/0000-0003-3516-5537	Wellcome Trust Senior Fellowship in Basic Biomedical Science [057559]; Wellcome Trust	Wellcome Trust Senior Fellowship in Basic Biomedical Science(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank all DNA donors, and we thank Santos Alonso, Jaume Bertranpetit, Helena Corte-Real, Adolfo Lopez de Munain and Carlos Polanco for provision of samples. We also thank Dolors Bramon (University of Barcelona) for historical advice and two anonymous reviewers for helpful comments. M.A.J. was supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (grant no. 057559), and S.M.A., E.B., P.L.B., SJ.B., and A.C.L. were supported by the Wellcome Trust.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Adams SM, 2006, FORENSIC SCI INT, V159, P14, DOI 10.1016/j.forsciint.2005.06.003; Anderung C, 2005, P NATL ACAD SCI USA, V102, P8431, DOI 10.1073/pnas.0503396102; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BAROJA JC, 2001, JUDIOS ESPANA MODERN, V1, P198; BEHAR D, 2006, ENCY JUDAICA, P450; Beleza S, 2006, ANN HUM GENET, V70, P181, DOI 10.1111/j.1529-8817.2005.00221.x; Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; Boone JL, 1999, ANNU REV ANTHROPOL, V28, P51, DOI 10.1146/annurev.anthro.28.1.51; Bosch E, 2002, FORENSIC SCI INT, V125, P42, DOI 10.1016/S0379-0738(01)00627-2; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; Bowden GR, 2008, MOL BIOL EVOL, V25, P301, DOI 10.1093/molbev/msm255; Brion M, 2005, INT J LEGAL MED, V119, P10, DOI 10.1007/s00414-004-0439-2; Brion M, 2003, AM J PHYS ANTHROPOL, V122, P147, DOI 10.1002/ajpa.10231; Bulliet R., 1979, CONVERSION ISLAM MED; CALAFELL F, 1994, AM J PHYS ANTHROPOL, V93, P201, DOI 10.1002/ajpa.1330930205; Carr Raymond, 2000, SPAIN HIST; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Collins R, 1989, ARAB CONQUEST SPAIN, P710; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Dupanloup I, 2004, MOL BIOL EVOL, V21, P1361, DOI 10.1093/molbev/msh135; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ellis N, 2002, GENOME RES, V12, P339; ESCACENA JL, 2000, PREHISTORIC IBERIA G; Fernandez-Santander A, 1999, AM J HUM BIOL, V11, P745, DOI 10.1002/(SICI)1520-6300(199911/12)11:6<745::AID-AJHB4>3.0.CO;2-W; Fletcher Richard, 1992, MOORISH SPAIN; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; FOSS A, 1975, IBIZA MINORCA; Gerber JS, 1992, JEWS SPAIN HIST SEPH; Glick T., 1979, ISLAMIC CHRISTIAN SP; Goncalves R, 2005, ANN HUM GENET, V69, P443, DOI 10.1111/j.1529-8817.2005.00161.x; Guichard Pierre, 1976, ALANDALUS ESTRUCTURA; Harvey L. P., 2005, MUSLIMS SPAIN 1500 1; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; MACKAY A, 1992, SPAIN JEWS SEPHARDI; Pereira L, 2005, HUM BIOL, V77, P213, DOI 10.1353/hub.2005.0041; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Picornell A, 2006, INT J LEGAL MED, V120, P271, DOI 10.1007/s00414-006-0083-0; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; REYMENT RA, 1983, ANN HUM BIOL, V10, P505, DOI 10.1080/03014468300006741; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Robino C, 2008, INT J LEGAL MED, V122, P251, DOI 10.1007/s00414-007-0203-5; Roewer L, 2005, HUM GENET, V116, P279, DOI 10.1007/s00439-004-1201-z; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Schlecht J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000093; Schneider S., 2000, ARLEQUIN VER 2 0 SOF; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Weale ME, 2002, MOL BIOL EVOL, V19, P1008, DOI 10.1093/oxfordjournals.molbev.a004160; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012; 1147, EXPUGNATIONE LYXBONE, P125	68	132	133	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					725	736		10.1016/j.ajhg.2008.11.007	http://dx.doi.org/10.1016/j.ajhg.2008.11.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	385NY	19061982	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000261822100007
J	Kato, M; Saitoh, S; Kamei, A; Shiraishi, H; Ueda, Y; Akasaka, M; Tohyama, J; Akasaka, N; Hayasaka, K				Kato, Mitsuhiro; Saitoh, Shinji; Kamei, Atsushi; Shiraishi, Hideaki; Ueda, Yuki; Akasaka, Manami; Tohyama, Jun; Akasaka, Noriyuki; Hayasaka, Kiyoshi			A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; HOMEOBOX GENE; WEST-SYNDROME; ABNORMAL GENITALIA; TRACT; DISORDERS; DYSTONIA; REPEAT; SPASMS	Early infantile epileptic encephalopathy with suppression-burst pattern (EIEE) is one of the most severe and earliest forms of epilepsx,, often evolving into West syndrome; however, the pathogenesis of EIEE remains unclear. ARX is a crucial,gene for the development of interneurons in the fetal brain, and a polyalanine expansion mutation of APX causes mental retardation and seizures, including those of West syndrome, in males. We screened the ARX mutation and found a hemizygous, de novo, 33-bp duplication in exon 2, 298_330dupGCGGCA(GCG)(9), in two of three unrelated male patients with ElEE. This mutation is thought to expand the original 16 alanine residues to 27 alanine residues (A110_A111 insAAAAAAAAAAA) in the first polyalanine tract of the ARX protein. Although ElEE is mainly associated with brain malformations, ARX is the first gene found to be responsible for idiopathic EIEE. Our observation that ElEE had a longer expansion of the polyalanine tract than is seen in West syndrome is consistent with the findings of earlier onset and more-severe phenotypes in ElEE than in West syndrome.	Yamagata Univ, Sch Med, Dept Pediat, Yamagata 990, Japan; Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 060, Japan; Nishi Niigata Chuo Natl Hosp, Dept Pediat, Niigata, Japan; Iwate Med Univ, Dept Pediat, Morioka, Iwate, Japan	Yamagata University; Hokkaido University; Iwate Medical University	Kato, M (corresponding author), 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	mkato@med.id.yamagata-u.ac.jp	Hayasaka, Kiyoshi/H-5340-2012; Shiraishi, Hideaki/A-8427-2012	Saitoh, Shinji/0000-0001-6911-3351; Hayasaka, Kiyoshi/0000-0003-3621-8901; Kato, Mitsuhiro/0000-0003-1485-8553				Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bonneau D, 2002, ANN NEUROL, V51, P340, DOI 10.1002/ana.10119; Brown LY, 2004, TRENDS GENET, V20, P51, DOI 10.1016/j.tig.2003.11.002; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Gronskov K, 2004, EUR J HUM GENET, V12, P701, DOI 10.1038/sj.ejhg.5201222; Hill ME, 2001, BRAIN, V124, P522, DOI 10.1093/brain/124.3.522; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kato M, 2005, J CHILD NEUROL, V20, P392, DOI 10.1177/08830738050200042001; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kato M, 2003, NEUROLOGY, V61, P267, DOI 10.1212/01.WNL.0000068012.69928.92; Kato M, 2006, EPILEPSY RES, V70, pS87, DOI 10.1016/j.eplepsyres.2006.02.008; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Lavoie H, 2003, HUM MOL GENET, V12, P2967, DOI 10.1093/hmg/ddg329; McKenzie O, 2007, NEUROSCIENCE, V146, P236, DOI 10.1016/j.neuroscience.2007.01.038; Miller SP, 1998, PEDIATR NEUROL, V19, P50, DOI 10.1016/S0887-8994(98)00009-5; MIYAKE S, 1987, SHONIKA RINSHO, V40, P1681; Nasrallah IM, 2004, J CELL BIOL, V167, P411, DOI 10.1083/jcb.200408091; Ohtahara S., 1976, NO TO HATTATSU TOKYO, V8, P270, DOI DOI 10.11251/OJJSCN1969.8.270; Ohtahara S, 2006, EPILEPSY RES, V70, pS58, DOI 10.1016/j.eplepsyres.2005.11.021; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Trochet D, 2005, HUM MOL GENET, V14, P3697, DOI 10.1093/hmg/ddi401; Van Esch H, 2004, CLIN GENET, V65, P503, DOI 10.1111/j.1399-0004.2004.00256.x; Wohlrab G, 2005, EUR J PEDIATR, V164, P326, DOI 10.1007/s00431-005-1622-2; YAMAMOTO T, 2002, ADV POLAR UPPER ATMO, V16, P13	29	132	139	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					361	366		10.1086/518903	http://dx.doi.org/10.1086/518903			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668384	Green Published, Bronze			2022-12-18	WOS:000248540400014
J	Weeks, DE; Conley, YP; Tsai, HJ; Mah, TS; Schmidt, S; Postel, EA; Agarwal, A; Haines, JL; Pericak-Vance, MA; Rosenfeld, PJ; Paul, TO; Eller, AW; Morse, LS; Dailey, JP; Ferrell, RE; Gorin, MB				Weeks, DE; Conley, YP; Tsai, HJ; Mah, TS; Schmidt, S; Postel, EA; Agarwal, A; Haines, JL; Pericak-Vance, MA; Rosenfeld, PJ; Paul, TO; Eller, AW; Morse, LS; Dailey, JP; Ferrell, RE; Gorin, MB			Age-related maculopathy: A genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-E GENE; MACULAR DEGENERATION; LINKAGE ANALYSIS; EPSILON-4 ALLELE; SMOKING; ASSOCIATION; MUTATION; PROGRAM; DISEASE; MODELS	Age-related maculopathy (ARM), or age-related macular degeneration, is one of the most common causes of visual impairment in the elderly population of developed nations. In a combined analysis of two previous genomewide scans that included 391 families, containing up to 452 affected sib pairs, we found linkage evidence in four regions: 1q31, 9p13, 10q26, and 17q25. We now have added a third set of families and have performed an integrated analysis incorporating 530 families and up to 736 affected sib pairs. Under three diagnostic models, we have conducted linkage analyses using parametric (heterogeneity LOD [HLOD] scores under an autosomal dominant model) and nonparametric (S-all statistic) methods. There is ongoing evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. If we treat the third set of families as a replication set, then two regions ( 10q26 and 17q25) are replicated, with LOD scores >1.0. If we pool all our data together, then four regions (1q31, 2q14.3, 10q26, and 17q25) show HLOD or S-all scores greater than or equal to2.0. Within the 1q31 region, we observed an HLOD of 2.72 (genomewide P = .061) under our least stringent diagnostic model, whereas the 17q25 region contained a maximal HLOD of 3.53 (genomewide P = .007) under our intermediate diagnostic model. We have evaluated our results with respect to the findings from several new independent genomewide linkage studies and also have completed ordered subset analyses (OSAs) with apolipoprotein E alleles, smoking history, and age at onset as stratifying covariates. The OSAs generate the interesting hypothesis that the effect of smoking on the risk of ARM is accentuated by a gene in the 10q26 region - a region implicated by four other studies.	Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA USA; Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; Duke Univ, Med Ctr, Dept Ophthalmol, Duke Eye Ctr, Durham, NC USA; Duke Univ, Med Ctr, Ctr Human Genet, Dept Med, Durham, NC USA; Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Ophthalmol, Nashville, TN USA; Univ Miami, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33152 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA; Univ Calif Davis, Dept Ophthalmol, Davis, CA 95616 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; Duke University; Vanderbilt University; Vanderbilt University; Bascom Palmer Eye Institute; University of Miami; The Smith-Kettlewell Eye Research Institute; University of California System; University of California Davis; Case Western Reserve University	Gorin, MB (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Eye & Ear Inst Bldg,203 Lothrop St, Pittsburgh, PA 15213 USA.	gorinmb@upmc.edu	Tsai, Hui-Ju/E-3937-2010; Weeks, Daniel E/B-2995-2012; Haines, Jonathan/C-3374-2012	Weeks, Daniel E/0000-0001-9410-7228; Haines, Jonathan/0000-0002-4351-4728; Morse, Lawrence/0000-0002-1758-2348	NATIONAL EYE INSTITUTE [R01EY009859] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY09859, R01 EY009859] Funding Source: Medline; NHGRI NIH HHS [N01-HG-48141, N01HG65403] Funding Source: Medline; NHLBI NIH HHS [N01HV48141] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Bonastre J, 2003, PHARMACOECONOMICS, V21, P181, DOI 10.2165/00019053-200321030-00003; Breitner JCS, 1998, ALZ DIS ASSOC DIS, V12, P40, DOI 10.1097/00002093-199803000-00006; Broman KW, 2001, GENET EPIDEMIOL, V20, P307, DOI 10.1002/gepi.2; Cordell HJ, 2001, ANN HUM GENET, V65, P491, DOI 10.1017/S0003480001008831; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Gorin MB, 1998, OX MG MED G, P407; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hauser ER, 1998, BIOMETRICS, V54, P1238, DOI 10.2307/2533653; Hauser ER, 2001, AM J HUM GENET, V69, P529; HAUSER ER, 2004, IN PRESS GENET EPIDE, V27; HODGE SE, 1983, AM J HUM GENET, V35, P1139; Hooper CY, 2003, CLIN EXP OPHTHALMOL, V31, P376, DOI 10.1046/j.1442-9071.2003.00683.x; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kenealy SJ, 2004, MOL VIS, V10, P57; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klaver CCW, 1997, ARCH OPHTHALMOL-CHIC, V115, P945, DOI 10.1001/archopht.1997.01100160115033; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Mandal N, 2002, BRIT J OPHTHALMOL, V86, P118, DOI 10.1136/bjo.86.1.118; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1992, AM J HUM GENET, V51, P283; Pang CP, 2000, OPHTHALMOLOGICA, V214, P289, DOI 10.1159/000027506; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Schultz DW, 2003, ARCH OPHTHALMOL-CHIC, V121, P679, DOI 10.1001/archopht.121.5.679; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; SCHULTZ DW, 2003, ASS RES VIS OPHTH M; SCHWARTZ B, 1994, SURV OPHTHALMOL, V39, P1, DOI 10.1016/S0039-6257(05)80040-2; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2001, HUM MOL GENET, V10, P2285, DOI 10.1093/hmg/10.20.2285; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Tamakoshi A, 1998, BRIT J OPHTHALMOL, V82, P207; Tamakoshi A, 1997, BRIT J OPHTHALMOL, V81, P901, DOI 10.1136/bjo.81.10.901; Vingerling JR, 1996, ARCH OPHTHALMOL-CHIC, V114, P1193, DOI 10.1001/archopht.1996.01100140393005; Watanabe RM, 1999, GENET EPIDEMIOL, V17, pS385; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4	51	132	140	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					174	189		10.1086/422476	http://dx.doi.org/10.1086/422476			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15168325	Bronze, Green Published			2022-12-18	WOS:000222702000003
J	Goldmuntz, E; Bamford, R; Karkera, JD; dela Cruz, J; Roessler, E; Muenke, M				Goldmuntz, E; Bamford, R; Karkera, JD; dela Cruz, J; Roessler, E; Muenke, M			CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEFT-RIGHT AXIS; CARDIAC-MALFORMATIONS; GENE; FREQUENCY; DEFECTS; ZIC3	Recent investigations identified heterozygous CFC1 mutations in subjects with heterotaxy syndrome, all of whom had congenital cardiac malformations, including malposition of the great arteries. We hypothesized that a subset of patients with similar types of congenital heart disease-namely, transposition of the great arteries and double-outlet right ventricle, in the absence of laterality defects-would also have CFC1 mutations. Our analysis of the CFC1 gene in patients with these cardiac disorders identified two disease-related mutations in 86 patients. The present study identifies the first autosomal single-gene defect for these cardiac malformations and indicates that some cases of transposition of the great arteries and double-outlet right ventricle can share a common genetic etiology with heterotaxy syndrome. In addition, these results demonstrate that the molecular pathway involving CFC1 plays a critical role in normal and abnormal cardiovascular development.	NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Muenke, M (corresponding author), NHGRI, Med Genet Branch, NIH, 10 Ctr Dr MSC 1852,Bldg 10,Room 10C103, Bethesda, MD 20892 USA.			Muenke, Maximilian/0000-0002-7719-6545	NHLBI NIH HHS [HL51533] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL051533] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000115, Z01HG000174] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Becker TA, 1996, AM J MED GENET, V66, P28, DOI 10.1002/(SICI)1096-8628(19961202)66:1<28::AID-AJMG7>3.0.CO;2-S; CASEY B, 1999, HEART DEV, P479; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; FERENCZ C, 1997, PERSPECTIVES PEDIAT, V5, P59; Fyler DC, 1992, NADAS PEDIAT CARDIOL; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Kathiriya IS, 2000, AM J MED GENET, V97, P271, DOI 10.1002/1096-8628(200024)97:4<271::AID-AJMG1277>3.0.CO;2-O; Megarbane A, 2000, EUR J HUM GENET, V8, P704, DOI 10.1038/sj.ejhg.5200526; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; PERRY LW, 1993, PERSPECTIVES PEDIAT, V4, P33; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shen MM, 1997, DEVELOPMENT, V124, P429; TAKAHASHI K, 1995, EUR J PEDIATR, V154, P878, DOI 10.1007/BF01957496; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	19	132	137	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					776	780		10.1086/339079	http://dx.doi.org/10.1086/339079			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11799476	Green Published, Bronze			2022-12-18	WOS:000173880000021
J	Czarny-Ratajczak, M; Lohiniva, J; Rogala, P; Kozlowski, K; Perala, M; Carter, L; Spector, TD; Kolodziej, L; Seppanen, U; Glazar, R; Krolewski, J; Latos-Bielenska, A; Ala-Kokko, L				Czarny-Ratajczak, M; Lohiniva, J; Rogala, P; Kozlowski, K; Perala, M; Carter, L; Spector, TD; Kolodziej, L; Seppanen, U; Glazar, R; Krolewski, J; Latos-Bielenska, A; Ala-Kokko, L			A mutation in COL9A1 causes multiple epiphyseal dysplasia: Further evidence for locus heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLIGOMERIC MATRIX PROTEIN; DOUBLE-LAYERED PATELLA; GENE-MUTATIONS; IX COLLAGEN; CARTILAGE; COMP; PSEUDOACHONDROPLASIA; IDENTIFICATION; CALCIUM; BINDING	Multiple epiphyseal dysplasia (MED) is an autosomal dominantly inherited chondrodysplasia. It is clinically highly heterogeneous, partially because of its complex genetic background. Mutations in four genes, COL9A2, COL9A3, COMP, and MATR3, all coding for cartilage extracellular matrix components (i.e., the alpha2 and alpha3 chains of collagen IX, cartilage oligomeric matrix protein, and matrilin-3), have been identified in this disease so far, but no mutations have yet been reported in the third collagen IX gene, COL9A1, which codes for the alpha1(IX) chain. MED with apparently recessive inheritance has been reported in some families. A homozygous R279W mutation was recently found in the diastrophic dysplasia sulfate transporter gene, DTDST, in a patient with MED who had a club foot and double-layered patella. The series consisted of 41 probands with MED, 16 of whom were familial and on 4 of whom linkage analyses were performed. Recombination was observed between COL9A1, COL9A2, COL9A3, and COMP and the MED phenotype in two of the families, and between COL9A2, COL9A3, and COMP and the phenotype in the other two families. Screening of COL9A1 for mutations in the two probands from the families in which this gene was not involved in the recombinations failed to identify any disease-causing mutations. The remaining 37 probands were screened for mutations in all three collagen IX genes and in the COMP gene. The probands with talipes deformities or multipartite patella were also screened for the R279W mutation in DTDST. The analysis resulted in identification of three mutations in COMP and one in COL9A1, but none in the other two collagen IX genes. Two of the probands with a multipartite patella had the homozygous DTDST mutation. The results show that mutations in COL9A1 can cause MED, but they also suggest that mutations in COL9A1, COL9A2, COL9A3, COMP, and DTDST are not the major causes of MED and that there exists at least one additional locus.	Univ Oulu, Dept Radiol, Oulu, Finland; Univ Oulu, Dept Med Biochem, Oulu, Finland; Univ Oulu, Collagen Res Unit, Bioctr, Oulu, Finland; Poznan Univ Med Sci, Dept Orthopaed, Poznan, Poland; Karl Marcinkowski Univ Med Sci, Dept Med Genet, Poznan, Poland; Royal Alexandra Hosp Children, Dept Radiol, Sydney, NSW, Australia; St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London, England; Pomeranian Med Univ, Orthopaed Clin Children, Szczecin, Poland; Univ Oulu, Bioctr, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Guy's & St Thomas' NHS Foundation Trust; Pomeranian Medical University; University of Oulu	Ala-Kokko, L (corresponding author), Tulane Univ, Ctr Hlth Sci, Ctr Gene Therapy, 1430 Tulane Ave,SL-99, New Orleans, LA 70112 USA.	lalako@tulane.edu	Spector, Tim D/F-6533-2012; Kolodziej, Lukas/J-2978-2014	Kolodziej, Lukas/0000-0002-0400-7918				Ballo R, 1997, AM J MED GENET, V68, P396, DOI 10.1002/(SICI)1096-8628(19970211)68:4<396::AID-AJMG4>3.3.CO;2-R; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; BREWTON RG, 1995, GENOMICS, V30, P329, DOI 10.1006/geno.1995.9870; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chapman KL, 2001, NAT GENET, V28, P393, DOI 10.1038/ng573; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; Deere M, 1999, AM J MED GENET, V85, P486, DOI 10.1002/(SICI)1096-8628(19990827)85:5<486::AID-AJMG10>3.0.CO;2-O; Deere M, 1998, AM J MED GENET, V80, P510, DOI 10.1002/(SICI)1096-8628(19981228)80:5<510::AID-AJMG14>3.0.CO;2-F; Delot E, 1999, HUM MOL GENET, V8, P123, DOI 10.1093/hmg/8.1.123; Diab M, 1996, BIOCHEM J, V314, P327, DOI 10.1042/bj3140327; FAIRBANK T, 1947, BRIT J SURG, V34, P225, DOI 10.1002/bjs.18003413502; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HOEFNAGE.D, 1967, ANN HUM GENET, V30, P201, DOI 10.1111/j.1469-1809.1967.tb00021.x; Holden P, 1999, AM J HUM GENET, V65, P31, DOI 10.1086/302440; Huber C, 2001, J MED GENET, V38, P191, DOI 10.1136/jmg.38.3.191; HULVEY JT, 1969, AMER J ROENTGENOL RA, V106, P170, DOI 10.2214/ajr.106.1.170; Hummel KM, 1998, BRIT J RHEUMATOL, V37, P721; Ikegawa S, 1998, HUM GENET, V103, P633, DOI 10.1007/s004390050883; Korkko J, 1997, HUM MUTAT, V9, P148; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; Loughlin J, 1998, HUM MUTAT, pS10; Maddox BK, 2000, J BIOL CHEM, V275, P11412, DOI 10.1074/jbc.275.15.11412; MAKELA TP, 1992, HUM MOL GENET, V1, P217, DOI 10.1093/hmg/1.3.217-a; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; MISENHEIMER TM, 1995, J BIOL CHEM, V270, P1729, DOI 10.1074/jbc.270.4.1729; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; Newman B, 2000, J MED GENET, V37, P64, DOI 10.1136/jmg.37.1.64; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OEHLMANN R, 1994, AM J HUM GENET, V54, P3; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Paassilta P, 1999, AM J HUM GENET, V64, P1036, DOI 10.1086/302328; Paassilta P, 1999, J BIOL CHEM, V274, P22469, DOI 10.1074/jbc.274.32.22469; Pihlajamaa T, 1998, MATRIX BIOL, V17, P237, DOI 10.1016/S0945-053X(98)90063-4; RIBBING S, 1937, ACTA RADIOL STOCKH S, V34, P77; Rimoin DL, 1998, AM J MED GENET, V79, P376; Schwartz BB, 1999, MEMORY, V7, P1, DOI 10.1080/741943714; Sheffield EG, 1998, J PEDIATR ORTHOPED, V18, P123, DOI 10.1097/00004694-199801000-00022; Silverman FN, 1996, AM J ROENTGENOL, V167, P835, DOI 10.2214/ajr.167.4.8819367; Spayde EC, 2000, MATRIX BIOL, V19, P121, DOI 10.1016/S0945-053X(00)00055-X; Superti-Furga A, 1999, J MED GENET, V36, P621; Susic S, 1997, CLIN GENET, V51, P219; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; WARMAN ML, 1994, GENOMICS, V23, P158, DOI 10.1006/geno.1994.1472; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354	48	132	150	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					969	980		10.1086/324023	http://dx.doi.org/10.1086/324023			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11565064	Green Published, Bronze			2022-12-18	WOS:000171413400005
J	Reichenberger, E; Tiziani, V; Watanabe, S; Park, L; Ueki, Y; Santanna, C; Baur, ST; Shiang, R; Grange, DK; Beighton, P; Gardner, J; Hamersma, H; Sellars, S; Ramesar, R; Lidral, AC; Sommer, A; do Amaral, CMR; Gorlin, RJ; Mulliken, JB; Olsen, BR				Reichenberger, E; Tiziani, V; Watanabe, S; Park, L; Ueki, Y; Santanna, C; Baur, ST; Shiang, R; Grange, DK; Beighton, P; Gardner, J; Hamersma, H; Sellars, S; Ramesar, R; Lidral, AC; Sommer, A; do Amaral, CMR; Gorlin, RJ; Mulliken, JB; Olsen, BR			Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME 5P; GENE; MICROSATELLITES; REGION; MOUSE; MAPS	Craniometaphyseal dysplasia (CMD) is a rare skeletal disorder characterized by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones. Linkage studies mapped the locus for the autosomal dominant form of CMD to an similar to5-cM interval on chromosome 5p, which is defined by recombinations between loci D5S810 and D5S1954. Mutational analysis of positional candidate genes was performed, and we describe herein three different mutations, in five different families and in isolated cases, in ANK, a multipass transmembrane protein involved in the transport of intracellular pyrophosphate into extracellular matrix. The mutations are two in-frame deletions and one in-frame insertion caused by a splicing defect. All mutations cluster within seven amino acids in one of the six possible cytosolic domains of ANK. These results suggest that the mutated protein has a dominant negative effect on the function of ANK, since reduced levels of pyrophosphate in bone matrix are known to increase mineralization.	Harvard Sch Dent Med, Forsyth Inst, Harvard Forsyth Dept Oral Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Cell Biol, Boston, MA USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Genet, Boston, MA USA; Harvard Univ, Sch Med, Childrens Hosp, Div Plast Surg, Boston, MA USA; Univ Fed Sao Paulo, EPM, Campinas, SP, Brazil; Inst Cirurg Plast Craniofacial SOBRAPAR, Campinas, SP, Brazil; Showa Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 142, Japan; Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA; St Louis Univ, Sch Med, Cardinal Glennon Childrens Hosp, Div Med Genet, St Louis, MO 63104 USA; Univ Cape Town, Sch Med, Dept Human Genet, ZA-7925 Cape Town, South Africa; Ohio State Univ, Coll Dent, Dept Orthodont, Columbus, OH 43210 USA; Childrens Hosp, Dept Genet, Columbus, OH 43205 USA; Univ Minnesota, Sch Dent, Dept Oral Biol & Genet, Minneapolis, MN 55455 USA	Harvard University; Forsyth Institute; Harvard School of Dental Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Universidade Federal de Sao Paulo (UNIFESP); Showa University; Virginia Commonwealth University; Saint Louis University; University of Cape Town; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Minnesota System; University of Minnesota Twin Cities	Reichenberger, E (corresponding author), Harvard Sch Dent Med, Forsyth Inst, Harvard Forsyth Dept Oral Biol, 140 The Fenway, Boston, MA 02115 USA.		Ramesar, Raj S/I-6941-2015; Tiziani, Valdenize/F-9848-2012	Ramesar, Raj S/0000-0001-5688-1634; Tiziani, Valdenize/0000-0001-6783-9212	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036819, R37AR036820, R01AR036820, R01AR036819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014667] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR036820, AR36819, R01 AR036819, AR36820, R37 AR036819] Funding Source: Medline; NIDCR NIH HHS [R01 DE014667-01, R01 DE014667, R01 DE014667-03, R01 DE014667-04, R01 DE014667-02] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862; CHAN D, 1991, J BIOL CHEM, V266, P12487; Church DM, 1997, GENOME RES, V7, P787, DOI 10.1101/gr.7.8.787; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GORLIN R J, 1969, Birth Defects Original Article Series, V5, P79; HAWKINS GA, 1994, BIOTECHNIQUES, V16, P418; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Iughetti P, 2000, AM J MED GENET, V95, P482, DOI 10.1002/1096-8628(20001218)95:5<482::AID-AJMG14>3.0.CO;2-X; JACKSON WPU, 1954, ARCH INTERN MED, V94, P871, DOI 10.1001/archinte.1954.00250060005001; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Nurnberg P, 1997, AM J HUM GENET, V61, P918, DOI 10.1086/514880; SWEET HO, 1981, J HERED, V72, P87, DOI 10.1093/oxfordjournals.jhered.a109459; Tiziani V, 1999, AM J HUM GENET, V65, P158, DOI 10.1086/302456	16	132	140	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1321	1326		10.1086/320612	http://dx.doi.org/10.1086/320612			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11326338	Green Published, Bronze			2022-12-18	WOS:000169094600002
J	Tarazona-Santos, E; Carvalho-Silva, DR; Pettener, D; Luiselli, D; De Stefano, GF; Labarga, CM; Rickards, O; Tyler-Smith, C; Pena, SDJ; Santos, FR				Tarazona-Santos, E; Carvalho-Silva, DR; Pettener, D; Luiselli, D; De Stefano, GF; Labarga, CM; Rickards, O; Tyler-Smith, C; Pena, SDJ; Santos, FR			Genetic differentiation in South Amerindians is related to environmental and cultural diversity: Evidence from the Y chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATIVE-AMERICAN POPULATIONS; NEW-WORLD; MTDNA VARIATION; DNA DIVERSITY; CENTRAL ANDES; MITOCHONDRIAL; FREQUENCIES; HISTORY; HAPLOTYPES; BOTTLENECKS	The geographic structure of Y-chromosome variability has been analyzed in native populations of South America, through use of the high-frequency Native American haplogroup defined by the DYS199-T allele and six Y-chromosome-linked microsatellites (DYS19, DYS389A, DYS389B, DYS390, DYS391, and DYS393), analyzed in 236 individuals. The following pattern of within- and among-population variability emerges from the analysis of microsatellite data: (1) the Andean populations exhibit significantly higher levels of within- population variability than do the eastern populations of South America; (2) the spatial-autocorrelation analysis suggests a significant geographic structure of Y-chromosome genetic variability in South America, although a typical evolutionary pattern could not be categorically identified; and (3) genetic-distance analyses and the analysis of molecular variance suggest greater homogeneity between Andean populations than between non-Andean ones. On the basis of these results, we propose a model for the evolution of the male lineages of South Amerindians that involves differential patterns of genetic drift and gene flow. In the western part of the continent, which is associated with the Andean area, populations have relatively large effective sizes and gene-flow levels among them, which has created a trend toward homogenization of the gene pool. On the other hand, eastern populations-settled in the Amazonian region, the central Brazilian plateau, and the Chaco region-have exhibited higher rates of genetic drift and lower levels of gene flow, with a resulting trend toward genetic differentiation. This model is consistent with the linguistic and cultural diversity of South Amerindians, the environmental heterogeneity of the continent, and the available paleoecological data.	Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-31270010 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Biol Geral, BR-31270010 Belo Horizonte, MG, Brazil; Univ Bologna, Dipartimento Biol, Area Antropol, Bologna, Italy; Univ Roma Tor Vergata, Dipartimento Biol, Rome, Italy; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Bologna; University of Rome Tor Vergata; University of Oxford	Santos, FR (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-31270010 Belo Horizonte, MG, Brazil.	fsantos@icb.ufmg.br	Santos, Fabrício Rodrigues/H-2370-2011; Tarazona-Santos, Eduardo/AAF-1110-2019; Rickards, Olga/L-7878-2015; Pettener, Davide/E-1576-2017; MARTINEZ-LABARGA, CRISTINA M/K-6011-2014	Santos, Fabrício Rodrigues/0000-0001-9088-1750; Rickards, Olga/0000-0003-2880-7466; MARTINEZ-LABARGA, CRISTINA M/0000-0003-0439-0379; Carvalho-Silva, Dr D/0000-0001-5662-1840; Tarazona, Eduardo/0000-0003-3508-3160				AB'SABER A N, 1990, Revista Brasileira de Biologia, V50, P805; BARBUJANI G, 1987, GENETICS, V117, P777; Belkhir K., 1998, GENETIX LOGICIELS WI; BERTORELLE G, 1995, GENETICS, V140, P811; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; BONAVIA D, 1991, PERU HOMBRE HIST ORI, V1; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; Carvalho-Silva DR, 1999, J MOL EVOL, V49, P204, DOI 10.1007/PL00006543; CAVALLISFORZA I, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; Cornuet JM, 1996, GENETICS, V144, P2001; CRAWFORD MH, 1998, ORIGIN NATIVE AM EVI; Dillehay TD, 1999, EVOL ANTHROPOL, V7, P206, DOI 10.1002/(SICI)1520-6505(1999)7:6<206::AID-EVAN5>3.0.CO;2-G; Dipierri JE, 1998, HUM BIOL, V70, P1001; EXCOFFIER L, 1992, GENETICS, V131, P479; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Forster P, 1996, AM J HUM GENET, V59, P935; HARLAN JR, 1971, SCIENCE, V174, P468, DOI 10.1126/science.174.4008.468; JAMES FC, 1990, ANNU REV ECOL SYST, V21, P129, DOI 10.1146/annurev.es.21.110190.001021; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kolman CJ, 1997, GENETICS, V147, P1289; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Luiselli D, 2000, AM J PHYS ANTHROPOL, V113, P5, DOI 10.1002/1096-8644(200009)113:1<5::AID-AJPA2>3.0.CO;2-U; MANTEL N, 1967, CANCER RES, V27, P209; MARUYAMA T, 1985, GENETICS, V111, P691; Merriwether DA, 1996, AM J HUM GENET, V59, P204; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; NEEL JV, 1978, ANNU REV GENET, V12, P365, DOI 10.1146/annurev.ge.12.120178.002053; Nei M., 1987, MOL EVOLUTIONARY GEN; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; Pettener D, 1998, HUM BIOL, V70, P865; Powell JF, 1999, YEARB PHYS ANTHROPOL, V42, P153; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; RICKARDS O, 1994, HUM BIOL, V66, P299; Ruiz-Linares A, 1999, P NATL ACAD SCI USA, V96, P6312, DOI 10.1073/pnas.96.11.6312; Salzano FM, 1988, S AM INDIANS CASE ST; SANCHEZALBORNOZ N, 1992, HIST AM LATINA, V1, P15; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; Santos FR, 1996, BRAZ J GENET, V19, P665, DOI 10.1590/S0100-84551996000400025; Santos FR, 1996, AM J HUM GENET, V58, P1369; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; SANTOS FR, 1999, DNA PROFILING DNA FI, P133; SCHNEIDER S, 2000, ARLEQUIN V 2 000 SOF; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SIMONI L, 2000, AM PAST AM PRESENT G, P123; SLATKIN M, 1995, GENETICS, V139, P457; Smouse PE, 1998, MOL ECOL, V7, P399, DOI 10.1046/j.1365-294x.1998.00370.x; SMOUSE PE, 1992, YEARB PHYS ANTHROPOL, V35, P187; SOKAL RR, 1979, CONT QUANTITATIVE EC; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TORRONI A, 1993, AM J HUM GENET, V53, P591; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1943, GENETICS, V28, P114; [No title captured]	59	132	135	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1485	1496		10.1086/320601	http://dx.doi.org/10.1086/320601			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11353402	Green Published, Bronze			2022-12-18	WOS:000169094600019
J	Buyse, IM; Fang, P; Hoon, KT; Amir, RE; Zoghbi, HY; Roa, BB				Buyse, IM; Fang, P; Hoon, KT; Amir, RE; Zoghbi, HY; Roa, BB			Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: Identification of several novel mutations and polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; GIRLS	Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting 1/10,000-15,000 girls. The disease-causing gene was identified as MECP2 on chromosome Xq28, and mutations have been found in similar to 80% of patients diagnosed with RTT. Numerous mutations have been identified in de novo and rare familial cases, and they occur primarily in the methyl-CpG-binding and transcriptional-repression domains of MeCP2. Our first diagnostic strategy used bidirectional sequencing of the entire MECP2 coding region. Subsequently, we implemented a two-tiered strategy that used denaturing high-performance liquid chromatography (DHPLC) for initial screening of nucleotide variants, followed by confirmatory sequencing analysis. If a definite mutation was not identified, then the entire MECP2 coding region was sequenced, to reduce the risk of false negatives. Collectively, we tested 228 unrelated female patients with a diagnosis of possible (209) or classic (19) RTT and found MECP2 mutations in 83 (40%) of 209 and 16 (84%) of 19 of the patients, respectively. Thirty-two different mutations were identified (8 missense, 9 nonsense, 1 splice site, and 14 frameshifts), of which 12 are novel and 9 recurrent in unrelated patients. Seven unclassified variants and eight polymorphisms were detected in 228 probands. Interestingly, we found that T203M, previously reported as a missense mutation in an autistic patient, is actually a benign polymorphism, according to parental analysis performed in a second case identified in this study. These findings highlight the complexities of missense variant interpretation and emphasize the importance of parental DNA analysis for establishing an etiologic relation between a possible mutation and disease. Overall, we found a 98.8% concordance rate between DHPLC and sequence analyses. One mutation initially missed by the DHPLC screening was identified by sequencing. Modified conditions subsequently enabled its detection, underscoring the need for multiple optimized conditions for DHPLC analysis. We conclude that this two-tiered approach provides a sensitive, robust, and efficient strategy for RTT molecular diagnosis.	Baylor Coll Med, Baylor DNA Diagnost Lab, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Roa, BB (corresponding author), Baylor Coll Med, Baylor DNA Diagnost Lab, Dept Mol & Human Genet, 1 Baylor Plaza,Room 205D, Houston, TX 77030 USA.	broa@bcm.tmc.edu		Zoghbi, Huda/0000-0002-0700-3349				Amano K, 2000, J HUM GENET, V45, P231, DOI 10.1007/s100380070032; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Cotton RGH, 1997, TRENDS GENET, V13, P43, DOI 10.1016/S0168-9525(97)01011-1; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Hampson K, 2000, J MED GENET, V37, P610, DOI 10.1136/jmg.37.8.610; Huppke P, 2000, HUM MOL GENET, V9, P1369, DOI 10.1093/hmg/9.9.1369; Kim SJ, 2000, HUM MUTAT, V15, P382, DOI 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU16>3.0.CO;2-8; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; Obata K, 2000, J MED GENET, V37, P608, DOI 10.1136/jmg.37.8.608; Oefner P. J., 1995, American Journal of Human Genetics, V57, pA266; OEFNER PJ, 1998, CURRENT PROTOCOLS S, V19; ORRICO A, 2000, FEBS LETT, P1; Reichwald K, 2000, MAMM GENOME, V11, P182, DOI 10.1007/s003350010035; Rett A, 1966, Wien Med Wochenschr, V116, P723; Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250	22	132	140	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1428	1436		10.1086/316913	http://dx.doi.org/10.1086/316913			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11055898	Green Published, Bronze			2022-12-18	WOS:000165607600008
J	Moses, EK; Lade, JA; Guo, GL; Wilton, AN; Grehan, M; Freed, K; Borg, A; Terwilliger, JD; North, R; Cooper, DW; Brennecke, SP				Moses, EK; Lade, JA; Guo, GL; Wilton, AN; Grehan, M; Freed, K; Borg, A; Terwilliger, JD; North, R; Cooper, DW; Brennecke, SP			A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREECLAMPSIA ECLAMPSIA; LINKAGE ANALYSIS; PREGNANCY; GENE; HYPERTENSION; CANDIDATE; ANGIOTENSINOGEN; REVEALS; DISEASE; FETAL	Epidemiological studies have shown that genetic factors contribute to the etiology of the common and serious pregnancy-specific disorder pre-eclampsia (PE)/eclampsia (E). Candidate-gene studies have provided evidence (albeit controversial) of linkage to several genes, including angiotensinogen on 1q42-43 and eNOS on 7q36. A recent medium-density genome scan in Icelandic families identified significant linkage to D2S286 (at 94.05 cM) on chromosome 2p12 and suggestive linkage to D2S321 (at 157.5 cM) on chromosome 2q23. In the present article, the authors report the results of a medium-density genome scan in 34 families, representing 121 affected women, from Australia and New Zealand. Multipoint nonparametric linkage analysis, using the GENEHUNTER-PLUS program, showed suggestive evidence of linkage to chromosome 2 (LOD = 2.58), at 144.7 cM, between D2S112 and D2S151, and to chromosome 11q23-24, between D11S925 and D11S4151 (LOD = 2.02 at 121.3 cM). Given the limited precision of estimates of the map location of disease-predisposing loci for complex traits, the present finding on chromosome 2 is consistent with the finding from the Icelandic study, and it may represent evidence of the same locus segregating in the population from Australia and New Zealand. The authors propose that the PE/E-linked locus on chromosome 2p should be designated the "PREG1" (pre-eclampsia, eclampsia gene 1) locus.	Royal Hosp Women, Dept Perinatal Med, Melbourne, Vic 3053, Australia; Univ Melbourne, Dept Obstet & Gynecol, Carlton, Vic 3053, Australia; La Trobe Univ, Dept Genet & Human Variat, Bundoora, Vic 3083, Australia; Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW, Australia; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA; New York State Psychiat Inst, New York, NY 10032 USA; Univ Auckland, Natl Womens Hosp, Dept Obstet & Gynecol, Auckland 1, New Zealand; Macquarie Univ, Sch Biol Sci, N Ryde, NSW, Australia	University of Melbourne; La Trobe University; University of New South Wales Sydney; Columbia University; Columbia University; New York State Psychiatry Institute; University of Auckland; Macquarie University	Moses, EK (corresponding author), Royal Hosp Women, Dept Perinatal Med, 132 Grattan St, Melbourne, Vic 3053, Australia.		Moses, Eric/A-3101-2010; Brennecke, Shaun/AFV-3919-2022; Wilton, Alan N/C-2430-2011	Brennecke, Shaun/0000-0003-3070-6971; Grehan, Madonna/0000-0002-8754-593X; Moses, Eric/0000-0001-7781-4465				ARBOGAST BW, 1994, LANCET, V343, P340, DOI 10.1016/S0140-6736(94)91169-X; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; ARNGRIMSSON R, 1995, HYPERTENS PREGNANCY, V14, P27, DOI 10.3109/10641959509058048; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; BROWN MA, 1993, MED J AUSTRALIA, V158, P700; CHESLEY LC, 1968, OBSTET GYNECOL, V32, P303; COOPER DW, 1979, J MED GENET, V16, P409, DOI 10.1136/jmg.16.6.409; COOPER DW, 1993, HYPERTENS PREGNANCY, V12, P1, DOI 10.3109/10641959309031050; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; GERRETSEN G, 1981, BRIT J OBSTET GYNAEC, V88, P876, DOI 10.1111/j.1471-0528.1981.tb02222.x; Graves JAM, 1998, REPROD FERT DEVELOP, V10, P23, DOI 10.1071/R98014; Guo GL, 1997, ELECTROPHORESIS, V18, P1646, DOI 10.1002/elps.1150180929; Guo GL, 1999, HUM GENET, V105, P641, DOI 10.1007/s004390051156; Harrison GA, 1997, AM J HUM GENET, V60, P1158; Higgins JR, 1998, CURR OPIN OBSTET GYN, V10, P129, DOI 10.1097/00001703-199804000-00009; Hovatta I, 1998, MOL PSYCHIATR, V3, P452, DOI 10.1038/sj.mp.4000443; HUMPHREY KE, 1995, BRIT J OBSTET GYNAEC, V102, P707, DOI 10.1111/j.1471-0528.1995.tb11427.x; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lade JA, 1999, HYPERTENS PREGNANCY, V18, P81, DOI 10.3109/10641959909009613; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Lim KH, 1997, AM J PATHOL, V151, P1809; Page NM, 2000, NATURE, V405, P797, DOI 10.1038/35015579; Pipkin FB, 1999, BIOL NEONATE, V76, P325, DOI 10.1159/000014175; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; ROBERTS JM, IN PRESS LANCET; ROBERTSON WB, 1967, J PATHOL BACTERIOL, V93, P581, DOI 10.1002/path.1700930219; Ros HS, 2000, AM J MED GENET, V91, P256; Taylor RN, 1997, AM J REPROD IMMUNOL, V37, P79; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Terwilliger JD, 2000, HUM BIOL, V72, P63; THORNTON JG, 1991, BRIT MED J, V303, P1241, DOI 10.1136/bmj.303.6812.1241; WILTON AN, 1991, TISSUE ANTIGENS, V38, P137, DOI 10.1111/j.1399-0039.1991.tb02027.x; WILTON AN, 1995, HYPERTENS PREGNANCY, V14, P251, DOI 10.3109/10641959509009586; WILTON AN, 1990, LANCET, V336, P653, DOI 10.1016/0140-6736(90)92149-C; Witlin AG, 1997, ANNU REV MED, V48, P115; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	40	132	141	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1581	1585		10.1086/316888	http://dx.doi.org/10.1086/316888			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11035632	Bronze, Green Published			2022-12-18	WOS:000165607600024
J	Xu, JF; Postma, DS; Howard, TD; Koppelman, GH; Zheng, SL; Stine, OC; Bleecker, ER; Meyers, DA				Xu, JF; Postma, DS; Howard, TD; Koppelman, GH; Zheng, SL; Stine, OC; Bleecker, ER; Meyers, DA			Major genes regulating total serum immunoglobulin E levels in families with asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRAIT LINKAGE ANALYSIS; GENOME-WIDE SEARCH; IGE LEVELS; VARIANCE-COMPONENTS; QUANTITATIVE TRAITS; PEDIGREES; INHERITANCE; MODEL; ASSOCIATION; SENSITIVITY	Immunoglobulin E (IgE) has a major role in the pathogenesis of allergic disorders and asthma. Previous data from 92 families, each identified through a proband with asthma, showed evidence for two major genes regulating total serum IgE levels. One of these genes mapped to 5q31-33. In the current study, the segregation analysis was extended by the addition of 108 probands and their families, ascertained in the same manner. A mixed recessive model (i.e., major recessive gene and residual genetic effect) was the best-fitting and most-parsimonious one-locus model of the segregation analysis. A mixed two-major-gem model (i.e., two major genes and residual genetic effect) fit the data significantly better than did the mixed recessive one-major-gene model. The second gene modified the effect of the first recessive gene. Individuals with the genotype aaBB (homozygous high-risk allele at the first gene and homozygous low-risk allele at the second locus) had normal IgE levels (mean 23 IU/ml), and only individuals with genotypes aaBb and aabb had high IgE levels (mean 282 IU/ml). A genomewide screening was performed using variance-component analysis. Significant evidence for linkage was found for a novel locus at 7q, with a multipoint LOD score of 3.36 (P = .00004). A LOD score of 3.65 (P = .00002) was obtained after genotyping additional markers in this region. Evidence for linkage was also found for two previously reported regions, 5q and 12q, with LOD scores of 2.73 (P = .0002) and 2.46 (P = .0004), respectively. These results suggest that several major genes, plus residual genetic effects, regulate total serum IgE levels.	Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genomics, Winston Salem, NC 27157 USA; Univ Groningen Hosp, Groningen, Netherlands; Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Groningen; University System of Maryland; University of Maryland Baltimore	Meyers, DA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genomics, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048341] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, 1P41RR03655] Funding Source: Medline; NHLBI NIH HHS [R01HL48341, R01 HL048341] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akaike H, 1974, IEEE T AUTOMAT CONTR, V19, P719; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; Barnes KC, 1996, GENOMICS, V37, P41, DOI 10.1006/geno.1996.0518; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; BURROWS B, 1991, J ALLERGY CLIN IMMUN, V88, P870, DOI 10.1016/0091-6749(91)90243-H; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DEVRIES K, 1962, INT ARCH ALLER A IMM, V20, P93, DOI 10.1159/000229248; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GERRARD JW, 1978, AM J HUM GENET, V30, P46; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; HALONEN M, 1992, AM REV RESPIR DIS, V146, P866, DOI 10.1164/ajrccm/146.4.866; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1989, GENET EPIDEMIOL, V6, P319, DOI 10.1002/gepi.1370060203; HOPP RJ, 1984, J ALLERGY CLIN IMMUN, V74, P154, DOI 10.1016/0091-6749(84)90279-3; Johansson S G, 1972, Prog Clin Immunol, V1, P157; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MARSH DG, 1974, P NATL ACAD SCI USA, V71, P3588, DOI 10.1073/pnas.71.9.3588; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MARTINEZ FD, 1994, AM J HUM GENET, V55, P555; MEYERS DA, 1987, AM J HUM GENET, V41, P51; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Panhuysen CIM, 1998, AM J RESP CRIT CARE, V157, P1734, DOI 10.1164/ajrccm.157.6.9606088; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sham PC, 1997, ANN HUM GENET, V61, P61; VANCAMP G, 1997, TRENDS GENET, V13, P82; Wiesch DG, 1999, J ALLERGY CLIN IMMUN, V104, P895, DOI 10.1016/S0091-6749(99)70065-5; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Williams JT, 1999, GENET EPIDEMIOL, V16, P113, DOI 10.1002/(SICI)1098-2272(1999)16:2<113::AID-GEPI1>3.0.CO;2-6; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; XU J, 1995, AM J HUM GENET, V57, P425	37	132	136	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1163	1173		10.1086/321190	http://dx.doi.org/10.1086/321190			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11023809	Bronze, Green Published			2022-12-18	WOS:000165091600014
J	Yasunaga, S; Grati, M; Chardenoux, S; Smith, TN; Friedman, TB; Lalwani, AK; Wilcox, ER; Petit, C				Yasunaga, S; Grati, M; Chardenoux, S; Smith, TN; Friedman, TB; Lalwani, AK; Wilcox, ER; Petit, C			OTOF encodes multiple long and short isoforms: Genetic evidence that the long ones underlie recessive deafness DFNB9	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; INNER-EAR; MUTATIONS; INSIGHTS; PROTEIN; DOMAIN; FORM	We have recently reported that OTOF underlies an autosomal recessive form of prelingual sensorineural deafness, DFNB9. The isolated 5-kb cDNA predicted a 1,230 amino acid (aa) C-terminus membrane-anchored cytosolic protein with three C2 domains. This protein belongs to a family of mammalian proteins sharing homology with the Caenorhabditis elegans fer-1. The two other known members of this family, dysferlin and myoferlin, both have six predicted C2 domains. By northern blot analysis, a 7-kb otoferlin mRNA could be detected in the human brain. We isolated the corresponding cDNA, which is expected to encode a 1,977-aa-long form of otoferlin with six C2 domains. A 7-kb cDNA derived from the murine orthologous gene, Otof, was also identified in the inner ear and the brain. The determination of the exon-intron structure of the human and murine genes showed that they are composed of 48 coding exons and extend similar to 90 kb and similar to 80 kb, respectively. Alternatively spliced transcripts could be detected that predict several long isoforms (six C2 domains) in humans and mice and short isoforms (three C2 domains) only in humans. Primers were designed to explore the first 19 OTOF exons, henceforth permitting exploration of the complete coding sequence of the gene in DFNB9 patients. In a southwestern Indian family affected by DFNB9, a mutation in the acceptor splice site of intron 8 was detected, which demonstrates that the long otoferlin isoforms are required for inner ear function.	Inst Pasteur, CNRS URA 1968, Unite Genet Deficits Sensoriels, F-75724 Paris 15, France; Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Petit, C (corresponding author), Inst Pasteur, CNRS URA 1968, Unite Genet Deficits Sensoriels, 25 Rue Dr Roux, F-75724 Paris 15, France.		Grati, M'hamed/C-9563-2011	Grati, M'hamed/0000-0002-4490-1682; Grati, Mhamed/0000-0001-5149-3245; Petit, Christine/0000-0002-9069-002X	NIDCD NIH HHS [ZO1 DC 00035, ZO1 DC 00038, T32 DC000035, T32 DC000038] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000039, T32DC000035, Z01DC000048, T32DC000038, Z01DC000038, Z01DC000035] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Achanzar WE, 1997, J CELL SCI, V110, P1073; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; WELL D, 1997, NAT GENET, V16, P191; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	18	132	143	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					591	600		10.1086/303049	http://dx.doi.org/10.1086/303049			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10903124	Green Published, Bronze			2022-12-18	WOS:000089002300006
J	Jakobs, PM; Hess, JF; FitzGerald, PG; Kramer, P; Weleber, RG; Litt, M				Jakobs, PM; Hess, JF; FitzGerald, PG; Kramer, P; Weleber, RG; Litt, M			Autosomal-dominant congenital cataract associated with a deletion mutation in the human beaded filament protein gene BFSP2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOSKELETAL PROTEIN; CRYSTALLIN GENE; SECONDARY STRUCTURE; MISSENSE MUTATION; SEQUENCE	Congenital cataracts are a common major abnormality of the eye that frequently cause blindness in infants. At least one-third of all cases are familial; autosomal-dominant congenital cataract appears to be the most-common familial form in the Western world. Elsewhere, in family ADCC-3, we mapped an autosomal-dominant cataract gene to chromosome 3q21-q22, near the gene that encodes a lens-specific beaded filament protein gene, BFSP2. By sequencing the coding regions of BFSP2, we found that a deletion mutation, Delta E233, is associated with cataracts in this family. This is the first report of an inherited cataract that is caused by a mutation in a cytoskeletal protein.	Oregon Hlth Sci Univ, Dept Mol Med, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA; Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California Davis	Litt, M (corresponding author), Oregon Hlth Sci Univ, Dept Mol Med, L103A, Portland, OR 97201 USA.				NEI NIH HHS [EY08747, R01 EY008747, EY11710] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011710, R01EY008747] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Conley YP, 2000, AM J HUM GENET, V66, P1426, DOI 10.1086/302871; FITZGERALD PG, 1989, CURR EYE RES, V8, P801, DOI 10.3109/02713688909000870; FITZGERALD PG, 1990, CURR EYE RES, V9, P1083, DOI 10.3109/02713689008997582; FITZGERALD PG, 1991, CURR EYE RES, V10, P471, DOI 10.3109/02713689109001754; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; FUCHS E, 1994, J CELL BIOL, V125, P511, DOI 10.1083/jcb.125.3.511; FUCHS E, 1994, J INVEST DERMATOL, V103, pS25, DOI 10.1111/1523-1747.ep12398924; GOUNARI F, 1993, J CELL BIOL, V121, P847, DOI 10.1083/jcb.121.4.847; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; Hess JF, 1998, EXP EYE RES, V66, P625, DOI 10.1006/exer.1998.0478; Hess JF, 1996, J BIOL CHEM, V271, P6729, DOI 10.1074/jbc.271.12.6729; HESS JF, 1993, CURR EYE RES, V12, P77, DOI 10.3109/02713689308999499; HESS JF, 1995, CURR EYE RES, V14, P11, DOI 10.3109/02713689508999909; Ionides A, 1999, BRIT J OPHTHALMOL, V83, P802, DOI 10.1136/bjo.83.7.802; Ireland M, 1989, Lens Eye Toxic Res, V6, P623; IRELAND M, 1984, EXP EYE RES, V38, P637, DOI 10.1016/0014-4835(84)90182-9; Irvine AD, 1997, NAT GENET, V16, P184, DOI 10.1038/ng0697-184; Kannabiran C, 1998, Mol Vis, V4, P21; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KRAMER PL, IN PRESS INVEST OPHT; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; PARRY D A D, 1992, Current Opinion in Cell Biology, V4, P94, DOI 10.1016/0955-0674(92)90064-J; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Sidjanin DJ, 1997, INVEST OPHTH VIS SCI, V38, P2502; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008	28	132	145	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1432	1436		10.1086/302872	http://dx.doi.org/10.1086/302872			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739768	Green Published, Bronze			2022-12-18	WOS:000088373400027
J	Sykes, B; Irven, C				Sykes, B; Irven, C			Surnames and the Y chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ISONYMY; PRIESTS	A randomly ascertained sample of males with the surname "Sykes" was typed with four Y-chromosome microsatellites. Almost half the sample shared the same Y-chromosome haplotype, which has not been observed in control samples either from the same geographic region of from the United Kingdom as a whole. This points to a single surname founder for extant Sykes males, even though written sources had predicted multiple origins. The distribution of other Sykes Y-chromosome haplotypes were not significantly different from those in controls and may be accounted for by the historical accumulation of nonpaternity during the past 700 years, in which case the average rate estimate is 1.3%/generation. If this pattern is reproduced with other surnames, it may have important forensic and genealogical applications.	Univ Oxford, Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Sykes, B (corresponding author), Univ Oxford, Inst Mol Med, Oxford OX3 9DS, England.							Barrai I, 1996, ANN HUM BIOL, V23, P431, DOI 10.1080/03014469600004672; CROW JF, 1980, HUM BIOL, V52, P1; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; LASKER GW, 1983, HUM BIOL, V55, P331; MACINTYRE S, 1991, LANCET, V338, P869, DOI 10.1016/0140-6736(91)91513-T; REDMONDS G, 1992, YORKSHIRE SURNAMES S, V2; Skorecki K, 1997, NATURE, V385, P32, DOI 10.1038/385032a0; Sturges C M, 1987, INHERITANCE ENGLISH; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083	11	132	145	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1417	1419		10.1086/302850	http://dx.doi.org/10.1086/302850			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739766	Green Published, Bronze			2022-12-18	WOS:000088373400024
J	Whitfield, JB; Cullen, LM; Jazwinska, EC; Powell, LW; Heath, AC; Zhu, G; Duffy, DL; Martin, NG				Whitfield, JB; Cullen, LM; Jazwinska, EC; Powell, LW; Heath, AC; Zhu, G; Duffy, DL; Martin, NG			Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEMOCHROMATOSIS GENE-MUTATIONS; ACUTE MYOCARDIAL-INFARCTION; HEREDITARY HEMOCHROMATOSIS; TRANSFERRIN RECEPTOR; COMBINED LINKAGE; LIVER-DISEASES; POPULATION; PREVALENCE; RISK; ASSOCIATION	The aim of this study was to assess and to compare the role of HFE polymorphisms and other genetic factors in variation in iron stores. Blood samples were obtained from 3,375 adult male and female twins (age range 29-82 years) recruited from the Australian Twin Registry. There were 1,233 complete pairs (562 monozygotic and 571 dizygotic twins). Serum iron, transferrin, transferrin saturation with iron, and ferritin were measured, and the HFE C282Y and H63D genotypes were determined. The frequency of the C282Y allele was .072, and that of the H63D allele was .141. Significant sources of variation in the indices of iron status included age, sex, age-sex interaction, body-mass index, and both the C282Y and H63D genotypes. The iron, transferrin, and saturation values of CC and CY subjects differed significantly, but the ferritin values did not. After correction for age and body-mass index, 23% and 31% of the variance in iron, 66% and 49% of the variance in transferrin, 33% and 47% of the variance in transferrin saturation, and 47% and 47% of the variance in ferritin could be explained by additive genetic factors, for men and women, respectively. HFE C282Y and H63D variation accounted for <5% of the corrected phenotypic variance, except for saturation (12% in women and 5% in men). We conclude that HFE CY and HD heterozygotes differ in iron status from the CC and HH homozygotes and that serum transferrin saturation is more affected than is serum ferritin. There are highly significant effects of other as-yet-unidentified genes on iron stores, in addition to HFE genotype.	Royal Prince Alfred Hosp, Dept Biochem, Camperdown, NSW 2050, Australia; Univ Sydney, Sydney, NSW 2006, Australia; Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia; Univ Queensland, Joint Genet Program, Brisbane, Qld, Australia; Washington Univ, Dept Psychiat, Missouri Alcoholism Res Ctr, St Louis, MO USA	University of Sydney; University of Sydney; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; Washington University (WUSTL)	Whitfield, JB (corresponding author), Royal Prince Alfred Hosp, Dept Biochem, Camperdown, NSW 2050, Australia.		Duffy, David L/B-7392-2013	Duffy, David L/0000-0001-7227-632X; Whitfield, John/0000-0002-1103-0876; Martin, Nicholas/0000-0003-4069-8020	NIAAA NIH HHS [AA11998, P50 AA011998, R01 AA010249] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA011998, R01AA010249, P50AA011998] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Ajioka RS, 1997, AM J HUM GENET, V60, P1439, DOI 10.1086/515466; Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1; BAYNES RD, 1994, IRON METABOLISM HLTH, P189; Bonkovsky HL, 1996, SEMIN LIVER DIS, V16, P65, DOI 10.1055/s-2007-1007220; Brissot P, 1999, J HEPATOL, V30, P588, DOI 10.1016/S0168-8278(99)80188-3; BROCK JH, 1994, IRON METABOLISM HLTH, P353; Bulaj ZJ, 1996, NEW ENGL J MED, V335, P1799, DOI 10.1056/NEJM199612123352403; Burt MJ, 1998, GUT, V43, P830, DOI 10.1136/gut.43.6.830; Danesh J, 1999, CIRCULATION, V99, P852, DOI 10.1161/01.CIR.99.7.852; Datz C, 1998, CLIN CHEM, V44, P2429; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Feder JN, 1996, NAT GENET, V14, P249; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; George DK, 1999, J GASTROEN HEPATOL, V14, P745, DOI 10.1046/j.1440-1746.1999.01944.x; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; HSING AW, 1995, INT J CANCER, V60, P160, DOI 10.1002/ijc.2910600204; Jeffrey GP, 1999, NAT GENET, V22, P325, DOI 10.1038/11892; Jouanolle AM, 1998, ANN GENET-PARIS, V41, P195; Kiechl S, 1997, CIRCULATION, V96, P3300; Kwan T, 1998, CLIN INVEST MED, V21, P251; LEGGETT BA, 1990, BRIT J HAEMATOL, V74, P525, DOI 10.1111/j.1365-2141.1990.tb06345.x; Lucotte G, 1998, BLOOD CELL MOL DIS, V24, P433, DOI 10.1006/bcmd.1998.0212; Mandishona E, 1998, HEPATOLOGY, V27, P1563, DOI 10.1002/hep.510270614; Martinez PA, 1997, BLOOD CELL MOL DIS, V23, P269; McDonnell SM, 1999, AM J MED, V107, P30, DOI 10.1016/S0002-9343(99)00163-1; Merryweather-Clarke AT, 1999, HUM MUTAT, V13, P154, DOI 10.1002/(SICI)1098-1004(1999)13:2<154::AID-HUMU8>3.0.CO;2-E; Moirand R, 1999, GASTROENTEROLOGY, V116, P372, DOI 10.1016/S0016-5085(99)70134-4; Mura C, 1999, BLOOD, V93, P2502, DOI 10.1182/blood.V93.8.2502.408k27_2502_2505; Murphy S, 1998, TISSUE ANTIGENS, V52, P484, DOI 10.1111/j.1399-0039.1998.tb03076.x; NEALE MC, 1992, METHODOLOGY GENETICS; Nielsen P, 1998, BRIT J HAEMATOL, V103, P842; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Powell W.L., 1994, IRON METABOLISM HLTH; Roest M, 1999, CIRCULATION, V100, P1268, DOI 10.1161/01.CIR.100.12.1268; Ryan E, 1998, BLOOD CELL MOL DIS, V24, P428, DOI 10.1006/bcmd.1998.0211; Salter-Cid L, 1999, P NATL ACAD SCI USA, V96, P5434, DOI 10.1073/pnas.96.10.5434; Sampietro M, 1999, HAEMATOLOGICA, V84, P248; Sanchez M, 1998, J HEPATOL, V29, P725, DOI 10.1016/S0168-8278(98)80252-3; SKIKNE BS, 1990, BLOOD, V75, P1870; STAL P, 1995, DIGEST DIS, V13, P205, DOI 10.1159/000171503; Steffensen R, 1998, TISSUE ANTIGENS, V52, P230, DOI 10.1111/j.1399-0039.1998.tb03037.x; Tuomainen TP, 1998, CIRCULATION, V97, P1461; Tuomainen TP, 1999, CIRCULATION, V100, P1274, DOI 10.1161/01.CIR.100.12.1274; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494; Zoller H, 1999, LANCET, V353, P2120, DOI 10.1016/S0140-6736(98)11179-0	45	132	137	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1246	1258		10.1086/302862	http://dx.doi.org/10.1086/302862			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739755	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000088373400009
J	Briggs, MD; Mortier, GR; Cole, WG; King, LM; Golik, SS; Bonaventure, J; Nuytinck, L; De Paepe, A; Leroy, JG; Biesecker, L; Lipson, M; Wilcox, WR; Lachman, RS; Rimoin, DL; Knowlton, RG; Cohn, DH				Briggs, MD; Mortier, GR; Cole, WG; King, LM; Golik, SS; Bonaventure, J; Nuytinck, L; De Paepe, A; Leroy, JG; Biesecker, L; Lipson, M; Wilcox, WR; Lachman, RS; Rimoin, DL; Knowlton, RG; Cohn, DH			Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia multiple epiphyseal dysplasia disease spectrum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERICENTROMERIC REGION; CHROMOSOME-19; COLLAGEN; LINKAGE; BINDING; THROMBOSPONDINS; CANDIDATE; RECEPTOR; DOMAIN; EDM2	Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED) are autosomal dominant osteochondrodysplasias that result in mild to severe short-limb dwarfism and early-onset osteoarthrosis. PSACH and some forms of MED result from mutations in the gene for cartilage oligomeric matrix protein (COMP; OMIM 600310 [http://www3.ncbi.nlm.nih.gov:80/ htbin-post/Omim/dispmim?600310]). We report the identification of COMP mutations in an additional 14 families with PSACH or MED phenotypes. Mutations predicted to result in single-amino acid deletions or substitutions, all in the region of the COMP gene encoding the calmodulin-like repeat elements, were identified in patients with moderate to severe PSACH. We also identified within this domain a missense mutation that produced MED Fairbank. In two families, one with mild PSACH and the second with a form of MED, we identified different substitutions for a residue in the carboxyl-terminal globular region of COMP. Both the clinical presentations of these two families and the identification of COMP-gene mutations provide evidence of phenotypic overlap between PSACH and MED. These data also reveal a role for the carboxyl-terminal domain in the structure and/or function of COMP.	Univ Calif Los Angeles, Sch Med,Burns & Allen Cedars Sinai Res Inst, Steven Spielberg Pediat Res Ctr, Ahmanson Dept Pediat, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Radiol, Los Angeles, CA USA; Univ Gent Hosp, Dept Med Genet, Ghent, Belgium; Univ Gent Hosp, Dept Pediat, Ghent, Belgium; Hosp Sick Children, Div Orthoped, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada; Necker Hosp, Paris, France; NIH, Natl Ctr Human Genome Res, Bethesda, MD 20892 USA; So Calif Permanente Med Grp, Sacramento, CA USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups; Jefferson University	Cohn, DH (corresponding author), Cedars Sinai Med Ctr, SSB-3,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	dcohn@mailgate.csmc.edu	Mortier, Geert/D-2542-2012; Biesecker, Leslie/AAG-2526-2021	Mortier, Geert/0000-0001-9871-4578; Nuytinck, Lieve/0000-0002-5165-6937	NIAMS NIH HHS [AR43139] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043139] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Ballo R, 1997, AM J MED GENET, V68, P396, DOI 10.1002/(SICI)1096-8628(19970211)68:4<396::AID-AJMG4>3.3.CO;2-R; BEIGHTON P, 1992, AM J MED GENET, V44, P223, DOI 10.1002/ajmg.1320440220; BRIGGS MD, 1993, GENOMICS, V18, P656, DOI 10.1016/S0888-7543(05)80369-6; BRIGGS MD, 1994, AM J HUM GENET, V55, P678; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; BRIGGS MD, 1995, 2 ANN M AM COLL MED; Cohn DH, 1996, ANN NY ACAD SCI, V785, P188, DOI 10.1111/j.1749-6632.1996.tb56258.x; DEERE M, 1995, AM J HUM GENET, V56, P698; DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x; FAIRBANK T, 1947, BRIT J SURG, V34, P225, DOI 10.1002/bjs.18003413502; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; GAO AG, 1994, J BIOL CHEM, V269, P29650; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; KINK JA, 1990, CELL, V62, P165, DOI 10.1016/0092-8674(90)90250-I; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LOUGHLIN J, 1998, HUM MUTAT S, V11, pS8; MAROTEAUX P, 1980, EUR J PEDIATR, V133, P227, DOI 10.1007/BF00496081; MAYNARD JA, 1972, LAB INVEST, V26, P40; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OEHLMANN R, 1994, AM J HUM GENET, V54, P3; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Ribbing S, 1937, ACTA RADIOL S, V34, P1; RIMOIN DL, 1994, HUM GENET, V93, P236, DOI 10.1007/BF00212015; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; STANESCU V, 1982, EUR J PEDIATR, V138, P221, DOI 10.1007/BF00441206; STANESCU V, 1977, ARCH FR PEDIATR   S3, V34, P1; TAKIGAWA M, 1989, CANCER RES, V49, P3996; TSAO PW, 1995, J BIOL CHEM, V270, P23747, DOI 10.1074/jbc.270.40.23747; TUCKWELL DS, 1994, J CELL SCI, V107, P993	33	132	142	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					311	319		10.1086/301713	http://dx.doi.org/10.1086/301713			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463320	Green Published, Bronze			2022-12-18	WOS:000072416000014
J	Mitchell, JJ; Capua, A; Clow, C; Scriver, CR				Mitchell, JJ; Capua, A; Clow, C; Scriver, CR			Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COST-BENEFIT-ANALYSIS; PREVENTION; MEDICINE	Programs for education, screening, and counseling of senior-high-school students, in populations at high risk for Tay-Sachs and beta-thalassemia diseases, have existed for >20 years in Montreal. Four process and outcome variables are reported here: (i) voluntary participation rates in the high-school cohort; (ii) uptake rates for the screening test; (iii) origin of carrier couples seeking the prenatal diagnosis option in the programs; and (iv) change in incidence of the two diseases. Between 1972 and 1992, we screened 14,844 Ashkenazi-Jewish students, identified 521 HexA-deficient carriers (frequency 1:28), reached 89% of the demographic cohort in the educational component of the program, and achieved 67% voluntary participation in the subsequent screening phase. The corresponding data for the beta-thalassemia program are 25,274 students (mainly of Mediterranean origin) representing 67% of the cohort with 61% voluntary participation in the screening phase (693 carriers; frequency 1:36). From demographic data, we deduce that virtually all the carriers identified in the high-school screening program remembered their status, had their partner tested if they did not already know they were a carrier couple, and took up the options for reproductive counseling/prenatal diagnosis. Ln Montreal, the current origin of all couples using prenatal diagnosis for Tay-Sachs and beta-thalassemia diseases is the corresponding genetic screening/testing program, whereas, at the beginning of the programs, it was always because there was a history of an affected person in the family. Incidence of the two diseases has fallen by 90%-95% over 20 years; the rare new cases are born (with two exceptions) outside the target communities or to nonscreened couples.	MONTREAL CHILDRENS HOSP, RES INST, MONTREAL, PQ H3H 1P3, CANADA; MCGILL UNIV, DEBELLE LAB BIOCHEM GENET, MONTREAL, PQ H3A 2T5, CANADA; MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ H3A 2T5, CANADA	McGill University; McGill University; McGill University			Mitchell, John/E-5727-2016	Mitchell, John/0000-0002-6055-6858				ARROW KJ, 1985, COLLECTED PAPERS KJ, P208; BAYLERAN J, 1984, CLIN CHIM ACTA, V143, P73, DOI 10.1016/0009-8981(84)90215-8; BECK E, 1974, NEW ENGL J MED, V291, P1166, DOI 10.1056/NEJM197411282912206; Bernstein T, 1994, RADON RENTAL HOUSING; *BUR STAT, 1988, EST POP MAR STAT AG; BYCK S, 1995, AM J HUM GENET, V57, P914; *C US, 1992, OTABA532; CAO A, 1994, AM J HUM GENET, V54, P397; CLOW CL, 1977, PEDIATRICS, V59, P86; DAGENAIS DL, 1985, SOC SCI MED, V20, P601, DOI 10.1016/0277-9536(85)90399-5; DEBRAEKELEER M, 1992, HUM GENET, V89, P83, DOI 10.1007/BF00207048; DELVIN E, 1974, CLIN CHIM ACTA, V53, P135, DOI 10.1016/0009-8981(74)90361-1; Drummond M.F., 1980, PRINCIPLES EC APPRAI; EVANS RG, 1988, DAEDALUS-US, V117, P155; FERNANDES MJG, 1992, GENET EPIDEMIOL, V9, P169, DOI 10.1002/gepi.1370090303; GOLD RJM, 1974, ANN HUM GENET, V37, P315, DOI 10.1111/j.1469-1809.1974.tb01838.x; Gravel R. A., 1995, METABOLIC MOL BASIS, P2839; KABACK M, 1993, JAMA-J AM MED ASSOC, V270, P2307, DOI 10.1001/jama.270.19.2307; KAPLAN F, 1991, CLIN INVEST MED, V14, P325; KNOPPERS BM, 1994, SCIENCE, V265, P2035, DOI 10.1126/science.8091225; MITCHELL J, 1993, J MED GENET, V30, P538, DOI 10.1136/jmg.30.7.538; MODELL B, 1991, J INHERIT METAB DIS, V14, P640, DOI 10.1007/BF01797934; MODELL B, 1980, BMJ-BRIT MED J, V280, P1347, DOI 10.1136/bmj.280.6228.1347; *NAT AC SCI, 1975, GEN SCREEN PROGR PRI; OSTROWSKY JT, 1985, AM J PUBLIC HEALTH, V75, P732, DOI 10.2105/AJPH.75.7.732; SCRIVER CR, 1984, AM J HUM GENET, V36, P1024; SCRIVER CR, 1978, AM BIOL TEACH, V40, P280, DOI 10.2307/4446244; WEATHERALL DJ, 1995, METABOLIC MOL BASES, P3417; WILFOND BS, 1995, AM J HUM GENET, V57, P1233; ZANNISHADJOPOUL.M, 1977, HUM GENET, V38, P315; ZEESMAN S, 1984, AM J MED GENET, V18, P769, DOI 10.1002/ajmg.1320180424	31	132	134	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					793	798						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	VL283	8808593				2022-12-18	WOS:A1996VL28300007
J	MEYERKLEINE, C; STEINMEYER, K; RICKER, K; JENTSCH, TJ; KOCH, MC				MEYERKLEINE, C; STEINMEYER, K; RICKER, K; JENTSCH, TJ; KOCH, MC			SPECTRUM OF MUTATIONS IN THE MAJOR HUMAN SKELETAL-MUSCLE CHLORIDE CHANNEL GENE (CLCNUI) LEADING TO MYOTONIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERCOSTAL MUSCLE; THOMSEN DISEASE; EXPRESSION; CONGENITA; DOMINANT; BECKER	Autosomal dominant myotonia congenita and autosomal recessive generalized myotonia (GM) are genetic disorders characterized by the symptom of myotonia, which is based on an electrical instability of the muscle fiber membrane. Recently, these two phenotypes have been associated with mutations in the major muscle chloride channel gene CLCN1 on human chromosome 7q35. We have systematically screened the open reading frame of the CLCN1 gene for mutations by SSC analysis (SSCA) in a panel of 24 families and 17 single unrelated patients with human myotonia. By direct sequencing of aberrant SSCA conformers we revealed 15 different mutations in a total of 18 unrelated families and 13 single patients. Of these, 10 were novel (7 missense mutations, 2 mutations leading to frameshift, and 1 mutation predicted to affect normal splicing). In our overall sample of 94 GM chromosomes we were able to detect 48 (51%) mutant GM alleles. Three mutations (F413C, R894X, and a 14-bp deletion in exon 13) account for 32% of the GM chromosomes in the German population. Our finding that A437T is probably a polymorphism is in contrast to a recent report that the recessive phenotype GM is associated with this amino acid change. We also demonstrate that the R894X mutation may act as a recessive or a dominant mutation in the CLCN1 gene, probably depending on the genetic background. Functional expression of the R894X mutant in Xenopus oocytes revealed a large reduction, but not complete abolition, of chloride currents. Further, it had a weak dominant negative effect on wild-type currents in coexpression studies. Reduction of currents predicted for heterozygous carriers are close to the borderline value, which is sufficient to elicit myotonia.	UNIV MARBURG,MED ZENTRUM HUMANGENET,D-35033 MARBURG,GERMANY; UNIV HAMBURG,ZENTRUM MOLEK NEUROBIOL,D-20246 HAMBURG,GERMANY; UNIV WURZBURG,NEUROL KLIN,W-8700 WURZBURG,GERMANY	Philipps University Marburg; University of Hamburg; University of Wurzburg				Jentsch, Thomas/0000-0002-3509-2553				ABDALLA JA, 1992, AM J HUM GENET, V51, P579; Becker P, 1977, TOPICS HUMAN GENETIC, VIII; BRYANT SH, 1971, J PHYSIOL-LONDON, V219, P367, DOI 10.1113/jphysiol.1971.sp009667; GEORGE AL, 1994, HUM MOL GENET, V3, P2071; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; HEINE R, 1994, HUM MOL GENET, V3, P1123, DOI 10.1093/hmg/3.7.1123; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; KOCH MC, 1993, J MED GENET, V30, P914, DOI 10.1136/jmg.30.11.914; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Koty P. P., 1994, American Journal of Human Genetics, V55, pA227; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KWIECINSKI H, 1988, MUSCLE NERVE, V11, P576, DOI 10.1002/mus.880110609; LEHMANNHORN F, 1995, HUM MOL GENET, V4, P1397, DOI 10.1093/hmg/4.8.1397; LIPICKY RJ, 1971, J CLIN INVEST, V50, P2091, DOI 10.1172/JCI106703; LORENZ C, 1994, HUM MOL GENET, V6, P941; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; MEHRKE G, 1988, MUSCLE NERVE, V11, P440, DOI 10.1002/mus.880110505; MEYERKLEINE C, 1994, HUM GENET, V93, P707; MEYERKLEINE C, 1994, HUM MOL GENET, V6, P1015; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; PUSCH M, IN PRESS NEURON; RICKER K, 1978, J NEUROL, V218, P253, DOI 10.1007/BF00312881; RUDEL R, 1988, MUSCLE NERVE, V11, P202, DOI 10.1002/mus.880110303; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547; YOUIL R, 1995, P NATL ACAD SCI USA, V92, P87, DOI 10.1073/pnas.92.1.87	31	132	137	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1325	1334						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533761				2022-12-18	WOS:A1995TE65500009
J	FRANCKE, U; BERG, MA; TYNAN, K; BRENN, T; LIU, WG; AOYAMA, T; GASNER, C; MILLER, DC; FURTHMAYR, H				FRANCKE, U; BERG, MA; TYNAN, K; BRENN, T; LIU, WG; AOYAMA, T; GASNER, C; MILLER, DC; FURTHMAYR, H			A GLY1127SER MUTATION IN AN EGF-LIKE DOMAIN OF THE FIBRILLIN-1 GENE IS A RISK FACTOR FOR ASCENDING AORTIC-ANEURYSM AND DISSECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; MARFAN-SYNDROME; III PROCOLLAGEN; CHROMOSOME-15; FAMILY; CALCIUM; COL3A1	Ascending aortic disease, ranging from mild aortic root enlargement to aneurysm and/or dissection, has been identified in 10 individuals of a kindred, none of whom had classical Marfan syndrome (MFS). Single-strand conformation analysis of the entire fibrillin-1 (FBN1) cDNA of an affected family member revealed a G-to-A transition at nucleotide 3379, predicting a Gly1127Ser substitution. The glycine in this position is highly conserved in EGF-like domains of FBN1 and other proteins. This mutation was present in 9 of 10 affected family members and in 1 young unaffected member but was not found in other unaffected members, in 168 chromosomes from normal controls, and in 188 chromosomes from other individuals with MFS or related phenotypes. FBN1 intragenic marker haplotypes ruled out the possibility that the other allele played a significant role in modulating the phenotype in this family. Pulse-chase studies revealed normal fibrillin synthesis but reduced fibrillin deposition into the extracellular matrix in cultured fibroblasts from a Gly1127Ser carrier. We postulate that the Gly1127Ser FBN1 mutation is responsible for reduced matrix deposition. We suggest that mutations such as this one may disrupt EGF-like domain folding less drastically than do substitutions of cysteine or of other amino acids important for calcium-binding that cause classical MFS. The Gly1127Ser mutation, therefore, produces a mild form of autosomal dominantly inherited weakness of elastic tissue, which predisposes to ascending aortic aneurysm and dissection later in life.	STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA; STANFORD UNIV,MED CTR,DEPT PEDIAT,STANFORD,CA; STANFORD UNIV,MED CTR,DEPT PATHOL,STANFORD,CA; STANFORD UNIV,MED CTR,DEPT CARDIOVASC SURG,STANFORD,CA; STANFORD UNIV,MED CTR,CTR MARFAN SYNDROME & RELATED CONNECT TISSUE DISO,STANFORD,CA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	FRANCKE, U (corresponding author), STANFORD UNIV,BECKMAN CTR MOLEC & GENET MED,HOWARD HUGHES MED INST,STANFORD,CA 94305, USA.		Furthmayr, Heinz -/A-6295-2010	Miller, D. Craig/0000-0001-7619-0080	NHGRI NIH HHS [HG00298] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000298] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AOYAMA T, 1993, HUM MOL GENET, V2, P2135, DOI 10.1093/hmg/2.12.2135; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; AOYAMA T, IN PRESS AM J MED GE; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; Bixler D, 1976, Birth Defects Orig Artic Ser, V12, P229; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; DENTON PH, 1988, BLOOD, V72, P1407; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V353, P337; EISENBERG MJ, 1993, AM HEART J, V125, P1380, DOI 10.1016/0002-8703(93)91011-3; HANLEY WB, 1967, BRIT HEART J, V29, P852; HIRST AE, 1958, MEDICINE, V37, P217, DOI 10.1097/00005792-195809000-00003; KAINULAINEN K, 1990, NEW ENGL J MED, V323, P935, DOI 10.1056/NEJM199010043231402; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; KONTUSAARI S, 1990, J CLIN INVEST, V86, P1465, DOI 10.1172/JCI114863; KUIVANIEMI H, 1991, J CLIN INVEST, V88, P1441, DOI 10.1172/JCI115452; LEE B, 1991, NATURE, V353, P330; LONNQVIST L, 1994, GENOMICS, V19, P573, DOI 10.1006/geno.1994.1110; MAGENIS RE, 1991, GENOMICS, V11, P346, DOI 10.1016/0888-7543(91)90142-2; MAJUMDER PP, 1991, AM J HUM GENET, V48, P164; MASLEN CL, 1991, NATURE, V353, P334; NARCISI P, 1993, AM J MED GENET, V46, P278, DOI 10.1002/ajmg.1320460308; NICOD P, 1989, J AM COLL CARDIOL, V13, P811, DOI 10.1016/0735-1097(89)90221-0; PEREIRA L, 1994, NEW ENGL J MED, V331, P148, DOI 10.1056/NEJM199407213310302; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; PYERITZ RE, 1989, JAMA-J AM MED ASSOC, V262, P3132, DOI 10.1001/jama.1989.03430220053025; TOYAMA M, 1989, BRIT HEART J, V61, P204; TROMP G, 1993, J CLIN INVEST, V91, P2539, DOI 10.1172/JCI116490; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; TYNAN K, 1993, HUM MOL GENET, V2, P1813, DOI 10.1093/hmg/2.11.1813; WEBER JL, 1989, AM J HUM GENET, V44, P388	33	132	136	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1287	1296						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762551				2022-12-18	WOS:A1995RA79400005
J	TRELOAR, SA; MARTIN, NG				TRELOAR, SA; MARTIN, NG			AGE AT MENARCHE AS A FITNESS TRAIT - NONADDITIVE GENETIC VARIANCE DETECTED IN A LARGE TWIN SAMPLE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									QUEENSLAND INST MED RES,BRAMSTON TERRACE,HERSTON,QLD 4006,AUSTRALIA	QIMR Berghofer Medical Research Institute								BASHI J, 1977, NATURE, V266, P440, DOI 10.1038/266440a0; BEHN BG, 1969, APR ANN M POP ASS AM; Bolk L, 1923, P K AKAD WET-AMSTERD, V26, P650; BRACKEN MB, 1985, ANN HUM BIOL, V12, P525, DOI 10.1080/03014468500008101; BULLOUGH VL, 1981, SCIENCE, V213, P365, DOI 10.1126/science.7017929; BURRELL RJ, 1961, HUM BIOL, V33, P250; CAMERON N, 1979, ANN HUM BIOL, V6, P505, DOI 10.1080/03014467900003921; CAREY G, 1986, BEHAV GENET, V16, P343; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CEDERLOEF R, 1961, ACTA GENET STAT MED, V11, P338; CHERN MM, 1980, MENSTRUAL CYCLE SYNT, P123; DAMON A, 1974, HUM BIOL, V46, P381; DAMON A, 1969, HUM BIOL, V41, P161; DRIFE JO, 1986, ANN NY ACAD SCI, V464, P58, DOI 10.1111/j.1749-6632.1986.tb15993.x; EAVES L, 1976, HEREDITY, V36, P205, DOI 10.1038/hdy.1976.25; EAVES LJ, 1988, BEHAV GENET, V18, P27, DOI 10.1007/BF01067073; EAVES LJ, 1989, BEHAV GENET, V19, P113, DOI 10.1007/BF01065887; EAVES LJ, 1970, THESIS U BIRMINGHAM; EVELETH PB, 1976, WORLDWIDE VARIATION, P213; FISCHBEIN S, 1977, ACTA GENET MED GEMEL, V26, P151, DOI 10.1017/S0001566000009946; Fisher RA, 1932, GENETICS, V17, P0107; FRISCH RE, 1981, NEW ENGL J MED, V305, P1019; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; GOLUB S, 1983, WOMEN HEALTH, V8, P17, DOI 10.1300/J013v08n02_02; GOODMAN MJ, 1983, ANN HUM BIOL, V10, P585, DOI 10.1080/03014468300006811; GOODMAN MJ, 1983, AGE MENARCHE YEAR BI; GRAHAM C, 1986, W INDIAN MED J, V35, P18; GRAYSON DA, 1989, BEHAV GENET, V19, P593, DOI 10.1007/BF01066256; HEATH AC, 1989, BEHAV GENET, V19, P9, DOI 10.1007/BF01065881; HEATH AC, 1984, GENETICS, V106, P719; HEWITT JK, 1989, BEHAV GENET, V19, P605, DOI 10.1007/BF01066257; HULSE FA, 1958, ARCH SUISSES ANTHR G, V22, P103; ISRAEL S, 1959, J Obstet Gynaecol Br Emp, V66, P311; JARDINE R, 1984, ACTA GENET MED GEMEL, V33, P435, DOI 10.1017/S0001566000005882; JARDINE R, 1984, Genetic Epidemiology, V1, P89, DOI 10.1002/gepi.1370010202; JARDINE R, 1985, THESIS AUSTR NATIONA; JONES B, 1972, MED J AUSTRALIA, V2, P533, DOI 10.5694/j.1326-5377.1972.tb47460.x; Joreskog KG, 1986, PRELIS PREPROCESSOR; JORESKOG KG, 1989, LISREL 716 GUIDE PRO; KAMPERT JB, 1988, AM J EPIDEMIOL, V128, P962; Kantero R-L, 1971, ACTA OBSTET GYN SCAN, Vcited 2018 Feb 14 50, P7; Kantero R-L, 1971, ACTA OBSTETRICA GYNE, V50, P30; KASRIEL J, 1976, J BIOSOC SCI, V8, P263, DOI 10.1017/S0021932000010737; KAUR DP, 1981, ANN HUM BIOL, V8, P333, DOI 10.1080/03014468100005131; KENDLER KS, 1983, AM J PSYCHIAT, V140, P1413; LIESTOL K, 1982, ANN HUM BIOL, V9, P521, DOI 10.1080/03014468200006051; MAGNUS P, 1983, CLIN GENET, V24, P103; MARLAY E, 1971, MED J AUSTRALIA, V1, P741, DOI 10.5694/j.1326-5377.1971.tb87832.x; MARTIN EJ, 1983, AM J EPIDEMIOL, V117, P634, DOI 10.1093/oxfordjournals.aje.a113587; MARTIN NC, 1986, H EYSENCK CONSENSUS; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; MARTIN NG, 1975, ANN HUM GENET, V39, P213, DOI 10.1111/j.1469-1809.1975.tb00124.x; MATHER K, 1974, HEREDITY, V32, P414, DOI 10.1038/hdy.1974.53; Mather K., 1973, GENETICAL STRUCTURE; Mather K, 1982, BIOMETRICAL GENETICS; MORRISYATES A, IN PRESS ACTA PSYCHI; NEALE MC, 1989, BEHAV GENET, V19, P37, DOI 10.1007/BF01065882; NEGRI E, 1988, AM J EPIDEMIOL, V128, P1207, DOI 10.1093/oxfordjournals.aje.a115075; NICHOLS RC, 1966, ACTA GENET STAT MED, V16, P265; Petri E, 1935, Z MORPHOL ANTHROPOL, V33, P43; PIKE MC, 1981, BANBURY REPORT, V8, P3; POPENOE PAUL, 1928, EUGENICAL NEWS, V13, P101; REBAR RW, 1981, JAMA-J AM MED ASSOC, V246, P1590, DOI 10.1001/jama.246.14.1590; Reymert ML, 1947, CHILD DEV, V18, P169; Richter J, 1980, Arztl Jugendkd, V71, P13; SAAR E, 1988, INT J BIOMETEOROL, V32, P33, DOI 10.1007/BF01623990; Shields J., 1962, MONOZYGOTIC TWINS BR; STAGER JM, 1988, MED SCI SPORT EXER, V20, P369, DOI 10.1249/00005768-198808000-00007; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; TANNER JM, 1965, BIOL SOCIAL PROBLEMS; TANNER JM, 1978, FETUS MAN PHYSICAL G; TISSERAND-PERRIER MARIE, 1953, JOUR GENET HUMAINE, V2, P87; TRELOAR AE, 1974, HUM BIOL, V46, P89; VANDENAKKER OBA, 1987, ACTA GENET MED GEMEL, V36, P541, DOI 10.1017/S0001566000006929; VIHKO RK, 1986, CANCER SURV, V5, P561; WEIR J, 1971, AM J OBSTET GYNECOL, V111, P594, DOI 10.1016/0002-9378(71)90478-9; WYSHAK G, 1983, ANN HUM BIOL, V10, P69, DOI 10.1080/03014468300006191; WYSHAK G, 1982, NEW ENGL J MED, V306, P1033, DOI 10.1056/NEJM198204293061707; ZACHARIA.L, 1970, AM J OBSTET GYNECOL, V108, P833, DOI 10.1016/0002-9378(70)90552-1; ZACHARIAS L, 1969, NEW ENGL J MED, V280, P868, DOI 10.1056/NEJM196904172801606	80	132	135	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					137	148						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349942				2022-12-18	WOS:A1990DK48200019
J	RAGHAVAN, SS; TOPOL, J; KOLODNY, EH				RAGHAVAN, SS; TOPOL, J; KOLODNY, EH			LEUKOCYTE BETA-GLUCOSIDASE IN HOMOZYGOTES AND HETEROZYGOTES FOR GAUCHER DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	RAGHAVAN, SS (corresponding author), EUNICE SHRIVER CTR MENTAL RETARDAT,DEPT BIOCHEM,200 TRAPELO RD,WALTHAM,MA 02154, USA.							BENYOSEPH Y, 1978, J CLIN PATHOL, V31, P1091, DOI 10.1136/jcp.31.11.1091; BEUTLER E, 1970, J LAB CLIN MED, V76, P747; BEUTLER E, 1976, J EXP MED, V143, P975, DOI 10.1084/jem.143.4.975; BEUTLER E, 1970, LANCET, V1, P612; BEUTLER E, 1971, AM J HUM GENET, V23, P62; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; BRADY RO, 1978, METABOLIC BASIS INHE, P731; BROADHEAD DM, 1977, CLIN CHIM ACTA, V75, P155, DOI 10.1016/0009-8981(77)90512-5; BUTTERWORTH J, 1978, CLIN CHIM ACTA, V87, P433, DOI 10.1016/0009-8981(78)90189-4; BUTTERWORTH J, 1972, CLIN CHIM ACTA, V41, P367, DOI 10.1016/0009-8981(72)90533-5; CHRISTOMANOU H, 1977, NEUROPADIATRIE, V8, P238, DOI 10.1055/s-0028-1091520; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; HO MW, 1973, BIOCHEM J, V136, P721, DOI 10.1042/bj1360721; HO MW, 1972, AM J HUM GENET, V24, P37; HULTBERG B, 1973, CLIN CHIM ACTA, V49, P93, DOI 10.1016/0009-8981(73)90347-1; HULTBERG B, 1970, CLIN CHIM ACTA, V28, P169, DOI 10.1016/0009-8981(70)90176-2; KAMPINE JP, 1967, SCIENCE, V155, P86, DOI 10.1126/science.155.3758.86; KANFER JN, 1975, BIOCHIM BIOPHYS ACTA, V391, P129, DOI 10.1016/0005-2744(75)90159-X; KLIBANSKY C, 1974, BIOMEDICINE, V20, P24; KOLODNY EH, 1976, CLIN CHIM ACTA, V70, P247, DOI 10.1016/0009-8981(76)90426-5; LISMAN JJW, 1973, NEUROBIOLOGY, V3, P264; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCMASTER MC, 1977, J LABELLED COMPD RAD, V13, P353, DOI 10.1002/jlcr.2580130309; MUELLER OT, 1977, J BIOL CHEM, V252, P825; OCKERMAN PA, 1968, BIOCHIM BIOPHYS ACTA, V165, P59, DOI 10.1016/0304-4165(68)90187-6; OWADA M, 1977, PEDIATR RES, V11, P641, DOI 10.1203/00006450-197705000-00004; PATRICK AD, 1965, BIOCHEM J, V97, pC17, DOI 10.1042/bj0970017C; PETERS SP, 1975, CLIN CHIM ACTA, V60, P391, DOI 10.1016/0009-8981(75)90083-2; PETERS SP, 1976, ARCH BIOCHEM BIOPHYS, V175, P569, DOI 10.1016/0003-9861(76)90547-6; RAGHAVAN SS, 1978, FED PROC, V37, P1767; Svennerholm L, 1978, Adv Exp Med Biol, V101, P689; TURNER BM, 1977, BIOCHIM BIOPHYS ACTA, V480, P442, DOI 10.1016/0005-2744(77)90036-5; Wenger D A, 1978, Adv Exp Med Biol, V101, P707; WENGER DA, 1978, CLIN GENET, V13, P145	34	132	134	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	2					158	173						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JS405	6770675				2022-12-18	WOS:A1980JS40500003
J	WILLARD, HF; LATT, SA				WILLARD, HF; LATT, SA			ANALYSIS OF DEOXYRIBONUCLEIC-ACID REPLICATION IN HUMAN X CHROMOSOMES BY FLUORESCENCE MICROSCOPY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP,MED CTR,DIV CLIN GENET,BOSTON,MA; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School								AMALDI F, 1973, EXP CELL RES, V80, P79, DOI 10.1016/0014-4827(73)90277-2; BARANOVSKAYA LT, 1972, ANN GENET-PARIS, V15, P271; BROWN SW, 1973, P NATL ACAD SCI USA, V70, P195, DOI 10.1073/pnas.70.1.195; CALDERON D, 1973, HUMANGENETIK, V18, P63; CHANDRA HS, 1962, ANN GENET PARIS, V10, P13; DUTRILLAUX B, 1973, CR ACAD SCI D NAT, V276, P3179; EVANS HJ, 1973, BRIT MED BULL, V29, P196, DOI 10.1093/oxfordjournals.bmb.a071007; GANNER E, 1971, CHROMOSOMA, V35, P326, DOI 10.1007/BF00326282; GERMAN J, 1964, J CELL BIOL, V20, P37, DOI 10.1083/jcb.20.1.37; GIANELLI F, 1970, MONOGRAPHS HUMAN GEN, V5, P1; GILBERT CW, 1962, NATURE, V195, P869, DOI 10.1038/195869a0; GILGENKRANTZ S, 1975, HUMANGENETIK, V26, P25, DOI 10.1007/BF00280282; GRZESCHIK KH, 1975, HUMANGENETIK, V29, P41, DOI 10.1007/BF00273350; HAND R, 1975, J CELL BIOL, V64, P89, DOI 10.1083/jcb.64.1.89; HUBERMAN JA, 1968, J MOL BIOL, V32, P327, DOI 10.1016/0022-2836(68)90013-2; LATT SA, 1974, EXP CELL RES, V86, P412, DOI 10.1016/0014-4827(74)90733-2; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; LATT SA, 1975, J HISTOCHEM CYTOCHEM, V23, P493, DOI 10.1177/23.7.1095650; LATT SA, 1975, SOMAT CELL GENET, V1, P293, DOI 10.1007/BF01538452; LAURENT C, 1975, HUMANGENETIK, V26, P35, DOI 10.1007/BF00280283; LIN MS, 1975, SOMAT CELL GENET, V1, P111, DOI 10.1007/BF01538735; LYON MF, 1972, BIOL REV, V47, P1; MARIN G, 1974, EXP CELL RES, V89, P368, DOI 10.1016/0014-4827(74)90802-7; MEUTH M, 1974, CELL, V2, P109, DOI 10.1016/0092-8674(74)90099-3; MILLER OJ, 1973, PROG MED GENET, V9, P1; PATAU K, 1965, HUMAN CHROMOSOME MET, P165; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; PRIEST JH, 1967, J CELL BIOL, V35, P483, DOI 10.1083/jcb.35.2.483; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; SAGER R, 1975, SCIENCE, V189, P426, DOI 10.1126/science.1098145; STUBBLEFIELD E, 1974, CELL NUCLEUS, V2, P149; THERMAN E, 1974, HUMANGENETIK, V25, P1; THERMAN E, 1974, CHROMOSOMA, V44, P361; WILLARD HF, 1975, AM J HUM GENET, V27, pA94; 1972, BIRTH DEFECTS OAS, V8, P1	35	132	133	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1976	28	3					213	227						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	BS306	1266850				2022-12-18	WOS:A1976BS30600003
J	SMITH, CAB				SMITH, CAB			SOME COMMENTS ON THE STATISTICAL METHODS USED IN LINKAGE INVESTIGATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANSCOMBE FJ, 1953, J ROY STAT SOC B, V15, P1; ANSCOMBE FJ, 1954, BIOMETRICS, V10, P89, DOI 10.2307/3001665; BARNARD GA, 1953, J R STATIST SOC B, V15, P22; Bayes T., 1763, PHILOS T ROY SOC LON, V53, P370, DOI [DOI 10.1098/RSTL.1763.0053, 10.1098/rstl.1763.0053]; Fisher R. A., 1956, STATISTICAL METHODS; KENDALL MG, 1946, ADV THEORY STATISTIC, V2; MORTON NE, 1957, AM J HUM GENET, V9, P55; MORTON NE, 1955, AM J HUM GENET, V7, P277; NEYMAN J, 1953, PHILOS T R SOC LOND, V231, P289; STEINBERG AG, 1956, AM J HUM GENET, V8, P177; WALD A, 1950, STATISTICAL DECISION; Wald A., 1947, SEQUENTIAL ANAL	12	132	131	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	4					289	304						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF076	13831904				2022-12-18	WOS:A1959WF07600001
J	Thauvin-Robinet, C; Auclair, M; Duplomb, L; Caron-Debarle, M; Avila, M; St-Onge, J; Le Merrer, M; Le Luyer, B; Heron, D; Mathieu-Dramard, M; Bitoun, P; Petit, JM; Odent, S; Amiel, J; Picot, D; Carmignac, V; Thevenon, J; Callier, P; Laville, M; Reznik, Y; Fagour, C; Nunes, ML; Capeau, J; Lascols, O; Huet, F; Faivre, L; Vigouroux, C; Riviere, JB				Thauvin-Robinet, Christel; Auclair, Martine; Duplomb, Laurence; Caron-Debarle, Martine; Avila, Magali; St-Onge, Judith; Le Merrer, Martine; Le Luyer, Bernard; Heron, Delphine; Mathieu-Dramard, Michele; Bitoun, Pierre; Petit, Jean-Michel; Odent, Sylvie; Amiel, Jeanne; Picot, Damien; Carmignac, Virginie; Thevenon, Julien; Callier, Patrick; Laville, Martine; Reznik, Yves; Fagour, Cedric; Nunes, Marie-Laure; Capeau, Jacqueline; Lascols, Olivier; Huet, Frederic; Faivre, Laurence; Vigouroux, Corinne; Riviere, Jean-Baptiste			PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICE LACKING; GROWTH; 3-KINASE; KINASE; EXPRESSION; INCREASES; PATIENT; CELLS; GENE; AKT1	Short stature, hyperextensibility of joints and/or inguinal hernia, ocular depression, Rieger anomaly, and teething delay (SHORT) syndrome is a developmental disorder with an unknown genetic cause and hallmarks that include insulin resistance and lack of subcutaneous fat. We ascertained two unrelated individuals with SHORT syndrome, hypothesized that the observed phenotype was most likely due to de novo mutations in the same gene, and performed whole-exome sequencing in the two probands and their unaffected parents. We then confirmed our initial observations in four other subjects with SHORT syndrome from three families, as well as 14 unrelated subjects presenting with syndromic insulin resistance and/or generalized lipoatrophy associated with dysmorphic features and growth retardation. Overall, we identified in nine affected individuals from eight families de novo or inherited PIK3R1 mutations, including a mutational hotspot (c.1945C>T [p.Arg649Trp]) present in four families. PIK3R1 encodes the p85 alpha, p55 alpha, and p50 alpha regulatory subunits of class IA phosphatidylinositol 3 kinases (PI3Ks), which are known to play a key role in insulin signaling. Functional data from fibroblasts derived from individuals with PIK3R1 mutations showed severe insulin resistance for both proximal and distal PI3K-dependent signaling. Our findings extend the genetic causes of severe insulin-resistance syndromes and provide important information with respect to the function of PIK3R1 in normal development and its role in human diseases, including growth delay, Rieger anomaly and other ocular affections, insulin resistance, diabetes, paucity of fat, and ovarian cysts.	[Thauvin-Robinet, Christel; Duplomb, Laurence; Avila, Magali; St-Onge, Judith; Picot, Damien; Carmignac, Virginie; Thevenon, Julien; Callier, Patrick; Huet, Frederic; Faivre, Laurence; Riviere, Jean-Baptiste] Univ Bourgogne, Genet Anomalies Dev, Equipe Accueil 4271, F-21079 Dijon, France; [Thauvin-Robinet, Christel; Thevenon, Julien; Faivre, Laurence] Ctr Hosp Univ Dijon, Ctr Genet, F-21079 Dijon, France; [Thauvin-Robinet, Christel; Thevenon, Julien; Faivre, Laurence] Ctr Hosp Univ Dijon, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France; [Auclair, Martine; Caron-Debarle, Martine; Capeau, Jacqueline; Lascols, Olivier] Inst Natl Sante & Rech Med, Unite Mixte Rech S938, F-75012 Paris, France; [Auclair, Martine; Caron-Debarle, Martine; Amiel, Jeanne; Capeau, Jacqueline; Lascols, Olivier; Vigouroux, Corinne] Univ Paris 06, Ctr Rech StAntoine, Unite Mixte Rech S938, F-75005 Paris, France; Univ Pitie Salpetriere, Grp Hosp, Inst Cardiometab & Nutr, F-75013 Paris, France; [St-Onge, Judith; Riviere, Jean-Baptiste] Ctr Hosp Univ Dijon, Genet Mol Lab, F-21079 Dijon, France; [Le Merrer, Martine] Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France; [Le Luyer, Bernard] Ctr Hosp Le Havre, Serv Pediat, F-76083 Le Havre, France; [Heron, Delphine] La Pitie Salpetriere, Dept Genet, F-75651 Paris, France; [Heron, Delphine] La Pitie Salpetriere, Ctr Reference Deficiences Intellectu, F-75651 Paris, France; [Mathieu-Dramard, Michele] Univ Amiens, Ctr Hosp, Serv Genet Clin, F-80054 Amiens, France; [Bitoun, Pierre] Univ Jean Verdier, Ctr Hosp, Serv Pediat, F-93143 Bondy, France; [Petit, Jean-Michel] Ctr Hosp Univ Dijon, Serv Endocrinol, F-21079 Dijon, France; [Odent, Sylvie] Ctr Hosp Univ Rennes, Serv Genet Clin, F-35203 Rennes, France; [Odent, Sylvie] Univ Rennes 1, Inst Genet & Dev Rennes, Unite Mixte Rech 6290, Ctr Natl Rech Sci, F-35203 Rennes, France; [Callier, Patrick] Ctr Hosp Univ Dijon, Lab Cytogenet, F-21079 Dijon, France; [Laville, Martine] Ctr Hosp Lyon Sud, Dept Endocrinol Diabetol & Nutr Hospice, F-69530 Pierre Benite, France; [Laville, Martine] Univ Claude Bernard Lyon, Ctr Rech Nutr Humaine Rhone Alpes, Ctr Europeen Nutr & Sante, Inst Natl Sante & Rech Med Unite 1060, F-69530 Pierre Benite, France; [Reznik, Yves] Ctr Hosp Univ Cote De Nacre, Serv Endocrinol, F-14033 Caen, France; [Reznik, Yves] Univ Caen Basse Normandie, Equipe Accueil 2608, Caen, France; [Reznik, Yves] Inst Natl Rech Agronom, Unite Contrat 2006, F-14032 Caen, France; [Fagour, Cedric; Nunes, Marie-Laure] Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Dept Endocrinol, F-33604 Pessac, France; [Capeau, Jacqueline; Vigouroux, Corinne] Assistance Publique Hop Paris, Hop Tenon, Serv Biochim & Hormonol, F-75020 Paris, France; [Lascols, Olivier] Assistance Publique Hop Paris, Hop St Antoine, Lab Commun Biol & Genet Mol, F-75012 Paris, France; [Huet, Frederic] Ctr Hosp Univ Dijon, Serv Pediat 1, F-21079 Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CHU Dijon Bourgogne; CHU Rennes; Universite de Rennes 1; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes 1; CHU Dijon Bourgogne; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; INRAE; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Dijon Bourgogne	Thauvin-Robinet, C (corresponding author), Univ Bourgogne, Genet Anomalies Dev, Equipe Accueil 4271, F-21079 Dijon, France.	christel.thauvin@chu-dijon.fr; jean-baptiste.riviere@u-bourgogne.fr	amiel, jeanne/AGX-1124-2022; amiel, jeanne/H-3501-2017	amiel, jeanne/0000-0001-5973-4728; Frederic, HUET/0000-0002-4510-7093; Auclair, Martine/0000-0003-3600-1999; Duplomb, Laurence/0000-0002-5715-3759; Bitoun, Pierre/0000-0001-6557-6826; Faivre, Laurence/0000-0001-9770-444X	Regional Council of Burgundy, a French government [ANR-10-IAHU]; National Heart, Lung, and Blood Institute [HL-102923, HL-102924, HL-102925, HL-102926, HL-103010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL103010, RC2HL103010, UC2HL102926, RC2HL102925, UC2HL102924, UC2HL102923, RC2HL102923, RC2HL102924, RC2HL102926, UC2HL102925] Funding Source: NIH RePORTER	Regional Council of Burgundy, a French government(Region Bourgogne-Franche-Comte); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We wish to thank the subjects and families involved in the study, PerkinElmer DNA Sequencing Service for the whole-exome-sequencing experiments, the University of Burgundy Centre de Calcul (see Web Resources) for technical support and management of the informatics platform, and the Dyscerne network (see Web Resources) for their help with this project. This work was supported by the Regional Council of Burgundy, a French government grant (ANR-10-IAHU) managed by the Agence Nationale de la Recherche (program "Investments for the Future," Institute of Cardiometabolism and Nutrition), the Institut de la Sante et de la Recherche Medicale, and the Universite Pierre et Marie Curie. We also thank the National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project (see Web Resources) and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402; Barbour LA, 2004, ENDOCRINOLOGY, V145, P1144, DOI 10.1210/en.2003-1297; Bartoli E, 2011, EUR J INTERN MED, V22, P8, DOI 10.1016/j.ejim.2010.07.008; Bonnel S, 2000, Ophthalmic Genet, V21, P235, DOI 10.1076/1381-6810(200012)21:4;1-H;FT235; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; DesboisMouthon C, 1996, METABOLISM, V45, P1493, DOI 10.1016/S0026-0495(96)90178-X; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FORMISANO P, 1993, J BIOL CHEM, V268, P5241; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Gherzi R, 2010, CELL DEATH DIFFER, V17, P975, DOI 10.1038/cdd.2009.194; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Karadeniz NN, 2004, AM J MED GENET A, V130A, P406, DOI 10.1002/ajmg.a.30206; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Koenig R, 2003, CLIN DYSMORPHOL, V12, P45, DOI 10.1097/00019605-200301000-00008; Krusenstjerna-Hafstrom T, 2011, J CLIN ENDOCR METAB, V96, P2548, DOI 10.1210/jc.2011-0273; Longo N, 2002, HUM MOL GENET, V11, P1465, DOI 10.1093/hmg/11.12.1465; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Mukherjee A, 2012, MOL CELL BIOL, V32, P490, DOI 10.1128/MCB.06361-11; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; QUON MJ, 1992, BIOCHEMISTRY-US, V31, P9947, DOI 10.1021/bi00156a013; Reis L, 2011, HUM GENET, V130, P495, DOI 10.1007/s00439-011-0968-y; Restuccia DF, 2012, DIS MODEL MECH, V5, P403, DOI 10.1242/dmm.008136; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Semple RK, 2011, ENDOCR REV, V32, P498, DOI 10.1210/er.2010-0020; Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Villegas Jacob, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2803s71	37	131	137	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					141	149		10.1016/j.ajhg.2013.05.019	http://dx.doi.org/10.1016/j.ajhg.2013.05.019			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23810378	Bronze, Green Published			2022-12-18	WOS:000321804500014
J	Merner, ND; Girard, SL; Catoire, H; Bourassa, CV; Belzi, VV; Riviere, JB; Hince, P; Levert, A; Dionne-Laporte, A; Spiegelman, D; Noreau, A; Diab, S; Szuto, A; Fournier, H; Raelson, J; Belouchi, M; Panisset, M; Cossette, P; Dupre, N; Bernard, G; Chouinard, S; Dion, PA; Rouleau, GA				Merner, Nancy D.; Girard, Simon L.; Catoire, Helene; Bourassa, Cynthia V.; Belzi, Veronique V.; Riviere, Jean-Baptiste; Hince, Pascale; Levert, Annie; Dionne-Laporte, Alexandre; Spiegelman, Dan; Noreau, Anne; Diab, Sabrina; Szuto, Anna; Fournier, Helene; Raelson, John; Belouchi, Majid; Panisset, Michel; Cossette, Patrick; Dupre, Nicolas; Bernard, Genevieve; Chouinard, Sylvain; Dion, Patrick A.; Rouleau, Guy A.			Exome Sequencing Identifies FUS Mutations as a Cause of Essential Tremor	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FAMILIAL ALS; GENE; DISORDER; DISEASE; FUS/TLS; PROTEIN; POPULATION; MECHANISM; RECEPTOR	Essential tremor (ET) is a common neurodegenerative disorder that is characterized by a postural or motion tremor. Despite a strong genetic basis, a gene with rare pathogenic mutations that cause ET has not yet been reported. We used exome sequencing to implement a simple approach to control for misdiagnosis of ET, as well as phenocopies involving sporadic and senile ET cases. We studied a large ET-affected family and identified a PUS p.Gln290* mutation as the cause of ET in this family. Further screening of 270 ET cases identified two additional rare missense FUS variants. Functional considerations suggest that the pathogenic effects of ET-specific PUS mutations are different from the effects observed when FUS is mutated in amyotrophic lateral sclerosis cases; we have shown that the ET PUS nonsense mutation is degraded by the nonsense-mediated-decay pathway, whereas amyotrophic lateral sclerosis FUS mutant transcripts are not.	[Merner, Nancy D.; Girard, Simon L.; Catoire, Helene; Bourassa, Cynthia V.; Belzi, Veronique V.; Riviere, Jean-Baptiste; Hince, Pascale; Levert, Annie; Dionne-Laporte, Alexandre; Spiegelman, Dan; Noreau, Anne; Diab, Sabrina; Szuto, Anna; Cossette, Patrick; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Res Ctr, CHU Montreal, Ctr Excellence Neurosci, Montreal, PQ H2L 2W5, Canada; [Merner, Nancy D.; Girard, Simon L.; Catoire, Helene; Bourassa, Cynthia V.; Belzi, Veronique V.; Riviere, Jean-Baptiste; Hince, Pascale; Levert, Annie; Dionne-Laporte, Alexandre; Spiegelman, Dan; Noreau, Anne; Diab, Sabrina; Szuto, Anna; Panisset, Michel; Cossette, Patrick; Bernard, Genevieve; Chouinard, Sylvain; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H2L 4M1, Canada; [Fournier, Helene; Raelson, John; Belouchi, Majid] Genizon BioSci, St Laurent, PQ H4T 1N3, Canada; [Panisset, Michel; Bernard, Genevieve; Chouinard, Sylvain; Rouleau, Guy A.] Univ Montreal, CHU Montreal, Montreal, PQ H2L 4M1, Canada; [Dupre, Nicolas] Univ Laval, Fac Med, Dept Neurol Sci, Ctr Hosp Affilie,Univ Quebec Enfant Jesus, Quebec City, PQ G1J 1Z4, Canada; [Dion, Patrick A.] Univ Montreal, Dept Pathol & Cellular Biol, Montreal, PQ H2L 2W5, Canada; [Rouleau, Guy A.] CHU Justin, Res Ctr, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University; Universite de Montreal	Rouleau, GA (corresponding author), Univ Montreal, Res Ctr, CHU Montreal, Ctr Excellence Neurosci, Montreal, PQ H2L 2W5, Canada.	guy.rouleau@umontreal.ca	Dupre, Nicolas/Y-1828-2019; Bernard, Geneviève/AAU-7569-2020; Belzil, Veronique/J-9361-2012	Bernard, Geneviève/0000-0002-9634-2966; spiegelman, dan/0000-0003-4971-8868; Girard, Simon/0000-0002-4089-2280; Merner, Nancy/0000-0002-8954-0155	Claude Laberge fellowship from the Reseau de Medecine Genetique Applique (RMGA); Chaire Jeanne-et-J.-Louis-Levesque en Genetique des Maladies du Cerveau de l'Universite de Montreal	Claude Laberge fellowship from the Reseau de Medecine Genetique Applique (RMGA); Chaire Jeanne-et-J.-Louis-Levesque en Genetique des Maladies du Cerveau de l'Universite de Montreal	N.D.M. is the recipient of a Claude Laberge fellowship from the Reseau de Medecine Genetique Applique (RMGA). The RMGA also supports the bioinformatics analytical team of G.A.R. G.A.R. holds the Canada Research Chair in Genetics of the Nervous System. This work was supported by the Chaire Jeanne-et-J.-Louis-Levesque en Genetique des Maladies du Cerveau de l'Universite de Montreal.	ARONSON AE, 1992, ANN OTO RHINOL LARYN, V101, P511, DOI 10.1177/000348949210100612; Belzil VV, 2011, AMYOTROPH LATERAL SC, V12, P113, DOI 10.3109/17482968.2010.536840; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; Deng H, 2007, BRAIN, V130, P1456, DOI 10.1093/brain/awm018; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Deuschl G, 2009, MOVEMENT DISORD, V24, P2033, DOI 10.1002/mds.22755; Erickson-Davis CR, 2010, J NEUROPATH EXP NEUR, V69, P262, DOI 10.1097/NEN.0b013e3181d1ad04; Gulcher JR, 1997, NAT GENET, V17, P84, DOI 10.1038/ng0997-84; Higgins JJ, 1997, MOVEMENT DISORD, V12, P859, DOI 10.1002/mds.870120605; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Jain S, 2006, ARCH NEUROL-CHICAGO, V63, P1100, DOI 10.1001/archneur.63.8.1100; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Louis ED, 1998, ARCH NEUROL-CHICAGO, V55, P823, DOI 10.1001/archneur.55.6.823; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Murakami T, 2012, HUM MOL GENET, V21, P1, DOI 10.1093/hmg/ddr417; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Schrag A, 2000, J NEUROL, V247, P955, DOI 10.1007/s004150070053; Shatunov A, 2006, BRAIN, V129, P2318, DOI 10.1093/brain/awl120; Spanaki C, 2009, MOVEMENT DISORD, V24, P1662, DOI 10.1002/mds.22655; Stefansson H, 2009, NAT GENET, V41, P277, DOI 10.1038/ng.299; Tateishi T, 2010, ACTA NEUROPATHOL, V119, P355, DOI 10.1007/s00401-009-0621-1; Van Langenhove T, 2010, NEUROLOGY, V74, P366, DOI 10.1212/WNL.0b013e3181ccc732; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Waibel S, 2010, NEUROLOGY, V75, P815, DOI 10.1212/WNL.0b013e3181f07e26; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Yan J, 2010, NEUROLOGY, V75, P807, DOI 10.1212/WNL.0b013e3181f07e0c	38	131	135	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					313	319		10.1016/j.ajhg.2012.07.002	http://dx.doi.org/10.1016/j.ajhg.2012.07.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22863194	Bronze, Green Published			2022-12-18	WOS:000307608700009
J	Forsberg, LA; Rasi, C; Razzaghian, HR; Pakalapati, G; Waite, L; Thilbeault, KS; Ronowicz, A; Wineinger, NE; Tiwari, HK; Boomsma, D; Westerman, MP; Harris, JR; Lyle, R; Essand, M; Eriksson, F; Assimes, TL; Iribarren, C; Strachan, E; O'Hanlon, TP; Rider, LG; Miller, FW; Giedraitis, V; Lannfelt, L; Ingelsson, M; Piotrowski, A; Pedersen, NL; Absher, D; Dumanski, JP				Forsberg, Lars A.; Rasi, Chiara; Razzaghian, Hamid R.; Pakalapati, Geeta; Waite, Lindsay; Thilbeault, Krista Stanton; Ronowicz, Anna; Wineinger, Nathan E.; Tiwari, Hemant K.; Boomsma, Dorret; Westerman, Maxwell P.; Harris, Jennifer R.; Lyle, Robert; Essand, Magnus; Eriksson, Fredrik; Assimes, Themistocles L.; Iribarren, Carlos; Strachan, Eric; O'Hanlon, Terrance P.; Rider, Lisa G.; Miller, Frederick W.; Giedraitis, Vilmantas; Lannfelt, Lars; Ingelsson, Martin; Piotrowski, Arkadiusz; Pedersen, Nancy L.; Absher, Devin; Dumanski, Jan P.			Age-Related Somatic Structural Changes in the Nuclear Genome of Human Blood Cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER-VARIATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; CORONARY-ARTERY-DISEASE; MYELODYSPLASTIC SYNDROMES; MONOZYGOTIC TWINS; MITOCHONDRIAL-DNA; HUMAN TISSUES; MOSAICISM; REARRANGEMENTS; ANEUPLOIDIES	Structural variations are among the most frequent interindividual genetic differences in the human genome. The frequency and distribution of de novo somatic structural variants in normal cells is, however, poorly explored. Using age-stratified cohorts of 318 monozygotic (MZ) twins and 296 single-born subjects, we describe age-related accumulation of copy-number variation in the nuclear genomes in vivo and frequency changes for both megabase- and kilobase-range variants. Megabase-range aberrations were found in 3.4% (9 of 264) of subjects >= 60 years old; these subjects included 78 MZ twin pairs and 108 single-born individuals. No such findings were observed in 81 MZ pairs or 180 single-born subjects who were 55 years old. Recurrent region- and gene-specific mutations, mostly deletions, were observed. Longitudinal analyses of 43 subjects whose data were collected 7-19 years apart suggest considerable variation in the rate of accumulation of clones carrying structural changes. Furthermore, the longitudinal analysis of individuals with structural aberrations suggests that there is a natural self-removal of aberrant cell clones from peripheral blood. In three healthy subjects, we detected somatic aberrations characteristic of patients with myelodysplastic syndrome. The recurrent rearrangements uncovered here are candidates for common age-related defects in human blood cells. We anticipate that extension of these results will allow determination of the genetic age of different somatic-cell lineages and estimation of possible individual differences between genetic and chronological age. Our work might also help to explain the cause of an age-related reduction in the number of cell clones in the blood; such a reduction is one of the hallmarks of immunosenescence.	[Forsberg, Lars A.; Rasi, Chiara; Razzaghian, Hamid R.; Pakalapati, Geeta; Essand, Magnus; Eriksson, Fredrik; Dumanski, Jan P.] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; [Waite, Lindsay; Thilbeault, Krista Stanton; Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Ronowicz, Anna; Piotrowski, Arkadiusz] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, PL-80416 Gdansk, Poland; [Wineinger, Nathan E.; Tiwari, Hemant K.] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Boomsma, Dorret] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Westerman, Maxwell P.] Mt Sinai Hosp, Med Ctr, Chicago, IL 60608 USA; [Harris, Jennifer R.] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, N-0403 Oslo, Norway; [Lyle, Robert] Oslo Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Iribarren, Carlos] Kaiser Fdn Res Inst, Oakland, CA 94612 USA; [Strachan, Eric] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Strachan, Eric] Univ Washington, Twin Registry, Seattle, WA 98104 USA; [O'Hanlon, Terrance P.; Rider, Lisa G.; Miller, Frederick W.] NIEHS, Environm Autoimmun Grp, NIH, Clin Res Ctr, Bethesda, MD 20892 USA; [Giedraitis, Vilmantas; Lannfelt, Lars; Ingelsson, Martin] Uppsala Univ, Dept Publ Hlth & Caring Sci, Div Mol Geriatr, S-75185 Uppsala, Sweden; [Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden	Uppsala University; HudsonAlpha Institute for Biotechnology; Fahrenheit Universities; Medical University Gdansk; University of Alabama System; University of Alabama Birmingham; Vrije Universiteit Amsterdam; Norwegian Institute of Public Health (NIPH); University of Oslo; Stanford University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Uppsala University; Karolinska Institutet	Dumanski, JP (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.	jan.dumanski@igp.uu.se	Boomsma, Dorret I/AAX-4470-2020; Piotrowski, Arkadiusz/A-5484-2010; Assimes, Themistocles Leonard/D-9696-2015; Rider, Lisa G/C-7083-2018; Miller, Frederick/D-2431-2019	Piotrowski, Arkadiusz/0000-0002-0823-0607; Assimes, Themistocles Leonard/0000-0003-2349-0009; Rider, Lisa G/0000-0002-6912-2458; Eriksson, Fredrik/0000-0001-9548-3276; Jones, Lindsay/0000-0002-4219-8356; Dumanski, Jan Piotr/0000-0002-1489-1452; Miller, Frederick/0000-0003-2831-9593; Forsberg, Lars/0000-0002-1701-755X	Ellison Medical Foundation; Swedish Cancer Society; Swedish Research Council [80576801, 70374401]; Science for Life Laboratory-Uppsala; Foundation for Polish Science [FOCUS 4/2008, FOCUS 4/08/2009]; Uppsala University, Uppsala University Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101074] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Science for Life Laboratory-Uppsala; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Uppsala University, Uppsala University Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Lars Feuk, Brigitte Schlegelberger, Jacek Witkowski, Greg Cooper, Richard Rosenquist Brandell, Eva Hellstrom-Lindberg, Chris Gunther, and Eva Tiensuu Janson for critical review of the manuscript and Larry Mansouri and Juan R. Gonzalez for methodological advice. This study was sponsored by grants from the Ellison Medical Foundation (J.P.D. and D.A.) and from the Swedish Cancer Society, the Swedish Research Council, and the Science for Life Laboratory-Uppsala (J.P.D.). A.P. acknowledges FOCUS 4/2008 and FOCUS 4/08/2009 grants from the Foundation for Polish Science. Genotyping was performed in part by the SNP&SEQ Technology Platform, which is supported by Uppsala University, Uppsala University Hospital, the Science for Life Laboratory-Uppsala, and the Swedish Research Council (contracts 80576801 and 70374401).	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2011, FAST STATS; Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Bernasconi P, 2006, ANN NY ACAD SCI, V1089, P395, DOI 10.1196/annals.1386.034; Braun T, 2011, LEUKEMIA RES, V35, P863, DOI 10.1016/j.leukres.2011.02.008; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Dumanski J.P., 2012, GENOMIC STR IN PRESS; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; Gunnarsson R, 2010, LEUKEMIA, V24, P211, DOI 10.1038/leu.2009.187; Gunnarsson R, 2008, GENE CHROMOSOME CANC, V47, P697, DOI 10.1002/gcc.20575; Haase D, 2008, ANN HEMATOL, V87, P515, DOI 10.1007/s00277-008-0483-y; Hagenkord JM, 2010, J MOL DIAGN, V12, P184, DOI 10.2353/jmoldx.2010.090118; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Razzaghian HR, 2010, AM J MED GENET A, V152A, P2595, DOI 10.1002/ajmg.a.33604; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sloter ED, 2007, FERTIL STERIL, V87, P1077, DOI 10.1016/j.fertnstert.2006.08.112; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Tiu RV, 2011, BLOOD, V117, P4552, DOI 10.1182/blood-2010-07-295857; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Workman C., 2002, GENOME BIOL, V3, P0048; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906	43	131	134	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					217	228		10.1016/j.ajhg.2011.12.009	http://dx.doi.org/10.1016/j.ajhg.2011.12.009			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22305530	Green Published, Bronze			2022-12-18	WOS:000300742200003
J	Davidson, AE; Millar, ID; Urquhart, JE; Burgess-Mullan, R; Shweikh, Y; Parry, N; O'Sullivan, J; Maher, GJ; McKibbin, M; Downes, SM; Lotery, AJ; Jacobson, SG; Brown, PD; Black, GCM; Manson, FDC				Davidson, Alice E.; Millar, Ian D.; Urquhart, Jill E.; Burgess-Mullan, Rosemary; Shweikh, Yusrah; Parry, Neil; O'Sullivan, James; Maher, Geoffrey J.; McKibbin, Martin; Downes, Susan M.; Lotery, Andrew J.; Jacobson, Samuel G.; Brown, Peter D.; Black, Graeme C. M.; Manson, Forbes D. C.			Missense Mutations in a Retinal Pigment Epithelium Protein, Bestrophin-1, Cause Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VITELLIFORM MACULAR DYSTROPHY; OPTICAL COHERENCE TOMOGRAPHY; CYSTIC-FIBROSIS; BEST-DISEASE; CL-CHANNELS; LIGHT PEAK; GENE; CONDUCTANCE; VMD2; TRANSPORT	Bestrophin-1 is preferentially expressed at the basolateral membrane of the retinal pigmented epithelium (RPE) of the retina. Mutations in the BEST] gene cause the retinal dystrophies vitelliform macular dystrophy, autosomal-dominant vitreochoroidopathy, and autosomal-recessive bestrophinopathy. Here, we describe four missense mutations in bestrophin-1, three that we believe are previously unreported, in patients diagnosed with autosomal-dominant and -recessive forms of retinitis pigmentosa (RP). The physiological function of bestrophin-1 remains poorly understood although its heterologous expression induces a Cl--specific current. We tested the effect of RP-causing variants on Cl- channel activity and cellular localization of bestrophin-1. Two (p.L140V and p.1205T) produced significantly decreased chloride-selective whole-cell currents in comparison to those of wild-type protein. In a model system of a polarized epithelium, two of three mutations (p.L140V and p.D228N) caused mislocalization of bestrophin-1 from the basolateral membrane to the cytoplasm. Mutations in bestrophin-1 are increasingly recognized as an important cause of inherited retinal dystrophy.	[Davidson, Alice E.; Burgess-Mullan, Rosemary; Shweikh, Yusrah; Maher, Geoffrey J.; Black, Graeme C. M.; Manson, Forbes D. C.] Univ Manchester, Manchester Acad Heath Sci Ctr, Cent Manchester Univ Hosp, NHS Fdn Trust, Manchester, Lancs, England; [Millar, Ian D.; Brown, Peter D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Urquhart, Jill E.; O'Sullivan, James] St Marys Hosp, Natl Genet Reference Lab, Manchester M13 0JH, Lancs, England; [Parry, Neil; Black, Graeme C. M.] Manchester Royal Eye Hosp, Cent Manchester Univ Hosp, NHS Fdn Trust, Manchester M13 9WH, Lancs, England; [McKibbin, Martin] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Downes, Susan M.] John Radcliffe Hosp, Oxford Eye Hosp, Oxford OX3 9DU, England; [Lotery, Andrew J.] Univ Southampton, Southampton, Hants, England; [Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA	Oxford University Hospitals NHS Foundation Trust; University of Manchester; University of Manchester; University of Manchester; Manchester Royal Eye Hospital; Oxford University Hospitals NHS Foundation Trust; Saint James's University Hospital; University of Oxford; University of Southampton; University of Pennsylvania; Pennsylvania Medicine	Manson, FDC (corresponding author), Univ Manchester, Manchester Acad Heath Sci Ctr, Cent Manchester Univ Hosp, NHS Fdn Trust, Manchester, Lancs, England.	forbes.manson@manchester.ac.uk	Urquhart, Jill/G-2282-2015; Manson, Forbes/G-2222-2015; Black, Graeme/K-7374-2015	Urquhart, Jill/0000-0002-5788-5511; Manson, Forbes/0000-0002-8342-660X; Black, Graeme/0000-0001-8727-6592; Lotery, Andrew/0000-0001-5541-4305; Jacobson, Samuel/0000-0003-2122-169X	National Eye Research Centre [SCIAD 051]; Fight for Sight; British Retinitis Pigmentosa Society; Macula Vision Research Foundation; Manchester Biomedical Research Centre; Manchester Academic Health Sciences Centre (MAHSC); National Institute for Health Research (NIHR); Biotechnology and Biological Sciences Research Council; Wellcome Trust; University of Manchester Strategic Fund; National Institute for Health Research [NF-SI-0507-10094] Funding Source: researchfish	National Eye Research Centre; Fight for Sight; British Retinitis Pigmentosa Society; Macula Vision Research Foundation; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Manchester Academic Health Sciences Centre (MAHSC); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester Strategic Fund; National Institute for Health Research(National Institute for Health Research (NIHR))	A.E.D. is supported by the National Eye Research Centre (SCIAD 051). G.J.M. is supported by Fight for Sight. J.O'S. and A.J.L. are supported by the British Retinitis Pigmentosa Society. S.G.J. is funded by the Macula Vision Research Foundation. Funding was also provided by the Manchester Biomedical Research Centre, the Manchester Academic Health Sciences Centre (MAHSC), and the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre. The confocal microscope used in this study was purchased with grants from the Biotechnology and Biological Sciences Research Council, The Wellcome Trust, and The University of Manchester Strategic Fund.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bakall B, 2003, INVEST OPHTH VIS SCI, V44, P3622, DOI 10.1167/iovs.03-0030; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barro-Soria R, 2008, BBA-MOL CELL RES, V1783, P1993, DOI 10.1016/j.bbamcr.2008.06.016; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Burgess R, 2008, AM J HUM GENET, V82, P19, DOI 10.1016/j.ajhg.2007.08.004; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Cordat E, 2006, BIOCHEM CELL BIOL, V84, P949, DOI 10.1139/O06-200; Gallemore RP, 1997, PROG RETIN EYE RES, V16, P509, DOI 10.1016/S1350-9462(96)00037-7; GALLEMORE RP, 1989, J NEUROSCI, V9, P1977; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Hartzell C, 2005, PHYSIOLOGY, V20, P292, DOI 10.1152/physiol.00021.2005; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; JAFFE GJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P958; KAUFMAN SJ, 1982, ARCH OPHTHALMOL-CHIC, V100, P272; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Krasnov KV, 2008, HUM MUTAT, V29, P1364, DOI 10.1002/humu.20866; Lotery AJ, 2000, INVEST OPHTH VIS SCI, V41, P1291; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marmorstein AD, 2002, INVEST OPHTH VIS SCI, V43, pU818; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Men G, 2004, AM J OPHTHALMOL, V137, P963, DOI 10.1016/j.ajo.2003.11.014; Mendes F, 2005, CELL PHYSIOL BIOCHEM, V16, P281, DOI 10.1159/000089857; Mickle JE, 2000, AM J HUM GENET, V66, P1485, DOI 10.1086/302893; Milam AH, 2001, EXP EYE RES, V73, P493, DOI 10.1006/exer.2001.1059; Milenkovic VM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-72; Milenkovic VM, 2007, J BIOL CHEM, V282, P1313, DOI 10.1074/jbc.M607383200; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Pianta MJ, 2003, EXP EYE RES, V76, P203, DOI 10.1016/S0014-4835(02)00280-4; Pierro L, 2002, AM J OPHTHALMOL, V134, P675, DOI 10.1016/S0002-9394(02)01685-9; Qu ZQ, 2009, J BIOL CHEM, V284, P16473, DOI 10.1074/jbc.M109.002246; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Stone Edwin M., 1992, Human Molecular Genetics, V1, P685, DOI 10.1093/hmg/1.9.685; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Vedantham V, 2005, AM J OPHTHALMOL, V139, P351, DOI 10.1016/j.ajo.2004.07.039; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yardley J, 2004, INVEST OPHTH VIS SCI, V45, P3683, DOI 10.1167/iovs.04-0550; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301; Yu K, 2006, INVEST OPHTH VIS SCI, V47, P4956, DOI 10.1167/iovs.06-0524	49	131	136	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					581	592		10.1016/j.ajhg.2009.09.015	http://dx.doi.org/10.1016/j.ajhg.2009.09.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19853238	Green Published, Bronze			2022-12-18	WOS:000271916500006
J	Saada, A; Vogel, RO; Hoefs, SJ; van den Brand, MA; Wessels, HJ; Willems, PH; Venselaar, H; Shaag, A; Barghuti, F; Reish, O; Shohat, M; Huynen, MA; Smeitink, JAM; van den Heuvel, LP; Nijtmans, LG				Saada, Ann; Vogel, Rutger O.; Hoefs, Saskia J.; van den Brand, Mariel A.; Wessels, Hans J.; Willems, Peter H.; Venselaar, Hanka; Shaag, Avraham; Barghuti, Flora; Reish, Orit; Shohat, Mordechai; Huynen, Martijn A.; Smeitink, Jan A. M.; van den Heuvel, Lambert P.; Nijtmans, Leo G.			Mutations in NDUFAF3 (C3ORF60), Encoding an NDUFAF4 (C6ORF66)-interacting Complex I Assembly Protein, Cause Fatal Neonatal Mitochondrial Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESPIRATORY-CHAIN; IDENTIFICATION; PATHOLOGY; CHAPERONE; SUBUNITS; GENE	Mitochondrial complex I deficiency is the most prevalent and least understood disorder of the oxidative phosphorylation system. The genetic cause of many cases of isolated complex I deficiency is unknown because of insufficient understanding of the complex I assembly process and the factors involved. We performed homozygosity mapping and gene sequencing to identify the genetic defect in five complex I-deficient patients from three different families. All patients harbored mutations in the NDUFAF3 (C3ORF60) gene, of which the pathogenic nature was assessed by NDUFAF3-GFP baculovirus complementation in fibroblasts. We found that NDUFAF3 is a genuine mitochondrial complex I assembly protein that interacts with complex I subunits. Furthermore, we show that NDUFAF3 tightly interacts with NDUFAF4 (C6ORF66), a protein previously implicated in complex I deficiency. Additional gene conservation analysis links NDUFAF3 to bacterial-membrane-insertion gene cluster SecF/SecD/YajC and to C8ORF38, also implicated in complex I deficiency. These data not only show that NDUFAF3 mutations cause complex I deficiency but also relate different complex I disease genes by the close cooperation of their encoded proteins during the assembly process.	[Vogel, Rutger O.; Hoefs, Saskia J.; van den Brand, Mariel A.; Wessels, Hans J.; Smeitink, Jan A. M.; van den Heuvel, Lambert P.; Nijtmans, Leo G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, Geert Grootepl 10, NL-6500 HB Nijmegen, Netherlands; [Saada, Ann; Shaag, Avraham] Hadassah Hebrew Univ, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; [Willems, Peter H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Membrane Biochem, NL-6500 HB Nijmegen, Netherlands; [Venselaar, Hanka; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; [Barghuti, Flora] Al Mustaqbal Hosp, IL-98700 Ramallah 98700, Palestine; [Reish, Orit] Assaf Harofeh Med Ctr, Genet Inst, IL-70300 Zerifin, Israel; [Shohat, Mordechai] Rabin Med Ctr, Dept Pediat & Genet, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel; [Shohat, Mordechai] Schneider Med Ctr, Dept Pediat & Genet, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel	Radboud University Nijmegen; Hebrew University of Jerusalem; Hadassah University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Rabin Medical Center	Nijtmans, LG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, Geert Grootepl 10, NL-6500 HB Nijmegen, Netherlands.	l.nijtmans@cukz.umcn.nl	Smeitink, Jan A.M./D-6064-2011; van den Brand, Mariel/S-1215-2017; Wessels, Hans J/P-6248-2015; Willems, P.H.G.M./L-4759-2015; Huijnen, M.A./H-8051-2014; Smeitink, Jan/C-1351-2013; Venselaar, Hanka/D-2009-2016; Nijtmans, L.G.J./L-4549-2015; Saada, Ann/J-6864-2017; van den Heuvel, L.P.W.J./H-8044-2014; van den Heuvel, Lambertus/AAM-1772-2021; Huynen, Martijn A/A-1530-2014	van den Brand, Mariel/0000-0001-9924-6083; Wessels, Hans J/0000-0001-5957-3127; Willems, P.H.G.M./0000-0002-0915-1599; Venselaar, Hanka/0000-0001-9824-6559; Saada, Ann/0000-0003-2951-0656; van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Huynen, Martijn A/0000-0001-6189-5491; reish, orit/0000-0002-9483-238X	Israeli Ministry of Health; Research Council for Earth and Life Sciences; European Community [LSHM-CTY-2004-005260]; Netherlands Bioinformatics Centre (NBIC)	Israeli Ministry of Health; Research Council for Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Netherlands Bioinformatics Centre (NBIC)	We thank Orly Elpeleg for critical evaluation of this manuscript. We are grateful to H. Lorberboum-Galski, B. Robinson, A. Lombes, and Frank van Kuppeveld for providing, respectively, the NDUFAF4 (C6ORF66), NDUFS2, ND1, and EGFP antibodies; to H. Swarts for generating GFP-tagged baculovirus, and to C. Dieteren for confocal imaging. A part of this work was supported by a grant from the Israeli Ministry of Health (A.S.), by the Research Council for Earth and Life Sciences (ALW) with the financial aid from the Netherlands Organization for Scientific Research (NWO) (R.V.), and by the European Community's Sixth Framework Programme for Research, Priority 1 "Life sciences, genomics and biotechnology for health," contract number LSHM-CTY-2004-005260 (MITOCIRCLE) (S.H. and L.vd.H.). H.V. acknowledges support from the Netherlands Bioinformatics Centre (NBIC).	Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; LAZAROU M, 2008, BIOCHIM BIOPHYS ACTA, V1793, P78; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407	33	131	140	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					718	727		10.1016/j.ajhg.2009.04.020	http://dx.doi.org/10.1016/j.ajhg.2009.04.020			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458SC	19463981	Bronze, Green Published			2022-12-18	WOS:000267042800003
J	Ostergaard, E; Christensen, E; Kristensen, E; Mogensen, B; Duno, M; Shoubridge, EA; Wibrand, F				Ostergaard, Elsebet; Christensen, Ernst; Kristensen, Elisabeth; Mogensen, Bodil; Duno, Morten; Shoubridge, Eric A.; Wibrand, Flemming			Deficiency of the a subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; SUCLA2 MUTATIONS; MEMBRANE-PROTEIN; COA SYNTHETASES; ENCEPHALOMYOPATHY; EXPRESSION; COMPLEXES; TISSUES; GENE	Fatal infantile lactic acidosis is a severe metabolic disorder characterized by the onset of lactic acidosis within the 1st d of life and early death. We found a combined respiratory-chain enzyme deficiency associated with mitochondrial DNA (mtDNA) depletion in a small consanguineous family with this disorder. To identify the disease-causing gene, we performed single-nucleotide polymorphism homozygosity mapping and found homozygous regions on four chromosomes. DNA sequencing revealed a homozygous 2-bp deletion in SUCLG1, a gene that encodes the a subunit of the Krebs-cycle enzyme succinate-coenzyme A ligase (SUCL). The mtDNA depletion is likely explained by decreased mitochondrial nucleoside diphosphate kinase (NDPK) activity resulting from the inability of NDPK to form a complex with SUCL.	Natl Univ Hosp, Rigshosp, Dept Clin Genet 4062, DK-2100 Copenhagen, Denmark; Natl Univ Hosp, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; Kennedy Inst, Natl Eye Clin, Glostrup, Denmark; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2T5, Canada	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; McGill University; McGill University	Ostergaard, E (corresponding author), Natl Univ Hosp, Rigshosp, Dept Clin Genet 4062, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	elsebet.oestergaard@rh.regionh.dk						BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Genin E, 1998, ANN HUM GENET, V62, P419, DOI 10.1046/j.1469-1809.1998.6250419.x; Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580; KADRMAS EF, 1991, BIOCHIM BIOPHYS ACTA, V1074, P339, DOI 10.1016/0304-4165(91)90083-S; KAVANAUGHBLACK A, 1994, P NATL ACAD SCI USA, V91, P5883, DOI 10.1073/pnas.91.13.5883; KOVACHY RJ, 1983, J BIOL CHEM, V258, P1415; Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710; KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4; Lambeth DO, 2006, BIOCHEM MOL BIOL EDU, V34, P21, DOI 10.1002/bmb.2006.49403401021; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765	19	131	137	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					383	387		10.1086/519222	http://dx.doi.org/10.1086/519222			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668387	Green Published, Bronze			2022-12-18	WOS:000248540400017
J	Oberstein, SAJL; Kriek, M; White, SJ; Kalf, ME; Szuhai, K; den Dunnen, JT; Breuning, MH; Hennekam, RCM				Oberstein, Saskia A. J. Lesnik; Kriek, Marjolein; White, Stefan J.; Kalf, Margot E.; Szuhai, Karoly; den Dunnen, Johan T.; Breuning, Martijn H.; Hennekam, Raoul C. M.			Peters plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; REARRANGEMENTS; FAMILIES; BRCA2	Peters Plus syndrome is an autosomal recessive disorder characterized by anterior eye-chamber abnormalities, disproportionate short stature, and developmental delay. After detection of amicrodeletion by array-based comparative genomic hybridization, we identified biallelic truncating mutations in the beta 1,3-galactosyltransferase-like gene (B3GALTL) in all 20 tested patients, showing that Peters Plus is a monogenic, primarily single-mutation syndrome. This finding is expected to put Peters Plus syndrome on the growing list of congenital malformation syndromes caused by glycosylation defects.	Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Mol & Cell Biol, NL-2300 RC Leiden, Netherlands; Inst Child Hlth, Clin & Mol Genet Unit, London, England; Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam	Oberstein, SAJL (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Clin Genet, K5-R,POB 2600, NL-2300 RC Leiden, Netherlands.	Lesnik@LUMC.nl	Oberstein, Saskia A.J. Lesnik/C-3643-2016; dunnen, johan den/ABH-4228-2020; Szuhai, Karoly/A-1100-2008	Oberstein, Saskia A.J. Lesnik/0000-0002-1268-8995; dunnen, johan den/0000-0002-6304-1710; Szuhai, Karoly/0000-0002-1228-4245				Diskin S, 2006, INVEST OPHTH VIS SCI, V47, P1491, DOI 10.1167/iovs.05-0736; Ferlin A, 2003, J CLIN ENDOCR METAB, V88, P4273, DOI 10.1210/jc.2003-030359; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Heinonen TYK, 2003, BIOCHEM BIOPH RES CO, V309, P166, DOI 10.1016/S0006-291X(03)01540-7; Jacques C, 2005, J CLIN ENDOCR METAB, V90, P2314, DOI 10.1210/jc.2004-1337; Jaeken J, 2003, J INHERIT METAB DIS, V26, P99, DOI 10.1023/A:1024431131208; Knijnenburg J, 2005, AM J MED GENET A, V132A, P36, DOI 10.1002/ajmg.a.30378; Tournier I, 2004, CANCER RES, V64, P8143, DOI 10.1158/0008-5472.CAN-04-2467; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Wenniger-Prick LJJMMD, 2002, ANN GENET-PARIS, V45, P97; Zhao ZM, 2006, GENE, V366, P316, DOI 10.1016/j.gene.2005.08.024	12	131	132	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					562	566		10.1086/507567	http://dx.doi.org/10.1086/507567			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909395	Green Published, Bronze			2022-12-18	WOS:000239830700019
J	Gouya, L; Martin-Schmitt, C; Robreau, AM; Austerlitz, F; Da Silva, V; Brun, P; Simonin, S; Lyoumi, S; Grandchamp, B; Beaumont, C; Herve, P; Deybach, JC				Gouya, L; Martin-Schmitt, C; Robreau, AM; Austerlitz, F; Da Silva, V; Brun, P; Simonin, S; Lyoumi, S; Grandchamp, B; Beaumont, C; Herve, P; Deybach, JC			Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FERROCHELATASE GENE; LOW EXPRESSION; WILD-TYPE; LIVER; MUTATION; PATIENT; PHENOTYPE; DISEASE; TRANSPLANTATION; INHERITANCE	Erythropoietic protoporphyria ( EPP) is an inherited disorder of heme biosynthesis that results from a partial deficiency of ferrochelatase ( FECH). Recently, we have shown that the inheritance of the common hypomorphic IVS3-48C allele trans to a deleterious mutation reduces FECH activity to below a critical threshold and accounts for the photosensitivity seen in patients. Rare cases of autosomal recessive inheritance have been reported. We studied a cohort of 173 white French EPP families and a group of 360 unrelated healthy subjects from four ethnic groups. The prevalences of the recessive and dominant autosomal forms of EPP are 4% ( 95% confidence interval 1 - 8) and 95% ( 95% confidence interval 91 - 99), respectively. In 97.9% of dominant cases, an IVS3-48C allele is coinherited with the deleterious mutation. The frequency of the IVS3-48C allele differs widely in the Japanese (43%), southeast Asian ( 31%), white French (11%), North African (2.7%), and black West African (< 1%) populations. These differences can be related to the prevalence of EPP in these populations and could account for the absence of EPP in black subjects. The phylogenic origin of the IVS3-48C haplotypes strongly suggests that the IVS3-48C allele arose from a single recent mutational event. Estimation of the age of the IVS3-48C allele from haplotype data in white and Asian populations yields an estimated age three to four times younger in the Japanese than in the white population, and this difference may be attributable either to differing demographic histories or to positive selection for the IVS3-48C allele in the Asian population. Finally, by calculating the K-A/K-S ratio in humans and chimpanzees, we show that the FECH protein sequence is subject to strong negative pressure. Overall, EPP looks like a Mendelian disorder, in which the prevalence of overt disease depends mainly on the frequency of a single common single-nucleotide polymorphism resulting from a unique mutational event that occurred 60,000 years ago.	Hop Louis Mourier, Ctr Francais Porphyries, F-92701 Colombes, France; Hop Louis Mourier, Serv Accueil Urgences, F-92701 Colombes, France; Univ Paris 07, INSERM, U656, Fac Med Xavier Bichat, Paris, France; Hop Xavier Bichat, Serv Biochim Hormonale & Gent, Paris, France; Fac Med Paris France Ouest, Garches, France; Univ Paris 11, Lab Ecol Systemat & Evolut, Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Deybach, JC (corresponding author), Hop Louis Mourier, Ctr Francais Porphyries, 178 Rue Renouillers, F-92701 Colombes, France.	jc.deybach@wanadoo.fr	PUY, HERVE/O-1785-2017; SCHMITT, Caroline/P-2859-2017	PUY, HERVE/0000-0003-3362-2634; SCHMITT, Caroline/0000-0001-5145-7260; Gouya, Laurent/0000-0002-1326-7025; Austerlitz, Frederic/0000-0001-8031-455X				ANDERSON KE, 2001, METABOLIC MOL BASES, P2991; Aplin C, 2001, J INVEST DERMATOL, V117, P1647, DOI 10.1046/j.0022-202x.2001.01560.x; Austerlitz F, 2003, GENETICS, V165, P1579; BLOOMER JR, 1988, HEPATOLOGY, V8, P402, DOI 10.1002/hep.1840080235; BONKOWSKY HL, 1975, J CLIN INVEST, V56, P1139, DOI 10.1172/JCI108189; Chen FP, 2002, CELL MOL BIOL, V48, P83; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Deacon AC, 2001, J CLIN PATHOL, V54, P500, DOI 10.1136/jcp.54.7.500; Delaunay J, 2002, ACTA HAEMATOL-BASEL, V108, P210, DOI 10.1159/000065657; DEYBACH JC, 1986, PORPHYRINS PORPHYRIA, P163; DOSS MO, 1989, CLIN BIOCHEM, V22, P223, DOI 10.1016/S0009-9120(89)80081-5; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Goerz G, 1996, BRIT J DERMATOL, V134, P880; Gouya L, 1996, AM J HUM GENET, V58, P292; Gouya L, 2002, NAT GENET, V30, P27, DOI 10.1038/ng809; Gouya L, 1999, BLOOD, V93, P2105, DOI 10.1182/blood.V93.6.2105.406k28_2105_2110; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kondo M, 2004, INT J HEMATOL, V79, P448, DOI 10.1532/IJH97.03127; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; LAMORIL J, 1991, BIOCHEM BIOPH RES CO, V181, P594, DOI 10.1016/0006-291X(91)91231-Z; Li F M, 1987, Biomed Chromatogr, V2, P164, DOI 10.1002/bmc.1130020408; Magness ST, 2002, BLOOD, V100, P1470, DOI 10.1182/blood-2001-12-0283; Meerman L, 2000, SCAND J GASTROENTERO, V35, P79; Najahi-Missaoui W, 2005, BLOOD, V106, P1098, DOI 10.1182/blood-2004-12-4661; NORDMANN Y, 1990, BIOSYNTHESIS HEME CH, P491; NORRIS PG, 1990, J INVEST DERMATOL, V95, P260, DOI 10.1111/1523-1747.ep12484876; Ohgari Y, 2005, HUM MOL GENET, V14, P327, DOI 10.1093/hmg/ddi029; Onaga Y, 2004, BIOCHEM BIOPH RES CO, V321, P851, DOI 10.1016/j.bbrc.2004.06.178; Poh-Fitzpatrick MB, 2002, J AM ACAD DERMATOL, V46, P861, DOI 10.1067/mjd.2002.120460; Povey S, 2001, HUM GENET, V109, P678, DOI 10.1007/s00439-001-0615-0; Risheg H, 2003, MOL GENET METAB, V80, P196, DOI 10.1016/j.ymgme.2003.07.001; ROSSI E, 1988, CLIN CHEM, V34, P2481; Rufenacht UB, 1998, AM J HUM GENET, V62, P1341, DOI 10.1086/301870; RUTH GR, 1977, SCIENCE, V198, P199, DOI 10.1126/science.905823; SARKANY RPE, 1994, LANCET, V344, P958, DOI 10.1016/S0140-6736(94)92314-0; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; Schneider-Yin X, 2000, EUR J PEDIATR, V159, P719, DOI 10.1007/s004310000494; Schoenfeld N, 2003, BLOOD CELL MOL DIS, V30, P298, DOI 10.1016/S1079-9796(03)00040-8; TODD DJ, 1994, BRIT J DERMATOL, V131, P751, DOI 10.1111/j.1365-2133.1994.tb08577.x; TUTOIS S, 1991, J CLIN INVEST, V88, P1730, DOI 10.1172/JCI115491; WENT LN, 1984, ANN HUM GENET, V48, P105, DOI 10.1111/j.1469-1809.1984.tb01006.x; Whatley SD, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016121; Wiman A, 2003, J HUM GENET, V48, P70, DOI 10.1007/s100380300009; Yasui Y, 2002, CLIN SCI, V102, P501, DOI 10.1042/CS20010226; Yotsumoto S, 2001, J INVEST DERMATOL, V117, P159, DOI 10.1046/j.0022-202x.2001.01365.x; Zietkiewicz E, 2003, AM J HUM GENET, V73, P994, DOI 10.1086/378777	47	131	141	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					2	14		10.1086/498620	http://dx.doi.org/10.1086/498620			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385445	Green Published, Bronze			2022-12-18	WOS:000233930400002
J	Shiffman, D; Ellis, SG; Rowland, CM; Malloy, MJ; Luke, MM; Iakoubova, OA; Pullinger, CR; Cassano, J; Aouizerat, BE; Fenwick, RG; Reitz, RE; Catanese, JJ; Leong, DU; Zellner, C; Sninsky, JJ; Topol, EJ; Devlin, JJ; Kane, JP				Shiffman, D; Ellis, SG; Rowland, CM; Malloy, MJ; Luke, MM; Iakoubova, OA; Pullinger, CR; Cassano, J; Aouizerat, BE; Fenwick, RG; Reitz, RE; Catanese, JJ; Leong, DU; Zellner, C; Sninsky, JJ; Topol, EJ; Devlin, JJ; Kane, JP			Identification of four gene variants associated with myocardial infarction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION-STRUCTURE; DISEASE; RISK; SUSCEPTIBILITY; PALLADIN; MARKERS; FUTURE; MOUSE	Family history is a major risk factor for myocardial infarction (MI). However, known gene variants associated with MI cannot fully explain the genetic component of MI risk. We hypothesized that a gene-centric association study that was not limited to candidate genes could identify novel genetic associations with MI. We studied 11,053 single-nucleotide polymorphisms (SNPs) in 6,891 genes, focusing on SNPs that could influence gene function to increase the likelihood of identifying disease-causing gene variants. To minimize false-positive associations generated by multiple testing, two studies were used to identify a limited number of nominally associated SNPs; a third study tested the hypotheses that these SNPs are associated with MI. In the initial study (of 340 cases and 346 controls), 63 7 SNPs were associated with MI (P <.05); these were evaluated in a second study (of 445 cases and 606 controls), and 31 of the 637 SNPs were associated with MI (P <.05) and had the same risk allele as in the first study. For each of these 31 SNPs, we tested the hypothesis that it is associated with MI, using a third study (of 560 cases and 891 controls). We found that four of these gene variants were associated with MI (P <.05; false-discovery rate < 10%) and had the same risk allele as in the first two studies. These gene variants encode the cytoskeletal protein palladin (KIA0992 [odds ratio (OR) 1.40]), a tyrosine kinase (ROS1 [OR 1.75]), and two G protein-coupled receptors (TAURSO [OR 1.58] and OR13G1 [OR 1.40]); all ORs are for carriers of two versus zero risk alleles. These findings could lead to a better understanding of MI pathophysiology and improved patient risk assessment.	Celera Diagnost Inc, Alameda, CA 94501 USA; Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA	Cleveland Clinic Foundation; University of California System; University of California San Francisco; Nichols Institute	Shiffman, D (corresponding author), Celera Diagnost Inc, 1401 Harbor Bay Pkway, Alameda, CA 94501 USA.	dov.shiffman@celeradiagnostics.com		Topol, Eric/0000-0002-1478-4729				*AM HEART ASS, 1995, J R STAT SOC B, V57, P1289; BIRCHMEIER C, 1987, P NATL ACAD SCI USA, V84, P9270, DOI 10.1073/pnas.84.24.9270; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Conte C, 2003, PHYSIOL GENOMICS, V14, P73, DOI 10.1152/physiolgenomics.00060.2003; DUFFY VB, 2004, GENETIC VARIATIONS T, P197; Faxon DP, 2004, CIRCULATION, V109, P2617, DOI 10.1161/01.CIR.0000128520.37674.EF; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gibbons GH, 2004, CIRCULATION, V109, P47, DOI 10.1161/01.CIR.0000133440.86427.26; Hao K, 2004, EUR J HUM GENET, V12, P1001, DOI 10.1038/sj.ejhg.5201273; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jones A, 2003, HYPERTENSION, V42, P500, DOI 10.1161/01.HYP.0000088853.27673.D0; Li YH, 2004, NEUROSCI LETT, V366, P268, DOI 10.1016/j.neulet.2004.05.047; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Zong CS, 1997, J BIOL CHEM, V272, P1500, DOI 10.1074/jbc.272.3.1500	29	131	145	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					596	605		10.1086/491674	http://dx.doi.org/10.1086/491674			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175505	Green Published, Bronze			2022-12-18	WOS:000232106900007
J	Hallmayer, JF; Kalaydjieva, L; Badcock, J; Dragovic, M; Howell, S; Michie, PT; Rock, D; Vile, D; Williams, R; Corder, EH; Hollingsworth, K; Jablensky, A				Hallmayer, JF; Kalaydjieva, L; Badcock, J; Dragovic, M; Howell, S; Michie, PT; Rock, D; Vile, D; Williams, R; Corder, EH; Hollingsworth, K; Jablensky, A			Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							1ST-EPISODE SCHIZOPHRENIA; FOLLOW-UP; LINKAGE; METAANALYSIS; SYMPTOMS; FAMILIES; REGIONS; SCAN	A novel phenotyping strategy in schizophrenia, targeting different neurocognitive domains, neurobehavioral features, and selected personality traits, has allowed us to identify a homogeneous familial subtype of the disease, characterized by pervasive neurocognitive deficit. Our genome scan data indicate that this subtype, which accounts for up to 50% of our sample, has a distinct genetic basis and explains linkage to chromosome 6p24 reported previously. If representative of other populations, the ratio of schizophrenia subtypes observed in our families could have a profound impact on sample heterogeneity and on the power of genetic studies to detect linkage and association. Our proposed abbreviated battery of tests should facilitate phenotype characterization for future genetic analyses and allow a focus on a crisply defined schizophrenia subtype, thus promoting a more informed search for susceptibility genes.	Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6000, Australia; Univ Western Australia, Ctr Clin Res Neuropsychiat, Perth, WA 6000, Australia; Queen Elizabeth II Med Ctr, Ctr Neurodegenerat Disorders, Perth, WA 6000, Australia; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; Duke Univ, Ctr Demog Studies, Durham, NC 27706 USA; Univ Newcastle, Sch Behav Sci, Callaghan, NSW, Australia	University of Western Australia; University of Western Australia; University of Western Australia; Stanford University; Duke University; University of Newcastle	Jablensky, A (corresponding author), Univ Western Australia, Sch Psychiat & Clin Neurosci, MRF Bldg,50 Murray St, Perth, WA 6000, Australia.	assen@cyllene.uwa.edu.au	Michie, Patricia/B-9880-2008; Jablensky, Assen/H-5116-2014; Badcock, Johanna C./C-3682-2013	Michie, Patricia/0000-0002-4169-8519; Jablensky, Assen/0000-0003-0602-6810; Badcock, Johanna C./0000-0003-4629-2929				Altshuler LL, 2004, BIOL PSYCHIAT, V56, P560, DOI 10.1016/j.biopsych.2004.08.002; Bailer U, 2000, NEUROPSYCHOBIOLOGY, V42, P175, DOI 10.1159/000026690; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Bleuler E., 1976, TXB PSYCHIAT; Brebion G, 2005, PSYCHOL MED, V35, P133, DOI 10.1017/S0033291704002879; Cannon TD, 2000, AM J HUM GENET, V67, P369, DOI 10.1086/303006; Cloninger CR., 1994, TEMPERAMENT CHARACTE; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hallmayer JF, 2003, MOL PSYCHIATR, V8, P511, DOI 10.1038/sj.mp.4001273; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Heinrichs RW, 2004, NEUROSCI BIOBEHAV R, V28, P379, DOI 10.1016/j.neubiorev.2004.06.003; Hoff AL, 1999, AM J PSYCHIAT, V156, P1336; Hwu HG, 2000, AM J MED GENET, V96, P74, DOI 10.1002/(SICI)1096-8628(20000207)96:1<74::AID-AJMG15>3.0.CO;2-G; Kaabi B, 2003, GENET EPIDEMIOL, V24, P253, DOI 10.1002/gepi.10234; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; KRAEPELIN E, 1971, PSYCHIAT; Kremen WS, 1998, AM J PSYCHIAT, V155, P672, DOI 10.1176/ajp.155.5.672; Manton K.G., 1994, STAT APPL USING FUZZ; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Sitskoom MM, 2004, SCHIZOPHR RES, V71, P285, DOI 10.1016/j.schres.2004.03.007; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Torrey EF, 2002, SCHIZOPHR RES, V58, P101, DOI 10.1016/S0920-9964(02)00381-X; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; WOODBURY MA, 1978, COMPUT BIOMED RES, V11, P277, DOI 10.1016/0010-4809(78)90012-5	28	131	139	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					468	476		10.1086/432816	http://dx.doi.org/10.1086/432816			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	956QE	16080121	Bronze, Green Published			2022-12-18	WOS:000231314100012
J	Sprecher, E; Ishida-Yamamoto, A; Mizrahi-Koren, M; Rapaport, D; Goldsher, D; Indelman, M; Topaz, O; Chefetz, I; Keren, H; O'Brien, TJ; Bercovich, D; Shalev, S; Geiger, D; Bergman, R; Horowitz, M; Mandel, H				Sprecher, E; Ishida-Yamamoto, A; Mizrahi-Koren, M; Rapaport, D; Goldsher, D; Indelman, M; Topaz, O; Chefetz, I; Keren, H; O'Brien, TJ; Bercovich, D; Shalev, S; Geiger, D; Bergman, R; Horowitz, M; Mandel, H			A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUSION; CELLS; IDENTIFICATION; MECHANISMS; DISEASE; SNAP-29; FAMILY	Neurocutaneous syndromes represent a vast, largely heterogeneous group of disorders characterized by neurological and dermatological manifestations, reflecting the common embryonic origin of epidermal and neural tissues. In the present report, we describe a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma (CEDNIK syndrome). Using homozygosity mapping in two large families, we localized the disease gene to 22q11.2 and identified, in all patients, a 1-bp deletion in SNAP29, which codes for a SNARE protein involved in vesicle fusion. SNAP29 expression was decreased in the skin of the patients, resulting in abnormal maturation of lamellar granules and, as a consequence, in mislocation of epidermal lipids and proteases. These data underscore the importance of vesicle trafficking regulatory mechanisms for proper neuroectodermal differentiation.	Rambam Med Ctr, Lab Mol Dermatol, Dept Dermatol, Haifa, Israel; Rambam Med Ctr, MRI Inst, Haifa, Israel; Rambam Med Ctr, Metab Dis Unit, Haifa, Israel; Rambam Med Ctr, Dept Pediat B, Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Biotechnol Interdisciplinary Unit, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Dept Comp Sci, IL-31096 Haifa, Israel; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 078, Japan; Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel; Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA; Migal Galilee Technol Ctr, Kiryat Shmona, Israel; Haemek Med Ctr, Genet Inst, Afula, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Asahikawa Medical College; Tel Aviv University; University of Arkansas System; University of Arkansas Medical Sciences; Emek Medical Center	Sprecher, E (corresponding author), Rambam Med Ctr, Lab Mol Dermatol, Dept Dermatol, Haifa, Israel.	e_sprecher@rambam.health.gov.il	Chefetz, Ilana/K-7589-2019					Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Bercovich D, 2003, GENET TEST, V7, P189, DOI 10.1089/109065703322537197; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; CANAANI D, 1986, SOMAT CELL MOLEC GEN, V12, P13, DOI 10.1007/BF01560723; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Deitcher D, 2002, SEMIN CELL DEV BIOL, V13, P71, DOI 10.1016/S1084-9521(02)00011-3; Fartasch M, 2004, J INVEST DERMATOL, V122, pXI; Feng D, 2002, BLOOD, V99, P4006, DOI 10.1182/blood.V99.11.4006; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Gonelle-Gispert C, 2000, J CELL SCI, V113, P3197; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; Hepp R, 2001, CELL TISSUE RES, V305, P247, DOI 10.1007/s004410100359; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; HOLLERAN WM, 1994, J CLIN INVEST, V93, P1756, DOI 10.1172/JCI117160; Huizing M, 2002, Curr Mol Med, V2, P451, DOI 10.2174/1566524023362357; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Nakatani Y, 2000, VIRCHOWS ARCH, V437, P304, DOI 10.1007/s004280000241; PAN PY, IN PRESS J BIOL CHEM; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tanimoto H, 1999, CANCER, V86, P2074, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2074::AID-CNCR27>3.3.CO;2-V; Ugur O, 2000, MOL BIOL CELL, V11, P1421, DOI 10.1091/mbc.11.4.1421; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; West Greenlee M. H., 1998, Journal of Comparative Neurology, V394, P374; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076	33	131	134	1	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					242	251		10.1086/432556	http://dx.doi.org/10.1086/432556			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	15968592	Green Published, Bronze			2022-12-18	WOS:000230387200006
J	Pal, DK; Evgrafov, OV; Tabares, P; Zhang, FL; Durner, M; Greenberg, DA				Pal, DK; Evgrafov, OV; Tabares, P; Zhang, FL; Durner, M; Greenberg, DA			BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; LINKAGE ANALYSIS; LOCALIZATION; LOCUS; CHROMOSOME; EXPRESSION; FAMILIES; MUTATION; HOMOLOG; REGION	Juvenile myoclonic epilepsy (JME) is a common form of generalized epilepsy that starts in adolescence. A major JME susceptibility locus (EJM1) was mapped to chromosomal region 6p21 in three independent linkage studies, and association was reported between JME and a microsatellite marker in the 6p21 region. The critical region for EJM1 is delimited by obligate recombinants at HLA-DQ and HLA-DP. In the present study, we found highly significant linkage disequilibrium (LD) between JME and a core haplotype of five single-nucleotide - polymorphism ( SNP) and microsatellite markers in this critical region, with LD peaking in the BRD2 (RING3) gene ( odds ratio 6.45; 95% confidence interval 2.36 - 17.58). DNA sequencing revealed two JME-associated SNP variants in the BRD2 ( RING3) promoter region but no other potentially causative coding mutations in 20 probands from families with positive LOD scores. BRD2 ( RING3) is a putative nuclear transcriptional regulator from a family of genes that are expressed during development. Our findings strongly suggest that BRD2 ( RING3) is EJM1, the first gene identified for a common idiopathic epilepsy. These findings also suggest that abnormalities of neural development may be a cause of common idiopathic epilepsy, and the findings have implications for the generalizability of proposed pathogenetic mechanisms, derived from diseases that show Mendelian transmission, to their complex counterparts.	Columbia Univ, Mailman Sch Publ Hlth, Div Stat Genet, Dept Biostat, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA; New York State Psychiat Inst & Hosp, Clin & Genet Epidemiol Unit, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Pal, DK (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Div Stat Genet, Dept Biostat, 722 W 168th, New York, NY 10032 USA.	dkp28@columbia.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941, R01NS037466] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31775, R01 DK031775] Funding Source: Medline; NIMH NIH HHS [R01 MH048858, MH48858] Funding Source: Medline; NINDS NIH HHS [R01 NS037466, NS27941, R01 NS027941, NS37466] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; BECKMANNAGETTA G, 1991, EPILEPSY RES, P105; Commission on Classification and Terminology of the ILAE, 1989, EPILEPSIA, V22, P489; Crowley TE, 2002, MOL ENDOCRINOL, V16, P1727, DOI 10.1210/me.2001-0353; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; DIGAN ME, 1986, DEV BIOL, V114, P161, DOI 10.1016/0012-1606(86)90392-1; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; Durner M, 2001, ANN NEUROL, V49, P328, DOI 10.1002/ana.69.abs; Evgrafov OV, 2002, AM J HUM GENET, V71, P481; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Flint AC, 1997, CURR OPIN NEUROL, V10, P92, DOI 10.1097/00019052-199704000-00004; GANS M, 1980, GENETICS, V96, P887; GANS M, 1975, GENETICS, V81, P683; Greenberg DA, 2000, AM J HUM GENET, V66, P508, DOI 10.1086/302763; GREENBERG DA, 1988, GENET EPIDEMIOL, V5, P81, DOI 10.1002/gepi.1370050204; GREENBERG DA, 1992, NEUROLOGY, V42, P56; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; Greenberg DA, 1999, GENET EPIDEMIOL, V17, pS449; Guo N, 2000, J CELL SCI, V113, P3085; Harkin LA, 2002, AM J HUM GENET, V70, P530, DOI 10.1086/338710; Janz D, 1957, DTSCH Z NERVENHEILK, V176, P348; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; McCarthy LC, 2001, GENOMICS, V78, P135, DOI 10.1006/geno.2001.6647; MEENCKE HJ, 1984, EPILEPSIA, V25, P8, DOI 10.1111/j.1528-1157.1984.tb04149.x; Mulley JC, 2003, CURR OPIN NEUROL, V16, P171, DOI 10.1097/00019052-200304000-00009; Rhee K, 1998, J CELL SCI, V111, P3541; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Sander T, 1997, NEUROLOGY, V49, P842, DOI 10.1212/WNL.49.3.842; *STAT CORP, 1996, STAT MAC VERS 5 0; Thorpe KL, 1997, GENE, V200, P177, DOI 10.1016/S0378-1119(97)00415-0; TSUBOI T, 1973, HUMANGENETIK, V19, P155; Wang SL, 1997, DEV BIOL, V188, P322, DOI 10.1006/dbio.1997.8655; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; Woermann FG, 1999, BRAIN, V122, P2101, DOI 10.1093/brain/122.11.2101	37	131	138	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					261	270		10.1086/377006	http://dx.doi.org/10.1086/377006			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12830434	Bronze, Green Published			2022-12-18	WOS:000184223900004
J	Flanigan, KM; von Niederhausern, A; Dunn, DM; Alder, J; Mendell, JR; Weiss, RB				Flanigan, KM; von Niederhausern, A; Dunn, DM; Alder, J; Mendell, JR; Weiss, RB			Rapid direct sequence analysis of the dystrophin gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POINT MUTATIONS; DMD GENE; DIAGNOSIS; DELETIONS	Mutations in the dystrophin gene result in both Duchenne and Becker muscular dystrophy (DMD and BMD), as well as X-linked dilated cardiomyopathy. Mutational analysis is complicated by the large size of the gene, which consists of 79 exons and 8 promoters spread over 2.2 million base pairs of genomic DNA. Deletions of one or more exons account for 55%-65% of cases of DMD and BMD, and a multiplex polymerase chain reaction method-currently the most widely available method of mutational analysis-detects similar to98% of deletions. Detection of point mutations and small subexonic rearrangements has remained challenging. We report the development of a method that allows direct sequence analysis of the dystrophin gene in a rapid, accurate, and economical fashion. This same method, termed "SCAIP" (single condition amplification/internal primer) sequencing, is applicable to other genes and should allow the development of widely available assays for any number of large, multiexon genes.	Univ Utah, Dept Neurol, Salt Lake City, UT USA; Univ Utah, Dept Human Genet, Salt Lake City, UT USA; Univ Utah, Dept Pathol, Salt Lake City, UT USA; Univ Utah, Dept Pediat, Salt Lake City, UT USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University	Flanigan, KM (corresponding author), Eccles Inst Human Genet, Room 7110B,15 N 2030 E St, Salt Lake City, UT 84112 USA.	kevin.flanigan@genetics.utah.edu	Alder, Jonathan/AAF-3540-2020	Alder, Jonathan/0000-0003-3741-6512; Flanigan, Kevin/0000-0001-6440-3376	NHGRI NIH HHS [U01 HG02138-04] Funding Source: Medline; NINDS NIH HHS [R01 NS043264, R01 NS43264-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG002138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043264] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEGGS AH, 1990, HUM GENET, V86, P45; Bennett RR, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-17; Chamberlain J.S., 1990, PCR PROTOCOLS GUIDE, P272; Cremonesi L, 1997, BIOTECHNIQUES, V22, P326, DOI 10.2144/97222rr01; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Mendell JR, 2001, NEUROLOGY, V57, P645, DOI 10.1212/WNL.57.4.645; MILLER RG, 1994, NEUROL CLIN, V12, P699, DOI 10.1016/S0733-8619(18)30072-0; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; ROEST PAM, 1993, NEUROMUSCULAR DISORD, V3, P391, DOI 10.1016/0960-8966(93)90083-V; Tuffery-Giraud S, 1999, HUM MUTAT, V14, P359, DOI 10.1002/(SICI)1098-1004(199911)14:5<359::AID-HUMU1>3.3.CO;2-B; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; Wilton SD, 1997, MUSCLE NERVE, V20, P728	18	131	155	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					931	939		10.1086/374176	http://dx.doi.org/10.1086/374176			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12632325	Green Published, Bronze			2022-12-18	WOS:000181972600013
J	Varret, M; Rabes, JP; Saint-Jore, B; Cenarro, A; Marinoni, JC; Civeira, F; Devillers, M; Krempf, M; Coulon, M; Thiart, R; Kotze, MJ; Schmidt, H; Buzzi, JC; Kostner, GM; Bertolini, S; Pocovi, M; Rosa, A; Farnier, M; Martinez, M; Junien, C; Boileau, C				Varret, M; Rabes, JP; Saint-Jore, B; Cenarro, A; Marinoni, JC; Civeira, F; Devillers, M; Krempf, M; Coulon, M; Thiart, R; Kotze, MJ; Schmidt, H; Buzzi, JC; Kostner, GM; Bertolini, S; Pocovi, M; Rosa, A; Farnier, M; Martinez, M; Junien, C; Boileau, C			A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFECTIVE APOLIPOPROTEIN B-100; DENSITY-LIPOPROTEIN RECEPTOR; STEROL CARRIER PROTEIN-2; HUMAN LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; LINKAGE ANALYSIS; MESSENGER-RNA; GENE; ASSIGNMENT; METABOLISM	Autosomal dominant hypercholesterolemia (ADH), one of the most frequent hereditary disorders, is characterized by an isolated elevation of LDL particles that leads to premature mortality from cardiovascular complications. It is generally assumed that mutations in the LDLR and APOB genes account for ADH. We identified one large French pedigree (HC2) and 12 additional white families with ADH in which me excluded linkage to the LDLR and APOB, implicating a new locus we named "FH3." A LOD score of 3.13 at a recombination fraction of 0 was obtained at markers D1S2892 and D1S2722. We localized the FH3 locus to a 9-cM interval at 1p34.1-p32. We tested four regional markers in another set of 12 ADH families. Positive LOD scores were obtained in three pedigrees, whereas linkage was excluded in the others. Heterogeneity tests indicated linkage to FH3 in similar to 27% of these non-LDLR/non-APOB ADH families and implied a fourth locus. Radiation hybrid mapping located four candidate genes at 1p34.1-p32, outside the critical region, showing no identity with FH3. Our results show that ADH is genetically more heterogeneous than conventionally accepted.	Univ Paris 05, Hop Necker Enfants Malad, Clin Maurice Lamy, INSERM,U383, F-75743 Paris 15, France; Hop St Louis, INSERM, U358, Paris, France; Ctr Hosp Univ Ambroise Pare, Lab Cent Biochim Hormonol & Genet Mol, Boulogne, France; Ctr Hosp Univ Hotel Dieu, Serv Endocrinol, Nantes, France; Point Med, Dijon, France; Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; Univ Stellenbosch, Fac Med, Div Human Genet, Med Res Council,Cape Heart Grp, ZA-7505 Tygerberg, South Africa; Graz Univ, Inst Med Biochem, A-8010 Graz, Austria; Univ Genoa, Dept Internal Med, Atherosclerosis Prevent Ctr, I-16126 Genoa, Italy; Univ Nacl Cordoba, Fac Ciencias Quim, Consejo Nacl Invest Cient & Tecn, Ctr Invest Quim Biol Cordoba,Dept Quim Biol, RA-5000 Cordoba, Argentina	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Nantes Universite; CHU de Nantes; University of Zaragoza; South African Medical Research Council; Stellenbosch University; University of Graz; University of Genoa; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Boileau, C (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Clin Maurice Lamy, INSERM,U383, 149-161 Rue Sevres, F-75743 Paris 15, France.		/V-4899-2019; Kotze, Maritha J/GMX-0989-2022; Martinez, Maria/B-3111-2013; VARRET, Mathilde/C-2279-2016; boileau, catherine/M-4482-2017	Martinez, Maria/0000-0003-2180-4537; VARRET, Mathilde/0000-0001-9261-1551; boileau, catherine/0000-0002-0371-7539; Kotze, Martha/0000-0002-6050-2876; Krempf, Michel/0000-0002-4353-9511; Rabes, Jean-Pierre/0000-0002-1215-1493				Civeira F, 1990, CLIN INVEST ARTERIOS, V2, P43; COLLOD G, 1994, NAT GENET, V8, P264, DOI 10.1038/ng1194-264; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; HARRINGTON CR, 1994, AM J PATHOL, V145, P1472; HE ZG, 1991, DNA CELL BIOL, V10, P559, DOI 10.1089/dna.1991.10.559; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; Kim DH, 1997, J BIOL CHEM, V272, P8498, DOI 10.1074/jbc.272.13.8498; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LAW SW, 1985, P NATL ACAD SCI USA, V82, P8340, DOI 10.1073/pnas.82.24.8340; LESTAVELDELATTRE S, 1994, METABOLISM, V43, P397, DOI 10.1016/0026-0495(94)90066-3; LINDGREN V, 1985, P NATL ACAD SCI USA, V82, P8567, DOI 10.1073/pnas.82.24.8567; MASANA L, 1990, ACTA PAEDIATR SCAND, V79, P475, DOI 10.1111/j.1651-2227.1990.tb11499.x; MISEREZ AR, 1995, ARTERIOSCL THROM VAS, V15, P1719, DOI 10.1161/01.ATV.15.10.1719; Moreda A, 1990, CLIN INVEST ARTERIOS, V2, P48; Nissen H, 1998, CLIN GENET, V54, P79; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OHBA T, 1994, GENOMICS, V24, P370, DOI 10.1006/geno.1994.1630; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Ott J., 1991, ANAL HUMAN GENETIC L; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Phelan CM, 1996, GENOMICS, V34, P63, DOI 10.1006/geno.1996.0241; RABES JP, 1997, MED SCI, V12, P1409; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; STEINMETZ J, 1990, REFERENCES BIOL CLIN, P190; Sun XM, 1997, ARTERIOSCL THROM VAS, V17, P3092, DOI 10.1161/01.ATV.17.11.3092; Varret M, 1997, M S-MED SCI, V13, P1399, DOI 10.4267/10608/571; Varret M, 1998, NUCLEIC ACIDS RES, V26, P248, DOI 10.1093/nar/26.1.248; Varret M, 1997, NUCLEIC ACIDS RES, V25, P172, DOI 10.1093/nar/25.1.172; WILLIAMS RR, 1993, AM J CARDIOL, V72, P180; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0; WONG WT, 1994, ONCOGENE, V9, P1591; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	36	131	165	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1378	1387		10.1086/302370	http://dx.doi.org/10.1086/302370			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205269	Green Published, Bronze			2022-12-18	WOS:000080093000016
J	Tonin, PN; Mes-Masson, AM; Futreal, PA; Morgan, K; Mahon, M; Foulkes, WD; Cole, DEC; Provencher, D; Ghadirian, P; Narod, SA				Tonin, PN; Mes-Masson, AM; Futreal, PA; Morgan, K; Mahon, M; Foulkes, WD; Cole, DEC; Provencher, D; Ghadirian, P; Narod, SA			Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; ASHKENAZI-JEWISH INDIVIDUALS; GERM-LINE MUTATIONS; SUSCEPTIBILITY GENE; HEREDITARY BREAST; CHROMOSOME 14Q11.2-Q13; QUEBEC POPULATION; CARRIER FREQUENCY; RECURRENT BRCA1; WOMEN	We have identified four mutations in each of the breast cancer-susceptibility genes, BRCA1 and BRCA2, in French Canadian breast cancer and breast/ovarian cancer families from Quebec. To identify founder effects, we examined independently ascertained French Canadian cancer families for the distribution of these eight mutations. Mutations were found in 41 of 97 families. Six of eight mutations were observed at least twice. The BRCA1 C4446T mutation was the most common mutation found, followed by the BRCA2 8765delAG mutation. Together, these mutations were found in 28 of 41 families identified to have a mutation. The odds of detection of any of the four BRCA1 mutations was 18.7 x greater if one or more cases of ovarian cancer were also present in the family. The odds of detection of any of the four BRCA2 mutations was 5.3 x greater if there were at least five cases of breast cancer in the family. Interestingly, the presence of a breast cancer case <36 years of age was strongly predictive of the presence of any of the eight mutations screened. Carriers of the same mutation, from different families, shared similar haplotypes, indicating that the mutant alleles were likely to be identical by descent for a mutation in the founder population. The identification of common BRCA1 and BRCA2 mutations will facilitate carrier detection in French Canadian breast cancer and breast/ovarian cancer families.	Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; McGill Univ, Div Med Genet, Dept Human Genet, Montreal, PQ H3A 2T5, Canada; McGill Univ, Div Med Genet, Dept Med, Montreal, PQ H3A 2T5, Canada; CHUM, Inst Canc Montreal, Ctr Rech, Montreal, PQ, Canada; Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Fac Med, Dept Obstet Gynecol, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada; CHUM, Ctr Rech, Unite Rech Epidemiol, Montreal, PQ, Canada; Sir MB Davis Jewish Gen Hosp, Canc Prevent Res Unit, Montreal, PQ, Canada; Duke Univ, Med Ctr, Div Gynecol Oncol, Dept Surg, Raleigh, NC USA; Duke Univ, Med Ctr, Div Gynecol Oncol, Dept Obstet & Gynecol, Raleigh, NC USA; Duke Univ, Med Ctr, Div Gynecol Oncol, Dept Genet, Raleigh, NC USA; Toronto Hosp, Dept Clin Biochem Med & Pediat, Toronto, ON M5T 2S8, Canada; Womens Coll Hosp, Ctr Res Womens Hlth, Toronto, ON M5S 1B2, Canada; Univ Toronto, Toronto, ON, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Duke University; Duke University; Duke University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto	Tonin, PN (corresponding author), Montreal Gen Hosp, Res Inst, Room L10-120,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	tonin@medcor.mcgill.ca	Foulkes, William D./AAR-9586-2021; Narod, Steven A/AAA-6112-2022	Foulkes, William D./0000-0001-7427-4651; Mes-Masson, Anne-Marie/0000-0002-6498-266X				Berman DB, 1996, AM J HUM GENET, V58, P1166; Berman DB, 1996, CANCER RES, V56, P3409; BOUCHARD G, 1988, EUR J POPUL, V4, P39, DOI 10.1007/BF01797106; BRAIS B, 1995, HUM MOL GENET, V4, P429, DOI 10.1093/hmg/4.3.429; Casaubon LK, 1996, AM J HUM GENET, V58, P28; CHARBONNEAU H, 1987, FRANCAIS ETABLIS CAN; CHARBONNEAU H, 1987, BEGINNING 1800, V1; Couch FJ, 1996, GENOMICS, V36, P86, DOI 10.1006/geno.1996.0428; DAVIGNON J, 1993, AM J CARDIOL, V72, pD6, DOI 10.1016/0002-9149(93)90003-U; DEBRAEKELEER M, 1993, NOUV REV FR HEMATOL, V35, P447; DEBRAEKELEER M, 1994, HUM BIOL, V66, P225; DEBRAEKELEER M, 1994, HUM BIOL, V66, P205; Durocher F, 1996, J MED GENET, V33, P814, DOI 10.1136/jmg.33.10.814; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; Gayther SA, 1997, AM J HUM GENET, V60, P1239; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Hakansson S, 1997, AM J HUM GENET, V60, P1068; HEYER E, 1995, AM J HUM GENET, V56, P970; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; Johannesdottir G, 1996, CANCER RES, V56, P3663; Johannsson O, 1996, AM J HUM GENET, V58, P441; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Labuda M, 1996, AM J HUM GENET, V59, P633; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MORIN C, 1993, AM J HUM GENET, V53, P488; NAROD SA, 1995, AM J HUM GENET, V56, P254; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Peelen T, 1997, AM J HUM GENET, V60, P1041; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; PODRATZ KC, 1986, AM J OBSTET GYNECOL, V154, P1319, DOI 10.1016/0002-9378(86)90719-2; Ramus SJ, 1997, AM J HUM GENET, V60, P1242; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; ROZEN R, 1992, AM J MED GENET, V42, P360, DOI 10.1002/ajmg.1320420322; Schubert EK, 1997, AM J HUM GENET, V60, P1031; Serova O, 1996, AM J HUM GENET, V58, P42; SerovaSinilnikova OM, 1997, AM J HUM GENET, V60, P1236; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; Stajich JM, 1996, ANN NEUROL, V40, P801, DOI 10.1002/ana.410400519; StoppaLyonnet D, 1997, AM J HUM GENET, V60, P1021; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; TONIN P, 1995, AM J HUM GENET, V57, P189; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; Vehmanen P, 1997, AM J HUM GENET, V60, P1050; Wagner TMU, 1996, LANCET, V347, P1263, DOI 10.1016/S0140-6736(96)90781-3; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	56	131	134	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1341	1351		10.1086/302099	http://dx.doi.org/10.1086/302099			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792861	Green Published, Bronze			2022-12-18	WOS:000076985200010
J	Duerr, RH; Barmada, MM; Zhang, LL; Davis, S; Preston, RA; Chensny, LJ; Brown, JL; Ehrlich, GD; Weeks, DE; Aston, CE				Duerr, RH; Barmada, MM; Zhang, LL; Davis, S; Preston, RA; Chensny, LJ; Brown, JL; Ehrlich, GD; Weeks, DE; Aston, CE			Linkage and association between inflammatory bowel disease and a locus on chromosome 12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAP	Genetic epidemiological studies have shown that genetic factors are important in the pathogenesis of the idiopathic inflammatory bowel diseases (IBD), Crohn disease (CD), and ulcerative colitis (UC). A genome screen in the United Kingdom found linkage of IBD to a 41-cM region of chromosome 12, surrounding D12S83. We aimed to replicate this linkage and to narrow the region of interest. Nonparametric linkage analyses at microsatellites surrounding D12S83 were performed in 122 North American Caucasian families containing 208 genotyped IBD-affected relative pairs. Transmission/disequilibrium tests (TDTs) were also performed. We confirmed that IBD is linked to chromosome 12 (peak GENEHUNTER-PLUS LOD* score 2.76 [P =.00016] between D12S1724 and D12S90). The evidence for linkage is contributed by both the group of CD-affected relative pairs (peak GENEHUNTER-PLUS LOD* score 1.79 [P =.0021] bet cs een D12S1724 and D12S90) and the group of UC-affected relative pairs (peak GENEHUNTER-PLUS LOD* score 1.82 [P =.0019] at D12S335). The TDT is positive at the D12S83 locus (global chi(2) = 16.41, 6 df, P = .012). In conclusion, we have independently confirmed linkage of IBD to the chromosome 12 region that we investigated. A positive TDT at D12S83 suggests that we have greatly narrowed the chromosome 12 region that contains an IBD locus.	Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pathol & Otolaryngol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Genom Sci, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford; Wellcome Centre for Human Genetics	Duerr, RH (corresponding author), 565 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	duerr+@pitt.edu	Davis, Sean/AAD-1801-2021; Duerr, Richard H/B-4188-2009; Weeks, Daniel E/B-2995-2012	Davis, Sean/0000-0002-8991-6458; Duerr, Richard H/0000-0001-6586-3905; Weeks, Daniel E/0000-0001-9410-7228; Barmada, M Michael/0000-0002-3604-6460; Ehrlich, Garth/0000-0003-1140-6594	NIDDK NIH HHS [DK50993] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050993] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Calkins BM, 1995, INFLAMM BOWEL DIS, P31; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Davis S, 1996, AM J HUM GENET, V58, P867; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Duerr RH, 1996, INFLAMM BOWEL DIS, V2, P48, DOI 10.1002/ibd.3780020108; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LASHNER BA, 1995, INFLAMM BOWEL DIS, P344; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; O'Connell JR, 1997, AM J HUM GENET, V61, pA288; Parkes M, 1998, GUT, V42, pA49; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SINGLETON JW, 1995, INFLAMM BOWEL DIS, P335; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; [No title captured]	17	131	138	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					95	100		10.1086/301929	http://dx.doi.org/10.1086/301929			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634527	Green Published, Bronze			2022-12-18	WOS:000074761000015
J	Marchington, DR; Hartshorne, GM; Barlow, D; Poulton, J				Marchington, DR; Hartshorne, GM; Barlow, D; Poulton, J			Homopolymeric tract heteroplasmy in mtDNA from tissues and single oocytes: Support for a genetic bottleneck	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; SEQUENCE; SEGREGATION; MUTATION; ADVANTAGE; REGION	While mtDNA polymorphisms at single base positions are common, the overwhelming majority of the mitochondrial genomes within a single individual are usually identical. When there is a point-mutation difference between a mother and her offspring, there may be a complete switching of mtDNA type within a single generation. It is generally assumed that there is a genetic bottleneck whereby a single or small number of founder mtDNA(s) populate the organism, but it is not known at which stages the restriction/amplification of mtDNA subtype(s) occur, and this uncertainty impedes antenatal diagnosis for mtDNA disorders. Length polymorphisms in homopolymeric tracts have been demonstrated in the large noncoding region of mtDNA. The have developed a new method, T-PCR (trimmed PCR), to quantitate heteroplasmy for two of these tracts (D310 and D16189). D310 variation is sufficient to indicate clonal origins of tissues and single oocytes. Tissues from normal individuals often possessed more than one length variant (heteroplasmy). However, there was no difference in the pattern of the length variants between somatic tissues in any control individual when bulk samples were taken. Oocytes from normal women undergoing in vitro fertilization were frequently heteroplasmic for length variants, and in two cases the modal length of the D310 tract differed in individual oocytes from the same woman. These data suggest that a restriction/amplification event, which we attribute to clonal expansion of founder mtDNA(s), has occurred by the time oocytes are mature, although further segregation may occur at a later stage. In contrast to controls, the length distribution of the D310 tract varied between tissues in a patient with heteroplasmic mtDNA rearrangements, suggesting that these mutants influence segregation. These findings have important implications for the genetic counselling of patients with pathogenic mtDNA mutations.	UNIV OXFORD,NUFFIELD DEPT OBSTET & GYNAECOL,OXFORD,ENGLAND	University of Oxford			Barlow, David/F-8738-2011	Poulton, Joanna/0000-0002-2460-5587	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BENDALL KE, 1995, AM J HUM GENET, V57, P248; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; HAUSWIRTH WW, 1984, CELL, V37, P1001, DOI 10.1016/0092-8674(84)90434-3; HECHT NB, 1984, DEV BIOL, V102, P452, DOI 10.1016/0012-1606(84)90210-0; HORAI S, 1990, AM J HUM GENET, V46, P828; HOWELL N, 1992, HUM GENET, V90, P117; JAZIN EE, IN PRESS P NATL ACAD; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KOEHLER CM, 1991, GENETICS, V129, P247; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; Marchington DR, 1996, HUM MOL GENET, V5, P473, DOI 10.1093/hmg/5.4.473; MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41; MONCKTON DG, 1994, NAT GENET, V8, P162, DOI 10.1038/ng1094-162; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366; POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124; SOLIGNAC M, 1987, GENETICS, V117, P687; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	21	131	133	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					408	416						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012414				2022-12-18	WOS:A1997WE93100020
J	Jurado, LAP; Peoples, R; Kaplan, P; Hamel, BCJ; Francke, U				Jurado, LAP; Peoples, R; Kaplan, P; Hamel, BCJ; Francke, U			Molecular definition of the chromosome 7 deletion in Williams syndrome and parent-of-origin effects on growth	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; IDIOPATHIC INFANTILE HYPERCALCEMIA; AUTOSOMAL-DOMINANT INHERITANCE; HUMAN ELASTIN GENE; BEUREN SYNDROME; PHENOTYPIC FEATURES; UNIPARENTAL DISOMY; LONG ARM; HEMIZYGOSITY; LOCUS	Williams syndrome (WS) is a developmental disorder with variable phenotypic expression associated, in most cases, with a hemizygous deletion of part of chromosomal band 7q11.23 that includes the elastin gene (ELN). We have investigated the frequency and size of the deletions, determined the parental origin, and correlated the molecular results with the clinical findings in 65 WS patients. Hemizygosity at the ELN locus was established by typing of two intragenic polymorphisms, quantitative Southern analysis, and/or FISH. Polymorphic markers covering the deletion and flanking regions were ordered by a combination of genetic and physical mapping. Genotyping of WS patients and available parents for 13 polymorphisms revealed that of 65 clinically defined WS patients, 61 (94%) had a deletion of the ELN locus and were also hemizygous (or noninformative) at loci D7S489B, D7S2476, D7S613, D7S2472, and D7S1870. None of the four patients without ELN deletion was hemizygous at any of the polymorphic loci studied. All patients were heterozygous (or noninformative) for centromeric (D7S1816, D7S1483, and D7S653) and telomeric (D7S489A, D7S675, and D7S669) flanking loci. The genetic distance between the most-centromeric deleted locus, D7S489B, and the most-telomeric one, D7S1870, is 2 cM. The breakpoints cluster at similar to 1 cM to either side of ELN. In 39 families informative for parental origin, all deletions were de novo, and 18 were paternally and 21 maternally derived. Comparison of clinical data, collected in a standardized quantifiable format, revealed significantly more severe growth retardation and microcephaly in the maternal deletion group. An imprinted locus, silent on the paternal chromosome and contributing to statural growth, may be affected by the deletion.	STANFORD UNIV, MED CTR, BECKMAN CTR, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA; STANFORD UNIV, SCH MED, DEPT GENET, STANFORD, CA 94305 USA; STANFORD UNIV, SCH MED, DEPT PEDIAT, STANFORD, CA 94305 USA; CHILDRENS HOSP PHILADELPHIA, PHILADELPHIA, PA 19104 USA; UNIV NIJMEGEN HOSP, NL-6500 HB NIJMEGEN, NETHERLANDS	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Radboud University Nijmegen			Pérez Jurado, Luis Alberto/M-7706-2015		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008404] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG00298] Funding Source: Medline; NIGMS NIH HHS [T32GM08404] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASHIR MM, 1989, J BIOL CHEM, V264, P8887; Beechey C. V., 1996, Mammalian Genome, V94, P96; BEUREN AJ, 1962, CIRCULATION, V26, P1235, DOI 10.1161/01.CIR.26.6.1235; BORG I, 1995, J MED GENET, V32, P692, DOI 10.1136/jmg.32.9.692; BUITING K, 1992, P NATL ACAD SCI USA, V89, P5457, DOI 10.1073/pnas.89.12.5457; BURN J, 1986, J MED GENET, V23, P389, DOI 10.1136/jmg.23.5.389; BZDUCH V, 1989, CLIN GENET, V35, P230; COLLEY A, 1992, J MED GENET, V29, P63, DOI 10.1136/jmg.29.1.63; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FOSTER K, 1993, ANN HUM GENET, V57, P87, DOI 10.1111/j.1469-1809.1993.tb00890.x; FRANCKE U, 1986, COLD SPRING HARB SYM, V51, P855, DOI 10.1101/SQB.1986.051.01.099; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; GILBERTDUSSARDIER B, 1995, AM J HUM GENET, V56, P542; GRIMM T, 1980, Z KARDIOL, V69, P168; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; HOGLUND P, 1994, AM J HUM GENET, V55, P747; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JEFFERSON RD, 1986, J MED GENET, V23, P474, DOI 10.1136/jmg.23.5.474; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; KOTZOT D, 1995, EUR J PEDIATR, V154, P477, DOI 10.1007/BF02029360; KUNZ J, 1994, GENOMICS, V22, P439, DOI 10.1006/geno.1994.1407; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOPEZRANGEL E, 1992, AM J MED GENET, V44, P720, DOI 10.1002/ajmg.1320440605; LOWERY MC, 1995, AM J HUM GENET, V57, P49; MARI A, 1995, HUM GENET, V96, P444; MARTIN NDT, 1984, ARCH DIS CHILD, V59, P605, DOI 10.1136/adc.59.7.605; MORRIS CA, 1993, AM J MED GENET, V47, P478, DOI 10.1002/ajmg.1320470409; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; OLSON TM, 1995, HUM MOL GENET, V4, P1677, DOI 10.1093/hmg/4.9.1677; PANKAU R, 1992, EUR J PEDIATR, V151, P751, DOI 10.1007/BF01959084; Peoples R, 1996, AM J HUM GENET, V58, P1370; PEREZ JLA, 1995, CYTOGENET CELL GENET, V70, P246; PEREZ JLA, 1994, J CLIN ENDOCR METAB, V78, P622; PEREZ JLA, 1996, P HUM GEN MAPP C MAR; Robinson WP, 1996, GENOMICS, V34, P17, DOI 10.1006/geno.1996.0237; SADLER LS, 1993, AM J MED GENET, V47, P468, DOI 10.1002/ajmg.1320470406; SINNOTT P, 1990, P NATL ACAD SCI USA, V87, P2107, DOI 10.1073/pnas.87.6.2107; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SUJANSKY E, 1995, P 16 DW SMITH WORKSH; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; THEODOSIOU AM, 1994, AM J HUM GENET, V55, P1209; TROMP G, 1991, NUCLEIC ACIDS RES, V19, P4314, DOI 10.1093/nar/19.15.4314-a; UDWIN O, 1990, DEV MED CHILD NEUROL, V32, P129, DOI 10.1111/j.1469-8749.1990.tb16912.x; VOSS R, 1989, AM J HUM GENET, V45, P373; WHITE RA, 1977, J PEDIATR-US, V91, P614, DOI 10.1016/S0022-3476(77)80516-7; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	53	131	135	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					781	792						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808592				2022-12-18	WOS:A1996VL28300006
J	PENTAO, L; LEWIS, RA; LEDBETTER, DH; PATEL, PI; LUPSKI, JR				PENTAO, L; LEWIS, RA; LEDBETTER, DH; PATEL, PI; LUPSKI, JR			MATERNAL UNIPARENTAL ISODISOMY OF CHROMOSOME-14 - ASSOCIATION WITH AUTOSOMAL RECESSIVE ROD MONOCHROMASY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; DISOMY; MARKERS; DISEASE; FILM	Rod monochromacy (complete congenital achromatopsia) is inherited as an autosomal recessive trait of unknown genetic location. The disorder is characterized by total absence of color discrimination because retinal cone photoreceptors do not develop systemic features do not occur. A 20-year-old white female with rod monochromacy presented with short stature (< 5th percentile), mild developmental delay, premature puberty, small hands and feet (length < 5th percentile), minimal dysmorphism, and a reproductive history of three consecutive first-trimester miscarriages. Cytogenetic analysis showed 45,XX,rob(14;14) in all 30 cells examined. Southern analysis of DNA from the patient and her phenotypically normal mother and two brothers (her father is deceased) ascertained the parental origin of the 14;14 Robertsonian translocation. Analysis of RFLPs associated with nine VNTR probes and two dinucleotide repeat polymorphisms from chromosome 14 demonstrated that the patient had inherited two copies of a single allele, each of which was maternally derived. A fully informative RFLP analysis of three probes from chromosome 14 enabled reconstruction of the paternal haplotype and showed the lack of any paternal contribution to the subject. These data are consistent with maternal isodisomy for all portions of chromosome 14 tested by these markers. This finding suggests that rod monochromacy maps to chromosome 14, and it emphasizes the importance of uniparental isodisomy to provide a putative chromosomal assignment of a gene for a rare autosomal recessive disorder.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT OPHTHALMOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine			Patel, Pragna/H-9129-2017	Patel, Pragna/0000-0003-3584-1072				CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P213; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; DECHEN J, 1990, AM J HUM GENET, V47, pA102; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FALLS HF, 1965, ARCH OPHTHALMOL-CHIC, V74, P610, DOI 10.1001/archopht.1965.00970040612005; FLYNN JT, 1981, INT OPHTHALMOL, V3, P91, DOI 10.1007/BF00133420; FRANCO B, 1991, HUM GENET, V87, P269, DOI 10.1007/BF00200903; FUJIMOTO E, 1988, NUCLEIC ACIDS RES, V16, P380, DOI 10.1093/nar/16.1.380; GHERMAN E, 1986, HUMAN CHROMOSOMES ST; GLICKSTEIN M, 1975, VISION RES, V15, P633, DOI 10.1016/0042-6989(75)90276-X; GRACIASESPINAL R, 1982, J MED GENET, V19, P465, DOI 10.1136/jmg.19.6.465; HAMERTON JL, 1975, CLIN GENET, V8, P223; HARRISON R, 1960, ARCH OPHTHALMOL-CHIC, V64, P685, DOI 10.1001/archopht.1960.01840010687010; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HOFF M, 1988, NUCLEIC ACIDS RES, V16, P10400, DOI 10.1093/nar/16.21.10400; HOFFMAN M, 1991, SCIENCE, V252, P1250, DOI 10.1126/science.1925535; JACKSON A, 1991, AM J HUM GENET, V49, pA2308; LASKEY RA, 1977, FEBS LETT, V82, P314, DOI 10.1016/0014-5793(77)80609-1; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; Lewis R.A., 1988, RETINAL DYSTROPHIES, P115; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUTY JA, 1991, NUCLEIC ACIDS RES, V19, P4308, DOI 10.1093/nar/19.15.4308; MARTIN C, 1988, NUCLEIC ACIDS RES, V16, P5220, DOI 10.1093/nar/16.11.5220; McKusick VA, 1990, MENDELIAN INHERITANC; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P381, DOI 10.1093/nar/16.1.381; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9364, DOI 10.1093/nar/16.19.9364; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P10073, DOI 10.1093/nar/15.23.10073; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P6257, DOI 10.1093/nar/16.13.6257; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P3120, DOI 10.1093/nar/16.7.3120; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P379, DOI 10.1093/nar/16.1.379; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P6255, DOI 10.1093/nar/16.13.6255; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NIIKAWA N, 1984, AM J HUM GENET, V36, P123; ORZECHOWSKI HD, 1987, NUCLEIC ACIDS RES, V15, P6310, DOI 10.1093/nar/15.15.6310; PATEL PI, 1990, AM J HUM GENET, V46, P801; SCHINZEL AA, 1991, AM J HUM GENET, V48, P424; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SURANI MA, 1988, TRENDS GENET, V4, P59, DOI 10.1016/0168-9525(88)90040-6; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x; VERRIEST G, 1969, Bulletin des Societes d'Ophtalmologie de France, V69, P901; VOSS R, 1989, AM J HUM GENET, V45, P373; WANG JCC, 1991, AM J HUM GENET, V48, P1069; WARBURTON D, 1988, AM J HUM GENET, V42, P215; ZHOU HG, 1983, CHINESE MED J-PEKING, V96, P625	48	131	132	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					690	699						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1347967				2022-12-18	WOS:A1992HL84800004
J	COGEN, PH; DANESHVAR, L; METZGER, AK; DUYK, G; EDWARDS, MSB; SHEFFIELD, VC				COGEN, PH; DANESHVAR, L; METZGER, AK; DUYK, G; EDWARDS, MSB; SHEFFIELD, VC			INVOLVEMENT OF MULTIPLE CHROMOSOME 17P LOCI IN MEDULLOBLASTOMA TUMORIGENESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P53 GENE; MUTATIONS; HETEROZYGOSITY; NEUROBLASTOMAS; CANCER	Loss of heterozygosity for sequences located on chromosome 17p in several tumor types is often associated with mutations in the tumor suppressor gene p53. We previously showed consistent deletion of chromosome 17p12-13.1 in medulloblastoma, a common childhood brain tumor. Using denaturing gradient gel electrophoresis and direct sequencing, we have detected p53 mutations in only two of 20 medulloblastoma specimens. Moreover, additional RFLP studies of these 20 specimens showed loss of heterozygosity at a more distal and distinct site 17p13.3. Deletion of 17p almost invariably signified a negative prognosis. Our results suggest that p53 mutations may contribute to the pathogenesis of medulloblastoma in relatively few cases. The consistent deletion of other discrete loci on 17p suggests that additional or alternative tumor suppressor genes may contribute to the tumor's phenotype.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT NEUROL SURG,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,BRAIN TUMOR RES CTR,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,DIV PEDIAT NEUROSURG,SAN FRANCISCO,CA 94143; UNIV IOWA,DIV MED GENET,DEPT PEDIAT,IOWA CITY,IA 52242	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa	COGEN, PH (corresponding author), EDITORIAL OFF,DEPT NEUROL SURG,1360 9TH AVE,SUITE 210,SAN FRANCISCO,CA 94122, USA.				NIGMS NIH HHS [GM07085] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007085] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; COGEN PH, 1990, GENOMICS, V8, P279, DOI 10.1016/0888-7543(90)90283-Z; COLES C, 1990, LANCET, V336, P761, DOI 10.1016/0140-6736(90)93236-I; FAIN PR, 1991, CYTOGENET CELL GENET, V57, P66; FEDER J, 1985, AM J HUM GENET, V37, P635; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; HALTINER M, 1985, NUCLEIC ACIDS RES, V13, P1015, DOI 10.1093/nar/13.3.1015; JAMES CD, 1988, CANCER RES, V48, P5546; KOPELSON G, 1983, CANCER, V51, P312, DOI 10.1002/1097-0142(19830115)51:2<312::AID-CNCR2820510225>3.0.CO;2-Y; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; METZGER AK, 1991, P NATL ACAD SCI USA, V88, P7825, DOI 10.1073/pnas.88.17.7825; MEYERS RM, 1987, METHOD ENZYMOL, V155, P501; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PACKER RJ, 1989, ONCOLOGY, V2, P35; RORKE LB, 1983, J NEUROPATH EXP NEUR, V42, P1, DOI 10.1097/00005072-198301000-00001; SAYLORS RL, 1991, CANCER RES, V51, P4721; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252	23	131	131	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					584	589						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1347196				2022-12-18	WOS:A1992HH97400018
J	EPSTEIN, CJ; KORENBERG, JR; ANNEREN, G; ANTONARAKIS, SE; AYME, S; COURCHESNE, E; EPSTEIN, LB; FOWLER, A; GRONER, Y; HURET, JL; KEMPER, TL; LOTT, IT; LUBIN, BH; MAGENIS, E; OPITZ, JM; PATTERSON, D; PRIEST, JH; PUESCHEL, SM; RAPOPORT, SI; SINET, PM; TANZI, RE; DELACRUZ, F				EPSTEIN, CJ; KORENBERG, JR; ANNEREN, G; ANTONARAKIS, SE; AYME, S; COURCHESNE, E; EPSTEIN, LB; FOWLER, A; GRONER, Y; HURET, JL; KEMPER, TL; LOTT, IT; LUBIN, BH; MAGENIS, E; OPITZ, JM; PATTERSON, D; PRIEST, JH; PUESCHEL, SM; RAPOPORT, SI; SINET, PM; TANZI, RE; DELACRUZ, F			PROTOCOLS TO ESTABLISH GENOTYPE-PHENOTYPE CORRELATIONS IN DOWN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADULT DOWNS-SYNDROME; ATLANTO-AXIAL INSTABILITY; QUANTITATIVE CT ANALYSIS; BRAIN-STEM RESPONSES; ALZHEIMERS-DISEASE; GLUCOSE-UTILIZATION; SYNDROME CHILDREN; DIFFERENT AGES; CHROMOSOME-21; REGION		NICHHD,MENTAL RETARDAT & DEV DISABIL BRANCH,EXECUT PLAZA N,ROOM 631,BETHESDA,MD 20892; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CANC RES INST,SAN FRANCISCO,CA 94143; CEDARS SINAI MED CTR,DEPT PEDIAT,LOS ANGELES,CA 90048; UNIV HOSP UPPSALA,DEPT CLIN GENET,UPPSALA,SWEDEN; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; HOP ENFANTS LA TIMONE,CTR GENET MED,F-13385 MARSEILLE 4,FRANCE; UNIV CALIF SAN DIEGO,SCH MED,DEPT NEUROSCI,LA JOLLA,CA 92093; HASKINS LABS INC,NEW HAVEN,CT 06511; WEIZMANN INST SCI,DEPT MOLEC GENET & VIROL,IL-76100 REHOVOT,ISRAEL; BOSTON CITY HOSP,DEPT NEUROL,BOSTON,MA 02118; CHR MIL,CNRS,URA 1338,PORTIERS,FRANCE; MASSACHUSETTS GEN HOSP,DEPT NEUROGENET,BOSTON,MA 02114; UNIV CALIF IRVINE,MED CTR,DEPT PEDIAT,IRVINE,CA 92717; CHILDRENS HOSP MED CTR NO CALIF,RES INST,OAKLAND,CA 94609; OREGON HLTH SCI UNIV,CTR CHILD DEV REHABIL,PORTLAND,OR 97201; SHODAIR CHILDRENS HOSP,HELENA,MT; ELEANOR ROOSEVELT INST CANC RES,DENVER,CO; EMORY UNIV,DEPT MED GENET,ATLANTA,GA 30322; RHODE ISL HOSP,CTR CHILD DEV,PROVIDENCE,RI 02902; BROWN UNIV,PROGRAM MED,PROVIDENCE,RI 02912; NIA,NEUROSCI LAB,BETHESDA,MD 20892; HOP NECKER ENFANTS MALAD,BIOCHIM GENET LAB,CNRS,URA 1335,F-75730 PARIS 15,FRANCE	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cedars Sinai Medical Center; Uppsala University; Uppsala University Hospital; Johns Hopkins University; Johns Hopkins University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of California System; University of California San Diego; Yale University; Haskins Laboratories; Weizmann Institute of Science; Boston Medical Center; Centre National de la Recherche Scientifique (CNRS); Harvard University; Massachusetts General Hospital; University of California System; University of California Irvine; Oregon Health & Science University; Emory University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS)			Ayme, Segolene/ABE-2545-2020; Tanzi, Rudolph/AAE-9622-2019; Antonarakis, Stylianos/N-8866-2014	Tanzi, Rudolph/0000-0002-7032-1454; Antonarakis, Stylianos/0000-0001-8907-5823	NATIONAL CANCER INSTITUTE [R01CA027903, R37CA027903, R01CA044446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG008938] Funding Source: NIH RePORTER; NCI NIH HHS [CA-44446, CA-27903] Funding Source: Medline; NIA NIH HHS [AG-08938] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; BALDINI A, 1991, GENOMICS, V9, P770, DOI 10.1016/0888-7543(91)90374-N; Bayley, 1993, BAYLEY SCALES INFANT; Beeghly M., 1990, CHILDREN DOWN SYNDRO, P329, DOI DOI 10.1017/CBO9780511581786.011; BENDA CE, 1971, PATHOLOGY NERVOUS SY, V2, P1361; BILOVSKY D, 1965, AM J MENT DEF, V70, P78; BLOUIN JL, 1990, AM J HUM GENET, V46, P518; BOLLING D R, 1971, Clinical Genetics, V2, P163; BORGAONKAR DS, 1971, JOHNS HOPKINS MED J, V128, P141; Brown R., 1973, 1 LANGUAGE; BURACK JA, 1988, J CHILD PSYCHOL PSYC, V29, P765, DOI 10.1111/j.1469-7610.1988.tb00752.x; CARRITT B, 1989, CYTOGENET CELL GENET, V51, P362; Carrow-Woolfolk E., 2014, TEST AUDITORY COMPRE; CHETTOUH Z, 1990, BIOTECHNIQUES, V9, P162; Corsi P., 1972, THESIS MCGILL U MONT, V34; COURCHESNE E, 1977, SCIENCE, V197, P589, DOI 10.1126/science.877575; Cowie V.A., 1970, STUDY EARLY DEV MONG; COX DR, 1990, CYTOGENET CELL GENET, V55, P235, DOI 10.1159/000133017; COX DR, 1990, SCIENCE, V250, P246; CROME L, 1966, J MENT DEFIC RES, V10, P69; CRONK C, 1988, PEDIATRICS, V81, P102; CROSLEY PA, 1989, J COMMUN DISORD, V22, P151, DOI 10.1016/0021-9924(89)90013-0; Dunn L. M., 2007, PEABODY PICTURE VOCA, DOI DOI 10.1037/T15144-000; Epstein C.J, 1986, CONSEQUENCES CHROMOS; EPSTEIN CJ, 1990, AM J MED GENET S, V7, P31; EVANS D, 1977, J MENT DEFIC RES, V21, P103; FOWLER A, 1988, PSYCHOBIOLOGY DOWN S; Fowler A., 1990, CHILDREN DOWN SYNDRO, P302, DOI [DOI 10.1017/CB09780511581786.010, 10.1017/CBO9780511581786.010]; FUDALA J, 1986, ARIZONA TEST ARTICUL; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GERBER A, 1984, TEMPLE U SHORT SYNTA; HAXBY JV, 1989, J MENT DEFIC RES, V33, P193; HORWITZ B, 1990, J MENT DEFIC RES, V34, P237; Hunt, 1975, ASSESSMENT INFANCY O; JERVIS GA, 1948, AM J PSYCHIAT, V105, P102, DOI 10.1176/ajp.105.2.102; Karrer R, 1988, EARLY IDENTIFICATION, P210; KAUFMAN AS, 1983, ADM SCORING MANUAL K; Kemper T.L., 1988, PSYCHOBIOLOGY DOWN S, P269; Kirk S., 1968, TEST ILLINOIS APTITU; KORENBERG J R, 1989, American Journal of Human Genetics, V45, pA79; KORENBERG J R, 1988, American Journal of Human Genetics, V43, pA110; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KORENBERG JR, 1991, MORPHOGENESIS DOWN S; LAWRENCE JB, 1990, GENOME ANAL, V1, P1; LINCOLN AJ, 1985, AM J MENT DEF, V89, P403; LOTT IT, 1982, ANN NY ACAD SCI, V396, P15, DOI 10.1111/j.1749-6632.1982.tb26840.x; MCCARTHY JJ, 1965, THESIS U ILLINOIS UR; MCCORMICK M K, 1988, American Journal of Human Genetics, V43, pA90; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; McCoy E. E., 1987, ONCOLOGY IMMUNOLOGY; Miller J. F., 1988, PSYCHOBIOLOGY DOWN S, P167; Miller J. F., 1981, ASSESSING LANGUAGE P; MOORE EE, 1977, AM J HUM GENET, V29, P389; MUIR WJ, 1988, J MENT DEFIC RES, V32, P455; NEWCOMBER PL, 1988, TEST LANGUAGE DEV PR; OLIVER C, 1986, PSYCHOL MED, V16, P307, DOI 10.1017/S0033291700009120; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; Prechtl H, 1977, NEUROLOGICAL EXAMINA; PREUS M, 1983, CLIN GENET, V23, P1; PREUS M, 1984, CLIN GENET, V26, P52; PUESCHEL SM, 1987, PEDIATRICS, V80, P555; PUESCHEL SM, 1987, J PEDIATR-US, V110, P515, DOI 10.1016/S0022-3476(87)80541-3; PUESCHEL SM, 1980, DOWN SYNDROME COMPRE; PUESCHEL SM, 1982, DOWN SYNDROME ADV BI; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; RAHMANI Z, 1990, AM J MED GENET, V7, P98; Reynell J., 1977, REYNELL DEV LANGUAGE; ROCHE AF, 1966, ACTA NEUROL SCAND, V42, P62, DOI 10.1111/j.1600-0404.1966.tb05985.x; ROSS MH, 1984, NEUROLOGY, V30, P909; SCARBOROUGH HS, IN PRESS APPL PSYCHO; SCHAPIRO M B, 1989, Neurology, V39, P169; SCHAPIRO MB, 1988, NEUROLOGY, V38, P938, DOI 10.1212/WNL.38.6.938; SCHAPIRO MB, 1987, NEUROLOGY, V37, P1424, DOI 10.1212/WNL.37.8.1424; SCHAPIRO MB, 1989, NEUROLOGY, V39, P1349, DOI 10.1212/WNL.39.10.1349; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; SHRIBERG L, 1982, J SPEECH HEAR DISORD, V47, P98; SHRIBERG LD, 1986, J SPEECH HEAR DISORD, V51, P140, DOI 10.1044/jshd.5102.140; SOKAL RR, 1974, SCIENCE, V185, P1115, DOI 10.1126/science.185.4157.1115; SOMMERS RK, 1977, AM J MENT DEF, V82, P44; Sparrow SS, 1984, VINELAND ADAPTIVE BE; SQUIRES N, 1986, EAR HEARING, V7, P83, DOI 10.1097/00003446-198604000-00006; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; TANZI RE, 1987, SCIENCE, V238, P666, DOI 10.1126/science.2890207; VARNHAGEN CK, 1987, AM J MENT RETARD, V91, P398; VIEGASPEQUIGNOT E, 1978, ANN GENET-PARIS, V21, P122; Wechsler D., 1974, MANUAL WECHSLER INTE; WIDEN JE, 1987, AM J MENT RETARD, V91, P472; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; YOUNG EC, 1983, PATTERNED ELICITATIO; YUNIS JJ, 1981, HUM PATHOL, V12, P540, DOI 10.1016/S0046-8177(81)80068-8; ZELLWEGER H, 1977, HDB CLIN NEUROLOGY, V31, P367; 1990, AM J MED GENET S, V7	92	131	134	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					207	235						29	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	1829580				2022-12-18	WOS:A1991FW51100024
J	SAKURABA, H; OSHIMA, A; FUKUHARA, Y; SHIMMOTO, M; NAGAO, Y; BISHOP, DF; DESNICK, RJ; SUZUKI, Y				SAKURABA, H; OSHIMA, A; FUKUHARA, Y; SHIMMOTO, M; NAGAO, Y; BISHOP, DF; DESNICK, RJ; SUZUKI, Y			IDENTIFICATION OF POINT MUTATIONS IN THE ALPHA-GALACTOSIDASE-A GENE IN CLASSICAL AND ATYPICAL HEMIZYGOTES WITH FABRY DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,DIV MED & MOLEC GENET,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	SAKURABA, H (corresponding author), TOKYO METROPOLITAN INST MED SCI,DEPT CLIN GENET,3-18-22 HONKOMAGOME,BUNKYO KU,TOKYO 113,JAPAN.		Bishop, David F./X-4102-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034045] Funding Source: NIH RePORTER; NIDDK NIH HHS [5 RO1 DK34045] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BACH G, 1982, CLIN GENET, V21, P59; BERNSTEIN HS, 1989, J CLIN INVEST, V83, P1390, DOI 10.1172/JCI114027; BISHOP DF, 1981, AM J HUM GENET, V33, pA71; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; BISHOP DF, 1986, P NATL ACAD SCI USA, V83, P4859, DOI 10.1073/pnas.83.13.4859; BISHOP DF, 1988, LIPID STORAGE DISORD, P809; CLARKE JTR, 1971, NEW ENGL J MED, V284, P233, DOI 10.1056/NEJM197102042840503; DESNICK RJ, 1987, ENZYME, V38, P54, DOI 10.1159/000469190; Desnick RJBD., 1989, METABOLIC BASIS INHE, V6, P1751; KOBAYASHI T, 1985, J NEUROL SCI, V67, P179, DOI 10.1016/0022-510X(85)90114-5; KOIDE T, 1990, FEBS LETT, V259, P353, DOI 10.1016/0014-5793(90)80046-L; KORNREICH R, 1989, NUCLEIC ACIDS RES, V17, P3301, DOI 10.1093/nar/17.8.3301; KORNREICH R, 1990, J BIOL CHEM, V265, P9139; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maniatis T., 1982, MOL CLONING; OSHIMA A, 1988, BIOCHEM BIOPH RES CO, V157, P238, DOI 10.1016/S0006-291X(88)80038-X; RIETRA PJG, 1976, J MOL MED, V190, P237; ROMEO G, 1975, BIOCHEM GENET, V13, P615, DOI 10.1007/BF00484919; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SWEELEY CC, 1963, J BIOL CHEM, V238, P3148	23	131	143	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1990	47	5					784	789						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EE940	2171331				2022-12-18	WOS:A1990EE94000003
J	NAKASE, H; MORAES, CT; RIZZUTO, R; LOMBES, A; DIMAURO, S; SCHON, EA				NAKASE, H; MORAES, CT; RIZZUTO, R; LOMBES, A; DIMAURO, S; SCHON, EA			TRANSCRIPTION AND TRANSLATION OF DELETED MITOCHONDRIAL GENOMES IN KEARNS-SAYRE SYNDROME - IMPLICATIONS FOR PATHOGENESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DEPT NEUROL,630 W 168TH ST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032	Columbia University; Columbia University			Lombes, Anne/G-4684-2014; Rizzuto, Rosario/B-6312-2008; Moraes, Carlos/AAT-3818-2021	Lombes, Anne/0000-0002-9064-0399; Rizzuto, Rosario/0000-0001-7044-5097	NINDS NIH HHS [NS11766] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, P01NS011766] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADOUTTE A, 1973, BIOCHIMIE, V55, P793, DOI 10.1016/S0300-9084(73)80031-8; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BERTRAND H, 1985, CELL, V41, P877, DOI 10.1016/S0092-8674(85)80068-4; BERTRAND H, 1986, CELL, V47, P829, DOI 10.1016/0092-8674(86)90525-8; BOUTRY M, 1987, NATURE, V328, P340, DOI 10.1038/328340a0; BURNETT KG, 1981, J CELL BIOL, V90, P108, DOI 10.1083/jcb.90.1.108; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CLARKWALKER GD, 1975, P NATL ACAD SCI USA, V72, P372, DOI 10.1073/pnas.72.1.372; DAVIS LG, 1986, BASIC METHODS MOL BI, P47; DITTA G, 1977, NATURE, V268, P64, DOI 10.1038/268064a0; EMR SD, 1986, J CELL BIOL, V102, P523, DOI 10.1083/jcb.102.2.523; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HAYASHI JI, 1986, CANCER RES, V46, P4001; HAYASHI JI, 1985, EXP CELL RES, V160, P387, DOI 10.1016/0014-4827(85)90185-5; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HURT EC, 1984, EMBO J, V3, P3149, DOI 10.1002/j.1460-2075.1984.tb02272.x; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MARIOTTINI P, 1986, P NATL ACAD SCI USA, V83, P1563, DOI 10.1073/pnas.83.6.1563; MERLE P, 1980, EUR J BIOCHEM, V105, P499, DOI 10.1111/j.1432-1033.1980.tb04525.x; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6; MORGENS PH, 1984, NUCLEIC ACIDS RES, V12, P5665, DOI 10.1093/nar/12.14.5665; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; OZIASAKINS P, 1988, CURR GENET, V13, P241, DOI 10.1007/BF00387770; PALVA TK, 1985, FEBS LETT, V192, P267, DOI 10.1016/0014-5793(85)80122-8; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SHANSKE S, IN PRESS NEUROLOGY; ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WHITE FA, 1984, MOL GEN GENET, P453; WILSON GN, 1978, P NATL ACAD SCI USA, V75, P5367, DOI 10.1073/pnas.75.11.5367; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZUPANC ML, 1989, ANN NEUROL, V26, P436	41	131	133	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					418	427						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	1689952				2022-12-18	WOS:A1990CT66800003
J	THOMAS, IT; FRIAS, JL; CANTU, ES; LAFER, CZ; FLANNERY, DB; GRAHAM, JG				THOMAS, IT; FRIAS, JL; CANTU, ES; LAFER, CZ; FLANNERY, DB; GRAHAM, JG			ASSOCIATION OF PIGMENTARY ANOMALIES WITH CHROMOSOMAL AND GENETIC MOSAICISM AND CHIMERISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV NEBRASKA,MED CTR,DEPT PEDIAT,OMAHA,NE 68105; UNIV FLORIDA,RC PHILIPS CYTOGENET LAB,GAINESVILLE,FL 32611; UNIV FLORIDA,DEPT PEDIAT,DIV GENET,GAINESVILLE,FL 32611; NEMOURS CHILDRENS CLIN,DEPT PEDIAT,DIV GENET,JACKSONVILLE,FL; MED COLL GEORGIA,AUGUSTA,GA 30912; CEDARS SINAI MED CTR,LOS ANGELES,CA 90048	University of Nebraska System; University of Nebraska Medical Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Georgia; Augusta University; Cedars Sinai Medical Center			Flannery, David/O-6719-2019					ABE T, 1978, ANN GENET-PARIS, V21, P109; ATNIP RL, 1971, CYTOGENETICS, V10, P305, DOI 10.1159/000130150; BERNSTEIN R, 1979, J MED GENET, V16, P254, DOI 10.1136/jmg.16.4.254; BLASCHKO A, 1901, NERVENVETEILUNG HAUT; BLOCH B, 1926, SCHWEIZ MED WSCHR, V56, P404; CANTU ED, IN PRESS CLIN GENET; CAREY JC, 1986, P GREENWOOD GENETIC, V5, P131; CHEMKE J, 1983, J MED GENET, V20, P135, DOI 10.1136/jmg.20.2.135; COREY MJ, 1978, AM J HUM GENET, V19, P378; DELOZIERBLANCHET CD, 1984, CLIN GENET, V25, P84; DONNAI D, 1988, J MED GENET, V25, P809, DOI 10.1136/jmg.25.12.809; DONNAI D, 1986, LANCET, V2, P1443; FERRIER P, 1964, LANCET, V1, P80; FINDLAY GH, 1980, BRIT J DERMATOL, V103, P489, DOI 10.1111/j.1365-2133.1980.tb01663.x; FITZGERALD PH, 1979, CLIN GENET, V15, P89; FLANNERY D B, 1985, American Journal of Human Genetics, V37, pA93; FUJIMOTO A, 1985, AM J MED GENET, V22, P333, DOI 10.1002/ajmg.1320220217; FULTON AB, 1977, AM J OPHTHALMOL, V84, P859, DOI 10.1016/0002-9394(77)90510-4; HALL BD, 1985, P GREENWOOD GENET CE, V5, P132; HAPPLE R, 1985, CLIN GENET, V27, P468; HAPPLE R, 1985, HUM GENET, V70, P200; Happle R, 1987, Curr Probl Dermatol, V17, P5; Hersh J H, 1983, J Clin Dysmorphol, V1, P20; HUNTER AGW, 1985, CLIN GENET, V28, P47; ITO M, 1951, JPN J DERMATOL, V62, P31; JACKSON R, 1976, BRIT J DERMATOL, V95, P349, DOI 10.1111/j.1365-2133.1976.tb00835.x; JOHNSON VP, 1979, AM J MED GENET, V3, P331, DOI 10.1002/ajmg.1320030404; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MINTZ B, 1967, P NATL ACAD SCI USA, V58, P344, DOI 10.1073/pnas.58.1.344; MINTZ B, 1974, ANNU REV GENET, V8, P411, DOI 10.1146/annurev.ge.08.120174.002211; MINTZ B, 1970, CONTROL MECHANISMS E, P15; MOORE KL, 1973, DEV HUMAN; NERI G, 1983, AM J MED GENET, V14, P307, DOI 10.1002/ajmg.1320140211; Pallister P D, 1977, Birth Defects Orig Artic Ser, V13, P103; REYNOLDS JF, 1987, AM J MED GENET, V27, P257, DOI 10.1002/ajmg.1320270204; ROTT HD, 1986, LANCET, V2, P343; SCHMIDT R, 1981, J MED GENET, V18, P304, DOI 10.1136/jmg.18.4.304; TEPLITZ RL, 1967, J PEDIATR-US, V70, P936, DOI 10.1016/S0022-3476(67)80266-X; THARAPEL AT, 1983, ANN GENET-PARIS, V26, P229; THOMAS IT, 1987, P GREENWOOD GENET CE, V6, P105; THOMAS IT, 1987, LANCET, V2, P343; THOMAS JT, 1987, PEDIATR RES, V21, pA294; TURLEAU C, 1986, HUM GENET, V74, P185, DOI 10.1007/BF00282090; VARELA M A, 1969, Journal of Medical Genetics, V6, P334, DOI 10.1136/jmg.6.3.334; WARBURTON D, 1987, AM J MED GENET, V27, P275, DOI 10.1002/ajmg.1320270205; WERTELECKI W, 1986, AM J MED GENET, V23, P739, DOI 10.1002/ajmg.1320230302; WILSON WG, 1983, AM J MED GENET, V16, P131, DOI 10.1002/ajmg.1320160119; ZUELZER WW, 1964, AM J HUM GENET, V16, P38	48	131	131	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					193	205						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2667350				2022-12-18	WOS:A1989AK38000002
J	ELSTON, RC; SOBEL, E				ELSTON, RC; SOBEL, E			SAMPLING CONSIDERATIONS IN THE GATHERING AND ANALYSIS OF PEDIGREE DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,GENET CURRICULUM,CHAPEL HILL,NC 27514; FRANCIS & SOBEL ASSOCIATES,SANTA FE,NM 87502	University of North Carolina; University of North Carolina Chapel Hill	ELSTON, RC (corresponding author), UNIV N CAROLINA,DEPT BIOSTAT,CHAPEL HILL,NC 27514, USA.							ELANDTJOHNSON RC, 1970, AM J HUM GENET, V22, P129; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; ELSTON RC, 1975, AM J HUM GENET, V27, P31; Fisher RA, 1934, ANN EUGENIC, V6, P13, DOI 10.1111/j.1469-1809.1934.tb02105.x; GO RCP, 1978, AM J HUM GENET, V30, P28; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1969, COMPUTER APPLICATION, P129; STENE J, 1977, BIOMETRICS, V33, P523, DOI 10.2307/2529367	11	131	131	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					62	69						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR115	373427				2022-12-18	WOS:A1979GR11500008
J	CHUNG, CS; MYRIANTHOPOULOS, NC				CHUNG, CS; MYRIANTHOPOULOS, NC			RACIAL AND PRENATAL FACTORS IN MAJOR CONGENITAL MALFORMATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALBERMAN ED, 1965, ARCH DIS CHILD, V40, P548, DOI 10.1136/adc.40.213.548; ALTEMUS LA, 1965, PEDIATRICS, V36, P56; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; COFFEY V P, 1957, Br J Prev Soc Med, V11, P174; DORN H F, 1955, J Chronic Dis, V1, P638, DOI 10.1016/0021-9681(55)90221-6; DRISCOLL SG, 1960, AM J DIS CHILD, V100, P818, DOI 10.1001/archpedi.1960.04020040820004; DUNN PM, 1964, LANCET, V2, P644; Eastman NJ, 1966, WILLIAMS OBSTET, V13, P1010; EDWARDS J H, 1958, Br J Prev Soc Med, V12, P115; EDWARDS JH, 1964, 2 INT C CONG MALF IN; ERHARDT CL, 1961, 1 INT C CONG MALF; Fisher RA, 1938, ANN EUGENIC, V8, P376, DOI 10.1111/j.1469-1809.1938.tb02189.x; Fogh-Andersen P., 1943, OPERA EX DOMO BIOL HEREDITARIAE HUMANAE UNIV HAFNIENSIS, V4, P1; GITTELSOHN AM, 1965, GENETICS EPIDEMIOLOG; HAGBARD L, 1956, ACTA OBSTET GYNEC S1, V35; HEWITT D, 1965, GENETICS EPIDEMIOLOG; IVY R H, 1962, Plast Reconstr Surg Transplant Bull, V30, P581, DOI 10.1097/00006534-196211000-00005; MCINTOSH R, 1954, PEDIATRICS, V14, P505; MI MP, 1965, ACTA GENET STAT MED, V15, P177; MORTON NE, 1967, GENETICS INTERRACIAL; NEEL J, 1965, GENETICS EPIDEMIO ED; NEEL JV, 1958, AM J HUM GENET, V10, P398; Neel JV, 1954, HUMAN HEREDITY; PEDERSEN LM, 1964, LANCET, V1, P1124; PENROSE LS, 1957, J MENT DEFIC RES, V1, P4; RUBIN A, 1958, J PEDIATR-US, V53, P579, DOI 10.1016/S0022-3476(58)80148-1; SALDANHA PH, 1964, 2 INT C CONG MALF IN; WALKER J, 1961, 1 INT C CONG MALF; WALLACE HM, 1953, PEDIATRICS, V12, P525; WILSON JSP, 1966, LANCET, V2, P940; WORCESTER J, 1964, BIOMETRICS, V20, P840, DOI 10.2307/2528134; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P445, DOI 10.1302/0301-620X.46B3.445	32	131	132	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1968	20	1					44	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5889	4295083				2022-12-18	WOS:A1968A588900003
